RESULT_COUNT: 5722,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
VRX,VRX:CT,BBG000DC8S17,Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options,2017-10-20 12:43:12 +0000,https://finance.yahoo.com/news/implied-volatility-surging-valeant-pharmaceuticals-124312798.html?.tsrc=rss,Investors in Valeant Pharmaceuticals (VRX) need to pay close attention to the stock based on moves in the options market lately.
VRX,VRX:US,BBG000DLFM21,Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options,2017-10-20 12:43:12 +0000,https://finance.yahoo.com/news/implied-volatility-surging-valeant-pharmaceuticals-124312798.html?.tsrc=rss,Investors in Valeant Pharmaceuticals (VRX) need to pay close attention to the stock based on moves in the options market lately.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals International is Now Oversold (VRX),2017-10-19 18:46:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J5LAPBE1FuA/valeant-pharmaceuticals-international-is-now-oversold-vrx-cm862171,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals International is Now Oversold (VRX),2017-10-19 18:46:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J5LAPBE1FuA/valeant-pharmaceuticals-international-is-now-oversold-vrx-cm862171,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:CT,BBG000DC8S17,3 Reasons to Stay Away From Valeant Pharmaceuticals Intl Inc Stock,2017-10-19 15:47:35 +0000,https://finance.yahoo.com/news/3-reasons-stay-away-valeant-154735608.html?.tsrc=rss,"During the past six months or so, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been regaining some of its footing.  CEO Joe Papa has wasted little time in cutting costs, streamlining the business and unloading of VRX stock’s assets.  Since April, VRX stock has rallied from $8.60 to $12.81."
VRX,VRX:US,BBG000DLFM21,3 Reasons to Stay Away From Valeant Pharmaceuticals Intl Inc Stock,2017-10-19 15:47:35 +0000,https://finance.yahoo.com/news/3-reasons-stay-away-valeant-154735608.html?.tsrc=rss,"During the past six months or so, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been regaining some of its footing.  CEO Joe Papa has wasted little time in cutting costs, streamlining the business and unloading of VRX stock’s assets.  Since April, VRX stock has rallied from $8.60 to $12.81."
VRX,VRX:US,BBG000DLFM21,Buy More Shopify Inc (US) While It’s Down,2017-10-19 14:52:14 +0000,https://finance.yahoo.com/news/buy-more-shopify-inc-us-145214662.html?.tsrc=rss,"Is it time to shop-the-drop in Shopify Inc (US) (NYSE:SHOP)?  If, like me, you demand a good deal but also worry about defective merchandise, then a bull call spread makes plenty of sense in SHOP stock.  Andrew Left of Citron Research recently targeted Shopify."
VRX,VRX:CT,BBG000DC8S17,Buy More Shopify Inc (US) While It’s Down,2017-10-19 14:52:14 +0000,https://finance.yahoo.com/news/buy-more-shopify-inc-us-145214662.html?.tsrc=rss,"Is it time to shop-the-drop in Shopify Inc (US) (NYSE:SHOP)?  If, like me, you demand a good deal but also worry about defective merchandise, then a bull call spread makes plenty of sense in SHOP stock.  Andrew Left of Citron Research recently targeted Shopify."
VRX,VRX:CT,BBG000DC8S17,GURU's Underlying Holdings Could Mean 10% Gain Potential,2017-10-19 14:48:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/scuHPQ0QAMY/gurus-underlying-holdings-could-mean-10-gain-potential-cm861879,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:US,BBG000DLFM21,GURU's Underlying Holdings Could Mean 10% Gain Potential,2017-10-19 14:48:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/scuHPQ0QAMY/gurus-underlying-holdings-could-mean-10-gain-potential-cm861879,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:US,BBG000DLFM21,"Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi",2017-10-19 13:00:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-acorda-130001205.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi"
VRX,VRX:CT,BBG000DC8S17,"Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi",2017-10-19 13:00:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-acorda-130001205.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-10-19 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_BNd5L_NaKI/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20171019-00992,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-10-19 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_BNd5L_NaKI/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20171019-00992,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Pricing Pressure, Competition Remain Headwinds for Pharma Stocks",2017-10-18 20:59:08 +0000,https://finance.yahoo.com/news/pricing-pressure-competition-remain-headwinds-205908706.html?.tsrc=rss,"Pricing Pressure, Competition Remain Headwinds for Pharma Stocks"
VRX,VRX:US,BBG000DLFM21,"Pricing Pressure, Competition Remain Headwinds for Pharma Stocks",2017-10-18 20:59:08 +0000,https://finance.yahoo.com/news/pricing-pressure-competition-remain-headwinds-205908706.html?.tsrc=rss,"Pricing Pressure, Competition Remain Headwinds for Pharma Stocks"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-10-18 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qzuLXcwT3jA/canadian-stocks-are-paring-early-gains--canadian-commentary-20171018-00902,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-10-18 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qzuLXcwT3jA/canadian-stocks-are-paring-early-gains--canadian-commentary-20171018-00902,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing After Major Aerospace Deal - Canadian Commentary,2017-10-17 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KptP7An7E1w/canadian-stocks-are-climbing-after-major-aerospace-deal--canadian-commentary-20171017-00964,Canadian Stocks Are Climbing After Major Aerospace Deal - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing After Major Aerospace Deal - Canadian Commentary,2017-10-17 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KptP7An7E1w/canadian-stocks-are-climbing-after-major-aerospace-deal--canadian-commentary-20171017-00964,Canadian Stocks Are Climbing After Major Aerospace Deal - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Shopify Inc (US) (SHOP) Stock: Has Citron Uncovered a Numbers Scheme?,2017-10-17 09:15:27 +0000,https://finance.yahoo.com/news/shopify-inc-us-shop-stock-091527675.html?.tsrc=rss,"Shopify Inc (US) (NYSE:SHOP) shares have lost about 17% of their value since short-sellers Citron Research issued a scathing report that called it an affiliate marketing scam comparable to Herbalife Ltd. (NYSE:HLF).  The Canadian e-commerce software company should have called Citron’s claim a compliment, since Herbalife’s value has doubled since hedge fund manager Bill Ackman put out his famous short call almost five years ago.  To me, the Citron report looks scary enough to act on. Other InvestorPlace writers disagree."
VRX,VRX:CT,BBG000DC8S17,Shopify Inc (US) (SHOP) Stock: Has Citron Uncovered a Numbers Scheme?,2017-10-17 09:15:27 +0000,https://finance.yahoo.com/news/shopify-inc-us-shop-stock-091527675.html?.tsrc=rss,"Shopify Inc (US) (NYSE:SHOP) shares have lost about 17% of their value since short-sellers Citron Research issued a scathing report that called it an affiliate marketing scam comparable to Herbalife Ltd. (NYSE:HLF).  The Canadian e-commerce software company should have called Citron’s claim a compliment, since Herbalife’s value has doubled since hedge fund manager Bill Ackman put out his famous short call almost five years ago.  To me, the Citron report looks scary enough to act on. Other InvestorPlace writers disagree."
VRX,VRX:US,BBG000DLFM21,Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes,2017-10-17 00:34:00 +0000,https://finance.yahoo.com/news/valeant-one-subsidiaries-announce-early-003400142.html?.tsrc=rss,"LAVAL, Quebec, Oct. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"") announced today the results to date of the pending cash tender offers (the ""Tender Offers"") by Valeant and Valeant Pharmaceuticals International (""VPI,"" and together with Valeant, the ""Offerors""), a wholly-owned subsidiary of Valeant, to purchase up to $1,000,000,000 aggregate principal amount (the ""Aggregate Maximum Purchase Amount"") of their respective outstanding notes listed in the table below (collectively, the ""Notes""), as well as the anticipated early settlement date for the Tender Offers on October 17, 2017 (the ""Early Settlement Date"").  Valeant is the Offeror for the notes issued by it, and VPI is the Offeror for the notes issued by it."
VRX,VRX:CT,BBG000DC8S17,Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes,2017-10-17 00:34:00 +0000,https://finance.yahoo.com/news/valeant-one-subsidiaries-announce-early-003400142.html?.tsrc=rss,"LAVAL, Quebec, Oct. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"") announced today the results to date of the pending cash tender offers (the ""Tender Offers"") by Valeant and Valeant Pharmaceuticals International (""VPI,"" and together with Valeant, the ""Offerors""), a wholly-owned subsidiary of Valeant, to purchase up to $1,000,000,000 aggregate principal amount (the ""Aggregate Maximum Purchase Amount"") of their respective outstanding notes listed in the table below (collectively, the ""Notes""), as well as the anticipated early settlement date for the Tender Offers on October 17, 2017 (the ""Early Settlement Date"").  Valeant is the Offeror for the notes issued by it, and VPI is the Offeror for the notes issued by it."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Celgene Corporation and Valeant Pharmaceuticals,2017-10-16 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000313.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 16, 2017 / Shares of Celgene Corporation saw a small gain on Friday despite any news, while Valeant Pharmaceuticals saw a loss of roughly 3% despite not having any significant ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Celgene Corporation and Valeant Pharmaceuticals,2017-10-16 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000313.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 16, 2017 / Shares of Celgene Corporation saw a small gain on Friday despite any news, while Valeant Pharmaceuticals saw a loss of roughly 3% despite not having any significant ..."
VRX,VRX:CT,BBG000DC8S17,Future Outlook Of The Healthcare Industry And Valeant Pharmaceuticals International Inc (VRX),2017-10-14 01:37:32 +0000,https://finance.yahoo.com/news/future-outlook-healthcare-industry-valeant-013732096.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc (NYSE:VRX), a CAD$4.82B mid-cap, is a healthcare company operating in an industry, which has experienced tailwinds from issues such as higher demand driven by an agingRead More..."
VRX,VRX:US,BBG000DLFM21,Future Outlook Of The Healthcare Industry And Valeant Pharmaceuticals International Inc (VRX),2017-10-14 01:37:32 +0000,https://finance.yahoo.com/news/future-outlook-healthcare-industry-valeant-013732096.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc (NYSE:VRX), a CAD$4.82B mid-cap, is a healthcare company operating in an industry, which has experienced tailwinds from issues such as higher demand driven by an agingRead More..."
VRX,VRX:US,BBG000DLFM21,Valeant: A Problem…Or Just More Noise?,2017-10-13 19:08:00 +0000,http://finance.yahoo.com/r/060f0825-3962-3b57-b5d4-d186a2d30c00/why-valeant-is-dropping-1507913812?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"October has been relatively quiet for Valeant Pharmaceuticals Internation  (VRX), with little in the way of attention getting news.  Yes, there have been some small successes in drug trials, and even a positive note from a Deutsche Bank analyst.  Today, however, Valeant's stock has more than doubled its October loss after Wells Fargo's David Maris  raised concerns about a lawsuit filed by  Depomed (DEPO) over an alleged $20 million in unpaid royalties: In the grand scheme of Valeant’s issues, an unpaid $20 million bill barely rises to the level of investor concern."
VRX,VRX:CT,BBG000DC8S17,Valeant: A Problem…Or Just More Noise?,2017-10-13 19:08:00 +0000,http://finance.yahoo.com/r/060f0825-3962-3b57-b5d4-d186a2d30c00/why-valeant-is-dropping-1507913812?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"October has been relatively quiet for Valeant Pharmaceuticals Internation  (VRX), with little in the way of attention getting news.  Yes, there have been some small successes in drug trials, and even a positive note from a Deutsche Bank analyst.  Today, however, Valeant's stock has more than doubled its October loss after Wells Fargo's David Maris  raised concerns about a lawsuit filed by  Depomed (DEPO) over an alleged $20 million in unpaid royalties: In the grand scheme of Valeant’s issues, an unpaid $20 million bill barely rises to the level of investor concern."
VRX,VRX:CT,BBG000DC8S17,Valeant Reports Positive Results on Psoriasis Drug Siliq,2017-10-13 19:01:07 +0000,https://finance.yahoo.com/news/valeant-reports-positive-results-psoriasis-190107852.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced encouraging results from the long-term phase III extension study, AMAGINE-2 on psoriasis drug Siliq."
VRX,VRX:US,BBG000DLFM21,Valeant Reports Positive Results on Psoriasis Drug Siliq,2017-10-13 19:01:07 +0000,https://finance.yahoo.com/news/valeant-reports-positive-results-psoriasis-190107852.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced encouraging results from the long-term phase III extension study, AMAGINE-2 on psoriasis drug Siliq."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals International Breaks Below 200-Day Moving Average - Notable for VRX,2017-10-13 16:14:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/43voaLsZ3I0/valeant-pharmaceuticals-international-breaks-below-200-day-moving-average-notable-for-vrx-cm859436,In trading on Friday shares of Valeant Pharmaceuticals International Inc Symbol VRX crossed below their 200 day moving average of 13 67 changing hands as low as 13 31 per share Valeant Pharmaceuticals International Inc shares are currently trading down about 3 2 on the day The chart
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals International Breaks Below 200-Day Moving Average - Notable for VRX,2017-10-13 16:14:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/43voaLsZ3I0/valeant-pharmaceuticals-international-breaks-below-200-day-moving-average-notable-for-vrx-cm859436,In trading on Friday shares of Valeant Pharmaceuticals International Inc Symbol VRX crossed below their 200 day moving average of 13 67 changing hands as low as 13 31 per share Valeant Pharmaceuticals International Inc shares are currently trading down about 3 2 on the day The chart
VRX,VRX:US,BBG000DLFM21,"It’s Time to Start Buying Beaten-Up Gilead Sciences, Inc. (GILD) Stock",2017-10-13 15:33:05 +0000,https://finance.yahoo.com/news/time-start-buying-beaten-gilead-153305041.html?.tsrc=rss,"Then there was the demise of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), followed by an EpiPen scandal at Mylan N.V. (NASDAQ:MYL).  While GILD stock also fell, the reasons were largely unrelated to the scandals which plagued its peers.  The company’s big Hepatitis C Virus (HCV) drug worked really well."
VRX,VRX:CT,BBG000DC8S17,"It’s Time to Start Buying Beaten-Up Gilead Sciences, Inc. (GILD) Stock",2017-10-13 15:33:05 +0000,https://finance.yahoo.com/news/time-start-buying-beaten-gilead-153305041.html?.tsrc=rss,"Then there was the demise of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), followed by an EpiPen scandal at Mylan N.V. (NASDAQ:MYL).  While GILD stock also fell, the reasons were largely unrelated to the scandals which plagued its peers.  The company’s big Hepatitis C Virus (HCV) drug worked really well."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : October 13, 2017",2017-10-13 12:37:34 +0000,http://finance.yahoo.com/r/cdfece69-b49c-3509-bac9-98cb11b5cae7/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-us-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : October 13, 2017",2017-10-13 12:37:34 +0000,http://finance.yahoo.com/r/cdfece69-b49c-3509-bac9-98cb11b5cae7/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-us-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing As Commodity Prices Rise - Canadian Commentary,2017-10-13 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OVmg5rRVPw8/canadian-stocks-are-climbing-as-commodity-prices-rise--canadian-commentary-20171013-00556,Canadian Stocks Are Climbing As Commodity Prices Rise - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing As Commodity Prices Rise - Canadian Commentary,2017-10-13 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OVmg5rRVPw8/canadian-stocks-are-climbing-as-commodity-prices-rise--canadian-commentary-20171013-00556,Canadian Stocks Are Climbing As Commodity Prices Rise - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS",2017-10-13 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ez3wUSPO7sc/once-sparkles-bdsi-makes-peace-coming-event-casts-its-shadow-before-atrs-20171013-00034,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS"
VRX,VRX:US,BBG000DLFM21,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS",2017-10-13 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ez3wUSPO7sc/once-sparkles-bdsi-makes-peace-coming-event-casts-its-shadow-before-atrs-20171013-00034,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS"
VRX,VRX:CT,BBG000DC8S17,"Shopify Inc (US) Stock News Is Dire, but So What?",2017-10-12 17:52:12 +0000,https://finance.yahoo.com/news/shopify-inc-us-stock-news-175212173.html?.tsrc=rss,"If the names Andrew Left or Citron Research ring a bell, there’s a reason.  Left, the lead (and seemingly only) analyst for Citron largely prompted the scrutiny of specialty pharmacy company Philidor, owned by Valeant Pharmaceuticals Intl Inc (NYSE:VRX)."
VRX,VRX:US,BBG000DLFM21,"Shopify Inc (US) Stock News Is Dire, but So What?",2017-10-12 17:52:12 +0000,https://finance.yahoo.com/news/shopify-inc-us-stock-news-175212173.html?.tsrc=rss,"If the names Andrew Left or Citron Research ring a bell, there’s a reason.  Left, the lead (and seemingly only) analyst for Citron largely prompted the scrutiny of specialty pharmacy company Philidor, owned by Valeant Pharmaceuticals Intl Inc (NYSE:VRX)."
VRX,VRX:US,BBG000DLFM21,Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile,2017-10-12 12:00:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-announces-two-findings-120000060.html?.tsrc=rss,Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
VRX,VRX:US,BBG000DLFM21,Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile,2017-10-12 12:00:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-announces-two-findings-120000391.html?.tsrc=rss,"LAVAL, Quebec, Oct. 12, 2017 /PRNewswire/ -- Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced results from the Pivotal Phase 3 long-term extension study (AMAGINE-2), which demonstrated that SILIQ™ (brodalumab) injection provided sustained high levels of skin clearance (PASI 100) over more than two years in patients with moderate-to-severe psoriasis.  SILIQ is indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies."
VRX,VRX:CT,BBG000DC8S17,Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile,2017-10-12 12:00:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-announces-two-findings-120000060.html?.tsrc=rss,Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
VRX,VRX:CT,BBG000DC8S17,Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile,2017-10-12 12:00:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-announces-two-findings-120000391.html?.tsrc=rss,"LAVAL, Quebec, Oct. 12, 2017 /PRNewswire/ -- Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced results from the Pivotal Phase 3 long-term extension study (AMAGINE-2), which demonstrated that SILIQ™ (brodalumab) injection provided sustained high levels of skin clearance (PASI 100) over more than two years in patients with moderate-to-severe psoriasis.  SILIQ is indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Declining As Crude Prices Fall - Canadian Commentary,2017-10-12 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1GkS4Q2hWNQ/canadian-stocks-are-declining-as-crude-prices-fall--canadian-commentary-20171012-00871,Canadian Stocks Are Declining As Crude Prices Fall - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Declining As Crude Prices Fall - Canadian Commentary,2017-10-12 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1GkS4Q2hWNQ/canadian-stocks-are-declining-as-crude-prices-fall--canadian-commentary-20171012-00871,Canadian Stocks Are Declining As Crude Prices Fall - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Ackman's Chipotle, Valeant Failures May Give ADP Holders Pause; NAFTA in Focus",2017-10-11 22:33:00 +0000,http://finance.yahoo.com/r/22d13b44-ce5e-3be8-9665-c967e9f86c05/ackman-chipotle-valeant-failures-give-adp-holders-pause-nafta-in-focus-icymi.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Wednesday, Oct. 11."
VRX,VRX:US,BBG000DLFM21,"Ackman's Chipotle, Valeant Failures May Give ADP Holders Pause; NAFTA in Focus",2017-10-11 22:33:00 +0000,http://finance.yahoo.com/r/22d13b44-ce5e-3be8-9665-c967e9f86c05/ackman-chipotle-valeant-failures-give-adp-holders-pause-nafta-in-focus-icymi.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Wednesday, Oct. 11."
VRX,VRX:US,BBG000DLFM21,New Strong Sell Stocks for October 11th,2017-10-11 13:05:01 +0000,https://finance.yahoo.com/news/strong-sell-stocks-october-11th-130501934.html?.tsrc=rss,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
VRX,VRX:CT,BBG000DC8S17,New Strong Sell Stocks for October 11th,2017-10-11 13:05:01 +0000,https://finance.yahoo.com/news/strong-sell-stocks-october-11th-130501934.html?.tsrc=rss,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
VRX,VRX:US,BBG000DLFM21,[$$] Valeant's 2016 Stock Collapse Opened Door for Latigo Debt Play,2017-10-10 23:36:44 +0000,http://finance.yahoo.com/r/5181bfcc-d11a-3c4f-80e8-2c8552458932/valeants-2016-stock-collapse-opened-door-for-latigo-debt-play-1507678044?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"In spring 2016, when many mutual funds and other investors were heaving over shares of Valeant Pharmaceuticals International as if trying to lighten a sinking ship, David Ford, co-founder of distressed-debt ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant's 2016 Stock Collapse Opened Door for Latigo Debt Play,2017-10-10 23:36:44 +0000,http://finance.yahoo.com/r/5181bfcc-d11a-3c4f-80e8-2c8552458932/valeants-2016-stock-collapse-opened-door-for-latigo-debt-play-1507678044?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"In spring 2016, when many mutual funds and other investors were heaving over shares of Valeant Pharmaceuticals International as if trying to lighten a sinking ship, David Ford, co-founder of distressed-debt ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Off Their Early Highs - Canadian Commentary,2017-10-10 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JPrO8XsJH7g/canadian-stocks-are-off-their-early-highs--canadian-commentary-20171010-00921,Canadian Stocks Are Off Their Early Highs - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Off Their Early Highs - Canadian Commentary,2017-10-10 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JPrO8XsJH7g/canadian-stocks-are-off-their-early-highs--canadian-commentary-20171010-00921,Canadian Stocks Are Off Their Early Highs - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant's Biggest Drug Gets a Shot at More Sales,2017-10-09 14:32:00 +0000,http://finance.yahoo.com/r/b1d82f8f-5ceb-3b62-bccc-1fa89cdf4274/valeants-biggest-drug-gets-a-shot-at-more-sales-1507559553?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are falling today despite a bullish analyst note that suggests the troubled drug maker’s biggest-selling drugs could grow market share in the next year.  Deutsche Bank’s Gregg Gilbert and Greg Fraser conducted a survey of 25 primary care physicians who frequently prescribe treatments for irritable bowel syndrome inorder to assess their views on Valeant’s Xifaxan and two rival drugs from Allergan (AGN).  The pair expect accelerating sales growth for Xifaxan, but flat sales for Allergan’s Viberzi and slowing growth for Linzess."
VRX,VRX:US,BBG000DLFM21,Valeant's Biggest Drug Gets a Shot at More Sales,2017-10-09 14:32:00 +0000,http://finance.yahoo.com/r/b1d82f8f-5ceb-3b62-bccc-1fa89cdf4274/valeants-biggest-drug-gets-a-shot-at-more-sales-1507559553?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are falling today despite a bullish analyst note that suggests the troubled drug maker’s biggest-selling drugs could grow market share in the next year.  Deutsche Bank’s Gregg Gilbert and Greg Fraser conducted a survey of 25 primary care physicians who frequently prescribe treatments for irritable bowel syndrome inorder to assess their views on Valeant’s Xifaxan and two rival drugs from Allergan (AGN).  The pair expect accelerating sales growth for Xifaxan, but flat sales for Allergan’s Viberzi and slowing growth for Linzess."
VRX,VRX:US,BBG000DLFM21,Why Investor Bullishness About AT&T Inc. (T) Stock Should Scare You,2017-10-06 22:56:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C_oFSYlf-cw/why-investor-bullishness-about-att-inc-t-stock-should-scare-you-cm856589,InvestorPlace Stock Market News Stock Advice amp Trading Tips The last time I wrote about AT amp T Inc NYSE T was mid September In that piece I suggested the 5 2 yield of AT amp T stock was hardly worth it Source Mike Mozart via Flickr My biggest concern
VRX,VRX:CT,BBG000DC8S17,Why Investor Bullishness About AT&T Inc. (T) Stock Should Scare You,2017-10-06 22:56:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C_oFSYlf-cw/why-investor-bullishness-about-att-inc-t-stock-should-scare-you-cm856589,InvestorPlace Stock Market News Stock Advice amp Trading Tips The last time I wrote about AT amp T Inc NYSE T was mid September In that piece I suggested the 5 2 yield of AT amp T stock was hardly worth it Source Mike Mozart via Flickr My biggest concern
VRX,VRX:US,BBG000DLFM21,Shopify Stock Will Plunge Almost 50% Says Prominent Short-Seller,2017-10-06 22:54:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MHIXBSWSDgE/shopify-stock-will-plunge-almost-50-says-prominent-short-seller-cm856560,InvestorPlace Stock Market News Stock Advice amp Trading Tips On Oct 4 shares of Shopify Inc US NYSE SHOP 160 fell 11 after a bearish report was issued by Citron Research s Andrew Left On Thursday shares are down even more and 160 Shopify stock is down a whopping 20
VRX,VRX:CT,BBG000DC8S17,Shopify Stock Will Plunge Almost 50% Says Prominent Short-Seller,2017-10-06 22:54:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MHIXBSWSDgE/shopify-stock-will-plunge-almost-50-says-prominent-short-seller-cm856560,InvestorPlace Stock Market News Stock Advice amp Trading Tips On Oct 4 shares of Shopify Inc US NYSE SHOP 160 fell 11 after a bearish report was issued by Citron Research s Andrew Left On Thursday shares are down even more and 160 Shopify stock is down a whopping 20
VRX,VRX:US,BBG000DLFM21,Shopify Stock Will Plunge Almost 50% Says Prominent Short-Seller,2017-10-06 17:47:24 +0000,https://finance.yahoo.com/news/shopify-stock-plunge-almost-50-174724078.html?.tsrc=rss,"On Oct. 4, shares of Shopify Inc (US) (NYSE:SHOP) fell 11% after a bearish report was issued by Citron Research’s Andrew Left.  Most famously, Left nailed the short sale in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  Perhaps this is why so many fear his other short calls — he could be right, in devastating manner. Although, it should be noted he has a pretty notable bullish call on BlackBerry Ltd (NASDAQ:BBRY), saying it could double as he compares it to Nvidia Corporation (NASDAQ:NVDA)."
VRX,VRX:CT,BBG000DC8S17,Shopify Stock Will Plunge Almost 50% Says Prominent Short-Seller,2017-10-06 17:47:24 +0000,https://finance.yahoo.com/news/shopify-stock-plunge-almost-50-174724078.html?.tsrc=rss,"On Oct. 4, shares of Shopify Inc (US) (NYSE:SHOP) fell 11% after a bearish report was issued by Citron Research’s Andrew Left.  Most famously, Left nailed the short sale in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  Perhaps this is why so many fear his other short calls — he could be right, in devastating manner. Although, it should be noted he has a pretty notable bullish call on BlackBerry Ltd (NASDAQ:BBRY), saying it could double as he compares it to Nvidia Corporation (NASDAQ:NVDA)."
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-10-06 12:00:31 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120031464.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-10-06 12:00:31 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120031464.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:CT,BBG000DC8S17,Why Investor Bullishness About AT&T Inc. (T) Stock Should Scare You,2017-10-06 08:00:42 +0000,https://finance.yahoo.com/news/why-investor-bullishness-t-inc-080042979.html?.tsrc=rss,"The last time I wrote about AT&T Inc (NYSE:T) was mid-September.  In my opinion, AT&T stock will be lucky to duplicate its 9.2% annualized total return over the next 12 years, making its 5.2% yield anything but risk-free.  Naturally, this offended some of the more sensitive AT&T longs and I heard from one of them."
VRX,VRX:US,BBG000DLFM21,Why Investor Bullishness About AT&T Inc. (T) Stock Should Scare You,2017-10-06 08:00:42 +0000,https://finance.yahoo.com/news/why-investor-bullishness-t-inc-080042979.html?.tsrc=rss,"The last time I wrote about AT&T Inc (NYSE:T) was mid-September.  In my opinion, AT&T stock will be lucky to duplicate its 9.2% annualized total return over the next 12 years, making its 5.2% yield anything but risk-free.  Naturally, this offended some of the more sensitive AT&T longs and I heard from one of them."
VRX,VRX:CT,BBG000DC8S17,VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors,2017-10-05 23:46:00 +0000,https://finance.yahoo.com/news/vrx-investor-alert-kyros-law-234600217.html?.tsrc=rss,"BOSTON , Oct. 5, 2017 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX)  that it is investigating legal claims against the company for possible securities ..."
VRX,VRX:US,BBG000DLFM21,VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors,2017-10-05 23:46:00 +0000,https://finance.yahoo.com/news/vrx-investor-alert-kyros-law-234600217.html?.tsrc=rss,"BOSTON , Oct. 5, 2017 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX)  that it is investigating legal claims against the company for possible securities ..."
VRX,VRX:CT,BBG000DC8S17,Left Is Kind of Right on Shopify Inc (US) (SHOP) Stock,2017-10-05 20:03:53 +0000,https://finance.yahoo.com/news/left-kind-shopify-inc-us-200353745.html?.tsrc=rss,"Left claims that Shopify’s marketing tactics run afoul of Federal Trade Commission regulations, which likely will lead to an investigation. From a valuation standpoint, he argues that SHOP stock essentially is just too overvalued.  Is Left Right on Shopify Stock?  While the standard cries of “market manipulation” have accompanied Citron’s bear raid, the firm does make a good case relative to Shopify’s advertising."
VRX,VRX:US,BBG000DLFM21,Left Is Kind of Right on Shopify Inc (US) (SHOP) Stock,2017-10-05 20:03:53 +0000,https://finance.yahoo.com/news/left-kind-shopify-inc-us-200353745.html?.tsrc=rss,"Left claims that Shopify’s marketing tactics run afoul of Federal Trade Commission regulations, which likely will lead to an investigation. From a valuation standpoint, he argues that SHOP stock essentially is just too overvalued.  Is Left Right on Shopify Stock?  While the standard cries of “market manipulation” have accompanied Citron’s bear raid, the firm does make a good case relative to Shopify’s advertising."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals (VRX) Stock Begs Just One Key Question,2017-10-05 16:43:49 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-vrx-stock-begs-164349455.html?.tsrc=rss,"If you’re having a tough time handicapping Valeant Pharmaceuticals Intl Inc (NYSE:VRX), don’t beat yourself up.  It is a moving target and VRX stock is a “gut feeling” kind of play in the midst of a major transition.  Two more developments unveiled within the past few days further muddy the waters as to where Valeant — and VRX stock — may be going."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals (VRX) Stock Begs Just One Key Question,2017-10-05 16:43:49 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-vrx-stock-begs-164349455.html?.tsrc=rss,"If you’re having a tough time handicapping Valeant Pharmaceuticals Intl Inc (NYSE:VRX), don’t beat yourself up.  It is a moving target and VRX stock is a “gut feeling” kind of play in the midst of a major transition.  Two more developments unveiled within the past few days further muddy the waters as to where Valeant — and VRX stock — may be going."
VRX,VRX:US,BBG000DLFM21,How to Approach Valeant Pharmaceuticals Intl Inc (VRX) Stock With Reason,2017-10-05 14:31:52 +0000,https://finance.yahoo.com/news/approach-valeant-pharmaceuticals-intl-inc-143152362.html?.tsrc=rss,"No doubt Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is still considered junk by some investors.  This week analysts at S&P Global Ratings, announced Valeant’s debt is still deep in junk territory.  The S&P update was prompted by Valeant, issuing $1.0 billion in new 8-year senior secured notes to repay an equal amount of senior unsecured debt from issues maturing in 2020."
VRX,VRX:CT,BBG000DC8S17,How to Approach Valeant Pharmaceuticals Intl Inc (VRX) Stock With Reason,2017-10-05 14:31:52 +0000,https://finance.yahoo.com/news/approach-valeant-pharmaceuticals-intl-inc-143152362.html?.tsrc=rss,"No doubt Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is still considered junk by some investors.  This week analysts at S&P Global Ratings, announced Valeant’s debt is still deep in junk territory.  The S&P update was prompted by Valeant, issuing $1.0 billion in new 8-year senior secured notes to repay an equal amount of senior unsecured debt from issues maturing in 2020."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary,2017-10-05 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_JolQ2GckSE/canadian-stocks-are-rising-on-energy-strength--canadian-commentary-20171005-00823,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary,2017-10-05 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_JolQ2GckSE/canadian-stocks-are-rising-on-energy-strength--canadian-commentary-20171005-00823,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology",2017-10-04 21:16:00 +0000,https://finance.yahoo.com/news/solta-medical-receives-fda-510-211600717.html?.tsrc=rss,"BOTHELL, Wash., Oct. 4, 2017 /PRNewswire/ -- Solta Medical, a division of Valeant Pharmaceuticals North America LLC, announced today that its Thermage FLX™ System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to non-invasively smooth skin on the face, eyes, and body.  Thermage FLX is the newest generation of Thermage® technologies known for non-invasively reducing the appearance of fine lines and wrinkles.  The system uses patented radiofrequency technology to create a uniform heating effect in the deep collagen-rich layers of the skin."
VRX,VRX:US,BBG000DLFM21,"Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology",2017-10-04 21:16:00 +0000,https://finance.yahoo.com/news/solta-medical-receives-fda-510-211600717.html?.tsrc=rss,"BOTHELL, Wash., Oct. 4, 2017 /PRNewswire/ -- Solta Medical, a division of Valeant Pharmaceuticals North America LLC, announced today that its Thermage FLX™ System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to non-invasively smooth skin on the face, eyes, and body.  Thermage FLX is the newest generation of Thermage® technologies known for non-invasively reducing the appearance of fine lines and wrinkles.  The system uses patented radiofrequency technology to create a uniform heating effect in the deep collagen-rich layers of the skin."
VRX,VRX:CT,BBG000DC8S17,Shopify Falls After Short-Seller Citron Criticizes Marketing Model,2017-10-04 20:32:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TI9sRlaCsMc/shopify-falls-after-short-seller-citron-criticizes-marketing-model-cm855297,Shares in Shopify SHOP plunged Wednesday after short seller Citron Research criticized the company s marketing model in a video post and set a price target of 60 roughly half its opening price ibd display video id 2326939 width 50 float left autostart true
VRX,VRX:US,BBG000DLFM21,Shopify Falls After Short-Seller Citron Criticizes Marketing Model,2017-10-04 20:32:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TI9sRlaCsMc/shopify-falls-after-short-seller-citron-criticizes-marketing-model-cm855297,Shares in Shopify SHOP plunged Wednesday after short seller Citron Research criticized the company s marketing model in a video post and set a price target of 60 roughly half its opening price ibd display video id 2326939 width 50 float left autostart true
VRX,VRX:CT,BBG000DC8S17,Why Did Shopify (SHOP) Stock Slump Today?,2017-10-04 20:32:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TyF2lDZkKos/why-did-shopify-shop-stock-slump-today-cm855403,Shares of Shopify SHOP fell more than 10 after notorious short selling firm Citron Research argued that the e commerce platform is fraudulently promoting get rich quick schemes In a video posted on Citron s website Andrew Left who has garnered attention for successful bets against
VRX,VRX:US,BBG000DLFM21,Why Did Shopify (SHOP) Stock Slump Today?,2017-10-04 20:32:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TyF2lDZkKos/why-did-shopify-shop-stock-slump-today-cm855403,Shares of Shopify SHOP fell more than 10 after notorious short selling firm Citron Research argued that the e commerce platform is fraudulently promoting get rich quick schemes In a video posted on Citron s website Andrew Left who has garnered attention for successful bets against
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : October 4, 2017",2017-10-04 15:29:01 +0000,http://finance.yahoo.com/r/b9366e1c-b88a-3223-afac-0f61b461a7f4/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-october-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Valeant Pharmaceuticals International, Inc. a score of 9. Our analysis is based on comparing Valeant Pharmaceuticals International, Inc. with the following peers – Pfizer Inc., AstraZeneca PLC, Merck KGaA Sponsored ADR, Novartis AG Sponsored ADR and CSPC Pharmaceutical Group Ltd. Sponsored ADR (PFE-US, AZNCF-US, MKKGY-US, NVS-US and ... Read more
<b>(Read more...)</b>"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : October 4, 2017",2017-10-04 15:29:01 +0000,http://finance.yahoo.com/r/b9366e1c-b88a-3223-afac-0f61b461a7f4/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-october-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Valeant Pharmaceuticals International, Inc. a score of 9. Our analysis is based on comparing Valeant Pharmaceuticals International, Inc. with the following peers – Pfizer Inc., AstraZeneca PLC, Merck KGaA Sponsored ADR, Novartis AG Sponsored ADR and CSPC Pharmaceutical Group Ltd. Sponsored ADR (PFE-US, AZNCF-US, MKKGY-US, NVS-US and ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology",2017-10-04 12:00:00 +0000,https://finance.yahoo.com/news/solta-medical-receives-fda-510-120000316.html?.tsrc=rss,"Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology"
VRX,VRX:US,BBG000DLFM21,"Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology",2017-10-04 12:00:00 +0000,https://finance.yahoo.com/news/solta-medical-receives-fda-510-120000316.html?.tsrc=rss,"Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Turn Positive After EIA Report - Canadian Commentary,2017-10-04 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qiSW42bY0uA/canadian-stocks-turn-positive-after-eia-report--canadian-commentary-20171004-00782,Canadian Stocks Turn Positive After EIA Report - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Turn Positive After EIA Report - Canadian Commentary,2017-10-04 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qiSW42bY0uA/canadian-stocks-turn-positive-after-eia-report--canadian-commentary-20171004-00782,Canadian Stocks Turn Positive After EIA Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts for Tuesday: Facebook Inc (FB), Amazon.com, Inc. (AMZN) and Netflix, Inc. (NFLX)",2017-10-03 20:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BKVbF7pqYag/3-big-stock-charts-for-tuesday-facebook-inc-fb-amazoncom-inc-amzn-and-netflix-inc-nflx-cm854874,InvestorPlace Stock Market News Stock Advice amp Trading Tips Stocks are set to continue their winning ways on Tuesday after the major indices closed at new all time highs on Monday s strong move The rally has an interesting aspect to it as financials and small caps are
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts for Tuesday: Facebook Inc (FB), Amazon.com, Inc. (AMZN) and Netflix, Inc. (NFLX)",2017-10-03 20:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BKVbF7pqYag/3-big-stock-charts-for-tuesday-facebook-inc-fb-amazoncom-inc-amzn-and-netflix-inc-nflx-cm854874,InvestorPlace Stock Market News Stock Advice amp Trading Tips Stocks are set to continue their winning ways on Tuesday after the major indices closed at new all time highs on Monday s strong move The rally has an interesting aspect to it as financials and small caps are
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Set for Near-100% Return,2017-10-03 19:54:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n3DCPpCwmG8/valeant-pharmaceuticals-intl-inc-vrx-stock-is-set-for-near-100-return-cm854835,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is not a long term bet by any means The company is struggling with elevated debt levels business restructuring and a severe image problem due to
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Set for Near-100% Return,2017-10-03 19:54:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n3DCPpCwmG8/valeant-pharmaceuticals-intl-inc-vrx-stock-is-set-for-near-100-return-cm854835,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is not a long term bet by any means The company is struggling with elevated debt levels business restructuring and a severe image problem due to
VRX,VRX:CT,BBG000DC8S17,"Fighting Debt Demons, Valeant Pharmaceuticals Just Priced a New Debt Offering",2017-10-03 18:55:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0EEH7i3CImg/fighting-debt-demons-valeant-pharmaceuticals-just-priced-a-new-debt-offering-cm854753,The theme of 2017 for embattled drug developer Valeant Pharmaceuticals NYSE VRX is baby steps After a miserable 2015 and 2016 which saw the company get buried under debt and accused of numerous scandals the current management team has been doing its best to stay under the
VRX,VRX:US,BBG000DLFM21,"Fighting Debt Demons, Valeant Pharmaceuticals Just Priced a New Debt Offering",2017-10-03 18:55:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0EEH7i3CImg/fighting-debt-demons-valeant-pharmaceuticals-just-priced-a-new-debt-offering-cm854753,The theme of 2017 for embattled drug developer Valeant Pharmaceuticals NYSE VRX is baby steps After a miserable 2015 and 2016 which saw the company get buried under debt and accused of numerous scandals the current management team has been doing its best to stay under the
VRX,VRX:US,BBG000DLFM21,"Fighting Debt Demons, Valeant Pharmaceuticals Just Priced a New Debt Offering",2017-10-03 17:35:00 +0000,http://finance.yahoo.com/r/72f80c55-d567-378f-a5de-5ba2ffc6fb5b/fighting-debt-demons-valeant-pharmaceuticals-just.aspx?yptr=yahoo&.tsrc=rss,Will things ever get better for this embattled drugmaker?
VRX,VRX:CT,BBG000DC8S17,"Fighting Debt Demons, Valeant Pharmaceuticals Just Priced a New Debt Offering",2017-10-03 17:35:00 +0000,http://finance.yahoo.com/r/72f80c55-d567-378f-a5de-5ba2ffc6fb5b/fighting-debt-demons-valeant-pharmaceuticals-just.aspx?yptr=yahoo&.tsrc=rss,Will things ever get better for this embattled drugmaker?
VRX,VRX:CT,BBG000DC8S17,Valeant: Still Deep in Junk Territory,2017-10-03 16:19:00 +0000,http://finance.yahoo.com/r/4d2e763b-fdcf-3ecc-be6b-6b4fc1cc374b/valeant-still-deep-in-junk-territory-1507047600?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The finances of Valeant Pharmaceutical International (VRX) are stabilizing, but the company is still deep into junk bond status as far as S&P Global Ratings is concerned.  The credit rating agency reaffirmed its single-B corporate credit rating Monday.  Valeant issued $1 billion eight-year secured notes Monday priced at par to yield 5.5%."
VRX,VRX:US,BBG000DLFM21,Valeant: Still Deep in Junk Territory,2017-10-03 16:19:00 +0000,http://finance.yahoo.com/r/4d2e763b-fdcf-3ecc-be6b-6b4fc1cc374b/valeant-still-deep-in-junk-territory-1507047600?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The finances of Valeant Pharmaceutical International (VRX) are stabilizing, but the company is still deep into junk bond status as far as S&P Global Ratings is concerned.  The credit rating agency reaffirmed its single-B corporate credit rating Monday.  Valeant issued $1 billion eight-year secured notes Monday priced at par to yield 5.5%."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Set for Near-100% Return,2017-10-03 15:15:23 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-151523019.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is not a long-term bet, by any means.  It’s a development that holds promise for Valeant options traders.  Click to EnlargeSpecifically, VRX stock broke above its 50-day moving average for the first time in two months yesterday."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Set for Near-100% Return,2017-10-03 15:15:23 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-151523019.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is not a long-term bet, by any means.  It’s a development that holds promise for Valeant options traders.  Click to EnlargeSpecifically, VRX stock broke above its 50-day moving average for the first time in two months yesterday."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : October 3, 2017",2017-10-03 12:17:16 +0000,http://finance.yahoo.com/r/a7eec734-833e-301b-9925-fe87ff3b8e7c/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrx-us-october-3-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : October 3, 2017",2017-10-03 12:17:16 +0000,http://finance.yahoo.com/r/a7eec734-833e-301b-9925-fe87ff3b8e7c/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrx-us-october-3-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals,2017-10-03 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000180.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 3, 2017 / U.S. markets kicked off the fourth quarter in the green Monday as investors appear optimistic that the markets record run will continue. The Dow Jones Industrial ..."
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe,2017-10-03 12:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-biotrue-oneday-120000273.html?.tsrc=rss,"LAVAL, Quebec , Oct. 3, 2017 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant""), ..."
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe,2017-10-03 12:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-biotrue-oneday-120000457.html?.tsrc=rss,Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals,2017-10-03 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000180.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 3, 2017 / U.S. markets kicked off the fourth quarter in the green Monday as investors appear optimistic that the markets record run will continue. The Dow Jones Industrial ..."
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe,2017-10-03 12:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-biotrue-oneday-120000457.html?.tsrc=rss,Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe,2017-10-03 12:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-biotrue-oneday-120000273.html?.tsrc=rss,"LAVAL, Quebec , Oct. 3, 2017 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant""), ..."
VRX,VRX:US,BBG000DLFM21,Valeant Will Release Third-Quarter 2017 Financial Results On November 7,2017-10-03 11:00:00 +0000,https://finance.yahoo.com/news/valeant-release-third-quarter-2017-110000018.html?.tsrc=rss,Valeant Will Release Third-Quarter 2017 Financial Results On November 7
VRX,VRX:CT,BBG000DC8S17,Valeant Will Release Third-Quarter 2017 Financial Results On November 7,2017-10-03 11:00:00 +0000,https://finance.yahoo.com/news/valeant-release-third-quarter-2017-110000018.html?.tsrc=rss,Valeant Will Release Third-Quarter 2017 Financial Results On November 7
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Pricing Of Private Offering Of Senior Secured Notes,2017-10-02 23:47:00 +0000,https://finance.yahoo.com/news/valeant-announces-pricing-private-offering-234700842.html?.tsrc=rss,Valeant Announces Pricing Of Private Offering Of Senior Secured Notes
VRX,VRX:US,BBG000DLFM21,Valeant Announces Pricing Of Private Offering Of Senior Secured Notes,2017-10-02 23:47:00 +0000,https://finance.yahoo.com/news/valeant-announces-pricing-private-offering-234700842.html?.tsrc=rss,Valeant Announces Pricing Of Private Offering Of Senior Secured Notes
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Pricing Of Private Offering Of Senior Secured Notes,2017-10-02 23:47:00 +0000,https://finance.yahoo.com/news/valeant-announces-pricing-private-offering-234700494.html?.tsrc=rss,"LAVAL, Quebec, Oct. 2, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"" or the ""Company"") announced today that it has priced its previously announced offering of $1,000,000,000 aggregate principal amount of 5.500% senior secured notes due 2025 (the ""Notes"").  Valeant intends to use the net proceeds from this offering, along with cash on hand, to repurchase $1,000,000,000 aggregate principal amount of outstanding notes pursuant to a tender offer announced earlier today, including Valeant Pharmaceuticals International's, a wholly-owned subsidiary of the Company, outstanding 7.000% Senior Notes due 2020 and 6.375% Senior Notes due 2020, up to $100 million of its outstanding 5.375% Senior Notes due 2020 and to pay related fees and expenses.  The Notes will be guaranteed by each of the Company's subsidiaries that is a guarantor under the Company's credit agreement and the Company's existing senior notes and will be secured on a first priority basis by liens on the assets that secure the Company's credit agreement and existing senior secured notes."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Pricing Of Private Offering Of Senior Secured Notes,2017-10-02 23:47:00 +0000,https://finance.yahoo.com/news/valeant-announces-pricing-private-offering-234700494.html?.tsrc=rss,"LAVAL, Quebec, Oct. 2, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"" or the ""Company"") announced today that it has priced its previously announced offering of $1,000,000,000 aggregate principal amount of 5.500% senior secured notes due 2025 (the ""Notes"").  Valeant intends to use the net proceeds from this offering, along with cash on hand, to repurchase $1,000,000,000 aggregate principal amount of outstanding notes pursuant to a tender offer announced earlier today, including Valeant Pharmaceuticals International's, a wholly-owned subsidiary of the Company, outstanding 7.000% Senior Notes due 2020 and 6.375% Senior Notes due 2020, up to $100 million of its outstanding 5.375% Senior Notes due 2020 and to pay related fees and expenses.  The Notes will be guaranteed by each of the Company's subsidiaries that is a guarantor under the Company's credit agreement and the Company's existing senior notes and will be secured on a first priority basis by liens on the assets that secure the Company's credit agreement and existing senior secured notes."
VRX,VRX:US,BBG000DLFM21,Valeant Digs Into Its Leverage Spiral,2017-10-02 18:03:22 +0000,http://finance.yahoo.com/r/ca03d9f8-b2d3-3a6f-b88e-3936e856b18c/valeant-sells-notes-deeper-into-a-leverage-spiral?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Its latest debt sale just kicks its problems down the road.
VRX,VRX:CT,BBG000DC8S17,Valeant Digs Into Its Leverage Spiral,2017-10-02 18:03:22 +0000,http://finance.yahoo.com/r/ca03d9f8-b2d3-3a6f-b88e-3936e856b18c/valeant-sells-notes-deeper-into-a-leverage-spiral?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Its latest debt sale just kicks its problems down the road.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Red-hot -- Canadian Commentary,2017-10-02 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3UeFHv1xRDo/canadian-stocks-are-redhot--canadian-commentary-20171002-01312,Canadian Stocks Are Red-hot -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Red-hot -- Canadian Commentary,2017-10-02 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3UeFHv1xRDo/canadian-stocks-are-redhot--canadian-commentary-20171002-01312,Canadian Stocks Are Red-hot -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Today&apos;s charts: Gun stocks rally; GM shares climb; HPE let Russia review cyber defense software,2017-10-02 16:12:38 +0000,https://finance.yahoo.com/news/todays-charts-gun-stocks-rally-gm-shares-climb-hpe-let-russia-review-cyber-defense-software-161238531.html?.tsrc=rss,"Gun stocks rose following the deadliest mass shooting in modern U.S. history Sunday night.  At least 58 people were killed and more than 500 were injured after a man opened fire into a crowd at an outdoor concert in Las Vegas.  Shares of Sturm Ruger (RGR) and American Outdoor Brands (AOBC), the parent company of Smith & Wesson, were up in midday trading on Monday."
VRX,VRX:US,BBG000DLFM21,Today&apos;s charts: Gun stocks rally; GM shares climb; HPE let Russia review cyber defense software,2017-10-02 16:12:38 +0000,https://finance.yahoo.com/news/todays-charts-gun-stocks-rally-gm-shares-climb-hpe-let-russia-review-cyber-defense-software-161238531.html?.tsrc=rss,"Gun stocks rose following the deadliest mass shooting in modern U.S. history Sunday night.  At least 58 people were killed and more than 500 were injured after a man opened fire into a crowd at an outdoor concert in Las Vegas.  Shares of Sturm Ruger (RGR) and American Outdoor Brands (AOBC), the parent company of Smith & Wesson, were up in midday trading on Monday."
VRX,VRX:CT,BBG000DC8S17,Today's charts: Gun stocks climb; Valeant shares drop; HPE reportedly let Russia review cyber defense software,2017-10-02 16:09:46 +0000,https://finance.yahoo.com/video/todays-charts-gun-stocks-climb-160946225.html?.tsrc=rss,"Yahoo Finance's Seana Smith is tracking Sturm Ruger, American Outdoor Brands, HP Enterprise and Valeant Pharmaceuticals in intraday trading on Monday."
VRX,VRX:US,BBG000DLFM21,Today's charts: Gun stocks climb; Valeant shares drop; HPE reportedly let Russia review cyber defense software,2017-10-02 16:09:46 +0000,https://finance.yahoo.com/video/todays-charts-gun-stocks-climb-160946225.html?.tsrc=rss,"Yahoo Finance's Seana Smith is tracking Sturm Ruger, American Outdoor Brands, HP Enterprise and Valeant Pharmaceuticals in intraday trading on Monday."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc -- Moody's assigns Ba3 to Valeant's secured notes; negative outlook",2017-10-02 13:49:05 +0000,http://finance.yahoo.com/r/bbb35b4a-1765-3465-ad27-7c02d6b4708d/viewresearchdoc.aspx?docid=PR_373371&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20171002_PR_373371&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's assigns Ba3 to Valeant's secured notes; negative outlook. Global Credit Research- 02 Oct 2017. New York, October 02, 2017-- Moody's Investors Service assigned a Ba3 rating to the ..."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc -- Moody's assigns Ba3 to Valeant's secured notes; negative outlook",2017-10-02 13:49:05 +0000,http://finance.yahoo.com/r/bbb35b4a-1765-3465-ad27-7c02d6b4708d/viewresearchdoc.aspx?docid=PR_373371&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20171002_PR_373371&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's assigns Ba3 to Valeant's secured notes; negative outlook. Global Credit Research- 02 Oct 2017. New York, October 02, 2017-- Moody's Investors Service assigned a Ba3 rating to the ..."
VRX,VRX:US,BBG000DLFM21,Why Valeant Stock (VRX) Can’t Survive the Coming Correction,2017-10-02 11:51:15 +0000,https://finance.yahoo.com/news/why-valeant-stock-vrx-t-115115178.html?.tsrc=rss,"When it comes to Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Valeant stock there’s no question I’m an unabashed bear.  Simply put, Valeant’s debt situation has forced it into a corner where the only way out is to sell one of its cornerstone assets such as Bausch & Lomb providing investors with even less reason to own VRX stock.  Well, I’ve just read an April 2017 report from the International Monetary Fund that’s given me even less enthusiasm for the company, something I didn’t think was possible."
VRX,VRX:CT,BBG000DC8S17,Why Valeant Stock (VRX) Can’t Survive the Coming Correction,2017-10-02 11:51:15 +0000,https://finance.yahoo.com/news/why-valeant-stock-vrx-t-115115178.html?.tsrc=rss,"When it comes to Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Valeant stock there’s no question I’m an unabashed bear.  Simply put, Valeant’s debt situation has forced it into a corner where the only way out is to sell one of its cornerstone assets such as Bausch & Lomb providing investors with even less reason to own VRX stock.  Well, I’ve just read an April 2017 report from the International Monetary Fund that’s given me even less enthusiasm for the company, something I didn’t think was possible."
VRX,VRX:US,BBG000DLFM21,Valeant to borrow $1 billion in bond market to help fund repayment of existing debt,2017-10-02 11:47:55 +0000,http://finance.yahoo.com/r/ce92e111-de99-385f-88d0-307c59302774/Story.aspx?guid=95EFFEFC-4633-4FE0-9447-4FB8DE402B3C&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. said Monday it is planning to issue $1 billion of bonds due 2025 and will use the proceeds to help fund the repurchase of existing notes. The company, which is ..."
VRX,VRX:CT,BBG000DC8S17,Valeant to borrow $1 billion in bond market to help fund repayment of existing debt,2017-10-02 11:47:55 +0000,http://finance.yahoo.com/r/ce92e111-de99-385f-88d0-307c59302774/Story.aspx?guid=95EFFEFC-4633-4FE0-9447-4FB8DE402B3C&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. said Monday it is planning to issue $1 billion of bonds due 2025 and will use the proceeds to help fund the repurchase of existing notes. The company, which is ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount",2017-10-02 11:36:00 +0000,https://finance.yahoo.com/news/valeant-one-subsidiaries-commence-cash-113600293.html?.tsrc=rss,"Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount"
VRX,VRX:US,BBG000DLFM21,"Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount",2017-10-02 11:36:00 +0000,https://finance.yahoo.com/news/valeant-one-subsidiaries-commence-cash-113600293.html?.tsrc=rss,"Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount"
VRX,VRX:US,BBG000DLFM21,Valeant Announces Launch Of Private Offering Of Senior Secured Notes,2017-10-02 11:35:00 +0000,https://finance.yahoo.com/news/valeant-announces-launch-private-offering-113500724.html?.tsrc=rss,Valeant Announces Launch Of Private Offering Of Senior Secured Notes
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Launch Of Private Offering Of Senior Secured Notes,2017-10-02 11:35:00 +0000,https://finance.yahoo.com/news/valeant-announces-launch-private-offering-113500724.html?.tsrc=rss,Valeant Announces Launch Of Private Offering Of Senior Secured Notes
VRX,VRX:US,BBG000DLFM21,Corporate News Blog - Valeant Agrees to Sell iNova Pharma; Set to Use Sale Proceeds to Repay Term Loan Debt,2017-10-02 11:10:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-valeant-agrees-111000641.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / October 2, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (""Valeant""), ..."
VRX,VRX:CT,BBG000DC8S17,Corporate News Blog - Valeant Agrees to Sell iNova Pharma; Set to Use Sale Proceeds to Repay Term Loan Debt,2017-10-02 11:10:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-valeant-agrees-111000641.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / October 2, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (""Valeant""), ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising Despite Energy Weakness - Canadian Commentary,2017-10-02 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/phUKl_vEXvM/canadian-stocks-are-rising-despite-energy-weakness--canadian-commentary-20171002-00945,Canadian Stocks Are Rising Despite Energy Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising Despite Energy Weakness - Canadian Commentary,2017-10-02 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/phUKl_vEXvM/canadian-stocks-are-rising-despite-energy-weakness--canadian-commentary-20171002-00945,Canadian Stocks Are Rising Despite Energy Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,TSX Starts Week Near Record Highs -- Canadian Commentary,2017-10-02 08:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NxeKDyJnIQc/tsx-starts-week-near-record-highs--canadian-commentary-20171002-00663,TSX Starts Week Near Record Highs -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,TSX Starts Week Near Record Highs -- Canadian Commentary,2017-10-02 08:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NxeKDyJnIQc/tsx-starts-week-near-record-highs--canadian-commentary-20171002-00663,TSX Starts Week Near Record Highs -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Commences Cash Tender Offer For $1 Bln Notes; To Also Issue Bonds,2017-10-02 07:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mVeSvCyt2_g/valeant-commences-cash-tender-offer-for-1-bln-notes-to-also-issue-bonds-20171002-00425,Valeant Commences Cash Tender Offer For $1 Bln Notes; To Also Issue Bonds
VRX,VRX:US,BBG000DLFM21,Valeant Commences Cash Tender Offer For $1 Bln Notes; To Also Issue Bonds,2017-10-02 07:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mVeSvCyt2_g/valeant-commences-cash-tender-offer-for-1-bln-notes-to-also-issue-bonds-20171002-00425,Valeant Commences Cash Tender Offer For $1 Bln Notes; To Also Issue Bonds
VRX,VRX:CT,BBG000DC8S17,[$$] More Borrowing Is Not the Answer at Valeant,2017-09-30 04:32:10 +0000,http://finance.yahoo.com/r/89c0878a-9e7f-3d99-b517-68f53e843c83/more-borrowing-is-not-the-answer-at-valeant-1506709085?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International is considering a new round of borrowing. That is one reason investors should consider cashing in after the stock’s big recent rally.
VRX,VRX:US,BBG000DLFM21,[$$] More Borrowing Is Not the Answer at Valeant,2017-09-30 04:32:10 +0000,http://finance.yahoo.com/r/89c0878a-9e7f-3d99-b517-68f53e843c83/more-borrowing-is-not-the-answer-at-valeant-1506709085?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International is considering a new round of borrowing. That is one reason investors should consider cashing in after the stock’s big recent rally.
VRX,VRX:CT,BBG000DC8S17,[$$] More Borrowing Is Not the Answer at Valeant,2017-09-29 21:08:02 +0000,http://finance.yahoo.com/r/89c0878a-9e7f-3d99-b517-68f53e843c83/more-borrowing-is-not-the-answer-at-valeant-1506709085?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International is considering a new round of borrowing. That is one reason investors should consider cashing in after the stock’s big recent rally.
VRX,VRX:US,BBG000DLFM21,[$$] More Borrowing Is Not the Answer at Valeant,2017-09-29 21:08:02 +0000,http://finance.yahoo.com/r/89c0878a-9e7f-3d99-b517-68f53e843c83/more-borrowing-is-not-the-answer-at-valeant-1506709085?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International is considering a new round of borrowing. That is one reason investors should consider cashing in after the stock’s big recent rally.
VRX,VRX:US,BBG000DLFM21,Valeant higher as $930 million sale of iNova closes,2017-09-29 17:21:00 +0000,https://finance.yahoo.com/video/valeant-higher-930-million-sale-172100315.html?.tsrc=rss,CNBC's Meg Tirrell reports on Valeant shares higher after the sale of its iNova business valued at $930 million.
VRX,VRX:CT,BBG000DC8S17,Valeant higher as $930 million sale of iNova closes,2017-09-29 17:21:00 +0000,https://finance.yahoo.com/video/valeant-higher-930-million-sale-172100315.html?.tsrc=rss,CNBC's Meg Tirrell reports on Valeant shares higher after the sale of its iNova business valued at $930 million.
VRX,VRX:CT,BBG000DC8S17,Stocks End Strong Quarter With Modest Gain -- Canadian Commentary,2017-09-29 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pk61mg4cfaQ/stocks-end-strong-quarter-with-modest-gain--canadian-commentary-20170929-00894,Stocks End Strong Quarter With Modest Gain -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Stocks End Strong Quarter With Modest Gain -- Canadian Commentary,2017-09-29 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pk61mg4cfaQ/stocks-end-strong-quarter-with-modest-gain--canadian-commentary-20170929-00894,Stocks End Strong Quarter With Modest Gain -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Debt Worries Outweigh Specialty Pharma Pipeline Potential,2017-09-29 14:48:00 +0000,http://finance.yahoo.com/r/8f164fc2-5496-362e-b4e1-02fd2dc19d70/debt-worries-outweigh-specialty-pharma-pipeline-potential-1506696444?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"BMO Capital Markets' Gary Nachman and his team recently hosted an event with executives from Valeant Pharmaceuticals (VRX), Impax Laboratories (IPXL) and Endo International (ENDP), as they try to navigate a ""challenging time in specialty pharma."" Nachman writes that all three companies have a high amount of leverage, but they're taking different approaches: While Valeant and Endo are taking a more long-term approach of addressing concerns about their debt by executing their main businesses, Impax appears to be planning a ""creative transaction"" in the near-term that Nachman writes could ""potentially transform the company,"" while also delevering its balance sheet."
VRX,VRX:US,BBG000DLFM21,Debt Worries Outweigh Specialty Pharma Pipeline Potential,2017-09-29 14:48:00 +0000,http://finance.yahoo.com/r/8f164fc2-5496-362e-b4e1-02fd2dc19d70/debt-worries-outweigh-specialty-pharma-pipeline-potential-1506696444?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"BMO Capital Markets' Gary Nachman and his team recently hosted an event with executives from Valeant Pharmaceuticals (VRX), Impax Laboratories (IPXL) and Endo International (ENDP), as they try to navigate a ""challenging time in specialty pharma."" Nachman writes that all three companies have a high amount of leverage, but they're taking different approaches: While Valeant and Endo are taking a more long-term approach of addressing concerns about their debt by executing their main businesses, Impax appears to be planning a ""creative transaction"" in the near-term that Nachman writes could ""potentially transform the company,"" while also delevering its balance sheet."
VRX,VRX:CT,BBG000DC8S17,Valeant: Opportunity Time?,2017-09-29 14:35:00 +0000,http://finance.yahoo.com/r/ccd5456e-9ea7-3a0c-b2a6-b46e635e2c99/valeant-opportunity-time-1506695752?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Given yesterday's confusion regarding a Canadian filing that resulted in a 4.3% drop in Valeant Pharmaceutical International's (VRX) shares, it's clear that investors are still conditioned to sell first and ask questions later.  The thing is, Valeant might not be the same company that it was one year ago."
VRX,VRX:US,BBG000DLFM21,Valeant: Opportunity Time?,2017-09-29 14:35:00 +0000,http://finance.yahoo.com/r/ccd5456e-9ea7-3a0c-b2a6-b46e635e2c99/valeant-opportunity-time-1506695752?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Given yesterday's confusion regarding a Canadian filing that resulted in a 4.3% drop in Valeant Pharmaceutical International's (VRX) shares, it's clear that investors are still conditioned to sell first and ask questions later.  The thing is, Valeant might not be the same company that it was one year ago."
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Sep 29, 2017 :  ZGNX, MTU, ROKU, NOK, HLT, QQQ, UN, MU, RAD, ERIC, VRX, NVDA",2017-09-29 12:52:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3JOau_FN4M0/pre-market-most-active-for-sep-29-2017-zgnx-mtu-roku-nok-hlt-qqq-un-mu-rad-eric-vrx-nvda-cm853009,The NASDAQ 100 Pre Market Indicator is up 5 69 to 5 938 76 The total Pre Market volume is currently 4 191 009 shares traded The following are the most active stocks for the pre market session Zogenix Inc ZGNX is 19 275 at 32 15 with 1 608 101 shares traded
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Sep 29, 2017 :  ZGNX, MTU, ROKU, NOK, HLT, QQQ, UN, MU, RAD, ERIC, VRX, NVDA",2017-09-29 12:52:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3JOau_FN4M0/pre-market-most-active-for-sep-29-2017-zgnx-mtu-roku-nok-hlt-qqq-un-mu-rad-eric-vrx-nvda-cm853009,The NASDAQ 100 Pre Market Indicator is up 5 69 to 5 938 76 The total Pre Market volume is currently 4 191 009 shares traded The following are the most active stocks for the pre market session Zogenix Inc ZGNX is 19 275 at 32 15 with 1 608 101 shares traded
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Trending Tickers: PTC Therapeutics and Valeant Pharmaceuticals,2017-09-29 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000469.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 29, 2017 / The Dow Jones Industrial Average and the S&P 500 Index edged higher Thursday as investors continued to digest details of the GOP's tax reform plan and data ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Trending Tickers: PTC Therapeutics and Valeant Pharmaceuticals,2017-09-29 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000469.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 29, 2017 / The Dow Jones Industrial Average and the S&P 500 Index edged higher Thursday as investors continued to digest details of the GOP's tax reform plan and data ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising Despite Lackluster GDP Report - Canadian Commentary,2017-09-29 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uU-1mzYn_No/canadian-stocks-are-rising-despite-lackluster-gdp-report--canadian-commentary-20170929-00629,Canadian Stocks Are Rising Despite Lackluster GDP Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising Despite Lackluster GDP Report - Canadian Commentary,2017-09-29 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uU-1mzYn_No/canadian-stocks-are-rising-despite-lackluster-gdp-report--canadian-commentary-20170929-00629,Canadian Stocks Are Rising Despite Lackluster GDP Report - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group,2017-09-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-inova-110000469.html?.tsrc=rss,"LAVAL, Quebec, Sept. 29, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced that it has completed the sale of the iNova Pharmaceuticals (""iNova"") business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash.  Valeant will use net proceeds of approximately $920 million from the sale to repay term loan debt under its Senior Credit Facility.  ""With the closure of the iNova sale, we've achieved another milestone in our efforts to reduce debt and simplify our portfolio,"" said Joseph C. Papa, chairman and CEO, Valeant."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group,2017-09-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-inova-110000517.html?.tsrc=rss,Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group,2017-09-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-inova-110000517.html?.tsrc=rss,Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group,2017-09-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-inova-110000469.html?.tsrc=rss,"LAVAL, Quebec, Sept. 29, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced that it has completed the sale of the iNova Pharmaceuticals (""iNova"") business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash.  Valeant will use net proceeds of approximately $920 million from the sale to repay term loan debt under its Senior Credit Facility.  ""With the closure of the iNova sale, we've achieved another milestone in our efforts to reduce debt and simplify our portfolio,"" said Joseph C. Papa, chairman and CEO, Valeant."
VRX,VRX:US,BBG000DLFM21,Stocks Poised To End Week At 4-Month Peak -- Canadian Commentary,2017-09-29 08:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TUPISx0pNoc/stocks-poised-to-end-week-at-4month-peak--canadian-commentary-20170929-00454,Stocks Poised To End Week At 4-Month Peak -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Stocks Poised To End Week At 4-Month Peak -- Canadian Commentary,2017-09-29 08:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TUPISx0pNoc/stocks-poised-to-end-week-at-4month-peak--canadian-commentary-20170929-00454,Stocks Poised To End Week At 4-Month Peak -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Closes Sale Of INova Pharma To Pacific Equity Partners And Carlyle Group,2017-09-29 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aeI9GenmCiQ/valeant-closes-sale-of-inova-pharma-to-pacific-equity-partners-and-carlyle-group-20170929-00285,Valeant Closes Sale Of INova Pharma To Pacific Equity Partners And Carlyle Group
VRX,VRX:US,BBG000DLFM21,Valeant Closes Sale Of INova Pharma To Pacific Equity Partners And Carlyle Group,2017-09-29 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aeI9GenmCiQ/valeant-closes-sale-of-inova-pharma-to-pacific-equity-partners-and-carlyle-group-20170929-00285,Valeant Closes Sale Of INova Pharma To Pacific Equity Partners And Carlyle Group
VRX,VRX:CT,BBG000DC8S17,Could Being Undervalued Boost Rite Aid (RAD) Stock?,2017-09-29 00:37:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3c9GMwtC_og/could-being-undervalued-boost-rite-aid-rad-stock-cm852916,InvestorPlace Stock Market News Stock Advice amp Trading Tips Last week brought some good news for holders of Rite Aid Corporation NYSE RAD stock Rite Aid announced that the FTC had approved its revised deal to sell nearly half of its stores to Walgreens
VRX,VRX:US,BBG000DLFM21,Could Being Undervalued Boost Rite Aid (RAD) Stock?,2017-09-29 00:37:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3c9GMwtC_og/could-being-undervalued-boost-rite-aid-rad-stock-cm852916,InvestorPlace Stock Market News Stock Advice amp Trading Tips Last week brought some good news for holders of Rite Aid Corporation NYSE RAD stock Rite Aid announced that the FTC had approved its revised deal to sell nearly half of its stores to Walgreens
VRX,VRX:CT,BBG000DC8S17,Could Being Undervalued Boost Rite Aid (RAD) Stock?,2017-09-28 19:37:02 +0000,https://finance.yahoo.com/news/could-being-undervalued-boost-rite-193702581.html?.tsrc=rss,"Last week brought some good news for holders of Rite Aid Corporation (NYSE:RAD) stock.  Rite Aid announced that the FTC had approved its revised deal to sell nearly half of its stores to Walgreens Boots Alliance Inc (NASDAQ:WBA) for $4.38 billion.  Walgreens tried to buy Rite Aid outright in 2015, but the deal was called off in June due to antitrust concerns."
VRX,VRX:US,BBG000DLFM21,Could Being Undervalued Boost Rite Aid (RAD) Stock?,2017-09-28 19:37:02 +0000,https://finance.yahoo.com/news/could-being-undervalued-boost-rite-193702581.html?.tsrc=rss,"Last week brought some good news for holders of Rite Aid Corporation (NYSE:RAD) stock.  Rite Aid announced that the FTC had approved its revised deal to sell nearly half of its stores to Walgreens Boots Alliance Inc (NASDAQ:WBA) for $4.38 billion.  Walgreens tried to buy Rite Aid outright in 2015, but the deal was called off in June due to antitrust concerns."
VRX,VRX:US,BBG000DLFM21,UPDATE: Why Valeant is Sinking,2017-09-28 16:39:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/coDRCDe4v7A/update-why-valeant-is-sinking-cm852608,UPDATE Well this is embarrassing It turns out that Valeant s private placement filing is only for senior notes not stock as one analyst had reasoned Still the filing does seem to be the catalyst for today s selloff Maybe just the possibility of adding more debt on top of the exciting
VRX,VRX:CT,BBG000DC8S17,UPDATE: Why Valeant is Sinking,2017-09-28 16:39:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/coDRCDe4v7A/update-why-valeant-is-sinking-cm852608,UPDATE Well this is embarrassing It turns out that Valeant s private placement filing is only for senior notes not stock as one analyst had reasoned Still the filing does seem to be the catalyst for today s selloff Maybe just the possibility of adding more debt on top of the exciting
VRX,VRX:CT,BBG000DC8S17,UPDATE: Why Valeant is Sinking,2017-09-28 15:27:00 +0000,http://finance.yahoo.com/r/2b60b382-7372-32ee-ab8e-3d8f275976ca/why-valeant-is-sinking-1506609886?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"UPDATE: Well, this is embarrassing. It turns out that Valeant's private placement filing is only for senior notes, not stock, as one analyst had reasoned. Still, the filing does seem to be the catalyst ..."
VRX,VRX:US,BBG000DLFM21,UPDATE: Why Valeant is Sinking,2017-09-28 15:27:00 +0000,http://finance.yahoo.com/r/2b60b382-7372-32ee-ab8e-3d8f275976ca/why-valeant-is-sinking-1506609886?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"UPDATE: Well, this is embarrassing. It turns out that Valeant's private placement filing is only for senior notes, not stock, as one analyst had reasoned. Still, the filing does seem to be the catalyst ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-09-28 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zd5JgbN4yew/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170928-00909,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-09-28 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zd5JgbN4yew/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170928-00909,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans,2017-09-28 01:22:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-provides-canadian-regulatory-012200720.html?.tsrc=rss,Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans,2017-09-28 01:22:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-provides-canadian-regulatory-012200720.html?.tsrc=rss,Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans
VRX,VRX:US,BBG000DLFM21,3 Top Stocks in Healthcare,2017-09-27 13:55:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aOWpGqsfJW0/3-top-stocks-in-healthcare-cm851584,Healthcare stocks are hot this year The sector tracking iShares S amp P Global Healthcare index has already tacked on a 17 gain this year If you re looking to catch a ride on the healthcare train Align Technology Inc NASDAQ ALGN Mazor Robotics Ltd NASDAQ MZOR
VRX,VRX:CT,BBG000DC8S17,3 Top Stocks in Healthcare,2017-09-27 13:55:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aOWpGqsfJW0/3-top-stocks-in-healthcare-cm851584,Healthcare stocks are hot this year The sector tracking iShares S amp P Global Healthcare index has already tacked on a 17 gain this year If you re looking to catch a ride on the healthcare train Align Technology Inc NASDAQ ALGN Mazor Robotics Ltd NASDAQ MZOR
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-27 12:00:25 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120025041.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-27 12:00:25 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120025041.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Recovering Following Yesterday's Loss - Canadian Commentary,2017-09-27 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SnFLYfUUD2w/canadian-stocks-are-recovering-following-yesterdays-loss--canadian-commentary-20170927-00836,Canadian Stocks Are Recovering Following Yesterday's Loss - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Recovering Following Yesterday's Loss - Canadian Commentary,2017-09-27 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SnFLYfUUD2w/canadian-stocks-are-recovering-following-yesterdays-loss--canadian-commentary-20170927-00836,Canadian Stocks Are Recovering Following Yesterday's Loss - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference,2017-09-27 11:00:00 +0000,https://finance.yahoo.com/news/valeant-participate-deutsche-bank-25th-110000764.html?.tsrc=rss,"LAVAL, Quebec , Sept. 27, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that Paul S. Herendeen , executive vice president, ..."
VRX,VRX:US,BBG000DLFM21,Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference,2017-09-27 11:00:00 +0000,https://finance.yahoo.com/news/valeant-participate-deutsche-bank-25th-110000764.html?.tsrc=rss,"LAVAL, Quebec , Sept. 27, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that Paul S. Herendeen , executive vice president, ..."
VRX,VRX:US,BBG000DLFM21,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 19:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rAwfgjO4Ips/is-teva-pharmaceutical-teva-stock-worth-the-risk-cm851359,InvestorPlace Stock Market News Stock Advice amp Trading Tips Those who do not learn from history are doomed to repeat it That feels awfully applicable when talking about 160 Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA Source Open Grid
VRX,VRX:CT,BBG000DC8S17,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 19:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rAwfgjO4Ips/is-teva-pharmaceutical-teva-stock-worth-the-risk-cm851359,InvestorPlace Stock Market News Stock Advice amp Trading Tips Those who do not learn from history are doomed to repeat it That feels awfully applicable when talking about 160 Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA Source Open Grid
VRX,VRX:US,BBG000DLFM21,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 15:25:20 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-teva-stock-worth-152520894.html?.tsrc=rss,"This highly levered, acquisition-focused growth story has come crashing down recently.  It is eerily similar to when the highly-levered, acquisition-focused growth story of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell apart not too long ago.  As we all know, VRX stock went bust and hasn’t recovered."
VRX,VRX:CT,BBG000DC8S17,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 15:25:20 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-teva-stock-worth-152520894.html?.tsrc=rss,"This highly levered, acquisition-focused growth story has come crashing down recently.  It is eerily similar to when the highly-levered, acquisition-focused growth story of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell apart not too long ago.  As we all know, VRX stock went bust and hasn’t recovered."
VRX,VRX:CT,BBG000DC8S17,How Low Does Valeant Pharmaceuticals' Debt Really Need to Go?,2017-09-26 12:51:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GjtYqGPpoXU/how-low-does-valeant-pharmaceuticals-debt-really-need-to-go-cm850809,There s as much of a chance that Valeant Pharmaceuticals NYSE VRX wipes out its debt of nearly 28 5 billion anytime soon as there is of Donald Trump receiving a birthday present from football player Colin Kaepernick Or vice versa But it s a mistake to think that Valeant
VRX,VRX:US,BBG000DLFM21,How Low Does Valeant Pharmaceuticals' Debt Really Need to Go?,2017-09-26 12:51:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GjtYqGPpoXU/how-low-does-valeant-pharmaceuticals-debt-really-need-to-go-cm850809,There s as much of a chance that Valeant Pharmaceuticals NYSE VRX wipes out its debt of nearly 28 5 billion anytime soon as there is of Donald Trump receiving a birthday present from football player Colin Kaepernick Or vice versa But it s a mistake to think that Valeant
VRX,VRX:CT,BBG000DC8S17,How Low Does Valeant Pharmaceuticals&apos; Debt Really Need to Go?,2017-09-26 11:37:00 +0000,http://finance.yahoo.com/r/88694516-7bea-3a29-ac82-21715a3992a9/how-low-does-valeant-pharmaceuticals-debt-really-n.aspx?yptr=yahoo&.tsrc=rss,It&apos;s much closer to Valeant&apos;s current debt load of $28.5 billion than it is to zero.
VRX,VRX:US,BBG000DLFM21,How Low Does Valeant Pharmaceuticals&apos; Debt Really Need to Go?,2017-09-26 11:37:00 +0000,http://finance.yahoo.com/r/88694516-7bea-3a29-ac82-21715a3992a9/how-low-does-valeant-pharmaceuticals-debt-really-n.aspx?yptr=yahoo&.tsrc=rss,It&apos;s much closer to Valeant&apos;s current debt load of $28.5 billion than it is to zero.
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals (VRX) Stock is Still no Bargain,2017-09-25 19:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0i1qhFsAPIU/why-valeant-pharmaceuticals-vrx-stock-is-still-no-bargain-cm850629,InvestorPlace Stock Market News Stock Advice amp Trading Tips Most of us have heard of Valeant Pharmaceuticals Intl Inc NYSE VRX VRX stock infamously went from approximately 260 per share during the summer of 2015 to around 9 a share earlier this
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals (VRX) Stock is Still no Bargain,2017-09-25 19:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0i1qhFsAPIU/why-valeant-pharmaceuticals-vrx-stock-is-still-no-bargain-cm850629,InvestorPlace Stock Market News Stock Advice amp Trading Tips Most of us have heard of Valeant Pharmaceuticals Intl Inc NYSE VRX VRX stock infamously went from approximately 260 per share during the summer of 2015 to around 9 a share earlier this
VRX,VRX:US,BBG000DLFM21,2 Things to Love About Microsoft Corporation (MSFT) Stock,2017-09-25 19:47:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N2FPcL6deRs/2-things-to-love-about-microsoft-corporation-msft-stock-cm850622,InvestorPlace Stock Market News Stock Advice amp Trading Tips Canada s national newspaper the Globe and Mail frequently runs a feature in its business section called Me and My Money where average Canadians discuss how they invest their retirement savings Author
VRX,VRX:CT,BBG000DC8S17,2 Things to Love About Microsoft Corporation (MSFT) Stock,2017-09-25 19:47:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N2FPcL6deRs/2-things-to-love-about-microsoft-corporation-msft-stock-cm850622,InvestorPlace Stock Market News Stock Advice amp Trading Tips Canada s national newspaper the Globe and Mail frequently runs a feature in its business section called Me and My Money where average Canadians discuss how they invest their retirement savings Author
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals (VRX) Stock is Still no Bargain,2017-09-25 15:00:13 +0000,https://finance.yahoo.com/news/why-valeant-pharmaceuticals-vrx-stock-150013464.html?.tsrc=rss,"Most of us have heard of Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  VRX stock infamously went from approximately $260 per share during the summer of 2015 to around $9 a share earlier this year.  VRX stock has since rebounded, selling for $17 and change in July before falling back to today’s levels near $14."
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals (VRX) Stock is Still no Bargain,2017-09-25 15:00:13 +0000,https://finance.yahoo.com/news/why-valeant-pharmaceuticals-vrx-stock-150013464.html?.tsrc=rss,"Most of us have heard of Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  VRX stock infamously went from approximately $260 per share during the summer of 2015 to around $9 a share earlier this year.  VRX stock has since rebounded, selling for $17 and change in July before falling back to today’s levels near $14."
VRX,VRX:US,BBG000DLFM21,Valeant Could Gain 33%. It's Still Not a Buy.,2017-09-25 13:56:00 +0000,http://finance.yahoo.com/r/31b34d0f-f265-3990-bf4f-93c48896d6ea/valeant-could-gain-33-its-still-not-a-buy-1506347805?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"While our target implies material upside, we are sticking with our Hold rating pending greater visibility on Xifaxan demand trends, the Siliq launch, stabilization of the Dermatology business, and further steps to strengthen the balance sheet.  Shares of Valeant Pharmaceuticals International have gained 0.9% to $14.14 at 9:47 a.m. today."
VRX,VRX:CT,BBG000DC8S17,Valeant Could Gain 33%. It's Still Not a Buy.,2017-09-25 13:56:00 +0000,http://finance.yahoo.com/r/31b34d0f-f265-3990-bf4f-93c48896d6ea/valeant-could-gain-33-its-still-not-a-buy-1506347805?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"While our target implies material upside, we are sticking with our Hold rating pending greater visibility on Xifaxan demand trends, the Siliq launch, stabilization of the Dermatology business, and further steps to strengthen the balance sheet.  Shares of Valeant Pharmaceuticals International have gained 0.9% to $14.14 at 9:47 a.m. today."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed Despite Energy Rally - Canadian Commentary,2017-09-25 11:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z-9fd52AUWg/canadian-stocks-are-little-changed-despite-energy-rally--canadian-commentary-20170925-00860,Canadian Stocks Are Little Changed Despite Energy Rally - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed Despite Energy Rally - Canadian Commentary,2017-09-25 11:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z-9fd52AUWg/canadian-stocks-are-little-changed-despite-energy-rally--canadian-commentary-20170925-00860,Canadian Stocks Are Little Changed Despite Energy Rally - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Generic Drug Makers Face Pricing Issues That Other Pharmas Don&apos;t,2017-09-22 17:25:18 +0000,http://finance.yahoo.com/r/e8943a6d-0fb4-3cd7-b343-b04496d4bf70/generic-drug-makers-face-pricing-issues-unlike-other-pharma-companies?src=A00220&yptr=yahoo&.tsrc=rss,"Everyone knows high prescription drug prices are a problem, but except for pharma stockholders, few people may realize that price cuts are rippling through the generic side of the industry."
VRX,VRX:CT,BBG000DC8S17,Generic Drug Makers Face Pricing Issues That Other Pharmas Don&apos;t,2017-09-22 17:25:18 +0000,http://finance.yahoo.com/r/e8943a6d-0fb4-3cd7-b343-b04496d4bf70/generic-drug-makers-face-pricing-issues-unlike-other-pharma-companies?src=A00220&yptr=yahoo&.tsrc=rss,"Everyone knows high prescription drug prices are a problem, but except for pharma stockholders, few people may realize that price cuts are rippling through the generic side of the industry."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Flat As Investors Turn Cautious - Canadian Commentary,2017-09-22 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/An9O74d4Zl8/canadian-stocks-are-flat-as-investors-turn-cautious--canadian-commentary-20170922-00491,Canadian Stocks Are Flat As Investors Turn Cautious - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Flat As Investors Turn Cautious - Canadian Commentary,2017-09-22 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/An9O74d4Zl8/canadian-stocks-are-flat-as-investors-turn-cautious--canadian-commentary-20170922-00491,Canadian Stocks Are Flat As Investors Turn Cautious - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Should Value Investors Consider Valeant Pharmaceuticals International (VRX) Stock?,2017-09-21 15:39:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s5d439MzGiI/should-value-investors-consider-valeant-pharmaceuticals-international-vrx-stock-cm848972,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
VRX,VRX:US,BBG000DLFM21,Should Value Investors Consider Valeant Pharmaceuticals International (VRX) Stock?,2017-09-21 15:39:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s5d439MzGiI/should-value-investors-consider-valeant-pharmaceuticals-international-vrx-stock-cm848972,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
VRX,VRX:CT,BBG000DC8S17,Should Value Investors Consider Valeant Pharmaceuticals International (VRX) Stock?,2017-09-21 13:55:01 +0000,https://finance.yahoo.com/news/value-investors-consider-valeant-pharmaceuticals-135501835.html?.tsrc=rss,"Valeant Pharmaceuticals is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front."
VRX,VRX:US,BBG000DLFM21,Should Value Investors Consider Valeant Pharmaceuticals International (VRX) Stock?,2017-09-21 13:55:01 +0000,https://finance.yahoo.com/news/value-investors-consider-valeant-pharmaceuticals-135501835.html?.tsrc=rss,"Valeant Pharmaceuticals is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front."
VRX,VRX:US,BBG000DLFM21,"John Paulson Buys Vistra Energy Corp, Altaba Inc, T-Mobile US Inc, Sells Extended Stay America ...",2017-09-21 12:34:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9gnLVTaX7AA/john-paulson-buys-vistra-energy-corp-altaba-inc-t-mobile-us-inc-sells-extended-stay-america-cm848863,John Paulson New Purchases VST AABA VWR HZNP XCRA NEWR DOVA BCR TGNA CTRP Added Positions TMUS VRX DISH MON MBBYF TEAM RAI NXPI FDX ISRG Reduced Positions STAY TEVA SHPG AGN MYL ALXN MNK AIG RLGY STE Sold Out AKRX MJN
VRX,VRX:CT,BBG000DC8S17,"John Paulson Buys Vistra Energy Corp, Altaba Inc, T-Mobile US Inc, Sells Extended Stay America ...",2017-09-21 12:34:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9gnLVTaX7AA/john-paulson-buys-vistra-energy-corp-altaba-inc-t-mobile-us-inc-sells-extended-stay-america-cm848863,John Paulson New Purchases VST AABA VWR HZNP XCRA NEWR DOVA BCR TGNA CTRP Added Positions TMUS VRX DISH MON MBBYF TEAM RAI NXPI FDX ISRG Reduced Positions STAY TEVA SHPG AGN MYL ALXN MNK AIG RLGY STE Sold Out AKRX MJN
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-21 12:00:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120042395.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-21 12:00:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120042395.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary,2017-09-20 10:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6KEuq8-ZyK4/canadian-stocks-are-rising-on-energy-strength--canadian-commentary-20170920-00777,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary,2017-09-20 10:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6KEuq8-ZyK4/canadian-stocks-are-rising-on-energy-strength--canadian-commentary-20170920-00777,Canadian Stocks Are Rising On Energy Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,GlassHouse: NuVasive Using The 'Valeant Playbook' To Deceive Investors,2017-09-19 15:01:15 +0000,https://finance.yahoo.com/news/glasshouse-nuvasive-using-valeant-playbook-150115805.html?.tsrc=rss,"Short seller GlassHouse Research has accused medical device company NuVasive, Inc. (NASDAQ: NUVA ) of “irregular accounting” practices and says the stock has more than 50 percent downside. In a new report, ..."
VRX,VRX:CT,BBG000DC8S17,GlassHouse: NuVasive Using The 'Valeant Playbook' To Deceive Investors,2017-09-19 15:01:15 +0000,https://finance.yahoo.com/news/glasshouse-nuvasive-using-valeant-playbook-150115805.html?.tsrc=rss,"Short seller GlassHouse Research has accused medical device company NuVasive, Inc. (NASDAQ: NUVA ) of “irregular accounting” practices and says the stock has more than 50 percent downside. In a new report, ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Is A New Drug Approval On The Horizon?,2017-09-18 14:33:00 +0000,http://finance.yahoo.com/r/a9b50ab9-fec9-381e-9ea0-d0b89cb98683/valeant-pharmaceuticals-is-a-new-drug-approval-on-the-horizon-1505745193?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"H.C. Wainwright’s Raghuram Selvaraju predicts that Valeant Pharmaceuticals (VRX) could receive FDA approval this week for its experimental glaucoma drug Vyzulta.  For those who are not familiar with the situation, in July 2016, Valeant announced that it had received a complete response letter from the FDA regarding Vyzulta.  The letter highlighted concerns about Bausch & Lomb’s manufacturing facility in Tampa."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Is A New Drug Approval On The Horizon?,2017-09-18 14:33:00 +0000,http://finance.yahoo.com/r/a9b50ab9-fec9-381e-9ea0-d0b89cb98683/valeant-pharmaceuticals-is-a-new-drug-approval-on-the-horizon-1505745193?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"H.C. Wainwright’s Raghuram Selvaraju predicts that Valeant Pharmaceuticals (VRX) could receive FDA approval this week for its experimental glaucoma drug Vyzulta.  For those who are not familiar with the situation, in July 2016, Valeant announced that it had received a complete response letter from the FDA regarding Vyzulta.  The letter highlighted concerns about Bausch & Lomb’s manufacturing facility in Tampa."
VRX,VRX:US,BBG000DLFM21,What You Should Know About The Drug Approval Valeant Could Receive This Week,2017-09-18 13:54:23 +0000,https://finance.yahoo.com/news/know-drug-approval-valeant-could-135423657.html?.tsrc=rss,"Amid “overstated” legal issues and in the aftermath of natural disaster, Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) may profit from a positive catalyst this week, according to H.C. Wainwright & Co. ..."
VRX,VRX:CT,BBG000DC8S17,What You Should Know About The Drug Approval Valeant Could Receive This Week,2017-09-18 13:54:23 +0000,https://finance.yahoo.com/news/know-drug-approval-valeant-could-135423657.html?.tsrc=rss,"Amid “overstated” legal issues and in the aftermath of natural disaster, Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) may profit from a positive catalyst this week, according to H.C. Wainwright & Co. ..."
VRX,VRX:CT,BBG000DC8S17,Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference,2017-09-18 11:00:00 +0000,https://finance.yahoo.com/news/valeant-participate-cantor-fitzgerald-global-110000468.html?.tsrc=rss,Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference
VRX,VRX:US,BBG000DLFM21,Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference,2017-09-18 11:00:00 +0000,https://finance.yahoo.com/news/valeant-participate-cantor-fitzgerald-global-110000468.html?.tsrc=rss,Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising Despite Commodity Weakness - Canadian Commentary,2017-09-18 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6ghJOFxseoI/canadian-stocks-are-rising-despite-commodity-weakness--canadian-commentary-20170918-00817,Canadian Stocks Are Rising Despite Commodity Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising Despite Commodity Weakness - Canadian Commentary,2017-09-18 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6ghJOFxseoI/canadian-stocks-are-rising-despite-commodity-weakness--canadian-commentary-20170918-00817,Canadian Stocks Are Rising Despite Commodity Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Own Alphabet Inc. Stock? Antitrust Is on the Horizon,2017-09-15 16:40:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPc0z_w865s/own-alphabet-inc-stock-antitrust-is-on-the-horizon-cm846433,InvestorPlace Stock Market News Stock Advice amp Trading Tips Truth be told Alphabet Inc NASDAQ GOOGL NASDAQ GOOG has been accused of operating an unfair monopoly ever since its search engine the expansive Google rose to prominence in
VRX,VRX:US,BBG000DLFM21,Own Alphabet Inc. Stock? Antitrust Is on the Horizon,2017-09-15 16:40:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPc0z_w865s/own-alphabet-inc-stock-antitrust-is-on-the-horizon-cm846433,InvestorPlace Stock Market News Stock Advice amp Trading Tips Truth be told Alphabet Inc NASDAQ GOOGL NASDAQ GOOG has been accused of operating an unfair monopoly ever since its search engine the expansive Google rose to prominence in
VRX,VRX:US,BBG000DLFM21,A Closer Look At 2 Activist Campaigns - ADP/Pershing Square And Procter & Gamble/Trian Partners,2017-09-15 16:39:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UrOBTv8SVbg/a-closer-look-at-2-activist-campaigns-adppershing-square-and-procter-gambletrian-partners-cm846432,By George Putnam ByGeorge Putnam In our previous note we explored investing in stocks after an activist investor has taken a position The five metrics that can help you evaluate whether the activist will be successful in boosting the stock included the following In our previous note
VRX,VRX:CT,BBG000DC8S17,A Closer Look At 2 Activist Campaigns - ADP/Pershing Square And Procter & Gamble/Trian Partners,2017-09-15 16:39:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UrOBTv8SVbg/a-closer-look-at-2-activist-campaigns-adppershing-square-and-procter-gambletrian-partners-cm846432,By George Putnam ByGeorge Putnam In our previous note we explored investing in stocks after an activist investor has taken a position The five metrics that can help you evaluate whether the activist will be successful in boosting the stock included the following In our previous note
VRX,VRX:US,BBG000DLFM21,"Valeant Commits $200,000 to Support Hurricane Relief Efforts",2017-09-15 13:00:00 +0000,https://finance.yahoo.com/news/valeant-commits-200-000-support-130000236.html?.tsrc=rss,"Valeant Commits $200,000 to Support Hurricane Relief Efforts"
VRX,VRX:CT,BBG000DC8S17,"Valeant Commits $200,000 to Support Hurricane Relief Efforts",2017-09-15 13:00:00 +0000,https://finance.yahoo.com/news/valeant-commits-200-000-support-130000236.html?.tsrc=rss,"Valeant Commits $200,000 to Support Hurricane Relief Efforts"
VRX,VRX:US,BBG000DLFM21,Own Alphabet Inc. Stock? Antitrust Is on the Horizon,2017-09-15 12:26:58 +0000,https://finance.yahoo.com/news/own-alphabet-inc-stock-antitrust-122658373.html?.tsrc=rss,"Truth be told, Alphabet Inc (NASDAQ:GOOGL, NASDAQ:GOOG) has been accused of operating an unfair monopoly ever since its search engine, the expansive Google, rose to prominence in the early 2000’s. The fact that it’s happening now shouldn’t be a surprise to GOOGL shareholders.  On the other hand, a closer inspection of the history of all the antitrust arguments against Alphabet will reveal the tone and timbre (not to mention the frequency) of these allegations is changing.  While it’s unlikely any of these pressures will dethrone Google’s as the king of internet advertising in the western hemisphere, the effort to loosen Alphabet’s grip on the market may finally be creating a real headwind for the behemoth."
VRX,VRX:CT,BBG000DC8S17,Own Alphabet Inc. Stock? Antitrust Is on the Horizon,2017-09-15 12:26:58 +0000,https://finance.yahoo.com/news/own-alphabet-inc-stock-antitrust-122658373.html?.tsrc=rss,"Truth be told, Alphabet Inc (NASDAQ:GOOGL, NASDAQ:GOOG) has been accused of operating an unfair monopoly ever since its search engine, the expansive Google, rose to prominence in the early 2000’s. The fact that it’s happening now shouldn’t be a surprise to GOOGL shareholders.  On the other hand, a closer inspection of the history of all the antitrust arguments against Alphabet will reveal the tone and timbre (not to mention the frequency) of these allegations is changing.  While it’s unlikely any of these pressures will dethrone Google’s as the king of internet advertising in the western hemisphere, the effort to loosen Alphabet’s grip on the market may finally be creating a real headwind for the behemoth."
VRX,VRX:CT,BBG000DC8S17,"Chou RRSP Fund Buys Valeant Pharmaceuticals International Inc, EXCO Resources Inc, Sells ...",2017-09-13 17:34:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fha2PCSSnhk/chou-rrsp-fund-buys-valeant-pharmaceuticals-international-inc-exco-resources-inc-sells-cm845252,Chou RRSP Fund New Purchases XCO Added Positions VRX Reduced Positions IFP CFX TS B New Purchases XCO New Purchases XCO Added Positions VRX Added Positions VRX Reduced Positions IFP CFX TS B
VRX,VRX:US,BBG000DLFM21,"Chou RRSP Fund Buys Valeant Pharmaceuticals International Inc, EXCO Resources Inc, Sells ...",2017-09-13 17:34:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fha2PCSSnhk/chou-rrsp-fund-buys-valeant-pharmaceuticals-international-inc-exco-resources-inc-sells-cm845252,Chou RRSP Fund New Purchases XCO Added Positions VRX Reduced Positions IFP CFX TS B New Purchases XCO New Purchases XCO Added Positions VRX Added Positions VRX Reduced Positions IFP CFX TS B
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-09-13 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mN7IMJPQaaU/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170913-00775,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-09-13 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mN7IMJPQaaU/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170913-00775,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Why Rite Aid Corporation (RAD) Stock Has More Room to Run,2017-09-12 18:35:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0Ga5yUXe18/why-rite-aid-corporation-rad-stock-has-more-room-to-run-cm844536,InvestorPlace Stock Market News Stock Advice amp Trading Tips One of Wall Street s oldest sayings is that one should never try to catch a falling knife That sentiment applied perfectly to 160 Rite Aid Corporation NYSE RAD all year RAD stock has only known one
VRX,VRX:US,BBG000DLFM21,Why Rite Aid Corporation (RAD) Stock Has More Room to Run,2017-09-12 18:35:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0Ga5yUXe18/why-rite-aid-corporation-rad-stock-has-more-room-to-run-cm844536,InvestorPlace Stock Market News Stock Advice amp Trading Tips One of Wall Street s oldest sayings is that one should never try to catch a falling knife That sentiment applied perfectly to 160 Rite Aid Corporation NYSE RAD all year RAD stock has only known one
VRX,VRX:US,BBG000DLFM21,"Tuesday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Snap Inc (SNAP) and Tesla Inc (TSLA)",2017-09-12 18:35:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sO1x_yK1ooI/tuesdays-vital-data-teva-pharmaceutical-industries-ltd-adr-teva-snap-inc-snap-and-tesla-inc-tsla-cm844533,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading higher again this morning as the North Korea hurricane relief rally continues Technology will be in focus today as traders count down to the release of Apple Inc s
VRX,VRX:CT,BBG000DC8S17,"Tuesday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Snap Inc (SNAP) and Tesla Inc (TSLA)",2017-09-12 18:35:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sO1x_yK1ooI/tuesdays-vital-data-teva-pharmaceutical-industries-ltd-adr-teva-snap-inc-snap-and-tesla-inc-tsla-cm844533,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading higher again this morning as the North Korea hurricane relief rally continues Technology will be in focus today as traders count down to the release of Apple Inc s
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is STILL Too Ugly to Buy,2017-09-12 13:14:35 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-131435634.html?.tsrc=rss,"There’s no doubt that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has made some progress so far this year.  Bankruptcy risk seemed material for Valeant stock as recently as earlier this year.  Under CEO Joe Papa, however, VRX stock has at least has bought itself some time."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is STILL Too Ugly to Buy,2017-09-12 13:14:35 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-131435634.html?.tsrc=rss,"There’s no doubt that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has made some progress so far this year.  Bankruptcy risk seemed material for Valeant stock as recently as earlier this year.  Under CEO Joe Papa, however, VRX stock has at least has bought itself some time."
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-12 12:01:03 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120103557.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-12 12:01:03 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120103557.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Trending Tickers: Endo International and Valeant Pharmaceuticals,2017-09-12 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000898.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 12, 2017 / Markets rallied sharply Monday as damage from Hurricane Irma was less-than-expected. The Dow Jones Industrial Average spiked 1.19 percent to close at 22,057.37, ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Trending Tickers: Endo International and Valeant Pharmaceuticals,2017-09-12 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000898.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 12, 2017 / Markets rallied sharply Monday as damage from Hurricane Irma was less-than-expected. The Dow Jones Industrial Average spiked 1.19 percent to close at 22,057.37, ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Extending Yesterday's Gains - Canadian Commentary,2017-09-12 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cip5JGNkfP0/canadian-stocks-are-extending-yesterdays-gains--canadian-commentary-20170912-00964,Canadian Stocks Are Extending Yesterday's Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Extending Yesterday's Gains - Canadian Commentary,2017-09-12 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cip5JGNkfP0/canadian-stocks-are-extending-yesterdays-gains--canadian-commentary-20170912-00964,Canadian Stocks Are Extending Yesterday's Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,DST faces class action over profit-sharing plan,2017-09-11 18:35:08 +0000,http://finance.yahoo.com/r/b8dc0e17-347b-3287-9700-8b938dbe2183/dst-systems-profit-sharing-class-action-lawsuit.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"A former employee at DST Systems Inc. filed a class-action lawsuit against the Kansas City company for breaching its fiduciary duty related to its employee retirement plan.  Stephanie Ostrander, who worked at DST from 1991 to 2016, filed the suit Thursday in federal court in Kansas City on behalf of all employees at the company who participate in its 401(k) profit-sharing plan."
VRX,VRX:CT,BBG000DC8S17,DST faces class action over profit-sharing plan,2017-09-11 18:35:08 +0000,http://finance.yahoo.com/r/b8dc0e17-347b-3287-9700-8b938dbe2183/dst-systems-profit-sharing-class-action-lawsuit.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"A former employee at DST Systems Inc. filed a class-action lawsuit against the Kansas City company for breaching its fiduciary duty related to its employee retirement plan.  Stephanie Ostrander, who worked at DST from 1991 to 2016, filed the suit Thursday in federal court in Kansas City on behalf of all employees at the company who participate in its 401(k) profit-sharing plan."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals International Breaks Above 200-Day Moving Average - Bullish for VRX,2017-09-11 17:36:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bFZ794_AyDQ/valeant-pharmaceuticals-international-breaks-above-200-day-moving-average-bullish-for-vrx-cm843867,In trading on Monday shares of Valeant Pharmaceuticals International Inc Symbol VRX crossed above their 200 day moving average of 13 85 changing hands as high as 14 13 per share Valeant Pharmaceuticals International Inc shares are currently trading up about 3 1 on the day The chart
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals International Breaks Above 200-Day Moving Average - Bullish for VRX,2017-09-11 17:36:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bFZ794_AyDQ/valeant-pharmaceuticals-international-breaks-above-200-day-moving-average-bullish-for-vrx-cm843867,In trading on Monday shares of Valeant Pharmaceuticals International Inc Symbol VRX crossed above their 200 day moving average of 13 85 changing hands as high as 14 13 per share Valeant Pharmaceuticals International Inc shares are currently trading up about 3 1 on the day The chart
VRX,VRX:US,BBG000DLFM21,Add Up The Pieces: GURU Could Be Worth $30,2017-09-11 14:39:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rl8PEYuc19E/add-up-the-pieces-guru-could-be-worth-30-cm843623,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:CT,BBG000DC8S17,Add Up The Pieces: GURU Could Be Worth $30,2017-09-11 14:39:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rl8PEYuc19E/add-up-the-pieces-guru-could-be-worth-30-cm843623,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:CT,BBG000DC8S17,"Buy Amazon, short Valeant among the top picks out of last year's Delivering Alpha",2017-09-11 13:49:29 +0000,http://finance.yahoo.com/r/33020cb5-b7cd-31aa-8a3b-1be2dc59d04a/104702189?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104702189&yptr=yahoo&.tsrc=rss,"Top investors had some solid picks, but some ideas may need a little more time to pan out."
VRX,VRX:US,BBG000DLFM21,"Buy Amazon, short Valeant among the top picks out of last year&apos;s Delivering Alpha",2017-09-11 13:49:29 +0000,https://finance.yahoo.com/news/buy-amazon-short-valeant-among-134929610.html?.tsrc=rss,"Top investors had some solid picks, but some ideas may need a little more time to pan out."
VRX,VRX:CT,BBG000DC8S17,"Buy Amazon, short Valeant among the top picks out of last year&apos;s Delivering Alpha",2017-09-11 13:49:29 +0000,https://finance.yahoo.com/news/buy-amazon-short-valeant-among-134929610.html?.tsrc=rss,"Top investors had some solid picks, but some ideas may need a little more time to pan out."
VRX,VRX:US,BBG000DLFM21,"Buy Amazon, short Valeant among the top picks out of last year's Delivering Alpha",2017-09-11 13:49:29 +0000,http://finance.yahoo.com/r/33020cb5-b7cd-31aa-8a3b-1be2dc59d04a/104702189?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104702189&yptr=yahoo&.tsrc=rss,"Top investors had some solid picks, but some ideas may need a little more time to pan out."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Tensions Ease - Canadian Commentary,2017-09-11 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8UWuZJMX0s/canadian-stocks-are-rising-as-tensions-ease--canadian-commentary-20170911-00800,Canadian Stocks Are Rising As Tensions Ease - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Tensions Ease - Canadian Commentary,2017-09-11 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8UWuZJMX0s/canadian-stocks-are-rising-as-tensions-ease--canadian-commentary-20170911-00800,Canadian Stocks Are Rising As Tensions Ease - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Follow the Crucial '$20 Level Rule' When Trading Stocks,2017-09-08 18:00:00 +0000,http://finance.yahoo.com/r/8e6f385c-192f-3be7-8b14-5c53074787d3/follow-the-crucial-20-level-rule-when-trading-stocks.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Breaking below the $20 for the first time in years is a warning signal.
VRX,VRX:CT,BBG000DC8S17,Follow the Crucial '$20 Level Rule' When Trading Stocks,2017-09-08 18:00:00 +0000,http://finance.yahoo.com/r/8e6f385c-192f-3be7-8b14-5c53074787d3/follow-the-crucial-20-level-rule-when-trading-stocks.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Breaking below the $20 for the first time in years is a warning signal.
VRX,VRX:CT,BBG000DC8S17,This Clear Catalyst Sent Valeant Pharmaceuticals Intl. Inc. 18% Lower in August,2017-09-08 15:54:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/93NbflDj68g/this-clear-catalyst-sent-valeant-pharmaceuticals-intl-inc-18-lower-in-august-cm842966,What happened Shares of Valeant Pharmaceuticals NYSE VRX a drugmaker that has predominantly grown via acquisitions over the years plunged by 18 during August according to data from S amp P Global Market Intelligence The standout reason for Valeant s poor performance
VRX,VRX:US,BBG000DLFM21,This Clear Catalyst Sent Valeant Pharmaceuticals Intl. Inc. 18% Lower in August,2017-09-08 15:54:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/93NbflDj68g/this-clear-catalyst-sent-valeant-pharmaceuticals-intl-inc-18-lower-in-august-cm842966,What happened Shares of Valeant Pharmaceuticals NYSE VRX a drugmaker that has predominantly grown via acquisitions over the years plunged by 18 during August according to data from S amp P Global Market Intelligence The standout reason for Valeant s poor performance
VRX,VRX:CT,BBG000DC8S17,This Clear Catalyst Sent Valeant Pharmaceuticals Intl. Inc. 18% Lower in August,2017-09-08 14:06:00 +0000,http://finance.yahoo.com/r/a5a326cb-99d2-302b-8230-89d0a764cea8/this-clear-catalyst-sent-valeant-pharmaceuticals-i.aspx?yptr=yahoo&.tsrc=rss,"Despite organic growth in its core operating segments, Wall Street remains concerned about the company&apos;s ability to pay down its debt."
VRX,VRX:US,BBG000DLFM21,This Clear Catalyst Sent Valeant Pharmaceuticals Intl. Inc. 18% Lower in August,2017-09-08 14:06:00 +0000,http://finance.yahoo.com/r/a5a326cb-99d2-302b-8230-89d0a764cea8/this-clear-catalyst-sent-valeant-pharmaceuticals-i.aspx?yptr=yahoo&.tsrc=rss,"Despite organic growth in its core operating segments, Wall Street remains concerned about the company&apos;s ability to pay down its debt."
VRX,VRX:US,BBG000DLFM21,$20 Should Be Your Cutoff Point,2017-09-08 12:00:00 +0000,http://finance.yahoo.com/r/bd78e03e-2774-3e88-8c63-40d536cda766/20-should-be-your-cutoff-point?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A stock that has been above $20 for years and then slips below $20 has a hard time finding new buyers.
VRX,VRX:CT,BBG000DC8S17,$20 Should Be Your Cutoff Point,2017-09-08 12:00:00 +0000,http://finance.yahoo.com/r/bd78e03e-2774-3e88-8c63-40d536cda766/20-should-be-your-cutoff-point?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A stock that has been above $20 for years and then slips below $20 has a hard time finding new buyers.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Dipping Despite Solid Jobs Report - Canadian Commentary,2017-09-08 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w2TuWLsmoPo/canadian-stocks-are-dipping-despite-solid-jobs-report--canadian-commentary-20170908-00551,Canadian Stocks Are Dipping Despite Solid Jobs Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Dipping Despite Solid Jobs Report - Canadian Commentary,2017-09-08 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w2TuWLsmoPo/canadian-stocks-are-dipping-despite-solid-jobs-report--canadian-commentary-20170908-00551,Canadian Stocks Are Dipping Despite Solid Jobs Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed Ahead Of EIA Report - Canadian Commentary,2017-09-07 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fPg0yCRATjU/canadian-stocks-are-little-changed-ahead-of-eia-report--canadian-commentary-20170907-01004,Canadian Stocks Are Little Changed Ahead Of EIA Report - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed Ahead Of EIA Report - Canadian Commentary,2017-09-07 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fPg0yCRATjU/canadian-stocks-are-little-changed-ahead-of-eia-report--canadian-commentary-20170907-01004,Canadian Stocks Are Little Changed Ahead Of EIA Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant To Participate At The Morgan Stanley Global Healthcare Conference,2017-09-06 11:00:00 +0000,https://finance.yahoo.com/news/valeant-participate-morgan-stanley-global-110000505.html?.tsrc=rss,"LAVAL, Quebec , Sept. 6, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that Joseph C. Papa , chairman and chief executive ..."
VRX,VRX:CT,BBG000DC8S17,Valeant To Participate At The Morgan Stanley Global Healthcare Conference,2017-09-06 11:00:00 +0000,https://finance.yahoo.com/news/valeant-participate-morgan-stanley-global-110000505.html?.tsrc=rss,"LAVAL, Quebec , Sept. 6, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that Joseph C. Papa , chairman and chief executive ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling After BoC Hikes Rates - Canadian Commentary,2017-09-06 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fnVUQRW9SDc/canadian-stocks-are-falling-after-boc-hikes-rates--canadian-commentary-20170906-00985,Canadian Stocks Are Falling After BoC Hikes Rates - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling After BoC Hikes Rates - Canadian Commentary,2017-09-06 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fnVUQRW9SDc/canadian-stocks-are-falling-after-boc-hikes-rates--canadian-commentary-20170906-00985,Canadian Stocks Are Falling After BoC Hikes Rates - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet",2017-09-06 02:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CyJAwP8WeIE/mdxg-revises-q3-outlook-two-down-one-to-go-for-blph-tech-opens-wallet-20170906-00050,"MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet"
VRX,VRX:US,BBG000DLFM21,"MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet",2017-09-06 02:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CyJAwP8WeIE/mdxg-revises-q3-outlook-two-down-one-to-go-for-blph-tech-opens-wallet-20170906-00050,"MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet"
VRX,VRX:US,BBG000DLFM21,Why Mallinckrodt Got Crushed,2017-09-05 20:51:00 +0000,http://finance.yahoo.com/r/535698df-4533-3417-a18e-18a77afa2bdf/why-mallinckrodt-got-crushed-1504644691?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It was a down day for the stock market.  The selloff by the Dow Industrials notwithstanding, Mallinckrodt (MNK) got manhandled after losing its bid to block Praxair (PX)  from marketing a generic version of  the respiratory treatment Inomax.  The court ruled invalidated Mallinckrodt’s patents, and sent the stock plunging more than 12.2% to end the day at $36.12 a share."
VRX,VRX:CT,BBG000DC8S17,Why Mallinckrodt Got Crushed,2017-09-05 20:51:00 +0000,http://finance.yahoo.com/r/535698df-4533-3417-a18e-18a77afa2bdf/why-mallinckrodt-got-crushed-1504644691?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It was a down day for the stock market.  The selloff by the Dow Industrials notwithstanding, Mallinckrodt (MNK) got manhandled after losing its bid to block Praxair (PX)  from marketing a generic version of  the respiratory treatment Inomax.  The court ruled invalidated Mallinckrodt’s patents, and sent the stock plunging more than 12.2% to end the day at $36.12 a share."
VRX,VRX:CT,BBG000DC8S17,Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118,2017-09-05 13:20:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-submits-drug-application-132000500.html?.tsrc=rss,Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118
VRX,VRX:US,BBG000DLFM21,Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118,2017-09-05 13:20:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-submits-drug-application-132000120.html?.tsrc=rss,"Novel Investigational Topical Lotion with Unique Formulation Targets the Treatment of Plaque Psoriasis LAVAL, Quebec , Sept. 5, 2017 /PRNewswire/ -- Ortho Dermatologics, a division of Valeant Pharmaceuticals ..."
VRX,VRX:CT,BBG000DC8S17,Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118,2017-09-05 13:20:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-submits-drug-application-132000120.html?.tsrc=rss,"Novel Investigational Topical Lotion with Unique Formulation Targets the Treatment of Plaque Psoriasis LAVAL, Quebec , Sept. 5, 2017 /PRNewswire/ -- Ortho Dermatologics, a division of Valeant Pharmaceuticals ..."
VRX,VRX:US,BBG000DLFM21,Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118,2017-09-05 13:20:00 +0000,https://finance.yahoo.com/news/ortho-dermatologics-submits-drug-application-132000500.html?.tsrc=rss,Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-05 12:00:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120037481.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-09-05 12:00:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120037481.html?.tsrc=rss,Valeant Pharmaceuticals International Inc NYSE:VRX
VRX,VRX:CT,BBG000DC8S17,Corporate News Blog - Intellipharmaceutics International Announces Appointment of CFO,2017-09-05 11:20:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-intellipharmaceutics-international-112000477.html?.tsrc=rss,"Research Desk Line-up: Valeant Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 5, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ..."
VRX,VRX:US,BBG000DLFM21,Corporate News Blog - Intellipharmaceutics International Announces Appointment of CFO,2017-09-05 11:20:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-intellipharmaceutics-international-112000477.html?.tsrc=rss,"Research Desk Line-up: Valeant Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 5, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down Despite Rising Commodity Prices - Canadian Commentary,2017-09-05 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jkqq9OLCXl4/canadian-stocks-are-down-despite-rising-commodity-prices--canadian-commentary-20170905-01015,Canadian Stocks Are Down Despite Rising Commodity Prices - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down Despite Rising Commodity Prices - Canadian Commentary,2017-09-05 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jkqq9OLCXl4/canadian-stocks-are-down-despite-rising-commodity-prices--canadian-commentary-20170905-01015,Canadian Stocks Are Down Despite Rising Commodity Prices - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Rite Aid Corporation",2017-09-02 17:48:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hZohvTYPo5o/better-buy-valeant-pharmaceuticals-international-inc-vs-rite-aid-corporation-cm840608,If there was a Bad News Bears team for the healthcare sector Valeant Pharmaceuticals International Inc NYSE VRX and Rite Aid NYSE RAD would be starters on the team for sure Valeant has lost over half of its market cap in the last 12 months while Rite Aid s market
VRX,VRX:CT,BBG000DC8S17,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Rite Aid Corporation",2017-09-02 17:48:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hZohvTYPo5o/better-buy-valeant-pharmaceuticals-international-inc-vs-rite-aid-corporation-cm840608,If there was a Bad News Bears team for the healthcare sector Valeant Pharmaceuticals International Inc NYSE VRX and Rite Aid NYSE RAD would be starters on the team for sure Valeant has lost over half of its market cap in the last 12 months while Rite Aid s market
VRX,VRX:US,BBG000DLFM21,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Rite Aid Corporation",2017-09-02 16:03:00 +0000,http://finance.yahoo.com/r/5c85257c-9641-38fc-86fb-195a514d5a1c/better-buy-valeant-pharmaceuticals-international-i.aspx?yptr=yahoo&.tsrc=rss,Which beaten-down stock wins in a matchup between Valeant and Rite Aid?
VRX,VRX:CT,BBG000DC8S17,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Rite Aid Corporation",2017-09-02 16:03:00 +0000,http://finance.yahoo.com/r/5c85257c-9641-38fc-86fb-195a514d5a1c/better-buy-valeant-pharmaceuticals-international-i.aspx?yptr=yahoo&.tsrc=rss,Which beaten-down stock wins in a matchup between Valeant and Rite Aid?
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Continues to Lose Ground: Can It Bounce Back?,2017-09-01 23:48:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTehI_lbuvI/valeant-vrx-continues-to-lose-ground-can-it-bounce-back-cm840522,Shares of Valeant Pharmaceuticals International Inc VRX have declined 7 6 so far in 2017 against 1 6 gain of the industry Shares fell further 6 9 on Aug 29 Once an acquisition giant Valeant has been caught up in various controversies since October 2015 due to price hike
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Continues to Lose Ground: Can It Bounce Back?,2017-09-01 23:48:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTehI_lbuvI/valeant-vrx-continues-to-lose-ground-can-it-bounce-back-cm840522,Shares of Valeant Pharmaceuticals International Inc VRX have declined 7 6 so far in 2017 against 1 6 gain of the industry Shares fell further 6 9 on Aug 29 Once an acquisition giant Valeant has been caught up in various controversies since October 2015 due to price hike
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Continues to Lose Ground: Can It Bounce Back?,2017-09-01 21:39:09 +0000,https://finance.yahoo.com/news/valeant-vrx-continues-lose-ground-213909095.html?.tsrc=rss,"Valeant has been caught up in various controversies due to price hike of specialty drugs, erroneous financial reporting and termination of contracts with Philidor Rx Services and woes do not end."
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Continues to Lose Ground: Can It Bounce Back?,2017-09-01 21:39:09 +0000,https://finance.yahoo.com/news/valeant-vrx-continues-lose-ground-213909095.html?.tsrc=rss,"Valeant has been caught up in various controversies due to price hike of specialty drugs, erroneous financial reporting and termination of contracts with Philidor Rx Services and woes do not end."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Be Just Fine,2017-09-01 17:53:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EpfsHWcXBZM/valeant-pharmaceuticals-intl-inc-vrx-stock-will-be-just-fine-cm840427,InvestorPlace Stock Market News Stock Advice amp Trading Tips Of late bears have taken charge in Valeant Pharmaceuticals Intl Inc NYSE VRX But if you re a contrarian a speculative long is looking reasonable both on and off the price chart of VRX stock Let me
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Be Just Fine,2017-09-01 17:53:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EpfsHWcXBZM/valeant-pharmaceuticals-intl-inc-vrx-stock-will-be-just-fine-cm840427,InvestorPlace Stock Market News Stock Advice amp Trading Tips Of late bears have taken charge in Valeant Pharmaceuticals Intl Inc NYSE VRX But if you re a contrarian a speculative long is looking reasonable both on and off the price chart of VRX stock Let me
VRX,VRX:CT,BBG000DC8S17,The Simple Reason I Won't Buy Intrexon,2017-09-01 14:53:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NFXn7NTIIvU/the-simple-reason-i-wont-buy-intrexon-cm840215,Complexity is one of the most adequate words that can be used to describe synthetic biology conglomerate Intrexon NYSE XON The company s management team Wall Street analysts and even individual investors often consider it to be a major long term advantage Who needs
VRX,VRX:US,BBG000DLFM21,The Simple Reason I Won't Buy Intrexon,2017-09-01 14:53:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NFXn7NTIIvU/the-simple-reason-i-wont-buy-intrexon-cm840215,Complexity is one of the most adequate words that can be used to describe synthetic biology conglomerate Intrexon NYSE XON The company s management team Wall Street analysts and even individual investors often consider it to be a major long term advantage Who needs
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Be Just Fine,2017-09-01 13:19:04 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-131904261.html?.tsrc=rss,"Of late, bears have taken charge in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  From VRX stock’s recent high of $18.17 in late July, it’s been a few very nice weeks to be short the former wunderkind drug manufacturer Valeant Pharmaceuticals.  Much of it has to do with Valeant facing a recently filed civil securities fraud lawsuit, which seeks a whopping $80 billion in damages."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Be Just Fine,2017-09-01 13:19:04 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-131904261.html?.tsrc=rss,"Of late, bears have taken charge in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  From VRX stock’s recent high of $18.17 in late July, it’s been a few very nice weeks to be short the former wunderkind drug manufacturer Valeant Pharmaceuticals.  Much of it has to do with Valeant facing a recently filed civil securities fraud lawsuit, which seeks a whopping $80 billion in damages."
VRX,VRX:CT,BBG000DC8S17,The Simple Reason I Won&apos;t Buy Intrexon,2017-09-01 13:02:00 +0000,http://finance.yahoo.com/r/396d00aa-50c5-3ffe-8baf-eaa50021b1ad/the-simple-reason-i-wont-buy-intrexon.aspx?yptr=yahoo&.tsrc=rss,"By hiding behind complexity, the synthetic biology conglomerate is taking the first steps down a troubling path."
VRX,VRX:US,BBG000DLFM21,The Simple Reason I Won&apos;t Buy Intrexon,2017-09-01 13:02:00 +0000,http://finance.yahoo.com/r/396d00aa-50c5-3ffe-8baf-eaa50021b1ad/the-simple-reason-i-wont-buy-intrexon.aspx?yptr=yahoo&.tsrc=rss,"By hiding behind complexity, the synthetic biology conglomerate is taking the first steps down a troubling path."
VRX,VRX:CT,BBG000DC8S17,Stock Exchange: Biggest Cause Of Trading Failure,2017-09-01 11:50:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EMCRwLoBS_U/stock-exchange-biggest-cause-of-trading-failure-cm840096,By Jeff Miller ByJeff Miller The Stock Exchange is all about trading Each week we do the following The Stock Exchange Stock ExchangeStock Exchange is all about trading Each week we do the following Discuss an important issue for traders highlight several technical
VRX,VRX:US,BBG000DLFM21,Stock Exchange: Biggest Cause Of Trading Failure,2017-09-01 11:50:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EMCRwLoBS_U/stock-exchange-biggest-cause-of-trading-failure-cm840096,By Jeff Miller ByJeff Miller The Stock Exchange is all about trading Each week we do the following The Stock Exchange Stock ExchangeStock Exchange is all about trading Each week we do the following Discuss an important issue for traders highlight several technical
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling After Weak U.S. Jobs Report - Canadian Commentary,2017-09-01 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUSgagX1ljk/canadian-stocks-are-falling-after-weak-us-jobs-report--canadian-commentary-20170901-00516,Canadian Stocks Are Falling After Weak U.S. Jobs Report - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling After Weak U.S. Jobs Report - Canadian Commentary,2017-09-01 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUSgagX1ljk/canadian-stocks-are-falling-after-weak-us-jobs-report--canadian-commentary-20170901-00516,Canadian Stocks Are Falling After Weak U.S. Jobs Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Wilmington company sues former partner following work for Salix, Valeant",2017-08-31 13:30:11 +0000,http://finance.yahoo.com/r/b9bdbb23-63c2-347c-96c6-647c726247ca/wilmington-company-sues-former-partner-following.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Wilmington-based Archer Healthcare – formerly known as AOS Research – has filed a Computer Fraud and Abuse Act lawsuit against a former joint-venture partner: Aurora, Colorado-based Questra Med Communications.  The suit follows the duo’s work for Salix Pharmaceuticals and Valeant Pharmaceuticals.  The trouble between Archer and Questra Med dates back to 2010 when the two companies were party to a joint venture."
VRX,VRX:CT,BBG000DC8S17,"Wilmington company sues former partner following work for Salix, Valeant",2017-08-31 13:30:11 +0000,http://finance.yahoo.com/r/b9bdbb23-63c2-347c-96c6-647c726247ca/wilmington-company-sues-former-partner-following.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Wilmington-based Archer Healthcare – formerly known as AOS Research – has filed a Computer Fraud and Abuse Act lawsuit against a former joint-venture partner: Aurora, Colorado-based Questra Med Communications.  The suit follows the duo’s work for Salix Pharmaceuticals and Valeant Pharmaceuticals.  The trouble between Archer and Questra Med dates back to 2010 when the two companies were party to a joint venture."
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-31 12:00:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120042721.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-31 12:00:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120042721.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Strong GDP Data - Canadian Commentary,2017-08-31 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RHGqOmTD98U/canadian-stocks-are-rising-on-strong-gdp-data--canadian-commentary-20170831-00757,Canadian Stocks Are Rising On Strong GDP Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Strong GDP Data - Canadian Commentary,2017-08-31 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RHGqOmTD98U/canadian-stocks-are-rising-on-strong-gdp-data--canadian-commentary-20170831-00757,Canadian Stocks Are Rising On Strong GDP Data - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,A Group Of Investors Is On A Mission To Help Traders Give Back Through Charity,2017-08-30 18:27:58 +0000,https://finance.yahoo.com/news/group-investors-mission-help-traders-182758756.html?.tsrc=rss,"If you’re a shareholder of Valeant Pharmaceuticals Intl Inc (NYSE: VRX ), GoPro Inc (NASDAQ: GPRO ) or Wayfair Inc (NYSE: W ), the last thing you’d think to call Citron head and infamous short seller Andrew ..."
VRX,VRX:US,BBG000DLFM21,A Group Of Investors Is On A Mission To Help Traders Give Back Through Charity,2017-08-30 18:27:58 +0000,https://finance.yahoo.com/news/group-investors-mission-help-traders-182758756.html?.tsrc=rss,"If you’re a shareholder of Valeant Pharmaceuticals Intl Inc (NYSE: VRX ), GoPro Inc (NASDAQ: GPRO ) or Wayfair Inc (NYSE: W ), the last thing you’d think to call Citron head and infamous short seller Andrew ..."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Trending Tickers: Rexahn Pharmaceuticals and Valeant Pharmaceuticals,2017-08-30 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000981.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 30, 2017 / U.S. markets rallied from the early drop to close in the green on Tuesday. The major indexes fell in early trading after news broke of a North Korean missile ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Trending Tickers: Rexahn Pharmaceuticals and Valeant Pharmaceuticals,2017-08-30 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000981.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 30, 2017 / U.S. markets rallied from the early drop to close in the green on Tuesday. The major indexes fell in early trading after news broke of a North Korean missile ..."
VRX,VRX:CT,BBG000DC8S17,This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier,2017-08-29 20:51:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aGvLXyhtKYE/this-simple-step-can-make-diabetes-patients-healthier-and-possibly-wealthier-cm838817,If you re one of the millions of Americans diagnosed with diabetes 160 large pharmacy benefits manager PBM Express Scripts NASDAQ ESRX has good news for you There s something you can do that will make you healthier It could even make you wealthier too Sound too good to
VRX,VRX:US,BBG000DLFM21,This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier,2017-08-29 20:51:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aGvLXyhtKYE/this-simple-step-can-make-diabetes-patients-healthier-and-possibly-wealthier-cm838817,If you re one of the millions of Americans diagnosed with diabetes 160 large pharmacy benefits manager PBM Express Scripts NASDAQ ESRX has good news for you There s something you can do that will make you healthier It could even make you wealthier too Sound too good to
VRX,VRX:US,BBG000DLFM21,"Why Finish Line Inc (FINL), Valeant Pharmaceuticals Intl Inc (VRX) and Best Buy Co Inc (BBY) Are 3 of Today’s Worst Stocks",2017-08-29 20:41:10 +0000,https://finance.yahoo.com/news/why-finish-line-inc-finl-204110112.html?.tsrc=rss,"Finish Line Inc (NASDAQ:FINL), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Best Buy Co Inc (NYSE:BBY) fell early, and weren’t able to pick themselves up off the mat.  What started out as a very good day for investors of electronics retailer Best Buy turned into a disastrous one, with BBY stock ending the day down a whopping 11.9%.  CEO Hubert Joly reversed the initial gain of 5%, however, by warning during the conference call that such strong same-store sales growth wasn’t the “new norm.” Though the company’s Q3 and full-year guidance suggested that growth at something near that pace was indeed in the cards, investors took Joly’s caution at face value."
VRX,VRX:CT,BBG000DC8S17,"Why Finish Line Inc (FINL), Valeant Pharmaceuticals Intl Inc (VRX) and Best Buy Co Inc (BBY) Are 3 of Today’s Worst Stocks",2017-08-29 20:41:10 +0000,https://finance.yahoo.com/news/why-finish-line-inc-finl-204110112.html?.tsrc=rss,"Finish Line Inc (NASDAQ:FINL), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Best Buy Co Inc (NYSE:BBY) fell early, and weren’t able to pick themselves up off the mat.  What started out as a very good day for investors of electronics retailer Best Buy turned into a disastrous one, with BBY stock ending the day down a whopping 11.9%.  CEO Hubert Joly reversed the initial gain of 5%, however, by warning during the conference call that such strong same-store sales growth wasn’t the “new norm.” Though the company’s Q3 and full-year guidance suggested that growth at something near that pace was indeed in the cards, investors took Joly’s caution at face value."
VRX,VRX:CT,BBG000DC8S17,"Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow",2017-08-29 19:50:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FjUvm3feiUQ/gilead-sciences-inc-gild-stock-still-has-room-to-grow-cm838818,InvestorPlace Stock Market News Stock Advice amp Trading Tips For a while Gilead Sciences Inc NASDAQ GILD was too shy to take advantage of its technical opportunities and it had many of them But in late June GILD stock rallied off a good earnings report It finally
VRX,VRX:US,BBG000DLFM21,"Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow",2017-08-29 19:50:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FjUvm3feiUQ/gilead-sciences-inc-gild-stock-still-has-room-to-grow-cm838818,InvestorPlace Stock Market News Stock Advice amp Trading Tips For a while Gilead Sciences Inc NASDAQ GILD was too shy to take advantage of its technical opportunities and it had many of them But in late June GILD stock rallied off a good earnings report It finally
VRX,VRX:US,BBG000DLFM21,Why Did Valeant Pharmaceuticals (VRX) Stock Fall Today?,2017-08-29 18:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MdMCJz2vq7k/why-did-valeant-pharmaceuticals-vrx-stock-fall-today-cm838759,Shares of Valeant Pharmaceuticals VRX fell more than 7 in morning trading Tuesday following a key analyst s warning that the struggling company still has numerous weaknesses in its business In a cautious note to clients today Mizuho s Irina Koffler highlighted her concerns about Valeant
VRX,VRX:CT,BBG000DC8S17,Why Did Valeant Pharmaceuticals (VRX) Stock Fall Today?,2017-08-29 18:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MdMCJz2vq7k/why-did-valeant-pharmaceuticals-vrx-stock-fall-today-cm838759,Shares of Valeant Pharmaceuticals VRX fell more than 7 in morning trading Tuesday following a key analyst s warning that the struggling company still has numerous weaknesses in its business In a cautious note to clients today Mizuho s Irina Koffler highlighted her concerns about Valeant
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals International Becomes Oversold (VRX),2017-08-29 17:51:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aK_5NyI9hvY/valeant-pharmaceuticals-international-becomes-oversold-vrx-cm838738,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals International Becomes Oversold (VRX),2017-08-29 17:51:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aK_5NyI9hvY/valeant-pharmaceuticals-international-becomes-oversold-vrx-cm838738,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:US,BBG000DLFM21,Valeant: No Fundamental Reasons for Today's Selloff?,2017-08-29 17:14:00 +0000,http://finance.yahoo.com/r/2e28e6e1-6283-34d1-8fca-5253efc07d86/valeant-no-fundamental-reasons-for-todays-selloff-1504026865?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When it comes to Valeant Pharmaceuticals International (VRX) a selloff is never just a selloff.  Shares of Valeant have dropped 7% to $13.23 at 1:02 p.m. today, but aside from an analyst cutting her price target on the stock--something we wrote about earlier--there's been no news on Valeant today.  Which is, what I assume, is the reason that Cantor Fitzgerald's Louise Chen and Brandon Folkes released a note this afternoon contending that there's ""no fundamental reasons for the stock weakness."" They explain: Recent stock weakness has in part been driven by a civil securities fraud lawsuit, which was filed in federal court in New Jersey, seeking ~$80B in damages."
VRX,VRX:CT,BBG000DC8S17,Valeant: No Fundamental Reasons for Today's Selloff?,2017-08-29 17:14:00 +0000,http://finance.yahoo.com/r/2e28e6e1-6283-34d1-8fca-5253efc07d86/valeant-no-fundamental-reasons-for-todays-selloff-1504026865?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When it comes to Valeant Pharmaceuticals International (VRX) a selloff is never just a selloff.  Shares of Valeant have dropped 7% to $13.23 at 1:02 p.m. today, but aside from an analyst cutting her price target on the stock--something we wrote about earlier--there's been no news on Valeant today.  Which is, what I assume, is the reason that Cantor Fitzgerald's Louise Chen and Brandon Folkes released a note this afternoon contending that there's ""no fundamental reasons for the stock weakness."" They explain: Recent stock weakness has in part been driven by a civil securities fraud lawsuit, which was filed in federal court in New Jersey, seeking ~$80B in damages."
VRX,VRX:CT,BBG000DC8S17,Why Did Valeant Pharmaceuticals (VRX) Stock Fall Today?,2017-08-29 16:43:04 +0000,https://finance.yahoo.com/news/why-did-valeant-pharmaceuticals-vrx-164304927.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals (VRX) fell more than 7% in morning trading Tuesday, following a key analyst&apos;s warning that the struggling company still has ""numerous weaknesses"" in its business."
VRX,VRX:US,BBG000DLFM21,Why Did Valeant Pharmaceuticals (VRX) Stock Fall Today?,2017-08-29 16:43:04 +0000,https://finance.yahoo.com/news/why-did-valeant-pharmaceuticals-vrx-164304927.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals (VRX) fell more than 7% in morning trading Tuesday, following a key analyst&apos;s warning that the struggling company still has ""numerous weaknesses"" in its business."
VRX,VRX:CT,BBG000DC8S17,Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic,2017-08-29 14:23:55 +0000,https://finance.yahoo.com/news/battered-teva-pharmaceutical-industries-ltd-142355186.html?.tsrc=rss,"All is not well for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  Teva bought Allergan’s generic drug business for $40.5 billion, which put severe pressure on its balance sheet.  One year ago, Teva had nearly $7 billion in cash and just $10.9 billion in debt."
VRX,VRX:US,BBG000DLFM21,Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic,2017-08-29 14:23:55 +0000,https://finance.yahoo.com/news/battered-teva-pharmaceutical-industries-ltd-142355186.html?.tsrc=rss,"All is not well for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  Teva bought Allergan’s generic drug business for $40.5 billion, which put severe pressure on its balance sheet.  One year ago, Teva had nearly $7 billion in cash and just $10.9 billion in debt."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals: Weakness, Weakness Everywhere?",2017-08-29 13:34:00 +0000,http://finance.yahoo.com/r/afbde8a9-5fb2-3553-9efe-035a553d9708/valeant-pharmaceuticals-weakness-weakness-everywhere-1504013667?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have gone basically nowhere this year, which probably should be considered a success given the losses it sustained in 2015 and 2016.  The bulls argue that the worst is behind Valeant as it pared down its debt and started focusing on getting the business growing again.  The bears argue that the market is too optimistic about Valeant's recovery, which could take a long, long time."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals: Weakness, Weakness Everywhere?",2017-08-29 13:34:00 +0000,http://finance.yahoo.com/r/afbde8a9-5fb2-3553-9efe-035a553d9708/valeant-pharmaceuticals-weakness-weakness-everywhere-1504013667?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have gone basically nowhere this year, which probably should be considered a success given the losses it sustained in 2015 and 2016.  The bulls argue that the worst is behind Valeant as it pared down its debt and started focusing on getting the business growing again.  The bears argue that the market is too optimistic about Valeant's recovery, which could take a long, long time."
VRX,VRX:CT,BBG000DC8S17,Energy Weakness Continues To Weigh On Bay Street - Canadian Commentary,2017-08-29 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B0jVF3bH3z8/energy-weakness-continues-to-weigh-on-bay-street--canadian-commentary-20170829-00782,Energy Weakness Continues To Weigh On Bay Street - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Energy Weakness Continues To Weigh On Bay Street - Canadian Commentary,2017-08-29 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B0jVF3bH3z8/energy-weakness-continues-to-weigh-on-bay-street--canadian-commentary-20170829-00782,Energy Weakness Continues To Weigh On Bay Street - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Monday’s Vital Data: Apple Inc. (AAPL), Tesla Inc (TSLA) and AT&T Inc. (T)",2017-08-28 17:48:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s8h8Ax1FV6s/mondays-vital-data-apple-inc-aapl-tesla-inc-tsla-and-att-inc-t-cm838101,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading cautiously higher this morning as Wall Street assesses the impact of Hurricane Harvey on Texas refineries and energy production facilities Now downgraded to a tropical storm
VRX,VRX:CT,BBG000DC8S17,"Monday’s Vital Data: Apple Inc. (AAPL), Tesla Inc (TSLA) and AT&T Inc. (T)",2017-08-28 17:48:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s8h8Ax1FV6s/mondays-vital-data-apple-inc-aapl-tesla-inc-tsla-and-att-inc-t-cm838101,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading cautiously higher this morning as Wall Street assesses the impact of Hurricane Harvey on Texas refineries and energy production facilities Now downgraded to a tropical storm
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Falls on New Legal Battle,2017-08-28 17:23:30 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-172330775.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was under pressure last week amid reports that mutual fund company Lord Abbett & Co. has filed a securities fraud lawsuit against Valeant, alleging that it bought VRX’s debt securities at artificially inflated price based on misleading information provided by Valeant.  The lawsuit Lord Abbett filed in federal court in New Jersey — location of Valeant’s U.S. headquarter — seeks damages of $80 billion in investor losses and under the New Jersey’s racketeer influenced and corrupt organizations (RICO) laws.  There have been tons of reason to be skeptical about Valeant Pharmaceuticals’ future and, in particular, the company’s ability to pay its massive debt pile of $28.5 billion, while it has just $1.5 billion in cash."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Falls on New Legal Battle,2017-08-28 17:23:30 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-172330775.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was under pressure last week amid reports that mutual fund company Lord Abbett & Co. has filed a securities fraud lawsuit against Valeant, alleging that it bought VRX’s debt securities at artificially inflated price based on misleading information provided by Valeant.  The lawsuit Lord Abbett filed in federal court in New Jersey — location of Valeant’s U.S. headquarter — seeks damages of $80 billion in investor losses and under the New Jersey’s racketeer influenced and corrupt organizations (RICO) laws.  There have been tons of reason to be skeptical about Valeant Pharmaceuticals’ future and, in particular, the company’s ability to pay its massive debt pile of $28.5 billion, while it has just $1.5 billion in cash."
VRX,VRX:US,BBG000DLFM21,Immune Design’s quest for a cancer vaccine could go the distance,2017-08-28 11:23:28 +0000,http://finance.yahoo.com/r/0601644b-da97-33e6-b058-e217b367bb28/Story.aspx?guid=6139155C-899F-11E7-BEE2-7AA989C8F417&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Developing a cancer vaccine is a tricky business, but Immune Design Corp.’s efforts could be the exception."
VRX,VRX:CT,BBG000DC8S17,Immune Design’s quest for a cancer vaccine could go the distance,2017-08-28 11:23:28 +0000,http://finance.yahoo.com/r/0601644b-da97-33e6-b058-e217b367bb28/Story.aspx?guid=6139155C-899F-11E7-BEE2-7AA989C8F417&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Developing a cancer vaccine is a tricky business, but Immune Design Corp.’s efforts could be the exception."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Energy Sector Struggles - Canadian Commentary,2017-08-28 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YML12tKBSJA/canadian-stocks-are-falling-as-energy-sector-struggles--canadian-commentary-20170828-00603,Canadian Stocks Are Falling As Energy Sector Struggles - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Energy Sector Struggles - Canadian Commentary,2017-08-28 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YML12tKBSJA/canadian-stocks-are-falling-as-energy-sector-struggles--canadian-commentary-20170828-00603,Canadian Stocks Are Falling As Energy Sector Struggles - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : August 25, 2017",2017-08-25 21:53:55 +0000,http://finance.yahoo.com/r/289611ba-1c6b-3a60-bf5b-bfba0c747ba5/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-august-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Valeant Pharmaceuticals International, Inc. Here are 5 ETFs with the largest exposure to VRX-US. Comparing the performance and risk of Valeant Pharmaceuticals International, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
VRX,VRX:US,BBG000DLFM21,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : August 25, 2017",2017-08-25 21:53:55 +0000,http://finance.yahoo.com/r/289611ba-1c6b-3a60-bf5b-bfba0c747ba5/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-august-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Valeant Pharmaceuticals International, Inc. Here are 5 ETFs with the largest exposure to VRX-US. Comparing the performance and risk of Valeant Pharmaceuticals International, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Why Ulta Beauty Inc (ULTA), Valeant Pharmaceuticals Intl Inc (VRX) and GameStop Corp. (GME) Are 3 of Today’s Worst Stocks",2017-08-25 20:39:44 +0000,https://finance.yahoo.com/news/why-ulta-beauty-inc-ulta-203944584.html?.tsrc=rss,"Whether beauty-supply retailer and salon operator Ulta Beauty did well last quarter is largely a matter of perspective.  For the period ending in July, Ulta Beauty turned $1.29 billion worth of revenue into earnings of $1.83 per share.  As impressive as last quarter’s results were, Ulta Beauty is a victim of its own success."
VRX,VRX:US,BBG000DLFM21,"Why Ulta Beauty Inc (ULTA), Valeant Pharmaceuticals Intl Inc (VRX) and GameStop Corp. (GME) Are 3 of Today’s Worst Stocks",2017-08-25 20:39:44 +0000,https://finance.yahoo.com/news/why-ulta-beauty-inc-ulta-203944584.html?.tsrc=rss,"Whether beauty-supply retailer and salon operator Ulta Beauty did well last quarter is largely a matter of perspective.  For the period ending in July, Ulta Beauty turned $1.29 billion worth of revenue into earnings of $1.83 per share.  As impressive as last quarter’s results were, Ulta Beauty is a victim of its own success."
VRX,VRX:CT,BBG000DC8S17,Is the Valeant Pharmaceuticals Intl Inc (VRX) Debt Situation Overblown?,2017-08-25 16:35:19 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-163519887.html?.tsrc=rss,"Should you or shouldn’t you go anywhere near VRX stock right now?  For the first seven months of 2015, investors obviously didn’t see a problem with Valeant.  In the beginning of the year, VRX stock sported a $50 billion market cap."
VRX,VRX:US,BBG000DLFM21,Is the Valeant Pharmaceuticals Intl Inc (VRX) Debt Situation Overblown?,2017-08-25 16:35:19 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-163519887.html?.tsrc=rss,"Should you or shouldn’t you go anywhere near VRX stock right now?  For the first seven months of 2015, investors obviously didn’t see a problem with Valeant.  In the beginning of the year, VRX stock sported a $50 billion market cap."
VRX,VRX:CT,BBG000DC8S17,Valeant's Legal Bills Are Piling Up Following Latest Securities Fraud Lawsuit,2017-08-25 14:00:00 +0000,http://finance.yahoo.com/r/e4a79d7c-ad58-3d69-9d34-d2e9acf0380a/valeant-s-legal-bills-are-piling-up-following-latest-securities-fraud-lawsuit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A mutual fund filed the lawsuit Wednesday.
VRX,VRX:US,BBG000DLFM21,Valeant's Legal Bills Are Piling Up Following Latest Securities Fraud Lawsuit,2017-08-25 14:00:00 +0000,http://finance.yahoo.com/r/e4a79d7c-ad58-3d69-9d34-d2e9acf0380a/valeant-s-legal-bills-are-piling-up-following-latest-securities-fraud-lawsuit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A mutual fund filed the lawsuit Wednesday.
VRX,VRX:CT,BBG000DC8S17,Valeant: The Long or Short of It,2017-08-25 13:45:00 +0000,http://finance.yahoo.com/r/a8beb5e1-6c1b-3a5b-8e91-964baffc2a90/valeant-the-long-or-short-of-it-1503668700?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have gained more than 70% since bottoming on April 21, as the market has come around to the view that the worst-case scenario might be off the table for the specialty-pharmaceutical company.  In a note published yesterday, Cantor Fitzgerald's Louise Chen and Brandon Folkes observe that short interest in Valeant has increase by 38% from July 31 through August 15.  This morning it appears to be a Bloomberg news story looking at a lawsuit filed on against Valeant on Wednesday."
VRX,VRX:US,BBG000DLFM21,Valeant: The Long or Short of It,2017-08-25 13:45:00 +0000,http://finance.yahoo.com/r/a8beb5e1-6c1b-3a5b-8e91-964baffc2a90/valeant-the-long-or-short-of-it-1503668700?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have gained more than 70% since bottoming on April 21, as the market has come around to the view that the worst-case scenario might be off the table for the specialty-pharmaceutical company.  In a note published yesterday, Cantor Fitzgerald's Louise Chen and Brandon Folkes observe that short interest in Valeant has increase by 38% from July 31 through August 15.  This morning it appears to be a Bloomberg news story looking at a lawsuit filed on against Valeant on Wednesday."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary,2017-08-25 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uwy0m4HPr24/canadian-stocks-are-little-changed-in-cautious-trade--canadian-commentary-20170825-00479,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary,2017-08-25 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uwy0m4HPr24/canadian-stocks-are-little-changed-in-cautious-trade--canadian-commentary-20170825-00479,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant’s Latest Legal Threat Could Be Especially Costly,2017-08-25 09:00:01 +0000,http://finance.yahoo.com/r/7618c7fa-f970-33d1-8f25-87d21a0cb485/valeant-s-latest-litigation-threat-could-be-especially-costly?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. has been selling assets, paying down debt and riding a recovery of its shares from their lowest point last spring. But one big uncertainty -- its potential legal ..."
VRX,VRX:US,BBG000DLFM21,Valeant’s Latest Legal Threat Could Be Especially Costly,2017-08-25 09:00:01 +0000,http://finance.yahoo.com/r/7618c7fa-f970-33d1-8f25-87d21a0cb485/valeant-s-latest-litigation-threat-could-be-especially-costly?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. has been selling assets, paying down debt and riding a recovery of its shares from their lowest point last spring. But one big uncertainty -- its potential legal ..."
VRX,VRX:CT,BBG000DC8S17,Here's the Simple Issue I Still Have With Valeant Pharmaceuticals (and Why You Shouldn't Buy),2017-08-24 14:40:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Q7HWQ1lcqs/heres-the-simple-issue-i-still-have-with-valeant-pharmaceuticals-and-why-you-shouldnt-buy-cm836458,Over the past two years only a small handful of publicly traded companies have the distinction of losing more than 90 of their value Drugmaker Valeant Pharmaceuticals NYSE VRX finds itself in that mix having shed about 94 of its value since peaking in early August 2015 at 264
VRX,VRX:US,BBG000DLFM21,Here's the Simple Issue I Still Have With Valeant Pharmaceuticals (and Why You Shouldn't Buy),2017-08-24 14:40:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Q7HWQ1lcqs/heres-the-simple-issue-i-still-have-with-valeant-pharmaceuticals-and-why-you-shouldnt-buy-cm836458,Over the past two years only a small handful of publicly traded companies have the distinction of losing more than 90 of their value Drugmaker Valeant Pharmaceuticals NYSE VRX finds itself in that mix having shed about 94 of its value since peaking in early August 2015 at 264
VRX,VRX:CT,BBG000DC8S17,Here&apos;s the Simple Issue I Still Have With Valeant Pharmaceuticals (and Why You Shouldn&apos;t Buy),2017-08-24 13:13:00 +0000,http://finance.yahoo.com/r/e5268a25-bf3c-369a-9534-32cafbfddcea/heres-the-simple-issue-i-still-have-with-valeant-p.aspx?yptr=yahoo&.tsrc=rss,"Can the company pay down its debt organically, without the help of asset sales? It&apos;s unlikely."
VRX,VRX:US,BBG000DLFM21,Here&apos;s the Simple Issue I Still Have With Valeant Pharmaceuticals (and Why You Shouldn&apos;t Buy),2017-08-24 13:13:00 +0000,http://finance.yahoo.com/r/e5268a25-bf3c-369a-9534-32cafbfddcea/heres-the-simple-issue-i-still-have-with-valeant-p.aspx?yptr=yahoo&.tsrc=rss,"Can the company pay down its debt organically, without the help of asset sales? It&apos;s unlikely."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed After Retail Sales - Canadian Commentary,2017-08-22 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lwv6WgCEGPk/canadian-stocks-are-little-changed-after-retail-sales--canadian-commentary-20170822-00739,Canadian Stocks Are Little Changed After Retail Sales - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed After Retail Sales - Canadian Commentary,2017-08-22 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lwv6WgCEGPk/canadian-stocks-are-little-changed-after-retail-sales--canadian-commentary-20170822-00739,Canadian Stocks Are Little Changed After Retail Sales - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,What's The FDA Saying About Valeant's Manufacturing Facility Issues?,2017-08-21 13:34:49 +0000,https://finance.yahoo.com/news/whats-fda-saying-valeants-manufacturing-133449243.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) investors can breathe a sigh of relief following the latest updates on the company’s Tampa facility, which was the subject of a Complete Response Letter Valeant ..."
VRX,VRX:CT,BBG000DC8S17,What's The FDA Saying About Valeant's Manufacturing Facility Issues?,2017-08-21 13:34:49 +0000,https://finance.yahoo.com/news/whats-fda-saying-valeants-manufacturing-133449243.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) investors can breathe a sigh of relief following the latest updates on the company’s Tampa facility, which was the subject of a Complete Response Letter Valeant ..."
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-21 12:01:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120116989.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-21 12:01:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120116989.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals Intl Inc. and VIVUS Inc.,2017-08-21 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000909.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 21, 2017 / Geopolitical concerns combined with the resignation of multiple advisors to President Trump pressured markets lower last week. On Friday, the Dow Jones Industrial ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals Intl Inc. and VIVUS Inc.,2017-08-21 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000909.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 21, 2017 / Geopolitical concerns combined with the resignation of multiple advisors to President Trump pressured markets lower last week. On Friday, the Dow Jones Industrial ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Dipping Despite Gold Strength - Canadian Commentary,2017-08-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tgjRj5bjiXM/canadian-stocks-are-dipping-despite-gold-strength--canadian-commentary-20170821-00633,Canadian Stocks Are Dipping Despite Gold Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Dipping Despite Gold Strength - Canadian Commentary,2017-08-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tgjRj5bjiXM/canadian-stocks-are-dipping-despite-gold-strength--canadian-commentary-20170821-00633,Canadian Stocks Are Dipping Despite Gold Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"GW Pharmaceuticals PLC- ADR (GWPH) Stock Is High-Risk, High Reward",2017-08-18 22:39:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OLyMZTzQFZg/gw-pharmaceuticals-plc-adr-gwph-stock-is-high-risk-high-reward-cm834234,InvestorPlace Stock Market News Stock Advice amp Trading Tips Marijuana has been making headlines for some time now as more and more states vote to legalize it While there is still some debate on its legalization throughout the country there s no denying the potential of
VRX,VRX:US,BBG000DLFM21,"GW Pharmaceuticals PLC- ADR (GWPH) Stock Is High-Risk, High Reward",2017-08-18 22:39:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OLyMZTzQFZg/gw-pharmaceuticals-plc-adr-gwph-stock-is-high-risk-high-reward-cm834234,InvestorPlace Stock Market News Stock Advice amp Trading Tips Marijuana has been making headlines for some time now as more and more states vote to legalize it While there is still some debate on its legalization throughout the country there s no denying the potential of
VRX,VRX:US,BBG000DLFM21,Seadrill Ltd (SDRL) Stock Isn’t Going to Make It,2017-08-18 20:40:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fu1okreC40s/seadrill-ltd-sdrl-stock-isnt-going-to-make-it-cm834202,InvestorPlace Stock Market News Stock Advice amp Trading Tips There have been no bigger causalities from the drop in oil prices than the deep water drillers And the biggest casualty of all could be Seadrill Ltd NYSE SDRL Source Sapura Onix via Wikimedia Modified
VRX,VRX:CT,BBG000DC8S17,Seadrill Ltd (SDRL) Stock Isn’t Going to Make It,2017-08-18 20:40:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fu1okreC40s/seadrill-ltd-sdrl-stock-isnt-going-to-make-it-cm834202,InvestorPlace Stock Market News Stock Advice amp Trading Tips There have been no bigger causalities from the drop in oil prices than the deep water drillers And the biggest casualty of all could be Seadrill Ltd NYSE SDRL Source Sapura Onix via Wikimedia Modified
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Gamble You Can Win,2017-08-18 18:40:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kr7Ivor-8Ug/valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-gamble-you-can-win-cm834143,InvestorPlace Stock Market News Stock Advice amp Trading Tips Let s just get this out of the way Trading a stock as volatile as Valeant Pharmaceuticals Intl Inc NYSE VRX is a gamble not an investment I consider setups as short term trades based on
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Gamble You Can Win,2017-08-18 18:40:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kr7Ivor-8Ug/valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-gamble-you-can-win-cm834143,InvestorPlace Stock Market News Stock Advice amp Trading Tips Let s just get this out of the way Trading a stock as volatile as Valeant Pharmaceuticals Intl Inc NYSE VRX is a gamble not an investment I consider setups as short term trades based on
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Gamble You Can Win,2017-08-18 13:53:32 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-135332988.html?.tsrc=rss,"Let’s just get this out of the way: Trading a stock as volatile as Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a gamble, not an investment.  VRX stock is down 40% in 12 months, but it’s almost flat this year.  Recently, Valeant had a 20% correction in as many days, which makes for a scary knife to catch."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Gamble You Can Win,2017-08-18 13:53:32 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-135332988.html?.tsrc=rss,"Let’s just get this out of the way: Trading a stock as volatile as Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a gamble, not an investment.  VRX stock is down 40% in 12 months, but it’s almost flat this year.  Recently, Valeant had a 20% correction in as many days, which makes for a scary knife to catch."
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-18 12:00:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120056047.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-18 12:00:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120056047.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:US,BBG000DLFM21,"Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain",2017-08-18 11:39:00 +0000,http://finance.yahoo.com/r/7b981bb1-42ce-3e81-846c-730d2b7f72c2/valeant-ceo-confident-divestitures-can-successfully-pare-debt-skeptics-remain.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"For his 'Executive Decision' segment, Cramer again sat down with Joe Papa, chairman and CEO of Valeant"
VRX,VRX:CT,BBG000DC8S17,"Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain",2017-08-18 11:39:00 +0000,http://finance.yahoo.com/r/7b981bb1-42ce-3e81-846c-730d2b7f72c2/valeant-ceo-confident-divestitures-can-successfully-pare-debt-skeptics-remain.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"For his 'Executive Decision' segment, Cramer again sat down with Joe Papa, chairman and CEO of Valeant"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-08-18 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_m5h-6ViqUw/canadian-stocks-are-paring-early-losses--canadian-commentary-20170818-00438,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-08-18 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_m5h-6ViqUw/canadian-stocks-are-paring-early-losses--canadian-commentary-20170818-00438,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Higher Today,2017-08-17 20:01:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rBjnAMlIGqQ/why-valeant-pharmaceuticals-intl-inc-vrx-stock-is-higher-today-cm833552,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX stock was up today on news that some of its manufacturing issues are being resolved Source Wikimedia Modified The manufacturing issues that the company was
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Higher Today,2017-08-17 20:01:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rBjnAMlIGqQ/why-valeant-pharmaceuticals-intl-inc-vrx-stock-is-higher-today-cm833552,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX stock was up today on news that some of its manufacturing issues are being resolved Source Wikimedia Modified The manufacturing issues that the company was
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Higher Today,2017-08-17 15:27:11 +0000,https://finance.yahoo.com/news/why-valeant-pharmaceuticals-intl-inc-152711268.html?.tsrc=rss,The manufacturing issues that the company was facing were connected to an investigation by the U.S. Food and Drug Administration (FDA).  Valeant Pharmaceuticals Intl Inc notes that the FDA is planning to give the facility a Voluntary Action Indicated VAI classification.  Valeant Pharmaceuticals Intl Inc says that the VAI classification will prevent manufacturing issues that further regulator actions could have caused.
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Higher Today,2017-08-17 15:27:11 +0000,https://finance.yahoo.com/news/why-valeant-pharmaceuticals-intl-inc-152711268.html?.tsrc=rss,The manufacturing issues that the company was facing were connected to an investigation by the U.S. Food and Drug Administration (FDA).  Valeant Pharmaceuticals Intl Inc notes that the FDA is planning to give the facility a Voluntary Action Indicated VAI classification.  Valeant Pharmaceuticals Intl Inc says that the VAI classification will prevent manufacturing issues that further regulator actions could have caused.
VRX,VRX:US,BBG000DLFM21,Valeant: Hard to Ignore the Positive Developments?,2017-08-17 13:38:00 +0000,http://finance.yahoo.com/r/7894c281-019d-356c-a149-886f399daec9/valeant-hard-to-ignore-the-positive-developments-1502977102?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have tumbled 14% in August as concerns about generic drugs following Teva Pharmaceutical Industries' (TEVA) earnings sparked a specialty-pharmaceutical stock selloff.  Valeant, however, is trying to make back some of those losses this week, with the stock up more than 2% today after the company announced that it was close to fixing problems at a Bausch & Lomb plant.  While this might seem like a minor piece of news, it has big implications for Valeant's stock."
VRX,VRX:CT,BBG000DC8S17,Valeant: Hard to Ignore the Positive Developments?,2017-08-17 13:38:00 +0000,http://finance.yahoo.com/r/7894c281-019d-356c-a149-886f399daec9/valeant-hard-to-ignore-the-positive-developments-1502977102?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have tumbled 14% in August as concerns about generic drugs following Teva Pharmaceutical Industries' (TEVA) earnings sparked a specialty-pharmaceutical stock selloff.  Valeant, however, is trying to make back some of those losses this week, with the stock up more than 2% today after the company announced that it was close to fixing problems at a Bausch & Lomb plant.  While this might seem like a minor piece of news, it has big implications for Valeant's stock."
VRX,VRX:CT,BBG000DC8S17,Valeant’s Tampa manufacturing plant on track for a better bill of health,2017-08-17 11:50:10 +0000,http://finance.yahoo.com/r/33b74b53-4003-3284-8891-bf3b85ad4a17/valeant-s-tampa-manufacturing-plant-on-track-for-a.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"The giant pharmaceutical company that owns a Tampa manufacturing plant that makes Bausch & Lomb products says it’s on track to fix the problems at the facility that kept it from winning approval for a new glaucoma drug.  The U.S. Food and Drug Administration has confirmed that issues related to a Good Manufacturing Practice inspection at the plant are being resolved, Joseph Papa, chairman and CEO of Valeant Pharmaceutical International Inc. (VRX) said Wednesday.  Valeant, based in Laval, Quebec and with a significant presence in the Tampa Bay area, is a high-profile specialty pharmaceutical company that has undergone “a challenging 15 months,” Papa told CNBC “Mad Money” host Jim Cramer , also on Wednesday."
VRX,VRX:US,BBG000DLFM21,Valeant’s Tampa manufacturing plant on track for a better bill of health,2017-08-17 11:50:10 +0000,http://finance.yahoo.com/r/33b74b53-4003-3284-8891-bf3b85ad4a17/valeant-s-tampa-manufacturing-plant-on-track-for-a.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"The giant pharmaceutical company that owns a Tampa manufacturing plant that makes Bausch & Lomb products says it’s on track to fix the problems at the facility that kept it from winning approval for a new glaucoma drug.  The U.S. Food and Drug Administration has confirmed that issues related to a Good Manufacturing Practice inspection at the plant are being resolved, Joseph Papa, chairman and CEO of Valeant Pharmaceutical International Inc. (VRX) said Wednesday.  Valeant, based in Laval, Quebec and with a significant presence in the Tampa Bay area, is a high-profile specialty pharmaceutical company that has undergone “a challenging 15 months,” Papa told CNBC “Mad Money” host Jim Cramer , also on Wednesday."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Slipping As Financial Stocks Struggle  - Canadian Commentary,2017-08-17 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/peuTC6OPOe0/canadian-stocks-are-slipping-as-financial-stocks-struggle---canadian-commentary-20170817-00710,Canadian Stocks Are Slipping As Financial Stocks Struggle  - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Slipping As Financial Stocks Struggle  - Canadian Commentary,2017-08-17 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/peuTC6OPOe0/canadian-stocks-are-slipping-as-financial-stocks-struggle---canadian-commentary-20170817-00710,Canadian Stocks Are Slipping As Financial Stocks Struggle  - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,TSX In Limbo On Low Oil Prices -- Canadian Commentary,2017-08-17 08:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sx_XoKu4pUM/tsx-in-limbo-on-low-oil-prices--canadian-commentary-20170817-00479,TSX In Limbo On Low Oil Prices -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,TSX In Limbo On Low Oil Prices -- Canadian Commentary,2017-08-17 08:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sx_XoKu4pUM/tsx-in-limbo-on-low-oil-prices--canadian-commentary-20170817-00479,TSX In Limbo On Low Oil Prices -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared",2017-08-17 01:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1207DPzn_rk/abio-to-report-data-in-q1-iova-fired-up-pmd-in-iowa-vrx-all-cleared-20170817-00031,"ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared"
VRX,VRX:US,BBG000DLFM21,"ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared",2017-08-17 01:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1207DPzn_rk/abio-to-report-data-in-q1-iova-fired-up-pmd-in-iowa-vrx-all-cleared-20170817-00031,"ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared"
VRX,VRX:US,BBG000DLFM21,Valeant Receives FDA Confirmation Of VAI Inspection For Tampa Facility,2017-08-17 00:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/08xWq-cCBks/valeant-receives-fda-confirmation-of-vai-inspection-for-tampa-facility-20170817-00008,Valeant Receives FDA Confirmation Of VAI Inspection For Tampa Facility
VRX,VRX:CT,BBG000DC8S17,Valeant Receives FDA Confirmation Of VAI Inspection For Tampa Facility,2017-08-17 00:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/08xWq-cCBks/valeant-receives-fda-confirmation-of-vai-inspection-for-tampa-facility-20170817-00008,Valeant Receives FDA Confirmation Of VAI Inspection For Tampa Facility
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Cramer's Top Takeaways,2017-08-16 23:24:00 +0000,http://finance.yahoo.com/r/fd9c3717-32a0-339d-a69c-7d735bb9559e/valeant-pharmaceuticals-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Joe Papa, chairman and CEO of Valeant Pharmaceuticals International, talks to Jim Cramer about his company's turnaround."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Cramer's Top Takeaways,2017-08-16 23:24:00 +0000,http://finance.yahoo.com/r/fd9c3717-32a0-339d-a69c-7d735bb9559e/valeant-pharmaceuticals-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Joe Papa, chairman and CEO of Valeant Pharmaceuticals International, talks to Jim Cramer about his company's turnaround."
VRX,VRX:US,BBG000DLFM21,"Valeant's Papa: 'It's been a challenging 15 months, but w...",2017-08-16 23:18:00 +0000,https://finance.yahoo.com/video/valeants-papa-challenging-15-months-231800080.html?.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround."
VRX,VRX:CT,BBG000DC8S17,"Valeant's Papa: 'It's been a challenging 15 months, but w...",2017-08-16 23:18:00 +0000,https://finance.yahoo.com/video/valeants-papa-challenging-15-months-231800080.html?.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals CEO Joe Papa: 'It's been a challe...,2017-08-16 22:41:00 +0000,https://finance.yahoo.com/video/valeant-pharmaceuticals-ceo-joe-papa-224100123.html?.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals CEO Joe Papa: 'It's been a challe...,2017-08-16 22:41:00 +0000,https://finance.yahoo.com/video/valeant-pharmaceuticals-ceo-joe-papa-224100123.html?.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals CEO: 'It's been a challenging 15 months, but we've made great progress'",2017-08-16 22:26:35 +0000,http://finance.yahoo.com/r/101404d1-aa5a-3a45-b816-7edd32b0d414/104656588?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104656588&yptr=yahoo&.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals CEO: &apos;It&apos;s been a challenging 15 months, but we&apos;ve made great progress&apos;",2017-08-16 22:26:35 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-ceo-apos-apos-222635395.html?.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker&apos;s turnaround."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals CEO: &apos;It&apos;s been a challenging 15 months, but we&apos;ve made great progress&apos;",2017-08-16 22:26:35 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-ceo-apos-apos-222635395.html?.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker&apos;s turnaround."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals CEO: 'It's been a challenging 15 months, but we've made great progress'",2017-08-16 22:26:35 +0000,http://finance.yahoo.com/r/101404d1-aa5a-3a45-b816-7edd32b0d414/104656588?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104656588&yptr=yahoo&.tsrc=rss,"Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround."
VRX,VRX:US,BBG000DLFM21,Valeant Pharma works to resolve FDA concerns at Tampa plant,2017-08-16 20:49:25 +0000,http://finance.yahoo.com/r/b3ddce9a-3a9d-311e-b0e4-f6d8cfec114c/Story.aspx?guid=14D018E3-27C4-40C1-AF44-9E36A99CDE73&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. shares ticked higher in the extended session Wednesday after the drugmaker said that issues from a Food and Drug Administration inspection were being resolved. ...
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma works to resolve FDA concerns at Tampa plant,2017-08-16 20:49:25 +0000,http://finance.yahoo.com/r/b3ddce9a-3a9d-311e-b0e4-f6d8cfec114c/Story.aspx?guid=14D018E3-27C4-40C1-AF44-9E36A99CDE73&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. shares ticked higher in the extended session Wednesday after the drugmaker said that issues from a Food and Drug Administration inspection were being resolved. ...
VRX,VRX:US,BBG000DLFM21,Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility,2017-08-16 20:15:00 +0000,https://finance.yahoo.com/news/valeant-receives-fda-confirmation-voluntary-201500813.html?.tsrc=rss,Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility
VRX,VRX:CT,BBG000DC8S17,Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility,2017-08-16 20:15:00 +0000,https://finance.yahoo.com/news/valeant-receives-fda-confirmation-voluntary-201500813.html?.tsrc=rss,Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility
VRX,VRX:CT,BBG000DC8S17,Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility,2017-08-16 20:15:00 +0000,https://finance.yahoo.com/news/valeant-receives-fda-confirmation-voluntary-201500937.html?.tsrc=rss,"LAVAL, Quebec, Aug. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced the U.S. Food and Drug Administration (FDA) confirmed it intends to issue a Voluntary Action Indicated (VAI) inspection classification for its Bausch + Lomb manufacturing facility in Tampa, Fla. as part of a forthcoming Establishment Inspection Record for the facility.  With this confirmation, manufacturing uncertainties related to current and upcoming regulatory submissions will be eliminated for products manufactured at the Tampa facility."
VRX,VRX:US,BBG000DLFM21,Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility,2017-08-16 20:15:00 +0000,https://finance.yahoo.com/news/valeant-receives-fda-confirmation-voluntary-201500937.html?.tsrc=rss,"LAVAL, Quebec, Aug. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced the U.S. Food and Drug Administration (FDA) confirmed it intends to issue a Voluntary Action Indicated (VAI) inspection classification for its Bausch + Lomb manufacturing facility in Tampa, Fla. as part of a forthcoming Establishment Inspection Record for the facility.  With this confirmation, manufacturing uncertainties related to current and upcoming regulatory submissions will be eliminated for products manufactured at the Tampa facility."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017",2017-08-16 15:25:15 +0000,http://finance.yahoo.com/r/1bd636d7-0032-3abe-b190-93b4bdbc4067/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q2-2017-by-the-numbers-august-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Valeant Pharmaceuticals International, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Valeant Pharmaceuticals International, Inc. – Pfizer Inc., AstraZeneca PLC, Merck KGaA Sponsored ADR and Novartis AG Sponsored ADR (PFE-US, AZNCF-US, MKKGY-US and NVS-US) that have also reported ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017",2017-08-16 15:25:15 +0000,http://finance.yahoo.com/r/1bd636d7-0032-3abe-b190-93b4bdbc4067/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q2-2017-by-the-numbers-august-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Valeant Pharmaceuticals International, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Valeant Pharmaceuticals International, Inc. – Pfizer Inc., AstraZeneca PLC, Merck KGaA Sponsored ADR and Novartis AG Sponsored ADR (PFE-US, AZNCF-US, MKKGY-US and NVS-US) that have also reported ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak,2017-08-16 14:16:55 +0000,https://finance.yahoo.com/news/bull-case-valeant-pharmaceuticals-intl-141655890.html?.tsrc=rss,"Giving credit where credit is due, I do think Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock looks stronger than it did just a couple of quarters ago.  VRX stock has still declined 1.5% so far this year, but the narrative surrounding the company has certainly changed.  On the Q2 conference call, Valeant management made a big deal of the fact that 73% of Q2 revenue came from Bausch & Lomb and the Salix business."
VRX,VRX:US,BBG000DLFM21,The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak,2017-08-16 14:16:55 +0000,https://finance.yahoo.com/news/bull-case-valeant-pharmaceuticals-intl-141655890.html?.tsrc=rss,"Giving credit where credit is due, I do think Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock looks stronger than it did just a couple of quarters ago.  VRX stock has still declined 1.5% so far this year, but the narrative surrounding the company has certainly changed.  On the Q2 conference call, Valeant management made a big deal of the fact that 73% of Q2 revenue came from Bausch & Lomb and the Salix business."
VRX,VRX:CT,BBG000DC8S17,"Francis Chou Buys Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries, ...",2017-08-16 11:35:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MSH49BM1TEw/francis-chou-buys-valeant-pharmaceuticals-international-inc-teva-pharmaceutical-industries-cm832584,Francis Chou Added Positions VRX TEVA Reduced Positions NOK C Added Positions VRX TEVA Added Positions VRX TEVA Reduced Positions NOK C Reduced Positions NOK C For the details of Francis Chou s
VRX,VRX:US,BBG000DLFM21,"Francis Chou Buys Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries, ...",2017-08-16 11:35:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MSH49BM1TEw/francis-chou-buys-valeant-pharmaceuticals-international-inc-teva-pharmaceutical-industries-cm832584,Francis Chou Added Positions VRX TEVA Reduced Positions NOK C Added Positions VRX TEVA Added Positions VRX TEVA Reduced Positions NOK C Reduced Positions NOK C For the details of Francis Chou s
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Modestly Higher In Cautious Trade - Canadian Commentary,2017-08-16 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4vDatPTBCuc/canadian-stocks-are-modestly-higher-in-cautious-trade--canadian-commentary-20170816-00695,Canadian Stocks Are Modestly Higher In Cautious Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Modestly Higher In Cautious Trade - Canadian Commentary,2017-08-16 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4vDatPTBCuc/canadian-stocks-are-modestly-higher-in-cautious-trade--canadian-commentary-20170816-00695,Canadian Stocks Are Modestly Higher In Cautious Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant",2017-08-14 17:36:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/opke0bQcE9c/the-zacks-analyst-blog-highlights-mylan-perrigo-esperions-zynerba-and-valeant-cm831788,For Immediate Release Chicago IL August 14 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant",2017-08-14 17:36:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/opke0bQcE9c/the-zacks-analyst-blog-highlights-mylan-perrigo-esperions-zynerba-and-valeant-cm831788,For Immediate Release Chicago IL August 14 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion&apos;s, Zynerba and Valeant",2017-08-14 15:49:03 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-mylan-154903752.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion&apos;s, Zynerba and Valeant"
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion&apos;s, Zynerba and Valeant",2017-08-14 15:49:03 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-mylan-154903752.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion&apos;s, Zynerba and Valeant"
VRX,VRX:US,BBG000DLFM21,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-12 12:01:15 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120115039.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:CT,BBG000DC8S17,See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc.,2017-08-12 12:01:15 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120115039.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
VRX,VRX:US,BBG000DLFM21,"When the drugmaker raised these heart drugs’ prices, patients stopped getting them",2017-08-11 14:20:12 +0000,http://finance.yahoo.com/r/7147c244-7520-3c24-8450-37d34de7857c/Story.aspx?guid=9B271D46-7DF0-11E7-B70F-204EE225F90B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,A case study on the effects of rising drug prices found those who need them most just don’t get them.
VRX,VRX:CT,BBG000DC8S17,"When the drugmaker raised these heart drugs’ prices, patients stopped getting them",2017-08-11 14:20:12 +0000,http://finance.yahoo.com/r/7147c244-7520-3c24-8450-37d34de7857c/Story.aspx?guid=9B271D46-7DF0-11E7-B70F-204EE225F90B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,A case study on the effects of rising drug prices found those who need them most just don’t get them.
VRX,VRX:US,BBG000DLFM21,Valeant: Three Steps to a Recovery?,2017-08-11 13:59:00 +0000,http://finance.yahoo.com/r/ef93b6ad-4030-3c3d-957b-671c90d943b3/valeant-three-steps-to-a-recovery-1502459959?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Ever since Teva Pharmaceuticals Industries (TEVA) reported its terrible earnings, specialty pharmaceutical companies have been under pressure--and Valeant Pharmaceuticals International (VRX) has been no ..."
VRX,VRX:CT,BBG000DC8S17,Valeant: Three Steps to a Recovery?,2017-08-11 13:59:00 +0000,http://finance.yahoo.com/r/ef93b6ad-4030-3c3d-957b-671c90d943b3/valeant-three-steps-to-a-recovery-1502459959?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Ever since Teva Pharmaceuticals Industries (TEVA) reported its terrible earnings, specialty pharmaceutical companies have been under pressure--and Valeant Pharmaceuticals International (VRX) has been no ..."
VRX,VRX:CT,BBG000DC8S17,"Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure",2017-08-11 13:40:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/upgHNSRuF5Y/pharma-stock-roundup-mylan-misses-perrigo-tops-in-q2-zynerba-plunges-on-study-failure-cm830794,Second quarter earnings season is drawing to a close with most major companies having reported results This week companies like Endo Mylan MYL Novo Nordisk and Perrigo PRGO presented their second quarter results Recap of the Week s Most Important Stories A Look at Q2
VRX,VRX:US,BBG000DLFM21,"Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure",2017-08-11 13:40:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/upgHNSRuF5Y/pharma-stock-roundup-mylan-misses-perrigo-tops-in-q2-zynerba-plunges-on-study-failure-cm830794,Second quarter earnings season is drawing to a close with most major companies having reported results This week companies like Endo Mylan MYL Novo Nordisk and Perrigo PRGO presented their second quarter results Recap of the Week s Most Important Stories A Look at Q2
VRX,VRX:US,BBG000DLFM21,"Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure",2017-08-11 11:05:11 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mylan-misses-110511193.html?.tsrc=rss,"This week, focus was on earnings announcements from companies like Mylan (MYL), Perrigo and Endo."
VRX,VRX:CT,BBG000DC8S17,"Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure",2017-08-11 11:05:11 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mylan-misses-110511193.html?.tsrc=rss,"This week, focus was on earnings announcements from companies like Mylan (MYL), Perrigo and Endo."
VRX,VRX:CT,BBG000DC8S17,"Robert Bruce Invests in Valvoline, 2 Pharmaceutical Companies",2017-08-10 23:22:24 +0000,https://finance.yahoo.com/news/robert-bruce-invests-valvoline-2-232224260.html?.tsrc=rss,The guru exited 2 other positions in 2nd quarter
VRX,VRX:US,BBG000DLFM21,"Robert Bruce Invests in Valvoline, 2 Pharmaceutical Companies",2017-08-10 23:22:24 +0000,https://finance.yahoo.com/news/robert-bruce-invests-valvoline-2-232224260.html?.tsrc=rss,The guru exited 2 other positions in 2nd quarter
VRX,VRX:US,BBG000DLFM21,5 Reasons Valeant's Situation Could Get Worse,2017-08-10 14:37:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dvT6d6pmh2Q/5-reasons-valeants-situation-could-get-worse-cm830112,Valeant Pharmaceuticals NYSE VRX announced some good news in its second quarter update on Tuesday The drugmaker now expects to cut its debt by 5 billion sooner than its previous target of February 2018 Valeant was also able to highlight rebounding sales
VRX,VRX:CT,BBG000DC8S17,5 Reasons Valeant's Situation Could Get Worse,2017-08-10 14:37:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dvT6d6pmh2Q/5-reasons-valeants-situation-could-get-worse-cm830112,Valeant Pharmaceuticals NYSE VRX announced some good news in its second quarter update on Tuesday The drugmaker now expects to cut its debt by 5 billion sooner than its previous target of February 2018 Valeant was also able to highlight rebounding sales
VRX,VRX:CT,BBG000DC8S17,5 Reasons Valeant&apos;s Situation Could Get Worse,2017-08-10 13:03:00 +0000,http://finance.yahoo.com/r/f164bc9f-241b-3f79-8037-dc376c6bea8a/5-reasons-valeants-situation-could-get-worse.aspx?yptr=yahoo&.tsrc=rss,Reducing $5 billion in debt earlier than promised is great -- but Valeant still faces some big challenges.
VRX,VRX:US,BBG000DLFM21,5 Reasons Valeant&apos;s Situation Could Get Worse,2017-08-10 13:03:00 +0000,http://finance.yahoo.com/r/f164bc9f-241b-3f79-8037-dc376c6bea8a/5-reasons-valeants-situation-could-get-worse.aspx?yptr=yahoo&.tsrc=rss,Reducing $5 billion in debt earlier than promised is great -- but Valeant still faces some big challenges.
VRX,VRX:US,BBG000DLFM21,Valeant and Teva Share Similar Ambitions With Similar Pitfalls,2017-08-09 22:36:00 +0000,http://finance.yahoo.com/r/a6119dd3-137d-3652-aa9b-9199a7bbbcf9/valeant-and-teva-share-similar-ambitions-with-similar-pitfalls.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Wed., Aug. 9."
VRX,VRX:CT,BBG000DC8S17,Valeant and Teva Share Similar Ambitions With Similar Pitfalls,2017-08-09 22:36:00 +0000,http://finance.yahoo.com/r/a6119dd3-137d-3652-aa9b-9199a7bbbcf9/valeant-and-teva-share-similar-ambitions-with-similar-pitfalls.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Wed., Aug. 9."
VRX,VRX:US,BBG000DLFM21,"Earnings Hangover Sacks Valeant Pharmaceuticals' Stock, Sending Shares Down 10%",2017-08-09 22:35:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c0secCoiOow/earnings-hangover-sacks-valeant-pharmaceuticals-stock-sending-shares-down-10-cm829859,What happened Shares of embattled drugmaker Valeant Pharmaceuticals NYSE VRX are pulling an about face after initially moving higher following the release of its second quarter earnings results before the opening bell on Tuesday August 8 While no major developments
VRX,VRX:CT,BBG000DC8S17,"Earnings Hangover Sacks Valeant Pharmaceuticals' Stock, Sending Shares Down 10%",2017-08-09 22:35:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c0secCoiOow/earnings-hangover-sacks-valeant-pharmaceuticals-stock-sending-shares-down-10-cm829859,What happened Shares of embattled drugmaker Valeant Pharmaceuticals NYSE VRX are pulling an about face after initially moving higher following the release of its second quarter earnings results before the opening bell on Tuesday August 8 While no major developments
VRX,VRX:CT,BBG000DC8S17,"Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy",2017-08-09 22:05:00 +0000,https://finance.yahoo.com/news/paulson-co-inc-reiterates-confidence-220500578.html?.tsrc=rss,"Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy"
VRX,VRX:CT,BBG000DC8S17,"Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy",2017-08-09 22:05:00 +0000,https://finance.yahoo.com/news/paulson-co-inc-reiterates-confidence-220500832.html?.tsrc=rss,"Marginally Reduces Holdings of Valeant Due to Required Rebalancing of Portfolio LAVAL, Quebec , Aug. 9, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" ..."
VRX,VRX:US,BBG000DLFM21,"Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy",2017-08-09 22:05:00 +0000,https://finance.yahoo.com/news/paulson-co-inc-reiterates-confidence-220500832.html?.tsrc=rss,"Marginally Reduces Holdings of Valeant Due to Required Rebalancing of Portfolio LAVAL, Quebec , Aug. 9, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" ..."
VRX,VRX:US,BBG000DLFM21,"Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy",2017-08-09 22:05:00 +0000,https://finance.yahoo.com/news/paulson-co-inc-reiterates-confidence-220500578.html?.tsrc=rss,"Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy"
VRX,VRX:US,BBG000DLFM21,"Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today",2017-08-09 21:36:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J7OLz_JYmII/heres-why-progenics-pharmaceuticals-inc-lost-ground-today-cm829825,What happened Despite upbeat recent developments shares of Progenics Pharmaceuticals Inc NASDAQ PGNX 160 fell 15 3 during Wednesday s session The biotech reported solid progress with clinical stage candidates but a steep drop in Relistor revenue weighed on the stock
VRX,VRX:CT,BBG000DC8S17,"Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today",2017-08-09 21:36:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J7OLz_JYmII/heres-why-progenics-pharmaceuticals-inc-lost-ground-today-cm829825,What happened Despite upbeat recent developments shares of Progenics Pharmaceuticals Inc NASDAQ PGNX 160 fell 15 3 during Wednesday s session The biotech reported solid progress with clinical stage candidates but a steep drop in Relistor revenue weighed on the stock
VRX,VRX:CT,BBG000DC8S17,"Why Priceline Group, Office Depot, and Valeant Pharmaceuticals International Slumped Today",2017-08-09 21:36:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2p_nfwxWn_w/why-priceline-group-office-depot-and-valeant-pharmaceuticals-international-slumped-today-cm829816,Wednesday was another down day for the stock market as major benchmarks finished with small losses of 0 3 or less for the session Deteriorating relations between the U S and North Korea were one cause for concern among some investors but most of the attention on Wall Street appeared
VRX,VRX:US,BBG000DLFM21,"Why Priceline Group, Office Depot, and Valeant Pharmaceuticals International Slumped Today",2017-08-09 21:36:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2p_nfwxWn_w/why-priceline-group-office-depot-and-valeant-pharmaceuticals-international-slumped-today-cm829816,Wednesday was another down day for the stock market as major benchmarks finished with small losses of 0 3 or less for the session Deteriorating relations between the U S and North Korea were one cause for concern among some investors but most of the attention on Wall Street appeared
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Beats Q2 Earnings, Sales in Line, Trims View",2017-08-09 21:35:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0umkNeff1TQ/valeant-vrx-beats-q2-earnings-sales-in-line-trims-view-cm829822,Shares of Valeant Pharmaceuticals Inc VRX surged 1 76 after the company announced that it is on target with its debt reduction plans Valeant s stock lost 12 against the industry s gain of 5 5 The company s adjusted earnings per share of 1 05 beat the Zacks Consensus Estimate of
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Beats Q2 Earnings, Sales in Line, Trims View",2017-08-09 21:35:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0umkNeff1TQ/valeant-vrx-beats-q2-earnings-sales-in-line-trims-view-cm829822,Shares of Valeant Pharmaceuticals Inc VRX surged 1 76 after the company announced that it is on target with its debt reduction plans Valeant s stock lost 12 against the industry s gain of 5 5 The company s adjusted earnings per share of 1 05 beat the Zacks Consensus Estimate of
VRX,VRX:CT,BBG000DC8S17,Notable Two Hundred Day Moving Average Cross - VRX,2017-08-09 21:35:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eG8VoWx0I24/notable-two-hundred-day-moving-average-cross-vrx-cm829807,In trading on Wednesday shares of Valeant Pharmaceuticals International Inc Symbol VRX crossed below their 200 day moving average of 14 46 changing hands as low as 13 97 per share Valeant Pharmaceuticals International Inc shares are currently trading off about 10 6 on the day The
VRX,VRX:US,BBG000DLFM21,Notable Two Hundred Day Moving Average Cross - VRX,2017-08-09 21:35:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eG8VoWx0I24/notable-two-hundred-day-moving-average-cross-vrx-cm829807,In trading on Wednesday shares of Valeant Pharmaceuticals International Inc Symbol VRX crossed below their 200 day moving average of 14 46 changing hands as low as 13 97 per share Valeant Pharmaceuticals International Inc shares are currently trading off about 10 6 on the day The
VRX,VRX:CT,BBG000DC8S17,"Earnings Hangover Sacks Valeant Pharmaceuticals&apos; Stock, Sending Shares Down 10%",2017-08-09 20:38:00 +0000,http://finance.yahoo.com/r/b41dcf73-2331-3f62-b5e7-76c0f450742b/earnings-hangover-sacks-valeant-pharmaceuticals-st.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s path back to growth may not be easy.
VRX,VRX:US,BBG000DLFM21,"Earnings Hangover Sacks Valeant Pharmaceuticals&apos; Stock, Sending Shares Down 10%",2017-08-09 20:38:00 +0000,http://finance.yahoo.com/r/b41dcf73-2331-3f62-b5e7-76c0f450742b/earnings-hangover-sacks-valeant-pharmaceuticals-st.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s path back to growth may not be easy.
VRX,VRX:US,BBG000DLFM21,"Why Priceline Group, Office Depot, and Valeant Pharmaceuticals International Slumped Today",2017-08-09 20:30:00 +0000,http://finance.yahoo.com/r/403e5d4d-62e1-310a-861a-47cfad8b78e7/why-priceline-group-office-depot-and-valeant-pharm.aspx?yptr=yahoo&.tsrc=rss,These stocks led the market lower. Find out why.
VRX,VRX:CT,BBG000DC8S17,"Why Priceline Group, Office Depot, and Valeant Pharmaceuticals International Slumped Today",2017-08-09 20:30:00 +0000,http://finance.yahoo.com/r/403e5d4d-62e1-310a-861a-47cfad8b78e7/why-priceline-group-office-depot-and-valeant-pharm.aspx?yptr=yahoo&.tsrc=rss,These stocks led the market lower. Find out why.
VRX,VRX:US,BBG000DLFM21,"Here&apos;s Why Progenics Pharmaceuticals, Inc. Lost Ground Today",2017-08-09 20:15:00 +0000,http://finance.yahoo.com/r/535b28e6-2bae-3904-affe-0a776b651d17/heres-why-progenics-pharmaceuticals-inc-lost-groun.aspx?yptr=yahoo&.tsrc=rss,The market couldn&apos;t see past a precipitous drop in royalty revenue during the first quarter.
VRX,VRX:CT,BBG000DC8S17,"Here&apos;s Why Progenics Pharmaceuticals, Inc. Lost Ground Today",2017-08-09 20:15:00 +0000,http://finance.yahoo.com/r/535b28e6-2bae-3904-affe-0a776b651d17/heres-why-progenics-pharmaceuticals-inc-lost-groun.aspx?yptr=yahoo&.tsrc=rss,The market couldn&apos;t see past a precipitous drop in royalty revenue during the first quarter.
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX ends lower as Valeant, financials drag",2017-08-09 20:04:29 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-ends-lower-200429958.html?.tsrc=rss,"Canada's main stock index finished lower on Wednesday, as Valeant Pharmaceuticals International and financial stocks led broad declines. The Toronto Stock Exchange's S&P/TSX composite index fell 39.02 ..."
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX ends lower as Valeant, financials drag",2017-08-09 20:04:29 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-ends-lower-200429958.html?.tsrc=rss,"Canada's main stock index finished lower on Wednesday, as Valeant Pharmaceuticals International and financial stocks led broad declines. The Toronto Stock Exchange's S&P/TSX composite index fell 39.02 ..."
VRX,VRX:US,BBG000DLFM21,Valeant Isn't Out Of The Woods Yet,2017-08-09 19:23:22 +0000,https://finance.yahoo.com/news/valeant-isnt-woods-yet-192322019.html?.tsrc=rss,"Investors initially celebrated a mixed Q2 earnings report from Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) to the tune of a 7 percent Tuesday-morning pop for the stock. However, that enthusiasm quickly ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Isn't Out Of The Woods Yet,2017-08-09 19:23:22 +0000,https://finance.yahoo.com/news/valeant-isnt-woods-yet-192322019.html?.tsrc=rss,"Investors initially celebrated a mixed Q2 earnings report from Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) to the tune of a 7 percent Tuesday-morning pop for the stock. However, that enthusiasm quickly ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Beats Q2 Earnings, Sales in Line, Trims View",2017-08-09 19:08:07 +0000,https://finance.yahoo.com/news/valeant-vrx-beats-q2-earnings-190807140.html?.tsrc=rss,Valeant&apos;s (VRX) second-quarter results were encouraging but the company trimmed its guidance due to recent divestitures.
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Beats Q2 Earnings, Sales in Line, Trims View",2017-08-09 19:08:07 +0000,https://finance.yahoo.com/news/valeant-vrx-beats-q2-earnings-190807140.html?.tsrc=rss,Valeant&apos;s (VRX) second-quarter results were encouraging but the company trimmed its guidance due to recent divestitures.
VRX,VRX:CT,BBG000DC8S17,"Valeant Isn't Out of Trouble Yet, Debt Remains Difficult to Curb",2017-08-09 16:02:00 +0000,http://finance.yahoo.com/r/84d05a43-07af-30f8-a8b2-a11226c43498/valeant-shares-jump-on-second-quarter-results.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Laval, Quebec-based pharmaceutical company updated its revenue guidance and maintained its adjusted Ebitda outlook."
VRX,VRX:US,BBG000DLFM21,"Valeant Isn't Out of Trouble Yet, Debt Remains Difficult to Curb",2017-08-09 16:02:00 +0000,http://finance.yahoo.com/r/84d05a43-07af-30f8-a8b2-a11226c43498/valeant-shares-jump-on-second-quarter-results.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Laval, Quebec-based pharmaceutical company updated its revenue guidance and maintained its adjusted Ebitda outlook."
VRX,VRX:CT,BBG000DC8S17,Finally! 3 Figures From Valeant's Second-Quarter Report That Demonstrate Improvement,2017-08-09 14:36:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b3gRcHVLkGE/finally-3-figures-from-valeants-second-quarter-report-that-demonstrate-improvement-cm829328,If you ve ever played the board game Chutes and Ladders and landed on space 87 which throws the player back 63 spaces you might have some idea of what it s been like to be a Valeant Pharmaceuticals NYSE VRX shareholder over the past two years The only difference is that Valeant
VRX,VRX:US,BBG000DLFM21,Finally! 3 Figures From Valeant's Second-Quarter Report That Demonstrate Improvement,2017-08-09 14:36:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b3gRcHVLkGE/finally-3-figures-from-valeants-second-quarter-report-that-demonstrate-improvement-cm829328,If you ve ever played the board game Chutes and Ladders and landed on space 87 which throws the player back 63 spaces you might have some idea of what it s been like to be a Valeant Pharmaceuticals NYSE VRX shareholder over the past two years The only difference is that Valeant
VRX,VRX:US,BBG000DLFM21,"Wednesday’s Vital Data: Bank of America Corp (BAC), SeaWorld Entertainment Inc. (SEAS) and BP plc (ADR) (BP)",2017-08-09 13:45:06 +0000,https://finance.yahoo.com/news/wednesday-vital-data-bank-america-134506280.html?.tsrc=rss,"U.S. stock futures are in full retreat this morning, as Wall Street is shaken by escalating tension between the U.S. and North Korea.  Yesterday, North Korea threatened missile strikes against the U.S. territory of Guam after President Donald Trump promised “fire and fury like the world has never seen” if North Korea doesn’t stop threatening the U.S. The ratcheted up saber-rattling between the two nations has created considerable uncertainty for traders."
VRX,VRX:CT,BBG000DC8S17,"Wednesday’s Vital Data: Bank of America Corp (BAC), SeaWorld Entertainment Inc. (SEAS) and BP plc (ADR) (BP)",2017-08-09 13:45:06 +0000,https://finance.yahoo.com/news/wednesday-vital-data-bank-america-134506280.html?.tsrc=rss,"U.S. stock futures are in full retreat this morning, as Wall Street is shaken by escalating tension between the U.S. and North Korea.  Yesterday, North Korea threatened missile strikes against the U.S. territory of Guam after President Donald Trump promised “fire and fury like the world has never seen” if North Korea doesn’t stop threatening the U.S. The ratcheted up saber-rattling between the two nations has created considerable uncertainty for traders."
VRX,VRX:CT,BBG000DC8S17,Valeant: A Plausible Path Forward?,2017-08-09 13:41:00 +0000,http://finance.yahoo.com/r/bb73aed1-7ba5-354b-81d0-36c88dc5f1db/valeant-a-plausible-path-forward-1502286096?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, Valeant Pharmaceuticals International (VRX) reported earnings that were good enough for it to close up nearly 2% but not hold onto what had been a 10% rise. So what should we make of the company ..."
VRX,VRX:US,BBG000DLFM21,Valeant: A Plausible Path Forward?,2017-08-09 13:41:00 +0000,http://finance.yahoo.com/r/bb73aed1-7ba5-354b-81d0-36c88dc5f1db/valeant-a-plausible-path-forward-1502286096?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, Valeant Pharmaceuticals International (VRX) reported earnings that were good enough for it to close up nearly 2% but not hold onto what had been a 10% rise. So what should we make of the company ..."
VRX,VRX:US,BBG000DLFM21,"Your first trade for Wednesday, August 9",2017-08-09 13:32:58 +0000,http://finance.yahoo.com/r/77a7bce0-408f-3448-a6bd-9f998413e6d7/104642549?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104642549&yptr=yahoo&.tsrc=rss,"The ""Fast Money"" traders share their first moves for the market open."
VRX,VRX:CT,BBG000DC8S17,"Your first trade for Wednesday, August 9",2017-08-09 13:32:58 +0000,https://finance.yahoo.com/news/first-trade-wednesday-august-9-133258879.html?.tsrc=rss,The &quot;Fast Money&quot; traders share their first moves for the market open.
VRX,VRX:US,BBG000DLFM21,"Your first trade for Wednesday, August 9",2017-08-09 13:32:58 +0000,https://finance.yahoo.com/news/first-trade-wednesday-august-9-133258879.html?.tsrc=rss,The &quot;Fast Money&quot; traders share their first moves for the market open.
VRX,VRX:CT,BBG000DC8S17,"Your first trade for Wednesday, August 9",2017-08-09 13:32:58 +0000,http://finance.yahoo.com/r/77a7bce0-408f-3448-a6bd-9f998413e6d7/104642549?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104642549&yptr=yahoo&.tsrc=rss,"The ""Fast Money"" traders share their first moves for the market open."
VRX,VRX:CT,BBG000DC8S17,Finally! 3 Figures From Valeant&apos;s Second-Quarter Report That Demonstrate Improvement,2017-08-09 13:16:00 +0000,http://finance.yahoo.com/r/bd637289-96c5-39f0-a41b-26d6fca04b77/finally-3-figures-from-valeants-second-quarter-rep.aspx?yptr=yahoo&.tsrc=rss,"However, Valeant is far from being out of the woods."
VRX,VRX:US,BBG000DLFM21,Finally! 3 Figures From Valeant&apos;s Second-Quarter Report That Demonstrate Improvement,2017-08-09 13:16:00 +0000,http://finance.yahoo.com/r/bd637289-96c5-39f0-a41b-26d6fca04b77/finally-3-figures-from-valeants-second-quarter-rep.aspx?yptr=yahoo&.tsrc=rss,"However, Valeant is far from being out of the woods."
VRX,VRX:CT,BBG000DC8S17,Valeant is on track to reduce about $5 billion of debt. But it has more than $27 billion to go,2017-08-09 12:20:19 +0000,http://finance.yahoo.com/r/16d56ebb-4a13-3d3e-b8e4-17d45acfe062/Story.aspx?guid=6CE66818-7C44-11E7-BE68-A3304057D7D4&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The company will face a debt “wall” starting with more than $5 billion due in 2020.
VRX,VRX:US,BBG000DLFM21,Valeant is on track to reduce about $5 billion of debt. But it has more than $27 billion to go,2017-08-09 12:20:19 +0000,http://finance.yahoo.com/r/16d56ebb-4a13-3d3e-b8e4-17d45acfe062/Story.aspx?guid=6CE66818-7C44-11E7-BE68-A3304057D7D4&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The company will face a debt “wall” starting with more than $5 billion due in 2020.
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Esperion Therapeutics and Valeant Pharmaceuticals,2017-08-09 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000508.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Esperion Therapeutics may not have been able to thrill the Street with its second quarter earnings yesterday, but shares still hit a new high after the company ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Esperion Therapeutics and Valeant Pharmaceuticals,2017-08-09 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000508.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Esperion Therapeutics may not have been able to thrill the Street with its second quarter earnings yesterday, but shares still hit a new high after the company ..."
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals (VRX) Back From the Dead?,2017-08-09 11:52:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VYtL9l71fWY/is-valeant-pharmaceuticals-vrx-back-from-the-dead-cm829219,"Biotech (Shutterstock photo)    Call it an overreaction, a temporary reprieve or even a dead cat bounce — all terms used Tuesday to describe the 10% rise in shares of Valeant Pharmaceuticals ( VRX ), reaching a high of $16.97 following the company’s second quarter earnings beat —  one thing is certain, those who"
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals (VRX) Back From the Dead?,2017-08-09 11:52:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VYtL9l71fWY/is-valeant-pharmaceuticals-vrx-back-from-the-dead-cm829219,"Biotech (Shutterstock photo)    Call it an overreaction, a temporary reprieve or even a dead cat bounce — all terms used Tuesday to describe the 10% rise in shares of Valeant Pharmaceuticals ( VRX ), reaching a high of $16.97 following the company’s second quarter earnings beat —  one thing is certain, those who"
VRX,VRX:US,BBG000DLFM21,"Working on a turnaround, Valeant gets a setback from its Bausch & Lomb plant in Tampa",2017-08-09 11:40:14 +0000,http://finance.yahoo.com/r/55221f4a-12f9-3281-83a8-2fc30db24621/working-on-a-turnaround-valeant-gets-a-setback.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Something is wrong at Valeant Pharmaceuticals International Inc.’s Bausch & Lomb plant in Tampa.  “We are working to resolve manufacturing quality issues at our Tampa facility,” said Joseph Papa, Valeant chairman and CEO, during a conference call with analysts Tuesday.  The FDA says it issues complete response letters  when communicating a decision to a drug company  that its new drug application to market a new or generic drug will not be approved in its present form."
VRX,VRX:CT,BBG000DC8S17,"Working on a turnaround, Valeant gets a setback from its Bausch & Lomb plant in Tampa",2017-08-09 11:40:14 +0000,http://finance.yahoo.com/r/55221f4a-12f9-3281-83a8-2fc30db24621/working-on-a-turnaround-valeant-gets-a-setback.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Something is wrong at Valeant Pharmaceuticals International Inc.’s Bausch & Lomb plant in Tampa.  “We are working to resolve manufacturing quality issues at our Tampa facility,” said Joseph Papa, Valeant chairman and CEO, during a conference call with analysts Tuesday.  The FDA says it issues complete response letters  when communicating a decision to a drug company  that its new drug application to market a new or generic drug will not be approved in its present form."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Flat Amid Rising Geopolitical Concerns - Canadian Commentary,2017-08-09 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HTb91F6fl80/canadian-stocks-are-flat-amid-rising-geopolitical-concerns--canadian-commentary-20170809-01028,Canadian Stocks Are Flat Amid Rising Geopolitical Concerns - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Flat Amid Rising Geopolitical Concerns - Canadian Commentary,2017-08-09 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HTb91F6fl80/canadian-stocks-are-flat-amid-rising-geopolitical-concerns--canadian-commentary-20170809-01028,Canadian Stocks Are Flat Amid Rising Geopolitical Concerns - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Valeant Rises on Earnings Beat, Progress on Debt Repayment",2017-08-08 22:03:35 +0000,https://finance.yahoo.com/news/valeant-rises-earnings-beat-progress-175120744.html?.tsrc=rss,Pharmaceutical company cuts full-year revenue forecast
VRX,VRX:US,BBG000DLFM21,"Valeant Rises on Earnings Beat, Progress on Debt Repayment",2017-08-08 22:03:35 +0000,https://finance.yahoo.com/news/valeant-rises-earnings-beat-progress-175120744.html?.tsrc=rss,Pharmaceutical company cuts full-year revenue forecast
VRX,VRX:US,BBG000DLFM21,Valeant reports 2Q loss,2017-08-08 21:58:28 +0000,https://finance.yahoo.com/news/valeant-reports-2q-loss-114653428.html?.tsrc=rss,"On a per-share basis, the Laval, Quebec-based company said it had a loss of 11 cents. Earnings, adjusted for one-time gains and costs, were $1.05 per share. The results surpassed Wall Street expectations. ..."
VRX,VRX:CT,BBG000DC8S17,Valeant reports 2Q loss,2017-08-08 21:58:28 +0000,https://finance.yahoo.com/news/valeant-reports-2q-loss-114653428.html?.tsrc=rss,"On a per-share basis, the Laval, Quebec-based company said it had a loss of 11 cents. Earnings, adjusted for one-time gains and costs, were $1.05 per share. The results surpassed Wall Street expectations. ..."
VRX,VRX:US,BBG000DLFM21,Here's Why Valeant Pharmaceuticals Intl. Inc. Surged as Much as 10%,2017-08-08 20:38:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j1GdlltECWM/heres-why-valeant-pharmaceuticals-intl-inc-surged-as-much-as-10-cm829024,What happened Shares of Valeant Pharmaceuticals NYSE VRX the embattled drugmaker that s traditionally grown through acquisitions and price hikes over the years surged as much as 10 during Tuesday s trading session after the company released its second quarter
VRX,VRX:CT,BBG000DC8S17,Here's Why Valeant Pharmaceuticals Intl. Inc. Surged as Much as 10%,2017-08-08 20:38:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j1GdlltECWM/heres-why-valeant-pharmaceuticals-intl-inc-surged-as-much-as-10-cm829024,What happened Shares of Valeant Pharmaceuticals NYSE VRX the embattled drugmaker that s traditionally grown through acquisitions and price hikes over the years surged as much as 10 during Tuesday s trading session after the company released its second quarter
VRX,VRX:US,BBG000DLFM21,Valeant Bonds Rise on Early Debt Repayment,2017-08-08 20:34:00 +0000,http://finance.yahoo.com/r/d751201d-4405-326e-9c0f-e5cfd58aa749/valeant-bonds-rise-on-early-debt-repayment-1502224493?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Stock investors weren't the only Valeant Pharmaceuticals (VRX) stakeholders happy on Tuesday with the company's second quarter results. Bond investors were also cheering. The main reason: The company said ...
VRX,VRX:CT,BBG000DC8S17,Valeant Bonds Rise on Early Debt Repayment,2017-08-08 20:34:00 +0000,http://finance.yahoo.com/r/d751201d-4405-326e-9c0f-e5cfd58aa749/valeant-bonds-rise-on-early-debt-repayment-1502224493?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Stock investors weren't the only Valeant Pharmaceuticals (VRX) stakeholders happy on Tuesday with the company's second quarter results. Bond investors were also cheering. The main reason: The company said ...
VRX,VRX:US,BBG000DLFM21,"Yes, Nvidia Corporation (NVDA) Stock Is Expensive – It’s Supposed to Be",2017-08-08 19:34:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gix9uvMXGmg/yes-nvidia-corporation-nvda-stock-is-expensive-its-supposed-to-be-cm829004,InvestorPlace Stock Market News Stock Advice amp Trading Tips Throughout much of this year I ve been a fan of Nvidia Corporation NASDAQ NVDA I love the financials the management team and its execution The company is a well oiled machine hence the dramatic surge in
VRX,VRX:CT,BBG000DC8S17,"Yes, Nvidia Corporation (NVDA) Stock Is Expensive – It’s Supposed to Be",2017-08-08 19:34:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gix9uvMXGmg/yes-nvidia-corporation-nvda-stock-is-expensive-its-supposed-to-be-cm829004,InvestorPlace Stock Market News Stock Advice amp Trading Tips Throughout much of this year I ve been a fan of Nvidia Corporation NASDAQ NVDA I love the financials the management team and its execution The company is a well oiled machine hence the dramatic surge in
VRX,VRX:US,BBG000DLFM21,"Time to Buy Advanced Micro Devices, Inc. (AMD) Stock as New Super-Chips Come Out?",2017-08-08 19:34:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DXiACOBieog/time-to-buy-advanced-micro-devices-inc-amd-stock-as-new-super-chips-come-out-cm829001,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Advanced Micro Devices Inc NASDAQ AMD have been struggling falling over 4 since the last day of July Although the decline may be disheartening it could be the buying opportunity investors have
VRX,VRX:CT,BBG000DC8S17,"Time to Buy Advanced Micro Devices, Inc. (AMD) Stock as New Super-Chips Come Out?",2017-08-08 19:34:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DXiACOBieog/time-to-buy-advanced-micro-devices-inc-amd-stock-as-new-super-chips-come-out-cm829001,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Advanced Micro Devices Inc NASDAQ AMD have been struggling falling over 4 since the last day of July Although the decline may be disheartening it could be the buying opportunity investors have
VRX,VRX:CT,BBG000DC8S17,Tesla Inc (TSLA) Stock Is Driving to New Heights,2017-08-08 19:34:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ImZHUZ_4TU/tesla-inc-tsla-stock-is-driving-to-new-heights-cm828998,InvestorPlace Stock Market News Stock Advice amp Trading Tips Runners are easy to spot on slow summer days While the rest of the market waffles around unchanged these momentum darlings are popping 2 to 3 160 more Take Tesla Inc NASDAQ TSLA for example The stock
VRX,VRX:US,BBG000DLFM21,Tesla Inc (TSLA) Stock Is Driving to New Heights,2017-08-08 19:34:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ImZHUZ_4TU/tesla-inc-tsla-stock-is-driving-to-new-heights-cm828998,InvestorPlace Stock Market News Stock Advice amp Trading Tips Runners are easy to spot on slow summer days While the rest of the market waffles around unchanged these momentum darlings are popping 2 to 3 160 more Take Tesla Inc NASDAQ TSLA for example The stock
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant/Teva: lost summer,2017-08-08 19:15:05 +0000,"http://finance.yahoo.com/r/7de55247-d77c-381c-9a8c-0737a7a35ffa/31996cae-7c55-11e7-9108-edda0bcbc928,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The summer of 2015 seems like a long time ago for the once-rollicking drugmaking luminaries. The first to crumble was Valeant Pharmaceuticals, a vehicle for buying smaller drugmakers and jacking up treatment ..."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant/Teva: lost summer,2017-08-08 19:15:05 +0000,"http://finance.yahoo.com/r/7de55247-d77c-381c-9a8c-0737a7a35ffa/31996cae-7c55-11e7-9108-edda0bcbc928,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The summer of 2015 seems like a long time ago for the once-rollicking drugmaking luminaries. The first to crumble was Valeant Pharmaceuticals, a vehicle for buying smaller drugmakers and jacking up treatment ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Bears Will Be Bears,2017-08-08 19:06:00 +0000,http://finance.yahoo.com/r/aa6216e0-3954-379b-a919-e4018c21cbd8/valeant-pharmaceuticals-bears-will-be-bears-1502219218?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"What do you do if you're a Valeant Pharmaceuticals International (VRX) bear and the company just reported earnings good enough to send its shares up more than 3%?  Cash from operations in 2Q17 of $268MM was less than the $410MM we had expected, negatively affected by $190MM of net payments made in resolution of the Salix securities class action...With revenues declining and significant debt, we believe the longer-term outlook for Valeant is not promising.  Sales fell 7.7%, on pricing pressure, fall in Diversified Products, and divestitures."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Bears Will Be Bears,2017-08-08 19:06:00 +0000,http://finance.yahoo.com/r/aa6216e0-3954-379b-a919-e4018c21cbd8/valeant-pharmaceuticals-bears-will-be-bears-1502219218?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"What do you do if you're a Valeant Pharmaceuticals International (VRX) bear and the company just reported earnings good enough to send its shares up more than 3%?  Cash from operations in 2Q17 of $268MM was less than the $410MM we had expected, negatively affected by $190MM of net payments made in resolution of the Salix securities class action...With revenues declining and significant debt, we believe the longer-term outlook for Valeant is not promising.  Sales fell 7.7%, on pricing pressure, fall in Diversified Products, and divestitures."
VRX,VRX:US,BBG000DLFM21,"Tuesday’s Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-08-08 18:35:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PIJpfKBU9vw/tuesdays-vital-data-apple-inc-aapl-alibaba-group-holding-ltd-baba-and-valeant-pharmaceuticals-intl-inc-vrx-cm828981,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading lower this morning as Wall Street eyes a rally in crude oil amid another influx of corporate earnings At last check crude was up slightly at 49 32 per barrel after Saudi Arabia
VRX,VRX:CT,BBG000DC8S17,"Tuesday’s Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-08-08 18:35:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PIJpfKBU9vw/tuesdays-vital-data-apple-inc-aapl-alibaba-group-holding-ltd-baba-and-valeant-pharmaceuticals-intl-inc-vrx-cm828981,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading lower this morning as Wall Street eyes a rally in crude oil amid another influx of corporate earnings At last check crude was up slightly at 49 32 per barrel after Saudi Arabia
VRX,VRX:US,BBG000DLFM21,Buy Wayfair Inc (W) Stock Before It Gets Bought Out,2017-08-08 18:34:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YLvnQD8rCa0/buy-wayfair-inc-w-stock-before-it-gets-bought-out-cm828975,InvestorPlace Stock Market News Stock Advice amp Trading Tips Home goods retailer Wayfair Inc NYSE W reported yet another loss Tuesday morning this time in its fiscal second quarter But whether Wayfair makes money is almost irrelevant at this point What has been driving
VRX,VRX:CT,BBG000DC8S17,Buy Wayfair Inc (W) Stock Before It Gets Bought Out,2017-08-08 18:34:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YLvnQD8rCa0/buy-wayfair-inc-w-stock-before-it-gets-bought-out-cm828975,InvestorPlace Stock Market News Stock Advice amp Trading Tips Home goods retailer Wayfair Inc NYSE W reported yet another loss Tuesday morning this time in its fiscal second quarter But whether Wayfair makes money is almost irrelevant at this point What has been driving
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Scores 2 Vital Victories,2017-08-08 18:34:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3qkc8_LfzfU/valeant-pharmaceuticals-intl-inc-vrx-stock-scores-2-vital-victories-cm828965,InvestorPlace Stock Market News Stock Advice amp Trading Tips By almost all accounts Valeant Pharmaceuticals Intl Inc NYSE VRX should be falling today Not only did revenue decline 8 on a year over year basis last quarter but the company is still booking GAAP losses and
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Scores 2 Vital Victories,2017-08-08 18:34:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3qkc8_LfzfU/valeant-pharmaceuticals-intl-inc-vrx-stock-scores-2-vital-victories-cm828965,InvestorPlace Stock Market News Stock Advice amp Trading Tips By almost all accounts Valeant Pharmaceuticals Intl Inc NYSE VRX should be falling today Not only did revenue decline 8 on a year over year basis last quarter but the company is still booking GAAP losses and
VRX,VRX:US,BBG000DLFM21,Here&apos;s Why Valeant Pharmaceuticals Intl. Inc. Surged as Much as 10%,2017-08-08 18:34:00 +0000,http://finance.yahoo.com/r/96d24f57-ee05-3f36-bff3-25823b3b93ac/heres-why-valeant-pharmaceuticals-intl-inc-surged.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s second-quarter report shows its first improvements in a long time.
VRX,VRX:CT,BBG000DC8S17,Here&apos;s Why Valeant Pharmaceuticals Intl. Inc. Surged as Much as 10%,2017-08-08 18:34:00 +0000,http://finance.yahoo.com/r/96d24f57-ee05-3f36-bff3-25823b3b93ac/heres-why-valeant-pharmaceuticals-intl-inc-surged.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s second-quarter report shows its first improvements in a long time.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals' Debt Reduction Overshadows Drop in Revenue,2017-08-08 17:38:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZD6FfDoeHf8/valeant-pharmaceuticals-debt-reduction-overshadows-drop-in-revenue-cm828915,One major question Valeant Pharmaceuticals NYSE VRX had to answer when the company reported its second quarter results was this How significant was the impact of loss of exclusivity for several of its drugs The drugmaker raised its full year 2017 guidance three months
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals' Debt Reduction Overshadows Drop in Revenue,2017-08-08 17:38:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZD6FfDoeHf8/valeant-pharmaceuticals-debt-reduction-overshadows-drop-in-revenue-cm828915,One major question Valeant Pharmaceuticals NYSE VRX had to answer when the company reported its second quarter results was this How significant was the impact of loss of exclusivity for several of its drugs The drugmaker raised its full year 2017 guidance three months
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Gain on Strength of Xifaxan,2017-08-08 17:17:33 +0000,https://finance.yahoo.com/video/valeant-shares-gain-strength-xifaxan-171733346.html?.tsrc=rss,"Aug.08 -- Bloomberg’s Cynthia Koons discusses pharma firm Valeant’s revenue guidance, its asset sales program and Bill Ackman’s investment in the company. She speaks on “Bloomberg Markets.”"
VRX,VRX:US,BBG000DLFM21,Valeant Shares Gain on Strength of Xifaxan,2017-08-08 17:17:33 +0000,https://finance.yahoo.com/video/valeant-shares-gain-strength-xifaxan-171733346.html?.tsrc=rss,"Aug.08 -- Bloomberg’s Cynthia Koons discusses pharma firm Valeant’s revenue guidance, its asset sales program and Bill Ackman’s investment in the company. She speaks on “Bloomberg Markets.”"
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant gains breathing room during recovery,2017-08-08 16:21:00 +0000,"http://finance.yahoo.com/r/9f3eee3b-9dfe-3f9e-bd70-320706e2e776/3ccfe28e-7c4f-11e7-9108-edda0bcbc928,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Valeant posted quarterly earnings that exceeded Wall Street expectations, handing the drugmaker a reprieve as it tries to tackle its $29bn of debts and recover from an accounting scandal that threatened ..."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant gains breathing room during recovery,2017-08-08 16:21:00 +0000,"http://finance.yahoo.com/r/9f3eee3b-9dfe-3f9e-bd70-320706e2e776/3ccfe28e-7c4f-11e7-9108-edda0bcbc928,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Valeant posted quarterly earnings that exceeded Wall Street expectations, handing the drugmaker a reprieve as it tries to tackle its $29bn of debts and recover from an accounting scandal that threatened ..."
VRX,VRX:US,BBG000DLFM21,"TSX Ekes Out Modest Gain, Led By Valeant -- Canadian Commentary",2017-08-08 16:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GrVRoIvcD_o/tsx-ekes-out-modest-gain-led-by-valeant--canadian-commentary-20170808-01594,"TSX Ekes Out Modest Gain, Led By Valeant -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"TSX Ekes Out Modest Gain, Led By Valeant -- Canadian Commentary",2017-08-08 16:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GrVRoIvcD_o/tsx-ekes-out-modest-gain-led-by-valeant--canadian-commentary-20170808-01594,"TSX Ekes Out Modest Gain, Led By Valeant -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals&apos; Debt Reduction Overshadows Drop in Revenue,2017-08-08 15:47:00 +0000,http://finance.yahoo.com/r/bda56b90-8efd-3d26-b590-66228c579c12/premium-valeant-pharmaceuticals-q2.aspx?yptr=yahoo&.tsrc=rss,The drugmaker expects to cut its debt by $5 billion sooner than expected.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals&apos; Debt Reduction Overshadows Drop in Revenue,2017-08-08 15:47:00 +0000,http://finance.yahoo.com/r/bda56b90-8efd-3d26-b590-66228c579c12/premium-valeant-pharmaceuticals-q2.aspx?yptr=yahoo&.tsrc=rss,The drugmaker expects to cut its debt by $5 billion sooner than expected.
VRX,VRX:CT,BBG000DC8S17,"Valeant says it will exceed debt repayment target, shares surge",2017-08-08 15:45:28 +0000,https://finance.yahoo.com/news/valeant-cuts-revenue-forecast-makes-114225802.html?.tsrc=rss,"Canada's Valeant Pharmaceuticals  International Inc  said on Tuesday it expects to  repay more than $5 billion in debt earlier than it had targeted,  news that pushed its shares up 9 percent.  Since taking the helm in April 2016, Chief Executive Joseph  Papa has been trying to rebuild the company's business and  regain investor confidence following a flurry of investigations  into its accounting and pricing practices."
VRX,VRX:US,BBG000DLFM21,"Valeant says it will exceed debt repayment target, shares surge",2017-08-08 15:45:28 +0000,https://finance.yahoo.com/news/valeant-cuts-revenue-forecast-makes-114225802.html?.tsrc=rss,"Canada's Valeant Pharmaceuticals  International Inc  said on Tuesday it expects to  repay more than $5 billion in debt earlier than it had targeted,  news that pushed its shares up 9 percent.  Since taking the helm in April 2016, Chief Executive Joseph  Papa has been trying to rebuild the company's business and  regain investor confidence following a flurry of investigations  into its accounting and pricing practices."
VRX,VRX:CT,BBG000DC8S17,"Valeant: Time, Time, Time is on My Side",2017-08-08 15:35:00 +0000,http://finance.yahoo.com/r/4330e12c-da88-37a8-80c4-2ed76cd3e27c/valeant-time-time-time-is-on-my-side-1502206538?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It doesn't take much to send shares of Valeant Pharmaceuticals International (VRX) higher--much higher--these days, as today's response to earnings demonstrates.  It's not that earnings weren't good, but were they so good the stock deserved to jump 9% to $16.75 at 11:20 a.m. today?  A day that's seen other specialty pharmaceutical companies like Endo International (ENDP) and Mallinckrodt (MNK) are dropping more than 5% after reporting  earnings of their own."
VRX,VRX:US,BBG000DLFM21,"Valeant: Time, Time, Time is on My Side",2017-08-08 15:35:00 +0000,http://finance.yahoo.com/r/4330e12c-da88-37a8-80c4-2ed76cd3e27c/valeant-time-time-time-is-on-my-side-1502206538?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It doesn't take much to send shares of Valeant Pharmaceuticals International (VRX) higher--much higher--these days, as today's response to earnings demonstrates.  It's not that earnings weren't good, but were they so good the stock deserved to jump 9% to $16.75 at 11:20 a.m. today?  A day that's seen other specialty pharmaceutical companies like Endo International (ENDP) and Mallinckrodt (MNK) are dropping more than 5% after reporting  earnings of their own."
VRX,VRX:US,BBG000DLFM21,Valeant's Guidance Gymnastics Point to a Cut,2017-08-08 15:28:30 +0000,http://finance.yahoo.com/r/a7463f03-23eb-327b-8223-e8ee67a18378/valeant-earnings-guidance-gymnastics?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,The pharma firm's Ebitda outlook is too shaky to survive long.
VRX,VRX:CT,BBG000DC8S17,Valeant's Guidance Gymnastics Point to a Cut,2017-08-08 15:28:30 +0000,http://finance.yahoo.com/r/a7463f03-23eb-327b-8223-e8ee67a18378/valeant-earnings-guidance-gymnastics?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,The pharma firm's Ebitda outlook is too shaky to survive long.
VRX,VRX:CT,BBG000DC8S17,Is This the Turnaround Valeant Pharma Has Been Waiting For?,2017-08-08 15:05:51 +0000,https://finance.yahoo.com/news/turnaround-valeant-pharma-waiting-150551612.html?.tsrc=rss,Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.
VRX,VRX:US,BBG000DLFM21,Is This the Turnaround Valeant Pharma Has Been Waiting For?,2017-08-08 15:05:51 +0000,https://finance.yahoo.com/news/turnaround-valeant-pharma-waiting-150551612.html?.tsrc=rss,Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX up on Valeant, Ritchie results; BlackBerry falls on sell rating",2017-08-08 15:00:48 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-valeant-ritchie-150048215.html?.tsrc=rss,Canada's main stock index was modestly higher on Tuesday as positive earnings results and a deal in the gaming sector helped offset declines in BlackBerry Ltd and other tech shares. Valeant Pharmaceuticals ...
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX up on Valeant, Ritchie results; BlackBerry falls on sell rating",2017-08-08 15:00:48 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-valeant-ritchie-150048215.html?.tsrc=rss,Canada's main stock index was modestly higher on Tuesday as positive earnings results and a deal in the gaming sector helped offset declines in BlackBerry Ltd and other tech shares. Valeant Pharmaceuticals ...
VRX,VRX:CT,BBG000DC8S17,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-08-08 14:41:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C-a_MaRycfU/are-options-traders-betting-on-a-big-move-in-valeant-pharmaceuticals-vrx-stock-cm828673,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the August 11th 2017 15 Call had some of the highest implied volatility of all equity options today What is Implied
VRX,VRX:US,BBG000DLFM21,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-08-08 14:41:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C-a_MaRycfU/are-options-traders-betting-on-a-big-move-in-valeant-pharmaceuticals-vrx-stock-cm828673,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the August 11th 2017 15 Call had some of the highest implied volatility of all equity options today What is Implied
VRX,VRX:US,BBG000DLFM21,ADP Stock Breakout Just Getting Started,2017-08-08 14:32:00 +0000,http://finance.yahoo.com/r/9de4b330-9ebc-3ff8-8815-6c9471e9d48b/adp-stock-breakout-just-getting-started?partner=YahooSA&yptr=yahoo&.tsrc=rss,Pershing Capital's 8.3% stake and actions to control ADP's board should attract speculative buying interest.
VRX,VRX:CT,BBG000DC8S17,ADP Stock Breakout Just Getting Started,2017-08-08 14:32:00 +0000,http://finance.yahoo.com/r/9de4b330-9ebc-3ff8-8815-6c9471e9d48b/adp-stock-breakout-just-getting-started?partner=YahooSA&yptr=yahoo&.tsrc=rss,Pershing Capital's 8.3% stake and actions to control ADP's board should attract speculative buying interest.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Scores 2 Vital Victories,2017-08-08 14:23:10 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-142310162.html?.tsrc=rss,"By almost all accounts, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) should be falling today.  In simplest terms, although the drugmaker did poorly in Q2 in the aggregate, Valeant demonstrated some success in two key areas that mean the most to the market right now: debt reduction and sales of gastrointestinal drug Xifaxan.  Aside from an accounting scandal — complete with the creation of a sham specialty pharmacy — the exit of a CEO and a mountain of debt, sheer distaste for its model of acquiring specialty drugs and cranking their prices up to extortion-like levels finally caught up with the company."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Scores 2 Vital Victories,2017-08-08 14:23:10 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-142310162.html?.tsrc=rss,"By almost all accounts, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) should be falling today.  In simplest terms, although the drugmaker did poorly in Q2 in the aggregate, Valeant demonstrated some success in two key areas that mean the most to the market right now: debt reduction and sales of gastrointestinal drug Xifaxan.  Aside from an accounting scandal — complete with the creation of a sham specialty pharmacy — the exit of a CEO and a mountain of debt, sheer distaste for its model of acquiring specialty drugs and cranking their prices up to extortion-like levels finally caught up with the company."
VRX,VRX:CT,BBG000DC8S17,Valeant Cuts Revenue Outlook,2017-08-08 14:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUpHi956EiM/valeant-cuts-revenue-outlook-20170808-01341,Valeant Cuts Revenue Outlook
VRX,VRX:US,BBG000DLFM21,Valeant Cuts Revenue Outlook,2017-08-08 14:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUpHi956EiM/valeant-cuts-revenue-outlook-20170808-01341,Valeant Cuts Revenue Outlook
VRX,VRX:CT,BBG000DC8S17,CANADA STOCKS-TSX opens higher; Valeant jumps,2017-08-08 13:45:57 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-opens-higher-134557310.html?.tsrc=rss,"Canada's main stock index opened modestly higher on Tuesday, as better-than-expected quarterly results from Valeant Pharmaceuticals International Inc helped offset declines in tech stocks. The Toronto ..."
VRX,VRX:US,BBG000DLFM21,CANADA STOCKS-TSX opens higher; Valeant jumps,2017-08-08 13:45:57 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-opens-higher-134557310.html?.tsrc=rss,"Canada's main stock index opened modestly higher on Tuesday, as better-than-expected quarterly results from Valeant Pharmaceuticals International Inc helped offset declines in tech stocks. The Toronto ..."
VRX,VRX:CT,BBG000DC8S17,"Tuesday’s Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-08-08 13:40:57 +0000,https://finance.yahoo.com/news/tuesday-vital-data-apple-inc-134057802.html?.tsrc=rss,"U.S. stock futures are trading lower this morning, as Wall Street eyes a rally in crude oil amid another influx of corporate earnings.  At last check, futures on the Dow Jones Industrial Average were down 0.08%, Nasdaq-100 futures were off by 0.23% and S&P 500 futures were lagging by 0.14%.  Turning to Monday’s options activity, Apple Inc. (NASDAQ:AAPL) CEO Tim Cook reportedly met with India’s Prime Minister recently to talk iPhone production and the company just bought India-based Eros Group’s entire content library of movies and music."
VRX,VRX:US,BBG000DLFM21,"Tuesday’s Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-08-08 13:40:57 +0000,https://finance.yahoo.com/news/tuesday-vital-data-apple-inc-134057802.html?.tsrc=rss,"U.S. stock futures are trading lower this morning, as Wall Street eyes a rally in crude oil amid another influx of corporate earnings.  At last check, futures on the Dow Jones Industrial Average were down 0.08%, Nasdaq-100 futures were off by 0.23% and S&P 500 futures were lagging by 0.14%.  Turning to Monday’s options activity, Apple Inc. (NASDAQ:AAPL) CEO Tim Cook reportedly met with India’s Prime Minister recently to talk iPhone production and the company just bought India-based Eros Group’s entire content library of movies and music."
VRX,VRX:CT,BBG000DC8S17,Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study,2017-08-08 13:29:00 +0000,http://finance.yahoo.com/r/cb4843a6-a890-339a-b27c-9737c1db833e/biotech-movers-fibrogen-leaps-on-results-for-pulmonary-fibrosis-study.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"FibroGen, Depomed and Valeant were among the biotech stock movers in premarket trading on Aug. 8."
VRX,VRX:US,BBG000DLFM21,Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study,2017-08-08 13:29:00 +0000,http://finance.yahoo.com/r/cb4843a6-a890-339a-b27c-9737c1db833e/biotech-movers-fibrogen-leaps-on-results-for-pulmonary-fibrosis-study.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"FibroGen, Depomed and Valeant were among the biotech stock movers in premarket trading on Aug. 8."
VRX,VRX:US,BBG000DLFM21,Morning News Call Canadienne - Aout 8,2017-08-08 13:10:35 +0000,https://finance.yahoo.com/news/morning-news-call-canadienne-aout-131035469.html?.tsrc=rss,Pour consulter la lettre d'information; cliquez sur le lien: http://share.thomsonreuters.com/assets/newsletters/Morning_News_Call/MNCCA_FR_08082017.pdf PRINCIPAUX INDICATEURS À L’AGENDA Pas d’indicateurs ...
VRX,VRX:CT,BBG000DC8S17,Morning News Call Canadienne - Aout 8,2017-08-08 13:10:35 +0000,https://finance.yahoo.com/news/morning-news-call-canadienne-aout-131035469.html?.tsrc=rss,Pour consulter la lettre d'information; cliquez sur le lien: http://share.thomsonreuters.com/assets/newsletters/Morning_News_Call/MNCCA_FR_08082017.pdf PRINCIPAUX INDICATEURS À L’AGENDA Pas d’indicateurs ...
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Aug 8, 2017 :  VRX, ENDP, TEVA, ABB, FGEN, QQQ, INVA, CAR, KORS, NVDA, HTZ, PAGP",2017-08-08 12:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/um4N-O5f0N0/pre-market-most-active-for-aug-8-2017-vrx-endp-teva-abb-fgen-qqq-inva-car-kors-nvda-htz-pagp-cm828565,The NASDAQ 100 Pre Market Indicator is down 1 37 to 5 933 36 The total Pre Market volume is currently 7 622 229 shares traded The following are the most active stocks for the pre market session Valeant Pharmaceuticals International Inc VRX is 1 37 at 16 74
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Aug 8, 2017 :  VRX, ENDP, TEVA, ABB, FGEN, QQQ, INVA, CAR, KORS, NVDA, HTZ, PAGP",2017-08-08 12:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/um4N-O5f0N0/pre-market-most-active-for-aug-8-2017-vrx-endp-teva-abb-fgen-qqq-inva-car-kors-nvda-htz-pagp-cm828565,The NASDAQ 100 Pre Market Indicator is down 1 37 to 5 933 36 The total Pre Market volume is currently 7 622 229 shares traded The following are the most active stocks for the pre market session Valeant Pharmaceuticals International Inc VRX is 1 37 at 16 74
VRX,VRX:US,BBG000DLFM21,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-08-08 12:46:12 +0000,https://finance.yahoo.com/news/options-traders-betting-big-move-124612970.html?.tsrc=rss,Valeant Pharmaceuticals (VRX) warrants investors&apos; attention based on moves in the options market lately.
VRX,VRX:CT,BBG000DC8S17,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-08-08 12:46:12 +0000,https://finance.yahoo.com/news/options-traders-betting-big-move-124612970.html?.tsrc=rss,Valeant Pharmaceuticals (VRX) warrants investors&apos; attention based on moves in the options market lately.
VRX,VRX:US,BBG000DLFM21,"Morning Movers: Valeant Soars, Michael Kors Jumps, Avis Budget Tumbles",2017-08-08 12:42:00 +0000,http://finance.yahoo.com/r/563f4f8b-0d15-3031-928b-6a525693ac6f/morning-movers-valeant-soars-michael-kors-jumps-avis-budget-tumbles-1502196171?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a lower open this morning--putting the Dow Jones Industrial Average's nine-day streak of new highs in jeopardy. S&P 500 futures have declined 0.1%, while Dow Jones Industrial Average ..."
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: Valeant Soars, Michael Kors Jumps, Avis Budget Tumbles",2017-08-08 12:42:00 +0000,http://finance.yahoo.com/r/563f4f8b-0d15-3031-928b-6a525693ac6f/morning-movers-valeant-soars-michael-kors-jumps-avis-budget-tumbles-1502196171?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a lower open this morning--putting the Dow Jones Industrial Average's nine-day streak of new highs in jeopardy. S&P 500 futures have declined 0.1%, while Dow Jones Industrial Average ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals,2017-08-08 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000548.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Valeant Pharmaceuticals had a positive day in the green yesterday, despite Teva Pharmaceuticals shares plummeting. It was just last week that Valeant saw its ..."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals,2017-08-08 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000548.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Valeant Pharmaceuticals had a positive day in the green yesterday, despite Teva Pharmaceuticals shares plummeting. It was just last week that Valeant saw its ..."
VRX,VRX:US,BBG000DLFM21,"UPDATED: Valeant stock surges 7.9% after Q2 loss, 2017 revenue guidance cut",2017-08-08 11:42:50 +0000,http://finance.yahoo.com/r/a859484e-94ba-3668-bdf2-016207572db5/Story.aspx?guid=4FA368D8-6A1E-4AF4-8E53-55631A10C5E3&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. shares surged 7.9% in premarket trade on Tuesday after the company reported a second-quarter loss and cut its 2017 revenue guidance. The company reported a loss ...
VRX,VRX:CT,BBG000DC8S17,"UPDATED: Valeant stock surges 7.9% after Q2 loss, 2017 revenue guidance cut",2017-08-08 11:42:50 +0000,http://finance.yahoo.com/r/a859484e-94ba-3668-bdf2-016207572db5/Story.aspx?guid=4FA368D8-6A1E-4AF4-8E53-55631A10C5E3&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. shares surged 7.9% in premarket trade on Tuesday after the company reported a second-quarter loss and cut its 2017 revenue guidance. The company reported a loss ...
VRX,VRX:CT,BBG000DC8S17,"Valeant's Top Drug Is Growing Again, Offsetting Wider Slump",2017-08-08 11:33:48 +0000,http://finance.yahoo.com/r/8c58d554-0dee-353a-8874-2acdeea1be3a/valeant-s-biggest-drug-is-growing-again-offsetting-wider-slump?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc.’s most important drug is showing signs of getting back on track, offsetting declining sales elsewhere as the company attempts a turnaround."
VRX,VRX:US,BBG000DLFM21,"Valeant's Top Drug Is Growing Again, Offsetting Wider Slump",2017-08-08 11:33:48 +0000,http://finance.yahoo.com/r/8c58d554-0dee-353a-8874-2acdeea1be3a/valeant-s-biggest-drug-is-growing-again-offsetting-wider-slump?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc.’s most important drug is showing signs of getting back on track, offsetting declining sales elsewhere as the company attempts a turnaround."
VRX,VRX:US,BBG000DLFM21,Valeant revenue falls 8 pct,2017-08-08 11:14:31 +0000,https://finance.yahoo.com/news/valeant-revenue-falls-8-pct-111431535.html?.tsrc=rss,"Canada's Valeant Pharmaceuticals International Inc reported a 7.8 percent fall in quarterly revenue, hurt by declines in volume and pricing of its generic and neurology products. Revenue fell to $2.23 ..."
VRX,VRX:CT,BBG000DC8S17,Valeant revenue falls 8 pct,2017-08-08 11:14:31 +0000,https://finance.yahoo.com/news/valeant-revenue-falls-8-pct-111431535.html?.tsrc=rss,"Canada's Valeant Pharmaceuticals International Inc reported a 7.8 percent fall in quarterly revenue, hurt by declines in volume and pricing of its generic and neurology products. Revenue fell to $2.23 ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up Slightly On Valeant Strength - Canadian Commentary,2017-08-08 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MxRlBEHGuxU/canadian-stocks-are-up-slightly-on-valeant-strength--canadian-commentary-20170808-01121,Canadian Stocks Are Up Slightly On Valeant Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up Slightly On Valeant Strength - Canadian Commentary,2017-08-08 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MxRlBEHGuxU/canadian-stocks-are-up-slightly-on-valeant-strength--canadian-commentary-20170808-01121,Canadian Stocks Are Up Slightly On Valeant Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Second-Quarter 2017 Results,2017-08-08 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-second-quarter-2017-110000442.html?.tsrc=rss,"LAVAL, Quebec , Aug. 8, 2017 /PRNewswire/ -- Second-Quarter 2017 Financial Results Revenues of $2.233 Billion GAAP Net Loss of $38 Million Adjusted Net Income (non-GAAP) of $362 Million Year-to-Date GAAP ..."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Second-Quarter 2017 Results,2017-08-08 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-second-quarter-2017-110000442.html?.tsrc=rss,"LAVAL, Quebec , Aug. 8, 2017 /PRNewswire/ -- Second-Quarter 2017 Financial Results Revenues of $2.233 Billion GAAP Net Loss of $38 Million Adjusted Net Income (non-GAAP) of $362 Million Year-to-Date GAAP ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Second-Quarter 2017 Results,2017-08-08 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-second-quarter-2017-110000555.html?.tsrc=rss,Valeant Announces Second-Quarter 2017 Results
VRX,VRX:US,BBG000DLFM21,Valeant Announces Second-Quarter 2017 Results,2017-08-08 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-second-quarter-2017-110000555.html?.tsrc=rss,Valeant Announces Second-Quarter 2017 Results
VRX,VRX:CT,BBG000DC8S17,"Earnings Reaction History: Valeant Pharmaceuticals International, 83.3% Follow-Through Indicator, 15.2% Sensitive",2017-08-08 10:54:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pOea_x7LlgQ/earnings-reaction-history-valeant-pharmaceuticals-international-833-follow-through-indicator-152-sensitive-cm828495,Expected Earnings Release 08 08 2017 PremarketExpected Earnings Release 08 08 2017 Premarket Avg Extended Hours Dollar Volume 47 411 943Avg Extended Hours Dollar Volume 47 411 943 Valeant Pharmaceuticals International VRX is due to issue its quarterly earnings report in the
VRX,VRX:US,BBG000DLFM21,"Earnings Reaction History: Valeant Pharmaceuticals International, 83.3% Follow-Through Indicator, 15.2% Sensitive",2017-08-08 10:54:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pOea_x7LlgQ/earnings-reaction-history-valeant-pharmaceuticals-international-833-follow-through-indicator-152-sensitive-cm828495,Expected Earnings Release 08 08 2017 PremarketExpected Earnings Release 08 08 2017 Premarket Avg Extended Hours Dollar Volume 47 411 943Avg Extended Hours Dollar Volume 47 411 943 Valeant Pharmaceuticals International VRX is due to issue its quarterly earnings report in the
VRX,VRX:CT,BBG000DC8S17,Investor Network: Valeant Pharmaceuticals International Inc to Host Earnings Call,2017-08-08 09:10:00 +0000,https://finance.yahoo.com/news/investor-network-valeant-pharmaceuticals-international-091000345.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Valeant Pharmaceuticals International Inc (NYSE: VRX ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, ..."
VRX,VRX:US,BBG000DLFM21,Investor Network: Valeant Pharmaceuticals International Inc to Host Earnings Call,2017-08-08 09:10:00 +0000,https://finance.yahoo.com/news/investor-network-valeant-pharmaceuticals-international-091000345.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Valeant Pharmaceuticals International Inc (NYSE: VRX ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, ..."
VRX,VRX:CT,BBG000DC8S17,Left Brain CEO: Valeant earnings a 'turnaround story',2017-08-08 08:22:00 +0000,https://finance.yahoo.com/video/left-brain-ceo-valeant-earnings-082200362.html?.tsrc=rss,"Noland Langford, CEO and portfolio manager at Left Brain, discusses pharmaceuticals firm Valeant's second-quarter earnings."
VRX,VRX:US,BBG000DLFM21,Left Brain CEO: Valeant earnings a 'turnaround story',2017-08-08 08:22:00 +0000,https://finance.yahoo.com/video/left-brain-ceo-valeant-earnings-082200362.html?.tsrc=rss,"Noland Langford, CEO and portfolio manager at Left Brain, discusses pharmaceuticals firm Valeant's second-quarter earnings."
VRX,VRX:CT,BBG000DC8S17,"PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y",2017-08-07 22:36:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ycxx52tGzN8/pdl-biopharma-pdli-q2-earnings-beat-revenues-rise-yy-cm828395,PDL BioPharma Inc PDLI reported earnings of 26 cents per share in the second quarter of 2017 surpassing both the Zacks Consensus Estimate and the year ago earnings of 9 cents per share The company generated total revenue of 143 8 million in the quarter significantly skyrocketing
VRX,VRX:US,BBG000DLFM21,"PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y",2017-08-07 22:36:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ycxx52tGzN8/pdl-biopharma-pdli-q2-earnings-beat-revenues-rise-yy-cm828395,PDL BioPharma Inc PDLI reported earnings of 26 cents per share in the second quarter of 2017 surpassing both the Zacks Consensus Estimate and the year ago earnings of 9 cents per share The company generated total revenue of 143 8 million in the quarter significantly skyrocketing
VRX,VRX:US,BBG000DLFM21,Alibaba Group Holding Ltd (BABA) Stock Will Soar High on “New Retail”,2017-08-07 22:35:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KVh1MpI1Uow/alibaba-group-holding-ltd-baba-stock-will-soar-high-on-new-retail-cm828418,InvestorPlace Stock Market News Stock Advice amp Trading Tips Alibaba Group Holding Ltd NYSE BABA stock has grabbed my attention over the last several months as everyone has seemingly turned bullish on the omni channel retail growth narrative 160 In short BABA 160
VRX,VRX:CT,BBG000DC8S17,Alibaba Group Holding Ltd (BABA) Stock Will Soar High on “New Retail”,2017-08-07 22:35:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KVh1MpI1Uow/alibaba-group-holding-ltd-baba-stock-will-soar-high-on-new-retail-cm828418,InvestorPlace Stock Market News Stock Advice amp Trading Tips Alibaba Group Holding Ltd NYSE BABA stock has grabbed my attention over the last several months as everyone has seemingly turned bullish on the omni channel retail growth narrative 160 In short BABA 160
VRX,VRX:US,BBG000DLFM21,The 2 Most Important Figures in Valeant's Second-Quarter Report (and Neither Is EPS or Debt),2017-08-07 20:38:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NiEfgI_f-dM/the-2-most-important-figures-in-valeants-second-quarter-report-and-neither-is-eps-or-debt-cm828322,Earnings season remains in full swing and tomorrow morning one of the most popular and embattled drugmakers in the entire market is set to reports its second quarter results Valeant Pharmaceuticals NYSE VRX is slated to release its quarterly performance before the opening
VRX,VRX:CT,BBG000DC8S17,The 2 Most Important Figures in Valeant's Second-Quarter Report (and Neither Is EPS or Debt),2017-08-07 20:38:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NiEfgI_f-dM/the-2-most-important-figures-in-valeants-second-quarter-report-and-neither-is-eps-or-debt-cm828322,Earnings season remains in full swing and tomorrow morning one of the most popular and embattled drugmakers in the entire market is set to reports its second quarter results Valeant Pharmaceuticals NYSE VRX is slated to release its quarterly performance before the opening
VRX,VRX:CT,BBG000DC8S17,"PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y",2017-08-07 20:32:08 +0000,https://finance.yahoo.com/news/pdl-biopharma-pdli-q2-earnings-203208062.html?.tsrc=rss,"PDL BioPharma&apos;s (PDLI) earnings surpass expectations. Revenues also significantly increase year over year, thanks to a rise in fair value of the Depomed royalty asset."
VRX,VRX:US,BBG000DLFM21,"PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y",2017-08-07 20:32:08 +0000,https://finance.yahoo.com/news/pdl-biopharma-pdli-q2-earnings-203208062.html?.tsrc=rss,"PDL BioPharma&apos;s (PDLI) earnings surpass expectations. Revenues also significantly increase year over year, thanks to a rise in fair value of the Depomed royalty asset."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Receives Complete Response Letter from the FDA for Latanoprostene Bunod Ophthalmic Solution, 0.024% NDA",2017-08-07 20:17:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-receives-complete-response-201700729.html?.tsrc=rss,"Valeant Pharmaceuticals Receives Complete Response Letter from the FDA for Latanoprostene Bunod Ophthalmic Solution, 0.024% NDA"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Receives Complete Response Letter from the FDA for Latanoprostene Bunod Ophthalmic Solution, 0.024% NDA",2017-08-07 20:17:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-receives-complete-response-201700729.html?.tsrc=rss,"Valeant Pharmaceuticals Receives Complete Response Letter from the FDA for Latanoprostene Bunod Ophthalmic Solution, 0.024% NDA"
VRX,VRX:CT,BBG000DC8S17,Can CVS Health Corp (CVS) Stock Stop Infuriating the Bulls?,2017-08-07 19:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/amip8vjWd8g/can-cvs-health-corp-cvs-stock-stop-infuriating-the-bulls-cm828332,InvestorPlace Stock Market News Stock Advice amp Trading Tips CVS Health Corp 160 NYSE CVS is one of the few stocks I have lost money on during the current bull market Try as I might I have real difficulty making sense of CVS stock at times Source Mike Mozart
VRX,VRX:US,BBG000DLFM21,Can CVS Health Corp (CVS) Stock Stop Infuriating the Bulls?,2017-08-07 19:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/amip8vjWd8g/can-cvs-health-corp-cvs-stock-stop-infuriating-the-bulls-cm828332,InvestorPlace Stock Market News Stock Advice amp Trading Tips CVS Health Corp 160 NYSE CVS is one of the few stocks I have lost money on during the current bull market Try as I might I have real difficulty making sense of CVS stock at times Source Mike Mozart
VRX,VRX:CT,BBG000DC8S17,"As Hard as It Is, Pass on Priceline Group Inc (PCLN) Stock Right Now",2017-08-07 19:35:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_sOrkTm0Doc/as-hard-as-it-is-pass-on-priceline-group-inc-pcln-stock-right-now-cm828327,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Priceline Group Inc NASDAQ PCLN have been on fire not just in 2017 but over the last several years In this year alone PCLN stock is up nearly 40 Over the past 12 months it s up 44 and more than
VRX,VRX:US,BBG000DLFM21,"As Hard as It Is, Pass on Priceline Group Inc (PCLN) Stock Right Now",2017-08-07 19:35:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_sOrkTm0Doc/as-hard-as-it-is-pass-on-priceline-group-inc-pcln-stock-right-now-cm828327,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Priceline Group Inc NASDAQ PCLN have been on fire not just in 2017 but over the last several years In this year alone PCLN stock is up nearly 40 Over the past 12 months it s up 44 and more than
VRX,VRX:CT,BBG000DC8S17,The 2 Most Important Figures in Valeant&apos;s Second-Quarter Report (and Neither Is EPS or Debt),2017-08-07 19:10:00 +0000,http://finance.yahoo.com/r/0c65d75e-1dd3-3a87-87ef-598edf79d382/the-2-most-important-figures-in-valeants-second-qu.aspx?yptr=yahoo&.tsrc=rss,These two figures will give you a much better understanding of the health of the company.
VRX,VRX:US,BBG000DLFM21,The 2 Most Important Figures in Valeant&apos;s Second-Quarter Report (and Neither Is EPS or Debt),2017-08-07 19:10:00 +0000,http://finance.yahoo.com/r/0c65d75e-1dd3-3a87-87ef-598edf79d382/the-2-most-important-figures-in-valeants-second-qu.aspx?yptr=yahoo&.tsrc=rss,These two figures will give you a much better understanding of the health of the company.
VRX,VRX:US,BBG000DLFM21,How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback,2017-08-07 18:35:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Hi3m5b93Wo/how-valeant-pharmaceuticals-intl-inc-vrx-stock-can-make-a-comeback-cm828300,InvestorPlace Stock Market News Stock Advice amp Trading Tips There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc 160 NYSE VRX stock ahead of its second quarter fiscal 2017 earnings results before Tuesday s opening bell For example VRX stock
VRX,VRX:CT,BBG000DC8S17,How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback,2017-08-07 18:35:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Hi3m5b93Wo/how-valeant-pharmaceuticals-intl-inc-vrx-stock-can-make-a-comeback-cm828300,InvestorPlace Stock Market News Stock Advice amp Trading Tips There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc 160 NYSE VRX stock ahead of its second quarter fiscal 2017 earnings results before Tuesday s opening bell For example VRX stock
VRX,VRX:CT,BBG000DC8S17,Trade of the Day: Bet on Bank of America Corp (BAC) Stock,2017-08-07 16:37:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YkIGtvdq7GA/trade-of-the-day-bet-on-bank-of-america-corp-bac-stock-cm828229,InvestorPlace Stock Market News Stock Advice amp Trading Tips The financial sector of the S amp P 500 as represented by the 160 Financial Select Sector SPDR Fund 160 NYSEARCA XLF although higher by over 9 for the year to date has been a pain trade for many traders
VRX,VRX:US,BBG000DLFM21,Trade of the Day: Bet on Bank of America Corp (BAC) Stock,2017-08-07 16:37:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YkIGtvdq7GA/trade-of-the-day-bet-on-bank-of-america-corp-bac-stock-cm828229,InvestorPlace Stock Market News Stock Advice amp Trading Tips The financial sector of the S amp P 500 as represented by the 160 Financial Select Sector SPDR Fund 160 NYSEARCA XLF although higher by over 9 for the year to date has been a pain trade for many traders
VRX,VRX:US,BBG000DLFM21,Valeant: Why Teva's Blowup Could Be Good News,2017-08-07 14:04:00 +0000,http://finance.yahoo.com/r/b4f3385c-827b-387d-9322-6996cfd39741/valeant-why-tevas-blowup-could-be-good-news-1502114661?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last week, Valeant Pharmaceuticals International (VRX) tumbled 10% but for once it had nothing to do with anything Valeant did.  Instead, it fell after Teva Pharmaceutical Industries (TEVA) announced god-awful earnings and guidance due to pressure in its generics business, pressures that were then extrapolated to just about every specialty-pharmaceutical company, including Valeant.  Valeant is scheduled to report earnings tomorrow, and last week's plunge creates an interesting setup going into the print: Was last week's pain enough to tamp down the reaction to bad news?"
VRX,VRX:CT,BBG000DC8S17,Valeant: Why Teva's Blowup Could Be Good News,2017-08-07 14:04:00 +0000,http://finance.yahoo.com/r/b4f3385c-827b-387d-9322-6996cfd39741/valeant-why-tevas-blowup-could-be-good-news-1502114661?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last week, Valeant Pharmaceuticals International (VRX) tumbled 10% but for once it had nothing to do with anything Valeant did.  Instead, it fell after Teva Pharmaceutical Industries (TEVA) announced god-awful earnings and guidance due to pressure in its generics business, pressures that were then extrapolated to just about every specialty-pharmaceutical company, including Valeant.  Valeant is scheduled to report earnings tomorrow, and last week's plunge creates an interesting setup going into the print: Was last week's pain enough to tamp down the reaction to bad news?"
VRX,VRX:US,BBG000DLFM21,How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback,2017-08-07 13:53:37 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-135337338.html?.tsrc=rss,"There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock ahead of its second-quarter fiscal 2017 earnings results before Tuesday’s opening bell.  The embattled drugmaker continues to make operational improvements, including divesting various non-core assets to lower debts.  Since falling to a 52-week low of $8.31 on April 24, Valeant stock has skyrocketed as much as 118%, reaching $18.17 on July 25."
VRX,VRX:CT,BBG000DC8S17,How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback,2017-08-07 13:53:37 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-135337338.html?.tsrc=rss,"There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock ahead of its second-quarter fiscal 2017 earnings results before Tuesday’s opening bell.  The embattled drugmaker continues to make operational improvements, including divesting various non-core assets to lower debts.  Since falling to a 52-week low of $8.31 on April 24, Valeant stock has skyrocketed as much as 118%, reaching $18.17 on July 25."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : August 7, 2017",2017-08-07 13:26:46 +0000,http://finance.yahoo.com/r/8be0b8e8-8a0b-334a-80f9-8d8058418322/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-us-august-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : August 7, 2017",2017-08-07 13:26:46 +0000,http://finance.yahoo.com/r/8be0b8e8-8a0b-334a-80f9-8d8058418322/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-us-august-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,3 Things You'll Want to Watch in Valeant Pharmaceuticals' Q2 Results,2017-08-06 20:59:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K1rJH962EC0/3-things-youll-want-to-watch-in-valeant-pharmaceuticals-q2-results-cm827823,Good news from Valeant Pharmaceuticals NYSE VRX That s what investors got the last time the drugmaker announced its quarterly results Valeant posted a profit in the first quarter Its balance sheet was improved Heck the company even raised its earnings guidance for
VRX,VRX:US,BBG000DLFM21,3 Things You'll Want to Watch in Valeant Pharmaceuticals' Q2 Results,2017-08-06 20:59:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K1rJH962EC0/3-things-youll-want-to-watch-in-valeant-pharmaceuticals-q2-results-cm827823,Good news from Valeant Pharmaceuticals NYSE VRX That s what investors got the last time the drugmaker announced its quarterly results Valeant posted a profit in the first quarter Its balance sheet was improved Heck the company even raised its earnings guidance for
VRX,VRX:CT,BBG000DC8S17,3 Things You&apos;ll Want to Watch in Valeant Pharmaceuticals&apos; Q2 Results,2017-08-06 19:02:00 +0000,http://finance.yahoo.com/r/94b1f20d-1aff-3523-972b-f5a81cb76aa8/3-things-youll-want-to-watch-in-valeant-pharmaceut.aspx?yptr=yahoo&.tsrc=rss,Here&apos;s what could make the difference in whether you love or hate Valeant&apos;s Q2 numbers.
VRX,VRX:US,BBG000DLFM21,3 Things You&apos;ll Want to Watch in Valeant Pharmaceuticals&apos; Q2 Results,2017-08-06 19:02:00 +0000,http://finance.yahoo.com/r/94b1f20d-1aff-3523-972b-f5a81cb76aa8/3-things-youll-want-to-watch-in-valeant-pharmaceut.aspx?yptr=yahoo&.tsrc=rss,Here&apos;s what could make the difference in whether you love or hate Valeant&apos;s Q2 numbers.
VRX,VRX:US,BBG000DLFM21,"Disney, Snap and More of the Top Earnings to Watch This Week",2017-08-06 14:20:57 +0000,https://finance.yahoo.com/news/disney-snap-more-top-earnings-142057125.html?.tsrc=rss,24/7 Wall St. has put together a preview of a few major companies scheduled to report their quarterly results this coming week.
VRX,VRX:CT,BBG000DC8S17,"Disney, Snap and More of the Top Earnings to Watch This Week",2017-08-06 14:20:57 +0000,https://finance.yahoo.com/news/disney-snap-more-top-earnings-142057125.html?.tsrc=rss,24/7 Wall St. has put together a preview of a few major companies scheduled to report their quarterly results this coming week.
VRX,VRX:CT,BBG000DC8S17,Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday,2017-08-05 15:52:00 +0000,http://finance.yahoo.com/r/58b4a0bc-7762-35f7-a192-683499f2f23b/earnings-preview-what-to-expect-from-valeant-pharmaceuticals-on-tuesday-2?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals is expected to earn $0.97/share on $2.24 billion in revenue. Meanwhile, the so-called Whisper number is $1.01."
VRX,VRX:US,BBG000DLFM21,Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday,2017-08-05 15:52:00 +0000,http://finance.yahoo.com/r/58b4a0bc-7762-35f7-a192-683499f2f23b/earnings-preview-what-to-expect-from-valeant-pharmaceuticals-on-tuesday-2?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals is expected to earn $0.97/share on $2.24 billion in revenue. Meanwhile, the so-called Whisper number is $1.01."
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts for Friday: GoPro Inc (GPRO), Valeant Pharmaceuticals Intl Inc (VRX) and Microchip Technology Inc. (MCHP)",2017-08-04 22:01:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fAToxN_xvq8/3-big-stock-charts-for-friday-gopro-inc-gpro-valeant-pharmaceuticals-intl-inc-vrx-and-microchip-technology-inc-mchp-cm827605,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market is trying to make a move back towards its highs for the last day of the week as light earnings reporting and no headline risk are allowing investors to push stocks higher on lighter volume There are
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts for Friday: GoPro Inc (GPRO), Valeant Pharmaceuticals Intl Inc (VRX) and Microchip Technology Inc. (MCHP)",2017-08-04 22:01:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fAToxN_xvq8/3-big-stock-charts-for-friday-gopro-inc-gpro-valeant-pharmaceuticals-intl-inc-vrx-and-microchip-technology-inc-mchp-cm827605,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market is trying to make a move back towards its highs for the last day of the week as light earnings reporting and no headline risk are allowing investors to push stocks higher on lighter volume There are
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Stupid Is as Stupid Does,2017-08-04 22:01:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Vptsvok4do/valeant-pharmaceuticals-intl-inc-vrx-stock-stupid-is-as-stupid-does-cm827604,InvestorPlace Stock Market News Stock Advice amp Trading Tips The phrase made famous in the movie Forrest Gump could just as easily apply to almost anyone speculating on the recovery of Valeant Pharmaceuticals Intl Inc NYSE VRX stock
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Stupid Is as Stupid Does,2017-08-04 22:01:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Vptsvok4do/valeant-pharmaceuticals-intl-inc-vrx-stock-stupid-is-as-stupid-does-cm827604,InvestorPlace Stock Market News Stock Advice amp Trading Tips The phrase made famous in the movie Forrest Gump could just as easily apply to almost anyone speculating on the recovery of Valeant Pharmaceuticals Intl Inc NYSE VRX stock
VRX,VRX:CT,BBG000DC8S17,3 Earnings Reports to Watch Next Week,2017-08-04 21:01:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pi43FG7qcVI/3-earnings-reports-to-watch-next-week-cm827573,InvestorPlace Stock Market News Stock Advice amp Trading Tips Earnings season is in full swing and as always some reports are more important than others For stocks that are struggling quarterly earnings represent a chance to change the narrative But they also run the risk of making
VRX,VRX:US,BBG000DLFM21,3 Earnings Reports to Watch Next Week,2017-08-04 21:01:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pi43FG7qcVI/3-earnings-reports-to-watch-next-week-cm827573,InvestorPlace Stock Market News Stock Advice amp Trading Tips Earnings season is in full swing and as always some reports are more important than others For stocks that are struggling quarterly earnings represent a chance to change the narrative But they also run the risk of making
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Stupid Is as Stupid Does,2017-08-04 17:57:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-175700398.html?.tsrc=rss,"The phrase made famous in the movie Forrest Gump could just as easily apply to almost anyone speculating on the recovery of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock.  Tom Hanks played Forrest Gump and won the Best Actor Oscar for his performance.  In the movie, Forrest Gump was talking about how looking stupid doesn’t make you stupid."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Stupid Is as Stupid Does,2017-08-04 17:57:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-175700398.html?.tsrc=rss,"The phrase made famous in the movie Forrest Gump could just as easily apply to almost anyone speculating on the recovery of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock.  Tom Hanks played Forrest Gump and won the Best Actor Oscar for his performance.  In the movie, Forrest Gump was talking about how looking stupid doesn’t make you stupid."
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts for Friday: GoPro Inc (GPRO), Valeant Pharmaceuticals Intl Inc (VRX) and Microchip Technology Inc. (MCHP)",2017-08-04 17:40:54 +0000,https://finance.yahoo.com/news/3-big-stock-charts-friday-174054340.html?.tsrc=rss,"Today’s three big stock charts look at the charts for GoPro Inc (NASDAQ:GPRO), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Microchip Technology Inc. (NASDAQ:MCHP) as these companies are making moves that put them in the top five for each of their indices.  Leave it to GoPro to figure out a way to pull a good quarter off.  The 20% rally in GPRO shares has catapulted the stock above its 50- and 200-day moving averages, both of which have been trending lower."
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts for Friday: GoPro Inc (GPRO), Valeant Pharmaceuticals Intl Inc (VRX) and Microchip Technology Inc. (MCHP)",2017-08-04 17:40:54 +0000,https://finance.yahoo.com/news/3-big-stock-charts-friday-174054340.html?.tsrc=rss,"Today’s three big stock charts look at the charts for GoPro Inc (NASDAQ:GPRO), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Microchip Technology Inc. (NASDAQ:MCHP) as these companies are making moves that put them in the top five for each of their indices.  Leave it to GoPro to figure out a way to pull a good quarter off.  The 20% rally in GPRO shares has catapulted the stock above its 50- and 200-day moving averages, both of which have been trending lower."
VRX,VRX:US,BBG000DLFM21,"Here&apos;s Bill Ackman&apos;s Latest Bet After Valeant, Herbalife, Chipotle Setbacks",2017-08-04 14:49:53 +0000,http://finance.yahoo.com/r/fafb48bd-c0aa-3a88-97f3-7c1f87c29282/heres-bill-ackmans-latest-bet-after-valeant-herbalife-chipotle-setbacks?src=A00220&yptr=yahoo&.tsrc=rss,"Bill Ackman is done with Valeant Pharmaceuticals, still shorting Herbalife and tweeting about Chipotle. Now the billionaire hedge funder is turning his gaze toward payroll firm Automatic Data Processing."
VRX,VRX:CT,BBG000DC8S17,"Here&apos;s Bill Ackman&apos;s Latest Bet After Valeant, Herbalife, Chipotle Setbacks",2017-08-04 14:49:53 +0000,http://finance.yahoo.com/r/fafb48bd-c0aa-3a88-97f3-7c1f87c29282/heres-bill-ackmans-latest-bet-after-valeant-herbalife-chipotle-setbacks?src=A00220&yptr=yahoo&.tsrc=rss,"Bill Ackman is done with Valeant Pharmaceuticals, still shorting Herbalife and tweeting about Chipotle. Now the billionaire hedge funder is turning his gaze toward payroll firm Automatic Data Processing."
VRX,VRX:CT,BBG000DC8S17,"P&G, Valeant Exemplify Wall Street's 'Overboarded' Problem; Musk Must Raise Funds",2017-08-04 14:38:00 +0000,http://finance.yahoo.com/r/fdeeb988-1a22-3c5d-b761-1bbedc955759/p-amp-g-valeant-exemplify-wall-street-s-overboarded-problem-musk-must-raise-funds-icymi-thursday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Thursday, Aug. 3."
VRX,VRX:US,BBG000DLFM21,"P&G, Valeant Exemplify Wall Street's 'Overboarded' Problem; Musk Must Raise Funds",2017-08-04 14:38:00 +0000,http://finance.yahoo.com/r/fdeeb988-1a22-3c5d-b761-1bbedc955759/p-amp-g-valeant-exemplify-wall-street-s-overboarded-problem-musk-must-raise-funds-icymi-thursday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Thursday, Aug. 3."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals,2017-08-04 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000225.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 4, 2017 / U.S. markets were mixed Thursday after the latest batch of corporate earnings. Disappointing performances from the technology and energy sectors dragged down ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals,2017-08-04 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000225.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 4, 2017 / U.S. markets were mixed Thursday after the latest batch of corporate earnings. Disappointing performances from the technology and energy sectors dragged down ..."
VRX,VRX:CT,BBG000DC8S17,'Boring' Valeant Poised for Q2 Beat,2017-08-03 14:51:00 +0000,http://finance.yahoo.com/r/eafe8a78-2ac7-3cd7-bd2e-750b7b85cbf8/boring-valeant-poised-for-q2-beat.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals will report second quarter earnings results next Tuesday, August 8."
VRX,VRX:US,BBG000DLFM21,'Boring' Valeant Poised for Q2 Beat,2017-08-03 14:51:00 +0000,http://finance.yahoo.com/r/eafe8a78-2ac7-3cd7-bd2e-750b7b85cbf8/boring-valeant-poised-for-q2-beat.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals will report second quarter earnings results next Tuesday, August 8."
VRX,VRX:US,BBG000DLFM21,Valeant: Why Boring is Better,2017-08-03 14:10:00 +0000,http://finance.yahoo.com/r/ac4f3fcd-7be7-304c-aec2-9612010f089a/valeant-why-boring-is-better-1501769403?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Valeant Pharmaceuticals International (VRX) are falling today--likely because Teva Pharmaceutical Industries (TEVA) is tanking after releasing its earnings--but one team of analysts expects no ...
VRX,VRX:CT,BBG000DC8S17,Valeant: Why Boring is Better,2017-08-03 14:10:00 +0000,http://finance.yahoo.com/r/ac4f3fcd-7be7-304c-aec2-9612010f089a/valeant-why-boring-is-better-1501769403?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Valeant Pharmaceuticals International (VRX) are falling today--likely because Teva Pharmaceutical Industries (TEVA) is tanking after releasing its earnings--but one team of analysts expects no ...
VRX,VRX:CT,BBG000DC8S17,Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?,2017-08-02 19:54:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T2SURedh-3I/will-teva-pharmaceutical-industries-ltd-adr-teva-stock-catch-a-break-cm826043,InvestorPlace Stock Market News Stock Advice amp Trading Tips When Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA reports quarterly earnings results on Aug 3 before market open good sales numbers may not do enough to give TEVA stock a boost Source Open
VRX,VRX:US,BBG000DLFM21,Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?,2017-08-02 19:54:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T2SURedh-3I/will-teva-pharmaceutical-industries-ltd-adr-teva-stock-catch-a-break-cm826043,InvestorPlace Stock Market News Stock Advice amp Trading Tips When Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA reports quarterly earnings results on Aug 3 before market open good sales numbers may not do enough to give TEVA stock a boost Source Open
VRX,VRX:US,BBG000DLFM21,Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?,2017-08-02 15:41:02 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-154102281.html?.tsrc=rss,"Investors will demand more details on Teva Pharmaceutical’s strategy in absorbing Actavis.  TEVA stock has strong fundamentals, a robust pipeline and has the flexibility to adjust for the upheaval in healthcare policies imposed by governments around the world.  Teva Pharmaceutical will need to show growth in operating cash flow in the quarter."
VRX,VRX:CT,BBG000DC8S17,Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?,2017-08-02 15:41:02 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-154102281.html?.tsrc=rss,"Investors will demand more details on Teva Pharmaceutical’s strategy in absorbing Actavis.  TEVA stock has strong fundamentals, a robust pipeline and has the flexibility to adjust for the upheaval in healthcare policies imposed by governments around the world.  Teva Pharmaceutical will need to show growth in operating cash flow in the quarter."
VRX,VRX:CT,BBG000DC8S17,Bill Ackman’s Pershing Square Capital’s Top Sells in 1Q17,2017-08-02 13:49:22 +0000,http://finance.yahoo.com/r/5142bac8-e2dd-3473-a6fd-cb0a29d61cbc/look-bill-ackmans-pershing-square-capitals-top-sells-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In the past quarters, Valeant Pharmaceuticals remained one of the top holdings of Pershing Square Capital Management."
VRX,VRX:US,BBG000DLFM21,Bill Ackman’s Pershing Square Capital’s Top Sells in 1Q17,2017-08-02 13:49:22 +0000,http://finance.yahoo.com/r/5142bac8-e2dd-3473-a6fd-cb0a29d61cbc/look-bill-ackmans-pershing-square-capitals-top-sells-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In the past quarters, Valeant Pharmaceuticals remained one of the top holdings of Pershing Square Capital Management."
VRX,VRX:US,BBG000DLFM21,Why ADP Stock Rose on Reports of Bill Ackman’s Position,2017-08-02 13:49:17 +0000,http://finance.yahoo.com/r/06f6d0cd-66f9-3ad9-8897-009f52d29825/adp-stock-jump-reports-bill-ackmans-position?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On Thursday, July 27, 2017, Automatic Data Processing (ADP) stock rose nearly 13.0% after reports suggested that Bill Ackman was investing in ADP stock."
VRX,VRX:CT,BBG000DC8S17,Why ADP Stock Rose on Reports of Bill Ackman’s Position,2017-08-02 13:49:17 +0000,http://finance.yahoo.com/r/06f6d0cd-66f9-3ad9-8897-009f52d29825/adp-stock-jump-reports-bill-ackmans-position?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On Thursday, July 27, 2017, Automatic Data Processing (ADP) stock rose nearly 13.0% after reports suggested that Bill Ackman was investing in ADP stock."
VRX,VRX:CT,BBG000DC8S17,Rumors About Ackman Investment Cause Spike in ADP Shares,2017-08-01 22:17:00 +0000,http://finance.yahoo.com/r/3885f0b4-ec96-358f-bb5f-710eba8339a2/rumors-about-ackman-investment-cause-spike-adp-shares?partner=YahooSA&yptr=yahoo&.tsrc=rss,Reports that billionaire Bill Ackman might be accumulating a stake in Automatic Data Processing have caused shares of the company to rise quickly.
VRX,VRX:US,BBG000DLFM21,Rumors About Ackman Investment Cause Spike in ADP Shares,2017-08-01 22:17:00 +0000,http://finance.yahoo.com/r/3885f0b4-ec96-358f-bb5f-710eba8339a2/rumors-about-ackman-investment-cause-spike-adp-shares?partner=YahooSA&yptr=yahoo&.tsrc=rss,Reports that billionaire Bill Ackman might be accumulating a stake in Automatic Data Processing have caused shares of the company to rise quickly.
VRX,VRX:US,BBG000DLFM21,It's Time for Investors to Get Over the Biggest Misconception About Valeant Pharmaceuticals,2017-08-01 20:55:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/24HCBfHfW1Q/its-time-for-investors-to-get-over-the-biggest-misconception-about-valeant-pharmaceuticals-cm825272,Nearly two years ago to the day Valeant Pharmaceuticals NYSE VRX would hit almost 264 a share in intraday trading and support a roughly 90 billion market valuation The embattled drugmaker has lost approximately 94 of its value since reaching that all time high Valeant s
VRX,VRX:CT,BBG000DC8S17,It's Time for Investors to Get Over the Biggest Misconception About Valeant Pharmaceuticals,2017-08-01 20:55:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/24HCBfHfW1Q/its-time-for-investors-to-get-over-the-biggest-misconception-about-valeant-pharmaceuticals-cm825272,Nearly two years ago to the day Valeant Pharmaceuticals NYSE VRX would hit almost 264 a share in intraday trading and support a roughly 90 billion market valuation The embattled drugmaker has lost approximately 94 of its value since reaching that all time high Valeant s
VRX,VRX:CT,BBG000DC8S17,It&apos;s Time for Investors to Get Over the Biggest Misconception About Valeant Pharmaceuticals,2017-08-01 19:05:00 +0000,http://finance.yahoo.com/r/ce343283-9543-3754-9b68-5f5bcc768592/its-time-for-investors-to-get-over-the-biggest-mis.aspx?yptr=yahoo&.tsrc=rss,"You&apos;re probably focusing on the wrong metric, and that could be hazardous to your wealth."
VRX,VRX:US,BBG000DLFM21,It&apos;s Time for Investors to Get Over the Biggest Misconception About Valeant Pharmaceuticals,2017-08-01 19:05:00 +0000,http://finance.yahoo.com/r/ce343283-9543-3754-9b68-5f5bcc768592/its-time-for-investors-to-get-over-the-biggest-mis.aspx?yptr=yahoo&.tsrc=rss,"You&apos;re probably focusing on the wrong metric, and that could be hazardous to your wealth."
VRX,VRX:CT,BBG000DC8S17,Keep Your Eye on the Dollar’s Decline,2017-08-01 16:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n5eBip3hvns/keep-your-eye-on-the-dollars-decline-cm825116,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities mostly finished lower on Monday as volatility continues to ramp up led by deepening weakness in big cap tech stocks Known as the FAANGs these were the stocks that have captivated the attention
VRX,VRX:US,BBG000DLFM21,Keep Your Eye on the Dollar’s Decline,2017-08-01 16:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n5eBip3hvns/keep-your-eye-on-the-dollars-decline-cm825116,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities mostly finished lower on Monday as volatility continues to ramp up led by deepening weakness in big cap tech stocks Known as the FAANGs these were the stocks that have captivated the attention
VRX,VRX:US,BBG000DLFM21,Don’t Expect Fireworks From Today’s Apple Inc. (AAPL) Earnings,2017-08-01 15:54:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LKb6W7ENa5g/dont-expect-fireworks-from-todays-apple-inc-aapl-earnings-cm825036,InvestorPlace Stock Market News Stock Advice amp Trading Tips The bull bear argument over Apple Inc NASDAQ AAPL stock has been won by the bulls so far this year AAPL stock is up 29 year to date and reached an all time in May before a recent pullback But I don t expect
VRX,VRX:CT,BBG000DC8S17,Don’t Expect Fireworks From Today’s Apple Inc. (AAPL) Earnings,2017-08-01 15:54:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LKb6W7ENa5g/dont-expect-fireworks-from-todays-apple-inc-aapl-earnings-cm825036,InvestorPlace Stock Market News Stock Advice amp Trading Tips The bull bear argument over Apple Inc NASDAQ AAPL stock has been won by the bulls so far this year AAPL stock is up 29 year to date and reached an all time in May before a recent pullback But I don t expect
VRX,VRX:US,BBG000DLFM21,EyeGate Pharma Enrolls First Patient in Phase 2b Clinical Study of EGP-437 for Cataract Surgery,2017-08-01 11:30:00 +0000,https://finance.yahoo.com/news/eyegate-pharma-enrolls-first-patient-113000467.html?.tsrc=rss,"WALTHAM, Mass., Aug. 01, 2017-- EyeGate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases and disorders of the eye, ..."
VRX,VRX:CT,BBG000DC8S17,EyeGate Pharma Enrolls First Patient in Phase 2b Clinical Study of EGP-437 for Cataract Surgery,2017-08-01 11:30:00 +0000,https://finance.yahoo.com/news/eyegate-pharma-enrolls-first-patient-113000467.html?.tsrc=rss,"WALTHAM, Mass., Aug. 01, 2017-- EyeGate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases and disorders of the eye, ..."
VRX,VRX:US,BBG000DLFM21,Dow Jones Pushes to Record Heights While Tech Falters,2017-08-01 01:53:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRpr26N49Tc/dow-jones-pushes-to-record-heights-while-tech-falters-cm824634,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities mostly finished lower on Monday as volatility continues to ramp up led by deepening weakness in big cap tech stocks Known as the FAANGs these were the stocks that have captivated the attention
VRX,VRX:CT,BBG000DC8S17,Dow Jones Pushes to Record Heights While Tech Falters,2017-08-01 01:53:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRpr26N49Tc/dow-jones-pushes-to-record-heights-while-tech-falters-cm824634,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities mostly finished lower on Monday as volatility continues to ramp up led by deepening weakness in big cap tech stocks Known as the FAANGs these were the stocks that have captivated the attention
VRX,VRX:US,BBG000DLFM21,3 Value Stocks for Daring Investors,2017-08-01 00:54:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8Pqv-nkadU/3-value-stocks-for-daring-investors-cm824624,Value stocks sometimes can seem very risky if they re being driven down by the market for a reason Maybe it s the death of retail or another PR nightmare that the market is selling which may leave a stock trading for less than its underlying value With that in mind we asked three
VRX,VRX:CT,BBG000DC8S17,3 Value Stocks for Daring Investors,2017-08-01 00:54:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8Pqv-nkadU/3-value-stocks-for-daring-investors-cm824624,Value stocks sometimes can seem very risky if they re being driven down by the market for a reason Maybe it s the death of retail or another PR nightmare that the market is selling which may leave a stock trading for less than its underlying value With that in mind we asked three
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is on Breakdown Watch,2017-07-31 23:54:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J3_1ehjzhaM/valeant-pharmaceuticals-intl-inc-vrx-stock-is-on-breakdown-watch-cm824617,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Valeant Pharmaceuticals Intl Inc 160 NYSE VRX is at significant risk of a technical breakdown threatening a 13 year to date recovery for the struggling pharmaceutical outfit Right now a 2 plus
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is on Breakdown Watch,2017-07-31 23:54:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J3_1ehjzhaM/valeant-pharmaceuticals-intl-inc-vrx-stock-is-on-breakdown-watch-cm824617,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Valeant Pharmaceuticals Intl Inc 160 NYSE VRX is at significant risk of a technical breakdown threatening a 13 year to date recovery for the struggling pharmaceutical outfit Right now a 2 plus
VRX,VRX:US,BBG000DLFM21,3 Value Stocks for Daring Investors,2017-07-31 23:15:00 +0000,http://finance.yahoo.com/r/91f34b5b-9725-359d-853f-b06396e3ccf6/3-value-stocks-for-daring-investors.aspx?yptr=yahoo&.tsrc=rss,"For investors jumping into retail, pharmaceuticals and casinos can be daring, but these three stocks are great values in today&apos;s market."
VRX,VRX:CT,BBG000DC8S17,3 Value Stocks for Daring Investors,2017-07-31 23:15:00 +0000,http://finance.yahoo.com/r/91f34b5b-9725-359d-853f-b06396e3ccf6/3-value-stocks-for-daring-investors.aspx?yptr=yahoo&.tsrc=rss,"For investors jumping into retail, pharmaceuticals and casinos can be daring, but these three stocks are great values in today&apos;s market."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is on Breakdown Watch,2017-07-31 19:24:40 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-192440641.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is at significant risk of a technical breakdown, threatening a 13% year-to-date recovery for the struggling pharmaceutical outfit.  Valeant was the center of a well-publicized campaign by short-seller Andrew Left of Citron Research back in 2015 alleging the company recorded false sales to specialty pharmacy Philidor.  VRX stock seemed to be turning things around."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is on Breakdown Watch,2017-07-31 19:24:40 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-192440641.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is at significant risk of a technical breakdown, threatening a 13% year-to-date recovery for the struggling pharmaceutical outfit.  Valeant was the center of a well-publicized campaign by short-seller Andrew Left of Citron Research back in 2015 alleging the company recorded false sales to specialty pharmacy Philidor.  VRX stock seemed to be turning things around."
VRX,VRX:CT,BBG000DC8S17,Biotech Stocks Facing FDA Decision In August,2017-07-31 01:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6SiGP_nfTo/biotech-stocks-facing-fda-decision-in-august-20170731-00044,Biotech Stocks Facing FDA Decision In August
VRX,VRX:US,BBG000DLFM21,Biotech Stocks Facing FDA Decision In August,2017-07-31 01:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6SiGP_nfTo/biotech-stocks-facing-fda-decision-in-august-20170731-00044,Biotech Stocks Facing FDA Decision In August
VRX,VRX:US,BBG000DLFM21,Ignore the Obamacare fight in Congress and buy these 5 health-care stocks,2017-07-29 12:08:26 +0000,http://finance.yahoo.com/r/21245a54-0139-3044-b78c-c4cfe62696e7/Story.aspx?guid=A3D5BCF6-720E-11E7-9E70-77DD8B13BB6F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Regardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves."
VRX,VRX:CT,BBG000DC8S17,Ignore the Obamacare fight in Congress and buy these 5 health-care stocks,2017-07-29 12:08:26 +0000,http://finance.yahoo.com/r/21245a54-0139-3044-b78c-c4cfe62696e7/Story.aspx?guid=A3D5BCF6-720E-11E7-9E70-77DD8B13BB6F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Regardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves."
VRX,VRX:CT,BBG000DC8S17,Valeant: 3 Reasons to Buy?,2017-07-28 16:27:00 +0000,http://finance.yahoo.com/r/3436baff-31d5-3fc3-bbe7-d7b3d2b160fd/valeant-3-reasons-to-buy-1501259251?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are sinking today after Wells Fargo analyst David Maris contended that UnitedHealth Group (UNH) had stopped paying for some of the specialty-pharmaceutical company's drugs.  Cantor Fitzgerald's Louise Chen and Brandon Folkes call the concerns ""overdone"" and offer ""three key reasons to own Valeant's stock now."" They are:  1) We think that Valeant can lower its debt to manageable levels in the medium term, but the Street is still overly concerned about Valeant’s high leverage ratio, in our view.  3) We think the Street is largely looking past some potential blockbuster drug opportunities for Valeant including Siliq/Brodalumab, Vyzulta, IDP-118 and Luminesse."
VRX,VRX:US,BBG000DLFM21,Valeant: 3 Reasons to Buy?,2017-07-28 16:27:00 +0000,http://finance.yahoo.com/r/3436baff-31d5-3fc3-bbe7-d7b3d2b160fd/valeant-3-reasons-to-buy-1501259251?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are sinking today after Wells Fargo analyst David Maris contended that UnitedHealth Group (UNH) had stopped paying for some of the specialty-pharmaceutical company's drugs.  Cantor Fitzgerald's Louise Chen and Brandon Folkes call the concerns ""overdone"" and offer ""three key reasons to own Valeant's stock now."" They are:  1) We think that Valeant can lower its debt to manageable levels in the medium term, but the Street is still overly concerned about Valeant’s high leverage ratio, in our view.  3) We think the Street is largely looking past some potential blockbuster drug opportunities for Valeant including Siliq/Brodalumab, Vyzulta, IDP-118 and Luminesse."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling Despite GDP Data - Canadian Commentary,2017-07-28 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bjaAok1xrbU/canadian-stocks-are-falling-despite-gdp-data--canadian-commentary-20170728-00844,Canadian Stocks Are Falling Despite GDP Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling Despite GDP Data - Canadian Commentary,2017-07-28 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bjaAok1xrbU/canadian-stocks-are-falling-despite-gdp-data--canadian-commentary-20170728-00844,Canadian Stocks Are Falling Despite GDP Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up On Energy Strength - Canadian Commentary,2017-07-27 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/95DY70OEJ_Y/canadian-stocks-are-up-on-energy-strength--canadian-commentary-20170727-01523,Canadian Stocks Are Up On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up On Energy Strength - Canadian Commentary,2017-07-27 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/95DY70OEJ_Y/canadian-stocks-are-up-on-energy-strength--canadian-commentary-20170727-01523,Canadian Stocks Are Up On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection,2017-07-27 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-u-launch-siliq-110000697.html?.tsrc=rss,Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection
VRX,VRX:US,BBG000DLFM21,Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection,2017-07-27 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-u-launch-siliq-110000697.html?.tsrc=rss,Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection
VRX,VRX:CT,BBG000DC8S17,Pharming Reports on Financial Results for the First Half of 2017,2017-07-27 05:00:00 +0000,https://finance.yahoo.com/news/pharming-reports-financial-results-first-050000827.html?.tsrc=rss,"LEIDEN, Netherlands , July 27, 2017 /PRNewswire/ -- Record revenue from product sales up 617 % on 2016 marks Pharming ' s first half year of operational profitability   Invest ment in commercial infrastructure ..."
VRX,VRX:US,BBG000DLFM21,Pharming Reports on Financial Results for the First Half of 2017,2017-07-27 05:00:00 +0000,https://finance.yahoo.com/news/pharming-reports-financial-results-first-050000827.html?.tsrc=rss,"LEIDEN, Netherlands , July 27, 2017 /PRNewswire/ -- Record revenue from product sales up 617 % on 2016 marks Pharming ' s first half year of operational profitability   Invest ment in commercial infrastructure ..."
VRX,VRX:CT,BBG000DC8S17,"Facebook, Valeant Pharmaceuticals and Advanced Micro Devices highlighted as Zacks Bull and Bear of the Day",2017-07-26 15:03:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6CQgOodyoXM/facebook-valeant-pharmaceuticals-and-advanced-micro-devices-highlighted-as-zacks-bull-and-bear-of-the-day-cm821745,For Immediate Release Chicago IL July 26 2017 Zacks Equity Research highlights Facebook NASDAQ FB Free Report as the Bull of the Day Valeant Pharmaceuticals NYSE VRX Free Report as the Bear of the Day In addition Zacks Equity Research
VRX,VRX:US,BBG000DLFM21,"Facebook, Valeant Pharmaceuticals and Advanced Micro Devices highlighted as Zacks Bull and Bear of the Day",2017-07-26 15:03:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6CQgOodyoXM/facebook-valeant-pharmaceuticals-and-advanced-micro-devices-highlighted-as-zacks-bull-and-bear-of-the-day-cm821745,For Immediate Release Chicago IL July 26 2017 Zacks Equity Research highlights Facebook NASDAQ FB Free Report as the Bull of the Day Valeant Pharmaceuticals NYSE VRX Free Report as the Bear of the Day In addition Zacks Equity Research
VRX,VRX:US,BBG000DLFM21,"Facebook, Valeant Pharmaceuticals and Advanced Micro Devices highlighted as Zacks Bull and Bear of the Day",2017-07-26 13:30:01 +0000,https://finance.yahoo.com/news/facebook-valeant-pharmaceuticals-advanced-micro-133001677.html?.tsrc=rss,"Facebook, Valeant Pharmaceuticals and Advanced Micro Devices highlighted as Zacks Bull and Bear of the Day"
VRX,VRX:CT,BBG000DC8S17,"Facebook, Valeant Pharmaceuticals and Advanced Micro Devices highlighted as Zacks Bull and Bear of the Day",2017-07-26 13:30:01 +0000,https://finance.yahoo.com/news/facebook-valeant-pharmaceuticals-advanced-micro-133001677.html?.tsrc=rss,"Facebook, Valeant Pharmaceuticals and Advanced Micro Devices highlighted as Zacks Bull and Bear of the Day"
VRX,VRX:US,BBG000DLFM21,Bear of the Day: Valeant Pharmaceuticals (VRX),2017-07-26 11:15:11 +0000,https://finance.yahoo.com/news/bear-day-valeant-pharmaceuticals-vrx-111511262.html?.tsrc=rss,Bear of the Day: Valeant Pharmaceuticals (VRX)
VRX,VRX:CT,BBG000DC8S17,Bear of the Day: Valeant Pharmaceuticals (VRX),2017-07-26 11:15:11 +0000,https://finance.yahoo.com/news/bear-day-valeant-pharmaceuticals-vrx-111511262.html?.tsrc=rss,Bear of the Day: Valeant Pharmaceuticals (VRX)
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-07-26 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sly-Unz-3yk/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170726-01139,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-07-26 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sly-Unz-3yk/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170726-01139,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Things Are Looking Bullish for Valeant Pharmaceuticals Intl Inc (VRX) Ahead of Q2 Print,2017-07-25 15:58:31 +0000,https://finance.yahoo.com/news/things-looking-bullish-valeant-pharmaceuticals-155831897.html?.tsrc=rss,Controversial drug-maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is due to report its Q2 results on August 8.  This improved sentiment gives an indication of the fact that this quarter has been kind to Valeant.  Valeant is actually on track to achieve this target due to a series of non-core divestures.
VRX,VRX:US,BBG000DLFM21,Things Are Looking Bullish for Valeant Pharmaceuticals Intl Inc (VRX) Ahead of Q2 Print,2017-07-25 15:58:31 +0000,https://finance.yahoo.com/news/things-looking-bullish-valeant-pharmaceuticals-155831897.html?.tsrc=rss,Controversial drug-maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is due to report its Q2 results on August 8.  This improved sentiment gives an indication of the fact that this quarter has been kind to Valeant.  Valeant is actually on track to achieve this target due to a series of non-core divestures.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising Along With Commodities - Canadian Commentary,2017-07-25 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8k73AS3FUn0/canadian-stocks-are-rising-along-with-commodities--canadian-commentary-20170725-01026,Canadian Stocks Are Rising Along With Commodities - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising Along With Commodities - Canadian Commentary,2017-07-25 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8k73AS3FUn0/canadian-stocks-are-rising-along-with-commodities--canadian-commentary-20170725-01026,Canadian Stocks Are Rising Along With Commodities - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-07-24 20:58:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dT9PXq1S1sA/should-you-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons-cm820537,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is back in style VRX stock has doubled off the lows from earlier this year That s a welcome change after a terrible run since mid 2015 It plunged from 250 at its peak
VRX,VRX:CT,BBG000DC8S17,"Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-07-24 20:58:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dT9PXq1S1sA/should-you-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons-cm820537,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is back in style VRX stock has doubled off the lows from earlier this year That s a welcome change after a terrible run since mid 2015 It plunged from 250 at its peak
VRX,VRX:US,BBG000DLFM21,"Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-07-24 16:30:02 +0000,https://finance.yahoo.com/news/buy-valeant-pharmaceuticals-intl-inc-163002199.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
VRX,VRX:CT,BBG000DC8S17,"Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-07-24 16:30:02 +0000,https://finance.yahoo.com/news/buy-valeant-pharmaceuticals-intl-inc-163002199.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
VRX,VRX:CT,BBG000DC8S17,"Yahoo Finance Live: Market Movers - Jul 24th, 2017",2017-07-24 11:20:00 +0000,https://finance.yahoo.com/video/yahoo-finance-live-market-movers-112000263.html?.tsrc=rss,Yahoo Finance's LIVE stock market coverage and analysis.
VRX,VRX:US,BBG000DLFM21,"Yahoo Finance Live: Market Movers - Jul 24th, 2017",2017-07-24 11:20:00 +0000,https://finance.yahoo.com/video/yahoo-finance-live-market-movers-112000263.html?.tsrc=rss,Yahoo Finance's LIVE stock market coverage and analysis.
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-07-24 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gMlPK1cXLC0/canadian-stocks-are-paring-early-losses--canadian-commentary-20170724-00777,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-07-24 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gMlPK1cXLC0/canadian-stocks-are-paring-early-losses--canadian-commentary-20170724-00777,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Why Rite Aid Corporation (RAD) Stock Can Survive These Stormy Waters,2017-07-21 19:07:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DcW9nvCC5GA/why-rite-aid-corporation-rad-stock-can-survive-these-stormy-waters-cm819558,InvestorPlace Stock Market News Stock Advice amp Trading Tips Since being left at the altar by Walgreens Boots Alliance Inc 160 NASDAQ WBA last month Rite Aid Corporation 160 NYSE RAD has looked like a dead company walking to investors losing one third of
VRX,VRX:US,BBG000DLFM21,Why Rite Aid Corporation (RAD) Stock Can Survive These Stormy Waters,2017-07-21 19:07:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DcW9nvCC5GA/why-rite-aid-corporation-rad-stock-can-survive-these-stormy-waters-cm819558,InvestorPlace Stock Market News Stock Advice amp Trading Tips Since being left at the altar by Walgreens Boots Alliance Inc 160 NASDAQ WBA last month Rite Aid Corporation 160 NYSE RAD has looked like a dead company walking to investors losing one third of
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Back From the Abyss,2017-07-21 18:08:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rtamq4sQepY/valeant-pharmaceuticals-intl-inc-vrx-stock-is-back-from-the-abyss-cm819521,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX is back from the dead 160 The company that crashed and nearly burned up on a strategy of debt based acquisitions and dicey sales strategies has been making a
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Back From the Abyss,2017-07-21 18:08:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rtamq4sQepY/valeant-pharmaceuticals-intl-inc-vrx-stock-is-back-from-the-abyss-cm819521,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX is back from the dead 160 The company that crashed and nearly burned up on a strategy of debt based acquisitions and dicey sales strategies has been making a
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Back From the Abyss,2017-07-21 13:38:12 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-133812511.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is back from the dead. The company that crashed and nearly burned up on a strategy of debt-based acquisitions and dicey sales strategies has been making a quiet comeback in 2017, this time in the garb of a chastened, almost-normal drug company.  It may be time for long-term investors to take another look at VRX stock.  Other InvestorPlace writers are also coming around to VRX as a long-term prospect."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Back From the Abyss,2017-07-21 13:38:12 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-133812511.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is back from the dead. The company that crashed and nearly burned up on a strategy of debt-based acquisitions and dicey sales strategies has been making a quiet comeback in 2017, this time in the garb of a chastened, almost-normal drug company.  It may be time for long-term investors to take another look at VRX stock.  Other InvestorPlace writers are also coming around to VRX as a long-term prospect."
VRX,VRX:US,BBG000DLFM21,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences",2017-07-21 12:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CRByQZH1iPM/better-buy-valeant-pharmaceuticals-international-inc-vs-gilead-sciences-cm819086,When it comes to the high flying healthcare sector there aren t many bargains to be had President Trump s recent change of heart regarding the possibility of hard caps on high priced prescription drugs after all sparked a widespread rally that s caused valuations to balloon over
VRX,VRX:CT,BBG000DC8S17,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences",2017-07-21 12:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CRByQZH1iPM/better-buy-valeant-pharmaceuticals-international-inc-vs-gilead-sciences-cm819086,When it comes to the high flying healthcare sector there aren t many bargains to be had President Trump s recent change of heart regarding the possibility of hard caps on high priced prescription drugs after all sparked a widespread rally that s caused valuations to balloon over
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Crude Rally Stalls - Canadian Commentary,2017-07-21 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7vYaEeFQJ0o/canadian-stocks-are-falling-as-crude-rally-stalls--canadian-commentary-20170721-00645,Canadian Stocks Are Falling As Crude Rally Stalls - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Crude Rally Stalls - Canadian Commentary,2017-07-21 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7vYaEeFQJ0o/canadian-stocks-are-falling-as-crude-rally-stalls--canadian-commentary-20170721-00645,Canadian Stocks Are Falling As Crude Rally Stalls - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences",2017-07-21 10:00:00 +0000,http://finance.yahoo.com/r/d2bd521f-0799-352b-845a-b86622550ff9/better-buy-valeant-pharmaceuticals-international-i.aspx?yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals and Gilead Sciences both look dirt cheap, but only one of these stocks is a real bargain."
VRX,VRX:CT,BBG000DC8S17,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences",2017-07-21 10:00:00 +0000,http://finance.yahoo.com/r/d2bd521f-0799-352b-845a-b86622550ff9/better-buy-valeant-pharmaceuticals-international-i.aspx?yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals and Gilead Sciences both look dirt cheap, but only one of these stocks is a real bargain."
VRX,VRX:CT,BBG000DC8S17,Sequoia Fund Seen Bouncing Back After Valeant Saga,2017-07-20 20:24:38 +0000,https://finance.yahoo.com/news/sequoia-fund-seen-bouncing-back-200154372.html?.tsrc=rss,Buffett-endorsed firm beating index for first time in three years
VRX,VRX:US,BBG000DLFM21,Sequoia Fund Seen Bouncing Back After Valeant Saga,2017-07-20 20:24:38 +0000,https://finance.yahoo.com/news/sequoia-fund-seen-bouncing-back-200154372.html?.tsrc=rss,Buffett-endorsed firm beating index for first time in three years
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-07-20 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JM37lxRhmjk/canadian-stocks-are-paring-early-gains--canadian-commentary-20170720-00990,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-07-20 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JM37lxRhmjk/canadian-stocks-are-paring-early-gains--canadian-commentary-20170720-00990,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Just Showed Why Its Share Price Has Deservedly Fallen by 93% Since August 2015,2017-07-19 20:04:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e8MN1_F99yQ/valeant-just-showed-why-its-share-price-has-deservedly-fallen-by-93-since-august-2015-cm818298,Most drug companies have been relatively unstoppable over the past couple of years partly because of the optimism surrounding a stock market that keeps hitting new all time highs and partly due to the incredible pricing power most drugmakers possess However Valeant
VRX,VRX:CT,BBG000DC8S17,Valeant Just Showed Why Its Share Price Has Deservedly Fallen by 93% Since August 2015,2017-07-19 20:04:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e8MN1_F99yQ/valeant-just-showed-why-its-share-price-has-deservedly-fallen-by-93-since-august-2015-cm818298,Most drug companies have been relatively unstoppable over the past couple of years partly because of the optimism surrounding a stock market that keeps hitting new all time highs and partly due to the incredible pricing power most drugmakers possess However Valeant
VRX,VRX:CT,BBG000DC8S17,Valeant Just Showed Why Its Share Price Has Deservedly Fallen by 93% Since August 2015,2017-07-19 18:03:00 +0000,http://finance.yahoo.com/r/1f4c2589-20d9-35f6-a153-0115292eee10/valeant-just-showed-why-its-share-price-has-deserv.aspx?yptr=yahoo&.tsrc=rss,Valeant just sold a non-core asset at a steep discount.
VRX,VRX:US,BBG000DLFM21,Valeant Just Showed Why Its Share Price Has Deservedly Fallen by 93% Since August 2015,2017-07-19 18:03:00 +0000,http://finance.yahoo.com/r/1f4c2589-20d9-35f6-a153-0115292eee10/valeant-just-showed-why-its-share-price-has-deserv.aspx?yptr=yahoo&.tsrc=rss,Valeant just sold a non-core asset at a steep discount.
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt,2017-07-19 16:06:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M9N3yWOYH5g/valeant-vrx-to-sell-obagi-for-190-million-to-lower-debt-cm818107,Valeant Pharmaceuticals International Inc VRX announced that it has entered into an agreement to sell its Obagi Medical Products business for 160 190 million 160 in cash to Haitong International Zhonghua Finance Acquisition Fund I L P The company acquired Obagi in 2013 Obagi
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt,2017-07-19 16:06:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M9N3yWOYH5g/valeant-vrx-to-sell-obagi-for-190-million-to-lower-debt-cm818107,Valeant Pharmaceuticals International Inc VRX announced that it has entered into an agreement to sell its Obagi Medical Products business for 160 190 million 160 in cash to Haitong International Zhonghua Finance Acquisition Fund I L P The company acquired Obagi in 2013 Obagi
VRX,VRX:US,BBG000DLFM21,When Should Investors Buy Options?,2017-07-19 15:37:00 +0000,http://finance.yahoo.com/r/b1401d87-172f-3d33-8ae5-63e3c1c08591/when-should-investors-buy-options.aspx?yptr=yahoo&.tsrc=rss,"If you’re an investor that’s thinking about buying options, there are a few things to keep in mind."
VRX,VRX:CT,BBG000DC8S17,When Should Investors Buy Options?,2017-07-19 15:37:00 +0000,http://finance.yahoo.com/r/b1401d87-172f-3d33-8ae5-63e3c1c08591/when-should-investors-buy-options.aspx?yptr=yahoo&.tsrc=rss,"If you’re an investor that’s thinking about buying options, there are a few things to keep in mind."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Intl Inc (VRX) In Good Debt Shape, Vertex Pharmaceuticals Incorporated (VRTX) Wows with Triple CF Combo Success",2017-07-19 14:54:47 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-145447424.html?.tsrc=rss,"As such, finding the giant right ""on track"" to settle $5 billion debt reduction commitments even before the beginning of 2018, the analyst reiterates a Buy rating on shares of VRX with a $35 price target, which represents a 102% increase from where the stock is currently trading."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Intl Inc (VRX) In Good Debt Shape, Vertex Pharmaceuticals Incorporated (VRTX) Wows with Triple CF Combo Success",2017-07-19 14:54:47 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-145447424.html?.tsrc=rss,"As such, finding the giant right ""on track"" to settle $5 billion debt reduction commitments even before the beginning of 2018, the analyst reiterates a Buy rating on shares of VRX with a $35 price target, which represents a 102% increase from where the stock is currently trading."
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt,2017-07-19 14:16:02 +0000,https://finance.yahoo.com/news/valeant-vrx-sell-obagi-190-141602222.html?.tsrc=rss,Valeant (VRX) has decided to sell Obagi Medical for $190 million and use the proceeds for reducing down debt.
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt,2017-07-19 14:16:02 +0000,https://finance.yahoo.com/news/valeant-vrx-sell-obagi-190-141602222.html?.tsrc=rss,Valeant (VRX) has decided to sell Obagi Medical for $190 million and use the proceeds for reducing down debt.
VRX,VRX:US,BBG000DLFM21,"Featured Company News - Valeant Pharma Divests its Skin Care Business, Obagi Medical Products Business",2017-07-19 11:10:00 +0000,https://finance.yahoo.com/news/featured-company-news-valeant-pharma-111000574.html?.tsrc=rss,"Research Desk Line-up: IntelliPharmaCeutics Intl. Post Earnings Coverage LONDON, UK / ACCESSWIRE / July 19, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ..."
VRX,VRX:CT,BBG000DC8S17,"Featured Company News - Valeant Pharma Divests its Skin Care Business, Obagi Medical Products Business",2017-07-19 11:10:00 +0000,https://finance.yahoo.com/news/featured-company-news-valeant-pharma-111000574.html?.tsrc=rss,"Research Desk Line-up: IntelliPharmaCeutics Intl. Post Earnings Coverage LONDON, UK / ACCESSWIRE / July 19, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ..."
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics",2017-07-18 15:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pT_6UX3BVBE/the-zacks-analyst-blog-highlights-valeant-pharmaceuticals-international-flexion-therapeutics-ignyta-and-anika-therapeutics-cm817391,For Immediate Release Chicago IL July 18 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics",2017-07-18 15:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pT_6UX3BVBE/the-zacks-analyst-blog-highlights-valeant-pharmaceuticals-international-flexion-therapeutics-ignyta-and-anika-therapeutics-cm817391,For Immediate Release Chicago IL July 18 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics",2017-07-18 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-valeant-133001406.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics"
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics",2017-07-18 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-valeant-133001406.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics"
VRX,VRX:US,BBG000DLFM21,"Street Talk: Tesla Inc (TSLA), Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX)",2017-07-18 12:23:46 +0000,https://finance.yahoo.com/news/street-talk-tesla-inc-tsla-122346722.html?.tsrc=rss,"Tesla Inc (NASDAQ:TSLA) CEO Elon Musk is downplaying his brainchild, telling an audience at the National Governors Association summer meeting this past weekend that it is astounding even to him how much the electric car giant's price has climbed in the market.  In fact, Musk himself voiced aloud thoughts daring to question if the stock's approximate 45% rally this year is even warranted- which is exactly what cautious investors needed to hear to send shares suddenly on an over 3% dip yesterday in reverse.  Musk ventured, ""I've gone on record several times saying our stock price is higher than we have any right to deserve,"" perhaps out of apprehension from such lofty and eager expectations for his giant's performance to back the numbers."
VRX,VRX:CT,BBG000DC8S17,"Street Talk: Tesla Inc (TSLA), Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX)",2017-07-18 12:23:46 +0000,https://finance.yahoo.com/news/street-talk-tesla-inc-tsla-122346722.html?.tsrc=rss,"Tesla Inc (NASDAQ:TSLA) CEO Elon Musk is downplaying his brainchild, telling an audience at the National Governors Association summer meeting this past weekend that it is astounding even to him how much the electric car giant's price has climbed in the market.  In fact, Musk himself voiced aloud thoughts daring to question if the stock's approximate 45% rally this year is even warranted- which is exactly what cautious investors needed to hear to send shares suddenly on an over 3% dip yesterday in reverse.  Musk ventured, ""I've gone on record several times saying our stock price is higher than we have any right to deserve,"" perhaps out of apprehension from such lofty and eager expectations for his giant's performance to back the numbers."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Impax Laboratories,2017-07-18 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000911.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 18, 2017 / Valeant Pharmaceuticals has sold its Obagi skin care unit to throw more money at a $5 billion debt it wants to reduce by February of 2018. Impax Laboratories ..."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Impax Laboratories,2017-07-18 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000911.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 18, 2017 / Valeant Pharmaceuticals has sold its Obagi skin care unit to throw more money at a $5 billion debt it wants to reduce by February of 2018. Impax Laboratories ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant is meeting its debt goals, but core business is still struggling",2017-07-18 11:13:18 +0000,http://finance.yahoo.com/r/f37b0881-5cd9-3298-a994-9125880e5199/Story.aspx?guid=C2CF35D0-6AFF-11E7-8A31-F6BB28ACF997&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Analysts have become more bullish on Valeant’s stock of late, but there are still obstacles to overcome."
VRX,VRX:US,BBG000DLFM21,"Valeant is meeting its debt goals, but core business is still struggling",2017-07-18 11:13:18 +0000,http://finance.yahoo.com/r/f37b0881-5cd9-3298-a994-9125880e5199/Story.aspx?guid=C2CF35D0-6AFF-11E7-8A31-F6BB28ACF997&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Analysts have become more bullish on Valeant’s stock of late, but there are still obstacles to overcome."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling Despite Rising Commodities - Canadian Commentary,2017-07-18 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xmrX_UZUrw8/canadian-stocks-are-falling-despite-rising-commodities--canadian-commentary-20170718-00860,Canadian Stocks Are Falling Despite Rising Commodities - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling Despite Rising Commodities - Canadian Commentary,2017-07-18 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xmrX_UZUrw8/canadian-stocks-are-falling-despite-rising-commodities--canadian-commentary-20170718-00860,Canadian Stocks Are Falling Despite Rising Commodities - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"The Unreformed Stock Picker: Without A Boss Bill Miller Is Betting On Amazon, Bitcoin And Bob Dylan",2017-07-18 10:00:00 +0000,http://finance.yahoo.com/r/07379ae7-10fa-31e6-8a68-c3543f9212ee/the-unreformed-stock-picker-without-a-boss-bill-miller-is-betting-on-amazon-bitcoin-and-bob-dylan?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag&yptr=yahoo&.tsrc=rss,Bill Miller beat the market for 15 straight years before he was hammered by the financial crisis. Now the legendary investor is happily running money on his own terms--long on risk and big ideas.
VRX,VRX:CT,BBG000DC8S17,"The Unreformed Stock Picker: Without A Boss Bill Miller Is Betting On Amazon, Bitcoin And Bob Dylan",2017-07-18 10:00:00 +0000,http://finance.yahoo.com/r/07379ae7-10fa-31e6-8a68-c3543f9212ee/the-unreformed-stock-picker-without-a-boss-bill-miller-is-betting-on-amazon-bitcoin-and-bob-dylan?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag&yptr=yahoo&.tsrc=rss,Bill Miller beat the market for 15 straight years before he was hammered by the financial crisis. Now the legendary investor is happily running money on his own terms--long on risk and big ideas.
VRX,VRX:CT,BBG000DC8S17,"Valeant Takes Haircut on 2013 Obagi Deal as Debt Pile Looms, Divestitures Continue",2017-07-17 22:20:00 +0000,http://finance.yahoo.com/r/54cec2cf-dab5-38c1-b4ca-f1d8251db7a9/valeant-continues-to-unwind-takes-haircut-on-2013-obagi-deal-as-debt-pile-looms.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Valeantacquired Obagi for $420 million but has sold the business for a fraction.
VRX,VRX:US,BBG000DLFM21,"Valeant Takes Haircut on 2013 Obagi Deal as Debt Pile Looms, Divestitures Continue",2017-07-17 22:20:00 +0000,http://finance.yahoo.com/r/54cec2cf-dab5-38c1-b4ca-f1d8251db7a9/valeant-continues-to-unwind-takes-haircut-on-2013-obagi-deal-as-debt-pile-looms.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Valeantacquired Obagi for $420 million but has sold the business for a fraction.
VRX,VRX:CT,BBG000DC8S17,"M&A Monday: Church & Dwight, Dominion Diamond, Valeant & More",2017-07-17 20:12:18 +0000,http://finance.yahoo.com/r/2562d113-8ff5-3c98-897f-3afa929d051d/ma-monday-church-dwight-dominion-diamond-valeant-more?src=A00220&yptr=yahoo&.tsrc=rss,"A slew of mergers and acquisitions news hit the headlines Monday, including a deal by Valeant Pharmaceuticals"
VRX,VRX:US,BBG000DLFM21,"M&A Monday: Church & Dwight, Dominion Diamond, Valeant & More",2017-07-17 20:12:18 +0000,http://finance.yahoo.com/r/2562d113-8ff5-3c98-897f-3afa929d051d/ma-monday-church-dwight-dominion-diamond-valeant-more?src=A00220&yptr=yahoo&.tsrc=rss,"A slew of mergers and acquisitions news hit the headlines Monday, including a deal by Valeant Pharmaceuticals"
VRX,VRX:CT,BBG000DC8S17,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back,2017-07-17 19:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-t9IHkiSJk/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-coming-back-cm817133,InvestorPlace Stock Market News Stock Advice amp Trading Tips If you have even a hint of a contrarian personality you should look no further than the pharmaceutical industry Thanks to various scandals and controversies like the one impacting Valeant Pharmaceuticals Intl Inc
VRX,VRX:US,BBG000DLFM21,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back,2017-07-17 19:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-t9IHkiSJk/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-coming-back-cm817133,InvestorPlace Stock Market News Stock Advice amp Trading Tips If you have even a hint of a contrarian personality you should look no further than the pharmaceutical industry Thanks to various scandals and controversies like the one impacting Valeant Pharmaceuticals Intl Inc
VRX,VRX:CT,BBG000DC8S17,"Pershing Square Sells $610 Million of Restaurant Brands, Stock Drops 2%",2017-07-17 19:38:00 +0000,http://finance.yahoo.com/r/7befad53-a3b3-31a7-bdef-732da9566880/pershing-square-sells-610-million-restaurant-brands-stock-drops-2?partner=YahooSA&yptr=yahoo&.tsrc=rss,The multinational company saw its stock decline by nearly 2% at market open.
VRX,VRX:US,BBG000DLFM21,"Pershing Square Sells $610 Million of Restaurant Brands, Stock Drops 2%",2017-07-17 19:38:00 +0000,http://finance.yahoo.com/r/7befad53-a3b3-31a7-bdef-732da9566880/pershing-square-sells-610-million-restaurant-brands-stock-drops-2?partner=YahooSA&yptr=yahoo&.tsrc=rss,The multinational company saw its stock decline by nearly 2% at market open.
VRX,VRX:CT,BBG000DC8S17,Stocks In Limbo As Financials Lag -- Canadian Commentary,2017-07-17 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cGo3V6j6QDc/stocks-in-limbo-as-financials-lag--canadian-commentary-20170717-01072,Stocks In Limbo As Financials Lag -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Stocks In Limbo As Financials Lag -- Canadian Commentary,2017-07-17 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cGo3V6j6QDc/stocks-in-limbo-as-financials-lag--canadian-commentary-20170717-01072,Stocks In Limbo As Financials Lag -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings,2017-07-17 15:54:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8eXeQBNoh8k/4-sell-ranked-drug-stocks-to-avoid-ahead-of-q2-earnings-cm816931,Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson amp Johnson JNJ reporting second quarter results tomorrow before the market opens Swiss pharma giant Novartis NVS which was in the news recently related to a favorable FDA advisory
VRX,VRX:US,BBG000DLFM21,4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings,2017-07-17 15:54:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8eXeQBNoh8k/4-sell-ranked-drug-stocks-to-avoid-ahead-of-q2-earnings-cm816931,Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson amp Johnson JNJ reporting second quarter results tomorrow before the market opens Swiss pharma giant Novartis NVS which was in the news recently related to a favorable FDA advisory
VRX,VRX:US,BBG000DLFM21,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back,2017-07-17 15:41:28 +0000,https://finance.yahoo.com/news/why-teva-pharmaceutical-industries-ltd-154128683.html?.tsrc=rss,"Under this condition, I believe Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is a compelling opportunity.  TEVA stock is a classic case of a good investment struggling with poor, and in this case, confounding decisions.  The woes surrounding Teva Pharmaceuticals have been broadcast ad-nauseam."
VRX,VRX:CT,BBG000DC8S17,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back,2017-07-17 15:41:28 +0000,https://finance.yahoo.com/news/why-teva-pharmaceutical-industries-ltd-154128683.html?.tsrc=rss,"Under this condition, I believe Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is a compelling opportunity.  TEVA stock is a classic case of a good investment struggling with poor, and in this case, confounding decisions.  The woes surrounding Teva Pharmaceuticals have been broadcast ad-nauseam."
VRX,VRX:US,BBG000DLFM21,Valeant Unloads Yet Another Unit,2017-07-17 15:30:00 +0000,http://finance.yahoo.com/r/341b0be9-5e6f-31eb-be40-2fa9c3ae61c7/valeant-pharmaceuticals-the-fire-sale-continues-1500305414?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are climbing Monday after the drug maker announced the $190 million sale of Obagi Medical Products to Shonghua Finance Acquisition Fund.  The deal is the latest asset sale by the beleaguered drug maker as it labors to meet its goal of $5 billion in debt reduction by February 2018.  The company has shed its iNova division, as well as cancer treatment maker Dendreon, and sold some skin care lines to L’Oreal, and is throwing the proceeds at its debt load."
VRX,VRX:CT,BBG000DC8S17,Valeant Unloads Yet Another Unit,2017-07-17 15:30:00 +0000,http://finance.yahoo.com/r/341b0be9-5e6f-31eb-be40-2fa9c3ae61c7/valeant-pharmaceuticals-the-fire-sale-continues-1500305414?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are climbing Monday after the drug maker announced the $190 million sale of Obagi Medical Products to Shonghua Finance Acquisition Fund.  The deal is the latest asset sale by the beleaguered drug maker as it labors to meet its goal of $5 billion in debt reduction by February 2018.  The company has shed its iNova division, as well as cancer treatment maker Dendreon, and sold some skin care lines to L’Oreal, and is throwing the proceeds at its debt load."
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Procter & Gamble, Blue Apron, Netflix, Citigroup, BlackRock",2017-07-17 13:30:23 +0000,http://finance.yahoo.com/r/84d01669-6197-3e8a-8b8c-973735b20afd/stocks-to-watch-procter-gamble-blue-apron-netflix-citigroup-blackrock-1500298158?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Monday’s session are Procter & Gamble Co., Blue Apron Holdings Inc., Netflix Inc., Citigroup Inc. and BlackRock Inc."
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Procter & Gamble, Blue Apron, Netflix, Citigroup, BlackRock",2017-07-17 13:30:23 +0000,http://finance.yahoo.com/r/84d01669-6197-3e8a-8b8c-973735b20afd/stocks-to-watch-procter-gamble-blue-apron-netflix-citigroup-blackrock-1500298158?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Monday’s session are Procter & Gamble Co., Blue Apron Holdings Inc., Netflix Inc., Citigroup Inc. and BlackRock Inc."
VRX,VRX:US,BBG000DLFM21,4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings,2017-07-17 13:26:01 +0000,https://finance.yahoo.com/news/4-sell-ranked-drug-stocks-132601774.html?.tsrc=rss,Here is a look at four drug stocks including Anika (ANIK) with a Sell Rank and negative earnings ESP that should be avoided ahead of earnings.
VRX,VRX:CT,BBG000DC8S17,4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings,2017-07-17 13:26:01 +0000,https://finance.yahoo.com/news/4-sell-ranked-drug-stocks-132601774.html?.tsrc=rss,Here is a look at four drug stocks including Anika (ANIK) with a Sell Rank and negative earnings ESP that should be avoided ahead of earnings.
VRX,VRX:US,BBG000DLFM21,Valeant agrees to sell Obagi Medical Products for $190 million in cash,2017-07-17 11:08:34 +0000,http://finance.yahoo.com/r/5ab2e8a5-afa2-3c1a-83f7-08faac9f88a9/Story.aspx?guid=835BF236-6DEA-4029-B11B-109C3CA9B6E7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. said Monday it has reached an agreement to sell its Obagi Medical Products business to Haitong International Zhonghua Finance Acquisition Fund I LP for $190 million ...
VRX,VRX:CT,BBG000DC8S17,Valeant agrees to sell Obagi Medical Products for $190 million in cash,2017-07-17 11:08:34 +0000,http://finance.yahoo.com/r/5ab2e8a5-afa2-3c1a-83f7-08faac9f88a9/Story.aspx?guid=835BF236-6DEA-4029-B11B-109C3CA9B6E7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. said Monday it has reached an agreement to sell its Obagi Medical Products business to Haitong International Zhonghua Finance Acquisition Fund I LP for $190 million ...
VRX,VRX:CT,BBG000DC8S17,Valeant Agrees To Sell Obagi Medical Products Business,2017-07-17 11:00:00 +0000,https://finance.yahoo.com/news/valeant-agrees-sell-obagi-medical-110000201.html?.tsrc=rss,Valeant Agrees To Sell Obagi Medical Products Business
VRX,VRX:CT,BBG000DC8S17,Valeant Agrees To Sell Obagi Medical Products Business,2017-07-17 11:00:00 +0000,https://finance.yahoo.com/news/valeant-agrees-sell-obagi-medical-110000111.html?.tsrc=rss,"LAVAL, Quebec, July 17, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. (the ""Fund"").  Limited partners of the Fund include industry veterans in other geographic markets, such as China Regenerative Medicine International Limited (8158.HK).  ""The sale of Obagi marks additional progress in our efforts to streamline our operations and reduce debt,"" Joseph C. Papa, chairman and CEO, Valeant."
VRX,VRX:US,BBG000DLFM21,Valeant Agrees To Sell Obagi Medical Products Business,2017-07-17 11:00:00 +0000,https://finance.yahoo.com/news/valeant-agrees-sell-obagi-medical-110000111.html?.tsrc=rss,"LAVAL, Quebec, July 17, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. (the ""Fund"").  Limited partners of the Fund include industry veterans in other geographic markets, such as China Regenerative Medicine International Limited (8158.HK).  ""The sale of Obagi marks additional progress in our efforts to streamline our operations and reduce debt,"" Joseph C. Papa, chairman and CEO, Valeant."
VRX,VRX:US,BBG000DLFM21,Valeant Agrees To Sell Obagi Medical Products Business,2017-07-17 11:00:00 +0000,https://finance.yahoo.com/news/valeant-agrees-sell-obagi-medical-110000201.html?.tsrc=rss,Valeant Agrees To Sell Obagi Medical Products Business
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary,2017-07-17 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3CHkaIDQvtU/canadian-stocks-are-rising-at-the-start-of-the-week--canadian-commentary-20170717-00745,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary,2017-07-17 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3CHkaIDQvtU/canadian-stocks-are-rising-at-the-start-of-the-week--canadian-commentary-20170717-00745,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Biotech Scoop: Valeant Pharmaceuticals Intl Inc (VRX), Teva Pharmaceutical (TEVA), and Kite Pharma (KITE)",2017-07-17 09:57:15 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-095715655.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc's (NYSE:VRX) fighting chances in the drug arena to compete may have just gotten slimmer.  Rival Johnson & Johnson's moderate-to-severe psoriasis treating drug Tremfya (guselkumab) gained a green light from the FDA last Wednesday, and Wells Fargo analyst David Maris believes this spells trouble for the biotech giant.  None of Valeant's other competitors suffer from the blackbox warning that Siliq (brodalumab) touts, warning of a suicide risk that could put Valeant in jeopardy against the likes of Lilly, Abbvie, Novartis, and now Johnson & Johnson trying to garner the best edge in the psoriasis market."
VRX,VRX:CT,BBG000DC8S17,"Biotech Scoop: Valeant Pharmaceuticals Intl Inc (VRX), Teva Pharmaceutical (TEVA), and Kite Pharma (KITE)",2017-07-17 09:57:15 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-095715655.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc's (NYSE:VRX) fighting chances in the drug arena to compete may have just gotten slimmer.  Rival Johnson & Johnson's moderate-to-severe psoriasis treating drug Tremfya (guselkumab) gained a green light from the FDA last Wednesday, and Wells Fargo analyst David Maris believes this spells trouble for the biotech giant.  None of Valeant's other competitors suffer from the blackbox warning that Siliq (brodalumab) touts, warning of a suicide risk that could put Valeant in jeopardy against the likes of Lilly, Abbvie, Novartis, and now Johnson & Johnson trying to garner the best edge in the psoriasis market."
VRX,VRX:US,BBG000DLFM21,China GDP May Boost Markets -- Canadian Commentary,2017-07-17 08:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MsxBNB_wom8/china-gdp-may-boost-markets--canadian-commentary-20170717-00518,China GDP May Boost Markets -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,China GDP May Boost Markets -- Canadian Commentary,2017-07-17 08:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MsxBNB_wom8/china-gdp-may-boost-markets--canadian-commentary-20170717-00518,China GDP May Boost Markets -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Announces Sale Of Obagi Medical Products Business - Quick Facts,2017-07-17 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mG5swCGtRdI/valeant-pharma-announces-sale-of-obagi-medical-products-business--quick-facts-20170717-00304,Valeant Pharma Announces Sale Of Obagi Medical Products Business - Quick Facts
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Announces Sale Of Obagi Medical Products Business - Quick Facts,2017-07-17 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mG5swCGtRdI/valeant-pharma-announces-sale-of-obagi-medical-products-business--quick-facts-20170717-00304,Valeant Pharma Announces Sale Of Obagi Medical Products Business - Quick Facts
VRX,VRX:US,BBG000DLFM21,Valeant Suffers Another Blow After the Approval of Johnson & Johnson's Psoriasis Treatment,2017-07-14 16:24:00 +0000,http://finance.yahoo.com/r/f436a023-9b2f-3566-82bf-d67c6cc1fa77/valeant-suffers-another-blow-after-the-approval-of-johnson-amp-johnson-s-psoriasis-treatment.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The approval of Johnson & Johnson's psoriasis treatment will have an adverse impact on Valeant in the second half of 2017, Wells Fargo argued."
VRX,VRX:CT,BBG000DC8S17,Valeant Suffers Another Blow After the Approval of Johnson & Johnson's Psoriasis Treatment,2017-07-14 16:24:00 +0000,http://finance.yahoo.com/r/f436a023-9b2f-3566-82bf-d67c6cc1fa77/valeant-suffers-another-blow-after-the-approval-of-johnson-amp-johnson-s-psoriasis-treatment.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The approval of Johnson & Johnson's psoriasis treatment will have an adverse impact on Valeant in the second half of 2017, Wells Fargo argued."
VRX,VRX:CT,BBG000DC8S17,J&J Psoriasis Drug Approval 'Another Negative' For Valeant,2017-07-14 13:35:00 +0000,http://finance.yahoo.com/r/3f71189f-2400-3a12-b44c-555397eb14ae/j-j-psoriasis-drug-approval-another-negative-for-valeant-1500039318?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"On Thursday, the Food and Drug Administration approved Johnson & Johnson's (JNJ) new psoriasis drug, Tremfya.   Wells Fargo's David Maris reiterated an Underperform rating on Valeant Pharmaceuticals (VRX) on Friday, calling the news ""another  negative"" for the company, which is about to launch its own psoriasis treatment.  With Taltz from Lilly, Humira from Abbvie, Cosentyx from Novartis, and now this new competitor from J&J, we do not see VRX as competitive in this market, especially with the marketing dollars others are spending and the black box warning Valeant's drug has (which none of the others have).  Add to this that Valeant's drug Siliq is dosed every two weeks, while others have far fewer injections."
VRX,VRX:US,BBG000DLFM21,J&J Psoriasis Drug Approval 'Another Negative' For Valeant,2017-07-14 13:35:00 +0000,http://finance.yahoo.com/r/3f71189f-2400-3a12-b44c-555397eb14ae/j-j-psoriasis-drug-approval-another-negative-for-valeant-1500039318?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"On Thursday, the Food and Drug Administration approved Johnson & Johnson's (JNJ) new psoriasis drug, Tremfya.   Wells Fargo's David Maris reiterated an Underperform rating on Valeant Pharmaceuticals (VRX) on Friday, calling the news ""another  negative"" for the company, which is about to launch its own psoriasis treatment.  With Taltz from Lilly, Humira from Abbvie, Cosentyx from Novartis, and now this new competitor from J&J, we do not see VRX as competitive in this market, especially with the marketing dollars others are spending and the black box warning Valeant's drug has (which none of the others have).  Add to this that Valeant's drug Siliq is dosed every two weeks, while others have far fewer injections."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals’ Overall Trajectory Remains on Edge, Teva Pharmaceutical May Face Difficulty Beating Consensus",2017-07-14 12:22:06 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-122206565.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) may have lessened its net debt, easing liquidity concerns, but as far as Piper Jaffray analyst David Amsellem sees the biotech giant, troubled waters have not ceased just yet.  With projected EBITDA for 2017 well beyond seven times over and domestic segment trends appearing less than robust, the analyst is not swayed by confidence from the stock's rally following April dips- nor by asset sales.  In reaction, the analyst reiterates an Underweight rating on shares of VRX with a $10 price target, which represents a 42% downside from where the shares last closed."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals’ Overall Trajectory Remains on Edge, Teva Pharmaceutical May Face Difficulty Beating Consensus",2017-07-14 12:22:06 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-122206565.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) may have lessened its net debt, easing liquidity concerns, but as far as Piper Jaffray analyst David Amsellem sees the biotech giant, troubled waters have not ceased just yet.  With projected EBITDA for 2017 well beyond seven times over and domestic segment trends appearing less than robust, the analyst is not swayed by confidence from the stock's rally following April dips- nor by asset sales.  In reaction, the analyst reiterates an Underweight rating on shares of VRX with a $10 price target, which represents a 42% downside from where the shares last closed."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Off Their Early Highs - Canadian Commentary,2017-07-14 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bh_8sjkL4l8/canadian-stocks-are-off-their-early-highs--canadian-commentary-20170714-00543,Canadian Stocks Are Off Their Early Highs - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Off Their Early Highs - Canadian Commentary,2017-07-14 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bh_8sjkL4l8/canadian-stocks-are-off-their-early-highs--canadian-commentary-20170714-00543,Canadian Stocks Are Off Their Early Highs - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher",2017-07-13 22:33:00 +0000,http://finance.yahoo.com/r/d4bfb88c-0456-3d9c-945e-f03620bd0005/valeant-shaves-another-chunk-from-its-crushing-debt-load.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The redemption follows the July 10 announcement that Valeant would pay down $811 million of its senior secured term loans.
VRX,VRX:US,BBG000DLFM21,"Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher",2017-07-13 22:33:00 +0000,http://finance.yahoo.com/r/d4bfb88c-0456-3d9c-945e-f03620bd0005/valeant-shaves-another-chunk-from-its-crushing-debt-load.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The redemption follows the July 10 announcement that Valeant would pay down $811 million of its senior secured term loans.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is No Longer a “Sewer”,2017-07-13 18:50:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6ut6TZ8wtc8/valeant-pharmaceuticals-intl-inc-vrx-stock-is-no-longer-a-sewer-cm815815,InvestorPlace Stock Market News Stock Advice amp Trading Tips If Valeant Pharmaceuticals Intl Inc NYSE VRX isn t on your bullish list yet you should put it there now The much maligned pharmaceuticals firm is finally turning the corner following months
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is No Longer a “Sewer”,2017-07-13 18:50:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6ut6TZ8wtc8/valeant-pharmaceuticals-intl-inc-vrx-stock-is-no-longer-a-sewer-cm815815,InvestorPlace Stock Market News Stock Advice amp Trading Tips If Valeant Pharmaceuticals Intl Inc NYSE VRX isn t on your bullish list yet you should put it there now The much maligned pharmaceuticals firm is finally turning the corner following months
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Intl Inc (VRX) Pays Off Further Debt, Apple Inc. (AAPL) iPhone 8 Delay Rumors Swirl",2017-07-13 16:56:42 +0000,https://finance.yahoo.com/news/thursday-market-insights-valeant-pharmaceuticals-165642723.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares slightly rose in Thursday's trading session, after the drug maker announced that it is redeeming approx. $500 million of Senior Notes using cash in hand on August 15 2017.  The company already paid back $1.1 billion of the principal amount of $1.6 billion in March this year.  Now, once the remaining Notes are redeemed, Valeant will have slashed its debt by over $4.8 billion since Q2 2016."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Intl Inc (VRX) Pays Off Further Debt, Apple Inc. (AAPL) iPhone 8 Delay Rumors Swirl",2017-07-13 16:56:42 +0000,https://finance.yahoo.com/news/thursday-market-insights-valeant-pharmaceuticals-165642723.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares slightly rose in Thursday's trading session, after the drug maker announced that it is redeeming approx. $500 million of Senior Notes using cash in hand on August 15 2017.  The company already paid back $1.1 billion of the principal amount of $1.6 billion in March this year.  Now, once the remaining Notes are redeemed, Valeant will have slashed its debt by over $4.8 billion since Q2 2016."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is No Longer a “Sewer”,2017-07-13 14:26:12 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-142612176.html?.tsrc=rss,"If Valeant Pharmaceuticals Intl Inc (NYSE:VRX) isn’t on your bullish list yet, you should put it there now.  A little over a year ago, everyone on Wall Street was blasting Valeant.  In the past year, Valeant has managed to put most of its legal woes behind it."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is No Longer a “Sewer”,2017-07-13 14:26:12 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-142612176.html?.tsrc=rss,"If Valeant Pharmaceuticals Intl Inc (NYSE:VRX) isn’t on your bullish list yet, you should put it there now.  A little over a year ago, everyone on Wall Street was blasting Valeant.  In the past year, Valeant has managed to put most of its legal woes behind it."
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Snap, Target, Macy's, Delta, American Airlines, Valeant",2017-07-13 14:04:56 +0000,http://finance.yahoo.com/r/0b65c2bb-c090-3113-9b53-bab31b26ce03/stocks-to-watch-snap-target-macys-delta-american-airlines-valeant-1499952633?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Thursday's session are Snap Inc., Target Corp., Macy's Inc., Delta Air Lines Inc. and American Airlines Group Inc."
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Snap, Target, Macy's, Delta, American Airlines, Valeant",2017-07-13 14:04:56 +0000,http://finance.yahoo.com/r/0b65c2bb-c090-3113-9b53-bab31b26ce03/stocks-to-watch-snap-target-macys-delta-american-airlines-valeant-1499952633?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Thursday's session are Snap Inc., Target Corp., Macy's Inc., Delta Air Lines Inc. and American Airlines Group Inc."
VRX,VRX:US,BBG000DLFM21,"Valeant redeems $500 million of debt, on track to meet or exceed $5 billion debt reduction goal",2017-07-13 12:42:16 +0000,http://finance.yahoo.com/r/fa7a7d39-c1b6-3180-bf8f-301894c6d502/Story.aspx?guid=64E8C790-A678-4DF2-9042-83034BB7E309&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. said Thursday it is redeeming the roughly $500 million of outstanding 6.75% notes that mature in 2018 using cash on hand, as it continues to work to reduce its ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant redeems $500 million of debt, on track to meet or exceed $5 billion debt reduction goal",2017-07-13 12:42:16 +0000,http://finance.yahoo.com/r/fa7a7d39-c1b6-3180-bf8f-301894c6d502/Story.aspx?guid=64E8C790-A678-4DF2-9042-83034BB7E309&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. said Thursday it is redeeming the roughly $500 million of outstanding 6.75% notes that mature in 2018 using cash on hand, as it continues to work to reduce its ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018,2017-07-13 12:30:00 +0000,https://finance.yahoo.com/news/valeant-announces-redemption-remaining-approximately-123000383.html?.tsrc=rss,"Upon Redemption, Valeant's Debt Reduction Will Total More than $4.8 Billion Since the End of First-Quarter 2016 LAVAL, Quebec , July 13, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ..."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018,2017-07-13 12:30:00 +0000,https://finance.yahoo.com/news/valeant-announces-redemption-remaining-approximately-123000383.html?.tsrc=rss,"Upon Redemption, Valeant's Debt Reduction Will Total More than $4.8 Billion Since the End of First-Quarter 2016 LAVAL, Quebec , July 13, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018,2017-07-13 12:30:00 +0000,https://finance.yahoo.com/news/valeant-announces-redemption-remaining-approximately-123000669.html?.tsrc=rss,Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018
VRX,VRX:US,BBG000DLFM21,Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018,2017-07-13 12:30:00 +0000,https://finance.yahoo.com/news/valeant-announces-redemption-remaining-approximately-123000669.html?.tsrc=rss,Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary,2017-07-13 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sJq8pckb3a0/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20170713-00832,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary,2017-07-13 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sJq8pckb3a0/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20170713-00832,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Why JPMorgan Chase & Co. (JPM) Stock Still Has What It Takes,2017-07-12 18:44:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I60edJPUb18/why-jpmorgan-chase-co-jpm-stock-still-has-what-it-takes-cm815246,InvestorPlace Stock Market News Stock Advice amp Trading Tips Spirits should be high going into JPMorgan Chase amp Co s NYSE JPM second quarter earnings call on Friday All banks passed the Federal Reserve Board s stress tests at the end of June meaning that they are
VRX,VRX:US,BBG000DLFM21,Why JPMorgan Chase & Co. (JPM) Stock Still Has What It Takes,2017-07-12 18:44:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I60edJPUb18/why-jpmorgan-chase-co-jpm-stock-still-has-what-it-takes-cm815246,InvestorPlace Stock Market News Stock Advice amp Trading Tips Spirits should be high going into JPMorgan Chase amp Co s NYSE JPM second quarter earnings call on Friday All banks passed the Federal Reserve Board s stress tests at the end of June meaning that they are
VRX,VRX:CT,BBG000DC8S17,"Valeant's Valuation 'Does Not Make Sense,' Warns Piper Jaffray",2017-07-12 16:09:00 +0000,http://finance.yahoo.com/r/7bb013f9-6113-3d19-a177-7256d35d8325/valeants-valuation-does-not-make-sense-warns-piper-jaffray-1499875787?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals (VRX) has more than doubled from its April lows and is up 16.5% since the start of the year. But that rally may be overoptimistic, warns Piper Jaffray's David Amsellem and Sameer ..."
VRX,VRX:US,BBG000DLFM21,"Valeant's Valuation 'Does Not Make Sense,' Warns Piper Jaffray",2017-07-12 16:09:00 +0000,http://finance.yahoo.com/r/7bb013f9-6113-3d19-a177-7256d35d8325/valeants-valuation-does-not-make-sense-warns-piper-jaffray-1499875787?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals (VRX) has more than doubled from its April lows and is up 16.5% since the start of the year. But that rally may be overoptimistic, warns Piper Jaffray's David Amsellem and Sameer ..."
VRX,VRX:US,BBG000DLFM21,Has Valeant Pharmaceuticals Intl Inc (VRX) Stock Finally Bottomed?,2017-07-12 12:44:39 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-124439196.html?.tsrc=rss,Has embattled drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) finally bottomed?  Can VRX stock ever be trusted again?  The market seems willing to bet that Valeant — which in the first quarter posted its first profit in six quarters and then raised guidance for 2017 — can not only sustain its operations but thrive.
VRX,VRX:CT,BBG000DC8S17,Has Valeant Pharmaceuticals Intl Inc (VRX) Stock Finally Bottomed?,2017-07-12 12:44:39 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-124439196.html?.tsrc=rss,Has embattled drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) finally bottomed?  Can VRX stock ever be trusted again?  The market seems willing to bet that Valeant — which in the first quarter posted its first profit in six quarters and then raised guidance for 2017 — can not only sustain its operations but thrive.
VRX,VRX:CT,BBG000DC8S17,Featured Company News - Valeant Pharma Pays Off $811 Million in Terms Loans,2017-07-12 11:50:00 +0000,https://finance.yahoo.com/news/featured-company-news-valeant-pharma-115000363.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / July 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Valeant Pharmaceuticals International, Inc. (NYSE: VRX ), following ..."
VRX,VRX:US,BBG000DLFM21,Featured Company News - Valeant Pharma Pays Off $811 Million in Terms Loans,2017-07-12 11:50:00 +0000,https://finance.yahoo.com/news/featured-company-news-valeant-pharma-115000363.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / July 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Valeant Pharmaceuticals International, Inc. (NYSE: VRX ), following ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising After BoC Raises Rates - Canadian Commentary,2017-07-12 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y17f6GqSgZs/canadian-stocks-are-rising-after-boc-raises-rates--canadian-commentary-20170712-00744,Canadian Stocks Are Rising After BoC Raises Rates - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising After BoC Raises Rates - Canadian Commentary,2017-07-12 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y17f6GqSgZs/canadian-stocks-are-rising-after-boc-raises-rates--canadian-commentary-20170712-00744,Canadian Stocks Are Rising After BoC Raises Rates - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Allergan Reports Positive New Data on Irritable Bowl Drug,2017-07-11 22:45:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nD2EhBsyE_8/allergan-reports-positive-new-data-on-irritable-bowl-drug-cm814761,Allergan plc AGN has announced encouraging results from a pooled analysis of two phase III studies evaluating the efficacy and safety of its marketed drug Viberzi eluxadoline for treatment of adults suffering from irritable bowel syndrome with diarrhea IBS D Notably the drug is
VRX,VRX:CT,BBG000DC8S17,Allergan Reports Positive New Data on Irritable Bowl Drug,2017-07-11 22:45:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nD2EhBsyE_8/allergan-reports-positive-new-data-on-irritable-bowl-drug-cm814761,Allergan plc AGN has announced encouraging results from a pooled analysis of two phase III studies evaluating the efficacy and safety of its marketed drug Viberzi eluxadoline for treatment of adults suffering from irritable bowel syndrome with diarrhea IBS D Notably the drug is
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-07-11 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZFTphaqOLTU/canadian-stocks-are-paring-early-losses--canadian-commentary-20170711-00805,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-07-11 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZFTphaqOLTU/canadian-stocks-are-paring-early-losses--canadian-commentary-20170711-00805,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Q2 2017 Financial Results Date And Conference Call Details,2017-07-10 21:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-q2-2017-financial-210000520.html?.tsrc=rss,"LAVAL, Quebec , July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release second quarter 2017 financial results on Tuesday, ..."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Q2 2017 Financial Results Date And Conference Call Details,2017-07-10 21:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-q2-2017-financial-210000520.html?.tsrc=rss,"LAVAL, Quebec , July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release second quarter 2017 financial results on Tuesday, ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant Continues Quest to Repay Massive $30 Billion Debt Load, Shares Close Higher",2017-07-10 20:54:00 +0000,http://finance.yahoo.com/r/3799836d-1942-3a6f-81c5-d849cda9d65f/valeant-shares-spike-after-drug-maker-cuts-debt-by-811m.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Valeant used proceeds from the Dendreon divestiture to help with its drive to pay down a total of $5 billion in debt.
VRX,VRX:US,BBG000DLFM21,"Valeant Continues Quest to Repay Massive $30 Billion Debt Load, Shares Close Higher",2017-07-10 20:54:00 +0000,http://finance.yahoo.com/r/3799836d-1942-3a6f-81c5-d849cda9d65f/valeant-shares-spike-after-drug-maker-cuts-debt-by-811m.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Valeant used proceeds from the Dendreon divestiture to help with its drive to pay down a total of $5 billion in debt.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Seeing a Lot of Quiet Buying,2017-07-10 20:47:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oGkCdUMzfEs/valeant-pharmaceuticals-intl-inc-vrx-stock-is-seeing-a-lot-of-quiet-buying-cm814111,InvestorPlace Stock Market News Stock Advice amp Trading Tips To say Valeant Pharmaceuticals Intl Inc NYSE VRX has had a rough past couple of years would be a considerable understatement Still down more than 90 since its August 2015 peak despite the rebound from less than
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Seeing a Lot of Quiet Buying,2017-07-10 20:47:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oGkCdUMzfEs/valeant-pharmaceuticals-intl-inc-vrx-stock-is-seeing-a-lot-of-quiet-buying-cm814111,InvestorPlace Stock Market News Stock Advice amp Trading Tips To say Valeant Pharmaceuticals Intl Inc NYSE VRX has had a rough past couple of years would be a considerable understatement Still down more than 90 since its August 2015 peak despite the rebound from less than
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Seeing a Lot of Quiet Buying,2017-07-10 15:52:52 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-155252694.html?.tsrc=rss,"To say Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has had a rough past couple of years would be a considerable understatement.  Whether anybody wants to admit it or not, genuine bullish interest in VRX stock has swollen since things hit rock bottom three months ago.  Many (though not all) indications are that the worst for Valeant Pharmaceuticals is in the rear-view mirror."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Seeing a Lot of Quiet Buying,2017-07-10 15:52:52 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-155252694.html?.tsrc=rss,"To say Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has had a rough past couple of years would be a considerable understatement.  Whether anybody wants to admit it or not, genuine bullish interest in VRX stock has swollen since things hit rock bottom three months ago.  Many (though not all) indications are that the worst for Valeant Pharmaceuticals is in the rear-view mirror."
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jul 10, 2017 :  USLV, ANF, MYCC, AUO, QQQ, NVDA, BAC, SWN, VRX, TSLA, MU, TVIX",2017-07-10 12:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I-BjNaUBybE/pre-market-most-active-for-jul-10-2017-uslv-anf-mycc-auo-qqq-nvda-bac-swn-vrx-tsla-mu-tvix-cm813647,The NASDAQ 100 Pre Market Indicator is up 10 02 to 5 666 49 The total Pre Market volume is currently 3 045 744 shares traded The following are the most active stocks for the pre market session VelocityShares 3x Long Silver ETN USLV is 0 44 at 9 17 with 484 308
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jul 10, 2017 :  USLV, ANF, MYCC, AUO, QQQ, NVDA, BAC, SWN, VRX, TSLA, MU, TVIX",2017-07-10 12:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I-BjNaUBybE/pre-market-most-active-for-jul-10-2017-uslv-anf-mycc-auo-qqq-nvda-bac-swn-vrx-tsla-mu-tvix-cm813647,The NASDAQ 100 Pre Market Indicator is up 10 02 to 5 666 49 The total Pre Market volume is currently 3 045 744 shares traded The following are the most active stocks for the pre market session VelocityShares 3x Long Silver ETN USLV is 0 44 at 9 17 with 484 308
VRX,VRX:US,BBG000DLFM21,"Valeant pays down $811 million of term loans, shares rise",2017-07-10 11:08:33 +0000,http://finance.yahoo.com/r/23d6cf3b-d852-3ac8-b6f2-9bd5fbc68181/Story.aspx?guid=7FC6C830-348E-4ADD-81FF-F0F6B58F2CE7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. shares jumped 1.2% in premarket trade Monday, after the company said it has paid down $811 million of senior secured loans, keeping it on track with its debt-reduction ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant pays down $811 million of term loans, shares rise",2017-07-10 11:08:33 +0000,http://finance.yahoo.com/r/23d6cf3b-d852-3ac8-b6f2-9bd5fbc68181/Story.aspx?guid=7FC6C830-348E-4ADD-81FF-F0F6B58F2CE7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. shares jumped 1.2% in premarket trade Monday, after the company said it has paid down $811 million of senior secured loans, keeping it on track with its debt-reduction ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pays Down $811 Million of Senior Secured Term Loans,2017-07-10 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pays-down-811-million-110000560.html?.tsrc=rss,"Debt Reduction Totals More than $4.3 Billion Since the End of First-Quarter 2016 LAVAL, Quebec , July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pays Down $811 Million of Senior Secured Term Loans,2017-07-10 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pays-down-811-million-110000560.html?.tsrc=rss,"Debt Reduction Totals More than $4.3 Billion Since the End of First-Quarter 2016 LAVAL, Quebec , July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Slipped Into The Red - Canadian Commentary,2017-07-10 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pnQkGc8bz4U/canadian-stocks-have-slipped-into-the-red--canadian-commentary-20170710-00807,Canadian Stocks Have Slipped Into The Red - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Slipped Into The Red - Canadian Commentary,2017-07-10 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pnQkGc8bz4U/canadian-stocks-have-slipped-into-the-red--canadian-commentary-20170710-00807,Canadian Stocks Have Slipped Into The Red - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,4 Big Reasons Valeant Pharmaceuticals Skyrocketed 44% in June,2017-07-07 15:48:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vl1jRUStndY/4-big-reasons-valeant-pharmaceuticals-skyrocketed-44-in-june-cm813013,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker that has primarily grown via acquisition and drug price hikes in recent years skyrocketed by 44 in June according to data from S amp P Global Market Intelligence No single event can
VRX,VRX:US,BBG000DLFM21,4 Big Reasons Valeant Pharmaceuticals Skyrocketed 44% in June,2017-07-07 15:48:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vl1jRUStndY/4-big-reasons-valeant-pharmaceuticals-skyrocketed-44-in-june-cm813013,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker that has primarily grown via acquisition and drug price hikes in recent years skyrocketed by 44 in June according to data from S amp P Global Market Intelligence No single event can
VRX,VRX:US,BBG000DLFM21,Stock Exchange: Can We Trade Geopolitical Risk?,2017-07-07 13:47:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ujUM81Z7Zfg/stock-exchange-can-we-trade-geopolitical-risk-cm812824,By Jeff Miller ByJeff Miller Our Stock Exchange is all about trading Each week we do the following Our Stock Exchange Stock ExchangeStock Exchange is all about trading Each week we do the following Discuss an important issue for traders highlight several technical
VRX,VRX:CT,BBG000DC8S17,Stock Exchange: Can We Trade Geopolitical Risk?,2017-07-07 13:47:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ujUM81Z7Zfg/stock-exchange-can-we-trade-geopolitical-risk-cm812824,By Jeff Miller ByJeff Miller Our Stock Exchange is all about trading Each week we do the following Our Stock Exchange Stock ExchangeStock Exchange is all about trading Each week we do the following Discuss an important issue for traders highlight several technical
VRX,VRX:CT,BBG000DC8S17,4 Big Reasons Valeant Pharmaceuticals Skyrocketed 44% in June,2017-07-07 13:43:00 +0000,http://finance.yahoo.com/r/96bc6a43-b264-35df-a1c4-72997974f1bf/4-big-reasons-valeant-pharmaceuticals-skyrocketed.aspx?yptr=yahoo&.tsrc=rss,"It was a perfect storm of good news, for once. But can it last?"
VRX,VRX:US,BBG000DLFM21,4 Big Reasons Valeant Pharmaceuticals Skyrocketed 44% in June,2017-07-07 13:43:00 +0000,http://finance.yahoo.com/r/96bc6a43-b264-35df-a1c4-72997974f1bf/4-big-reasons-valeant-pharmaceuticals-skyrocketed.aspx?yptr=yahoo&.tsrc=rss,"It was a perfect storm of good news, for once. But can it last?"
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Celsion Corporation,2017-07-07 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000507.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 7, 2017 / Valeant may be selling off more units soon to pay off its nearly $29 billion debt. The company just recently closed on its sale of its Dendreon subsidiary to ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Celsion Corporation,2017-07-07 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000507.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 7, 2017 / Valeant may be selling off more units soon to pay off its nearly $29 billion debt. The company just recently closed on its sale of its Dendreon subsidiary to ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling Despite Strong Employment Data - Canadian Commentary,2017-07-07 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TunJjyj3mMs/canadian-stocks-are-falling-despite-strong-employment-data--canadian-commentary-20170707-00506,Canadian Stocks Are Falling Despite Strong Employment Data - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling Despite Strong Employment Data - Canadian Commentary,2017-07-07 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TunJjyj3mMs/canadian-stocks-are-falling-despite-strong-employment-data--canadian-commentary-20170707-00506,Canadian Stocks Are Falling Despite Strong Employment Data - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Do Valeant Fundamentals Justify The Decrease In Bearish Sentiment?,2017-07-06 15:13:39 +0000,https://finance.yahoo.com/news/valeant-fundamentals-justify-decrease-bearish-151339803.html?.tsrc=rss,"As Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) shares continue to surge, JPMorgan analyst Chris Schott is not buying into the hype as he maintained his Neutral rating with a $10 price target. “Over the ..."
VRX,VRX:US,BBG000DLFM21,Do Valeant Fundamentals Justify The Decrease In Bearish Sentiment?,2017-07-06 15:13:39 +0000,https://finance.yahoo.com/news/valeant-fundamentals-justify-decrease-bearish-151339803.html?.tsrc=rss,"As Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) shares continue to surge, JPMorgan analyst Chris Schott is not buying into the hype as he maintained his Neutral rating with a $10 price target. “Over the ..."
VRX,VRX:US,BBG000DLFM21,Valeant: A Long Road Ahead?,2017-07-06 15:02:00 +0000,http://finance.yahoo.com/r/f38cd7f6-9280-3a19-9bca-ec77073216fd/valeant-a-long-road-ahead-1499353359?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Bill Ackman was right about one thing: Shares of Valeant Pharmaceuticals International (VRX) did rally after he exited his position. They've gained 40% since mid-March, when Ackman's Pershing Square revealed ..."
VRX,VRX:CT,BBG000DC8S17,Valeant: A Long Road Ahead?,2017-07-06 15:02:00 +0000,http://finance.yahoo.com/r/f38cd7f6-9280-3a19-9bca-ec77073216fd/valeant-a-long-road-ahead-1499353359?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Bill Ackman was right about one thing: Shares of Valeant Pharmaceuticals International (VRX) did rally after he exited his position. They've gained 40% since mid-March, when Ackman's Pershing Square revealed ..."
VRX,VRX:CT,BBG000DC8S17,John Paulson Is Truly a Glutton for Punishment,2017-07-06 14:48:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GyCYTu6U0-4/john-paulson-is-truly-a-glutton-for-punishment-cm812342,No one can deny that hedge fund manager John Paulson has great ideas from time to time In 2006 Paulson s hedge fund began to heavily bet against credit default swaps because he smelled trouble within the housing and banking industries In 2007 when subprime loans started to be
VRX,VRX:US,BBG000DLFM21,John Paulson Is Truly a Glutton for Punishment,2017-07-06 14:48:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GyCYTu6U0-4/john-paulson-is-truly-a-glutton-for-punishment-cm812342,No one can deny that hedge fund manager John Paulson has great ideas from time to time In 2006 Paulson s hedge fund began to heavily bet against credit default swaps because he smelled trouble within the housing and banking industries In 2007 when subprime loans started to be
VRX,VRX:US,BBG000DLFM21,John Paulson Is Truly a Glutton for Punishment,2017-07-06 13:01:00 +0000,http://finance.yahoo.com/r/b7c6ec46-3a00-32e6-a32e-e9a00d267cf7/john-paulson-is-truly-a-glutton-for-punishment.aspx?yptr=yahoo&.tsrc=rss,Paulson&apos;s hedge fund just increased its stake in Valeant by 2.7 million shares. Will it backfire?
VRX,VRX:CT,BBG000DC8S17,John Paulson Is Truly a Glutton for Punishment,2017-07-06 13:01:00 +0000,http://finance.yahoo.com/r/b7c6ec46-3a00-32e6-a32e-e9a00d267cf7/john-paulson-is-truly-a-glutton-for-punishment.aspx?yptr=yahoo&.tsrc=rss,Paulson&apos;s hedge fund just increased its stake in Valeant by 2.7 million shares. Will it backfire?
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jul 6, 2017 :  BAC, QQQ, TVIX, TSLA, ERIC, XIV, MU, BABA, VRX, EBR, BBVA, GE",2017-07-06 12:53:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8fdXT39v9RA/pre-market-most-active-for-jul-6-2017-bac-qqq-tvix-tsla-eric-xiv-mu-baba-vrx-ebr-bbva-ge-cm812241,The NASDAQ 100 Pre Market Indicator is down 35 43 to 5 613 39 The total Pre Market volume is currently 3 901 263 shares traded The following are the most active stocks for the pre market session Bank of America Corporation BAC is 0 06 at 24 86 with 524 859
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jul 6, 2017 :  BAC, QQQ, TVIX, TSLA, ERIC, XIV, MU, BABA, VRX, EBR, BBVA, GE",2017-07-06 12:53:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8fdXT39v9RA/pre-market-most-active-for-jul-6-2017-bac-qqq-tvix-tsla-eric-xiv-mu-baba-vrx-ebr-bbva-ge-cm812241,The NASDAQ 100 Pre Market Indicator is down 35 43 to 5 613 39 The total Pre Market volume is currently 3 901 263 shares traded The following are the most active stocks for the pre market session Bank of America Corporation BAC is 0 06 at 24 86 with 524 859
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Japan Launches Bausch + Lomb AQUALOX® Contact Lenses,2017-07-06 11:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-japan-launches-bausch-110000708.html?.tsrc=rss,"First New Innovation in the Bi-weekly Contact Lens Category in Five Years LAVAL, Quebec , July 6, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling On Global Cues - Canadian Commentary,2017-07-06 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YW6m0KHZa_k/canadian-stocks-are-falling-on-global-cues--canadian-commentary-20170706-00796,Canadian Stocks Are Falling On Global Cues - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling On Global Cues - Canadian Commentary,2017-07-06 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YW6m0KHZa_k/canadian-stocks-are-falling-on-global-cues--canadian-commentary-20170706-00796,Canadian Stocks Are Falling On Global Cues - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Japan Launches Bausch + Lomb AQUALOX® Contact Lenses,2017-07-06 11:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-japan-launches-bausch-110000708.html?.tsrc=rss,"First New Innovation in the Bi-weekly Contact Lens Category in Five Years LAVAL, Quebec , July 6, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned ..."
VRX,VRX:CT,BBG000DC8S17,Why Chesapeake Energy Corporation (CHK) Stock Isn’t Coming Back Soon,2017-07-05 17:00:18 +0000,https://finance.yahoo.com/news/why-chesapeake-energy-corporation-chk-170018712.html?.tsrc=rss,"If today is a day ending in the letter “y,” you will likely find someone yelling into the wind that Chesapeake Energy Corporation (NYSE:CHK) is a screaming buy. The company made $75 million, 8 cents per share, during the March quarter, and analysts are expecting that to double, to 15 cents, when it next reports earnings Aug. 3, they will whisper.  Interest peaked during the fracking boom early this decade, when swashbuckling founder Aubrey McClendon helped solve the Northeast’s energy crisis with cheap natural gas from Pennsylvania’s Marcellus Shale.  Natural gas prices spiked to over $6 per mcf in 2014, but then fell, to as low as $1.78 per mcf in 2015."
VRX,VRX:US,BBG000DLFM21,Why Chesapeake Energy Corporation (CHK) Stock Isn’t Coming Back Soon,2017-07-05 17:00:18 +0000,https://finance.yahoo.com/news/why-chesapeake-energy-corporation-chk-170018712.html?.tsrc=rss,"If today is a day ending in the letter “y,” you will likely find someone yelling into the wind that Chesapeake Energy Corporation (NYSE:CHK) is a screaming buy. The company made $75 million, 8 cents per share, during the March quarter, and analysts are expecting that to double, to 15 cents, when it next reports earnings Aug. 3, they will whisper.  Interest peaked during the fracking boom early this decade, when swashbuckling founder Aubrey McClendon helped solve the Northeast’s energy crisis with cheap natural gas from Pennsylvania’s Marcellus Shale.  Natural gas prices spiked to over $6 per mcf in 2014, but then fell, to as low as $1.78 per mcf in 2015."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down As Energy Sector Sinks - Canadian Commentary,2017-07-05 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IDkhkair3CM/canadian-stocks-are-down-as-energy-sector-sinks--canadian-commentary-20170705-00704,Canadian Stocks Are Down As Energy Sector Sinks - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down As Energy Sector Sinks - Canadian Commentary,2017-07-05 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IDkhkair3CM/canadian-stocks-are-down-as-energy-sector-sinks--canadian-commentary-20170705-00704,Canadian Stocks Are Down As Energy Sector Sinks - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Energy Transfer Partners LP (ETP) Is a High-Risk Contrarian Buy,2017-07-04 17:43:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LJRkG6dO9-A/energy-transfer-partners-lp-etp-is-a-high-risk-contrarian-buy-cm811607,InvestorPlace Stock Market News Stock Advice amp Trading Tips If you like contrarian plays Energy Transfer Partners LP NYSE ETP is for you ETP stock or LP units as they re technically known has fallen roughly 70 from late 2014 highs The news for the ETP stock price
VRX,VRX:US,BBG000DLFM21,Energy Transfer Partners LP (ETP) Is a High-Risk Contrarian Buy,2017-07-04 17:43:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LJRkG6dO9-A/energy-transfer-partners-lp-etp-is-a-high-risk-contrarian-buy-cm811607,InvestorPlace Stock Market News Stock Advice amp Trading Tips If you like contrarian plays Energy Transfer Partners LP NYSE ETP is for you ETP stock or LP units as they re technically known has fallen roughly 70 from late 2014 highs The news for the ETP stock price
VRX,VRX:US,BBG000DLFM21,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Reach $40,2017-07-03 15:46:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_32ZHTcr3pQ/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-reach-40-cm811309,InvestorPlace Stock Market News Stock Advice amp Trading Tips Despite what appears to be an unhealthy market for drug stocks weighed by political pressures on pricing Teva Pharmaceutical Industries Ltd ADR NYSE TEVA still could be compelling trade With TEVA stock down
VRX,VRX:CT,BBG000DC8S17,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Reach $40,2017-07-03 15:46:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_32ZHTcr3pQ/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-reach-40-cm811309,InvestorPlace Stock Market News Stock Advice amp Trading Tips Despite what appears to be an unhealthy market for drug stocks weighed by political pressures on pricing Teva Pharmaceutical Industries Ltd ADR NYSE TEVA still could be compelling trade With TEVA stock down
VRX,VRX:CT,BBG000DC8S17,Have You Hugged a Short-Selling Activist Today?,2017-07-02 13:42:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gx7TLs1wY20/have-you-hugged-a-short-selling-activist-today-cm810935,There s a class of people we revere above all other in society those who take risks on the behalf of others These people don t stand to gain much materially for their efforts but they undertake them for the benefit of all Saints religious figures warriors soldiers
VRX,VRX:US,BBG000DLFM21,Have You Hugged a Short-Selling Activist Today?,2017-07-02 13:42:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gx7TLs1wY20/have-you-hugged-a-short-selling-activist-today-cm810935,There s a class of people we revere above all other in society those who take risks on the behalf of others These people don t stand to gain much materially for their efforts but they undertake them for the benefit of all Saints religious figures warriors soldiers
VRX,VRX:CT,BBG000DC8S17,The Market In 5 Minutes,2017-06-30 13:06:16 +0000,https://finance.yahoo.com/news/market-5-minutes-130616738.html?.tsrc=rss,"IN THE NEWS Benzinga Following a price target hike from Cantor Fitzgerald on Wednesday, Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) shareholders find themselves in an unfamiliar place—fresh six-month ..."
VRX,VRX:US,BBG000DLFM21,The Market In 5 Minutes,2017-06-30 13:06:16 +0000,https://finance.yahoo.com/news/market-5-minutes-130616738.html?.tsrc=rss,"IN THE NEWS Benzinga Following a price target hike from Cantor Fitzgerald on Wednesday, Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) shareholders find themselves in an unfamiliar place—fresh six-month ..."
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jun 30, 2017 :  SPLS, MU, QQQ, RAD, BAC, NKE, APRN, VRX, XIV, KT, TVIX, TSLA",2017-06-30 12:52:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AoeV70yhIOQ/pre-market-most-active-for-jun-30-2017-spls-mu-qqq-rad-bac-nke-aprn-vrx-xiv-kt-tvix-tsla-cm810356,The NASDAQ 100 Pre Market Indicator is up 5 84 to 5 658 86 The total Pre Market volume is currently 3 486 821 shares traded The following are the most active stocks for the pre market session Staples Inc SPLS is unchanged at 10 08 with 2 324 996 shares traded SPLS
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jun 30, 2017 :  SPLS, MU, QQQ, RAD, BAC, NKE, APRN, VRX, XIV, KT, TVIX, TSLA",2017-06-30 12:52:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AoeV70yhIOQ/pre-market-most-active-for-jun-30-2017-spls-mu-qqq-rad-bac-nke-aprn-vrx-xiv-kt-tvix-tsla-cm810356,The NASDAQ 100 Pre Market Indicator is up 5 84 to 5 658 86 The total Pre Market volume is currently 3 486 821 shares traded The following are the most active stocks for the pre market session Staples Inc SPLS is unchanged at 10 08 with 2 324 996 shares traded SPLS
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant After Ackman: Paulson Logs 26% Gain,2017-06-30 11:57:00 +0000,http://finance.yahoo.com/r/c1a7919b-3d8b-33e8-ac12-5da5849727bf/valeant-after-ackman-paulson-logs-26-gain-1498823857?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Have we finally reached Valeant Pharmaceuticals International’s (VRX) inflection point?  John Paulson, head of hedge fund Paulson & Co., was elected as a director of the troubled Canadian drugmaker last week, expanding the board to 11 from 10.  Bill Ackman, chief executive and founder of Pershing Square Capital Management, lasted about a year as a director before concluding that getting out with a $4 billion loss on the investment was late but better than being completely wiped out."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant After Ackman: Paulson Logs 26% Gain,2017-06-30 11:57:00 +0000,http://finance.yahoo.com/r/c1a7919b-3d8b-33e8-ac12-5da5849727bf/valeant-after-ackman-paulson-logs-26-gain-1498823857?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Have we finally reached Valeant Pharmaceuticals International’s (VRX) inflection point?  John Paulson, head of hedge fund Paulson & Co., was elected as a director of the troubled Canadian drugmaker last week, expanding the board to 11 from 10.  Bill Ackman, chief executive and founder of Pershing Square Capital Management, lasted about a year as a director before concluding that getting out with a $4 billion loss on the investment was late but better than being completely wiped out."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling After GDP Meets Expectations - Canadian Commentary,2017-06-30 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53KqehW1ZBM/canadian-stocks-are-falling-after-gdp-meets-expectations--canadian-commentary-20170630-00564,Canadian Stocks Are Falling After GDP Meets Expectations - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling After GDP Meets Expectations - Canadian Commentary,2017-06-30 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53KqehW1ZBM/canadian-stocks-are-falling-after-gdp-meets-expectations--canadian-commentary-20170630-00564,Canadian Stocks Are Falling After GDP Meets Expectations - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International,2017-06-30 11:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-named-most-trusted-110000672.html?.tsrc=rss,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International,2017-06-30 11:00:00 +0000,https://finance.yahoo.com/news/bausch-lomb-named-most-trusted-110000672.html?.tsrc=rss,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International
VRX,VRX:CT,BBG000DC8S17,Sanpower's SVP Says Dendreon Deal Is a Milestone,2017-06-30 02:12:43 +0000,https://finance.yahoo.com/video/sanpowers-svp-says-dendreon-deal-021243589.html?.tsrc=rss,"Jun.29 -- Xu Fang, senior vice president and Dendreon Chairman at Sanpower group, discusses completing the Dendreon purchase from Valeant. She speaks on &quot;Bloomberg Markets: Asia.&quot;"
VRX,VRX:US,BBG000DLFM21,Sanpower's SVP Says Dendreon Deal Is a Milestone,2017-06-30 02:12:43 +0000,https://finance.yahoo.com/video/sanpowers-svp-says-dendreon-deal-021243589.html?.tsrc=rss,"Jun.29 -- Xu Fang, senior vice president and Dendreon Chairman at Sanpower group, discusses completing the Dendreon purchase from Valeant. She speaks on &quot;Bloomberg Markets: Asia.&quot;"
VRX,VRX:CT,BBG000DC8S17,"Pricing, Competition Remain Headwinds for Pharma in 2017",2017-06-29 23:03:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2bAOJobSSZc/pricing-competition-remain-headwinds-for-pharma-in-2017-cm810281,Although fears regarding the drug pricing issue have waned it will nevertheless remain a headwind until the Trump administration comes out with a policy for controlling drug prices Drug pricing is an issue that weighed on pharma and biotech stocks for more than a year The sector
VRX,VRX:US,BBG000DLFM21,"Pricing, Competition Remain Headwinds for Pharma in 2017",2017-06-29 23:03:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2bAOJobSSZc/pricing-competition-remain-headwinds-for-pharma-in-2017-cm810281,Although fears regarding the drug pricing issue have waned it will nevertheless remain a headwind until the Trump administration comes out with a policy for controlling drug prices Drug pricing is an issue that weighed on pharma and biotech stocks for more than a year The sector
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps,2017-06-29 21:13:00 +0000,http://finance.yahoo.com/r/4234b1a6-cf14-3432-8b8b-1671922673fe/valeant-pharma-continues-asset-sales-instead-of-riskier-debt-swaps.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Laval, Quebec-based specialty pharmaceutical company is likely to sell off more of its business segments as it seeks to pay down nearly $29 billion in debt."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps,2017-06-29 21:13:00 +0000,http://finance.yahoo.com/r/4234b1a6-cf14-3432-8b8b-1671922673fe/valeant-pharma-continues-asset-sales-instead-of-riskier-debt-swaps.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Laval, Quebec-based specialty pharmaceutical company is likely to sell off more of its business segments as it seeks to pay down nearly $29 billion in debt."
VRX,VRX:CT,BBG000DC8S17,Benzinga's Option Alert Recap From June 29,2017-06-29 20:17:47 +0000,https://finance.yahoo.com/news/benzingas-option-alert-recap-june-201747798.html?.tsrc=rss,"Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity. Here's a recap of the options alerts from Thursday, June 29, 2017. All timestamps are in Eastern ..."
VRX,VRX:US,BBG000DLFM21,Benzinga's Option Alert Recap From June 29,2017-06-29 20:17:47 +0000,https://finance.yahoo.com/news/benzingas-option-alert-recap-june-201747798.html?.tsrc=rss,"Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity. Here's a recap of the options alerts from Thursday, June 29, 2017. All timestamps are in Eastern ..."
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts for Thursday: Merck & Co., Inc. (MRK), Gilead Sciences, Inc. (GILD) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-06-29 20:05:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xcAVLjxkO5U/3-big-stock-charts-for-thursday-merck-co-inc-mrk-gilead-sciences-inc-gild-and-valeant-pharmaceuticals-intl-inc-vrx-cm810222,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotechnology and pharmaceutical companies have been showing a lot of strength lately as investors have been migrating back into the sector The reason for the migration back to these stocks is the fact that
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts for Thursday: Merck & Co., Inc. (MRK), Gilead Sciences, Inc. (GILD) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-06-29 20:05:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xcAVLjxkO5U/3-big-stock-charts-for-thursday-merck-co-inc-mrk-gilead-sciences-inc-gild-and-valeant-pharmaceuticals-intl-inc-vrx-cm810222,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotechnology and pharmaceutical companies have been showing a lot of strength lately as investors have been migrating back into the sector The reason for the migration back to these stocks is the fact that
VRX,VRX:CT,BBG000DC8S17,"Advanced Micro Devices, Inc. (AMD) Stock Needs More Than Ryzen",2017-06-29 19:05:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SoJXVr9DrHg/advanced-micro-devices-inc-amd-stock-needs-more-than-ryzen-cm810189,InvestorPlace Stock Market News Stock Advice amp Trading Tips After a blowout 2016 Advanced Micro Devices Inc NASDAQ AMD stock has had a roller coaster 2017 A strong early year run sent AMD stock to its highest levels in almost a decade Source Shutterstock But 160
VRX,VRX:US,BBG000DLFM21,"Advanced Micro Devices, Inc. (AMD) Stock Needs More Than Ryzen",2017-06-29 19:05:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SoJXVr9DrHg/advanced-micro-devices-inc-amd-stock-needs-more-than-ryzen-cm810189,InvestorPlace Stock Market News Stock Advice amp Trading Tips After a blowout 2016 Advanced Micro Devices Inc NASDAQ AMD stock has had a roller coaster 2017 A strong early year run sent AMD stock to its highest levels in almost a decade Source Shutterstock But 160
VRX,VRX:CT,BBG000DC8S17,Walgreens Boots Alliance Inc (WBA) Stock Climbs Pile of Rite Aid’s Bones,2017-06-29 18:06:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kvEnheBS3pA/walgreens-boots-alliance-inc-wba-stock-climbs-pile-of-rite-aids-bones-cm810173,InvestorPlace Stock Market News Stock Advice amp Trading Tips Walgreens Boots Alliance Inc 160 NASDAQ WBA made lemonade out of its Rite Aid Corporation 160 NYSE RAD lemons cancelling its merger with the troubled pharmacy chain and gobbling up its stores
VRX,VRX:US,BBG000DLFM21,Walgreens Boots Alliance Inc (WBA) Stock Climbs Pile of Rite Aid’s Bones,2017-06-29 18:06:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kvEnheBS3pA/walgreens-boots-alliance-inc-wba-stock-climbs-pile-of-rite-aids-bones-cm810173,InvestorPlace Stock Market News Stock Advice amp Trading Tips Walgreens Boots Alliance Inc 160 NASDAQ WBA made lemonade out of its Rite Aid Corporation 160 NYSE RAD lemons cancelling its merger with the troubled pharmacy chain and gobbling up its stores
VRX,VRX:US,BBG000DLFM21,Vulnerable Drugmakers Can't Shrug Off the FDA,2017-06-29 18:00:10 +0000,http://finance.yahoo.com/r/792b393c-fcc3-3b62-9908-749266eea42a/fda-drug-list-valeant-mylan-can-t-shrug-this-off?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Investors are ignoring the latest sign of a pricing crackdown.
VRX,VRX:CT,BBG000DC8S17,Vulnerable Drugmakers Can't Shrug Off the FDA,2017-06-29 18:00:10 +0000,http://finance.yahoo.com/r/792b393c-fcc3-3b62-9908-749266eea42a/fda-drug-list-valeant-mylan-can-t-shrug-this-off?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Investors are ignoring the latest sign of a pricing crackdown.
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Untouchable,2017-06-29 17:07:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JKFM2Au95H8/why-valeant-pharmaceuticals-intl-inc-vrx-stock-is-untouchable-cm810129,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX has been trading very well over the last couple of months rallying more than 100 from its 52 week low on April 24 Recent volume tells me that buyers are
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Untouchable,2017-06-29 17:07:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JKFM2Au95H8/why-valeant-pharmaceuticals-intl-inc-vrx-stock-is-untouchable-cm810129,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX has been trading very well over the last couple of months rallying more than 100 from its 52 week low on April 24 Recent volume tells me that buyers are
VRX,VRX:US,BBG000DLFM21,Valeant's (VRX) NDA for Bowel Cleansing Drug Accepted by FDA,2017-06-29 17:05:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XNieVOJfUVc/valeants-vrx-nda-for-bowel-cleansing-drug-accepted-by-fda-cm810076,Valeant Pharmaceuticals International Inc s VRX wholly owned subsidiary Salix Pharmaceuticals announced that the FDA has accepted its New Drug Application for Plenvu NER1006 A low volume 1L polyethylene glycol based bowel preparation Plenvu has been developed for whole
VRX,VRX:CT,BBG000DC8S17,Valeant's (VRX) NDA for Bowel Cleansing Drug Accepted by FDA,2017-06-29 17:05:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XNieVOJfUVc/valeants-vrx-nda-for-bowel-cleansing-drug-accepted-by-fda-cm810076,Valeant Pharmaceuticals International Inc s VRX wholly owned subsidiary Salix Pharmaceuticals announced that the FDA has accepted its New Drug Application for Plenvu NER1006 A low volume 1L polyethylene glycol based bowel preparation Plenvu has been developed for whole
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts for Thursday: Merck & Co., Inc. (MRK), Gilead Sciences, Inc. (GILD) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-06-29 16:01:46 +0000,https://finance.yahoo.com/news/3-big-stock-charts-thursday-160146283.html?.tsrc=rss,"The rapid rally has put a few names like Merck & Co., Inc. (NYSE:MRK), Gilead Sciences, Inc. (NASDAQ:GILD) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in positions where they are indicating a better buying opportunity is likely coming in the near-term.  Pharma giant Merck didn’t tumble to the relative lows that many of the other companies on our screens saw, but Merck shares now appear to be hitting an overbought level as they are breaking into an intermediate-term bullish trend.  Last week, as Merck stock was trying to break into a volatility rally higher, they were rejected by the $66-price-level near the March highs."
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts for Thursday: Merck & Co., Inc. (MRK), Gilead Sciences, Inc. (GILD) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-06-29 16:01:46 +0000,https://finance.yahoo.com/news/3-big-stock-charts-thursday-160146283.html?.tsrc=rss,"The rapid rally has put a few names like Merck & Co., Inc. (NYSE:MRK), Gilead Sciences, Inc. (NASDAQ:GILD) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in positions where they are indicating a better buying opportunity is likely coming in the near-term.  Pharma giant Merck didn’t tumble to the relative lows that many of the other companies on our screens saw, but Merck shares now appear to be hitting an overbought level as they are breaking into an intermediate-term bullish trend.  Last week, as Merck stock was trying to break into a volatility rally higher, they were rejected by the $66-price-level near the March highs."
VRX,VRX:CT,BBG000DC8S17,5 Reasons Valeant Can Keep Flying,2017-06-29 15:14:00 +0000,http://finance.yahoo.com/r/35139619-1dd4-3253-96fb-5ebf43ebe88c/5-reasons-valeant-can-keep-flying-1498749267?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have gained more than 45% in June, as the company has completed asset sales and paid down debt. But has its shares come too far too fast? If you listen ..."
VRX,VRX:US,BBG000DLFM21,5 Reasons Valeant Can Keep Flying,2017-06-29 15:14:00 +0000,http://finance.yahoo.com/r/35139619-1dd4-3253-96fb-5ebf43ebe88c/5-reasons-valeant-can-keep-flying-1498749267?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have gained more than 45% in June, as the company has completed asset sales and paid down debt. But has its shares come too far too fast? If you listen ..."
VRX,VRX:US,BBG000DLFM21,Valeant&apos;s (VRX) NDA for Bowel Cleansing Drug Accepted by FDA,2017-06-29 14:49:02 +0000,https://finance.yahoo.com/news/valeant-apos-vrx-nda-bowel-144902744.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc.&apos;s (VRX) wholly owned subsidiary, Salix Pharmaceuticals, announced that the FDA has accepted its New Drug Application for Plenvu."
VRX,VRX:CT,BBG000DC8S17,Valeant&apos;s (VRX) NDA for Bowel Cleansing Drug Accepted by FDA,2017-06-29 14:49:02 +0000,https://finance.yahoo.com/news/valeant-apos-vrx-nda-bowel-144902744.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc.&apos;s (VRX) wholly owned subsidiary, Salix Pharmaceuticals, announced that the FDA has accepted its New Drug Application for Plenvu."
VRX,VRX:US,BBG000DLFM21,Top 3 Companies Owned by Valeant (VRX),2017-06-29 14:28:00 +0000,http://finance.yahoo.com/r/a790288d-c230-3579-9522-93c619149d7a/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,Top 3 Companies Owned by Valeant (VRX),2017-06-29 14:28:00 +0000,http://finance.yahoo.com/r/a790288d-c230-3579-9522-93c619149d7a/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,Valeant's Chart Is Actually Looking Pretty Good For A Change,2017-06-29 14:01:59 +0000,https://finance.yahoo.com/news/valeants-chart-actually-looking-pretty-140159192.html?.tsrc=rss,"Following a price target hike from Cantor Fitzgerald on Wednesday, Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) shareholders find themselves in an unfamiliar place—fresh six-month highs. After a disastrous ..."
VRX,VRX:US,BBG000DLFM21,Valeant's Chart Is Actually Looking Pretty Good For A Change,2017-06-29 14:01:59 +0000,https://finance.yahoo.com/news/valeants-chart-actually-looking-pretty-140159192.html?.tsrc=rss,"Following a price target hike from Cantor Fitzgerald on Wednesday, Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) shareholders find themselves in an unfamiliar place—fresh six-month highs. After a disastrous ..."
VRX,VRX:US,BBG000DLFM21,Valeant Could be Worth 30% More If It Can Continue to Execute Turnaround Efforts,2017-06-29 13:52:00 +0000,http://finance.yahoo.com/r/338bdfac-729b-3c87-805d-6ee5ec6cab24/valeant-could-be-worth-30-more-if-it-can-continue-to-execute-various-initiatives.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,This is the checklist.
VRX,VRX:CT,BBG000DC8S17,Valeant Could be Worth 30% More If It Can Continue to Execute Turnaround Efforts,2017-06-29 13:52:00 +0000,http://finance.yahoo.com/r/338bdfac-729b-3c87-805d-6ee5ec6cab24/valeant-could-be-worth-30-more-if-it-can-continue-to-execute-various-initiatives.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,This is the checklist.
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 06/29/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, SRPT, NVS",2017-06-29 13:22:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e_AkNqB2YbI/health-care-sector-update-for-06292017-jnj-pfe-abt-mrk-amgn-vrx-srpt-nvs-cm809780,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN 0 04 AMGN 0 04 Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In health care
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 06/29/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, SRPT, NVS",2017-06-29 13:22:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e_AkNqB2YbI/health-care-sector-update-for-06292017-jnj-pfe-abt-mrk-amgn-vrx-srpt-nvs-cm809780,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN 0 04 AMGN 0 04 Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In health care
VRX,VRX:US,BBG000DLFM21,"Your first trade for Thursday, June 29",2017-06-29 13:07:31 +0000,https://finance.yahoo.com/news/first-trade-thursday-june-29-130731102.html?.tsrc=rss,The &quot;Fast Money&quot; traders shared their first trades for the market open.
VRX,VRX:CT,BBG000DC8S17,"Your first trade for Thursday, June 29",2017-06-29 13:07:31 +0000,http://finance.yahoo.com/r/fdde224e-b28b-3684-a20a-01fdf1cd854f/104558907?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104558907&yptr=yahoo&.tsrc=rss,"The ""Fast Money"" traders shared their first trades for the market open."
VRX,VRX:US,BBG000DLFM21,"Your first trade for Thursday, June 29",2017-06-29 13:07:31 +0000,http://finance.yahoo.com/r/fdde224e-b28b-3684-a20a-01fdf1cd854f/104558907?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104558907&yptr=yahoo&.tsrc=rss,"The ""Fast Money"" traders shared their first trades for the market open."
VRX,VRX:CT,BBG000DC8S17,"Your first trade for Thursday, June 29",2017-06-29 13:07:31 +0000,https://finance.yahoo.com/news/first-trade-thursday-june-29-130731102.html?.tsrc=rss,The &quot;Fast Money&quot; traders shared their first trades for the market open.
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Untouchable,2017-06-29 12:59:53 +0000,https://finance.yahoo.com/news/why-valeant-pharmaceuticals-intl-inc-125953036.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been trading very well over the last couple of months, rallying more than 100% from its 52-week low on April 24.  The biggest issue I have with Valeant is the huge amount of debt the company carries on its balance sheet.  As VRX stock has climbed, there is speculation that management will begin to settle some of their debt issues by offering current bond holders equity in lieu of bonds."
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Untouchable,2017-06-29 12:59:53 +0000,https://finance.yahoo.com/news/why-valeant-pharmaceuticals-intl-inc-125953036.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been trading very well over the last couple of months, rallying more than 100% from its 52-week low on April 24.  The biggest issue I have with Valeant is the huge amount of debt the company carries on its balance sheet.  As VRX stock has climbed, there is speculation that management will begin to settle some of their debt issues by offering current bond holders equity in lieu of bonds."
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jun 29, 2017 :  SPLS, RAD, BAC, GOV, CRZO, IPG, QQQ, VRX, WBA, FRED, JPM, C",2017-06-29 12:52:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zFubnSz3M1Q/pre-market-most-active-for-jun-29-2017-spls-rad-bac-gov-crzo-ipg-qqq-vrx-wba-fred-jpm-c-cm809765,The NASDAQ 100 Pre Market Indicator is down 5 75 to 5 747 28 The total Pre Market volume is currently 26 131 349 shares traded The following are the most active stocks for the pre market session Staples Inc SPLS is 0 19 at 10 12 with 33 347 927 shares
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jun 29, 2017 :  SPLS, RAD, BAC, GOV, CRZO, IPG, QQQ, VRX, WBA, FRED, JPM, C",2017-06-29 12:52:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zFubnSz3M1Q/pre-market-most-active-for-jun-29-2017-spls-rad-bac-gov-crzo-ipg-qqq-vrx-wba-fred-jpm-c-cm809765,The NASDAQ 100 Pre Market Indicator is down 5 75 to 5 747 28 The total Pre Market volume is currently 26 131 349 shares traded The following are the most active stocks for the pre market session Staples Inc SPLS is 0 19 at 10 12 with 33 347 927 shares
VRX,VRX:US,BBG000DLFM21,Valeant Investors: Cantor Says It's Time To Stop Waiting For The Other Shoe To Drop,2017-06-29 12:50:31 +0000,https://finance.yahoo.com/news/valeant-investors-cantor-says-time-125031937.html?.tsrc=rss,Analysts at Cantor Fitzgerald turned incrementally bullish on Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) after the once-troubled pharmaceutical company is showing signs of sustaining momentum. Cantor ...
VRX,VRX:CT,BBG000DC8S17,Valeant Investors: Cantor Says It's Time To Stop Waiting For The Other Shoe To Drop,2017-06-29 12:50:31 +0000,https://finance.yahoo.com/news/valeant-investors-cantor-says-time-125031937.html?.tsrc=rss,Analysts at Cantor Fitzgerald turned incrementally bullish on Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) after the once-troubled pharmaceutical company is showing signs of sustaining momentum. Cantor ...
VRX,VRX:CT,BBG000DC8S17,Sanpower Group Completes the Acquisition of Dendreon from Valeant,2017-06-29 12:37:00 +0000,https://finance.yahoo.com/news/sanpower-group-completes-acquisition-dendreon-123700757.html?.tsrc=rss,"NANJING, China, June 29, 2017 /PRNewswire/ -- Sanpower Group, a Chinese private conglomerate, announced the completion of its 100% acquisition of Dendreon, from Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)  for $819.9 million in cash.  Dendreon's core product, PROVENGE, is the first and only FDA-approved cellular immunotherapy for prostate cancer.  PROVENGE was officially approved by U.S. Food and Drug Administration in April 2010 for treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)."
VRX,VRX:US,BBG000DLFM21,Sanpower Group Completes the Acquisition of Dendreon from Valeant,2017-06-29 12:37:00 +0000,https://finance.yahoo.com/news/sanpower-group-completes-acquisition-dendreon-123700757.html?.tsrc=rss,"NANJING, China, June 29, 2017 /PRNewswire/ -- Sanpower Group, a Chinese private conglomerate, announced the completion of its 100% acquisition of Dendreon, from Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)  for $819.9 million in cash.  Dendreon's core product, PROVENGE, is the first and only FDA-approved cellular immunotherapy for prostate cancer.  PROVENGE was officially approved by U.S. Food and Drug Administration in April 2010 for treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)."
VRX,VRX:US,BBG000DLFM21,"Morning Movers: Constellation Brands Jumps, Sarepta Climbs, Valeant Gains",2017-06-29 12:31:00 +0000,http://finance.yahoo.com/r/bc9dc5d1-cca7-3f36-aa2f-8b8e45d0f6bb/morning-movers-constellation-brands-jumps-sarepta-climbs-valeant-gains-1498739513?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a mixed open this morning following yesterday's rally. S&P 500 futures have risen 0.2%, while Dow Jones Industrial Average futures have gained 0.2%. Nasdaq Composite futures have fallen ..."
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: Constellation Brands Jumps, Sarepta Climbs, Valeant Gains",2017-06-29 12:31:00 +0000,http://finance.yahoo.com/r/bc9dc5d1-cca7-3f36-aa2f-8b8e45d0f6bb/morning-movers-constellation-brands-jumps-sarepta-climbs-valeant-gains-1498739513?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a mixed open this morning following yesterday's rally. S&P 500 futures have risen 0.2%, while Dow Jones Industrial Average futures have gained 0.2%. Nasdaq Composite futures have fallen ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group,2017-06-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-dendreon-110000074.html?.tsrc=rss,Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group,2017-06-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-dendreon-110000650.html?.tsrc=rss,"LAVAL, Quebec, June 29, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the Sanpower Group, Co., Ltd. (""Sanpower""), for $819.9 million in cash.  Valeant will use net proceeds from the sale to permanently repay term loan debt under its Senior Credit Facility.  With the closing of this transaction, the Company reiterates its expectation to pay down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of August 2016."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group,2017-06-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-dendreon-110000650.html?.tsrc=rss,"LAVAL, Quebec, June 29, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"" or the ""Company"") today announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the Sanpower Group, Co., Ltd. (""Sanpower""), for $819.9 million in cash.  Valeant will use net proceeds from the sale to permanently repay term loan debt under its Senior Credit Facility.  With the closing of this transaction, the Company reiterates its expectation to pay down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of August 2016."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group,2017-06-29 11:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-dendreon-110000074.html?.tsrc=rss,Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Losing Ground On Broad Weakness - Canadian Commentary,2017-06-29 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rnSlZpL9CAc/canadian-stocks-are-losing-ground-on-broad-weakness--canadian-commentary-20170629-00777,Canadian Stocks Are Losing Ground On Broad Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Losing Ground On Broad Weakness - Canadian Commentary,2017-06-29 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rnSlZpL9CAc/canadian-stocks-are-losing-ground-on-broad-weakness--canadian-commentary-20170629-00777,Canadian Stocks Are Losing Ground On Broad Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Affiliate Completes Sale Of Dendreon - Quick Facts,2017-06-29 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f-hBzv7MemM/valeant-pharma-affiliate-completes-sale-of-dendreon--quick-facts-20170629-00330,Valeant Pharma Affiliate Completes Sale Of Dendreon - Quick Facts
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Affiliate Completes Sale Of Dendreon - Quick Facts,2017-06-29 07:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f-hBzv7MemM/valeant-pharma-affiliate-completes-sale-of-dendreon--quick-facts-20170629-00330,Valeant Pharma Affiliate Completes Sale Of Dendreon - Quick Facts
VRX,VRX:CT,BBG000DC8S17,Salix Announces Filing Acceptance for PLENVU®* Next Generation Bowel Cleansing Preparation for Colonoscopies,2017-06-28 22:00:00 +0000,https://finance.yahoo.com/news/salix-announces-filing-acceptance-plenvu-220000238.html?.tsrc=rss,"Expects FDA Decision in First-Quarter 2018 BRIDGEWATER, N.J. , June 28, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX AND TSX: VRX)  wholly owned subsidiary, Salix Pharmaceuticals, ..."
VRX,VRX:US,BBG000DLFM21,Salix Announces Filing Acceptance for PLENVU®* Next Generation Bowel Cleansing Preparation for Colonoscopies,2017-06-28 22:00:00 +0000,https://finance.yahoo.com/news/salix-announces-filing-acceptance-plenvu-220000238.html?.tsrc=rss,"Expects FDA Decision in First-Quarter 2018 BRIDGEWATER, N.J. , June 28, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX AND TSX: VRX)  wholly owned subsidiary, Salix Pharmaceuticals, ..."
VRX,VRX:CT,BBG000DC8S17,"&quot;Fast Money&quot; final trades: TBT, VRX, and more",2017-06-28 21:59:00 +0000,https://finance.yahoo.com/video/fast-money-final-trades-tbt-215900294.html?.tsrc=rss,"The “Fast Money” traders discuss their final trades for the day including Discover Financial, Europe Financials ETF, ProShares 20-Year Treasury and Valeant Pharmaceuticals."
VRX,VRX:US,BBG000DLFM21,"&quot;Fast Money&quot; final trades: TBT, VRX, and more",2017-06-28 21:59:00 +0000,https://finance.yahoo.com/video/fast-money-final-trades-tbt-215900294.html?.tsrc=rss,"The “Fast Money” traders discuss their final trades for the day including Discover Financial, Europe Financials ETF, ProShares 20-Year Treasury and Valeant Pharmaceuticals."
VRX,VRX:CT,BBG000DC8S17,Cantor Boosts Price Target for Valeant Pharmaceuticals Intl Inc; Here’s Why,2017-06-28 21:45:58 +0000,https://finance.yahoo.com/news/cantor-boosts-price-target-valeant-214558170.html?.tsrc=rss,"In a big vote of confidence, Cantor analyst Louise Chen reiterates an Overweight rating on shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), while boosting his price target to $23.00 (from $18.00), as he believes the company has reached a positive inflection point in its turnaround.  Chen opined, ""Valeant's strong execution against its stated objectives increases our confidence that Joe Papa, CEO, and Paul Herendeen, CFO, can return the company back to growth.  ""We think Valeant could continue to refinance its debt to push out the maturities beyond where they are today."
VRX,VRX:US,BBG000DLFM21,Cantor Boosts Price Target for Valeant Pharmaceuticals Intl Inc; Here’s Why,2017-06-28 21:45:58 +0000,https://finance.yahoo.com/news/cantor-boosts-price-target-valeant-214558170.html?.tsrc=rss,"In a big vote of confidence, Cantor analyst Louise Chen reiterates an Overweight rating on shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), while boosting his price target to $23.00 (from $18.00), as he believes the company has reached a positive inflection point in its turnaround.  Chen opined, ""Valeant's strong execution against its stated objectives increases our confidence that Joe Papa, CEO, and Paul Herendeen, CFO, can return the company back to growth.  ""We think Valeant could continue to refinance its debt to push out the maturities beyond where they are today."
VRX,VRX:US,BBG000DLFM21,Paulson Dives Deeper Into Valeant With Increased Holding,2017-06-28 21:15:19 +0000,https://finance.yahoo.com/news/paulson-dives-deeper-valeant-increased-231016091.html?.tsrc=rss,"With funds sinking, Paulson buys even more of troubled pharma"
VRX,VRX:CT,BBG000DC8S17,Paulson Dives Deeper Into Valeant With Increased Holding,2017-06-28 21:15:19 +0000,https://finance.yahoo.com/news/paulson-dives-deeper-valeant-increased-231016091.html?.tsrc=rss,"With funds sinking, Paulson buys even more of troubled pharma"
VRX,VRX:CT,BBG000DC8S17,Will Valeant’s Lenders Have to Take a Haircut Through Debt-Equity Swap?,2017-06-28 20:50:44 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-lenders-205044935.html?.tsrc=rss,"On June 20, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) presented at the Goldman Sachs Second Annual Leveraged Finance Conference. During the Q&A session, CFO Paul Herendeen stated, ""I've been seeing some flack about this in the investment community, it's like we've said, equity and equity-linked type securities are on the table.  Since that statement Valeant shares rose nearly 30%, sending Bill Ackman scrambling.  Wells Fargo analyst David Maris, one of Valeant's biggest bears, commented, ""Based on our experience and feedback from our high yield debt analyst, we think that most debt holders do not have the ability or interest to take cross-structure risk."
VRX,VRX:US,BBG000DLFM21,Will Valeant’s Lenders Have to Take a Haircut Through Debt-Equity Swap?,2017-06-28 20:50:44 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-lenders-205044935.html?.tsrc=rss,"On June 20, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) presented at the Goldman Sachs Second Annual Leveraged Finance Conference. During the Q&A session, CFO Paul Herendeen stated, ""I've been seeing some flack about this in the investment community, it's like we've said, equity and equity-linked type securities are on the table.  Since that statement Valeant shares rose nearly 30%, sending Bill Ackman scrambling.  Wells Fargo analyst David Maris, one of Valeant's biggest bears, commented, ""Based on our experience and feedback from our high yield debt analyst, we think that most debt holders do not have the ability or interest to take cross-structure risk."
VRX,VRX:CT,BBG000DC8S17,Paulson Dives Deeper Into Valeant With Increased Holding,2017-06-28 19:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-XmGbYEuIPc/paulson-dives-deeper-into-valeant-with-increased-holding-cm809598,Investors like Bill Ackman Trades Portfolio have lost fortunes on a pharmaceutical company called Valeant VRX Now that some of the murkiness surrounding the company has begun to clear slightly John Paulson Trades Portfolio is hoping to make one disclosing Monday that he
VRX,VRX:US,BBG000DLFM21,Paulson Dives Deeper Into Valeant With Increased Holding,2017-06-28 19:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-XmGbYEuIPc/paulson-dives-deeper-into-valeant-with-increased-holding-cm809598,Investors like Bill Ackman Trades Portfolio have lost fortunes on a pharmaceutical company called Valeant VRX Now that some of the murkiness surrounding the company has begun to clear slightly John Paulson Trades Portfolio is hoping to make one disclosing Monday that he
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Pared Their Early Gains - Canadian Commentary,2017-06-28 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HzbctMC4qgE/canadian-stocks-have-pared-their-early-gains--canadian-commentary-20170628-00745,Canadian Stocks Have Pared Their Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Pared Their Early Gains - Canadian Commentary,2017-06-28 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HzbctMC4qgE/canadian-stocks-have-pared-their-early-gains--canadian-commentary-20170628-00745,Canadian Stocks Have Pared Their Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Most Exposed With FDA Generics Push,2017-06-28 09:47:00 +0000,http://finance.yahoo.com/r/b070ecf2-04d0-35e3-ae83-5ce26af661e8/valeant-most-exposed-fda-generics-push?partner=YahooSA&yptr=yahoo&.tsrc=rss,Valeant might be the biggest victim of the FDA’s bid to lower drug prices by boosting generic competition.
VRX,VRX:CT,BBG000DC8S17,Valeant Most Exposed With FDA Generics Push,2017-06-28 09:47:00 +0000,http://finance.yahoo.com/r/b070ecf2-04d0-35e3-ae83-5ce26af661e8/valeant-most-exposed-fda-generics-push?partner=YahooSA&yptr=yahoo&.tsrc=rss,Valeant might be the biggest victim of the FDA’s bid to lower drug prices by boosting generic competition.
VRX,VRX:CT,BBG000DC8S17,Is a Sprint Corp (S) and T-Mobile US Inc (TMUS) Merger Off the Table?,2017-06-27 20:50:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q-dQM91Xs7E/is-a-sprint-corp-s-and-t-mobile-us-inc-tmus-merger-off-the-table-cm809081,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Sprint Corp NYSE S rallied Tuesday on news of a wireless deal However it wasn t with the company you may think 160 T Mobile US Inc NASDAQ TMUS Instead Sprint stock was climbing after
VRX,VRX:US,BBG000DLFM21,Is a Sprint Corp (S) and T-Mobile US Inc (TMUS) Merger Off the Table?,2017-06-27 20:50:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q-dQM91Xs7E/is-a-sprint-corp-s-and-t-mobile-us-inc-tmus-merger-off-the-table-cm809081,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Sprint Corp NYSE S rallied Tuesday on news of a wireless deal However it wasn t with the company you may think 160 T Mobile US Inc NASDAQ TMUS Instead Sprint stock was climbing after
VRX,VRX:US,BBG000DLFM21,Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock Even After This Rip,2017-06-27 18:50:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zvmhQIgfEq8/go-long-valeant-pharmaceuticals-intl-inc-vrx-stock-even-after-this-rip-cm809012,InvestorPlace Stock Market News Stock Advice amp Trading Tips In my previous write ups I ve referred to my Valeant Pharmaceuticals Intl Inc NYSE VRX trades as bets It s not because I am a fan of gambling but it s because of how the stock trades The price action resembles
VRX,VRX:CT,BBG000DC8S17,Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock Even After This Rip,2017-06-27 18:50:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zvmhQIgfEq8/go-long-valeant-pharmaceuticals-intl-inc-vrx-stock-even-after-this-rip-cm809012,InvestorPlace Stock Market News Stock Advice amp Trading Tips In my previous write ups I ve referred to my Valeant Pharmaceuticals Intl Inc NYSE VRX trades as bets It s not because I am a fan of gambling but it s because of how the stock trades The price action resembles
VRX,VRX:CT,BBG000DC8S17,"Valeant: Out of the Frying Pan, Into the Fire",2017-06-27 18:02:00 +0000,http://finance.yahoo.com/r/f21aaf46-59a6-384d-9213-77b33b3d2a43/valeant-out-of-the-frying-pan-into-the-fire-1498586566?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) spiked yesterday on speculation regarding a possible debt-to-equity swap by the troubled drug maker.  Wells Fargo analyst David Maris weighed in on the notion today, arguing that even if a swap does happen, it does not repair poor business trends or the increasingly unlikelihood that Valeant can deliver the strong earnings growth promised by consensus forecasts.  As Maris writes: Based on our experience and feedback from our high yield debt analyst, we think that most debt holders do not have the ability or interest to take cross structure risk."
VRX,VRX:US,BBG000DLFM21,"Valeant: Out of the Frying Pan, Into the Fire",2017-06-27 18:02:00 +0000,http://finance.yahoo.com/r/f21aaf46-59a6-384d-9213-77b33b3d2a43/valeant-out-of-the-frying-pan-into-the-fire-1498586566?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) spiked yesterday on speculation regarding a possible debt-to-equity swap by the troubled drug maker.  Wells Fargo analyst David Maris weighed in on the notion today, arguing that even if a swap does happen, it does not repair poor business trends or the increasingly unlikelihood that Valeant can deliver the strong earnings growth promised by consensus forecasts.  As Maris writes: Based on our experience and feedback from our high yield debt analyst, we think that most debt holders do not have the ability or interest to take cross structure risk."
VRX,VRX:CT,BBG000DC8S17,Trade Best Buy Co Inc (BBY) Stock to Double Your Dough!,2017-06-27 16:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CHiupve09sM/trade-best-buy-co-inc-bby-stock-to-double-your-dough-cm808935,InvestorPlace Stock Market News Stock Advice amp Trading Tips A survey of Monday s sector performance reveals retail stocks were on the move Indeed the SPDR Retail ETF NYSEARCA XRT popped just shy of 2 while the broader market dithered That friends is some
VRX,VRX:US,BBG000DLFM21,Trade Best Buy Co Inc (BBY) Stock to Double Your Dough!,2017-06-27 16:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CHiupve09sM/trade-best-buy-co-inc-bby-stock-to-double-your-dough-cm808935,InvestorPlace Stock Market News Stock Advice amp Trading Tips A survey of Monday s sector performance reveals retail stocks were on the move Indeed the SPDR Retail ETF NYSEARCA XRT popped just shy of 2 while the broader market dithered That friends is some
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals International Reaches Analyst Target Price,2017-06-27 14:49:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BW99YGzGPV0/valeant-pharmaceuticals-international-reaches-analyst-target-price-cm808710,In recent trading shares of Valeant Pharmaceuticals International Inc Symbol VRX have crossed above the average analyst 12 month target price of 15 91 changing hands for 17 08 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals International Reaches Analyst Target Price,2017-06-27 14:49:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BW99YGzGPV0/valeant-pharmaceuticals-international-reaches-analyst-target-price-cm808710,In recent trading shares of Valeant Pharmaceuticals International Inc Symbol VRX have crossed above the average analyst 12 month target price of 15 91 changing hands for 17 08 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade
VRX,VRX:CT,BBG000DC8S17,Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock Even After This Rip,2017-06-27 14:27:16 +0000,https://finance.yahoo.com/news/long-valeant-pharmaceuticals-intl-inc-142716158.html?.tsrc=rss,"In my previous write-ups, I’ve referred to my Valeant Pharmaceuticals Intl Inc (NYSE:VRX) trades as bets.  It’s not because I am a fan of gambling but it’s because of how the stock trades.  VRX stock fits the bill."
VRX,VRX:US,BBG000DLFM21,Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock Even After This Rip,2017-06-27 14:27:16 +0000,https://finance.yahoo.com/news/long-valeant-pharmaceuticals-intl-inc-142716158.html?.tsrc=rss,"In my previous write-ups, I’ve referred to my Valeant Pharmaceuticals Intl Inc (NYSE:VRX) trades as bets.  It’s not because I am a fan of gambling but it’s because of how the stock trades.  VRX stock fits the bill."
VRX,VRX:CT,BBG000DC8S17,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-06-27 13:53:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EmVzMEc51eQ/are-options-traders-betting-on-a-big-move-in-valeant-pharmaceuticals-vrx-stock-cm808754,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the July 21 st 2017 5 00 Put had some of the highest implied volatility of all equity options today What is
VRX,VRX:US,BBG000DLFM21,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-06-27 13:53:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EmVzMEc51eQ/are-options-traders-betting-on-a-big-move-in-valeant-pharmaceuticals-vrx-stock-cm808754,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the July 21 st 2017 5 00 Put had some of the highest implied volatility of all equity options today What is
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's Big Triumph Becomes His Big Problem,2017-06-27 13:51:44 +0000,http://finance.yahoo.com/r/226aaabc-8f7e-3179-b051-79558c80f759/bill-ackman-s-big-triumph-becomes-his-big-problem?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,One of the activist investor's greatest deals is under legal attack. There's no easy way out.
VRX,VRX:US,BBG000DLFM21,Bill Ackman's Big Triumph Becomes His Big Problem,2017-06-27 13:51:44 +0000,http://finance.yahoo.com/r/226aaabc-8f7e-3179-b051-79558c80f759/bill-ackman-s-big-triumph-becomes-his-big-problem?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,One of the activist investor's greatest deals is under legal attack. There's no easy way out.
VRX,VRX:CT,BBG000DC8S17,Paulson Ups Valeant Stake; Activist Investor Targets Nestle -- ICYMI Monday,2017-06-27 13:49:00 +0000,http://finance.yahoo.com/r/7f315b6a-f80d-3b38-84cf-8e5c2dea901e/activist-investor-targets-nestle-dow-breaks-losing-streak-icymi-monday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's what you need to know now.
VRX,VRX:US,BBG000DLFM21,Paulson Ups Valeant Stake; Activist Investor Targets Nestle -- ICYMI Monday,2017-06-27 13:49:00 +0000,http://finance.yahoo.com/r/7f315b6a-f80d-3b38-84cf-8e5c2dea901e/activist-investor-targets-nestle-dow-breaks-losing-streak-icymi-monday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's what you need to know now.
VRX,VRX:CT,BBG000DC8S17,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-06-27 12:33:12 +0000,https://finance.yahoo.com/news/options-traders-betting-big-move-123312443.html?.tsrc=rss,Investors need to pay close attention to Valeant Pharmaceuticals (VRX) stock based on the movements in the options market lately.
VRX,VRX:US,BBG000DLFM21,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-06-27 12:33:12 +0000,https://finance.yahoo.com/news/options-traders-betting-big-move-123312443.html?.tsrc=rss,Investors need to pay close attention to Valeant Pharmaceuticals (VRX) stock based on the movements in the options market lately.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Flat Despite Rising Commodity Prices - Canadian Commentary,2017-06-27 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n0RG8Ry-UJg/canadian-stocks-are-flat-despite-rising-commodity-prices--canadian-commentary-20170627-00829,Canadian Stocks Are Flat Despite Rising Commodity Prices - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Flat Despite Rising Commodity Prices - Canadian Commentary,2017-06-27 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n0RG8Ry-UJg/canadian-stocks-are-flat-despite-rising-commodity-prices--canadian-commentary-20170627-00829,Canadian Stocks Are Flat Despite Rising Commodity Prices - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers,2017-06-27 01:32:00 +0000,http://finance.yahoo.com/r/9925331a-89a8-351e-9199-96b62c122441/biotech-movers-seattle-genetics-fibrogen-sangamo.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Seattle Genetics, FibroGen and Sangamo were among the biotech stock movers in premarket trading on June 26."
VRX,VRX:CT,BBG000DC8S17,Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers,2017-06-27 01:32:00 +0000,http://finance.yahoo.com/r/9925331a-89a8-351e-9199-96b62c122441/biotech-movers-seattle-genetics-fibrogen-sangamo.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Seattle Genetics, FibroGen and Sangamo were among the biotech stock movers in premarket trading on June 26."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Could Have 30% Upside,2017-06-27 00:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/41IU1taxLfU/valeant-pharmaceuticals-intl-inc-vrx-stock-could-have-30-upside-cm808413,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of beleaguered drug maker Valeant Pharmaceuticals Intl Inc NYSE VRX are on the mend popping roughly 8 on Monday to test 160 above their 50 week moving average for the first time since summer 2015 This
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Could Have 30% Upside,2017-06-27 00:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/41IU1taxLfU/valeant-pharmaceuticals-intl-inc-vrx-stock-could-have-30-upside-cm808413,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of beleaguered drug maker Valeant Pharmaceuticals Intl Inc NYSE VRX are on the mend popping roughly 8 on Monday to test 160 above their 50 week moving average for the first time since summer 2015 This
VRX,VRX:US,BBG000DLFM21,"Advanced Micro Devices, Inc. (AMD) Stock Is Spunky and Resilient, But …",2017-06-27 00:49:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_M_y9Uw0G9k/advanced-micro-devices-inc-amd-stock-is-spunky-and-resilient-but-cm808412,InvestorPlace Stock Market News Stock Advice amp Trading Tips My most recent analyses of 160 Advanced Micro Devices Inc 160 NASDAQ AMD were less than enthusiastic about AMD stock Source Shutterstock What with the semiconductor company bringing out a lot of
VRX,VRX:CT,BBG000DC8S17,"Advanced Micro Devices, Inc. (AMD) Stock Is Spunky and Resilient, But …",2017-06-27 00:49:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_M_y9Uw0G9k/advanced-micro-devices-inc-amd-stock-is-spunky-and-resilient-but-cm808412,InvestorPlace Stock Market News Stock Advice amp Trading Tips My most recent analyses of 160 Advanced Micro Devices Inc 160 NASDAQ AMD were less than enthusiastic about AMD stock Source Shutterstock What with the semiconductor company bringing out a lot of
VRX,VRX:CT,BBG000DC8S17,"Why Rite Aid, Valeant Pharmaceuticals, and Hertz Global Holdings Jumped Today",2017-06-26 21:50:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZtoguFT6smw/why-rite-aid-valeant-pharmaceuticals-and-hertz-global-holdings-jumped-today-cm808357,The stock market continued its string of mild moves on Monday with major benchmarks closing mixed and little changed from where they ended last week The trading session featured another rotation out of technology stocks as sectors like utilities that are typically seen as defensive
VRX,VRX:US,BBG000DLFM21,"Why Rite Aid, Valeant Pharmaceuticals, and Hertz Global Holdings Jumped Today",2017-06-26 21:50:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZtoguFT6smw/why-rite-aid-valeant-pharmaceuticals-and-hertz-global-holdings-jumped-today-cm808357,The stock market continued its string of mild moves on Monday with major benchmarks closing mixed and little changed from where they ended last week The trading session featured another rotation out of technology stocks as sectors like utilities that are typically seen as defensive
VRX,VRX:US,BBG000DLFM21,Valeant: Paulson & Co. Puts (a Bit More) Money Where its Mouth is,2017-06-26 21:28:00 +0000,http://finance.yahoo.com/r/4bfefce9-e8cc-3086-835f-4f9628e830ea/valeant-paulson-co-puts-a-bit-more-money-where-its-mouth-is-1498512513?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Paulson & Co. increased into stake in Valeant Pharmaceuticals International (VRX) to 6.3% excluding cash-settled swaps from 5.6%, according to a filing submitted to the Securities & Exchange Commission after ..."
VRX,VRX:CT,BBG000DC8S17,Valeant: Paulson & Co. Puts (a Bit More) Money Where its Mouth is,2017-06-26 21:28:00 +0000,http://finance.yahoo.com/r/4bfefce9-e8cc-3086-835f-4f9628e830ea/valeant-paulson-co-puts-a-bit-more-money-where-its-mouth-is-1498512513?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Paulson & Co. increased into stake in Valeant Pharmaceuticals International (VRX) to 6.3% excluding cash-settled swaps from 5.6%, according to a filing submitted to the Securities & Exchange Commission after ..."
VRX,VRX:US,BBG000DLFM21,Hedge fund Paulson & Co discloses 6.3 percent stake in Valeant,2017-06-26 21:27:47 +0000,https://finance.yahoo.com/news/hedgefund-paulson-co-declares-6-205316014.html?.tsrc=rss,New York-based hedge fund Paulson & Co on Monday reported a 6.3 percent stake in embattled Canadian drugmaker Valeant Pharmaceuticals International Inc . The disclosure comes a week after billionaire investor ...
VRX,VRX:CT,BBG000DC8S17,Hedge fund Paulson & Co discloses 6.3 percent stake in Valeant,2017-06-26 21:27:47 +0000,https://finance.yahoo.com/news/hedgefund-paulson-co-declares-6-205316014.html?.tsrc=rss,New York-based hedge fund Paulson & Co on Monday reported a 6.3 percent stake in embattled Canadian drugmaker Valeant Pharmaceuticals International Inc . The disclosure comes a week after billionaire investor ...
VRX,VRX:CT,BBG000DC8S17,Paulson Boosts His Stake in Valeant Pharmaceuticals to 6.3%,2017-06-26 20:55:58 +0000,http://finance.yahoo.com/r/3b59b1e5-3a66-35ea-9279-ef58a1fbf85c/john-paulson-boosts-his-stake-in-valeant-pharmaceuticals-to-6-3?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Billionaire John Paulson, the largest shareholder in Valeant Pharmaceuticals International Inc., increased his stake in the drugmaker to 6.3 percent, from 5.7 percent at the end of March."
VRX,VRX:US,BBG000DLFM21,Paulson Boosts His Stake in Valeant Pharmaceuticals to 6.3%,2017-06-26 20:55:58 +0000,http://finance.yahoo.com/r/3b59b1e5-3a66-35ea-9279-ef58a1fbf85c/john-paulson-boosts-his-stake-in-valeant-pharmaceuticals-to-6-3?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Billionaire John Paulson, the largest shareholder in Valeant Pharmaceuticals International Inc., increased his stake in the drugmaker to 6.3 percent, from 5.7 percent at the end of March."
VRX,VRX:US,BBG000DLFM21,Biden tells Ackman ‘never disrespect’ memory of his dead son,2017-06-26 20:38:20 +0000,http://finance.yahoo.com/r/3541da22-fd93-31f2-86c9-668ef8ad85e3/Story.aspx?guid=EC0B97A4-58DF-11E7-A14A-01B0C0F64320&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The hedge-fund manager, who runs Pershing Square and boasts a net worth of $1.4 billion, reportedly locked horns with former Vice President Joe Biden at a dinner in Las Vegas."
VRX,VRX:CT,BBG000DC8S17,Biden tells Ackman ‘never disrespect’ memory of his dead son,2017-06-26 20:38:20 +0000,http://finance.yahoo.com/r/3541da22-fd93-31f2-86c9-668ef8ad85e3/Story.aspx?guid=EC0B97A4-58DF-11E7-A14A-01B0C0F64320&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The hedge-fund manager, who runs Pershing Square and boasts a net worth of $1.4 billion, reportedly locked horns with former Vice President Joe Biden at a dinner in Las Vegas."
VRX,VRX:CT,BBG000DC8S17,"Why Rite Aid, Valeant Pharmaceuticals, and Hertz Global Holdings Jumped Today",2017-06-26 20:31:00 +0000,http://finance.yahoo.com/r/d9868805-c342-34df-952d-b37f49866d54/why-rite-aid-valeant-pharmaceuticals-and-hertz-glo.aspx?yptr=yahoo&.tsrc=rss,"On a quiet day for the market, these stocks climbed. Find out why."
VRX,VRX:US,BBG000DLFM21,"Why Rite Aid, Valeant Pharmaceuticals, and Hertz Global Holdings Jumped Today",2017-06-26 20:31:00 +0000,http://finance.yahoo.com/r/d9868805-c342-34df-952d-b37f49866d54/why-rite-aid-valeant-pharmaceuticals-and-hertz-glo.aspx?yptr=yahoo&.tsrc=rss,"On a quiet day for the market, these stocks climbed. Find out why."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Could Have 30% Upside,2017-06-26 20:24:54 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-202454057.html?.tsrc=rss,"Shares of beleaguered drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are on the mend, popping roughly 8% on Monday to test above their 50-week moving average for the first time since summer 2015.  This is one of a few good signs for VRX stock, which could have as much as 30% upside in the weeks ahead."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Could Have 30% Upside,2017-06-26 20:24:54 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-202454057.html?.tsrc=rss,"Shares of beleaguered drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are on the mend, popping roughly 8% on Monday to test above their 50-week moving average for the first time since summer 2015.  This is one of a few good signs for VRX stock, which could have as much as 30% upside in the weeks ahead."
VRX,VRX:CT,BBG000DC8S17,3 Cheap Healthcare Stocks You Can Buy Right Now,2017-06-26 18:51:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wotDP_DYUCo/3-cheap-healthcare-stocks-you-can-buy-right-now-cm808267,Healthcare stocks are in the the midst of a historic run fueled by wider access to medical services around the globe and a surge in new drug approvals over the past few years in the United States Consequently there aren t a whole lot of healthcare stocks that qualify as cheap
VRX,VRX:US,BBG000DLFM21,3 Cheap Healthcare Stocks You Can Buy Right Now,2017-06-26 18:51:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wotDP_DYUCo/3-cheap-healthcare-stocks-you-can-buy-right-now-cm808267,Healthcare stocks are in the the midst of a historic run fueled by wider access to medical services around the globe and a surge in new drug approvals over the past few years in the United States Consequently there aren t a whole lot of healthcare stocks that qualify as cheap
VRX,VRX:US,BBG000DLFM21,Valeant Pharma: A Debt Swap?,2017-06-26 18:17:00 +0000,http://finance.yahoo.com/r/776a7947-bc63-3e80-9dcb-7c540131cbc6/valeant-pharma-a-debt-swap-1498501031?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Why are shares of Valeant Pharmaceuticals International (VRX) rising and does the market have it right?  According to Evercore ISI analyst Umer Raffat, anytime the market receives a signal of some sort that the embattled drug maker has value beyond its pile of debt, the stock price rises and short sellers cover their positions.  Today, a 7.8% spike in Valeant’s share price is linked to speculation that a debt-to-equity swap could be on the horizon, Raffat says."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma: A Debt Swap?,2017-06-26 18:17:00 +0000,http://finance.yahoo.com/r/776a7947-bc63-3e80-9dcb-7c540131cbc6/valeant-pharma-a-debt-swap-1498501031?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Why are shares of Valeant Pharmaceuticals International (VRX) rising and does the market have it right?  According to Evercore ISI analyst Umer Raffat, anytime the market receives a signal of some sort that the embattled drug maker has value beyond its pile of debt, the stock price rises and short sellers cover their positions.  Today, a 7.8% spike in Valeant’s share price is linked to speculation that a debt-to-equity swap could be on the horizon, Raffat says."
VRX,VRX:US,BBG000DLFM21,3 Cheap Healthcare Stocks You Can Buy Right Now,2017-06-26 17:08:00 +0000,http://finance.yahoo.com/r/b089c862-88b0-3407-992d-881142e87ce3/3-cheap-healthcare-stocks-you-can-buy-right-now.aspx?yptr=yahoo&.tsrc=rss,"Amarin, Horizon Pharma, and Valeant Pharmaceuticals may be downright bargains right now. Here&apos;s why."
VRX,VRX:CT,BBG000DC8S17,3 Cheap Healthcare Stocks You Can Buy Right Now,2017-06-26 17:08:00 +0000,http://finance.yahoo.com/r/b089c862-88b0-3407-992d-881142e87ce3/3-cheap-healthcare-stocks-you-can-buy-right-now.aspx?yptr=yahoo&.tsrc=rss,"Amarin, Horizon Pharma, and Valeant Pharmaceuticals may be downright bargains right now. Here&apos;s why."
VRX,VRX:US,BBG000DLFM21,Billionaire Ackman Could Win Big on Blackstone's Platform Buy,2017-06-26 15:29:00 +0000,http://finance.yahoo.com/r/0bdf7d65-71a0-3d6d-9ac7-00ded0c0bc57/billionaire-ackman-could-win-big-blackstones-platform-buy-vrx-pah?partner=YahooSA&yptr=yahoo&.tsrc=rss,Bill Ackman may reap the benefits if Blackstone Group buys half of Platform Specialty Products.
VRX,VRX:CT,BBG000DC8S17,Billionaire Ackman Could Win Big on Blackstone's Platform Buy,2017-06-26 15:29:00 +0000,http://finance.yahoo.com/r/0bdf7d65-71a0-3d6d-9ac7-00ded0c0bc57/billionaire-ackman-could-win-big-blackstones-platform-buy-vrx-pah?partner=YahooSA&yptr=yahoo&.tsrc=rss,Bill Ackman may reap the benefits if Blackstone Group buys half of Platform Specialty Products.
VRX,VRX:CT,BBG000DC8S17,CANADA STOCKS-TSX down as softer commodity prices weigh on resource shares,2017-06-26 15:02:45 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-down-softer-150245362.html?.tsrc=rss,Canada's main stock index fell on Monday as declines in heavyweight sectors such as energy and materials outweighed moderate gains in a number of other groups. Gold miners were the most influential decliners ...
VRX,VRX:US,BBG000DLFM21,CANADA STOCKS-TSX down as softer commodity prices weigh on resource shares,2017-06-26 15:02:45 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-down-softer-150245362.html?.tsrc=rss,Canada's main stock index fell on Monday as declines in heavyweight sectors such as energy and materials outweighed moderate gains in a number of other groups. Gold miners were the most influential decliners ...
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jun 26, 2017 :  AZN, VRX, MU, SGEN, P, QQQ, BAC, USLV, FB, CB, AAPL, TSM",2017-06-26 12:59:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/90T4d9KLvdg/pre-market-most-active-for-jun-26-2017-azn-vrx-mu-sgen-p-qqq-bac-uslv-fb-cb-aapl-tsm-cm807949,The NASDAQ 100 Pre Market Indicator is up 21 37 to 5 824 48 The total Pre Market volume is currently 3 636 063 shares traded The following are the most active stocks for the pre market session Astrazeneca PLC AZN is 0 36 at 35 43 with 451 394 shares traded AZN
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jun 26, 2017 :  AZN, VRX, MU, SGEN, P, QQQ, BAC, USLV, FB, CB, AAPL, TSM",2017-06-26 12:59:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/90T4d9KLvdg/pre-market-most-active-for-jun-26-2017-azn-vrx-mu-sgen-p-qqq-bac-uslv-fb-cb-aapl-tsm-cm807949,The NASDAQ 100 Pre Market Indicator is up 21 37 to 5 824 48 The total Pre Market volume is currently 3 636 063 shares traded The following are the most active stocks for the pre market session Astrazeneca PLC AZN is 0 36 at 35 43 with 451 394 shares traded AZN
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling As Commodities Weaken - Canadian Commentary,2017-06-26 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p5earn0B7zk/canadian-stocks-are-struggling-as-commodities-weaken--canadian-commentary-20170626-00749,Canadian Stocks Are Struggling As Commodities Weaken - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling As Commodities Weaken - Canadian Commentary,2017-06-26 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p5earn0B7zk/canadian-stocks-are-struggling-as-commodities-weaken--canadian-commentary-20170626-00749,Canadian Stocks Are Struggling As Commodities Weaken - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Paulson Times Appointment to Valeant's Board Perfectly,2017-06-23 21:50:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oOh9l97myiM/paulson-times-appointment-to-valeants-board-perfectly-cm807659,Valeant Pharmaceuticals NYSE VRX 160 shares soared this week after hedge fund manager John Paulson joined its board and reports emerged out of Washington D C suggesting that President Donald Trump may embrace industry friendly drug price reforms A helping hand
VRX,VRX:CT,BBG000DC8S17,Paulson Times Appointment to Valeant's Board Perfectly,2017-06-23 21:50:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oOh9l97myiM/paulson-times-appointment-to-valeants-board-perfectly-cm807659,Valeant Pharmaceuticals NYSE VRX 160 shares soared this week after hedge fund manager John Paulson joined its board and reports emerged out of Washington D C suggesting that President Donald Trump may embrace industry friendly drug price reforms A helping hand
VRX,VRX:CT,BBG000DC8S17,Paulson Times Appointment to Valeant&apos;s Board Perfectly,2017-06-23 20:02:00 +0000,http://finance.yahoo.com/r/14291ea7-b3a8-3dd2-8f23-73037e222230/top-hedge-fund-manager-times-his-appointment-to-va.aspx?yptr=yahoo&.tsrc=rss,"John Paulson joined Valeant Pharmaceuticals board this week just as news reports broke suggesting drug price reforms coming out of Washington, D.C. will be friendlier than feared."
VRX,VRX:US,BBG000DLFM21,Paulson Times Appointment to Valeant&apos;s Board Perfectly,2017-06-23 20:02:00 +0000,http://finance.yahoo.com/r/14291ea7-b3a8-3dd2-8f23-73037e222230/top-hedge-fund-manager-times-his-appointment-to-va.aspx?yptr=yahoo&.tsrc=rss,"John Paulson joined Valeant Pharmaceuticals board this week just as news reports broke suggesting drug price reforms coming out of Washington, D.C. will be friendlier than feared."
VRX,VRX:US,BBG000DLFM21,Embrace United States Steel Corporation (X) Stock as It Heats Up,2017-06-23 19:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yenLc_ot4Bc/embrace-united-states-steel-corporation-x-stock-as-it-heats-up-cm807630,InvestorPlace Stock Market News Stock Advice amp Trading Tips Steel stocks are percolating on Friday morning and it s about time United States Steel Corporation NYSE X and AK Steel Holding Corporation NYSE AKS have had a terrible year thus far and were in
VRX,VRX:CT,BBG000DC8S17,Embrace United States Steel Corporation (X) Stock as It Heats Up,2017-06-23 19:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yenLc_ot4Bc/embrace-united-states-steel-corporation-x-stock-as-it-heats-up-cm807630,InvestorPlace Stock Market News Stock Advice amp Trading Tips Steel stocks are percolating on Friday morning and it s about time United States Steel Corporation NYSE X and AK Steel Holding Corporation NYSE AKS have had a terrible year thus far and were in
VRX,VRX:CT,BBG000DC8S17,"Friday’s Vital Data: Advanced Micro Devices, Inc. (AMD), Valeant Pharmaceuticals Intl Inc (VRX) and BlackBerry Ltd (BBRY)",2017-06-23 17:53:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AP_yvwJHRh4/fridays-vital-data-advanced-micro-devices-inc-amd-valeant-pharmaceuticals-intl-inc-vrx-and-blackberry-ltd-bbry-cm807573,InvestorPlace Stock Market News Stock Advice amp Trading Tips Despite a string of setbacks this week the Dow Jones Industrial Average is still on track to post gains for the fifth straight week Oil remains a concern with futures contracts hitting their lowest prices
VRX,VRX:US,BBG000DLFM21,"Friday’s Vital Data: Advanced Micro Devices, Inc. (AMD), Valeant Pharmaceuticals Intl Inc (VRX) and BlackBerry Ltd (BBRY)",2017-06-23 17:53:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AP_yvwJHRh4/fridays-vital-data-advanced-micro-devices-inc-amd-valeant-pharmaceuticals-intl-inc-vrx-and-blackberry-ltd-bbry-cm807573,InvestorPlace Stock Market News Stock Advice amp Trading Tips Despite a string of setbacks this week the Dow Jones Industrial Average is still on track to post gains for the fifth straight week Oil remains a concern with futures contracts hitting their lowest prices
VRX,VRX:CT,BBG000DC8S17,Nvidia Corporation (NVDA) Stock Is Too Hot. Buy This Instead.,2017-06-23 15:54:30 +0000,https://finance.yahoo.com/news/nvidia-corporation-nvda-stock-too-155430765.html?.tsrc=rss,"NVDA stock is up 42% year-to-date and 224% over the past year.  Under CEO Jensen Huang, who has been at the helm since founding the company in 1993, Nvidia has become the leader in graphics chips.  Now the firm is in the race to develop chips specialized for artificial intelligence (AI), which will be needed in next-generation technologies such as self-driving cars."
VRX,VRX:US,BBG000DLFM21,Nvidia Corporation (NVDA) Stock Is Too Hot. Buy This Instead.,2017-06-23 15:54:30 +0000,https://finance.yahoo.com/news/nvidia-corporation-nvda-stock-too-155430765.html?.tsrc=rss,"NVDA stock is up 42% year-to-date and 224% over the past year.  Under CEO Jensen Huang, who has been at the helm since founding the company in 1993, Nvidia has become the leader in graphics chips.  Now the firm is in the race to develop chips specialized for artificial intelligence (AI), which will be needed in next-generation technologies such as self-driving cars."
VRX,VRX:CT,BBG000DC8S17,What Bill Miller Thinks about Valeant Now,2017-06-23 13:06:56 +0000,http://finance.yahoo.com/r/4e9cb8f8-4fd4-3f87-abf9-0811abfdb475/bill-miller-valeant-pharma-stock-go-60-3-5-years?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"About a year ago, legendary investor Bill Miller said at the Delivering Alpha Conference in September 2016 that he liked Valeant Pharmaceuticals (VRX)."
VRX,VRX:US,BBG000DLFM21,What Bill Miller Thinks about Valeant Now,2017-06-23 13:06:56 +0000,http://finance.yahoo.com/r/4e9cb8f8-4fd4-3f87-abf9-0811abfdb475/bill-miller-valeant-pharma-stock-go-60-3-5-years?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"About a year ago, legendary investor Bill Miller said at the Delivering Alpha Conference in September 2016 that he liked Valeant Pharmaceuticals (VRX)."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising Along With Commodity Prices - Canadian Commentary,2017-06-23 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m4QhEUUFwUk/canadian-stocks-are-rising-along-with-commodity-prices--canadian-commentary-20170623-00491,Canadian Stocks Are Rising Along With Commodity Prices - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising Along With Commodity Prices - Canadian Commentary,2017-06-23 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m4QhEUUFwUk/canadian-stocks-are-rising-along-with-commodity-prices--canadian-commentary-20170623-00491,Canadian Stocks Are Rising Along With Commodity Prices - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Advanced Micro Devices, Inc. (AMD) Stock Is a Buy, More Than Ever!",2017-06-22 22:21:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Arc6fGAp5pE/advanced-micro-devices-inc-amd-stock-is-a-buy-more-than-ever-cm807184,InvestorPlace Stock Market News Stock Advice amp Trading Tips If you ve been waiting for confirmation to pick up Advanced Micro Devices Inc NASDAQ AMD there s growing evidence on and off the price chart that the time is now And if you re interested in improving
VRX,VRX:US,BBG000DLFM21,"Advanced Micro Devices, Inc. (AMD) Stock Is a Buy, More Than Ever!",2017-06-22 22:21:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Arc6fGAp5pE/advanced-micro-devices-inc-amd-stock-is-a-buy-more-than-ever-cm807184,InvestorPlace Stock Market News Stock Advice amp Trading Tips If you ve been waiting for confirmation to pick up Advanced Micro Devices Inc NASDAQ AMD there s growing evidence on and off the price chart that the time is now And if you re interested in improving
VRX,VRX:US,BBG000DLFM21,"Why Barnes & Noble, SunPower, and Valeant Pharmaceuticals Jumped Today",2017-06-22 22:21:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fcbNmmbfDzg/why-barnes-noble-sunpower-and-valeant-pharmaceuticals-jumped-today-cm807162,The stock market didn t see big movements on Thursday as major benchmarks finished close to where they began the day Investors paid close attention to news from Washington where a draft release of the Senate version of the Trumpcare bill was made available A halt to the slide in
VRX,VRX:CT,BBG000DC8S17,"Why Barnes & Noble, SunPower, and Valeant Pharmaceuticals Jumped Today",2017-06-22 22:21:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fcbNmmbfDzg/why-barnes-noble-sunpower-and-valeant-pharmaceuticals-jumped-today-cm807162,The stock market didn t see big movements on Thursday as major benchmarks finished close to where they began the day Investors paid close attention to news from Washington where a draft release of the Senate version of the Trumpcare bill was made available A halt to the slide in
VRX,VRX:US,BBG000DLFM21,Dicks Sporting Goods Inc (DKS) Stock Could Be Amazon’s (AMZN) Next Target,2017-06-22 21:21:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZCZY5Vkd2QM/dicks-sporting-goods-inc-dks-stock-could-be-amazons-amzn-next-target-cm807172,InvestorPlace Stock Market News Stock Advice amp Trading Tips Sports retailers have had a tough week As if Amazon com Inc NASDAQ AMZN launching Prime Wardrobe on Tuesday wasn t enough rumors swirled Wednesday morning that 160 Nike Inc NYSE NKE was going to
VRX,VRX:CT,BBG000DC8S17,Dicks Sporting Goods Inc (DKS) Stock Could Be Amazon’s (AMZN) Next Target,2017-06-22 21:21:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZCZY5Vkd2QM/dicks-sporting-goods-inc-dks-stock-could-be-amazons-amzn-next-target-cm807172,InvestorPlace Stock Market News Stock Advice amp Trading Tips Sports retailers have had a tough week As if Amazon com Inc NASDAQ AMZN launching Prime Wardrobe on Tuesday wasn t enough rumors swirled Wednesday morning that 160 Nike Inc NYSE NKE was going to
VRX,VRX:US,BBG000DLFM21,"Why Barnes & Noble, SunPower, and Valeant Pharmaceuticals Jumped Today",2017-06-22 20:40:00 +0000,http://finance.yahoo.com/r/0036c445-5c61-3cff-acef-f9ddb1463615/why-barnes-noble-sunpower-and-valeant-pharmaceutic.aspx?yptr=yahoo&.tsrc=rss,These stocks rose on a quiet day for the market. Find out why.
VRX,VRX:CT,BBG000DC8S17,"Why Barnes & Noble, SunPower, and Valeant Pharmaceuticals Jumped Today",2017-06-22 20:40:00 +0000,http://finance.yahoo.com/r/0036c445-5c61-3cff-acef-f9ddb1463615/why-barnes-noble-sunpower-and-valeant-pharmaceutic.aspx?yptr=yahoo&.tsrc=rss,These stocks rose on a quiet day for the market. Find out why.
VRX,VRX:CT,BBG000DC8S17,Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case?,2017-06-22 20:22:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sxFpcj7vpc8/does-valeant-pharmaceuticals-intl-inc-vrx-stock-have-a-bull-case-cm807139,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is one of the decade s great cautionary tales Everyone now knows the story behind VRX stock Source Wikimedia Modified The Valeant Pharmaceutical strategy was to
VRX,VRX:US,BBG000DLFM21,Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case?,2017-06-22 20:22:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sxFpcj7vpc8/does-valeant-pharmaceuticals-intl-inc-vrx-stock-have-a-bull-case-cm807139,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is one of the decade s great cautionary tales Everyone now knows the story behind VRX stock Source Wikimedia Modified The Valeant Pharmaceutical strategy was to
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 06/22/2017: VRX,TROV,KMDA",2017-06-22 19:59:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i8ho9QdVF_E/health-care-sector-update-for-06222017-vrxtrovkmda-cm807110,Top Health Care StocksTop Health Care Stocks JNJ 1 0 JNJ 1 0 PFE 1 0 PFE 1 0 ABT 1 4 ABT 1 4 MRK 1 1 MRK 1 1 AMGN 1 6 AMGN 1 6 Health care stocks were sharply higher again on Thursday with the NYSE Health Care Index NYP jumping out to a more than 1 5 advance while shares
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 06/22/2017: VRX,TROV,KMDA",2017-06-22 19:59:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i8ho9QdVF_E/health-care-sector-update-for-06222017-vrxtrovkmda-cm807110,Top Health Care StocksTop Health Care Stocks JNJ 1 0 JNJ 1 0 PFE 1 0 PFE 1 0 ABT 1 4 ABT 1 4 MRK 1 1 MRK 1 1 AMGN 1 6 AMGN 1 6 Health care stocks were sharply higher again on Thursday with the NYSE Health Care Index NYP jumping out to a more than 1 5 advance while shares
VRX,VRX:CT,BBG000DC8S17,"Thursday's ETF Movers: PJP, IAT",2017-06-22 19:20:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rRVvi07MgAo/thursdays-etf-movers-pjp-iat-cm807062,In trading on Thursday the PowerShares Dynamic Pharmaceuticals Portfolio ETF PJP is outperforming other ETFs up about 2 2 on the day Components of that ETF showing particular strength include shares of Valeant Pharmaceuticals VRX up about 12 4 and shares of Lannett LCI
VRX,VRX:US,BBG000DLFM21,"Thursday's ETF Movers: PJP, IAT",2017-06-22 19:20:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rRVvi07MgAo/thursdays-etf-movers-pjp-iat-cm807062,In trading on Thursday the PowerShares Dynamic Pharmaceuticals Portfolio ETF PJP is outperforming other ETFs up about 2 2 on the day Components of that ETF showing particular strength include shares of Valeant Pharmaceuticals VRX up about 12 4 and shares of Lannett LCI
VRX,VRX:US,BBG000DLFM21,Hospitals Rise on Senate Health Bill But Long-Term Prognosis in Question,2017-06-22 16:08:00 +0000,http://finance.yahoo.com/r/bbfe6131-80bb-38fb-87d5-ed526b2a2fb0/hospitals-rise-on-senate-health-bill-but-long-term-prognosis-in-question-1498147731?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Details of the Senate health bill have finally emerged, and judging by the markets reaction, it's clearly good news for insurers like UnitedHealth Group (UNH), pharmaceutical stocks that have historically relied on rising drug prices like Valeant Pharmaceuticals International (VRX), and even hospitals like HCA Healthcare (HCA).  Mizuho's Sheryl Skolnick explains why: Medicaid goes away, albeit a bit more slowly, starting in 2021 versus 2020, and cuts hit hardest in 7 years from now instead of 3, but the cuts will apparently be even deeper than the $800+B in the House bill.  Thoughtful investors will realize, based on our volume analysis, that the expansion of Medicaid coverage was one of the few sources of volume growth since 2013 for the industry."
VRX,VRX:CT,BBG000DC8S17,Hospitals Rise on Senate Health Bill But Long-Term Prognosis in Question,2017-06-22 16:08:00 +0000,http://finance.yahoo.com/r/bbfe6131-80bb-38fb-87d5-ed526b2a2fb0/hospitals-rise-on-senate-health-bill-but-long-term-prognosis-in-question-1498147731?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Details of the Senate health bill have finally emerged, and judging by the markets reaction, it's clearly good news for insurers like UnitedHealth Group (UNH), pharmaceutical stocks that have historically relied on rising drug prices like Valeant Pharmaceuticals International (VRX), and even hospitals like HCA Healthcare (HCA).  Mizuho's Sheryl Skolnick explains why: Medicaid goes away, albeit a bit more slowly, starting in 2021 versus 2020, and cuts hit hardest in 7 years from now instead of 3, but the cuts will apparently be even deeper than the $800+B in the House bill.  Thoughtful investors will realize, based on our volume analysis, that the expansion of Medicaid coverage was one of the few sources of volume growth since 2013 for the industry."
VRX,VRX:CT,BBG000DC8S17,Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case?,2017-06-22 15:38:26 +0000,https://finance.yahoo.com/news/does-valeant-pharmaceuticals-intl-inc-153826160.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is one of the decade’s great cautionary tales.  The Valeant Pharmaceutical strategy was to buy drug companies for their sales, ditch the research, hike the prices and move the profits to Canada, where taxes are lower."
VRX,VRX:US,BBG000DLFM21,Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case?,2017-06-22 15:38:26 +0000,https://finance.yahoo.com/news/does-valeant-pharmaceuticals-intl-inc-153826160.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is one of the decade’s great cautionary tales.  The Valeant Pharmaceutical strategy was to buy drug companies for their sales, ditch the research, hike the prices and move the profits to Canada, where taxes are lower."
VRX,VRX:US,BBG000DLFM21,InPlay from Briefing.com,2017-06-22 14:47:34 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
VRX,VRX:CT,BBG000DC8S17,InPlay from Briefing.com,2017-06-22 14:47:34 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
VRX,VRX:US,BBG000DLFM21,"Donald Trump Softens Stance on Drug Prices, Sends Biotech Stocks Soaring",2017-06-22 13:22:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z99M2wku-Ck/donald-trump-softens-stance-on-drug-prices-sends-biotech-stocks-soaring-cm806692,Donald Trump campaigned on reining in sky high drug prices and as recently as January he said the industry was getting away with murder His tough talk has been bad news for biopharma stocks However an executive order that he could soon sign is reportedly friendlier to the
VRX,VRX:CT,BBG000DC8S17,"Donald Trump Softens Stance on Drug Prices, Sends Biotech Stocks Soaring",2017-06-22 13:22:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z99M2wku-Ck/donald-trump-softens-stance-on-drug-prices-sends-biotech-stocks-soaring-cm806692,Donald Trump campaigned on reining in sky high drug prices and as recently as January he said the industry was getting away with murder His tough talk has been bad news for biopharma stocks However an executive order that he could soon sign is reportedly friendlier to the
VRX,VRX:CT,BBG000DC8S17,"Donald Trump Softens Stance on Drug Prices, Sends Biotech Stocks Soaring",2017-06-22 12:01:00 +0000,http://finance.yahoo.com/r/f06298b8-c00a-3354-8c15-f134c1efca32/donald-trump-drug-pricing-policies-better-for-biot.aspx?yptr=yahoo&.tsrc=rss,An executive order the president could soon sign includes industry-supported proposals to improve drug prices.
VRX,VRX:US,BBG000DLFM21,"Donald Trump Softens Stance on Drug Prices, Sends Biotech Stocks Soaring",2017-06-22 12:01:00 +0000,http://finance.yahoo.com/r/f06298b8-c00a-3354-8c15-f134c1efca32/donald-trump-drug-pricing-policies-better-for-biot.aspx?yptr=yahoo&.tsrc=rss,An executive order the president could soon sign includes industry-supported proposals to improve drug prices.
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International,2017-06-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-named-most-trusted-113000596.html?.tsrc=rss,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International,2017-06-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-named-most-trusted-113000475.html?.tsrc=rss,"LAVAL, Quebec, June 22, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, today announced that Bausch + Lomb contact lens solutions have been named the most trusted contact lens solution brand for the second consecutive year in Canada by BrandSpark International.  The 2017 BrandSpark Most Trusted Awards were given based on the results of a survey of more than 20,000 Canadians.  According to the results of the survey, the main reasons consumers shared that they trust Bausch + Lomb was due to the high level of performance and quality experienced using the company's contact lens solutions, such as Biotrue® and renu® multi-purpose solutions, as well as the amount of recommendations received from their optometrists to use the products in their contact lens care regimen."
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International,2017-06-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-named-most-trusted-113000475.html?.tsrc=rss,"LAVAL, Quebec, June 22, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, today announced that Bausch + Lomb contact lens solutions have been named the most trusted contact lens solution brand for the second consecutive year in Canada by BrandSpark International.  The 2017 BrandSpark Most Trusted Awards were given based on the results of a survey of more than 20,000 Canadians.  According to the results of the survey, the main reasons consumers shared that they trust Bausch + Lomb was due to the high level of performance and quality experienced using the company's contact lens solutions, such as Biotrue® and renu® multi-purpose solutions, as well as the amount of recommendations received from their optometrists to use the products in their contact lens care regimen."
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International,2017-06-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-named-most-trusted-113000596.html?.tsrc=rss,Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising In Early Trade - Canadian Commentary,2017-06-22 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pTx35Mnb5jc/canadian-stocks-are-rising-in-early-trade--canadian-commentary-20170622-00770,Canadian Stocks Are Rising In Early Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising In Early Trade - Canadian Commentary,2017-06-22 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pTx35Mnb5jc/canadian-stocks-are-rising-in-early-trade--canadian-commentary-20170622-00770,Canadian Stocks Are Rising In Early Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,7 Healthcare Stocks to Buy Now,2017-06-21 22:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PCltdn2YVU4/7-healthcare-stocks-to-buy-now-cm806577,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the benefit of perfect hindsight the middle of 2015 represented a high tide in healthcare investing Source Shutterstock While the sector overall has recovered this year the Health Care SPDR ETF NYSEARCA
VRX,VRX:US,BBG000DLFM21,7 Healthcare Stocks to Buy Now,2017-06-21 22:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PCltdn2YVU4/7-healthcare-stocks-to-buy-now-cm806577,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the benefit of perfect hindsight the middle of 2015 represented a high tide in healthcare investing Source Shutterstock While the sector overall has recovered this year the Health Care SPDR ETF NYSEARCA
VRX,VRX:US,BBG000DLFM21,"Mizuho Expects Valeant Pharmaceuticals Intl Inc (VRX) Shares to Drift Lower, Pacific Crest Cheers Amazon.com, Inc.’s (AMZN) New Prime Wardrobe Service",2017-06-21 18:11:28 +0000,https://finance.yahoo.com/news/mizuho-expects-valeant-pharmaceuticals-intl-181128815.html?.tsrc=rss,Valeant: Challenges Pose Significant Downside Risk
VRX,VRX:CT,BBG000DC8S17,"Mizuho Expects Valeant Pharmaceuticals Intl Inc (VRX) Shares to Drift Lower, Pacific Crest Cheers Amazon.com, Inc.’s (AMZN) New Prime Wardrobe Service",2017-06-21 18:11:28 +0000,https://finance.yahoo.com/news/mizuho-expects-valeant-pharmaceuticals-intl-181128815.html?.tsrc=rss,Valeant: Challenges Pose Significant Downside Risk
VRX,VRX:US,BBG000DLFM21,John Paulson Joining Valeant Pharmaceuticals' Board Isn't a Sufficient Reason to Get Excited,2017-06-21 15:22:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EjyLy_gOgbk/john-paulson-joining-valeant-pharmaceuticals-board-isnt-a-sufficient-reason-to-get-excited-cm806167,We don t get to say this too often but Valeant Pharmaceuticals NYSE VRX was a standout performer during Monday s trading session Shares of the embattled drugmaker moved higher by 6 4 though they re still about 95 lower from where they were nearly two years ago Valeant s
VRX,VRX:CT,BBG000DC8S17,John Paulson Joining Valeant Pharmaceuticals' Board Isn't a Sufficient Reason to Get Excited,2017-06-21 15:22:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EjyLy_gOgbk/john-paulson-joining-valeant-pharmaceuticals-board-isnt-a-sufficient-reason-to-get-excited-cm806167,We don t get to say this too often but Valeant Pharmaceuticals NYSE VRX was a standout performer during Monday s trading session Shares of the embattled drugmaker moved higher by 6 4 though they re still about 95 lower from where they were nearly two years ago Valeant s
VRX,VRX:US,BBG000DLFM21,John Paulson Joining Valeant Pharmaceuticals&apos; Board Isn&apos;t a Sufficient Reason to Get Excited,2017-06-21 14:08:00 +0000,http://finance.yahoo.com/r/d4c8b65f-fc00-3b02-9d7f-dedf9e57ff38/john-paulson-joining-valeant-pharmaceuticals-board.aspx?yptr=yahoo&.tsrc=rss,Issues with Valeant&apos;s core businesses and debt aren&apos;t going to be cured by the addition of Paulson.
VRX,VRX:CT,BBG000DC8S17,John Paulson Joining Valeant Pharmaceuticals&apos; Board Isn&apos;t a Sufficient Reason to Get Excited,2017-06-21 14:08:00 +0000,http://finance.yahoo.com/r/d4c8b65f-fc00-3b02-9d7f-dedf9e57ff38/john-paulson-joining-valeant-pharmaceuticals-board.aspx?yptr=yahoo&.tsrc=rss,Issues with Valeant&apos;s core businesses and debt aren&apos;t going to be cured by the addition of Paulson.
VRX,VRX:CT,BBG000DC8S17,Corporate News Blog - Billionaire Hedge Fund Manager John Paulson Elected to Valeant Pharma's Board,2017-06-21 12:15:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-billionaire-hedge-121500080.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / June 21, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Valeant Pharmaceuticals International, Inc. (NYSE: VRX ), following ..."
VRX,VRX:US,BBG000DLFM21,Corporate News Blog - Billionaire Hedge Fund Manager John Paulson Elected to Valeant Pharma's Board,2017-06-21 12:15:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-billionaire-hedge-121500080.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / June 21, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Valeant Pharmaceuticals International, Inc. (NYSE: VRX ), following ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are In Recovery Mode - Canadian Commentary,2017-06-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Nq0KVMjno8/canadian-stocks-are-in-recovery-mode--canadian-commentary-20170621-00771,Canadian Stocks Are In Recovery Mode - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are In Recovery Mode - Canadian Commentary,2017-06-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Nq0KVMjno8/canadian-stocks-are-in-recovery-mode--canadian-commentary-20170621-00771,Canadian Stocks Are In Recovery Mode - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors,2017-06-20 21:35:00 +0000,https://finance.yahoo.com/news/vrx-investor-alert-kyros-law-213500562.html?.tsrc=rss,"BOSTON , June 20, 2017 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX) that it is investigating legal claims against the company for possible securities ..."
VRX,VRX:CT,BBG000DC8S17,VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors,2017-06-20 21:35:00 +0000,https://finance.yahoo.com/news/vrx-investor-alert-kyros-law-213500562.html?.tsrc=rss,"BOSTON , June 20, 2017 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX) that it is investigating legal claims against the company for possible securities ..."
VRX,VRX:CT,BBG000DC8S17,"Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock",2017-06-20 21:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sZpM62xiLc0/why-this-billionaire-just-bought-gilead-sciences-synergy-and-valeant-stock-cm805928,Israel Izzy Englander has made plenty of smart stock picks during his career The co founder of the Millennium Management hedge fund is worth more than 5 billion as a result Englander just added to his fund s positions in three drug stocks Gilead Sciences NASDAQ
VRX,VRX:US,BBG000DLFM21,"Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock",2017-06-20 21:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sZpM62xiLc0/why-this-billionaire-just-bought-gilead-sciences-synergy-and-valeant-stock-cm805928,Israel Izzy Englander has made plenty of smart stock picks during his career The co founder of the Millennium Management hedge fund is worth more than 5 billion as a result Englander just added to his fund s positions in three drug stocks Gilead Sciences NASDAQ
VRX,VRX:CT,BBG000DC8S17,"Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock",2017-06-20 19:42:00 +0000,http://finance.yahoo.com/r/e625ae97-d59d-3adc-a920-601aedeab032/why-this-billionaire-just-bought-gilead-sciences-s.aspx?yptr=yahoo&.tsrc=rss,"Izzy Englander bought more shares of Gilead Sciences, Synergy, and Valeant during the first quarter. Why is the billionaire so bullish about these drug stocks?"
VRX,VRX:US,BBG000DLFM21,"Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock",2017-06-20 19:42:00 +0000,http://finance.yahoo.com/r/e625ae97-d59d-3adc-a920-601aedeab032/why-this-billionaire-just-bought-gilead-sciences-s.aspx?yptr=yahoo&.tsrc=rss,"Izzy Englander bought more shares of Gilead Sciences, Synergy, and Valeant during the first quarter. Why is the billionaire so bullish about these drug stocks?"
VRX,VRX:US,BBG000DLFM21,John Paulson Joins Valeant's Board During Trying Transition,2017-06-20 18:20:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N61drRu-2jY/john-paulson-joins-valeants-board-during-trying-transition-cm805877,Valeant s board has become a revolving door of billionaires Valeant s board has become a revolving door of billionaires Three months after Bill Ackman Trades Portfolio s exit enter John Paulson Trades Portfolio The head of New York based John Paulson Trades Portfolio amp
VRX,VRX:CT,BBG000DC8S17,John Paulson Joins Valeant's Board During Trying Transition,2017-06-20 18:20:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N61drRu-2jY/john-paulson-joins-valeants-board-during-trying-transition-cm805877,Valeant s board has become a revolving door of billionaires Valeant s board has become a revolving door of billionaires Three months after Bill Ackman Trades Portfolio s exit enter John Paulson Trades Portfolio The head of New York based John Paulson Trades Portfolio amp
VRX,VRX:US,BBG000DLFM21,"Is Ford Motor Company (F) Stock Undervalued, Or Cheap for a Reason?",2017-06-20 17:35:49 +0000,https://finance.yahoo.com/news/ford-motor-company-f-stock-173549636.html?.tsrc=rss,"Low multiples make Ford Motor Company (NYSE:F) stock look tantalizingly cheap.  You can buy Ford stock for 12 times earnings and only 7 times forward earnings.  Ford stock also trades at 0.29 times sales, 1.45 times book value and 4.8 times free cash flow."
VRX,VRX:CT,BBG000DC8S17,"Is Ford Motor Company (F) Stock Undervalued, Or Cheap for a Reason?",2017-06-20 17:35:49 +0000,https://finance.yahoo.com/news/ford-motor-company-f-stock-173549636.html?.tsrc=rss,"Low multiples make Ford Motor Company (NYSE:F) stock look tantalizingly cheap.  You can buy Ford stock for 12 times earnings and only 7 times forward earnings.  Ford stock also trades at 0.29 times sales, 1.45 times book value and 4.8 times free cash flow."
VRX,VRX:US,BBG000DLFM21,"Company News for June 20, 2017",2017-06-20 16:24:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zIynQ-khqZQ/company-news-for-june-20-2017-cm805709,160 160 160 Shares of Rice Energy Inc RICE surged 24 8 after EQT Corporation EQT decided to purchase Rice Energy for 6 7 billion 160 160 160 Rigel Pharmaceuticals Inc s RIGL shares soared 11 2 after the company declared that its New Drug Application NDA was
VRX,VRX:CT,BBG000DC8S17,"Company News for June 20, 2017",2017-06-20 16:24:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zIynQ-khqZQ/company-news-for-june-20-2017-cm805709,160 160 160 Shares of Rice Energy Inc RICE surged 24 8 after EQT Corporation EQT decided to purchase Rice Energy for 6 7 billion 160 160 160 Rigel Pharmaceuticals Inc s RIGL shares soared 11 2 after the company declared that its New Drug Application NDA was
VRX,VRX:CT,BBG000DC8S17,"Company News for June 20, 2017",2017-06-20 14:19:02 +0000,https://finance.yahoo.com/news/company-news-june-20-2017-141902382.html?.tsrc=rss,"Companies in the News are: RICE,EQT,RIGL,NVDQ,SYK,VRX"
VRX,VRX:US,BBG000DLFM21,"Company News for June 20, 2017",2017-06-20 14:19:02 +0000,https://finance.yahoo.com/news/company-news-june-20-2017-141902382.html?.tsrc=rss,"Companies in the News are: RICE,EQT,RIGL,NVDQ,SYK,VRX"
VRX,VRX:US,BBG000DLFM21,"Yes, Valeant is Rising But…",2017-06-20 13:52:00 +0000,http://finance.yahoo.com/r/a7c4cea9-4c25-3d0e-b688-07a843e59023/yes-valeant-is-rising-but-1497966729?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International (VRX) has gained 9.8% so far in June as investors bet that the worst is behind the beleaguered specialty pharmaceutical company. Yesterday's news that hedge-fund manager ...
VRX,VRX:CT,BBG000DC8S17,"Yes, Valeant is Rising But…",2017-06-20 13:52:00 +0000,http://finance.yahoo.com/r/a7c4cea9-4c25-3d0e-b688-07a843e59023/yes-valeant-is-rising-but-1497966729?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International (VRX) has gained 9.8% so far in June as investors bet that the worst is behind the beleaguered specialty pharmaceutical company. Yesterday's news that hedge-fund manager ...
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Clovis Oncology and Valeant Pharmaceuticals,2017-06-20 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000682.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 20, 2017 / Clovis Oncology soars to a share price it hasn't seen in almost two years after revealing positive trial results for its ovarian cancer drug Rubraca. Shares ..."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Clovis Oncology and Valeant Pharmaceuticals,2017-06-20 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000682.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 20, 2017 / Clovis Oncology soars to a share price it hasn't seen in almost two years after revealing positive trial results for its ovarian cancer drug Rubraca. Shares ..."
VRX,VRX:US,BBG000DLFM21,[$$] Hedge-Fund Manager John Paulson Joins Valeant Board,2017-06-20 04:37:21 +0000,http://finance.yahoo.com/r/2c81dbdd-d608-38d7-b541-406d3a59a7d7/hedge-fund-manager-john-paulson-joins-valeant-board-1497878417?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Hedge-fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals, a sign that the investor remains bullish on the drugmaker’s prospects despite accruing steep losses on investments in ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Hedge-Fund Manager John Paulson Joins Valeant Board,2017-06-20 04:37:21 +0000,http://finance.yahoo.com/r/2c81dbdd-d608-38d7-b541-406d3a59a7d7/hedge-fund-manager-john-paulson-joins-valeant-board-1497878417?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Hedge-fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals, a sign that the investor remains bullish on the drugmaker’s prospects despite accruing steep losses on investments in ..."
VRX,VRX:US,BBG000DLFM21,Why Tesla Inc (TSLA) Stock Is Going to $400,2017-06-19 23:19:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/268gooV2YDc/why-tesla-inc-tsla-stock-is-going-to-400-cm805407,InvestorPlace Stock Market News Stock Advice amp Trading Tips Tesla Inc 160 NASDAQ TSLA is overbought and overvalued TSLA stock traders know it Options traders know it My colleagues here at InvestorPlace and at Banyan Hill know it Even CEO
VRX,VRX:CT,BBG000DC8S17,Why Tesla Inc (TSLA) Stock Is Going to $400,2017-06-19 23:19:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/268gooV2YDc/why-tesla-inc-tsla-stock-is-going-to-400-cm805407,InvestorPlace Stock Market News Stock Advice amp Trading Tips Tesla Inc 160 NASDAQ TSLA is overbought and overvalued TSLA stock traders know it Options traders know it My colleagues here at InvestorPlace and at Banyan Hill know it Even CEO
VRX,VRX:CT,BBG000DC8S17,John Paulson Joins Valeant's Board During Trying Transition,2017-06-19 22:31:28 +0000,https://finance.yahoo.com/news/john-paulson-joins-valeants-board-223128809.html?.tsrc=rss,Paulson enters fray as Ackman cuts losses
VRX,VRX:US,BBG000DLFM21,John Paulson Joins Valeant's Board During Trying Transition,2017-06-19 22:31:28 +0000,https://finance.yahoo.com/news/john-paulson-joins-valeants-board-223128809.html?.tsrc=rss,Paulson enters fray as Ackman cuts losses
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Rite Aid, and Novadaq Technologies Jumped Today",2017-06-19 22:20:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wkNsCUg3fEk/why-valeant-pharmaceuticals-rite-aid-and-novadaq-technologies-jumped-today-cm805378,Monday was a strong day on Wall Street with the Dow Jones Industrials and S amp P 500 hitting record highs on new optimism from market participants The technology sector which has gotten hit hard recently bounced back from its losses and continued strength from other pockets
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Rite Aid, and Novadaq Technologies Jumped Today",2017-06-19 22:20:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wkNsCUg3fEk/why-valeant-pharmaceuticals-rite-aid-and-novadaq-technologies-jumped-today-cm805378,Monday was a strong day on Wall Street with the Dow Jones Industrials and S amp P 500 hitting record highs on new optimism from market participants The technology sector which has gotten hit hard recently bounced back from its losses and continued strength from other pockets
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 22:19:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Itsgu_jwGQI/valeant-pharmaceuticals-intl-inc-vrx-stock-isnt-healed-by-paulsons-presence-cm805395,InvestorPlace Stock Market News Stock Advice amp Trading Tips It remains to be seen if John Paulson s presence on the board of directors of Valeant Pharmaceuticals Intl Inc NYSE VRX will make a positive difference for the beleaguered company But as far as owners of VRX
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 22:19:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Itsgu_jwGQI/valeant-pharmaceuticals-intl-inc-vrx-stock-isnt-healed-by-paulsons-presence-cm805395,InvestorPlace Stock Market News Stock Advice amp Trading Tips It remains to be seen if John Paulson s presence on the board of directors of Valeant Pharmaceuticals Intl Inc NYSE VRX will make a positive difference for the beleaguered company But as far as owners of VRX
VRX,VRX:US,BBG000DLFM21,Snap Inc (SNAP) Stock Finally Finds a Moat … Swimming With Alligators,2017-06-19 22:19:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MPJuDnexX2M/snap-inc-snap-stock-finally-finds-a-moat-swimming-with-alligators-cm805390,InvestorPlace Stock Market News Stock Advice amp Trading Tips Snap Inc NYSE SNAP stock is jumping today as investors are getting excited about the financial prospects of original content on the social sharing platform Time Warner Inc NYSE TWX signed a 100
VRX,VRX:CT,BBG000DC8S17,Snap Inc (SNAP) Stock Finally Finds a Moat … Swimming With Alligators,2017-06-19 22:19:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MPJuDnexX2M/snap-inc-snap-stock-finally-finds-a-moat-swimming-with-alligators-cm805390,InvestorPlace Stock Market News Stock Advice amp Trading Tips Snap Inc NYSE SNAP stock is jumping today as investors are getting excited about the financial prospects of original content on the social sharing platform Time Warner Inc NYSE TWX signed a 100
VRX,VRX:CT,BBG000DC8S17,"Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications",2017-06-19 22:00:00 +0000,https://finance.yahoo.com/news/valeant-appoints-arthur-j-shannon-220000751.html?.tsrc=rss,"LAVAL, Quebec, June 19, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced Arthur J. Shannon has joined the company as senior vice president, head of Investor Relations and Communications.  Mr. Shannon has more than 20 years of experience in the field of investor relations."
VRX,VRX:US,BBG000DLFM21,"Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications",2017-06-19 22:00:00 +0000,https://finance.yahoo.com/news/valeant-appoints-arthur-j-shannon-220000751.html?.tsrc=rss,"LAVAL, Quebec, June 19, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced Arthur J. Shannon has joined the company as senior vice president, head of Investor Relations and Communications.  Mr. Shannon has more than 20 years of experience in the field of investor relations."
VRX,VRX:CT,BBG000DC8S17,Gabelli's Jonas Doesn't Expect Much Change at Valeant,2017-06-19 21:37:18 +0000,https://finance.yahoo.com/video/gabellis-jonas-doesnt-expect-much-213718396.html?.tsrc=rss,"Jun.19 -- Jeff Jonas, a portfolio manager at Gabelli & Co., discusses billionaire hedge-fund manager John Paulson joining the board of Valeant Pharmaceuticals International Inc. He speaks with Bloomberg's Scarlet Fu and Julia Chatterley on &quot;Bloomberg Markets.&quot;"
VRX,VRX:US,BBG000DLFM21,Gabelli's Jonas Doesn't Expect Much Change at Valeant,2017-06-19 21:37:18 +0000,https://finance.yahoo.com/video/gabellis-jonas-doesnt-expect-much-213718396.html?.tsrc=rss,"Jun.19 -- Jeff Jonas, a portfolio manager at Gabelli & Co., discusses billionaire hedge-fund manager John Paulson joining the board of Valeant Pharmaceuticals International Inc. He speaks with Bloomberg's Scarlet Fu and Julia Chatterley on &quot;Bloomberg Markets.&quot;"
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Rite Aid, and Novadaq Technologies Jumped Today",2017-06-19 20:32:00 +0000,http://finance.yahoo.com/r/a339faea-2888-3dbd-b8a9-497d0fe92978/why-valeant-pharmaceuticals-rite-aid-and-novadaq-t.aspx?yptr=yahoo&.tsrc=rss,These stocks led the markets sharply higher. Find out why.
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Rite Aid, and Novadaq Technologies Jumped Today",2017-06-19 20:32:00 +0000,http://finance.yahoo.com/r/a339faea-2888-3dbd-b8a9-497d0fe92978/why-valeant-pharmaceuticals-rite-aid-and-novadaq-t.aspx?yptr=yahoo&.tsrc=rss,These stocks led the markets sharply higher. Find out why.
VRX,VRX:US,BBG000DLFM21,Why John Paulson Can't Rescue Valeant's Stock,2017-06-19 19:33:00 +0000,http://finance.yahoo.com/r/dacf551c-bbbb-3747-ad58-388194ec2bfb/why-john-paulson-cant-rescue-valeants-stock?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Valeant stock soared after its largest shareholder, hedge fund billionaire John Paulson, joined its board."
VRX,VRX:CT,BBG000DC8S17,Why John Paulson Can't Rescue Valeant's Stock,2017-06-19 19:33:00 +0000,http://finance.yahoo.com/r/dacf551c-bbbb-3747-ad58-388194ec2bfb/why-john-paulson-cant-rescue-valeants-stock?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Valeant stock soared after its largest shareholder, hedge fund billionaire John Paulson, joined its board."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 17:47:28 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-174728345.html?.tsrc=rss,"It remains to be seen if John Paulson’s presence on the board of directors of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will make a positive difference for the beleaguered company.  John Paulson is the chief of hedge fund Paulson & Co., which rose to infamy after making a (very) correct bearish call on the U.S. housing market in 2007."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 17:47:28 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-174728345.html?.tsrc=rss,"It remains to be seen if John Paulson’s presence on the board of directors of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will make a positive difference for the beleaguered company.  John Paulson is the chief of hedge fund Paulson & Co., which rose to infamy after making a (very) correct bearish call on the U.S. housing market in 2007."
VRX,VRX:US,BBG000DLFM21,John Paulson Won't Save Valeant,2017-06-19 17:14:49 +0000,http://finance.yahoo.com/r/3f8768dd-993e-3bca-9448-46cfbe1ea1de/john-paulson-won-t-save-valeant?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Its problems are too big for one board member, whose history with pharma is rocky."
VRX,VRX:CT,BBG000DC8S17,John Paulson Won't Save Valeant,2017-06-19 17:14:49 +0000,http://finance.yahoo.com/r/3f8768dd-993e-3bca-9448-46cfbe1ea1de/john-paulson-won-t-save-valeant?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Its problems are too big for one board member, whose history with pharma is rocky."
VRX,VRX:CT,BBG000DC8S17,Billionaire John Paulson Wants You to Buy Valeant -- Here's What the Chart Says,2017-06-19 17:04:00 +0000,http://finance.yahoo.com/r/73a33fd1-f844-335d-bf79-72bc6953dbe1/billionaire-john-paulson-wants-you-to-buy-valeant-here-s-what-the-chart-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The price action is pointing toward more upside in this beaten-down biotech stock.
VRX,VRX:US,BBG000DLFM21,Valeant: Accentuate the Negative?,2017-06-19 17:04:00 +0000,http://finance.yahoo.com/r/48db9667-6142-3194-8e1e-fd1dd4eca80b/valeant-accentuate-the-negative-1497891884?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Few analysts are as bearish on Valeant Pharmaceuticals International (VRX) as Wells Fargo's David Maris.  When Valeant offers better-than-expected EBITDA guidance, Maris is there to point out that EPS would be a better metric to watch.  When Valeant sells off a piece of itself, Maris is there to note that the deal is too small to make a dent in its enormous debt load."
VRX,VRX:CT,BBG000DC8S17,Valeant: Accentuate the Negative?,2017-06-19 17:04:00 +0000,http://finance.yahoo.com/r/48db9667-6142-3194-8e1e-fd1dd4eca80b/valeant-accentuate-the-negative-1497891884?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Few analysts are as bearish on Valeant Pharmaceuticals International (VRX) as Wells Fargo's David Maris.  When Valeant offers better-than-expected EBITDA guidance, Maris is there to point out that EPS would be a better metric to watch.  When Valeant sells off a piece of itself, Maris is there to note that the deal is too small to make a dent in its enormous debt load."
VRX,VRX:US,BBG000DLFM21,Billionaire John Paulson Wants You to Buy Valeant -- Here's What the Chart Says,2017-06-19 17:04:00 +0000,http://finance.yahoo.com/r/73a33fd1-f844-335d-bf79-72bc6953dbe1/billionaire-john-paulson-wants-you-to-buy-valeant-here-s-what-the-chart-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The price action is pointing toward more upside in this beaten-down biotech stock.
VRX,VRX:CT,BBG000DC8S17,TSX Snaps Out Of Funk -- Canadian Commentary,2017-06-19 16:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8cGQdd7YSt4/tsx-snaps-out-of-funk--canadian-commentary-20170619-01094,TSX Snaps Out Of Funk -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,TSX Snaps Out Of Funk -- Canadian Commentary,2017-06-19 16:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8cGQdd7YSt4/tsx-snaps-out-of-funk--canadian-commentary-20170619-01094,TSX Snaps Out Of Funk -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,John Paulson joins Valeant's board after his firm took a ...,2017-06-19 14:41:00 +0000,https://finance.yahoo.com/video/john-paulson-joins-valeants-board-144100689.html?.tsrc=rss,Hedge fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals.
VRX,VRX:US,BBG000DLFM21,John Paulson joins Valeant's board after his firm took a ...,2017-06-19 14:41:00 +0000,https://finance.yahoo.com/video/john-paulson-joins-valeants-board-144100689.html?.tsrc=rss,Hedge fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals.
VRX,VRX:CT,BBG000DC8S17,"Costco downgraded, again; Amazon eyes new high, Valeant soars on Paulson board announcement; Boeing unveils new 737",2017-06-19 14:35:40 +0000,https://finance.yahoo.com/video/costco-downgraded-again-amazon-eyes-143540631.html?.tsrc=rss,"Costco, Amazon, Whole Foods Market, Boeing, Lockheed Martin, Disney and Valeant Pharmaceuticals are among the stocks to watch."
VRX,VRX:US,BBG000DLFM21,"Costco downgraded, again; Amazon eyes new high, Valeant soars on Paulson board announcement; Boeing unveils new 737",2017-06-19 14:35:40 +0000,https://finance.yahoo.com/video/costco-downgraded-again-amazon-eyes-143540631.html?.tsrc=rss,"Costco, Amazon, Whole Foods Market, Boeing, Lockheed Martin, Disney and Valeant Pharmaceuticals are among the stocks to watch."
VRX,VRX:CT,BBG000DC8S17,Billionaire Hedge Funder John Paulson Joins Valeant Board,2017-06-19 14:28:00 +0000,http://finance.yahoo.com/r/c91843aa-d2cd-3c79-82d8-75cbff643425/billionaire-hedge-funder-john-paulson-joins-valeant-board-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,The hedge fund manager John Paulson joins the pharmaceutical company's board after losing almost $2 billion on a bad bet on Valeant stock.
VRX,VRX:US,BBG000DLFM21,Billionaire Hedge Funder John Paulson Joins Valeant Board,2017-06-19 14:28:00 +0000,http://finance.yahoo.com/r/c91843aa-d2cd-3c79-82d8-75cbff643425/billionaire-hedge-funder-john-paulson-joins-valeant-board-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,The hedge fund manager John Paulson joins the pharmaceutical company's board after losing almost $2 billion on a bad bet on Valeant stock.
VRX,VRX:US,BBG000DLFM21,"Billionaire investor Paulson joins Valeant board, shares jump",2017-06-19 14:12:37 +0000,https://finance.yahoo.com/news/valeants-largest-shareholder-john-paulson-130102453.html?.tsrc=rss,"Investors appeared to see Paulson's becoming a director as a vote of confidence in Valeant, sending its U.S.-listed shares up 5.1.  The move comes as Valeant sells off assets to pay down its $30 billion debt.  ""With his significant business and financial expertise, John will be a strong addition to the board,"" Valeant Chief Executive Officer Joe Papa said in a statement."
VRX,VRX:CT,BBG000DC8S17,"Billionaire investor Paulson joins Valeant board, shares jump",2017-06-19 14:12:37 +0000,https://finance.yahoo.com/news/valeants-largest-shareholder-john-paulson-130102453.html?.tsrc=rss,"Investors appeared to see Paulson's becoming a director as a vote of confidence in Valeant, sending its U.S.-listed shares up 5.1.  The move comes as Valeant sells off assets to pay down its $30 billion debt.  ""With his significant business and financial expertise, John will be a strong addition to the board,"" Valeant Chief Executive Officer Joe Papa said in a statement."
VRX,VRX:US,BBG000DLFM21,Can John Paulson Revive Valeant?,2017-06-19 13:59:00 +0000,http://finance.yahoo.com/r/ad771dfe-1c43-3619-bf6e-479145d4271c/can-john-paulson-revive-valeant-1497880803?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Instead, the activist investor and hedge fund manager joined the drugmaker's board of directors.  Chairman and CEO Joseph Papa said of Paulson in a press release, ""With his significant business and financial expertise, John will be a strong addition to the board.  Last week, Cantor Fitzgerald's Louise Chen and Brandon Folkes put an Outperform rating on Valeant arguing that it's time to stop looking in the rearview mirror."
VRX,VRX:CT,BBG000DC8S17,Can John Paulson Revive Valeant?,2017-06-19 13:59:00 +0000,http://finance.yahoo.com/r/ad771dfe-1c43-3619-bf6e-479145d4271c/can-john-paulson-revive-valeant-1497880803?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Instead, the activist investor and hedge fund manager joined the drugmaker's board of directors.  Chairman and CEO Joseph Papa said of Paulson in a press release, ""With his significant business and financial expertise, John will be a strong addition to the board.  Last week, Cantor Fitzgerald's Louise Chen and Brandon Folkes put an Outperform rating on Valeant arguing that it's time to stop looking in the rearview mirror."
VRX,VRX:US,BBG000DLFM21,"James Flynn Plays Two Key Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD)",2017-06-19 13:53:30 +0000,https://finance.yahoo.com/news/james-flynn-plays-two-key-135330239.html?.tsrc=rss,"Prominent hedge fund manager James E. Flynn of the Deerfield Management fund has indicated a bullish outlook towards two controversial healthcare stocks in Q1 2017, according to the latest 13F forms filed with the SEC.  Flynn opened new positions in specialty biopharma Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and flailing biotech Gilead Sciences, Inc. (NASDAQ:GILD).  James E. Flynn is the Managing Partner of the $7 billion healthcare-focused Deerfield fund- a role which he has held since 2005."
VRX,VRX:CT,BBG000DC8S17,"James Flynn Plays Two Key Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD)",2017-06-19 13:53:30 +0000,https://finance.yahoo.com/news/james-flynn-plays-two-key-135330239.html?.tsrc=rss,"Prominent hedge fund manager James E. Flynn of the Deerfield Management fund has indicated a bullish outlook towards two controversial healthcare stocks in Q1 2017, according to the latest 13F forms filed with the SEC.  Flynn opened new positions in specialty biopharma Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and flailing biotech Gilead Sciences, Inc. (NASDAQ:GILD).  James E. Flynn is the Managing Partner of the $7 billion healthcare-focused Deerfield fund- a role which he has held since 2005."
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Apple, Amazon, Rice Energy, Valeant",2017-06-19 13:29:39 +0000,http://finance.yahoo.com/r/f4de0894-6a76-342a-9df8-0725cd733ffe/stocks-to-watch-apple-amazon-rice-energy-valeant-1497878977?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Monday’s session are Apple Inc. and other highflying tech stocks, Rice Energy Inc. and Valeant Pharmaceuticals International Inc."
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Apple, Amazon, Rice Energy, Valeant",2017-06-19 13:29:39 +0000,http://finance.yahoo.com/r/f4de0894-6a76-342a-9df8-0725cd733ffe/stocks-to-watch-apple-amazon-rice-energy-valeant-1497878977?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Monday’s session are Apple Inc. and other highflying tech stocks, Rice Energy Inc. and Valeant Pharmaceuticals International Inc."
VRX,VRX:US,BBG000DLFM21,Top 3 Companies Owned by Valeant (VRX),2017-06-19 13:27:00 +0000,http://finance.yahoo.com/r/a500e6fe-67f0-3af4-939d-5cc0be248dc5/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,Top 3 Companies Owned by Valeant (VRX),2017-06-19 13:27:00 +0000,http://finance.yahoo.com/r/a500e6fe-67f0-3af4-939d-5cc0be248dc5/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,"Stocks edge higher and Trump meets with Bezos, Cook and other tech execs",2017-06-19 13:26:08 +0000,https://finance.yahoo.com/news/stocks-edge-higher-trump-meets-bezos-cook-tech-execs-132608847.html?.tsrc=rss,"Wall Street is gearing up for another record-breaking session. Stocks started the week with solid gains with the Dow eyeing a fresh record as investors look for bargains in the beaten up tech and retail sector. Yahoo Finance’s Alexis Christoforous, Myles Udland and Melody Hahm discuss the day’s top stories, including President Trump meeting at the White House with CEOs from tech titans including Apple (AAPL) and Amazon (AMZN)."
VRX,VRX:US,BBG000DLFM21,"Stocks edge higher and Trump meets with Bezos, Cook and other tech execs",2017-06-19 13:26:08 +0000,https://finance.yahoo.com/news/stocks-edge-higher-trump-meets-bezos-cook-tech-execs-132608847.html?.tsrc=rss,"Wall Street is gearing up for another record-breaking session. Stocks started the week with solid gains with the Dow eyeing a fresh record as investors look for bargains in the beaten up tech and retail sector. Yahoo Finance’s Alexis Christoforous, Myles Udland and Melody Hahm discuss the day’s top stories, including President Trump meeting at the White House with CEOs from tech titans including Apple (AAPL) and Amazon (AMZN)."
VRX,VRX:US,BBG000DLFM21,[$$] Hedge-Fund Manager John Paulson Joins Valeant Board,2017-06-19 13:22:02 +0000,http://finance.yahoo.com/r/2c81dbdd-d608-38d7-b541-406d3a59a7d7/hedge-fund-manager-john-paulson-joins-valeant-board-1497878417?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Hedge-fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals, a sign that the investor remains bullish on the drugmaker’s prospects despite accruing steep losses on investments in ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Hedge-Fund Manager John Paulson Joins Valeant Board,2017-06-19 13:22:02 +0000,http://finance.yahoo.com/r/2c81dbdd-d608-38d7-b541-406d3a59a7d7/hedge-fund-manager-john-paulson-joins-valeant-board-1497878417?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Hedge-fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals, a sign that the investor remains bullish on the drugmaker’s prospects despite accruing steep losses on investments in ..."
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 06/19/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, MACK, MDT",2017-06-19 13:20:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DAH2CNGB5c8/health-care-sector-update-for-06192017-jnj-pfe-abt-mrk-amgn-vrx-mack-mdt-cm804907,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 0 3 PFE 0 3 ABT 0 6 ABT 0 6 MRK flatMRK flat AMGN 0 4 AMGN 0 4 Health care shares were mostly firmer in pre market trade Monday Health care shares were mostly firmer in pre market trade Monday In health
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 06/19/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, MACK, MDT",2017-06-19 13:20:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DAH2CNGB5c8/health-care-sector-update-for-06192017-jnj-pfe-abt-mrk-amgn-vrx-mack-mdt-cm804907,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 0 3 PFE 0 3 ABT 0 6 ABT 0 6 MRK flatMRK flat AMGN 0 4 AMGN 0 4 Health care shares were mostly firmer in pre market trade Monday Health care shares were mostly firmer in pre market trade Monday In health
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jun 19, 2017 :  AEG, RICE, CLVS, AUY, QQQ, NVDQ, VRX, RIGL, HL, TSRO, KR, JD",2017-06-19 12:59:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JhzwvVCoHcI/pre-market-most-active-for-jun-19-2017-aeg-rice-clvs-auy-qqq-nvdq-vrx-rigl-hl-tsro-kr-jd-cm804906,The NASDAQ 100 Pre Market Indicator is up 32 17 to 5 713 65 The total Pre Market volume is currently 7 766 242 shares traded The following are the most active stocks for the pre market session Aegon NV AEG is 0 03 at 5 06 with 1 120 700 shares traded AEG s
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jun 19, 2017 :  AEG, RICE, CLVS, AUY, QQQ, NVDQ, VRX, RIGL, HL, TSRO, KR, JD",2017-06-19 12:59:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JhzwvVCoHcI/pre-market-most-active-for-jun-19-2017-aeg-rice-clvs-auy-qqq-nvdq-vrx-rigl-hl-tsro-kr-jd-cm804906,The NASDAQ 100 Pre Market Indicator is up 32 17 to 5 713 65 The total Pre Market volume is currently 7 766 242 shares traded The following are the most active stocks for the pre market session Aegon NV AEG is 0 03 at 5 06 with 1 120 700 shares traded AEG s
VRX,VRX:US,BBG000DLFM21,Valeant Posting Strong Gain After Paulson Elected To Board,2017-06-19 12:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4nbkPY8EYbs/valeant-posting-strong-gain-after-paulson-elected-to-board-20170619-00918,Valeant Posting Strong Gain After Paulson Elected To Board
VRX,VRX:CT,BBG000DC8S17,Valeant Posting Strong Gain After Paulson Elected To Board,2017-06-19 12:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4nbkPY8EYbs/valeant-posting-strong-gain-after-paulson-elected-to-board-20170619-00918,Valeant Posting Strong Gain After Paulson Elected To Board
VRX,VRX:US,BBG000DLFM21,"Early movers: WFM, COST, VRX, KR & more",2017-06-19 12:34:55 +0000,http://finance.yahoo.com/r/5cbd4be3-a386-3277-aed6-41b0e9ea6a1f/104537466?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104537466&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
VRX,VRX:CT,BBG000DC8S17,"Early movers: WFM, COST, VRX, KR & more",2017-06-19 12:34:55 +0000,http://finance.yahoo.com/r/5cbd4be3-a386-3277-aed6-41b0e9ea6a1f/104537466?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104537466&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
VRX,VRX:US,BBG000DLFM21,John Paulson joins Valeant's board after his firm took a nearly $2 billion hit on its stock,2017-06-19 12:28:02 +0000,http://finance.yahoo.com/r/b8df869a-f26e-3b57-bda6-b791ea444f26/104537384?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104537384&yptr=yahoo&.tsrc=rss,Hedge fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals.
VRX,VRX:CT,BBG000DC8S17,John Paulson joins Valeant's board after his firm took a nearly $2 billion hit on its stock,2017-06-19 12:28:02 +0000,http://finance.yahoo.com/r/b8df869a-f26e-3b57-bda6-b791ea444f26/104537384?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104537384&yptr=yahoo&.tsrc=rss,Hedge fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals.
VRX,VRX:US,BBG000DLFM21,Valeant Stock Jumps After John Paulson Named to Board,2017-06-19 12:21:00 +0000,http://finance.yahoo.com/r/01f99cbd-a756-3ea0-9785-830c15c328f5/valeant-stock-jumps-after-john-paulson-is-named-to-board.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Paulson is Valeant's largest shareholder.
VRX,VRX:CT,BBG000DC8S17,Valeant Stock Jumps After John Paulson Named to Board,2017-06-19 12:21:00 +0000,http://finance.yahoo.com/r/01f99cbd-a756-3ea0-9785-830c15c328f5/valeant-stock-jumps-after-john-paulson-is-named-to-board.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Paulson is Valeant's largest shareholder.
VRX,VRX:CT,BBG000DC8S17,Valeant's stock surges after largest shareholder John Paulson elected to board,2017-06-19 11:45:53 +0000,https://finance.yahoo.com/news/valeants-stock-surges-largest-shareholder-114553903.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals International Inc. surged 5% in premarket trade Monday, after the drug maker said billionaire hedge fund manager John Paulson was elected to its board of directors. Paulson's ..."
VRX,VRX:US,BBG000DLFM21,Valeant's stock surges after largest shareholder John Paulson elected to board,2017-06-19 11:45:53 +0000,https://finance.yahoo.com/news/valeants-stock-surges-largest-shareholder-114553903.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals International Inc. surged 5% in premarket trade Monday, after the drug maker said billionaire hedge fund manager John Paulson was elected to its board of directors. Paulson's ..."
VRX,VRX:US,BBG000DLFM21,Valeant's stock surges after largest shareholder John Paulson elected to board,2017-06-19 11:45:53 +0000,http://finance.yahoo.com/r/2c88c83f-47d8-39e0-839e-5cc06f6ef921/Story.aspx?guid=C2C77259-9F7C-4F09-90B7-5B69DE9773AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International Inc. surged 5% in premarket trade Monday, after the drug maker said billionaire hedge fund manager John Paulson was elected to its board of directors. Paulson's ..."
VRX,VRX:CT,BBG000DC8S17,Valeant's stock surges after largest shareholder John Paulson elected to board,2017-06-19 11:45:53 +0000,http://finance.yahoo.com/r/2c88c83f-47d8-39e0-839e-5cc06f6ef921/Story.aspx?guid=C2C77259-9F7C-4F09-90B7-5B69DE9773AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International Inc. surged 5% in premarket trade Monday, after the drug maker said billionaire hedge fund manager John Paulson was elected to its board of directors. Paulson's ..."
VRX,VRX:US,BBG000DLFM21,Valeant's largest shareholder John Paulson joins board,2017-06-19 11:39:26 +0000,https://finance.yahoo.com/news/valeants-largest-shareholder-john-paulson-113926189.html?.tsrc=rss,"Activist investor and hedge fund manager  John Paulson has joined Valeant Pharmaceuticals International  Inc's  board, a move that comes at a time when  the embattled Canadian drugmaker is restructuring itself to  repay debt.  Valeant's U.S.-listed shares were up 5.9 percent at $13.40  in premarket trading on Monday.  Paulson's hedge fund Paulson & Co had a 5.68 percent stake  in Valeant as of March 31, making it the largest shareholder in  the company, according to Reuters data."
VRX,VRX:CT,BBG000DC8S17,Valeant's largest shareholder John Paulson joins board,2017-06-19 11:39:26 +0000,https://finance.yahoo.com/news/valeants-largest-shareholder-john-paulson-113926189.html?.tsrc=rss,"Activist investor and hedge fund manager  John Paulson has joined Valeant Pharmaceuticals International  Inc's  board, a move that comes at a time when  the embattled Canadian drugmaker is restructuring itself to  repay debt.  Valeant's U.S.-listed shares were up 5.9 percent at $13.40  in premarket trading on Monday.  Paulson's hedge fund Paulson & Co had a 5.68 percent stake  in Valeant as of March 31, making it the largest shareholder in  the company, according to Reuters data."
VRX,VRX:CT,BBG000DC8S17,Valeant adds shareholder John Paulson to board,2017-06-19 11:22:20 +0000,https://finance.yahoo.com/news/valeant-adds-shareholder-john-paulson-111103754.html?.tsrc=rss,"Canadian drugmaker Valeant Pharmaceuticals said it appointed hedge fund manager and billionaire investor John Paulson to its board. Paulson, who heads hedge fund Paulson & Co, joined the board on June ..."
VRX,VRX:US,BBG000DLFM21,Valeant adds shareholder John Paulson to board,2017-06-19 11:22:20 +0000,https://finance.yahoo.com/news/valeant-adds-shareholder-john-paulson-111103754.html?.tsrc=rss,"Canadian drugmaker Valeant Pharmaceuticals said it appointed hedge fund manager and billionaire investor John Paulson to its board. Paulson, who heads hedge fund Paulson & Co, joined the board on June ..."
VRX,VRX:CT,BBG000DC8S17,Billionaire John Paulson Joins Valeant’s Board of Directors,2017-06-19 11:15:34 +0000,https://finance.yahoo.com/news/billionaire-john-paulson-joins-valeant-111534881.html?.tsrc=rss,Billionaire hedge fund manager John Paulson joined the board of Valeant Pharmaceuticals International Inc. to help the drugmaker with its turnaround.
VRX,VRX:US,BBG000DLFM21,Billionaire John Paulson Joins Valeant’s Board of Directors,2017-06-19 11:15:34 +0000,https://finance.yahoo.com/news/billionaire-john-paulson-joins-valeant-111534881.html?.tsrc=rss,Billionaire hedge fund manager John Paulson joined the board of Valeant Pharmaceuticals International Inc. to help the drugmaker with its turnaround.
VRX,VRX:CT,BBG000DC8S17,John Paulson Joins Valeant Board Of Directors,2017-06-19 11:00:00 +0000,https://finance.yahoo.com/news/john-paulson-joins-valeant-board-110000874.html?.tsrc=rss,"LAVAL, Quebec, June 19, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that its board of directors has elected John Paulson to serve as a director, effective June 14, 2017.  With the addition of Mr. Paulson, Valeant has a total of 11 members on its board, 10 of whom are independent.  ""We are pleased to welcome John to Valeant's board of directors,"" said Joseph C. Papa, chairman and CEO, Valeant."
VRX,VRX:US,BBG000DLFM21,John Paulson Joins Valeant Board Of Directors,2017-06-19 11:00:00 +0000,https://finance.yahoo.com/news/john-paulson-joins-valeant-board-110000874.html?.tsrc=rss,"LAVAL, Quebec, June 19, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that its board of directors has elected John Paulson to serve as a director, effective June 14, 2017.  With the addition of Mr. Paulson, Valeant has a total of 11 members on its board, 10 of whom are independent.  ""We are pleased to welcome John to Valeant's board of directors,"" said Joseph C. Papa, chairman and CEO, Valeant."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Global Cues - Canadian Commentary,2017-06-19 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RBgo3sbx6lI/canadian-stocks-are-climbing-on-global-cues--canadian-commentary-20170619-00794,Canadian Stocks Are Climbing On Global Cues - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Global Cues - Canadian Commentary,2017-06-19 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RBgo3sbx6lI/canadian-stocks-are-climbing-on-global-cues--canadian-commentary-20170619-00794,Canadian Stocks Are Climbing On Global Cues - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Bay Street Set For Subdued Session -- Canadian Commentary,2017-06-19 09:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VDjlvAAKNYE/bay-street-set-for-subdued-session--canadian-commentary-20170619-00657,Bay Street Set For Subdued Session -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bay Street Set For Subdued Session -- Canadian Commentary,2017-06-19 09:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VDjlvAAKNYE/bay-street-set-for-subdued-session--canadian-commentary-20170619-00657,Bay Street Set For Subdued Session -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pharma: John Paulson Joins Board - Quick Facts,2017-06-19 07:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-xLRFejXbLQ/valeant-pharma-john-paulson-joins-board--quick-facts-20170619-00319,Valeant Pharma: John Paulson Joins Board - Quick Facts
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma: John Paulson Joins Board - Quick Facts,2017-06-19 07:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-xLRFejXbLQ/valeant-pharma-john-paulson-joins-board--quick-facts-20170619-00319,Valeant Pharma: John Paulson Joins Board - Quick Facts
VRX,VRX:US,BBG000DLFM21,"Investing legend and Amazon bull Bill Miller likes Whole Foods deal, plus Valeant and bitcoin",2017-06-16 21:28:17 +0000,http://finance.yahoo.com/r/b5935cc1-77e1-356a-bfea-da1a2d40b330/104534946?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104534946&yptr=yahoo&.tsrc=rss,"A major shareholder in the online retailer, Miller said Amazon CEO Jeff Bezos has moved on a company that fits in well with his overall investing strategy."
VRX,VRX:CT,BBG000DC8S17,"Investing legend and Amazon bull Bill Miller likes Whole Foods deal, plus Valeant and bitcoin",2017-06-16 21:28:17 +0000,http://finance.yahoo.com/r/b5935cc1-77e1-356a-bfea-da1a2d40b330/104534946?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104534946&yptr=yahoo&.tsrc=rss,"A major shareholder in the online retailer, Miller said Amazon CEO Jeff Bezos has moved on a company that fits in well with his overall investing strategy."
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 06/16/2017: VRX,CLSN,IDXG",2017-06-16 17:48:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CR-XlBKsYEo/health-care-sector-update-for-06162017-vrxclsnidxg-cm804514,Top Health Care StocksTop Health Care Stocks JNJ 0 88 JNJ 0 88 PFE 0 41 PFE 0 41 ABT 0 45 ABT 0 45 MRK 0 37 MRK 0 37 AMGN 0 99 AMGN 0 99 Health care stocks were mixed Friday with the NYSE Health Care Index posting a 0 3 advance while shares of health care companies in the S amp
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 06/16/2017: VRX,CLSN,IDXG",2017-06-16 17:48:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CR-XlBKsYEo/health-care-sector-update-for-06162017-vrxclsnidxg-cm804514,Top Health Care StocksTop Health Care Stocks JNJ 0 88 JNJ 0 88 PFE 0 41 PFE 0 41 ABT 0 45 ABT 0 45 MRK 0 37 MRK 0 37 AMGN 0 99 AMGN 0 99 Health care stocks were mixed Friday with the NYSE Health Care Index posting a 0 3 advance while shares of health care companies in the S amp
VRX,VRX:US,BBG000DLFM21,Valeant: Stop Looking in the Rearview Mirror!,2017-06-16 14:54:00 +0000,http://finance.yahoo.com/r/69438647-ba8c-3191-ae88-69965c377bac/valeant-stop-looking-in-the-rearview-mirror-1497624875?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of specialty pharmaceutical companies, including Valeant Pharmaceuticals International (VRX), Horizon Pharma (HZNP), Perrigo (PRGO), and Mallinckrodt (MNK), have been under pressure for a while now, as investors have remained focused on their business models of raising prices.  In offering her upbeat view on specialty-pharmaceutical companies, Chen recommends investors to not ""look back, because objects in the rearview mirror can appear closer than they are."" In fact, she claims that management has already started to pivot from the old model of constantly rising prices, and the ones that can ""innovate and/or save the healthcare system money can thrive under the new order."" Chen initiated coverage on Aclaris Therapeutics (ACRS), Horizon Pharma, Impax Laboratories (IPXL), Mallinckrodt, Perrigo, Theravance Biopharma (TBPH), Valeant, Zoetis (ZTS), and Shire (SHPG), which she calls her ""highest conviction recommendation."
VRX,VRX:CT,BBG000DC8S17,Valeant: Stop Looking in the Rearview Mirror!,2017-06-16 14:54:00 +0000,http://finance.yahoo.com/r/69438647-ba8c-3191-ae88-69965c377bac/valeant-stop-looking-in-the-rearview-mirror-1497624875?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of specialty pharmaceutical companies, including Valeant Pharmaceuticals International (VRX), Horizon Pharma (HZNP), Perrigo (PRGO), and Mallinckrodt (MNK), have been under pressure for a while now, as investors have remained focused on their business models of raising prices.  In offering her upbeat view on specialty-pharmaceutical companies, Chen recommends investors to not ""look back, because objects in the rearview mirror can appear closer than they are."" In fact, she claims that management has already started to pivot from the old model of constantly rising prices, and the ones that can ""innovate and/or save the healthcare system money can thrive under the new order."" Chen initiated coverage on Aclaris Therapeutics (ACRS), Horizon Pharma, Impax Laboratories (IPXL), Mallinckrodt, Perrigo, Theravance Biopharma (TBPH), Valeant, Zoetis (ZTS), and Shire (SHPG), which she calls her ""highest conviction recommendation."
VRX,VRX:CT,BBG000DC8S17,3 Dividend Stocks in Healthcare,2017-06-16 14:10:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GtNVYqGiDqk/3-dividend-stocks-in-healthcare-cm804267,The healthcare sector can be an enormously profitable area to hunt for dividend stocks Top healthcare companies after all often sport ginormous free cash flows and sustainable levels of growth Based on this insight we turned to our contributors to ask them which
VRX,VRX:US,BBG000DLFM21,3 Dividend Stocks in Healthcare,2017-06-16 14:10:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GtNVYqGiDqk/3-dividend-stocks-in-healthcare-cm804267,The healthcare sector can be an enormously profitable area to hunt for dividend stocks Top healthcare companies after all often sport ginormous free cash flows and sustainable levels of growth Based on this insight we turned to our contributors to ask them which
VRX,VRX:US,BBG000DLFM21,"Cantor’s First Take: Bullish on Valeant Pharmaceuticals Intl Inc (VRX), Sidelined on Endo International (ENDP)",2017-06-16 13:10:43 +0000,https://finance.yahoo.com/news/cantor-first-bullish-valeant-pharmaceuticals-131043955.html?.tsrc=rss,"Cantor analyst Louise Chen is out with initiation reports assessing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with more confidence than the rest of the Street's sentiment, but less positive on Endo International plc (NASDAQ:ENDP).  The Street is not giving enough credence to the strength of Valeant's pipeline, wagers Chen.  According to TipRanks, which measures analysts' and bloggers' success rate based on how their calls perform, Louise Chen is ranked #4,497 out of 4,574 analysts."
VRX,VRX:CT,BBG000DC8S17,"Cantor’s First Take: Bullish on Valeant Pharmaceuticals Intl Inc (VRX), Sidelined on Endo International (ENDP)",2017-06-16 13:10:43 +0000,https://finance.yahoo.com/news/cantor-first-bullish-valeant-pharmaceuticals-131043955.html?.tsrc=rss,"Cantor analyst Louise Chen is out with initiation reports assessing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with more confidence than the rest of the Street's sentiment, but less positive on Endo International plc (NASDAQ:ENDP).  The Street is not giving enough credence to the strength of Valeant's pipeline, wagers Chen.  According to TipRanks, which measures analysts' and bloggers' success rate based on how their calls perform, Louise Chen is ranked #4,497 out of 4,574 analysts."
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jun 16, 2017 :  FTI, OAKS, VRX, STM, FNSR, FCAU, KR, QQQ, NVDA, USLV, AUPH, XIV",2017-06-16 12:56:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mG__tOadois/pre-market-most-active-for-jun-16-2017-fti-oaks-vrx-stm-fnsr-fcau-kr-qqq-nvda-uslv-auph-xiv-cm804227,The NASDAQ 100 Pre Market Indicator is up 7 38 to 5 708 27 The total Pre Market volume is currently 3 869 040 shares traded The following are the most active stocks for the pre market session TechnipFMC plc FTI is 0 35 at 27 31 with 605 968 shares traded following
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jun 16, 2017 :  FTI, OAKS, VRX, STM, FNSR, FCAU, KR, QQQ, NVDA, USLV, AUPH, XIV",2017-06-16 12:56:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mG__tOadois/pre-market-most-active-for-jun-16-2017-fti-oaks-vrx-stm-fnsr-fcau-kr-qqq-nvda-uslv-auph-xiv-cm804227,The NASDAQ 100 Pre Market Indicator is up 7 38 to 5 708 27 The total Pre Market volume is currently 3 869 040 shares traded The following are the most active stocks for the pre market session TechnipFMC plc FTI is 0 35 at 27 31 with 605 968 shares traded following
VRX,VRX:US,BBG000DLFM21,"Morning Movers: Celgene Gains, Nike Drops, Valeant Rises",2017-06-16 12:30:00 +0000,http://finance.yahoo.com/r/a5985b1e-def4-39bf-a71c-64afe4228996/morning-movers-celgene-gains-nike-drops-valeant-rises-1497616254?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open this morning following recent selling pressure. S&P 500 futures have risen 0.1%, while Dow Jones Industrial Average futures have advanced 0.1%. Nasdaq Composite futures ..."
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: Celgene Gains, Nike Drops, Valeant Rises",2017-06-16 12:30:00 +0000,http://finance.yahoo.com/r/a5985b1e-def4-39bf-a71c-64afe4228996/morning-movers-celgene-gains-nike-drops-valeant-rises-1497616254?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open this morning following recent selling pressure. S&P 500 futures have risen 0.1%, while Dow Jones Industrial Average futures have advanced 0.1%. Nasdaq Composite futures ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary,2017-06-16 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FO6s8vukHPs/canadian-stocks-are-paring-their-early-losses--canadian-commentary-20170616-00465,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary,2017-06-16 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FO6s8vukHPs/canadian-stocks-are-paring-their-early-losses--canadian-commentary-20170616-00465,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Great Speculative Value,2017-06-16 01:07:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RWKcsWfyEMA/valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-great-speculative-value-cm804173,InvestorPlace Stock Market News Stock Advice amp Trading Tips Are you a contrarian but also like the company of a storied value investor on your side Then look no further than Valeant Pharmaceuticals Intl Inc NYSE VRX But instead of buying VRX stock you re also not alone
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Great Speculative Value,2017-06-16 01:07:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RWKcsWfyEMA/valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-great-speculative-value-cm804173,InvestorPlace Stock Market News Stock Advice amp Trading Tips Are you a contrarian but also like the company of a storied value investor on your side Then look no further than Valeant Pharmaceuticals Intl Inc NYSE VRX But instead of buying VRX stock you re also not alone
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Great Speculative Value,2017-06-15 19:38:21 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-193821171.html?.tsrc=rss,"Then look no further than Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  VRX stock has been on the rebound since I last wrote about the much-maligned — and rightfully so — drug company in late March.  Given the past success, you might think I’m doubling down on VRX stock as a bear, but you’d be wrong."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Great Speculative Value,2017-06-15 19:38:21 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-193821171.html?.tsrc=rss,"Then look no further than Valeant Pharmaceuticals Intl Inc (NYSE:VRX).  VRX stock has been on the rebound since I last wrote about the much-maligned — and rightfully so — drug company in late March.  Given the past success, you might think I’m doubling down on VRX stock as a bear, but you’d be wrong."
VRX,VRX:CT,BBG000DC8S17,"The 2 Best Bill Miller Stock Picks (AMZN,VRX)",2017-06-14 22:07:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lk9UV1v4v2c/the-2-best-bill-miller-stock-picks-amznvrx-cm803587,InvestorPlace Stock Market News Stock Advice amp Trading Tips Bill Miller is back on a winning streak Once a hero of Wall Street with an enviable record of 15 straight years of beating the S amp P 500 he suffered the same fate as everyday investors during the
VRX,VRX:US,BBG000DLFM21,"The 2 Best Bill Miller Stock Picks (AMZN,VRX)",2017-06-14 22:07:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lk9UV1v4v2c/the-2-best-bill-miller-stock-picks-amznvrx-cm803587,InvestorPlace Stock Market News Stock Advice amp Trading Tips Bill Miller is back on a winning streak Once a hero of Wall Street with an enviable record of 15 straight years of beating the S amp P 500 he suffered the same fate as everyday investors during the
VRX,VRX:US,BBG000DLFM21,Analysts Predict 11% Upside For The Holdings of PPH,2017-06-14 14:09:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UR0lJhmcYxo/analysts-predict-11-upside-for-the-holdings-of-pph-cm803258,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
VRX,VRX:CT,BBG000DC8S17,Analysts Predict 11% Upside For The Holdings of PPH,2017-06-14 14:09:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UR0lJhmcYxo/analysts-predict-11-upside-for-the-holdings-of-pph-cm803258,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
VRX,VRX:US,BBG000DLFM21,Valeant  (VRX) Down 4% Since Earnings Report: Can It Rebound?,2017-06-14 13:10:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W5qEpLSvu0I/valeant-vrx-down-4-since-earnings-report-can-it-rebound-cm803109,A month has gone by since the last earnings report for Valeant Pharmaceuticals International Inc VRX Shares have lost about 4 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a
VRX,VRX:CT,BBG000DC8S17,Valeant  (VRX) Down 4% Since Earnings Report: Can It Rebound?,2017-06-14 13:10:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W5qEpLSvu0I/valeant-vrx-down-4-since-earnings-report-can-it-rebound-cm803109,A month has gone by since the last earnings report for Valeant Pharmaceuticals International Inc VRX Shares have lost about 4 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Down 4% Since Earnings Report: Can It Rebound?,2017-06-14 11:07:11 +0000,https://finance.yahoo.com/news/valeant-vrx-down-4-since-110711944.html?.tsrc=rss,Valeant (VRX) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Down 4% Since Earnings Report: Can It Rebound?,2017-06-14 11:07:11 +0000,https://finance.yahoo.com/news/valeant-vrx-down-4-since-110711944.html?.tsrc=rss,Valeant (VRX) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Energy Stocks Struggle - Canadian Commentary,2017-06-14 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jd9mwAPRKGQ/canadian-stocks-are-falling-as-energy-stocks-struggle--canadian-commentary-20170614-00763,Canadian Stocks Are Falling As Energy Stocks Struggle - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Energy Stocks Struggle - Canadian Commentary,2017-06-14 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jd9mwAPRKGQ/canadian-stocks-are-falling-as-energy-stocks-struggle--canadian-commentary-20170614-00763,Canadian Stocks Are Falling As Energy Stocks Struggle - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Tesla Inc (TSLA) Stock May Face a Reckoning,2017-06-13 13:50:30 +0000,https://finance.yahoo.com/news/tesla-inc-tsla-stock-may-135030975.html?.tsrc=rss,Tesla Inc (NASDAQ:TSLA) is perhaps the most controversial stock on Wall Street.  Then there is Chamath Palihapitiya — a venture capitalist and former alum of Facebook Inc (NASDAQ:FB) alum — who believes that Tesla stock could be the next Apple Inc. (NASDAQ:AAPL).  Note that he has purchased convertible securities in Tesla stock!
VRX,VRX:CT,BBG000DC8S17,Tesla Inc (TSLA) Stock May Face a Reckoning,2017-06-13 13:50:30 +0000,https://finance.yahoo.com/news/tesla-inc-tsla-stock-may-135030975.html?.tsrc=rss,Tesla Inc (NASDAQ:TSLA) is perhaps the most controversial stock on Wall Street.  Then there is Chamath Palihapitiya — a venture capitalist and former alum of Facebook Inc (NASDAQ:FB) alum — who believes that Tesla stock could be the next Apple Inc. (NASDAQ:AAPL).  Note that he has purchased convertible securities in Tesla stock!
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Commodity Prices Weaken - Canadian Commentary,2017-06-13 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0cvNDPRYHKQ/canadian-stocks-are-falling-as-commodity-prices-weaken--canadian-commentary-20170613-00840,Canadian Stocks Are Falling As Commodity Prices Weaken - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Commodity Prices Weaken - Canadian Commentary,2017-06-13 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0cvNDPRYHKQ/canadian-stocks-are-falling-as-commodity-prices-weaken--canadian-commentary-20170613-00840,Canadian Stocks Are Falling As Commodity Prices Weaken - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M,2017-06-12 23:27:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iZB1D9veufc/valeant-inks-deal-to-divest-inova-pharmaceuticals-for-930m-cm802384,Valeant Pharmaceuticals International Inc VRX announced that it has signed a deal to sell iNova Pharmaceuticals for 930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group Shares of Valeant Pharma have underperformed
VRX,VRX:CT,BBG000DC8S17,Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M,2017-06-12 23:27:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iZB1D9veufc/valeant-inks-deal-to-divest-inova-pharmaceuticals-for-930m-cm802384,Valeant Pharmaceuticals International Inc VRX announced that it has signed a deal to sell iNova Pharmaceuticals for 930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group Shares of Valeant Pharma have underperformed
VRX,VRX:CT,BBG000DC8S17,Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M,2017-06-12 20:49:08 +0000,https://finance.yahoo.com/news/valeant-inks-deal-divest-inova-204908752.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced that it has signed a deal to sell iNova Pharmaceuticals for $930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group."
VRX,VRX:US,BBG000DLFM21,Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M,2017-06-12 20:49:08 +0000,https://finance.yahoo.com/news/valeant-inks-deal-divest-inova-204908752.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced that it has signed a deal to sell iNova Pharmaceuticals for $930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group."
VRX,VRX:US,BBG000DLFM21,Valeant: Accentuate the Positive?,2017-06-12 19:02:00 +0000,http://finance.yahoo.com/r/09d54e56-e1df-312f-891d-d1dfbc93ebd4/valeant-accentuate-the-positive-1497294171?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last Thursday, shares of Valeant Pharmaceuticals International (VRX) jumped 9% after the company announced that it had sold its iNova business for more than $900 million, with the proceeds set aside for paying down its debt.  In a report from June 8, RBC's Douglas Miehm and Joel Hurren, who rate Valeant Market Perform with a $19 target price, contend that not only was iNova sold last week, but ""more importantly, VRX has executed on its strategy again."" They explain: Progress continues toward $5B in debt repayment by February 2018.  Management continues to make progress towards its commitment to $5B of debt repayment by Feb/18."
VRX,VRX:CT,BBG000DC8S17,Valeant: Accentuate the Positive?,2017-06-12 19:02:00 +0000,http://finance.yahoo.com/r/09d54e56-e1df-312f-891d-d1dfbc93ebd4/valeant-accentuate-the-positive-1497294171?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last Thursday, shares of Valeant Pharmaceuticals International (VRX) jumped 9% after the company announced that it had sold its iNova business for more than $900 million, with the proceeds set aside for paying down its debt.  In a report from June 8, RBC's Douglas Miehm and Joel Hurren, who rate Valeant Market Perform with a $19 target price, contend that not only was iNova sold last week, but ""more importantly, VRX has executed on its strategy again."" They explain: Progress continues toward $5B in debt repayment by February 2018.  Management continues to make progress towards its commitment to $5B of debt repayment by Feb/18."
VRX,VRX:CT,BBG000DC8S17,Trader Who Called Valeant Short Predicts Nvidia Decline,2017-06-12 18:08:00 +0000,http://finance.yahoo.com/r/affe9780-37e8-3a3e-b6e7-d7dc463b4be9/trader-who-called-valeant-short-predicts-nvidia-decline-vrx-nvda?partner=YahooSA&yptr=yahoo&.tsrc=rss,Andrew Left of Citron Research successfully shorted Valeant and other companies. Now he sees Nvidia as the latest target.
VRX,VRX:US,BBG000DLFM21,Trader Who Called Valeant Short Predicts Nvidia Decline,2017-06-12 18:08:00 +0000,http://finance.yahoo.com/r/affe9780-37e8-3a3e-b6e7-d7dc463b4be9/trader-who-called-valeant-short-predicts-nvidia-decline-vrx-nvda?partner=YahooSA&yptr=yahoo&.tsrc=rss,Andrew Left of Citron Research successfully shorted Valeant and other companies. Now he sees Nvidia as the latest target.
VRX,VRX:US,BBG000DLFM21,It's Happening Again: Valeant's Stock Jumped for a Silly Reason,2017-06-12 17:28:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FWm-p5AWlyc/its-happening-again-valeants-stock-jumped-for-a-silly-reason-cm802214,Read closely because we don t get to say this all too often Valeant Pharmaceuticals NYSE VRX stock had a great day on Thursday The embattled drugmaker known for growing by acquisition had lost 95 of its market value since reaching 264 per share in the summer of 2015
VRX,VRX:CT,BBG000DC8S17,It's Happening Again: Valeant's Stock Jumped for a Silly Reason,2017-06-12 17:28:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FWm-p5AWlyc/its-happening-again-valeants-stock-jumped-for-a-silly-reason-cm802214,Read closely because we don t get to say this all too often Valeant Pharmaceuticals NYSE VRX stock had a great day on Thursday The embattled drugmaker known for growing by acquisition had lost 95 of its market value since reaching 264 per share in the summer of 2015
VRX,VRX:US,BBG000DLFM21,"Billionaire Israel ‘Izzy’ Englander Bets on Three Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP)",2017-06-12 16:40:55 +0000,https://finance.yahoo.com/news/billionaire-israel-izzy-englander-bets-164055145.html?.tsrc=rss,"Israel ""Izzy"" Englander is a self-made man living the American dream, whose Polish parents have since seen their son carve out a small fortune for himself of a whopping $5.2 billion.  An NYU graduate, this hedge fund guru kick-started Millenium Management 28 years ago, taking the firm from $35 million to now $34 billion in assets.  A man who once worked along Wall Street, Englander learned the ins and outs of the financial world, managing to return 13% for Millenium seven years ago, and achieving a 6% rise one year later."
VRX,VRX:CT,BBG000DC8S17,"Billionaire Israel ‘Izzy’ Englander Bets on Three Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP)",2017-06-12 16:40:55 +0000,https://finance.yahoo.com/news/billionaire-israel-izzy-englander-bets-164055145.html?.tsrc=rss,"Israel ""Izzy"" Englander is a self-made man living the American dream, whose Polish parents have since seen their son carve out a small fortune for himself of a whopping $5.2 billion.  An NYU graduate, this hedge fund guru kick-started Millenium Management 28 years ago, taking the firm from $35 million to now $34 billion in assets.  A man who once worked along Wall Street, Englander learned the ins and outs of the financial world, managing to return 13% for Millenium seven years ago, and achieving a 6% rise one year later."
VRX,VRX:US,BBG000DLFM21,It&apos;s Happening Again: Valeant&apos;s Stock Jumped for a Silly Reason,2017-06-12 15:46:00 +0000,http://finance.yahoo.com/r/a08967dd-2db1-38fe-954d-42070f5a344b/its-happening-again-valeants-stock-jumped-for-a-si.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s sale of iNova Pharmaceuticals doesn&apos;t change a thing.
VRX,VRX:CT,BBG000DC8S17,It&apos;s Happening Again: Valeant&apos;s Stock Jumped for a Silly Reason,2017-06-12 15:46:00 +0000,http://finance.yahoo.com/r/a08967dd-2db1-38fe-954d-42070f5a344b/its-happening-again-valeants-stock-jumped-for-a-si.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s sale of iNova Pharmaceuticals doesn&apos;t change a thing.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-06-12 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EODEyEGDxe4/canadian-stocks-are-paring-early-gains--canadian-commentary-20170612-00699,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-06-12 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EODEyEGDxe4/canadian-stocks-are-paring-early-gains--canadian-commentary-20170612-00699,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,What Valeant Pharmaceuticals' Latest Sale Means (and Doesn't Mean) for Investors,2017-06-10 17:26:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YXA9cfr7N7o/what-valeant-pharmaceuticals-latest-sale-means-and-doesnt-mean-for-investors-cm801614,Believe it or not Valeant Pharmaceuticals NYSE VRX is on a roll Shares of the beleaguered drugmaker are up over 30 in the last month Most of those gains stemmed from Valeant reporting a profit in the first quarter and raising its full year 2017 guidance However the
VRX,VRX:CT,BBG000DC8S17,What Valeant Pharmaceuticals' Latest Sale Means (and Doesn't Mean) for Investors,2017-06-10 17:26:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YXA9cfr7N7o/what-valeant-pharmaceuticals-latest-sale-means-and-doesnt-mean-for-investors-cm801614,Believe it or not Valeant Pharmaceuticals NYSE VRX is on a roll Shares of the beleaguered drugmaker are up over 30 in the last month Most of those gains stemmed from Valeant reporting a profit in the first quarter and raising its full year 2017 guidance However the
VRX,VRX:CT,BBG000DC8S17,What Valeant Pharmaceuticals&apos; Latest Sale Means (and Doesn&apos;t Mean) for Investors,2017-06-10 16:03:00 +0000,http://finance.yahoo.com/r/b6a8acf7-255b-368e-8077-1f4d5b9bb8bd/what-valeant-pharmaceuticals-latest-sale-means-and.aspx?yptr=yahoo&.tsrc=rss,Valeant plans to sell iNova Pharmaceuticals. Good news? Yes. Great news? Not really.
VRX,VRX:US,BBG000DLFM21,What Valeant Pharmaceuticals&apos; Latest Sale Means (and Doesn&apos;t Mean) for Investors,2017-06-10 16:03:00 +0000,http://finance.yahoo.com/r/b6a8acf7-255b-368e-8077-1f4d5b9bb8bd/what-valeant-pharmaceuticals-latest-sale-means-and.aspx?yptr=yahoo&.tsrc=rss,Valeant plans to sell iNova Pharmaceuticals. Good news? Yes. Great news? Not really.
VRX,VRX:CT,BBG000DC8S17,"Is First Solar, Inc. (FSLR) Stock a Good Bet on the Solar Revolution?",2017-06-09 21:29:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byEVq1zMmHI/is-first-solar-inc-fslr-stock-a-good-bet-on-the-solar-revolution-cm801523,InvestorPlace Stock Market News Stock Advice amp Trading Tips In the ever expanding world of opportunities in the renewable energy space companies operating in the solar and wind categories have seen increased interest of late following the recent buzz concerning the
VRX,VRX:US,BBG000DLFM21,"Is First Solar, Inc. (FSLR) Stock a Good Bet on the Solar Revolution?",2017-06-09 21:29:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byEVq1zMmHI/is-first-solar-inc-fslr-stock-a-good-bet-on-the-solar-revolution-cm801523,InvestorPlace Stock Market News Stock Advice amp Trading Tips In the ever expanding world of opportunities in the renewable energy space companies operating in the solar and wind categories have seen increased interest of late following the recent buzz concerning the
VRX,VRX:CT,BBG000DC8S17,UnitedHealth Group Inc (UNH) Stock Is a Healthy Buy Even at All-Time Highs,2017-06-09 20:29:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RCe4_v96Hn8/unitedhealth-group-inc-unh-stock-is-a-healthy-buy-even-at-all-time-highs-cm801485,InvestorPlace Stock Market News Stock Advice amp Trading Tips As those who invest with me know I focus a lot of my strategy on owning great American companies I believe this is the best way to build long term wealth and now is a great time to be buying these kinds of
VRX,VRX:US,BBG000DLFM21,UnitedHealth Group Inc (UNH) Stock Is a Healthy Buy Even at All-Time Highs,2017-06-09 20:29:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RCe4_v96Hn8/unitedhealth-group-inc-unh-stock-is-a-healthy-buy-even-at-all-time-highs-cm801485,InvestorPlace Stock Market News Stock Advice amp Trading Tips As those who invest with me know I focus a lot of my strategy on owning great American companies I believe this is the best way to build long term wealth and now is a great time to be buying these kinds of
VRX,VRX:CT,BBG000DC8S17,"Citron's Andrew Left Hammers Nvidia (NVDA), Shares Dip",2017-06-09 19:27:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ieouhnTKJNY/citrons-andrew-left-hammers-nvidia-nvda-shares-dip-cm801371,Shares of Nvidia Corporation NVDA fell more than 7 from their intraday peak slumping nearly 2 5 from yesterday s closing price after the company was called out by notorious short seller Citron Research on Friday The buzz began when Citron s Andrew Left who rose to fame after
VRX,VRX:US,BBG000DLFM21,"Citron's Andrew Left Hammers Nvidia (NVDA), Shares Dip",2017-06-09 19:27:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ieouhnTKJNY/citrons-andrew-left-hammers-nvidia-nvda-shares-dip-cm801371,Shares of Nvidia Corporation NVDA fell more than 7 from their intraday peak slumping nearly 2 5 from yesterday s closing price after the company was called out by notorious short seller Citron Research on Friday The buzz began when Citron s Andrew Left who rose to fame after
VRX,VRX:US,BBG000DLFM21,Valeant: What It Wants You to Ignore?,2017-06-09 18:47:00 +0000,http://finance.yahoo.com/r/c98f493f-4d97-34e2-b000-0a27d35b4f59/valeant-what-it-wants-you-to-ignore-1497034025?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have surged almost 50% since bottoming at $8.51 on April 21, with beleaguered specialty-pharmaceutical company getting a boost from asset sales, better ..."
VRX,VRX:CT,BBG000DC8S17,Valeant: What It Wants You to Ignore?,2017-06-09 18:47:00 +0000,http://finance.yahoo.com/r/c98f493f-4d97-34e2-b000-0a27d35b4f59/valeant-what-it-wants-you-to-ignore-1497034025?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have surged almost 50% since bottoming at $8.51 on April 21, with beleaguered specialty-pharmaceutical company getting a boost from asset sales, better ..."
VRX,VRX:US,BBG000DLFM21,What Valeant Pharmaceuticals' $930 Million Deal Means,2017-06-09 15:29:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eJiAaqKIq18/what-valeant-pharmaceuticals-930-million-deal-means-cm801177,Valeant Pharmaceuticals NYSE VRX 160 is laser focused on reducing its debt and it took another step toward improving its balance sheet yesterday by agreeing to divest its iNova Pharmaceuticals business to a company backed by the investment managers Carlyle Group and Pacific
VRX,VRX:CT,BBG000DC8S17,What Valeant Pharmaceuticals' $930 Million Deal Means,2017-06-09 15:29:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eJiAaqKIq18/what-valeant-pharmaceuticals-930-million-deal-means-cm801177,Valeant Pharmaceuticals NYSE VRX 160 is laser focused on reducing its debt and it took another step toward improving its balance sheet yesterday by agreeing to divest its iNova Pharmaceuticals business to a company backed by the investment managers Carlyle Group and Pacific
VRX,VRX:CT,BBG000DC8S17,What Valeant Pharmaceuticals&apos; $930 Million Deal Means,2017-06-09 14:00:00 +0000,http://finance.yahoo.com/r/d7270ccf-6f0b-305d-aced-eb52c2867cf9/valeant-pharmaceuticals-inks-a-930-million-deal.aspx?yptr=yahoo&.tsrc=rss,The company is selling its iNova Pharmaceuticals unit for $930 million as part of its effort to downsize its debt.
VRX,VRX:US,BBG000DLFM21,What Valeant Pharmaceuticals&apos; $930 Million Deal Means,2017-06-09 14:00:00 +0000,http://finance.yahoo.com/r/d7270ccf-6f0b-305d-aced-eb52c2867cf9/valeant-pharmaceuticals-inks-a-930-million-deal.aspx?yptr=yahoo&.tsrc=rss,The company is selling its iNova Pharmaceuticals unit for $930 million as part of its effort to downsize its debt.
VRX,VRX:US,BBG000DLFM21,Instant Analysis: Valeant to Sell iNova Unit for $930 Million,2017-06-09 13:29:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/32S9Af4F7q0/instant-analysis-valeant-to-sell-inova-unit-for-930-million-cm801038,What happened Valeant Pharmaceuticals NYSE VRX is shedding one of its business units The company has struck a deal to unload its iNova Pharmaceuticals business for 930 million The buyer is a company jointly owned by affiliates of alternative asset manager Carlyle
VRX,VRX:CT,BBG000DC8S17,Instant Analysis: Valeant to Sell iNova Unit for $930 Million,2017-06-09 13:29:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/32S9Af4F7q0/instant-analysis-valeant-to-sell-inova-unit-for-930-million-cm801038,What happened Valeant Pharmaceuticals NYSE VRX is shedding one of its business units The company has struck a deal to unload its iNova Pharmaceuticals business for 930 million The buyer is a company jointly owned by affiliates of alternative asset manager Carlyle
VRX,VRX:US,BBG000DLFM21,"Canaccord Lifts Price Target on Valeant Pharmaceuticals Intl Inc (VRX), Cuts Endo International plc",2017-06-09 13:08:47 +0000,https://finance.yahoo.com/news/canaccord-lifts-price-target-valeant-130847661.html?.tsrc=rss,"Canaccord analysts are out with neutral standpoints on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo International plc (NASDAQ:ENDP).  Canaccord analyst Neil Maruoka raised his price target for Valeant shares to $14.00 (from $12.00), following the news that the drug maker has agreed to sell iNova Pharmaceuticals for $930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group."
VRX,VRX:CT,BBG000DC8S17,"Canaccord Lifts Price Target on Valeant Pharmaceuticals Intl Inc (VRX), Cuts Endo International plc",2017-06-09 13:08:47 +0000,https://finance.yahoo.com/news/canaccord-lifts-price-target-valeant-130847661.html?.tsrc=rss,"Canaccord analysts are out with neutral standpoints on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo International plc (NASDAQ:ENDP).  Canaccord analyst Neil Maruoka raised his price target for Valeant shares to $14.00 (from $12.00), following the news that the drug maker has agreed to sell iNova Pharmaceuticals for $930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals,2017-06-09 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000268.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 9, 2017 / Shares of Endo International may have closed the day in the green but everything changed after hours when the stock plunged into the red. The FDA has asked the ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals,2017-06-09 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000268.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 9, 2017 / Shares of Endo International may have closed the day in the green but everything changed after hours when the stock plunged into the red. The FDA has asked the ..."
VRX,VRX:CT,BBG000DC8S17,Instant Analysis: Valeant to Sell iNova Unit for $930 Million,2017-06-09 11:57:00 +0000,http://finance.yahoo.com/r/77961f48-15f8-3c57-b460-b07487ad901d/instant-analysis-valeant-to-sell-inova-unit-for-93.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s latest divestment is part of a strategy to slim down and raise funds for debt retirement.
VRX,VRX:US,BBG000DLFM21,Instant Analysis: Valeant to Sell iNova Unit for $930 Million,2017-06-09 11:57:00 +0000,http://finance.yahoo.com/r/77961f48-15f8-3c57-b460-b07487ad901d/instant-analysis-valeant-to-sell-inova-unit-for-93.aspx?yptr=yahoo&.tsrc=rss,Valeant&apos;s latest divestment is part of a strategy to slim down and raise funds for debt retirement.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Strong Jobs Data - Canadian Commentary,2017-06-09 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xu8cVfrPplg/canadian-stocks-are-rising-on-strong-jobs-data--canadian-commentary-20170609-00557,Canadian Stocks Are Rising On Strong Jobs Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Strong Jobs Data - Canadian Commentary,2017-06-09 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xu8cVfrPplg/canadian-stocks-are-rising-on-strong-jobs-data--canadian-commentary-20170609-00557,Canadian Stocks Are Rising On Strong Jobs Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,[$$] Valeant to Sell iNova Unit for $930 Million,2017-06-09 05:21:16 +0000,http://finance.yahoo.com/r/edb8c4c5-26cc-3aa1-a289-2afa6ac0c553/valeant-to-sell-inova-unit-for-930-million-1496922848?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals reached a deal to sell its iNova Pharmaceuticals unit for $930 million, as it works to reset itself after a crisis, cutting billions in debt and refocusing on its core treatment ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant to Sell iNova Unit for $930 Million,2017-06-09 05:21:16 +0000,http://finance.yahoo.com/r/edb8c4c5-26cc-3aa1-a289-2afa6ac0c553/valeant-to-sell-inova-unit-for-930-million-1496922848?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals reached a deal to sell its iNova Pharmaceuticals unit for $930 million, as it works to reset itself after a crisis, cutting billions in debt and refocusing on its core treatment ..."
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl. Inc. Jumped Higher Today,2017-06-08 22:28:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T8KCzBKxAEM/why-valeant-pharmaceuticals-intl-inc-jumped-higher-today-cm800912,What happened Shares of Valeant Pharmaceuticals NYSE VRX closed up 9 having been up as much as 10 7 today after the drugmaker announced 160 that it is selling its iNova Pharmaceuticals business to a pair of private equity groups for 930 million in cash
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl. Inc. Jumped Higher Today,2017-06-08 22:28:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T8KCzBKxAEM/why-valeant-pharmaceuticals-intl-inc-jumped-higher-today-cm800912,What happened Shares of Valeant Pharmaceuticals NYSE VRX closed up 9 having been up as much as 10 7 today after the drugmaker announced 160 that it is selling its iNova Pharmaceuticals business to a pair of private equity groups for 930 million in cash
VRX,VRX:CT,BBG000DC8S17,This Bullish BlackBerry Ltd (BBRY) Stock Note May Have Underestimated It,2017-06-08 21:29:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RCQo3RshUsc/this-bullish-blackberry-ltd-bbry-stock-note-may-have-underestimated-it-cm800920,InvestorPlace Stock Market News Stock Advice amp Trading Tips Macquarie analyst Gus Papageorgiou recently predicted that BlackBerry Ltd NADSAQ BBRY stock could reach 45 by 2020 However the analyst may have underestimated the potential of BBRY stock
VRX,VRX:US,BBG000DLFM21,This Bullish BlackBerry Ltd (BBRY) Stock Note May Have Underestimated It,2017-06-08 21:29:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RCQo3RshUsc/this-bullish-blackberry-ltd-bbry-stock-note-may-have-underestimated-it-cm800920,InvestorPlace Stock Market News Stock Advice amp Trading Tips Macquarie analyst Gus Papageorgiou recently predicted that BlackBerry Ltd NADSAQ BBRY stock could reach 45 by 2020 However the analyst may have underestimated the potential of BBRY stock
VRX,VRX:CT,BBG000DC8S17,Why Bank of America Corp (BAC) Stock Will Reward Your Patience,2017-06-08 21:29:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AzHAOOrREqw/why-bank-of-america-corp-bac-stock-will-reward-your-patience-cm800919,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s no sugar coating the fact that the past three months haven t been great ones for Bank of America Corp NYSE BAC shareholders While BAC stock rallied 33 between the election of President Donald Trump and
VRX,VRX:US,BBG000DLFM21,Why Bank of America Corp (BAC) Stock Will Reward Your Patience,2017-06-08 21:29:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AzHAOOrREqw/why-bank-of-america-corp-bac-stock-will-reward-your-patience-cm800919,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s no sugar coating the fact that the past three months haven t been great ones for Bank of America Corp NYSE BAC shareholders While BAC stock rallied 33 between the election of President Donald Trump and
VRX,VRX:US,BBG000DLFM21,Top Market News: What Happened In Investing Today,2017-06-08 21:27:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-QEtIMrFQig/top-market-news-what-happened-in-investing-today-cm800906,By SA Editor Mike Taylor CFA BySA Editor Mike Taylor CFA Yahoo Verizon Yahoo VerizonYahoo Verizon I sort of regret that I never worked at freestanding Yahoo Wikipedia I sort of regret that I never worked at freestanding Yahoo Wikipedia Yahoo s YHOO
VRX,VRX:CT,BBG000DC8S17,Top Market News: What Happened In Investing Today,2017-06-08 21:27:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-QEtIMrFQig/top-market-news-what-happened-in-investing-today-cm800906,By SA Editor Mike Taylor CFA BySA Editor Mike Taylor CFA Yahoo Verizon Yahoo VerizonYahoo Verizon I sort of regret that I never worked at freestanding Yahoo Wikipedia I sort of regret that I never worked at freestanding Yahoo Wikipedia Yahoo s YHOO
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Hudbay Minerals, and Comtech Telecommunications Jumped Today",2017-06-08 20:32:00 +0000,http://finance.yahoo.com/r/d13ac2fe-baa0-3e41-a65c-f1ab2c09bece/why-valeant-pharmaceuticals-hudbay-minerals-and-co.aspx?yptr=yahoo&.tsrc=rss,"On another quiet day for the markets, these stocks posted big gains. Find out why."
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Hudbay Minerals, and Comtech Telecommunications Jumped Today",2017-06-08 20:32:00 +0000,http://finance.yahoo.com/r/d13ac2fe-baa0-3e41-a65c-f1ab2c09bece/why-valeant-pharmaceuticals-hudbay-minerals-and-co.aspx?yptr=yahoo&.tsrc=rss,"On another quiet day for the markets, these stocks posted big gains. Find out why."
VRX,VRX:CT,BBG000DC8S17,Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers,2017-06-08 20:30:00 +0000,http://finance.yahoo.com/r/9d50f0ec-9d75-3324-a962-05326ad26fcb/valeant-shares-soar-on-latest-divestiture-massive-debt-load-still-looms.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.
VRX,VRX:US,BBG000DLFM21,Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers,2017-06-08 20:30:00 +0000,http://finance.yahoo.com/r/9d50f0ec-9d75-3324-a962-05326ad26fcb/valeant-shares-soar-on-latest-divestiture-massive-debt-load-still-looms.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.
VRX,VRX:US,BBG000DLFM21,Don’t Buy the Valeant Pharmaceuticals Intl Inc (VRX) Stock Hype,2017-06-08 20:29:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/55rE7VoyF48/dont-buy-the-valeant-pharmaceuticals-intl-inc-vrx-stock-hype-cm800885,InvestorPlace Stock Market News Stock Advice amp Trading Tips True to his promise Valeant Pharmaceuticals Intl Inc NYSE VRX CEO Joseph Papa continues to work toward his goal of reducing the drugmaker s debt announcing the impending sale of iNova unit this morning The
VRX,VRX:CT,BBG000DC8S17,Don’t Buy the Valeant Pharmaceuticals Intl Inc (VRX) Stock Hype,2017-06-08 20:29:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/55rE7VoyF48/dont-buy-the-valeant-pharmaceuticals-intl-inc-vrx-stock-hype-cm800885,InvestorPlace Stock Market News Stock Advice amp Trading Tips True to his promise Valeant Pharmaceuticals Intl Inc NYSE VRX CEO Joseph Papa continues to work toward his goal of reducing the drugmaker s debt announcing the impending sale of iNova unit this morning The
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl. Inc. Jumped Higher Today,2017-06-08 20:24:00 +0000,http://finance.yahoo.com/r/46ea404f-08ac-3e78-be10-462fc6656b46/why-valeant-pharmaceuticals-intl-inc-jumped-higher.aspx?yptr=yahoo&.tsrc=rss,The pharmaceutical company continues to sell off assets to pay down debt.
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl. Inc. Jumped Higher Today,2017-06-08 20:24:00 +0000,http://finance.yahoo.com/r/46ea404f-08ac-3e78-be10-462fc6656b46/why-valeant-pharmaceuticals-intl-inc-jumped-higher.aspx?yptr=yahoo&.tsrc=rss,The pharmaceutical company continues to sell off assets to pay down debt.
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX ends higher as Valeant bounces, banks gain",2017-06-08 20:14:16 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-ends-higher-201416833.html?.tsrc=rss,"Canada's main stock index ended higher on Thursday, helped by gains for banking stocks after the Bank of Canada said it considers the system robust and a jump in Valeant Pharmaceuticals after it announced ..."
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX ends higher as Valeant bounces, banks gain",2017-06-08 20:14:16 +0000,https://finance.yahoo.com/news/canada-stocks-tsx-ends-higher-201416833.html?.tsrc=rss,"Canada's main stock index ended higher on Thursday, helped by gains for banking stocks after the Bank of Canada said it considers the system robust and a jump in Valeant Pharmaceuticals after it announced ..."
VRX,VRX:CT,BBG000DC8S17,Stocks Deflate as Wall Street Digests Fallout of Comey Testimony,2017-06-08 18:51:00 +0000,http://finance.yahoo.com/r/88433a3c-5841-3942-a409-f11757e3cf60/stocks-tiptoe-higher-as-comey-talks-russia-interference-discussions-with-trump.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks deflate from session highs on Thursday as Wall Street digests public testimony from former FBI Director James Comey.
VRX,VRX:US,BBG000DLFM21,Stocks Deflate as Wall Street Digests Fallout of Comey Testimony,2017-06-08 18:51:00 +0000,http://finance.yahoo.com/r/88433a3c-5841-3942-a409-f11757e3cf60/stocks-tiptoe-higher-as-comey-talks-russia-interference-discussions-with-trump.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks deflate from session highs on Thursday as Wall Street digests public testimony from former FBI Director James Comey.
VRX,VRX:US,BBG000DLFM21,Valeant Still Has A Big Debt Problem,2017-06-08 17:37:00 +0000,http://finance.yahoo.com/r/e7ef6ddc-1fb2-350c-9175-fd3d7fb7dbe2/valeant-still-has-big-debt-problem-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Valeant will sell its iNova Pharmaceuticals unit for $930 million, but it still has a huge debt."
VRX,VRX:CT,BBG000DC8S17,Valeant Still Has A Big Debt Problem,2017-06-08 17:37:00 +0000,http://finance.yahoo.com/r/e7ef6ddc-1fb2-350c-9175-fd3d7fb7dbe2/valeant-still-has-big-debt-problem-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Valeant will sell its iNova Pharmaceuticals unit for $930 million, but it still has a huge debt."
VRX,VRX:CT,BBG000DC8S17,UPDATE: Valeant Pharmaceuticals: Almost There?,2017-06-08 17:04:00 +0000,http://finance.yahoo.com/r/171f5a6d-2780-394d-8991-32b5fd6bc7c2/valeant-pharmaceuticals-almost-there-1496931454?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Valeant Pharmaceuticals International (VRX) are up nearly 8% today after the beleaguered specialty-pharmaceutical company said it had sold its iNova division for $930 million. The Wall Street ...
VRX,VRX:US,BBG000DLFM21,UPDATE: Valeant Pharmaceuticals: Almost There?,2017-06-08 17:04:00 +0000,http://finance.yahoo.com/r/171f5a6d-2780-394d-8991-32b5fd6bc7c2/valeant-pharmaceuticals-almost-there-1496931454?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Valeant Pharmaceuticals International (VRX) are up nearly 8% today after the beleaguered specialty-pharmaceutical company said it had sold its iNova division for $930 million. The Wall Street ...
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Bigger is Better,2017-06-08 16:54:00 +0000,http://finance.yahoo.com/r/bb6a5329-da8b-3dda-bf72-98a69c5a3a95/valeant-pharmaceuticals-bigger-is-better-1496940850?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) has sold its iNova division for $930 million.  Valeant plans to throw the cash from the sale at its debt load, bringing the company within $500 million of it goal of $5 billion in debt reduction by February 2018.  Gary Nacham at BMO Capital Markets was pleased to see Valeant “finally execute” on the deal and applauded the company’s aggressive debt reduction strategy.” Still, he notes the sale “does not move the needle on VRX’s net leverage, which remains at a very high 7.8x,” so assets sales “will need to continue and at some point will probably need to be of a much greater magnitude.” Meanwhile, he notes that the deal highlights some challenges for Valeant in executing these asset sales."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Bigger is Better,2017-06-08 16:54:00 +0000,http://finance.yahoo.com/r/bb6a5329-da8b-3dda-bf72-98a69c5a3a95/valeant-pharmaceuticals-bigger-is-better-1496940850?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) has sold its iNova division for $930 million.  Valeant plans to throw the cash from the sale at its debt load, bringing the company within $500 million of it goal of $5 billion in debt reduction by February 2018.  Gary Nacham at BMO Capital Markets was pleased to see Valeant “finally execute” on the deal and applauded the company’s aggressive debt reduction strategy.” Still, he notes the sale “does not move the needle on VRX’s net leverage, which remains at a very high 7.8x,” so assets sales “will need to continue and at some point will probably need to be of a much greater magnitude.” Meanwhile, he notes that the deal highlights some challenges for Valeant in executing these asset sales."
VRX,VRX:US,BBG000DLFM21,Today&apos;s charts: Nordstrom jumps on talks to go private; Valeant sells iNova Pharmaceuticals for $930M; Nvidia gets most bullish call,2017-06-08 16:32:03 +0000,https://finance.yahoo.com/news/todays-charts-nordstrom-jumps-talks-go-private-valeant-sells-inova-pharmaceuticals-930m-nvidia-gets-bullish-call-163203121.html?.tsrc=rss,"Yahoo Finance is tracking Nvidia, Valeant, Nordstrom and Alibaba in intraday trading on Thursday."
VRX,VRX:CT,BBG000DC8S17,Today&apos;s charts: Nordstrom jumps on talks to go private; Valeant sells iNova Pharmaceuticals for $930M; Nvidia gets most bullish call,2017-06-08 16:32:03 +0000,https://finance.yahoo.com/news/todays-charts-nordstrom-jumps-talks-go-private-valeant-sells-inova-pharmaceuticals-930m-nvidia-gets-bullish-call-163203121.html?.tsrc=rss,"Yahoo Finance is tracking Nvidia, Valeant, Nordstrom and Alibaba in intraday trading on Thursday."
VRX,VRX:US,BBG000DLFM21,"TSX Rises, Led By Banks -- Canadian Commentary",2017-06-08 16:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BXyU8yWoTYU/tsx-rises-led-by-banks--canadian-commentary-20170608-01143,"TSX Rises, Led By Banks -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"TSX Rises, Led By Banks -- Canadian Commentary",2017-06-08 16:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BXyU8yWoTYU/tsx-rises-led-by-banks--canadian-commentary-20170608-01143,"TSX Rises, Led By Banks -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,Today's charts: Nordstrom jumps on talks of going private; Nvidia's most bullish call yet; Valeant Pharmaceuticals gains,2017-06-08 16:06:50 +0000,https://finance.yahoo.com/video/todays-charts-nordstrom-jumps-talks-160650929.html?.tsrc=rss,"Yahoo Finance's Seana Smith is tracking Nvidia, Valeant Pharmaceuticals, Nordstrom and Alibaba in intraday trading on Thursday."
VRX,VRX:CT,BBG000DC8S17,Today's charts: Nordstrom jumps on talks of going private; Nvidia's most bullish call yet; Valeant Pharmaceuticals gains,2017-06-08 16:06:50 +0000,https://finance.yahoo.com/video/todays-charts-nordstrom-jumps-talks-160650929.html?.tsrc=rss,"Yahoo Finance's Seana Smith is tracking Nvidia, Valeant Pharmaceuticals, Nordstrom and Alibaba in intraday trading on Thursday."
VRX,VRX:US,BBG000DLFM21,Don’t Buy the Valeant Pharmaceuticals Intl Inc (VRX) Stock Hype,2017-06-08 15:27:39 +0000,https://finance.yahoo.com/news/don-t-buy-valeant-pharmaceuticals-152739543.html?.tsrc=rss,"True to his promise, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) CEO Joseph Papa continues to work toward his goal of reducing the drugmaker’s debt, announcing the impending sale of iNova unit this morning.  The market applauded the move, sending VRX stock up 8.7% in Thursday’s early trading, offsetting a similarly-sized loss from the day before.  As has been the case with Valeant Pharmaceuticals for a while now, it’s not clear if the plan does more harm than good."
VRX,VRX:CT,BBG000DC8S17,Don’t Buy the Valeant Pharmaceuticals Intl Inc (VRX) Stock Hype,2017-06-08 15:27:39 +0000,https://finance.yahoo.com/news/don-t-buy-valeant-pharmaceuticals-152739543.html?.tsrc=rss,"True to his promise, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) CEO Joseph Papa continues to work toward his goal of reducing the drugmaker’s debt, announcing the impending sale of iNova unit this morning.  The market applauded the move, sending VRX stock up 8.7% in Thursday’s early trading, offsetting a similarly-sized loss from the day before.  As has been the case with Valeant Pharmaceuticals for a while now, it’s not clear if the plan does more harm than good."
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant to Sell iNova Unit for $930 Million,2017-06-08 14:16:51 +0000,http://finance.yahoo.com/r/edb8c4c5-26cc-3aa1-a289-2afa6ac0c553/valeant-to-sell-inova-unit-for-930-million-1496922848?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals reached a deal to sell its iNova Pharmaceuticals unit for $930 million, as it works to reset itself after a crisis, cutting billions in debt and refocusing on its core treatment ..."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant to Sell iNova Unit for $930 Million,2017-06-08 14:16:51 +0000,http://finance.yahoo.com/r/edb8c4c5-26cc-3aa1-a289-2afa6ac0c553/valeant-to-sell-inova-unit-for-930-million-1496922848?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals reached a deal to sell its iNova Pharmaceuticals unit for $930 million, as it works to reset itself after a crisis, cutting billions in debt and refocusing on its core treatment ..."
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Nordstrom, Ford, Yahoo, Nvidia, Valeant",2017-06-08 13:28:10 +0000,http://finance.yahoo.com/r/0707db34-7572-3376-896e-aaf1c503b05a/stocks-to-watch-nordstrom-ford-yahoo-nvidia-valeant?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Thursday’s session are Nordstrom, Ford, Nvidia, Yahoo and Valeant Pharmaceuticals."
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Nordstrom, Ford, Yahoo, Nvidia, Valeant",2017-06-08 13:28:10 +0000,http://finance.yahoo.com/r/0707db34-7572-3376-896e-aaf1c503b05a/stocks-to-watch-nordstrom-ford-yahoo-nvidia-valeant?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Thursday’s session are Nordstrom, Ford, Nvidia, Yahoo and Valeant Pharmaceuticals."
VRX,VRX:CT,BBG000DC8S17,Valeant to Sell iNova Unit in Latest Bid to Pay Off Long-Term Debt,2017-06-08 13:19:00 +0000,http://finance.yahoo.com/r/1125db75-c020-3589-8660-eaf2148996cb/valeant-to-sell-inova-unit-in-latest-bid-to-pay-off-long-term-debt.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The unit has a strong presence in Australia, South Africa and Asia."
VRX,VRX:US,BBG000DLFM21,Valeant to Sell iNova Unit in Latest Bid to Pay Off Long-Term Debt,2017-06-08 13:19:00 +0000,http://finance.yahoo.com/r/1125db75-c020-3589-8660-eaf2148996cb/valeant-to-sell-inova-unit-in-latest-bid-to-pay-off-long-term-debt.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The unit has a strong presence in Australia, South Africa and Asia."
VRX,VRX:US,BBG000DLFM21,Valeant Posting Strong Gain On Sale Of INova Pharmaceuticals,2017-06-08 12:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3kiOgs5_KSA/valeant-posting-strong-gain-on-sale-of-inova-pharmaceuticals-20170608-00917,Valeant Posting Strong Gain On Sale Of INova Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,Valeant Posting Strong Gain On Sale Of INova Pharmaceuticals,2017-06-08 12:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3kiOgs5_KSA/valeant-posting-strong-gain-on-sale-of-inova-pharmaceuticals-20170608-00917,Valeant Posting Strong Gain On Sale Of INova Pharmaceuticals
VRX,VRX:US,BBG000DLFM21,Valeant to sell iNova unit for $930 mln to repay debt,2017-06-08 12:40:24 +0000,https://finance.yahoo.com/news/valeant-sell-inova-pharma-business-113505926.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc  said it would sell its iNova Pharmaceuticals  business for $930 million, as Chief Executive Officer Joseph  Papa steps up efforts to slash the embattled Canadian  drugmaker's huge debt pile.  The company's U.S.-listed shares were up about 3.5 percent  at $12.60 in premarket trading on Thursday."
VRX,VRX:CT,BBG000DC8S17,Valeant to sell iNova unit for $930 mln to repay debt,2017-06-08 12:40:24 +0000,https://finance.yahoo.com/news/valeant-sell-inova-pharma-business-113505926.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc  said it would sell its iNova Pharmaceuticals  business for $930 million, as Chief Executive Officer Joseph  Papa steps up efforts to slash the embattled Canadian  drugmaker's huge debt pile.  The company's U.S.-listed shares were up about 3.5 percent  at $12.60 in premarket trading on Thursday."
VRX,VRX:US,BBG000DLFM21,"Morning Movers: Valeant Gains on iNova Sale, Urban Outfitters Slumps",2017-06-08 12:31:00 +0000,http://finance.yahoo.com/r/f2ac8494-eb76-3c93-b4d3-20e7ce66c430/morning-movers-valeant-gains-on-inova-sale-urban-outfitters-slumps-1496925101?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open this morning as former FBI Director James Comey prepares to testify before the U.S. Senate. S&P 500 futures have ticked up 0.1%, while Dow Jones Industrial Average futures ..."
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: Valeant Gains on iNova Sale, Urban Outfitters Slumps",2017-06-08 12:31:00 +0000,http://finance.yahoo.com/r/f2ac8494-eb76-3c93-b4d3-20e7ce66c430/morning-movers-valeant-gains-on-inova-sale-urban-outfitters-slumps-1496925101?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open this morning as former FBI Director James Comey prepares to testify before the U.S. Senate. S&P 500 futures have ticked up 0.1%, while Dow Jones Industrial Average futures ..."
VRX,VRX:US,BBG000DLFM21,UPDATE: Valeant shares jump 5% premarket on news of sale of iNova Pharmaceuticals for $930 million,2017-06-08 12:10:18 +0000,http://finance.yahoo.com/r/aca2964d-f89f-302a-918a-d33d8dc4c20f/Story.aspx?guid=2B3AFE05-C21A-4933-AFBC-E6C49880ED11&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. said Thursday it has agreed to sell iNova Pharmaceuticals to a company owned by funds managed by private-equity firms Pacific Equity Partners and The Carlyle ...
VRX,VRX:CT,BBG000DC8S17,UPDATE: Valeant shares jump 5% premarket on news of sale of iNova Pharmaceuticals for $930 million,2017-06-08 12:10:18 +0000,http://finance.yahoo.com/r/aca2964d-f89f-302a-918a-d33d8dc4c20f/Story.aspx?guid=2B3AFE05-C21A-4933-AFBC-E6C49880ED11&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. said Thursday it has agreed to sell iNova Pharmaceuticals to a company owned by funds managed by private-equity firms Pacific Equity Partners and The Carlyle ...
VRX,VRX:CT,BBG000DC8S17,"Valeant's sale of iNova is debt neutral, says Evercore analyst",2017-06-08 12:07:33 +0000,http://finance.yahoo.com/r/eeff3e75-0c43-3ba1-8e57-350260fb1971/Story.aspx?guid=57819781-3C05-40EA-9241-8EF4E04212B7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc.'s sale of iNova Pharmaceutical for $930 million in cash appears to be debt neutral, Evercore analyst Umer Raffat wrote in a note. Valeant said it plans to use ..."
VRX,VRX:US,BBG000DLFM21,"Valeant's sale of iNova is debt neutral, says Evercore analyst",2017-06-08 12:07:33 +0000,http://finance.yahoo.com/r/eeff3e75-0c43-3ba1-8e57-350260fb1971/Story.aspx?guid=57819781-3C05-40EA-9241-8EF4E04212B7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc.'s sale of iNova Pharmaceutical for $930 million in cash appears to be debt neutral, Evercore analyst Umer Raffat wrote in a note. Valeant said it plans to use ..."
VRX,VRX:CT,BBG000DC8S17,"Early movers: BABA, SJM, P, URBN, VRX, YHOO, AMZN & more",2017-06-08 11:48:14 +0000,http://finance.yahoo.com/r/7ccd3971-42d9-3c45-947b-1fd65dc6f0eb/104517641?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104517641&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
VRX,VRX:US,BBG000DLFM21,"Early movers: BABA, SJM, P, URBN, VRX, YHOO, AMZN & more",2017-06-08 11:48:14 +0000,http://finance.yahoo.com/r/7ccd3971-42d9-3c45-947b-1fd65dc6f0eb/104517641?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104517641&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Sale of iNova Pharmaceuticals for $930 Million,2017-06-08 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-sale-inova-pharmaceuticals-110000352.html?.tsrc=rss,"LAVAL, Quebec, June 8, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced it has entered into an agreement to sell its iNova Pharmaceuticals (""iNova"") business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash.  ""The sale of iNova is part of the company's ongoing efforts to both simplify our operating model and strengthen our balance sheet,"" said Joseph C. Papa, chairman and chief executive officer, Valeant."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Inched Into Positive Territory - Canadian Commentary,2017-06-08 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z-YHLTrNkbg/canadian-stocks-have-inched-into-positive-territory--canadian-commentary-20170608-00796,Canadian Stocks Have Inched Into Positive Territory - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Announces Sale of iNova Pharmaceuticals for $930 Million,2017-06-08 11:00:00 +0000,https://finance.yahoo.com/news/valeant-announces-sale-inova-pharmaceuticals-110000352.html?.tsrc=rss,"LAVAL, Quebec, June 8, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced it has entered into an agreement to sell its iNova Pharmaceuticals (""iNova"") business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash.  ""The sale of iNova is part of the company's ongoing efforts to both simplify our operating model and strengthen our balance sheet,"" said Joseph C. Papa, chairman and chief executive officer, Valeant."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Inched Into Positive Territory - Canadian Commentary,2017-06-08 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z-YHLTrNkbg/canadian-stocks-have-inched-into-positive-territory--canadian-commentary-20170608-00796,Canadian Stocks Have Inched Into Positive Territory - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Bay Street On Edge As Oil Nears $45 -- Canadian Commentary,2017-06-08 08:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uCqUjeQxVSw/bay-street-on-edge-as-oil-nears-45--canadian-commentary-20170608-00428,Bay Street On Edge As Oil Nears $45 -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bay Street On Edge As Oil Nears $45 -- Canadian Commentary,2017-06-08 08:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uCqUjeQxVSw/bay-street-on-edge-as-oil-nears-45--canadian-commentary-20170608-00428,Bay Street On Edge As Oil Nears $45 -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,The Not-So-Subtle Reason Behind Valeant Pharmaceuticals' 30% Rise in May,2017-06-07 22:27:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rxti356tNbI/the-not-so-subtle-reason-behind-valeant-pharmaceuticals-30-rise-in-may-cm800301,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker known for growing by acquisition and raising prices on mature therapies exploded 30 higher in May according to data from S amp P Global Market Intelligence The reason for the surge
VRX,VRX:CT,BBG000DC8S17,The Not-So-Subtle Reason Behind Valeant Pharmaceuticals' 30% Rise in May,2017-06-07 22:27:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rxti356tNbI/the-not-so-subtle-reason-behind-valeant-pharmaceuticals-30-rise-in-may-cm800301,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker known for growing by acquisition and raising prices on mature therapies exploded 30 higher in May according to data from S amp P Global Market Intelligence The reason for the surge
VRX,VRX:CT,BBG000DC8S17,The Not-So-Subtle Reason Behind Valeant Pharmaceuticals&apos; 30% Rise in May,2017-06-07 20:42:00 +0000,http://finance.yahoo.com/r/78fa16eb-61b4-302c-8aee-210194479621/the-not-so-subtle-reason-behind-valeant-pharmaceut.aspx?yptr=yahoo&.tsrc=rss,"A better-than-expected earnings report lights a fire under optimists -- but if they aren&apos;t careful, they could get burned."
VRX,VRX:US,BBG000DLFM21,The Not-So-Subtle Reason Behind Valeant Pharmaceuticals&apos; 30% Rise in May,2017-06-07 20:42:00 +0000,http://finance.yahoo.com/r/78fa16eb-61b4-302c-8aee-210194479621/the-not-so-subtle-reason-behind-valeant-pharmaceut.aspx?yptr=yahoo&.tsrc=rss,"A better-than-expected earnings report lights a fire under optimists -- but if they aren&apos;t careful, they could get burned."
VRX,VRX:US,BBG000DLFM21,"Tiger Cub Rob Citrone Is Bullish on Valeant Pharmaceuticals Intl Inc (VRX), Advanced Micro Devices, Inc (AMD), Slashes Amazon.com, Inc. (AMZN)",2017-06-07 18:29:54 +0000,https://finance.yahoo.com/news/tiger-cub-rob-citrone-turns-182954110.html?.tsrc=rss,"Rob Citrone is fund manager of the $5.37 billion Discovery Capital Management fund.  In Q1 Citrone made some interesting portfolio adjustments- initiating holdings in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Advanced Micro Devices, Inc (NASDAQ:AMD) while slashing the fund’s holding of one of the market’s most popular stocks, e-commerce giant Amazon.com, Inc. (NASDAQ:AMZN).  Citrone began his career in Julian Robertson’s legendary fund Tiger Management giving him the ‘Tiger Cub’ nickname along with other big-name fund manager such as Steve Mandel and Lee Ainslie."
VRX,VRX:CT,BBG000DC8S17,"Tiger Cub Rob Citrone Is Bullish on Valeant Pharmaceuticals Intl Inc (VRX), Advanced Micro Devices, Inc (AMD), Slashes Amazon.com, Inc. (AMZN)",2017-06-07 18:29:54 +0000,https://finance.yahoo.com/news/tiger-cub-rob-citrone-turns-182954110.html?.tsrc=rss,"Rob Citrone is fund manager of the $5.37 billion Discovery Capital Management fund.  In Q1 Citrone made some interesting portfolio adjustments- initiating holdings in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Advanced Micro Devices, Inc (NASDAQ:AMD) while slashing the fund’s holding of one of the market’s most popular stocks, e-commerce giant Amazon.com, Inc. (NASDAQ:AMZN).  Citrone began his career in Julian Robertson’s legendary fund Tiger Management giving him the ‘Tiger Cub’ nickname along with other big-name fund manager such as Steve Mandel and Lee Ainslie."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Dropped As Crude Prices Tumble - Canadian Commentary,2017-06-07 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CYK11xJceb0/canadian-stocks-have-dropped-as-crude-prices-tumble--canadian-commentary-20170607-00825,Canadian Stocks Have Dropped As Crude Prices Tumble - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Dropped As Crude Prices Tumble - Canadian Commentary,2017-06-07 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CYK11xJceb0/canadian-stocks-have-dropped-as-crude-prices-tumble--canadian-commentary-20170607-00825,Canadian Stocks Have Dropped As Crude Prices Tumble - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Dive in Valeant Pharmaceuticals Intl Inc (VRX) While It’s Still Trash,2017-06-06 22:16:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NixpZw3eFmI/dive-in-valeant-pharmaceuticals-intl-inc-vrx-while-its-still-trash-cm799699,InvestorPlace Stock Market News Stock Advice amp Trading Tips All the cigarette butt investors out there get ready to take a few more puffs I m about to go out on a limb and describe a terrifying trade only the most brave or troubled investors would consider going long the
VRX,VRX:US,BBG000DLFM21,Dive in Valeant Pharmaceuticals Intl Inc (VRX) While It’s Still Trash,2017-06-06 22:16:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NixpZw3eFmI/dive-in-valeant-pharmaceuticals-intl-inc-vrx-while-its-still-trash-cm799699,InvestorPlace Stock Market News Stock Advice amp Trading Tips All the cigarette butt investors out there get ready to take a few more puffs I m about to go out on a limb and describe a terrifying trade only the most brave or troubled investors would consider going long the
VRX,VRX:US,BBG000DLFM21,Gold Rally Drives TSX Higher -- Canadian Commentary,2017-06-06 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/82I75Eor1oM/gold-rally-drives-tsx-higher--canadian-commentary-20170606-01223,Gold Rally Drives TSX Higher -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Gold Rally Drives TSX Higher -- Canadian Commentary,2017-06-06 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/82I75Eor1oM/gold-rally-drives-tsx-higher--canadian-commentary-20170606-01223,Gold Rally Drives TSX Higher -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Perrigo: As the Revolving Door Spins,2017-06-06 16:16:00 +0000,http://finance.yahoo.com/r/7d0cf911-404e-3a59-92a1-79d12fa4032b/perrigo-as-the-revolving-door-spins-1496765812?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"This year hasn't been kind to specialty-pharmaceutical company Perrigo (PRGO), which has dropped 15% in 2017, worse even than Valeant Pharmaceuticals International (VRX), which has fallen 14%. Valeant, ..."
VRX,VRX:US,BBG000DLFM21,Perrigo: As the Revolving Door Spins,2017-06-06 16:16:00 +0000,http://finance.yahoo.com/r/7d0cf911-404e-3a59-92a1-79d12fa4032b/perrigo-as-the-revolving-door-spins-1496765812?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"This year hasn't been kind to specialty-pharmaceutical company Perrigo (PRGO), which has dropped 15% in 2017, worse even than Valeant Pharmaceuticals International (VRX), which has fallen 14%. Valeant, ..."
VRX,VRX:US,BBG000DLFM21,Don't Buy Valeant's Latest Asset-Sale Hype,2017-06-06 15:38:56 +0000,http://finance.yahoo.com/r/83d70390-88b0-3e92-8c40-241886b44409/valeant-eye-surgery-unit-sale-brace-for-disappointment?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Its eye-surgery unit shouldn't fetch the price investors hope.
VRX,VRX:CT,BBG000DC8S17,Don't Buy Valeant's Latest Asset-Sale Hype,2017-06-06 15:38:56 +0000,http://finance.yahoo.com/r/83d70390-88b0-3e92-8c40-241886b44409/valeant-eye-surgery-unit-sale-brace-for-disappointment?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Its eye-surgery unit shouldn't fetch the price investors hope.
VRX,VRX:CT,BBG000DC8S17,Valeant surges 4% on report that it's in talks to sell eye surgical products business,2017-06-06 13:46:56 +0000,http://finance.yahoo.com/r/a55d999b-440b-3e90-a2c5-75f0b53af3c9/Story.aspx?guid=94570D1D-1503-4521-A1EB-7A3CC7D3D89A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. shares surged 4% in morning trade Tuesday after a Bloomberg News report that the company is in talks to sell the surgical products business of its Bausch & Lomb ...
VRX,VRX:US,BBG000DLFM21,Valeant surges 4% on report that it's in talks to sell eye surgical products business,2017-06-06 13:46:56 +0000,http://finance.yahoo.com/r/a55d999b-440b-3e90-a2c5-75f0b53af3c9/Story.aspx?guid=94570D1D-1503-4521-A1EB-7A3CC7D3D89A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals International Inc. shares surged 4% in morning trade Tuesday after a Bloomberg News report that the company is in talks to sell the surgical products business of its Bausch & Lomb ...
VRX,VRX:CT,BBG000DC8S17,Valeant in talks to sell eye-surgery assets to Carl Zeiss - Bbg,2017-06-06 13:43:56 +0000,https://finance.yahoo.com/news/valeant-talks-sell-eye-surgery-134356168.html?.tsrc=rss,"Canadian drugmaker Valeant  Pharmaceuticals International Inc  is in talks  to sell its Bausch & Lomb unit's surgical products business to  Germany's Carl Zeiss Meditec AG, Bloomberg reported.  Valeant's eye-surgery assets may be valued at about $2  billion in a sale, Bloomberg reported, citing people familiar  with the matter.  ""We don't comment on speculation or rumors,"" Valeant  spokeswoman Lainie Keller said in an email."
VRX,VRX:US,BBG000DLFM21,Valeant in talks to sell eye-surgery assets to Carl Zeiss - Bbg,2017-06-06 13:43:56 +0000,https://finance.yahoo.com/news/valeant-talks-sell-eye-surgery-134356168.html?.tsrc=rss,"Canadian drugmaker Valeant  Pharmaceuticals International Inc  is in talks  to sell its Bausch & Lomb unit's surgical products business to  Germany's Carl Zeiss Meditec AG, Bloomberg reported.  Valeant's eye-surgery assets may be valued at about $2  billion in a sale, Bloomberg reported, citing people familiar  with the matter.  ""We don't comment on speculation or rumors,"" Valeant  spokeswoman Lainie Keller said in an email."
VRX,VRX:US,BBG000DLFM21,Valeant Is in Talks to Sell Eye-Surgery Assets to Carl Zeiss,2017-06-06 11:01:55 +0000,http://finance.yahoo.com/r/fd12821b-88f8-3665-82b3-a9d38b1d5a99/valeant-said-in-talks-to-sell-eye-surgery-assets-to-carl-zeiss?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. is in talks to sell its Bausch & Lomb unit’s surgical products business to German medical technology maker Carl Zeiss Meditec AG, people familiar with the matter ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Is in Talks to Sell Eye-Surgery Assets to Carl Zeiss,2017-06-06 11:01:55 +0000,http://finance.yahoo.com/r/fd12821b-88f8-3665-82b3-a9d38b1d5a99/valeant-said-in-talks-to-sell-eye-surgery-assets-to-carl-zeiss?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. is in talks to sell its Bausch & Lomb unit’s surgical products business to German medical technology maker Carl Zeiss Meditec AG, people familiar with the matter ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Recovering On Gold Strength - Canadian Commentary,2017-06-06 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DuXE2AN_uFY/canadian-stocks-are-recovering-on-gold-strength--canadian-commentary-20170606-00810,Canadian Stocks Are Recovering On Gold Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Recovering On Gold Strength - Canadian Commentary,2017-06-06 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DuXE2AN_uFY/canadian-stocks-are-recovering-on-gold-strength--canadian-commentary-20170606-00810,Canadian Stocks Are Recovering On Gold Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Here's Why Mallinckrodt (MNK) Shares are Lower Today,2017-06-05 23:01:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YZHEGIm8Y9w/heres-why-mallinckrodt-mnk-shares-are-lower-today-cm799036,On Monday shares of pharmaceutical company Mallinckrodt Plc MNK are slipping down about 5 to 40 50 per share in afternoon trading MNK dropped about 8 in heavy morning trading after a new report from short seller Citron Research targeted the company Citron s report focused
VRX,VRX:US,BBG000DLFM21,Here's Why Mallinckrodt (MNK) Shares are Lower Today,2017-06-05 23:01:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YZHEGIm8Y9w/heres-why-mallinckrodt-mnk-shares-are-lower-today-cm799036,On Monday shares of pharmaceutical company Mallinckrodt Plc MNK are slipping down about 5 to 40 50 per share in afternoon trading MNK dropped about 8 in heavy morning trading after a new report from short seller Citron Research targeted the company Citron s report focused
VRX,VRX:CT,BBG000DC8S17,3 Active Managers That Will Crush Cheap Index Funds,2017-06-05 22:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yly34KVm3ik/3-active-managers-that-will-crush-cheap-index-funds-cm799044,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the exception of traditional retailers there may not be a more contrarian move than to bet on alternative asset managers They have been reviled in the media not necessarily undeservedly so for high fees and
VRX,VRX:US,BBG000DLFM21,3 Active Managers That Will Crush Cheap Index Funds,2017-06-05 22:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yly34KVm3ik/3-active-managers-that-will-crush-cheap-index-funds-cm799044,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the exception of traditional retailers there may not be a more contrarian move than to bet on alternative asset managers They have been reviled in the media not necessarily undeservedly so for high fees and
VRX,VRX:US,BBG000DLFM21,"Mallinckrodt stock tumbles after new Citron Research report targets $40,000-a-vial drug",2017-06-05 18:36:43 +0000,http://finance.yahoo.com/r/35fd0ef1-039b-337b-947f-98d0e2160d2a/Story.aspx?guid=EF8FE49E-4A01-11E7-A1D7-BEF8BED2BE0B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The short-seller claimed a recent development could send Mallinckrodt shares to zero and make the company bankrupt.
VRX,VRX:CT,BBG000DC8S17,"Mallinckrodt stock tumbles after new Citron Research report targets $40,000-a-vial drug",2017-06-05 18:36:43 +0000,http://finance.yahoo.com/r/35fd0ef1-039b-337b-947f-98d0e2160d2a/Story.aspx?guid=EF8FE49E-4A01-11E7-A1D7-BEF8BED2BE0B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The short-seller claimed a recent development could send Mallinckrodt shares to zero and make the company bankrupt.
VRX,VRX:US,BBG000DLFM21,"Citron Takes Aim at Mallinckrodt, Blasts Acthar Gel Medication",2017-06-05 15:58:00 +0000,http://finance.yahoo.com/r/29400b3c-a47c-36a6-b459-d19e06af1f3a/citron-takes-aim-at-mallinckrodt-blasts-acthar-gel-medication.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Citron attacked Mallinckrodt's partnership with Express Scripts ESRX, liking it to the role specialty prescription company Philidor played for embattled pharma company Valeant."
VRX,VRX:CT,BBG000DC8S17,"Citron Takes Aim at Mallinckrodt, Blasts Acthar Gel Medication",2017-06-05 15:58:00 +0000,http://finance.yahoo.com/r/29400b3c-a47c-36a6-b459-d19e06af1f3a/citron-takes-aim-at-mallinckrodt-blasts-acthar-gel-medication.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Citron attacked Mallinckrodt's partnership with Express Scripts ESRX, liking it to the role specialty prescription company Philidor played for embattled pharma company Valeant."
VRX,VRX:US,BBG000DLFM21,Investors Are Fleeing John Paulson's Once Hot Hedge Fund,2017-06-05 13:51:37 +0000,https://finance.yahoo.com/news/investors-fleeing-john-paulsons-once-135137764.html?.tsrc=rss,"Hedge fund manager John Paulson accurately predicted the housing market collapse and positioned his investments accordingly. Years later, his once hot hedge fund is now anything but as investors are fleeing. ..."
VRX,VRX:CT,BBG000DC8S17,Investors Are Fleeing John Paulson's Once Hot Hedge Fund,2017-06-05 13:51:37 +0000,https://finance.yahoo.com/news/investors-fleeing-john-paulsons-once-135137764.html?.tsrc=rss,"Hedge fund manager John Paulson accurately predicted the housing market collapse and positioned his investments accordingly. Years later, his once hot hedge fund is now anything but as investors are fleeing. ..."
VRX,VRX:US,BBG000DLFM21,Safirstein Metcalf LLP and HGT Law Remind Investors About Update on Valeant Pharmaceuticals International Inc. Class Action - VRX,2017-06-05 12:45:00 +0000,https://finance.yahoo.com/news/safirstein-metcalf-llp-hgt-law-124500050.html?.tsrc=rss,"NEW YORK, June 05, 2017-- Safirstein Metcalf LLP and HGT Law are updating shareholders of Valeant Pharmaceuticals, Inc. of recent developments in the ongoing shareholder class action. On April 28, 2017, ..."
VRX,VRX:CT,BBG000DC8S17,Safirstein Metcalf LLP and HGT Law Remind Investors About Update on Valeant Pharmaceuticals International Inc. Class Action - VRX,2017-06-05 12:45:00 +0000,https://finance.yahoo.com/news/safirstein-metcalf-llp-hgt-law-124500050.html?.tsrc=rss,"NEW YORK, June 05, 2017-- Safirstein Metcalf LLP and HGT Law are updating shareholders of Valeant Pharmaceuticals, Inc. of recent developments in the ongoing shareholder class action. On April 28, 2017, ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-06-05 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cAqRekK_N0A/canadian-stocks-are-paring-early-losses--canadian-commentary-20170605-00800,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-06-05 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cAqRekK_N0A/canadian-stocks-are-paring-early-losses--canadian-commentary-20170605-00800,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Crude Prices Drop - Canadian Commentary,2017-06-02 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gFmq3lSDkrE/canadian-stocks-are-falling-as-crude-prices-drop--canadian-commentary-20170602-00569,Canadian Stocks Are Falling As Crude Prices Drop - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Crude Prices Drop - Canadian Commentary,2017-06-02 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gFmq3lSDkrE/canadian-stocks-are-falling-as-crude-prices-drop--canadian-commentary-20170602-00569,Canadian Stocks Are Falling As Crude Prices Drop - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,3 Ways Facebook Inc (FB) Stock Can Go Off the Rails,2017-06-01 22:33:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_sIgwmBiFH8/3-ways-facebook-inc-fb-stock-can-go-off-the-rails-cm797734,InvestorPlace Stock Market News Stock Advice amp Trading Tips Last week was the fifth anniversary of the Facebook Inc NASDAQ FB IPO Of course back then the deal looked doomed 160 Mark Zuckerberg s roadshow was underwhelming and there was also a technical glitch that
VRX,VRX:CT,BBG000DC8S17,3 Ways Facebook Inc (FB) Stock Can Go Off the Rails,2017-06-01 22:33:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_sIgwmBiFH8/3-ways-facebook-inc-fb-stock-can-go-off-the-rails-cm797734,InvestorPlace Stock Market News Stock Advice amp Trading Tips Last week was the fifth anniversary of the Facebook Inc NASDAQ FB IPO Of course back then the deal looked doomed 160 Mark Zuckerberg s roadshow was underwhelming and there was also a technical glitch that
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary,2017-06-01 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BEL2nfrSSGo/canadian-stocks-are-climbing-on-broad-strength--canadian-commentary-20170601-00999,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary,2017-06-01 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BEL2nfrSSGo/canadian-stocks-are-climbing-on-broad-strength--canadian-commentary-20170601-00999,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover,2017-05-31 22:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPvHKLuZacc/how-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-recover-cm797145,InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been an awful awful run for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA And the lousy performance in TEVA stock is showing no signs of giving up this week Source Open Grid Scheduler
VRX,VRX:CT,BBG000DC8S17,How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover,2017-05-31 22:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPvHKLuZacc/how-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-recover-cm797145,InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been an awful awful run for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA And the lousy performance in TEVA stock is showing no signs of giving up this week Source Open Grid Scheduler
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Present At Financial Industry Conferences,2017-05-31 21:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-present-financial-industry-210000326.html?.tsrc=rss,"LAVAL, Quebec, May 31, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that  Paul Herendeen, executive vice president and chief financial officer, ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Present At Financial Industry Conferences,2017-05-31 21:00:00 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-present-financial-industry-210000326.html?.tsrc=rss,"LAVAL, Quebec, May 31, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that  Paul Herendeen, executive vice president and chief financial officer, ..."
VRX,VRX:US,BBG000DLFM21,We just witnessed 2 perfect examples of Wall Street billionaires spinning major fails,2017-05-31 16:31:19 +0000,https://finance.yahoo.com/news/just-witnessed-2-perfect-examples-163119270.html?.tsrc=rss,"It seems that in this world of constant Trump-watching, some of Wall Street's recent foibles have..."
VRX,VRX:CT,BBG000DC8S17,We just witnessed 2 perfect examples of Wall Street billionaires spinning major fails,2017-05-31 16:31:19 +0000,https://finance.yahoo.com/news/just-witnessed-2-perfect-examples-163119270.html?.tsrc=rss,"It seems that in this world of constant Trump-watching, some of Wall Street's recent foibles have..."
VRX,VRX:CT,BBG000DC8S17,"EYEG: Pipeline Progress Continues, Includes First Valeant Ocular Surgery Development Milestone",2017-05-31 15:00:00 +0000,https://finance.yahoo.com/news/eyeg-pipeline-progress-continues-includes-150000335.html?.tsrc=rss,"By Brian Marckx, CFA NASDAQ:EYEG NASDAQ:VRX Q1 Financial Results, Operating Update… Earlier this month EyeGate (NASDAQ:EYEG) reported Q1 financial results and provided a business update.  In terms of the ..."
VRX,VRX:US,BBG000DLFM21,"EYEG: Pipeline Progress Continues, Includes First Valeant Ocular Surgery Development Milestone",2017-05-31 15:00:00 +0000,https://finance.yahoo.com/news/eyeg-pipeline-progress-continues-includes-150000335.html?.tsrc=rss,"By Brian Marckx, CFA NASDAQ:EYEG NASDAQ:VRX Q1 Financial Results, Operating Update… Earlier this month EyeGate (NASDAQ:EYEG) reported Q1 financial results and provided a business update.  In terms of the ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Editas Medicine,2017-05-31 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000355.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 31, 2017 / Editas Medicine's shares plunged yesterday after a published paper in the scientific journal Nature Methods revealed that the genome editing tool CRISPR/Cas9, ..."
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Editas Medicine,2017-05-31 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000355.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 31, 2017 / Editas Medicine's shares plunged yesterday after a published paper in the scientific journal Nature Methods revealed that the genome editing tool CRISPR/Cas9, ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Sinking Despite Solid GDP Report - Canadian Commentary,2017-05-31 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tHttRC8DvYg/canadian-stocks-are-sinking-despite-solid-gdp-report--canadian-commentary-20170531-00867,Canadian Stocks Are Sinking Despite Solid GDP Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Sinking Despite Solid GDP Report - Canadian Commentary,2017-05-31 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tHttRC8DvYg/canadian-stocks-are-sinking-despite-solid-gdp-report--canadian-commentary-20170531-00867,Canadian Stocks Are Sinking Despite Solid GDP Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Slipping On Energy Weakness - Canadian Commentary,2017-05-30 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u0qk1aROzlE/canadian-stocks-are-slipping-on-energy-weakness--canadian-commentary-20170530-00787,Canadian Stocks Are Slipping On Energy Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Slipping On Energy Weakness - Canadian Commentary,2017-05-30 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u0qk1aROzlE/canadian-stocks-are-slipping-on-energy-weakness--canadian-commentary-20170530-00787,Canadian Stocks Are Slipping On Energy Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Top 3 Companies Owned by Valeant (VRX),2017-05-26 14:53:00 +0000,http://finance.yahoo.com/r/dc80498d-b808-3a3e-82ef-54fdeec95eee/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,Top 3 Companies Owned by Valeant (VRX),2017-05-26 14:53:00 +0000,http://finance.yahoo.com/r/dc80498d-b808-3a3e-82ef-54fdeec95eee/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Dipping In Early Trade - Canadian Commentary,2017-05-26 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UP58K2Plua0/canadian-stocks-are-dipping-in-early-trade--canadian-commentary-20170526-00477,Canadian Stocks Are Dipping In Early Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Dipping In Early Trade - Canadian Commentary,2017-05-26 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UP58K2Plua0/canadian-stocks-are-dipping-in-early-trade--canadian-commentary-20170526-00477,Canadian Stocks Are Dipping In Early Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant's Numbers: Are They As Good As They Seem?,2017-05-25 17:33:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6EurlDCHIZk/valeants-numbers-are-they-as-good-as-they-seem-cm794705,Worry that Valeant Pharmaceuticals NYSE VRX could struggle to pay back debt has made its stock one of the market s worst performers since 2015 However its shares have rocketed higher this month after management increased its full year EBITDA guidance Does this
VRX,VRX:CT,BBG000DC8S17,Valeant's Numbers: Are They As Good As They Seem?,2017-05-25 17:33:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6EurlDCHIZk/valeants-numbers-are-they-as-good-as-they-seem-cm794705,Worry that Valeant Pharmaceuticals NYSE VRX could struggle to pay back debt has made its stock one of the market s worst performers since 2015 However its shares have rocketed higher this month after management increased its full year EBITDA guidance Does this
VRX,VRX:CT,BBG000DC8S17,Valeant&apos;s Numbers: Are They As Good As They Seem?,2017-05-25 15:46:00 +0000,http://finance.yahoo.com/r/738c77c2-4ffa-3fe7-baeb-3caaa8765a6d/valeants-numbers-are-they-as-good-as-they-seem.aspx?yptr=yahoo&.tsrc=rss,An increase in EBITDA guidance doesn&apos;t necessarily mean this company&apos;s back on track.
VRX,VRX:US,BBG000DLFM21,Valeant&apos;s Numbers: Are They As Good As They Seem?,2017-05-25 15:46:00 +0000,http://finance.yahoo.com/r/738c77c2-4ffa-3fe7-baeb-3caaa8765a6d/valeants-numbers-are-they-as-good-as-they-seem.aspx?yptr=yahoo&.tsrc=rss,An increase in EBITDA guidance doesn&apos;t necessarily mean this company&apos;s back on track.
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Bank Earnings - Canadian Commentary,2017-05-25 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1-8yOHMkgUI/canadian-stocks-are-rising-on-bank-earnings--canadian-commentary-20170525-00808,Canadian Stocks Are Rising On Bank Earnings - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Bank Earnings - Canadian Commentary,2017-05-25 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1-8yOHMkgUI/canadian-stocks-are-rising-on-bank-earnings--canadian-commentary-20170525-00808,Canadian Stocks Are Rising On Bank Earnings - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Going to $40,2017-05-24 18:31:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QfOwHOmZD7g/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-going-to-40-cm794106,InvestorPlace Stock Market News Stock Advice amp Trading Tips Beaten down pharma specialist Teva Pharmaceutical Industries Ltd ADR NYSE TEVA which has seen its value plummet some 45 over the past year remains an intriguing option for risk
VRX,VRX:US,BBG000DLFM21,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Going to $40,2017-05-24 18:31:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QfOwHOmZD7g/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-going-to-40-cm794106,InvestorPlace Stock Market News Stock Advice amp Trading Tips Beaten down pharma specialist Teva Pharmaceutical Industries Ltd ADR NYSE TEVA which has seen its value plummet some 45 over the past year remains an intriguing option for risk
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Banks Weaken -- Canadian Commentary,2017-05-24 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bUZsE4l5nuI/canadian-stocks-are-falling-as-banks-weaken--canadian-commentary-20170524-00833,Canadian Stocks Are Falling As Banks Weaken -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Banks Weaken -- Canadian Commentary,2017-05-24 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bUZsE4l5nuI/canadian-stocks-are-falling-as-banks-weaken--canadian-commentary-20170524-00833,Canadian Stocks Are Falling As Banks Weaken -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant and Gilead: Beaten Down Bargains or Truly Terrible?,2017-05-23 19:12:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jJQ0bvE7N7k/valeant-and-gilead-beaten-down-bargains-or-truly-terrible-cm793493,Valeant Pharmaceuticals NYSE VRX and Gilead Sciences NASDAQ GILD are in the bargain bin but first quarter financial results show that sales continue to decline at both companies Are these companies making enough progress to make them worth owning in
VRX,VRX:US,BBG000DLFM21,Valeant and Gilead: Beaten Down Bargains or Truly Terrible?,2017-05-23 19:12:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jJQ0bvE7N7k/valeant-and-gilead-beaten-down-bargains-or-truly-terrible-cm793493,Valeant Pharmaceuticals NYSE VRX and Gilead Sciences NASDAQ GILD are in the bargain bin but first quarter financial results show that sales continue to decline at both companies Are these companies making enough progress to make them worth owning in
VRX,VRX:CT,BBG000DC8S17,Valeant and Gilead: Beaten Down Bargains or Truly Terrible?,2017-05-23 18:06:00 +0000,http://finance.yahoo.com/r/662b751e-3fb0-3479-ac3f-abf13308bbfe/industry-focus-healthcare-05-17-2017.aspx?yptr=yahoo&.tsrc=rss,"Valeant and Gilead Sciences&apos; are arguably cheap stocks, but big questions remain that still make them risky to buy."
VRX,VRX:US,BBG000DLFM21,Valeant and Gilead: Beaten Down Bargains or Truly Terrible?,2017-05-23 18:06:00 +0000,http://finance.yahoo.com/r/662b751e-3fb0-3479-ac3f-abf13308bbfe/industry-focus-healthcare-05-17-2017.aspx?yptr=yahoo&.tsrc=rss,"Valeant and Gilead Sciences&apos; are arguably cheap stocks, but big questions remain that still make them risky to buy."
VRX,VRX:CT,BBG000DC8S17,Time to Buy Valeant Pharmaceuticals,2017-05-23 16:56:00 +0000,http://finance.yahoo.com/r/6fdadf75-ce1d-3c92-b99e-89f6297c1c36/time-buy-valeant-pharmaceuticals-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals is setting off buy signals after Bill Ackman's Pershing Capital pulled up stakes and took a massive loss. (VRX)
VRX,VRX:US,BBG000DLFM21,Time to Buy Valeant Pharmaceuticals,2017-05-23 16:56:00 +0000,http://finance.yahoo.com/r/6fdadf75-ce1d-3c92-b99e-89f6297c1c36/time-buy-valeant-pharmaceuticals-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals is setting off buy signals after Bill Ackman's Pershing Capital pulled up stakes and took a massive loss. (VRX)
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains -- Canadian Commentary,2017-05-23 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BKeAbowDYXA/canadian-stocks-are-paring-early-gains--canadian-commentary-20170523-00896,Canadian Stocks Are Paring Early Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains -- Canadian Commentary,2017-05-23 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BKeAbowDYXA/canadian-stocks-are-paring-early-gains--canadian-commentary-20170523-00896,Canadian Stocks Are Paring Early Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab,2017-05-22 23:12:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PrcDQO0NKHI/astrazeneca-azn-gets-positive-chmp-opinion-for-brodalumab-cm792960,Astrazeneca PLC AZN and its partner LEO Pharma received a positive opinion from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA The Committee recommended the approval of brodalumab for the treatment of adult patients with moderate to severe
VRX,VRX:CT,BBG000DC8S17,Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab,2017-05-22 23:12:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PrcDQO0NKHI/astrazeneca-azn-gets-positive-chmp-opinion-for-brodalumab-cm792960,Astrazeneca PLC AZN and its partner LEO Pharma received a positive opinion from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA The Committee recommended the approval of brodalumab for the treatment of adult patients with moderate to severe
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 05/22/2017: AVY,EYEG,VRX,BSTG",2017-05-22 20:31:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTeAAd_3WVI/health-care-sector-update-for-05222017-avyeyegvrxbstg-cm792907,Top Health Care StocksTop Health Care Stocks JNJ 0 21 JNJ 0 21 PFE 0 88 PFE 0 88 ABT 1 39 ABT 1 39 MRK 0 44 MRK 0 44 AMGN 2 26 AMGN 2 26 Health care stocks still were somewhat higher in late Monday trading with the NYSE Health Care Index rising almost 0 3 while shares of
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 05/22/2017: AVY,EYEG,VRX,BSTG",2017-05-22 20:31:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTeAAd_3WVI/health-care-sector-update-for-05222017-avyeyegvrxbstg-cm792907,Top Health Care StocksTop Health Care Stocks JNJ 0 21 JNJ 0 21 PFE 0 88 PFE 0 88 ABT 1 39 ABT 1 39 MRK 0 44 MRK 0 44 AMGN 2 26 AMGN 2 26 Health care stocks still were somewhat higher in late Monday trading with the NYSE Health Care Index rising almost 0 3 while shares of
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 05/22/2017: RDUS,AMGN,EYEG,VRX,BSTG",2017-05-22 18:31:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OuFo1Hyo3E0/health-care-sector-update-for-05222017-rdusamgneyegvrxbstg-cm792859,Top Health Care StocksTop Health Care Stocks JNJ 0 28 JNJ 0 28 PFE 0 77 PFE 0 77 ABT 1 34 ABT 1 34 MRK 0 61 MRK 0 61 AMGN 2 50 AMGN 2 50 Health care stocks were holding on to slim gains Monday with the NYSE Health Care Index rising almost 0 2 while shares of health care
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 05/22/2017: RDUS,AMGN,EYEG,VRX,BSTG",2017-05-22 18:31:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OuFo1Hyo3E0/health-care-sector-update-for-05222017-rdusamgneyegvrxbstg-cm792859,Top Health Care StocksTop Health Care Stocks JNJ 0 28 JNJ 0 28 PFE 0 77 PFE 0 77 ABT 1 34 ABT 1 34 MRK 0 61 MRK 0 61 AMGN 2 50 AMGN 2 50 Health care stocks were holding on to slim gains Monday with the NYSE Health Care Index rising almost 0 2 while shares of health care
VRX,VRX:US,BBG000DLFM21,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 14:14:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iIrH_ODdBGw/3-drug-stocks-billionaire-money-managers-dumped-big-time-in-the-first-quarter-cm792533,Monday May 15 was an important day for Wall Street and investors It was the last day for money managers with more than 100 million in assets under management to file 13F paperwork with the Securities and Exchange Commission that in effect discloses their portfolio holding as of
VRX,VRX:CT,BBG000DC8S17,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 14:14:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iIrH_ODdBGw/3-drug-stocks-billionaire-money-managers-dumped-big-time-in-the-first-quarter-cm792533,Monday May 15 was an important day for Wall Street and investors It was the last day for money managers with more than 100 million in assets under management to file 13F paperwork with the Securities and Exchange Commission that in effect discloses their portfolio holding as of
VRX,VRX:US,BBG000DLFM21,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 12:27:00 +0000,http://finance.yahoo.com/r/3c080f35-6f74-3b88-b068-e8990e4b124f/3-drug-stocks-billionaire-money-managers-dumped-bi.aspx?yptr=yahoo&.tsrc=rss,Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
VRX,VRX:CT,BBG000DC8S17,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 12:27:00 +0000,http://finance.yahoo.com/r/3c080f35-6f74-3b88-b068-e8990e4b124f/3-drug-stocks-billionaire-money-managers-dumped-bi.aspx?yptr=yahoo&.tsrc=rss,Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
VRX,VRX:CT,BBG000DC8S17,Eyegate Pharma stock surges 11% after receiving Valeant milestone payment,2017-05-22 12:25:57 +0000,http://finance.yahoo.com/r/6cbc1615-d172-3ac3-88fd-d361d31b5923/Story.aspx?guid=23C334E5-2142-408E-B772-24F771C9D440&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its first milestone payment from Valeant Pharmaceuticals International Inc. resulting from ...
VRX,VRX:US,BBG000DLFM21,Eyegate Pharma stock surges 11% after receiving Valeant milestone payment,2017-05-22 12:25:57 +0000,http://finance.yahoo.com/r/6cbc1615-d172-3ac3-88fd-d361d31b5923/Story.aspx?guid=23C334E5-2142-408E-B772-24F771C9D440&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its first milestone payment from Valeant Pharmaceuticals International Inc. resulting from ...
VRX,VRX:CT,BBG000DC8S17,Eyegate Pharma stock surges 11% after receiving Valeant milestone payment,2017-05-22 12:25:57 +0000,https://finance.yahoo.com/news/eyegate-pharma-stock-surges-11-122557035.html?.tsrc=rss,Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its first milestone payment from Valeant Pharmaceuticals International Inc. resulting from ...
VRX,VRX:US,BBG000DLFM21,Eyegate Pharma stock surges 11% after receiving Valeant milestone payment,2017-05-22 12:25:57 +0000,https://finance.yahoo.com/news/eyegate-pharma-stock-surges-11-122557035.html?.tsrc=rss,Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its first milestone payment from Valeant Pharmaceuticals International Inc. resulting from ...
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution,2017-05-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-renu-advanced-113000236.html?.tsrc=rss,"New & Improved Formula Builds on Trusted 30-Year Heritage of Meeting Consumers' Lens Care Solution Needs   LAVAL, Quebec, May 22, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: ..."
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution,2017-05-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-renu-advanced-113000236.html?.tsrc=rss,"New & Improved Formula Builds on Trusted 30-Year Heritage of Meeting Consumers' Lens Care Solution Needs   LAVAL, Quebec, May 22, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: ..."
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution,2017-05-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-renu-advanced-113000122.html?.tsrc=rss,Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution,2017-05-22 11:30:00 +0000,https://finance.yahoo.com/news/bausch-lomb-introduces-renu-advanced-113000122.html?.tsrc=rss,Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution
VRX,VRX:US,BBG000DLFM21,3 Value Stocks for Ambitious Investors,2017-05-21 15:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VlKm6WhirZI/3-value-stocks-for-ambitious-investors-cm792343,Deep value stocks aren t for the faint of heart That said ambitious investors can find incredible profit opportunities among stocks that are so beaten down that the current price the stock market assigns to the whole company isn t much more than its core assets are worth After all
VRX,VRX:CT,BBG000DC8S17,3 Value Stocks for Ambitious Investors,2017-05-21 15:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VlKm6WhirZI/3-value-stocks-for-ambitious-investors-cm792343,Deep value stocks aren t for the faint of heart That said ambitious investors can find incredible profit opportunities among stocks that are so beaten down that the current price the stock market assigns to the whole company isn t much more than its core assets are worth After all
VRX,VRX:US,BBG000DLFM21,3 Value Stocks for Ambitious Investors,2017-05-21 13:04:00 +0000,http://finance.yahoo.com/r/27235e5c-4e9e-362a-8505-e35d37282a5c/3-value-stocks-for-ambitious-investors.aspx?yptr=yahoo&.tsrc=rss,Feeling brave? These value stocks could provide incredible returns to investors willing to take on the risk.
VRX,VRX:CT,BBG000DC8S17,3 Value Stocks for Ambitious Investors,2017-05-21 13:04:00 +0000,http://finance.yahoo.com/r/27235e5c-4e9e-362a-8505-e35d37282a5c/3-value-stocks-for-ambitious-investors.aspx?yptr=yahoo&.tsrc=rss,Feeling brave? These value stocks could provide incredible returns to investors willing to take on the risk.
VRX,VRX:US,BBG000DLFM21,Ackman has ‘something to prove’ after Valeant mistake,2017-05-20 16:47:35 +0000,https://finance.yahoo.com/news/bill-ackman-something-prove-valeant-023238520.html?.tsrc=rss,The billionaire investor says he has “something to prove” after taking a big loss on its bet on Valeant.
VRX,VRX:CT,BBG000DC8S17,Ackman has ‘something to prove’ after Valeant mistake,2017-05-20 16:47:35 +0000,https://finance.yahoo.com/news/bill-ackman-something-prove-valeant-023238520.html?.tsrc=rss,The billionaire investor says he has “something to prove” after taking a big loss on its bet on Valeant.
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Details Missteps With Valeant Investment,2017-05-19 20:50:00 +0000,http://finance.yahoo.com/r/3a99fe52-8d7a-31c2-b414-3d9716e8cc37/pershing-s-ackman-tells-hedge-fund-managers-about-his-biggest-investment-mistake.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The embattled activist talked about his troubled investment in Valeant, his efforts at Chipotle and what he'd like to see the Trump Administration focus its energy on."
VRX,VRX:US,BBG000DLFM21,Bill Ackman Details Missteps With Valeant Investment,2017-05-19 20:50:00 +0000,http://finance.yahoo.com/r/3a99fe52-8d7a-31c2-b414-3d9716e8cc37/pershing-s-ackman-tells-hedge-fund-managers-about-his-biggest-investment-mistake.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The embattled activist talked about his troubled investment in Valeant, his efforts at Chipotle and what he'd like to see the Trump Administration focus its energy on."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Intrigued…Really?,2017-05-19 17:33:00 +0000,http://finance.yahoo.com/r/316c21e1-5aae-3e85-badb-ab90d5856099/valeant-pharmaceuticals-intriguedreally-1495215191?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"This very blog has offered up no shortage of opinions on shares Valeant Pharmaceuticals International (VRX)...some good, some bad and some still undecided.  Quoting from Gilbert’s recent note, StreetInsider reported: We have been cautious/skeptical on VRX for a very long time, and uncertainties around the growth potential and durability of key franchises, the potential cost of past sins, and the heavy debt load have kept us at Hold."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Intrigued…Really?,2017-05-19 17:33:00 +0000,http://finance.yahoo.com/r/316c21e1-5aae-3e85-badb-ab90d5856099/valeant-pharmaceuticals-intriguedreally-1495215191?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"This very blog has offered up no shortage of opinions on shares Valeant Pharmaceuticals International (VRX)...some good, some bad and some still undecided.  Quoting from Gilbert’s recent note, StreetInsider reported: We have been cautious/skeptical on VRX for a very long time, and uncertainties around the growth potential and durability of key franchises, the potential cost of past sins, and the heavy debt load have kept us at Hold."
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA,2017-05-19 16:15:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8db26Pn_g0k/valeant-vrx-decides-to-extend-stay-on-xifaxans-anda-cm791976,Valeant Pharmaceuticals International Inc VRX and Actavis Laboratories Inc which is now a part of Teva Pharmaceuticals Inc TEVA announced that both the companies have agreed to stay outstanding litigation and extend the 30 month stay regarding the latter s Abbreviated New Drug
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA,2017-05-19 16:15:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8db26Pn_g0k/valeant-vrx-decides-to-extend-stay-on-xifaxans-anda-cm791976,Valeant Pharmaceuticals International Inc VRX and Actavis Laboratories Inc which is now a part of Teva Pharmaceuticals Inc TEVA announced that both the companies have agreed to stay outstanding litigation and extend the 30 month stay regarding the latter s Abbreviated New Drug
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Decides to Extend Stay on Xifaxan&apos;s ANDA,2017-05-19 13:48:01 +0000,https://finance.yahoo.com/news/valeant-vrx-decides-extend-stay-134801886.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced that it has decided to stay outstanding litigation and extend the 30-month stay regarding Teva&apos;s ANDA for a generic version of Xifaxan 550 mg tablets."
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Decides to Extend Stay on Xifaxan&apos;s ANDA,2017-05-19 13:48:01 +0000,https://finance.yahoo.com/news/valeant-vrx-decides-extend-stay-134801886.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced that it has decided to stay outstanding litigation and extend the 30-month stay regarding Teva&apos;s ANDA for a generic version of Xifaxan 550 mg tablets."
VRX,VRX:US,BBG000DLFM21,5 Things You Must Know Before the Market Opens Friday,2017-05-19 11:23:00 +0000,http://finance.yahoo.com/r/f52494db-1496-3b1e-b82c-4a2bf862cf01/5-things-you-must-know-before-the-market-opens-friday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,U.S. stock futures and global shares are higher as investors looked to recoup losses from a week that saw volatility rise amid turmoil in the Trump White House.
VRX,VRX:CT,BBG000DC8S17,5 Things You Must Know Before the Market Opens Friday,2017-05-19 11:23:00 +0000,http://finance.yahoo.com/r/f52494db-1496-3b1e-b82c-4a2bf862cf01/5-things-you-must-know-before-the-market-opens-friday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,U.S. stock futures and global shares are higher as investors looked to recoup losses from a week that saw volatility rise amid turmoil in the Trump White House.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rallying On Energy Strength - Canadian Commentary,2017-05-19 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ESYoOFiVrLU/canadian-stocks-are-rallying-on-energy-strength--canadian-commentary-20170519-00528,Canadian Stocks Are Rallying On Energy Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rallying On Energy Strength - Canadian Commentary,2017-05-19 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ESYoOFiVrLU/canadian-stocks-are-rallying-on-energy-strength--canadian-commentary-20170519-00528,Canadian Stocks Are Rallying On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bill Ackman has ‘something to prove’ after Valeant mistake,2017-05-19 07:24:37 +0000,http://finance.yahoo.com/r/d8ac3992-2988-3384-be19-4b2cee20f909/Story.aspx?guid=3DBB1EC4-3C27-11E7-911B-74EEBDF756B0&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The billionaire investor says he has “something to prove” after taking a big loss on its bet on Valeant.
VRX,VRX:US,BBG000DLFM21,Bill Ackman has ‘something to prove’ after Valeant mistake,2017-05-19 07:24:37 +0000,http://finance.yahoo.com/r/d8ac3992-2988-3384-be19-4b2cee20f909/Story.aspx?guid=3DBB1EC4-3C27-11E7-911B-74EEBDF756B0&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The billionaire investor says he has “something to prove” after taking a big loss on its bet on Valeant.
VRX,VRX:US,BBG000DLFM21,"Humbled by Valeant, Ackman goes back to basics",2017-05-19 02:04:44 +0000,https://finance.yahoo.com/news/humbled-valeant-ackman-goes-back-020444763.html?.tsrc=rss,"Bill Ackman said on Thursday  he is poised to go on a great investment run after a humiliating  bet forced his hedge fund firm to return to basics.  Ackman suggested that after his fund's downturn, he is now  ready for a comeback, saying that chief executives who have  recently suffered setbacks after otherwise strong careers are  often great to bet on.  For Ackman, that setback was an ill-fated bet on Valeant  Pharmaceuticals International Inc. Ackman bailed out of  the stock in March, but not before it played a big role in two  years of double-digit portfolio losses for his $11 billion hedge  fund firm Pershing Square Capital Management."
VRX,VRX:CT,BBG000DC8S17,"Humbled by Valeant, Ackman goes back to basics",2017-05-19 02:04:44 +0000,https://finance.yahoo.com/news/humbled-valeant-ackman-goes-back-020444763.html?.tsrc=rss,"Bill Ackman said on Thursday  he is poised to go on a great investment run after a humiliating  bet forced his hedge fund firm to return to basics.  Ackman suggested that after his fund's downturn, he is now  ready for a comeback, saying that chief executives who have  recently suffered setbacks after otherwise strong careers are  often great to bet on.  For Ackman, that setback was an ill-fated bet on Valeant  Pharmaceuticals International Inc. Ackman bailed out of  the stock in March, but not before it played a big role in two  years of double-digit portfolio losses for his $11 billion hedge  fund firm Pershing Square Capital Management."
VRX,VRX:US,BBG000DLFM21,SALT Spotlight: Ackman Explains His Valeant 'Mistake',2017-05-19 01:15:00 +0000,http://finance.yahoo.com/r/a418ca07-257b-3f17-8c46-45d42524b042/salt-spotlight-ackman-explains-his-valeant-mistake-1495156551?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"By now, we all know that Pershing Square's William Ackman  made a big mistake with Valeant Pharmaceuticals International (VRX), which he bought near its highs, and recently sold.  Today, at the SALT Conference, Ackman explained how he made that mistake.  Ackman said his biggest mistake with Valeant was going outside what had always worked for Pershing."
VRX,VRX:CT,BBG000DC8S17,SALT Spotlight: Ackman Explains His Valeant 'Mistake',2017-05-19 01:15:00 +0000,http://finance.yahoo.com/r/a418ca07-257b-3f17-8c46-45d42524b042/salt-spotlight-ackman-explains-his-valeant-mistake-1495156551?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"By now, we all know that Pershing Square's William Ackman  made a big mistake with Valeant Pharmaceuticals International (VRX), which he bought near its highs, and recently sold.  Today, at the SALT Conference, Ackman explained how he made that mistake.  Ackman said his biggest mistake with Valeant was going outside what had always worked for Pershing."
VRX,VRX:US,BBG000DLFM21,It's the Truth: Valeant Pharmaceuticals' Debt Situation Is Worse Now Than a Year Ago,2017-05-18 16:15:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OJdcUMorasg/its-the-truth-valeant-pharmaceuticals-debt-situation-is-worse-now-than-a-year-ago-cm791328,Until recently shares of embattled drug developer Valeant Pharmaceuticals NYSE VRX simply couldn t catch a break The once high flying stock that commanded a 90 billion valuation tumbled to a valuation of just 3 billion in recent months In fact Valeant s market cap was
VRX,VRX:CT,BBG000DC8S17,It's the Truth: Valeant Pharmaceuticals' Debt Situation Is Worse Now Than a Year Ago,2017-05-18 16:15:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OJdcUMorasg/its-the-truth-valeant-pharmaceuticals-debt-situation-is-worse-now-than-a-year-ago-cm791328,Until recently shares of embattled drug developer Valeant Pharmaceuticals NYSE VRX simply couldn t catch a break The once high flying stock that commanded a 90 billion valuation tumbled to a valuation of just 3 billion in recent months In fact Valeant s market cap was
VRX,VRX:US,BBG000DLFM21,It&apos;s the Truth: Valeant Pharmaceuticals&apos; Debt Situation Is Worse Now Than a Year Ago,2017-05-18 14:43:00 +0000,http://finance.yahoo.com/r/5e688023-af86-3d8f-bf9f-adbf68983747/its-the-truth-valeant-pharmaceuticals-debt-situati.aspx?yptr=yahoo&.tsrc=rss,"Valeant&apos;s EBITDA-to-interest coverage ratio has moved notably lower, despite paying off $3.5 billion in debt over the past year."
VRX,VRX:CT,BBG000DC8S17,It&apos;s the Truth: Valeant Pharmaceuticals&apos; Debt Situation Is Worse Now Than a Year Ago,2017-05-18 14:43:00 +0000,http://finance.yahoo.com/r/5e688023-af86-3d8f-bf9f-adbf68983747/its-the-truth-valeant-pharmaceuticals-debt-situati.aspx?yptr=yahoo&.tsrc=rss,"Valeant&apos;s EBITDA-to-interest coverage ratio has moved notably lower, despite paying off $3.5 billion in debt over the past year."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Has Reversed Early Losses - Canadian Commentary,2017-05-18 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G4wSTgFCR4M/canadian-stocks-has-reversed-early-losses--canadian-commentary-20170518-00887,Canadian Stocks Has Reversed Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Has Reversed Early Losses - Canadian Commentary,2017-05-18 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G4wSTgFCR4M/canadian-stocks-has-reversed-early-losses--canadian-commentary-20170518-00887,Canadian Stocks Has Reversed Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Pershing Square Trims Mondelez, APD and Obviously Valeant: 13F Filing",2017-05-17 18:23:00 +0000,http://finance.yahoo.com/r/af96e418-c46f-317a-a1e7-24ff3035508f/pershing-square-trims-mondelez-apd-and-obviously-valeant-13f-filing-mdlz-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Apart from its notorious dumping of Valeant stock, the firm cut its holdings in snack maker Mondelez and Air Products and Chemicals."
VRX,VRX:US,BBG000DLFM21,"Pershing Square Trims Mondelez, APD and Obviously Valeant: 13F Filing",2017-05-17 18:23:00 +0000,http://finance.yahoo.com/r/af96e418-c46f-317a-a1e7-24ff3035508f/pershing-square-trims-mondelez-apd-and-obviously-valeant-13f-filing-mdlz-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Apart from its notorious dumping of Valeant stock, the firm cut its holdings in snack maker Mondelez and Air Products and Chemicals."
VRX,VRX:US,BBG000DLFM21,Stocks Billionaire Bill Ackman Is Selling Now,2017-05-17 18:14:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jbdDK3xKf8c/stocks-billionaire-bill-ackman-is-selling-now-cm790717,Pershing Square Capital Management s recently filed 13F shows that Bill Ackman s hedge fund has been doing some selling The hedge fund manager slashed its holdings of Valeant NYSE VRX Mondelez NASDAQ MDLZ and Air Products amp Chemicals NYSE APD 160 in the
VRX,VRX:CT,BBG000DC8S17,Stocks Billionaire Bill Ackman Is Selling Now,2017-05-17 18:14:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jbdDK3xKf8c/stocks-billionaire-bill-ackman-is-selling-now-cm790717,Pershing Square Capital Management s recently filed 13F shows that Bill Ackman s hedge fund has been doing some selling The hedge fund manager slashed its holdings of Valeant NYSE VRX Mondelez NASDAQ MDLZ and Air Products amp Chemicals NYSE APD 160 in the
VRX,VRX:US,BBG000DLFM21,Stocks Billionaire Bill Ackman Is Selling Now,2017-05-17 17:00:00 +0000,http://finance.yahoo.com/r/edaf4632-4aa7-3339-9c41-4f2ec6083101/stocks-billionaire-bill-ackman-is-selling-now.aspx?yptr=yahoo&.tsrc=rss,Here are three stocks Bill Ackman dumped in the first quarter.
VRX,VRX:CT,BBG000DC8S17,Stocks Billionaire Bill Ackman Is Selling Now,2017-05-17 17:00:00 +0000,http://finance.yahoo.com/r/edaf4632-4aa7-3339-9c41-4f2ec6083101/stocks-billionaire-bill-ackman-is-selling-now.aspx?yptr=yahoo&.tsrc=rss,Here are three stocks Bill Ackman dumped in the first quarter.
VRX,VRX:US,BBG000DLFM21,Stocks Bludgeoned In Widespread Sell-off -- Canadian Commentary,2017-05-17 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0pqJ6hSAnCI/stocks-bludgeoned-in-widespread-selloff--canadian-commentary-20170517-01102,Stocks Bludgeoned In Widespread Sell-off -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Stocks Bludgeoned In Widespread Sell-off -- Canadian Commentary,2017-05-17 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0pqJ6hSAnCI/stocks-bludgeoned-in-widespread-selloff--canadian-commentary-20170517-01102,Stocks Bludgeoned In Widespread Sell-off -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Allergan's Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 16:15:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/koJKe6prTjw/allergans-irritable-bowel-drug-viberzi-approved-in-canada-cm790612,Allergan plc AGN announced that Health Canada has approved Viberzi eluxadoline for the treatment of adults suffering with irritable bowel syndrome with diarrhea IBS D The drug is marketed in the U S and Europe as a twice daily oral treatment A look at the company s share price
VRX,VRX:CT,BBG000DC8S17,Allergan's Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 16:15:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/koJKe6prTjw/allergans-irritable-bowel-drug-viberzi-approved-in-canada-cm790612,Allergan plc AGN announced that Health Canada has approved Viberzi eluxadoline for the treatment of adults suffering with irritable bowel syndrome with diarrhea IBS D The drug is marketed in the U S and Europe as a twice daily oral treatment A look at the company s share price
VRX,VRX:US,BBG000DLFM21,Biotech And Pharma Industry And Stock News,2017-05-17 16:11:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
VRX,VRX:CT,BBG000DC8S17,Biotech And Pharma Industry And Stock News,2017-05-17 16:11:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
VRX,VRX:US,BBG000DLFM21,3 Brand-Name Stocks That Billionaire Money Managers Ditched in the First Quarter,2017-05-17 14:13:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-eHZwwFYH9g/3-brand-name-stocks-that-billionaire-money-managers-ditched-in-the-first-quarter-cm790415,It s that time again folks Four times a year money managers with more than 100 million in assets under management are required to disclose their holdings to the Securities and Exchange Commission for the previous quarter This Monday May 15 was the deadline for that paperwork 13F
VRX,VRX:CT,BBG000DC8S17,3 Brand-Name Stocks That Billionaire Money Managers Ditched in the First Quarter,2017-05-17 14:13:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-eHZwwFYH9g/3-brand-name-stocks-that-billionaire-money-managers-ditched-in-the-first-quarter-cm790415,It s that time again folks Four times a year money managers with more than 100 million in assets under management are required to disclose their holdings to the Securities and Exchange Commission for the previous quarter This Monday May 15 was the deadline for that paperwork 13F
VRX,VRX:CT,BBG000DC8S17,Allergan&apos;s Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 14:01:02 +0000,https://finance.yahoo.com/news/allergan-apos-irritable-bowel-drug-140102069.html?.tsrc=rss,Allergan plc (AGN) announced that Health Canada approved Viberzi (eluxadoline) for the treatment of adults suffering with irritable bowel syndrome with diarrhea (IBS-D)
VRX,VRX:US,BBG000DLFM21,Allergan&apos;s Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 14:01:02 +0000,https://finance.yahoo.com/news/allergan-apos-irritable-bowel-drug-140102069.html?.tsrc=rss,Allergan plc (AGN) announced that Health Canada approved Viberzi (eluxadoline) for the treatment of adults suffering with irritable bowel syndrome with diarrhea (IBS-D)
VRX,VRX:US,BBG000DLFM21,3 Brand-Name Stocks That Billionaire Money Managers Ditched in the First Quarter,2017-05-17 13:07:00 +0000,http://finance.yahoo.com/r/bf99fd9c-afe8-3e34-aab5-6bb24a04d18d/3-brand-name-stocks-that-billionaire-money-manager.aspx?yptr=yahoo&.tsrc=rss,The most valuable publicly traded company in the world was one such name on the chopping block.
VRX,VRX:CT,BBG000DC8S17,3 Brand-Name Stocks That Billionaire Money Managers Ditched in the First Quarter,2017-05-17 13:07:00 +0000,http://finance.yahoo.com/r/bf99fd9c-afe8-3e34-aab5-6bb24a04d18d/3-brand-name-stocks-that-billionaire-money-manager.aspx?yptr=yahoo&.tsrc=rss,The most valuable publicly traded company in the world was one such name on the chopping block.
VRX,VRX:CT,BBG000DC8S17,Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan,2017-05-17 11:20:20 +0000,http://finance.yahoo.com/r/9eac0c66-b455-3450-9d0c-0f13d3d2558b/Story.aspx?guid=6A82CA7B-57D9-411B-9253-5C14AEE3E750&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Salix Pharmaceuticals Inc. and its parent Valeant Pharmaceuticals International Inc. and Actavis Laboratories Inc., at Actavis' request, have agreed to stay outstanding litigation regarding Actavis' application ..."
VRX,VRX:US,BBG000DLFM21,Valeant and Actavis agree to stay litigation relating to Valeant's top-selling drug Xifaxan,2017-05-17 11:20:20 +0000,http://finance.yahoo.com/r/9eac0c66-b455-3450-9d0c-0f13d3d2558b/Story.aspx?guid=6A82CA7B-57D9-411B-9253-5C14AEE3E750&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Salix Pharmaceuticals Inc. and its parent Valeant Pharmaceuticals International Inc. and Actavis Laboratories Inc., at Actavis' request, have agreed to stay outstanding litigation regarding Actavis' application ..."
VRX,VRX:US,BBG000DLFM21,"Valeant, Activis Call Truce Over Xifaxan",2017-05-17 11:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IRrd2kT_b9A/valeant-activis-call-truce-over-xifaxan-20170517-00786,"Valeant, Activis Call Truce Over Xifaxan"
VRX,VRX:CT,BBG000DC8S17,"Valeant, Activis Call Truce Over Xifaxan",2017-05-17 11:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IRrd2kT_b9A/valeant-activis-call-truce-over-xifaxan-20170517-00786,"Valeant, Activis Call Truce Over Xifaxan"
VRX,VRX:US,BBG000DLFM21,Statement Regarding Xifaxan Intellectual Property Litigation,2017-05-17 11:00:00 +0000,https://finance.yahoo.com/news/statement-regarding-xifaxan-intellectual-property-110000683.html?.tsrc=rss,"LAVAL, Quebec, May 17, 2017 /PRNewswire/ -- Salix Pharmaceuticals, Inc. and parent Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") and Actavis Laboratories, Inc., ..."
VRX,VRX:CT,BBG000DC8S17,Statement Regarding Xifaxan Intellectual Property Litigation,2017-05-17 11:00:00 +0000,https://finance.yahoo.com/news/statement-regarding-xifaxan-intellectual-property-110000683.html?.tsrc=rss,"LAVAL, Quebec, May 17, 2017 /PRNewswire/ -- Salix Pharmaceuticals, Inc. and parent Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") and Actavis Laboratories, Inc., ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Under Pressure Due To Trump Concerns - Canadian Commentary,2017-05-17 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TZNuse3LBdE/canadian-stocks-are-under-pressure-due-to-trump-concerns--canadian-commentary-20170517-00761,Canadian Stocks Are Under Pressure Due To Trump Concerns - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Under Pressure Due To Trump Concerns - Canadian Commentary,2017-05-17 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TZNuse3LBdE/canadian-stocks-are-under-pressure-due-to-trump-concerns--canadian-commentary-20170517-00761,Canadian Stocks Are Under Pressure Due To Trump Concerns - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Trump Turmoil Rattles Bay Street -- Canadian Commentary,2017-05-17 08:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rirgr2Lulac/trump-turmoil-rattles-bay-street--canadian-commentary-20170517-00502,Trump Turmoil Rattles Bay Street -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Trump Turmoil Rattles Bay Street -- Canadian Commentary,2017-05-17 08:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rirgr2Lulac/trump-turmoil-rattles-bay-street--canadian-commentary-20170517-00502,Trump Turmoil Rattles Bay Street -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka",2017-05-16 16:20:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZTg-U2W4p0o/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka-cm789994,Teva Pharmaceutical Industries Ltd TEVA announced the launch of a generic version of Valeant Pharmaceuticals International Inc s VRX diabetes drug Glumetza in the U S The drug will be available in 500 mg and 1000 mg tablets Teva s shares have underperformed the Zacks
VRX,VRX:US,BBG000DLFM21,"Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka",2017-05-16 16:20:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZTg-U2W4p0o/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka-cm789994,Teva Pharmaceutical Industries Ltd TEVA announced the launch of a generic version of Valeant Pharmaceuticals International Inc s VRX diabetes drug Glumetza in the U S The drug will be available in 500 mg and 1000 mg tablets Teva s shares have underperformed the Zacks
VRX,VRX:US,BBG000DLFM21,"Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka",2017-05-16 13:54:01 +0000,https://finance.yahoo.com/news/teva-teva-launches-glumetza-generic-135401905.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.&apos;s (VRX) diabetes drug, Glumetza, in the U.S."
VRX,VRX:CT,BBG000DC8S17,"Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka",2017-05-16 13:54:01 +0000,https://finance.yahoo.com/news/teva-teva-launches-glumetza-generic-135401905.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.&apos;s (VRX) diabetes drug, Glumetza, in the U.S."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-05-16 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uSGAo1fulfw/canadian-stocks-are-paring-early-gains--canadian-commentary-20170516-00928,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-05-16 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uSGAo1fulfw/canadian-stocks-are-paring-early-gains--canadian-commentary-20170516-00928,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,[$$] ValueAct’s Jeffrey Ubben Hands Reins to Protégé Mason Morfit,2017-05-16 04:32:29 +0000,http://finance.yahoo.com/r/8aa58cdf-aeb1-32ce-a41b-40aed083a23c/valueacts-jeffrey-ubben-hands-reins-to-protege-mason-morfit-1494878078?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Activist investor Jeffrey Ubben is handing his $16 billion portfolio to the next generation, with ValueAct Capital Management tapping Mason Morfit to serve as chief investment officer."
VRX,VRX:US,BBG000DLFM21,[$$] ValueAct’s Jeffrey Ubben Hands Reins to Protégé Mason Morfit,2017-05-16 04:32:29 +0000,http://finance.yahoo.com/r/8aa58cdf-aeb1-32ce-a41b-40aed083a23c/valueacts-jeffrey-ubben-hands-reins-to-protege-mason-morfit-1494878078?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Activist investor Jeffrey Ubben is handing his $16 billion portfolio to the next generation, with ValueAct Capital Management tapping Mason Morfit to serve as chief investment officer."
VRX,VRX:US,BBG000DLFM21,Safirstein Metcalf LLP and HGT Law Updates Investors on Valeant Pharmaceuticals International Inc. Investor Class Action - VRX,2017-05-15 22:20:00 +0000,https://finance.yahoo.com/news/safirstein-metcalf-llp-hgt-law-222000939.html?.tsrc=rss,"NEW YORK, May 15, 2017-- Safirstein Metcalf LLP and HGT Law are updating shareholders of Valeant Pharmaceuticals, Inc. of recent developments in the ongoing shareholder class action. On May 1, 2017, U.S. ..."
VRX,VRX:CT,BBG000DC8S17,Safirstein Metcalf LLP and HGT Law Updates Investors on Valeant Pharmaceuticals International Inc. Investor Class Action - VRX,2017-05-15 22:20:00 +0000,https://finance.yahoo.com/news/safirstein-metcalf-llp-hgt-law-222000939.html?.tsrc=rss,"NEW YORK, May 15, 2017-- Safirstein Metcalf LLP and HGT Law are updating shareholders of Valeant Pharmaceuticals, Inc. of recent developments in the ongoing shareholder class action. On May 1, 2017, U.S. ..."
VRX,VRX:US,BBG000DLFM21,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : May 15, 2017",2017-05-15 20:54:31 +0000,http://finance.yahoo.com/r/8926ba6e-f441-31e9-a25b-f6d4969b75e4/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-may-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Valeant Pharmaceuticals International, Inc. Here are 5 ETFs with the largest exposure to VRX-US. Comparing the performance and risk of Valeant Pharmaceuticals International, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : May 15, 2017",2017-05-15 20:54:31 +0000,http://finance.yahoo.com/r/8926ba6e-f441-31e9-a25b-f6d4969b75e4/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-may-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Valeant Pharmaceuticals International, Inc. Here are 5 ETFs with the largest exposure to VRX-US. Comparing the performance and risk of Valeant Pharmaceuticals International, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,The short seller who uncovered Valeant has found his next target in health care,2017-05-15 20:05:39 +0000,http://finance.yahoo.com/r/c565a40c-c666-3a9d-bf28-da176c852951/104470576?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104470576&yptr=yahoo&.tsrc=rss,"Citron Research's Andrew Left, who gained notoriety for successful bets against companies such as Valeant, posted a bearish report on Exact Sciences."
VRX,VRX:CT,BBG000DC8S17,The short seller who uncovered Valeant has found his next target in health care,2017-05-15 20:05:39 +0000,https://finance.yahoo.com/news/short-seller-uncovered-valeant-found-200539600.html?.tsrc=rss,"Citron Research&apos;s Andrew Left, who gained notoriety for successful bets against companies such as Valeant, posted a bearish report on Exact Sciences."
VRX,VRX:US,BBG000DLFM21,The short seller who uncovered Valeant has found his next target in health care,2017-05-15 20:05:39 +0000,http://finance.yahoo.com/r/c565a40c-c666-3a9d-bf28-da176c852951/104470576?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104470576&yptr=yahoo&.tsrc=rss,"Citron Research's Andrew Left, who gained notoriety for successful bets against companies such as Valeant, posted a bearish report on Exact Sciences."
VRX,VRX:US,BBG000DLFM21,The short seller who uncovered Valeant has found his next target in health care,2017-05-15 20:05:39 +0000,https://finance.yahoo.com/news/short-seller-uncovered-valeant-found-200539600.html?.tsrc=rss,"Citron Research&apos;s Andrew Left, who gained notoriety for successful bets against companies such as Valeant, posted a bearish report on Exact Sciences."
VRX,VRX:US,BBG000DLFM21,[$$] Ubben steps down as investment head at ValueAct,2017-05-15 19:34:28 +0000,"http://finance.yahoo.com/r/a72bb984-0c76-3a4c-92ea-29c193db81c6/3d8995d0-3915-11e7-821a-6027b8a20f23,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Jeff Ubben, the activist investor who built ValueAct into a $16bn hedge fund, is standing down from daily oversight of its portfolio and handing the reins to his protégé, Mason Morfit. Mr Ubben will remain ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Ubben steps down as investment head at ValueAct,2017-05-15 19:34:28 +0000,"http://finance.yahoo.com/r/a72bb984-0c76-3a4c-92ea-29c193db81c6/3d8995d0-3915-11e7-821a-6027b8a20f23,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Jeff Ubben, the activist investor who built ValueAct into a $16bn hedge fund, is standing down from daily oversight of its portfolio and handing the reins to his protégé, Mason Morfit. Mr Ubben will remain ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Why One Bear is Staying Bearish,2017-05-15 13:54:00 +0000,http://finance.yahoo.com/r/8c154bc8-0301-36a3-9a9e-ccc0c8beae07/valeant-pharmaceuticals-why-one-bear-is-staying-bearish-1494856492?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last week, shares of Valeant Pharmaceuticals International (VRX) soared 35% after the beaten-down specialty-pharmaceutical company raised its 2017 adjusted EBITDA guidance, causing an abrupt shift in sentiment.  In a blog post, Bronte Capital's John Hempton  explains why he doesn't buy the good news, and the entire post is worth reading.  Valeant's revenue isn't growing, Hempton says, so they must be cutting cost."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Why One Bear is Staying Bearish,2017-05-15 13:54:00 +0000,http://finance.yahoo.com/r/8c154bc8-0301-36a3-9a9e-ccc0c8beae07/valeant-pharmaceuticals-why-one-bear-is-staying-bearish-1494856492?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last week, shares of Valeant Pharmaceuticals International (VRX) soared 35% after the beaten-down specialty-pharmaceutical company raised its 2017 adjusted EBITDA guidance, causing an abrupt shift in sentiment.  In a blog post, Bronte Capital's John Hempton  explains why he doesn't buy the good news, and the entire post is worth reading.  Valeant's revenue isn't growing, Hempton says, so they must be cutting cost."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-05-15 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ooNV9lsT8qc/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170515-00930,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-05-15 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ooNV9lsT8qc/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170515-00930,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Weekend roundup: Good and bad company earnings | Sound investing advice | Crumbling support for Putin,2017-05-14 14:03:08 +0000,http://finance.yahoo.com/r/fd758fa7-26fc-3221-ae18-1f08c201fbc2/Story.aspx?guid=8F8FA626-3703-11E7-8780-25CF199941A8&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Here are MarketWatch articles to read this weekend.
VRX,VRX:US,BBG000DLFM21,Weekend roundup: Good and bad company earnings | Sound investing advice | Crumbling support for Putin,2017-05-14 14:03:08 +0000,http://finance.yahoo.com/r/fd758fa7-26fc-3221-ae18-1f08c201fbc2/Story.aspx?guid=8F8FA626-3703-11E7-8780-25CF199941A8&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Here are MarketWatch articles to read this weekend.
VRX,VRX:US,BBG000DLFM21,"Francis Chou Buys Endo International PLC, Teva Pharmaceutical Industries, Valeant ...",2017-05-13 13:14:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jJeb9mzmntA/francis-chou-buys-endo-international-plc-teva-pharmaceutical-industries-valeant-cm788894,Francis Chou New Purchases ENDP TEVA Added Positions VRX SD SD Reduced Positions NOK Sold Out AZN GSK New Purchases ENDP TEVA New Purchases ENDP TEVA Added Positions VRX SD SD Added Positions
VRX,VRX:CT,BBG000DC8S17,"Francis Chou Buys Endo International PLC, Teva Pharmaceutical Industries, Valeant ...",2017-05-13 13:14:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jJeb9mzmntA/francis-chou-buys-endo-international-plc-teva-pharmaceutical-industries-valeant-cm788894,Francis Chou New Purchases ENDP TEVA Added Positions VRX SD SD Reduced Positions NOK Sold Out AZN GSK New Purchases ENDP TEVA New Purchases ENDP TEVA Added Positions VRX SD SD Added Positions
VRX,VRX:CT,BBG000DC8S17,Court Battle May Be Responsible For Drugmaker&apos;s 40% Spike,2017-05-12 20:08:36 +0000,http://finance.yahoo.com/r/a8fdca56-4ae2-3ac3-aff0-2739347aafdb/is-a-court-battle-responsible-for-spiking-this-drugmakers-stock?src=A00220&yptr=yahoo&.tsrc=rss,Valeant stock has gained 40% since Monday after a Delaware judge sided with the company on two patent issues related to antibiotic Xifaxan.
VRX,VRX:US,BBG000DLFM21,Court Battle May Be Responsible For Drugmaker&apos;s 40% Spike,2017-05-12 20:08:36 +0000,http://finance.yahoo.com/r/a8fdca56-4ae2-3ac3-aff0-2739347aafdb/is-a-court-battle-responsible-for-spiking-this-drugmakers-stock?src=A00220&yptr=yahoo&.tsrc=rss,Valeant stock has gained 40% since Monday after a Delaware judge sided with the company on two patent issues related to antibiotic Xifaxan.
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Living to Fight Another Day?,2017-05-12 16:52:00 +0000,http://finance.yahoo.com/r/4563be38-7f8e-3691-9639-445445569397/valeant-pharmaceuticals-living-to-fight-another-day-1494607951?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have soared 36% so far this week following better-than-expected earnings that didn't include a guidance cut, and a good deal of reading between the lines in court filings.  While the bears are still bearish, the change in sentiment has been notable, even if few analysts are willing to say that Valeant is out of the woods.  Barclays analyst Douglas Tsao and team contend that Valeant is ""living to fight another day."" They explain: VRX 1Q17 earnings didn’t bring a feared cut to guidance, but with upside largely from LOEs “outperformance” it’s too early to say the company is ready to move into turnaround phase."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Living to Fight Another Day?,2017-05-12 16:52:00 +0000,http://finance.yahoo.com/r/4563be38-7f8e-3691-9639-445445569397/valeant-pharmaceuticals-living-to-fight-another-day-1494607951?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have soared 36% so far this week following better-than-expected earnings that didn't include a guidance cut, and a good deal of reading between the lines in court filings.  While the bears are still bearish, the change in sentiment has been notable, even if few analysts are willing to say that Valeant is out of the woods.  Barclays analyst Douglas Tsao and team contend that Valeant is ""living to fight another day."" They explain: VRX 1Q17 earnings didn’t bring a feared cut to guidance, but with upside largely from LOEs “outperformance” it’s too early to say the company is ready to move into turnaround phase."
VRX,VRX:CT,BBG000DC8S17,"Company News for May 12, 2017",2017-05-12 16:26:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdxE1XqCj1Y/company-news-for-may-12-2017-cm788556,160 160 160 Shares of Straight Path Communications Inc STRP declined 20 4 after the company agreed to sell itself to Verizon Communications Inc VZ 160 160 160 Whole Foods Market Inc s WFM shares advanced 2 2 after the company reported second quarter 2017 revenues
VRX,VRX:US,BBG000DLFM21,"Company News for May 12, 2017",2017-05-12 16:26:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdxE1XqCj1Y/company-news-for-may-12-2017-cm788556,160 160 160 Shares of Straight Path Communications Inc STRP declined 20 4 after the company agreed to sell itself to Verizon Communications Inc VZ 160 160 160 Whole Foods Market Inc s WFM shares advanced 2 2 after the company reported second quarter 2017 revenues
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017",2017-05-12 14:38:14 +0000,http://finance.yahoo.com/r/b11c4785-a6e2-38b2-8c4d-7272df7c1fd8/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Valeant Pharmaceuticals International, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Valeant Pharmaceuticals International, Inc. – Pfizer Inc., AstraZeneca PLC and Novartis AG Sponsored ADR (PFE-US, AZNCF-US and NVS-US) that have also reported for this period. Highlights Summary ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017",2017-05-12 14:38:14 +0000,http://finance.yahoo.com/r/b11c4785-a6e2-38b2-8c4d-7272df7c1fd8/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Valeant Pharmaceuticals International, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Valeant Pharmaceuticals International, Inc. – Pfizer Inc., AstraZeneca PLC and Novartis AG Sponsored ADR (PFE-US, AZNCF-US and NVS-US) that have also reported for this period. Highlights Summary ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Company News for May 12, 2017",2017-05-12 14:07:02 +0000,http://finance.yahoo.com/news/company-news-may-12-2017-140702701.html?.tsrc=rss,"Companies in the News are: STRP,VZ,WFM,VRX,SYMC"
VRX,VRX:US,BBG000DLFM21,"Company News for May 12, 2017",2017-05-12 14:07:02 +0000,http://finance.yahoo.com/news/company-news-may-12-2017-140702701.html?.tsrc=rss,"Companies in the News are: STRP,VZ,WFM,VRX,SYMC"
VRX,VRX:CT,BBG000DC8S17,Why prescription drug prices keep going up,2017-05-12 13:31:59 +0000,http://finance.yahoo.com/news/prescription-drug-prices-keep-going-133159672.html?.tsrc=rss,Prices of prescription drugs have skyrocketed in recent years. Here&apos;s a look at why.
VRX,VRX:US,BBG000DLFM21,Why prescription drug prices keep going up,2017-05-12 13:31:59 +0000,http://finance.yahoo.com/news/prescription-drug-prices-keep-going-133159672.html?.tsrc=rss,Prices of prescription drugs have skyrocketed in recent years. Here&apos;s a look at why.
VRX,VRX:US,BBG000DLFM21,Is This the Real Reason Valeant's Shares Are Skyrocketing?,2017-05-12 13:12:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Dq6EPXEIPU/is-this-the-real-reason-valeants-shares-are-skyrocketing-cm788313,Despite reporting that sales continued to decline in the first quarter Valeant Pharmaceuticals NYSE VRX share price is up 47 since the end of April What gives Personally I think shares are rallying because short sellers are rushing to cover after realizing it s less
VRX,VRX:CT,BBG000DC8S17,Is This the Real Reason Valeant's Shares Are Skyrocketing?,2017-05-12 13:12:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Dq6EPXEIPU/is-this-the-real-reason-valeants-shares-are-skyrocketing-cm788313,Despite reporting that sales continued to decline in the first quarter Valeant Pharmaceuticals NYSE VRX share price is up 47 since the end of April What gives Personally I think shares are rallying because short sellers are rushing to cover after realizing it s less
VRX,VRX:CT,BBG000DC8S17,Is This the Real Reason Valeant&apos;s Shares Are Skyrocketing?,2017-05-12 11:22:00 +0000,http://finance.yahoo.com/r/20fe6369-ed02-3d2d-bb3f-e473692e0532/is-this-the-real-reason-valeants-shares-are-skyroc.aspx?yptr=yahoo&.tsrc=rss,A big short squeeze could be behind Valeant&apos;s soaring share price this week.
VRX,VRX:US,BBG000DLFM21,Is This the Real Reason Valeant&apos;s Shares Are Skyrocketing?,2017-05-12 11:22:00 +0000,http://finance.yahoo.com/r/20fe6369-ed02-3d2d-bb3f-e473692e0532/is-this-the-real-reason-valeants-shares-are-skyroc.aspx?yptr=yahoo&.tsrc=rss,A big short squeeze could be behind Valeant&apos;s soaring share price this week.
VRX,VRX:CT,BBG000DC8S17,6 Hot Stock Charts WIth Unusual Volume,2017-05-12 11:00:00 +0000,http://finance.yahoo.com/r/f8f23677-972e-3db6-8ba0-3b5ad1a798ba/6-hot-stock-charts-with-unusual-volume.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's a technical look at how to play six stocks trending higher with unusual volume flows.
VRX,VRX:US,BBG000DLFM21,6 Hot Stock Charts WIth Unusual Volume,2017-05-12 11:00:00 +0000,http://finance.yahoo.com/r/f8f23677-972e-3db6-8ba0-3b5ad1a798ba/6-hot-stock-charts-with-unusual-volume.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's a technical look at how to play six stocks trending higher with unusual volume flows.
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary,2017-05-12 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4XXfq6DzqUM/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20170512-00601,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary,2017-05-12 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4XXfq6DzqUM/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20170512-00601,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Stocks Threaten Breakdown Amid Comey Turmoil,2017-05-12 02:00:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sVrayskSS54/stocks-threaten-breakdown-amid-comey-turmoil-cm788254,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are at risk of breaking down out of one of the tightest trading ranges in history moving lower on Thursday as large cap stocks tested their 50 day moving average for the first time since mid
VRX,VRX:US,BBG000DLFM21,Stocks Threaten Breakdown Amid Comey Turmoil,2017-05-12 02:00:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sVrayskSS54/stocks-threaten-breakdown-amid-comey-turmoil-cm788254,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are at risk of breaking down out of one of the tightest trading ranges in history moving lower on Thursday as large cap stocks tested their 50 day moving average for the first time since mid
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : May 11, 2017",2017-05-11 23:51:27 +0000,http://finance.yahoo.com/r/879f00f8-df0f-3ed5-be7d-2d0933831d43/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-may-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Valeant Pharmaceuticals International, Inc. a score of 16. Our analysis is based on comparing Valeant Pharmaceuticals International, Inc. with the following peers – Pfizer Inc., AstraZeneca PLC, Merck KGaA Unsponsored ADR, Novartis AG Sponsored ADR and CSPC Pharmaceutical Group Ltd. Sponsored ADR (PFE-US, AZNCF-US, MKGAY-US, NVS-US and ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : May 11, 2017",2017-05-11 23:51:27 +0000,http://finance.yahoo.com/r/879f00f8-df0f-3ed5-be7d-2d0933831d43/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-may-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Valeant Pharmaceuticals International, Inc. a score of 16. Our analysis is based on comparing Valeant Pharmaceuticals International, Inc. with the following peers – Pfizer Inc., AstraZeneca PLC, Merck KGaA Unsponsored ADR, Novartis AG Sponsored ADR and CSPC Pharmaceutical Group Ltd. Sponsored ADR (PFE-US, AZNCF-US, MKGAY-US, NVS-US and ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,UnitedHealth Group Inc (UNH) Wins No Matter the Healthcare Outcome,2017-05-11 23:02:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fvJtXJiIt3w/unitedhealth-group-inc-unh-wins-no-matter-the-healthcare-outcome-cm788240,InvestorPlace Stock Market News Stock Advice amp Trading Tips UnitedHealth Group Inc NYSE UNH is the biggest healthcare insurer in the U S by market cap Its rivals Anthem Inc NYSE ANTM Aetna Inc NYSE AET and Cigna Corporation NYSE CIG are
VRX,VRX:US,BBG000DLFM21,UnitedHealth Group Inc (UNH) Wins No Matter the Healthcare Outcome,2017-05-11 23:02:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fvJtXJiIt3w/unitedhealth-group-inc-unh-wins-no-matter-the-healthcare-outcome-cm788240,InvestorPlace Stock Market News Stock Advice amp Trading Tips UnitedHealth Group Inc NYSE UNH is the biggest healthcare insurer in the U S by market cap Its rivals Anthem Inc NYSE ANTM Aetna Inc NYSE AET and Cigna Corporation NYSE CIG are
VRX,VRX:CT,BBG000DC8S17,The 2 Likely Reasons Valeant Pharmaceuticals Surged by as Much as 15%,2017-05-11 23:01:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QOUHmiEaB8c/the-2-likely-reasons-valeant-pharmaceuticals-surged-by-as-much-as-15-cm788202,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drug developer whose primary method of growth over the past couple of years has been via acquisitions and price hikes on its therapies surged as much as 15 on Thursday for their third consecutive day
VRX,VRX:US,BBG000DLFM21,The 2 Likely Reasons Valeant Pharmaceuticals Surged by as Much as 15%,2017-05-11 23:01:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QOUHmiEaB8c/the-2-likely-reasons-valeant-pharmaceuticals-surged-by-as-much-as-15-cm788202,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drug developer whose primary method of growth over the past couple of years has been via acquisitions and price hikes on its therapies surged as much as 15 on Thursday for their third consecutive day
VRX,VRX:US,BBG000DLFM21,Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free,2017-05-11 22:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7CYnLHooBZw/go-long-valeant-pharmaceuticals-intl-inc-vrx-stock-for-free-cm788225,InvestorPlace Stock Market News Stock Advice amp Trading Tips I classify Valeant Pharmaceuticals Intl Inc NYSE VRX trades as casino trades because lately they have been more like gambling than investing But I do need more speculative plays in my portfolio and VRX stock
VRX,VRX:CT,BBG000DC8S17,Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free,2017-05-11 22:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7CYnLHooBZw/go-long-valeant-pharmaceuticals-intl-inc-vrx-stock-for-free-cm788225,InvestorPlace Stock Market News Stock Advice amp Trading Tips I classify Valeant Pharmaceuticals Intl Inc NYSE VRX trades as casino trades because lately they have been more like gambling than investing But I do need more speculative plays in my portfolio and VRX stock
VRX,VRX:CT,BBG000DC8S17,The Number to Watch in Nvidia Corporation (NVDA) Stock Is $121,2017-05-11 22:02:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RqeOqQPNFO4/the-number-to-watch-in-nvidia-corporation-nvda-stock-is-121-cm788222,InvestorPlace Stock Market News Stock Advice amp Trading Tips Nvidia Corporation NASDAQ NVDA blew past earnings estimates on Tuesday and that sent shares up nearly 18 on Wednesday to close at new all time highs at 121 29 NVDA stock is doing even
VRX,VRX:US,BBG000DLFM21,The Number to Watch in Nvidia Corporation (NVDA) Stock Is $121,2017-05-11 22:02:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RqeOqQPNFO4/the-number-to-watch-in-nvidia-corporation-nvda-stock-is-121-cm788222,InvestorPlace Stock Market News Stock Advice amp Trading Tips Nvidia Corporation NASDAQ NVDA blew past earnings estimates on Tuesday and that sent shares up nearly 18 on Wednesday to close at new all time highs at 121 29 NVDA stock is doing even
VRX,VRX:US,BBG000DLFM21,The 2 Likely Reasons Valeant Pharmaceuticals Surged by as Much as 15%,2017-05-11 21:57:00 +0000,http://finance.yahoo.com/r/31be7c61-bfbc-39c1-b42f-e0144cc5eb88/the-2-likely-reasons-valeant-pharmaceuticals-surge.aspx?yptr=yahoo&.tsrc=rss,Optimism from Valeant&apos;s earnings report and short covering are pushing the stock higher.
VRX,VRX:CT,BBG000DC8S17,The 2 Likely Reasons Valeant Pharmaceuticals Surged by as Much as 15%,2017-05-11 21:57:00 +0000,http://finance.yahoo.com/r/31be7c61-bfbc-39c1-b42f-e0144cc5eb88/the-2-likely-reasons-valeant-pharmaceuticals-surge.aspx?yptr=yahoo&.tsrc=rss,Optimism from Valeant&apos;s earnings report and short covering are pushing the stock higher.
VRX,VRX:US,BBG000DLFM21,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Bounce Now,2017-05-11 18:04:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fg8OVYwKZxo/teva-pharmaceutical-industries-ltd-adr-teva-stock-can-bounce-now-cm788081,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stockholders desperately needed good news heading into Thursday s 160 first quarter earnings report After all TEVA stock has been in
VRX,VRX:CT,BBG000DC8S17,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Bounce Now,2017-05-11 18:04:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fg8OVYwKZxo/teva-pharmaceutical-industries-ltd-adr-teva-stock-can-bounce-now-cm788081,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stockholders desperately needed good news heading into Thursday s 160 first quarter earnings report After all TEVA stock has been in
VRX,VRX:CT,BBG000DC8S17,Apple Inc (AAPL) Stock May Be On “Pause” for Some Time,2017-05-11 18:03:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-e9kONAwxBM/apple-inc-aapl-stock-may-be-on-pause-for-some-time-cm788077,InvestorPlace Stock Market News Stock Advice amp Trading Tips Wall Street s reaction to Apple Inc s NASDAQ AAPL fiscal second quarter results was 160 certainly lackluster with the stock off less than 1 on the news But then again the shares had already staged a nice
VRX,VRX:US,BBG000DLFM21,Apple Inc (AAPL) Stock May Be On “Pause” for Some Time,2017-05-11 18:03:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-e9kONAwxBM/apple-inc-aapl-stock-may-be-on-pause-for-some-time-cm788077,InvestorPlace Stock Market News Stock Advice amp Trading Tips Wall Street s reaction to Apple Inc s NASDAQ AAPL fiscal second quarter results was 160 certainly lackluster with the stock off less than 1 on the news But then again the shares had already staged a nice
VRX,VRX:US,BBG000DLFM21,InPlay from Briefing.com,2017-05-11 16:55:45 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
VRX,VRX:CT,BBG000DC8S17,InPlay from Briefing.com,2017-05-11 16:55:45 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
VRX,VRX:CT,BBG000DC8S17,Valeant Up 7% After Positive Patent Litigation Developments On Xifaxan,2017-05-11 15:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VuEoqzmp7Bk/valeant-up-7-after-positive-patent-litigation-developments-on-xifaxan-20170511-01383,Valeant Up 7% After Positive Patent Litigation Developments On Xifaxan
VRX,VRX:US,BBG000DLFM21,Valeant Up 7% After Positive Patent Litigation Developments On Xifaxan,2017-05-11 15:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VuEoqzmp7Bk/valeant-up-7-after-positive-patent-litigation-developments-on-xifaxan-20170511-01383,Valeant Up 7% After Positive Patent Litigation Developments On Xifaxan
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Feeling Sentimental?,2017-05-11 14:16:00 +0000,http://finance.yahoo.com/r/6b383c86-62e1-34b4-95bf-ff32dd46c40c/valeant-pharmaceuticals-feeling-sentimental-1494512164?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) is trying to gain for the third time since reporting earnings on Tuesday morning, which says something considering the fact that the stock had gained 31% since Monday's close.  In a note released on May 9, RBC's Douglas Miehm and Joel Hurren, for instance, write that Valeant's ""first guidance increase in two years, although modest, may signal the beginning of a transition for Valeant."" They explain: Valeant reported Q1/17 results that were in-line to slightly below our expectations, but the focal point from today's print was the increase in EBITDA guidance for the year.  Shares of Valeant Pharmaceuticals International have gained 0.6% to $12.75 at 9:50 a.m. today."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Feeling Sentimental?,2017-05-11 14:16:00 +0000,http://finance.yahoo.com/r/6b383c86-62e1-34b4-95bf-ff32dd46c40c/valeant-pharmaceuticals-feeling-sentimental-1494512164?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) is trying to gain for the third time since reporting earnings on Tuesday morning, which says something considering the fact that the stock had gained 31% since Monday's close.  In a note released on May 9, RBC's Douglas Miehm and Joel Hurren, for instance, write that Valeant's ""first guidance increase in two years, although modest, may signal the beginning of a transition for Valeant."" They explain: Valeant reported Q1/17 results that were in-line to slightly below our expectations, but the focal point from today's print was the increase in EBITDA guidance for the year.  Shares of Valeant Pharmaceuticals International have gained 0.6% to $12.75 at 9:50 a.m. today."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Banks Tumble - Canadian Commentary,2017-05-11 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0nFc3MWssiQ/canadian-stocks-are-falling-as-banks-tumble--canadian-commentary-20170511-01031,Canadian Stocks Are Falling As Banks Tumble - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Banks Tumble - Canadian Commentary,2017-05-11 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0nFc3MWssiQ/canadian-stocks-are-falling-as-banks-tumble--canadian-commentary-20170511-01031,Canadian Stocks Are Falling As Banks Tumble - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Rockets Higher: Why I'm Not Buying,2017-05-10 23:03:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bLv7RMQoY7I/valeant-rockets-higher-why-im-not-buying-cm787567,Valeant Pharmaceuticals NYSE VRX shares are on a tear and the company s first quarter financial results show that management is making headway in paying down debt However the business itself continues to sputter and ultimately this rally could be short lived if sales can t
VRX,VRX:CT,BBG000DC8S17,Valeant Rockets Higher: Why I'm Not Buying,2017-05-10 23:03:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bLv7RMQoY7I/valeant-rockets-higher-why-im-not-buying-cm787567,Valeant Pharmaceuticals NYSE VRX shares are on a tear and the company s first quarter financial results show that management is making headway in paying down debt However the business itself continues to sputter and ultimately this rally could be short lived if sales can t
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised",2017-05-10 22:01:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vp3IbUyzz5w/valeant-vrx-q1-earnings-revenues-miss-view-raised-cm787523,Shares of Valeant Pharmaceuticals Inc VRX surged significantly after the company raised the annual guidance for 2017 concurrent with the first quarter 2017 earnings We note that the shares of Valeant have underperformed the Zacks classified Medical Drugs industry in the last
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised",2017-05-10 22:01:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vp3IbUyzz5w/valeant-vrx-q1-earnings-revenues-miss-view-raised-cm787523,Shares of Valeant Pharmaceuticals Inc VRX surged significantly after the company raised the annual guidance for 2017 concurrent with the first quarter 2017 earnings We note that the shares of Valeant have underperformed the Zacks classified Medical Drugs industry in the last
VRX,VRX:US,BBG000DLFM21,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Has a Chance,2017-05-10 22:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O_L6WypJKGQ/teva-pharmaceutical-industries-ltd-adr-teva-stock-still-has-a-chance-cm787544,InvestorPlace Stock Market News Stock Advice amp Trading Tips The year for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has certainly been awful with the shares off about 14 Yet last year was even worse TEVA stock plunged from 56 44 to 31 15 Source Open
VRX,VRX:CT,BBG000DC8S17,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Has a Chance,2017-05-10 22:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O_L6WypJKGQ/teva-pharmaceutical-industries-ltd-adr-teva-stock-still-has-a-chance-cm787544,InvestorPlace Stock Market News Stock Advice amp Trading Tips The year for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has certainly been awful with the shares off about 14 Yet last year was even worse TEVA stock plunged from 56 44 to 31 15 Source Open
VRX,VRX:US,BBG000DLFM21,Valeant Rockets Higher: Why I&apos;m Not Buying,2017-05-10 21:02:00 +0000,http://finance.yahoo.com/r/ffbd3bf0-cbdb-3c70-85b6-dbba9360cdf6/valeant-rockets-higher-why-im-not-buying.aspx?yptr=yahoo&.tsrc=rss,"Valeant may be paying off debt, but interest payments are growing, not shrinking, and its sales continue to decline."
VRX,VRX:CT,BBG000DC8S17,Valeant Rockets Higher: Why I&apos;m Not Buying,2017-05-10 21:02:00 +0000,http://finance.yahoo.com/r/ffbd3bf0-cbdb-3c70-85b6-dbba9360cdf6/valeant-rockets-higher-why-im-not-buying.aspx?yptr=yahoo&.tsrc=rss,"Valeant may be paying off debt, but interest payments are growing, not shrinking, and its sales continue to decline."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Present At Health Care Conferences,2017-05-10 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-present-health-care-210000963.html?.tsrc=rss,"LAVAL, Quebec, May 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Present At Health Care Conferences,2017-05-10 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-present-health-care-210000963.html?.tsrc=rss,"LAVAL, Quebec, May 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to ..."
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised",2017-05-10 19:48:07 +0000,http://finance.yahoo.com/news/valeant-vrx-q1-earnings-revenues-194807659.html?.tsrc=rss,Shares of Valeant Pharmaceuticals Inc. (VRX) surged significantly after the company raised the annual guidance for 2017 concurrent with the first-quarter 2017 earnings.
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised",2017-05-10 19:48:07 +0000,http://finance.yahoo.com/news/valeant-vrx-q1-earnings-revenues-194807659.html?.tsrc=rss,Shares of Valeant Pharmaceuticals Inc. (VRX) surged significantly after the company raised the annual guidance for 2017 concurrent with the first-quarter 2017 earnings.
VRX,VRX:US,BBG000DLFM21,"Wednesday’s Vital Data: Nvidia Corporation (NVDA), Walt Disney Co (DIS) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-05-10 18:00:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3FvCuO5FbzM/wednesdays-vital-data-nvidia-corporation-nvda-walt-disney-co-dis-and-valeant-pharmaceuticals-intl-inc-vrx-cm787374,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading broadly lower as Wall Street seeks shelter amid a shakeup in Washington President Donald Trump s abrupt firing of FBI Director James Comey caught traders off guard perpetuating
VRX,VRX:CT,BBG000DC8S17,"Wednesday’s Vital Data: Nvidia Corporation (NVDA), Walt Disney Co (DIS) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-05-10 18:00:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3FvCuO5FbzM/wednesdays-vital-data-nvidia-corporation-nvda-walt-disney-co-dis-and-valeant-pharmaceuticals-intl-inc-vrx-cm787374,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading broadly lower as Wall Street seeks shelter amid a shakeup in Washington President Donald Trump s abrupt firing of FBI Director James Comey caught traders off guard perpetuating
VRX,VRX:CT,BBG000DC8S17,"Valeant Expresses Confidence In Outlook, But Might Be Too Early To Get Bullish",2017-05-10 16:09:40 +0000,http://finance.yahoo.com/news/valeant-expresses-confidence-outlook-might-160940480.html?.tsrc=rss,The latest chapter in the Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) drama is a happy one. Shares of the battered pharma stock are up nearly 24 percent this week after the company reported Q1 earnings ...
VRX,VRX:US,BBG000DLFM21,"Valeant Expresses Confidence In Outlook, But Might Be Too Early To Get Bullish",2017-05-10 16:09:40 +0000,http://finance.yahoo.com/news/valeant-expresses-confidence-outlook-might-160940480.html?.tsrc=rss,The latest chapter in the Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) drama is a happy one. Shares of the battered pharma stock are up nearly 24 percent this week after the company reported Q1 earnings ...
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals' Q1 Report Might Be the Greatest Smoke-and-Mirrors Show You'll Ever See,2017-05-10 15:03:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tkOkJvlPJxA/valeant-pharmaceuticals-q1-report-might-be-the-greatest-smoke-and-mirrors-show-youll-ever-see-cm787116,On Tuesday morning embattled drugmaker Valeant Pharmaceuticals NYSE VRX released its much anticipated first quarter earnings results and its share price responded by gaining a whopping 24 Good days aren t all too common for Valeant and its shareholders since the summer of
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals' Q1 Report Might Be the Greatest Smoke-and-Mirrors Show You'll Ever See,2017-05-10 15:03:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tkOkJvlPJxA/valeant-pharmaceuticals-q1-report-might-be-the-greatest-smoke-and-mirrors-show-youll-ever-see-cm787116,On Tuesday morning embattled drugmaker Valeant Pharmaceuticals NYSE VRX released its much anticipated first quarter earnings results and its share price responded by gaining a whopping 24 Good days aren t all too common for Valeant and its shareholders since the summer of
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: The End of the Beginning?,2017-05-10 14:15:00 +0000,http://finance.yahoo.com/r/cddce437-cd1e-3035-9742-9e8e978f6846/valeant-pharmaceuticals-the-end-of-the-beginning-1494425730?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) gained 24% yesterday after reporting earnings, so what would it do for an encore?  Rodman & Renshaw analyst Raghuram Selvaraju writes that the ""silver linings [are] apparent,"" even as he reiterates his Neutral rating."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: The End of the Beginning?,2017-05-10 14:15:00 +0000,http://finance.yahoo.com/r/cddce437-cd1e-3035-9742-9e8e978f6846/valeant-pharmaceuticals-the-end-of-the-beginning-1494425730?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) gained 24% yesterday after reporting earnings, so what would it do for an encore?  Rodman & Renshaw analyst Raghuram Selvaraju writes that the ""silver linings [are] apparent,"" even as he reiterates his Neutral rating."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals&apos; Q1 Report Might Be the Greatest Smoke-and-Mirrors Show You&apos;ll Ever See,2017-05-10 13:22:00 +0000,http://finance.yahoo.com/r/6a6d12f6-f62a-3729-8c64-0832c305f637/valeant-pharmaceuticals-q1-report-might-be-the-gre.aspx?yptr=yahoo&.tsrc=rss,Dig beneath the headlines and you&apos;ll see a company that made very few improvements during the first quarter.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals&apos; Q1 Report Might Be the Greatest Smoke-and-Mirrors Show You&apos;ll Ever See,2017-05-10 13:22:00 +0000,http://finance.yahoo.com/r/6a6d12f6-f62a-3729-8c64-0832c305f637/valeant-pharmaceuticals-q1-report-might-be-the-gre.aspx?yptr=yahoo&.tsrc=rss,Dig beneath the headlines and you&apos;ll see a company that made very few improvements during the first quarter.
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : May 10, 2017",2017-05-10 12:18:44 +0000,http://finance.yahoo.com/r/40da0e66-f0f0-3eaf-bd85-b95dbb2bf6da/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrx-us-may-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day ... Read more
<b>(Read more...)</b>"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : May 10, 2017",2017-05-10 12:18:44 +0000,http://finance.yahoo.com/r/40da0e66-f0f0-3eaf-bd85-b95dbb2bf6da/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrx-us-may-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Valeant Pharmaceuticals International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day ... Read more
<b>(Read more...)</b>"
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals,2017-05-10 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000417.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 10, 2017 / The S&P 500 Index and NASDAQ Composite Index hit new intraday highs on Tuesday as continued strength in corporate earnings and a positive outlook for the U.S. ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals,2017-05-10 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000417.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 10, 2017 / The S&P 500 Index and NASDAQ Composite Index hit new intraday highs on Tuesday as continued strength in corporate earnings and a positive outlook for the U.S. ..."
VRX,VRX:CT,BBG000DC8S17,Valeant shares rocket 24% as investors cheer moves to reduce debt,2017-05-10 10:59:11 +0000,http://finance.yahoo.com/r/e957220c-8295-3076-938d-dc4342b880f2/Story.aspx?guid=2DFB00E2-34D6-11E7-B4B9-B113D3C4BB05&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Troubled drug company reduced its debt by $1.3 billion in the latest quarter, easing investor concerns."
VRX,VRX:US,BBG000DLFM21,Valeant shares rocket 24% as investors cheer moves to reduce debt,2017-05-10 10:59:11 +0000,http://finance.yahoo.com/r/e957220c-8295-3076-938d-dc4342b880f2/Story.aspx?guid=2DFB00E2-34D6-11E7-B4B9-B113D3C4BB05&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Troubled drug company reduced its debt by $1.3 billion in the latest quarter, easing investor concerns."
VRX,VRX:US,BBG000DLFM21,Valeant Shows Signs Its Turnaround Efforts Are Bearing Fruit; Jim Cramer Weighs In,2017-05-09 22:24:00 +0000,http://finance.yahoo.com/r/27a7cb2d-0a9e-3085-91cc-b5e9b09f0949/valeant-misses-on-first-quarter-revenue-but-raises-2017-ebitda-guidance.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant's reducing debt and extending near-term maturities. It may not be on its last leg, the way most investors thought."
VRX,VRX:CT,BBG000DC8S17,Valeant Shows Signs Its Turnaround Efforts Are Bearing Fruit; Jim Cramer Weighs In,2017-05-09 22:24:00 +0000,http://finance.yahoo.com/r/27a7cb2d-0a9e-3085-91cc-b5e9b09f0949/valeant-misses-on-first-quarter-revenue-but-raises-2017-ebitda-guidance.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant's reducing debt and extending near-term maturities. It may not be on its last leg, the way most investors thought."
VRX,VRX:CT,BBG000DC8S17,"Valeant Moves Its Debt Pile, Gets Some Breathing Room",2017-05-09 22:23:00 +0000,http://finance.yahoo.com/r/53507de0-51ed-3905-98af-16636bafac9c/valeant-moves-its-debt-pile-gets-some-breathing-room.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,But analysts say Valeant still must bolster lackluster sales in key products and crank out some true earnings drivers from its product pipeline.
VRX,VRX:US,BBG000DLFM21,"Valeant Moves Its Debt Pile, Gets Some Breathing Room",2017-05-09 22:23:00 +0000,http://finance.yahoo.com/r/53507de0-51ed-3905-98af-16636bafac9c/valeant-moves-its-debt-pile-gets-some-breathing-room.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,But analysts say Valeant still must bolster lackluster sales in key products and crank out some true earnings drivers from its product pipeline.
VRX,VRX:CT,BBG000DC8S17,"Why Sturm Ruger, Wayfair, and Valeant Pharmaceuticals Jumped Today",2017-05-09 22:03:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A3_M7JL9Puc/why-sturm-ruger-wayfair-and-valeant-pharmaceuticals-jumped-today-cm786865,Tuesday was another relatively calm day on Wall Street with the Nasdaq hitting a fresh record but the S amp P 500 falling back from its own all time highs late in the day With earnings season starting to wind down investors will now turn their attention to macroeconomic
VRX,VRX:US,BBG000DLFM21,"Why Sturm Ruger, Wayfair, and Valeant Pharmaceuticals Jumped Today",2017-05-09 22:03:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A3_M7JL9Puc/why-sturm-ruger-wayfair-and-valeant-pharmaceuticals-jumped-today-cm786865,Tuesday was another relatively calm day on Wall Street with the Nasdaq hitting a fresh record but the S amp P 500 falling back from its own all time highs late in the day With earnings season starting to wind down investors will now turn their attention to macroeconomic
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX down as banks and energy weigh; Valeant, Home Capital soars",2017-05-09 21:21:54 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-down-banks-212154980.html?.tsrc=rss,"Canada's main stock index fell on  Tuesday as banks, oil and gas companies pulled the market lower,  but losses were modestly tempered by Valeant Pharmaceuticals  International and Home Capital Group Inc  stocks, which soared as investors cheered news from the  companies.  The Toronto Stock Exchange's S&P/TSX composite index  fell 82.88 points, or 0.53 percent, to 15,569.2.  Thirteen of the 15 biggest drags on the index were financial  and energy companies, and accounted for the bulk of declines."
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX down as banks and energy weigh; Valeant, Home Capital soars",2017-05-09 21:21:54 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-down-banks-212154980.html?.tsrc=rss,"Canada's main stock index fell on  Tuesday as banks, oil and gas companies pulled the market lower,  but losses were modestly tempered by Valeant Pharmaceuticals  International and Home Capital Group Inc  stocks, which soared as investors cheered news from the  companies.  The Toronto Stock Exchange's S&P/TSX composite index  fell 82.88 points, or 0.53 percent, to 15,569.2.  Thirteen of the 15 biggest drags on the index were financial  and energy companies, and accounted for the bulk of declines."
VRX,VRX:CT,BBG000DC8S17,Valeant Surges While Analysts Remain Cautious,2017-05-09 21:18:58 +0000,http://finance.yahoo.com/r/c9e16afa-082c-33f8-bce3-defaabd20199/valeant-surges-while-analysts-remain-cautious-video?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. sounded an upbeat note about its future profits, sending the drugmaker’s beaten down shares surging even as analysts remain wary. Bloomberg Gadfly's Max Nisen ..."
VRX,VRX:US,BBG000DLFM21,Valeant Surges While Analysts Remain Cautious,2017-05-09 21:18:58 +0000,http://finance.yahoo.com/r/c9e16afa-082c-33f8-bce3-defaabd20199/valeant-surges-while-analysts-remain-cautious-video?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. sounded an upbeat note about its future profits, sending the drugmaker’s beaten down shares surging even as analysts remain wary. Bloomberg Gadfly's Max Nisen ..."
VRX,VRX:US,BBG000DLFM21,"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM...",2017-05-09 20:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/heAx42q9Jds/gainers--losers-of-may-9-vrx-endp-ptla-scyx-nxtm-20170509-02070,"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM..."
VRX,VRX:CT,BBG000DC8S17,"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM...",2017-05-09 20:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/heAx42q9Jds/gainers--losers-of-may-9-vrx-endp-ptla-scyx-nxtm-20170509-02070,"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM..."
VRX,VRX:US,BBG000DLFM21,"Why Sturm Ruger, Wayfair, and Valeant Pharmaceuticals Jumped Today",2017-05-09 20:29:00 +0000,http://finance.yahoo.com/r/b9392d8e-7170-35a0-81d1-f9a04e2c7334/why-sturm-ruger-wayfair-and-valeant-pharmaceutical.aspx?yptr=yahoo&.tsrc=rss,"On a sluggish market day, these stocks climbed. Find out why."
VRX,VRX:CT,BBG000DC8S17,"Why Sturm Ruger, Wayfair, and Valeant Pharmaceuticals Jumped Today",2017-05-09 20:29:00 +0000,http://finance.yahoo.com/r/b9392d8e-7170-35a0-81d1-f9a04e2c7334/why-sturm-ruger-wayfair-and-valeant-pharmaceutical.aspx?yptr=yahoo&.tsrc=rss,"On a sluggish market day, these stocks climbed. Find out why."
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 05/09/2017: VRX,NVAX,FLGT",2017-05-09 20:20:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4D0rXV86zWg/health-care-sector-update-for-05092017-vrxnvaxflgt-cm786801,Top Health Care StocksTop Health Care Stocks JNJ 0 08 JNJ 0 08 PFE 0 10 PFE 0 10 ABT 0 16 ABT 0 16 MRK 1 09 MRK 1 09 AMGN 0 09 AMGN 0 09 Health care stocks were narrowly mixed in late trade giving back small gains from earlier today and with the NYSE Health Care Index adding
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 05/09/2017: VRX,NVAX,FLGT",2017-05-09 20:20:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4D0rXV86zWg/health-care-sector-update-for-05092017-vrxnvaxflgt-cm786801,Top Health Care StocksTop Health Care Stocks JNJ 0 08 JNJ 0 08 PFE 0 10 PFE 0 10 ABT 0 16 ABT 0 16 MRK 1 09 MRK 1 09 AMGN 0 09 AMGN 0 09 Health care stocks were narrowly mixed in late trade giving back small gains from earlier today and with the NYSE Health Care Index adding
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX dragged by banks and energy; Valeant, Home Capital surges",2017-05-09 20:16:51 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-dragged-banks-201651768.html?.tsrc=rss,"Canada's main stock index fell more than half a percent on Tuesday as bank and energy stocks led the market lower, but Valeant Pharmaceuticals International and Home Capital Group Inc stocks soared as ..."
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX dragged by banks and energy; Valeant, Home Capital surges",2017-05-09 20:16:51 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-dragged-banks-201651768.html?.tsrc=rss,"Canada's main stock index fell more than half a percent on Tuesday as bank and energy stocks led the market lower, but Valeant Pharmaceuticals International and Home Capital Group Inc stocks soared as ..."
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Stock Is Soaring Today,2017-05-09 20:03:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VxGiVHUGaM4/why-valeant-pharmaceuticals-stock-is-soaring-today-cm786743,What happened As of 1 15 p m EDT Valeant Pharmaceuticals NYSE VRX stock is up by a noteworthy 26 6 as the result of a surprisingly upbeat adjustment to its 2017 annual guidance As part of its first quarter earnings report the drugmaker upped its full year adjusted
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Stock Is Soaring Today,2017-05-09 20:03:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VxGiVHUGaM4/why-valeant-pharmaceuticals-stock-is-soaring-today-cm786743,What happened As of 1 15 p m EDT Valeant Pharmaceuticals NYSE VRX stock is up by a noteworthy 26 6 as the result of a surprisingly upbeat adjustment to its 2017 annual guidance As part of its first quarter earnings report the drugmaker upped its full year adjusted
VRX,VRX:US,BBG000DLFM21,Trade Boeing Co (BA) Stock With Highflying Confidence,2017-05-09 19:02:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9zDM2nGRLO8/trade-boeing-co-ba-stock-with-highflying-confidence-cm786759,InvestorPlace Stock Market News Stock Advice amp Trading Tips Stocks like Apple Inc NASDAQ AAPL and Netflix Inc NASDAQ NFLX have grabbed headlines with their post earnings moves but another lesser ballyhooed stock looks interesting from an options
VRX,VRX:CT,BBG000DC8S17,Trade Boeing Co (BA) Stock With Highflying Confidence,2017-05-09 19:02:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9zDM2nGRLO8/trade-boeing-co-ba-stock-with-highflying-confidence-cm786759,InvestorPlace Stock Market News Stock Advice amp Trading Tips Stocks like Apple Inc NASDAQ AAPL and Netflix Inc NASDAQ NFLX have grabbed headlines with their post earnings moves but another lesser ballyhooed stock looks interesting from an options
VRX,VRX:CT,BBG000DC8S17,"Valeant: Business Shows Some Stability, But ...",2017-05-09 18:46:00 +0000,http://finance.yahoo.com/news/valeant-business-shows-stability-184600716.html?.tsrc=rss,We continue to have modest expectations for new products and the pipeline.
VRX,VRX:US,BBG000DLFM21,"Valeant: Business Shows Some Stability, But ...",2017-05-09 18:46:00 +0000,http://finance.yahoo.com/news/valeant-business-shows-stability-184600716.html?.tsrc=rss,We continue to have modest expectations for new products and the pipeline.
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Stock Is Soaring Today,2017-05-09 18:43:00 +0000,http://finance.yahoo.com/r/634f7215-e185-3ed6-8f35-c03c9333e129/why-valeant-pharmaceuticals-stock-is-soaring-today.aspx?yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals could be turning the corner.
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Stock Is Soaring Today,2017-05-09 18:43:00 +0000,http://finance.yahoo.com/r/634f7215-e185-3ed6-8f35-c03c9333e129/why-valeant-pharmaceuticals-stock-is-soaring-today.aspx?yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals could be turning the corner.
VRX,VRX:US,BBG000DLFM21,Valeant: Is That All?,2017-05-09 18:40:00 +0000,http://finance.yahoo.com/r/cfbeefba-818d-304b-a633-2369f123e7dd/valeant-is-that-all-1494355206?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are soaring today after the specialty-pharmaceutical company beat earnings forecasts and offered upbeat guidance (never mind the revenue miss).  Wells Fargo's David Maris offers a reminder as why that might not be the best idea: Sometimes Valeant leaves the best (or worst, as the case may be) for its filings.  Maris explains: Overall, we understand Valeant's decision to highlight in its press release the EBITDA raise of 1.3% as this is better than the recent trend, although we note to investors that the $50 million raise is relative to approximately $28.88 billion of total debt."
VRX,VRX:CT,BBG000DC8S17,Valeant: Is That All?,2017-05-09 18:40:00 +0000,http://finance.yahoo.com/r/cfbeefba-818d-304b-a633-2369f123e7dd/valeant-is-that-all-1494355206?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are soaring today after the specialty-pharmaceutical company beat earnings forecasts and offered upbeat guidance (never mind the revenue miss).  Wells Fargo's David Maris offers a reminder as why that might not be the best idea: Sometimes Valeant leaves the best (or worst, as the case may be) for its filings.  Maris explains: Overall, we understand Valeant's decision to highlight in its press release the EBITDA raise of 1.3% as this is better than the recent trend, although we note to investors that the $50 million raise is relative to approximately $28.88 billion of total debt."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Raises Full-Year Outlook After Posting a First-Quarter Profit,2017-05-09 18:04:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NUXQCSXDz_k/valeant-pharmaceuticals-raises-full-year-outlook-after-posting-a-first-quarter-profit-cm786662,When Valeant Pharmaceuticals NYSE VRX reported its fourth quarter and full year 2016 results in February there wasn t much good news to be found Sales fell in every business segment and earnings plunged The scenario was better than it s been in a while when the
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Raises Full-Year Outlook After Posting a First-Quarter Profit,2017-05-09 18:04:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NUXQCSXDz_k/valeant-pharmaceuticals-raises-full-year-outlook-after-posting-a-first-quarter-profit-cm786662,When Valeant Pharmaceuticals NYSE VRX reported its fourth quarter and full year 2016 results in February there wasn t much good news to be found Sales fell in every business segment and earnings plunged The scenario was better than it s been in a while when the
VRX,VRX:US,BBG000DLFM21,How to Trade Nvidia Corporation (NVDA) Stock Around Q1 Earnings,2017-05-09 18:01:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jbL8RwlAkw8/how-to-trade-nvidia-corporation-nvda-stock-around-q1-earnings-cm786690,InvestorPlace Stock Market News Stock Advice amp Trading Tips Nvidia Corporation NASDAQ NVDA will step onto the earnings stage after the close of trading this afternoon Investors no doubt tired of the listing performance of NVDA stock are hoping that its fortunes
VRX,VRX:CT,BBG000DC8S17,How to Trade Nvidia Corporation (NVDA) Stock Around Q1 Earnings,2017-05-09 18:01:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jbL8RwlAkw8/how-to-trade-nvidia-corporation-nvda-stock-around-q1-earnings-cm786690,InvestorPlace Stock Market News Stock Advice amp Trading Tips Nvidia Corporation NASDAQ NVDA will step onto the earnings stage after the close of trading this afternoon Investors no doubt tired of the listing performance of NVDA stock are hoping that its fortunes
VRX,VRX:CT,BBG000DC8S17,Trader: Investors should watch Valeant's core business,2017-05-09 17:43:00 +0000,http://finance.yahoo.com/video/trader-investors-watch-valeants-core-174300356.html?.tsrc=rss,"Tim Seymour, Triogem Asset Management, weighs in on his draft stock pick Valeant Pharmaceuticals."
VRX,VRX:US,BBG000DLFM21,Trader: Investors should watch Valeant's core business,2017-05-09 17:43:00 +0000,http://finance.yahoo.com/video/trader-investors-watch-valeants-core-174300356.html?.tsrc=rss,"Tim Seymour, Triogem Asset Management, weighs in on his draft stock pick Valeant Pharmaceuticals."
VRX,VRX:US,BBG000DLFM21,Valeant Can't Paper Over Its Problems,2017-05-09 17:28:24 +0000,http://finance.yahoo.com/r/1b23ed99-7679-38c8-8e30-4b1668db9f5b/valeant-earnings-forecast-boost-can-t-paper-over-issues?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,The pharma firm's debt mountain and business woes are still overwhelming.
VRX,VRX:CT,BBG000DC8S17,Valeant Can't Paper Over Its Problems,2017-05-09 17:28:24 +0000,http://finance.yahoo.com/r/1b23ed99-7679-38c8-8e30-4b1668db9f5b/valeant-earnings-forecast-boost-can-t-paper-over-issues?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,The pharma firm's debt mountain and business woes are still overwhelming.
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Raises Full-Year Outlook After Posting a First-Quarter Profit,2017-05-09 16:23:00 +0000,http://finance.yahoo.com/r/d6aa2870-3203-3b94-89cc-c1215f5c7705/valeant-pharmaceuticals-raises-full-year-outlook-a.aspx?yptr=yahoo&.tsrc=rss,"First-quarter sales declined as expected, but a one-time tax benefit helped the drugmaker return to profitability."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Raises Full-Year Outlook After Posting a First-Quarter Profit,2017-05-09 16:23:00 +0000,http://finance.yahoo.com/r/d6aa2870-3203-3b94-89cc-c1215f5c7705/valeant-pharmaceuticals-raises-full-year-outlook-a.aspx?yptr=yahoo&.tsrc=rss,"First-quarter sales declined as expected, but a one-time tax benefit helped the drugmaker return to profitability."
VRX,VRX:US,BBG000DLFM21,"TSX Lags Despite Valeant, Home Capital Rebound -- Canadian Commentary",2017-05-09 16:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eyYpSPrTvcM/tsx-lags-despite-valeant-home-capital-rebound--canadian-commentary-20170509-01809,"TSX Lags Despite Valeant, Home Capital Rebound -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"TSX Lags Despite Valeant, Home Capital Rebound -- Canadian Commentary",2017-05-09 16:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eyYpSPrTvcM/tsx-lags-despite-valeant-home-capital-rebound--canadian-commentary-20170509-01809,"TSX Lags Despite Valeant, Home Capital Rebound -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,Stocks Close Mixed But Nasdaq Reaches New Record High - U.S. Commentary,2017-05-09 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VTg7d6ISQjg/stocks-close-mixed-but-nasdaq-reaches-new-record-high--us-commentary-20170509-01798,Stocks Close Mixed But Nasdaq Reaches New Record High - U.S. Commentary
VRX,VRX:CT,BBG000DC8S17,Stocks Close Mixed But Nasdaq Reaches New Record High - U.S. Commentary,2017-05-09 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VTg7d6ISQjg/stocks-close-mixed-but-nasdaq-reaches-new-record-high--us-commentary-20170509-01798,Stocks Close Mixed But Nasdaq Reaches New Record High - U.S. Commentary
VRX,VRX:US,BBG000DLFM21,[$$] Valeant shares jump as it lifts full-year earnings guidance,2017-05-09 15:56:22 +0000,"http://finance.yahoo.com/r/fc4fc243-df3f-3fe4-9195-f31bae974a94/814189b2-34c5-11e7-99bd-13beb0903fa3,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Valeant, the Canadian drugmaker that lost almost two-thirds of its value over the past year, has posted a profit in its first quarter despite falling revenues as it got a boost from a one-off tax benefit. ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant shares jump as it lifts full-year earnings guidance,2017-05-09 15:56:22 +0000,"http://finance.yahoo.com/r/fc4fc243-df3f-3fe4-9195-f31bae974a94/814189b2-34c5-11e7-99bd-13beb0903fa3,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Valeant, the Canadian drugmaker that lost almost two-thirds of its value over the past year, has posted a profit in its first quarter despite falling revenues as it got a boost from a one-off tax benefit. ..."
VRX,VRX:US,BBG000DLFM21,Drugmaker Valeant raises profit forecast; shares spike,2017-05-09 15:22:17 +0000,http://finance.yahoo.com/news/tax-benefit-helps-valeant-post-111125071.html?.tsrc=rss,"Laval, Quebec-based Valeant said it expected 2017 earnings before interest, tax, depreciation and amortization of $3.60 billion to $3.75 billion, excluding special items.  The results came after billionaire investor William Ackman sold his entire stake in Valeant in March at a loss of more than $3 billion.  Valeant's shares were up 20.6 percent at $11.71 in New York."
VRX,VRX:CT,BBG000DC8S17,Drugmaker Valeant raises profit forecast; shares spike,2017-05-09 15:22:17 +0000,http://finance.yahoo.com/news/tax-benefit-helps-valeant-post-111125071.html?.tsrc=rss,"Laval, Quebec-based Valeant said it expected 2017 earnings before interest, tax, depreciation and amortization of $3.60 billion to $3.75 billion, excluding special items.  The results came after billionaire investor William Ackman sold his entire stake in Valeant in March at a loss of more than $3 billion.  Valeant's shares were up 20.6 percent at $11.71 in New York."
VRX,VRX:US,BBG000DLFM21,Valeant turns First Profit in Six Quarters,2017-05-09 15:12:00 +0000,http://finance.yahoo.com/r/fda58ae9-aa14-3dc4-84a0-6edec34047fb/valeant-turns-first-profit-six-quarters-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Is it too little, too late for Valeant investors?"
VRX,VRX:CT,BBG000DC8S17,Valeant turns First Profit in Six Quarters,2017-05-09 15:12:00 +0000,http://finance.yahoo.com/r/fda58ae9-aa14-3dc4-84a0-6edec34047fb/valeant-turns-first-profit-six-quarters-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Is it too little, too late for Valeant investors?"
VRX,VRX:CT,BBG000DC8S17,Valeant swings to a profit,2017-05-09 14:48:44 +0000,https://www.yahoo.com/news/valeant-swings-profit-144844250.html?.tsrc=rss,"The troubled drugmaker posted its first profit in six quarters, helped by a one-time tax gain. As Fred Katayama reports, Valeant also raised its earnings outlook."
VRX,VRX:US,BBG000DLFM21,Valeant swings to a profit,2017-05-09 14:48:44 +0000,https://www.yahoo.com/news/valeant-swings-profit-144844250.html?.tsrc=rss,"The troubled drugmaker posted its first profit in six quarters, helped by a one-time tax gain. As Fred Katayama reports, Valeant also raised its earnings outlook."
VRX,VRX:US,BBG000DLFM21,"Wall Street Sees Slightly Higher Open; Corporate Earnings, Fed Speakers in Focus",2017-05-09 14:00:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N82eHRNNmQI/wall-street-sees-slightly-higher-open-corporate-earnings-fed-speakers-in-focus-cm786377,U S stock futures edged higher on Tuesday as traders shifted focus from Emmanuel Macron s victory in the French presidential race and looked ahead to a slate of Federal Reserve speakers and corporate earnings U S stock futures edged higher on Tuesday as traders shifted focus from
VRX,VRX:CT,BBG000DC8S17,"Wall Street Sees Slightly Higher Open; Corporate Earnings, Fed Speakers in Focus",2017-05-09 14:00:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N82eHRNNmQI/wall-street-sees-slightly-higher-open-corporate-earnings-fed-speakers-in-focus-cm786377,U S stock futures edged higher on Tuesday as traders shifted focus from Emmanuel Macron s victory in the French presidential race and looked ahead to a slate of Federal Reserve speakers and corporate earnings U S stock futures edged higher on Tuesday as traders shifted focus from
VRX,VRX:CT,BBG000DC8S17,"Valeant: Up, Up & Away!",2017-05-09 13:56:00 +0000,http://finance.yahoo.com/r/4c5a06c9-9af6-3652-8e30-eb68088737fe/valeant-up-up-away-1494338196?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Valeant Pharmaceuticals International (VRX) are soaring today after the beaten-down specialty pharmaceutical company beat earnings forecasts this morning. Valeant reported a profit of $1.79 a ...
VRX,VRX:US,BBG000DLFM21,"Valeant: Up, Up & Away!",2017-05-09 13:56:00 +0000,http://finance.yahoo.com/r/4c5a06c9-9af6-3652-8e30-eb68088737fe/valeant-up-up-away-1494338196?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Valeant Pharmaceuticals International (VRX) are soaring today after the beaten-down specialty pharmaceutical company beat earnings forecasts this morning. Valeant reported a profit of $1.79 a ...
VRX,VRX:US,BBG000DLFM21,"US STOCKS-S&P, Nasdaq hit record highs as volatility drops",2017-05-09 13:52:19 +0000,http://finance.yahoo.com/news/us-stocks-p-nasdaq-hit-135219309.html?.tsrc=rss,"The VIX, Wall Street's ""fear gauge"", hit 9.57 points,  the lowest since late 2006, a day after closing at its lowest  level in over two decades.  A falling VIX typically indicates a  bullish outlook for stocks.  The 10-year U.S. Treasury yield rose to its highest in a  month, while gold prices fell, indicating a shift in investor  preference for riskier assets."
VRX,VRX:CT,BBG000DC8S17,"US STOCKS-S&P, Nasdaq hit record highs as volatility drops",2017-05-09 13:52:19 +0000,http://finance.yahoo.com/news/us-stocks-p-nasdaq-hit-135219309.html?.tsrc=rss,"The VIX, Wall Street's ""fear gauge"", hit 9.57 points,  the lowest since late 2006, a day after closing at its lowest  level in over two decades.  A falling VIX typically indicates a  bullish outlook for stocks.  The 10-year U.S. Treasury yield rose to its highest in a  month, while gold prices fell, indicating a shift in investor  preference for riskier assets."
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX dips as losses for energy offset Home Capital, Valeant",2017-05-09 13:49:52 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-dips-losses-134952078.html?.tsrc=rss,"Canada's main stock index dipped on Tuesday as energy shares fell, offsetting a jump in Home Capital Group Inc on a plan to sell part of its mortgage book, while Valeant Pharmaceuticals International Inc ..."
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX dips as losses for energy offset Home Capital, Valeant",2017-05-09 13:49:52 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-dips-losses-134952078.html?.tsrc=rss,"Canada's main stock index dipped on Tuesday as energy shares fell, offsetting a jump in Home Capital Group Inc on a plan to sell part of its mortgage book, while Valeant Pharmaceuticals International Inc ..."
VRX,VRX:CT,BBG000DC8S17,Biotech Movers: Valeant Shares Jump After Raising Adjusted Ebitda Outlook,2017-05-09 13:27:00 +0000,http://finance.yahoo.com/r/a0330425-9a7c-32f1-bcee-64733ce803ed/biotech-movers-valeant-shares-jump-after-raising-adjusted-ebitda-outlook.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant, NantKwest and Aralez were among the biotech movers in premarket trading on Tuesday."
VRX,VRX:US,BBG000DLFM21,Biotech Movers: Valeant Shares Jump After Raising Adjusted Ebitda Outlook,2017-05-09 13:27:00 +0000,http://finance.yahoo.com/r/a0330425-9a7c-32f1-bcee-64733ce803ed/biotech-movers-valeant-shares-jump-after-raising-adjusted-ebitda-outlook.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant, NantKwest and Aralez were among the biotech movers in premarket trading on Tuesday."
VRX,VRX:US,BBG000DLFM21,"Valeant Posting Strong Gain On Upbeat Q1 Earnings, Guidance",2017-05-09 13:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kot5ikQOJNo/valeant-posting-strong-gain-on-upbeat-q1-earnings-guidance-20170509-01367,"Valeant Posting Strong Gain On Upbeat Q1 Earnings, Guidance"
VRX,VRX:CT,BBG000DC8S17,"Valeant Posting Strong Gain On Upbeat Q1 Earnings, Guidance",2017-05-09 13:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kot5ikQOJNo/valeant-posting-strong-gain-on-upbeat-q1-earnings-guidance-20170509-01367,"Valeant Posting Strong Gain On Upbeat Q1 Earnings, Guidance"
VRX,VRX:CT,BBG000DC8S17,US STOCKS-Wall St set to open higher as risk-on sentiment improves,2017-05-09 13:01:50 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-set-130150133.html?.tsrc=rss,"U.S. stocks were poised to open slightly  higher on Tuesday, with market volatility at its lowest in more  than two decades following Emmanuel Macron's victory in the  French presidential election and strong U.S. corporate earnings."
VRX,VRX:US,BBG000DLFM21,US STOCKS-Wall St set to open higher as risk-on sentiment improves,2017-05-09 13:01:50 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-set-130150133.html?.tsrc=rss,"U.S. stocks were poised to open slightly  higher on Tuesday, with market volatility at its lowest in more  than two decades following Emmanuel Macron's victory in the  French presidential election and strong U.S. corporate earnings."
VRX,VRX:US,BBG000DLFM21,"US Futures Edge Higher Amid Corporate Earnings, Fed Speakers",2017-05-09 13:01:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0zb0e2ySbZY/us-futures-edge-higher-amid-corporate-earnings-fed-speakers-cm786332,U S stock futures posted some small gains on Tuesday as traders shifted focus from Emmanuel Macron s victory in the French presidential race and looked ahead to a slate of Federal Reserve speakers and corporate earnings U S stock futures posted some small gains on Tuesday as traders shifted
VRX,VRX:CT,BBG000DC8S17,"US Futures Edge Higher Amid Corporate Earnings, Fed Speakers",2017-05-09 13:01:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0zb0e2ySbZY/us-futures-edge-higher-amid-corporate-earnings-fed-speakers-cm786332,U S stock futures posted some small gains on Tuesday as traders shifted focus from Emmanuel Macron s victory in the French presidential race and looked ahead to a slate of Federal Reserve speakers and corporate earnings U S stock futures posted some small gains on Tuesday as traders shifted
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for May 9, 2017 :  VRX, KAMN, P, HTZ, AAPL, RAD, ENDP, AUO, XIV, QQQ, TVIX, CAMT",2017-05-09 13:00:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/loCEiVdmrjs/pre-market-most-active-for-may-9-2017-vrx-kamn-p-htz-aapl-rad-endp-auo-xiv-qqq-tvix-camt-cm786334,The NASDAQ 100 Pre Market Indicator is up 10 29 to 5 669 36 The total Pre Market volume is currently 7 958 065 shares traded The following are the most active stocks for the pre market session Valeant Pharmaceuticals International Inc VRX is 1 6 at 11 31
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for May 9, 2017 :  VRX, KAMN, P, HTZ, AAPL, RAD, ENDP, AUO, XIV, QQQ, TVIX, CAMT",2017-05-09 13:00:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/loCEiVdmrjs/pre-market-most-active-for-may-9-2017-vrx-kamn-p-htz-aapl-rad-endp-auo-xiv-qqq-tvix-camt-cm786334,The NASDAQ 100 Pre Market Indicator is up 10 29 to 5 669 36 The total Pre Market volume is currently 7 958 065 shares traded The following are the most active stocks for the pre market session Valeant Pharmaceuticals International Inc VRX is 1 6 at 11 31
VRX,VRX:CT,BBG000DC8S17,Morning News Call Canadienne - Mai 9,2017-05-09 12:44:31 +0000,http://finance.yahoo.com/news/morning-news-call-canadienne-mai-124431323.html?.tsrc=rss,Pour consulter la lettre d'information; cliquez sur le lien: http://share.thomsonreuters.com/assets/newsletters/Morning_News_Call/MNCCA_FR_05092017.pdf PRINCIPAUX INDICATEURS À L’AGENDA 08:30 Permis de ...
VRX,VRX:US,BBG000DLFM21,Morning News Call Canadienne - Mai 9,2017-05-09 12:44:31 +0000,http://finance.yahoo.com/news/morning-news-call-canadienne-mai-124431323.html?.tsrc=rss,Pour consulter la lettre d'information; cliquez sur le lien: http://share.thomsonreuters.com/assets/newsletters/Morning_News_Call/MNCCA_FR_05092017.pdf PRINCIPAUX INDICATEURS À L’AGENDA 08:30 Permis de ...
VRX,VRX:US,BBG000DLFM21,Valeant explodes after boosting guidance,2017-05-09 12:37:00 +0000,http://finance.yahoo.com/news/valeant-explodes-boosting-guidance-123700006.html?.tsrc=rss,Shares of Valeant Pharmaceuticals surged by 15% to $11.21 after the company raised its 2017...
VRX,VRX:CT,BBG000DC8S17,Valeant explodes after boosting guidance,2017-05-09 12:37:00 +0000,http://finance.yahoo.com/news/valeant-explodes-boosting-guidance-123700006.html?.tsrc=rss,Shares of Valeant Pharmaceuticals surged by 15% to $11.21 after the company raised its 2017...
VRX,VRX:US,BBG000DLFM21,Top 3 Companies Owned by Valeant (VRX),2017-05-09 12:35:00 +0000,http://finance.yahoo.com/r/06bcb618-92e5-34ef-aa2f-0bb0993017b3/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,Top 3 Companies Owned by Valeant (VRX),2017-05-09 12:35:00 +0000,http://finance.yahoo.com/r/06bcb618-92e5-34ef-aa2f-0bb0993017b3/top-3-companies-owned-valeant-vrx.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates as subsidiaries.
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: Valeant Surges, Hertz Tumbles, Marriott Jumps",2017-05-09 12:29:00 +0000,http://finance.yahoo.com/r/acb42fc7-45f3-3f96-93e0-eed1f01ed58c/morning-movers-valeant-surges-hertz-tumbles-marriott-jumps-1494332945?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set to open slightly higher this morning after finishing flat yesterday following the French Presidential election. S&P 500 futures have ticked up 0.1%, while Dow Jones Industrial Average futures ..."
VRX,VRX:US,BBG000DLFM21,"Morning Movers: Valeant Surges, Hertz Tumbles, Marriott Jumps",2017-05-09 12:29:00 +0000,http://finance.yahoo.com/r/acb42fc7-45f3-3f96-93e0-eed1f01ed58c/morning-movers-valeant-surges-hertz-tumbles-marriott-jumps-1494332945?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set to open slightly higher this morning after finishing flat yesterday following the French Presidential election. S&P 500 futures have ticked up 0.1%, while Dow Jones Industrial Average futures ..."
VRX,VRX:US,BBG000DLFM21,"Drugmaker Valeant tops 1Q profit forecasts, chops debt again",2017-05-09 12:28:47 +0000,http://finance.yahoo.com/r/085b8748-082e-3e8d-808c-65bfa17c810a/valeant-tops-1q-profit-forecasts-114650818.html?.tsrc=rss,"LAVAL, Quebec (AP) — Shares of Valeant Pharmaceuticals surged after the Canadian drugmaker topped Wall Street's first-quarter expectations and said it chopped its debt by another $1.3 billion, giving it more financial flexibility."
VRX,VRX:CT,BBG000DC8S17,"Drugmaker Valeant tops 1Q profit forecasts, chops debt again",2017-05-09 12:28:47 +0000,http://finance.yahoo.com/r/085b8748-082e-3e8d-808c-65bfa17c810a/valeant-tops-1q-profit-forecasts-114650818.html?.tsrc=rss,"LAVAL, Quebec (AP) — Shares of Valeant Pharmaceuticals surged after the Canadian drugmaker topped Wall Street's first-quarter expectations and said it chopped its debt by another $1.3 billion, giving it more financial flexibility."
VRX,VRX:US,BBG000DLFM21,TransDigm Results May Mitigate Shortselling Concerns,2017-05-09 12:22:00 +0000,http://finance.yahoo.com/r/f03bc515-43e7-3074-8e26-8eb3253ad3cb/transdigm-results-may-mitigate-shortselling-concerns.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The aerospace components maker lightened up on its own estimates for full year results and now expects 2017 earnings per share of $12.09-$12.33, versus an analyst average $12.22 estimate."
VRX,VRX:CT,BBG000DC8S17,TransDigm Results May Mitigate Shortselling Concerns,2017-05-09 12:22:00 +0000,http://finance.yahoo.com/r/f03bc515-43e7-3074-8e26-8eb3253ad3cb/transdigm-results-may-mitigate-shortselling-concerns.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The aerospace components maker lightened up on its own estimates for full year results and now expects 2017 earnings per share of $12.09-$12.33, versus an analyst average $12.22 estimate."
VRX,VRX:US,BBG000DLFM21,Stocks Give Back Ground But Remain Modestly Higher - U.S. Commentary,2017-05-09 12:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8aALjSEoXXk/stocks-give-back-ground-but-remain-modestly-higher--us-commentary-20170509-01245,Stocks Give Back Ground But Remain Modestly Higher - U.S. Commentary
VRX,VRX:CT,BBG000DC8S17,Stocks Give Back Ground But Remain Modestly Higher - U.S. Commentary,2017-05-09 12:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8aALjSEoXXk/stocks-give-back-ground-but-remain-modestly-higher--us-commentary-20170509-01245,Stocks Give Back Ground But Remain Modestly Higher - U.S. Commentary
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Pipeline, Catalysts and Price Targets",2017-05-09 12:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-pipeline-catalysts-price-120000361.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is issuing a comprehensive ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Pipeline, Catalysts and Price Targets",2017-05-09 12:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-pipeline-catalysts-price-120000361.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is issuing a comprehensive ..."
VRX,VRX:US,BBG000DLFM21,How Valeant Earnings Beat Estimates,2017-05-09 11:45:06 +0000,http://finance.yahoo.com/news/valeant-earnings-beat-estimates-114506750.html?.tsrc=rss,Canadian pharmaceutical maker Valeant posted a big beat on both earnings and revenues Tuesday morning. The company also raised its adjusted EBITDA guidance for the full fiscal year.
VRX,VRX:CT,BBG000DC8S17,How Valeant Earnings Beat Estimates,2017-05-09 11:45:06 +0000,http://finance.yahoo.com/news/valeant-earnings-beat-estimates-114506750.html?.tsrc=rss,Canadian pharmaceutical maker Valeant posted a big beat on both earnings and revenues Tuesday morning. The company also raised its adjusted EBITDA guidance for the full fiscal year.
VRX,VRX:US,BBG000DLFM21,"Valeant Shares Surge as Drugmaker Boosts Cash Pile, Forecast",2017-05-09 11:21:32 +0000,http://finance.yahoo.com/r/b601b490-fb17-3d4b-8b4a-c37b95dd9f7e/valeant-shares-surge-as-drugmaker-boosts-earnings-guidance?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. said it’s making progress selling assets and is bringing in more cash, helping cut debt and allowing it to boost its full-year forecast."
VRX,VRX:CT,BBG000DC8S17,"Valeant Shares Surge as Drugmaker Boosts Cash Pile, Forecast",2017-05-09 11:21:32 +0000,http://finance.yahoo.com/r/b601b490-fb17-3d4b-8b4a-c37b95dd9f7e/valeant-shares-surge-as-drugmaker-boosts-earnings-guidance?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International Inc. said it’s making progress selling assets and is bringing in more cash, helping cut debt and allowing it to boost its full-year forecast."
VRX,VRX:US,BBG000DLFM21,Valeant's stock soars after profit beats expectations,2017-05-09 11:14:52 +0000,http://finance.yahoo.com/r/eb5c815f-f9e8-3104-a17a-4651b61d1592/Story.aspx?guid=C90515DD-08D8-41EE-A05A-816E3A31AC9E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International Inc. soared 11% in premarket trade Tuesday, after the drug maker beat first-quarter profit expectations, although revenue came up shy. The company swung ..."
VRX,VRX:CT,BBG000DC8S17,Valeant's stock soars after profit beats expectations,2017-05-09 11:14:52 +0000,http://finance.yahoo.com/r/eb5c815f-f9e8-3104-a17a-4651b61d1592/Story.aspx?guid=C90515DD-08D8-41EE-A05A-816E3A31AC9E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International Inc. soared 11% in premarket trade Tuesday, after the drug maker beat first-quarter profit expectations, although revenue came up shy. The company swung ..."
VRX,VRX:US,BBG000DLFM21,Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range,2017-05-09 11:00:00 +0000,http://finance.yahoo.com/news/valeant-announces-first-quarter-2017-110000359.html?.tsrc=rss,Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range
VRX,VRX:CT,BBG000DC8S17,Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range,2017-05-09 11:00:00 +0000,http://finance.yahoo.com/news/valeant-announces-first-quarter-2017-110000359.html?.tsrc=rss,Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range
VRX,VRX:CT,BBG000DC8S17,"Earnings Reaction History: Valeant Pharmaceuticals International, 75.0% Follow-Through Indicator, 13.4% Sensitive",2017-05-09 10:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qv0qynEqw-w/earnings-reaction-history-valeant-pharmaceuticals-international-750-follow-through-indicator-134-sensitive-cm786300,Expected Earnings Release 05 09 2017 PremarketExpected Earnings Release 05 09 2017 Premarket Avg Extended Hours Dollar Volume 44 601 644Avg Extended Hours Dollar Volume 44 601 644 Valeant Pharmaceuticals International VRX is due to issue its quarterly earnings report in the
VRX,VRX:US,BBG000DLFM21,"Earnings Reaction History: Valeant Pharmaceuticals International, 75.0% Follow-Through Indicator, 13.4% Sensitive",2017-05-09 10:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qv0qynEqw-w/earnings-reaction-history-valeant-pharmaceuticals-international-750-follow-through-indicator-134-sensitive-cm786300,Expected Earnings Release 05 09 2017 PremarketExpected Earnings Release 05 09 2017 Premarket Avg Extended Hours Dollar Volume 44 601 644Avg Extended Hours Dollar Volume 44 601 644 Valeant Pharmaceuticals International VRX is due to issue its quarterly earnings report in the
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Turns To Profit In Q1; Raises FY17 Adj. EBITDA Outlook,2017-05-09 07:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/18q_TzuYdt0/valeant-pharma-turns-to-profit-in-q1-raises-fy17-adj-ebitda-outlook-20170509-00490,Valeant Pharma Turns To Profit In Q1; Raises FY17 Adj. EBITDA Outlook
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Turns To Profit In Q1; Raises FY17 Adj. EBITDA Outlook,2017-05-09 07:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/18q_TzuYdt0/valeant-pharma-turns-to-profit-in-q1-raises-fy17-adj-ebitda-outlook-20170509-00490,Valeant Pharma Turns To Profit In Q1; Raises FY17 Adj. EBITDA Outlook
VRX,VRX:US,BBG000DLFM21,"FDA Snubs TXMD, AGRX To Try Luck Again, CYTK Abuzz, ROKA Surges After-Hours",2017-05-09 06:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sebEBqF77TY/fda-snubs-txmd-agrx-to-try-luck-again-cytk-abuzz-roka-surges-afterhours-20170509-00239,"FDA Snubs TXMD, AGRX To Try Luck Again, CYTK Abuzz, ROKA Surges After-Hours"
VRX,VRX:CT,BBG000DC8S17,"FDA Snubs TXMD, AGRX To Try Luck Again, CYTK Abuzz, ROKA Surges After-Hours",2017-05-09 06:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sebEBqF77TY/fda-snubs-txmd-agrx-to-try-luck-again-cytk-abuzz-roka-surges-afterhours-20170509-00239,"FDA Snubs TXMD, AGRX To Try Luck Again, CYTK Abuzz, ROKA Surges After-Hours"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Reports Tomorrow Morning, and This Is the Only Number That Matters",2017-05-09 00:02:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/25v6Z3VftXQ/valeant-pharmaceuticals-reports-tomorrow-morning-and-this-is-the-only-number-that-matters-cm786229,Earnings season has been a time when Valeant Pharmaceuticals NYSE VRX shareholders have played ostrich over the past year and a half and with good reason Last year Valeant wound up lowering its profit outlook and earnings before interest taxes depreciation and
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Reports Tomorrow Morning, and This Is the Only Number That Matters",2017-05-09 00:02:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/25v6Z3VftXQ/valeant-pharmaceuticals-reports-tomorrow-morning-and-this-is-the-only-number-that-matters-cm786229,Earnings season has been a time when Valeant Pharmaceuticals NYSE VRX shareholders have played ostrich over the past year and a half and with good reason Last year Valeant wound up lowering its profit outlook and earnings before interest taxes depreciation and
VRX,VRX:CT,BBG000DC8S17,"Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%",2017-05-08 22:47:00 +0000,http://finance.yahoo.com/news/bausch-lomb-announces-pdufa-date-224700305.html?.tsrc=rss,"LAVAL, Quebec, May 8, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for brimonidine tartrate ophthalmic solution, 0.025% (Luminesse™*), and set a PDUFA action date of December 27, 2017.  Luminesse is a topical vasoconstrictor formulation to be used Over-the-Counter (OTC) as an eye drop to relieve redness of the eye due to minor eye irritations."
VRX,VRX:CT,BBG000DC8S17,"Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%",2017-05-08 22:47:00 +0000,http://finance.yahoo.com/news/bausch-lomb-announces-pdufa-date-224700894.html?.tsrc=rss,"Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%"
VRX,VRX:US,BBG000DLFM21,"Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%",2017-05-08 22:47:00 +0000,http://finance.yahoo.com/news/bausch-lomb-announces-pdufa-date-224700305.html?.tsrc=rss,"LAVAL, Quebec, May 8, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for brimonidine tartrate ophthalmic solution, 0.025% (Luminesse™*), and set a PDUFA action date of December 27, 2017.  Luminesse is a topical vasoconstrictor formulation to be used Over-the-Counter (OTC) as an eye drop to relieve redness of the eye due to minor eye irritations."
VRX,VRX:US,BBG000DLFM21,"Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%",2017-05-08 22:47:00 +0000,http://finance.yahoo.com/news/bausch-lomb-announces-pdufa-date-224700894.html?.tsrc=rss,"Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Reports Tomorrow Morning, and This Is the Only Number That Matters",2017-05-08 22:15:00 +0000,http://finance.yahoo.com/r/9f36fe29-d99c-377d-b2ca-0644cb745146/valeant-pharmaceuticals-reports-tomorrow-morning-a.aspx?yptr=yahoo&.tsrc=rss,Hint: It has nothing to do with sales or earnings per share.
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Reports Tomorrow Morning, and This Is the Only Number That Matters",2017-05-08 22:15:00 +0000,http://finance.yahoo.com/r/9f36fe29-d99c-377d-b2ca-0644cb745146/valeant-pharmaceuticals-reports-tomorrow-morning-a.aspx?yptr=yahoo&.tsrc=rss,Hint: It has nothing to do with sales or earnings per share.
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Comments on Valeant in Annual Shareholder Letter,2017-05-08 20:57:19 +0000,http://finance.yahoo.com/news/bill-ackman-comments-valeant-annual-205719726.html?.tsrc=rss,Guru stock highlight
VRX,VRX:US,BBG000DLFM21,Bill Ackman Comments on Valeant in Annual Shareholder Letter,2017-05-08 20:57:19 +0000,http://finance.yahoo.com/news/bill-ackman-comments-valeant-annual-205719726.html?.tsrc=rss,Guru stock highlight
VRX,VRX:US,BBG000DLFM21,Bill Ackman's 2017 Shareholder Letter and Portfolio Commentary,2017-05-08 20:24:40 +0000,http://finance.yahoo.com/news/bill-ackmans-2017-shareholder-letter-202440063.html?.tsrc=rss,Ackman discusses his year and updates on his holdings
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's 2017 Shareholder Letter and Portfolio Commentary,2017-05-08 20:24:40 +0000,http://finance.yahoo.com/news/bill-ackmans-2017-shareholder-letter-202440063.html?.tsrc=rss,Ackman discusses his year and updates on his holdings
VRX,VRX:US,BBG000DLFM21,Coach Stock Is a Screaming Buy After Kate Spade Buyout (COH),2017-05-08 19:01:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u6Vhxn-43XA/coach-stock-is-a-screaming-buy-after-kate-spade-buyout-coh-cm786097,InvestorPlace Stock Market News Stock Advice amp Trading Tips The rumblings that 160 Kate Spade amp Co NYSE KATE was exploring a sale started at the end of 2016 From that point on everyone assumed Coach Inc NYSE COH would be part of the conversation and
VRX,VRX:CT,BBG000DC8S17,Coach Stock Is a Screaming Buy After Kate Spade Buyout (COH),2017-05-08 19:01:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u6Vhxn-43XA/coach-stock-is-a-screaming-buy-after-kate-spade-buyout-coh-cm786097,InvestorPlace Stock Market News Stock Advice amp Trading Tips The rumblings that 160 Kate Spade amp Co NYSE KATE was exploring a sale started at the end of 2016 From that point on everyone assumed Coach Inc NYSE COH would be part of the conversation and
VRX,VRX:US,BBG000DLFM21,Under Armour Inc (UAA) Stock Is Vomiting Its Earnings Rally,2017-05-08 18:01:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7DVPvwCq6IM/under-armour-inc-uaa-stock-is-vomiting-its-earnings-rally-cm786036,InvestorPlace Stock Market News Stock Advice amp Trading Tips Apparently Under Armour Inc NYSE UAA is doing better than I expected Driven by pretty solid growth overseas the company topped first quarter earnings expectations last month sending UAA stock skipping
VRX,VRX:CT,BBG000DC8S17,Under Armour Inc (UAA) Stock Is Vomiting Its Earnings Rally,2017-05-08 18:01:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7DVPvwCq6IM/under-armour-inc-uaa-stock-is-vomiting-its-earnings-rally-cm786036,InvestorPlace Stock Market News Stock Advice amp Trading Tips Apparently Under Armour Inc NYSE UAA is doing better than I expected Driven by pretty solid growth overseas the company topped first quarter earnings expectations last month sending UAA stock skipping
VRX,VRX:CT,BBG000DC8S17,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Has 25% Upside,2017-05-08 18:01:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJxZConnWDc/teva-pharmaceutical-industries-ltd-adr-teva-stock-has-25-upside-cm786031,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors who are looking for a beaten down pharma stock should consider Teva Pharmaceutical Industries Ltd ADR NYSE TEVA which has seen its value plummet nearly 40 160 over the past year including
VRX,VRX:US,BBG000DLFM21,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Has 25% Upside,2017-05-08 18:01:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJxZConnWDc/teva-pharmaceutical-industries-ltd-adr-teva-stock-has-25-upside-cm786031,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors who are looking for a beaten down pharma stock should consider Teva Pharmaceutical Industries Ltd ADR NYSE TEVA which has seen its value plummet nearly 40 160 over the past year including
VRX,VRX:CT,BBG000DC8S17,Facebook Inc (FB) Stock Is Losing a War With Itself,2017-05-08 18:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ITRlXMKFJnA/facebook-inc-fb-stock-is-losing-a-war-with-itself-cm786026,InvestorPlace Stock Market News Stock Advice amp Trading Tips While most analysts remain bullish on Facebook Inc 160 NASDAQ FB the company faces a war with itself and its own users that it seems incapable of winning Thus FB stock which seems almost invincible might
VRX,VRX:US,BBG000DLFM21,Facebook Inc (FB) Stock Is Losing a War With Itself,2017-05-08 18:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ITRlXMKFJnA/facebook-inc-fb-stock-is-losing-a-war-with-itself-cm786026,InvestorPlace Stock Market News Stock Advice amp Trading Tips While most analysts remain bullish on Facebook Inc 160 NASDAQ FB the company faces a war with itself and its own users that it seems incapable of winning Thus FB stock which seems almost invincible might
VRX,VRX:US,BBG000DLFM21,Pershing Shows It Isn't Done With The Biotech World After Valeant,2017-05-08 16:42:25 +0000,http://finance.yahoo.com/news/pershing-shows-isnt-done-biotech-164225232.html?.tsrc=rss,"Last week, Pershing Square CEO Bill Ackman told Bloomberg he would likely shy away from pharmaceutical companies following his billion loss in Valeant Pharmaceuticals Intl Inc (NYSE: VRX ). Perhaps Ackman ..."
VRX,VRX:CT,BBG000DC8S17,Pershing Shows It Isn't Done With The Biotech World After Valeant,2017-05-08 16:42:25 +0000,http://finance.yahoo.com/news/pershing-shows-isnt-done-biotech-164225232.html?.tsrc=rss,"Last week, Pershing Square CEO Bill Ackman told Bloomberg he would likely shy away from pharmaceutical companies following his billion loss in Valeant Pharmaceuticals Intl Inc (NYSE: VRX ). Perhaps Ackman ..."
VRX,VRX:US,BBG000DLFM21,"5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More",2017-05-08 16:19:00 +0000,http://finance.yahoo.com/r/50855a3c-a0c4-34c4-a760-a0476aebcdd8/5-earnings-short-squeeze-plays-snap-nvidia-amp-more.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,These heavily shorted stocks could squeeze the short-sellers if they report bullish earnings this week.
VRX,VRX:CT,BBG000DC8S17,"5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More",2017-05-08 16:19:00 +0000,http://finance.yahoo.com/r/50855a3c-a0c4-34c4-a760-a0476aebcdd8/5-earnings-short-squeeze-plays-snap-nvidia-amp-more.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,These heavily shorted stocks could squeeze the short-sellers if they report bullish earnings this week.
VRX,VRX:CT,BBG000DC8S17,More Trouble Ahead For Valeant?,2017-05-08 15:29:00 +0000,http://finance.yahoo.com/r/6425cbd8-a042-3ad1-9163-33428e6664e3/more-trouble-ahead-for-valeant-1494257361?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) is slated to release first quarter financial results on Tuesday.  Last year, J&J lost several similar cases, including verdicts of $72 million, $70 million and $55 million, and faces multiple federal class action suits.  Wells Fargo’s Maris remains bearish on Valeant and warns of “bad news” ahead."
VRX,VRX:US,BBG000DLFM21,More Trouble Ahead For Valeant?,2017-05-08 15:29:00 +0000,http://finance.yahoo.com/r/6425cbd8-a042-3ad1-9163-33428e6664e3/more-trouble-ahead-for-valeant-1494257361?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) is slated to release first quarter financial results on Tuesday.  Last year, J&J lost several similar cases, including verdicts of $72 million, $70 million and $55 million, and faces multiple federal class action suits.  Wells Fargo’s Maris remains bearish on Valeant and warns of “bad news” ahead."
VRX,VRX:US,BBG000DLFM21,"Disney, Snap, Whole Foods and More Key Earnings Reports Coming This Week",2017-05-07 14:25:20 +0000,http://finance.yahoo.com/news/disney-snap-whole-foods-more-142520015.html?.tsrc=rss,"24/7 Wall St. has put together a preview of Disney, Valeant Pharmaceuticals and a other major companies scheduled to report their quarterly results this coming week."
VRX,VRX:CT,BBG000DC8S17,"Disney, Snap, Whole Foods and More Key Earnings Reports Coming This Week",2017-05-07 14:25:20 +0000,http://finance.yahoo.com/news/disney-snap-whole-foods-more-142520015.html?.tsrc=rss,"24/7 Wall St. has put together a preview of Disney, Valeant Pharmaceuticals and a other major companies scheduled to report their quarterly results this coming week."
VRX,VRX:CT,BBG000DC8S17,Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday,2017-05-07 14:05:00 +0000,http://finance.yahoo.com/r/c04da190-d12e-3e97-a303-78e19a80cc24/earnings-preview-what-to-expect-from-valeant-pharmaceuticals-on-tuesday?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals is expected to earn $0.96/share on $2.16 billion in revenue. Meanwhile, the so-called Whisper number is $0.96."
VRX,VRX:US,BBG000DLFM21,Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday,2017-05-07 14:05:00 +0000,http://finance.yahoo.com/r/c04da190-d12e-3e97-a303-78e19a80cc24/earnings-preview-what-to-expect-from-valeant-pharmaceuticals-on-tuesday?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals is expected to earn $0.96/share on $2.16 billion in revenue. Meanwhile, the so-called Whisper number is $0.96."
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership,2017-05-05 22:08:00 +0000,http://finance.yahoo.com/news/valeant-announces-key-appointments-dermatology-220800805.html?.tsrc=rss,"LAVAL, Quebec, May 5, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced appointments to the dermatology leadership team of Michael McMyne, who has joined as vice president of Sales, and Stacey Williams, who has joined as vice president of Marketing.  Additionally, the company announced Lainie Keller has joined as vice president of Corporate Communications."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership,2017-05-05 22:08:00 +0000,http://finance.yahoo.com/news/valeant-announces-key-appointments-dermatology-220800805.html?.tsrc=rss,"LAVAL, Quebec, May 5, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced appointments to the dermatology leadership team of Michael McMyne, who has joined as vice president of Sales, and Stacey Williams, who has joined as vice president of Marketing.  Additionally, the company announced Lainie Keller has joined as vice president of Corporate Communications."
VRX,VRX:CT,BBG000DC8S17,What to Expect From Valeant Pharmaceuticals' Q1 Results,2017-05-05 20:28:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/upDvhnfxZg0/what-to-expect-from-valeant-pharmaceuticals-q1-results-cm785231,There wasn t much good news when Valeant Pharmaceuticals NYSE VRX reported its fourth quarter and full year 2016 results in February Revenue was down and losses worsened Valeant s CEO Joe Papa however says that 2016 was a stabilizing year Papa looks at 2017 as the beginning
VRX,VRX:US,BBG000DLFM21,What to Expect From Valeant Pharmaceuticals' Q1 Results,2017-05-05 20:28:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/upDvhnfxZg0/what-to-expect-from-valeant-pharmaceuticals-q1-results-cm785231,There wasn t much good news when Valeant Pharmaceuticals NYSE VRX reported its fourth quarter and full year 2016 results in February Revenue was down and losses worsened Valeant s CEO Joe Papa however says that 2016 was a stabilizing year Papa looks at 2017 as the beginning
VRX,VRX:US,BBG000DLFM21,What to Expect From Valeant Pharmaceuticals&apos; Q1 Results,2017-05-05 18:41:00 +0000,http://finance.yahoo.com/r/3ad06e1f-6096-3916-8c5f-a7ef1deb2dbc/what-to-expect-from-valeant-pharmaceuticals-q1-res.aspx?yptr=yahoo&.tsrc=rss,Will Valeant show improvement in the first quarter? There are several factors that could make doing so difficult.
VRX,VRX:CT,BBG000DC8S17,What to Expect From Valeant Pharmaceuticals&apos; Q1 Results,2017-05-05 18:41:00 +0000,http://finance.yahoo.com/r/3ad06e1f-6096-3916-8c5f-a7ef1deb2dbc/what-to-expect-from-valeant-pharmaceuticals-q1-res.aspx?yptr=yahoo&.tsrc=rss,Will Valeant show improvement in the first quarter? There are several factors that could make doing so difficult.
VRX,VRX:CT,BBG000DC8S17,3 Earnings Reports That You Do Not Want to Miss,2017-05-05 18:27:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CIELTq5hRoQ/3-earnings-reports-that-you-do-not-want-to-miss-cm785193,InvestorPlace Stock Market News Stock Advice amp Trading Tips Apple Inc NASDAQ AAPL Etsy Inc NASDAQ ETSY and Advanced Micro Devices Inc NASDAQ AMD were just a few of the companies that reported earnings this past week to mixed results
VRX,VRX:US,BBG000DLFM21,3 Earnings Reports That You Do Not Want to Miss,2017-05-05 18:27:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CIELTq5hRoQ/3-earnings-reports-that-you-do-not-want-to-miss-cm785193,InvestorPlace Stock Market News Stock Advice amp Trading Tips Apple Inc NASDAQ AAPL Etsy Inc NASDAQ ETSY and Advanced Micro Devices Inc NASDAQ AMD were just a few of the companies that reported earnings this past week to mixed results
VRX,VRX:CT,BBG000DC8S17,Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options,2017-05-05 14:24:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oYFROnUraQo/implied-volatility-surging-for-valeant-pharmaceuticals-vrx-stock-options-cm784816,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the December 5 th 2017 8 Call had some of the highest implied volatility of all equity options today What is
VRX,VRX:US,BBG000DLFM21,Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options,2017-05-05 14:24:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oYFROnUraQo/implied-volatility-surging-for-valeant-pharmaceuticals-vrx-stock-options-cm784816,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the December 5 th 2017 8 Call had some of the highest implied volatility of all equity options today What is
VRX,VRX:CT,BBG000DC8S17,Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options,2017-05-05 12:47:12 +0000,http://finance.yahoo.com/news/implied-volatility-surging-valeant-pharmaceuticals-124712855.html?.tsrc=rss,"Investors in Valeant Pharmaceuticals International, Inc. (VRX) need to pay close attention to the stock based on moves in the options market lately."
VRX,VRX:US,BBG000DLFM21,Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options,2017-05-05 12:47:12 +0000,http://finance.yahoo.com/news/implied-volatility-surging-valeant-pharmaceuticals-124712855.html?.tsrc=rss,"Investors in Valeant Pharmaceuticals International, Inc. (VRX) need to pay close attention to the stock based on moves in the options market lately."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Commodities Stabilize - Canadian Commentary,2017-05-05 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yn8sGUjr-j8/canadian-stocks-are-rising-as-commodities-stabilize--canadian-commentary-20170505-00692,Canadian Stocks Are Rising As Commodities Stabilize - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Commodities Stabilize - Canadian Commentary,2017-05-05 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yn8sGUjr-j8/canadian-stocks-are-rising-as-commodities-stabilize--canadian-commentary-20170505-00692,Canadian Stocks Are Rising As Commodities Stabilize - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Shocker: Valeant Pharmaceuticals Slides Another 16% in April. Here's the Big Reason Why,2017-05-04 15:54:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SR0_fLMFDiQ/shocker-valeant-pharmaceuticals-slides-another-16-in-april-heres-the-big-reason-why-cm784138,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker that s mostly grown through acquisitions and price increases throughout the years fell another 16 in April to more than a 10 year low according to data from S amp P Global Market
VRX,VRX:US,BBG000DLFM21,Shocker: Valeant Pharmaceuticals Slides Another 16% in April. Here's the Big Reason Why,2017-05-04 15:54:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SR0_fLMFDiQ/shocker-valeant-pharmaceuticals-slides-another-16-in-april-heres-the-big-reason-why-cm784138,What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker that s mostly grown through acquisitions and price increases throughout the years fell another 16 in April to more than a 10 year low according to data from S amp P Global Market
VRX,VRX:CT,BBG000DC8S17,VRX June 23rd Options Begin Trading,2017-05-04 15:32:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nhvG63sAkIg/vrx-june-23rd-options-begin-trading-cm784235,Investors in Valeant Pharmaceuticals International Inc Symbol VRX saw new options become available today for the June 23rd expiration At Stock Options Channel our YieldBoost formula has looked up and down the VRX options chain for the new June 23rd contracts and identified one put and
VRX,VRX:US,BBG000DLFM21,VRX June 23rd Options Begin Trading,2017-05-04 15:32:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nhvG63sAkIg/vrx-june-23rd-options-begin-trading-cm784235,Investors in Valeant Pharmaceuticals International Inc Symbol VRX saw new options become available today for the June 23rd expiration At Stock Options Channel our YieldBoost formula has looked up and down the VRX options chain for the new June 23rd contracts and identified one put and
VRX,VRX:CT,BBG000DC8S17,Valeant: When Earnings are Almost an Afterthought,2017-05-04 13:57:00 +0000,http://finance.yahoo.com/r/f3a856e2-6961-3d7f-84ea-2abe4b64b45d/valeant-when-earnings-are-almost-an-afterthought-1493906266?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) is set to release its earnings on May 9, but earnings might be the last thing investors are worried about. That's been the takeaway from recent analyst reports ..."
VRX,VRX:US,BBG000DLFM21,Valeant: When Earnings are Almost an Afterthought,2017-05-04 13:57:00 +0000,http://finance.yahoo.com/r/f3a856e2-6961-3d7f-84ea-2abe4b64b45d/valeant-when-earnings-are-almost-an-afterthought-1493906266?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International (VRX) is set to release its earnings on May 9, but earnings might be the last thing investors are worried about. That's been the takeaway from recent analyst reports ..."
VRX,VRX:CT,BBG000DC8S17,Shocker: Valeant Pharmaceuticals Slides Another 16% in April. Here&apos;s the Big Reason Why,2017-05-04 13:43:00 +0000,http://finance.yahoo.com/r/6bf463f4-b621-3058-ba4f-3e08b917f07c/shocker-valeant-pharmaceuticals-slides-another-16.aspx?yptr=yahoo&.tsrc=rss,"Despite being valued below its full-year EBITDA forecast, Valeant&apos;s debt woes continue to take center stage."
VRX,VRX:US,BBG000DLFM21,Shocker: Valeant Pharmaceuticals Slides Another 16% in April. Here&apos;s the Big Reason Why,2017-05-04 13:43:00 +0000,http://finance.yahoo.com/r/6bf463f4-b621-3058-ba4f-3e08b917f07c/shocker-valeant-pharmaceuticals-slides-another-16.aspx?yptr=yahoo&.tsrc=rss,"Despite being valued below its full-year EBITDA forecast, Valeant&apos;s debt woes continue to take center stage."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down On Commodity Weakness - Canadian Commentary,2017-05-04 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pxNELaPylGc/canadian-stocks-are-down-on-commodity-weakness--canadian-commentary-20170504-01347,Canadian Stocks Are Down On Commodity Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down On Commodity Weakness - Canadian Commentary,2017-05-04 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pxNELaPylGc/canadian-stocks-are-down-on-commodity-weakness--canadian-commentary-20170504-01347,Canadian Stocks Are Down On Commodity Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Announces 2017 Annual Meeting Results,2017-05-03 22:02:00 +0000,http://finance.yahoo.com/news/valeant-announces-2017-annual-meeting-220200943.html?.tsrc=rss,Valeant Announces 2017 Annual Meeting Results
VRX,VRX:CT,BBG000DC8S17,Valeant Announces 2017 Annual Meeting Results,2017-05-03 22:02:00 +0000,http://finance.yahoo.com/news/valeant-announces-2017-annual-meeting-220200943.html?.tsrc=rss,Valeant Announces 2017 Annual Meeting Results
VRX,VRX:CT,BBG000DC8S17,Dow Jones Industrial Average Edges Higher After Fed Decision,2017-05-03 20:48:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-cVn05itiBU/dow-jones-industrial-average-edges-higher-after-fed-decision-cm783758,The 160 Dow Jones Industrial Average DJIA 160 spent most of the day trading in the red but clawed its way higher after the Fed s policy announcement The central bank kept interest rates unchanged as expected and said the economic slowdown in the first quarter was transitory
VRX,VRX:US,BBG000DLFM21,Dow Jones Industrial Average Edges Higher After Fed Decision,2017-05-03 20:48:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-cVn05itiBU/dow-jones-industrial-average-edges-higher-after-fed-decision-cm783758,The 160 Dow Jones Industrial Average DJIA 160 spent most of the day trading in the red but clawed its way higher after the Fed s policy announcement The central bank kept interest rates unchanged as expected and said the economic slowdown in the first quarter was transitory
VRX,VRX:US,BBG000DLFM21,Ackman's Pershing Square to Be Listed on London Stock Exchange,2017-05-03 20:26:00 +0000,http://finance.yahoo.com/r/251f3354-142d-3569-b5f8-37086020b1df/ackmans-pershing-square-be-listed-london-stock-exchange-vrx-cmg?partner=YahooSA&yptr=yahoo&.tsrc=rss,"For the first time, British investors will be able to invest in Bill Ackman's legendary fund via the London Stock Exchange."
VRX,VRX:CT,BBG000DC8S17,Ackman's Pershing Square to Be Listed on London Stock Exchange,2017-05-03 20:26:00 +0000,http://finance.yahoo.com/r/251f3354-142d-3569-b5f8-37086020b1df/ackmans-pershing-square-be-listed-london-stock-exchange-vrx-cmg?partner=YahooSA&yptr=yahoo&.tsrc=rss,"For the first time, British investors will be able to invest in Bill Ackman's legendary fund via the London Stock Exchange."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Could More Than Double,2017-05-03 19:49:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DrMnIkd4FL0/valeant-pharmaceuticals-intl-inc-vrx-stock-could-more-than-double-cm783640,InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been a great week for embattled healthcare firm 160 Valeant Pharmaceuticals Intl Inc NYSE VRX On Monday it announced the results of paying down some debt ahead of schedule On Tuesday it held its
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Could More Than Double,2017-05-03 19:49:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DrMnIkd4FL0/valeant-pharmaceuticals-intl-inc-vrx-stock-could-more-than-double-cm783640,InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been a great week for embattled healthcare firm 160 Valeant Pharmaceuticals Intl Inc NYSE VRX On Monday it announced the results of paying down some debt ahead of schedule On Tuesday it held its
VRX,VRX:CT,BBG000DC8S17,"Buy Advanced Micro Devices, Inc. (AMD) Stock Before It Rebounds to $15",2017-05-03 19:49:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JUWckt9ZHSo/buy-advanced-micro-devices-inc-amd-stock-before-it-rebounds-to-15-cm783628,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of semiconductor giant Advanced Micro Devices Inc NASDAQ AMD have been crushed recently with AMD stock falling nearly 25 after the company reported mixed first quarter earnings that included a miss
VRX,VRX:US,BBG000DLFM21,"Buy Advanced Micro Devices, Inc. (AMD) Stock Before It Rebounds to $15",2017-05-03 19:49:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JUWckt9ZHSo/buy-advanced-micro-devices-inc-amd-stock-before-it-rebounds-to-15-cm783628,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of semiconductor giant Advanced Micro Devices Inc NASDAQ AMD have been crushed recently with AMD stock falling nearly 25 after the company reported mixed first quarter earnings that included a miss
VRX,VRX:CT,BBG000DC8S17,Why Chesapeake Energy Corporation (CHK) Stock Earnings Look Tempting,2017-05-03 19:48:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8fW9By-9f8/why-chesapeake-energy-corporation-chk-stock-earnings-look-tempting-cm783610,InvestorPlace Stock Market News Stock Advice amp Trading Tips If there s a word that can describe 2017 so far for Chesapeake Energy Corporation NYSE CHK it s quiet In 2015 it looked like CHK stock might go to zero Chesapeake Energy spent 2016 frantically reshaping
VRX,VRX:US,BBG000DLFM21,Why Chesapeake Energy Corporation (CHK) Stock Earnings Look Tempting,2017-05-03 19:48:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8fW9By-9f8/why-chesapeake-energy-corporation-chk-stock-earnings-look-tempting-cm783610,InvestorPlace Stock Market News Stock Advice amp Trading Tips If there s a word that can describe 2017 so far for Chesapeake Energy Corporation NYSE CHK it s quiet In 2015 it looked like CHK stock might go to zero Chesapeake Energy spent 2016 frantically reshaping
VRX,VRX:US,BBG000DLFM21,"How to Trade Gilead Sciences, Inc. (GILD) Stock After Its Q1 Miss",2017-05-03 19:47:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Idl87mNX4A8/how-to-trade-gilead-sciences-inc-gild-stock-after-its-q1-miss-cm783576,InvestorPlace Stock Market News Stock Advice amp Trading Tips Gilead Sciences Inc NASDAQ GILD shares are getting whacked following weaker than expected earnings The biopharmaceutical company reported earnings of 2 23 per share and revenues of 6 5 billion Both fell short
VRX,VRX:CT,BBG000DC8S17,"How to Trade Gilead Sciences, Inc. (GILD) Stock After Its Q1 Miss",2017-05-03 19:47:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Idl87mNX4A8/how-to-trade-gilead-sciences-inc-gild-stock-after-its-q1-miss-cm783576,InvestorPlace Stock Market News Stock Advice amp Trading Tips Gilead Sciences Inc NASDAQ GILD shares are getting whacked following weaker than expected earnings The biopharmaceutical company reported earnings of 2 23 per share and revenues of 6 5 billion Both fell short
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for May 3, 2017 :  HTA, TWLO, AAPL, IBN, VRX, FEYE, GRPN, OCLR, AKAM, ETSY, MT, TWTR",2017-05-03 12:56:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zW02hvXcZ_g/pre-market-most-active-for-may-3-2017-hta-twlo-aapl-ibn-vrx-feye-grpn-oclr-akam-etsy-mt-twtr-cm783279,The NASDAQ 100 Pre Market Indicator is down 13 55 to 5 630 52 The total Pre Market volume is currently 6 928 699 shares traded The following are the most active stocks for the pre market session Healthcare Trust of America Inc HTA is 0 22 at 29 40 with 1 793
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for May 3, 2017 :  HTA, TWLO, AAPL, IBN, VRX, FEYE, GRPN, OCLR, AKAM, ETSY, MT, TWTR",2017-05-03 12:56:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zW02hvXcZ_g/pre-market-most-active-for-may-3-2017-hta-twlo-aapl-ibn-vrx-feye-grpn-oclr-akam-etsy-mt-twtr-cm783279,The NASDAQ 100 Pre Market Indicator is down 13 55 to 5 630 52 The total Pre Market volume is currently 6 928 699 shares traded The following are the most active stocks for the pre market session Healthcare Trust of America Inc HTA is 0 22 at 29 40 with 1 793
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-05-03 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e1NJa3bjLKc/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170503-01131,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-05-03 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e1NJa3bjLKc/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170503-01131,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,10 Solid Value Stocks at Great Prices (and 10 to Pass Up),2017-05-03 10:00:00 +0000,http://finance.yahoo.com/r/a1b7fe13-32d8-3d6f-aaa5-cbae29e5cd13/article.aspx?id=806329&SR=Yahoo&yptr=yahoo&.tsrc=rss,"We examined the nearly 500 holdings in the Morningstar US Value Index and found some solid stocks at great prices, and others that look too expensive."
VRX,VRX:CT,BBG000DC8S17,10 Solid Value Stocks at Great Prices (and 10 to Pass Up),2017-05-03 10:00:00 +0000,http://finance.yahoo.com/r/a1b7fe13-32d8-3d6f-aaa5-cbae29e5cd13/article.aspx?id=806329&SR=Yahoo&yptr=yahoo&.tsrc=rss,"We examined the nearly 500 holdings in the Morningstar US Value Index and found some solid stocks at great prices, and others that look too expensive."
VRX,VRX:US,BBG000DLFM21,[$$] Revolt Against Sky-High Drug Prices Prompts a Pioneer to Cash Out,2017-05-03 04:27:04 +0000,http://finance.yahoo.com/r/ca34fd8c-d487-395a-b83e-37d530566ae1/bipartisan-backlash-on-drug-prices-prompts-one-company-to-cash-out-1493754978?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Jeffrey Aronin hoped to eventually sell Marathon Pharmaceuticals for billions of dollars, but then the company said it would charge $89,000 a year for a muscular-dystrophy drug."
VRX,VRX:CT,BBG000DC8S17,[$$] Revolt Against Sky-High Drug Prices Prompts a Pioneer to Cash Out,2017-05-03 04:27:04 +0000,http://finance.yahoo.com/r/ca34fd8c-d487-395a-b83e-37d530566ae1/bipartisan-backlash-on-drug-prices-prompts-one-company-to-cash-out-1493754978?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Jeffrey Aronin hoped to eventually sell Marathon Pharmaceuticals for billions of dollars, but then the company said it would charge $89,000 a year for a muscular-dystrophy drug."
VRX,VRX:US,BBG000DLFM21,Bill Ackman Is Back to Black,2017-05-02 23:31:10 +0000,http://finance.yahoo.com/news/bill-ackman-back-black-233110178.html?.tsrc=rss,Pershing returns exceed one percent for the first time in almost two years with Valeant gone
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Is Back to Black,2017-05-02 23:31:10 +0000,http://finance.yahoo.com/news/bill-ackman-back-black-233110178.html?.tsrc=rss,Pershing returns exceed one percent for the first time in almost two years with Valeant gone
VRX,VRX:US,BBG000DLFM21,Valeant Again Turns Over a New Leaf,2017-05-02 16:36:58 +0000,http://finance.yahoo.com/r/f6953fba-7666-340b-9289-a4003d81bda6/valeant-again-turns-over-a-new-leaf?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,How to reverse a 96% share price decline in less than two years?
VRX,VRX:CT,BBG000DC8S17,Valeant Again Turns Over a New Leaf,2017-05-02 16:36:58 +0000,http://finance.yahoo.com/r/f6953fba-7666-340b-9289-a4003d81bda6/valeant-again-turns-over-a-new-leaf?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,How to reverse a 96% share price decline in less than two years?
VRX,VRX:US,BBG000DLFM21,Drug-maker Valeant on course to debt repayment target: CEO,2017-05-02 15:55:55 +0000,http://finance.yahoo.com/news/drug-maker-valeant-course-debt-141139111.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc (VRX.TO), weighed down by debt from years of acquisitions, is on pace to meet its target of repaying $5 billion in debt between August, 2016 and February, 2018, Chief Executive Joe Papa told shareholders on Tuesday.  ""We feel very comfortable that we will achieve that $5 billion debt paydown through a combination of asset sales plus the operational results,"" Papa told reporters after the meeting.  Canada-based Valeant's debt climbed to a total of more than $30 billion under former CEO Mike Pearson, whom Papa replaced one year ago."
VRX,VRX:CT,BBG000DC8S17,Drug-maker Valeant on course to debt repayment target: CEO,2017-05-02 15:55:55 +0000,http://finance.yahoo.com/news/drug-maker-valeant-course-debt-141139111.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc (VRX.TO), weighed down by debt from years of acquisitions, is on pace to meet its target of repaying $5 billion in debt between August, 2016 and February, 2018, Chief Executive Joe Papa told shareholders on Tuesday.  ""We feel very comfortable that we will achieve that $5 billion debt paydown through a combination of asset sales plus the operational results,"" Papa told reporters after the meeting.  Canada-based Valeant's debt climbed to a total of more than $30 billion under former CEO Mike Pearson, whom Papa replaced one year ago."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Open to Name Change, CEO Papa Says",2017-05-02 15:32:00 +0000,http://finance.yahoo.com/r/54142bcb-2999-39d9-b0d4-b0cd49ef17f4/valeant-pharmaceuticals-open-to-name-change-ceo-papa-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Joe Papa's comments come after a two-year period that has seen Valeant lose over 95% of its value over harsh criticisms of its business.
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Open to Name Change, CEO Papa Says",2017-05-02 15:32:00 +0000,http://finance.yahoo.com/r/54142bcb-2999-39d9-b0d4-b0cd49ef17f4/valeant-pharmaceuticals-open-to-name-change-ceo-papa-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Joe Papa's comments come after a two-year period that has seen Valeant lose over 95% of its value over harsh criticisms of its business.
VRX,VRX:CT,BBG000DC8S17,Drug-maker Valeant on course to debt repayment target: CEO,2017-05-02 13:58:21 +0000,http://finance.yahoo.com/news/drug-maker-valeant-course-debt-135821078.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc, weighed down by debt from years of acquisitions, is on pace to meeting its target of repaying $5 billion in debt between August, 2016 and February, 2018, Chief ..."
VRX,VRX:US,BBG000DLFM21,Drug-maker Valeant on course to debt repayment target: CEO,2017-05-02 13:58:21 +0000,http://finance.yahoo.com/news/drug-maker-valeant-course-debt-135821078.html?.tsrc=rss,"Valeant Pharmaceuticals International Inc, weighed down by debt from years of acquisitions, is on pace to meeting its target of repaying $5 billion in debt between August, 2016 and February, 2018, Chief ..."
VRX,VRX:US,BBG000DLFM21,Valeant Ponders a Name Change to Try and Escape Past Reputation,2017-05-02 13:57:05 +0000,http://finance.yahoo.com/r/5be88553-4000-36e1-aa27-971eef52ca31/valeant-ponders-a-name-change-to-try-and-escape-past-reputation?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Valeant is ready to move on from “Valeant.”
VRX,VRX:CT,BBG000DC8S17,Valeant Ponders a Name Change to Try to Escape Its Reputation,2017-05-02 13:57:05 +0000,http://finance.yahoo.com/news/valeant-ponders-name-change-try-135705858.html?.tsrc=rss,Valeant is ready to move on from “Valeant.”
VRX,VRX:US,BBG000DLFM21,Valeant Ponders a Name Change to Try to Escape Its Reputation,2017-05-02 13:57:05 +0000,http://finance.yahoo.com/news/valeant-ponders-name-change-try-135705858.html?.tsrc=rss,Valeant is ready to move on from “Valeant.”
VRX,VRX:CT,BBG000DC8S17,Valeant Ponders a Name Change to Try and Escape Past Reputation,2017-05-02 13:57:05 +0000,http://finance.yahoo.com/r/5be88553-4000-36e1-aa27-971eef52ca31/valeant-ponders-a-name-change-to-try-and-escape-past-reputation?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Valeant is ready to move on from “Valeant.”
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: US Ecology and Valeant Pharmaceuticals,2017-05-02 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000984.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 2, 2017 / Gains from major tech players, such as Alphabet, Facebook and Twitter, combined with continued strength in corporate earnings helped lift major indexes Monday. ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: US Ecology and Valeant Pharmaceuticals,2017-05-02 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000984.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 2, 2017 / Gains from major tech players, such as Alphabet, Facebook and Twitter, combined with continued strength in corporate earnings helped lift major indexes Monday. ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing After Early Dip - Canadian Commentary,2017-05-02 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hm4ZxgMGWwA/canadian-stocks-are-climbing-after-early-dip--canadian-commentary-20170502-01137,Canadian Stocks Are Climbing After Early Dip - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing After Early Dip - Canadian Commentary,2017-05-02 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hm4ZxgMGWwA/canadian-stocks-are-climbing-after-early-dip--canadian-commentary-20170502-01137,Canadian Stocks Are Climbing After Early Dip - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Pays Down $220 Million in Unscheduled Debt Payments,2017-05-02 04:26:41 +0000,http://finance.yahoo.com/r/cadc7a15-5e3d-3592-a267-531fe6e072ac/valeant-pays-down-220-million-in-unscheduled-debt-payments-1493634601?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Valeant Pharmaceutical Industries Inc. said Monday it has made $220 million in unscheduled payments in the drug company’s latest effort to reduce its multibillion-dollar debt.
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Pays Down $220 Million in Unscheduled Debt Payments,2017-05-02 04:26:41 +0000,http://finance.yahoo.com/r/cadc7a15-5e3d-3592-a267-531fe6e072ac/valeant-pays-down-220-million-in-unscheduled-debt-payments-1493634601?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Valeant Pharmaceutical Industries Inc. said Monday it has made $220 million in unscheduled payments in the drug company’s latest effort to reduce its multibillion-dollar debt.
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Addl Debt Reduction Of About $220 Mln,2017-05-01 23:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PDYB0jMTRnk/valeant-announces-addl-debt-reduction-of-about-220-mln-20170501-01435,Valeant Announces Addl Debt Reduction Of About $220 Mln
VRX,VRX:US,BBG000DLFM21,Valeant Announces Addl Debt Reduction Of About $220 Mln,2017-05-01 23:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PDYB0jMTRnk/valeant-announces-addl-debt-reduction-of-about-220-mln-20170501-01435,Valeant Announces Addl Debt Reduction Of About $220 Mln
VRX,VRX:CT,BBG000DC8S17,Why Valeant is Flying,2017-05-01 15:29:00 +0000,http://finance.yahoo.com/r/1b1342cd-565c-37bd-887e-a97b35f06145/why-valeant-is-flying-1493652574?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are soaring today after the beleaguered specialty-pharmaceutical company said it would pay down more of its massive debt load.  From Valeant's press release: Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that, following the earlier-than-expected closing of the sale of three skincare brands to L'Oréal and the closing of the divestiture of a manufacturing facility in Brazil, it has reduced its senior secured terms loans by approximately an additional $220 million as of Monday May 1, 2017.  The company continues to advance toward its expectation of paying down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of August 2016."
VRX,VRX:US,BBG000DLFM21,Why Valeant is Flying,2017-05-01 15:29:00 +0000,http://finance.yahoo.com/r/1b1342cd-565c-37bd-887e-a97b35f06145/why-valeant-is-flying-1493652574?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are soaring today after the beleaguered specialty-pharmaceutical company said it would pay down more of its massive debt load.  From Valeant's press release: Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced that, following the earlier-than-expected closing of the sale of three skincare brands to L'Oréal and the closing of the divestiture of a manufacturing facility in Brazil, it has reduced its senior secured terms loans by approximately an additional $220 million as of Monday May 1, 2017.  The company continues to advance toward its expectation of paying down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of August 2016."
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Valeant, Tribune, Twitter",2017-05-01 13:19:58 +0000,http://finance.yahoo.com/r/5dd9e0d6-fd0a-32c2-a621-dc8b5cefa2e1/stocks-to-watch-valeant-tribune-twitter?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Monday's session are Valeant Pharmaceutical Industries Inc., Tribune Media Co. and Twitter Inc."
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Valeant, Tribune, Twitter",2017-05-01 13:19:58 +0000,http://finance.yahoo.com/r/5dd9e0d6-fd0a-32c2-a621-dc8b5cefa2e1/stocks-to-watch-valeant-tribune-twitter?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Monday's session are Valeant Pharmaceutical Industries Inc., Tribune Media Co. and Twitter Inc."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary,2017-05-01 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FlL4wqtfOUQ/canadian-stocks-are-little-changed-in-cautious-trade--canadian-commentary-20170501-00700,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary,2017-05-01 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FlL4wqtfOUQ/canadian-stocks-are-little-changed-in-cautious-trade--canadian-commentary-20170501-00700,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Additional Debt Reduction Of Approximately $220 Million,2017-05-01 10:30:00 +0000,http://finance.yahoo.com/news/valeant-announces-additional-debt-reduction-103000491.html?.tsrc=rss,Valeant Announces Additional Debt Reduction Of Approximately $220 Million
VRX,VRX:US,BBG000DLFM21,Valeant Announces Additional Debt Reduction Of Approximately $220 Million,2017-05-01 10:30:00 +0000,http://finance.yahoo.com/news/valeant-announces-additional-debt-reduction-103000491.html?.tsrc=rss,Valeant Announces Additional Debt Reduction Of Approximately $220 Million
VRX,VRX:CT,BBG000DC8S17,"Teva Pharmaceutical Is Looking to Deal, and That's a Good Thing",2017-04-28 15:27:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x7sjk3w74PY/teva-pharmaceutical-is-looking-to-deal-and-thats-a-good-thing-cm781093,The tables have turned pretty quickly for Israeli based branded and generic drug developer Teva Pharmaceutical Industries NYSE TEVA In July 2015 shares of the company were trading north of 72 an all time high Today Teva s stock is struggling to hang onto the 30 mark which
VRX,VRX:US,BBG000DLFM21,"Teva Pharmaceutical Is Looking to Deal, and That's a Good Thing",2017-04-28 15:27:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x7sjk3w74PY/teva-pharmaceutical-is-looking-to-deal-and-thats-a-good-thing-cm781093,The tables have turned pretty quickly for Israeli based branded and generic drug developer Teva Pharmaceutical Industries NYSE TEVA In July 2015 shares of the company were trading north of 72 an all time high Today Teva s stock is struggling to hang onto the 30 mark which
VRX,VRX:US,BBG000DLFM21,"Teva Pharmaceutical Is Looking to Deal, and That&apos;s a Good Thing",2017-04-28 14:21:00 +0000,http://finance.yahoo.com/r/f5e2aaf8-b8b4-33d3-9065-50ddfc8b31d8/teva-pharmaceutical-is-looking-to-deal-and-thats-a.aspx?yptr=yahoo&.tsrc=rss,Teva&apos;s oncology division could be on the chopping block.
VRX,VRX:CT,BBG000DC8S17,"Teva Pharmaceutical Is Looking to Deal, and That&apos;s a Good Thing",2017-04-28 14:21:00 +0000,http://finance.yahoo.com/r/f5e2aaf8-b8b4-33d3-9065-50ddfc8b31d8/teva-pharmaceutical-is-looking-to-deal-and-thats-a.aspx?yptr=yahoo&.tsrc=rss,Teva&apos;s oncology division could be on the chopping block.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Surging As Crude Oil Rebounds - Canadian Commentary,2017-04-28 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/frcyhh0MVRI/canadian-stocks-are-surging-as-crude-oil-rebounds--canadian-commentary-20170428-00847,Canadian Stocks Are Surging As Crude Oil Rebounds - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Surging As Crude Oil Rebounds - Canadian Commentary,2017-04-28 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/frcyhh0MVRI/canadian-stocks-are-surging-as-crude-oil-rebounds--canadian-commentary-20170428-00847,Canadian Stocks Are Surging As Crude Oil Rebounds - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21)",2017-04-28 10:41:24 +0000,http://finance.yahoo.com/news/2-valeant-prices-psoriasis-treatment-104124159.html?.tsrc=rss,"Canadian drugmaker Valeant  Pharmaceuticals International Inc  said it had  priced its recently approved plaque psoriasis treatment at  $3,500 per month, ahead of an expected U.S. launch in the second  half of 2017.  Siliq is the lowest priced injectable biologic psoriasis  treatment currently on the market, Valeant said on Friday.  The treatment, which blocks a cell receptor known as  interleukin-17 to tamp down inflammation, will compete with a  host of existing IL-17 inhibitors including Cosentyx from  Novartis AG and Taltz from Eli Lilly & Co."
VRX,VRX:US,BBG000DLFM21,"UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21)",2017-04-28 10:41:24 +0000,http://finance.yahoo.com/news/2-valeant-prices-psoriasis-treatment-104124159.html?.tsrc=rss,"Canadian drugmaker Valeant  Pharmaceuticals International Inc  said it had  priced its recently approved plaque psoriasis treatment at  $3,500 per month, ahead of an expected U.S. launch in the second  half of 2017.  Siliq is the lowest priced injectable biologic psoriasis  treatment currently on the market, Valeant said on Friday.  The treatment, which blocks a cell receptor known as  interleukin-17 to tamp down inflammation, will compete with a  host of existing IL-17 inhibitors including Cosentyx from  Novartis AG and Taltz from Eli Lilly & Co."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down Again On Crude Weakness - Canadian Commentary,2017-04-27 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S-9vmPy0LBE/canadian-stocks-are-down-again-on-crude-weakness--canadian-commentary-20170427-01390,Canadian Stocks Are Down Again On Crude Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down Again On Crude Weakness - Canadian Commentary,2017-04-27 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S-9vmPy0LBE/canadian-stocks-are-down-again-on-crude-weakness--canadian-commentary-20170427-01390,Canadian Stocks Are Down Again On Crude Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,[$$] Wall Street’s New Problem: When Fund Titans Invest on the Side,2017-04-27 04:04:13 +0000,http://finance.yahoo.com/r/cfc316b2-3093-3e91-b8f1-651d6c946665/wall-streets-new-problem-when-fund-titans-invest-on-the-side-1493218214?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"By putting some of their wealth in private ‘family offices’ and other personal investment vehicles, some billionaire managers of private-equity and hedge funds are dividing their time, duplicating strategies ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Wall Street’s New Problem: When Fund Titans Invest on the Side,2017-04-27 04:04:13 +0000,http://finance.yahoo.com/r/cfc316b2-3093-3e91-b8f1-651d6c946665/wall-streets-new-problem-when-fund-titans-invest-on-the-side-1493218214?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"By putting some of their wealth in private ‘family offices’ and other personal investment vehicles, some billionaire managers of private-equity and hedge funds are dividing their time, duplicating strategies ..."
VRX,VRX:US,BBG000DLFM21,Hedge fund billionaire Bill Ackman provides a perfect example of how the rich get richer,2017-04-26 18:01:25 +0000,http://finance.yahoo.com/news/hedge-fund-billionaire-bill-ackman-180125949.html?.tsrc=rss,There's a great piece in The Wall Street Journal about how Wall Street's masters of the universe...
VRX,VRX:CT,BBG000DC8S17,Hedge fund billionaire Bill Ackman provides a perfect example of how the rich get richer,2017-04-26 18:01:25 +0000,http://finance.yahoo.com/news/hedge-fund-billionaire-bill-ackman-180125949.html?.tsrc=rss,There's a great piece in The Wall Street Journal about how Wall Street's masters of the universe...
VRX,VRX:US,BBG000DLFM21,[$$] Wall Street's New Problem: When Fund Titans Invest on the Side,2017-04-26 15:47:37 +0000,http://finance.yahoo.com/r/cfc316b2-3093-3e91-b8f1-651d6c946665/wall-streets-new-problem-when-fund-titans-invest-on-the-side-1493218214?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"By putting some of their wealth in private ‘family offices’ and other personal investment vehicles, some billionaire managers of private-equity and hedge funds are dividing their time, duplicating strategies ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Wall Street's New Problem: When Fund Titans Invest on the Side,2017-04-26 15:47:37 +0000,http://finance.yahoo.com/r/cfc316b2-3093-3e91-b8f1-651d6c946665/wall-streets-new-problem-when-fund-titans-invest-on-the-side-1493218214?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"By putting some of their wealth in private ‘family offices’ and other personal investment vehicles, some billionaire managers of private-equity and hedge funds are dividing their time, duplicating strategies ..."
VRX,VRX:CT,BBG000DC8S17,Health Care Sector Update for 04/26/2017: VRX,2017-04-26 13:43:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0WmCMWIVneE/health-care-sector-update-for-04262017-vrx-cm779390,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE flatPFE flat ABT 0 1 ABT 0 1 MRK flatMRK flat AMGN 0 7 AMGN 0 7 Health care shares were mainly unchanged in pre market trade on Wednesday Health care shares were mainly unchanged in pre market trade on Wednesday
VRX,VRX:US,BBG000DLFM21,Health Care Sector Update for 04/26/2017: VRX,2017-04-26 13:43:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0WmCMWIVneE/health-care-sector-update-for-04262017-vrx-cm779390,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE flatPFE flat ABT 0 1 ABT 0 1 MRK flatMRK flat AMGN 0 7 AMGN 0 7 Health care shares were mainly unchanged in pre market trade on Wednesday Health care shares were mainly unchanged in pre market trade on Wednesday
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: Valeant Jumps, Boeing Drops, Seagate Tumbles",2017-04-26 13:01:00 +0000,http://finance.yahoo.com/r/71e9b5b1-77df-3b93-a4a5-8e59faa7a178/morning-movers-valeant-jumps-boeing-drops-seagate-tumbles?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set to take a breather today after the Dow Jones Industrial Average broke 21,000 and the Nasdaq Composite crossed 6,000. S&P 500 futures are little changed, while Dow Jones Industrial Average ..."
VRX,VRX:US,BBG000DLFM21,"Morning Movers: Valeant Jumps, Boeing Drops, Seagate Tumbles",2017-04-26 13:01:00 +0000,http://finance.yahoo.com/r/71e9b5b1-77df-3b93-a4a5-8e59faa7a178/morning-movers-valeant-jumps-boeing-drops-seagate-tumbles?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set to take a breather today after the Dow Jones Industrial Average broke 21,000 and the Nasdaq Composite crossed 6,000. S&P 500 futures are little changed, while Dow Jones Industrial Average ..."
VRX,VRX:US,BBG000DLFM21,"Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System",2017-04-26 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-receives-510-k-113000789.html?.tsrc=rss,"Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System"
VRX,VRX:US,BBG000DLFM21,"Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System",2017-04-26 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-receives-510-k-113000852.html?.tsrc=rss,"LAVAL, Quebec, April 26, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Vitesse™, the first and only hypersonic  device for vitreous removal,  which uses a novel, single-needle design and a continuously open-port system.  This new technology represents the first major vitreous removal innovation in 40 years, and one that will be available exclusively on the company's new Stellaris Elite™ Vision Enhancement System."
VRX,VRX:CT,BBG000DC8S17,"Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System",2017-04-26 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-receives-510-k-113000852.html?.tsrc=rss,"LAVAL, Quebec, April 26, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Vitesse™, the first and only hypersonic  device for vitreous removal,  which uses a novel, single-needle design and a continuously open-port system.  This new technology represents the first major vitreous removal innovation in 40 years, and one that will be available exclusively on the company's new Stellaris Elite™ Vision Enhancement System."
VRX,VRX:CT,BBG000DC8S17,"Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System",2017-04-26 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-receives-510-k-113000789.html?.tsrc=rss,"Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse™, The First And Only Hypersonic, Open-Port Vitrectomy System"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down In Cautious Trade - Canadian Commentary,2017-04-26 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cZOizMs_gkM/canadian-stocks-are-down-in-cautious-trade--canadian-commentary-20170426-01116,Canadian Stocks Are Down In Cautious Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down In Cautious Trade - Canadian Commentary,2017-04-26 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cZOizMs_gkM/canadian-stocks-are-down-in-cautious-trade--canadian-commentary-20170426-01116,Canadian Stocks Are Down In Cautious Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant's Bausch + Lomb Gets 510(k) Clearance From FDA For Vitesse - Quick Facts,2017-04-26 08:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E6wupAOTvoE/valeants-bausch--lomb-gets-510k-clearance-from-fda-for-vitesse---quick-facts-20170426-00714,Valeant's Bausch + Lomb Gets 510(k) Clearance From FDA For Vitesse - Quick Facts
VRX,VRX:US,BBG000DLFM21,Valeant's Bausch + Lomb Gets 510(k) Clearance From FDA For Vitesse - Quick Facts,2017-04-26 08:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E6wupAOTvoE/valeants-bausch--lomb-gets-510k-clearance-from-fda-for-vitesse---quick-facts-20170426-00714,Valeant's Bausch + Lomb Gets 510(k) Clearance From FDA For Vitesse - Quick Facts
VRX,VRX:US,BBG000DLFM21,Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?,2017-04-25 14:05:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_luUbEaDs2o/will-low-pricing-for-siliq-be-enough-to-help-valeant-turn-things-around-cm778473,Valeant Pharmaceuticals NYSE VRX has been more bullish about the prospects for brodalumab now branded as Siliq than anyone Amgen bailed out on the 160 psoriasis drug after late stage study results raised concerns about Siliq causing patients to have suicidal
VRX,VRX:CT,BBG000DC8S17,Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?,2017-04-25 14:05:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_luUbEaDs2o/will-low-pricing-for-siliq-be-enough-to-help-valeant-turn-things-around-cm778473,Valeant Pharmaceuticals NYSE VRX has been more bullish about the prospects for brodalumab now branded as Siliq than anyone Amgen bailed out on the 160 psoriasis drug after late stage study results raised concerns about Siliq causing patients to have suicidal
VRX,VRX:CT,BBG000DC8S17,Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?,2017-04-25 12:22:00 +0000,http://finance.yahoo.com/r/76d5aafd-2c86-3a08-a9b8-17abb615f26a/will-low-pricing-for-siliq-be-enough-to-help-valea.aspx?yptr=yahoo&.tsrc=rss,Valeant is undercutting Novartis and Lilly with its pricing of psoriasis drug Siliq. How much will the strategy help?
VRX,VRX:US,BBG000DLFM21,Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?,2017-04-25 12:22:00 +0000,http://finance.yahoo.com/r/76d5aafd-2c86-3a08-a9b8-17abb615f26a/will-low-pricing-for-siliq-be-enough-to-help-valea.aspx?yptr=yahoo&.tsrc=rss,Valeant is undercutting Novartis and Lilly with its pricing of psoriasis drug Siliq. How much will the strategy help?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Adding To Yesterday's Gains - Canadian Commentary,2017-04-25 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pNqgkM9qZmI/canadian-stocks-are-adding-to-yesterdays-gains--canadian-commentary-20170425-01152,Canadian Stocks Are Adding To Yesterday's Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Adding To Yesterday's Gains - Canadian Commentary,2017-04-25 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pNqgkM9qZmI/canadian-stocks-are-adding-to-yesterdays-gains--canadian-commentary-20170425-01152,Canadian Stocks Are Adding To Yesterday's Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Rite Aid, DryShips Stumble into Monday’s 52-Week Low Club",2017-04-24 20:04:35 +0000,http://finance.yahoo.com/news/rite-aid-dryships-stumble-monday-200435614.html?.tsrc=rss,"Rite Aid, DryShips, Mattel, and Valeant all posted new 52-week lows on Monday."
VRX,VRX:CT,BBG000DC8S17,"Rite Aid, DryShips Stumble into Monday’s 52-Week Low Club",2017-04-24 20:04:35 +0000,http://finance.yahoo.com/news/rite-aid-dryships-stumble-monday-200435614.html?.tsrc=rss,"Rite Aid, DryShips, Mattel, and Valeant all posted new 52-week lows on Monday."
VRX,VRX:CT,BBG000DC8S17,Blog Coverage: Valeant Announces the Pricing for SILIQ as the Lowest Priced Injectable Biologic for Moderate-To-Severe Plaque Psoriasis,2017-04-24 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeant-announces-pricing-121500471.html?.tsrc=rss,"Upcoming AWS Coverage on Adamis Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / April 24, 2017 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, ..."
VRX,VRX:US,BBG000DLFM21,Blog Coverage: Valeant Announces the Pricing for SILIQ as the Lowest Priced Injectable Biologic for Moderate-To-Severe Plaque Psoriasis,2017-04-24 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeant-announces-pricing-121500471.html?.tsrc=rss,"Upcoming AWS Coverage on Adamis Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / April 24, 2017 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Bank Stocks Surge - Canadian Commentary,2017-04-24 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fy3sq-hYX-M/canadian-stocks-are-rising-as-bank-stocks-surge--canadian-commentary-20170424-00844,Canadian Stocks Are Rising As Bank Stocks Surge - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Bank Stocks Surge - Canadian Commentary,2017-04-24 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fy3sq-hYX-M/canadian-stocks-are-rising-as-bank-stocks-surge--canadian-commentary-20170424-00844,Canadian Stocks Are Rising As Bank Stocks Surge - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,The Scariest Prescription Drug Price Chart You'll Ever See,2017-04-23 15:02:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oqFwTOsyBnU/the-scariest-prescription-drug-price-chart-youll-ever-see-cm777578,If you believe that brand name prescription drug prices are out of control you re probably not alone Prescription drug costs have been soaring at a pace that s far beyond the rate of inflation for years and the pattern has shown few signs of slowing What s become a cash cow
VRX,VRX:US,BBG000DLFM21,The Scariest Prescription Drug Price Chart You'll Ever See,2017-04-23 15:02:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oqFwTOsyBnU/the-scariest-prescription-drug-price-chart-youll-ever-see-cm777578,If you believe that brand name prescription drug prices are out of control you re probably not alone Prescription drug costs have been soaring at a pace that s far beyond the rate of inflation for years and the pattern has shown few signs of slowing What s become a cash cow
VRX,VRX:CT,BBG000DC8S17,The Scariest Prescription Drug Price Chart You&apos;ll Ever See,2017-04-23 13:40:00 +0000,http://finance.yahoo.com/r/31a6768f-7a20-3bec-b0cc-ad61c2542fe8/the-scariest-prescription-drug-price-chart-youll-e.aspx?yptr=yahoo&.tsrc=rss,Prescription drug price inflation has outpaced the Consumer Price Index by more than 150 percentage points over the past decade.
VRX,VRX:US,BBG000DLFM21,The Scariest Prescription Drug Price Chart You&apos;ll Ever See,2017-04-23 13:40:00 +0000,http://finance.yahoo.com/r/31a6768f-7a20-3bec-b0cc-ad61c2542fe8/the-scariest-prescription-drug-price-chart-youll-e.aspx?yptr=yahoo&.tsrc=rss,Prescription drug price inflation has outpaced the Consumer Price Index by more than 150 percentage points over the past decade.
VRX,VRX:US,BBG000DLFM21,Why Now Is Not the Time to Buy Valeant Pharmaceuticals,2017-04-22 20:02:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LdVDJA7uuZY/why-now-is-not-the-time-to-buy-valeant-pharmaceuticals-cm777538,Just a few short years ago Valeant Pharmaceuticals NYSE VRX was a red hot stock The company s CEO at the time Michael Pearson was hailed as a genius and was the toast of Wall Street Several big name hedge funds even piled into the stock with the hope of striking it
VRX,VRX:CT,BBG000DC8S17,Why Now Is Not the Time to Buy Valeant Pharmaceuticals,2017-04-22 20:02:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LdVDJA7uuZY/why-now-is-not-the-time-to-buy-valeant-pharmaceuticals-cm777538,Just a few short years ago Valeant Pharmaceuticals NYSE VRX was a red hot stock The company s CEO at the time Michael Pearson was hailed as a genius and was the toast of Wall Street Several big name hedge funds even piled into the stock with the hope of striking it
VRX,VRX:US,BBG000DLFM21,Why Now Is Not the Time to Buy Valeant Pharmaceuticals,2017-04-22 18:12:00 +0000,http://finance.yahoo.com/r/8aa86004-c1cd-3c91-9f86-b1e94fb569d5/why-now-is-not-the-time-to-buy-valeant-pharmaceuti.aspx?yptr=yahoo&.tsrc=rss,Are you thinking about buying into this former Wall Street darling? Here are three reasons why you might want to reconsider.
VRX,VRX:CT,BBG000DC8S17,Why Now Is Not the Time to Buy Valeant Pharmaceuticals,2017-04-22 18:12:00 +0000,http://finance.yahoo.com/r/8aa86004-c1cd-3c91-9f86-b1e94fb569d5/why-now-is-not-the-time-to-buy-valeant-pharmaceuti.aspx?yptr=yahoo&.tsrc=rss,Are you thinking about buying into this former Wall Street darling? Here are three reasons why you might want to reconsider.
VRX,VRX:CT,BBG000DC8S17,"Why General Electric Company (GE), Mattel, Inc. (MAT) and Freeport-McMoRan Inc (FCX) Are 3 of Today’s Worst Stocks",2017-04-22 07:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WT5Ip1MeEm8/why-general-electric-company-ge-mattel-inc-mat-and-freeport-mcmoran-inc-fcx-are-3-of-todays-worst-stocks-cm777443,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market was on the precipice of sending a bullish message by way of a strong technical thrust that would leave key ceilings in the rear view mirror Alas buying effort once again faded before any true
VRX,VRX:US,BBG000DLFM21,"Why General Electric Company (GE), Mattel, Inc. (MAT) and Freeport-McMoRan Inc (FCX) Are 3 of Today’s Worst Stocks",2017-04-22 07:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WT5Ip1MeEm8/why-general-electric-company-ge-mattel-inc-mat-and-freeport-mcmoran-inc-fcx-are-3-of-todays-worst-stocks-cm777443,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market was on the precipice of sending a bullish message by way of a strong technical thrust that would leave key ceilings in the rear view mirror Alas buying effort once again faded before any true
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Manhattan Associates, and NCR Slumped Today",2017-04-21 22:03:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5CyM7KHHDbw/why-valeant-pharmaceuticals-manhattan-associates-and-ncr-slumped-today-cm777363,The stock market was generally flat on Friday with major benchmarks finishing narrowly mixed Oil prices fell below the 50 per barrel mark spurring pessimism in the energy industry and the key French election could signal whether Europe is likely to keep seeing internal turmoil in
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Manhattan Associates, and NCR Slumped Today",2017-04-21 22:03:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5CyM7KHHDbw/why-valeant-pharmaceuticals-manhattan-associates-and-ncr-slumped-today-cm777363,The stock market was generally flat on Friday with major benchmarks finishing narrowly mixed Oil prices fell below the 50 per barrel mark spurring pessimism in the energy industry and the key French election could signal whether Europe is likely to keep seeing internal turmoil in
VRX,VRX:CT,BBG000DC8S17,"Valeant Shares Plummet as Debt Issues Remain Unsolved, Prices New Psoriasis Drug",2017-04-21 20:43:00 +0000,http://finance.yahoo.com/r/9992f400-1de8-35db-978f-4a3c40a1b85f/valeant-shares-plummet-as-debt-issues-remain-unsolved-prices-of-new-psoriasis-drug.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The drugmaker's stock fell after Wells Fargo lowered its price target range.
VRX,VRX:US,BBG000DLFM21,"Valeant Shares Plummet as Debt Issues Remain Unsolved, Prices New Psoriasis Drug",2017-04-21 20:43:00 +0000,http://finance.yahoo.com/r/9992f400-1de8-35db-978f-4a3c40a1b85f/valeant-shares-plummet-as-debt-issues-remain-unsolved-prices-of-new-psoriasis-drug.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The drugmaker's stock fell after Wells Fargo lowered its price target range.
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Manhattan Associates, and NCR Slumped Today",2017-04-21 20:27:28 +0000,http://finance.yahoo.com/r/10fc0bed-297e-3c5d-86be-6ec734896f94/why-valeant-pharmaceuticals-manhattan-associates-a.aspx?yptr=yahoo&.tsrc=rss,These stocks fell on a sluggish day for the stock market. Find out why.
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Manhattan Associates, and NCR Slumped Today",2017-04-21 20:27:28 +0000,http://finance.yahoo.com/r/10fc0bed-297e-3c5d-86be-6ec734896f94/why-valeant-pharmaceuticals-manhattan-associates-a.aspx?yptr=yahoo&.tsrc=rss,These stocks fell on a sluggish day for the stock market. Find out why.
VRX,VRX:CT,BBG000DC8S17,1 Current and 1 Former Healthcare CEO Who Deserve Far More Flak Than United Airlines' Oscar Munoz,2017-04-21 19:03:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yUCS1xpY1IU/1-current-and-1-former-healthcare-ceo-who-deserve-far-more-flak-than-united-airlines-oscar-munoz-cm777260,It s been more than a week since United Continental Holdings NYSE UAL CEO Oscar Munoz came under fire for the way he handled the consumer backlash after a paying customer was forcibly removed from a United flight On the day of the incident Munoz stood behind the decision of
VRX,VRX:US,BBG000DLFM21,1 Current and 1 Former Healthcare CEO Who Deserve Far More Flak Than United Airlines' Oscar Munoz,2017-04-21 19:03:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yUCS1xpY1IU/1-current-and-1-former-healthcare-ceo-who-deserve-far-more-flak-than-united-airlines-oscar-munoz-cm777260,It s been more than a week since United Continental Holdings NYSE UAL CEO Oscar Munoz came under fire for the way he handled the consumer backlash after a paying customer was forcibly removed from a United flight On the day of the incident Munoz stood behind the decision of
VRX,VRX:CT,BBG000DC8S17,1 Current and 1 Former Healthcare CEO Who Deserve Far More Flak Than United Airlines&apos; Oscar Munoz,2017-04-21 17:36:00 +0000,http://finance.yahoo.com/r/94f00152-7dd9-3727-aa3b-cf7ddfd0b1a1/1-current-and-1-former-healthcare-ceo-who-deserve.aspx?yptr=yahoo&.tsrc=rss,"Forget Oscar Munoz. Instead, direct your disgust toward Valeant&apos;s former CEO and Mylan&apos;s current CEO."
VRX,VRX:US,BBG000DLFM21,1 Current and 1 Former Healthcare CEO Who Deserve Far More Flak Than United Airlines&apos; Oscar Munoz,2017-04-21 17:36:00 +0000,http://finance.yahoo.com/r/94f00152-7dd9-3727-aa3b-cf7ddfd0b1a1/1-current-and-1-former-healthcare-ceo-who-deserve.aspx?yptr=yahoo&.tsrc=rss,"Forget Oscar Munoz. Instead, direct your disgust toward Valeant&apos;s former CEO and Mylan&apos;s current CEO."
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Friday: Visa Inc (V), Valeant Pharmaceuticals Intl Inc (VRX) and E*Trade Financial Corp (ETFC)",2017-04-21 17:06:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EvCEdMfhflA/3-stocks-to-watch-on-friday-visa-inc-v-valeant-pharmaceuticals-intl-inc-vrx-and-etrade-financial-corp-etfc-cm777236,InvestorPlace Stock Market News Stock Advice amp Trading Tips Thursday was one of the stronger days that U S equities have enjoyed for weeks led by a big showing from the financial sector The S amp P 500 Index and the 160 Nasdaq Composite gained 0 8 apiece
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Friday: Visa Inc (V), Valeant Pharmaceuticals Intl Inc (VRX) and E*Trade Financial Corp (ETFC)",2017-04-21 17:06:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EvCEdMfhflA/3-stocks-to-watch-on-friday-visa-inc-v-valeant-pharmaceuticals-intl-inc-vrx-and-etrade-financial-corp-etfc-cm777236,InvestorPlace Stock Market News Stock Advice amp Trading Tips Thursday was one of the stronger days that U S equities have enjoyed for weeks led by a big showing from the financial sector The S amp P 500 Index and the 160 Nasdaq Composite gained 0 8 apiece
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Not Worth the Risk!,2017-04-21 16:28:00 +0000,http://finance.yahoo.com/r/adaf4851-d92d-3e9c-9a2b-2a00f423d865/valeant-pharmaceuticals-not-worth-the-risk?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, we noted that analysts were starting to preview earnings for Valeant Pharmaceuticals International (VRX) despite the fact that it isn't scheduled to report until May 2.  JPMorgan's Chris Schott, for one, noted that Valeant might beat forecasts but worried that other factors could overwhelm that positive.  Maris, too writes that Valeant might beat forecasts, but he doesn't feel the need to change his Underperform rating on the stock, and even dropped his price target to a range of $7 to $9 from a range of $10 to $13."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Not Worth the Risk!,2017-04-21 16:28:00 +0000,http://finance.yahoo.com/r/adaf4851-d92d-3e9c-9a2b-2a00f423d865/valeant-pharmaceuticals-not-worth-the-risk?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, we noted that analysts were starting to preview earnings for Valeant Pharmaceuticals International (VRX) despite the fact that it isn't scheduled to report until May 2.  JPMorgan's Chris Schott, for one, noted that Valeant might beat forecasts but worried that other factors could overwhelm that positive.  Maris, too writes that Valeant might beat forecasts, but he doesn't feel the need to change his Underperform rating on the stock, and even dropped his price target to a range of $7 to $9 from a range of $10 to $13."
VRX,VRX:CT,BBG000DC8S17,TSX Flat To End Jittery Week -- Canadian Commentary,2017-04-21 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rj1nBgco6Ww/tsx-flat-to-end-jittery-week--canadian-commentary-20170421-00915,TSX Flat To End Jittery Week -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,TSX Flat To End Jittery Week -- Canadian Commentary,2017-04-21 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rj1nBgco6Ww/tsx-flat-to-end-jittery-week--canadian-commentary-20170421-00915,TSX Flat To End Jittery Week -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Jim Cramer -- Valeant's Not Worth the Speculation,2017-04-21 15:26:00 +0000,http://finance.yahoo.com/r/7aa472cf-122f-325e-b1ab-1becbeb48cf5/jim-cramer-valeant-s-not-worth-the-speculation.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant's debt load is massive and buying the stock is a risky bet, Cramer said."
VRX,VRX:CT,BBG000DC8S17,Jim Cramer -- Valeant's Not Worth the Speculation,2017-04-21 15:26:00 +0000,http://finance.yahoo.com/r/7aa472cf-122f-325e-b1ab-1becbeb48cf5/jim-cramer-valeant-s-not-worth-the-speculation.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant's debt load is massive and buying the stock is a risky bet, Cramer said."
VRX,VRX:US,BBG000DLFM21,Cramer's Stop Trading: Valeant,2017-04-21 13:55:00 +0000,http://finance.yahoo.com/video/cramers-stop-trading-valeant-135500715.html?.tsrc=rss,CNBC's Jim Cramer explains why he is watching shares of Valeant Pharmaceuticals.
VRX,VRX:CT,BBG000DC8S17,Cramer's Stop Trading: Valeant,2017-04-21 13:55:00 +0000,http://finance.yahoo.com/video/cramers-stop-trading-valeant-135500715.html?.tsrc=rss,CNBC's Jim Cramer explains why he is watching shares of Valeant Pharmaceuticals.
VRX,VRX:US,BBG000DLFM21,"Valeant prices psoriasis treatment at $3,500 per month",2017-04-21 13:36:32 +0000,http://finance.yahoo.com/news/valeant-prices-psoriasis-treatment-3-124614593.html?.tsrc=rss,"Canadian drugmaker Valeant  Pharmaceuticals International Inc  said it had  priced its recently approved plaque psoriasis treatment at  $3,500 per month, ahead of an expected U.S. launch in the second  half of 2017.  Siliq is the lowest priced injectable biologic psoriasis  treatment currently on the market, Valeant said on Friday.  The treatment, which blocks a cell receptor known as  interleukin-17 to tamp down inflammation, will compete with a  host of existing IL-17 inhibitors including Cosentyx from  Novartis AG and Taltz from Eli Lilly & Co."
VRX,VRX:CT,BBG000DC8S17,"Valeant prices psoriasis treatment at $3,500 per month",2017-04-21 13:36:32 +0000,http://finance.yahoo.com/news/valeant-prices-psoriasis-treatment-3-124614593.html?.tsrc=rss,"Canadian drugmaker Valeant  Pharmaceuticals International Inc  said it had  priced its recently approved plaque psoriasis treatment at  $3,500 per month, ahead of an expected U.S. launch in the second  half of 2017.  Siliq is the lowest priced injectable biologic psoriasis  treatment currently on the market, Valeant said on Friday.  The treatment, which blocks a cell receptor known as  interleukin-17 to tamp down inflammation, will compete with a  host of existing IL-17 inhibitors including Cosentyx from  Novartis AG and Taltz from Eli Lilly & Co."
VRX,VRX:CT,BBG000DC8S17,"Valeant prices psoriasis treatment at $3,500 per month",2017-04-21 11:53:21 +0000,http://finance.yahoo.com/news/valeant-prices-psoriasis-treatment-3-115321432.html?.tsrc=rss,"Embattled Canadian drugmaker Valeant Pharmaceuticals International Inc, said on Friday that it had priced its recently approved plaque psoriasis treatment at $3,500 per month. The drug, Siliq, is the lowest ..."
VRX,VRX:US,BBG000DLFM21,"Valeant prices psoriasis treatment at $3,500 per month",2017-04-21 11:53:21 +0000,http://finance.yahoo.com/news/valeant-prices-psoriasis-treatment-3-115321432.html?.tsrc=rss,"Embattled Canadian drugmaker Valeant Pharmaceuticals International Inc, said on Friday that it had priced its recently approved plaque psoriasis treatment at $3,500 per month. The drug, Siliq, is the lowest ..."
VRX,VRX:US,BBG000DLFM21,"Valeant says its plaque psoriasis drug will cost $3,500 a month",2017-04-21 11:46:40 +0000,http://finance.yahoo.com/r/089e2604-87e9-3ad0-bb00-39d0c13caabd/Story.aspx?guid=3DBFE7D9-F701-470D-B316-15D1307B60FF&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International said early Friday that the company's new plaque psoriasis drug Siliq will cost $3,500 a month. Siliq, an injectable drug that Valeant got the rights for from AstraZeneca ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant says its plaque psoriasis drug will cost $3,500 a month",2017-04-21 11:46:40 +0000,http://finance.yahoo.com/r/089e2604-87e9-3ad0-bb00-39d0c13caabd/Story.aspx?guid=3DBFE7D9-F701-470D-B316-15D1307B60FF&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals International said early Friday that the company's new plaque psoriasis drug Siliq will cost $3,500 a month. Siliq, an injectable drug that Valeant got the rights for from AstraZeneca ..."
VRX,VRX:CT,BBG000DC8S17,Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis,2017-04-21 11:30:00 +0000,http://finance.yahoo.com/news/valeants-patient-access-pricing-committee-113000350.html?.tsrc=rss,Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
VRX,VRX:US,BBG000DLFM21,Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis,2017-04-21 11:30:00 +0000,http://finance.yahoo.com/news/valeants-patient-access-pricing-committee-113000492.html?.tsrc=rss,"LAVAL, Quebec, April 21, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), the company has decided to list SILIQ™ (brodalumab) injection, at $3,500 per month, which is the lowest injectable biologic psoriasis treatment currently on the market.  SILIQ will also be included in the company's patient access program to further offer financial support and access to patients.  SILIQ, a monoclonal antibody that targets the IL-17 receptor for patients with moderate-to-severe plaque psoriasis, is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. SILIQ is the only product that included the psoriasis area and severity index (PASI 100) during clinical trials as a primary endpoint."
VRX,VRX:CT,BBG000DC8S17,Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis,2017-04-21 11:30:00 +0000,http://finance.yahoo.com/news/valeants-patient-access-pricing-committee-113000492.html?.tsrc=rss,"LAVAL, Quebec, April 21, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), the company has decided to list SILIQ™ (brodalumab) injection, at $3,500 per month, which is the lowest injectable biologic psoriasis treatment currently on the market.  SILIQ will also be included in the company's patient access program to further offer financial support and access to patients.  SILIQ, a monoclonal antibody that targets the IL-17 receptor for patients with moderate-to-severe plaque psoriasis, is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. SILIQ is the only product that included the psoriasis area and severity index (PASI 100) during clinical trials as a primary endpoint."
VRX,VRX:US,BBG000DLFM21,Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis,2017-04-21 11:30:00 +0000,http://finance.yahoo.com/news/valeants-patient-access-pricing-committee-113000350.html?.tsrc=rss,Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ™ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary,2017-04-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kgB70oS4tWI/canadian-stocks-are-little-changed-in-cautious-trade--canadian-commentary-20170421-00621,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary,2017-04-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kgB70oS4tWI/canadian-stocks-are-little-changed-in-cautious-trade--canadian-commentary-20170421-00621,Canadian Stocks Are Little Changed In Cautious Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"TSX Unable To Sustain Direction, French Vote Looms -- Canadian Commentary",2017-04-21 08:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mZ2FuOX24m0/tsx-unable-to-sustain-direction-french-vote-looms--canadian-commentary-20170421-00386,"TSX Unable To Sustain Direction, French Vote Looms -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"TSX Unable To Sustain Direction, French Vote Looms -- Canadian Commentary",2017-04-21 08:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mZ2FuOX24m0/tsx-unable-to-sustain-direction-french-vote-looms--canadian-commentary-20170421-00386,"TSX Unable To Sustain Direction, French Vote Looms -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Announces Pricing For SILIQ - Quick Facts,2017-04-21 07:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VmMHBCB3Y6o/valeant-pharma-announces-pricing-for-siliq--quick-facts-20170421-00329,Valeant Pharma Announces Pricing For SILIQ - Quick Facts
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Announces Pricing For SILIQ - Quick Facts,2017-04-21 07:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VmMHBCB3Y6o/valeant-pharma-announces-pricing-for-siliq--quick-facts-20170421-00329,Valeant Pharma Announces Pricing For SILIQ - Quick Facts
VRX,VRX:US,BBG000DLFM21,Valeant: Will Earnings Even Matter?,2017-04-20 14:34:00 +0000,http://finance.yahoo.com/r/17cf96b9-8abd-358e-ab97-80a655ce3446/valeant-will-earnings-even-matter?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have shed three-quarters of their value during the past 12 months. And it has so many issues, ranging from its massive debt load to its struggles to ..."
VRX,VRX:CT,BBG000DC8S17,Valeant: Will Earnings Even Matter?,2017-04-20 14:34:00 +0000,http://finance.yahoo.com/r/17cf96b9-8abd-358e-ab97-80a655ce3446/valeant-will-earnings-even-matter?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have shed three-quarters of their value during the past 12 months. And it has so many issues, ranging from its massive debt load to its struggles to ..."
VRX,VRX:CT,BBG000DC8S17,4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings,2017-04-20 14:04:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9yqWW85_hDw/4-sell-ranked-drug-stocks-investors-should-avoid-ahead-of-earnings-cm776382,Earnings season for the biotech and pharma sector has not exactly started on a positive note with industry bellwether Johnson amp Johnson JNJ reporting mixed first quarter results While earnings surpassed expectations revenues missed Read more J amp J Q1 Earnings Beat Estimates Pharma
VRX,VRX:US,BBG000DLFM21,4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings,2017-04-20 14:04:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9yqWW85_hDw/4-sell-ranked-drug-stocks-investors-should-avoid-ahead-of-earnings-cm776382,Earnings season for the biotech and pharma sector has not exactly started on a positive note with industry bellwether Johnson amp Johnson JNJ reporting mixed first quarter results While earnings surpassed expectations revenues missed Read more J amp J Q1 Earnings Beat Estimates Pharma
VRX,VRX:US,BBG000DLFM21,4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings,2017-04-20 12:36:12 +0000,http://finance.yahoo.com/news/4-sell-ranked-drug-stocks-123612433.html?.tsrc=rss,Here is a look at four Sell-Ranked drug stocks with negative earnings ESP that should be avoided ahead of earnings.
VRX,VRX:CT,BBG000DC8S17,4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings,2017-04-20 12:36:12 +0000,http://finance.yahoo.com/news/4-sell-ranked-drug-stocks-123612433.html?.tsrc=rss,Here is a look at four Sell-Ranked drug stocks with negative earnings ESP that should be avoided ahead of earnings.
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary,2017-04-20 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PEn5uVeyRjM/canadian-stocks-are-climbing-on-broad-strength--canadian-commentary-20170420-01017,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary,2017-04-20 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PEn5uVeyRjM/canadian-stocks-are-climbing-on-broad-strength--canadian-commentary-20170420-01017,Canadian Stocks Are Climbing On Broad Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Profit From the Valeant Pharmaceuticals Intl Inc (VRX) Death Spiral,2017-04-19 19:02:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UgrNJ_9ORro/profit-from-the-valeant-pharmaceuticals-intl-inc-vrx-death-spiral-cm776031,InvestorPlace Stock Market News Stock Advice amp Trading Tips The unending nightmare for Valeant Pharmaceuticals Intl Inc 160 NYSE VRX shareholders continued this week Rather than cooking up some new horror the company 160 settled for one of its recurring themes a
VRX,VRX:US,BBG000DLFM21,Profit From the Valeant Pharmaceuticals Intl Inc (VRX) Death Spiral,2017-04-19 19:02:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UgrNJ_9ORro/profit-from-the-valeant-pharmaceuticals-intl-inc-vrx-death-spiral-cm776031,InvestorPlace Stock Market News Stock Advice amp Trading Tips The unending nightmare for Valeant Pharmaceuticals Intl Inc 160 NYSE VRX shareholders continued this week Rather than cooking up some new horror the company 160 settled for one of its recurring themes a
VRX,VRX:CT,BBG000DC8S17,Facebook Inc (FB) Stock Is Headed to $150 on Earnings,2017-04-19 19:02:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-tzIUA5HkOE/facebook-inc-fb-stock-is-headed-to-150-on-earnings-cm776022,InvestorPlace Stock Market News Stock Advice amp Trading Tips We re in the thick of earnings season and Wall Street has turned its attention to many of the usual big hitters for guidance As you have seen from the results this earnings season has been very hit or miss especially
VRX,VRX:US,BBG000DLFM21,Facebook Inc (FB) Stock Is Headed to $150 on Earnings,2017-04-19 19:02:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-tzIUA5HkOE/facebook-inc-fb-stock-is-headed-to-150-on-earnings-cm776022,InvestorPlace Stock Market News Stock Advice amp Trading Tips We re in the thick of earnings season and Wall Street has turned its attention to many of the usual big hitters for guidance As you have seen from the results this earnings season has been very hit or miss especially
VRX,VRX:US,BBG000DLFM21,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals,2017-04-19 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000692.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 19, 2017 / U.S. markets were dragged down by the Banking and Healthcare sectors Tuesday after Goldman Sachs and Johnson & Johnson reported earnings that fell short of ..."
VRX,VRX:CT,BBG000DC8S17,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals,2017-04-19 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000692.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 19, 2017 / U.S. markets were dragged down by the Banking and Healthcare sectors Tuesday after Goldman Sachs and Johnson & Johnson reported earnings that fell short of ..."
VRX,VRX:US,BBG000DLFM21,[$$] Investors bet on Incyte drug success,2017-04-19 11:00:08 +0000,"http://finance.yahoo.com/r/d5bdbc9b-45f6-3207-b5c4-634e5064750d/c71b04d6-23c2-11e7-a34a-538b4cb30025,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The huge escalator running through the headquarters of Incyte, the US biotech company, harks backs to the building's former life as a department store. Where smartly dressed shop assistants once sold ladieswear ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Investors bet on Incyte drug success,2017-04-19 11:00:08 +0000,"http://finance.yahoo.com/r/d5bdbc9b-45f6-3207-b5c4-634e5064750d/c71b04d6-23c2-11e7-a34a-538b4cb30025,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The huge escalator running through the headquarters of Incyte, the US biotech company, harks backs to the building's former life as a department store. Where smartly dressed shop assistants once sold ladieswear ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-04-19 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RAfBc-hKIcI/canadian-stocks-are-paring-early-gains--canadian-commentary-20170419-00786,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-04-19 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RAfBc-hKIcI/canadian-stocks-are-paring-early-gains--canadian-commentary-20170419-00786,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,10 Stocks That Won’t Exist in a Decade,2017-04-19 00:02:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LryJXdcKaU4/10-stocks-that-wont-exist-in-a-decade-cm775599,InvestorPlace Stock Market News Stock Advice amp Trading Tips The one constant is change as the old cliche goes and that s true in the markets as well Mergers spin offs and bankruptcies consistently change the landscape of publicly traded companies Source Shutterstock
VRX,VRX:US,BBG000DLFM21,10 Stocks That Won’t Exist in a Decade,2017-04-19 00:02:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LryJXdcKaU4/10-stocks-that-wont-exist-in-a-decade-cm775599,InvestorPlace Stock Market News Stock Advice amp Trading Tips The one constant is change as the old cliche goes and that s true in the markets as well Mergers spin offs and bankruptcies consistently change the landscape of publicly traded companies Source Shutterstock
VRX,VRX:CT,BBG000DC8S17,How Drug-Company 'Benevolence' Silences the Sick,2017-04-18 14:00:11 +0000,http://finance.yahoo.com/r/af77c629-770a-3caf-a7e8-683529ab9faf/valeant-drug-company-benevolence-and-the-silence-of-the-sick?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Step 1: Make medicine wildly expensive. Step 2: Toss a few bucks at patients and advocates. Step 3: Listen to the quiet.
VRX,VRX:US,BBG000DLFM21,How Drug-Company 'Benevolence' Silences the Sick,2017-04-18 14:00:11 +0000,http://finance.yahoo.com/r/af77c629-770a-3caf-a7e8-683529ab9faf/valeant-drug-company-benevolence-and-the-silence-of-the-sick?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Step 1: Make medicine wildly expensive. Step 2: Toss a few bucks at patients and advocates. Step 3: Listen to the quiet.
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-04-18 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ik315qgUvzQ/canadian-stocks-are-paring-early-losses--canadian-commentary-20170418-00898,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-04-18 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ik315qgUvzQ/canadian-stocks-are-paring-early-losses--canadian-commentary-20170418-00898,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing After Easter Break - Canadian Commentary,2017-04-17 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zqHO5mjAu6s/canadian-stocks-are-climbing-after-easter-break--canadian-commentary-20170417-00491,Canadian Stocks Are Climbing After Easter Break - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing After Easter Break - Canadian Commentary,2017-04-17 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zqHO5mjAu6s/canadian-stocks-are-climbing-after-easter-break--canadian-commentary-20170417-00491,Canadian Stocks Are Climbing After Easter Break - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Why Chipotle Mexican Grill, Inc. (CMG) Stock Is Slowly Inching Its Way Up",2017-04-13 19:56:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/peijPPncvq0/why-chipotle-mexican-grill-inc-cmg-stock-is-slowly-inching-its-way-up-cm774038,InvestorPlace Stock Market News Stock Advice amp Trading Tips Back in November analysts were telling investors to sell Chipotle Mexican Grill Inc NYSE CMG but hedge fund manager Bill Ackman of Pershing Square Capital Management disagreed with the CMG stock
VRX,VRX:CT,BBG000DC8S17,"Why Chipotle Mexican Grill, Inc. (CMG) Stock Is Slowly Inching Its Way Up",2017-04-13 19:56:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/peijPPncvq0/why-chipotle-mexican-grill-inc-cmg-stock-is-slowly-inching-its-way-up-cm774038,InvestorPlace Stock Market News Stock Advice amp Trading Tips Back in November analysts were telling investors to sell Chipotle Mexican Grill Inc NYSE CMG but hedge fund manager Bill Ackman of Pershing Square Capital Management disagreed with the CMG stock
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals' Market Cap Is Now Lower Than Its Projected Full-Year EBITDA,2017-04-13 15:57:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JL5KykTG8zQ/valeant-pharmaceuticals-market-cap-is-now-lower-than-its-projected-full-year-ebitda-cm773840,The hits just keep on coming for embattled drugmaker Valeant Pharmaceuticals NYSE VRX Recently Valeant s stock broke lower through the 10 per share price barrier falling to a level investors haven t regularly seen since 2008 Its market cap of 3 3 billion now sits some
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals' Market Cap Is Now Lower Than Its Projected Full-Year EBITDA,2017-04-13 15:57:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JL5KykTG8zQ/valeant-pharmaceuticals-market-cap-is-now-lower-than-its-projected-full-year-ebitda-cm773840,The hits just keep on coming for embattled drugmaker Valeant Pharmaceuticals NYSE VRX Recently Valeant s stock broke lower through the 10 per share price barrier falling to a level investors haven t regularly seen since 2008 Its market cap of 3 3 billion now sits some
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals&apos; Market Cap Is Now Lower Than Its Projected Full-Year EBITDA,2017-04-13 14:21:00 +0000,http://finance.yahoo.com/r/db2e65a1-8c27-3cb4-98ca-566c1faaf94e/valeant-pharmaceuticals-market-cap-is-now-lower-th.aspx?yptr=yahoo&.tsrc=rss,Practically every data point suggests that Valeant is in deep trouble.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals&apos; Market Cap Is Now Lower Than Its Projected Full-Year EBITDA,2017-04-13 14:21:00 +0000,http://finance.yahoo.com/r/db2e65a1-8c27-3cb4-98ca-566c1faaf94e/valeant-pharmaceuticals-market-cap-is-now-lower-th.aspx?yptr=yahoo&.tsrc=rss,Practically every data point suggests that Valeant is in deep trouble.
VRX,VRX:CT,BBG000DC8S17,Aerie Reports Positive Data on Ophthalmic Drug Rhopressa,2017-04-13 13:58:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h2rWdBvCVSY/aerie-reports-positive-data-on-ophthalmic-drug-rhopressa-cm773673,Aerie Pharmaceuticals Inc AERI reported encouraging six month top line safety and efficacy results from the phase III trial ROCKET 4 on lead product candidate Rhopressa We note that Aerie is evaluating Rhopressa a novel once daily eye drop for its ability to lower intraocular
VRX,VRX:US,BBG000DLFM21,Aerie Reports Positive Data on Ophthalmic Drug Rhopressa,2017-04-13 13:58:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h2rWdBvCVSY/aerie-reports-positive-data-on-ophthalmic-drug-rhopressa-cm773673,Aerie Pharmaceuticals Inc AERI reported encouraging six month top line safety and efficacy results from the phase III trial ROCKET 4 on lead product candidate Rhopressa We note that Aerie is evaluating Rhopressa a novel once daily eye drop for its ability to lower intraocular
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Extending Recent Losses - Canadian Commentary,2017-04-13 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U5m10SFNJEQ/canadian-stocks-are-extending-recent-losses--canadian-commentary-20170413-00743,Canadian Stocks Are Extending Recent Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Extending Recent Losses - Canadian Commentary,2017-04-13 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U5m10SFNJEQ/canadian-stocks-are-extending-recent-losses--canadian-commentary-20170413-00743,Canadian Stocks Are Extending Recent Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Slipping In Early Trade - Canadian Commentary,2017-04-11 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j_gPlLEHOgk/canadian-stocks-are-slipping-in-early-trade--canadian-commentary-20170411-00789,Canadian Stocks Are Slipping In Early Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Slipping In Early Trade - Canadian Commentary,2017-04-11 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j_gPlLEHOgk/canadian-stocks-are-slipping-in-early-trade--canadian-commentary-20170411-00789,Canadian Stocks Are Slipping In Early Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"AXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA",2017-04-11 02:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MhWCSwdEhLQ/axon-names-new-ceo-anth-awaits-data-in-q3-nicox-gets-2nd-chance-from-fda-20170411-00078,"AXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA"
VRX,VRX:CT,BBG000DC8S17,"AXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA",2017-04-11 02:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MhWCSwdEhLQ/axon-names-new-ceo-anth-awaits-data-in-q3-nicox-gets-2nd-chance-from-fda-20170411-00078,"AXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call,2017-04-10 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-2017-annual-210000343.html?.tsrc=rss,Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call,2017-04-10 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-2017-annual-210000326.html?.tsrc=rss,"LAVAL, Quebec, April 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (""Valeant"" or the ""Company"") today announced that it will conduct a ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call,2017-04-10 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-2017-annual-210000326.html?.tsrc=rss,"LAVAL, Quebec, April 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (""Valeant"" or the ""Company"") today announced that it will conduct a ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call,2017-04-10 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-2017-annual-210000343.html?.tsrc=rss,Valeant Pharmaceuticals Announces 2017 Annual Meeting Of Shareholders Webcast And Q1 2017 Financial Results Conference Call
VRX,VRX:CT,BBG000DC8S17,Losing Money on a Stock? Blame Your Brain,2017-04-10 15:57:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nmX3YfciLDk/losing-money-on-a-stock-blame-your-brain-cm772166,In this episode of Industry Focus Healthcare Motley Fool analyst Kristine Harjes is joined by contributor Todd Campbell to investigate the relationship between 160 psychology and investing and explain how you can 160 outsmart your 160 biases A
VRX,VRX:US,BBG000DLFM21,Losing Money on a Stock? Blame Your Brain,2017-04-10 15:57:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nmX3YfciLDk/losing-money-on-a-stock-blame-your-brain-cm772166,In this episode of Industry Focus Healthcare Motley Fool analyst Kristine Harjes is joined by contributor Todd Campbell to investigate the relationship between 160 psychology and investing and explain how you can 160 outsmart your 160 biases A
VRX,VRX:US,BBG000DLFM21,Valeant: It's Not a Game of Chess – Part IV,2017-04-10 15:53:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkNBWXEf4DM/valeant-its-not-a-game-of-chess-part-iv-cm772197,The key to Valeant s business model was its acquisition strategy Valeant used the following parameters to guide investors on its acquisition criteria The key to Valeant s business model was its acquisition strategy Valeant used the following parameters to guide investors on its
VRX,VRX:CT,BBG000DC8S17,Valeant: It's Not a Game of Chess – Part IV,2017-04-10 15:53:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkNBWXEf4DM/valeant-its-not-a-game-of-chess-part-iv-cm772197,The key to Valeant s business model was its acquisition strategy Valeant used the following parameters to guide investors on its acquisition criteria The key to Valeant s business model was its acquisition strategy Valeant used the following parameters to guide investors on its
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-04-10 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k9lp2sFjd-w/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170410-00731,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-04-10 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k9lp2sFjd-w/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170410-00731,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Takeaways and Observations; Play a Tesla Tune: Doug Kass' Views,2017-04-10 05:00:00 +0000,http://finance.yahoo.com/r/2e9c8705-b2ff-326d-8e8d-4f4396f2c2e6/takeaways-and-observations-play-a-tesla-tune-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Doug Kass shares his thoughts on Tesla and the second quarter.
VRX,VRX:CT,BBG000DC8S17,Takeaways and Observations; Play a Tesla Tune: Doug Kass' Views,2017-04-10 05:00:00 +0000,http://finance.yahoo.com/r/2e9c8705-b2ff-326d-8e8d-4f4396f2c2e6/takeaways-and-observations-play-a-tesla-tune-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Doug Kass shares his thoughts on Tesla and the second quarter.
VRX,VRX:CT,BBG000DC8S17,Valeant: It's Not a Game of Chess - Part IV,2017-04-09 19:55:45 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-195545208.html?.tsrc=rss,A case study of the company's rise and fall
VRX,VRX:US,BBG000DLFM21,Valeant: It's Not a Game of Chess - Part IV,2017-04-09 19:55:45 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-195545208.html?.tsrc=rss,A case study of the company's rise and fall
VRX,VRX:US,BBG000DLFM21,"Valeant, DryShips Stuck in Friday’s 52-Week Low Club",2017-04-07 20:04:38 +0000,http://finance.yahoo.com/news/valeant-dryships-stuck-friday-52-200438889.html?.tsrc=rss,"DryShips, Valeant, Top Ships and Palatin Technologies posted fresh 52-week lows on Friday."
VRX,VRX:CT,BBG000DC8S17,"Valeant, DryShips Stuck in Friday’s 52-Week Low Club",2017-04-07 20:04:38 +0000,http://finance.yahoo.com/news/valeant-dryships-stuck-friday-52-200438889.html?.tsrc=rss,"DryShips, Valeant, Top Ships and Palatin Technologies posted fresh 52-week lows on Friday."
VRX,VRX:CT,BBG000DC8S17,Why Valeant Just Popped,2017-04-07 17:41:00 +0000,http://finance.yahoo.com/r/ee2a9898-6ee9-32bf-b0c7-30f0be946ce8/why-valeant-just-popped?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"At 1:00 p.m., Valeant Pharmaceuticals International (VRX) was trading at $9.53. 20 Minutes later it had jumped 2.7% to $9.79. What gives? Credit Akorn (AKRX), which has jumped 13% after Bloomberg reported ..."
VRX,VRX:US,BBG000DLFM21,Why Valeant Just Popped,2017-04-07 17:41:00 +0000,http://finance.yahoo.com/r/ee2a9898-6ee9-32bf-b0c7-30f0be946ce8/why-valeant-just-popped?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"At 1:00 p.m., Valeant Pharmaceuticals International (VRX) was trading at $9.53. 20 Minutes later it had jumped 2.7% to $9.79. What gives? Credit Akorn (AKRX), which has jumped 13% after Bloomberg reported ..."
VRX,VRX:US,BBG000DLFM21,Valeant Shares on Pace to Finish Week at Lowest Level Since 2008,2017-04-07 14:25:00 +0000,http://finance.yahoo.com/r/12c8591f-792b-3403-9f3e-25d1d710a979/valeant-shares-on-pace-to-finish-week-at-lowest-level-since-2008.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Can the drugmaker bounce back?
VRX,VRX:CT,BBG000DC8S17,Valeant Shares on Pace to Finish Week at Lowest Level Since 2008,2017-04-07 14:25:00 +0000,http://finance.yahoo.com/r/12c8591f-792b-3403-9f3e-25d1d710a979/valeant-shares-on-pace-to-finish-week-at-lowest-level-since-2008.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Can the drugmaker bounce back?
VRX,VRX:US,BBG000DLFM21,Blog Coverage Valeant's Bausch + Lomb Receives FDA Clearance for Vision Enhancement System,2017-04-07 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeants-bausch-lomb-121500083.html?.tsrc=rss,"Upcoming AWS Coverage on PetMed Express LONDON, UK / ACCESSWIRE / April 7, 2017 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, Inc. (NYSE: VRX ). On April ..."
VRX,VRX:CT,BBG000DC8S17,Blog Coverage Valeant's Bausch + Lomb Receives FDA Clearance for Vision Enhancement System,2017-04-07 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeants-bausch-lomb-121500083.html?.tsrc=rss,"Upcoming AWS Coverage on PetMed Express LONDON, UK / ACCESSWIRE / April 7, 2017 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, Inc. (NYSE: VRX ). On April ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down After Weak US Jobs Report - Canadian Commentary,2017-04-07 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FOgNZaRo7Bo/canadian-stocks-are-down-after-weak-us-jobs-report--canadian-commentary-20170407-00537,Canadian Stocks Are Down After Weak US Jobs Report - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down After Weak US Jobs Report - Canadian Commentary,2017-04-07 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FOgNZaRo7Bo/canadian-stocks-are-down-after-weak-us-jobs-report--canadian-commentary-20170407-00537,Canadian Stocks Are Down After Weak US Jobs Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Valeant, DryShips Don’t Escape Thursday’s 52-Week Low Club",2017-04-06 20:04:08 +0000,http://finance.yahoo.com/news/valeant-dryships-don-t-escape-200408613.html?.tsrc=rss,"Valeant, DryShips, Novovax, and TopShips posted new 52-week lows Thursday."
VRX,VRX:CT,BBG000DC8S17,"Valeant, DryShips Don’t Escape Thursday’s 52-Week Low Club",2017-04-06 20:04:08 +0000,http://finance.yahoo.com/news/valeant-dryships-don-t-escape-200408613.html?.tsrc=rss,"Valeant, DryShips, Novovax, and TopShips posted new 52-week lows Thursday."
VRX,VRX:CT,BBG000DC8S17,Can Valeant Pharmaceuticals Regain Its Mojo?,2017-04-06 14:57:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zSW1BStL7Ds/can-valeant-pharmaceuticals-regain-its-mojo-cm770705,It s been a long time since Valeant Pharmaceuticals NYSE VRX stock was in a legitimate uptrend Despite the hiring of a new CEO last year to right the ship Valeant s share price has continued to fall The question that investors must ask now isn t when Valeant will turn
VRX,VRX:US,BBG000DLFM21,Can Valeant Pharmaceuticals Regain Its Mojo?,2017-04-06 14:57:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zSW1BStL7Ds/can-valeant-pharmaceuticals-regain-its-mojo-cm770705,It s been a long time since Valeant Pharmaceuticals NYSE VRX stock was in a legitimate uptrend Despite the hiring of a new CEO last year to right the ship Valeant s share price has continued to fall The question that investors must ask now isn t when Valeant will turn
VRX,VRX:CT,BBG000DC8S17,Valeant's Merry-Go-Round of Disappointment Won't Stop,2017-04-06 13:49:19 +0000,http://finance.yahoo.com/r/023a2acd-b42d-3995-874d-2f0dc3d60405/valeant-inova-bids-the-disappointment-won-t-end?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Time to accept the struggling pharma firm can't hit its fire-sale target.
VRX,VRX:US,BBG000DLFM21,Valeant's Merry-Go-Round of Disappointment Won't Stop,2017-04-06 13:49:19 +0000,http://finance.yahoo.com/r/023a2acd-b42d-3995-874d-2f0dc3d60405/valeant-inova-bids-the-disappointment-won-t-end?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Time to accept the struggling pharma firm can't hit its fire-sale target.
VRX,VRX:CT,BBG000DC8S17,Can Valeant Pharmaceuticals Regain Its Mojo?,2017-04-06 13:23:00 +0000,http://finance.yahoo.com/r/c6088b0f-a95b-3e20-ac11-b21ec71b4af3/can-valeant-pharmaceuticals-regain-its-mojo.aspx?yptr=yahoo&.tsrc=rss,A comeback is looking more and more unlikely.
VRX,VRX:US,BBG000DLFM21,Can Valeant Pharmaceuticals Regain Its Mojo?,2017-04-06 13:23:00 +0000,http://finance.yahoo.com/r/c6088b0f-a95b-3e20-ac11-b21ec71b4af3/can-valeant-pharmaceuticals-regain-its-mojo.aspx?yptr=yahoo&.tsrc=rss,A comeback is looking more and more unlikely.
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Receives 510(k) Clearance From FDA For Stellaris Elite™ Next-Generation Phacoemulsification Platform,2017-04-06 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-receives-510-k-113000840.html?.tsrc=rss,"LAVAL, Quebec, April 6, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Stellaris Elite™ Vision Enhancement System, the company's next generation phacoemulsification cataract platform.  ""We are pleased to continue to deliver on our planned 2017 product launches with the approval of the Stellaris Elite platform,"" said Joseph C. Papa, Chairman and CEO of Valeant."
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Receives 510(k) Clearance From FDA For Stellaris Elite™ Next-Generation Phacoemulsification Platform,2017-04-06 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-receives-510-k-113000840.html?.tsrc=rss,"LAVAL, Quebec, April 6, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Stellaris Elite™ Vision Enhancement System, the company's next generation phacoemulsification cataract platform.  ""We are pleased to continue to deliver on our planned 2017 product launches with the approval of the Stellaris Elite platform,"" said Joseph C. Papa, Chairman and CEO of Valeant."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up Slightly On Stable Crude Prices - Canadian Commentary,2017-04-06 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GHTQPmZ-JBY/canadian-stocks-are-up-slightly-on-stable-crude-prices--canadian-commentary-20170406-00825,Canadian Stocks Are Up Slightly On Stable Crude Prices - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up Slightly On Stable Crude Prices - Canadian Commentary,2017-04-06 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GHTQPmZ-JBY/canadian-stocks-are-up-slightly-on-stable-crude-prices--canadian-commentary-20170406-00825,Canadian Stocks Are Up Slightly On Stable Crude Prices - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks May Nudge Higher At The Open -- Canadian Commentary,2017-04-06 07:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HsuIuJuhHuE/canadian-stocks-may-nudge-higher-at-the-open--canadian-commentary-20170406-00355,Canadian Stocks May Nudge Higher At The Open -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks May Nudge Higher At The Open -- Canadian Commentary,2017-04-06 07:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HsuIuJuhHuE/canadian-stocks-may-nudge-higher-at-the-open--canadian-commentary-20170406-00355,Canadian Stocks May Nudge Higher At The Open -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Bauch + Lomb Gets 510(k) Clearance From FDA For Stellaris Elite Platform,2017-04-06 07:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z89NConMk5g/bauch--lomb-gets-510k-clearance-from-fda-for-stellaris-elite-platform-20170406-00338,Bauch + Lomb Gets 510(k) Clearance From FDA For Stellaris Elite Platform
VRX,VRX:CT,BBG000DC8S17,Bauch + Lomb Gets 510(k) Clearance From FDA For Stellaris Elite Platform,2017-04-06 07:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z89NConMk5g/bauch--lomb-gets-510k-clearance-from-fda-for-stellaris-elite-platform-20170406-00338,Bauch + Lomb Gets 510(k) Clearance From FDA For Stellaris Elite Platform
VRX,VRX:US,BBG000DLFM21,Valeant trades in below $10 for first time since 2008,2017-04-05 20:19:49 +0000,http://finance.yahoo.com/news/valeant-trades-below-10-first-201949674.html?.tsrc=rss,The latest dip in Valeant shares came after reports surfaced that the firm was having a difficult time selling one of its divisions
VRX,VRX:CT,BBG000DC8S17,Valeant trades in below $10 for first time since 2008,2017-04-05 20:19:49 +0000,http://finance.yahoo.com/news/valeant-trades-below-10-first-201949674.html?.tsrc=rss,The latest dip in Valeant shares came after reports surfaced that the firm was having a difficult time selling one of its divisions
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Close Below $10 for First Time Since 2008,2017-04-05 20:03:00 +0000,http://finance.yahoo.com/r/89d5e8e4-b4ae-37a9-8e5b-bf9f39e0f43d/valeant-shares-set-to-close-below-10-for-first-time-since-2008.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Can the drugmaker bounce back?
VRX,VRX:US,BBG000DLFM21,Valeant Shares Close Below $10 for First Time Since 2008,2017-04-05 20:03:00 +0000,http://finance.yahoo.com/r/89d5e8e4-b4ae-37a9-8e5b-bf9f39e0f43d/valeant-shares-set-to-close-below-10-for-first-time-since-2008.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Can the drugmaker bounce back?
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Smells Like Death,2017-04-05 19:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ogvbd383Luo/valeant-pharmaceuticals-intl-inc-vrx-stock-smells-like-death-cm770391,InvestorPlace Stock Market News Stock Advice amp Trading Tips The seemingly endless slide in Valeant Pharmaceuticals Intl Inc NYSE VRX reached new depths on Wednesday And if recent history is any indication the new 52 week low for VRX stock 9 66 will hold for a
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Smells Like Death,2017-04-05 19:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ogvbd383Luo/valeant-pharmaceuticals-intl-inc-vrx-stock-smells-like-death-cm770391,InvestorPlace Stock Market News Stock Advice amp Trading Tips The seemingly endless slide in Valeant Pharmaceuticals Intl Inc NYSE VRX reached new depths on Wednesday And if recent history is any indication the new 52 week low for VRX stock 9 66 will hold for a
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Continues to Slump: Should You Buy the Dip?,2017-04-05 19:53:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ly0HOrcX6SQ/valeant-vrx-stock-continues-to-slump-should-you-buy-the-dip-cm770352,Shares of Valeant Pharmaceuticals VRX continued their slump on Wednesday slipping another 5 4 during the morning trading hours The struggling stock is now down more than 30 on the year and the pressure to turn things around is starting to pile on company management Is a bounce back
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Continues to Slump: Should You Buy the Dip?,2017-04-05 19:53:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ly0HOrcX6SQ/valeant-vrx-stock-continues-to-slump-should-you-buy-the-dip-cm770352,Shares of Valeant Pharmaceuticals VRX continued their slump on Wednesday slipping another 5 4 during the morning trading hours The struggling stock is now down more than 30 on the year and the pressure to turn things around is starting to pile on company management Is a bounce back
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Continues to Slump: Should You Buy the Dip?,2017-04-05 17:53:05 +0000,http://finance.yahoo.com/news/valeant-vrx-stock-continues-slump-175305823.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals (VRX) continued their slump on Wednesday, slipping another 5.4% during the morning trading hours. Is a bounce back imminent, or will Valeant continue its remarkable freefall?"
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Continues to Slump: Should You Buy the Dip?,2017-04-05 17:53:05 +0000,http://finance.yahoo.com/news/valeant-vrx-stock-continues-slump-175305823.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals (VRX) continued their slump on Wednesday, slipping another 5.4% during the morning trading hours. Is a bounce back imminent, or will Valeant continue its remarkable freefall?"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Is In Hat-Size Territory,2017-04-05 16:59:00 +0000,http://finance.yahoo.com/r/d9583025-cc88-3304-b757-8c6719ab0c37/valeant-pharma-hatsize-territory-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals stock is in free fall and has drifted below $10 a share.
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Is In Hat-Size Territory,2017-04-05 16:59:00 +0000,http://finance.yahoo.com/r/d9583025-cc88-3304-b757-8c6719ab0c37/valeant-pharma-hatsize-territory-vrx?partner=YahooSA&yptr=yahoo&.tsrc=rss,Valeant Pharmaceuticals stock is in free fall and has drifted below $10 a share.
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Faces Pricing Issues, Generic Threats Loom",2017-04-05 16:55:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SzUzS5jKWLY/valeant-vrx-faces-pricing-issues-generic-threats-loom-cm770236,Shares of Valeant Pharmaceuticals International Inc VRX hit a 52 week low of 10 08 on Apr 4 What is Hurting Valeant Pharmaceuticals Valeant relies heavily on acquisitions for growth thereby focusing less on organic growth Valeant s share price shows that the company
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Faces Pricing Issues, Generic Threats Loom",2017-04-05 16:55:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SzUzS5jKWLY/valeant-vrx-faces-pricing-issues-generic-threats-loom-cm770236,Shares of Valeant Pharmaceuticals International Inc VRX hit a 52 week low of 10 08 on Apr 4 What is Hurting Valeant Pharmaceuticals Valeant relies heavily on acquisitions for growth thereby focusing less on organic growth Valeant s share price shows that the company
VRX,VRX:US,BBG000DLFM21,Assessing Cultural Risk in Micro-Caps,2017-04-05 16:53:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZI4JGepydGY/assessing-cultural-risk-in-micro-caps-cm770280,Value investing involves finding securities that have been mispriced by the market More often than not the quest to find mispriced securities leads you into the small cap arena of the market and for good reason small cap stocks are generally volatile and uncovered by Wall Street which
VRX,VRX:CT,BBG000DC8S17,Assessing Cultural Risk in Micro-Caps,2017-04-05 16:53:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZI4JGepydGY/assessing-cultural-risk-in-micro-caps-cm770280,Value investing involves finding securities that have been mispriced by the market More often than not the quest to find mispriced securities leads you into the small cap arena of the market and for good reason small cap stocks are generally volatile and uncovered by Wall Street which
VRX,VRX:CT,BBG000DC8S17,"Valeant Tumbles Below $10 on Struggle to Sell Assets, Raise Cash",2017-04-05 16:46:30 +0000,http://finance.yahoo.com/news/valeant-tumbles-below-10-struggle-164630607.html?.tsrc=rss,Valeant Pharmaceuticals International Inc. is a single-digit stock once again.
VRX,VRX:US,BBG000DLFM21,"Valeant Tumbles Below $10 on Struggle to Sell Assets, Raise Cash",2017-04-05 16:46:30 +0000,http://finance.yahoo.com/news/valeant-tumbles-below-10-struggle-164630607.html?.tsrc=rss,Valeant Pharmaceuticals International Inc. is a single-digit stock once again.
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Faces Pricing Issues, Generic Threats Loom",2017-04-05 15:18:03 +0000,http://finance.yahoo.com/news/valeant-vrx-faces-pricing-issues-151803184.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals International, Inc. (VRX) hit a 52-week low of $10.08 on Apr 4."
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Faces Pricing Issues, Generic Threats Loom",2017-04-05 15:18:03 +0000,http://finance.yahoo.com/news/valeant-vrx-faces-pricing-issues-151803184.html?.tsrc=rss,"Shares of Valeant Pharmaceuticals International, Inc. (VRX) hit a 52-week low of $10.08 on Apr 4."
VRX,VRX:CT,BBG000DC8S17,Why Valeant is Crashing,2017-04-05 13:57:00 +0000,http://finance.yahoo.com/r/384c9f0c-405a-3f8c-a74c-182b14a93127/why-valeant-is-crashing?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are in free fall this morning after reports that the beaten-down specialty-pharmaceutical company is having a tough time selling a division for the price it wants.  Wells Fargo's David Maris explains why the news is bad for Valeant: The Australian Business Review is reporting that Valeant's iNova has received lukewarm interest with bids coming in below the $1 billion mark, an amount that some investors thought it would be sold for.  To us, this is another disappointment in what was promised to be $8 billion worth of asset sales that so far has only been approximately $2 billion."
VRX,VRX:US,BBG000DLFM21,Why Valeant is Crashing,2017-04-05 13:57:00 +0000,http://finance.yahoo.com/r/384c9f0c-405a-3f8c-a74c-182b14a93127/why-valeant-is-crashing?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are in free fall this morning after reports that the beaten-down specialty-pharmaceutical company is having a tough time selling a division for the price it wants.  Wells Fargo's David Maris explains why the news is bad for Valeant: The Australian Business Review is reporting that Valeant's iNova has received lukewarm interest with bids coming in below the $1 billion mark, an amount that some investors thought it would be sold for.  To us, this is another disappointment in what was promised to be $8 billion worth of asset sales that so far has only been approximately $2 billion."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up On Energy Strength - Canadian Commentary,2017-04-05 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7uF_MNndNlk/canadian-stocks-are-up-on-energy-strength--canadian-commentary-20170405-00803,Canadian Stocks Are Up On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up On Energy Strength - Canadian Commentary,2017-04-05 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7uF_MNndNlk/canadian-stocks-are-up-on-energy-strength--canadian-commentary-20170405-00803,Canadian Stocks Are Up On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,4 Reasons Valeant Pharmaceuticals Int'l Inc. Nosedived 23% in March,2017-04-04 21:25:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kBZvkd1_ZSI/4-reasons-valeant-pharmaceuticals-intl-inc-nosedived-23-in-march-cm769845,What happened Shares of Valeant Pharmaceuticals NYSE VRX the embattled drugmaker that s predominantly grown via acquisition over the past couple of years tanked another 23 in March according to data from S amp P Global Market Intelligence While there is a laundry
VRX,VRX:US,BBG000DLFM21,4 Reasons Valeant Pharmaceuticals Int'l Inc. Nosedived 23% in March,2017-04-04 21:25:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kBZvkd1_ZSI/4-reasons-valeant-pharmaceuticals-intl-inc-nosedived-23-in-march-cm769845,What happened Shares of Valeant Pharmaceuticals NYSE VRX the embattled drugmaker that s predominantly grown via acquisition over the past couple of years tanked another 23 in March according to data from S amp P Global Market Intelligence While there is a laundry
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Slightly Higher On Gold Strength - Canadian Commentary,2017-04-04 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dBhCS93tYLQ/canadian-stocks-are-slightly-higher-on-gold-strength--canadian-commentary-20170404-00851,Canadian Stocks Are Slightly Higher On Gold Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Slightly Higher On Gold Strength - Canadian Commentary,2017-04-04 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dBhCS93tYLQ/canadian-stocks-are-slightly-higher-on-gold-strength--canadian-commentary-20170404-00851,Canadian Stocks Are Slightly Higher On Gold Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Tesoro Corporation Stock (TSO) Is Perfect For Our Vulnerable Market,2017-04-03 19:35:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CJ4J0Lp5pHw/tesoro-corporation-stock-tso-is-perfect-for-our-vulnerable-market-cm769233,InvestorPlace Stock Market News Stock Advice amp Trading Tips Many of the traders I talk to are wondering what Bill Ackman could be thinking Ackman is a hedge fund manager the founder and CEO of Pershing Square Capital Management which has about 11
VRX,VRX:CT,BBG000DC8S17,Tesoro Corporation Stock (TSO) Is Perfect For Our Vulnerable Market,2017-04-03 19:35:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CJ4J0Lp5pHw/tesoro-corporation-stock-tso-is-perfect-for-our-vulnerable-market-cm769233,InvestorPlace Stock Market News Stock Advice amp Trading Tips Many of the traders I talk to are wondering what Bill Ackman could be thinking Ackman is a hedge fund manager the founder and CEO of Pershing Square Capital Management which has about 11
VRX,VRX:US,BBG000DLFM21,Oversold Conditions For Valeant Pharmaceuticals International (VRX),2017-04-03 17:37:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T26D3yIj2M4/oversold-conditions-for-valeant-pharmaceuticals-international-vrx-cm769157,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:CT,BBG000DC8S17,Oversold Conditions For Valeant Pharmaceuticals International (VRX),2017-04-03 17:37:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T26D3yIj2M4/oversold-conditions-for-valeant-pharmaceuticals-international-vrx-cm769157,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:CT,BBG000DC8S17,Valeant: It Is Not a Game of Chess - Part III,2017-04-03 16:50:09 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-165009856.html,Valeant: It Is Not a Game of Chess - Part III
VRX,VRX:US,BBG000DLFM21,Valeant: It Is Not a Game of Chess - Part III,2017-04-03 16:50:09 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-165009856.html,Valeant: It Is Not a Game of Chess - Part III
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Still Searches for a Bottom,2017-04-03 14:42:00 +0000,http://realmoney.thestreet.com/articles/04/03/2017/valeant-pharmaceuticals-still-searches-bottom?puc=yahoo&cm_ven=YAHOO,Valeant Pharmaceuticals Still Searches for a Bottom
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Still Searches for a Bottom,2017-04-03 14:42:00 +0000,http://realmoney.thestreet.com/articles/04/03/2017/valeant-pharmaceuticals-still-searches-bottom?puc=yahoo&cm_ven=YAHOO,Valeant Pharmaceuticals Still Searches for a Bottom
VRX,VRX:US,BBG000DLFM21,Bill Ackman Just Gave Up on Valeant. Should You Too?,2017-04-03 13:38:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6L-fgb79L04/bill-ackman-just-gave-up-on-valeant-should-you-too-cm768905,It s good to learn from your mistakes It s better to learn from other people s mistakes Warren Buffett Earlier this month it was reported that billionaire hedge fund manager Bill Ackman of Pershing Square Capital had sold out of his stake in Valeant
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Just Gave Up on Valeant. Should You Too?,2017-04-03 13:38:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6L-fgb79L04/bill-ackman-just-gave-up-on-valeant-should-you-too-cm768905,It s good to learn from your mistakes It s better to learn from other people s mistakes Warren Buffett Earlier this month it was reported that billionaire hedge fund manager Bill Ackman of Pershing Square Capital had sold out of his stake in Valeant
VRX,VRX:US,BBG000DLFM21,Bill Ackman Just Gave Up on Valeant. Should You Too?,2017-04-03 12:00:00 +0000,https://www.fool.com/investing/2017/04/03/bill-ackman-just-gave-up-on-valeant-should-you-too.aspx,Bill Ackman Just Gave Up on Valeant. Should You Too?
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Just Gave Up on Valeant. Should You Too?,2017-04-03 12:00:00 +0000,https://www.fool.com/investing/2017/04/03/bill-ackman-just-gave-up-on-valeant-should-you-too.aspx,Bill Ackman Just Gave Up on Valeant. Should You Too?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Giving Back Early Gains - Canadian Commentary,2017-04-03 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KjPLB13XjIE/canadian-stocks-are-giving-back-early-gains--canadian-commentary-20170403-00903,Canadian Stocks Are Giving Back Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Giving Back Early Gains - Canadian Commentary,2017-04-03 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KjPLB13XjIE/canadian-stocks-are-giving-back-early-gains--canadian-commentary-20170403-00903,Canadian Stocks Are Giving Back Early Gains - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's Mea Culpa Cited These 3 Factors for Valeant's Downfall,2017-03-31 23:59:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bv9RYnmDpk8/bill-ackmans-mea-culpa-cited-these-3-factors-for-valeants-downfall-cm768602,Hedge fund manager Bill Ackman who runs Pershing Square Capital Management has a long career of successful investments However what Ackman will likely be best remembered for is his gigantic investing flub with Valeant Pharmaceuticals NYSE VRX For roughly two years Ackman
VRX,VRX:US,BBG000DLFM21,Bill Ackman's Mea Culpa Cited These 3 Factors for Valeant's Downfall,2017-03-31 23:59:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bv9RYnmDpk8/bill-ackmans-mea-culpa-cited-these-3-factors-for-valeants-downfall-cm768602,Hedge fund manager Bill Ackman who runs Pershing Square Capital Management has a long career of successful investments However what Ackman will likely be best remembered for is his gigantic investing flub with Valeant Pharmaceuticals NYSE VRX For roughly two years Ackman
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's Mea Culpa Cited These 3 Factors for Valeant's Downfall,2017-03-31 22:15:00 +0000,https://www.fool.com/investing/2017/03/31/bill-ackmans-mea-culpa-cited-these-3-factors-for-v.aspx,Bill Ackman's Mea Culpa Cited These 3 Factors for Valeant's Downfall
VRX,VRX:US,BBG000DLFM21,Bill Ackman's Mea Culpa Cited These 3 Factors for Valeant's Downfall,2017-03-31 22:15:00 +0000,https://www.fool.com/investing/2017/03/31/bill-ackmans-mea-culpa-cited-these-3-factors-for-v.aspx,Bill Ackman's Mea Culpa Cited These 3 Factors for Valeant's Downfall
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts for Friday: Bank of America Corp (BAC), Goldman Sachs Group Inc (GS) and JPMorgan Chase & Co. (JPM)",2017-03-31 21:00:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FIXLeZ0DBR4/3-big-stock-charts-for-friday-bank-of-america-corp-bac-goldman-sachs-group-inc-gs-and-jpmorgan-chase-co-jpm-cm768577,InvestorPlace Stock Market News Stock Advice amp Trading Tips The financials and regional banks have taken a hit from a combination of profit taking and a potential shift in the interest rate outlook Yesterday s rally was led by the financials which are normally good for
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts for Friday: Bank of America Corp (BAC), Goldman Sachs Group Inc (GS) and JPMorgan Chase & Co. (JPM)",2017-03-31 21:00:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FIXLeZ0DBR4/3-big-stock-charts-for-friday-bank-of-america-corp-bac-goldman-sachs-group-inc-gs-and-jpmorgan-chase-co-jpm-cm768577,InvestorPlace Stock Market News Stock Advice amp Trading Tips The financials and regional banks have taken a hit from a combination of profit taking and a potential shift in the interest rate outlook Yesterday s rally was led by the financials which are normally good for
VRX,VRX:CT,BBG000DC8S17,Why Is Valeant (VRX) Down 17.7% Since the Last Earnings Report?,2017-03-31 14:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/95VAebwNxYU/why-is-valeant-vrx-down-177-since-the-last-earnings-report-cm768194,A month has gone by since the last earnings report for Valeant Pharmaceuticals International Inc VRX Shares have lost about 17 7 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for
VRX,VRX:US,BBG000DLFM21,Why Is Valeant (VRX) Down 17.7% Since the Last Earnings Report?,2017-03-31 14:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/95VAebwNxYU/why-is-valeant-vrx-down-177-since-the-last-earnings-report-cm768194,A month has gone by since the last earnings report for Valeant Pharmaceuticals International Inc VRX Shares have lost about 17 7 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for
VRX,VRX:CT,BBG000DC8S17,Why Is Valeant (VRX) Down 17.7% Since the Last Earnings Report?,2017-03-31 11:40:11 +0000,http://finance.yahoo.com/news/why-valeant-vrx-down-17-114011604.html,Why Is Valeant (VRX) Down 17.7% Since the Last Earnings Report?
VRX,VRX:US,BBG000DLFM21,Why Is Valeant (VRX) Down 17.7% Since the Last Earnings Report?,2017-03-31 11:40:11 +0000,http://finance.yahoo.com/news/why-valeant-vrx-down-17-114011604.html,Why Is Valeant (VRX) Down 17.7% Since the Last Earnings Report?
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down Despite Strong GDP Report - Canadian Commentary,2017-03-31 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BiHTTg4pq08/canadian-stocks-are-down-despite-strong-gdp-report--canadian-commentary-20170331-00643,Canadian Stocks Are Down Despite Strong GDP Report - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down Despite Strong GDP Report - Canadian Commentary,2017-03-31 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BiHTTg4pq08/canadian-stocks-are-down-despite-strong-gdp-report--canadian-commentary-20170331-00643,Canadian Stocks Are Down Despite Strong GDP Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Cenovus Falls After Conoco Deal, Valeant Resumes Decline: Most Active Stocks, March 30",2017-03-31 01:10:00 +0000,https://www.thestreet.com/story/14066707/1/cenovus-falls-on-expensive-oil-play-valeant-resumes-decline-most-active-stocks-march-30.html?puc=yahoo&cm_ven=YAHOO,"Cenovus Falls After Conoco Deal, Valeant Resumes Decline: Most Active Stocks, March 30"
VRX,VRX:CT,BBG000DC8S17,"Cenovus Falls After Conoco Deal, Valeant Resumes Decline: Most Active Stocks, March 30",2017-03-31 01:10:00 +0000,https://www.thestreet.com/story/14066707/1/cenovus-falls-on-expensive-oil-play-valeant-resumes-decline-most-active-stocks-march-30.html?puc=yahoo&cm_ven=YAHOO,"Cenovus Falls After Conoco Deal, Valeant Resumes Decline: Most Active Stocks, March 30"
VRX,VRX:CT,BBG000DC8S17,Why Apple Inc. (AAPL) Stock Is Still a Value Play,2017-03-30 22:59:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FbU2glsgn9M/why-apple-inc-aapl-stock-is-still-a-value-play-cm768062,InvestorPlace Stock Market News Stock Advice amp Trading Tips Gotham Asset Management co founder Joel Greenblatt certainly thinks Apple Inc NASDAQ AAPL 160 provides good value for buyers of AAPL stock Source Shutterstock In a recent interview Greenblatt talked about
VRX,VRX:US,BBG000DLFM21,Why Apple Inc. (AAPL) Stock Is Still a Value Play,2017-03-30 22:59:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FbU2glsgn9M/why-apple-inc-aapl-stock-is-still-a-value-play-cm768062,InvestorPlace Stock Market News Stock Advice amp Trading Tips Gotham Asset Management co founder Joel Greenblatt certainly thinks Apple Inc NASDAQ AAPL 160 provides good value for buyers of AAPL stock Source Shutterstock In a recent interview Greenblatt talked about
VRX,VRX:CT,BBG000DC8S17,Ackman to hedge fund clients: 'Deeply and profoundly sorry' for Valeant,2017-03-30 20:43:56 +0000,http://www.bizjournals.com/newyork/news/2017/03/30/ackman-to-hedge-fund-clients-deeply-and-profoundly.html?ana=yahoo,Ackman to hedge fund clients: 'Deeply and profoundly sorry' for Valeant
VRX,VRX:US,BBG000DLFM21,Ackman to hedge fund clients: 'Deeply and profoundly sorry' for Valeant,2017-03-30 20:43:56 +0000,http://www.bizjournals.com/newyork/news/2017/03/30/ackman-to-hedge-fund-clients-deeply-and-profoundly.html?ana=yahoo,Ackman to hedge fund clients: 'Deeply and profoundly sorry' for Valeant
VRX,VRX:CT,BBG000DC8S17,Why It’s So Hard for Activist Investors to Find Value,2017-03-30 19:07:26 +0000,http://finance.yahoo.com/video/why-hard-activist-investors-value-190726953.html,Why It’s So Hard for Activist Investors to Find Value
VRX,VRX:US,BBG000DLFM21,Why It’s So Hard for Activist Investors to Find Value,2017-03-30 19:07:26 +0000,http://finance.yahoo.com/video/why-hard-activist-investors-value-190726953.html,Why It’s So Hard for Activist Investors to Find Value
VRX,VRX:CT,BBG000DC8S17,Why Buying Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Nuts,2017-03-30 19:01:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r3Zr1NWh7MM/why-buying-valeant-pharmaceuticals-intl-inc-vrx-stock-isnt-nuts-cm767972,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the stock on the verge of new multi year lows and the headlines looking mostly grim it s tough to get excited about Valeant Pharmaceuticals Intl Inc NYSE VRX here Indeed the biggest and best bullish
VRX,VRX:US,BBG000DLFM21,Why Buying Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Nuts,2017-03-30 19:01:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r3Zr1NWh7MM/why-buying-valeant-pharmaceuticals-intl-inc-vrx-stock-isnt-nuts-cm767972,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the stock on the verge of new multi year lows and the headlines looking mostly grim it s tough to get excited about Valeant Pharmaceuticals Intl Inc NYSE VRX here Indeed the biggest and best bullish
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Apologizes for Valeant Investment Error,2017-03-30 19:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MyubDFEWLeU/bill-ackman-apologizes-for-valeant-investment-error-cm767915,In a letter addressed to shareholders Bill Ackman chairman of Perishing Square Holdings Ltd stated that investing in Valeant Pharmaceuticals VRX was a big mistake on his part The chairman stated that firm s stake in Valeant was the primary driver of negative performance in 2016 The firm
VRX,VRX:US,BBG000DLFM21,Bill Ackman Apologizes for Valeant Investment Error,2017-03-30 19:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MyubDFEWLeU/bill-ackman-apologizes-for-valeant-investment-error-cm767915,In a letter addressed to shareholders Bill Ackman chairman of Perishing Square Holdings Ltd stated that investing in Valeant Pharmaceuticals VRX was a big mistake on his part The chairman stated that firm s stake in Valeant was the primary driver of negative performance in 2016 The firm
VRX,VRX:US,BBG000DLFM21,Ackman Reflects on His Valeant Investment,2017-03-30 18:47:00 +0000,https://www.thestreet.com/slideshow/14066228/1/ackman-reflects-on-his-valeant-investment.html?puc=yahoo&cm_ven=YAHOO,Ackman Reflects on His Valeant Investment
VRX,VRX:CT,BBG000DC8S17,Ackman Reflects on His Valeant Investment,2017-03-30 18:47:00 +0000,https://www.thestreet.com/slideshow/14066228/1/ackman-reflects-on-his-valeant-investment.html?puc=yahoo&cm_ven=YAHOO,Ackman Reflects on His Valeant Investment
VRX,VRX:CT,BBG000DC8S17,"Next Stop for Amazon.com, Inc. (AMZN) Stock: $1,000 or $850?",2017-03-30 18:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sLDBKxJZaKQ/next-stop-for-amazoncom-inc-amzn-stock-1000-or-850-cm767933,InvestorPlace Stock Market News Stock Advice amp Trading Tips It took more than two months but Amazon com Inc NASDAQ AMZN finally had a breakout moment yesterday Amazon jumped 2 on the day but it was less about the size of the move and more
VRX,VRX:US,BBG000DLFM21,"Next Stop for Amazon.com, Inc. (AMZN) Stock: $1,000 or $850?",2017-03-30 18:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sLDBKxJZaKQ/next-stop-for-amazoncom-inc-amzn-stock-1000-or-850-cm767933,InvestorPlace Stock Market News Stock Advice amp Trading Tips It took more than two months but Amazon com Inc NASDAQ AMZN finally had a breakout moment yesterday Amazon jumped 2 on the day but it was less about the size of the move and more
VRX,VRX:US,BBG000DLFM21,"Bill Ackman Releases Annual Letter, Apologizes for Losing All That Money",2017-03-30 17:45:05 +0000,http://finance.yahoo.com/news/bill-ackman-gives-annual-letter-174505204.html,"Bill Ackman Releases Annual Letter, Apologizes for Losing All That Money"
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman Releases Annual Letter, Apologizes for Losing All That Money",2017-03-30 17:45:05 +0000,http://finance.yahoo.com/news/bill-ackman-gives-annual-letter-174505204.html,"Bill Ackman Releases Annual Letter, Apologizes for Losing All That Money"
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Thursday: Apple Inc. (AAPL), ConocoPhillips (COP) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-03-30 17:02:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qIXFgqfH85I/3-stocks-to-watch-on-thursday-apple-inc-aapl-conocophillips-cop-and-valeant-pharmaceuticals-intl-inc-vrx-cm767897,InvestorPlace Stock Market News Stock Advice amp Trading Tips Window dressing Hardly The last few days of the quarter continue to see mixed trading which included a middling Wednesday despite a big 2 4 bump in crude oil The S amp P 500 Index 160 improved by 0 1
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Thursday: Apple Inc. (AAPL), ConocoPhillips (COP) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-03-30 17:02:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qIXFgqfH85I/3-stocks-to-watch-on-thursday-apple-inc-aapl-conocophillips-cop-and-valeant-pharmaceuticals-intl-inc-vrx-cm767897,InvestorPlace Stock Market News Stock Advice amp Trading Tips Window dressing Hardly The last few days of the quarter continue to see mixed trading which included a middling Wednesday despite a big 2 4 bump in crude oil The S amp P 500 Index 160 improved by 0 1
VRX,VRX:CT,BBG000DC8S17,"Embrace Facebook Inc (FB) Stock, Just Don’t Chase It!",2017-03-30 17:02:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2uA-ObID5Ws/embrace-facebook-inc-fb-stock-just-dont-chase-it-cm767896,InvestorPlace Stock Market News Stock Advice amp Trading Tips Some of the largest technology and tech related stocks are set to close out the first quarter of 2017 with significant gains Take 160 Facebook Inc NASDAQ FB which as of Wednesday s close
VRX,VRX:US,BBG000DLFM21,"Embrace Facebook Inc (FB) Stock, Just Don’t Chase It!",2017-03-30 17:02:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2uA-ObID5Ws/embrace-facebook-inc-fb-stock-just-dont-chase-it-cm767896,InvestorPlace Stock Market News Stock Advice amp Trading Tips Some of the largest technology and tech related stocks are set to close out the first quarter of 2017 with significant gains Take 160 Facebook Inc NASDAQ FB which as of Wednesday s close
VRX,VRX:CT,BBG000DC8S17,"Advanced Micro Devices, Inc. (AMD) Stock Will Hit New Highs in Weeks",2017-03-30 17:02:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RPfTdIH1Zjg/advanced-micro-devices-inc-amd-stock-will-hit-new-highs-in-weeks-cm767894,InvestorPlace Stock Market News Stock Advice amp Trading Tips I ve been keeping a close eye on Advanced Micro Devices Inc 160 NASDAQ AMD over the last couple of months and that has a lot to do with one of my primary strategies Source AMD Those of you who have
VRX,VRX:US,BBG000DLFM21,"Advanced Micro Devices, Inc. (AMD) Stock Will Hit New Highs in Weeks",2017-03-30 17:02:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RPfTdIH1Zjg/advanced-micro-devices-inc-amd-stock-will-hit-new-highs-in-weeks-cm767894,InvestorPlace Stock Market News Stock Advice amp Trading Tips I ve been keeping a close eye on Advanced Micro Devices Inc 160 NASDAQ AMD over the last couple of months and that has a lot to do with one of my primary strategies Source AMD Those of you who have
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Apologizes for Valeant Investment Error,2017-03-30 16:35:04 +0000,http://finance.yahoo.com/news/bill-ackman-apologizes-valeant-investment-163504740.html,Bill Ackman Apologizes for Valeant Investment Error
VRX,VRX:US,BBG000DLFM21,Bill Ackman Apologizes for Valeant Investment Error,2017-03-30 16:35:04 +0000,http://finance.yahoo.com/news/bill-ackman-apologizes-valeant-investment-163504740.html,Bill Ackman Apologizes for Valeant Investment Error
VRX,VRX:US,BBG000DLFM21,What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?,2017-03-30 15:04:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q5Du2KghoBM/what-makes-valeant-pharmaceuticals-vrx-a-strong-sell-cm767681,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:CT,BBG000DC8S17,What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?,2017-03-30 15:04:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q5Du2KghoBM/what-makes-valeant-pharmaceuticals-vrx-a-strong-sell-cm767681,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:CT,BBG000DC8S17,The Ultimate Kick in the Pants: Valeant's Former CEO Is Suing the Company,2017-03-30 15:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f4DNFNqbKZs/the-ultimate-kick-in-the-pants-valeants-former-ceo-is-suing-the-company-cm767710,Never say never when it comes to Valeant Pharmaceuticals NYSE VRX because things can always get worse 160 According to news reports the embattled drug developer is now being sued by its former chief executive officer J Michael Pearson The suit alleges that Pearson was due
VRX,VRX:US,BBG000DLFM21,The Ultimate Kick in the Pants: Valeant's Former CEO Is Suing the Company,2017-03-30 15:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f4DNFNqbKZs/the-ultimate-kick-in-the-pants-valeants-former-ceo-is-suing-the-company-cm767710,Never say never when it comes to Valeant Pharmaceuticals NYSE VRX because things can always get worse 160 According to news reports the embattled drug developer is now being sued by its former chief executive officer J Michael Pearson The suit alleges that Pearson was due
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc -- Moody's raises Valeant's SGL to SGL-2; affirms existing ratings; negative outlook",2017-03-30 14:48:09 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_364402&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170330_PR_364402,"Valeant Pharmaceuticals International, Inc -- Moody's raises Valeant's SGL to SGL-2; affirms existing ratings; negative outlook"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc -- Moody's raises Valeant's SGL to SGL-2; affirms existing ratings; negative outlook",2017-03-30 14:48:09 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_364402&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170330_PR_364402,"Valeant Pharmaceuticals International, Inc -- Moody's raises Valeant's SGL to SGL-2; affirms existing ratings; negative outlook"
VRX,VRX:US,BBG000DLFM21,"Pershing Square's Bill Ackman is Really, Really, Really Sorry",2017-03-30 14:13:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/30/pershing-squares-bill-ackman-is-really-really-really-sorry/?mod=yahoobarrons&ru=yahoo,"Pershing Square's Bill Ackman is Really, Really, Really Sorry"
VRX,VRX:CT,BBG000DC8S17,"Pershing Square's Bill Ackman is Really, Really, Really Sorry",2017-03-30 14:13:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/30/pershing-squares-bill-ackman-is-really-really-really-sorry/?mod=yahoobarrons&ru=yahoo,"Pershing Square's Bill Ackman is Really, Really, Really Sorry"
VRX,VRX:US,BBG000DLFM21,Ackman Says He's Sorry For Valeant Investment,2017-03-30 13:58:00 +0000,https://www.thestreet.com/story/14065814/1/ackman-says-he-s-sorry-for-valeant-investment.html?puc=yahoo&cm_ven=YAHOO,Ackman Says He's Sorry For Valeant Investment
VRX,VRX:CT,BBG000DC8S17,Ackman Says He's Sorry For Valeant Investment,2017-03-30 13:58:00 +0000,https://www.thestreet.com/story/14065814/1/ackman-says-he-s-sorry-for-valeant-investment.html?puc=yahoo&cm_ven=YAHOO,Ackman Says He's Sorry For Valeant Investment
VRX,VRX:CT,BBG000DC8S17,The Ultimate Kick in the Pants: Valeant's Former CEO Is Suing the Company,2017-03-30 13:09:00 +0000,https://www.fool.com/investing/2017/03/30/the-ultimate-kick-in-the-pants-valeants-former-ceo.aspx,The Ultimate Kick in the Pants: Valeant's Former CEO Is Suing the Company
VRX,VRX:US,BBG000DLFM21,The Ultimate Kick in the Pants: Valeant's Former CEO Is Suing the Company,2017-03-30 13:09:00 +0000,https://www.fool.com/investing/2017/03/30/the-ultimate-kick-in-the-pants-valeants-former-ceo.aspx,The Ultimate Kick in the Pants: Valeant's Former CEO Is Suing the Company
VRX,VRX:CT,BBG000DC8S17,Bill Ackman To Investors: 'Deeply And Profoundly' Sorry For The Valeant Fiasco,2017-03-30 12:55:21 +0000,http://finance.yahoo.com/news/bill-ackman-investors-deeply-profoundly-125521882.html,Bill Ackman To Investors: 'Deeply And Profoundly' Sorry For The Valeant Fiasco
VRX,VRX:US,BBG000DLFM21,Bill Ackman To Investors: 'Deeply And Profoundly' Sorry For The Valeant Fiasco,2017-03-30 12:55:21 +0000,http://finance.yahoo.com/news/bill-ackman-investors-deeply-profoundly-125521882.html,Bill Ackman To Investors: 'Deeply And Profoundly' Sorry For The Valeant Fiasco
VRX,VRX:US,BBG000DLFM21,What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?,2017-03-30 12:51:12 +0000,http://finance.yahoo.com/news/makes-valeant-pharmaceuticals-vrx-strong-125112298.html,What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?
VRX,VRX:CT,BBG000DC8S17,What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?,2017-03-30 12:51:12 +0000,http://finance.yahoo.com/news/makes-valeant-pharmaceuticals-vrx-strong-125112298.html,What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb ULTRA® for Astigmatism Contact Lenses Introduced,2017-03-30 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-ultra-astigmatism-contact-113000738.html,[CNW Group] - Bausch + Lomb ULTRA® for Astigmatism Contact Lenses Introduced
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb ULTRA® for Astigmatism Contact Lenses Introduced,2017-03-30 11:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-ultra-astigmatism-contact-113000738.html,[CNW Group] - Bausch + Lomb ULTRA® for Astigmatism Contact Lenses Introduced
VRX,VRX:CT,BBG000DC8S17,Bill Ackman apologizes for $4 billion Valeant mistake (finally),2017-03-30 11:27:37 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0732EF64-1533-11E7-BCC7-456FC1EDA05D&siteid=yhoof2,Bill Ackman apologizes for $4 billion Valeant mistake (finally)
VRX,VRX:US,BBG000DLFM21,Bill Ackman apologizes for $4 billion Valeant mistake (finally),2017-03-30 11:27:37 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0732EF64-1533-11E7-BCC7-456FC1EDA05D&siteid=yhoof2,Bill Ackman apologizes for $4 billion Valeant mistake (finally)
VRX,VRX:CT,BBG000DC8S17,5 Things You Must Know Before the Market Opens Thursday,2017-03-30 11:09:00 +0000,https://www.thestreet.com/story/14063630/1/5-things-you-must-know-before-the-market-opens-thursday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Thursday
VRX,VRX:US,BBG000DLFM21,5 Things You Must Know Before the Market Opens Thursday,2017-03-30 11:09:00 +0000,https://www.thestreet.com/story/14063630/1/5-things-you-must-know-before-the-market-opens-thursday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Thursday
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling On Energy Weakness - Canadian Commentary,2017-03-30 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/00yKouf_a6A/canadian-stocks-are-falling-on-energy-weakness--canadian-commentary-20170330-00854,Canadian Stocks Are Falling On Energy Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling On Energy Weakness - Canadian Commentary,2017-03-30 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/00yKouf_a6A/canadian-stocks-are-falling-on-energy-weakness--canadian-commentary-20170330-00854,Canadian Stocks Are Falling On Energy Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Apologizes For Valeant: 'Huge Mistake',2017-03-30 10:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wp0S9VMMMdE/bill-ackman-apologizes-for-valeant-huge-mistake-20170330-00813,Bill Ackman Apologizes For Valeant: 'Huge Mistake'
VRX,VRX:US,BBG000DLFM21,Bill Ackman Apologizes For Valeant: 'Huge Mistake',2017-03-30 10:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wp0S9VMMMdE/bill-ackman-apologizes-for-valeant-huge-mistake-20170330-00813,Bill Ackman Apologizes For Valeant: 'Huge Mistake'
VRX,VRX:CT,BBG000DC8S17,Valeant Investment Was a 'Huge Mistake',2017-03-29 23:32:00 +0000,http://www.investopedia.com/news/valeant-investment-was-huge-mistake-vrx/?partner=YahooSA,Valeant Investment Was a 'Huge Mistake'
VRX,VRX:US,BBG000DLFM21,Valeant Investment Was a 'Huge Mistake',2017-03-29 23:32:00 +0000,http://www.investopedia.com/news/valeant-investment-was-huge-mistake-vrx/?partner=YahooSA,Valeant Investment Was a 'Huge Mistake'
VRX,VRX:CT,BBG000DC8S17,"Ackman apologizes for Valeant losses, calls bet a mistake",2017-03-29 22:27:28 +0000,http://finance.yahoo.com/news/ackman-apologizes-valeant-losses-calls-222728803.html,"Ackman apologizes for Valeant losses, calls bet a mistake"
VRX,VRX:US,BBG000DLFM21,"Ackman apologizes for Valeant losses, calls bet a mistake",2017-03-29 22:27:28 +0000,http://finance.yahoo.com/news/ackman-apologizes-valeant-losses-calls-222728803.html,"Ackman apologizes for Valeant losses, calls bet a mistake"
VRX,VRX:US,BBG000DLFM21,Ackman Is 'Profoundly' Sorry for $4 Billion Valeant 'Mistake',2017-03-29 20:16:20 +0000,http://finance.yahoo.com/news/ackman-profoundly-sorry-4-billion-201620127.html,Ackman Is 'Profoundly' Sorry for $4 Billion Valeant 'Mistake'
VRX,VRX:CT,BBG000DC8S17,Ackman Is 'Profoundly' Sorry for $4 Billion Valeant 'Mistake',2017-03-29 20:16:20 +0000,http://finance.yahoo.com/news/ackman-profoundly-sorry-4-billion-201620127.html,Ackman Is 'Profoundly' Sorry for $4 Billion Valeant 'Mistake'
VRX,VRX:US,BBG000DLFM21,Here's the Bill Ackman apology Wall Street's been waiting for,2017-03-29 19:47:18 +0000,http://finance.yahoo.com/news/heres-bill-ackman-apology-wall-194718706.html,Here's the Bill Ackman apology Wall Street's been waiting for
VRX,VRX:CT,BBG000DC8S17,Here's the Bill Ackman apology Wall Street's been waiting for,2017-03-29 19:47:18 +0000,http://finance.yahoo.com/news/heres-bill-ackman-apology-wall-194718706.html,Here's the Bill Ackman apology Wall Street's been waiting for
VRX,VRX:CT,BBG000DC8S17,Roundtable: 1 Stock I Won’t Touch With a 10-Foot Pole,2017-03-29 18:01:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yY-E1u2YH7c/roundtable-1-stock-i-wont-touch-with-a-10-foot-pole-cm767415,Valeant Pharmaceuticals NYSE VRX Twitter NYSE TWTR and BofI Holding NASDAQ BOFI each have unique challenges that make three of our Motley Fool contributors think it s best to sit on the sidelines right now Read on to learn what obstacles these companies
VRX,VRX:US,BBG000DLFM21,Roundtable: 1 Stock I Won’t Touch With a 10-Foot Pole,2017-03-29 18:01:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yY-E1u2YH7c/roundtable-1-stock-i-wont-touch-with-a-10-foot-pole-cm767415,Valeant Pharmaceuticals NYSE VRX Twitter NYSE TWTR and BofI Holding NASDAQ BOFI each have unique challenges that make three of our Motley Fool contributors think it s best to sit on the sidelines right now Read on to learn what obstacles these companies
VRX,VRX:CT,BBG000DC8S17,Valeant's Banks Extend a Lifeline,2017-03-29 16:58:00 +0000,https://www.thestreet.com/story/14064431/1/valeant-extends-the-date-of-credit-commitment.html?puc=yahoo&cm_ven=YAHOO,Valeant's Banks Extend a Lifeline
VRX,VRX:US,BBG000DLFM21,Valeant's Banks Extend a Lifeline,2017-03-29 16:58:00 +0000,https://www.thestreet.com/story/14064431/1/valeant-extends-the-date-of-credit-commitment.html?puc=yahoo&cm_ven=YAHOO,Valeant's Banks Extend a Lifeline
VRX,VRX:CT,BBG000DC8S17,3 Stocks We Won't Touch With a 10-Foot Pole,2017-03-29 16:00:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VbGYZAUxwCc/3-stocks-we-wont-touch-with-a-10-foot-pole-cm767215,Valeant Pharmaceuticals NYSE VRX Twitter NYSE TWTR and BofI Holding NASDAQ BOFI each have unique challenges that make three of our Motley Fool contributors think it s best to sit on the sidelines right now Read on to learn what obstacles these companies
VRX,VRX:US,BBG000DLFM21,3 Stocks We Won't Touch With a 10-Foot Pole,2017-03-29 16:00:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VbGYZAUxwCc/3-stocks-we-wont-touch-with-a-10-foot-pole-cm767215,Valeant Pharmaceuticals NYSE VRX Twitter NYSE TWTR and BofI Holding NASDAQ BOFI each have unique challenges that make three of our Motley Fool contributors think it s best to sit on the sidelines right now Read on to learn what obstacles these companies
VRX,VRX:CT,BBG000DC8S17,Shares of Valeant Rise as 2018 Debt Maturities Extended,2017-03-29 15:46:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/29/shares-of-valeant-rise-as-2018-debt-maturities-extended/?mod=yahoobarrons&ru=yahoo,Shares of Valeant Rise as 2018 Debt Maturities Extended
VRX,VRX:US,BBG000DLFM21,Shares of Valeant Rise as 2018 Debt Maturities Extended,2017-03-29 15:46:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/29/shares-of-valeant-rise-as-2018-debt-maturities-extended/?mod=yahoobarrons&ru=yahoo,Shares of Valeant Rise as 2018 Debt Maturities Extended
VRX,VRX:CT,BBG000DC8S17,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-03-29 15:04:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fYF1fdWO7uA/are-options-traders-betting-on-a-big-move-in-valeant-pharmaceuticals-vrx-stock-cm767172,Investors in shares of Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the Put which expires on Mar 31 2017 for the 12 50 strike price had some of the highest implied volatility of all
VRX,VRX:US,BBG000DLFM21,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-03-29 15:04:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fYF1fdWO7uA/are-options-traders-betting-on-a-big-move-in-valeant-pharmaceuticals-vrx-stock-cm767172,Investors in shares of Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the Put which expires on Mar 31 2017 for the 12 50 strike price had some of the highest implied volatility of all
VRX,VRX:US,BBG000DLFM21,Roundtable: 1 Stock I Won’t Touch With a 10-Foot Pole,2017-03-29 14:40:00 +0000,https://www.fool.com/investing/2017/03/29/roundtable-1-stock-i-wont-touch-with-a-10-foot-pol.aspx,Roundtable: 1 Stock I Won’t Touch With a 10-Foot Pole
VRX,VRX:CT,BBG000DC8S17,Roundtable: 1 Stock I Won’t Touch With a 10-Foot Pole,2017-03-29 14:40:00 +0000,https://www.fool.com/investing/2017/03/29/roundtable-1-stock-i-wont-touch-with-a-10-foot-pol.aspx,Roundtable: 1 Stock I Won’t Touch With a 10-Foot Pole
VRX,VRX:US,BBG000DLFM21,3 Stocks We Won't Touch With a 10-Foot Pole,2017-03-29 14:40:00 +0000,https://www.fool.com/investing/2017/03/29/3-stocks-we-wont-touch-with-a-10-foot-pole.aspx,3 Stocks We Won't Touch With a 10-Foot Pole
VRX,VRX:CT,BBG000DC8S17,3 Stocks We Won't Touch With a 10-Foot Pole,2017-03-29 14:40:00 +0000,https://www.fool.com/investing/2017/03/29/3-stocks-we-wont-touch-with-a-10-foot-pole.aspx,3 Stocks We Won't Touch With a 10-Foot Pole
VRX,VRX:CT,BBG000DC8S17,10:19 am Valeant Pharma showing strong lift off the opening to bring last week's high of 11.14 in play...,2017-03-29 14:19:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#vrx,10:19 am Valeant Pharma showing strong lift off the opening to bring last week's high of 11.14 in play...
VRX,VRX:US,BBG000DLFM21,10:19 am Valeant Pharma showing strong lift off the opening to bring last week's high of 11.14 in play...,2017-03-29 14:19:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#vrx,10:19 am Valeant Pharma showing strong lift off the opening to bring last week's high of 11.14 in play...
VRX,VRX:CT,BBG000DC8S17,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-03-29 12:43:12 +0000,http://finance.yahoo.com/news/options-traders-betting-big-move-124312992.html,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?
VRX,VRX:US,BBG000DLFM21,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?,2017-03-29 12:43:12 +0000,http://finance.yahoo.com/news/options-traders-betting-big-move-124312992.html,Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Crude Inventory Data - Canadian Commentary,2017-03-29 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DPACcSasKQM/canadian-stocks-are-climbing-on-crude-inventory-data--canadian-commentary-20170329-00806,Canadian Stocks Are Climbing On Crude Inventory Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Crude Inventory Data - Canadian Commentary,2017-03-29 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DPACcSasKQM/canadian-stocks-are-climbing-on-crude-inventory-data--canadian-commentary-20170329-00806,Canadian Stocks Are Climbing On Crude Inventory Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Behind the Bill Ackman Controversies,2017-03-28 21:54:47 +0000,http://finance.yahoo.com/news/behind-bill-ackman-controversies-215447708.html,Behind the Bill Ackman Controversies
VRX,VRX:CT,BBG000DC8S17,Behind the Bill Ackman Controversies,2017-03-28 21:54:47 +0000,http://finance.yahoo.com/news/behind-bill-ackman-controversies-215447708.html,Behind the Bill Ackman Controversies
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial",2017-03-28 21:30:45 +0000,http://biz.yahoo.com/e/170328/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial"
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial",2017-03-28 21:30:45 +0000,http://biz.yahoo.com/e/170328/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock May Be Healthy for Long-Term Investors,2017-03-28 18:58:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JM-pbo1x6ao/valeant-pharmaceuticals-intl-inc-vrx-stock-may-be-healthy-for-long-term-investors-cm766847,InvestorPlace Stock Market News Stock Advice amp Trading Tips Since reporting quarterly earnings that showed significant deterioration in sales for its Salix and Bausch amp Lomb unit Valeant Pharmaceuticals Intl Inc NYSE VRX is still a compelling turnaround story The
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock May Be Healthy for Long-Term Investors,2017-03-28 18:58:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JM-pbo1x6ao/valeant-pharmaceuticals-intl-inc-vrx-stock-may-be-healthy-for-long-term-investors-cm766847,InvestorPlace Stock Market News Stock Advice amp Trading Tips Since reporting quarterly earnings that showed significant deterioration in sales for its Salix and Bausch amp Lomb unit Valeant Pharmaceuticals Intl Inc NYSE VRX is still a compelling turnaround story The
VRX,VRX:US,BBG000DLFM21,"Orexigen Inks Commercialization Deal for Contrave, Stock Up",2017-03-28 17:00:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mMQnBEFOczI/orexigen-inks-commercialization-deal-for-contrave-stock-up-cm766710,Orexigen Therapeutics Inc s OREX shares gained 3 8 on Mar 27 2017 after the company announced that it has entered into a commercialization and distributorship agreement with Italian pharmaceutical company Bruno Farmaceutici for its obesity drug Contrave EU trade name Mysimba
VRX,VRX:CT,BBG000DC8S17,"Orexigen Inks Commercialization Deal for Contrave, Stock Up",2017-03-28 17:00:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mMQnBEFOczI/orexigen-inks-commercialization-deal-for-contrave-stock-up-cm766710,Orexigen Therapeutics Inc s OREX shares gained 3 8 on Mar 27 2017 after the company announced that it has entered into a commercialization and distributorship agreement with Italian pharmaceutical company Bruno Farmaceutici for its obesity drug Contrave EU trade name Mysimba
VRX,VRX:CT,BBG000DC8S17,"Orexigen Inks Commercialization Deal for Contrave, Stock Up",2017-03-28 15:07:03 +0000,http://finance.yahoo.com/news/orexigen-inks-commercialization-deal-contrave-150703341.html,"Orexigen Inks Commercialization Deal for Contrave, Stock Up"
VRX,VRX:US,BBG000DLFM21,"Orexigen Inks Commercialization Deal for Contrave, Stock Up",2017-03-28 15:07:03 +0000,http://finance.yahoo.com/news/orexigen-inks-commercialization-deal-contrave-150703341.html,"Orexigen Inks Commercialization Deal for Contrave, Stock Up"
VRX,VRX:US,BBG000DLFM21,Former Valeant CEO Files Suit Against the Company,2017-03-28 13:12:00 +0000,https://www.thestreet.com/story/14062182/1/former-valeant-ceo-files-suit-against-the-company.html?puc=yahoo&cm_ven=YAHOO,Former Valeant CEO Files Suit Against the Company
VRX,VRX:CT,BBG000DC8S17,Former Valeant CEO Files Suit Against the Company,2017-03-28 13:12:00 +0000,https://www.thestreet.com/story/14062182/1/former-valeant-ceo-files-suit-against-the-company.html?puc=yahoo&cm_ven=YAHOO,Former Valeant CEO Files Suit Against the Company
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Crude Prices Recover - Canadian Commentary,2017-03-28 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ANKJN7bISpM/canadian-stocks-are-rising-as-crude-prices-recover--canadian-commentary-20170328-00887,Canadian Stocks Are Rising As Crude Prices Recover - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Crude Prices Recover - Canadian Commentary,2017-03-28 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ANKJN7bISpM/canadian-stocks-are-rising-as-crude-prices-recover--canadian-commentary-20170328-00887,Canadian Stocks Are Rising As Crude Prices Recover - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Showing Some Resilience -- Canadian Commentary,2017-03-28 08:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uqXbhgb1yNA/canadian-stocks-showing-some-resilience--canadian-commentary-20170328-00486,Canadian Stocks Showing Some Resilience -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Showing Some Resilience -- Canadian Commentary,2017-03-28 08:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uqXbhgb1yNA/canadian-stocks-showing-some-resilience--canadian-commentary-20170328-00486,Canadian Stocks Showing Some Resilience -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Ex-CEO Pearson Sues Drugmaker Over Withheld Shares,2017-03-28 00:52:03 +0000,https://www.bloomberg.com/news/articles/2017-03-28/valeant-ex-ceo-pearson-sues-drugmaker-over-withheld-shares?cmpid=yhoo.headline,Valeant Ex-CEO Pearson Sues Drugmaker Over Withheld Shares
VRX,VRX:US,BBG000DLFM21,Valeant Ex-CEO Pearson Sues Drugmaker Over Withheld Shares,2017-03-28 00:52:03 +0000,https://www.bloomberg.com/news/articles/2017-03-28/valeant-ex-ceo-pearson-sues-drugmaker-over-withheld-shares?cmpid=yhoo.headline,Valeant Ex-CEO Pearson Sues Drugmaker Over Withheld Shares
VRX,VRX:CT,BBG000DC8S17,"Latticework of Mental Models: Better Decisions, Better Investors",2017-03-27 22:58:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hHRpv4AM37E/latticework-of-mental-models-better-decisions-better-investors-cm766253,How do we become better investors Better decision makers Having a latticework of mental models to hang our thoughts and choices on is a great start Creating these models is how we learn to become better decision makers Before creating our latticework of mental models we need to create
VRX,VRX:US,BBG000DLFM21,"Latticework of Mental Models: Better Decisions, Better Investors",2017-03-27 22:58:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hHRpv4AM37E/latticework-of-mental-models-better-decisions-better-investors-cm766253,How do we become better investors Better decision makers Having a latticework of mental models to hang our thoughts and choices on is a great start Creating these models is how we learn to become better decision makers Before creating our latticework of mental models we need to create
VRX,VRX:US,BBG000DLFM21,Valeant Ex-CEO Pearson Sues Company Over Unpaid Stock Award,2017-03-27 22:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w1JuR7NPN08/valeant-exceo-pearson-sues-company-over-unpaid-stock-award-20170327-01317,Valeant Ex-CEO Pearson Sues Company Over Unpaid Stock Award
VRX,VRX:CT,BBG000DC8S17,Valeant Ex-CEO Pearson Sues Company Over Unpaid Stock Award,2017-03-27 22:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w1JuR7NPN08/valeant-exceo-pearson-sues-company-over-unpaid-stock-award-20170327-01317,Valeant Ex-CEO Pearson Sues Company Over Unpaid Stock Award
VRX,VRX:US,BBG000DLFM21,Former Valeant CEO sues company over unmade compensation -WSJ,2017-03-27 22:42:19 +0000,http://finance.yahoo.com/news/former-valeant-ceo-sues-company-224219180.html,"[Reuters] - Former Valeant Pharmaceuticals International Inc Chief Executive Michael Pearson has filed a lawsuit against the Canadian drugmaker, alleging it refused to pay him more than 3 million shares he is owed, the Wall Street Journal reported on Monday. Based on Valeant's stock price of $10.81 at the close of trading Monday on the NYSE, the shares have a market value of about $32.43 million. Pearson filed the suit on Monday in the U.S. District Court of New Jersey, saying Valeant breached his contract by not paying him 580,676 shares and 2.5 million performance shares due in November under the terms of his separation agreement, the Journal reported."
VRX,VRX:CT,BBG000DC8S17,Former Valeant CEO sues company over unmade compensation -WSJ,2017-03-27 22:42:19 +0000,http://finance.yahoo.com/news/former-valeant-ceo-sues-company-224219180.html,"[Reuters] - Former Valeant Pharmaceuticals International Inc Chief Executive Michael Pearson has filed a lawsuit against the Canadian drugmaker, alleging it refused to pay him more than 3 million shares he is owed, the Wall Street Journal reported on Monday. Based on Valeant's stock price of $10.81 at the close of trading Monday on the NYSE, the shares have a market value of about $32.43 million. Pearson filed the suit on Monday in the U.S. District Court of New Jersey, saying Valeant breached his contract by not paying him 580,676 shares and 2.5 million performance shares due in November under the terms of his separation agreement, the Journal reported."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Former CEO Sues Company Over Unmade Payments,2017-03-27 22:02:59 +0000,https://www.wsj.com/articles/valeant-ex-ceo-michael-pearson-sues-company-over-unmade-payments-1490651632?mod=yahoo_hs,[$$] Valeant Former CEO Sues Company Over Unmade Payments
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Former CEO Sues Company Over Unmade Payments,2017-03-27 22:02:59 +0000,https://www.wsj.com/articles/valeant-ex-ceo-michael-pearson-sues-company-over-unmade-payments-1490651632?mod=yahoo_hs,[$$] Valeant Former CEO Sues Company Over Unmade Payments
VRX,VRX:CT,BBG000DC8S17,TransDigm: The End is Nigh?,2017-03-27 16:43:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/27/transdigm-the-end-is-nigh/?mod=yahoobarrons&ru=yahoo,TransDigm: The End is Nigh?
VRX,VRX:US,BBG000DLFM21,TransDigm: The End is Nigh?,2017-03-27 16:43:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/27/transdigm-the-end-is-nigh/?mod=yahoobarrons&ru=yahoo,TransDigm: The End is Nigh?
VRX,VRX:CT,BBG000DC8S17,Drug Manufacturers Continue to be Plagued by Pricing Concerns: Today's Research Reports on Valeant Pharmaceuticals and Mylan,2017-03-27 13:30:00 +0000,http://finance.yahoo.com/news/drug-manufacturers-continue-plagued-pricing-133000892.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 27, 2017 / Valeant's share price took a 1.01% dip today, to close at $10.75 compared to the previous day's market value of $10.86. Valeant CEO Joseph Papa was paid an ..."
VRX,VRX:US,BBG000DLFM21,Drug Manufacturers Continue to be Plagued by Pricing Concerns: Today's Research Reports on Valeant Pharmaceuticals and Mylan,2017-03-27 13:30:00 +0000,http://finance.yahoo.com/news/drug-manufacturers-continue-plagued-pricing-133000892.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 27, 2017 / Valeant's share price took a 1.01% dip today, to close at $10.75 compared to the previous day's market value of $10.86. Valeant CEO Joseph Papa was paid an ..."
VRX,VRX:US,BBG000DLFM21,Vyzulta May Be a Potent Therapy for Glaucoma in the Future,2017-03-27 11:36:43 +0000,http://marketrealist.com/2017/03/vyzulta-may-prove-potent-therapy-glaucoma-future-years/?utm_source=yahoo&utm_medium=feed,Vyzulta May Be a Potent Therapy for Glaucoma in the Future
VRX,VRX:CT,BBG000DC8S17,Vyzulta May Be a Potent Therapy for Glaucoma in the Future,2017-03-27 11:36:43 +0000,http://marketrealist.com/2017/03/vyzulta-may-prove-potent-therapy-glaucoma-future-years/?utm_source=yahoo&utm_medium=feed,Vyzulta May Be a Potent Therapy for Glaucoma in the Future
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Has Recovered From Early Losses - Canadian Commentary,2017-03-27 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x7Axp8xb5vQ/canadian-stocks-has-recovered-from-early-losses--canadian-commentary-20170327-00812,Canadian Stocks Has Recovered From Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Has Recovered From Early Losses - Canadian Commentary,2017-03-27 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x7Axp8xb5vQ/canadian-stocks-has-recovered-from-early-losses--canadian-commentary-20170327-00812,Canadian Stocks Has Recovered From Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant),2017-03-25 19:58:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qIyCn2dEt6E/can-you-guess-which-drugmaker-has-the-most-debt-hint-its-not-valeant-cm765623,Which drugmaker do you think has the most debt Some might think the correct answer is Valeant Pharmaceuticals NYSE VRX After all the company is shedding assets to try to reduce its massive debt load However Valeant doesn t have the highest debt among pharmaceutical
VRX,VRX:CT,BBG000DC8S17,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant),2017-03-25 19:58:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qIyCn2dEt6E/can-you-guess-which-drugmaker-has-the-most-debt-hint-its-not-valeant-cm765623,Which drugmaker do you think has the most debt Some might think the correct answer is Valeant Pharmaceuticals NYSE VRX After all the company is shedding assets to try to reduce its massive debt load However Valeant doesn t have the highest debt among pharmaceutical
VRX,VRX:CT,BBG000DC8S17,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant),2017-03-25 18:01:00 +0000,https://www.fool.com/investing/2017/03/25/can-you-guess-which-drugmaker-has-the-most-debt-hi.aspx,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant)
VRX,VRX:US,BBG000DLFM21,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant),2017-03-25 18:01:00 +0000,https://www.fool.com/investing/2017/03/25/can-you-guess-which-drugmaker-has-the-most-debt-hi.aspx,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant)
VRX,VRX:CT,BBG000DC8S17,Francis Chou Comments on Valeant,2017-03-25 12:58:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YE3MH8-srI4/francis-chou-comments-on-valeant-cm765573,NYSE VRX Valeant could return to trading at the normal multiples if its debt is significantly reduced and the impact and costs of litigations are determined Valeant could return to trading at the normal multiples if its debt is significantly reduced and the impact and costs
VRX,VRX:US,BBG000DLFM21,Francis Chou Comments on Valeant,2017-03-25 12:58:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YE3MH8-srI4/francis-chou-comments-on-valeant-cm765573,NYSE VRX Valeant could return to trading at the normal multiples if its debt is significantly reduced and the impact and costs of litigations are determined Valeant could return to trading at the normal multiples if its debt is significantly reduced and the impact and costs
VRX,VRX:CT,BBG000DC8S17,Johnson & Johnson's CEO Believes Trump Is Missing the Point on Drug-Price Reform,2017-03-24 22:58:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zIoXSaqeLLY/johnson-johnsons-ceo-believes-trump-is-missing-the-point-on-drug-price-reform-cm765505,Healthcare conglomerate Johnson amp Johnson NYSE JNJ is about as steady as they come for investors Its more than 250 subsidiaries and three primary operating segments consumer health products medical devices and pharmaceuticals each come together to form one perfect
VRX,VRX:US,BBG000DLFM21,Johnson & Johnson's CEO Believes Trump Is Missing the Point on Drug-Price Reform,2017-03-24 22:58:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zIoXSaqeLLY/johnson-johnsons-ceo-believes-trump-is-missing-the-point-on-drug-price-reform-cm765505,Healthcare conglomerate Johnson amp Johnson NYSE JNJ is about as steady as they come for investors Its more than 250 subsidiaries and three primary operating segments consumer health products medical devices and pharmaceuticals each come together to form one perfect
VRX,VRX:CT,BBG000DC8S17,Johnson & Johnson's CEO Believes Trump Is Missing the Point on Drug-Price Reform,2017-03-24 21:45:00 +0000,https://www.fool.com/investing/2017/03/24/johnson-johnsons-ceo-believes-trump-is-missing-the.aspx,Johnson & Johnson's CEO Believes Trump Is Missing the Point on Drug-Price Reform
VRX,VRX:US,BBG000DLFM21,Johnson & Johnson's CEO Believes Trump Is Missing the Point on Drug-Price Reform,2017-03-24 21:45:00 +0000,https://www.fool.com/investing/2017/03/24/johnson-johnsons-ceo-believes-trump-is-missing-the.aspx,Johnson & Johnson's CEO Believes Trump Is Missing the Point on Drug-Price Reform
VRX,VRX:US,BBG000DLFM21,Can Anyone Challenge Allergan In Medical-Aesthetics Market?,2017-03-24 18:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6bTYoH1ZxgA/can-anyone-challenge-allergan-in-medical-aesthetics-market-cm765346,Fat freezing ear pinning breast augmenting Allergan AGN isn t making expansion in the medical aesthetics market easy for rivals like Hologic HOLX Johnson amp Johnson JNJ and Valeant Pharmaceuticals VRX analysts say Since
VRX,VRX:CT,BBG000DC8S17,Can Anyone Challenge Allergan In Medical-Aesthetics Market?,2017-03-24 18:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6bTYoH1ZxgA/can-anyone-challenge-allergan-in-medical-aesthetics-market-cm765346,Fat freezing ear pinning breast augmenting Allergan AGN isn t making expansion in the medical aesthetics market easy for rivals like Hologic HOLX Johnson amp Johnson JNJ and Valeant Pharmaceuticals VRX analysts say Since
VRX,VRX:CT,BBG000DC8S17,Francis Chou Comments on Valeant,2017-03-24 17:52:43 +0000,http://finance.yahoo.com/news/francis-chou-comments-valeant-175243312.html,Francis Chou Comments on Valeant
VRX,VRX:US,BBG000DLFM21,Francis Chou Comments on Valeant,2017-03-24 17:52:43 +0000,http://finance.yahoo.com/news/francis-chou-comments-valeant-175243312.html,Francis Chou Comments on Valeant
VRX,VRX:CT,BBG000DC8S17,Chou Opportunity Fund 4th Quarter Message to Shareholders,2017-03-24 17:48:24 +0000,http://finance.yahoo.com/news/chou-opportunity-fund-4th-quarter-174402188.html,Chou Opportunity Fund 4th Quarter Message to Shareholders
VRX,VRX:US,BBG000DLFM21,Chou Opportunity Fund 4th Quarter Message to Shareholders,2017-03-24 17:48:24 +0000,http://finance.yahoo.com/news/chou-opportunity-fund-4th-quarter-174402188.html,Chou Opportunity Fund 4th Quarter Message to Shareholders
VRX,VRX:CT,BBG000DC8S17,Bausch & Lomb Continues to be Key Growth Driver for Valeant,2017-03-24 14:35:43 +0000,http://marketrealist.com/2017/03/bausch-lomb-segment-continues-key-growth-driver-valeant-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Bausch & Lomb Continues to be Key Growth Driver for Valeant
VRX,VRX:US,BBG000DLFM21,Bausch & Lomb Continues to be Key Growth Driver for Valeant,2017-03-24 14:35:43 +0000,http://marketrealist.com/2017/03/bausch-lomb-segment-continues-key-growth-driver-valeant-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Bausch & Lomb Continues to be Key Growth Driver for Valeant
VRX,VRX:US,BBG000DLFM21,Valeant’s Diversified Products Revenue May Drop in 2017,2017-03-24 13:05:43 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-diversified-products-segment-may-witness-drop-revenues-2017/?utm_source=yahoo&utm_medium=feed,Valeant’s Diversified Products Revenue May Drop in 2017
VRX,VRX:CT,BBG000DC8S17,Valeant’s Diversified Products Revenue May Drop in 2017,2017-03-24 13:05:43 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-diversified-products-segment-may-witness-drop-revenues-2017/?utm_source=yahoo&utm_medium=feed,Valeant’s Diversified Products Revenue May Drop in 2017
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals is Developing its Sales Force,2017-03-24 11:35:43 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-actively-developing-sales-force-2017/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals is Developing its Sales Force
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals is Developing its Sales Force,2017-03-24 11:35:43 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-actively-developing-sales-force-2017/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals is Developing its Sales Force
VRX,VRX:US,BBG000DLFM21,Nike Inc (NKE) Stock Went On Sale — Go Long,2017-03-23 19:02:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qhfJsnTocRI/nike-inc-nke-stock-went-on-sale-go-long-cm764879,InvestorPlace Stock Market News Stock Advice amp Trading Tips I ve always been a believer that earnings events have a binary effect on their underlying equities The reactions are often short term and a complete coin flip Market expectation is what drives the event price not the
VRX,VRX:CT,BBG000DC8S17,Nike Inc (NKE) Stock Went On Sale — Go Long,2017-03-23 19:02:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qhfJsnTocRI/nike-inc-nke-stock-went-on-sale-go-long-cm764879,InvestorPlace Stock Market News Stock Advice amp Trading Tips I ve always been a believer that earnings events have a binary effect on their underlying equities The reactions are often short term and a complete coin flip Market expectation is what drives the event price not the
VRX,VRX:US,BBG000DLFM21,A Safer Way to Play Valeant and Community Health,2017-03-23 18:47:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/23/a-safer-way-to-play-valeant-and-community-health/?mod=yahoobarrons&ru=yahoo,A Safer Way to Play Valeant and Community Health
VRX,VRX:CT,BBG000DC8S17,A Safer Way to Play Valeant and Community Health,2017-03-23 18:47:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/23/a-safer-way-to-play-valeant-and-community-health/?mod=yahoobarrons&ru=yahoo,A Safer Way to Play Valeant and Community Health
VRX,VRX:CT,BBG000DC8S17,The 'Dogs' of Wall Street: Here's a Look at Some of the Worst Performing Stocks of the Year,2017-03-23 16:35:00 +0000,https://www.thestreet.com/slideshow/14055594/1/the-dogs-of-wall-street-here-s-a-look-at-some-of-the-worst-performing-stocks-of-the-year.html?puc=yahoo&cm_ven=YAHOO,The 'Dogs' of Wall Street: Here's a Look at Some of the Worst Performing Stocks of the Year
VRX,VRX:US,BBG000DLFM21,The 'Dogs' of Wall Street: Here's a Look at Some of the Worst Performing Stocks of the Year,2017-03-23 16:35:00 +0000,https://www.thestreet.com/slideshow/14055594/1/the-dogs-of-wall-street-here-s-a-look-at-some-of-the-worst-performing-stocks-of-the-year.html?puc=yahoo&cm_ven=YAHOO,The 'Dogs' of Wall Street: Here's a Look at Some of the Worst Performing Stocks of the Year
VRX,VRX:US,BBG000DLFM21,'Female Viagra' founder: GOP health bill would hurt the 'sexual revolution',2017-03-23 15:05:28 +0000,http://finance.yahoo.com/news/female-viagra-founder-gop-health-bill-would-hurt-the-sexual-revolution-150528779.html,'Female Viagra' founder: GOP health bill would hurt the 'sexual revolution'
VRX,VRX:CT,BBG000DC8S17,'Female Viagra' founder: GOP health bill would hurt the 'sexual revolution',2017-03-23 15:05:28 +0000,http://finance.yahoo.com/news/female-viagra-founder-gop-health-bill-would-hurt-the-sexual-revolution-150528779.html,'Female Viagra' founder: GOP health bill would hurt the 'sexual revolution'
VRX,VRX:US,BBG000DLFM21,"Valeant CEO Compensation Revealed, Shares Climb",2017-03-23 14:49:00 +0000,https://www.thestreet.com/story/14057108/1/valeant-ceo-compensation-revealed-shares-climb.html?puc=yahoo&cm_ven=YAHOO,"Valeant CEO Compensation Revealed, Shares Climb"
VRX,VRX:CT,BBG000DC8S17,"Valeant CEO Compensation Revealed, Shares Climb",2017-03-23 14:49:00 +0000,https://www.thestreet.com/story/14057108/1/valeant-ceo-compensation-revealed-shares-climb.html?puc=yahoo&cm_ven=YAHOO,"Valeant CEO Compensation Revealed, Shares Climb"
VRX,VRX:US,BBG000DLFM21,Siliq May be a Strong Growth Driver for Valeant in 2017,2017-03-23 14:35:48 +0000,http://marketrealist.com/2017/03/siliq-may-prove-strong-growth-driver-valeant-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Siliq May be a Strong Growth Driver for Valeant in 2017
VRX,VRX:CT,BBG000DC8S17,Siliq May be a Strong Growth Driver for Valeant in 2017,2017-03-23 14:35:48 +0000,http://marketrealist.com/2017/03/siliq-may-prove-strong-growth-driver-valeant-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Siliq May be a Strong Growth Driver for Valeant in 2017
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Is Back at the Sohn Investment Conference This Year,2017-03-23 14:26:41 +0000,http://blogs.wsj.com/moneybeat/2017/03/23/bill-ackman-is-back-at-the-sohn-investment-conference-this-year/?mod=yahoo_hs,Bill Ackman Is Back at the Sohn Investment Conference This Year
VRX,VRX:US,BBG000DLFM21,Bill Ackman Is Back at the Sohn Investment Conference This Year,2017-03-23 14:26:41 +0000,http://blogs.wsj.com/moneybeat/2017/03/23/bill-ackman-is-back-at-the-sohn-investment-conference-this-year/?mod=yahoo_hs,Bill Ackman Is Back at the Sohn Investment Conference This Year
VRX,VRX:US,BBG000DLFM21,Valeant: Room to Move?,2017-03-23 14:16:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/23/valeant-room-to-move/?mod=yahoobarrons&ru=yahoo,Valeant: Room to Move?
VRX,VRX:CT,BBG000DC8S17,Valeant: Room to Move?,2017-03-23 14:16:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/23/valeant-room-to-move/?mod=yahoobarrons&ru=yahoo,Valeant: Room to Move?
VRX,VRX:CT,BBG000DC8S17,New Product Launches May Boost Valeant’s Dermatology Revenue,2017-03-23 13:06:03 +0000,http://marketrealist.com/2017/03/new-product-launches-may-boost-valeant-pharmaceuticals-dermatology-revenues-future-years/?utm_source=yahoo&utm_medium=feed,New Product Launches May Boost Valeant’s Dermatology Revenue
VRX,VRX:US,BBG000DLFM21,New Product Launches May Boost Valeant’s Dermatology Revenue,2017-03-23 13:06:03 +0000,http://marketrealist.com/2017/03/new-product-launches-may-boost-valeant-pharmaceuticals-dermatology-revenues-future-years/?utm_source=yahoo&utm_medium=feed,New Product Launches May Boost Valeant’s Dermatology Revenue
VRX,VRX:US,BBG000DLFM21,Valeant’s Dermatology Business Felt Pricing Pressure in 2016,2017-03-23 11:36:15 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-dermatology-business-witnessed-pricing-pressures-2016/?utm_source=yahoo&utm_medium=feed,Valeant’s Dermatology Business Felt Pricing Pressure in 2016
VRX,VRX:CT,BBG000DC8S17,Valeant’s Dermatology Business Felt Pricing Pressure in 2016,2017-03-23 11:36:15 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-dermatology-business-witnessed-pricing-pressures-2016/?utm_source=yahoo&utm_medium=feed,Valeant’s Dermatology Business Felt Pricing Pressure in 2016
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed Ahead Of U.S. Vote - Canadian Commentary,2017-03-23 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XzPipbbgtxA/canadian-stocks-are-little-changed-ahead-of-us-vote--canadian-commentary-20170323-00731,Canadian Stocks Are Little Changed Ahead Of U.S. Vote - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed Ahead Of U.S. Vote - Canadian Commentary,2017-03-23 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XzPipbbgtxA/canadian-stocks-are-little-changed-ahead-of-us-vote--canadian-commentary-20170323-00731,Canadian Stocks Are Little Changed Ahead Of U.S. Vote - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Closes Down Slightly After Completing Refi,2017-03-22 22:33:00 +0000,https://www.thestreet.com/story/14055065/1/valeant-slumps-on-refinancing-completion.html?puc=yahoo&cm_ven=YAHOO,Valeant Closes Down Slightly After Completing Refi
VRX,VRX:CT,BBG000DC8S17,Valeant Closes Down Slightly After Completing Refi,2017-03-22 22:33:00 +0000,https://www.thestreet.com/story/14055065/1/valeant-slumps-on-refinancing-completion.html?puc=yahoo&cm_ven=YAHOO,Valeant Closes Down Slightly After Completing Refi
VRX,VRX:US,BBG000DLFM21,Valeant Rearranges Deck Chairs,2017-03-22 17:48:06 +0000,https://www.bloomberg.com/gadfly/articles/2017-03-22/valeant-refinancing-rearranging-deck-chairs?cmpid=yhoo.headline,Valeant Rearranges Deck Chairs
VRX,VRX:CT,BBG000DC8S17,Valeant Rearranges Deck Chairs,2017-03-22 17:48:06 +0000,https://www.bloomberg.com/gadfly/articles/2017-03-22/valeant-refinancing-rearranging-deck-chairs?cmpid=yhoo.headline,Valeant Rearranges Deck Chairs
VRX,VRX:US,BBG000DLFM21,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen",2017-03-22 16:11:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4CJPvriO7Yc/zacks-investment-ideas-feature-highlights-nasdaq-biotechnology-index-gilead-valeant-pharma-celgene-and-amgen-cm764125,For Immediate Release Chicago IL March 22 2017 Today Zacks Investment Ideas feature highlights Features Nasdaq Biotechnology Index NASDAQ IBB Free Report Gilead NASDAQ GILD Free Report Valeant Pharma NYSE VRX Free Report Celgene NASDAQ
VRX,VRX:CT,BBG000DC8S17,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen",2017-03-22 16:11:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4CJPvriO7Yc/zacks-investment-ideas-feature-highlights-nasdaq-biotechnology-index-gilead-valeant-pharma-celgene-and-amgen-cm764125,For Immediate Release Chicago IL March 22 2017 Today Zacks Investment Ideas feature highlights Features Nasdaq Biotechnology Index NASDAQ IBB Free Report Gilead NASDAQ GILD Free Report Valeant Pharma NYSE VRX Free Report Celgene NASDAQ
VRX,VRX:CT,BBG000DC8S17,Relistor May Be Solid Growth Opportunity for Valeant in 2017,2017-03-22 14:36:52 +0000,http://marketrealist.com/2017/03/relistor-may-prove-solid-growth-opportunity-valeant-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Relistor May Be Solid Growth Opportunity for Valeant in 2017
VRX,VRX:US,BBG000DLFM21,Relistor May Be Solid Growth Opportunity for Valeant in 2017,2017-03-22 14:36:52 +0000,http://marketrealist.com/2017/03/relistor-may-prove-solid-growth-opportunity-valeant-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Relistor May Be Solid Growth Opportunity for Valeant in 2017
VRX,VRX:CT,BBG000DC8S17,TransDigm Looks Cheap - But No Thanks,2017-03-22 14:06:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m7E-UjUW6Nc/transdigm-looks-cheap-but-no-thanks-cm764022,I became interested in aircraft parts supplier TransDigm TDG because I m a big fan of Mark Massey of AltaRock Partners at year end it was his largest position 21 of the portfolio I became interested in aircraft parts supplierTransDigmTransDigm TDG because I m a big fan of
VRX,VRX:US,BBG000DLFM21,TransDigm Looks Cheap - But No Thanks,2017-03-22 14:06:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m7E-UjUW6Nc/transdigm-looks-cheap-but-no-thanks-cm764022,I became interested in aircraft parts supplier TransDigm TDG because I m a big fan of Mark Massey of AltaRock Partners at year end it was his largest position 21 of the portfolio I became interested in aircraft parts supplierTransDigmTransDigm TDG because I m a big fan of
VRX,VRX:CT,BBG000DC8S17,Valeant's IBS-D Drug Could See Competition with FDA Changes,2017-03-22 13:48:00 +0000,http://www.investopedia.com/news/valeants-ibsd-drug-could-see-competition-vrx/?partner=YahooSA,Valeant's IBS-D Drug Could See Competition with FDA Changes
VRX,VRX:US,BBG000DLFM21,Valeant's IBS-D Drug Could See Competition with FDA Changes,2017-03-22 13:48:00 +0000,http://www.investopedia.com/news/valeants-ibsd-drug-could-see-competition-vrx/?partner=YahooSA,Valeant's IBS-D Drug Could See Competition with FDA Changes
VRX,VRX:CT,BBG000DC8S17,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen",2017-03-22 13:30:01 +0000,http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-133001627.html,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen"
VRX,VRX:US,BBG000DLFM21,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen",2017-03-22 13:30:01 +0000,http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-133001627.html,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen"
VRX,VRX:CT,BBG000DC8S17,Xifaxan Expected to Witness Robust Growth in 2017,2017-03-22 13:06:45 +0000,http://marketrealist.com/2017/03/xifaxan-expected-witness-robust-growth-trends-2017/?utm_source=yahoo&utm_medium=feed,Xifaxan Expected to Witness Robust Growth in 2017
VRX,VRX:US,BBG000DLFM21,Xifaxan Expected to Witness Robust Growth in 2017,2017-03-22 13:06:45 +0000,http://marketrealist.com/2017/03/xifaxan-expected-witness-robust-growth-trends-2017/?utm_source=yahoo&utm_medium=feed,Xifaxan Expected to Witness Robust Growth in 2017
VRX,VRX:US,BBG000DLFM21,Headwinds Seen by Valeant Pharmaceuticals in 2016,2017-03-22 11:37:02 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-witnessed-multiple-headwinds-2016/?utm_source=yahoo&utm_medium=feed,Headwinds Seen by Valeant Pharmaceuticals in 2016
VRX,VRX:CT,BBG000DC8S17,Headwinds Seen by Valeant Pharmaceuticals in 2016,2017-03-22 11:37:02 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-witnessed-multiple-headwinds-2016/?utm_source=yahoo&utm_medium=feed,Headwinds Seen by Valeant Pharmaceuticals in 2016
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling Further On Crude Weakness - Canadian Commentary,2017-03-22 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r-eoQ8XbQGQ/canadian-stocks-are-falling-further-on-crude-weakness--canadian-commentary-20170322-00689,Canadian Stocks Are Falling Further On Crude Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling Further On Crude Weakness - Canadian Commentary,2017-03-22 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r-eoQ8XbQGQ/canadian-stocks-are-falling-further-on-crude-weakness--canadian-commentary-20170322-00689,Canadian Stocks Are Falling Further On Crude Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA,2017-03-21 22:06:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YMC3vqWpZEM/valeants-vrx-glaucoma-candidate-gets-pdufa-date-from-fda-cm763794,Valeant Pharmaceuticals International Inc s VRX wholly owned subsidiary Bausch Lomb and Nicox S A announced that the FDA has set a PDUFA date of Aug 24 for its decision on the New Drug Application NDA for latanoprostene bunod ophthalmic solution 0 024 We note that
VRX,VRX:CT,BBG000DC8S17,Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA,2017-03-21 22:06:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YMC3vqWpZEM/valeants-vrx-glaucoma-candidate-gets-pdufa-date-from-fda-cm763794,Valeant Pharmaceuticals International Inc s VRX wholly owned subsidiary Bausch Lomb and Nicox S A announced that the FDA has set a PDUFA date of Aug 24 for its decision on the New Drug Application NDA for latanoprostene bunod ophthalmic solution 0 024 We note that
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation",2017-03-21 20:51:10 +0000,http://biz.yahoo.com/e/170321/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation",2017-03-21 20:51:10 +0000,http://biz.yahoo.com/e/170321/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation"
VRX,VRX:CT,BBG000DC8S17,Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA,2017-03-21 20:32:08 +0000,http://finance.yahoo.com/news/valeants-vrx-glaucoma-candidate-gets-203208726.html,Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA
VRX,VRX:US,BBG000DLFM21,Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA,2017-03-21 20:32:08 +0000,http://finance.yahoo.com/news/valeants-vrx-glaucoma-candidate-gets-203208726.html,Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA
VRX,VRX:US,BBG000DLFM21,Valeant Completes Refinancing Transactions,2017-03-21 20:30:00 +0000,http://finance.yahoo.com/news/valeant-completes-refinancing-transactions-203000675.html,[CNW Group] - Valeant Completes Refinancing Transactions
VRX,VRX:CT,BBG000DC8S17,Valeant Completes Refinancing Transactions,2017-03-21 20:30:00 +0000,http://finance.yahoo.com/news/valeant-completes-refinancing-transactions-203000675.html,[CNW Group] - Valeant Completes Refinancing Transactions
VRX,VRX:CT,BBG000DC8S17,"How Micron Technology, Inc. (MU) Stock Can Deliver the Goods",2017-03-21 19:07:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sipJ1PXSwVE/how-micron-technology-inc-mu-stock-can-deliver-the-goods-cm763744,InvestorPlace Stock Market News Stock Advice amp Trading Tips Micron Technology Inc NASDAQ MU easily stands out as one of the top comeback stories of 2016 After suffering steep volatility earlier in the year along with the sector specific Market Vectors Semiconductor
VRX,VRX:US,BBG000DLFM21,"How Micron Technology, Inc. (MU) Stock Can Deliver the Goods",2017-03-21 19:07:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sipJ1PXSwVE/how-micron-technology-inc-mu-stock-can-deliver-the-goods-cm763744,InvestorPlace Stock Market News Stock Advice amp Trading Tips Micron Technology Inc NASDAQ MU easily stands out as one of the top comeback stories of 2016 After suffering steep volatility earlier in the year along with the sector specific Market Vectors Semiconductor
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Worth the Risk?,2017-03-21 18:07:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sv693f2ghtw/is-valeant-pharmaceuticals-intl-inc-vrx-stock-worth-the-risk-cm763705,InvestorPlace Stock Market News Stock Advice amp Trading Tips The dust is still settling from this week s announcement that Pershing Square Capital Management LP billionaire and activist investor Bill Ackman s investment firm has eliminated its remaining holding in
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Worth the Risk?,2017-03-21 18:07:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sv693f2ghtw/is-valeant-pharmaceuticals-intl-inc-vrx-stock-worth-the-risk-cm763705,InvestorPlace Stock Market News Stock Advice amp Trading Tips The dust is still settling from this week s announcement that Pershing Square Capital Management LP billionaire and activist investor Bill Ackman s investment firm has eliminated its remaining holding in
VRX,VRX:CT,BBG000DC8S17,Should Facebook Inc Just Buy Snap Inc.?,2017-03-21 18:06:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aCKu01F8q_w/should-facebook-inc-just-buy-snap-inc-cm763692,InvestorPlace Stock Market News Stock Advice amp Trading Tips When Facebook Inc NASDAQ FB first tried to buy Snapchat for 3 billion in 2013 many pundits thought Snap Inc 160 NYSE SNAP should have agreed to the offer Of
VRX,VRX:US,BBG000DLFM21,Should Facebook Inc Just Buy Snap Inc.?,2017-03-21 18:06:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aCKu01F8q_w/should-facebook-inc-just-buy-snap-inc-cm763692,InvestorPlace Stock Market News Stock Advice amp Trading Tips When Facebook Inc NASDAQ FB first tried to buy Snapchat for 3 billion in 2013 many pundits thought Snap Inc 160 NYSE SNAP should have agreed to the offer Of
VRX,VRX:CT,BBG000DC8S17,Valeant Completes Bond Tender Offer,2017-03-21 17:23:31 +0000,http://blogs.wsj.com/cfo/2017/03/21/valeant-completes-bond-tender-offer/?mod=yahoo_hs,Valeant Completes Bond Tender Offer
VRX,VRX:US,BBG000DLFM21,Valeant Completes Bond Tender Offer,2017-03-21 17:23:31 +0000,http://blogs.wsj.com/cfo/2017/03/21/valeant-completes-bond-tender-offer/?mod=yahoo_hs,Valeant Completes Bond Tender Offer
VRX,VRX:US,BBG000DLFM21,Jazz Sleep Disorder Drug Positive in Phase III Studies,2017-03-21 17:09:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nRy7WMDYNck/jazz-sleep-disorder-drug-positive-in-phase-iii-studies-cm763601,Jazz Pharmaceuticals plc JAZZ recently announced positive efficacy results from two phase III studies evaluating the safety and efficacy of its lead pipeline candidate JZP 110 for the treatment of excessive sleepiness ES associated with obstructive sleep apnea OSA Jazz s shares
VRX,VRX:CT,BBG000DC8S17,Jazz Sleep Disorder Drug Positive in Phase III Studies,2017-03-21 17:09:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nRy7WMDYNck/jazz-sleep-disorder-drug-positive-in-phase-iii-studies-cm763601,Jazz Pharmaceuticals plc JAZZ recently announced positive efficacy results from two phase III studies evaluating the safety and efficacy of its lead pipeline candidate JZP 110 for the treatment of excessive sleepiness ES associated with obstructive sleep apnea OSA Jazz s shares
VRX,VRX:CT,BBG000DC8S17,Valeant’s Net Profit Margins Expected to Narrow in 2017,2017-03-21 14:37:54 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-expected-witness-drop-net-profit-margins-2017/?utm_source=yahoo&utm_medium=feed,Valeant’s Net Profit Margins Expected to Narrow in 2017
VRX,VRX:US,BBG000DLFM21,Valeant’s Net Profit Margins Expected to Narrow in 2017,2017-03-21 14:37:54 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-expected-witness-drop-net-profit-margins-2017/?utm_source=yahoo&utm_medium=feed,Valeant’s Net Profit Margins Expected to Narrow in 2017
VRX,VRX:US,BBG000DLFM21,"Valeant's Post-Ackman Recovery Is Characterized By 'Less Money, More Problems'",2017-03-21 14:02:46 +0000,http://finance.yahoo.com/news/valeants-post-ackman-recovery-characterized-140246747.html,"Valeant's Post-Ackman Recovery Is Characterized By 'Less Money, More Problems'"
VRX,VRX:CT,BBG000DC8S17,"Valeant's Post-Ackman Recovery Is Characterized By 'Less Money, More Problems'",2017-03-21 14:02:46 +0000,http://finance.yahoo.com/news/valeants-post-ackman-recovery-characterized-140246747.html,"Valeant's Post-Ackman Recovery Is Characterized By 'Less Money, More Problems'"
VRX,VRX:US,BBG000DLFM21,Biotech Bull Making a Comeback,2017-03-21 13:08:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xc3sNhMXRBg/biotech-bull-making-a-comeback-cm763355,In October of 2015 I wrote a special report for Zacks Confidential titled Biotech Outlook Bursting Bubble or Buying Opportunity At the time the Nasdaq Biotechnology Index IBB had fallen over 25 from its peak at 400 in the 3rd quarter of 2015 Here s was my introduction It
VRX,VRX:CT,BBG000DC8S17,Biotech Bull Making a Comeback,2017-03-21 13:08:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xc3sNhMXRBg/biotech-bull-making-a-comeback-cm763355,In October of 2015 I wrote a special report for Zacks Confidential titled Biotech Outlook Bursting Bubble or Buying Opportunity At the time the Nasdaq Biotechnology Index IBB had fallen over 25 from its peak at 400 in the 3rd quarter of 2015 Here s was my introduction It
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Expects Lower Revenue in 2017,2017-03-21 13:07:21 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-expected-witness-decline-revenues-2017/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals Expects Lower Revenue in 2017
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Expects Lower Revenue in 2017,2017-03-21 13:07:21 +0000,http://marketrealist.com/2017/03/valeant-pharmaceuticals-expected-witness-decline-revenues-2017/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals Expects Lower Revenue in 2017
VRX,VRX:US,BBG000DLFM21,[$$] Options Traders Bet on More Big Moves in Valeant,2017-03-21 12:55:02 +0000,https://www.wsj.com/articles/options-traders-bet-on-more-big-moves-in-valeant-1490100898?mod=yahoo_hs,[$$] Options Traders Bet on More Big Moves in Valeant
VRX,VRX:CT,BBG000DC8S17,[$$] Options Traders Bet on More Big Moves in Valeant,2017-03-21 12:55:02 +0000,https://www.wsj.com/articles/options-traders-bet-on-more-big-moves-in-valeant-1490100898?mod=yahoo_hs,[$$] Options Traders Bet on More Big Moves in Valeant
VRX,VRX:CT,BBG000DC8S17,Analysts’ Recommendations for Valeant Pharmaceuticals in 2017,2017-03-21 11:37:28 +0000,http://marketrealist.com/2017/03/analysts-recommendations-valeant-pharmaceutical-2017/?utm_source=yahoo&utm_medium=feed,Analysts’ Recommendations for Valeant Pharmaceuticals in 2017
VRX,VRX:US,BBG000DLFM21,Analysts’ Recommendations for Valeant Pharmaceuticals in 2017,2017-03-21 11:37:28 +0000,http://marketrealist.com/2017/03/analysts-recommendations-valeant-pharmaceutical-2017/?utm_source=yahoo&utm_medium=feed,Analysts’ Recommendations for Valeant Pharmaceuticals in 2017
VRX,VRX:US,BBG000DLFM21,Biotech Bull Making a Comeback,2017-03-21 11:00:11 +0000,http://finance.yahoo.com/news/biotech-bull-making-comeback-110011037.html,Biotech Bull Making a Comeback
VRX,VRX:CT,BBG000DC8S17,Biotech Bull Making a Comeback,2017-03-21 11:00:11 +0000,http://finance.yahoo.com/news/biotech-bull-making-comeback-110011037.html,Biotech Bull Making a Comeback
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-03-21 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BEtUqNXEpqs/canadian-stocks-are-paring-early-gains--canadian-commentary-20170321-00794,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains - Canadian Commentary,2017-03-21 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BEtUqNXEpqs/canadian-stocks-are-paring-early-gains--canadian-commentary-20170321-00794,Canadian Stocks Are Paring Early Gains - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"With Ackman Out, Valeant Confronts Rocky Road to Revival",2017-03-21 09:00:00 +0000,https://www.bloomberg.com/news/articles/2017-03-21/with-ackman-out-valeant-confronts-rocky-road-to-revival?cmpid=yhoo.headline,"With Ackman Out, Valeant Confronts Rocky Road to Revival"
VRX,VRX:US,BBG000DLFM21,"With Ackman Out, Valeant Confronts Rocky Road to Revival",2017-03-21 09:00:00 +0000,https://www.bloomberg.com/news/articles/2017-03-21/with-ackman-out-valeant-confronts-rocky-road-to-revival?cmpid=yhoo.headline,"With Ackman Out, Valeant Confronts Rocky Road to Revival"
VRX,VRX:CT,BBG000DC8S17,Traders Turn to Valeant Options to Bet on Big Moves,2017-03-21 04:12:09 +0000,http://blogs.wsj.com/moneybeat/2017/03/20/traders-turn-to-valeant-options-to-bet-on-big-moves/?ru=yahoo?mod=yahoo_itp,Traders Turn to Valeant Options to Bet on Big Moves
VRX,VRX:US,BBG000DLFM21,Traders Turn to Valeant Options to Bet on Big Moves,2017-03-21 04:12:09 +0000,http://blogs.wsj.com/moneybeat/2017/03/20/traders-turn-to-valeant-options-to-bet-on-big-moves/?ru=yahoo?mod=yahoo_itp,Traders Turn to Valeant Options to Bet on Big Moves
VRX,VRX:US,BBG000DLFM21,"PTIE Surges After-hours, Valeant Gets FDA Date, JAZZ Hits Right Notes",2017-03-21 02:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i6aAlU_F7EM/ptie-surges-afterhours-valeant-gets-fda-date-jazz-hits-right-notes-20170321-00057,"PTIE Surges After-hours, Valeant Gets FDA Date, JAZZ Hits Right Notes"
VRX,VRX:CT,BBG000DC8S17,"PTIE Surges After-hours, Valeant Gets FDA Date, JAZZ Hits Right Notes",2017-03-21 02:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i6aAlU_F7EM/ptie-surges-afterhours-valeant-gets-fda-date-jazz-hits-right-notes-20170321-00057,"PTIE Surges After-hours, Valeant Gets FDA Date, JAZZ Hits Right Notes"
VRX,VRX:US,BBG000DLFM21,Valeant Announces the Early Results of Tender Offers for Its 6.75% Senior Notes Due 2018,2017-03-21 01:45:00 +0000,http://finance.yahoo.com/news/valeant-announces-early-results-tender-014500970.html,[CNW Group] - Valeant Announces the Early Results of Tender Offers for Its 6.75% Senior Notes Due 2018
VRX,VRX:CT,BBG000DC8S17,Valeant Announces the Early Results of Tender Offers for Its 6.75% Senior Notes Due 2018,2017-03-21 01:45:00 +0000,http://finance.yahoo.com/news/valeant-announces-early-results-tender-014500970.html,[CNW Group] - Valeant Announces the Early Results of Tender Offers for Its 6.75% Senior Notes Due 2018
VRX,VRX:CT,BBG000DC8S17,Valeant Announces the Early Results of Tender Offers for Its 6.75% Senior Notes Due 2018,2017-03-21 01:45:00 +0000,http://finance.yahoo.com/news/valeant-announces-early-results-tender-014500021.html,"[PR Newswire] - LAVAL, Quebec, March 20, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"" or the ""Company"") announced today that as of 5:00 p.m. New York City time on March 20, 2017 (the ""Early Participation Date""), holders of its outstanding 6.75% Senior Notes due 2018 (the ""Notes"") had validly tendered $1,552,046,000 in aggregate principal amount of the Notes in connection with the Company's offer to purchase for cash up to $1,100,000,000 aggregate principal amount of the Notes (the ""Tender Offer""), which the Company commenced on March 7, 2017. As a result of the oversubscription of the Tender Offer, the Company has accepted for purchase tendered Notes on a prorated basis in the manner described in the Company's Offer to Purchase dated March 7, 2017."
VRX,VRX:US,BBG000DLFM21,Valeant Announces the Early Results of Tender Offers for Its 6.75% Senior Notes Due 2018,2017-03-21 01:45:00 +0000,http://finance.yahoo.com/news/valeant-announces-early-results-tender-014500021.html,"[PR Newswire] - LAVAL, Quebec, March 20, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"" or the ""Company"") announced today that as of 5:00 p.m. New York City time on March 20, 2017 (the ""Early Participation Date""), holders of its outstanding 6.75% Senior Notes due 2018 (the ""Notes"") had validly tendered $1,552,046,000 in aggregate principal amount of the Notes in connection with the Company's offer to purchase for cash up to $1,100,000,000 aggregate principal amount of the Notes (the ""Tender Offer""), which the Company commenced on March 7, 2017. As a result of the oversubscription of the Tender Offer, the Company has accepted for purchase tendered Notes on a prorated basis in the manner described in the Company's Offer to Purchase dated March 7, 2017."
VRX,VRX:CT,BBG000DC8S17,[$$] Traders Bet on More Big Moves in Valeant,2017-03-21 01:34:25 +0000,http://online.wsj.com/article/SB21603728370429183552404583034911166505222.html?ru=yahoo?mod=yahoo_itp,[$$] Traders Bet on More Big Moves in Valeant
VRX,VRX:US,BBG000DLFM21,[$$] Traders Bet on More Big Moves in Valeant,2017-03-21 01:34:25 +0000,http://online.wsj.com/article/SB21603728370429183552404583034911166505222.html?ru=yahoo?mod=yahoo_itp,[$$] Traders Bet on More Big Moves in Valeant
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod,2017-03-20 21:00:00 +0000,http://finance.yahoo.com/news/bausch-lomb-nicox-announce-pdufa-210000933.html,[CNW Group] - Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod,2017-03-20 21:00:00 +0000,http://finance.yahoo.com/news/bausch-lomb-nicox-announce-pdufa-210000933.html,[CNW Group] - Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod
VRX,VRX:CT,BBG000DC8S17,Valeant - It's Not a Game of Chess Part II,2017-03-20 20:10:26 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-172538473.html,Valeant - It's Not a Game of Chess Part II
VRX,VRX:US,BBG000DLFM21,Valeant - It's Not a Game of Chess Part II,2017-03-20 20:10:26 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-172538473.html,Valeant - It's Not a Game of Chess Part II
VRX,VRX:US,BBG000DLFM21,3 lessons from Bill Ackman's $4B trading loss in Valeant,2017-03-20 18:20:37 +0000,http://finance.yahoo.com/news/3-lessons-from-bill-ackmans-4b-trading-loss-in-valeant-182037105.html,3 lessons from Bill Ackman's $4B trading loss in Valeant
VRX,VRX:CT,BBG000DC8S17,3 lessons from Bill Ackman's $4B trading loss in Valeant,2017-03-20 18:20:37 +0000,http://finance.yahoo.com/news/3-lessons-from-bill-ackmans-4b-trading-loss-in-valeant-182037105.html,3 lessons from Bill Ackman's $4B trading loss in Valeant
VRX,VRX:US,BBG000DLFM21,Valeant: What's the Prescription?,2017-03-20 16:25:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/20/valeant-whats-the-prescription/?mod=yahoobarrons&ru=yahoo,Valeant: What's the Prescription?
VRX,VRX:CT,BBG000DC8S17,Valeant: What's the Prescription?,2017-03-20 16:25:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/20/valeant-whats-the-prescription/?mod=yahoobarrons&ru=yahoo,Valeant: What's the Prescription?
VRX,VRX:US,BBG000DLFM21,Another Smart Hedge Fund Manager Is About to Be Duped By Valeant's Value Trap,2017-03-20 15:10:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9tghFttYLlQ/another-smart-hedge-fund-manager-is-about-to-be-duped-by-valeants-value-trap-cm762859,It s pretty safe to say that embattled drugmaker Valeant Pharmaceuticals NYSE VRX has cost Wall Street institutional money managers and the average investor quite a bit of money Valeant s latest victim was billionaire hedge fund manager Bill Ackman whose fund Pershing
VRX,VRX:CT,BBG000DC8S17,Another Smart Hedge Fund Manager Is About to Be Duped By Valeant's Value Trap,2017-03-20 15:10:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9tghFttYLlQ/another-smart-hedge-fund-manager-is-about-to-be-duped-by-valeants-value-trap-cm762859,It s pretty safe to say that embattled drugmaker Valeant Pharmaceuticals NYSE VRX has cost Wall Street institutional money managers and the average investor quite a bit of money Valeant s latest victim was billionaire hedge fund manager Bill Ackman whose fund Pershing
VRX,VRX:CT,BBG000DC8S17,Traders Turn to Valeant Options to Bet on Big Moves,2017-03-20 14:21:52 +0000,http://blogs.wsj.com/moneybeat/2017/03/20/traders-turn-to-valeant-options-to-bet-on-big-moves/?mod=yahoo_hs,Traders Turn to Valeant Options to Bet on Big Moves
VRX,VRX:US,BBG000DLFM21,Traders Turn to Valeant Options to Bet on Big Moves,2017-03-20 14:21:52 +0000,http://blogs.wsj.com/moneybeat/2017/03/20/traders-turn-to-valeant-options-to-bet-on-big-moves/?mod=yahoo_hs,Traders Turn to Valeant Options to Bet on Big Moves
VRX,VRX:US,BBG000DLFM21,Another Smart Hedge Fund Manager Is About to Be Duped By Valeant's Value Trap,2017-03-20 13:40:00 +0000,https://www.fool.com/investing/2017/03/20/another-smart-hedge-fund-manager-is-about-to-be-du.aspx,Another Smart Hedge Fund Manager Is About to Be Duped By Valeant's Value Trap
VRX,VRX:CT,BBG000DC8S17,Another Smart Hedge Fund Manager Is About to Be Duped By Valeant's Value Trap,2017-03-20 13:40:00 +0000,https://www.fool.com/investing/2017/03/20/another-smart-hedge-fund-manager-is-about-to-be-du.aspx,Another Smart Hedge Fund Manager Is About to Be Duped By Valeant's Value Trap
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed As The New Week Begins - Canadian Commentary,2017-03-20 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a_v09mE_Jq8/canadian-stocks-are-little-changed-as-the-new-week-begins--canadian-commentary-20170320-00737,Canadian Stocks Are Little Changed As The New Week Begins - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed As The New Week Begins - Canadian Commentary,2017-03-20 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a_v09mE_Jq8/canadian-stocks-are-little-changed-as-the-new-week-begins--canadian-commentary-20170320-00737,Canadian Stocks Are Little Changed As The New Week Begins - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Chipotle, Herbalife, Sears: Doug Kass' Views",2017-03-20 05:00:00 +0000,https://www.thestreet.com/story/14050415/1/chipotle-herbalife-sears-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Chipotle, Herbalife, Sears: Doug Kass' Views"
VRX,VRX:CT,BBG000DC8S17,"Chipotle, Herbalife, Sears: Doug Kass' Views",2017-03-20 05:00:00 +0000,https://www.thestreet.com/story/14050415/1/chipotle-herbalife-sears-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Chipotle, Herbalife, Sears: Doug Kass' Views"
VRX,VRX:CT,BBG000DC8S17,William Ackman’s Valeant Loss Is Short-Sellers’ Gain,2017-03-20 04:07:01 +0000,http://blogs.wsj.com/moneybeat/2017/03/17/william-ackmans-valeant-loss-is-short-sellers-gain/?ru=yahoo?mod=yahoo_itp,William Ackman’s Valeant Loss Is Short-Sellers’ Gain
VRX,VRX:US,BBG000DLFM21,William Ackman’s Valeant Loss Is Short-Sellers’ Gain,2017-03-20 04:07:01 +0000,http://blogs.wsj.com/moneybeat/2017/03/17/william-ackmans-valeant-loss-is-short-sellers-gain/?ru=yahoo?mod=yahoo_itp,William Ackman’s Valeant Loss Is Short-Sellers’ Gain
VRX,VRX:CT,BBG000DC8S17,Stocks Decline to Their 3-Year Lows,2017-03-19 17:40:14 +0000,http://finance.yahoo.com/news/stocks-decline-3-lows-173251911.html,Stocks Decline to Their 3-Year Lows
VRX,VRX:US,BBG000DLFM21,Stocks Decline to Their 3-Year Lows,2017-03-19 17:40:14 +0000,http://finance.yahoo.com/news/stocks-decline-3-lows-173251911.html,Stocks Decline to Their 3-Year Lows
VRX,VRX:CT,BBG000DC8S17,Hedge Fund Hairball,2017-03-18 16:56:00 +0000,http://www.forbes.com/sites/tomaspray/2017/03/18/hedge-fund-hairball/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Hedge Fund Hairball
VRX,VRX:US,BBG000DLFM21,Hedge Fund Hairball,2017-03-18 16:56:00 +0000,http://www.forbes.com/sites/tomaspray/2017/03/18/hedge-fund-hairball/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Hedge Fund Hairball
VRX,VRX:US,BBG000DLFM21,Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?,2017-03-18 16:20:00 +0000,https://www.thestreet.com/story/14045782/1/why-are-so-many-employees-selling-stock-options-and-is-that-really-a-good-idea.html?puc=yahoo&cm_ven=YAHOO,Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?
VRX,VRX:CT,BBG000DC8S17,Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?,2017-03-18 16:20:00 +0000,https://www.thestreet.com/story/14045782/1/why-are-so-many-employees-selling-stock-options-and-is-that-really-a-good-idea.html?puc=yahoo&cm_ven=YAHOO,Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?
VRX,VRX:US,BBG000DLFM21,Did Ackman Make the Right Decision to Sell Valeant?,2017-03-18 15:05:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fIYyfyaVbGU/did-ackman-make-the-right-decision-to-sell-valeant-cm762565,Bill Ackman Trades Portfolio s decision to sell his long standing stake in Valeant Pharmaceuticals VRX has attracted plenty of attention over the past week His decision to throw in the towel may have come as a surprise to many considering his previous comments and it is fair to
VRX,VRX:CT,BBG000DC8S17,Did Ackman Make the Right Decision to Sell Valeant?,2017-03-18 15:05:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fIYyfyaVbGU/did-ackman-make-the-right-decision-to-sell-valeant-cm762565,Bill Ackman Trades Portfolio s decision to sell his long standing stake in Valeant Pharmaceuticals VRX has attracted plenty of attention over the past week His decision to throw in the towel may have come as a surprise to many considering his previous comments and it is fair to
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase,2017-03-18 00:05:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KLXKUaHMdyA/valeant-vrx-shares-up-on-valueacts-52-stake-increase-cm762486,Shares of Valeant Pharmaceuticals VRX were up after investor ValueAct Capital management increased its stake in the company to 5 2 160 The news boosted investors confidence in the beleaguered company which has been in the spotlight throughout 2016 The news comes right after the stock
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase,2017-03-18 00:05:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KLXKUaHMdyA/valeant-vrx-shares-up-on-valueacts-52-stake-increase-cm762486,Shares of Valeant Pharmaceuticals VRX were up after investor ValueAct Capital management increased its stake in the company to 5 2 160 The news boosted investors confidence in the beleaguered company which has been in the spotlight throughout 2016 The news comes right after the stock
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase,2017-03-17 21:48:09 +0000,http://finance.yahoo.com/news/valeant-vrx-shares-valueacts-5-214809247.html,Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase,2017-03-17 21:48:09 +0000,http://finance.yahoo.com/news/valeant-vrx-shares-valueacts-5-214809247.html,Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers",2017-03-17 20:24:22 +0000,http://biz.yahoo.com/e/170317/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers",2017-03-17 20:24:22 +0000,http://biz.yahoo.com/e/170317/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers"
VRX,VRX:CT,BBG000DC8S17,William Ackman's Valeant Loss Is Short-Sellers' Gain,2017-03-17 20:02:20 +0000,http://blogs.wsj.com/moneybeat/2017/03/17/william-ackmans-valeant-loss-is-short-sellers-gain/?mod=yahoo_hs,William Ackman's Valeant Loss Is Short-Sellers' Gain
VRX,VRX:US,BBG000DLFM21,William Ackman's Valeant Loss Is Short-Sellers' Gain,2017-03-17 20:02:20 +0000,http://blogs.wsj.com/moneybeat/2017/03/17/william-ackmans-valeant-loss-is-short-sellers-gain/?mod=yahoo_hs,William Ackman's Valeant Loss Is Short-Sellers' Gain
VRX,VRX:CT,BBG000DC8S17,Did Ackman Make the Right Decision to Sell Valeant?,2017-03-17 19:07:47 +0000,http://finance.yahoo.com/news/did-ackman-decision-sell-valeant-190747744.html,Did Ackman Make the Right Decision to Sell Valeant?
VRX,VRX:US,BBG000DLFM21,Did Ackman Make the Right Decision to Sell Valeant?,2017-03-17 19:07:47 +0000,http://finance.yahoo.com/news/did-ackman-decision-sell-valeant-190747744.html,Did Ackman Make the Right Decision to Sell Valeant?
VRX,VRX:US,BBG000DLFM21,Ackman's Valeant Holdings Lost Pershing $7.7 Million a Day,2017-03-17 17:09:00 +0000,http://www.investopedia.com/news/ackmans-valeant-holdings-lost-pershing-77-million-day-vrx/?partner=YahooSA,Ackman's Valeant Holdings Lost Pershing $7.7 Million a Day
VRX,VRX:CT,BBG000DC8S17,Ackman's Valeant Holdings Lost Pershing $7.7 Million a Day,2017-03-17 17:09:00 +0000,http://www.investopedia.com/news/ackmans-valeant-holdings-lost-pershing-77-million-day-vrx/?partner=YahooSA,Ackman's Valeant Holdings Lost Pershing $7.7 Million a Day
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Friday: Netflix, Inc. (NFLX), Valeant Pharmaceuticals Intl Inc (VRX) and Adobe Systems Incorporated (ADBE)",2017-03-17 17:08:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X6NJsG4QexI/3-stocks-to-watch-on-friday-netflix-inc-nflx-valeant-pharmaceuticals-intl-inc-vrx-and-adobe-systems-incorporated-adbe-cm762340,InvestorPlace Stock Market News Stock Advice amp Trading Tips Thursday was a dim day for U S equities as gold climbed and the dollar suffered a setback The 160 S amp P 500 Index lost 0 2 the 160 Dow Jones Industrial Average fell 0 1 and the 160
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Friday: Netflix, Inc. (NFLX), Valeant Pharmaceuticals Intl Inc (VRX) and Adobe Systems Incorporated (ADBE)",2017-03-17 17:08:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X6NJsG4QexI/3-stocks-to-watch-on-friday-netflix-inc-nflx-valeant-pharmaceuticals-intl-inc-vrx-and-adobe-systems-incorporated-adbe-cm762340,InvestorPlace Stock Market News Stock Advice amp Trading Tips Thursday was a dim day for U S equities as gold climbed and the dollar suffered a setback The 160 S amp P 500 Index lost 0 2 the 160 Dow Jones Industrial Average fell 0 1 and the 160
VRX,VRX:US,BBG000DLFM21,ValueAct bet another $32 million on Valeant as stock hits 8-year low,2017-03-17 17:02:36 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=27D39292-7610-4AC9-865C-F1F3497CE795&siteid=yhoof2,ValueAct bet another $32 million on Valeant as stock hits 8-year low
VRX,VRX:CT,BBG000DC8S17,ValueAct bet another $32 million on Valeant as stock hits 8-year low,2017-03-17 17:02:36 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=27D39292-7610-4AC9-865C-F1F3497CE795&siteid=yhoof2,ValueAct bet another $32 million on Valeant as stock hits 8-year low
VRX,VRX:US,BBG000DLFM21,"Valeant: Dude, Where'd My Gains Go?",2017-03-17 16:29:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/17/valeant-dude-whered-my-gains-go/?mod=yahoobarrons&ru=yahoo,"Valeant: Dude, Where'd My Gains Go?"
VRX,VRX:CT,BBG000DC8S17,"Valeant: Dude, Where'd My Gains Go?",2017-03-17 16:29:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/17/valeant-dude-whered-my-gains-go/?mod=yahoobarrons&ru=yahoo,"Valeant: Dude, Where'd My Gains Go?"
VRX,VRX:CT,BBG000DC8S17,[video]Stocks Creep Lower as Health Care Selloff Extends Into Day 2,2017-03-17 15:42:00 +0000,https://www.thestreet.com/story/14049133/1/stocks-creep-lower-as-health-care-selloff-extends-into-day-2.html?puc=yahoo&cm_ven=YAHOO,[video]Stocks Creep Lower as Health Care Selloff Extends Into Day 2
VRX,VRX:US,BBG000DLFM21,[video]Stocks Creep Lower as Health Care Selloff Extends Into Day 2,2017-03-17 15:42:00 +0000,https://www.thestreet.com/story/14049133/1/stocks-creep-lower-as-health-care-selloff-extends-into-day-2.html?puc=yahoo&cm_ven=YAHOO,[video]Stocks Creep Lower as Health Care Selloff Extends Into Day 2
VRX,VRX:CT,BBG000DC8S17,"Apple, Caterpillar, Valeant, and More: Why These Five Stocks Are in the Spotlight",2017-03-17 14:56:29 +0000,http://www.insidermonkey.com/blog/apple-caterpillar-valeant-and-more-why-these-five-stocks-are-in-the-spotlight-567139/,"Apple, Caterpillar, Valeant, and More: Why These Five Stocks Are in the Spotlight"
VRX,VRX:US,BBG000DLFM21,"Apple, Caterpillar, Valeant, and More: Why These Five Stocks Are in the Spotlight",2017-03-17 14:56:29 +0000,http://www.insidermonkey.com/blog/apple-caterpillar-valeant-and-more-why-these-five-stocks-are-in-the-spotlight-567139/,"Apple, Caterpillar, Valeant, and More: Why These Five Stocks Are in the Spotlight"
VRX,VRX:CT,BBG000DC8S17,This Key Measure Shows the S&P Could Be Headed for a 5% Pullback,2017-03-17 14:37:00 +0000,http://finance.yahoo.com/news/video-key-measure-shows-p-143700069.html,This Key Measure Shows the S&P Could Be Headed for a 5% Pullback
VRX,VRX:US,BBG000DLFM21,This Key Measure Shows the S&P Could Be Headed for a 5% Pullback,2017-03-17 14:37:00 +0000,http://finance.yahoo.com/news/video-key-measure-shows-p-143700069.html,This Key Measure Shows the S&P Could Be Headed for a 5% Pullback
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Adobe, Tiffany, Valeant",2017-03-17 14:04:25 +0000,http://blogs.wsj.com/moneybeat/2017/03/17/stocks-to-watch-abobe-tiffany-valeant/?mod=yahoo_hs,"Stocks to Watch: Adobe, Tiffany, Valeant"
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Adobe, Tiffany, Valeant",2017-03-17 14:04:25 +0000,http://blogs.wsj.com/moneybeat/2017/03/17/stocks-to-watch-abobe-tiffany-valeant/?mod=yahoo_hs,"Stocks to Watch: Adobe, Tiffany, Valeant"
VRX,VRX:CT,BBG000DC8S17,"Tiffany shines on beat, Valeant is getting some love, Adobe does it again",2017-03-17 13:20:35 +0000,http://finance.yahoo.com/news/tiffany-shines-on-beat-valeant-is-getting-some-love-adobe-does-it-again-132035534.html,"Tiffany shines on beat, Valeant is getting some love, Adobe does it again"
VRX,VRX:US,BBG000DLFM21,"Tiffany shines on beat, Valeant is getting some love, Adobe does it again",2017-03-17 13:20:35 +0000,http://finance.yahoo.com/news/tiffany-shines-on-beat-valeant-is-getting-some-love-adobe-does-it-again-132035534.html,"Tiffany shines on beat, Valeant is getting some love, Adobe does it again"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Some Activist Investors Still Like It,2017-03-17 13:14:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/17/valeant-pharmaceuticals-some-activist-investors-still-like-it/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Some Activist Investors Still Like It
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Some Activist Investors Still Like It,2017-03-17 13:14:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/17/valeant-pharmaceuticals-some-activist-investors-still-like-it/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Some Activist Investors Still Like It
VRX,VRX:US,BBG000DLFM21,Valeant: It's Not a Game of Chess- Part I,2017-03-17 13:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9pQ8wPUK4cE/valeant-its-not-a-game-of-chess-part-i-cm762050,I have always been interested in extreme successes and failures as case studies No doubt Valeant Pharmaceuticals VRX has been the most fascinating story I have followed in the investing world over the past few years What started as a promising business model designed by an ambitious
VRX,VRX:CT,BBG000DC8S17,Valeant: It's Not a Game of Chess- Part I,2017-03-17 13:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9pQ8wPUK4cE/valeant-its-not-a-game-of-chess-part-i-cm762050,I have always been interested in extreme successes and failures as case studies No doubt Valeant Pharmaceuticals VRX has been the most fascinating story I have followed in the investing world over the past few years What started as a promising business model designed by an ambitious
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Mar 17, 2017 :  KEP, EDIT, UN, MT, VRX, CS, BAC, NFLX, MU, QQQ, TSLA, NVDA",2017-03-17 12:55:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k8Hc7RdVPTo/pre-market-most-active-for-mar-17-2017-kep-edit-un-mt-vrx-cs-bac-nflx-mu-qqq-tsla-nvda-cm762048,The NASDAQ 100 Pre Market Indicator is up 3 94 to 5 416 02 The total Pre Market volume is currently 7 050 221 shares traded The following are the most active stocks for the pre market session Korea Electric Power Corporation KEP is 0 06 at 19 07 with 4 202 668
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Mar 17, 2017 :  KEP, EDIT, UN, MT, VRX, CS, BAC, NFLX, MU, QQQ, TSLA, NVDA",2017-03-17 12:55:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k8Hc7RdVPTo/pre-market-most-active-for-mar-17-2017-kep-edit-un-mt-vrx-cs-bac-nflx-mu-qqq-tsla-nvda-cm762048,The NASDAQ 100 Pre Market Indicator is up 3 94 to 5 416 02 The total Pre Market volume is currently 7 050 221 shares traded The following are the most active stocks for the pre market session Korea Electric Power Corporation KEP is 0 06 at 19 07 with 4 202 668
VRX,VRX:US,BBG000DLFM21,"Stock Futures Mixed as Crude Rises, G-20 Summit Kicks Off",2017-03-17 12:27:00 +0000,https://www.thestreet.com/story/14047588/1/stock-futures-mostly-higher-crude-rises-ahead-of-consumer-sentiment-data.html?puc=yahoo&cm_ven=YAHOO,[at TheStreet] - Stock futures move mostly higher on Friday as crude oil attempts another rebound to close out the week.
VRX,VRX:CT,BBG000DC8S17,"Stock Futures Mixed as Crude Rises, G-20 Summit Kicks Off",2017-03-17 12:27:00 +0000,https://www.thestreet.com/story/14047588/1/stock-futures-mostly-higher-crude-rises-ahead-of-consumer-sentiment-data.html?puc=yahoo&cm_ven=YAHOO,[at TheStreet] - Stock futures move mostly higher on Friday as crude oil attempts another rebound to close out the week.
VRX,VRX:US,BBG000DLFM21,Pres Trump to meet with Angela Merkel after calling her policies 'insane',2017-03-17 12:18:24 +0000,http://finance.yahoo.com/news/pres-trump-to-meet-with-angela-merkel-after-calling-her-policies-insane-121824128.html,Pres Trump to meet with Angela Merkel after calling her policies 'insane'
VRX,VRX:CT,BBG000DC8S17,Pres Trump to meet with Angela Merkel after calling her policies 'insane',2017-03-17 12:18:24 +0000,http://finance.yahoo.com/news/pres-trump-to-meet-with-angela-merkel-after-calling-her-policies-insane-121824128.html,Pres Trump to meet with Angela Merkel after calling her policies 'insane'
VRX,VRX:CT,BBG000DC8S17,"Early movers: TIF, ADBE, CAT, VRX, NFLX, C, AAPL, KKR, GOOS & more",2017-03-17 11:52:47 +0000,http://www.cnbc.com/id/104348336?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104348336,"Early movers: TIF, ADBE, CAT, VRX, NFLX, C, AAPL, KKR, GOOS & more"
VRX,VRX:US,BBG000DLFM21,"Early movers: TIF, ADBE, CAT, VRX, NFLX, C, AAPL, KKR, GOOS & more",2017-03-17 11:52:47 +0000,http://www.cnbc.com/id/104348336?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104348336,"Early movers: TIF, ADBE, CAT, VRX, NFLX, C, AAPL, KKR, GOOS & more"
VRX,VRX:CT,BBG000DC8S17,The Contrarian: Analyst Crapshoot on Valeant,2017-03-17 10:00:00 +0000,http://www.investopedia.com/news/contrarian-analyst-crapshoot-valeant-vrx/?partner=YahooSA,The Contrarian: Analyst Crapshoot on Valeant
VRX,VRX:US,BBG000DLFM21,The Contrarian: Analyst Crapshoot on Valeant,2017-03-17 10:00:00 +0000,http://www.investopedia.com/news/contrarian-analyst-crapshoot-valeant-vrx/?partner=YahooSA,The Contrarian: Analyst Crapshoot on Valeant
VRX,VRX:CT,BBG000DC8S17,Valeant: Don't Get Stuck In The Revolving Door,2017-03-17 09:16:00 +0000,http://www.investopedia.com/news/valeant-dont-get-stuck-revolving-door-vrx/?partner=YahooSA,Valeant: Don't Get Stuck In The Revolving Door
VRX,VRX:US,BBG000DLFM21,Valeant: Don't Get Stuck In The Revolving Door,2017-03-17 09:16:00 +0000,http://www.investopedia.com/news/valeant-dont-get-stuck-revolving-door-vrx/?partner=YahooSA,Valeant: Don't Get Stuck In The Revolving Door
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Intl Inc (VRX) Stock: Goodbye, Not Good Buy",2017-03-16 22:07:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CJvYxuzrrzs/valeant-pharmaceuticals-intl-inc-vrx-stock-goodbye-not-good-buy-cm761957,InvestorPlace Stock Market News Stock Advice amp Trading Tips Some may be tempted to declare capitulation in Valeant Pharmaceuticals Intl Inc NYSE VRX as one notorious and maligned bull bids farewell Loathing aside heavy debt and a burdensome
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Intl Inc (VRX) Stock: Goodbye, Not Good Buy",2017-03-16 22:07:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CJvYxuzrrzs/valeant-pharmaceuticals-intl-inc-vrx-stock-goodbye-not-good-buy-cm761957,InvestorPlace Stock Market News Stock Advice amp Trading Tips Some may be tempted to declare capitulation in Valeant Pharmaceuticals Intl Inc NYSE VRX as one notorious and maligned bull bids farewell Loathing aside heavy debt and a burdensome
VRX,VRX:CT,BBG000DC8S17,Valeant shares pop 4% after activist investor ValueAct ups stake,2017-03-16 21:59:16 +0000,http://www.cnbc.com/id/104347016?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104347016,Valeant shares pop 4% after activist investor ValueAct ups stake
VRX,VRX:US,BBG000DLFM21,Valeant shares pop 4% after activist investor ValueAct ups stake,2017-03-16 21:59:16 +0000,http://www.cnbc.com/id/104347016?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104347016,Valeant shares pop 4% after activist investor ValueAct ups stake
VRX,VRX:US,BBG000DLFM21,Valeant Shares Skyrocket After Hours on ValueAct Buy,2017-03-16 21:05:00 +0000,https://www.thestreet.com/story/14048049/1/valeant-shares-skyrocket-after-hours-on-valueact-buy.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Skyrocket After Hours on ValueAct Buy
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Skyrocket After Hours on ValueAct Buy,2017-03-16 21:05:00 +0000,https://www.thestreet.com/story/14048049/1/valeant-shares-skyrocket-after-hours-on-valueact-buy.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Skyrocket After Hours on ValueAct Buy
VRX,VRX:CT,BBG000DC8S17,Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock,2017-03-16 20:56:00 +0000,http://finance.yahoo.com/news/heres-much-valeant-short-sellers-205600331.html,Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock
VRX,VRX:US,BBG000DLFM21,Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock,2017-03-16 20:56:00 +0000,http://finance.yahoo.com/news/heres-much-valeant-short-sellers-205600331.html,Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock
VRX,VRX:US,BBG000DLFM21,"Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make?",2017-03-16 19:36:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/16/valeant-yes-ackmans-a-loser-but-how-much-did-short-sellers-make/?mod=yahoobarrons&ru=yahoo,"Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make?"
VRX,VRX:CT,BBG000DC8S17,"Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make?",2017-03-16 19:36:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/16/valeant-yes-ackmans-a-loser-but-how-much-did-short-sellers-make/?mod=yahoobarrons&ru=yahoo,"Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make?"
VRX,VRX:US,BBG000DLFM21,Valeant: It's Not a Game of Chess- Part I,2017-03-16 17:22:01 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-172201683.html,Valeant: It's Not a Game of Chess- Part I
VRX,VRX:CT,BBG000DC8S17,Valeant: It's Not a Game of Chess- Part I,2017-03-16 17:22:01 +0000,http://finance.yahoo.com/news/valeant-not-game-chess-part-172201683.html,Valeant: It's Not a Game of Chess- Part I
VRX,VRX:CT,BBG000DC8S17,"Court allows Allergan shareholders to go after Ackman, Valeant as a class",2017-03-16 16:35:16 +0000,http://www.bizjournals.com/newyork/news/2017/03/16/court-allows-allergan-shareholders-to-go-after.html?ana=yahoo,"Court allows Allergan shareholders to go after Ackman, Valeant as a class"
VRX,VRX:US,BBG000DLFM21,"Court allows Allergan shareholders to go after Ackman, Valeant as a class",2017-03-16 16:35:16 +0000,http://www.bizjournals.com/newyork/news/2017/03/16/court-allows-allergan-shareholders-to-go-after.html?ana=yahoo,"Court allows Allergan shareholders to go after Ackman, Valeant as a class"
VRX,VRX:US,BBG000DLFM21,Ackman's Investors Won't Get Their Yachts,2017-03-16 10:30:06 +0000,https://www.bloomberg.com/view/articles/2017-03-16/ackman-s-investors-won-t-get-their-yachts?cmpid=yhoo.headline,Ackman's Investors Won't Get Their Yachts
VRX,VRX:CT,BBG000DC8S17,Ackman's Investors Won't Get Their Yachts,2017-03-16 10:30:06 +0000,https://www.bloomberg.com/view/articles/2017-03-16/ackman-s-investors-won-t-get-their-yachts?cmpid=yhoo.headline,Ackman's Investors Won't Get Their Yachts
VRX,VRX:CT,BBG000DC8S17,Why I Won't Be Bottom-Fishing Shares in Valeant,2017-03-15 23:06:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JPMbMVmV418/why-i-wont-be-bottom-fishing-shares-in-valeant-cm761412,Valeant Pharmaceuticals NYSE VRX shares have lost more than 90 of their value and news that longtime shareholder and company cheerleader Bill Ackman has sold his stake added to those losses this week Although the company s shares are undeniably on the clearance rack here s why I
VRX,VRX:US,BBG000DLFM21,Why I Won't Be Bottom-Fishing Shares in Valeant,2017-03-15 23:06:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JPMbMVmV418/why-i-wont-be-bottom-fishing-shares-in-valeant-cm761412,Valeant Pharmaceuticals NYSE VRX shares have lost more than 90 of their value and news that longtime shareholder and company cheerleader Bill Ackman has sold his stake added to those losses this week Although the company s shares are undeniably on the clearance rack here s why I
VRX,VRX:CT,BBG000DC8S17,Why I Won't Be Bottom-Fishing Shares in Valeant,2017-03-15 21:02:00 +0000,https://www.fool.com/investing/2017/03/15/why-i-wont-be-bottom-fishing-shares-in-valeant.aspx,Why I Won't Be Bottom-Fishing Shares in Valeant
VRX,VRX:US,BBG000DLFM21,Why I Won't Be Bottom-Fishing Shares in Valeant,2017-03-15 21:02:00 +0000,https://www.fool.com/investing/2017/03/15/why-i-wont-be-bottom-fishing-shares-in-valeant.aspx,Why I Won't Be Bottom-Fishing Shares in Valeant
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 03/15/2017: VRX,CPRX,CXRX",2017-03-15 20:25:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c8PW_bP58n4/health-care-sector-update-for-03152017-vrxcprxcxrx-cm761350,Top Health Care StocksTop Health Care Stocks JNJ 1 42 JNJ 1 42 PFE 1 31 PFE 1 31 MRK 1 23 MRK 1 23 ABT 1 14 ABT 1 14 AMGN 1 94 AMGN 1 94 Health care stocks were broadly higher today with the NYSE Health Care Index posting a 1 2 increase while shares of health care companies in
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 03/15/2017: VRX,CPRX,CXRX",2017-03-15 20:25:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c8PW_bP58n4/health-care-sector-update-for-03152017-vrxcprxcxrx-cm761350,Top Health Care StocksTop Health Care Stocks JNJ 1 42 JNJ 1 42 PFE 1 31 PFE 1 31 MRK 1 23 MRK 1 23 ABT 1 14 ABT 1 14 AMGN 1 94 AMGN 1 94 Health care stocks were broadly higher today with the NYSE Health Care Index posting a 1 2 increase while shares of health care companies in
VRX,VRX:CT,BBG000DC8S17,"Wednesday’s Vital Data: Valeant Pharmaceuticals Intl Inc (VRX), Tesla Inc (TSLA) and Delta Air Lines, Inc. (DAL)",2017-03-15 18:05:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BHvokiIe2-Q/wednesdays-vital-data-valeant-pharmaceuticals-intl-inc-vrx-tesla-inc-tsla-and-delta-air-lines-inc-dal-cm761284,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are indicating a bit of a rebound from yesterday s losses which is a bit surprising given the dearth of data set to wash over Wall Street in the next two days While a rate hike from the
VRX,VRX:US,BBG000DLFM21,"Wednesday’s Vital Data: Valeant Pharmaceuticals Intl Inc (VRX), Tesla Inc (TSLA) and Delta Air Lines, Inc. (DAL)",2017-03-15 18:05:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BHvokiIe2-Q/wednesdays-vital-data-valeant-pharmaceuticals-intl-inc-vrx-tesla-inc-tsla-and-delta-air-lines-inc-dal-cm761284,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are indicating a bit of a rebound from yesterday s losses which is a bit surprising given the dearth of data set to wash over Wall Street in the next two days While a rate hike from the
VRX,VRX:US,BBG000DLFM21,"Company News for March 15, 2017",2017-03-15 16:10:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZQH46OyUiXQ/company-news-for-march-15-2017-cm761116,Shares of DSW Inc DSW advanced 0 9 after posting fiscal fourth quarter earnings of 0 20 per share beating the Zacks Consensus Estimate of 0 16 MoneyGram International Inc s MGI shares jumped 24 6 on news that Euronet Worldwide Inc EEFT will buy the company
VRX,VRX:CT,BBG000DC8S17,"Company News for March 15, 2017",2017-03-15 16:10:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZQH46OyUiXQ/company-news-for-march-15-2017-cm761116,Shares of DSW Inc DSW advanced 0 9 after posting fiscal fourth quarter earnings of 0 20 per share beating the Zacks Consensus Estimate of 0 16 MoneyGram International Inc s MGI shares jumped 24 6 on news that Euronet Worldwide Inc EEFT will buy the company
VRX,VRX:US,BBG000DLFM21,What Ackman’s exit means for Valeant,2017-03-15 15:35:18 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=622C7B80-08C0-11E7-84E1-1600A899F5E2&siteid=yhoof2,What Ackman’s exit means for Valeant
VRX,VRX:CT,BBG000DC8S17,What Ackman’s exit means for Valeant,2017-03-15 15:35:18 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=622C7B80-08C0-11E7-84E1-1600A899F5E2&siteid=yhoof2,What Ackman’s exit means for Valeant
VRX,VRX:US,BBG000DLFM21,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead",2017-03-15 15:10:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5aHbc55hL50/after-valeant-here-are-5-drug-stocks-bill-ackman-should-buy-instead-cm761004,Billionaire investor Bill Ackman has finally decided to pull out his investment in Canada based drugmaker Valeant Pharmaceuticals International Inc VRX Hedge fund Pershing Square made the announcement earlier this week and said that while Ackman and Steve Fraidin will remain on the
VRX,VRX:CT,BBG000DC8S17,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead",2017-03-15 15:10:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5aHbc55hL50/after-valeant-here-are-5-drug-stocks-bill-ackman-should-buy-instead-cm761004,Billionaire investor Bill Ackman has finally decided to pull out his investment in Canada based drugmaker Valeant Pharmaceuticals International Inc VRX Hedge fund Pershing Square made the announcement earlier this week and said that while Ackman and Steve Fraidin will remain on the
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman Playing Herbalife Like a Rookie, Too",2017-03-15 14:32:00 +0000,https://www.thestreet.com/story/14017944/1/bill-ackman-playing-herbalife-like-a-rookie-too.html?puc=yahoo&cm_ven=YAHOO,"Bill Ackman Playing Herbalife Like a Rookie, Too"
VRX,VRX:US,BBG000DLFM21,"Bill Ackman Playing Herbalife Like a Rookie, Too",2017-03-15 14:32:00 +0000,https://www.thestreet.com/story/14017944/1/bill-ackman-playing-herbalife-like-a-rookie-too.html?puc=yahoo&cm_ven=YAHOO,"Bill Ackman Playing Herbalife Like a Rookie, Too"
VRX,VRX:CT,BBG000DC8S17,"Why Valeant, Oclaro, Time Warner, and More Are in the Spotlight",2017-03-15 14:21:24 +0000,http://www.insidermonkey.com/blog/why-valeant-oclaro-time-warner-and-more-are-in-the-spotlight-566560/,"Why Valeant, Oclaro, Time Warner, and More Are in the Spotlight"
VRX,VRX:US,BBG000DLFM21,"Why Valeant, Oclaro, Time Warner, and More Are in the Spotlight",2017-03-15 14:21:24 +0000,http://www.insidermonkey.com/blog/why-valeant-oclaro-time-warner-and-more-are-in-the-spotlight-566560/,"Why Valeant, Oclaro, Time Warner, and More Are in the Spotlight"
VRX,VRX:US,BBG000DLFM21,"Valeant: No, This is Not a Good Time to Buy",2017-03-15 14:14:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/15/valeant-no-this-is-not-a-good-time-to-buy/?mod=yahoobarrons&ru=yahoo,"Valeant: No, This is Not a Good Time to Buy"
VRX,VRX:CT,BBG000DC8S17,"Valeant: No, This is Not a Good Time to Buy",2017-03-15 14:14:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/15/valeant-no-this-is-not-a-good-time-to-buy/?mod=yahoobarrons&ru=yahoo,"Valeant: No, This is Not a Good Time to Buy"
VRX,VRX:US,BBG000DLFM21,"Company News for March 15, 2017",2017-03-15 14:10:02 +0000,http://finance.yahoo.com/news/company-news-march-15-2017-141002054.html,"Company News for March 15, 2017"
VRX,VRX:CT,BBG000DC8S17,"Company News for March 15, 2017",2017-03-15 14:10:02 +0000,http://finance.yahoo.com/news/company-news-march-15-2017-141002054.html,"Company News for March 15, 2017"
VRX,VRX:US,BBG000DLFM21,Is Valeant Finished Now That Ackman Is Out of the Picture?,2017-03-15 13:45:46 +0000,http://finance.yahoo.com/news/valeant-finished-now-ackman-picture-134546681.html,Is Valeant Finished Now That Ackman Is Out of the Picture?
VRX,VRX:CT,BBG000DC8S17,Is Valeant Finished Now That Ackman Is Out of the Picture?,2017-03-15 13:45:46 +0000,http://finance.yahoo.com/news/valeant-finished-now-ackman-picture-134546681.html,Is Valeant Finished Now That Ackman Is Out of the Picture?
VRX,VRX:US,BBG000DLFM21,Today's Feature on Companies from the Biotech Sector: Adeptus Health and Valeant Pharmaceuticals,2017-03-15 13:30:00 +0000,http://finance.yahoo.com/news/todays-feature-companies-biotech-sector-133000135.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 15, 2017 / Long term success in the medical sector is dependent on a number of factors – innovation and demand for a particular drug; the use of a medical service, such ..."
VRX,VRX:CT,BBG000DC8S17,Today's Feature on Companies from the Biotech Sector: Adeptus Health and Valeant Pharmaceuticals,2017-03-15 13:30:00 +0000,http://finance.yahoo.com/news/todays-feature-companies-biotech-sector-133000135.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 15, 2017 / Long term success in the medical sector is dependent on a number of factors – innovation and demand for a particular drug; the use of a medical service, such ..."
VRX,VRX:US,BBG000DLFM21,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead",2017-03-15 13:22:01 +0000,http://finance.yahoo.com/news/valeant-5-drug-stocks-bill-132201437.html,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead"
VRX,VRX:CT,BBG000DC8S17,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead",2017-03-15 13:22:01 +0000,http://finance.yahoo.com/news/valeant-5-drug-stocks-bill-132201437.html,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead"
VRX,VRX:US,BBG000DLFM21,Stifel Out With 4 Contrarian Stocks to Buy With Big Upside Potential,2017-03-15 12:55:03 +0000,http://finance.yahoo.com/news/stifel-4-contrarian-stocks-buy-125503910.html,Stifel Out With 4 Contrarian Stocks to Buy With Big Upside Potential
VRX,VRX:CT,BBG000DC8S17,Stifel Out With 4 Contrarian Stocks to Buy With Big Upside Potential,2017-03-15 12:55:03 +0000,http://finance.yahoo.com/news/stifel-4-contrarian-stocks-buy-125503910.html,Stifel Out With 4 Contrarian Stocks to Buy With Big Upside Potential
VRX,VRX:US,BBG000DLFM21,Valeant: Traders Vs. Portfolio Managers,2017-03-15 11:58:08 +0000,http://finance.yahoo.com/news/valeant-traders-vs-portfolio-managers-115808663.html,Valeant: Traders Vs. Portfolio Managers
VRX,VRX:CT,BBG000DC8S17,Valeant: Traders Vs. Portfolio Managers,2017-03-15 11:58:08 +0000,http://finance.yahoo.com/news/valeant-traders-vs-portfolio-managers-115808663.html,Valeant: Traders Vs. Portfolio Managers
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Introduces Biotrue® ONEday For Astigmatism Contact Lenses,2017-03-15 11:00:00 +0000,http://finance.yahoo.com/news/bausch-lomb-introduces-biotrue-oneday-110000556.html,[CNW Group] - Bausch + Lomb Introduces Biotrue® ONEday For Astigmatism Contact Lenses
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Introduces Biotrue® ONEday For Astigmatism Contact Lenses,2017-03-15 11:00:00 +0000,http://finance.yahoo.com/news/bausch-lomb-introduces-biotrue-oneday-110000556.html,[CNW Group] - Bausch + Lomb Introduces Biotrue® ONEday For Astigmatism Contact Lenses
VRX,VRX:CT,BBG000DC8S17,"Apple, Facebook and Tesla: Off the Charts",2017-03-15 10:32:00 +0000,https://www.thestreet.com/story/14043421/1/apple-facebook-and-tesla-off-the-charts.html?puc=yahoo&cm_ven=YAHOO,"Apple, Facebook and Tesla: Off the Charts"
VRX,VRX:US,BBG000DLFM21,"Apple, Facebook and Tesla: Off the Charts",2017-03-15 10:32:00 +0000,https://www.thestreet.com/story/14043421/1/apple-facebook-and-tesla-off-the-charts.html?puc=yahoo&cm_ven=YAHOO,"Apple, Facebook and Tesla: Off the Charts"
VRX,VRX:US,BBG000DLFM21,Nucor: Cramer's Top Takeaways,2017-03-15 10:24:00 +0000,https://www.thestreet.com/story/14043572/1/nucor-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,Nucor: Cramer's Top Takeaways
VRX,VRX:CT,BBG000DC8S17,Nucor: Cramer's Top Takeaways,2017-03-15 10:24:00 +0000,https://www.thestreet.com/story/14043572/1/nucor-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,Nucor: Cramer's Top Takeaways
VRX,VRX:CT,BBG000DC8S17,Prologis: Cramer's Top Takeaways,2017-03-15 10:23:00 +0000,https://www.thestreet.com/story/14043587/1/prologis-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,Prologis: Cramer's Top Takeaways
VRX,VRX:US,BBG000DLFM21,Prologis: Cramer's Top Takeaways,2017-03-15 10:23:00 +0000,https://www.thestreet.com/story/14043587/1/prologis-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,Prologis: Cramer's Top Takeaways
VRX,VRX:CT,BBG000DC8S17,"Once paid by Vertex, Trump's FDA pick would be tasked with regulating it",2017-03-15 09:45:08 +0000,http://www.bizjournals.com/boston/news/2017/03/15/once-paid-by-vertex-trumps-fda-pick-would-be.html?ana=yahoo,"Once paid by Vertex, Trump's FDA pick would be tasked with regulating it"
VRX,VRX:US,BBG000DLFM21,"Once paid by Vertex, Trump's FDA pick would be tasked with regulating it",2017-03-15 09:45:08 +0000,http://www.bizjournals.com/boston/news/2017/03/15/once-paid-by-vertex-trumps-fda-pick-would-be.html?ana=yahoo,"Once paid by Vertex, Trump's FDA pick would be tasked with regulating it"
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Stock Slides to Lowest Point Since 2009 After Ackman’s Exit,2017-03-15 04:29:50 +0000,https://www.wsj.com/articles/valeant-stock-slides-to-lowest-point-since-2009-after-ackmans-exit-1489503388?ru=yahoo?mod=yahoo_itp,[$$] Valeant Stock Slides to Lowest Point Since 2009 After Ackman’s Exit
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Stock Slides to Lowest Point Since 2009 After Ackman’s Exit,2017-03-15 04:29:50 +0000,https://www.wsj.com/articles/valeant-stock-slides-to-lowest-point-since-2009-after-ackmans-exit-1489503388?ru=yahoo?mod=yahoo_itp,[$$] Valeant Stock Slides to Lowest Point Since 2009 After Ackman’s Exit
VRX,VRX:CT,BBG000DC8S17,12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17),2017-03-15 00:25:00 +0000,https://www.thestreet.com/story/14043524/1/12-years-and-still-finding-the-bulls-for-you-cramer-s-mad-money-recap-tuesday-3-14-17.html?puc=yahoo&cm_ven=YAHOO,12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17)
VRX,VRX:US,BBG000DLFM21,12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17),2017-03-15 00:25:00 +0000,https://www.thestreet.com/story/14043524/1/12-years-and-still-finding-the-bulls-for-you-cramer-s-mad-money-recap-tuesday-3-14-17.html?puc=yahoo&cm_ven=YAHOO,12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17)
VRX,VRX:US,BBG000DLFM21,"Is Chipotle Mexican Grill, Inc. (CMG) Stock Next on Ackman’s Hit List?",2017-03-15 00:05:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KEps5pn4sAI/is-chipotle-mexican-grill-inc-cmg-stock-next-on-ackmans-hit-list-cm760864,InvestorPlace Stock Market News Stock Advice amp Trading Tips The biggest news story Monday was easily Bill Ackman s announcement that Pershing Square Capital Management Ackman s multibillion dollar hedge fund had sold its entire Valeant Pharmaceuticals Intl Inc NYSE
VRX,VRX:CT,BBG000DC8S17,"Is Chipotle Mexican Grill, Inc. (CMG) Stock Next on Ackman’s Hit List?",2017-03-15 00:05:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KEps5pn4sAI/is-chipotle-mexican-grill-inc-cmg-stock-next-on-ackmans-hit-list-cm760864,InvestorPlace Stock Market News Stock Advice amp Trading Tips The biggest news story Monday was easily Bill Ackman s announcement that Pershing Square Capital Management Ackman s multibillion dollar hedge fund had sold its entire Valeant Pharmaceuticals Intl Inc NYSE
VRX,VRX:US,BBG000DLFM21,"Bill Ackman Has Had Enough Precipitous Declines for One Stock, Sells Valeant",2017-03-14 22:51:41 +0000,http://finance.yahoo.com/news/bill-ackman-had-enough-precipitous-225141665.html,"Bill Ackman Has Had Enough Precipitous Declines for One Stock, Sells Valeant"
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman Has Had Enough Precipitous Declines for One Stock, Sells Valeant",2017-03-14 22:51:41 +0000,http://finance.yahoo.com/news/bill-ackman-had-enough-precipitous-225141665.html,"Bill Ackman Has Had Enough Precipitous Declines for One Stock, Sells Valeant"
VRX,VRX:CT,BBG000DC8S17,Valeant shares fall as Ackman exit highlights company's challenges,2017-03-14 22:29:46 +0000,http://in.finance.yahoo.com/news/valeant-shares-fall-ackman-exit-222946544.html,Valeant shares fall as Ackman exit highlights company's challenges
VRX,VRX:US,BBG000DLFM21,Valeant shares fall as Ackman exit highlights company's challenges,2017-03-14 22:29:46 +0000,http://in.finance.yahoo.com/news/valeant-shares-fall-ackman-exit-222946544.html,Valeant shares fall as Ackman exit highlights company's challenges
VRX,VRX:US,BBG000DLFM21,Why Ackman's Valeant Trade Turned Into a Bust,2017-03-14 22:17:23 +0000,http://finance.yahoo.com/video/why-ackmans-valeant-trade-turned-221723123.html,Why Ackman's Valeant Trade Turned Into a Bust
VRX,VRX:CT,BBG000DC8S17,Why Ackman's Valeant Trade Turned Into a Bust,2017-03-14 22:17:23 +0000,http://finance.yahoo.com/video/why-ackmans-valeant-trade-turned-221723123.html,Why Ackman's Valeant Trade Turned Into a Bust
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Tilly's, and Pandora Media Slumped Today",2017-03-14 22:06:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cGFmHxqCj00/why-valeant-pharmaceuticals-tillys-and-pandora-media-slumped-today-cm760797,Tuesday was a poor day for the stock market which lost ground as investors waited for the outcome of the ongoing two day meeting of the Federal Reserve s monetary policy making body Interest rates are likely to get their first boost of the year from the Federal Open Market Committee
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Tilly's, and Pandora Media Slumped Today",2017-03-14 22:06:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cGFmHxqCj00/why-valeant-pharmaceuticals-tillys-and-pandora-media-slumped-today-cm760797,Tuesday was a poor day for the stock market which lost ground as investors waited for the outcome of the ongoing two day meeting of the Federal Reserve s monetary policy making body Interest rates are likely to get their first boost of the year from the Federal Open Market Committee
VRX,VRX:US,BBG000DLFM21,"How to Short Cisco Systems, Inc. (CSCO) Stock for Free",2017-03-14 22:05:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eC1q0i4VEMk/how-to-short-cisco-systems-inc-csco-stock-for-free-cm760811,InvestorPlace Stock Market News Stock Advice amp Trading Tips This year has been kind to Cisco Systems Inc NASDAQ CSCO stock which has risen all the way back to 2007 levels If I zoom out the monthly chart shows more upside potential relative to all time highs but on
VRX,VRX:CT,BBG000DC8S17,"How to Short Cisco Systems, Inc. (CSCO) Stock for Free",2017-03-14 22:05:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eC1q0i4VEMk/how-to-short-cisco-systems-inc-csco-stock-for-free-cm760811,InvestorPlace Stock Market News Stock Advice amp Trading Tips This year has been kind to Cisco Systems Inc NASDAQ CSCO stock which has risen all the way back to 2007 levels If I zoom out the monthly chart shows more upside potential relative to all time highs but on
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Tilly's, and Pandora Media Slumped Today",2017-03-14 20:45:00 +0000,http://www.fool.com/investing/2017/03/14/why-valeant-pharmaceuticals-tillys-and-pandora-med.aspx,"Why Valeant Pharmaceuticals, Tilly's, and Pandora Media Slumped Today"
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Tilly's, and Pandora Media Slumped Today",2017-03-14 20:45:00 +0000,http://www.fool.com/investing/2017/03/14/why-valeant-pharmaceuticals-tillys-and-pandora-med.aspx,"Why Valeant Pharmaceuticals, Tilly's, and Pandora Media Slumped Today"
VRX,VRX:CT,BBG000DC8S17,The lesson of Bill Ackman’s $3 billion loss on Valeant Pharmaceuticals,2017-03-14 20:38:53 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=229F1086-08ED-11E7-9134-706AC7433493&siteid=yhoof2,The lesson of Bill Ackman’s $3 billion loss on Valeant Pharmaceuticals
VRX,VRX:US,BBG000DLFM21,The lesson of Bill Ackman’s $3 billion loss on Valeant Pharmaceuticals,2017-03-14 20:38:53 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=229F1086-08ED-11E7-9134-706AC7433493&siteid=yhoof2,The lesson of Bill Ackman’s $3 billion loss on Valeant Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Stock Falls to Lowest Point Since 2009 After Ackman's Exit,2017-03-14 20:34:38 +0000,https://www.wsj.com/articles/valeant-stock-slides-to-lowest-point-since-2009-after-ackmans-exit-1489503388?mod=yahoo_hs,[$$] Valeant Stock Falls to Lowest Point Since 2009 After Ackman's Exit
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Stock Falls to Lowest Point Since 2009 After Ackman's Exit,2017-03-14 20:34:38 +0000,https://www.wsj.com/articles/valeant-stock-slides-to-lowest-point-since-2009-after-ackmans-exit-1489503388?mod=yahoo_hs,[$$] Valeant Stock Falls to Lowest Point Since 2009 After Ackman's Exit
VRX,VRX:CT,BBG000DC8S17,Valeant Dives To 8-Year Low After Ackman 'Throws In The Towel',2017-03-14 20:13:58 +0000,http://www.investors.com/news/technology/valeant-dives-to-8-year-low-after-william-ackman-throws-in-the-towel/?src=A00220A,Valeant Dives To 8-Year Low After Ackman 'Throws In The Towel'
VRX,VRX:US,BBG000DLFM21,Valeant Dives To 8-Year Low After Ackman 'Throws In The Towel',2017-03-14 20:13:58 +0000,http://www.investors.com/news/technology/valeant-dives-to-8-year-low-after-william-ackman-throws-in-the-towel/?src=A00220A,Valeant Dives To 8-Year Low After Ackman 'Throws In The Towel'
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX posts lowest close this year as energy, Valeant weigh",2017-03-14 20:10:54 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-posts-lowest-201054427.html,"CANADA STOCKS-TSX posts lowest close this year as energy, Valeant weigh"
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX posts lowest close this year as energy, Valeant weigh",2017-03-14 20:10:54 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-posts-lowest-201054427.html,"CANADA STOCKS-TSX posts lowest close this year as energy, Valeant weigh"
VRX,VRX:CT,BBG000DC8S17,Ackman's exit sends Valeant shares to more than 7-year low,2017-03-14 20:09:28 +0000,http://www.cnbc.com/id/104341031?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104341031,Ackman's exit sends Valeant shares to more than 7-year low
VRX,VRX:US,BBG000DLFM21,Ackman's exit sends Valeant shares to more than 7-year low,2017-03-14 20:09:28 +0000,http://www.cnbc.com/id/104341031?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104341031,Ackman's exit sends Valeant shares to more than 7-year low
VRX,VRX:CT,BBG000DC8S17,Buy Alibaba Group Holding Ltd (BABA) Stock Now With a Discount on Risk,2017-03-14 20:06:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6A9EnSHXtjA/buy-alibaba-group-holding-ltd-baba-stock-now-with-a-discount-on-risk-cm760759,InvestorPlace Stock Market News Stock Advice amp Trading Tips I don t know Jack about what s lifting shares of Alibaba Group Holding Ltd NYSE BABA Monday More to the point confidence in BABA stock s price chart and a lower risk spread opportunity means an otherwise
VRX,VRX:US,BBG000DLFM21,Buy Alibaba Group Holding Ltd (BABA) Stock Now With a Discount on Risk,2017-03-14 20:06:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6A9EnSHXtjA/buy-alibaba-group-holding-ltd-baba-stock-now-with-a-discount-on-risk-cm760759,InvestorPlace Stock Market News Stock Advice amp Trading Tips I don t know Jack about what s lifting shares of Alibaba Group Holding Ltd NYSE BABA Monday More to the point confidence in BABA stock s price chart and a lower risk spread opportunity means an otherwise
VRX,VRX:CT,BBG000DC8S17,Wild Weather Mutes Activity in a Down Day for Wall Street,2017-03-14 20:06:00 +0000,https://www.thestreet.com/story/14043095/1/wild-weather-mutes-activity-in-a-down-day-for-wall-street.html?puc=yahoo&cm_ven=YAHOO,Wild Weather Mutes Activity in a Down Day for Wall Street
VRX,VRX:US,BBG000DLFM21,Wild Weather Mutes Activity in a Down Day for Wall Street,2017-03-14 20:06:00 +0000,https://www.thestreet.com/story/14043095/1/wild-weather-mutes-activity-in-a-down-day-for-wall-street.html?puc=yahoo&cm_ven=YAHOO,Wild Weather Mutes Activity in a Down Day for Wall Street
VRX,VRX:US,BBG000DLFM21,"Valeant, JC Penney Plunge Into Tuesday’s 52-Week Low Club",2017-03-14 20:04:34 +0000,http://finance.yahoo.com/news/valeant-j-c-penney-plunge-200434577.html,"Valeant, JC Penney Plunge Into Tuesday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,"Valeant, JC Penney Plunge Into Tuesday’s 52-Week Low Club",2017-03-14 20:04:34 +0000,http://finance.yahoo.com/news/valeant-j-c-penney-plunge-200434577.html,"Valeant, JC Penney Plunge Into Tuesday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Still Reeling From Ackman Exit,2017-03-14 20:04:00 +0000,https://www.thestreet.com/story/14043157/1/valeant-shares-still-reeling-from-ackman-exit.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Still Reeling From Ackman Exit
VRX,VRX:US,BBG000DLFM21,Valeant Shares Still Reeling From Ackman Exit,2017-03-14 20:04:00 +0000,https://www.thestreet.com/story/14043157/1/valeant-shares-still-reeling-from-ackman-exit.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Still Reeling From Ackman Exit
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: What Was Bill Ackman Thinking?,2017-03-14 19:59:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/14/valeant-pharmaceuticals-what-was-bill-ackman-thinking/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: What Was Bill Ackman Thinking?
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: What Was Bill Ackman Thinking?,2017-03-14 19:59:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/14/valeant-pharmaceuticals-what-was-bill-ackman-thinking/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: What Was Bill Ackman Thinking?
VRX,VRX:CT,BBG000DC8S17,Valeant: 5 Reasons Ackman's Exit Sends a Really Bad Message,2017-03-14 19:47:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/14/valeant-5-reasons-ackmans-exit-leaves-sends-a-really-bad-message/?mod=yahoobarrons&ru=yahoo,Valeant: 5 Reasons Ackman's Exit Sends a Really Bad Message
VRX,VRX:US,BBG000DLFM21,Valeant: 5 Reasons Ackman's Exit Sends a Really Bad Message,2017-03-14 19:47:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/14/valeant-5-reasons-ackmans-exit-leaves-sends-a-really-bad-message/?mod=yahoobarrons&ru=yahoo,Valeant: 5 Reasons Ackman's Exit Sends a Really Bad Message
VRX,VRX:CT,BBG000DC8S17,Valeant's Legal Risks Mount as Ackman Exits Stock and Board,2017-03-14 19:22:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/14/valeants-legal-risks-mount-as-ackman-exits-stock-and-board/?mod=yahoobarrons&ru=yahoo,Valeant's Legal Risks Mount as Ackman Exits Stock and Board
VRX,VRX:US,BBG000DLFM21,Valeant's Legal Risks Mount as Ackman Exits Stock and Board,2017-03-14 19:22:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/14/valeants-legal-risks-mount-as-ackman-exits-stock-and-board/?mod=yahoobarrons&ru=yahoo,Valeant's Legal Risks Mount as Ackman Exits Stock and Board
VRX,VRX:CT,BBG000DC8S17,How A Big Hedge Fund Ace Lost 95%,2017-03-14 19:11:00 +0000,http://www.forbes.com/sites/investor/2017/03/14/how-a-big-hedgefund-ace-lost-95/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,How A Big Hedge Fund Ace Lost 95%
VRX,VRX:US,BBG000DLFM21,How A Big Hedge Fund Ace Lost 95%,2017-03-14 19:11:00 +0000,http://www.forbes.com/sites/investor/2017/03/14/how-a-big-hedgefund-ace-lost-95/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,How A Big Hedge Fund Ace Lost 95%
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Is Down 10% Today,2017-03-14 19:06:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qWS5GS079lo/why-valeant-pharmaceuticals-is-down-10-today-cm760694,What happened Following a decision by longtime investor and hedge fund manager Bill Ackman to sell his shares in the struggling drugmaker Valeant Pharmaceuticals NYSE VRX 160 stock price was down 10 at 12 45 160 p m EDT today So what At one point Bill Ackman
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Is Down 10% Today,2017-03-14 19:06:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qWS5GS079lo/why-valeant-pharmaceuticals-is-down-10-today-cm760694,What happened Following a decision by longtime investor and hedge fund manager Bill Ackman to sell his shares in the struggling drugmaker Valeant Pharmaceuticals NYSE VRX 160 stock price was down 10 at 12 45 160 p m EDT today So what At one point Bill Ackman
VRX,VRX:US,BBG000DLFM21,[video]Chipotle Will Require Ackman-Like Patience,2017-03-14 18:53:00 +0000,https://www.thestreet.com/story/14042941/1/chipotle-will-require-ackman-like-patience.html?puc=yahoo&cm_ven=YAHOO,[video]Chipotle Will Require Ackman-Like Patience
VRX,VRX:CT,BBG000DC8S17,[video]Chipotle Will Require Ackman-Like Patience,2017-03-14 18:53:00 +0000,https://www.thestreet.com/story/14042941/1/chipotle-will-require-ackman-like-patience.html?puc=yahoo&cm_ven=YAHOO,[video]Chipotle Will Require Ackman-Like Patience
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Exits Valeant,2017-03-14 18:49:00 +0000,http://www.thestreet.com/video/14042974/bill-ackman-exits-valeant.html?puc=yahoov&cm_ven=YAHOOV,Bill Ackman Exits Valeant
VRX,VRX:US,BBG000DLFM21,Bill Ackman Exits Valeant,2017-03-14 18:49:00 +0000,http://www.thestreet.com/video/14042974/bill-ackman-exits-valeant.html?puc=yahoov&cm_ven=YAHOOV,Bill Ackman Exits Valeant
VRX,VRX:US,BBG000DLFM21,"Stocks Hold Lower as Blizzard Conditions Stifle Activity, Crude Pressures Energy Names",2017-03-14 18:48:00 +0000,https://www.thestreet.com/story/14042586/1/stocks-fall-in-low-volume-trading-as-blizzard-conditions-stifle-activity.html?puc=yahoo&cm_ven=YAHOO,"Stocks Hold Lower as Blizzard Conditions Stifle Activity, Crude Pressures Energy Names"
VRX,VRX:CT,BBG000DC8S17,"Stocks Hold Lower as Blizzard Conditions Stifle Activity, Crude Pressures Energy Names",2017-03-14 18:48:00 +0000,https://www.thestreet.com/story/14042586/1/stocks-fall-in-low-volume-trading-as-blizzard-conditions-stifle-activity.html?puc=yahoo&cm_ven=YAHOO,"Stocks Hold Lower as Blizzard Conditions Stifle Activity, Crude Pressures Energy Names"
VRX,VRX:CT,BBG000DC8S17,A Brief Timeline Of The Bill Ackman-Valeant Relationship,2017-03-14 18:37:16 +0000,http://finance.yahoo.com/news/brief-timeline-bill-ackman-valeant-183716831.html,A Brief Timeline Of The Bill Ackman-Valeant Relationship
VRX,VRX:US,BBG000DLFM21,A Brief Timeline Of The Bill Ackman-Valeant Relationship,2017-03-14 18:37:16 +0000,http://finance.yahoo.com/news/brief-timeline-bill-ackman-valeant-183716831.html,A Brief Timeline Of The Bill Ackman-Valeant Relationship
VRX,VRX:US,BBG000DLFM21,Valeant: How Do You Stay Bullish?,2017-03-14 18:31:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/14/valeant-how-do-stay-bullish/?mod=yahoobarrons&ru=yahoo,Valeant: How Do You Stay Bullish?
VRX,VRX:CT,BBG000DC8S17,Valeant: How Do You Stay Bullish?,2017-03-14 18:31:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/14/valeant-how-do-stay-bullish/?mod=yahoobarrons&ru=yahoo,Valeant: How Do You Stay Bullish?
VRX,VRX:US,BBG000DLFM21,TransDigm Stock Upgraded: What You Need to Know,2017-03-14 18:06:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0tqC407AJCw/transdigm-stock-upgraded-what-you-need-to-know-cm760656,Every day Wall Street analysts upgrade some stocks downgrade others and initiate coverage on a few more But do these analysts even know what they re talking about Today we re taking one high profile Wall Street pick and putting it under the microscope The past
VRX,VRX:CT,BBG000DC8S17,TransDigm Stock Upgraded: What You Need to Know,2017-03-14 18:06:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0tqC407AJCw/transdigm-stock-upgraded-what-you-need-to-know-cm760656,Every day Wall Street analysts upgrade some stocks downgrade others and initiate coverage on a few more But do these analysts even know what they re talking about Today we re taking one high profile Wall Street pick and putting it under the microscope The past
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Tuesday: Ruby Tuesday, Inc. (RT), Valeant Pharmaceuticals Intl Inc (VRX) and Moneygram International Inc (MGI)",2017-03-14 18:05:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k1W17wQ_43I/3-stocks-to-watch-on-tuesday-ruby-tuesday-inc-rt-valeant-pharmaceuticals-intl-inc-vrx-and-moneygram-international-inc-mgi-cm760688,InvestorPlace Stock Market News Stock Advice amp Trading Tips It was a mixed day for U S equities as many fear higher inflation due to higher wages and falling unemployment rates The 160 S amp P 500 Index gained a fraction of a percent the 160 Dow Jones
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Tuesday: Ruby Tuesday, Inc. (RT), Valeant Pharmaceuticals Intl Inc (VRX) and Moneygram International Inc (MGI)",2017-03-14 18:05:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k1W17wQ_43I/3-stocks-to-watch-on-tuesday-ruby-tuesday-inc-rt-valeant-pharmaceuticals-intl-inc-vrx-and-moneygram-international-inc-mgi-cm760688,InvestorPlace Stock Market News Stock Advice amp Trading Tips It was a mixed day for U S equities as many fear higher inflation due to higher wages and falling unemployment rates The 160 S amp P 500 Index gained a fraction of a percent the 160 Dow Jones
VRX,VRX:US,BBG000DLFM21,Bill Ackman Is Done Losing Money on Valeant,2017-03-14 17:48:35 +0000,https://www.bloomberg.com/view/articles/2017-03-14/bill-ackman-is-done-losing-money-on-valeant?cmpid=yhoo.headline,Bill Ackman Is Done Losing Money on Valeant
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Is Done Losing Money on Valeant,2017-03-14 17:48:35 +0000,https://www.bloomberg.com/view/articles/2017-03-14/bill-ackman-is-done-losing-money-on-valeant?cmpid=yhoo.headline,Bill Ackman Is Done Losing Money on Valeant
VRX,VRX:US,BBG000DLFM21,3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX),2017-03-14 17:45:32 +0000,http://www.insidermonkey.com/blog/3-hedge-funds-still-love-valeant-pharmaceuticals-intl-inc-vrx-566277/,3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX)
VRX,VRX:CT,BBG000DC8S17,3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX),2017-03-14 17:45:32 +0000,http://www.insidermonkey.com/blog/3-hedge-funds-still-love-valeant-pharmaceuticals-intl-inc-vrx-566277/,3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX)
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Is Down 10% Today,2017-03-14 17:42:00 +0000,http://www.fool.com/investing/2017/03/14/why-valeant-pharmaceuticals-is-down-10-today.aspx,Why Valeant Pharmaceuticals Is Down 10% Today
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Is Down 10% Today,2017-03-14 17:42:00 +0000,http://www.fool.com/investing/2017/03/14/why-valeant-pharmaceuticals-is-down-10-today.aspx,Why Valeant Pharmaceuticals Is Down 10% Today
VRX,VRX:CT,BBG000DC8S17,LPC: Valeant refinancing on track despite Ackman stock sale,2017-03-14 17:38:50 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-refinancing-track-despite-173850557.html,"[Reuters - UK Focus] - Drugmaker Valeant Pharmaceuticals will not see any changes to its planned refinancing in the wake of billionaire William Ackman and his hedge fund Pershing Square selling its share of the company, sources said. Valeant is extending the maturity date on three loans to 2022 in order to match the maturity date of its term loan F. The company is also paying down revolving credit debt and its term loan A debt as part of the refinancing effort, which includes the US$3.25bn sale of secured notes. The company, which has approximately US$30bn in debt, saw its stock drop to all-time lows as it dipped under US$11 per share on Tuesday after news emerged that Ackman and his hedge funder were selling their entire position of approximately 27 million shares."
VRX,VRX:US,BBG000DLFM21,LPC: Valeant refinancing on track despite Ackman stock sale,2017-03-14 17:38:50 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-refinancing-track-despite-173850557.html,"[Reuters - UK Focus] - Drugmaker Valeant Pharmaceuticals will not see any changes to its planned refinancing in the wake of billionaire William Ackman and his hedge fund Pershing Square selling its share of the company, sources said. Valeant is extending the maturity date on three loans to 2022 in order to match the maturity date of its term loan F. The company is also paying down revolving credit debt and its term loan A debt as part of the refinancing effort, which includes the US$3.25bn sale of secured notes. The company, which has approximately US$30bn in debt, saw its stock drop to all-time lows as it dipped under US$11 per share on Tuesday after news emerged that Ackman and his hedge funder were selling their entire position of approximately 27 million shares."
VRX,VRX:US,BBG000DLFM21,Why Alibaba Stock Could Hit $120 (BABA),2017-03-14 17:05:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g3PV0Gf6_Vc/why-alibaba-stock-could-hit-120-baba-cm760651,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of 160 Alibaba Group Holding Ltd NYSE BABA are higher by a stellar 20 year to date despite largely meandering sideways since late January Like a great many momentum and growth stocks BABA stock got an
VRX,VRX:CT,BBG000DC8S17,Why Alibaba Stock Could Hit $120 (BABA),2017-03-14 17:05:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g3PV0Gf6_Vc/why-alibaba-stock-could-hit-120-baba-cm760651,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of 160 Alibaba Group Holding Ltd NYSE BABA are higher by a stellar 20 year to date despite largely meandering sideways since late January Like a great many momentum and growth stocks BABA stock got an
VRX,VRX:CT,BBG000DC8S17,All the Talk Is of Ackman and Valeant,2017-03-14 17:01:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/all-talk-ackman-and-valeant?puc=yahoo&cm_ven=YAHOO,All the Talk Is of Ackman and Valeant
VRX,VRX:US,BBG000DLFM21,All the Talk Is of Ackman and Valeant,2017-03-14 17:01:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/all-talk-ackman-and-valeant?puc=yahoo&cm_ven=YAHOO,All the Talk Is of Ackman and Valeant
VRX,VRX:US,BBG000DLFM21,Ackman's Valeant Bust Shows the Cost of Inconsistency,2017-03-14 16:54:56 +0000,https://www.bloomberg.com/view/articles/2017-03-14/ackman-s-valeant-bust-shows-the-cost-of-inconsistency?cmpid=yhoo.headline,Ackman's Valeant Bust Shows the Cost of Inconsistency
VRX,VRX:CT,BBG000DC8S17,Ackman's Valeant Bust Shows the Cost of Inconsistency,2017-03-14 16:54:56 +0000,https://www.bloomberg.com/view/articles/2017-03-14/ackman-s-valeant-bust-shows-the-cost-of-inconsistency?cmpid=yhoo.headline,Ackman's Valeant Bust Shows the Cost of Inconsistency
VRX,VRX:CT,BBG000DC8S17,Chipotle Will Require Ackman-Like Patience,2017-03-14 16:53:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/chipotle-will-require-ackman-patience?puc=yahoo&cm_ven=YAHOO,Chipotle Will Require Ackman-Like Patience
VRX,VRX:US,BBG000DLFM21,Chipotle Will Require Ackman-Like Patience,2017-03-14 16:53:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/chipotle-will-require-ackman-patience?puc=yahoo&cm_ven=YAHOO,Chipotle Will Require Ackman-Like Patience
VRX,VRX:CT,BBG000DC8S17,TransDigm Stock Upgraded: What You Need to Know,2017-03-14 16:40:52 +0000,http://www.fool.com/investing/2017/03/14/transdigm-stock-upgraded-what-you-need-to-know.aspx,TransDigm Stock Upgraded: What You Need to Know
VRX,VRX:US,BBG000DLFM21,TransDigm Stock Upgraded: What You Need to Know,2017-03-14 16:40:52 +0000,http://www.fool.com/investing/2017/03/14/transdigm-stock-upgraded-what-you-need-to-know.aspx,TransDigm Stock Upgraded: What You Need to Know
VRX,VRX:CT,BBG000DC8S17,Valeant shares plunge as Ackman exits stake,2017-03-14 16:32:49 +0000,http://uk.finance.yahoo.com/news/valeant-shares-plunge-ackman-exits-163249026.html,Valeant shares plunge as Ackman exits stake
VRX,VRX:US,BBG000DLFM21,Valeant shares plunge as Ackman exits stake,2017-03-14 16:32:49 +0000,http://uk.finance.yahoo.com/news/valeant-shares-plunge-ackman-exits-163249026.html,Valeant shares plunge as Ackman exits stake
VRX,VRX:CT,BBG000DC8S17,"TSX Down Triple-digits On Valeant, Oil Weakness -- Canadian Commentary",2017-03-14 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lknw4t-D3IQ/tsx-down-tripledigits-on-valeant-oil-weakness--canadian-commentary-20170314-01120,"TSX Down Triple-digits On Valeant, Oil Weakness -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"TSX Down Triple-digits On Valeant, Oil Weakness -- Canadian Commentary",2017-03-14 16:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lknw4t-D3IQ/tsx-down-tripledigits-on-valeant-oil-weakness--canadian-commentary-20170314-01120,"TSX Down Triple-digits On Valeant, Oil Weakness -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Stocks Slide as Crude Oil Declines, Blizzard Cripples New York",2017-03-14 15:12:00 +0000,https://www.thestreet.com/story/14042072/1/stocks-slide-as-crude-oil-declines-blizzard-cripples-new-york.html?puc=yahoo&cm_ven=YAHOO,"Stocks Slide as Crude Oil Declines, Blizzard Cripples New York"
VRX,VRX:CT,BBG000DC8S17,"Stocks Slide as Crude Oil Declines, Blizzard Cripples New York",2017-03-14 15:12:00 +0000,https://www.thestreet.com/story/14042072/1/stocks-slide-as-crude-oil-declines-blizzard-cripples-new-york.html?puc=yahoo&cm_ven=YAHOO,"Stocks Slide as Crude Oil Declines, Blizzard Cripples New York"
VRX,VRX:US,BBG000DLFM21,The Smartest Move Billionaire Bill Ackman Made Was Selling His Remaining Valeant Stake,2017-03-14 15:07:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/voY5myxQV5M/the-smartest-move-billionaire-bill-ackman-made-was-selling-his-remaining-valeant-stake-cm760466,You win some and you lose some For billionaire investor Bill Ackman of Pershing Square Capital Management embattled drugmaker Valeant Pharmaceuticals NYSE VRX may very well represent the worst investment of his lifetime after the billionaire announced yesterday that he d sold out
VRX,VRX:CT,BBG000DC8S17,The Smartest Move Billionaire Bill Ackman Made Was Selling His Remaining Valeant Stake,2017-03-14 15:07:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/voY5myxQV5M/the-smartest-move-billionaire-bill-ackman-made-was-selling-his-remaining-valeant-stake-cm760466,You win some and you lose some For billionaire investor Bill Ackman of Pershing Square Capital Management embattled drugmaker Valeant Pharmaceuticals NYSE VRX may very well represent the worst investment of his lifetime after the billionaire announced yesterday that he d sold out
VRX,VRX:CT,BBG000DC8S17,The Lesson from Bill Ackman's Valeant (VRX) Woes,2017-03-14 14:48:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0fHWHmbBJEY/the-lesson-from-bill-ackmans-valeant-vrx-woes-cm760518,"There is big news in the world of hedge funds this morning, where Bill Ackman has, we are told, bailed out of his well-reported position in Valeant Pharmaceutical ( VRX ). For those who have managed to avoid the saga, Ackman’s fund, Pershing Square, invested in the firm a couple of years ago, when consolidation in"
VRX,VRX:US,BBG000DLFM21,The Lesson from Bill Ackman's Valeant (VRX) Woes,2017-03-14 14:48:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0fHWHmbBJEY/the-lesson-from-bill-ackmans-valeant-vrx-woes-cm760518,"There is big news in the world of hedge funds this morning, where Bill Ackman has, we are told, bailed out of his well-reported position in Valeant Pharmaceutical ( VRX ). For those who have managed to avoid the saga, Ackman’s fund, Pershing Square, invested in the firm a couple of years ago, when consolidation in"
VRX,VRX:CT,BBG000DC8S17,[video]Valeant's Downtrends Are Still Intact,2017-03-14 14:45:00 +0000,https://www.thestreet.com/story/14042110/1/valeant-s-downtrends-are-still-intact.html?puc=yahoo&cm_ven=YAHOO,[video]Valeant's Downtrends Are Still Intact
VRX,VRX:US,BBG000DLFM21,[video]Valeant's Downtrends Are Still Intact,2017-03-14 14:45:00 +0000,https://www.thestreet.com/story/14042110/1/valeant-s-downtrends-are-still-intact.html?puc=yahoo&cm_ven=YAHOO,[video]Valeant's Downtrends Are Still Intact
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX falls as energy stocks weigh, Valeant slumps",2017-03-14 14:17:24 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-falls-energy-141724087.html,"CANADA STOCKS-TSX falls as energy stocks weigh, Valeant slumps"
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX falls as energy stocks weigh, Valeant slumps",2017-03-14 14:17:24 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-falls-energy-141724087.html,"CANADA STOCKS-TSX falls as energy stocks weigh, Valeant slumps"
VRX,VRX:CT,BBG000DC8S17,Valeant: Not the End of the World?,2017-03-14 14:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/14/valeant-not-the-end-of-the-world/?mod=yahoobarrons&ru=yahoo,Valeant: Not the End of the World?
VRX,VRX:US,BBG000DLFM21,Valeant: Not the End of the World?,2017-03-14 14:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/14/valeant-not-the-end-of-the-world/?mod=yahoobarrons&ru=yahoo,Valeant: Not the End of the World?
VRX,VRX:CT,BBG000DC8S17,How Much Money Did Bill Ackman Lose In Valeant?,2017-03-14 14:10:08 +0000,http://finance.yahoo.com/news/much-money-did-bill-ackman-141008313.html,How Much Money Did Bill Ackman Lose In Valeant?
VRX,VRX:US,BBG000DLFM21,How Much Money Did Bill Ackman Lose In Valeant?,2017-03-14 14:10:08 +0000,http://finance.yahoo.com/news/much-money-did-bill-ackman-141008313.html,How Much Money Did Bill Ackman Lose In Valeant?
VRX,VRX:CT,BBG000DC8S17,"Ackman dumps Valeant stake, Disney gets upgraded, Ruby Tuesday soars on potential sale",2017-03-14 13:59:11 +0000,http://finance.yahoo.com/news/ackman-dumps-valeant-stake-disney-gets-upgraded-ruby-tuesday-soars-on-potential-sale-135911086.html,"Ackman dumps Valeant stake, Disney gets upgraded, Ruby Tuesday soars on potential sale"
VRX,VRX:US,BBG000DLFM21,"Ackman dumps Valeant stake, Disney gets upgraded, Ruby Tuesday soars on potential sale",2017-03-14 13:59:11 +0000,http://finance.yahoo.com/news/ackman-dumps-valeant-stake-disney-gets-upgraded-ruby-tuesday-soars-on-potential-sale-135911086.html,"Ackman dumps Valeant stake, Disney gets upgraded, Ruby Tuesday soars on potential sale"
VRX,VRX:CT,BBG000DC8S17,"And yes, Valeant's stock is getting hammered",2017-03-14 13:53:00 +0000,http://finance.yahoo.com/news/yes-valeants-stock-getting-hammered-135300286.html,"And yes, Valeant's stock is getting hammered"
VRX,VRX:US,BBG000DLFM21,"And yes, Valeant's stock is getting hammered",2017-03-14 13:53:00 +0000,http://finance.yahoo.com/news/yes-valeants-stock-getting-hammered-135300286.html,"And yes, Valeant's stock is getting hammered"
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss,2017-03-14 13:48:41 +0000,http://finance.yahoo.com/video/bill-ackman-sells-valeant-stake-134841291.html,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss
VRX,VRX:US,BBG000DLFM21,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss,2017-03-14 13:48:41 +0000,http://finance.yahoo.com/video/bill-ackman-sells-valeant-stake-134841291.html,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss
VRX,VRX:US,BBG000DLFM21,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss,2017-03-14 13:48:15 +0000,https://www.bloomberg.com/news/videos/2017-03-14/bill-ackman-sells-valeant-stake-after-2-8-billion-loss-video?cmpid=yhoo.headline,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss,2017-03-14 13:48:15 +0000,https://www.bloomberg.com/news/videos/2017-03-14/bill-ackman-sells-valeant-stake-after-2-8-billion-loss-video?cmpid=yhoo.headline,Bill Ackman Sells Valeant Stake After $2.8 Billion Loss
VRX,VRX:US,BBG000DLFM21,"Stocks Open Lower; Chevron, Exxon, UnitedHealth Drag On Dow",2017-03-14 13:46:04 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-point-to-flat-start-arris-soars-on-goldman-upgrade/?src=A00220A,"Stocks Open Lower; Chevron, Exxon, UnitedHealth Drag On Dow"
VRX,VRX:CT,BBG000DC8S17,"Stocks Open Lower; Chevron, Exxon, UnitedHealth Drag On Dow",2017-03-14 13:46:04 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-point-to-flat-start-arris-soars-on-goldman-upgrade/?src=A00220A,"Stocks Open Lower; Chevron, Exxon, UnitedHealth Drag On Dow"
VRX,VRX:US,BBG000DLFM21,Valeant Slumps as Longtime Backer Ackman Exits With a Loss,2017-03-14 13:43:15 +0000,https://www.bloomberg.com/news/articles/2017-03-14/valeant-slumps-after-long-time-backer-ackman-exits-with-a-loss?cmpid=yhoo.headline,Valeant Slumps as Longtime Backer Ackman Exits With a Loss
VRX,VRX:US,BBG000DLFM21,Valeant Slumps After Longtime Backer Ackman Exits With a Loss,2017-03-14 13:43:15 +0000,http://finance.yahoo.com/news/valeant-slumps-longtime-backer-ackman-134315130.html,Valeant Slumps After Longtime Backer Ackman Exits With a Loss
VRX,VRX:CT,BBG000DC8S17,Valeant Slumps After Longtime Backer Ackman Exits With a Loss,2017-03-14 13:43:15 +0000,http://finance.yahoo.com/news/valeant-slumps-longtime-backer-ackman-134315130.html,Valeant Slumps After Longtime Backer Ackman Exits With a Loss
VRX,VRX:CT,BBG000DC8S17,Valeant Slumps as Longtime Backer Ackman Exits With a Loss,2017-03-14 13:43:15 +0000,https://www.bloomberg.com/news/articles/2017-03-14/valeant-slumps-after-long-time-backer-ackman-exits-with-a-loss?cmpid=yhoo.headline,Valeant Slumps as Longtime Backer Ackman Exits With a Loss
VRX,VRX:CT,BBG000DC8S17,Pershing Square's Valeant Sale Sends 'Untimely Poor Signal',2017-03-14 13:38:05 +0000,http://finance.yahoo.com/news/pershing-squares-valeant-sale-sends-133805497.html,Pershing Square's Valeant Sale Sends 'Untimely Poor Signal'
VRX,VRX:US,BBG000DLFM21,Pershing Square's Valeant Sale Sends 'Untimely Poor Signal',2017-03-14 13:38:05 +0000,http://finance.yahoo.com/news/pershing-squares-valeant-sale-sends-133805497.html,Pershing Square's Valeant Sale Sends 'Untimely Poor Signal'
VRX,VRX:CT,BBG000DC8S17,Valeant's collapse — from Clinton's tweet to Ackman's exit,2017-03-14 13:34:00 +0000,http://finance.yahoo.com/news/valeants-downfall-illustrated-stock-chart-121300749.html,Valeant's collapse — from Clinton's tweet to Ackman's exit
VRX,VRX:US,BBG000DLFM21,Valeant's collapse — from Clinton's tweet to Ackman's exit,2017-03-14 13:34:00 +0000,http://finance.yahoo.com/news/valeants-downfall-illustrated-stock-chart-121300749.html,Valeant's collapse — from Clinton's tweet to Ackman's exit
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma: Did The Other Shoe Just Drop?,2017-03-14 13:22:00 +0000,http://www.investopedia.com/news/valeant-did-other-shoe-just-drop-vrx/?partner=YahooSA,Valeant Pharma: Did The Other Shoe Just Drop?
VRX,VRX:US,BBG000DLFM21,Valeant Pharma: Did The Other Shoe Just Drop?,2017-03-14 13:22:00 +0000,http://www.investopedia.com/news/valeant-did-other-shoe-just-drop-vrx/?partner=YahooSA,Valeant Pharma: Did The Other Shoe Just Drop?
VRX,VRX:US,BBG000DLFM21,The Smartest Move Billionaire Bill Ackman Made Was Selling His Remaining Valeant Stake,2017-03-14 13:09:00 +0000,http://www.fool.com/investing/2017/03/14/the-smartest-move-billionaire-bill-ackman-made-was.aspx,The Smartest Move Billionaire Bill Ackman Made Was Selling His Remaining Valeant Stake
VRX,VRX:CT,BBG000DC8S17,The Smartest Move Billionaire Bill Ackman Made Was Selling His Remaining Valeant Stake,2017-03-14 13:09:00 +0000,http://www.fool.com/investing/2017/03/14/the-smartest-move-billionaire-bill-ackman-made-was.aspx,The Smartest Move Billionaire Bill Ackman Made Was Selling His Remaining Valeant Stake
VRX,VRX:US,BBG000DLFM21,"Ackman's Pershing Square sells Valeant stake, takes $3 billion loss",2017-03-14 12:57:32 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-sells-valeant-000246465.html,"[Reuters] - Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc on Monday with a loss of more than $3 billion as he sold his entire stake in the struggling drug company after trying to rescue it for some 18 months. The abrupt and unexpected move by the powerful activist investor sent Valeant shares tumbling almost 10 percent in after-hours trading. For Ackman, it marked a dramatic climbdown from his vocal support of the company, but should help soothe his own investors who had begun to show signs of concern about mounting losses in his portfolio."
VRX,VRX:CT,BBG000DC8S17,"Ackman's Pershing Square sells Valeant stake, takes $3 billion loss",2017-03-14 12:57:32 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-sells-valeant-000246465.html,"[Reuters] - Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc on Monday with a loss of more than $3 billion as he sold his entire stake in the struggling drug company after trying to rescue it for some 18 months. The abrupt and unexpected move by the powerful activist investor sent Valeant shares tumbling almost 10 percent in after-hours trading. For Ackman, it marked a dramatic climbdown from his vocal support of the company, but should help soothe his own investors who had begun to show signs of concern about mounting losses in his portfolio."
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Mar 14, 2017 :  NUAN, AUPH, VRX, MGI, WIX, MBLY, TVIX, DOC, QQQ, BAC, BP, FCX",2017-03-14 12:55:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oqej5bPdGqU/pre-market-most-active-for-mar-14-2017-nuan-auph-vrx-mgi-wix-mbly-tvix-doc-qqq-bac-bp-fcx-cm760338,The NASDAQ 100 Pre Market Indicator is down 4 22 to 5 390 35 The total Pre Market volume is currently 5 848 193 shares traded The following are the most active stocks for the pre market session Nuance Communications Inc NUAN is unchanged at 17 09 with 11 598
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Mar 14, 2017 :  NUAN, AUPH, VRX, MGI, WIX, MBLY, TVIX, DOC, QQQ, BAC, BP, FCX",2017-03-14 12:55:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oqej5bPdGqU/pre-market-most-active-for-mar-14-2017-nuan-auph-vrx-mgi-wix-mbly-tvix-doc-qqq-bac-bp-fcx-cm760338,The NASDAQ 100 Pre Market Indicator is down 4 22 to 5 390 35 The total Pre Market volume is currently 5 848 193 shares traded The following are the most active stocks for the pre market session Nuance Communications Inc NUAN is unchanged at 17 09 with 11 598
VRX,VRX:US,BBG000DLFM21,Valeant's Downtrends Are Still Intact,2017-03-14 12:46:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/valeants-downtrends-are-still-intact?puc=yahoo&cm_ven=YAHOO,Valeant's Downtrends Are Still Intact
VRX,VRX:CT,BBG000DC8S17,Valeant's Downtrends Are Still Intact,2017-03-14 12:46:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/valeants-downtrends-are-still-intact?puc=yahoo&cm_ven=YAHOO,Valeant's Downtrends Are Still Intact
VRX,VRX:CT,BBG000DC8S17,Stock Futures Extend Decline as Oil Drops on OPEC's Production Forecasts,2017-03-14 12:41:00 +0000,https://www.thestreet.com/story/14040755/1/stock-futures-slip-as-wall-street-buckles-down-for-northeast-snowstorm-fed-meeting.html?puc=yahoo&cm_ven=YAHOO,Stock Futures Extend Decline as Oil Drops on OPEC's Production Forecasts
VRX,VRX:US,BBG000DLFM21,Stock Futures Extend Decline as Oil Drops on OPEC's Production Forecasts,2017-03-14 12:41:00 +0000,https://www.thestreet.com/story/14040755/1/stock-futures-slip-as-wall-street-buckles-down-for-northeast-snowstorm-fed-meeting.html?puc=yahoo&cm_ven=YAHOO,Stock Futures Extend Decline as Oil Drops on OPEC's Production Forecasts
VRX,VRX:US,BBG000DLFM21,"Investors wait for Stella to pass, Fed to raise rates",2017-03-14 12:25:41 +0000,http://finance.yahoo.com/news/investors-wait-for-stella-to-pass-fed-to-raise-rates-122541652.html,"Investors wait for Stella to pass, Fed to raise rates"
VRX,VRX:CT,BBG000DC8S17,"Investors wait for Stella to pass, Fed to raise rates",2017-03-14 12:25:41 +0000,http://finance.yahoo.com/news/investors-wait-for-stella-to-pass-fed-to-raise-rates-122541652.html,"Investors wait for Stella to pass, Fed to raise rates"
VRX,VRX:US,BBG000DLFM21,"Early movers: DIS, GLW, DGX, DSW, MGI, ABT & more",2017-03-14 12:11:27 +0000,http://www.cnbc.com/id/104340477?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104340477,"Early movers: DIS, GLW, DGX, DSW, MGI, ABT & more"
VRX,VRX:CT,BBG000DC8S17,"Early movers: DIS, GLW, DGX, DSW, MGI, ABT & more",2017-03-14 12:11:27 +0000,http://www.cnbc.com/id/104340477?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104340477,"Early movers: DIS, GLW, DGX, DSW, MGI, ABT & more"
VRX,VRX:US,BBG000DLFM21,"Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight",2017-03-14 12:00:58 +0000,http://www.insidermonkey.com/blog/why-valeant-tesla-citrix-systems-ruby-tuesday-and-stellar-biotechnologies-are-in-the-spotlight-566105/,"Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight"
VRX,VRX:CT,BBG000DC8S17,"Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight",2017-03-14 12:00:58 +0000,http://www.insidermonkey.com/blog/why-valeant-tesla-citrix-systems-ruby-tuesday-and-stellar-biotechnologies-are-in-the-spotlight-566105/,"Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight"
VRX,VRX:US,BBG000DLFM21,"Bill Ackman sells Valeant stake, to step down from board",2017-03-14 11:32:56 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=29498BB4-082F-11E7-84E1-1600A899F5E2&siteid=yhoof2,"Bill Ackman sells Valeant stake, to step down from board"
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman sells Valeant stake, to step down from board",2017-03-14 11:32:56 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=29498BB4-082F-11E7-84E1-1600A899F5E2&siteid=yhoof2,"Bill Ackman sells Valeant stake, to step down from board"
VRX,VRX:CT,BBG000DC8S17,5 Things You Should Know Before the Market Opens Tuesday,2017-03-14 11:25:00 +0000,https://www.thestreet.com/story/14039233/1/5-things-you-should-know-before-the-market-opens-tuesday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Should Know Before the Market Opens Tuesday
VRX,VRX:US,BBG000DLFM21,5 Things You Should Know Before the Market Opens Tuesday,2017-03-14 11:25:00 +0000,https://www.thestreet.com/story/14039233/1/5-things-you-should-know-before-the-market-opens-tuesday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Should Know Before the Market Opens Tuesday
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Tanks on Ackman Exit Reports (VRX),2017-03-14 11:05:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yRg2aSKbEyA/valeant-pharmaceuticals-tanks-on-ackman-exit-reports-vrx-cm760317,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is down 9 in Monday s early after market trade amid reports that billionaire hedge fund manager Bill Ackman has called it quits If true it ends a two year
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Tanks on Ackman Exit Reports (VRX),2017-03-14 11:05:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yRg2aSKbEyA/valeant-pharmaceuticals-tanks-on-ackman-exit-reports-vrx-cm760317,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is down 9 in Monday s early after market trade amid reports that billionaire hedge fund manager Bill Ackman has called it quits If true it ends a two year
VRX,VRX:CT,BBG000DC8S17,Trader's Daily Notebook: The Calm During the Storm,2017-03-14 11:00:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/traders-daily-notebook-calm-during-storm?puc=yahoo&cm_ven=YAHOO,Trader's Daily Notebook: The Calm During the Storm
VRX,VRX:US,BBG000DLFM21,Trader's Daily Notebook: The Calm During the Storm,2017-03-14 11:00:00 +0000,http://realmoney.thestreet.com/articles/03/14/2017/traders-daily-notebook-calm-during-storm?puc=yahoo&cm_ven=YAHOO,Trader's Daily Notebook: The Calm During the Storm
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling Along With Crude Prices - Canadian Commentary,2017-03-14 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nJZL8TCxZMw/canadian-stocks-are-falling-along-with-crude-prices--canadian-commentary-20170314-00802,Canadian Stocks Are Falling Along With Crude Prices - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling Along With Crude Prices - Canadian Commentary,2017-03-14 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nJZL8TCxZMw/canadian-stocks-are-falling-along-with-crude-prices--canadian-commentary-20170314-00802,Canadian Stocks Are Falling Along With Crude Prices - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Oil Stocks May Succumb, Valeant Activists Capitulate -- Canadian Commentary",2017-03-14 08:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6is8syjyK4/oil-stocks-may-succumb-valeant-activists-capitulate--canadian-commentary-20170314-00486,"Oil Stocks May Succumb, Valeant Activists Capitulate -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Oil Stocks May Succumb, Valeant Activists Capitulate -- Canadian Commentary",2017-03-14 08:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6is8syjyK4/oil-stocks-may-succumb-valeant-activists-capitulate--canadian-commentary-20170314-00486,"Oil Stocks May Succumb, Valeant Activists Capitulate -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,[$$] William Ackman’s Pershing Square Sold Stake in Valeant,2017-03-14 04:02:04 +0000,https://www.wsj.com/articles/william-ackmans-pershing-square-sold-stake-in-valeant-1489439314?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history...."
VRX,VRX:US,BBG000DLFM21,[$$] William Ackman’s Pershing Square Sold Stake in Valeant,2017-03-14 04:02:04 +0000,https://www.wsj.com/articles/william-ackmans-pershing-square-sold-stake-in-valeant-1489439314?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history...."
VRX,VRX:US,BBG000DLFM21,[$$] Pershing Square Sold Stake in Valeant,2017-03-14 01:59:47 +0000,https://www.wsj.com/articles/william-ackmans-pershing-square-sold-stake-in-valeant-1489439314?mod=yahoo_hs,"[at The Wall Street Journal] - William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history...."
VRX,VRX:CT,BBG000DC8S17,[$$] Pershing Square Sold Stake in Valeant,2017-03-14 01:59:47 +0000,https://www.wsj.com/articles/william-ackmans-pershing-square-sold-stake-in-valeant-1489439314?mod=yahoo_hs,"[at The Wall Street Journal] - William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history...."
VRX,VRX:US,BBG000DLFM21,Ackman’s Pershing Square cuts losses by selling entire stake in Valeant,2017-03-14 00:35:09 +0000,http://www.bizjournals.com/newyork/news/2017/03/13/ackman-pershing-square-cuts-sells-valeant.html?ana=yahoo,Ackman’s Pershing Square cuts losses by selling entire stake in Valeant
VRX,VRX:CT,BBG000DC8S17,Ackman’s Pershing Square cuts losses by selling entire stake in Valeant,2017-03-14 00:35:09 +0000,http://www.bizjournals.com/newyork/news/2017/03/13/ackman-pershing-square-cuts-sells-valeant.html?ana=yahoo,Ackman’s Pershing Square cuts losses by selling entire stake in Valeant
VRX,VRX:CT,BBG000DC8S17,Valeant's downfall from Hillary Clinton,2017-03-14 00:29:17 +0000,http://finance.yahoo.com/news/collapse-valeant-told-stock-chart-002917819.html,Valeant's downfall from Hillary Clinton
VRX,VRX:US,BBG000DLFM21,Valeant's downfall from Hillary Clinton,2017-03-14 00:29:17 +0000,http://finance.yahoo.com/news/collapse-valeant-told-stock-chart-002917819.html,Valeant's downfall from Hillary Clinton
VRX,VRX:US,BBG000DLFM21,"Ackman's Pershing Square sells Valeant stake, takes $3 billion loss",2017-03-14 00:04:52 +0000,http://sg.finance.yahoo.com/news/ackmans-pershing-square-sells-valeant-000452484.html,"Ackman's Pershing Square sells Valeant stake, takes $3 billion loss"
VRX,VRX:CT,BBG000DC8S17,"Ackman's Pershing Square sells Valeant stake, takes $3 billion loss",2017-03-14 00:04:52 +0000,http://sg.finance.yahoo.com/news/ackmans-pershing-square-sells-valeant-000452484.html,"Ackman's Pershing Square sells Valeant stake, takes $3 billion loss"
VRX,VRX:CT,BBG000DC8S17,"Ackman's Pershing Square sells Valeant stake, takes $3 bln loss",2017-03-14 00:02:03 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-sells-valeant-000203849.html,"[Reuters] - Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc on Monday with a loss of more than $3 billion as he sold his entire stake in the struggling drug company after trying to rescue it for some 18 months. The abrupt and unexpected move by the powerful activist investor sent Valeant shares tumbling almost 10 percent in after-hours trading. For Ackman, it marked a dramatic climbdown from his vocal support of the company, but should help soothe his own investors who had begun to show signs of concern about mounting losses in his portfolio."
VRX,VRX:US,BBG000DLFM21,"Ackman's Pershing Square sells Valeant stake, takes $3 bln loss",2017-03-14 00:02:03 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-sells-valeant-000203849.html,"[Reuters] - Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc on Monday with a loss of more than $3 billion as he sold his entire stake in the struggling drug company after trying to rescue it for some 18 months. The abrupt and unexpected move by the powerful activist investor sent Valeant shares tumbling almost 10 percent in after-hours trading. For Ackman, it marked a dramatic climbdown from his vocal support of the company, but should help soothe his own investors who had begun to show signs of concern about mounting losses in his portfolio."
VRX,VRX:US,BBG000DLFM21,Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong,2017-03-13 23:31:04 +0000,http://finance.yahoo.com/news/bill-ackman-pinpointed-moment-shouldve-233104885.html,Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong
VRX,VRX:CT,BBG000DC8S17,Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong,2017-03-13 23:31:04 +0000,http://finance.yahoo.com/news/bill-ackman-pinpointed-moment-shouldve-233104885.html,Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong
VRX,VRX:CT,BBG000DC8S17,"Ackman Sells Valeant Stake, To Step Down From Board",2017-03-13 23:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-rdVEZJkBf4/ackman-sells-valeant-stake-to-step-down-from-board-20170313-01314,"Ackman Sells Valeant Stake, To Step Down From Board"
VRX,VRX:US,BBG000DLFM21,"Ackman Sells Valeant Stake, To Step Down From Board",2017-03-13 23:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-rdVEZJkBf4/ackman-sells-valeant-stake-to-step-down-from-board-20170313-01314,"Ackman Sells Valeant Stake, To Step Down From Board"
VRX,VRX:US,BBG000DLFM21,Activist investor Ackman's hedge fund sells Valeant stake,2017-03-13 22:56:17 +0000,http://sg.finance.yahoo.com/news/activist-investor-ackmans-hedge-fund-211711755.html,Activist investor Ackman's hedge fund sells Valeant stake
VRX,VRX:CT,BBG000DC8S17,Activist investor Ackman's hedge fund sells Valeant stake,2017-03-13 22:56:17 +0000,http://sg.finance.yahoo.com/news/activist-investor-ackmans-hedge-fund-211711755.html,Activist investor Ackman's hedge fund sells Valeant stake
VRX,VRX:CT,BBG000DC8S17,One stock helped decimate Bill Ackman's hedge fund performance,2017-03-13 22:40:04 +0000,http://finance.yahoo.com/news/one-stock-helped-decimate-billionaire-224004689.html,One stock helped decimate Bill Ackman's hedge fund performance
VRX,VRX:US,BBG000DLFM21,One stock helped decimate Bill Ackman's hedge fund performance,2017-03-13 22:40:04 +0000,http://finance.yahoo.com/news/one-stock-helped-decimate-billionaire-224004689.html,One stock helped decimate Bill Ackman's hedge fund performance
VRX,VRX:US,BBG000DLFM21,Activist investor Ackman's hedge fund sells Valeant stake,2017-03-13 22:00:35 +0000,http://finance.yahoo.com/news/activist-investor-ackmans-hedge-fund-sells-valeant-stake-211711656--finance.html,Activist investor Ackman's hedge fund sells Valeant stake
VRX,VRX:CT,BBG000DC8S17,Activist investor Ackman's hedge fund sells Valeant stake,2017-03-13 22:00:35 +0000,http://finance.yahoo.com/news/activist-investor-ackmans-hedge-fund-sells-valeant-stake-211711656--finance.html,Activist investor Ackman's hedge fund sells Valeant stake
VRX,VRX:US,BBG000DLFM21,Valeant Shares Tumble After Ackman Liquidates Stake,2017-03-13 21:39:00 +0000,https://www.thestreet.com/story/14041292/1/valeant-shares-tumble-after-ackman-liquidates-stake.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Tumble After Ackman Liquidates Stake
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Tumble After Ackman Liquidates Stake,2017-03-13 21:39:00 +0000,https://www.thestreet.com/story/14041292/1/valeant-shares-tumble-after-ackman-liquidates-stake.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Tumble After Ackman Liquidates Stake
VRX,VRX:US,BBG000DLFM21,Ackman Said to Liquidate Valeant Shares,2017-03-13 21:25:00 +0000,https://www.thestreet.com/story/14041270/1/ackman-said-to-liquidate-valeant-shares.html?puc=yahoo&cm_ven=YAHOO,Ackman Said to Liquidate Valeant Shares
VRX,VRX:CT,BBG000DC8S17,Ackman Said to Liquidate Valeant Shares,2017-03-13 21:25:00 +0000,https://www.thestreet.com/story/14041270/1/ackman-said-to-liquidate-valeant-shares.html?puc=yahoo&cm_ven=YAHOO,Ackman Said to Liquidate Valeant Shares
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Bill Ackman's Pershing Square is Officially Out!!!,2017-03-13 21:17:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/13/valeant-pharmaceuticals-bill-ackman-is-officially-out/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Bill Ackman's Pershing Square is Officially Out!!!
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Bill Ackman's Pershing Square is Officially Out!!!,2017-03-13 21:17:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/13/valeant-pharmaceuticals-bill-ackman-is-officially-out/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Bill Ackman's Pershing Square is Officially Out!!!
VRX,VRX:CT,BBG000DC8S17,"After Hours Most Active for Mar 13, 2017 :  XRX, VRX, MSFT, GG, GE, AUPH, HES, TXN, AAPL, TMUS, MU",2017-03-13 21:05:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3WaJrCvXDnQ/after-hours-most-active-for-mar-13-2017-xrx-vrx-msft-gg-ge-auph-hes-txn-aapl-tmus-mu-cm760227,The NASDAQ 100 After Hours Indicator is down 24 to 5 394 33 The total After hours volume is currently 44 600 995 shares traded The following are the most active stocks for the after hours session Xerox Corporation XRX is unchanged at 7 31 with 5 723 517
VRX,VRX:US,BBG000DLFM21,"After Hours Most Active for Mar 13, 2017 :  XRX, VRX, MSFT, GG, GE, AUPH, HES, TXN, AAPL, TMUS, MU",2017-03-13 21:05:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3WaJrCvXDnQ/after-hours-most-active-for-mar-13-2017-xrx-vrx-msft-gg-ge-auph-hes-txn-aapl-tmus-mu-cm760227,The NASDAQ 100 After Hours Indicator is down 24 to 5 394 33 The total After hours volume is currently 44 600 995 shares traded The following are the most active stocks for the after hours session Xerox Corporation XRX is unchanged at 7 31 with 5 723 517
VRX,VRX:CT,BBG000DC8S17,"Pershing Square Dumps Valeant Stake, Ackman to Leave Board",2017-03-13 20:51:29 +0000,http://finance.yahoo.com/news/pershing-square-sells-stake-valeant-205129338.html,"Pershing Square Dumps Valeant Stake, Ackman to Leave Board"
VRX,VRX:CT,BBG000DC8S17,Ackman Sells Valeant Stake After at Least $2.8 Billion Loss,2017-03-13 20:51:29 +0000,https://www.bloomberg.com/news/articles/2017-03-13/valeant-falls-as-bill-ackman-sells-out-departs-company-s-board?cmpid=yhoo.headline,Ackman Sells Valeant Stake After at Least $2.8 Billion Loss
VRX,VRX:US,BBG000DLFM21,Ackman Sells Valeant Stake After at Least $2.8 Billion Loss,2017-03-13 20:51:29 +0000,https://www.bloomberg.com/news/articles/2017-03-13/valeant-falls-as-bill-ackman-sells-out-departs-company-s-board?cmpid=yhoo.headline,Ackman Sells Valeant Stake After at Least $2.8 Billion Loss
VRX,VRX:US,BBG000DLFM21,"Pershing Square Dumps Valeant Stake, Ackman to Leave Board",2017-03-13 20:51:29 +0000,http://finance.yahoo.com/news/pershing-square-sells-stake-valeant-205129338.html,"Pershing Square Dumps Valeant Stake, Ackman to Leave Board"
VRX,VRX:US,BBG000DLFM21,"Bill Ackman bails on his massive, money-losing bet on Valeant",2017-03-13 20:48:56 +0000,http://finance.yahoo.com/news/bill-ackman-bails-on-his-massive-money-losing-bet-on-valeant-204856665.html,"Bill Ackman bails on his massive, money-losing bet on Valeant"
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman bails on his massive, money-losing bet on Valeant",2017-03-13 20:48:56 +0000,http://finance.yahoo.com/news/bill-ackman-bails-on-his-massive-money-losing-bet-on-valeant-204856665.html,"Bill Ackman bails on his massive, money-losing bet on Valeant"
VRX,VRX:US,BBG000DLFM21,Valeant sinks on media report Bill Ackman sold stake,2017-03-13 20:43:52 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=3C5BF702-5927-4548-AB53-7B3E975F813C&siteid=yhoof2,Valeant sinks on media report Bill Ackman sold stake
VRX,VRX:CT,BBG000DC8S17,Valeant sinks on media report Bill Ackman sold stake,2017-03-13 20:43:52 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=3C5BF702-5927-4548-AB53-7B3E975F813C&siteid=yhoof2,Valeant sinks on media report Bill Ackman sold stake
VRX,VRX:US,BBG000DLFM21,Ackman's Pershing Square exits ailing investment in Valeant,2017-03-13 20:42:12 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-exits-ailing-204212564.html,Ackman's Pershing Square exits ailing investment in Valeant
VRX,VRX:CT,BBG000DC8S17,Ackman's Pershing Square exits ailing investment in Valeant,2017-03-13 20:42:12 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-exits-ailing-204212564.html,Ackman's Pershing Square exits ailing investment in Valeant
VRX,VRX:CT,BBG000DC8S17,Bill Ackman is selling his entire stake in Valeant Pharmaceuticals,2017-03-13 20:29:10 +0000,http://finance.yahoo.com/news/report-ackman-folds-202910746.html,Bill Ackman is selling his entire stake in Valeant Pharmaceuticals
VRX,VRX:US,BBG000DLFM21,Bill Ackman is selling his entire stake in Valeant Pharmaceuticals,2017-03-13 20:29:10 +0000,http://finance.yahoo.com/news/report-ackman-folds-202910746.html,Bill Ackman is selling his entire stake in Valeant Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,Ackman Out of Valeant Pharmaceuticals,2017-03-13 20:26:00 +0000,https://www.thestreet.com/story/14041042/1/ackman-out-of-valeant-pharmaceuticals.html?puc=yahoo&cm_ven=YAHOO,Ackman Out of Valeant Pharmaceuticals
VRX,VRX:US,BBG000DLFM21,Ackman Out of Valeant Pharmaceuticals,2017-03-13 20:26:00 +0000,https://www.thestreet.com/story/14041042/1/ackman-out-of-valeant-pharmaceuticals.html?puc=yahoo&cm_ven=YAHOO,Ackman Out of Valeant Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,3 Companies That Probably Won't Survive Till 2019,2017-03-13 18:07:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oCy8hXtPrYA/3-companies-that-probably-wont-survive-till-2019-cm760108,The stock market has absolutely been on fire over the trailing 12 months The broad based S amp P 500 has increased by a whopping 17 over that times pan which is more than double the historical average increase in stocks including dividend reinvestment of 7 over a one year
VRX,VRX:US,BBG000DLFM21,3 Companies That Probably Won't Survive Till 2019,2017-03-13 18:07:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oCy8hXtPrYA/3-companies-that-probably-wont-survive-till-2019-cm760108,The stock market has absolutely been on fire over the trailing 12 months The broad based S amp P 500 has increased by a whopping 17 over that times pan which is more than double the historical average increase in stocks including dividend reinvestment of 7 over a one year
VRX,VRX:CT,BBG000DC8S17,3 Companies That Probably Won't Survive Till 2019,2017-03-13 16:12:00 +0000,http://www.fool.com/investing/2017/03/13/3-companies-that-probably-wont-survive-till-2019.aspx,3 Companies That Probably Won't Survive Till 2019
VRX,VRX:US,BBG000DLFM21,3 Companies That Probably Won't Survive Till 2019,2017-03-13 16:12:00 +0000,http://www.fool.com/investing/2017/03/13/3-companies-that-probably-wont-survive-till-2019.aspx,3 Companies That Probably Won't Survive Till 2019
VRX,VRX:CT,BBG000DC8S17,"Preet Bharara Refused To Resign As Federal Prosecutor, So President Trump Fired Him",2017-03-13 13:08:47 +0000,http://finance.yahoo.com/news/preet-bharara-refused-resign-federal-130847543.html,"Preet Bharara Refused To Resign As Federal Prosecutor, So President Trump Fired Him"
VRX,VRX:US,BBG000DLFM21,"Preet Bharara Refused To Resign As Federal Prosecutor, So President Trump Fired Him",2017-03-13 13:08:47 +0000,http://finance.yahoo.com/news/preet-bharara-refused-resign-federal-130847543.html,"Preet Bharara Refused To Resign As Federal Prosecutor, So President Trump Fired Him"
VRX,VRX:US,BBG000DLFM21,Why Valeant Stock Didn't Rally More On Its Deal With Creditors,2017-03-13 12:11:00 +0000,http://www.forbes.com/sites/petertchir/2017/03/13/why-valeant-stock-didnt-rally-more-on-its-deal-with-creditors/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Why Valeant Stock Didn't Rally More On Its Deal With Creditors
VRX,VRX:CT,BBG000DC8S17,Why Valeant Stock Didn't Rally More On Its Deal With Creditors,2017-03-13 12:11:00 +0000,http://www.forbes.com/sites/petertchir/2017/03/13/why-valeant-stock-didnt-rally-more-on-its-deal-with-creditors/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Why Valeant Stock Didn't Rally More On Its Deal With Creditors
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary,2017-03-13 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NXRZX-lI8LY/canadian-stocks-are-rising-at-the-start-of-the-week--canadian-commentary-20170313-00779,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary,2017-03-13 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NXRZX-lI8LY/canadian-stocks-are-rising-at-the-start-of-the-week--canadian-commentary-20170313-00779,Canadian Stocks Are Rising At The Start Of The Week - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Here's Why Valeant's Stock Had Another Disastrous Week,2017-03-13 00:34:00 +0000,https://www.thestreet.com/story/14036858/1/here-s-why-valeant-struggled-this-week.html?puc=yahoo&cm_ven=YAHOO,Here's Why Valeant's Stock Had Another Disastrous Week
VRX,VRX:US,BBG000DLFM21,Here's Why Valeant's Stock Had Another Disastrous Week,2017-03-13 00:34:00 +0000,https://www.thestreet.com/story/14036858/1/here-s-why-valeant-struggled-this-week.html?puc=yahoo&cm_ven=YAHOO,Here's Why Valeant's Stock Had Another Disastrous Week
VRX,VRX:CT,BBG000DC8S17,The Biggest Loser: TransDigm Group Drops 4.2% on Valeant Comparisons,2017-03-10 23:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/10/the-biggest-loser-transdigm-group-drops-4-2-on-valeant-comparisons/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: TransDigm Group Drops 4.2% on Valeant Comparisons
VRX,VRX:US,BBG000DLFM21,The Biggest Loser: TransDigm Group Drops 4.2% on Valeant Comparisons,2017-03-10 23:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/10/the-biggest-loser-transdigm-group-drops-4-2-on-valeant-comparisons/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: TransDigm Group Drops 4.2% on Valeant Comparisons
VRX,VRX:CT,BBG000DC8S17,Valeant Receives Lender Consent For Refinancing And Amendment Of Credit Agreement,2017-03-10 21:30:00 +0000,http://finance.yahoo.com/news/valeant-receives-lender-consent-refinancing-213000101.html,[CNW Group] - Valeant Receives Lender Consent For Refinancing And Amendment Of Credit Agreement
VRX,VRX:US,BBG000DLFM21,Valeant Receives Lender Consent For Refinancing And Amendment Of Credit Agreement,2017-03-10 21:30:00 +0000,http://finance.yahoo.com/news/valeant-receives-lender-consent-refinancing-213000101.html,[CNW Group] - Valeant Receives Lender Consent For Refinancing And Amendment Of Credit Agreement
VRX,VRX:US,BBG000DLFM21,TransDigm extends recent losses after short seller Citron weighs in,2017-03-10 18:35:46 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0CC9019F-EB0E-4160-95E1-DCE4E02EEAD2&siteid=yhoof2,TransDigm extends recent losses after short seller Citron weighs in
VRX,VRX:CT,BBG000DC8S17,TransDigm extends recent losses after short seller Citron weighs in,2017-03-10 18:35:46 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0CC9019F-EB0E-4160-95E1-DCE4E02EEAD2&siteid=yhoof2,TransDigm extends recent losses after short seller Citron weighs in
VRX,VRX:CT,BBG000DC8S17,Citron’s Left Says TransDigm Could Drop 40% in Two Weeks,2017-03-10 18:31:28 +0000,http://finance.yahoo.com/video/citron-left-says-transdigm-won-183128421.html,Citron’s Left Says TransDigm Could Drop 40% in Two Weeks
VRX,VRX:US,BBG000DLFM21,Citron’s Left Says TransDigm Could Drop 40% in Two Weeks,2017-03-10 18:31:28 +0000,http://finance.yahoo.com/video/citron-left-says-transdigm-won-183128421.html,Citron’s Left Says TransDigm Could Drop 40% in Two Weeks
VRX,VRX:US,BBG000DLFM21,Valeant rallies support with key refi,2017-03-10 18:25:14 +0000,http://finance.yahoo.com/news/valeant-rallies-support-key-refi-182514823.html,"[Reuters] - Valeant Pharmaceuticals has taken advantage of a welcoming US leveraged market to refinance, repay and extend the maturity on its creaking US$30bn debt pile with a mix of new loans and bonds as the troubled Canadian drugmaker’s equity price remains under pressure. The deals will allow Valeant to complete a critical maturity extension which will push the maturities on three existing loans to 2022, and remove two covenants, after debt investors gave the struggling company a much-needed vote of confidence. Valeant asked lenders to remove two covenants: a key interest coverage ratio test, which has been under pressure since the company’s equity price collapsed, and a secured leverage ratio requirement."
VRX,VRX:CT,BBG000DC8S17,Valeant rallies support with key refi,2017-03-10 18:25:14 +0000,http://finance.yahoo.com/news/valeant-rallies-support-key-refi-182514823.html,"[Reuters] - Valeant Pharmaceuticals has taken advantage of a welcoming US leveraged market to refinance, repay and extend the maturity on its creaking US$30bn debt pile with a mix of new loans and bonds as the troubled Canadian drugmaker’s equity price remains under pressure. The deals will allow Valeant to complete a critical maturity extension which will push the maturities on three existing loans to 2022, and remove two covenants, after debt investors gave the struggling company a much-needed vote of confidence. Valeant asked lenders to remove two covenants: a key interest coverage ratio test, which has been under pressure since the company’s equity price collapsed, and a secured leverage ratio requirement."
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-10 12:48:37 +0000,http://biz.yahoo.com/e/170310/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-10 12:48:37 +0000,http://biz.yahoo.com/e/170310/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Pricing And Upsize Of Private Offering Of Senior Secured Notes,2017-03-10 11:30:00 +0000,http://finance.yahoo.com/news/valeant-announces-pricing-upsize-private-113000293.html,"[PR Newswire] - LAVAL, Quebec, March 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"" or the ""Company"") announced today that it has priced its previously announced offering of $1.25 billion aggregate principal amount of 6.50% senior secured notes due 2022 (the ""2022 Notes"") and $2 billion aggregate principal amount of 7.00% senior secured notes due 2024 (the ""2024 Notes"" and, together with the 2022 Notes, the ""Notes""). The offering is expected to close on or about March 21, 2017. The offering of Notes is being conducted in connection with the Company's previously announced refinancing and amendment of its existing credit agreement (the ""Refinancing"")."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Pricing And Upsize Of Private Offering Of Senior Secured Notes,2017-03-10 11:30:00 +0000,http://finance.yahoo.com/news/valeant-announces-pricing-upsize-private-113000293.html,"[PR Newswire] - LAVAL, Quebec, March 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant"" or the ""Company"") announced today that it has priced its previously announced offering of $1.25 billion aggregate principal amount of 6.50% senior secured notes due 2022 (the ""2022 Notes"") and $2 billion aggregate principal amount of 7.00% senior secured notes due 2024 (the ""2024 Notes"" and, together with the 2022 Notes, the ""Notes""). The offering is expected to close on or about March 21, 2017. The offering of Notes is being conducted in connection with the Company's previously announced refinancing and amendment of its existing credit agreement (the ""Refinancing"")."
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Upsizing Of Cash Tender Offer For Its 6.75% Senior Notes Due 2018,2017-03-10 11:30:00 +0000,http://finance.yahoo.com/news/valeant-announces-upsizing-cash-tender-113000378.html,"[PR Newswire] - LAVAL, Quebec, March 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant,"" the ""Company"" or ""we"") announced today that it has increased the maximum aggregate principal amount of its outstanding 6.75% Senior Notes Due 2018 (the ""Notes"") that it may purchase pursuant to its previously announced offer to purchase for cash upon terms and subject to the conditions set forth in the Offer to Purchase, dated March 7, 2017, as supplemented by this release, and a related Letter of Transmittal. The Company announced that it has increased the maximum aggregate principal amount of Notes that may be purchased pursuant to the tender offer from $600,000,000 to $1,100,000,000. All other terms and conditions of the tender offer will remain the same."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Upsizing Of Cash Tender Offer For Its 6.75% Senior Notes Due 2018,2017-03-10 11:30:00 +0000,http://finance.yahoo.com/news/valeant-announces-upsizing-cash-tender-113000378.html,"[PR Newswire] - LAVAL, Quebec, March 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) (""Valeant,"" the ""Company"" or ""we"") announced today that it has increased the maximum aggregate principal amount of its outstanding 6.75% Senior Notes Due 2018 (the ""Notes"") that it may purchase pursuant to its previously announced offer to purchase for cash upon terms and subject to the conditions set forth in the Offer to Purchase, dated March 7, 2017, as supplemented by this release, and a related Letter of Transmittal. The Company announced that it has increased the maximum aggregate principal amount of Notes that may be purchased pursuant to the tender offer from $600,000,000 to $1,100,000,000. All other terms and conditions of the tender offer will remain the same."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up On Strong Employment Data - Canadian Commentary,2017-03-10 10:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BlOOXrd2ncE/canadian-stocks-are-up-on-strong-employment-data--canadian-commentary-20170310-00533,Canadian Stocks Are Up On Strong Employment Data - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up On Strong Employment Data - Canadian Commentary,2017-03-10 10:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BlOOXrd2ncE/canadian-stocks-are-up-on-strong-employment-data--canadian-commentary-20170310-00533,Canadian Stocks Are Up On Strong Employment Data - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Upsizing Of Tender Offer For 6.75% Senior Notes Due 2018,2017-03-10 06:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FqF2_RqbeOA/valeant-announces-upsizing-of-tender-offer-for-675-senior-notes-due-2018-20170310-00202,Valeant Announces Upsizing Of Tender Offer For 6.75% Senior Notes Due 2018
VRX,VRX:US,BBG000DLFM21,Valeant Announces Upsizing Of Tender Offer For 6.75% Senior Notes Due 2018,2017-03-10 06:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FqF2_RqbeOA/valeant-announces-upsizing-of-tender-offer-for-675-senior-notes-due-2018-20170310-00202,Valeant Announces Upsizing Of Tender Offer For 6.75% Senior Notes Due 2018
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc -- Moody's Publishes Covenant Quality Assessment for Valeant Pharmaceuticals International, Inc",2017-03-10 02:36:03 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_363342&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20170309_PR_363342,"Valeant Pharmaceuticals International, Inc -- Moody's Publishes Covenant Quality Assessment for Valeant Pharmaceuticals International, Inc"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc -- Moody's Publishes Covenant Quality Assessment for Valeant Pharmaceuticals International, Inc",2017-03-10 02:36:03 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_363342&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20170309_PR_363342,"Valeant Pharmaceuticals International, Inc -- Moody's Publishes Covenant Quality Assessment for Valeant Pharmaceuticals International, Inc"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is as Ugly as It Gets,2017-03-09 21:15:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aR_1fAQdMoA/valeant-pharmaceuticals-intl-inc-vrx-stock-is-as-ugly-as-it-gets-cm758862,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s no sugarcoating it here The chart of 160 Valeant Pharmaceuticals Intl Inc NYSE VRX is about as ugly as it gets This week has VRX stock sitting at its lowest levels since 2009 It s
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is as Ugly as It Gets,2017-03-09 21:15:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aR_1fAQdMoA/valeant-pharmaceuticals-intl-inc-vrx-stock-is-as-ugly-as-it-gets-cm758862,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s no sugarcoating it here The chart of 160 Valeant Pharmaceuticals Intl Inc NYSE VRX is about as ugly as it gets This week has VRX stock sitting at its lowest levels since 2009 It s
VRX,VRX:US,BBG000DLFM21,Valeant Refinancing Billions in Short-Term Debt,2017-03-09 21:14:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/09/valeant-refinancing-billions-in-short-term-debt/?mod=yahoobarrons&ru=yahoo,Valeant Refinancing Billions in Short-Term Debt
VRX,VRX:CT,BBG000DC8S17,Valeant Refinancing Billions in Short-Term Debt,2017-03-09 21:14:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/09/valeant-refinancing-billions-in-short-term-debt/?mod=yahoobarrons&ru=yahoo,Valeant Refinancing Billions in Short-Term Debt
VRX,VRX:US,BBG000DLFM21,Ackman Lost Bet on Herbalife,2017-03-09 18:50:00 +0000,https://www.thestreet.com/story/14017944/1/ackman-lost-bet-on-herbalife.html?puc=yahoo&cm_ven=YAHOO,Ackman Lost Bet on Herbalife
VRX,VRX:CT,BBG000DC8S17,Ackman Lost Bet on Herbalife,2017-03-09 18:50:00 +0000,https://www.thestreet.com/story/14017944/1/ackman-lost-bet-on-herbalife.html?puc=yahoo&cm_ven=YAHOO,Ackman Lost Bet on Herbalife
VRX,VRX:CT,BBG000DC8S17,Valeant: How Low Can It Go?,2017-03-09 18:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/09/valeant-how-low-can-it-go/?mod=yahoobarrons&ru=yahoo,Valeant: How Low Can It Go?
VRX,VRX:US,BBG000DLFM21,Valeant: How Low Can It Go?,2017-03-09 18:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/09/valeant-how-low-can-it-go/?mod=yahoobarrons&ru=yahoo,Valeant: How Low Can It Go?
VRX,VRX:US,BBG000DLFM21,Valeant Launches Loan Offering Days After Paying Down $1.1 Billion in Debt,2017-03-09 17:17:00 +0000,https://www.thestreet.com/story/14034902/1/valeant-launches-loan-offering-days-after-paying-down-1-1-billion-in-debt.html?puc=yahoo&cm_ven=YAHOO,Valeant Launches Loan Offering Days After Paying Down $1.1 Billion in Debt
VRX,VRX:CT,BBG000DC8S17,Valeant Launches Loan Offering Days After Paying Down $1.1 Billion in Debt,2017-03-09 17:17:00 +0000,https://www.thestreet.com/story/14034902/1/valeant-launches-loan-offering-days-after-paying-down-1-1-billion-in-debt.html?puc=yahoo&cm_ven=YAHOO,Valeant Launches Loan Offering Days After Paying Down $1.1 Billion in Debt
VRX,VRX:US,BBG000DLFM21,Use these metrics to help you select a stock,2017-03-09 16:55:50 +0000,http://finance.yahoo.com/tumblr/blog-use-these-metrics-to-help-you-select-a-stock-165600541.html,Use these metrics to help you select a stock
VRX,VRX:CT,BBG000DC8S17,Use these metrics to help you select a stock,2017-03-09 16:55:50 +0000,http://finance.yahoo.com/tumblr/blog-use-these-metrics-to-help-you-select-a-stock-165600541.html,Use these metrics to help you select a stock
VRX,VRX:CT,BBG000DC8S17,Morgan Stanley Lowers Valeant Price Target,2017-03-09 14:07:00 +0000,https://www.thestreet.com/story/14034729/1/morgan-stanley-lowers-valeant-price-target.html?puc=yahoo&cm_ven=YAHOO,Morgan Stanley Lowers Valeant Price Target
VRX,VRX:CT,BBG000DC8S17,Valeant Announces New Debt Offering,2017-03-09 14:07:00 +0000,http://www.investopedia.com/news/valeant-announces-new-debt-offering-vrx/?partner=YahooSA,Valeant Announces New Debt Offering
VRX,VRX:US,BBG000DLFM21,Valeant Announces New Debt Offering,2017-03-09 14:07:00 +0000,http://www.investopedia.com/news/valeant-announces-new-debt-offering-vrx/?partner=YahooSA,Valeant Announces New Debt Offering
VRX,VRX:US,BBG000DLFM21,Morgan Stanley Lowers Valeant Price Target,2017-03-09 14:07:00 +0000,https://www.thestreet.com/story/14034729/1/morgan-stanley-lowers-valeant-price-target.html?puc=yahoo&cm_ven=YAHOO,Morgan Stanley Lowers Valeant Price Target
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-09 11:54:23 +0000,http://biz.yahoo.com/e/170309/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-09 11:54:23 +0000,http://biz.yahoo.com/e/170309/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
VRX,VRX:US,BBG000DLFM21,Valeant Announces Launch Of Private Offering Of Senior Secured Notes,2017-03-09 11:45:00 +0000,http://finance.yahoo.com/news/valeant-announces-launch-private-offering-114500052.html,[CNW Group] - Valeant Announces Launch Of Private Offering Of Senior Secured Notes
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Launch Of Private Offering Of Senior Secured Notes,2017-03-09 11:45:00 +0000,http://finance.yahoo.com/news/valeant-announces-launch-private-offering-114500052.html,[CNW Group] - Valeant Announces Launch Of Private Offering Of Senior Secured Notes
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing Despite Drop In Crude Prices - Canadian Commentary,2017-03-09 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2M2wXIrkjek/canadian-stocks-are-climbing-despite-drop-in-crude-prices--canadian-commentary-20170309-00876,Canadian Stocks Are Climbing Despite Drop In Crude Prices - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing Despite Drop In Crude Prices - Canadian Commentary,2017-03-09 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2M2wXIrkjek/canadian-stocks-are-climbing-despite-drop-in-crude-prices--canadian-commentary-20170309-00876,Canadian Stocks Are Climbing Despite Drop In Crude Prices - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down",2017-03-09 00:12:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2lxcIv02zR0/valeant-vrx-issues-notes-restructures-debt-shares-down-cm758221,Valeant Pharmaceuticals International Inc VRX commenced an offer to purchase cash up to 600 million of aggregate principal amount of the outstanding 6 75 senior notes due 2018 On Mar 3 the company had announced the divesture of its skincare products The company used the net proceeds
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down",2017-03-09 00:12:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2lxcIv02zR0/valeant-vrx-issues-notes-restructures-debt-shares-down-cm758221,Valeant Pharmaceuticals International Inc VRX commenced an offer to purchase cash up to 600 million of aggregate principal amount of the outstanding 6 75 senior notes due 2018 On Mar 3 the company had announced the divesture of its skincare products The company used the net proceeds
VRX,VRX:US,BBG000DLFM21,Valeant's Refinancing Explained,2017-03-08 22:29:23 +0000,http://finance.yahoo.com/news/valeants-refinancing-explained-222923025.html,Valeant's Refinancing Explained
VRX,VRX:CT,BBG000DC8S17,Valeant's Refinancing Explained,2017-03-08 22:29:23 +0000,http://finance.yahoo.com/news/valeants-refinancing-explained-222923025.html,Valeant's Refinancing Explained
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down",2017-03-08 22:17:10 +0000,http://finance.yahoo.com/news/valeant-vrx-issues-notes-restructures-221710262.html,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down"
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down",2017-03-08 22:17:10 +0000,http://finance.yahoo.com/news/valeant-vrx-issues-notes-restructures-221710262.html,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down"
VRX,VRX:CT,BBG000DC8S17,"David Tepper Discusses Allergan Investment, Market Valuation",2017-03-08 21:08:29 +0000,http://finance.yahoo.com/news/david-tepper-discusses-allergan-investment-210829925.html,"David Tepper Discusses Allergan Investment, Market Valuation"
VRX,VRX:US,BBG000DLFM21,"David Tepper Discusses Allergan Investment, Market Valuation",2017-03-08 21:08:29 +0000,http://finance.yahoo.com/news/david-tepper-discusses-allergan-investment-210829925.html,"David Tepper Discusses Allergan Investment, Market Valuation"
VRX,VRX:US,BBG000DLFM21,Valeant's Possible Debt Deal Shows Its Management Team Is Completely Missing the Point,2017-03-08 17:14:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkIlO5bwxqk/valeants-possible-debt-deal-shows-its-management-team-is-completely-missing-the-point-cm757920,One step forward two steps back This is a dance that shareholders of embattled drugmaker Valeant Pharmaceuticals NYSE VRX are getting all too familiar with Valeant Pharmaceuticals shares have now lost 95 of their value since the summer of 2015 as a confluence of factors
VRX,VRX:CT,BBG000DC8S17,Valeant's Possible Debt Deal Shows Its Management Team Is Completely Missing the Point,2017-03-08 17:14:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkIlO5bwxqk/valeants-possible-debt-deal-shows-its-management-team-is-completely-missing-the-point-cm757920,One step forward two steps back This is a dance that shareholders of embattled drugmaker Valeant Pharmaceuticals NYSE VRX are getting all too familiar with Valeant Pharmaceuticals shares have now lost 95 of their value since the summer of 2015 as a confluence of factors
VRX,VRX:CT,BBG000DC8S17,You Can Now Pre-Order 'Invest Like a Guru' on Amazon,2017-03-08 17:12:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bdeavlFKMMM/you-can-now-pre-order-invest-like-a-guru-on-amazon-cm757988,After 12 months of hard work Invest Like a Guru the book by GuruFocus founder Dr Charlie Tian is set for release in April You can now pre order Invest Like a Guru on Amazon Here is the link After 12 months of hard work Invest Like a Guru the book by GuruFocus founder Dr Charlie
VRX,VRX:US,BBG000DLFM21,You Can Now Pre-Order 'Invest Like a Guru' on Amazon,2017-03-08 17:12:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bdeavlFKMMM/you-can-now-pre-order-invest-like-a-guru-on-amazon-cm757988,After 12 months of hard work Invest Like a Guru the book by GuruFocus founder Dr Charlie Tian is set for release in April You can now pre order Invest Like a Guru on Amazon Here is the link After 12 months of hard work Invest Like a Guru the book by GuruFocus founder Dr Charlie
VRX,VRX:US,BBG000DLFM21,Valeant's Possible Debt Deal Shows Its Management Team Is Completely Missing the Point,2017-03-08 15:45:00 +0000,http://www.fool.com/investing/2017/03/08/valeants-possible-debt-deal-shows-its-management-t.aspx,Valeant's Possible Debt Deal Shows Its Management Team Is Completely Missing the Point
VRX,VRX:CT,BBG000DC8S17,Valeant's Possible Debt Deal Shows Its Management Team Is Completely Missing the Point,2017-03-08 15:45:00 +0000,http://www.fool.com/investing/2017/03/08/valeants-possible-debt-deal-shows-its-management-t.aspx,Valeant's Possible Debt Deal Shows Its Management Team Is Completely Missing the Point
VRX,VRX:CT,BBG000DC8S17,Valeant: Smaller…and Smaller…and Smaller,2017-03-08 15:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/08/valeant-winding-down/?mod=yahoobarrons&ru=yahoo,Valeant: Smaller…and Smaller…and Smaller
VRX,VRX:US,BBG000DLFM21,Valeant: Smaller…and Smaller…and Smaller,2017-03-08 15:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/08/valeant-winding-down/?mod=yahoobarrons&ru=yahoo,Valeant: Smaller…and Smaller…and Smaller
VRX,VRX:CT,BBG000DC8S17,ESPN Layoffs Likely to Hit On-Air Personalities,2017-03-08 04:12:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JKmUhXb5wRs/espn-layoffs-likely-to-hit-on-air-personalities-cm757666,InvestorPlace Stock Market News Stock Advice amp Trading Tips Walt Disney Co NYSE DIS announced a round of 160 ESPN 160 layoffs that will probably affect some well known on air personalities Source By Disney via Wikimedia Commons The announcement came
VRX,VRX:US,BBG000DLFM21,ESPN Layoffs Likely to Hit On-Air Personalities,2017-03-08 04:12:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JKmUhXb5wRs/espn-layoffs-likely-to-hit-on-air-personalities-cm757666,InvestorPlace Stock Market News Stock Advice amp Trading Tips Walt Disney Co NYSE DIS announced a round of 160 ESPN 160 layoffs that will probably affect some well known on air personalities Source By Disney via Wikimedia Commons The announcement came
VRX,VRX:US,BBG000DLFM21,"Brown-Forman Corporation (BF.B) Stock Slips on Q3 Earnings Miss, Outlook",2017-03-08 00:12:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8zwJ7DHYPPE/brown-forman-corporation-bfb-stock-slips-on-q3-earnings-miss-outlook-cm757644,InvestorPlace Stock Market News Stock Advice amp Trading Tips Brown Forman Corporation NYSE BF B reported quarterly earnings data that missed the mark Tuesday The beverage provider unveiled earnings for its fiscal third quarter
VRX,VRX:CT,BBG000DC8S17,"Brown-Forman Corporation (BF.B) Stock Slips on Q3 Earnings Miss, Outlook",2017-03-08 00:12:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8zwJ7DHYPPE/brown-forman-corporation-bfb-stock-slips-on-q3-earnings-miss-outlook-cm757644,InvestorPlace Stock Market News Stock Advice amp Trading Tips Brown Forman Corporation NYSE BF B reported quarterly earnings data that missed the mark Tuesday The beverage provider unveiled earnings for its fiscal third quarter
VRX,VRX:US,BBG000DLFM21,Why Dicks Sporting Goods Inc (DKS) Stock Is Dropping Today,2017-03-07 23:12:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GeVXHOxm8BE/why-dicks-sporting-goods-inc-dks-stock-is-dropping-today-cm757613,InvestorPlace Stock Market News Stock Advice amp Trading Tips Dicks Sporting Goods Inc NYSE DKS posted strong financial results Tuesday but the company s earnings were weaker than the previous year The retailer unveiled that it
VRX,VRX:CT,BBG000DC8S17,Why Dicks Sporting Goods Inc (DKS) Stock Is Dropping Today,2017-03-07 23:12:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GeVXHOxm8BE/why-dicks-sporting-goods-inc-dks-stock-is-dropping-today-cm757613,InvestorPlace Stock Market News Stock Advice amp Trading Tips Dicks Sporting Goods Inc NYSE DKS posted strong financial results Tuesday but the company s earnings were weaker than the previous year The retailer unveiled that it
VRX,VRX:US,BBG000DLFM21,"Valeant Commences Cash Tender Offer For Up To $600,000,000 Outstanding Principal Amount Of Its 6.75% Senior Notes Due 2018",2017-03-07 22:00:00 +0000,http://finance.yahoo.com/news/valeant-commences-cash-tender-offer-220000613.html,"[CNW Group] - Valeant Commences Cash Tender Offer For Up To $600,000,000 Outstanding Principal Amount Of Its 6.75% Senior Notes Due 2018"
VRX,VRX:CT,BBG000DC8S17,"Valeant Commences Cash Tender Offer For Up To $600,000,000 Outstanding Principal Amount Of Its 6.75% Senior Notes Due 2018",2017-03-07 22:00:00 +0000,http://finance.yahoo.com/news/valeant-commences-cash-tender-offer-220000613.html,"[CNW Group] - Valeant Commences Cash Tender Offer For Up To $600,000,000 Outstanding Principal Amount Of Its 6.75% Senior Notes Due 2018"
VRX,VRX:US,BBG000DLFM21,"Valeant, DryShips Plunge into Tuesday’s 52-Week Low Club",2017-03-07 21:04:50 +0000,http://finance.yahoo.com/news/valeant-dryships-plunge-tuesday-52-210450018.html,"Valeant, DryShips Plunge into Tuesday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,"Valeant, DryShips Plunge into Tuesday’s 52-Week Low Club",2017-03-07 21:04:50 +0000,http://finance.yahoo.com/news/valeant-dryships-plunge-tuesday-52-210450018.html,"Valeant, DryShips Plunge into Tuesday’s 52-Week Low Club"
VRX,VRX:US,BBG000DLFM21,"Valeant shares, bonds slump after it says it will seek to amend more of its debt covenants",2017-03-07 20:21:20 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=71C3C0D3-7615-4FA3-A2F0-CBF3093B232A&siteid=yhoof2,"Valeant shares, bonds slump after it says it will seek to amend more of its debt covenants"
VRX,VRX:CT,BBG000DC8S17,"Valeant shares, bonds slump after it says it will seek to amend more of its debt covenants",2017-03-07 20:21:20 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=71C3C0D3-7615-4FA3-A2F0-CBF3093B232A&siteid=yhoof2,"Valeant shares, bonds slump after it says it will seek to amend more of its debt covenants"
VRX,VRX:US,BBG000DLFM21,Market Vectors Junior Gold Miners ETF (GDXJ) Is Oversold. Time to Strike.,2017-03-07 20:13:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ffndtb0Ptdo/market-vectors-junior-gold-miners-etf-gdxj-is-oversold-time-to-strike-cm757476,InvestorPlace Stock Market News Stock Advice amp Trading Tips Gold stocks are suffering their largest selloff since late last year Just look at the damage inflicted across the broad swath of gold mining exchange traded funds The Market Vectors Gold Miners ETF NYSEARCA GDX
VRX,VRX:CT,BBG000DC8S17,Market Vectors Junior Gold Miners ETF (GDXJ) Is Oversold. Time to Strike.,2017-03-07 20:13:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ffndtb0Ptdo/market-vectors-junior-gold-miners-etf-gdxj-is-oversold-time-to-strike-cm757476,InvestorPlace Stock Market News Stock Advice amp Trading Tips Gold stocks are suffering their largest selloff since late last year Just look at the damage inflicted across the broad swath of gold mining exchange traded funds The Market Vectors Gold Miners ETF NYSEARCA GDX
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Tuesday: EnteroMedics Inc (ETRM), MeetMe Inc (MEET) and Casey’s General Stores Inc (CASY)",2017-03-07 20:12:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IHENQp_FcCw/3-stocks-to-watch-on-tuesday-enteromedics-inc-etrm-meetme-inc-meet-and-caseys-general-stores-inc-casy-cm757462,InvestorPlace Stock Market News Stock Advice amp Trading Tips Monday was a weak day for U S equities as the markets become more unsure about the goings on at the federal level with President Donald Trump accusing former President Barack Obama and his team of tapping
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Tuesday: EnteroMedics Inc (ETRM), MeetMe Inc (MEET) and Casey’s General Stores Inc (CASY)",2017-03-07 20:12:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IHENQp_FcCw/3-stocks-to-watch-on-tuesday-enteromedics-inc-etrm-meetme-inc-meet-and-caseys-general-stores-inc-casy-cm757462,InvestorPlace Stock Market News Stock Advice amp Trading Tips Monday was a weak day for U S equities as the markets become more unsure about the goings on at the federal level with President Donald Trump accusing former President Barack Obama and his team of tapping
VRX,VRX:CT,BBG000DC8S17,Is Tesla Inc (TSLA) Stock Really Going to Crash 26%?,2017-03-07 20:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mQr1yLMOeiQ/is-tesla-inc-tsla-stock-really-going-to-crash-26-cm757449,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Tesla Inc NASDAQ TSLA have been on a tear in 2017 up 17 despite a double digit drop in shares since mid February After reporting earnings on Feb 22 TSLA stock initially rallied before turning
VRX,VRX:US,BBG000DLFM21,Is Tesla Inc (TSLA) Stock Really Going to Crash 26%?,2017-03-07 20:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mQr1yLMOeiQ/is-tesla-inc-tsla-stock-really-going-to-crash-26-cm757449,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Tesla Inc NASDAQ TSLA have been on a tear in 2017 up 17 despite a double digit drop in shares since mid February After reporting earnings on Feb 22 TSLA stock initially rallied before turning
VRX,VRX:CT,BBG000DC8S17,RSI Alert: Valeant Pharmaceuticals International (VRX) Now Oversold,2017-03-07 19:14:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5MgkIkjr_js/rsi-alert-valeant-pharmaceuticals-international-vrx-now-oversold-cm757405,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:US,BBG000DLFM21,RSI Alert: Valeant Pharmaceuticals International (VRX) Now Oversold,2017-03-07 19:14:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5MgkIkjr_js/rsi-alert-valeant-pharmaceuticals-international-vrx-now-oversold-cm757405,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials",2017-03-07 18:04:18 +0000,http://finance.yahoo.com/q/is?s=vrx,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials",2017-03-07 18:04:18 +0000,http://finance.yahoo.com/q/is?s=vrx,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials"
VRX,VRX:US,BBG000DLFM21,"Supernus, Valeant, Endo Stocks Lose Big After Trump Drug-Pricing Tweet",2017-03-07 17:51:44 +0000,http://www.investors.com/news/technology/supernus-valeant-endo-stocks-lose-big-after-trump-drug-pricing-tweet/?src=A00220A,"Supernus, Valeant, Endo Stocks Lose Big After Trump Drug-Pricing Tweet"
VRX,VRX:CT,BBG000DC8S17,"Supernus, Valeant, Endo Stocks Lose Big After Trump Drug-Pricing Tweet",2017-03-07 17:51:44 +0000,http://www.investors.com/news/technology/supernus-valeant-endo-stocks-lose-big-after-trump-drug-pricing-tweet/?src=A00220A,"Supernus, Valeant, Endo Stocks Lose Big After Trump Drug-Pricing Tweet"
VRX,VRX:US,BBG000DLFM21,Add Up The Parts: FVL Could Be Worth $26,2017-03-07 16:12:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H2CwGbPVIpc/add-up-the-parts-fvl-could-be-worth-26-cm757210,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:CT,BBG000DC8S17,Add Up The Parts: FVL Could Be Worth $26,2017-03-07 16:12:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H2CwGbPVIpc/add-up-the-parts-fvl-could-be-worth-26-cm757210,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:US,BBG000DLFM21,PreMarket Prep Recap For March 7,2017-03-07 15:56:54 +0000,http://finance.yahoo.com/news/premarket-prep-recap-march-7-155654909.html,PreMarket Prep Recap For March 7
VRX,VRX:CT,BBG000DC8S17,PreMarket Prep Recap For March 7,2017-03-07 15:56:54 +0000,http://finance.yahoo.com/news/premarket-prep-recap-march-7-155654909.html,PreMarket Prep Recap For March 7
VRX,VRX:US,BBG000DLFM21,"Another Day, Another Steep Decline In Valeant",2017-03-07 15:43:00 +0000,http://www.investopedia.com/news/another-day-another-steep-decline-vrx-vrx/?partner=YahooSA,"Another Day, Another Steep Decline In Valeant"
VRX,VRX:CT,BBG000DC8S17,"Another Day, Another Steep Decline In Valeant",2017-03-07 15:43:00 +0000,http://www.investopedia.com/news/another-day-another-steep-decline-vrx-vrx/?partner=YahooSA,"Another Day, Another Steep Decline In Valeant"
VRX,VRX:US,BBG000DLFM21,Valeant Plummets for Second Day,2017-03-07 15:23:00 +0000,https://www.thestreet.com/story/14030220/1/valeant-plummets-for-second-day.html?puc=yahoo&cm_ven=YAHOO,Valeant Plummets for Second Day
VRX,VRX:CT,BBG000DC8S17,Valeant Plummets for Second Day,2017-03-07 15:23:00 +0000,https://www.thestreet.com/story/14030220/1/valeant-plummets-for-second-day.html?puc=yahoo&cm_ven=YAHOO,Valeant Plummets for Second Day
VRX,VRX:US,BBG000DLFM21,Valeant: Why Now? Because It Can,2017-03-07 15:02:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/07/valeant-why-now-because-we-can/?mod=yahoobarrons&ru=yahoo,Valeant: Why Now? Because It Can
VRX,VRX:CT,BBG000DC8S17,Valeant: Why Now? Because It Can,2017-03-07 15:02:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/07/valeant-why-now-because-we-can/?mod=yahoobarrons&ru=yahoo,Valeant: Why Now? Because It Can
VRX,VRX:CT,BBG000DC8S17,Concerns From Valeant's 10-K: $8 Billion Of Asset Sales Is Now A Mirage,2017-03-07 12:46:18 +0000,http://finance.yahoo.com/news/concerns-valeants-10-k-8-124618952.html,Concerns From Valeant's 10-K: $8 Billion Of Asset Sales Is Now A Mirage
VRX,VRX:US,BBG000DLFM21,Concerns From Valeant's 10-K: $8 Billion Of Asset Sales Is Now A Mirage,2017-03-07 12:46:18 +0000,http://finance.yahoo.com/news/concerns-valeants-10-k-8-124618952.html,Concerns From Valeant's 10-K: $8 Billion Of Asset Sales Is Now A Mirage
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling In Early Trade - Canadian Commentary,2017-03-07 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JOsjSQdkOv8/canadian-stocks-are-struggling-in-early-trade--canadian-commentary-20170307-00946,Canadian Stocks Are Struggling In Early Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling In Early Trade - Canadian Commentary,2017-03-07 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JOsjSQdkOv8/canadian-stocks-are-struggling-in-early-trade--canadian-commentary-20170307-00946,Canadian Stocks Are Struggling In Early Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Slides 4% on Debt Restructuring Announcement,2017-03-06 23:12:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BX_4sPi7pYY/valeant-vrx-stock-slides-4-on-debt-restructuring-announcement-cm756890,Pharmaceutical and biotech company Valeant Pharma VRX slipped down 4 33 to 12 50 intraday Monday due to an announcement of debt restructuring Negatively impacting EPS the company announced it paid 1 1 billion in loans after selling their skincare assets to L Oreal LRLCY Valeant is
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Slides 4% on Debt Restructuring Announcement,2017-03-06 23:12:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BX_4sPi7pYY/valeant-vrx-stock-slides-4-on-debt-restructuring-announcement-cm756890,Pharmaceutical and biotech company Valeant Pharma VRX slipped down 4 33 to 12 50 intraday Monday due to an announcement of debt restructuring Negatively impacting EPS the company announced it paid 1 1 billion in loans after selling their skincare assets to L Oreal LRLCY Valeant is
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Dive on Reports of New Debt,2017-03-06 21:26:00 +0000,https://www.thestreet.com/story/14028383/1/valeant-shares-fall-on-reports-of-new-debt.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Dive on Reports of New Debt
VRX,VRX:US,BBG000DLFM21,Valeant Shares Dive on Reports of New Debt,2017-03-06 21:26:00 +0000,https://www.thestreet.com/story/14028383/1/valeant-shares-fall-on-reports-of-new-debt.html?puc=yahoo&cm_ven=YAHOO,Valeant Shares Dive on Reports of New Debt
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Slides 4% on Debt Restructuring Announcement,2017-03-06 21:14:09 +0000,http://finance.yahoo.com/news/valeant-vrx-stock-slides-4-211409484.html,Valeant (VRX) Stock Slides 4% on Debt Restructuring Announcement
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Slides 4% on Debt Restructuring Announcement,2017-03-06 21:14:09 +0000,http://finance.yahoo.com/news/valeant-vrx-stock-slides-4-211409484.html,Valeant (VRX) Stock Slides 4% on Debt Restructuring Announcement
VRX,VRX:US,BBG000DLFM21,"Rite Aid, Frontier Communications Tumble into Monday’s 52-Week Low Club",2017-03-06 21:04:25 +0000,http://finance.yahoo.com/news/rite-aid-frontier-communications-tumble-210425980.html,"Rite Aid, Frontier Communications Tumble into Monday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,"Rite Aid, Frontier Communications Tumble into Monday’s 52-Week Low Club",2017-03-06 21:04:25 +0000,http://finance.yahoo.com/news/rite-aid-frontier-communications-tumble-210425980.html,"Rite Aid, Frontier Communications Tumble into Monday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,LPC: Valeant seeks new debt to support refinancing effort,2017-03-06 20:52:25 +0000,http://finance.yahoo.com/news/lpc-valeant-seeks-debt-support-205225542.html,"[Reuters] - Valeant Pharmaceuticals International Inc plans to line up a US$3.06bn incremental term loan and junk bond sale as part of a debt restructuring, sources said. In addition to the new debt offering, the company paid down about US$1.1bn of senior secured term loans with proceeds from the sale of its skincare products assets on March 3, according to a Monday regulatory filing. Valeant is also repaying a portion of its 6.75% senior notes due in 2018 and extending the maturity date of its revolving credit facility with the proceeds from the new loan and a secured high-yield bond."
VRX,VRX:US,BBG000DLFM21,LPC: Valeant seeks new debt to support refinancing effort,2017-03-06 20:52:25 +0000,http://finance.yahoo.com/news/lpc-valeant-seeks-debt-support-205225542.html,"[Reuters] - Valeant Pharmaceuticals International Inc plans to line up a US$3.06bn incremental term loan and junk bond sale as part of a debt restructuring, sources said. In addition to the new debt offering, the company paid down about US$1.1bn of senior secured term loans with proceeds from the sale of its skincare products assets on March 3, according to a Monday regulatory filing. Valeant is also repaying a portion of its 6.75% senior notes due in 2018 and extending the maturity date of its revolving credit facility with the proceeds from the new loan and a secured high-yield bond."
VRX,VRX:CT,BBG000DC8S17,Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal,2017-03-06 20:45:10 +0000,http://finance.yahoo.com/news/why-one-key-analyst-believes-204510037.html,Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal
VRX,VRX:US,BBG000DLFM21,Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal,2017-03-06 20:45:10 +0000,http://finance.yahoo.com/news/why-one-key-analyst-believes-204510037.html,Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal
VRX,VRX:CT,BBG000DC8S17,Valeant Looking to Repay Debt But Will it Help?,2017-03-06 20:14:00 +0000,http://www.investopedia.com/news/valeant-looking-repay-debt-vrx/?partner=YahooSA,Valeant Looking to Repay Debt But Will it Help?
VRX,VRX:US,BBG000DLFM21,Valeant Looking to Repay Debt But Will it Help?,2017-03-06 20:14:00 +0000,http://www.investopedia.com/news/valeant-looking-repay-debt-vrx/?partner=YahooSA,Valeant Looking to Repay Debt But Will it Help?
VRX,VRX:CT,BBG000DC8S17,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : March 6, 2017",2017-03-06 19:08:40 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-march-6-2017-2/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : March 6, 2017"
VRX,VRX:US,BBG000DLFM21,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : March 6, 2017",2017-03-06 19:08:40 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-march-6-2017-2/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : March 6, 2017"
VRX,VRX:US,BBG000DLFM21,It's another day of 'good news is bad news' at Bill Ackman's nightmare stock,2017-03-06 18:16:03 +0000,http://finance.yahoo.com/news/another-day-good-news-bad-181603967.html,It's another day of 'good news is bad news' at Bill Ackman's nightmare stock
VRX,VRX:CT,BBG000DC8S17,It's another day of 'good news is bad news' at Bill Ackman's nightmare stock,2017-03-06 18:16:03 +0000,http://finance.yahoo.com/news/another-day-good-news-bad-181603967.html,It's another day of 'good news is bad news' at Bill Ackman's nightmare stock
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017",2017-03-06 17:28:58 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-2016-by-the-numbers-march-6-2017/,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017",2017-03-06 17:28:58 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-2016-by-the-numbers-march-6-2017/,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017"
VRX,VRX:CT,BBG000DC8S17,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2017-03-06 16:18:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5OQPbPWTjGI/should-you-get-rid-of-valeant-pharmaceuticals-international-vrx-now-cm756611,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:US,BBG000DLFM21,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2017-03-06 16:18:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5OQPbPWTjGI/should-you-get-rid-of-valeant-pharmaceuticals-international-vrx-now-cm756611,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:US,BBG000DLFM21,VRX Escrow Corp. -- Moody's assigns Ba3 to Valeant's sr. sec. loan and sr. sec. notes; affirms B3 CFR; outlook negative,2017-03-06 16:09:02 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_362990&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170306_PR_362990,VRX Escrow Corp. -- Moody's assigns Ba3 to Valeant's sr. sec. loan and sr. sec. notes; affirms B3 CFR; outlook negative
VRX,VRX:CT,BBG000DC8S17,VRX Escrow Corp. -- Moody's assigns Ba3 to Valeant's sr. sec. loan and sr. sec. notes; affirms B3 CFR; outlook negative,2017-03-06 16:09:02 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_362990&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170306_PR_362990,VRX Escrow Corp. -- Moody's assigns Ba3 to Valeant's sr. sec. loan and sr. sec. notes; affirms B3 CFR; outlook negative
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: No Room to Maneuver?,2017-03-06 15:29:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/06/valeant-pharmaceuticals-no-room-to-maneuver/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: No Room to Maneuver?
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: No Room to Maneuver?,2017-03-06 15:29:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/06/valeant-pharmaceuticals-no-room-to-maneuver/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: No Room to Maneuver?
VRX,VRX:US,BBG000DLFM21,LPC: Valeant seeks US$3bn loan to support refinancing effort,2017-03-06 14:56:26 +0000,http://finance.yahoo.com/news/lpc-valeant-seeks-us-3bn-145626847.html,"[Reuters] - Valeant Pharmaceuticals International Inc plans to line up a US$3.06bn incremental term loan as part of a debt restructuring, sources said. In addition to the new debt offering, the company paid down about US$1.1bn of senior secured term loans with proceeds from the sale of its skincare products assets on March 3, according to a Monday regulatory filing. Valeant is also repaying a portion of its 6.75% senior notes due in 2018 and extending the maturity date of its revolving credit facility."
VRX,VRX:CT,BBG000DC8S17,LPC: Valeant seeks US$3bn loan to support refinancing effort,2017-03-06 14:56:26 +0000,http://finance.yahoo.com/news/lpc-valeant-seeks-us-3bn-145626847.html,"[Reuters] - Valeant Pharmaceuticals International Inc plans to line up a US$3.06bn incremental term loan as part of a debt restructuring, sources said. In addition to the new debt offering, the company paid down about US$1.1bn of senior secured term loans with proceeds from the sale of its skincare products assets on March 3, according to a Monday regulatory filing. Valeant is also repaying a portion of its 6.75% senior notes due in 2018 and extending the maturity date of its revolving credit facility."
VRX,VRX:US,BBG000DLFM21,Markets Post Election Rally Strengthens: Today's Research Reports on Advanced Micro Devices and Valeant Pharmaceuticals,2017-03-06 14:45:00 +0000,http://finance.yahoo.com/news/markets-post-election-rally-strengthens-144500096.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 6, 2017 / The markets' post-election rally has strengthened as investor optimism on the health of the U.S. economy continues to grow. The Dow Jones Industrial Average ..."
VRX,VRX:CT,BBG000DC8S17,Markets Post Election Rally Strengthens: Today's Research Reports on Advanced Micro Devices and Valeant Pharmaceuticals,2017-03-06 14:45:00 +0000,http://finance.yahoo.com/news/markets-post-election-rally-strengthens-144500096.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 6, 2017 / The markets' post-election rally has strengthened as investor optimism on the health of the U.S. economy continues to grow. The Dow Jones Industrial Average ..."
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: General Motors Drops, Valeant Gains, Delta Slides",2017-03-06 14:20:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/06/morning-movers-general-motors-drops-valeant-gains-delta-slides/?mod=yahoobarrons&ru=yahoo,"Morning Movers: General Motors Drops, Valeant Gains, Delta Slides"
VRX,VRX:US,BBG000DLFM21,"Morning Movers: General Motors Drops, Valeant Gains, Delta Slides",2017-03-06 14:20:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/06/morning-movers-general-motors-drops-valeant-gains-delta-slides/?mod=yahoobarrons&ru=yahoo,"Morning Movers: General Motors Drops, Valeant Gains, Delta Slides"
VRX,VRX:CT,BBG000DC8S17,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2017-03-06 13:42:01 +0000,http://finance.yahoo.com/news/rid-valeant-pharmaceuticals-international-vrx-134201726.html,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?
VRX,VRX:US,BBG000DLFM21,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2017-03-06 13:42:01 +0000,http://finance.yahoo.com/news/rid-valeant-pharmaceuticals-international-vrx-134201726.html,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?
VRX,VRX:CT,BBG000DC8S17,5 FDA Decisions to Watch Out for in Mar 2017,2017-03-06 12:39:12 +0000,http://finance.yahoo.com/news/5-fda-decisions-watch-mar-123912086.html,5 FDA Decisions to Watch Out for in Mar 2017
VRX,VRX:US,BBG000DLFM21,5 FDA Decisions to Watch Out for in Mar 2017,2017-03-06 12:39:12 +0000,http://finance.yahoo.com/news/5-fda-decisions-watch-mar-123912086.html,5 FDA Decisions to Watch Out for in Mar 2017
VRX,VRX:CT,BBG000DC8S17,Valeant Completes Approximately $1.1 Billion Pay Down Of Senior Secured Term Loans From Divestitures; To Seek Refinancing And Amendment Of Credit Agreement,2017-03-06 11:45:00 +0000,http://finance.yahoo.com/news/valeant-completes-approximately-1-1-114500694.html,[CNW Group] - Valeant Completes Approximately $1.1 Billion Pay Down Of Senior Secured Term Loans From Divestitures; To Seek Refinancing And Amendment Of Credit Agreement
VRX,VRX:US,BBG000DLFM21,Valeant Completes Approximately $1.1 Billion Pay Down Of Senior Secured Term Loans From Divestitures; To Seek Refinancing And Amendment Of Credit Agreement,2017-03-06 11:45:00 +0000,http://finance.yahoo.com/news/valeant-completes-approximately-1-1-114500694.html,[CNW Group] - Valeant Completes Approximately $1.1 Billion Pay Down Of Senior Secured Term Loans From Divestitures; To Seek Refinancing And Amendment Of Credit Agreement
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-03-06 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O0R2Xvv9YFs/canadian-stocks-are-paring-early-losses--canadian-commentary-20170306-00850,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Losses - Canadian Commentary,2017-03-06 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O0R2Xvv9YFs/canadian-stocks-are-paring-early-losses--canadian-commentary-20170306-00850,Canadian Stocks Are Paring Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Completes $1.1 Bln Pay Down Of Term Loans; To Seek Refinancing,2017-03-06 07:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H6E-bMNwXek/valeant-completes-11-bln-pay-down-of-term-loans-to-seek-refinancing-20170306-00317,Valeant Completes $1.1 Bln Pay Down Of Term Loans; To Seek Refinancing
VRX,VRX:CT,BBG000DC8S17,Valeant Completes $1.1 Bln Pay Down Of Term Loans; To Seek Refinancing,2017-03-06 07:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H6E-bMNwXek/valeant-completes-11-bln-pay-down-of-term-loans-to-seek-refinancing-20170306-00317,Valeant Completes $1.1 Bln Pay Down Of Term Loans; To Seek Refinancing
VRX,VRX:CT,BBG000DC8S17,10 Things We Learned From Our Daily Facebook Show With Jim Cramer,2017-03-04 15:24:00 +0000,https://www.thestreet.com/story/14026480/1/10-things-we-learned-from-our-daily-facebook-show-with-jim-cramer.html?puc=yahoo&cm_ven=YAHOO,10 Things We Learned From Our Daily Facebook Show With Jim Cramer
VRX,VRX:US,BBG000DLFM21,10 Things We Learned From Our Daily Facebook Show With Jim Cramer,2017-03-04 15:24:00 +0000,https://www.thestreet.com/story/14026480/1/10-things-we-learned-from-our-daily-facebook-show-with-jim-cramer.html?puc=yahoo&cm_ven=YAHOO,10 Things We Learned From Our Daily Facebook Show With Jim Cramer
VRX,VRX:CT,BBG000DC8S17,Why Analysts Are Looking at Valeant Pharma Differently After Earnings,2017-03-04 14:45:12 +0000,http://finance.yahoo.com/news/why-analysts-looking-valeant-pharma-144512036.html,Why Analysts Are Looking at Valeant Pharma Differently After Earnings
VRX,VRX:US,BBG000DLFM21,Why Analysts Are Looking at Valeant Pharma Differently After Earnings,2017-03-04 14:45:12 +0000,http://finance.yahoo.com/news/why-analysts-looking-valeant-pharma-144512036.html,Why Analysts Are Looking at Valeant Pharma Differently After Earnings
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals Intl Inc (VRX), Advanced Micro Devices, Inc. (AMD) and Macy’s Inc (M) are 3 of Today’s Worst Stocks",2017-03-04 13:13:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GpupAdTQPlM/why-valeant-pharmaceuticals-intl-inc-vrx-advanced-micro-devices-inc-amd-and-macys-inc-m-are-3-of-todays-worst-stocks-cm756285,InvestorPlace Stock Market News Stock Advice amp Trading Tips Once again the bears had a prime opportunity to tip the market over Once again they squandered it While stocks started the day s trading mostly in the red cutting into Wednesday s opening gap
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals Intl Inc (VRX), Advanced Micro Devices, Inc. (AMD) and Macy’s Inc (M) are 3 of Today’s Worst Stocks",2017-03-04 13:13:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GpupAdTQPlM/why-valeant-pharmaceuticals-intl-inc-vrx-advanced-micro-devices-inc-amd-and-macys-inc-m-are-3-of-todays-worst-stocks-cm756285,InvestorPlace Stock Market News Stock Advice amp Trading Tips Once again the bears had a prime opportunity to tip the market over Once again they squandered it While stocks started the day s trading mostly in the red cutting into Wednesday s opening gap
VRX,VRX:US,BBG000DLFM21,"Target, Valeant Slide into Friday’s 52-Week Low Club",2017-03-03 21:04:09 +0000,http://finance.yahoo.com/news/target-valeant-slide-friday-52-210409665.html,"Target, Valeant Slide into Friday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,"Target, Valeant Slide into Friday’s 52-Week Low Club",2017-03-03 21:04:09 +0000,http://finance.yahoo.com/news/target-valeant-slide-friday-52-210409665.html,"Target, Valeant Slide into Friday’s 52-Week Low Club"
VRX,VRX:US,BBG000DLFM21,Bill Ackman's nightmare stock is getting kicked around again,2017-03-03 20:47:31 +0000,http://finance.yahoo.com/news/bill-ackmans-nightmare-stock-getting-204731386.html,Bill Ackman's nightmare stock is getting kicked around again
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's nightmare stock is getting kicked around again,2017-03-03 20:47:31 +0000,http://finance.yahoo.com/news/bill-ackmans-nightmare-stock-getting-204731386.html,Bill Ackman's nightmare stock is getting kicked around again
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Completes Sale Of CeraVe, AcneFree And AMBI Skincare Brands To L'Oréal",2017-03-03 19:34:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-cerave-193400877.html,"[CNW Group] - Valeant Pharmaceuticals Completes Sale Of CeraVe, AcneFree And AMBI Skincare Brands To L'Oréal"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Completes Sale Of CeraVe, AcneFree And AMBI Skincare Brands To L'Oréal",2017-03-03 19:34:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-completes-sale-cerave-193400877.html,"[CNW Group] - Valeant Pharmaceuticals Completes Sale Of CeraVe, AcneFree And AMBI Skincare Brands To L'Oréal"
VRX,VRX:CT,BBG000DC8S17,10-Ks Explained: How To Use The News Companies Save For Their Filings,2017-03-03 18:27:52 +0000,http://finance.yahoo.com/news/10-ks-explained-news-companies-182752981.html,10-Ks Explained: How To Use The News Companies Save For Their Filings
VRX,VRX:US,BBG000DLFM21,10-Ks Explained: How To Use The News Companies Save For Their Filings,2017-03-03 18:27:52 +0000,http://finance.yahoo.com/news/10-ks-explained-news-companies-182752981.html,10-Ks Explained: How To Use The News Companies Save For Their Filings
VRX,VRX:US,BBG000DLFM21,Bay Street Revival Despite Clear U.S. Rate Hike Signal -- Canadian Commentary,2017-03-03 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g54sMODG5fE/bay-street-revival-despite-clear-us-rate-hike-signal--canadian-commentary-20170303-00765,Bay Street Revival Despite Clear U.S. Rate Hike Signal -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valaent Down Draft Continues,2017-03-03 16:17:00 +0000,http://www.investopedia.com/news/valaent-down-draft-continues-vrx/?partner=YahooSA,Valaent Down Draft Continues
VRX,VRX:CT,BBG000DC8S17,Valaent Down Draft Continues,2017-03-03 16:17:00 +0000,http://www.investopedia.com/news/valaent-down-draft-continues-vrx/?partner=YahooSA,Valaent Down Draft Continues
VRX,VRX:CT,BBG000DC8S17,Bay Street Revival Despite Clear U.S. Rate Hike Signal -- Canadian Commentary,2017-03-03 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g54sMODG5fE/bay-street-revival-despite-clear-us-rate-hike-signal--canadian-commentary-20170303-00765,Bay Street Revival Despite Clear U.S. Rate Hike Signal -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 15:45:27 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017/,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 15:45:27 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017/,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017"
VRX,VRX:US,BBG000DLFM21,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug",2017-03-03 13:33:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mylan-endo-133301707.html,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug"
VRX,VRX:CT,BBG000DC8S17,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug",2017-03-03 13:33:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mylan-endo-133301707.html,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug"
VRX,VRX:US,BBG000DLFM21,Is This The Best Biotech Play for 2017?,2017-03-02 23:04:00 +0000,https://www.thestreet.com/story/14025233/1/is-this-the-best-biotech-play-for-2017.html?puc=yahoo&cm_ven=YAHOO,Is This The Best Biotech Play for 2017?
VRX,VRX:CT,BBG000DC8S17,Is This The Best Biotech Play for 2017?,2017-03-02 23:04:00 +0000,https://www.thestreet.com/story/14025233/1/is-this-the-best-biotech-play-for-2017.html?puc=yahoo&cm_ven=YAHOO,Is This The Best Biotech Play for 2017?
VRX,VRX:CT,BBG000DC8S17,"How to Handle Red-Hot Advanced Micro Devices, Inc. (AMD) Stock",2017-03-02 20:14:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/syn9nmBgpaE/how-to-handle-red-hot-advanced-micro-devices-inc-amd-stock-cm755630,InvestorPlace Stock Market News Stock Advice amp Trading Tips Advanced Micro Devices Inc NASDAQ AMD has put on an incredible show Sure the entire sector is in the midst of a breakout but the 500 plus 12 month performance of AMD well it sticks out Source
VRX,VRX:US,BBG000DLFM21,"How to Handle Red-Hot Advanced Micro Devices, Inc. (AMD) Stock",2017-03-02 20:14:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/syn9nmBgpaE/how-to-handle-red-hot-advanced-micro-devices-inc-amd-stock-cm755630,InvestorPlace Stock Market News Stock Advice amp Trading Tips Advanced Micro Devices Inc NASDAQ AMD has put on an incredible show Sure the entire sector is in the midst of a breakout but the 500 plus 12 month performance of AMD well it sticks out Source
VRX,VRX:CT,BBG000DC8S17,Catch Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free,2017-03-02 19:14:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jq_b0V8hSJY/catch-valeant-pharmaceuticals-intl-inc-vrx-stock-for-free-cm755601,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is not your typical stock It s a polarized name that has haters and avid fans alike I fit in neither camp I love the price action of VRX stock and nothing else
VRX,VRX:US,BBG000DLFM21,Catch Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free,2017-03-02 19:14:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jq_b0V8hSJY/catch-valeant-pharmaceuticals-intl-inc-vrx-stock-for-free-cm755601,InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is not your typical stock It s a polarized name that has haters and avid fans alike I fit in neither camp I love the price action of VRX stock and nothing else
VRX,VRX:US,BBG000DLFM21,"3 Reasons Amazon.com, Inc. (AMZN) Stock Will Keep Growing Like a Weed",2017-03-02 19:14:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4YbJcaeun3o/3-reasons-amazoncom-inc-amzn-stock-will-keep-growing-like-a-weed-cm755598,InvestorPlace Stock Market News Stock Advice amp Trading Tips E commerce giant Amazon com Inc NASDAQ AMZN has delivered returns of more than 60 to investors throughout the past year With online shopping more popular than ever many investors may be questioning whether
VRX,VRX:CT,BBG000DC8S17,"3 Reasons Amazon.com, Inc. (AMZN) Stock Will Keep Growing Like a Weed",2017-03-02 19:14:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4YbJcaeun3o/3-reasons-amazoncom-inc-amzn-stock-will-keep-growing-like-a-weed-cm755598,InvestorPlace Stock Market News Stock Advice amp Trading Tips E commerce giant Amazon com Inc NASDAQ AMZN has delivered returns of more than 60 to investors throughout the past year With online shopping more popular than ever many investors may be questioning whether
VRX,VRX:US,BBG000DLFM21,"Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International",2017-03-02 16:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0qZ1NRJ9xFI/zacks-industry-outlook-highlights-sanofi-astrazeneca-novo-nordisk-gilead-sciences-and-valeant-pharmaceuticals-international-cm755341,For Immediate Release Chicago IL March 02 2017 Today Zacks Equity Research discusses the Industry Pharma Part 3 including Sanofi SNY Free Report AstraZeneca s AZN Free Report Novo Nordisk A S NVO Free Report Gilead Sciences Inc GILD
VRX,VRX:CT,BBG000DC8S17,"Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International",2017-03-02 16:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0qZ1NRJ9xFI/zacks-industry-outlook-highlights-sanofi-astrazeneca-novo-nordisk-gilead-sciences-and-valeant-pharmaceuticals-international-cm755341,For Immediate Release Chicago IL March 02 2017 Today Zacks Equity Research discusses the Industry Pharma Part 3 including Sanofi SNY Free Report AstraZeneca s AZN Free Report Novo Nordisk A S NVO Free Report Gilead Sciences Inc GILD
VRX,VRX:US,BBG000DLFM21,"Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International",2017-03-02 14:30:02 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-sanofi-143002630.html,"Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International"
VRX,VRX:CT,BBG000DC8S17,"Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International",2017-03-02 14:30:02 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-sanofi-143002630.html,"Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International"
VRX,VRX:CT,BBG000DC8S17,EYEG: Several Major Development Milestones Expected in 2017,2017-03-02 14:30:00 +0000,http://finance.yahoo.com/news/eyeg-several-major-development-milestones-143000057.html,EYEG: Several Major Development Milestones Expected in 2017
VRX,VRX:US,BBG000DLFM21,EYEG: Several Major Development Milestones Expected in 2017,2017-03-02 14:30:00 +0000,http://finance.yahoo.com/news/eyeg-several-major-development-milestones-143000057.html,EYEG: Several Major Development Milestones Expected in 2017
VRX,VRX:US,BBG000DLFM21,"Morning Movers: Shake Shack Sinks, Abercrombie & Fitch Jumps, Valeant Climbs",2017-03-02 14:23:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/02/morning-movers-shake-shack-sinks-abercrombie-fitch-jumps-valeant-climbs/?mod=yahoobarrons&ru=yahoo,"Morning Movers: Shake Shack Sinks, Abercrombie & Fitch Jumps, Valeant Climbs"
VRX,VRX:CT,BBG000DC8S17,"Morning Movers: Shake Shack Sinks, Abercrombie & Fitch Jumps, Valeant Climbs",2017-03-02 14:23:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/02/morning-movers-shake-shack-sinks-abercrombie-fitch-jumps-valeant-climbs/?mod=yahoobarrons&ru=yahoo,"Morning Movers: Shake Shack Sinks, Abercrombie & Fitch Jumps, Valeant Climbs"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Pared Early Losses - Canadian Commentary,2017-03-02 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M82clox844w/canadian-stocks-have-pared-early-losses--canadian-commentary-20170302-01071,Canadian Stocks Have Pared Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Pared Early Losses - Canadian Commentary,2017-03-02 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z3uxfSRNciI/canadian-stocks-have-pared-early-losses--canadian-commentary-20170302-01072,Canadian Stocks Have Pared Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Pared Early Losses - Canadian Commentary,2017-03-02 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M82clox844w/canadian-stocks-have-pared-early-losses--canadian-commentary-20170302-01071,Canadian Stocks Have Pared Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Pared Early Losses - Canadian Commentary,2017-03-02 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z3uxfSRNciI/canadian-stocks-have-pared-early-losses--canadian-commentary-20170302-01072,Canadian Stocks Have Pared Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant's New Bonus Math Puts Debt Holders in Driver's Seat,2017-03-02 10:00:00 +0000,https://www.bloomberg.com/news/articles/2017-03-02/valeant-s-new-bonus-math-puts-debt-holders-in-driver-s-seat?cmpid=yhoo.headline,Valeant's New Bonus Math Puts Debt Holders in Driver's Seat
VRX,VRX:CT,BBG000DC8S17,Valeant's New Bonus Math Puts Debt Holders in Driver's Seat,2017-03-02 10:00:00 +0000,https://www.bloomberg.com/news/articles/2017-03-02/valeant-s-new-bonus-math-puts-debt-holders-in-driver-s-seat?cmpid=yhoo.headline,Valeant's New Bonus Math Puts Debt Holders in Driver's Seat
VRX,VRX:US,BBG000DLFM21,Pricing to Remain Pharma Headline Risk in 2017,2017-03-02 06:11:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yEH9cTkEVdo/pricing-to-remain-pharma-headline-risk-in-2017-cm755190,Drug Pricing Issues to Remain a Headwind Drug pricing is an issue that has been weighing on pharma and biotech stocks for more than a year now The sector which previously had a stellar run started its downward trend in Sep 2015 when a single tweet by Democratic Presidential candidate
VRX,VRX:CT,BBG000DC8S17,Pricing to Remain Pharma Headline Risk in 2017,2017-03-02 06:11:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yEH9cTkEVdo/pricing-to-remain-pharma-headline-risk-in-2017-cm755190,Drug Pricing Issues to Remain a Headwind Drug pricing is an issue that has been weighing on pharma and biotech stocks for more than a year now The sector which previously had a stellar run started its downward trend in Sep 2015 when a single tweet by Democratic Presidential candidate
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Tops Q4 Earnings, Shares Down on Tepid View",2017-03-02 00:13:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTHTVBxt89w/valeant-vrx-tops-q4-earnings-shares-down-on-tepid-view-cm755148,Shares of Valeant Pharmaceuticals Inc VRX fell over 13 9 following the company s dismal guidance for 2017 concurrent with the fourth quarter 2016 earnings We note that the shares of Valeant have underperformed the Zacks classified Medical Drugs industry in the last one year The
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Tops Q4 Earnings, Shares Down on Tepid View",2017-03-02 00:13:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTHTVBxt89w/valeant-vrx-tops-q4-earnings-shares-down-on-tepid-view-cm755148,Shares of Valeant Pharmaceuticals Inc VRX fell over 13 9 following the company s dismal guidance for 2017 concurrent with the fourth quarter 2016 earnings We note that the shares of Valeant have underperformed the Zacks classified Medical Drugs industry in the last one year The
VRX,VRX:US,BBG000DLFM21,Cramer: Don't Punish Stocks Equally for the Fault of One,2017-03-02 00:01:00 +0000,http://realmoney.thestreet.com/articles/03/01/2017/cramer-dont-punish-stocks-equally-fault-one?puc=yahoo&cm_ven=YAHOO,Cramer: Don't Punish Stocks Equally for the Fault of One
VRX,VRX:CT,BBG000DC8S17,Cramer: Don't Punish Stocks Equally for the Fault of One,2017-03-02 00:01:00 +0000,http://realmoney.thestreet.com/articles/03/01/2017/cramer-dont-punish-stocks-equally-fault-one?puc=yahoo&cm_ven=YAHOO,Cramer: Don't Punish Stocks Equally for the Fault of One
VRX,VRX:CT,BBG000DC8S17,It's Time to Face the Facts: Valeant Pharmaceuticals Is in Deep Trouble,2017-03-01 23:14:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Zk8SF022dk/its-time-to-face-the-facts-valeant-pharmaceuticals-is-in-deep-trouble-cm755108,Before the opening bell on Tuesday embattled drug developer Valeant Pharmaceuticals NYSE VRX reported its fourth quarter and full year results As you might have imagined by the 14 decline in the company s share price yesterday Valeant s report didn t sit well with Wall
VRX,VRX:US,BBG000DLFM21,It's Time to Face the Facts: Valeant Pharmaceuticals Is in Deep Trouble,2017-03-01 23:14:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Zk8SF022dk/its-time-to-face-the-facts-valeant-pharmaceuticals-is-in-deep-trouble-cm755108,Before the opening bell on Tuesday embattled drug developer Valeant Pharmaceuticals NYSE VRX reported its fourth quarter and full year results As you might have imagined by the 14 decline in the company s share price yesterday Valeant s report didn t sit well with Wall
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Corrects Misleading Report About Salix Investigation,2017-03-01 23:10:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-corrects-misleading-report-231000960.html,[CNW Group] - Valeant Pharmaceuticals Corrects Misleading Report About Salix Investigation
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Corrects Misleading Report About Salix Investigation,2017-03-01 23:10:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-corrects-misleading-report-231000960.html,[CNW Group] - Valeant Pharmaceuticals Corrects Misleading Report About Salix Investigation
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Tops Q4 Earnings, Shares Down on Tepid View",2017-03-01 21:46:09 +0000,http://finance.yahoo.com/news/valeant-vrx-tops-q4-earnings-214609403.html,"Valeant (VRX) Tops Q4 Earnings, Shares Down on Tepid View"
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Tops Q4 Earnings, Shares Down on Tepid View",2017-03-01 21:46:09 +0000,http://finance.yahoo.com/news/valeant-vrx-tops-q4-earnings-214609403.html,"Valeant (VRX) Tops Q4 Earnings, Shares Down on Tepid View"
VRX,VRX:CT,BBG000DC8S17,It's Time to Face the Facts: Valeant Pharmaceuticals Is in Deep Trouble,2017-03-01 21:21:00 +0000,http://www.fool.com/investing/2017/03/01/its-time-to-face-the-facts-valeant-pharmaceuticals.aspx,It's Time to Face the Facts: Valeant Pharmaceuticals Is in Deep Trouble
VRX,VRX:US,BBG000DLFM21,It's Time to Face the Facts: Valeant Pharmaceuticals Is in Deep Trouble,2017-03-01 21:21:00 +0000,http://www.fool.com/investing/2017/03/01/its-time-to-face-the-facts-valeant-pharmaceuticals.aspx,It's Time to Face the Facts: Valeant Pharmaceuticals Is in Deep Trouble
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's nightmare stock is getting stomped for the 2nd day in a row,2017-03-01 21:00:09 +0000,http://finance.yahoo.com/news/bill-ackmans-nightmare-stock-getting-210009494.html,Bill Ackman's nightmare stock is getting stomped for the 2nd day in a row
VRX,VRX:US,BBG000DLFM21,Bill Ackman's nightmare stock is getting stomped for the 2nd day in a row,2017-03-01 21:00:09 +0000,http://finance.yahoo.com/news/bill-ackmans-nightmare-stock-getting-210009494.html,Bill Ackman's nightmare stock is getting stomped for the 2nd day in a row
VRX,VRX:CT,BBG000DC8S17,Valeant stock falls 5% after company files 10-K,2017-03-01 20:50:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=09B5E755-6DCC-4987-B063-B5AF1F0EC4FD&siteid=yhoof2,Valeant stock falls 5% after company files 10-K
VRX,VRX:US,BBG000DLFM21,Valeant stock falls 5% after company files 10-K,2017-03-01 20:50:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=09B5E755-6DCC-4987-B063-B5AF1F0EC4FD&siteid=yhoof2,Valeant stock falls 5% after company files 10-K
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-K, Annual Report",2017-03-01 20:09:06 +0000,http://biz.yahoo.com/e/170301/vrx10-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-K, Annual Report"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-K, Annual Report",2017-03-01 20:09:06 +0000,http://biz.yahoo.com/e/170301/vrx10-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-K, Annual Report"
VRX,VRX:US,BBG000DLFM21,"Company News for March 01, 2017",2017-03-01 17:12:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/86I-j0Ecgns/company-news-for-march-01-2017-cm754849,Shares of Valeant Pharmaceuticals International Inc VRX decreased 13 9 after posting fourth quarter earnings of 1 26 per share down from the year ago figure of 2 51 Priceline Group Inc s PCLN shares advanced 5 6 after announcing fourth quarter non GAAP earnings per
VRX,VRX:CT,BBG000DC8S17,"Company News for March 01, 2017",2017-03-01 17:12:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/86I-j0Ecgns/company-news-for-march-01-2017-cm754849,Shares of Valeant Pharmaceuticals International Inc VRX decreased 13 9 after posting fourth quarter earnings of 1 26 per share down from the year ago figure of 2 51 Priceline Group Inc s PCLN shares advanced 5 6 after announcing fourth quarter non GAAP earnings per
VRX,VRX:CT,BBG000DC8S17,Valeant: The Long and Winding Road,2017-03-01 16:14:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/01/valeant-the-long-and-winding-road/?mod=yahoobarrons&ru=yahoo,Valeant: The Long and Winding Road
VRX,VRX:US,BBG000DLFM21,Valeant: The Long and Winding Road,2017-03-01 16:14:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/01/valeant-the-long-and-winding-road/?mod=yahoobarrons&ru=yahoo,Valeant: The Long and Winding Road
VRX,VRX:US,BBG000DLFM21,5 Things Valeant's Management Said That You Probably Wish It Hadn't,2017-03-01 15:14:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EL761sgcgUI/5-things-valeants-management-said-that-you-probably-wish-it-hadnt-cm754725,You only needed to look at Valeant Pharmaceuticals NYSE VRX share price on Tuesday to know that things didn t go well when the company reported its fourth quarter results As bad as those results were though it was Valeant s outlook for 2017 that really caused the stock to
VRX,VRX:CT,BBG000DC8S17,5 Things Valeant's Management Said That You Probably Wish It Hadn't,2017-03-01 15:14:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EL761sgcgUI/5-things-valeants-management-said-that-you-probably-wish-it-hadnt-cm754725,You only needed to look at Valeant Pharmaceuticals NYSE VRX share price on Tuesday to know that things didn t go well when the company reported its fourth quarter results As bad as those results were though it was Valeant s outlook for 2017 that really caused the stock to
VRX,VRX:US,BBG000DLFM21,"Company News for March 01, 2017",2017-03-01 15:10:03 +0000,http://finance.yahoo.com/news/company-news-march-01-2017-151003556.html,"Company News for March 01, 2017"
VRX,VRX:CT,BBG000DC8S17,"Company News for March 01, 2017",2017-03-01 15:10:03 +0000,http://finance.yahoo.com/news/company-news-march-01-2017-151003556.html,"Company News for March 01, 2017"
VRX,VRX:CT,BBG000DC8S17,5 Things Valeant's Management Said That You Probably Wish It Hadn't,2017-03-01 13:21:00 +0000,http://www.fool.com/investing/2017/03/01/5-things-valeants-management-said-that-you-probabl.aspx,5 Things Valeant's Management Said That You Probably Wish It Hadn't
VRX,VRX:US,BBG000DLFM21,5 Things Valeant's Management Said That You Probably Wish It Hadn't,2017-03-01 13:21:00 +0000,http://www.fool.com/investing/2017/03/01/5-things-valeants-management-said-that-you-probabl.aspx,5 Things Valeant's Management Said That You Probably Wish It Hadn't
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rebounding After Trump Speech - Canadian Commentary,2017-03-01 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/89iyrcdAfpA/canadian-stocks-are-rebounding-after-trump-speech--canadian-commentary-20170301-01112,Canadian Stocks Are Rebounding After Trump Speech - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rebounding After Trump Speech - Canadian Commentary,2017-03-01 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/89iyrcdAfpA/canadian-stocks-are-rebounding-after-trump-speech--canadian-commentary-20170301-01112,Canadian Stocks Are Rebounding After Trump Speech - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Sales Drop; Plans To Relaunch 'Female Viagra',2017-03-01 09:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hu2hgYLAwj4/valeant-sales-drop-plans-to-relaunch-female-viagra-20170301-01010,Valeant Sales Drop; Plans To Relaunch 'Female Viagra'
VRX,VRX:CT,BBG000DC8S17,Valeant Sales Drop; Plans To Relaunch 'Female Viagra',2017-03-01 09:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hu2hgYLAwj4/valeant-sales-drop-plans-to-relaunch-female-viagra-20170301-01010,Valeant Sales Drop; Plans To Relaunch 'Female Viagra'
VRX,VRX:CT,BBG000DC8S17,"Why Charles Schwab Corp (SCHW), Valeant Pharmaceuticals Intl Inc (VRX) and Perrigo Company plc Ordinary Shares (PRGO) Are 3 of Today’s Worst Stocks",2017-03-01 07:12:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/icS40_t7gFo/why-charles-schwab-corp-schw-valeant-pharmaceuticals-intl-inc-vrx-and-perrigo-company-plc-ordinary-shares-prgo-are-3-of-todays-worst-stocks-cm754617,InvestorPlace Stock Market News Stock Advice amp Trading Tips The Dow Jones Industrial Average s 12 day winning streak wasn t extended to a 13th session leaving it just shy of tying a 1987 record The S amp P 500 ended the day down 0 26 closing at 2 363 64 following
VRX,VRX:US,BBG000DLFM21,"Why Charles Schwab Corp (SCHW), Valeant Pharmaceuticals Intl Inc (VRX) and Perrigo Company plc Ordinary Shares (PRGO) Are 3 of Today’s Worst Stocks",2017-03-01 07:12:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/icS40_t7gFo/why-charles-schwab-corp-schw-valeant-pharmaceuticals-intl-inc-vrx-and-perrigo-company-plc-ordinary-shares-prgo-are-3-of-todays-worst-stocks-cm754617,InvestorPlace Stock Market News Stock Advice amp Trading Tips The Dow Jones Industrial Average s 12 day winning streak wasn t extended to a 13th session leaving it just shy of tying a 1987 record The S amp P 500 ended the day down 0 26 closing at 2 363 64 following
VRX,VRX:CT,BBG000DC8S17,Sky-High Priceline Group (PCLN) Stock Can Still Book You Free Profits,2017-03-01 07:11:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1eDeUNiwV5I/sky-high-priceline-group-pcln-stock-can-still-book-you-free-profits-cm754613,InvestorPlace Stock Market News Stock Advice amp Trading Tips I always say that Priceline Group Inc NASDAQ PCLN is the poster child for all momentum stocks Today PCLN stock is up 6 on a favorable earnings reaction Source Priceline com This wouldn t be the first
VRX,VRX:US,BBG000DLFM21,Sky-High Priceline Group (PCLN) Stock Can Still Book You Free Profits,2017-03-01 07:11:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1eDeUNiwV5I/sky-high-priceline-group-pcln-stock-can-still-book-you-free-profits-cm754613,InvestorPlace Stock Market News Stock Advice amp Trading Tips I always say that Priceline Group Inc NASDAQ PCLN is the poster child for all momentum stocks Today PCLN stock is up 6 on a favorable earnings reaction Source Priceline com This wouldn t be the first
VRX,VRX:US,BBG000DLFM21,[$$] Valeant’s Revenue Falls 13%,2017-03-01 06:06:54 +0000,https://www.wsj.com/articles/valeants-revenue-falls-13-1488287244?ru=yahoo?mod=yahoo_itp,[$$] Valeant’s Revenue Falls 13%
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant’s Revenue Falls 13%,2017-03-01 06:06:54 +0000,https://www.wsj.com/articles/valeants-revenue-falls-13-1488287244?ru=yahoo?mod=yahoo_itp,[$$] Valeant’s Revenue Falls 13%
VRX,VRX:US,BBG000DLFM21,[$$] Valeant's Revenue Falls 13%,2017-03-01 00:04:23 +0000,https://www.wsj.com/articles/valeants-revenue-falls-13-1488287244?mod=yahoo_hs,[$$] Valeant's Revenue Falls 13%
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant's Revenue Falls 13%,2017-03-01 00:04:23 +0000,https://www.wsj.com/articles/valeants-revenue-falls-13-1488287244?mod=yahoo_hs,[$$] Valeant's Revenue Falls 13%
VRX,VRX:US,BBG000DLFM21,"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO...",2017-02-28 22:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jYIlQDqDXo4/gainers--losers-of-feb28-kite-pbmd-life-vrx-prgo-20170228-02153,"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO..."
VRX,VRX:CT,BBG000DC8S17,"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO...",2017-02-28 22:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jYIlQDqDXo4/gainers--losers-of-feb28-kite-pbmd-life-vrx-prgo-20170228-02153,"Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO..."
VRX,VRX:US,BBG000DLFM21,Valeant updates status of Bausch & Lomb Tampa plant,2017-02-28 22:38:59 +0000,http://www.bizjournals.com/tampabay/news/2017/02/28/valeant-updates-status-of-bausch-lomb-tampa-plant.html?ana=yahoo,Valeant updates status of Bausch & Lomb Tampa plant
VRX,VRX:CT,BBG000DC8S17,Valeant updates status of Bausch & Lomb Tampa plant,2017-02-28 22:38:59 +0000,http://www.bizjournals.com/tampabay/news/2017/02/28/valeant-updates-status-of-bausch-lomb-tampa-plant.html?ana=yahoo,Valeant updates status of Bausch & Lomb Tampa plant
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Is Tumbling Today,2017-02-28 21:51:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hwJz6A2V-tg/why-valeant-pharmaceuticals-is-tumbling-today-cm754477,What happened After the company reported fourth quarter and full year financial results shares in Valeant Pharmaceuticals NYSE VRX fell by 12 9 at 2 15 p m EST on Tuesday So what Valeant Pharmaceuticals investors have been dealt a seemingly endless stream of
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Is Tumbling Today,2017-02-28 21:51:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hwJz6A2V-tg/why-valeant-pharmaceuticals-is-tumbling-today-cm754477,What happened After the company reported fourth quarter and full year financial results shares in Valeant Pharmaceuticals NYSE VRX fell by 12 9 at 2 15 p m EST on Tuesday So what Valeant Pharmaceuticals investors have been dealt a seemingly endless stream of
VRX,VRX:CT,BBG000DC8S17,Valeant will relaunch ‘female Viagra’ drug with poor track record,2017-02-28 21:42:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=47070B0A-FDC0-11E6-B497-45A446776EAA&siteid=yhoof2,Valeant will relaunch ‘female Viagra’ drug with poor track record
VRX,VRX:US,BBG000DLFM21,Valeant will relaunch ‘female Viagra’ drug with poor track record,2017-02-28 21:42:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=47070B0A-FDC0-11E6-B497-45A446776EAA&siteid=yhoof2,Valeant will relaunch ‘female Viagra’ drug with poor track record
VRX,VRX:CT,BBG000DC8S17,"Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive",2017-02-28 21:13:34 +0000,http://www.investors.com/news/technology/kite-ionis-outplay-med-sector-as-perrigo-tenet-valeant-dive/,"Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive"
VRX,VRX:US,BBG000DLFM21,"Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive",2017-02-28 21:13:34 +0000,http://www.investors.com/news/technology/kite-ionis-outplay-med-sector-as-perrigo-tenet-valeant-dive/,"Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive"
VRX,VRX:US,BBG000DLFM21,Valeant Gets Rocked as Investors Weigh Ability to Drive Organic Growth,2017-02-28 21:13:00 +0000,https://www.thestreet.com/story/14018947/1/valeant-shares-plummet-after-reporting-13-drop-in-sales.html?puc=yahoo&cm_ven=YAHOO,Valeant Gets Rocked as Investors Weigh Ability to Drive Organic Growth
VRX,VRX:CT,BBG000DC8S17,Valeant Gets Rocked as Investors Weigh Ability to Drive Organic Growth,2017-02-28 21:13:00 +0000,https://www.thestreet.com/story/14018947/1/valeant-shares-plummet-after-reporting-13-drop-in-sales.html?puc=yahoo&cm_ven=YAHOO,Valeant Gets Rocked as Investors Weigh Ability to Drive Organic Growth
VRX,VRX:US,BBG000DLFM21,"Valeant Plunges On 2017 Earnings Outlook, 'Unrealistic' Brand Sales",2017-02-28 21:00:56 +0000,http://www.investors.com/news/technology/valeant-plunges-on-2017-ebitda-guide-unrealistic-branded-bl-outlook/,"Valeant Plunges On 2017 Earnings Outlook, 'Unrealistic' Brand Sales"
VRX,VRX:CT,BBG000DC8S17,"Valeant Plunges On 2017 Earnings Outlook, 'Unrealistic' Brand Sales",2017-02-28 21:00:56 +0000,http://www.investors.com/news/technology/valeant-plunges-on-2017-ebitda-guide-unrealistic-branded-bl-outlook/,"Valeant Plunges On 2017 Earnings Outlook, 'Unrealistic' Brand Sales"
VRX,VRX:CT,BBG000DC8S17,Stocks Drop as Markets Grow Impatient Ahead of Trump's Congressional Address,2017-02-28 19:59:00 +0000,https://www.thestreet.com/story/14019333/1/stocks-pull-lower-ahead-of-trump-s-congressional-address.html?puc=yahoo&cm_ven=YAHOO,Stocks Drop as Markets Grow Impatient Ahead of Trump's Congressional Address
VRX,VRX:US,BBG000DLFM21,Stocks Drop as Markets Grow Impatient Ahead of Trump's Congressional Address,2017-02-28 19:59:00 +0000,https://www.thestreet.com/story/14019333/1/stocks-pull-lower-ahead-of-trump-s-congressional-address.html?puc=yahoo&cm_ven=YAHOO,Stocks Drop as Markets Grow Impatient Ahead of Trump's Congressional Address
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Is Tumbling Today,2017-02-28 19:42:00 +0000,http://www.fool.com/investing/2017/02/28/why-valeant-pharmaceuticals-is-tumbling-today.aspx,Why Valeant Pharmaceuticals Is Tumbling Today
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Is Tumbling Today,2017-02-28 19:42:00 +0000,http://www.fool.com/investing/2017/02/28/why-valeant-pharmaceuticals-is-tumbling-today.aspx,Why Valeant Pharmaceuticals Is Tumbling Today
VRX,VRX:CT,BBG000DC8S17,Valeant's Leverage Could Reach '8x or Worse' Says Gimme Credit,2017-02-28 18:58:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/02/28/valeants-leverage-could-reach-8x-or-worse-says-gimme-credit/?mod=yahoobarrons&ru=yahoo,Valeant's Leverage Could Reach '8x or Worse' Says Gimme Credit
VRX,VRX:US,BBG000DLFM21,Valeant's Leverage Could Reach '8x or Worse' Says Gimme Credit,2017-02-28 18:58:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/02/28/valeants-leverage-could-reach-8x-or-worse-says-gimme-credit/?mod=yahoobarrons&ru=yahoo,Valeant's Leverage Could Reach '8x or Worse' Says Gimme Credit
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Tuesday: Priceline Group Inc (PCLN), Valeant Pharmaceuticals Intl Inc (VRX) and Workday Inc (WDAY)",2017-02-28 18:49:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SAeTkUSKJbE/3-stocks-to-watch-on-tuesday-priceline-group-inc-pcln-valeant-pharmaceuticals-intl-inc-vrx-and-workday-inc-wday-cm754339,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S markets finished slightly higher on Monday extending their rally as oil ticked upward The 160 S amp P 500 Index 160 and 160 Dow Jones Industrial Average were 0 1 better while the 160
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Tuesday: Priceline Group Inc (PCLN), Valeant Pharmaceuticals Intl Inc (VRX) and Workday Inc (WDAY)",2017-02-28 18:49:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SAeTkUSKJbE/3-stocks-to-watch-on-tuesday-priceline-group-inc-pcln-valeant-pharmaceuticals-intl-inc-vrx-and-workday-inc-wday-cm754339,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S markets finished slightly higher on Monday extending their rally as oil ticked upward The 160 S amp P 500 Index 160 and 160 Dow Jones Industrial Average were 0 1 better while the 160
VRX,VRX:CT,BBG000DC8S17,"Tuesday’s Vital Data: Advanced Micro Devices, Inc. (AMD), Mondelez International Inc (MDLZ) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-02-28 18:49:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8KhEQDLyl0U/tuesdays-vital-data-advanced-micro-devices-inc-amd-mondelez-international-inc-mdlz-and-valeant-pharmaceuticals-intl-inc-vrx-cm754336,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are mixed heading into the last day of February as Wall Street prepares for President Donald Trump s address to Congress later tonight Trump is expected to address a wide range of
VRX,VRX:US,BBG000DLFM21,"Tuesday’s Vital Data: Advanced Micro Devices, Inc. (AMD), Mondelez International Inc (MDLZ) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-02-28 18:49:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8KhEQDLyl0U/tuesdays-vital-data-advanced-micro-devices-inc-amd-mondelez-international-inc-mdlz-and-valeant-pharmaceuticals-intl-inc-vrx-cm754336,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are mixed heading into the last day of February as Wall Street prepares for President Donald Trump s address to Congress later tonight Trump is expected to address a wide range of
VRX,VRX:CT,BBG000DC8S17,Valeant: 'Saying It Does Not Make It So',2017-02-28 18:04:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/28/valeant-saying-it-does-not-make-it-so/?mod=yahoobarrons&ru=yahoo,Valeant: 'Saying It Does Not Make It So'
VRX,VRX:US,BBG000DLFM21,Valeant: 'Saying It Does Not Make It So',2017-02-28 18:04:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/28/valeant-saying-it-does-not-make-it-so/?mod=yahoobarrons&ru=yahoo,Valeant: 'Saying It Does Not Make It So'
VRX,VRX:CT,BBG000DC8S17,"""New Valeant"" Looks Suspiciously Like the Old One",2017-02-28 17:30:24 +0000,https://www.bloomberg.com/gadfly/articles/2017-02-28/valeant-pharmaceutical-earnings-changes-only-skin-deep?cmpid=yhoo.headline,"""New Valeant"" Looks Suspiciously Like the Old One"
VRX,VRX:US,BBG000DLFM21,"""New Valeant"" Looks Suspiciously Like the Old One",2017-02-28 17:30:24 +0000,https://www.bloomberg.com/gadfly/articles/2017-02-28/valeant-pharmaceutical-earnings-changes-only-skin-deep?cmpid=yhoo.headline,"""New Valeant"" Looks Suspiciously Like the Old One"
VRX,VRX:CT,BBG000DC8S17,Valeant: Just When Things Were Looking Up For Ackman,2017-02-28 17:27:00 +0000,http://blogs.barrons.com/focusonfunds/2017/02/28/valeant-just-when-things-were-looking-up-for-ackman/?mod=yahoobarrons&ru=yahoo,Valeant: Just When Things Were Looking Up For Ackman
VRX,VRX:US,BBG000DLFM21,Valeant: Just When Things Were Looking Up For Ackman,2017-02-28 17:27:00 +0000,http://blogs.barrons.com/focusonfunds/2017/02/28/valeant-just-when-things-were-looking-up-for-ackman/?mod=yahoobarrons&ru=yahoo,Valeant: Just When Things Were Looking Up For Ackman
VRX,VRX:US,BBG000DLFM21,Why Valeant Missed the Mark Despite an Earnings Beat,2017-02-28 17:05:10 +0000,http://finance.yahoo.com/news/why-valeant-missed-mark-despite-170510112.html,Why Valeant Missed the Mark Despite an Earnings Beat
VRX,VRX:CT,BBG000DC8S17,Why Valeant Missed the Mark Despite an Earnings Beat,2017-02-28 17:05:10 +0000,http://finance.yahoo.com/news/why-valeant-missed-mark-despite-170510112.html,Why Valeant Missed the Mark Despite an Earnings Beat
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Is a Potential Sell,2017-02-28 17:02:05 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-potential-sell-170205436.html,Valeant Pharmaceuticals Is a Potential Sell
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Is a Potential Sell,2017-02-28 17:02:05 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-potential-sell-170205436.html,Valeant Pharmaceuticals Is a Potential Sell
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Reports Steeper Q4 Loss on Lower Product Sales,2017-02-28 16:51:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMi6RzjcR8U/valeant-pharmaceuticals-reports-steeper-q4-loss-on-lower-product-sales-cm754201,Valeant Pharmaceuticals NYSE VRX hasn t been able to report good news in its quarterly results for quite a while The drugmaker s challenges have proven difficult to overcome So when the company provided its fourth quarter update before the market opened on Tuesday few expected
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Reports Steeper Q4 Loss on Lower Product Sales,2017-02-28 16:51:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMi6RzjcR8U/valeant-pharmaceuticals-reports-steeper-q4-loss-on-lower-product-sales-cm754201,Valeant Pharmaceuticals NYSE VRX hasn t been able to report good news in its quarterly results for quite a while The drugmaker s challenges have proven difficult to overcome So when the company provided its fourth quarter update before the market opened on Tuesday few expected
VRX,VRX:US,BBG000DLFM21,Big Money Still Long Valeant,2017-02-28 16:24:09 +0000,http://finance.yahoo.com/news/big-money-still-long-valeant-151230773.html,Big Money Still Long Valeant
VRX,VRX:CT,BBG000DC8S17,Big Money Still Long Valeant,2017-02-28 16:24:09 +0000,http://finance.yahoo.com/news/big-money-still-long-valeant-151230773.html,Big Money Still Long Valeant
VRX,VRX:US,BBG000DLFM21,"Canadian Stocks Continue Pull Back, Valeant Plunges -- Canadian Commentary",2017-02-28 16:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oyiGX6fOOCQ/canadian-stocks-continue-pull-back-valeant-plunges--canadian-commentary-20170228-01774,"Canadian Stocks Continue Pull Back, Valeant Plunges -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"Canadian Stocks Continue Pull Back, Valeant Plunges -- Canadian Commentary",2017-02-28 16:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oyiGX6fOOCQ/canadian-stocks-continue-pull-back-valeant-plunges--canadian-commentary-20170228-01774,"Canadian Stocks Continue Pull Back, Valeant Plunges -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's nightmare stock can do no right,2017-02-28 15:39:45 +0000,http://finance.yahoo.com/news/bill-ackmans-nightmare-stock-no-153945467.html,Bill Ackman's nightmare stock can do no right
VRX,VRX:US,BBG000DLFM21,Bill Ackman's nightmare stock can do no right,2017-02-28 15:39:45 +0000,http://finance.yahoo.com/news/bill-ackmans-nightmare-stock-no-153945467.html,Bill Ackman's nightmare stock can do no right
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Reports Steeper Q4 Loss on Lower Product Sales,2017-02-28 15:27:00 +0000,http://www.fool.com/investing/2017/02/28/valeant-pharmaceuticals-reports-steeper-q4-loss-on.aspx,Valeant Pharmaceuticals Reports Steeper Q4 Loss on Lower Product Sales
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Reports Steeper Q4 Loss on Lower Product Sales,2017-02-28 15:27:00 +0000,http://www.fool.com/investing/2017/02/28/valeant-pharmaceuticals-reports-steeper-q4-loss-on.aspx,Valeant Pharmaceuticals Reports Steeper Q4 Loss on Lower Product Sales
VRX,VRX:CT,BBG000DC8S17,Valeant predicts tough 2017 with revenue to decline,2017-02-28 15:18:48 +0000,http://sg.finance.yahoo.com/news/valeant-pharmas-revenue-falls-third-122120560.html,Valeant predicts tough 2017 with revenue to decline
VRX,VRX:US,BBG000DLFM21,Valeant predicts tough 2017 with revenue to decline,2017-02-28 15:18:48 +0000,http://sg.finance.yahoo.com/news/valeant-pharmas-revenue-falls-third-122120560.html,Valeant predicts tough 2017 with revenue to decline
VRX,VRX:CT,BBG000DC8S17,Valeant Meltdown After Bad Q4 & FY16 Earnings,2017-02-28 15:18:00 +0000,http://www.investopedia.com/news/valeant-meltdown-after-bad-q4-fy16-earnings-vrx/?partner=YahooSA,Valeant Meltdown After Bad Q4 & FY16 Earnings
VRX,VRX:US,BBG000DLFM21,Valeant Meltdown After Bad Q4 & FY16 Earnings,2017-02-28 15:18:00 +0000,http://www.investopedia.com/news/valeant-meltdown-after-bad-q4-fy16-earnings-vrx/?partner=YahooSA,Valeant Meltdown After Bad Q4 & FY16 Earnings
VRX,VRX:CT,BBG000DC8S17,Why Valeant's Earnings Beat Doesn't Matter,2017-02-28 15:05:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/28/why-valeants-earnings-beat-doesnt-matter/?mod=yahoobarrons&ru=yahoo,Why Valeant's Earnings Beat Doesn't Matter
VRX,VRX:US,BBG000DLFM21,Why Valeant's Earnings Beat Doesn't Matter,2017-02-28 15:05:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/28/why-valeants-earnings-beat-doesnt-matter/?mod=yahoobarrons&ru=yahoo,Why Valeant's Earnings Beat Doesn't Matter
VRX,VRX:US,BBG000DLFM21,Is the Options Market Predicting a Spike in Valeant Pharmaceuticals International (VRX) Stock?,2017-02-28 14:53:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kVJQpPWer8Y/is-the-options-market-predicting-a-spike-in-valeant-pharmaceuticals-international-vrx-stock-cm754168,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the March 3rd 2017 12 5 Put had some of the highest implied volatility of all equity options today What is
VRX,VRX:CT,BBG000DC8S17,Is the Options Market Predicting a Spike in Valeant Pharmaceuticals International (VRX) Stock?,2017-02-28 14:53:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kVJQpPWer8Y/is-the-options-market-predicting-a-spike-in-valeant-pharmaceuticals-international-vrx-stock-cm754168,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the March 3rd 2017 12 5 Put had some of the highest implied volatility of all equity options today What is
VRX,VRX:US,BBG000DLFM21,"Stocks Open Lower; Priceline, Nutrisystem Jump; Target Plunges",2017-02-28 14:40:29 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-soft-priceline-target-in-motion-ahead-of-q4-gdp/,[at Investor's Business Daily] - Stocks opened modestly lower Tuesday' after a mild fourth-quarter revision in gross domestic product and as investors looked toward President Trump's first address to Congress.
VRX,VRX:CT,BBG000DC8S17,"Stocks Open Lower; Priceline, Nutrisystem Jump; Target Plunges",2017-02-28 14:40:29 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-soft-priceline-target-in-motion-ahead-of-q4-gdp/,[at Investor's Business Daily] - Stocks opened modestly lower Tuesday' after a mild fourth-quarter revision in gross domestic product and as investors looked toward President Trump's first address to Congress.
VRX,VRX:US,BBG000DLFM21,"Target sinks to multi-year low, Priceline pops to new high, Valeant falls despite beat",2017-02-28 14:36:02 +0000,http://finance.yahoo.com/news/target-sinks-to-multi-year-low-priceline-pops-to-new-high-valeant-falls-despite-beat-143602508.html,"Target sinks to multi-year low, Priceline pops to new high, Valeant falls despite beat"
VRX,VRX:CT,BBG000DC8S17,"Target sinks to multi-year low, Priceline pops to new high, Valeant falls despite beat",2017-02-28 14:36:02 +0000,http://finance.yahoo.com/news/target-sinks-to-multi-year-low-priceline-pops-to-new-high-valeant-falls-despite-beat-143602508.html,"Target sinks to multi-year low, Priceline pops to new high, Valeant falls despite beat"
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Target, Valeant Pharma, Domino's",2017-02-28 14:25:00 +0000,http://blogs.wsj.com/moneybeat/2017/02/28/stocks-to-watch-target-valeant-pharma-dominos/?mod=yahoo_hs,"Stocks to Watch: Target, Valeant Pharma, Domino's"
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Target, Valeant Pharma, Domino's",2017-02-28 14:25:00 +0000,http://blogs.wsj.com/moneybeat/2017/02/28/stocks-to-watch-target-valeant-pharma-dominos/?mod=yahoo_hs,"Stocks to Watch: Target, Valeant Pharma, Domino's"
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Feb 28, 2017 :  VIAV, TGT, VRX, CNHI, SBY, O, BAC, ENDP, FTR, TVIX, LIFE, CEMP",2017-02-28 13:59:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J_AF8H1bUlI/pre-market-most-active-for-feb-28-2017-viav-tgt-vrx-cnhi-sby-o-bac-endp-ftr-tvix-life-cemp-cm754015,The NASDAQ 100 Pre Market Indicator is up 2 38 to 5 349 93 The total Pre Market volume is currently 12 333 114 shares traded The following are the most active stocks for the pre market session Viavi Solutions Inc VIAV is unchanged at 9 98 with 5 010 219 shares
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Feb 28, 2017 :  VIAV, TGT, VRX, CNHI, SBY, O, BAC, ENDP, FTR, TVIX, LIFE, CEMP",2017-02-28 13:59:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J_AF8H1bUlI/pre-market-most-active-for-feb-28-2017-viav-tgt-vrx-cnhi-sby-o-bac-endp-ftr-tvix-life-cemp-cm754015,The NASDAQ 100 Pre Market Indicator is up 2 38 to 5 349 93 The total Pre Market volume is currently 12 333 114 shares traded The following are the most active stocks for the pre market session Viavi Solutions Inc VIAV is unchanged at 9 98 with 5 010 219 shares
VRX,VRX:US,BBG000DLFM21,Morning News Call Canadienne - Février 28,2017-02-28 13:50:44 +0000,http://finance.yahoo.com/news/morning-news-call-canadienne-f-135044414.html,Morning News Call Canadienne - Février 28
VRX,VRX:CT,BBG000DC8S17,Morning News Call Canadienne - Février 28,2017-02-28 13:50:44 +0000,http://finance.yahoo.com/news/morning-news-call-canadienne-f-135044414.html,Morning News Call Canadienne - Février 28
VRX,VRX:CT,BBG000DC8S17,Is the Options Market Predicting a Spike in Valeant Pharmaceuticals International (VRX) Stock?,2017-02-28 13:34:01 +0000,http://finance.yahoo.com/news/options-market-predicting-spike-valeant-133401546.html,Is the Options Market Predicting a Spike in Valeant Pharmaceuticals International (VRX) Stock?
VRX,VRX:US,BBG000DLFM21,Is the Options Market Predicting a Spike in Valeant Pharmaceuticals International (VRX) Stock?,2017-02-28 13:34:01 +0000,http://finance.yahoo.com/news/options-market-predicting-spike-valeant-133401546.html,Is the Options Market Predicting a Spike in Valeant Pharmaceuticals International (VRX) Stock?
VRX,VRX:CT,BBG000DC8S17,"Investors prepare for Trump in prime time as Fidelity cuts commissions, YouTube passes 1B hours of daily viewing",2017-02-28 13:20:00 +0000,http://finance.yahoo.com/news/investors-prepare-for-trump-in-prime-time-as-fidelity-cuts-commissions-youtube-passes-1b-hours-of-daily-viewing-132000551.html,"Investors prepare for Trump in prime time as Fidelity cuts commissions, YouTube passes 1B hours of daily viewing"
VRX,VRX:US,BBG000DLFM21,"Investors prepare for Trump in prime time as Fidelity cuts commissions, YouTube passes 1B hours of daily viewing",2017-02-28 13:20:00 +0000,http://finance.yahoo.com/news/investors-prepare-for-trump-in-prime-time-as-fidelity-cuts-commissions-youtube-passes-1b-hours-of-daily-viewing-132000551.html,"Investors prepare for Trump in prime time as Fidelity cuts commissions, YouTube passes 1B hours of daily viewing"
VRX,VRX:CT,BBG000DC8S17,Valeant reports 4Q loss,2017-02-28 13:19:32 +0000,http://sg.finance.yahoo.com/news/valeant-reports-4q-loss-131932404.html,Valeant reports 4Q loss
VRX,VRX:US,BBG000DLFM21,Valeant reports 4Q loss,2017-02-28 13:19:32 +0000,http://sg.finance.yahoo.com/news/valeant-reports-4q-loss-131932404.html,Valeant reports 4Q loss
VRX,VRX:CT,BBG000DC8S17,Why You Should Wait to Buy These 3 Stocks,2017-02-28 12:20:34 +0000,http://www.fool.com/investing/2017/02/27/why-you-should-wait-to-buy-these-3-stocks.aspx,Why You Should Wait to Buy These 3 Stocks
VRX,VRX:US,BBG000DLFM21,Why You Should Wait to Buy These 3 Stocks,2017-02-28 12:20:34 +0000,http://www.fool.com/investing/2017/02/27/why-you-should-wait-to-buy-these-3-stocks.aspx,Why You Should Wait to Buy These 3 Stocks
VRX,VRX:CT,BBG000DC8S17,Valeant posts wider loss for fourth quarter as revenue dips,2017-02-28 12:19:02 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=17BA0989-0E71-4292-878C-538A5242C9DA&siteid=yhoof2,Valeant posts wider loss for fourth quarter as revenue dips
VRX,VRX:US,BBG000DLFM21,Valeant posts wider loss for fourth quarter as revenue dips,2017-02-28 12:19:02 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=17BA0989-0E71-4292-878C-538A5242C9DA&siteid=yhoof2,Valeant posts wider loss for fourth quarter as revenue dips
VRX,VRX:CT,BBG000DC8S17,Valeant's Declining Sales Show Turnaround Has Long Way to Go,2017-02-28 12:18:41 +0000,https://www.bloomberg.com/news/articles/2017-02-28/valeant-earnings-beat-estimates-as-ceo-papa-pursues-turnaround?cmpid=yhoo.headline,Valeant's Declining Sales Show Turnaround Has Long Way to Go
VRX,VRX:US,BBG000DLFM21,Valeant's Declining Sales Show Turnaround Has Long Way to Go,2017-02-28 12:18:41 +0000,https://www.bloomberg.com/news/articles/2017-02-28/valeant-earnings-beat-estimates-as-ceo-papa-pursues-turnaround?cmpid=yhoo.headline,Valeant's Declining Sales Show Turnaround Has Long Way to Go
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma's revenue falls for third straight quarter,2017-02-28 12:11:39 +0000,http://finance.yahoo.com/news/valeant-pharmas-revenue-falls-third-121139295.html,Valeant Pharma's revenue falls for third straight quarter
VRX,VRX:US,BBG000DLFM21,Valeant Pharma's revenue falls for third straight quarter,2017-02-28 12:11:39 +0000,http://finance.yahoo.com/news/valeant-pharmas-revenue-falls-third-121139295.html,Valeant Pharma's revenue falls for third straight quarter
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ",2017-02-28 12:03:26 +0000,http://biz.yahoo.com/e/170228/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ",2017-02-28 12:03:26 +0000,http://biz.yahoo.com/e/170228/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ"
VRX,VRX:CT,BBG000DC8S17,Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance,2017-02-28 12:00:00 +0000,http://finance.yahoo.com/news/valeant-reports-fourth-quarter-full-120000227.html,"[PR Newswire] - LAVAL, Quebec, Feb. 28, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (""Valeant"" or the ""Company"" or ""We"") today announced fourth ..."
VRX,VRX:US,BBG000DLFM21,Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance,2017-02-28 12:00:00 +0000,http://finance.yahoo.com/news/valeant-reports-fourth-quarter-full-120000227.html,"[PR Newswire] - LAVAL, Quebec, Feb. 28, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (""Valeant"" or the ""Company"" or ""We"") today announced fourth ..."
VRX,VRX:CT,BBG000DC8S17,"Earnings Reaction History: Valeant Pharmaceuticals International, 75.0% Follow-Through Indicator, 12.4% Sensitive",2017-02-28 11:50:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5POA4WJszh0/earnings-reaction-history-valeant-pharmaceuticals-international-750-follow-through-indicator-124-sensitive-cm753971,Expected Earnings Release 02 28 2017 PremarketExpected Earnings Release 02 28 2017 Premarket Avg Extended Hours Dollar Volume 42 254 236Avg Extended Hours Dollar Volume 42 254 236 Valeant Pharmaceuticals International VRX is due to issue its quarterly earnings report in the
VRX,VRX:US,BBG000DLFM21,"Earnings Reaction History: Valeant Pharmaceuticals International, 75.0% Follow-Through Indicator, 12.4% Sensitive",2017-02-28 11:50:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5POA4WJszh0/earnings-reaction-history-valeant-pharmaceuticals-international-750-follow-through-indicator-124-sensitive-cm753971,Expected Earnings Release 02 28 2017 PremarketExpected Earnings Release 02 28 2017 Premarket Avg Extended Hours Dollar Volume 42 254 236Avg Extended Hours Dollar Volume 42 254 236 Valeant Pharmaceuticals International VRX is due to issue its quarterly earnings report in the
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Strength Of Gold Stocks - Canadian Commentary,2017-02-28 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/070H5mhmwJ8/canadian-stocks-are-rising-on-strength-of-gold-stocks--canadian-commentary-20170228-01204,Canadian Stocks Are Rising On Strength Of Gold Stocks - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Strength Of Gold Stocks - Canadian Commentary,2017-02-28 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/070H5mhmwJ8/canadian-stocks-are-rising-on-strength-of-gold-stocks--canadian-commentary-20170228-01204,Canadian Stocks Are Rising On Strength Of Gold Stocks - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,TSX May Wobble Despite Strong Bank Earnings -- Canadian Commentary,2017-02-28 08:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HXK9y5pXV0s/tsx-may-wobble-despite-strong-bank-earnings--canadian-commentary-20170228-00855,TSX May Wobble Despite Strong Bank Earnings -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,TSX May Wobble Despite Strong Bank Earnings -- Canadian Commentary,2017-02-28 08:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HXK9y5pXV0s/tsx-may-wobble-despite-strong-bank-earnings--canadian-commentary-20170228-00855,TSX May Wobble Despite Strong Bank Earnings -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Q4 Loss Widens,2017-02-28 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wZPWyoGgKVo/valeant-q4-loss-widens-20170228-00565,Valeant Q4 Loss Widens
VRX,VRX:CT,BBG000DC8S17,Valeant Q4 Loss Widens,2017-02-28 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wZPWyoGgKVo/valeant-q4-loss-widens-20170228-00565,Valeant Q4 Loss Widens
VRX,VRX:US,BBG000DLFM21,Can Ford Motor Company (F) Rev Up Its Engines?,2017-02-28 00:49:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XqTcEGCvSEA/can-ford-motor-company-f-rev-up-its-engines-cm753927,InvestorPlace Stock Market News Stock Advice amp Trading Tips Within the automotive community Ford Motor Company NYSE F has a few colorful nicknames perhaps the most common one is Fixed Or Repaired Daily but there s quite a few I haven t heard before These include
VRX,VRX:CT,BBG000DC8S17,Can Ford Motor Company (F) Rev Up Its Engines?,2017-02-28 00:49:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XqTcEGCvSEA/can-ford-motor-company-f-rev-up-its-engines-cm753927,InvestorPlace Stock Market News Stock Advice amp Trading Tips Within the automotive community Ford Motor Company NYSE F has a few colorful nicknames perhaps the most common one is Fixed Or Repaired Daily but there s quite a few I haven t heard before These include
VRX,VRX:CT,BBG000DC8S17,"Advanced Micro Devices, Inc. (AMD) Stock Is Going to Stumble Soon",2017-02-28 00:49:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VTFx54VmzMw/advanced-micro-devices-inc-amd-stock-is-going-to-stumble-soon-cm753925,InvestorPlace Stock Market News Stock Advice amp Trading Tips The rebound in Advanced Micro Devices Inc 160 NASDAQ AMD is one heck of a story Just one year ago the stock was trading below 2 and appeared to be on the brink of extinction Then suddenly it turned
VRX,VRX:US,BBG000DLFM21,"Advanced Micro Devices, Inc. (AMD) Stock Is Going to Stumble Soon",2017-02-28 00:49:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VTFx54VmzMw/advanced-micro-devices-inc-amd-stock-is-going-to-stumble-soon-cm753925,InvestorPlace Stock Market News Stock Advice amp Trading Tips The rebound in Advanced Micro Devices Inc 160 NASDAQ AMD is one heck of a story Just one year ago the stock was trading below 2 and appeared to be on the brink of extinction Then suddenly it turned
VRX,VRX:US,BBG000DLFM21,The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results,2017-02-27 23:51:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f8QYokc8jCs/the-only-number-that-matters-when-valeant-pharmaceuticals-reports-its-q4-results-cm753899,Earnings season is in full swing and while fourth quarter earnings are expected to be an upside catalyst for most companies shareholders of embattled drugmaker Valeant Pharmaceuticals NYSE VRX are probably terrified Valeant which was at one time worth around 90 billion has
VRX,VRX:CT,BBG000DC8S17,The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results,2017-02-27 23:51:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f8QYokc8jCs/the-only-number-that-matters-when-valeant-pharmaceuticals-reports-its-q4-results-cm753899,Earnings season is in full swing and while fourth quarter earnings are expected to be an upside catalyst for most companies shareholders of embattled drugmaker Valeant Pharmaceuticals NYSE VRX are probably terrified Valeant which was at one time worth around 90 billion has
VRX,VRX:CT,BBG000DC8S17,The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results,2017-02-27 22:05:04 +0000,http://www.fool.com/investing/2017/02/27/the-only-number-that-matters-when-valeant-pharmace.aspx,The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results
VRX,VRX:US,BBG000DLFM21,The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results,2017-02-27 22:05:04 +0000,http://www.fool.com/investing/2017/02/27/the-only-number-that-matters-when-valeant-pharmace.aspx,The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results
VRX,VRX:US,BBG000DLFM21,A quick reminder that Bill Ackman's worst nightmare is still very much a thing,2017-02-27 21:26:54 +0000,http://finance.yahoo.com/news/quick-reminder-bill-ackmans-worst-212654036.html,A quick reminder that Bill Ackman's worst nightmare is still very much a thing
VRX,VRX:CT,BBG000DC8S17,A quick reminder that Bill Ackman's worst nightmare is still very much a thing,2017-02-27 21:26:54 +0000,http://finance.yahoo.com/news/quick-reminder-bill-ackmans-worst-212654036.html,A quick reminder that Bill Ackman's worst nightmare is still very much a thing
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Earnings Report for February 28, 2017 :  BNS, BMO, TGT, SRE, CNP, LNG, DPZ, VRX, NRG, IONS, PDCE, MDCO",2017-02-27 21:19:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-1zyMJFWwGY/pre-market-earnings-report-for-february-28-2017-bns-bmo-tgt-sre-cnp-lng-dpz-vrx-nrg-ions-pdce-mdco-cm753829,The following companies are expected to report earnings prior to market open on 02 28 2017 Visit our Earnings Calendar for a full list of expected earnings releases Bank of Nova Scotia BNS is reporting for the quarter ending January 31 2017 The
VRX,VRX:US,BBG000DLFM21,"Pre-Market Earnings Report for February 28, 2017 :  BNS, BMO, TGT, SRE, CNP, LNG, DPZ, VRX, NRG, IONS, PDCE, MDCO",2017-02-27 21:19:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-1zyMJFWwGY/pre-market-earnings-report-for-february-28-2017-bns-bmo-tgt-sre-cnp-lng-dpz-vrx-nrg-ions-pdce-mdco-cm753829,The following companies are expected to report earnings prior to market open on 02 28 2017 Visit our Earnings Calendar for a full list of expected earnings releases Bank of Nova Scotia BNS is reporting for the quarter ending January 31 2017 The
VRX,VRX:US,BBG000DLFM21,5 Stocks to Watch Before the Market Opens Tomorrow,2017-02-27 20:29:35 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-tomorrow-202940164.html,5 Stocks to Watch Before the Market Opens Tomorrow
VRX,VRX:CT,BBG000DC8S17,5 Stocks to Watch Before the Market Opens Tomorrow,2017-02-27 20:29:35 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-tomorrow-202940164.html,5 Stocks to Watch Before the Market Opens Tomorrow
VRX,VRX:CT,BBG000DC8S17,Alibaba Group Holding Ltd (BABA) Will Try to Dominate India,2017-02-27 19:50:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/glDZLyyZ74o/alibaba-group-holding-ltd-baba-will-try-to-dominate-india-cm753785,InvestorPlace Stock Market News Stock Advice amp Trading Tips While China s e commerce market is still growing Alibaba Group Holding Ltd NYSE BABA and its affiliate Ant Financial are already looking south to India Last year Morgan Stanley predicted that the
VRX,VRX:US,BBG000DLFM21,Alibaba Group Holding Ltd (BABA) Will Try to Dominate India,2017-02-27 19:50:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/glDZLyyZ74o/alibaba-group-holding-ltd-baba-will-try-to-dominate-india-cm753785,InvestorPlace Stock Market News Stock Advice amp Trading Tips While China s e commerce market is still growing Alibaba Group Holding Ltd NYSE BABA and its affiliate Ant Financial are already looking south to India Last year Morgan Stanley predicted that the
VRX,VRX:CT,BBG000DC8S17,Why Valeant Might Beat Earnings Expectations…and Why It Won't Matter,2017-02-27 18:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/27/why-valeant-might-beat-earnings-expectations-and-why-it-wont-matter/?mod=yahoobarrons&ru=yahoo,Why Valeant Might Beat Earnings Expectations…and Why It Won't Matter
VRX,VRX:US,BBG000DLFM21,Why Valeant Might Beat Earnings Expectations…and Why It Won't Matter,2017-02-27 18:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/27/why-valeant-might-beat-earnings-expectations-and-why-it-wont-matter/?mod=yahoobarrons&ru=yahoo,Why Valeant Might Beat Earnings Expectations…and Why It Won't Matter
VRX,VRX:CT,BBG000DC8S17,Jim Cramer Is Passing on Valeant Ahead of Earnings,2017-02-27 18:23:00 +0000,https://www.thestreet.com/story/14017469/1/jim-cramer-is-passing-on-valeant-ahead-of-earnings.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer Is Passing on Valeant Ahead of Earnings
VRX,VRX:US,BBG000DLFM21,Jim Cramer Is Passing on Valeant Ahead of Earnings,2017-02-27 18:23:00 +0000,https://www.thestreet.com/story/14017469/1/jim-cramer-is-passing-on-valeant-ahead-of-earnings.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer Is Passing on Valeant Ahead of Earnings
VRX,VRX:US,BBG000DLFM21,5 Earnings Short-Squeeze Plays to Boost Your Returns,2017-02-27 18:14:00 +0000,https://www.thestreet.com/story/14017225/1/5-earnings-short-squeeze-plays-to-boost-your-returns.html?puc=yahoo&cm_ven=YAHOO,5 Earnings Short-Squeeze Plays to Boost Your Returns
VRX,VRX:CT,BBG000DC8S17,5 Earnings Short-Squeeze Plays to Boost Your Returns,2017-02-27 18:14:00 +0000,https://www.thestreet.com/story/14017225/1/5-earnings-short-squeeze-plays-to-boost-your-returns.html?puc=yahoo&cm_ven=YAHOO,5 Earnings Short-Squeeze Plays to Boost Your Returns
VRX,VRX:US,BBG000DLFM21,Valeant Ups Sales Force Ahead of Q4 Results,2017-02-27 16:07:00 +0000,http://www.investopedia.com/news/previewing-valeants-q4-and-fy-results-vrx/?partner=YahooSA,Valeant Ups Sales Force Ahead of Q4 Results
VRX,VRX:CT,BBG000DC8S17,Valeant Ups Sales Force Ahead of Q4 Results,2017-02-27 16:07:00 +0000,http://www.investopedia.com/news/previewing-valeants-q4-and-fy-results-vrx/?partner=YahooSA,Valeant Ups Sales Force Ahead of Q4 Results
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Stock Climbs Ahead of Earnings Release,2017-02-27 15:19:00 +0000,https://www.thestreet.com/story/14017147/1/valeant-pharmaceuticals-climbs-ahead-of-earnings-release.html?puc=yahoo&cm_ven=YAHOO,Valeant Pharmaceuticals Stock Climbs Ahead of Earnings Release
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Stock Climbs Ahead of Earnings Release,2017-02-27 15:19:00 +0000,https://www.thestreet.com/story/14017147/1/valeant-pharmaceuticals-climbs-ahead-of-earnings-release.html?puc=yahoo&cm_ven=YAHOO,Valeant Pharmaceuticals Stock Climbs Ahead of Earnings Release
VRX,VRX:CT,BBG000DC8S17,Why Valeant is Flying on the Eve of Earnings,2017-02-27 15:05:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/27/why-valeant-is-flying-on-the-eve-of-earnings/?mod=yahoobarrons&ru=yahoo,Why Valeant is Flying on the Eve of Earnings
VRX,VRX:US,BBG000DLFM21,Why Valeant is Flying on the Eve of Earnings,2017-02-27 15:05:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/27/why-valeant-is-flying-on-the-eve-of-earnings/?mod=yahoobarrons&ru=yahoo,Why Valeant is Flying on the Eve of Earnings
VRX,VRX:US,BBG000DLFM21,Valeant's High Debt Load Puts Q4 Focus On EBITDA Guidance,2017-02-27 14:12:10 +0000,http://finance.yahoo.com/news/valeants-high-debt-load-puts-141210301.html,Valeant's High Debt Load Puts Q4 Focus On EBITDA Guidance
VRX,VRX:CT,BBG000DC8S17,Valeant's High Debt Load Puts Q4 Focus On EBITDA Guidance,2017-02-27 14:12:10 +0000,http://finance.yahoo.com/news/valeants-high-debt-load-puts-141210301.html,Valeant's High Debt Load Puts Q4 Focus On EBITDA Guidance
VRX,VRX:US,BBG000DLFM21,Why You Should Wait to Buy These 3 Stocks,2017-02-27 13:52:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VFmQUIbACRY/why-you-should-wait-to-buy-these-3-stocks-cm753406,Shares of Yelp Inc NYSE YELP Valeant Pharmaceuticals Intl Inc NYSE VRX and Hain Celestial Group Inc NASDAQ HAIN 160 may look attractive to investors right now Yelp 160 is coming off a subpar quarter which has its stock down by 22 in the past few weeks
VRX,VRX:CT,BBG000DC8S17,Why You Should Wait to Buy These 3 Stocks,2017-02-27 13:52:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VFmQUIbACRY/why-you-should-wait-to-buy-these-3-stocks-cm753406,Shares of Yelp Inc NYSE YELP Valeant Pharmaceuticals Intl Inc NYSE VRX and Hain Celestial Group Inc NASDAQ HAIN 160 may look attractive to investors right now Yelp 160 is coming off a subpar quarter which has its stock down by 22 in the past few weeks
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Overvaluation Situation,2017-02-27 13:00:00 +0000,http://www.investopedia.com/investing/valeant-pharmaceuticals-overvaluation/?partner=YahooSA,Valeant Pharmaceuticals: Overvaluation Situation
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Overvaluation Situation,2017-02-27 13:00:00 +0000,http://www.investopedia.com/investing/valeant-pharmaceuticals-overvaluation/?partner=YahooSA,Valeant Pharmaceuticals: Overvaluation Situation
VRX,VRX:US,BBG000DLFM21,Valeant sub Salix hired 250 employees to bolster its GI commitment,2017-02-27 12:13:08 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=CBB68EBB-9877-4CB0-AB45-754D2D35C5DD&siteid=yhoof2,Valeant sub Salix hired 250 employees to bolster its GI commitment
VRX,VRX:CT,BBG000DC8S17,Valeant sub Salix hired 250 employees to bolster its GI commitment,2017-02-27 12:13:08 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=CBB68EBB-9877-4CB0-AB45-754D2D35C5DD&siteid=yhoof2,Valeant sub Salix hired 250 employees to bolster its GI commitment
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Deployment Of Expanded Salix Sales Force To Capture Untapped Market Opportunity,2017-02-27 12:00:00 +0000,http://finance.yahoo.com/news/valeant-announces-deployment-expanded-salix-120000116.html,[CNW Group] - Valeant Announces Deployment Of Expanded Salix Sales Force To Capture Untapped Market Opportunity
VRX,VRX:US,BBG000DLFM21,Valeant Announces Deployment Of Expanded Salix Sales Force To Capture Untapped Market Opportunity,2017-02-27 12:00:00 +0000,http://finance.yahoo.com/news/valeant-announces-deployment-expanded-salix-120000116.html,[CNW Group] - Valeant Announces Deployment Of Expanded Salix Sales Force To Capture Untapped Market Opportunity
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary,2017-02-27 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kEXXdX82my0/canadian-stocks-are-paring-their-early-losses--canadian-commentary-20170227-01003,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary,2017-02-27 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kEXXdX82my0/canadian-stocks-are-paring-their-early-losses--canadian-commentary-20170227-01003,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Facing Criticism, Drug Makers Keep Lid On Price Increases",2017-02-27 06:51:36 +0000,https://www.wsj.com/articles/facing-criticism-drug-makers-keep-lid-on-price-increases-1488157893?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President ..."
VRX,VRX:CT,BBG000DC8S17,"Facing Criticism, Drug Makers Keep Lid On Price Increases",2017-02-27 06:51:36 +0000,https://www.wsj.com/articles/facing-criticism-drug-makers-keep-lid-on-price-increases-1488157893?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President ..."
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod,2017-02-27 06:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-nicox-resubmit-us-063000922.html,[CNW Group] - Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod,2017-02-27 06:30:00 +0000,http://finance.yahoo.com/news/bausch-lomb-nicox-resubmit-us-063000922.html,[CNW Group] - Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod
VRX,VRX:US,BBG000DLFM21,Biotech Stocks Facing FDA Decision In March,2017-02-27 05:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uBycQmSKtBM/biotech-stocks-facing-fda-decision-in-march-20170227-00289,Biotech Stocks Facing FDA Decision In March
VRX,VRX:CT,BBG000DC8S17,Biotech Stocks Facing FDA Decision In March,2017-02-27 05:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uBycQmSKtBM/biotech-stocks-facing-fda-decision-in-march-20170227-00289,Biotech Stocks Facing FDA Decision In March
VRX,VRX:CT,BBG000DC8S17,Drug Companies Keep Lid on Price Increases,2017-02-27 01:03:02 +0000,http://online.wsj.com/article/SB22580892754490123402004582619611883364468.html?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Facing mounting criticism about prices, drug companies put some limits on their increases this year."
VRX,VRX:US,BBG000DLFM21,Drug Companies Keep Lid on Price Increases,2017-02-27 01:03:02 +0000,http://online.wsj.com/article/SB22580892754490123402004582619611883364468.html?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Facing mounting criticism about prices, drug companies put some limits on their increases this year."
VRX,VRX:CT,BBG000DC8S17,Top Biopharma Movers of the Past Week,2017-02-25 15:25:04 +0000,http://finance.yahoo.com/news/top-biopharma-movers-past-week-152504078.html,Top Biopharma Movers of the Past Week
VRX,VRX:US,BBG000DLFM21,Top Biopharma Movers of the Past Week,2017-02-25 15:25:04 +0000,http://finance.yahoo.com/news/top-biopharma-movers-past-week-152504078.html,Top Biopharma Movers of the Past Week
VRX,VRX:CT,BBG000DC8S17,[$$] Hyena capitalism receives a swift kick from the Unilever giraffe,2017-02-24 19:44:28 +0000,"http://www.ft.com/cms/s/ff99754a-fa91-11e6-9516-2d969e0d3b65,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Hyena capitalism receives a swift kick from the Unilever giraffe
VRX,VRX:US,BBG000DLFM21,[$$] Hyena capitalism receives a swift kick from the Unilever giraffe,2017-02-24 19:44:28 +0000,"http://www.ft.com/cms/s/ff99754a-fa91-11e6-9516-2d969e0d3b65,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Hyena capitalism receives a swift kick from the Unilever giraffe
VRX,VRX:US,BBG000DLFM21,Sequoia Fund wins dismissal of lawsuit over huge Valeant stake,2017-02-24 18:29:51 +0000,http://finance.yahoo.com/news/sequoia-fund-wins-dismissal-lawsuit-182951838.html,Sequoia Fund wins dismissal of lawsuit over huge Valeant stake
VRX,VRX:CT,BBG000DC8S17,Sequoia Fund wins dismissal of lawsuit over huge Valeant stake,2017-02-24 18:29:51 +0000,http://finance.yahoo.com/news/sequoia-fund-wins-dismissal-lawsuit-182951838.html,Sequoia Fund wins dismissal of lawsuit over huge Valeant stake
VRX,VRX:US,BBG000DLFM21,Valeant's Ugly Earnings History May Repeat Itself,2017-02-24 15:47:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/24/valeants-ugly-earnings-history-may-repeat-itself/?mod=yahoobarrons&ru=yahoo,Valeant's Ugly Earnings History May Repeat Itself
VRX,VRX:CT,BBG000DC8S17,Valeant's Ugly Earnings History May Repeat Itself,2017-02-24 15:47:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/24/valeants-ugly-earnings-history-may-repeat-itself/?mod=yahoobarrons&ru=yahoo,Valeant's Ugly Earnings History May Repeat Itself
VRX,VRX:US,BBG000DLFM21,The Demise Of The Erectile Dysfunction TV Ads,2017-02-24 12:58:00 +0000,http://www.forbes.com/sites/johnlamattina/2017/02/24/the-demise-of-the-erectile-dysfunction-tv-ads/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,The Demise Of The Erectile Dysfunction TV Ads
VRX,VRX:CT,BBG000DC8S17,The Demise Of The Erectile Dysfunction TV Ads,2017-02-24 12:58:00 +0000,http://www.forbes.com/sites/johnlamattina/2017/02/24/the-demise-of-the-erectile-dysfunction-tv-ads/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,The Demise Of The Erectile Dysfunction TV Ads
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Sinking On Broad Weakness - Canadian Commentary,2017-02-24 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ld-LPxSMMd8/canadian-stocks-are-sinking-on-broad-weakness--canadian-commentary-20170224-00742,Canadian Stocks Are Sinking On Broad Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Sinking On Broad Weakness - Canadian Commentary,2017-02-24 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ld-LPxSMMd8/canadian-stocks-are-sinking-on-broad-weakness--canadian-commentary-20170224-00742,Canadian Stocks Are Sinking On Broad Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Thursday's ETF with Unusual Volume: PPH,2017-02-23 19:49:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TNx2Z8W2pgo/thursdays-etf-with-unusual-volume-pph-cm752257,The Pharmaceutical ETF PPH is seeing unusually high volume in afternoon trading Thursday with over 2 0 million shares traded versus three month average volume of about 243 000 Shares of PPH were up about 1 1 on the day Components of that ETF with the highest volume on Thursday
VRX,VRX:CT,BBG000DC8S17,Thursday's ETF with Unusual Volume: PPH,2017-02-23 19:49:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TNx2Z8W2pgo/thursdays-etf-with-unusual-volume-pph-cm752257,The Pharmaceutical ETF PPH is seeing unusually high volume in afternoon trading Thursday with over 2 0 million shares traded versus three month average volume of about 243 000 Shares of PPH were up about 1 1 on the day Components of that ETF with the highest volume on Thursday
VRX,VRX:US,BBG000DLFM21,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap,2017-02-23 17:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJWUEwQ_m9A/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-crazy-cheap-cm752236,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA desperately needed some good news heading into its fourth quarter earnings report TEVA stock hit its lowest level in over a decade the week before after its
VRX,VRX:CT,BBG000DC8S17,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap,2017-02-23 17:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJWUEwQ_m9A/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-crazy-cheap-cm752236,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA desperately needed some good news heading into its fourth quarter earnings report TEVA stock hit its lowest level in over a decade the week before after its
VRX,VRX:US,BBG000DLFM21,Former Valeant and Philidor executives plead not guilty in fraud scheme,2017-02-23 16:43:35 +0000,http://finance.yahoo.com/news/former-valeant-philidor-execs-plead-163950016.html,"[Reuters] - A former Valeant Pharmaceuticals International Inc executive and the former chief executive of mail order pharmacy Philidor Rx Services pleaded not guilty on Thursday to charges they orchestrated a multi-million dollar fraud and kickback scheme. Federal prosecutors accused Gary Tanner, who was a senior director at Canadian drugmaker Valeant, of working with former Philidor Chief Executive Officer Andrew Davenport to drive business and funding from Valeant to Philidor."
VRX,VRX:CT,BBG000DC8S17,Former Valeant and Philidor executives plead not guilty in fraud scheme,2017-02-23 16:43:35 +0000,http://finance.yahoo.com/news/former-valeant-philidor-execs-plead-163950016.html,"[Reuters] - A former Valeant Pharmaceuticals International Inc executive and the former chief executive of mail order pharmacy Philidor Rx Services pleaded not guilty on Thursday to charges they orchestrated a multi-million dollar fraud and kickback scheme. Federal prosecutors accused Gary Tanner, who was a senior director at Canadian drugmaker Valeant, of working with former Philidor Chief Executive Officer Andrew Davenport to drive business and funding from Valeant to Philidor."
VRX,VRX:CT,BBG000DC8S17,Former Valeant and Philidor execs plead not guilty in fraud scheme,2017-02-23 16:28:46 +0000,http://finance.yahoo.com/news/former-valeant-philidor-execs-plead-162846971.html,"[Reuters] - A former Valeant Pharmaceuticals International Inc executive and the former chief executive of mail order pharmacy Philidor Rx Services pleaded not guilty on Thursday to charges they orchestrated a multi-million dollar fraud and kickback scheme. Federal prosecutors accused Gary Tanner, who was a senior director at Canadian drugmaker Valeant, of working with former Philidor Chief Executive Officer Andrew Davenport to drive business and funding from Valeant to Philidor."
VRX,VRX:US,BBG000DLFM21,Former Valeant and Philidor execs plead not guilty in fraud scheme,2017-02-23 16:28:46 +0000,http://finance.yahoo.com/news/former-valeant-philidor-execs-plead-162846971.html,"[Reuters] - A former Valeant Pharmaceuticals International Inc executive and the former chief executive of mail order pharmacy Philidor Rx Services pleaded not guilty on Thursday to charges they orchestrated a multi-million dollar fraud and kickback scheme. Federal prosecutors accused Gary Tanner, who was a senior director at Canadian drugmaker Valeant, of working with former Philidor Chief Executive Officer Andrew Davenport to drive business and funding from Valeant to Philidor."
VRX,VRX:US,BBG000DLFM21,Did 50 Salespeople Leave Valeant? Wells Fargo Investigates,2017-02-23 16:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/23/did-50-salespeople-leave-valeant-wells-fargo-investigates/?mod=yahoobarrons&ru=yahoo,Did 50 Salespeople Leave Valeant? Wells Fargo Investigates
VRX,VRX:CT,BBG000DC8S17,Did 50 Salespeople Leave Valeant? Wells Fargo Investigates,2017-02-23 16:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/23/did-50-salespeople-leave-valeant-wells-fargo-investigates/?mod=yahoobarrons&ru=yahoo,Did 50 Salespeople Leave Valeant? Wells Fargo Investigates
VRX,VRX:US,BBG000DLFM21,"Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products",2017-02-23 12:00:00 +0000,http://finance.yahoo.com/news/obagi-medical-products-announces-collaboration-120000621.html,"[CNW Group] - Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products"
VRX,VRX:CT,BBG000DC8S17,"Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products",2017-02-23 12:00:00 +0000,http://finance.yahoo.com/news/obagi-medical-products-announces-collaboration-120000621.html,"[CNW Group] - Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Their Early Gains - Canadian Commentary,2017-02-23 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XcxUypNSPAg/canadian-stocks-are-paring-their-early-gains--canadian-commentary-20170223-01152,Canadian Stocks Are Paring Their Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Their Early Gains - Canadian Commentary,2017-02-23 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XcxUypNSPAg/canadian-stocks-are-paring-their-early-gains--canadian-commentary-20170223-01152,Canadian Stocks Are Paring Their Early Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,PRESS DIGEST- New York Times business news - Feb 23,2017-02-23 07:08:53 +0000,http://finance.yahoo.com/news/press-digest-york-times-business-070853823.html,"[Reuters] - The following are the top stories on the New York Times business pages. - Valeant Pharmaceuticals has been trading near record low, at around $16 per share, and at levels not seen in seven years. This spells big financial trouble for one of its largest shareholders, Pershing Square Capital (IPO-PERS.L), the hedge fund company managed by the billionaire William Ackman, whose efforts to salvage Valeant and his reputation as a savvy investor are looking increasingly desperate."
VRX,VRX:CT,BBG000DC8S17,PRESS DIGEST- New York Times business news - Feb 23,2017-02-23 07:08:53 +0000,http://finance.yahoo.com/news/press-digest-york-times-business-070853823.html,"[Reuters] - The following are the top stories on the New York Times business pages. - Valeant Pharmaceuticals has been trading near record low, at around $16 per share, and at levels not seen in seven years. This spells big financial trouble for one of its largest shareholders, Pershing Square Capital (IPO-PERS.L), the hedge fund company managed by the billionaire William Ackman, whose efforts to salvage Valeant and his reputation as a savvy investor are looking increasingly desperate."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling On Commodity Weakness - Canadian Commentary,2017-02-22 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k3N7XWci8ug/canadian-stocks-are-falling-on-commodity-weakness--canadian-commentary-20170222-00983,Canadian Stocks Are Falling On Commodity Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling On Commodity Weakness - Canadian Commentary,2017-02-22 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k3N7XWci8ug/canadian-stocks-are-falling-on-commodity-weakness--canadian-commentary-20170222-00983,Canadian Stocks Are Falling On Commodity Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal,2017-02-21 22:25:08 +0000,http://www.bizjournals.com/boston/news/2017/02/21/tiny-waltham-biotechs-market-cap-doubles-after.html?ana=yahoo,​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal
VRX,VRX:CT,BBG000DC8S17,​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal,2017-02-21 22:25:08 +0000,http://www.bizjournals.com/boston/news/2017/02/21/tiny-waltham-biotechs-market-cap-doubles-after.html?ana=yahoo,​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal
VRX,VRX:CT,BBG000DC8S17,Close Update: Averages Ink Record Highs As Retailers Report Strong Q4,2017-02-21 22:06:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eav2_bw6lXE/close-update-averages-ink-record-highs-as-retailers-report-strong-q4-cm750924,Fueled by strong quarterly results in the retail sector and sizable gains in oil futures the benchmark averages closed at record highs with the Dow Jones Industrial Average in its longest winning streak since this summer Component stocks Walmart WMT and Home Depot HD led Dow
VRX,VRX:US,BBG000DLFM21,Close Update: Averages Ink Record Highs As Retailers Report Strong Q4,2017-02-21 22:06:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eav2_bw6lXE/close-update-averages-ink-record-highs-as-retailers-report-strong-q4-cm750924,Fueled by strong quarterly results in the retail sector and sizable gains in oil futures the benchmark averages closed at record highs with the Dow Jones Industrial Average in its longest winning streak since this summer Component stocks Walmart WMT and Home Depot HD led Dow
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 02/21/2017: CYH,EYEG,VRX,CDTX",2017-02-21 21:26:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8NLm_NW6FE/health-care-sector-update-for-02212017-cyheyegvrxcdtx-cm750893,Top Health Care StocksTop Health Care Stocks JNJ 0 77 JNJ 0 77 PFE 0 18 PFE 0 18 MRK 0 79 MRK 0 79 ABT 0 35 ABT 0 35 AMGN 0 03 AMGN 0 03 Health care stocks were mostly higher in late afternoon trading with the NYSE Health Care Index rising about 0 4 while shares of health
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 02/21/2017: CYH,EYEG,VRX,CDTX",2017-02-21 21:26:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8NLm_NW6FE/health-care-sector-update-for-02212017-cyheyegvrxcdtx-cm750893,Top Health Care StocksTop Health Care Stocks JNJ 0 77 JNJ 0 77 PFE 0 18 PFE 0 18 MRK 0 79 MRK 0 79 ABT 0 35 ABT 0 35 AMGN 0 03 AMGN 0 03 Health care stocks were mostly higher in late afternoon trading with the NYSE Health Care Index rising about 0 4 while shares of health
VRX,VRX:CT,BBG000DC8S17,Valeant Acquires Eyegate Licensing Rights,2017-02-21 20:57:00 +0000,https://www.thestreet.com/story/14010117/1/valeant-acquires-eyegate-licensing-rights.html?puc=yahoo&cm_ven=YAHOO,Valeant Acquires Eyegate Licensing Rights
VRX,VRX:US,BBG000DLFM21,Valeant Acquires Eyegate Licensing Rights,2017-02-21 20:57:00 +0000,https://www.thestreet.com/story/14010117/1/valeant-acquires-eyegate-licensing-rights.html?puc=yahoo&cm_ven=YAHOO,Valeant Acquires Eyegate Licensing Rights
VRX,VRX:US,BBG000DLFM21,"Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH...",2017-02-21 19:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gda4OqtvtOg/gainers--losers-of-the-day-eyeg-blph-vsar-mnta-amph-20170221-01881,"Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH..."
VRX,VRX:CT,BBG000DC8S17,"Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH...",2017-02-21 19:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gda4OqtvtOg/gainers--losers-of-the-day-eyeg-blph-vsar-mnta-amph-20170221-01881,"Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH..."
VRX,VRX:US,BBG000DLFM21,Midday Update: Upbeat Retail Quarterly Results Lifts Indices to Record Highs,2017-02-21 18:06:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kC89rJtA5GA/midday-update-upbeat-retail-quarterly-results-lifts-indices-to-record-highs-cm750745,Led by gains in the retail and energy sectors the benchmark indices set new record highs on Tuesday Dow component stocks Walmart WMT and Home Depot HD were leading advancers after both beat Q4 EPS and revenue expectations setting the retail sector of the S amp P 500 up for a near
VRX,VRX:CT,BBG000DC8S17,Midday Update: Upbeat Retail Quarterly Results Lifts Indices to Record Highs,2017-02-21 18:06:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kC89rJtA5GA/midday-update-upbeat-retail-quarterly-results-lifts-indices-to-record-highs-cm750745,Led by gains in the retail and energy sectors the benchmark indices set new record highs on Tuesday Dow component stocks Walmart WMT and Home Depot HD were leading advancers after both beat Q4 EPS and revenue expectations setting the retail sector of the S amp P 500 up for a near
VRX,VRX:US,BBG000DLFM21,"APOP Pops On Study Data, EYEG Catches Investors' Eyes, CDTX Loses Radiance",2017-02-21 17:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z2NfBuvUjKc/apop-pops-on-study-data-eyeg-catches-investors-eyes-cdtx-loses-radiance-20170221-01799,"APOP Pops On Study Data, EYEG Catches Investors' Eyes, CDTX Loses Radiance"
VRX,VRX:CT,BBG000DC8S17,"APOP Pops On Study Data, EYEG Catches Investors' Eyes, CDTX Loses Radiance",2017-02-21 17:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z2NfBuvUjKc/apop-pops-on-study-data-eyeg-catches-investors-eyes-cdtx-loses-radiance-20170221-01799,"APOP Pops On Study Data, EYEG Catches Investors' Eyes, CDTX Loses Radiance"
VRX,VRX:US,BBG000DLFM21,This Guru Loves Valeant; Should You?,2017-02-21 17:06:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yl_sFXF6BwQ/this-guru-loves-valeant-should-you-cm750706,Hedge funds final 13F forms for 2016 were published last week and as usual the data has been scrutinized by the financial media There were a few surprises in the figures including Warren Buffett Trades Portfolio s new favorite position Apple AAPL and the general
VRX,VRX:CT,BBG000DC8S17,This Guru Loves Valeant; Should You?,2017-02-21 17:06:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yl_sFXF6BwQ/this-guru-loves-valeant-should-you-cm750706,Hedge funds final 13F forms for 2016 were published last week and as usual the data has been scrutinized by the financial media There were a few surprises in the figures including Warren Buffett Trades Portfolio s new favorite position Apple AAPL and the general
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson",2017-02-21 16:11:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D_C1tak9H14/the-zacks-analyst-blog-highlights-merck-valeant-pharmaceuticals-international-allergan-astrazeneca-and-johnson-johnson-cm750634,For Immediate Release Chicago IL February 21 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson",2017-02-21 16:11:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D_C1tak9H14/the-zacks-analyst-blog-highlights-merck-valeant-pharmaceuticals-international-allergan-astrazeneca-and-johnson-johnson-cm750634,For Immediate Release Chicago IL February 21 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRX,VRX:CT,BBG000DC8S17,Tuesday’s Top Biopharma Movers,2017-02-21 16:10:39 +0000,http://finance.yahoo.com/news/tuesday-top-biopharma-movers-161039297.html,Tuesday’s Top Biopharma Movers
VRX,VRX:US,BBG000DLFM21,Tuesday’s Top Biopharma Movers,2017-02-21 16:10:39 +0000,http://finance.yahoo.com/news/tuesday-top-biopharma-movers-161039297.html,Tuesday’s Top Biopharma Movers
VRX,VRX:US,BBG000DLFM21,Stock Futures Trade Higher on Upbeat Retail Earnings,2017-02-21 14:52:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KL81gi5OkWc/stock-futures-trade-higher-on-upbeat-retail-earnings-cm750434,Stocks were set to open higher Tuesday as upbeat retail Q4 earnings and higher oil prices sets the blue chip index up for a seventh consecutive day higher Stocks were set to open higher Tuesday as upbeat retail Q4 earnings and higheroil prices sets the blue chip index up for a
VRX,VRX:CT,BBG000DC8S17,Stock Futures Trade Higher on Upbeat Retail Earnings,2017-02-21 14:52:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KL81gi5OkWc/stock-futures-trade-higher-on-upbeat-retail-earnings-cm750434,Stocks were set to open higher Tuesday as upbeat retail Q4 earnings and higher oil prices sets the blue chip index up for a seventh consecutive day higher Stocks were set to open higher Tuesday as upbeat retail Q4 earnings and higheroil prices sets the blue chip index up for a
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson",2017-02-21 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-143002469.html,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson"
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson",2017-02-21 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-143002469.html,"The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson"
VRX,VRX:CT,BBG000DC8S17,EyeGate Pharma surges 15% on news of Valeant licensing agreement,2017-02-21 12:44:24 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=AAC88FF9-B9C5-421C-A659-EB6CF303A89F&siteid=yhoof2,EyeGate Pharma surges 15% on news of Valeant licensing agreement
VRX,VRX:US,BBG000DLFM21,EyeGate Pharma surges 15% on news of Valeant licensing agreement,2017-02-21 12:44:24 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=AAC88FF9-B9C5-421C-A659-EB6CF303A89F&siteid=yhoof2,EyeGate Pharma surges 15% on news of Valeant licensing agreement
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients,2017-02-21 12:30:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-eyegate-enter-licensing-123000745.html,[CNW Group] - Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients,2017-02-21 12:30:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-eyegate-enter-licensing-123000745.html,[CNW Group] - Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-02-21 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kV97l6N7HsM/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170221-01129,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-02-21 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kV97l6N7HsM/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170221-01129,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,This Guru Loves Valeant; Should You?,2017-02-20 20:40:18 +0000,http://finance.yahoo.com/news/guru-loves-valeant-204018723.html,This Guru Loves Valeant; Should You?
VRX,VRX:CT,BBG000DC8S17,This Guru Loves Valeant; Should You?,2017-02-20 20:40:18 +0000,http://finance.yahoo.com/news/guru-loves-valeant-204018723.html,This Guru Loves Valeant; Should You?
VRX,VRX:US,BBG000DLFM21,[$$] Unilever was a deal too far for Kraft Heinz,2017-02-20 18:33:34 +0000,"http://www.ft.com/cms/s/820fe386-f76a-11e6-bd4e-68d53499ed71,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Profit has many good qualities, but does not yet have the right to vote. Workers do, and politicians listen to them. So there was probably some anxiety in London and Amsterdam late last week when the news ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Unilever was a deal too far for Kraft Heinz,2017-02-20 18:33:34 +0000,"http://www.ft.com/cms/s/820fe386-f76a-11e6-bd4e-68d53499ed71,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Profit has many good qualities, but does not yet have the right to vote. Workers do, and politicians listen to them. So there was probably some anxiety in London and Amsterdam late last week when the news ..."
VRX,VRX:CT,BBG000DC8S17,Sequoia's Foundation Looks Stronger Than It Was Before,2017-02-19 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=794295&SR=Yahoo,Sequoia's Foundation Looks Stronger Than It Was Before
VRX,VRX:US,BBG000DLFM21,Sequoia's Foundation Looks Stronger Than It Was Before,2017-02-19 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=794295&SR=Yahoo,Sequoia's Foundation Looks Stronger Than It Was Before
VRX,VRX:CT,BBG000DC8S17,Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.,2017-02-17 15:55:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J2Io5NmZFD0/valeants-vrx-plaque-psoriasis-drug-approved-in-the-us-cm749536,Valeant Pharmaceuticals International Inc VRX recently announced that the the FDA has approved its Biologic License Application BLA for Siliq brodalumab injection the treatment of moderate to severe plaque psoriasis in adult patients The FDA has approved the subcutaneous use of the
VRX,VRX:US,BBG000DLFM21,Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.,2017-02-17 15:55:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J2Io5NmZFD0/valeants-vrx-plaque-psoriasis-drug-approved-in-the-us-cm749536,Valeant Pharmaceuticals International Inc VRX recently announced that the the FDA has approved its Biologic License Application BLA for Siliq brodalumab injection the treatment of moderate to severe plaque psoriasis in adult patients The FDA has approved the subcutaneous use of the
VRX,VRX:CT,BBG000DC8S17,It Happened Again! Another Drugmaker Got Caught With an Exorbitant Price Hike,2017-02-17 15:54:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/saRHRvwRKOQ/it-happened-again-another-drugmaker-got-caught-with-an-exorbitant-price-hike-cm749576,If you thought that Martin Shkreli was the lone bad apple of the bunch think again In September 2015 the so called Bad Boy of Pharma was called out by regulators for acquiring rare disease drug Daraprim through his privately held drug company Turing Pharmaceuticals Shkreli
VRX,VRX:US,BBG000DLFM21,It Happened Again! Another Drugmaker Got Caught With an Exorbitant Price Hike,2017-02-17 15:54:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/saRHRvwRKOQ/it-happened-again-another-drugmaker-got-caught-with-an-exorbitant-price-hike-cm749576,If you thought that Martin Shkreli was the lone bad apple of the bunch think again In September 2015 the so called Bad Boy of Pharma was called out by regulators for acquiring rare disease drug Daraprim through his privately held drug company Turing Pharmaceuticals Shkreli
VRX,VRX:US,BBG000DLFM21,Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.,2017-02-17 14:12:02 +0000,http://finance.yahoo.com/news/valeants-vrx-plaque-psoriasis-drug-141202363.html,Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
VRX,VRX:CT,BBG000DC8S17,Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.,2017-02-17 14:12:02 +0000,http://finance.yahoo.com/news/valeants-vrx-plaque-psoriasis-drug-141202363.html,Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
VRX,VRX:CT,BBG000DC8S17,It Happened Again! Another Drugmaker Got Caught With an Exorbitant Price Hike,2017-02-17 14:09:06 +0000,http://www.fool.com/investing/2017/02/17/it-happened-again-another-drugmaker-got-caught-wit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,It Happened Again! Another Drugmaker Got Caught With an Exorbitant Price Hike
VRX,VRX:US,BBG000DLFM21,It Happened Again! Another Drugmaker Got Caught With an Exorbitant Price Hike,2017-02-17 14:09:06 +0000,http://www.fool.com/investing/2017/02/17/it-happened-again-another-drugmaker-got-caught-wit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,It Happened Again! Another Drugmaker Got Caught With an Exorbitant Price Hike
VRX,VRX:US,BBG000DLFM21,AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial,2017-02-17 13:05:00 +0000,https://www.thestreet.com/story/14006488/1/astrazeneca-stock-rises-on-successful-breast-cancer-drug-trial.html?puc=yahoo&cm_ven=YAHOO,AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
VRX,VRX:CT,BBG000DC8S17,AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial,2017-02-17 13:05:00 +0000,https://www.thestreet.com/story/14006488/1/astrazeneca-stock-rises-on-successful-breast-cancer-drug-trial.html?puc=yahoo&cm_ven=YAHOO,AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary,2017-02-17 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ohSDSk4GA60/canadian-stocks-are-paring-their-early-losses--canadian-commentary-20170217-00674,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary,2017-02-17 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ohSDSk4GA60/canadian-stocks-are-paring-their-early-losses--canadian-commentary-20170217-00674,Canadian Stocks Are Paring Their Early Losses - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Accipiter Capital Management, Llc Buys Community Health Systems, Tenet Healthcare, Quorum ...",2017-02-17 06:53:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J_aS_x8C09M/accipiter-capital-management-llc-buys-community-health-systems-tenet-healthcare-quorum-cm749349,Accipiter Capital Management Llc New Purchases THC Added Positions CYH QHC TEVA Reduced Positions VRX PRGO FELP Sold Out SHPG New Purchases THC New Purchases THC Added Positions CYH QHC TEVA Added
VRX,VRX:US,BBG000DLFM21,"Accipiter Capital Management, Llc Buys Community Health Systems, Tenet Healthcare, Quorum ...",2017-02-17 06:53:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J_aS_x8C09M/accipiter-capital-management-llc-buys-community-health-systems-tenet-healthcare-quorum-cm749349,Accipiter Capital Management Llc New Purchases THC Added Positions CYH QHC TEVA Reduced Positions VRX PRGO FELP Sold Out SHPG New Purchases THC New Purchases THC Added Positions CYH QHC TEVA Added
VRX,VRX:CT,BBG000DC8S17,Don't Count on Valeant's New Drug to Save the Day,2017-02-16 22:55:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wIpmEpMRBYw/dont-count-on-valeants-new-drug-to-save-the-day-cm749230,Valeant Pharmaceuticals NYSE VRX is going through a major restructuring that it hopes will allow it to return to growth and investors who ve endured big losses are eager for new drugs to launch that could help the company get back on its feet This week the U S Food and
VRX,VRX:US,BBG000DLFM21,Don't Count on Valeant's New Drug to Save the Day,2017-02-16 22:55:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wIpmEpMRBYw/dont-count-on-valeants-new-drug-to-save-the-day-cm749230,Valeant Pharmaceuticals NYSE VRX is going through a major restructuring that it hopes will allow it to return to growth and investors who ve endured big losses are eager for new drugs to launch that could help the company get back on its feet This week the U S Food and
VRX,VRX:CT,BBG000DC8S17,Don't Count on Valeant's New Drug to Save the Day,2017-02-16 21:41:05 +0000,http://www.fool.com/investing/2017/02/16/dont-count-on-valeants-new-drug-to-save-the-day.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Don't Count on Valeant's New Drug to Save the Day
VRX,VRX:US,BBG000DLFM21,Don't Count on Valeant's New Drug to Save the Day,2017-02-16 21:41:05 +0000,http://www.fool.com/investing/2017/02/16/dont-count-on-valeants-new-drug-to-save-the-day.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Don't Count on Valeant's New Drug to Save the Day
VRX,VRX:US,BBG000DLFM21,"Bill Ackman Expands Chipotle Position, Cuts Zoetis",2017-02-16 19:53:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zqtwup4lSAE/bill-ackman-expands-chipotle-position-cuts-zoetis-cm749160,Activist investor Bill Ackman Trades Portfolio founder of Pershing Square Capital Management buys the common stock of companies and pushes for changes so that the market can realize the values of these companies Like fellow activist investor Carl Icahn Trades Portfolio Ackman
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman Expands Chipotle Position, Cuts Zoetis",2017-02-16 19:53:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zqtwup4lSAE/bill-ackman-expands-chipotle-position-cuts-zoetis-cm749160,Activist investor Bill Ackman Trades Portfolio founder of Pershing Square Capital Management buys the common stock of companies and pushes for changes so that the market can realize the values of these companies Like fellow activist investor Carl Icahn Trades Portfolio Ackman
VRX,VRX:CT,BBG000DC8S17,"Francis Chou Adds to Valeant, Trims Sears in 4th Quarter",2017-02-16 18:55:57 +0000,http://finance.yahoo.com/news/francis-chou-adds-valeant-trims-174753673.html,"Francis Chou Adds to Valeant, Trims Sears in 4th Quarter"
VRX,VRX:US,BBG000DLFM21,"Francis Chou Adds to Valeant, Trims Sears in 4th Quarter",2017-02-16 18:55:57 +0000,http://finance.yahoo.com/news/francis-chou-adds-valeant-trims-174753673.html,"Francis Chou Adds to Valeant, Trims Sears in 4th Quarter"
VRX,VRX:US,BBG000DLFM21,"Billionaire Bill Ackman’s Pershing Square Boosts Bet on Fast Food Industry, Cuts Down on Healthcare",2017-02-16 18:43:37 +0000,http://www.insidermonkey.com/blog/billionaire-bill-ackmans-pershing-square-boosts-bet-on-fast-food-industry-cuts-down-on-healthcare-559503/,"Billionaire Bill Ackman’s Pershing Square Boosts Bet on Fast Food Industry, Cuts Down on Healthcare"
VRX,VRX:CT,BBG000DC8S17,"Billionaire Bill Ackman’s Pershing Square Boosts Bet on Fast Food Industry, Cuts Down on Healthcare",2017-02-16 18:43:37 +0000,http://www.insidermonkey.com/blog/billionaire-bill-ackmans-pershing-square-boosts-bet-on-fast-food-industry-cuts-down-on-healthcare-559503/,"Billionaire Bill Ackman’s Pershing Square Boosts Bet on Fast Food Industry, Cuts Down on Healthcare"
VRX,VRX:CT,BBG000DC8S17,Why This FDA Approval for Valeant Is Not as Good as First Thought,2017-02-16 17:05:32 +0000,http://finance.yahoo.com/news/why-fda-approval-valeant-not-170532454.html,Why This FDA Approval for Valeant Is Not as Good as First Thought
VRX,VRX:US,BBG000DLFM21,Why This FDA Approval for Valeant Is Not as Good as First Thought,2017-02-16 17:05:32 +0000,http://finance.yahoo.com/news/why-fda-approval-valeant-not-170532454.html,Why This FDA Approval for Valeant Is Not as Good as First Thought
VRX,VRX:CT,BBG000DC8S17,Allergan's Roll-Up Is Not Breaking Even (SEC Letter Response),2017-02-16 16:55:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kjVip28BQj8/allergans-roll-up-is-not-breaking-even-sec-letter-response-cm748857,By SigmaCap BySigmaCap On February 13 The Wall Street Journal broke news of a recent letter from the SEC to Allergan AGN highlighting its concerns about AGN s non GAAP earnings practices This letter corroborates my concerns about AGN s approach In its earnings AGN excludes
VRX,VRX:US,BBG000DLFM21,Allergan's Roll-Up Is Not Breaking Even (SEC Letter Response),2017-02-16 16:55:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kjVip28BQj8/allergans-roll-up-is-not-breaking-even-sec-letter-response-cm748857,By SigmaCap BySigmaCap On February 13 The Wall Street Journal broke news of a recent letter from the SEC to Allergan AGN highlighting its concerns about AGN s non GAAP earnings practices This letter corroborates my concerns about AGN s approach In its earnings AGN excludes
VRX,VRX:CT,BBG000DC8S17,New Valeant Approval is a Surprise Irritant,2017-02-16 16:54:57 +0000,http://blogs.wsj.com/moneybeat/2017/02/16/new-valeant-approval-is-a-surprise-irritant/?mod=yahoo_hs,New Valeant Approval is a Surprise Irritant
VRX,VRX:US,BBG000DLFM21,New Valeant Approval is a Surprise Irritant,2017-02-16 16:54:57 +0000,http://blogs.wsj.com/moneybeat/2017/02/16/new-valeant-approval-is-a-surprise-irritant/?mod=yahoo_hs,New Valeant Approval is a Surprise Irritant
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Dead in the Water?,2017-02-16 15:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/16/valeant-pharmaceuticals-dead-in-the-water/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Dead in the Water?
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Dead in the Water?,2017-02-16 15:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/16/valeant-pharmaceuticals-dead-in-the-water/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Dead in the Water?
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Kate Spade, MGM Resorts, Avon Products",2017-02-16 15:04:17 +0000,http://blogs.wsj.com/moneybeat/2017/02/16/stocks-to-watch-kate-spade-mgm-resorts-avon-products/?mod=yahoo_hs,"Stocks to Watch: Kate Spade, MGM Resorts, Avon Products"
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Kate Spade, MGM Resorts, Avon Products",2017-02-16 15:04:17 +0000,http://blogs.wsj.com/moneybeat/2017/02/16/stocks-to-watch-kate-spade-mgm-resorts-avon-products/?mod=yahoo_hs,"Stocks to Watch: Kate Spade, MGM Resorts, Avon Products"
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Feb 16, 2017 :  ERIC, GNC, BAC, VRX, MOH, KATE, OSIS, RDS/B, CSCO, TVIX, GRPN, HIMX",2017-02-16 13:53:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZPllGXSkW5U/pre-market-most-active-for-feb-16-2017-eric-gnc-bac-vrx-moh-kate-osis-rdsb-csco-tvix-grpn-himx-cm748761,The NASDAQ 100 Pre Market Indicator is up 2 91 to 5 305 3 The total Pre Market volume is currently 7 682 446 shares traded The following are the most active stocks for the pre market session Ericsson ERIC is 0 1252 at 6 02 with 1 025 752 shares traded ERIC s
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Feb 16, 2017 :  ERIC, GNC, BAC, VRX, MOH, KATE, OSIS, RDS/B, CSCO, TVIX, GRPN, HIMX",2017-02-16 13:53:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZPllGXSkW5U/pre-market-most-active-for-feb-16-2017-eric-gnc-bac-vrx-moh-kate-osis-rdsb-csco-tvix-grpn-himx-cm748761,The NASDAQ 100 Pre Market Indicator is up 2 91 to 5 305 3 The total Pre Market volume is currently 7 682 446 shares traded The following are the most active stocks for the pre market session Ericsson ERIC is 0 1252 at 6 02 with 1 025 752 shares traded ERIC s
VRX,VRX:CT,BBG000DC8S17,Valeant stock surges 3% after psoriasis drug gets FDA approval,2017-02-16 12:22:38 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=2B85A101-F262-415A-8750-A9382BE7CBAB&siteid=yhoof2,Valeant stock surges 3% after psoriasis drug gets FDA approval
VRX,VRX:US,BBG000DLFM21,Valeant stock surges 3% after psoriasis drug gets FDA approval,2017-02-16 12:22:38 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=2B85A101-F262-415A-8750-A9382BE7CBAB&siteid=yhoof2,Valeant stock surges 3% after psoriasis drug gets FDA approval
VRX,VRX:US,BBG000DLFM21,Valeant Receives FDA Approval Of SILIQ™ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis,2017-02-16 12:00:00 +0000,http://finance.yahoo.com/news/valeant-receives-fda-approval-siliq-120000505.html,"[PR Newswire] - LAVAL, Quebec, Feb. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for SILIQ™ (brodalumab) injection, for subcutaneous use, a monoclonal antibody that targets the IL-17 receptor for patients with moderate-to-severe plaque psoriasis. SILIQ is indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. Valeant expects to commence sales and marketing of SILIQ in the U.S. in the second half of 2017."
VRX,VRX:CT,BBG000DC8S17,Valeant Receives FDA Approval Of SILIQ™ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis,2017-02-16 12:00:00 +0000,http://finance.yahoo.com/news/valeant-receives-fda-approval-siliq-120000505.html,"[PR Newswire] - LAVAL, Quebec, Feb. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for SILIQ™ (brodalumab) injection, for subcutaneous use, a monoclonal antibody that targets the IL-17 receptor for patients with moderate-to-severe plaque psoriasis. SILIQ is indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. Valeant expects to commence sales and marketing of SILIQ in the U.S. in the second half of 2017."
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Nearly Flat In Early Trade - Canadian Commentary,2017-02-16 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jU5n-rdW-Mg/canadian-stocks-are-nearly-flat-in-early-trade--canadian-commentary-20170216-01049,Canadian Stocks Are Nearly Flat In Early Trade - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Nearly Flat In Early Trade - Canadian Commentary,2017-02-16 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jU5n-rdW-Mg/canadian-stocks-are-nearly-flat-in-early-trade--canadian-commentary-20170216-01049,Canadian Stocks Are Nearly Flat In Early Trade - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma: FDA Approves BLA For Brodalumab Injection - Quick Facts,2017-02-16 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VQ2iAWgYMQU/valeant-pharma-fda-approves-bla-for-brodalumab-injection--quick-facts-20170216-00427,Valeant Pharma: FDA Approves BLA For Brodalumab Injection - Quick Facts
VRX,VRX:US,BBG000DLFM21,Valeant Pharma: FDA Approves BLA For Brodalumab Injection - Quick Facts,2017-02-16 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VQ2iAWgYMQU/valeant-pharma-fda-approves-bla-for-brodalumab-injection--quick-facts-20170216-00427,Valeant Pharma: FDA Approves BLA For Brodalumab Injection - Quick Facts
VRX,VRX:US,BBG000DLFM21,"ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX",2017-02-16 04:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53lFvIEJb04/ardx-kidney-drug-passes-phase-3-study-edit-up-on-crispr-news-fda-nod-for-vrx-20170216-00196,"ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX"
VRX,VRX:CT,BBG000DC8S17,"ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX",2017-02-16 04:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53lFvIEJb04/ardx-kidney-drug-passes-phase-3-study-edit-up-on-crispr-news-fda-nod-for-vrx-20170216-00196,"ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX"
VRX,VRX:US,BBG000DLFM21,"Bill Ackman Expands Chipotle Position, Cuts Zoetis",2017-02-15 23:37:32 +0000,http://finance.yahoo.com/news/bill-ackman-expands-chipotle-position-233732026.html,"Bill Ackman Expands Chipotle Position, Cuts Zoetis"
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman Expands Chipotle Position, Cuts Zoetis",2017-02-15 23:37:32 +0000,http://finance.yahoo.com/news/bill-ackman-expands-chipotle-position-233732026.html,"Bill Ackman Expands Chipotle Position, Cuts Zoetis"
VRX,VRX:CT,BBG000DC8S17,FDA approves Valeant's drug to treat plaque psoriasis,2017-02-15 23:34:06 +0000,http://finance.yahoo.com/news/fda-approves-valeants-drug-treat-233406536.html,[Reuters] - The U.S. Food and Drug Administration on Wednesday approved Valeant Pharmaceuticals International Inc's Siliq to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is an autoimmune disorder ...
VRX,VRX:US,BBG000DLFM21,FDA approves Valeant's drug to treat plaque psoriasis,2017-02-15 23:34:06 +0000,http://finance.yahoo.com/news/fda-approves-valeants-drug-treat-233406536.html,[Reuters] - The U.S. Food and Drug Administration on Wednesday approved Valeant Pharmaceuticals International Inc's Siliq to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is an autoimmune disorder ...
VRX,VRX:CT,BBG000DC8S17,"Dow Jones Industrial Average, S&P, Nasdaq Nab Streak Not Seen Since '92",2017-02-15 22:53:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7DWY6jODPo/dow-jones-industrial-average-sp-nasdaq-nab-streak-not-seen-since-92-cm748590,The 160 Dow Jones Industrial Average DJIA 160 S amp P 500 Index SPX and Nasdaq Composite COMP all hit record closing highs for the fifth day in a row a signal not sounded since the early 1990s after President Donald Trump weighed in on his highly anticipated tax
VRX,VRX:US,BBG000DLFM21,"Dow Jones Industrial Average, S&P, Nasdaq Nab Streak Not Seen Since '92",2017-02-15 22:53:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7DWY6jODPo/dow-jones-industrial-average-sp-nasdaq-nab-streak-not-seen-since-92-cm748590,The 160 Dow Jones Industrial Average DJIA 160 S amp P 500 Index SPX and Nasdaq Composite COMP all hit record closing highs for the fifth day in a row a signal not sounded since the early 1990s after President Donald Trump weighed in on his highly anticipated tax
VRX,VRX:US,BBG000DLFM21,FDA Approves Valeant''s Siliq To Treat Plaque Psoriasis,2017-02-15 21:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qJgqIrVhGqU/fda-approves-valeants-siliq-to-treat-plaque-psoriasis-20170215-01681,FDA Approves Valeant''s Siliq To Treat Plaque Psoriasis
VRX,VRX:CT,BBG000DC8S17,FDA Approves Valeant''s Siliq To Treat Plaque Psoriasis,2017-02-15 21:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qJgqIrVhGqU/fda-approves-valeants-siliq-to-treat-plaque-psoriasis-20170215-01681,FDA Approves Valeant''s Siliq To Treat Plaque Psoriasis
VRX,VRX:US,BBG000DLFM21,"PepsiCo, Inc. (PEP) Q4 Earnings Leave Coke in the Dust",2017-02-15 18:54:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/itF96Zd-80A/pepsico-inc-pep-q4-earnings-leave-coke-in-the-dust-cm748484,InvestorPlace Stock Market News Stock Advice amp Trading Tips PepsiCo Inc NYSE PEP laid another beat down on its supposed rival The Coca Cola Co 160 NYSE KO with its fourth quarter earnings While PEP stock wasn t doing much Wednesday morning the company
VRX,VRX:CT,BBG000DC8S17,"PepsiCo, Inc. (PEP) Q4 Earnings Leave Coke in the Dust",2017-02-15 18:54:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/itF96Zd-80A/pepsico-inc-pep-q4-earnings-leave-coke-in-the-dust-cm748484,InvestorPlace Stock Market News Stock Advice amp Trading Tips PepsiCo Inc NYSE PEP laid another beat down on its supposed rival The Coca Cola Co 160 NYSE KO with its fourth quarter earnings While PEP stock wasn t doing much Wednesday morning the company
VRX,VRX:CT,BBG000DC8S17,Wednesday's ETF with Unusual Volume: PPH,2017-02-15 18:53:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aDmPr8O3unk/wednesdays-etf-with-unusual-volume-pph-cm748451,The VanEck Vectors Pharmaceutical ETF is seeing unusually high volume in afternoon trading Wednesday with over 984 000 shares traded versus three month average volume of about 196 000 Shares of PPH were up about 0 8 on the day Components of that ETF with the highest volume on
VRX,VRX:US,BBG000DLFM21,Wednesday's ETF with Unusual Volume: PPH,2017-02-15 18:53:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aDmPr8O3unk/wednesdays-etf-with-unusual-volume-pph-cm748451,The VanEck Vectors Pharmaceutical ETF is seeing unusually high volume in afternoon trading Wednesday with over 984 000 shares traded versus three month average volume of about 196 000 Shares of PPH were up about 0 8 on the day Components of that ETF with the highest volume on
VRX,VRX:US,BBG000DLFM21,These 3 Hedge Funds Are Playing With Fire,2017-02-15 17:55:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5x0VcnrwuCE/these-3-hedge-funds-are-playing-with-fire-cm748426,For most Americans mid February means Valentine s Day For investors mid February means the filing of Form 13F by high profile money managers with the Securities and Exchange Commission SEC Money managers who run funds with more than 100 million in assets under management are
VRX,VRX:CT,BBG000DC8S17,These 3 Hedge Funds Are Playing With Fire,2017-02-15 17:55:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5x0VcnrwuCE/these-3-hedge-funds-are-playing-with-fire-cm748426,For most Americans mid February means Valentine s Day For investors mid February means the filing of Form 13F by high profile money managers with the Securities and Exchange Commission SEC Money managers who run funds with more than 100 million in assets under management are
VRX,VRX:CT,BBG000DC8S17,These 3 Hedge Funds Are Playing With Fire,2017-02-15 15:49:05 +0000,http://www.fool.com/investing/2017/02/15/these-3-hedge-funds-are-playing-with-fire.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Hedge Funds Are Playing With Fire
VRX,VRX:US,BBG000DLFM21,These 3 Hedge Funds Are Playing With Fire,2017-02-15 15:49:05 +0000,http://www.fool.com/investing/2017/02/15/these-3-hedge-funds-are-playing-with-fire.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Hedge Funds Are Playing With Fire
VRX,VRX:CT,BBG000DC8S17,Eli Lilly Is Great Stock to Buy Now,2017-02-15 15:42:00 +0000,https://www.thestreet.com/story/14002149/1/eli-lilly-is-great-stock-to-buy-now.html?puc=yahoo&cm_ven=YAHOO,Eli Lilly Is Great Stock to Buy Now
VRX,VRX:US,BBG000DLFM21,Eli Lilly Is Great Stock to Buy Now,2017-02-15 15:42:00 +0000,https://www.thestreet.com/story/14002149/1/eli-lilly-is-great-stock-to-buy-now.html?puc=yahoo&cm_ven=YAHOO,Eli Lilly Is Great Stock to Buy Now
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Extending Recent Gains - Canadian Commentary,2017-02-15 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NbApSEYGcJ8/canadian-stocks-are-extending-recent-gains--canadian-commentary-20170215-00907,Canadian Stocks Are Extending Recent Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Extending Recent Gains - Canadian Commentary,2017-02-15 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NbApSEYGcJ8/canadian-stocks-are-extending-recent-gains--canadian-commentary-20170215-00907,Canadian Stocks Are Extending Recent Gains - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Ackman boosted Chipotle holdings, pared Valeant in 4th quarter",2017-02-14 22:24:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=960FE67C-5D96-4862-BEAF-D932FC254F05&siteid=yhoof2,"Ackman boosted Chipotle holdings, pared Valeant in 4th quarter"
VRX,VRX:CT,BBG000DC8S17,"Ackman boosted Chipotle holdings, pared Valeant in 4th quarter",2017-02-14 22:24:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=960FE67C-5D96-4862-BEAF-D932FC254F05&siteid=yhoof2,"Ackman boosted Chipotle holdings, pared Valeant in 4th quarter"
VRX,VRX:CT,BBG000DC8S17,Valeant: Why $3.75 Billion is the Most Important Number,2017-02-14 15:39:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/14/valeant-why-3-75-billion-is-the-most-important-number/?mod=yahoobarrons&ru=yahoo,Valeant: Why $3.75 Billion is the Most Important Number
VRX,VRX:US,BBG000DLFM21,Valeant: Why $3.75 Billion is the Most Important Number,2017-02-14 15:39:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/14/valeant-why-3-75-billion-is-the-most-important-number/?mod=yahoobarrons&ru=yahoo,Valeant: Why $3.75 Billion is the Most Important Number
VRX,VRX:CT,BBG000DC8S17,"Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit",2017-02-14 14:24:00 +0000,https://www.thestreet.com/story/14001319/1/valeant-pershing-square-will-split-legal-costs-on-allergan-lawsuit.html?puc=yahoo&cm_ven=YAHOO,"Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit"
VRX,VRX:US,BBG000DLFM21,"Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit",2017-02-14 14:24:00 +0000,https://www.thestreet.com/story/14001319/1/valeant-pershing-square-will-split-legal-costs-on-allergan-lawsuit.html?puc=yahoo&cm_ven=YAHOO,"Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Pulling Back After Recent Run Up - Canadian Commentary,2017-02-14 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AR0ss0vJuXU/canadian-stocks-are-pulling-back-after-recent-run-up--canadian-commentary-20170214-00948,Canadian Stocks Are Pulling Back After Recent Run Up - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Pulling Back After Recent Run Up - Canadian Commentary,2017-02-14 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AR0ss0vJuXU/canadian-stocks-are-pulling-back-after-recent-run-up--canadian-commentary-20170214-00948,Canadian Stocks Are Pulling Back After Recent Run Up - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Participate At Healthcare Conferences,2017-02-13 22:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-healthcare-conferences-220000385.html,"[PR Newswire] - LAVAL, Quebec, Feb. 13, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, Chairman and CEO, will participate in the following ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Participate At Healthcare Conferences,2017-02-13 22:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-healthcare-conferences-220000748.html,[CNW Group] - Valeant Pharmaceuticals To Participate At Healthcare Conferences
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Participate At Healthcare Conferences,2017-02-13 22:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-healthcare-conferences-220000748.html,[CNW Group] - Valeant Pharmaceuticals To Participate At Healthcare Conferences
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Participate At Healthcare Conferences,2017-02-13 22:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-healthcare-conferences-220000385.html,"[PR Newswire] - LAVAL, Quebec, Feb. 13, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, Chairman and CEO, will participate in the following ..."
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement",2017-02-13 21:34:45 +0000,http://biz.yahoo.com/e/170213/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement",2017-02-13 21:34:45 +0000,http://biz.yahoo.com/e/170213/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up Slightly At The Start Of The Week - Canadian Commentary,2017-02-13 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/II30v_-vNGE/canadian-stocks-are-up-slightly-at-the-start-of-the-week--canadian-commentary-20170213-00846,Canadian Stocks Are Up Slightly At The Start Of The Week - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up Slightly At The Start Of The Week - Canadian Commentary,2017-02-13 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/II30v_-vNGE/canadian-stocks-are-up-slightly-at-the-start-of-the-week--canadian-commentary-20170213-00846,Canadian Stocks Are Up Slightly At The Start Of The Week - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceutcials: I Guess That's Why They Call It 'Equal Weight',2017-02-10 18:58:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/10/valeant-pharmaceutcials-i-guess-thats-why-they-call-it-equal-weight/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceutcials: I Guess That's Why They Call It 'Equal Weight'
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceutcials: I Guess That's Why They Call It 'Equal Weight',2017-02-10 18:58:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/10/valeant-pharmaceutcials-i-guess-thats-why-they-call-it-equal-weight/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceutcials: I Guess That's Why They Call It 'Equal Weight'
VRX,VRX:CT,BBG000DC8S17,The Important Lesson We Can All Learn From Valeant Pharmaceuticals,2017-02-09 17:20:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A2GsjETdBj0/the-important-lesson-we-can-all-learn-from-valeant-pharmaceuticals-cm745577,Arguably no company has been a bigger disappointment for investors since the summer of 2015 than drugmaker Valeant Pharmaceuticals NYSE VRX and that s a pretty bold statement considering that some companies seem to be spiraling out of control ahem Sears Holdings
VRX,VRX:US,BBG000DLFM21,The Important Lesson We Can All Learn From Valeant Pharmaceuticals,2017-02-09 17:20:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A2GsjETdBj0/the-important-lesson-we-can-all-learn-from-valeant-pharmaceuticals-cm745577,Arguably no company has been a bigger disappointment for investors since the summer of 2015 than drugmaker Valeant Pharmaceuticals NYSE VRX and that s a pretty bold statement considering that some companies seem to be spiraling out of control ahem Sears Holdings
VRX,VRX:US,BBG000DLFM21,The Important Lesson We Can All Learn From Valeant Pharmaceuticals,2017-02-09 15:49:05 +0000,http://www.fool.com/investing/2017/02/09/the-important-lesson-we-can-all-learn-from-valeant.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Important Lesson We Can All Learn From Valeant Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,The Important Lesson We Can All Learn From Valeant Pharmaceuticals,2017-02-09 15:49:05 +0000,http://www.fool.com/investing/2017/02/09/the-important-lesson-we-can-all-learn-from-valeant.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Important Lesson We Can All Learn From Valeant Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing As Energy Rebounds - Canadian Commentary,2017-02-09 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t0xCmlIFDLI/canadian-stocks-are-climbing-as-energy-rebounds--canadian-commentary-20170209-01096,Canadian Stocks Are Climbing As Energy Rebounds - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing As Energy Rebounds - Canadian Commentary,2017-02-09 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t0xCmlIFDLI/canadian-stocks-are-climbing-as-energy-rebounds--canadian-commentary-20170209-01096,Canadian Stocks Are Climbing As Energy Rebounds - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Valeant: Another Analyst Cuts Target, Stays Buy Rated Into Earnings",2017-02-08 14:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/08/valeant-another-analyst-cuts-target-stays-buy-rated-into-earnings/?mod=yahoobarrons&ru=yahoo,"Valeant: Another Analyst Cuts Target, Stays Buy Rated Into Earnings"
VRX,VRX:US,BBG000DLFM21,"Valeant: Another Analyst Cuts Target, Stays Buy Rated Into Earnings",2017-02-08 14:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/08/valeant-another-analyst-cuts-target-stays-buy-rated-into-earnings/?mod=yahoobarrons&ru=yahoo,"Valeant: Another Analyst Cuts Target, Stays Buy Rated Into Earnings"
VRX,VRX:CT,BBG000DC8S17,What Bill Miller Thinks about Valeant Pharmaceuticals,2017-02-08 12:36:57 +0000,http://marketrealist.com/2017/02/bill-miller-valeant-pharmaceuticals-providing-opportunity/?utm_source=yahoo&utm_medium=feed,What Bill Miller Thinks about Valeant Pharmaceuticals
VRX,VRX:US,BBG000DLFM21,What Bill Miller Thinks about Valeant Pharmaceuticals,2017-02-08 12:36:57 +0000,http://marketrealist.com/2017/02/bill-miller-valeant-pharmaceuticals-providing-opportunity/?utm_source=yahoo&utm_medium=feed,What Bill Miller Thinks about Valeant Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down On Energy Weakness - Canadian Commentary,2017-02-08 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XjqBuSdoJso/canadian-stocks-are-down-on-energy-weakness--canadian-commentary-20170208-00981,Canadian Stocks Are Down On Energy Weakness - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down On Energy Weakness - Canadian Commentary,2017-02-08 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XjqBuSdoJso/canadian-stocks-are-down-on-energy-weakness--canadian-commentary-20170208-00981,Canadian Stocks Are Down On Energy Weakness - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Should I Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-02-07 22:17:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P31fDpXeEGk/should-i-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons-cm744551,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When writing a pros cons article 160 on Valeant Pharmaceuticals Intl Inc NYSE VRX I admittedly 160 did not have much trouble coming up with the cons Let s face it the company has been an
VRX,VRX:US,BBG000DLFM21,"Should I Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-02-07 22:17:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P31fDpXeEGk/should-i-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons-cm744551,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When writing a pros cons article 160 on Valeant Pharmaceuticals Intl Inc NYSE VRX I admittedly 160 did not have much trouble coming up with the cons Let s face it the company has been an
VRX,VRX:US,BBG000DLFM21,"Ruane, Cunniff & Goldfarb's Sequoia Fund 4th Quarter Shareholder Letter",2017-02-07 17:20:58 +0000,http://finance.yahoo.com/news/ruane-cunniff-goldfarbs-sequoia-fund-172058898.html,"Ruane, Cunniff & Goldfarb's Sequoia Fund 4th Quarter Shareholder Letter"
VRX,VRX:CT,BBG000DC8S17,"Ruane, Cunniff & Goldfarb's Sequoia Fund 4th Quarter Shareholder Letter",2017-02-07 17:20:58 +0000,http://finance.yahoo.com/news/ruane-cunniff-goldfarbs-sequoia-fund-172058898.html,"Ruane, Cunniff & Goldfarb's Sequoia Fund 4th Quarter Shareholder Letter"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Worthy of Your Trust?,2017-02-07 15:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/07/valeant-pharmaceuticals-worthy-of-your-trust/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Worthy of Your Trust?
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Worthy of Your Trust?,2017-02-07 15:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/07/valeant-pharmaceuticals-worthy-of-your-trust/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Worthy of Your Trust?
VRX,VRX:CT,BBG000DC8S17,Perrigo says it has filed for FDA approval for a generic version of Valeant's acne gel,2017-02-07 13:24:12 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0EFC6E1D-A186-49BE-8EB7-E52970C48FA9&siteid=yhoof2,Perrigo says it has filed for FDA approval for a generic version of Valeant's acne gel
VRX,VRX:US,BBG000DLFM21,Perrigo says it has filed for FDA approval for a generic version of Valeant's acne gel,2017-02-07 13:24:12 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0EFC6E1D-A186-49BE-8EB7-E52970C48FA9&siteid=yhoof2,Perrigo says it has filed for FDA approval for a generic version of Valeant's acne gel
VRX,VRX:CT,BBG000DC8S17,Perrigo Files New Drug Application For Generic Version Of Onexton Gel,2017-02-07 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qwk0hur2XKo/perrigo-files-new-drug-application-for-generic-version-of-onexton-gel-20170207-00666,Perrigo Files New Drug Application For Generic Version Of Onexton Gel
VRX,VRX:US,BBG000DLFM21,Perrigo Files New Drug Application For Generic Version Of Onexton Gel,2017-02-07 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qwk0hur2XKo/perrigo-files-new-drug-application-for-generic-version-of-onexton-gel-20170207-00666,Perrigo Files New Drug Application For Generic Version Of Onexton Gel
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Finally Stabilize,2017-02-06 21:17:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CyOppkdnL50/why-valeant-pharmaceuticals-intl-inc-vrx-stock-will-finally-stabilize-cm743858,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When the President of the United States lightens his focus on high drug prices and instead looks at the whole Medicare system and its pricing structure for patient care as a whole well generic drug
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Finally Stabilize,2017-02-06 21:17:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CyOppkdnL50/why-valeant-pharmaceuticals-intl-inc-vrx-stock-will-finally-stabilize-cm743858,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When the President of the United States lightens his focus on high drug prices and instead looks at the whole Medicare system and its pricing structure for patient care as a whole well generic drug
VRX,VRX:CT,BBG000DC8S17,Twilio Inc (TWLO) Q4 Earnings Preview,2017-02-06 21:17:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U8cYbfBEMPU/twilio-inc-twlo-q4-earnings-preview-cm743852,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips To say Twilio Inc NYSE TWLO has taken investors on something of a roller coaster ride over the course the past eight months would be a considerable understatement Twilio stock rallied from its
VRX,VRX:US,BBG000DLFM21,Twilio Inc (TWLO) Q4 Earnings Preview,2017-02-06 21:17:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U8cYbfBEMPU/twilio-inc-twlo-q4-earnings-preview-cm743852,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips To say Twilio Inc NYSE TWLO has taken investors on something of a roller coaster ride over the course the past eight months would be a considerable understatement Twilio stock rallied from its
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals: Why This Earnings Report is Really, Really Important",2017-02-06 16:53:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/06/valeant-pharmaceuticals-why-this-earnings-report-is-really-really-important/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Why This Earnings Report is Really, Really Important"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals: Why This Earnings Report is Really, Really Important",2017-02-06 16:53:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/06/valeant-pharmaceuticals-why-this-earnings-report-is-really-really-important/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Why This Earnings Report is Really, Really Important"
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals' Rebound Fizzled,2017-02-06 11:45:01 +0000,http://www.fool.com/investing/2017/02/05/why-valeant-pharmaceuticals-rebound-fizzled.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Valeant Pharmaceuticals' Rebound Fizzled
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals' Rebound Fizzled,2017-02-06 11:45:01 +0000,http://www.fool.com/investing/2017/02/05/why-valeant-pharmaceuticals-rebound-fizzled.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Valeant Pharmaceuticals' Rebound Fizzled
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-02-06 10:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lcT_7SP5pT4/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170206-00825,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-02-06 10:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lcT_7SP5pT4/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170206-00825,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals' Rebound Fizzled,2017-02-05 13:18:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q9iuae7Qnd8/why-valeant-pharmaceuticals-rebound-fizzled-cm743337,For a few weeks in January Valeant Pharmaceuticals NYSE VRX stock outperformed the S amp P 500 index The run didn t last long though Here s why Valeant s rebound quickly fizzled Anatomy of a letdown The first phase of Valeant s failed rebound started with the stock
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals' Rebound Fizzled,2017-02-05 13:18:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q9iuae7Qnd8/why-valeant-pharmaceuticals-rebound-fizzled-cm743337,For a few weeks in January Valeant Pharmaceuticals NYSE VRX stock outperformed the S amp P 500 index The run didn t last long though Here s why Valeant s rebound quickly fizzled Anatomy of a letdown The first phase of Valeant s failed rebound started with the stock
VRX,VRX:CT,BBG000DC8S17,"How Options Traders Nailed Amazon.com, Inc. (AMZN) Earnings",2017-02-03 20:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-6qO-4cP-K8/how-options-traders-nailed-amazoncom-inc-amzn-earnings-cm743152,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips In a market known for its power of perfect pricing nowhere is that more obvious than in Amazon com Inc NASDAQ AMZN But if you re looking for answers from AMZN stock that s only one half of
VRX,VRX:US,BBG000DLFM21,"How Options Traders Nailed Amazon.com, Inc. (AMZN) Earnings",2017-02-03 20:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-6qO-4cP-K8/how-options-traders-nailed-amazoncom-inc-amzn-earnings-cm743152,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips In a market known for its power of perfect pricing nowhere is that more obvious than in Amazon com Inc NASDAQ AMZN But if you re looking for answers from AMZN stock that s only one half of
VRX,VRX:US,BBG000DLFM21,Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics,2017-02-03 17:52:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Wf2WPrqwLQ/mercks-sneak-peek-into-its-drug-pricing-may-not-be-enough-to-satisfy-skeptics-cm742998,Image source Getty Images Welcome to 2017 where price transparency has become a top priority for drug developers following the targeting of Valeant Pharmaceuticals NYSE VRX and Mylan NASDAQ MYL for their pricing practices last year For those who may not
VRX,VRX:CT,BBG000DC8S17,Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics,2017-02-03 17:52:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Wf2WPrqwLQ/mercks-sneak-peek-into-its-drug-pricing-may-not-be-enough-to-satisfy-skeptics-cm742998,Image source Getty Images Welcome to 2017 where price transparency has become a top priority for drug developers following the targeting of Valeant Pharmaceuticals NYSE VRX and Mylan NASDAQ MYL for their pricing practices last year For those who may not
VRX,VRX:CT,BBG000DC8S17,Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics,2017-02-03 15:23:08 +0000,http://www.fool.com/investing/2017/02/03/mercks-sneak-peek-into-its-drug-pricing-may-not-be.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics
VRX,VRX:US,BBG000DLFM21,Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics,2017-02-03 15:23:08 +0000,http://www.fool.com/investing/2017/02/03/mercks-sneak-peek-into-its-drug-pricing-may-not-be.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Merck's Sneak Peek Into Its Drug Pricing May Not Be Enough to Satisfy Skeptics
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising After Strong U.S. Jobs Report - Canadian Commentary,2017-02-03 10:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YUq5rZnF6Dg/canadian-stocks-are-rising-after-strong-us-jobs-report--canadian-commentary-20170203-00647,Canadian Stocks Are Rising After Strong U.S. Jobs Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising After Strong U.S. Jobs Report - Canadian Commentary,2017-02-03 10:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YUq5rZnF6Dg/canadian-stocks-are-rising-after-strong-us-jobs-report--canadian-commentary-20170203-00647,Canadian Stocks Are Rising After Strong U.S. Jobs Report - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Short Seller Picks Next Target,2017-02-03 00:36:53 +0000,http://finance.yahoo.com/video/valeant-short-seller-picks-next-003653567.html,Valeant Short Seller Picks Next Target
VRX,VRX:CT,BBG000DC8S17,Valeant Short Seller Picks Next Target,2017-02-03 00:36:53 +0000,http://finance.yahoo.com/video/valeant-short-seller-picks-next-003653567.html,Valeant Short Seller Picks Next Target
VRX,VRX:CT,BBG000DC8S17,Warning: Don’t Sell Nvidia Corporation (NVDA) Stock Short!,2017-02-02 23:32:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UYD9FgxZAms/warning-dont-sell-nvidia-corporation-nvda-stock-short-cm742603,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Nvidia Corporation NASDAQ NVDA whose shares spiked 224 in 2016 has been lethal for short sellers They lost a stunning 4 4 billion And yes it will probably still be bad for them to
VRX,VRX:US,BBG000DLFM21,Warning: Don’t Sell Nvidia Corporation (NVDA) Stock Short!,2017-02-02 23:32:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UYD9FgxZAms/warning-dont-sell-nvidia-corporation-nvda-stock-short-cm742603,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Nvidia Corporation NASDAQ NVDA whose shares spiked 224 in 2016 has been lethal for short sellers They lost a stunning 4 4 billion And yes it will probably still be bad for them to
VRX,VRX:CT,BBG000DC8S17,7 Stocks You Should Sell Right Now,2017-02-02 14:50:02 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S015-7-stocks-you-should-sell-right-now/index.html?rid=SYN-yahoo&rpageid=16172,7 Stocks You Should Sell Right Now
VRX,VRX:US,BBG000DLFM21,7 Stocks You Should Sell Right Now,2017-02-02 14:50:02 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S015-7-stocks-you-should-sell-right-now/index.html?rid=SYN-yahoo&rpageid=16172,7 Stocks You Should Sell Right Now
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-02-02 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5jMWXJeLjoY/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170202-01046,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-02-02 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5jMWXJeLjoY/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170202-01046,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals",2017-02-01 16:35:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WJiBKnPfQLo/the-zacks-analyst-blog-highlights-synergy-pharmaceuticals-amgen-valeant-pharmaceuticals-international-celgene-and-lexicon-pharmaceuticals-cm741587,For Immediate Release Chicago IL February 01 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals",2017-02-01 16:35:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WJiBKnPfQLo/the-zacks-analyst-blog-highlights-synergy-pharmaceuticals-amgen-valeant-pharmaceuticals-international-celgene-and-lexicon-pharmaceuticals-cm741587,For Immediate Release Chicago IL February 01 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRX,VRX:US,BBG000DLFM21,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals",2017-02-01 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-synergy-143002700.html,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals"
VRX,VRX:CT,BBG000DC8S17,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals",2017-02-01 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-synergy-143002700.html,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Gold Weakens - Canadian Commentary,2017-02-01 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sJZTG5crSBw/canadian-stocks-are-falling-as-gold-weakens--canadian-commentary-20170201-00986,Canadian Stocks Are Falling As Gold Weakens - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Gold Weakens - Canadian Commentary,2017-02-01 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sJZTG5crSBw/canadian-stocks-are-falling-as-gold-weakens--canadian-commentary-20170201-00986,Canadian Stocks Are Falling As Gold Weakens - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,The Short Seller Who Crushed Valeant Has Picked His Next Target,2017-02-01 10:00:01 +0000,http://www.bloomberg.com/news/articles/2017-02-01/stock-s-up-1-500-ceo-s-flush-and-andrew-left-sees-a-big-bubble?cmpid=yhoo.headline,The Short Seller Who Crushed Valeant Has Picked His Next Target
VRX,VRX:CT,BBG000DC8S17,The Short Seller Who Crushed Valeant Has Picked His Next Target,2017-02-01 10:00:01 +0000,http://www.bloomberg.com/news/articles/2017-02-01/stock-s-up-1-500-ceo-s-flush-and-andrew-left-sees-a-big-bubble?cmpid=yhoo.headline,The Short Seller Who Crushed Valeant Has Picked His Next Target
VRX,VRX:US,BBG000DLFM21,4 FDA Decisions to Watch Out for in Feb 2017,2017-01-31 13:33:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fs_oSg_FQn8/4-fda-decisions-to-watch-out-for-in-feb-2017-cm740607,Last year there was a notable dip in FDA novel drug approvals with the agency giving its nod to 22 treatments well below the 45 approvals in 2015 and 41 in 2014 So far in 2017 only one drug has gained approval Synergy Pharmaceuticals Inc s SGYP Trulance for the treatment of
VRX,VRX:CT,BBG000DC8S17,4 FDA Decisions to Watch Out for in Feb 2017,2017-01-31 13:33:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fs_oSg_FQn8/4-fda-decisions-to-watch-out-for-in-feb-2017-cm740607,Last year there was a notable dip in FDA novel drug approvals with the agency giving its nod to 22 treatments well below the 45 approvals in 2015 and 41 in 2014 So far in 2017 only one drug has gained approval Synergy Pharmaceuticals Inc s SGYP Trulance for the treatment of
VRX,VRX:US,BBG000DLFM21,4 FDA Decisions to Watch Out for in Feb 2017,2017-01-31 11:43:11 +0000,http://finance.yahoo.com/news/4-fda-decisions-watch-feb-114311066.html,4 FDA Decisions to Watch Out for in Feb 2017
VRX,VRX:CT,BBG000DC8S17,4 FDA Decisions to Watch Out for in Feb 2017,2017-01-31 11:43:11 +0000,http://finance.yahoo.com/news/4-fda-decisions-watch-feb-114311066.html,4 FDA Decisions to Watch Out for in Feb 2017
VRX,VRX:CT,BBG000DC8S17,Valeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance,2017-01-30 21:30:00 +0000,http://finance.yahoo.com/news/valeant-hold-conference-call-present-213000265.html,"[PR Newswire] - LAVAL, Quebec, Jan. 30, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (""Valeant"" or the ""Company"") today announced that it plans to hold a ..."
VRX,VRX:US,BBG000DLFM21,Valeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance,2017-01-30 21:30:00 +0000,http://finance.yahoo.com/news/valeant-hold-conference-call-present-213000265.html,"[PR Newswire] - LAVAL, Quebec, Jan. 30, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (""Valeant"" or the ""Company"") today announced that it plans to hold a ..."
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals' Turnaround Finally in the Cards?,2017-01-30 19:32:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6qc5xjoAGvg/is-valeant-pharmaceuticals-turnaround-finally-in-the-cards-cm740386,Image source Getty Images There are no two ways about it Embattled drug company Valeant Pharmaceuticals NYSE VRX had a miserable 2016 ending the year down by 86 Even worse between the summer of 2015 and the end of 2016 Valeant s share price had fallen by about 94
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals' Turnaround Finally in the Cards?,2017-01-30 19:32:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6qc5xjoAGvg/is-valeant-pharmaceuticals-turnaround-finally-in-the-cards-cm740386,Image source Getty Images There are no two ways about it Embattled drug company Valeant Pharmaceuticals NYSE VRX had a miserable 2016 ending the year down by 86 Even worse between the summer of 2015 and the end of 2016 Valeant s share price had fallen by about 94
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals' Turnaround Finally in the Cards?,2017-01-30 18:12:59 +0000,http://www.fool.com/investing/2017/01/30/is-valeant-pharmaceuticals-turnaround-finally-in-t.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals' Turnaround Finally in the Cards?
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals' Turnaround Finally in the Cards?,2017-01-30 18:12:59 +0000,http://www.fool.com/investing/2017/01/30/is-valeant-pharmaceuticals-turnaround-finally-in-t.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals' Turnaround Finally in the Cards?
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: A Challenging Setup?,2017-01-30 16:16:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/30/valeant-pharmaceuticals-a-challenging-setup/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: A Challenging Setup?
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: A Challenging Setup?,2017-01-30 16:16:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/30/valeant-pharmaceuticals-a-challenging-setup/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: A Challenging Setup?
VRX,VRX:US,BBG000DLFM21,Peek Under The Hood: PPH Has 23% Upside,2017-01-30 15:32:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2TTg-l3Wnd4/peek-under-the-hood-pph-has-23-upside-cm740043,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
VRX,VRX:CT,BBG000DC8S17,Peek Under The Hood: PPH Has 23% Upside,2017-01-30 15:32:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2TTg-l3Wnd4/peek-under-the-hood-pph-has-23-upside-cm740043,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary,2017-01-30 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7eONqE7HMLU/canadian-stocks-are-sinking-at-the-start-of-the-week--canadian-commentary-20170130-00743,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary,2017-01-30 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLqAQGSN4ik/canadian-stocks-are-sinking-at-the-start-of-the-week--canadian-commentary-20170130-00744,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary,2017-01-30 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLqAQGSN4ik/canadian-stocks-are-sinking-at-the-start-of-the-week--canadian-commentary-20170130-00744,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary,2017-01-30 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7eONqE7HMLU/canadian-stocks-are-sinking-at-the-start-of-the-week--canadian-commentary-20170130-00743,Canadian Stocks Are Sinking At The Start Of The Week - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Dow Jones Industrial Average Snags First Weekly Finish Above 20K,2017-01-27 22:31:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f1-0izoH0t0/dow-jones-industrial-average-snags-first-weekly-finish-above-20k-cm739637,After starting the session on modest gains the 160 Dow Jones Industrial Average DJIA fell back below Thursday s close as traders digested the latest round of economic data and blue chip earnings Weighing on stocks was a lower than expected reading for fourth quarter gross
VRX,VRX:US,BBG000DLFM21,Dow Jones Industrial Average Snags First Weekly Finish Above 20K,2017-01-27 22:31:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f1-0izoH0t0/dow-jones-industrial-average-snags-first-weekly-finish-above-20k-cm739637,After starting the session on modest gains the 160 Dow Jones Industrial Average DJIA fell back below Thursday s close as traders digested the latest round of economic data and blue chip earnings Weighing on stocks was a lower than expected reading for fourth quarter gross
VRX,VRX:US,BBG000DLFM21,"Pershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance",2017-01-27 17:49:13 +0000,http://finance.yahoo.com/news/pershing-square-defends-valeants-progress-174913090.html,"Pershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance"
VRX,VRX:CT,BBG000DC8S17,"Pershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance",2017-01-27 17:49:13 +0000,http://finance.yahoo.com/news/pershing-square-defends-valeants-progress-174913090.html,"Pershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary,2017-01-27 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1AoTdtB5uec/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20170127-00618,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary,2017-01-27 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1AoTdtB5uec/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20170127-00618,Canadian Stocks Have Slipped Into Negative Territory - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Stock Rises 5% on Possible Asset Sales,2017-01-26 17:27:00 +0000,http://www.investopedia.com/news/valeant-stock-rises-5-possible-asset-sales-vrx/?partner=YahooSA,Valeant Stock Rises 5% on Possible Asset Sales
VRX,VRX:CT,BBG000DC8S17,Valeant Stock Rises 5% on Possible Asset Sales,2017-01-26 17:27:00 +0000,http://www.investopedia.com/news/valeant-stock-rises-5-possible-asset-sales-vrx/?partner=YahooSA,Valeant Stock Rises 5% on Possible Asset Sales
VRX,VRX:CT,BBG000DC8S17,"Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day",2017-01-26 16:35:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tGKLh7x6GNw/broadcom-valeant-pharmaceuticals-apple-amazon-and-netflix-highlighted-as-zacks-bull-and-bear-of-the-day-broadcom-valeant-pharmaceuticals-apple-amazon-and-netflix-highlighted-as-zacks-bull-and-bear-of-the-day-cm738707,For Immediate Release Chicago IL January 26 2017 Zacks Equity Research highlights Broadcom NASDAQ AVGO Free Report as the Bull of the Day and Valeant Pharmaceuticals NYSE VRX Free Report as the Bear of the Day In addition Zacks Equity Research
VRX,VRX:US,BBG000DLFM21,"Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day",2017-01-26 16:35:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tGKLh7x6GNw/broadcom-valeant-pharmaceuticals-apple-amazon-and-netflix-highlighted-as-zacks-bull-and-bear-of-the-day-broadcom-valeant-pharmaceuticals-apple-amazon-and-netflix-highlighted-as-zacks-bull-and-bear-of-the-day-cm738707,For Immediate Release Chicago IL January 26 2017 Zacks Equity Research highlights Broadcom NASDAQ AVGO Free Report as the Bull of the Day and Valeant Pharmaceuticals NYSE VRX Free Report as the Bear of the Day In addition Zacks Equity Research
VRX,VRX:CT,BBG000DC8S17,Bear of the Day: Valeant Pharmaceuticals (VRX),2017-01-26 14:35:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pWPhoZ4PP64/bear-of-the-day-valeant-pharmaceuticals-vrx-cm738651,I don t enjoy kicking this once beloved company when it s down but Valeant Pharmaceuticals VRX has it coming again as earnings estimates slip In the past week another investment bank revised lower their EPS projection for this year knocking the the Zacks Consensus down to 5 17
VRX,VRX:US,BBG000DLFM21,Bear of the Day: Valeant Pharmaceuticals (VRX),2017-01-26 14:35:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pWPhoZ4PP64/bear-of-the-day-valeant-pharmaceuticals-vrx-cm738651,I don t enjoy kicking this once beloved company when it s down but Valeant Pharmaceuticals VRX has it coming again as earnings estimates slip In the past week another investment bank revised lower their EPS projection for this year knocking the the Zacks Consensus down to 5 17
VRX,VRX:US,BBG000DLFM21,"Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day",2017-01-26 14:30:02 +0000,http://finance.yahoo.com/news/broadcom-valeant-pharmaceuticals-apple-amazon-143002926.html,"Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day"
VRX,VRX:CT,BBG000DC8S17,"Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day",2017-01-26 14:30:02 +0000,http://finance.yahoo.com/news/broadcom-valeant-pharmaceuticals-apple-amazon-143002926.html,"Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day Broadcom, Valeant Pharmaceuticals, Apple, Amazon and Netflix highlighted as Zacks Bull and Bear of the Day"
VRX,VRX:CT,BBG000DC8S17,Bear of the Day: Valeant Pharmaceuticals (VRX),2017-01-26 12:00:12 +0000,http://finance.yahoo.com/news/bear-day-valeant-pharmaceuticals-vrx-120012015.html,Bear of the Day: Valeant Pharmaceuticals (VRX)
VRX,VRX:US,BBG000DLFM21,Bear of the Day: Valeant Pharmaceuticals (VRX),2017-01-26 12:00:12 +0000,http://finance.yahoo.com/news/bear-day-valeant-pharmaceuticals-vrx-120012015.html,Bear of the Day: Valeant Pharmaceuticals (VRX)
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-01-26 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7BwhZpc2fpA/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170126-01002,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary,2017-01-26 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7BwhZpc2fpA/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20170126-01002,Canadian Stocks Are Struggling To Find Direction - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Biotech Stocks Facing FDA Decision In February,2017-01-26 04:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dqQ5wiKja1s/biotech-stocks-facing-fda-decision-in-february-20170126-00181,Biotech Stocks Facing FDA Decision In February
VRX,VRX:CT,BBG000DC8S17,Biotech Stocks Facing FDA Decision In February,2017-01-26 04:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dqQ5wiKja1s/biotech-stocks-facing-fda-decision-in-february-20170126-00181,Biotech Stocks Facing FDA Decision In February
VRX,VRX:CT,BBG000DC8S17,10.8% of ACTX Holdings Seeing Recent Insider Buys,2017-01-25 15:31:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x65RQs0Sc8c/108-of-actx-holdings-seeing-recent-insider-buys-cm737993,A look at the weighted underlying holdings of the Guru Activist Index ETF Symbol ACTX shows an impressive 10 8 of holdings on a weighted basis have experienced insider buying within the past six months Restaurant Brands International Inc Symbol QSR which makes up 2 32 of the
VRX,VRX:US,BBG000DLFM21,10.8% of ACTX Holdings Seeing Recent Insider Buys,2017-01-25 15:31:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x65RQs0Sc8c/108-of-actx-holdings-seeing-recent-insider-buys-cm737993,A look at the weighted underlying holdings of the Guru Activist Index ETF Symbol ACTX shows an impressive 10 8 of holdings on a weighted basis have experienced insider buying within the past six months Restaurant Brands International Inc Symbol QSR which makes up 2 32 of the
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up As Global Markets Rally - Canadian Commentary,2017-01-25 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zb7VBiedKiE/canadian-stocks-are-up-as-global-markets-rally--canadian-commentary-20170125-00837,Canadian Stocks Are Up As Global Markets Rally - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up As Global Markets Rally - Canadian Commentary,2017-01-25 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zb7VBiedKiE/canadian-stocks-are-up-as-global-markets-rally--canadian-commentary-20170125-00837,Canadian Stocks Are Up As Global Markets Rally - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Options Insight: How to Play Valeant,2017-01-24 20:46:09 +0000,http://finance.yahoo.com/video/options-insight-play-valeant-204609177.html,Options Insight: How to Play Valeant
VRX,VRX:US,BBG000DLFM21,Options Insight: How to Play Valeant,2017-01-24 20:46:09 +0000,http://finance.yahoo.com/video/options-insight-play-valeant-204609177.html,Options Insight: How to Play Valeant
VRX,VRX:CT,BBG000DC8S17,"Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-01-24 17:31:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AqHEnsFTpPI/should-you-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons-cm737379,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has imploded over the past 18 months VRX stock is down nearly 95 since it peaked in 2015 The company has made a fool of many famous investors
VRX,VRX:US,BBG000DLFM21,"Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-01-24 17:31:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AqHEnsFTpPI/should-you-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons-cm737379,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has imploded over the past 18 months VRX stock is down nearly 95 since it peaked in 2015 The company has made a fool of many famous investors
VRX,VRX:US,BBG000DLFM21,New Strong Sell Stocks for January 24th,2017-01-24 16:36:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9QPVzexnRvk/new-strong-sell-stocks-for-january-24th-cm737362,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today iRobot Corporation IRBT designs builds and sells robots for the consumer market worldwide The Zacks Consensus Estimate for its current year earnings has been revised 4 3 downward over the last 30 days
VRX,VRX:CT,BBG000DC8S17,New Strong Sell Stocks for January 24th,2017-01-24 16:36:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9QPVzexnRvk/new-strong-sell-stocks-for-january-24th-cm737362,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today iRobot Corporation IRBT designs builds and sells robots for the consumer market worldwide The Zacks Consensus Estimate for its current year earnings has been revised 4 3 downward over the last 30 days
VRX,VRX:CT,BBG000DC8S17,Exxon Mobil Corporation (XOM) Stock Catches Permian Fever,2017-01-24 14:31:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BHX1LBRjEwM/exxon-mobil-corporation-xom-stock-catches-permian-fever-cm737152,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Exxon Mobil Corporation NYSE XOM was busy over the last few days writing some big checks And no I m not talking about finalizing outgoing CEO Rex Tillerson s pay and severance package We re
VRX,VRX:US,BBG000DLFM21,Exxon Mobil Corporation (XOM) Stock Catches Permian Fever,2017-01-24 14:31:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BHX1LBRjEwM/exxon-mobil-corporation-xom-stock-catches-permian-fever-cm737152,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Exxon Mobil Corporation NYSE XOM was busy over the last few days writing some big checks And no I m not talking about finalizing outgoing CEO Rex Tillerson s pay and severance package We re
VRX,VRX:US,BBG000DLFM21,New Strong Sell Stocks for January 24th,2017-01-24 14:16:02 +0000,http://finance.yahoo.com/news/strong-sell-stocks-january-24th-141602948.html,New Strong Sell Stocks for January 24th
VRX,VRX:CT,BBG000DC8S17,New Strong Sell Stocks for January 24th,2017-01-24 14:16:02 +0000,http://finance.yahoo.com/news/strong-sell-stocks-january-24th-141602948.html,New Strong Sell Stocks for January 24th
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Resource Strength - Canadian Commentary,2017-01-24 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m9mnmgKNSbc/canadian-stocks-are-rising-on-resource-strength--canadian-commentary-20170124-00913,Canadian Stocks Are Rising On Resource Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Resource Strength - Canadian Commentary,2017-01-24 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m9mnmgKNSbc/canadian-stocks-are-rising-on-resource-strength--canadian-commentary-20170124-00913,Canadian Stocks Are Rising On Resource Strength - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Analysts dismiss Citron's sour take on TransDigm,2017-01-23 19:45:00 +0000,https://www.thestreet.com/story/13962492/1/analysts-dismiss-citron-s-sour-take-on-transdigm.html?puc=yahoo&cm_ven=YAHOO,Analysts dismiss Citron's sour take on TransDigm
VRX,VRX:CT,BBG000DC8S17,Analysts dismiss Citron's sour take on TransDigm,2017-01-23 19:45:00 +0000,https://www.thestreet.com/story/13962492/1/analysts-dismiss-citron-s-sour-take-on-transdigm.html?puc=yahoo&cm_ven=YAHOO,Analysts dismiss Citron's sour take on TransDigm
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Weakening As Crude Oil Prices Fall - Canadian Commentary,2017-01-23 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eoFEcKz02cQ/canadian-stocks-are-weakening-as-crude-oil-prices-fall--canadian-commentary-20170123-00794,Canadian Stocks Are Weakening As Crude Oil Prices Fall - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Weakening As Crude Oil Prices Fall - Canadian Commentary,2017-01-23 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eoFEcKz02cQ/canadian-stocks-are-weakening-as-crude-oil-prices-fall--canadian-commentary-20170123-00794,Canadian Stocks Are Weakening As Crude Oil Prices Fall - Canadian Commentary
VRX,VRX:US,BBG000DLFM21,A Fond Farewell,2017-01-22 15:36:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O4EyIMdQGPM/a-fond-farewell-cm736434,In an article last year I used a quote by Seth Klarman Trades Portfolio that said investing was an arrogant act Having just published my 100th article here on GuruFocus it seems to me being a writer on value investing could fall under the same definition First one has to assume
VRX,VRX:CT,BBG000DC8S17,A Fond Farewell,2017-01-22 15:36:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O4EyIMdQGPM/a-fond-farewell-cm736434,In an article last year I used a quote by Seth Klarman Trades Portfolio that said investing was an arrogant act Having just published my 100th article here on GuruFocus it seems to me being a writer on value investing could fall under the same definition First one has to assume
VRX,VRX:CT,BBG000DC8S17,What Will Valeant Pharmaceuticals Sell Off Next?,2017-01-21 19:42:39 +0000,http://www.fool.com/investing/2017/01/20/what-will-valeant-pharmaceuticals-sell-off-next.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Will Valeant Pharmaceuticals Sell Off Next?
VRX,VRX:US,BBG000DLFM21,What Will Valeant Pharmaceuticals Sell Off Next?,2017-01-21 19:42:39 +0000,http://www.fool.com/investing/2017/01/20/what-will-valeant-pharmaceuticals-sell-off-next.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Will Valeant Pharmaceuticals Sell Off Next?
VRX,VRX:CT,BBG000DC8S17,A Fond Farewell,2017-01-21 19:20:04 +0000,http://finance.yahoo.com/news/fond-farewell-192004987.html,A Fond Farewell
VRX,VRX:US,BBG000DLFM21,A Fond Farewell,2017-01-21 19:20:04 +0000,http://finance.yahoo.com/news/fond-farewell-192004987.html,A Fond Farewell
VRX,VRX:CT,BBG000DC8S17,What Will Valeant Pharmaceuticals Sell Off Next?,2017-01-20 21:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GX6NLRB1Th4/what-will-valeant-pharmaceuticals-sell-off-next-cm736211,Believe it or not Valeant Pharmaceuticals NYSE VRX stock is actually outperforming the S amp P 500 160 so far in 2017 That s a far cry from the shellacking Valeant took last year losing 85 of its value Selling some of its assets is helping the drugmaker to take the
VRX,VRX:US,BBG000DLFM21,What Will Valeant Pharmaceuticals Sell Off Next?,2017-01-20 21:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GX6NLRB1Th4/what-will-valeant-pharmaceuticals-sell-off-next-cm736211,Believe it or not Valeant Pharmaceuticals NYSE VRX stock is actually outperforming the S amp P 500 160 so far in 2017 That s a far cry from the shellacking Valeant took last year losing 85 of its value Selling some of its assets is helping the drugmaker to take the
VRX,VRX:US,BBG000DLFM21,Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock,2017-01-20 20:31:00 +0000,https://www.thestreet.com/story/13960921/1/short-seller-andrew-left-says-trump-should-target-this-aerospace-stock.html?puc=yahoo&cm_ven=YAHOO,Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock
VRX,VRX:CT,BBG000DC8S17,Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock,2017-01-20 20:31:00 +0000,https://www.thestreet.com/story/13960921/1/short-seller-andrew-left-says-trump-should-target-this-aerospace-stock.html?puc=yahoo&cm_ven=YAHOO,Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock
VRX,VRX:CT,BBG000DC8S17,Why TransDigm Stock Tumbled 12% Today,2017-01-20 18:38:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XLVwf9r58T4/why-transdigm-stock-tumbled-12-today-cm736117,Analyst warns TransDigm stock could go down in flames IMAGE SOURCE GETTY IMAGES What happened Airplane parts supplier TransDigm Group Incorporated NYSE TDG is seeing its stock pummeled in early Friday trading down 12 as of 11 30 a m So what
VRX,VRX:US,BBG000DLFM21,Why TransDigm Stock Tumbled 12% Today,2017-01-20 18:38:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XLVwf9r58T4/why-transdigm-stock-tumbled-12-today-cm736117,Analyst warns TransDigm stock could go down in flames IMAGE SOURCE GETTY IMAGES What happened Airplane parts supplier TransDigm Group Incorporated NYSE TDG is seeing its stock pummeled in early Friday trading down 12 as of 11 30 a m So what
VRX,VRX:US,BBG000DLFM21,Profit From the Next Big Move in Valeant Pharmaceuticals Intl Inc (VRX) Stock,2017-01-20 17:39:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/38O87Z24F6Q/profit-from-the-next-big-move-in-valeant-pharmaceuticals-intl-inc-vrx-stock-cm736126,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The scandal and missteps of 2015 and 2016 may have faded but Valeant Pharmaceuticals Intl Inc NYSE VRX is still a wildcard for investors For traders wanting to position for a large price move
VRX,VRX:CT,BBG000DC8S17,Profit From the Next Big Move in Valeant Pharmaceuticals Intl Inc (VRX) Stock,2017-01-20 17:39:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/38O87Z24F6Q/profit-from-the-next-big-move-in-valeant-pharmaceuticals-intl-inc-vrx-stock-cm736126,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The scandal and missteps of 2015 and 2016 may have faded but Valeant Pharmaceuticals Intl Inc NYSE VRX is still a wildcard for investors For traders wanting to position for a large price move
VRX,VRX:CT,BBG000DC8S17,Why TransDigm Stock Tumbled 12% Today,2017-01-20 17:12:05 +0000,http://www.fool.com/investing/2017/01/20/why-transdigm-stock-tumbled-12-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why TransDigm Stock Tumbled 12% Today
VRX,VRX:US,BBG000DLFM21,Why TransDigm Stock Tumbled 12% Today,2017-01-20 17:12:05 +0000,http://www.fool.com/investing/2017/01/20/why-transdigm-stock-tumbled-12-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why TransDigm Stock Tumbled 12% Today
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-01-20 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Xy8XGAjn2Y/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170120-00547,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary,2017-01-20 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Xy8XGAjn2Y/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20170120-00547,Canadian Stocks Are Climbing On Energy Strength - Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids,2017-01-18 21:27:43 +0000,http://blogs.wsj.com/moneybeat/2017/01/18/dealpolitik-sec-tilts-playing-field-against-targets-of-hostile-bids/?mod=yahoo_hs,Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids
VRX,VRX:US,BBG000DLFM21,Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids,2017-01-18 21:27:43 +0000,http://blogs.wsj.com/moneybeat/2017/01/18/dealpolitik-sec-tilts-playing-field-against-targets-of-hostile-bids/?mod=yahoo_hs,Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids
VRX,VRX:CT,BBG000DC8S17,Short Sellers Now Fleeing Valeant Stock,2017-01-17 23:19:00 +0000,http://www.investopedia.com/news/short-sellers-now-fleeing-valeant-stock-vrx/?partner=YahooSA,Short Sellers Now Fleeing Valeant Stock
VRX,VRX:US,BBG000DLFM21,Short Sellers Now Fleeing Valeant Stock,2017-01-17 23:19:00 +0000,http://www.investopedia.com/news/short-sellers-now-fleeing-valeant-stock-vrx/?partner=YahooSA,Short Sellers Now Fleeing Valeant Stock
VRX,VRX:CT,BBG000DC8S17,[$$] Allergan Admits to Disclosure Violations During Valeant Bid,2017-01-17 22:49:55 +0000,http://www.wsj.com/articles/allergan-admits-to-disclosure-violations-during-valeant-bid-1484693391?mod=yahoo_hs,[$$] Allergan Admits to Disclosure Violations During Valeant Bid
VRX,VRX:US,BBG000DLFM21,[$$] Allergan Admits to Disclosure Violations During Valeant Bid,2017-01-17 22:49:55 +0000,http://www.wsj.com/articles/allergan-admits-to-disclosure-violations-during-valeant-bid-1484693391?mod=yahoo_hs,[$$] Allergan Admits to Disclosure Violations During Valeant Bid
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Eases Into the New Year,2017-01-17 21:44:00 +0000,http://www.investopedia.com/news/bill-ackman-eases-new-year-vrx/?partner=YahooSA,Bill Ackman Eases Into the New Year
VRX,VRX:US,BBG000DLFM21,Bill Ackman Eases Into the New Year,2017-01-17 21:44:00 +0000,http://www.investopedia.com/news/bill-ackman-eases-new-year-vrx/?partner=YahooSA,Bill Ackman Eases Into the New Year
VRX,VRX:CT,BBG000DC8S17,Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks,2017-01-17 21:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uamSiJLhw6E/allergan-to-pay-15-mln-fine-for-disclosure-failures-during-merger-talks-20170117-01757,Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks
VRX,VRX:US,BBG000DLFM21,Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks,2017-01-17 21:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uamSiJLhw6E/allergan-to-pay-15-mln-fine-for-disclosure-failures-during-merger-talks-20170117-01757,Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks
VRX,VRX:CT,BBG000DC8S17,Mario Gabelli on Viacom: Potential Growth in the Media Sector,2017-01-17 12:37:25 +0000,http://marketrealist.com/2017/01/mario-gabelli-viacom-potential-growth-media-sector/?utm_source=yahoo&utm_medium=feed,Mario Gabelli on Viacom: Potential Growth in the Media Sector
VRX,VRX:US,BBG000DLFM21,Mario Gabelli on Viacom: Potential Growth in the Media Sector,2017-01-17 12:37:25 +0000,http://marketrealist.com/2017/01/mario-gabelli-viacom-potential-growth-media-sector/?utm_source=yahoo&utm_medium=feed,Mario Gabelli on Viacom: Potential Growth in the Media Sector
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Dipping At The Start Of The Week -- Canadian Commentary,2017-01-16 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2EZjuiVuskI/canadian-stocks-are-dipping-at-the-start-of-the-week--canadian-commentary-20170116-00411,Canadian Stocks Are Dipping At The Start Of The Week -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Dipping At The Start Of The Week -- Canadian Commentary,2017-01-16 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2EZjuiVuskI/canadian-stocks-are-dipping-at-the-start-of-the-week--canadian-commentary-20170116-00411,Canadian Stocks Are Dipping At The Start Of The Week -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Will This Be a Genius or Foolish Move for Johnson & Johnson?,2017-01-13 21:39:47 +0000,http://www.fool.com/investing/2017/01/13/will-this-be-a-genius-or-foolish-move-for-johnson.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Will This Be a Genius or Foolish Move for Johnson & Johnson?
VRX,VRX:US,BBG000DLFM21,Will This Be a Genius or Foolish Move for Johnson & Johnson?,2017-01-13 21:39:47 +0000,http://www.fool.com/investing/2017/01/13/will-this-be-a-genius-or-foolish-move-for-johnson.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Will This Be a Genius or Foolish Move for Johnson & Johnson?
VRX,VRX:US,BBG000DLFM21,Will This Be a Genius or Foolish Move for Johnson & Johnson?,2017-01-13 15:39:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D14FvKnin5g/will-this-be-a-genius-or-foolish-move-for-johnson-johnson-cm733232,Image source Johnson amp Johnson For quite a few investors healthcare conglomerate Johnson amp Johnson NYSE JNJ is a portfolio staple Johnson amp Johnson is comprised of more than 250 different subsidiaries and three primary operating segments healthcare
VRX,VRX:CT,BBG000DC8S17,Will This Be a Genius or Foolish Move for Johnson & Johnson?,2017-01-13 15:39:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D14FvKnin5g/will-this-be-a-genius-or-foolish-move-for-johnson-johnson-cm733232,Image source Johnson amp Johnson For quite a few investors healthcare conglomerate Johnson amp Johnson NYSE JNJ is a portfolio staple Johnson amp Johnson is comprised of more than 250 different subsidiaries and three primary operating segments healthcare
VRX,VRX:US,BBG000DLFM21,The strange deal 2 drug makers had over a medicine with a skyrocketing price,2017-01-13 15:33:44 +0000,http://finance.yahoo.com/news/valeant-kadmon-wilsons-treatment-syprine-153344072.html,The strange deal 2 drug makers had over a medicine with a skyrocketing price
VRX,VRX:CT,BBG000DC8S17,The strange deal 2 drug makers had over a medicine with a skyrocketing price,2017-01-13 15:33:44 +0000,http://finance.yahoo.com/news/valeant-kadmon-wilsons-treatment-syprine-153344072.html,The strange deal 2 drug makers had over a medicine with a skyrocketing price
VRX,VRX:US,BBG000DLFM21,"Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News",2017-01-13 11:02:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-trump-targets-110211779.html,"Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News"
VRX,VRX:CT,BBG000DC8S17,"Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News",2017-01-13 11:02:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-trump-targets-110211779.html,"Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Bank Stocks Rally -- Canadian Commentary,2017-01-13 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IsLi3Kj9jLs/canadian-stocks-are-rising-as-bank-stocks-rally--canadian-commentary-20170113-00333,Canadian Stocks Are Rising As Bank Stocks Rally -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Bank Stocks Rally -- Canadian Commentary,2017-01-13 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IsLi3Kj9jLs/canadian-stocks-are-rising-as-bank-stocks-rally--canadian-commentary-20170113-00333,Canadian Stocks Are Rising As Bank Stocks Rally -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : January 12, 2017",2017-01-12 19:35:51 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-january-12-2017/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : January 12, 2017"
VRX,VRX:CT,BBG000DC8S17,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : January 12, 2017",2017-01-12 19:35:51 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-january-12-2017/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : January 12, 2017"
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead?,2017-01-12 16:33:08 +0000,http://www.insidermonkey.com/blog/is-valeant-pharmaceuticals-intl-inc-vrx-stock-back-from-the-dead-517117/,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead?
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead?,2017-01-12 16:33:08 +0000,http://www.insidermonkey.com/blog/is-valeant-pharmaceuticals-intl-inc-vrx-stock-back-from-the-dead-517117/,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead?
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : January 12, 2017",2017-01-12 15:19:23 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-january-12-2017/,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : January 12, 2017"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : January 12, 2017",2017-01-12 15:19:23 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-january-12-2017/,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : January 12, 2017"
VRX,VRX:CT,BBG000DC8S17,12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies,2017-01-12 14:37:24 +0000,http://www.insidermonkey.com/blog/12-health-benefits-of-medical-marijuana-according-to-publicly-traded-weed-companies-517034/,12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
VRX,VRX:US,BBG000DLFM21,12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies,2017-01-12 14:37:24 +0000,http://www.insidermonkey.com/blog/12-health-benefits-of-medical-marijuana-according-to-publicly-traded-weed-companies-517034/,12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
VRX,VRX:US,BBG000DLFM21,Trump criticism leads to falling stock prices at these Tampa employers,2017-01-12 12:35:07 +0000,http://www.bizjournals.com/tampabay/news/2017/01/12/trump-criticism-leads-to-falling-stock-prices-at.html?ana=yahoo,Trump criticism leads to falling stock prices at these Tampa employers
VRX,VRX:CT,BBG000DC8S17,Trump criticism leads to falling stock prices at these Tampa employers,2017-01-12 12:35:07 +0000,http://www.bizjournals.com/tampabay/news/2017/01/12/trump-criticism-leads-to-falling-stock-prices-at.html?ana=yahoo,Trump criticism leads to falling stock prices at these Tampa employers
VRX,VRX:CT,BBG000DC8S17,Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again,2017-01-12 12:15:12 +0000,http://finance.yahoo.com/news/deja-vu-drug-stocks-trump-121512876.html,Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
VRX,VRX:US,BBG000DLFM21,Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again,2017-01-12 12:15:12 +0000,http://finance.yahoo.com/news/deja-vu-drug-stocks-trump-121512876.html,Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
VRX,VRX:US,BBG000DLFM21,Valeant Streamlines Portfolio with Skincare Brands Sale,2017-01-11 23:57:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FLZL628lYxU/valeant-streamlines-portfolio-with-skincare-brands-sale-cm732490,Beleaguered Valeant Pharmaceuticals International Inc VRX announced that it has entered into an agreement to sell its CeraVe AcneFree and AMBI skincare brands to L Oréal for 1 3 billion in cash Shares of Valeant underperformed the Zacks classified Medical Drugs in the last 12
VRX,VRX:CT,BBG000DC8S17,Valeant Streamlines Portfolio with Skincare Brands Sale,2017-01-11 23:57:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FLZL628lYxU/valeant-streamlines-portfolio-with-skincare-brands-sale-cm732490,Beleaguered Valeant Pharmaceuticals International Inc VRX announced that it has entered into an agreement to sell its CeraVe AcneFree and AMBI skincare brands to L Oréal for 1 3 billion in cash Shares of Valeant underperformed the Zacks classified Medical Drugs in the last 12
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Separating Fact From Fiction,2017-01-11 22:57:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vFai2OSisnc/valeant-pharmaceuticals-separating-fact-from-fiction-cm732462,How much of what you think about Valeant Pharmaceuticals NYSE VRX is true Valeant CEO Joe Papa spoke at the J P Morgan Healthcare Conference on Wednesday and presented his view about where the company is now and where it s headed Papa s perspective differs from what
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Separating Fact From Fiction,2017-01-11 22:57:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vFai2OSisnc/valeant-pharmaceuticals-separating-fact-from-fiction-cm732462,How much of what you think about Valeant Pharmaceuticals NYSE VRX is true Valeant CEO Joe Papa spoke at the J P Morgan Healthcare Conference on Wednesday and presented his view about where the company is now and where it s headed Papa s perspective differs from what
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Separating Fact From Fiction,2017-01-11 21:54:07 +0000,http://www.fool.com/investing/2017/01/11/valeant-pharmaceuticals-separating-fact-from-ficti.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals: Separating Fact From Fiction
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Separating Fact From Fiction,2017-01-11 21:54:07 +0000,http://www.fool.com/investing/2017/01/11/valeant-pharmaceuticals-separating-fact-from-ficti.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals: Separating Fact From Fiction
VRX,VRX:CT,BBG000DC8S17,Valeant Streamlines Portfolio with Skincare Brands Sale,2017-01-11 21:42:09 +0000,http://finance.yahoo.com/news/valeant-streamlines-portfolio-skincare-brands-214209103.html,Valeant Streamlines Portfolio with Skincare Brands Sale
VRX,VRX:US,BBG000DLFM21,Valeant Streamlines Portfolio with Skincare Brands Sale,2017-01-11 21:42:09 +0000,http://finance.yahoo.com/news/valeant-streamlines-portfolio-skincare-brands-214209103.html,Valeant Streamlines Portfolio with Skincare Brands Sale
VRX,VRX:CT,BBG000DC8S17,Drug Stocks Tank As Trump Vows To Attack High Drug Prices,2017-01-11 21:21:47 +0000,http://www.investors.com/news/technology/drug-stocks-tank-as-trump-vows-to-attack-high-drug-prices/,Drug Stocks Tank As Trump Vows To Attack High Drug Prices
VRX,VRX:US,BBG000DLFM21,Drug Stocks Tank As Trump Vows To Attack High Drug Prices,2017-01-11 21:21:47 +0000,http://www.investors.com/news/technology/drug-stocks-tank-as-trump-vows-to-attack-high-drug-prices/,Drug Stocks Tank As Trump Vows To Attack High Drug Prices
VRX,VRX:US,BBG000DLFM21,Wednesday’s Top Biopharma Movers,2017-01-11 20:22:17 +0000,http://finance.yahoo.com/news/wednesday-top-biopharma-movers-202217751.html,Wednesday’s Top Biopharma Movers
VRX,VRX:CT,BBG000DC8S17,Wednesday’s Top Biopharma Movers,2017-01-11 20:22:17 +0000,http://finance.yahoo.com/news/wednesday-top-biopharma-movers-202217751.html,Wednesday’s Top Biopharma Movers
VRX,VRX:US,BBG000DLFM21,Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different,2017-01-11 19:51:00 +0000,https://www.thestreet.com/story/13949672/1/quot-the-new-valeant-quot.html?puc=yahoo&cm_ven=YAHOO,Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different
VRX,VRX:CT,BBG000DC8S17,Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different,2017-01-11 19:51:00 +0000,https://www.thestreet.com/story/13949672/1/quot-the-new-valeant-quot.html?puc=yahoo&cm_ven=YAHOO,Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts for Wednesday: Rite Aid Corporation (RAD), Valeant Pharmaceuticals Intl Inc (VRX) and Williams Companies Inc (WMB)",2017-01-11 18:57:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8W3TM4MdV0s/3-big-stock-charts-for-wednesday-rite-aid-corporation-rad-valeant-pharmaceuticals-intl-inc-vrx-and-williams-companies-inc-wmb-cm732377,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Trading remains tight as the market prepares for the fourth quarter earnings season to get off to its start Historically we look at this period as the set up for a late January and
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts for Wednesday: Rite Aid Corporation (RAD), Valeant Pharmaceuticals Intl Inc (VRX) and Williams Companies Inc (WMB)",2017-01-11 18:57:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8W3TM4MdV0s/3-big-stock-charts-for-wednesday-rite-aid-corporation-rad-valeant-pharmaceuticals-intl-inc-vrx-and-williams-companies-inc-wmb-cm732377,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Trading remains tight as the market prepares for the fourth quarter earnings season to get off to its start Historically we look at this period as the set up for a late January and
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Now Comes the Hard Part,2017-01-11 17:40:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-now-comes-the-hard-part/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Now Comes the Hard Part
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Now Comes the Hard Part,2017-01-11 17:40:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-now-comes-the-hard-part/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Now Comes the Hard Part
VRX,VRX:US,BBG000DLFM21,"Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons",2017-01-11 16:58:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1THeiswGjjE/should-you-buy-amgen-inc-amgn-stock-3-pros-3-cons-cm732201,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Last year 160 wasn t a great year for the biotech industry The sector was rocked by various price hike scandals These came under particular scrutiny as then frontrunner Hillary Clinton specifically went
VRX,VRX:CT,BBG000DC8S17,"Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons",2017-01-11 16:58:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1THeiswGjjE/should-you-buy-amgen-inc-amgn-stock-3-pros-3-cons-cm732201,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Last year 160 wasn t a great year for the biotech industry The sector was rocked by various price hike scandals These came under particular scrutiny as then frontrunner Hillary Clinton specifically went
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: 'A Long Road to Recovery',2017-01-11 15:15:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-a-long-road-to-recovery/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: 'A Long Road to Recovery'
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: 'A Long Road to Recovery',2017-01-11 15:15:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-a-long-road-to-recovery/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: 'A Long Road to Recovery'
VRX,VRX:US,BBG000DLFM21,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2017-01-11 15:01:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hf_KiLv8bLE/do-options-traders-know-something-about-valeant-pharmaceuticals-vrx-stock-we-dont-cm732155,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the January 20th 2017 27 50 Call had some of the highest implied volatility of all equity options today What is
VRX,VRX:CT,BBG000DC8S17,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2017-01-11 15:01:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hf_KiLv8bLE/do-options-traders-know-something-about-valeant-pharmaceuticals-vrx-stock-we-dont-cm732155,Investors in Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the January 20th 2017 27 50 Call had some of the highest implied volatility of all equity options today What is
VRX,VRX:CT,BBG000DC8S17,Latest Research Reports on Market Movers Valeant Pharmaceuticals and Chipotle Mexican Grill,2017-01-11 14:30:00 +0000,http://finance.yahoo.com/news/latest-research-reports-market-movers-143000748.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 11, 2017 / The Dow Jones Industrial Average dropped slightly Tuesday as the Index was dragged lower by declines from the energy sector. The Dow declined 31.85 points, ..."
VRX,VRX:US,BBG000DLFM21,Latest Research Reports on Market Movers Valeant Pharmaceuticals and Chipotle Mexican Grill,2017-01-11 14:30:00 +0000,http://finance.yahoo.com/news/latest-research-reports-market-movers-143000748.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 11, 2017 / The Dow Jones Industrial Average dropped slightly Tuesday as the Index was dragged lower by declines from the energy sector. The Dow declined 31.85 points, ..."
VRX,VRX:US,BBG000DLFM21,This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time,2017-01-11 13:52:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4SkRMTbP5iI/this-is-the-smartest-move-valeant-pharmaceuticals-has-made-in-a-really-long-time-cm731987,Image source Nguyen Hung Vu Flickr Finally the shareholders of Valeant Pharmaceuticals NYSE VRX have a genuine reason to cheer about the company As announced early Tuesday morning Valeant is selling some 2 1 billion worth of its assets to help pay down the more than
VRX,VRX:CT,BBG000DC8S17,This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time,2017-01-11 13:52:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4SkRMTbP5iI/this-is-the-smartest-move-valeant-pharmaceuticals-has-made-in-a-really-long-time-cm731987,Image source Nguyen Hung Vu Flickr Finally the shareholders of Valeant Pharmaceuticals NYSE VRX have a genuine reason to cheer about the company As announced early Tuesday morning Valeant is selling some 2 1 billion worth of its assets to help pay down the more than
VRX,VRX:CT,BBG000DC8S17,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2017-01-11 13:40:01 +0000,http://finance.yahoo.com/news/options-traders-know-something-valeant-134001277.html,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?
VRX,VRX:US,BBG000DLFM21,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2017-01-11 13:40:01 +0000,http://finance.yahoo.com/news/options-traders-know-something-valeant-134001277.html,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?
VRX,VRX:US,BBG000DLFM21,Blog Coverage Valeant Sells-Off Its Skin Care Brands to L'Oreal,2017-01-11 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeant-sells-off-131500271.html,"[Accesswire] - Upcoming AWS Coverage on Alkermes LONDON, UK / ACCESSWIRE / January 11, 2017 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) as the company ..."
VRX,VRX:CT,BBG000DC8S17,Blog Coverage Valeant Sells-Off Its Skin Care Brands to L'Oreal,2017-01-11 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeant-sells-off-131500271.html,"[Accesswire] - Upcoming AWS Coverage on Alkermes LONDON, UK / ACCESSWIRE / January 11, 2017 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) as the company ..."
VRX,VRX:US,BBG000DLFM21,5 Biotech Stocks That Are Catching Fire,2017-01-11 13:00:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KEeF4-1CeeA/5-biotech-stocks-that-are-catching-fire-cm731920,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips While U S equities continue their sideways skid just below the Dow 20 000 threshold a level that has provided intractable for the last five weeks buyers aren t sitting still Since the New Year
VRX,VRX:CT,BBG000DC8S17,5 Biotech Stocks That Are Catching Fire,2017-01-11 13:00:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KEeF4-1CeeA/5-biotech-stocks-that-are-catching-fire-cm731920,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips While U S equities continue their sideways skid just below the Dow 20 000 threshold a level that has provided intractable for the last five weeks buyers aren t sitting still Since the New Year
VRX,VRX:CT,BBG000DC8S17,This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time,2017-01-11 12:41:07 +0000,http://www.fool.com/investing/2017/01/11/this-is-the-smartest-move-valeant-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time
VRX,VRX:US,BBG000DLFM21,This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time,2017-01-11 12:41:07 +0000,http://www.fool.com/investing/2017/01/11/this-is-the-smartest-move-valeant-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : January 11, 2017",2017-01-11 12:30:35 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrx-us-january-11-2017/,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : January 11, 2017"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : January 11, 2017",2017-01-11 12:30:35 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrx-us-january-11-2017/,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : January 11, 2017"
VRX,VRX:CT,BBG000DC8S17,Valeant Soars 14% on $2.12B Worth of Asset Sales,2017-01-11 11:25:00 +0000,http://www.investopedia.com/news/valeant-soars-14-212b-worth-asset-sales-vrx/?partner=YahooSA,Valeant Soars 14% on $2.12B Worth of Asset Sales
VRX,VRX:US,BBG000DLFM21,Valeant Soars 14% on $2.12B Worth of Asset Sales,2017-01-11 11:25:00 +0000,http://www.investopedia.com/news/valeant-soars-14-212b-worth-asset-sales-vrx/?partner=YahooSA,Valeant Soars 14% on $2.12B Worth of Asset Sales
VRX,VRX:US,BBG000DLFM21,[$$] L’Oréal Looks to Gain U.S. Share by Buying Valeant Brands,2017-01-11 05:07:46 +0000,http://www.wsj.com/articles/loreal-looks-to-gain-u-s-share-by-buying-valeant-brands-1484053710?ru=yahoo?mod=yahoo_itp,[$$] L’Oréal Looks to Gain U.S. Share by Buying Valeant Brands
VRX,VRX:CT,BBG000DC8S17,[$$] L’Oréal Looks to Gain U.S. Share by Buying Valeant Brands,2017-01-11 05:07:46 +0000,http://www.wsj.com/articles/loreal-looks-to-gain-u-s-share-by-buying-valeant-brands-1484053710?ru=yahoo?mod=yahoo_itp,[$$] L’Oréal Looks to Gain U.S. Share by Buying Valeant Brands
VRX,VRX:US,BBG000DLFM21,"So Long DSCI, MRK Seeks New Use For Old Drug, VRX Does It Again, PSTI On Watch",2017-01-11 01:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GQ3ylPi9Ld4/so-long-dsci-mrk-seeks-new-use-for-old-drug-vrx-does-it-again-psti-on-watch-20170111-00015,"So Long DSCI, MRK Seeks New Use For Old Drug, VRX Does It Again, PSTI On Watch"
VRX,VRX:CT,BBG000DC8S17,"So Long DSCI, MRK Seeks New Use For Old Drug, VRX Does It Again, PSTI On Watch",2017-01-11 01:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GQ3ylPi9Ld4/so-long-dsci-mrk-seeks-new-use-for-old-drug-vrx-does-it-again-psti-on-watch-20170111-00015,"So Long DSCI, MRK Seeks New Use For Old Drug, VRX Does It Again, PSTI On Watch"
VRX,VRX:CT,BBG000DC8S17,Celebrate One Debacle of a Merger With Another -- ICYMI,2017-01-10 23:15:00 +0000,https://www.thestreet.com/story/13949617/1/celebrate-one-debacle-of-a-merger-with-another-icymi.html?puc=yahoo&cm_ven=YAHOO,Celebrate One Debacle of a Merger With Another -- ICYMI
VRX,VRX:US,BBG000DLFM21,Celebrate One Debacle of a Merger With Another -- ICYMI,2017-01-10 23:15:00 +0000,https://www.thestreet.com/story/13949617/1/celebrate-one-debacle-of-a-merger-with-another-icymi.html?puc=yahoo&cm_ven=YAHOO,Celebrate One Debacle of a Merger With Another -- ICYMI
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition",2017-01-10 22:11:00 +0000,http://biz.yahoo.com/e/170110/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition"
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition",2017-01-10 22:11:00 +0000,http://biz.yahoo.com/e/170110/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition"
VRX,VRX:CT,BBG000DC8S17,Valeant Sells $2.1 Billion in Assets to Ease Debt Burden,2017-01-10 22:08:48 +0000,http://finance.yahoo.com/video/valeant-sells-2-1-billion-220848332.html,Valeant Sells $2.1 Billion in Assets to Ease Debt Burden
VRX,VRX:US,BBG000DLFM21,Valeant Sells $2.1 Billion in Assets to Ease Debt Burden,2017-01-10 22:08:48 +0000,http://finance.yahoo.com/video/valeant-sells-2-1-billion-220848332.html,Valeant Sells $2.1 Billion in Assets to Ease Debt Burden
VRX,VRX:CT,BBG000DC8S17,'Valeant Sale One of Many That Need to Get Done',2017-01-10 22:06:44 +0000,http://finance.yahoo.com/video/valeant-sale-one-many-done-220644809.html,'Valeant Sale One of Many That Need to Get Done'
VRX,VRX:US,BBG000DLFM21,'Valeant Sale One of Many That Need to Get Done',2017-01-10 22:06:44 +0000,http://finance.yahoo.com/video/valeant-sale-one-many-done-220644809.html,'Valeant Sale One of Many That Need to Get Done'
VRX,VRX:US,BBG000DLFM21,Nasdaq closes at 4th straight record—marks best such streak since 1999,2017-01-10 21:55:51 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=4ADF798A-D70D-11E6-B2D1-5BB37AF8AA48&siteid=yhoof2,Nasdaq closes at 4th straight record—marks best such streak since 1999
VRX,VRX:CT,BBG000DC8S17,Nasdaq closes at 4th straight record—marks best such streak since 1999,2017-01-10 21:55:51 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=4ADF798A-D70D-11E6-B2D1-5BB37AF8AA48&siteid=yhoof2,Nasdaq closes at 4th straight record—marks best such streak since 1999
VRX,VRX:US,BBG000DLFM21,CANADA STOCKS-TSX rises with financials and materials; Valeant jumps,2017-01-10 21:49:33 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-financials-214933384.html,CANADA STOCKS-TSX rises with financials and materials; Valeant jumps
VRX,VRX:CT,BBG000DC8S17,CANADA STOCKS-TSX rises with financials and materials; Valeant jumps,2017-01-10 21:49:33 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-financials-214933384.html,CANADA STOCKS-TSX rises with financials and materials; Valeant jumps
VRX,VRX:US,BBG000DLFM21,"Jaguar Animal Health, Inc. (NAS:JAGX) Given Company Update by Aegis Capital Corp.",2017-01-10 21:21:00 +0000,http://au.finance.yahoo.com/news/jaguar-animal-health-inc-nas-212100487.html,"[ABN Newswire] - New York, United States, Jan 11, 2017 - (ABN Newswire) - (NetworkNewsWire) Jaguar Animal Health, Inc. (NAS:JAGX - News), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp. (http://nnw.fm/8Jn4H). The company update was announced after JAGX made several decisions that Aegis believes could improve the outlook for the company. The company, which is committed to identifying animal health market opportunities to develop products specific to various species, announced that it has proposed a business combination with its parent company, Napo Therapeutics, Inc., to form a single entity."
VRX,VRX:CT,BBG000DC8S17,"Jaguar Animal Health, Inc. (NAS:JAGX) Given Company Update by Aegis Capital Corp.",2017-01-10 21:21:00 +0000,http://au.finance.yahoo.com/news/jaguar-animal-health-inc-nas-212100487.html,"[ABN Newswire] - New York, United States, Jan 11, 2017 - (ABN Newswire) - (NetworkNewsWire) Jaguar Animal Health, Inc. (NAS:JAGX - News), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp. (http://nnw.fm/8Jn4H). The company update was announced after JAGX made several decisions that Aegis believes could improve the outlook for the company. The company, which is committed to identifying animal health market opportunities to develop products specific to various species, announced that it has proposed a business combination with its parent company, Napo Therapeutics, Inc., to form a single entity."
VRX,VRX:CT,BBG000DC8S17,CANADA STOCKS-TSX rises with financials and materials groups,2017-01-10 21:08:30 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-financials-210830962.html,CANADA STOCKS-TSX rises with financials and materials groups
VRX,VRX:US,BBG000DLFM21,CANADA STOCKS-TSX rises with financials and materials groups,2017-01-10 21:08:30 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-financials-210830962.html,CANADA STOCKS-TSX rises with financials and materials groups
VRX,VRX:CT,BBG000DC8S17,Tuesday’s Top Biopharma Movers,2017-01-10 20:30:54 +0000,http://finance.yahoo.com/news/tuesday-top-biopharma-movers-203054644.html,Tuesday’s Top Biopharma Movers
VRX,VRX:US,BBG000DLFM21,Tuesday’s Top Biopharma Movers,2017-01-10 20:30:54 +0000,http://finance.yahoo.com/news/tuesday-top-biopharma-movers-203054644.html,Tuesday’s Top Biopharma Movers
VRX,VRX:US,BBG000DLFM21,Valeant lessens debt load with billion-dollar L'Oréal deal,2017-01-10 20:05:10 +0000,http://www.bizjournals.com/newyork/news/2017/01/10/valeant-lessens-debt-load-with-loreal-deal.html?ana=yahoo,Valeant lessens debt load with billion-dollar L'Oréal deal
VRX,VRX:CT,BBG000DC8S17,Valeant lessens debt load with billion-dollar L'Oréal deal,2017-01-10 20:05:10 +0000,http://www.bizjournals.com/newyork/news/2017/01/10/valeant-lessens-debt-load-with-loreal-deal.html?ana=yahoo,Valeant lessens debt load with billion-dollar L'Oréal deal
VRX,VRX:CT,BBG000DC8S17,Will This Cure What Ails Valeant Pharmaceuticals?,2017-01-10 19:51:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TN6I5othw90/will-this-cure-what-ails-valeant-pharmaceuticals-cm731818,A tumultuous year of disappointing news caused shares of Valeant Pharmaceuticals NYSE VRX to lose 85 of their value in 2016 Can management turn things around in 2017 In this clip from the Motley Fool s Industry Focus Healthcare podcast analyst Kristine Harjes
VRX,VRX:US,BBG000DLFM21,Will This Cure What Ails Valeant Pharmaceuticals?,2017-01-10 19:51:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TN6I5othw90/will-this-cure-what-ails-valeant-pharmaceuticals-cm731818,A tumultuous year of disappointing news caused shares of Valeant Pharmaceuticals NYSE VRX to lose 85 of their value in 2016 Can management turn things around in 2017 In this clip from the Motley Fool s Industry Focus Healthcare podcast analyst Kristine Harjes
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 01/10/2017: VRX,BIOC,NSTG",2017-01-10 19:10:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0HHIdkk1Eyw/health-care-sector-update-for-01102017-vrxbiocnstg-cm731808,Top Health Care StocksTop Health Care Stocks JNJ 0 54 JNJ 0 54 PFE 0 43 PFE 0 43 MRK 1 87 MRK 1 87 ABT 0 45 ABT 0 45 AMGN 0 18 AMGN 0 18 Health care stocks were again on positive ground Tuesday with the NYSE Health Care Index adding about 0 6 while shares of health care
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 01/10/2017: VRX,BIOC,NSTG",2017-01-10 19:10:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0HHIdkk1Eyw/health-care-sector-update-for-01102017-vrxbiocnstg-cm731808,Top Health Care StocksTop Health Care Stocks JNJ 0 54 JNJ 0 54 PFE 0 43 PFE 0 43 MRK 1 87 MRK 1 87 ABT 0 45 ABT 0 45 AMGN 0 18 AMGN 0 18 Health care stocks were again on positive ground Tuesday with the NYSE Health Care Index adding about 0 6 while shares of health care
VRX,VRX:CT,BBG000DC8S17,Valeant: A Solid Price?,2017-01-10 19:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/10/valeant-a-solid-price/?mod=yahoobarrons&ru=yahoo,Valeant: A Solid Price?
VRX,VRX:US,BBG000DLFM21,Valeant: A Solid Price?,2017-01-10 19:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/10/valeant-a-solid-price/?mod=yahoobarrons&ru=yahoo,Valeant: A Solid Price?
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc -- Moody's: Valeant asset sales credit positive",2017-01-10 19:06:01 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_360512&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20170110_PR_360512,"Valeant Pharmaceuticals International, Inc -- Moody's: Valeant asset sales credit positive"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc -- Moody's: Valeant asset sales credit positive",2017-01-10 19:06:01 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_360512&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20170110_PR_360512,"Valeant Pharmaceuticals International, Inc -- Moody's: Valeant asset sales credit positive"
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Stock Is Jumping Today,2017-01-10 18:52:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8TLA1xwiDgc/why-valeant-pharmaceuticals-stock-is-jumping-today-cm731791,Image source Getty Images What happened After Valeant Pharmaceuticals NYSE VRX 160 reported that it s selling some of its non core assets for more than 2 billion shares traded up as much as 14 on Tuesday As of 12 05 p m EST shares had settled to a 5 1 gain So
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Stock Is Jumping Today,2017-01-10 18:52:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8TLA1xwiDgc/why-valeant-pharmaceuticals-stock-is-jumping-today-cm731791,Image source Getty Images What happened After Valeant Pharmaceuticals NYSE VRX 160 reported that it s selling some of its non core assets for more than 2 billion shares traded up as much as 14 on Tuesday As of 12 05 p m EST shares had settled to a 5 1 gain So
VRX,VRX:US,BBG000DLFM21,Will This Cure What Ails Valeant Pharmaceuticals?,2017-01-10 18:40:28 +0000,http://www.fool.com/investing/2017/01/10/will-this-cure-what-ails-valeant-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Will This Cure What Ails Valeant Pharmaceuticals?
VRX,VRX:CT,BBG000DC8S17,Will This Cure What Ails Valeant Pharmaceuticals?,2017-01-10 18:40:28 +0000,http://www.fool.com/investing/2017/01/10/will-this-cure-what-ails-valeant-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Will This Cure What Ails Valeant Pharmaceuticals?
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant: on the rebound,2017-01-10 18:14:29 +0000,"http://www.ft.com/cms/s/1638f522-d757-11e6-944b-e7eb37a6aa8e,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - When your former love interest announces their marriage to someone else, there can be a temptation to jump into the arms of the next person to come along. Often, this will be unwise. But in some cases ..."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant: on the rebound,2017-01-10 18:14:29 +0000,"http://www.ft.com/cms/s/1638f522-d757-11e6-944b-e7eb37a6aa8e,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - When your former love interest announces their marriage to someone else, there can be a temptation to jump into the arms of the next person to come along. Often, this will be unwise. But in some cases ..."
VRX,VRX:US,BBG000DLFM21,Priceline Group Inc (PCLN) Stock Is Your Ticket to Profits,2017-01-10 17:52:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6sKwa17EbhM/priceline-group-inc-pcln-stock-is-your-ticket-to-profits-cm731723,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Priceline Group Inc NASDAQ PCLN is a well managed company that in the long run should remain a winner I like going long PCLN stock any meaningful
VRX,VRX:CT,BBG000DC8S17,Priceline Group Inc (PCLN) Stock Is Your Ticket to Profits,2017-01-10 17:52:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6sKwa17EbhM/priceline-group-inc-pcln-stock-is-your-ticket-to-profits-cm731723,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Priceline Group Inc NASDAQ PCLN is a well managed company that in the long run should remain a winner I like going long PCLN stock any meaningful
VRX,VRX:CT,BBG000DC8S17,Bank of America Corp (BAC) Q4 Earnings Preview,2017-01-10 17:52:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A2X_yRONQEY/bank-of-america-corp-bac-q4-earnings-preview-cm731715,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Bank of America Corp NYSE BAC a Dow Jones Industrial Average constituent and the country s second largest financial institution reports fourth quarter earnings Friday morning The big question
VRX,VRX:US,BBG000DLFM21,Bank of America Corp (BAC) Q4 Earnings Preview,2017-01-10 17:52:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A2X_yRONQEY/bank-of-america-corp-bac-q4-earnings-preview-cm731715,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Bank of America Corp NYSE BAC a Dow Jones Industrial Average constituent and the country s second largest financial institution reports fourth quarter earnings Friday morning The big question
VRX,VRX:CT,BBG000DC8S17,Valeant Gets Breathing Room But Little Else,2017-01-10 17:38:20 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-10/valeant-skin-care-dendreon-sales-only-buy-some-breathing-room?cmpid=yhoo.headline,Valeant Gets Breathing Room But Little Else
VRX,VRX:US,BBG000DLFM21,Valeant Gets Breathing Room But Little Else,2017-01-10 17:38:20 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-10/valeant-skin-care-dendreon-sales-only-buy-some-breathing-room?cmpid=yhoo.headline,Valeant Gets Breathing Room But Little Else
VRX,VRX:US,BBG000DLFM21,Here's What Valeant Could Still Divest,2017-01-10 17:32:00 +0000,https://www.thestreet.com/story/13949015/1/here-s-what-valeant-could-still-divest.html?puc=yahoo&cm_ven=YAHOO,Here's What Valeant Could Still Divest
VRX,VRX:CT,BBG000DC8S17,Here's What Valeant Could Still Divest,2017-01-10 17:32:00 +0000,https://www.thestreet.com/story/13949015/1/here-s-what-valeant-could-still-divest.html?puc=yahoo&cm_ven=YAHOO,Here's What Valeant Could Still Divest
VRX,VRX:US,BBG000DLFM21,Markets Look to Trump's News Conference,2017-01-10 17:20:00 +0000,http://finance.yahoo.com/news/markets-look-trumps-news-conference-172000160.html,Markets Look to Trump's News Conference
VRX,VRX:CT,BBG000DC8S17,Markets Look to Trump's News Conference,2017-01-10 17:20:00 +0000,http://finance.yahoo.com/news/markets-look-trumps-news-conference-172000160.html,Markets Look to Trump's News Conference
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Stock Is Jumping Today,2017-01-10 17:11:34 +0000,http://www.fool.com/investing/2017/01/10/why-valeant-pharmaceuticals-is-jumping-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Valeant Pharmaceuticals Stock Is Jumping Today
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Stock Is Jumping Today,2017-01-10 17:11:34 +0000,http://www.fool.com/investing/2017/01/10/why-valeant-pharmaceuticals-is-jumping-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Valeant Pharmaceuticals Stock Is Jumping Today
VRX,VRX:CT,BBG000DC8S17,What's Left Of Valeant's Assets After This Morning's Sale?,2017-01-10 16:59:07 +0000,http://finance.yahoo.com/news/whats-left-valeants-assets-mornings-165907096.html,What's Left Of Valeant's Assets After This Morning's Sale?
VRX,VRX:US,BBG000DLFM21,What's Left Of Valeant's Assets After This Morning's Sale?,2017-01-10 16:59:07 +0000,http://finance.yahoo.com/news/whats-left-valeants-assets-mornings-165907096.html,What's Left Of Valeant's Assets After This Morning's Sale?
VRX,VRX:CT,BBG000DC8S17,Valeant to Sell Dendreon Unit to Sanpower for $820 Million,2017-01-10 16:53:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W0wGuzC1p6Q/valeant-to-sell-dendreon-unit-to-sanpower-for-820-million-cm731677,Beleaguered Valeant Pharmaceuticals International Inc VRX announced that its affiliate has entered into a definitive agreement to sell all the outstanding equity interests in Dendreon Pharmaceuticals Inc to the China based Sanpower Group Co Ltd Shares of Valeant underperformed
VRX,VRX:US,BBG000DLFM21,Valeant to Sell Dendreon Unit to Sanpower for $820 Million,2017-01-10 16:53:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W0wGuzC1p6Q/valeant-to-sell-dendreon-unit-to-sanpower-for-820-million-cm731677,Beleaguered Valeant Pharmaceuticals International Inc VRX announced that its affiliate has entered into a definitive agreement to sell all the outstanding equity interests in Dendreon Pharmaceuticals Inc to the China based Sanpower Group Co Ltd Shares of Valeant underperformed
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Breakup Gold,2017-01-10 16:53:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U_xMjqC5GHE/valeant-pharmaceuticals-intl-inc-vrx-stock-is-breakup-gold-cm731761,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX has begun the process of its own breakup and for VRX stock holders this might be one of the best conclusions they could ve hoped for
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Breakup Gold,2017-01-10 16:53:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U_xMjqC5GHE/valeant-pharmaceuticals-intl-inc-vrx-stock-is-breakup-gold-cm731761,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX has begun the process of its own breakup and for VRX stock holders this might be one of the best conclusions they could ve hoped for
VRX,VRX:US,BBG000DLFM21,"Charts of the day: Valeant shares jump, Chipotle climbs on sales trend",2017-01-10 16:43:25 +0000,http://finance.yahoo.com/news/charts-of-the-day-chipotle-valeant-pharmaceuticals-164325233.html,"Charts of the day: Valeant shares jump, Chipotle climbs on sales trend"
VRX,VRX:CT,BBG000DC8S17,"Charts of the day: Valeant shares jump, Chipotle climbs on sales trend",2017-01-10 16:43:25 +0000,http://finance.yahoo.com/news/charts-of-the-day-chipotle-valeant-pharmaceuticals-164325233.html,"Charts of the day: Valeant shares jump, Chipotle climbs on sales trend"
VRX,VRX:US,BBG000DLFM21,Stocks Close Mixed For Second Consecutive Session - U.S. Commentary,2017-01-10 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/18vuXr1uUpc/stocks-close-mixed-for-second-consecutive-session--us-commentary-20170110-00983,Stocks Close Mixed For Second Consecutive Session - U.S. Commentary
VRX,VRX:CT,BBG000DC8S17,Stocks Close Mixed For Second Consecutive Session - U.S. Commentary,2017-01-10 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/18vuXr1uUpc/stocks-close-mixed-for-second-consecutive-session--us-commentary-20170110-00983,Stocks Close Mixed For Second Consecutive Session - U.S. Commentary
VRX,VRX:US,BBG000DLFM21,Valeant's Asset Sale To L'Oreal Explained,2017-01-10 16:12:31 +0000,http://finance.yahoo.com/news/valeants-asset-sale-loreal-explained-161231298.html,Valeant's Asset Sale To L'Oreal Explained
VRX,VRX:CT,BBG000DC8S17,Valeant's Asset Sale To L'Oreal Explained,2017-01-10 16:12:31 +0000,http://finance.yahoo.com/news/valeants-asset-sale-loreal-explained-161231298.html,Valeant's Asset Sale To L'Oreal Explained
VRX,VRX:US,BBG000DLFM21,Why Valeant Is Making a Run,2017-01-10 16:05:14 +0000,http://finance.yahoo.com/news/why-valeant-making-run-160514140.html,Why Valeant Is Making a Run
VRX,VRX:CT,BBG000DC8S17,Why Valeant Is Making a Run,2017-01-10 16:05:14 +0000,http://finance.yahoo.com/news/why-valeant-making-run-160514140.html,Why Valeant Is Making a Run
VRX,VRX:US,BBG000DLFM21,Valeant Turns Assets to Cash With $2.1 Billion in Deals,2017-01-10 15:44:44 +0000,http://finance.yahoo.com/video/valeant-turns-assets-cash-2-154444693.html,Valeant Turns Assets to Cash With $2.1 Billion in Deals
VRX,VRX:CT,BBG000DC8S17,Valeant Turns Assets to Cash With $2.1 Billion in Deals,2017-01-10 15:44:44 +0000,http://finance.yahoo.com/video/valeant-turns-assets-cash-2-154444693.html,Valeant Turns Assets to Cash With $2.1 Billion in Deals
VRX,VRX:US,BBG000DLFM21,Top Biotech Resolutions for 2017,2017-01-10 15:41:05 +0000,http://www.fool.com/investing/2017/01/09/top-biotech-resolutions-for-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Biotech Resolutions for 2017
VRX,VRX:CT,BBG000DC8S17,Top Biotech Resolutions for 2017,2017-01-10 15:41:05 +0000,http://www.fool.com/investing/2017/01/09/top-biotech-resolutions-for-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Biotech Resolutions for 2017
VRX,VRX:CT,BBG000DC8S17,Valeant: A Good Start?,2017-01-10 15:31:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/10/valeant-a-good-start/?mod=yahoobarrons&ru=yahoo,Valeant: A Good Start?
VRX,VRX:US,BBG000DLFM21,Valeant: A Good Start?,2017-01-10 15:31:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/10/valeant-a-good-start/?mod=yahoobarrons&ru=yahoo,Valeant: A Good Start?
VRX,VRX:CT,BBG000DC8S17,CANADA STOCKS-TSX rises with materials stocks; Valeant jumps,2017-01-10 15:24:22 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-materials-152422717.html,CANADA STOCKS-TSX rises with materials stocks; Valeant jumps
VRX,VRX:US,BBG000DLFM21,CANADA STOCKS-TSX rises with materials stocks; Valeant jumps,2017-01-10 15:24:22 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-materials-152422717.html,CANADA STOCKS-TSX rises with materials stocks; Valeant jumps
VRX,VRX:US,BBG000DLFM21,"Valeant unloads more assets, Goldman Sachs gets downgraded, Yahoo changes coming",2017-01-10 15:16:28 +0000,http://finance.yahoo.com/news/valeant-unloads-more-assets-goldman-sachs-gets-downgraded-yahoo-changes-coming-151628404.html,"Valeant unloads more assets, Goldman Sachs gets downgraded, Yahoo changes coming"
VRX,VRX:CT,BBG000DC8S17,"Valeant unloads more assets, Goldman Sachs gets downgraded, Yahoo changes coming",2017-01-10 15:16:28 +0000,http://finance.yahoo.com/news/valeant-unloads-more-assets-goldman-sachs-gets-downgraded-yahoo-changes-coming-151628404.html,"Valeant unloads more assets, Goldman Sachs gets downgraded, Yahoo changes coming"
VRX,VRX:CT,BBG000DC8S17,"Stocks Mixed; Why Are Illumina, Valeant, Barracuda Soaring?",2017-01-10 15:12:16 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-inch-up-small-caps-quiet-illumina-bio-rad-qorvo-climb/,"Stocks Mixed; Why Are Illumina, Valeant, Barracuda Soaring?"
VRX,VRX:US,BBG000DLFM21,"Stocks Mixed; Why Are Illumina, Valeant, Barracuda Soaring?",2017-01-10 15:12:16 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-inch-up-small-caps-quiet-illumina-bio-rad-qorvo-climb/,"Stocks Mixed; Why Are Illumina, Valeant, Barracuda Soaring?"
VRX,VRX:CT,BBG000DC8S17,L'Oreal Buys Skincare Lines From Valeant for $1.3 Billion -- and Jim Cramer's Comments,2017-01-10 15:09:00 +0000,https://www.thestreet.com/story/13947857/1/l-or-eacute-al-buys-three-skincare-lines-from-valeant-for-1-3-billion.html?puc=yahoo&cm_ven=YAHOO,L'Oreal Buys Skincare Lines From Valeant for $1.3 Billion -- and Jim Cramer's Comments
VRX,VRX:US,BBG000DLFM21,L'Oreal Buys Skincare Lines From Valeant for $1.3 Billion -- and Jim Cramer's Comments,2017-01-10 15:09:00 +0000,https://www.thestreet.com/story/13947857/1/l-or-eacute-al-buys-three-skincare-lines-from-valeant-for-1-3-billion.html?puc=yahoo&cm_ven=YAHOO,L'Oreal Buys Skincare Lines From Valeant for $1.3 Billion -- and Jim Cramer's Comments
VRX,VRX:CT,BBG000DC8S17,"Valeant's Laundry List: Products, Divestitures And Debt Load",2017-01-10 14:59:29 +0000,http://finance.yahoo.com/news/valeants-laundry-list-products-divestitures-145929136.html,"Valeant's Laundry List: Products, Divestitures And Debt Load"
VRX,VRX:US,BBG000DLFM21,"Valeant's Laundry List: Products, Divestitures And Debt Load",2017-01-10 14:59:29 +0000,http://finance.yahoo.com/news/valeants-laundry-list-products-divestitures-145929136.html,"Valeant's Laundry List: Products, Divestitures And Debt Load"
VRX,VRX:US,BBG000DLFM21,3 Tempting Stocks We're Avoiding,2017-01-10 14:52:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fxdlxe0-6YY/3-tempting-stocks-were-avoiding-cm731451,Image source Getty Images Have you ever come across a company that seemed like too good of a value to pass up If you re a long term investor the answer to this question is almost assuredly yes On occasion these perceived to be tempting stocks can deliver handsome returns over
VRX,VRX:CT,BBG000DC8S17,3 Tempting Stocks We're Avoiding,2017-01-10 14:52:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fxdlxe0-6YY/3-tempting-stocks-were-avoiding-cm731451,Image source Getty Images Have you ever come across a company that seemed like too good of a value to pass up If you re a long term investor the answer to this question is almost assuredly yes On occasion these perceived to be tempting stocks can deliver handsome returns over
VRX,VRX:CT,BBG000DC8S17,Valeant to Sell Dendreon Unit to Sanpower for $820 Million,2017-01-10 14:49:02 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-unit-sanpower-144902932.html,Valeant to Sell Dendreon Unit to Sanpower for $820 Million
VRX,VRX:US,BBG000DLFM21,Valeant to Sell Dendreon Unit to Sanpower for $820 Million,2017-01-10 14:49:02 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-unit-sanpower-144902932.html,Valeant to Sell Dendreon Unit to Sanpower for $820 Million
VRX,VRX:US,BBG000DLFM21,Valeant Stock Gains on Possible Salix Interest,2017-01-10 14:49:00 +0000,http://www.investopedia.com/news/valeant-stock-gains-possible-salix-interest-vrx/?partner=YahooSA,Valeant Stock Gains on Possible Salix Interest
VRX,VRX:CT,BBG000DC8S17,Valeant Stock Gains on Possible Salix Interest,2017-01-10 14:49:00 +0000,http://www.investopedia.com/news/valeant-stock-gains-possible-salix-interest-vrx/?partner=YahooSA,Valeant Stock Gains on Possible Salix Interest
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 01/10/2017: IMNP, VRX, JNJ, PFE, ABT, MRK, AMGN",2017-01-10 14:29:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FqfzK9eh-GE/health-care-sector-update-for-01102017-imnp-vrx-jnj-pfe-abt-mrk-amgn-cm731492,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 1 1 PFE 1 1 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly unchanged in pre market trade Tuesday Health care shares were mostly unchanged in pre market trade Tuesday In health
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 01/10/2017: IMNP, VRX, JNJ, PFE, ABT, MRK, AMGN",2017-01-10 14:29:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FqfzK9eh-GE/health-care-sector-update-for-01102017-imnp-vrx-jnj-pfe-abt-mrk-amgn-cm731492,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 1 1 PFE 1 1 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly unchanged in pre market trade Tuesday Health care shares were mostly unchanged in pre market trade Tuesday In health
VRX,VRX:US,BBG000DLFM21,"Stock Futures Cautious as Wall Street Braces For Earnings, Trump Press Conference",2017-01-10 14:29:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UCu0JXAiHgQ/stock-futures-cautious-as-wall-street-braces-for-earnings-trump-press-conference-cm731484,Stock futures were mixed ahead of Tuesday s open with the Dow and S amp P 500 slightly negative but the Nasdaq Composite looking to set another record high on gains in internet and semiconductor stocks Stock futures were mixed ahead of Tuesday s open with the Dow and S P 500 slightly negative
VRX,VRX:CT,BBG000DC8S17,"Stock Futures Cautious as Wall Street Braces For Earnings, Trump Press Conference",2017-01-10 14:29:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UCu0JXAiHgQ/stock-futures-cautious-as-wall-street-braces-for-earnings-trump-press-conference-cm731484,Stock futures were mixed ahead of Tuesday s open with the Dow and S amp P 500 slightly negative but the Nasdaq Composite looking to set another record high on gains in internet and semiconductor stocks Stock futures were mixed ahead of Tuesday s open with the Dow and S P 500 slightly negative
VRX,VRX:US,BBG000DLFM21,[$$] L'Oréal Looks to Gain U.S. Share by Buying Valeant Brands,2017-01-10 14:28:57 +0000,http://www.wsj.com/articles/loreal-looks-to-gain-u-s-share-by-buying-valeant-brands-1484053710?mod=yahoo_hs,[$$] L'Oréal Looks to Gain U.S. Share by Buying Valeant Brands
VRX,VRX:CT,BBG000DC8S17,[$$] L'Oréal Looks to Gain U.S. Share by Buying Valeant Brands,2017-01-10 14:28:57 +0000,http://www.wsj.com/articles/loreal-looks-to-gain-u-s-share-by-buying-valeant-brands-1484053710?mod=yahoo_hs,[$$] L'Oréal Looks to Gain U.S. Share by Buying Valeant Brands
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Yahoo, Chipotle, Valeant",2017-01-10 14:19:44 +0000,http://blogs.wsj.com/moneybeat/2017/01/10/stocks-to-watch-yahoo-chipotle-valeant/?mod=yahoo_hs,"Stocks to Watch: Yahoo, Chipotle, Valeant"
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Yahoo, Chipotle, Valeant",2017-01-10 14:19:44 +0000,http://blogs.wsj.com/moneybeat/2017/01/10/stocks-to-watch-yahoo-chipotle-valeant/?mod=yahoo_hs,"Stocks to Watch: Yahoo, Chipotle, Valeant"
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Jan 10, 2017 :  WMB, VRX, ING, UGP, FCX, TTM, VOD, TLT, TVIX, MACK, QQQ, ILMN",2017-01-10 13:59:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Meyf-YvD6ys/pre-market-most-active-for-jan-10-2017-wmb-vrx-ing-ugp-fcx-ttm-vod-tlt-tvix-mack-qqq-ilmn-cm731448,The NASDAQ 100 Pre Market Indicator is up 2 85 to 5 027 75 The total Pre Market volume is currently 13 486 750 shares traded The following are the most active stocks for the pre market session Williams Companies Inc The WMB is 3 36 at 28 57 with 5 717 960
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Jan 10, 2017 :  WMB, VRX, ING, UGP, FCX, TTM, VOD, TLT, TVIX, MACK, QQQ, ILMN",2017-01-10 13:59:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Meyf-YvD6ys/pre-market-most-active-for-jan-10-2017-wmb-vrx-ing-ugp-fcx-ttm-vod-tlt-tvix-mack-qqq-ilmn-cm731448,The NASDAQ 100 Pre Market Indicator is up 2 85 to 5 027 75 The total Pre Market volume is currently 13 486 750 shares traded The following are the most active stocks for the pre market session Williams Companies Inc The WMB is 3 36 at 28 57 with 5 717 960
VRX,VRX:US,BBG000DLFM21,3 Tempting Stocks We're Avoiding,2017-01-10 13:38:33 +0000,http://www.fool.com/investing/2017/01/10/3-tempting-stocks-were-avoiding.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Tempting Stocks We're Avoiding
VRX,VRX:CT,BBG000DC8S17,3 Tempting Stocks We're Avoiding,2017-01-10 13:38:33 +0000,http://www.fool.com/investing/2017/01/10/3-tempting-stocks-were-avoiding.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Tempting Stocks We're Avoiding
VRX,VRX:US,BBG000DLFM21,"Small businesses feel great, dealmaking on a tear and World Cup growth",2017-01-10 13:14:05 +0000,http://finance.yahoo.com/news/small-businesses-feel-great-dealmaking-on-a-tear-and-world-cup-growth-131405332.html,"Small businesses feel great, dealmaking on a tear and World Cup growth"
VRX,VRX:CT,BBG000DC8S17,"Small businesses feel great, dealmaking on a tear and World Cup growth",2017-01-10 13:14:05 +0000,http://finance.yahoo.com/news/small-businesses-feel-great-dealmaking-on-a-tear-and-world-cup-growth-131405332.html,"Small businesses feel great, dealmaking on a tear and World Cup growth"
VRX,VRX:US,BBG000DLFM21,Valeant sells $2B in assets to begin paying down debt,2017-01-10 12:59:02 +0000,http://sg.finance.yahoo.com/news/valeant-sells-3-skincare-brands-113652771.html,Valeant sells $2B in assets to begin paying down debt
VRX,VRX:CT,BBG000DC8S17,Valeant sells $2B in assets to begin paying down debt,2017-01-10 12:59:02 +0000,http://finance.yahoo.com/news/valeant-sells-3-skincare-brands-113652283.html,Valeant sells $2B in assets to begin paying down debt
VRX,VRX:US,BBG000DLFM21,Valeant sells $2B in assets to begin paying down debt,2017-01-10 12:59:02 +0000,http://finance.yahoo.com/news/valeant-sells-3-skincare-brands-113652283.html,Valeant sells $2B in assets to begin paying down debt
VRX,VRX:CT,BBG000DC8S17,Valeant sells $2B in assets to begin paying down debt,2017-01-10 12:59:02 +0000,http://sg.finance.yahoo.com/news/valeant-sells-3-skincare-brands-113652771.html,Valeant sells $2B in assets to begin paying down debt
VRX,VRX:US,BBG000DLFM21,"Early movers: YHOO, VRX, CUDA, UNH, BABA, JNJ, GS & more",2017-01-10 12:51:47 +0000,http://www.cnbc.com/id/104209446?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104209446,[at CNBC] - These are the stocks posting the largest moves before the bell.
VRX,VRX:CT,BBG000DC8S17,"Early movers: YHOO, VRX, CUDA, UNH, BABA, JNJ, GS & more",2017-01-10 12:51:47 +0000,http://www.cnbc.com/id/104209446?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104209446,[at CNBC] - These are the stocks posting the largest moves before the bell.
VRX,VRX:CT,BBG000DC8S17,Valeant Pulls Back Off Best Levels But Remains Positive,2017-01-10 12:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u4WfY1JPfs4/valeant-pulls-back-off-best-levels-but-remains-positive-20170110-00787,Valeant Pulls Back Off Best Levels But Remains Positive
VRX,VRX:US,BBG000DLFM21,Valeant Pulls Back Off Best Levels But Remains Positive,2017-01-10 12:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u4WfY1JPfs4/valeant-pulls-back-off-best-levels-but-remains-positive-20170110-00787,Valeant Pulls Back Off Best Levels But Remains Positive
VRX,VRX:US,BBG000DLFM21,L'Oreal's Pricey Problem Solvers,2017-01-10 12:11:08 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-10/worth-it-for-loreal-to-pay-up-for-valeant-skincare-acquisition?cmpid=yhoo.headline,L'Oreal's Pricey Problem Solvers
VRX,VRX:CT,BBG000DC8S17,L'Oreal's Pricey Problem Solvers,2017-01-10 12:11:08 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-10/worth-it-for-loreal-to-pay-up-for-valeant-skincare-acquisition?cmpid=yhoo.headline,L'Oreal's Pricey Problem Solvers
VRX,VRX:CT,BBG000DC8S17,"Stocks Move To The Upside, Nasdaq Reaches Record High - U.S. Commentary",2017-01-10 12:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KXlRQcIQ_2U/stocks-move-to-the-upside-nasdaq-reaches-record-high--us-commentary-20170110-00767,"Stocks Move To The Upside, Nasdaq Reaches Record High - U.S. Commentary"
VRX,VRX:US,BBG000DLFM21,"Stocks Move To The Upside, Nasdaq Reaches Record High - U.S. Commentary",2017-01-10 12:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KXlRQcIQ_2U/stocks-move-to-the-upside-nasdaq-reaches-record-high--us-commentary-20170110-00767,"Stocks Move To The Upside, Nasdaq Reaches Record High - U.S. Commentary"
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant raises $2.1bn through asset sales,2017-01-10 11:57:14 +0000,"http://www.ft.com/cms/s/7cb39bda-d717-11e6-944b-e7eb37a6aa8e,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Valeant Pharmaceuticals International has sold several assets for $2.1bn as the struggling Canadian drugmaker seeks to restructure its business and pay down debt. Valeant, which has lost more than 90 per ..."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant raises $2.1bn through asset sales,2017-01-10 11:57:14 +0000,"http://www.ft.com/cms/s/7cb39bda-d717-11e6-944b-e7eb37a6aa8e,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Valeant Pharmaceuticals International has sold several assets for $2.1bn as the struggling Canadian drugmaker seeks to restructure its business and pay down debt. Valeant, which has lost more than 90 per ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Attempting To Rebound -- Canadian Commentary,2017-01-10 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z6990u2YoeI/canadian-stocks-are-attempting-to-rebound--canadian-commentary-20170110-00705,Canadian Stocks Are Attempting To Rebound -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Attempting To Rebound -- Canadian Commentary,2017-01-10 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z6990u2YoeI/canadian-stocks-are-attempting-to-rebound--canadian-commentary-20170110-00705,Canadian Stocks Are Attempting To Rebound -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA® For Presbyopia Contact Lenses,2017-01-10 11:00:00 +0000,http://finance.yahoo.com/news/bausch-lomb-launches-expanded-parameters-110000166.html,[CNW Group] - Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA® For Presbyopia Contact Lenses
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118,2017-01-10 11:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-results-second-110000549.html,[CNW Group] - Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118,2017-01-10 11:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-results-second-110000549.html,[CNW Group] - Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA® For Presbyopia Contact Lenses,2017-01-10 11:00:00 +0000,http://finance.yahoo.com/news/bausch-lomb-launches-expanded-parameters-110000166.html,[CNW Group] - Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA® For Presbyopia Contact Lenses
VRX,VRX:CT,BBG000DC8S17,Stocks May Continue To Experience Choppy Trading - U.S. Commentary,2017-01-10 08:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ocUJG8qLnrg/stocks-may-continue-to-experience-choppy-trading--us-commentary-20170110-00472,Stocks May Continue To Experience Choppy Trading - U.S. Commentary
VRX,VRX:US,BBG000DLFM21,Stocks May Continue To Experience Choppy Trading - U.S. Commentary,2017-01-10 08:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ocUJG8qLnrg/stocks-may-continue-to-experience-choppy-trading--us-commentary-20170110-00472,Stocks May Continue To Experience Choppy Trading - U.S. Commentary
VRX,VRX:US,BBG000DLFM21,"Valeant To Sell CeraVe, AcneFree And AMBI Skincare Brands To L'Oreal For $1.3 Billion",2017-01-10 08:17:00 +0000,http://finance.yahoo.com/news/valeant-sell-cerave-acnefree-ambi-081700886.html,"[PR Newswire] - LAVAL, Quebec, Jan. 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/VRXTSX: VRX) (""Valeant"" or the ""Company"") today announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. The CeraVe, AcneFree, and AMBI product lines have annualized revenue of approximately of $168 million. ""We are pleased to announce the progress we are making in reshaping our product portfolio and driving value for our shareholders,"" said Valeant CEO Joseph C. Papa. ""The success of these products, and today's transaction, is a testament to the Valeant teams who have impressively grown these brands over the past several years."
VRX,VRX:CT,BBG000DC8S17,"Valeant To Sell CeraVe, AcneFree And AMBI Skincare Brands To L'Oreal For $1.3 Billion",2017-01-10 08:17:00 +0000,http://finance.yahoo.com/news/valeant-sell-cerave-acnefree-ambi-081700886.html,"[PR Newswire] - LAVAL, Quebec, Jan. 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/VRXTSX: VRX) (""Valeant"" or the ""Company"") today announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. The CeraVe, AcneFree, and AMBI product lines have annualized revenue of approximately of $168 million. ""We are pleased to announce the progress we are making in reshaping our product portfolio and driving value for our shareholders,"" said Valeant CEO Joseph C. Papa. ""The success of these products, and today's transaction, is a testament to the Valeant teams who have impressively grown these brands over the past several years."
VRX,VRX:US,BBG000DLFM21,Valeant to Sell $2.1 Billion in Assets to Pay Down Debt,2017-01-10 07:46:17 +0000,http://www.bloomberg.com/news/articles/2017-01-10/valeant-to-sell-skincare-brands-to-l-oreal-for-1-3-billion?cmpid=yhoo.headline,Valeant to Sell $2.1 Billion in Assets to Pay Down Debt
VRX,VRX:CT,BBG000DC8S17,Valeant to Sell $2.1 Billion in Assets to Pay Down Debt,2017-01-10 07:46:17 +0000,http://www.bloomberg.com/news/articles/2017-01-10/valeant-to-sell-skincare-brands-to-l-oreal-for-1-3-billion?cmpid=yhoo.headline,Valeant to Sell $2.1 Billion in Assets to Pay Down Debt
VRX,VRX:US,BBG000DLFM21,"Amended: L'OrÃ©alÂ to Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln",2017-01-10 07:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fZaMox_qCAg/amended-lor%C3%A3al%C3%A2%C2%A0to-acquire-cerave-acnefree-and-ambi-skincare-brands-for-13-bln-20170110-00211,"Amended: L'OrÃ©alÂ to Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln"
VRX,VRX:CT,BBG000DC8S17,"Amended: L'OrÃ©alÂ to Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln",2017-01-10 07:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fZaMox_qCAg/amended-lor%C3%A3al%C3%A2%C2%A0to-acquire-cerave-acnefree-and-ambi-skincare-brands-for-13-bln-20170110-00211,"Amended: L'OrÃ©alÂ to Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln"
VRX,VRX:CT,BBG000DC8S17,Wall Street Eyes Greener Pastures,2017-01-10 07:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DJpquLp3gXo/wall-street-eyes-greener-pastures-20170110-00202,Wall Street Eyes Greener Pastures
VRX,VRX:US,BBG000DLFM21,Wall Street Eyes Greener Pastures,2017-01-10 07:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DJpquLp3gXo/wall-street-eyes-greener-pastures-20170110-00202,Wall Street Eyes Greener Pastures
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA,2017-01-10 06:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r5vOXQ3vA7Q/bausch--lomb-launches-expanded-parameters-for-bausch--lomb-ultra-20170110-00118,Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA,2017-01-10 06:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r5vOXQ3vA7Q/bausch--lomb-launches-expanded-parameters-for-bausch--lomb-ultra-20170110-00118,Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA
VRX,VRX:US,BBG000DLFM21,Valeant Reports Results Of Second Phase 3 Study For Psoriasis Treatment,2017-01-10 06:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CzoRDREl5vA/valeant-reports-results-of-second-phase-3-study-for-psoriasis-treatment-20170110-00114,Valeant Reports Results Of Second Phase 3 Study For Psoriasis Treatment
VRX,VRX:CT,BBG000DC8S17,Valeant Reports Results Of Second Phase 3 Study For Psoriasis Treatment,2017-01-10 06:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CzoRDREl5vA/valeant-reports-results-of-second-phase-3-study-for-psoriasis-treatment-20170110-00114,Valeant Reports Results Of Second Phase 3 Study For Psoriasis Treatment
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million,2017-01-10 06:02:41 +0000,http://www.wsj.com/articles/valeant-nears-deal-to-sell-dendreon-cancer-business-to-sanpower-for-more-than-750-million-1484019727?ru=yahoo?mod=yahoo_itp,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million,2017-01-10 06:02:41 +0000,http://www.wsj.com/articles/valeant-nears-deal-to-sell-dendreon-cancer-business-to-sanpower-for-more-than-750-million-1484019727?ru=yahoo?mod=yahoo_itp,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million
VRX,VRX:CT,BBG000DC8S17,Valeant To Sell Dendreon Cancer Business To China's Sanpower For $820 Million Cash,2017-01-10 05:08:00 +0000,http://blogs.barrons.com/asiastocks/2017/01/10/valeant-to-sell-dendreon-cancer-business-to-chinas-sanpower-for-820-million-cash/?mod=yahoobarrons&ru=yahoo,Valeant To Sell Dendreon Cancer Business To China's Sanpower For $820 Million Cash
VRX,VRX:US,BBG000DLFM21,Valeant To Sell Dendreon Cancer Business To China's Sanpower For $820 Million Cash,2017-01-10 05:08:00 +0000,http://blogs.barrons.com/asiastocks/2017/01/10/valeant-to-sell-dendreon-cancer-business-to-chinas-sanpower-for-820-million-cash/?mod=yahoobarrons&ru=yahoo,Valeant To Sell Dendreon Cancer Business To China's Sanpower For $820 Million Cash
VRX,VRX:US,BBG000DLFM21,Valeant to sell Dendreon unit to China's Sanpower for $820 million,2017-01-10 04:47:04 +0000,http://sg.finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-040309937.html,Valeant to sell Dendreon unit to China's Sanpower for $820 million
VRX,VRX:CT,BBG000DC8S17,Valeant to sell Dendreon unit to China's Sanpower for $820 million,2017-01-10 04:47:04 +0000,http://sg.finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-040309937.html,Valeant to sell Dendreon unit to China's Sanpower for $820 million
VRX,VRX:US,BBG000DLFM21,Valeant to sell Dendreon unit to China's Sanpower for $820 mln,2017-01-10 04:45:55 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-044555838.html,"[Reuters] - Canada's Valeant Pharmaceuticals International Inc said its affiliate will sell its Dendreon cancer business to China's Sanpower Group Co Ltd for $819.9 million, as the drugmaker continues to shed its non-core assets to repay debt. Dendreon makes prostate cancer vaccine Provenge that was approved by the U.S. Food and Drug Administration in 2010. ""With this sale, we are better aligning our product portfolio with Valeant's new operating strategy by exiting the urological oncology business, which is one of our non-core assets,"" Valeant Chief Executive Joseph Papa said in a statement on Monday."
VRX,VRX:CT,BBG000DC8S17,Valeant to sell Dendreon unit to China's Sanpower for $820 mln,2017-01-10 04:45:55 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-044555838.html,"[Reuters] - Canada's Valeant Pharmaceuticals International Inc said its affiliate will sell its Dendreon cancer business to China's Sanpower Group Co Ltd for $819.9 million, as the drugmaker continues to shed its non-core assets to repay debt. Dendreon makes prostate cancer vaccine Provenge that was approved by the U.S. Food and Drug Administration in 2010. ""With this sale, we are better aligning our product portfolio with Valeant's new operating strategy by exiting the urological oncology business, which is one of our non-core assets,"" Valeant Chief Executive Joseph Papa said in a statement on Monday."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million,2017-01-10 04:29:15 +0000,http://www.wsj.com/articles/valeant-nears-deal-to-sell-dendreon-cancer-business-to-sanpower-for-more-than-750-million-1484019727?mod=yahoo_hs,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million,2017-01-10 04:29:15 +0000,http://www.wsj.com/articles/valeant-nears-deal-to-sell-dendreon-cancer-business-to-sanpower-for-more-than-750-million-1484019727?mod=yahoo_hs,[$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million
VRX,VRX:US,BBG000DLFM21,Valeant to sell Dendreon unit to China's Sanpower for $819.9 mln,2017-01-10 03:58:41 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-035841132.html,Valeant to sell Dendreon unit to China's Sanpower for $819.9 mln
VRX,VRX:CT,BBG000DC8S17,Valeant to sell Dendreon unit to China's Sanpower for $819.9 mln,2017-01-10 03:58:41 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-035841132.html,Valeant to sell Dendreon unit to China's Sanpower for $819.9 mln
VRX,VRX:CT,BBG000DC8S17,Valeant to sell its Dendreon cancer business to China's Sanpower,2017-01-10 03:54:51 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=BB5508ED-7101-4A09-9F0A-0F61DF7CC516&siteid=yhoof2,Valeant to sell its Dendreon cancer business to China's Sanpower
VRX,VRX:US,BBG000DLFM21,Valeant to sell its Dendreon cancer business to China's Sanpower,2017-01-10 03:54:51 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=BB5508ED-7101-4A09-9F0A-0F61DF7CC516&siteid=yhoof2,Valeant to sell its Dendreon cancer business to China's Sanpower
VRX,VRX:CT,BBG000DC8S17,Valeant To Sell Dendreon To Sanpower Group For $819.9 Million In Cash,2017-01-10 03:40:00 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-sanpower-group-034000145.html,"[PR Newswire] - LAVAL, Quebec, Jan. 9, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) (""Valeant"" or the ""Company"") today announced that its affiliate has entered into a definitive agreement to sell all of the outstanding equity interests in Dendreon Pharmaceuticals, Inc. (""Dendreon"") to the Sanpower Group Co., Ltd., one of the largest privately owned conglomerates in China. Under the terms of the transaction, Valeant will receive cash consideration of $819.9 million at completion. ""With this sale, we are better aligning our product portfolio with Valeant's new operating strategy by exiting the urological oncology business, which is one of our non-core assets,"" said Valeant CEO Joseph C. Papa."
VRX,VRX:US,BBG000DLFM21,Valeant To Sell Dendreon To Sanpower Group For $819.9 Million In Cash,2017-01-10 03:40:00 +0000,http://finance.yahoo.com/news/valeant-sell-dendreon-sanpower-group-034000145.html,"[PR Newswire] - LAVAL, Quebec, Jan. 9, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) (""Valeant"" or the ""Company"") today announced that its affiliate has entered into a definitive agreement to sell all of the outstanding equity interests in Dendreon Pharmaceuticals, Inc. (""Dendreon"") to the Sanpower Group Co., Ltd., one of the largest privately owned conglomerates in China. Under the terms of the transaction, Valeant will receive cash consideration of $819.9 million at completion. ""With this sale, we are better aligning our product portfolio with Valeant's new operating strategy by exiting the urological oncology business, which is one of our non-core assets,"" said Valeant CEO Joseph C. Papa."
VRX,VRX:US,BBG000DLFM21,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln",2017-01-10 03:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-eWYJoYYxqQ/valeant-to-acquire-cerave-acnefree-and-ambi-skincare-brands-for-13-bln-20170110-00059,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln"
VRX,VRX:CT,BBG000DC8S17,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln",2017-01-10 03:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yzvthzIgsB8/valeant-to-acquire-cerave-acnefree-and-ambi-skincare-brands-for-13-bln-20170110-00058,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln"
VRX,VRX:US,BBG000DLFM21,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln",2017-01-10 03:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yzvthzIgsB8/valeant-to-acquire-cerave-acnefree-and-ambi-skincare-brands-for-13-bln-20170110-00058,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln"
VRX,VRX:CT,BBG000DC8S17,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln",2017-01-10 03:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-eWYJoYYxqQ/valeant-to-acquire-cerave-acnefree-and-ambi-skincare-brands-for-13-bln-20170110-00059,"Valeant To Acquire CeraVe, AcneFree And Ambi Skincare Brands For $1.3 Bln"
VRX,VRX:US,BBG000DLFM21,Valeant To Sell Provenge Owner Dendreon To Sanpower For $819.9 Mln Cash,2017-01-09 23:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SiYZosj0qYM/valeant-to-sell-provenge-owner-dendreon-to-sanpower-for-8199-mln-cash-20170109-01127,Valeant To Sell Provenge Owner Dendreon To Sanpower For $819.9 Mln Cash
VRX,VRX:CT,BBG000DC8S17,Valeant To Sell Provenge Owner Dendreon To Sanpower For $819.9 Mln Cash,2017-01-09 23:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SiYZosj0qYM/valeant-to-sell-provenge-owner-dendreon-to-sanpower-for-8199-mln-cash-20170109-01127,Valeant To Sell Provenge Owner Dendreon To Sanpower For $819.9 Mln Cash
VRX,VRX:US,BBG000DLFM21,Valeant hiked prices for a dizzying number of drugs last week,2017-01-09 21:58:19 +0000,http://finance.yahoo.com/news/valeant-hiked-prices-dizzying-number-215819771.html,Valeant hiked prices for a dizzying number of drugs last week
VRX,VRX:CT,BBG000DC8S17,Valeant hiked prices for a dizzying number of drugs last week,2017-01-09 21:58:19 +0000,http://finance.yahoo.com/news/valeant-hiked-prices-dizzying-number-215819771.html,Valeant hiked prices for a dizzying number of drugs last week
VRX,VRX:CT,BBG000DC8S17,Top Biotech Resolutions for 2017,2017-01-09 17:52:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kF2ga1VOMxk/top-biotech-resolutions-for-2017-cm731145,Battered by bad news beaten up biopharma has some work to do to restore investor confidence in 2017 The industry remains under scrutiny because of pricing decisions pipeline failures and profit concerns What can top stocks like Gilead Sciences NASDAQ GILD and
VRX,VRX:US,BBG000DLFM21,Top Biotech Resolutions for 2017,2017-01-09 17:52:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kF2ga1VOMxk/top-biotech-resolutions-for-2017-cm731145,Battered by bad news beaten up biopharma has some work to do to restore investor confidence in 2017 The industry remains under scrutiny because of pricing decisions pipeline failures and profit concerns What can top stocks like Gilead Sciences NASDAQ GILD and
VRX,VRX:CT,BBG000DC8S17,Why Valeant Stock Rose 5.5% Last Week,2017-01-09 17:51:00 +0000,http://www.investopedia.com/news/why-valeant-stock-rose-55-last-week-vrx/?partner=YahooSA,Why Valeant Stock Rose 5.5% Last Week
VRX,VRX:US,BBG000DLFM21,Why Valeant Stock Rose 5.5% Last Week,2017-01-09 17:51:00 +0000,http://www.investopedia.com/news/why-valeant-stock-rose-55-last-week-vrx/?partner=YahooSA,Why Valeant Stock Rose 5.5% Last Week
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Crude Oil Prices Weaken -- Canadian Commentary,2017-01-09 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V-owaFdGxJ4/canadian-stocks-are-falling-as-crude-oil-prices-weaken--canadian-commentary-20170109-00702,Canadian Stocks Are Falling As Crude Oil Prices Weaken -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Crude Oil Prices Weaken -- Canadian Commentary,2017-01-09 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V-owaFdGxJ4/canadian-stocks-are-falling-as-crude-oil-prices-weaken--canadian-commentary-20170109-00702,Canadian Stocks Are Falling As Crude Oil Prices Weaken -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,What If You Considered Gilead Sciences a Start-Up?,2017-01-08 19:13:34 +0000,http://www.fool.com/investing/2017/01/07/what-if-you-considered-gilead-sciences-a-start-up.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What If You Considered Gilead Sciences a Start-Up?
VRX,VRX:US,BBG000DLFM21,What If You Considered Gilead Sciences a Start-Up?,2017-01-08 19:13:34 +0000,http://www.fool.com/investing/2017/01/07/what-if-you-considered-gilead-sciences-a-start-up.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What If You Considered Gilead Sciences a Start-Up?
VRX,VRX:US,BBG000DLFM21,5 Destroyed Stocks That Could Be Major Buys In 2017,2017-01-07 21:20:00 +0000,https://www.thestreet.com/story/13939260/1/here-s-why-these-5-underdog-stocks-are-set-to-turn-around-in-2017.html?puc=yahoo&cm_ven=YAHOO,5 Destroyed Stocks That Could Be Major Buys In 2017
VRX,VRX:CT,BBG000DC8S17,5 Destroyed Stocks That Could Be Major Buys In 2017,2017-01-07 21:20:00 +0000,https://www.thestreet.com/story/13939260/1/here-s-why-these-5-underdog-stocks-are-set-to-turn-around-in-2017.html?puc=yahoo&cm_ven=YAHOO,5 Destroyed Stocks That Could Be Major Buys In 2017
VRX,VRX:CT,BBG000DC8S17,The Biggest Hedge Fund Failures of 2016,2017-01-06 18:59:00 +0000,http://www.investopedia.com/news/biggest-hedge-fund-failures-2016-vrxpshas/?partner=YahooSA,The Biggest Hedge Fund Failures of 2016
VRX,VRX:US,BBG000DLFM21,The Biggest Hedge Fund Failures of 2016,2017-01-06 18:59:00 +0000,http://www.investopedia.com/news/biggest-hedge-fund-failures-2016-vrxpshas/?partner=YahooSA,The Biggest Hedge Fund Failures of 2016
VRX,VRX:CT,BBG000DC8S17,The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016,2017-01-06 16:40:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-yCMX_sHJs/the-laundry-list-of-reasons-why-valeant-pharmaceuticals-intl-inc-plummeted-86-in-2016-cm730388,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX a drugmaker that s primarily grown by acquisition in recent years plummeted 86 in 2016 according to data from S amp P Global Market Intelligence making it one of the year
VRX,VRX:US,BBG000DLFM21,The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016,2017-01-06 16:40:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-yCMX_sHJs/the-laundry-list-of-reasons-why-valeant-pharmaceuticals-intl-inc-plummeted-86-in-2016-cm730388,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX a drugmaker that s primarily grown by acquisition in recent years plummeted 86 in 2016 according to data from S amp P Global Market Intelligence making it one of the year
VRX,VRX:CT,BBG000DC8S17,The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016,2017-01-06 15:22:05 +0000,http://www.fool.com/investing/2017/01/06/the-laundry-list-of-reasons-why-valeant-pharmaceut.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016
VRX,VRX:US,BBG000DLFM21,The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016,2017-01-06 15:22:05 +0000,http://www.fool.com/investing/2017/01/06/the-laundry-list-of-reasons-why-valeant-pharmaceut.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary,2017-01-06 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YMQUqy2f4nM/canadian-stocks-are-pulling-back-on-gold-weakness--canadian-commentary-20170106-00414,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary,2017-01-06 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YMQUqy2f4nM/canadian-stocks-are-pulling-back-on-gold-weakness--canadian-commentary-20170106-00414,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare,2017-01-05 15:30:00 +0000,https://www.thestreet.com/story/13942819/1/six-happenings-you-won-t-want-to-miss-when-frisco-takes-center-stage-in-healthcare.html?puc=yahoo&cm_ven=YAHOO,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare
VRX,VRX:US,BBG000DLFM21,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare,2017-01-05 15:30:00 +0000,https://www.thestreet.com/story/13942819/1/six-happenings-you-won-t-want-to-miss-when-frisco-takes-center-stage-in-healthcare.html?puc=yahoo&cm_ven=YAHOO,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary,2017-01-05 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Go6rtoQEU9o/canadian-stocks-are-climbing-on-gold-strength--canadian-commentary-20170105-00796,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary,2017-01-05 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Go6rtoQEU9o/canadian-stocks-are-climbing-on-gold-strength--canadian-commentary-20170105-00796,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Hawkish Fed Fails to Spook Dow Jones Industrial Average,2017-01-04 22:36:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qgwrhlJUfjo/hawkish-fed-fails-to-spook-dow-jones-industrial-average-cm729551,The 160 Dow Jones Industrial Average DJIA 160 explored a relatively narrow range of 77 points as traders awaited then digested the minutes from December s Federal Reserve meeting Specifically the minutes suggested a more hawkish tone from some Fed officials who said the
VRX,VRX:CT,BBG000DC8S17,Hawkish Fed Fails to Spook Dow Jones Industrial Average,2017-01-04 22:36:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qgwrhlJUfjo/hawkish-fed-fails-to-spook-dow-jones-industrial-average-cm729551,The 160 Dow Jones Industrial Average DJIA 160 explored a relatively narrow range of 77 points as traders awaited then digested the minutes from December s Federal Reserve meeting Specifically the minutes suggested a more hawkish tone from some Fed officials who said the
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial",2017-01-04 22:03:41 +0000,http://biz.yahoo.com/e/170104/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial"
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial",2017-01-04 22:03:41 +0000,http://biz.yahoo.com/e/170104/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors,2017-01-04 21:33:12 +0000,http://www.publicnow.com/view/E9685D2F9C18729A8ADFD8A7FBAEA3758C74C3F2,"[at noodls] - LAVAL, Quebec, Jan. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today announced that the Board of Directors has elected Richard (Dick) U. DeSchutter ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors,2017-01-04 21:33:12 +0000,http://www.publicnow.com/view/E9685D2F9C18729A8ADFD8A7FBAEA3758C74C3F2,"[at noodls] - LAVAL, Quebec, Jan. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today announced that the Board of Directors has elected Richard (Dick) U. DeSchutter ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference,2017-01-04 21:30:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-present-35th-annual-213000449.html,[CNW Group] - Valeant Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference,2017-01-04 21:30:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-present-35th-annual-213000449.html,[CNW Group] - Valeant Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference
VRX,VRX:US,BBG000DLFM21,Health Care Stocks With Short-term Upside (AGN),2017-01-04 18:00:00 +0000,http://www.investopedia.com/stock-analysis/cotd/010417/health-care-stocks-shortterm-upside-agn-vrx-agn-vrx-endp.aspx?partner=YahooSA,Health Care Stocks With Short-term Upside (AGN)
VRX,VRX:CT,BBG000DC8S17,Health Care Stocks With Short-term Upside (AGN),2017-01-04 18:00:00 +0000,http://www.investopedia.com/stock-analysis/cotd/010417/health-care-stocks-shortterm-upside-agn-vrx-agn-vrx-endp.aspx?partner=YahooSA,Health Care Stocks With Short-term Upside (AGN)
VRX,VRX:US,BBG000DLFM21,Valeant: Here's Why Piper Says It's Not Investable,2017-01-04 15:18:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/04/valeant-heres-why-piper-says-its-not-investable/?mod=yahoobarrons&ru=yahoo,Valeant: Here's Why Piper Says It's Not Investable
VRX,VRX:CT,BBG000DC8S17,Valeant: Here's Why Piper Says It's Not Investable,2017-01-04 15:18:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/04/valeant-heres-why-piper-says-its-not-investable/?mod=yahoobarrons&ru=yahoo,Valeant: Here's Why Piper Says It's Not Investable
VRX,VRX:CT,BBG000DC8S17,Jim Cramer -- Valeant Has Too Much Debt,2017-01-04 15:06:00 +0000,https://www.thestreet.com/story/13941967/1/jim-cramer-valeant-has-too-much-debt.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer -- Valeant Has Too Much Debt
VRX,VRX:US,BBG000DLFM21,Jim Cramer -- Valeant Has Too Much Debt,2017-01-04 15:06:00 +0000,https://www.thestreet.com/story/13941967/1/jim-cramer-valeant-has-too-much-debt.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer -- Valeant Has Too Much Debt
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Extending Their Gains -- Canadian Commentary,2017-01-04 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GjwsLF8Y_ns/canadian-stocks-are-extending-their-gains--canadian-commentary-20170104-00753,Canadian Stocks Are Extending Their Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Extending Their Gains -- Canadian Commentary,2017-01-04 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GjwsLF8Y_ns/canadian-stocks-are-extending-their-gains--canadian-commentary-20170104-00753,Canadian Stocks Are Extending Their Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Cramer: Reviewing S&P's Hit-and-Miss Parade,2017-01-04 00:01:00 +0000,http://realmoney.thestreet.com/articles/01/03/2017/cramer-reviewing-sps-hit-and-miss-parade?puc=yahoo&cm_ven=YAHOO,Cramer: Reviewing S&P's Hit-and-Miss Parade
VRX,VRX:CT,BBG000DC8S17,Cramer: Reviewing S&P's Hit-and-Miss Parade,2017-01-04 00:01:00 +0000,http://realmoney.thestreet.com/articles/01/03/2017/cramer-reviewing-sps-hit-and-miss-parade?puc=yahoo&cm_ven=YAHOO,Cramer: Reviewing S&P's Hit-and-Miss Parade
VRX,VRX:CT,BBG000DC8S17,Is Valeant (VRX) Fated for Terrible 2017 As Well?,2017-01-03 22:38:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u64kNE56hho/is-valeant-vrx-fated-for-terrible-2017-as-well-cm728932,Shares of Valeant Pharmaceuticals Inc VRX slumped 85 3 in 2016 eroding a chunk of shareholders net worth Shares of Valeant underperformed the Zacks classified Medical Drugs industry 2016 as well taking into account a decline of 22 9 for the industry Once an acquisition
VRX,VRX:US,BBG000DLFM21,Is Valeant (VRX) Fated for Terrible 2017 As Well?,2017-01-03 22:38:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u64kNE56hho/is-valeant-vrx-fated-for-terrible-2017-as-well-cm728932,Shares of Valeant Pharmaceuticals Inc VRX slumped 85 3 in 2016 eroding a chunk of shareholders net worth Shares of Valeant underperformed the Zacks classified Medical Drugs industry 2016 as well taking into account a decline of 22 9 for the industry Once an acquisition
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl. Inc.'s Biggest Catalysts in 2017,2017-01-03 22:37:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lHpx7_rJNVw/valeant-pharmaceuticals-intl-incs-biggest-catalysts-in-2017-cm728938,Image source Getty Images There s no tiptoeing around it 2016 was a miserable year for shareholders of Valeant Pharmaceuticals NYSE VRX With a year to date loss of 86 through Dec 29 Valeant would make a strong candidate for worst stock of the year However despite
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl. Inc.'s Biggest Catalysts in 2017,2017-01-03 22:37:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lHpx7_rJNVw/valeant-pharmaceuticals-intl-incs-biggest-catalysts-in-2017-cm728938,Image source Getty Images There s no tiptoeing around it 2016 was a miserable year for shareholders of Valeant Pharmaceuticals NYSE VRX With a year to date loss of 86 through Dec 29 Valeant would make a strong candidate for worst stock of the year However despite
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl. Inc.'s Biggest Catalysts in 2017,2017-01-03 21:24:07 +0000,http://www.fool.com/investing/2017/01/03/valeant-pharmaceuticals-intl-incs-biggest-catalyst.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Intl. Inc.'s Biggest Catalysts in 2017
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl. Inc.'s Biggest Catalysts in 2017,2017-01-03 21:24:07 +0000,http://www.fool.com/investing/2017/01/03/valeant-pharmaceuticals-intl-incs-biggest-catalyst.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Intl. Inc.'s Biggest Catalysts in 2017
VRX,VRX:CT,BBG000DC8S17,Is Valeant (VRX) Fated for Terrible 2017 As Well?,2017-01-03 20:22:08 +0000,http://finance.yahoo.com/news/valeant-vrx-fated-terrible-2017-202208831.html,Is Valeant (VRX) Fated for Terrible 2017 As Well?
VRX,VRX:US,BBG000DLFM21,Is Valeant (VRX) Fated for Terrible 2017 As Well?,2017-01-03 20:22:08 +0000,http://finance.yahoo.com/news/valeant-vrx-fated-terrible-2017-202208831.html,Is Valeant (VRX) Fated for Terrible 2017 As Well?
VRX,VRX:CT,BBG000DC8S17,Will Valeant Stock Remain Toxic in 2017?,2017-01-03 18:44:00 +0000,http://www.investopedia.com/news/will-valeant-stock-remain-toxic-2017-vrx/?partner=YahooSA,Will Valeant Stock Remain Toxic in 2017?
VRX,VRX:US,BBG000DLFM21,Will Valeant Stock Remain Toxic in 2017?,2017-01-03 18:44:00 +0000,http://www.investopedia.com/news/will-valeant-stock-remain-toxic-2017-vrx/?partner=YahooSA,Will Valeant Stock Remain Toxic in 2017?
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing After Surge In Crude Prices -- Canadian Commentary,2017-01-03 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cV_b_ltTQCM/canadian-stocks-are-climbing-after-surge-in-crude-prices--canadian-commentary-20170103-00624,Canadian Stocks Are Climbing After Surge In Crude Prices -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing After Surge In Crude Prices -- Canadian Commentary,2017-01-03 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cV_b_ltTQCM/canadian-stocks-are-climbing-after-surge-in-crude-prices--canadian-commentary-20170103-00624,Canadian Stocks Are Climbing After Surge In Crude Prices -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,A Sampling Of Citron's Most Influential Tweets,2017-01-02 15:13:33 +0000,http://finance.yahoo.com/news/sampling-citrons-most-influential-tweets-151333590.html,A Sampling Of Citron's Most Influential Tweets
VRX,VRX:US,BBG000DLFM21,A Sampling Of Citron's Most Influential Tweets,2017-01-02 15:13:33 +0000,http://finance.yahoo.com/news/sampling-citrons-most-influential-tweets-151333590.html,A Sampling Of Citron's Most Influential Tweets
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary,2016-12-30 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QqYa-edo8hs/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20161230-00154,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary,2016-12-30 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QqYa-edo8hs/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20161230-00154,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,4 Biotech Stocks with Bright Prospects in 2017,2016-12-29 22:29:10 +0000,http://finance.yahoo.com/news/4-biotech-stocks-bright-prospects-222910692.html,4 Biotech Stocks with Bright Prospects in 2017
VRX,VRX:CT,BBG000DC8S17,4 Biotech Stocks with Bright Prospects in 2017,2016-12-29 22:29:10 +0000,http://finance.yahoo.com/news/4-biotech-stocks-bright-prospects-222910692.html,4 Biotech Stocks with Bright Prospects in 2017
VRX,VRX:CT,BBG000DC8S17,"Watch Beaten-Down Drug Companies, Hospitals in 2017",2016-12-29 21:00:00 +0000,http://realmoney.thestreet.com/articles/12/29/2016/watch-beaten-down-drug-companies-hospitals-2017?puc=yahoo&cm_ven=YAHOO,"Watch Beaten-Down Drug Companies, Hospitals in 2017"
VRX,VRX:US,BBG000DLFM21,"Watch Beaten-Down Drug Companies, Hospitals in 2017",2016-12-29 21:00:00 +0000,http://realmoney.thestreet.com/articles/12/29/2016/watch-beaten-down-drug-companies-hospitals-2017?puc=yahoo&cm_ven=YAHOO,"Watch Beaten-Down Drug Companies, Hospitals in 2017"
VRX,VRX:CT,BBG000DC8S17,3 Reasons to Fire Your Money Manager For 2017,2016-12-29 19:34:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/htEYThGgskQ/3-reasons-to-fire-your-money-manager-for-2017-cm727619,"""Women lie, men lie, but numbers don’t,"" Hip hop mogul Jay Z, a.k.a Sean Carter   It doesn't get more basic than that, referring to the quote above and the implication of how straightforward numbers are. But that doesn't mean those who fiddle with numbers such as investment money managers won't come up with excuses"
VRX,VRX:US,BBG000DLFM21,3 Reasons to Fire Your Money Manager For 2017,2016-12-29 19:34:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/htEYThGgskQ/3-reasons-to-fire-your-money-manager-for-2017-cm727619,"""Women lie, men lie, but numbers don’t,"" Hip hop mogul Jay Z, a.k.a Sean Carter   It doesn't get more basic than that, referring to the quote above and the implication of how straightforward numbers are. But that doesn't mean those who fiddle with numbers such as investment money managers won't come up with excuses"
VRX,VRX:US,BBG000DLFM21,"Thursday’s Vital Data: Apple Inc. (AAPL), Nvidia Corporation (NVDA), and Valeant Pharmaceuticals Intl Inc (VRX)",2016-12-29 17:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VtsNkjhjDMo/thursdays-vital-data-apple-inc-aapl-nvidia-corporation-nvda-and-valeant-pharmaceuticals-intl-inc-vrx-cm727498,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are mixed heading into the open as Wall Street faces another round of data before heading into the New Year s break Weekly jobless claims and November trade balance
VRX,VRX:CT,BBG000DC8S17,"Thursday’s Vital Data: Apple Inc. (AAPL), Nvidia Corporation (NVDA), and Valeant Pharmaceuticals Intl Inc (VRX)",2016-12-29 17:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VtsNkjhjDMo/thursdays-vital-data-apple-inc-aapl-nvidia-corporation-nvda-and-valeant-pharmaceuticals-intl-inc-vrx-cm727498,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are mixed heading into the open as Wall Street faces another round of data before heading into the New Year s break Weekly jobless claims and November trade balance
VRX,VRX:CT,BBG000DC8S17,"Heard on the Street in 2016: We Were Right, Except When We Were Wrong",2016-12-29 16:28:56 +0000,http://blogs.wsj.com/moneybeat/2016/12/29/heard-on-the-street-in-2016-we-were-right-except-when-we-were-wrong/?mod=yahoo_hs,"Heard on the Street in 2016: We Were Right, Except When We Were Wrong"
VRX,VRX:US,BBG000DLFM21,"Heard on the Street in 2016: We Were Right, Except When We Were Wrong",2016-12-29 16:28:56 +0000,http://blogs.wsj.com/moneybeat/2016/12/29/heard-on-the-street-in-2016-we-were-right-except-when-we-were-wrong/?mod=yahoo_hs,"Heard on the Street in 2016: We Were Right, Except When We Were Wrong"
VRX,VRX:US,BBG000DLFM21,Mallinckrodt: Turning Into Sourdough?,2016-12-29 14:34:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/29/mallinckrodt-turning-into-sourdough/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: Turning Into Sourdough?
VRX,VRX:CT,BBG000DC8S17,Mallinckrodt: Turning Into Sourdough?,2016-12-29 14:34:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/29/mallinckrodt-turning-into-sourdough/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: Turning Into Sourdough?
VRX,VRX:CT,BBG000DC8S17,Why Did Valeant Pharmaceuticals Update Its 2016 EPS Guidance?,2016-12-29 12:35:48 +0000,http://marketrealist.com/2016/12/valeant-pharmaceuticals-updated-2016-eps-guidance/?utm_source=yahoo&utm_medium=feed,Why Did Valeant Pharmaceuticals Update Its 2016 EPS Guidance?
VRX,VRX:US,BBG000DLFM21,Why Did Valeant Pharmaceuticals Update Its 2016 EPS Guidance?,2016-12-29 12:35:48 +0000,http://marketrealist.com/2016/12/valeant-pharmaceuticals-updated-2016-eps-guidance/?utm_source=yahoo&utm_medium=feed,Why Did Valeant Pharmaceuticals Update Its 2016 EPS Guidance?
VRX,VRX:CT,BBG000DC8S17,Valeant's Meltdown in 2016: A Year In Review,2016-12-28 17:23:00 +0000,http://www.investopedia.com/articles/investing/122816/valeants-meltdown-2016-year-review-vrx.asp?partner=YahooSA,Valeant's Meltdown in 2016: A Year In Review
VRX,VRX:US,BBG000DLFM21,Valeant's Meltdown in 2016: A Year In Review,2016-12-28 17:23:00 +0000,http://www.investopedia.com/articles/investing/122816/valeants-meltdown-2016-year-review-vrx.asp?partner=YahooSA,Valeant's Meltdown in 2016: A Year In Review
VRX,VRX:CT,BBG000DC8S17,VRX’s US Diversified Products Segment Could See Falling Revenues in 2017,2016-12-28 15:36:35 +0000,http://marketrealist.com/2016/12/u-s-diversified-products-segment-expected-witness-revenue-decline-2017/?utm_source=yahoo&utm_medium=feed,VRX’s US Diversified Products Segment Could See Falling Revenues in 2017
VRX,VRX:US,BBG000DLFM21,VRX’s US Diversified Products Segment Could See Falling Revenues in 2017,2016-12-28 15:36:35 +0000,http://marketrealist.com/2016/12/u-s-diversified-products-segment-expected-witness-revenue-decline-2017/?utm_source=yahoo&utm_medium=feed,VRX’s US Diversified Products Segment Could See Falling Revenues in 2017
VRX,VRX:CT,BBG000DC8S17,VRX’s Gastrointestinal Segment Saw Robust Revenue Growth in 2016,2016-12-28 14:06:36 +0000,http://marketrealist.com/2016/12/valeant-pharmaceuticals-gastro-intestinal-segment-continues-report-robust-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,VRX’s Gastrointestinal Segment Saw Robust Revenue Growth in 2016
VRX,VRX:US,BBG000DLFM21,VRX’s Gastrointestinal Segment Saw Robust Revenue Growth in 2016,2016-12-28 14:06:36 +0000,http://marketrealist.com/2016/12/valeant-pharmaceuticals-gastro-intestinal-segment-continues-report-robust-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,VRX’s Gastrointestinal Segment Saw Robust Revenue Growth in 2016
VRX,VRX:US,BBG000DLFM21,VRX’s Branded Rx Segment Witnessed Drop in Revenues in 2016,2016-12-28 12:36:18 +0000,http://marketrealist.com/2016/12/branded-rx-segment-witnessed-drop-revenues-2016/?utm_source=yahoo&utm_medium=feed,VRX’s Branded Rx Segment Witnessed Drop in Revenues in 2016
VRX,VRX:CT,BBG000DC8S17,VRX’s Branded Rx Segment Witnessed Drop in Revenues in 2016,2016-12-28 12:36:18 +0000,http://marketrealist.com/2016/12/branded-rx-segment-witnessed-drop-revenues-2016/?utm_source=yahoo&utm_medium=feed,VRX’s Branded Rx Segment Witnessed Drop in Revenues in 2016
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Resource Strength -- Canadian Commentary,2016-12-28 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Ow0wafdjl8/canadian-stocks-are-rising-on-resource-strength--canadian-commentary-20161228-00178,Canadian Stocks Are Rising On Resource Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Resource Strength -- Canadian Commentary,2016-12-28 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Ow0wafdjl8/canadian-stocks-are-rising-on-resource-strength--canadian-commentary-20161228-00178,Canadian Stocks Are Rising On Resource Strength -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,International Segment: Key Driver of VRX’s Revenue Growth in 2016,2016-12-27 23:05:35 +0000,http://marketrealist.com/2016/12/international-segment-key-driver-valeant-pharmaceuticals-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,International Segment: Key Driver of VRX’s Revenue Growth in 2016
VRX,VRX:US,BBG000DLFM21,International Segment: Key Driver of VRX’s Revenue Growth in 2016,2016-12-27 23:05:35 +0000,http://marketrealist.com/2016/12/international-segment-key-driver-valeant-pharmaceuticals-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,International Segment: Key Driver of VRX’s Revenue Growth in 2016
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Could See Modest Revenue Decline in 2016,2016-12-27 21:24:05 +0000,http://marketrealist.com/2016/12/valeant-pharmaceuticals-expected-witness-modest-revenue-decline-2016/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals Could See Modest Revenue Decline in 2016
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Could See Modest Revenue Decline in 2016,2016-12-27 21:24:05 +0000,http://marketrealist.com/2016/12/valeant-pharmaceuticals-expected-witness-modest-revenue-decline-2016/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals Could See Modest Revenue Decline in 2016
VRX,VRX:CT,BBG000DC8S17,These 3 Big 2016 Losers Look Like They Will Continue to Struggle,2016-12-27 16:38:00 +0000,https://www.thestreet.com/story/13937042/1/these-3-big-2016-losers-look-like-they-will-continue-to-struggle.html?puc=yahoo&cm_ven=YAHOO,These 3 Big 2016 Losers Look Like They Will Continue to Struggle
VRX,VRX:US,BBG000DLFM21,These 3 Big 2016 Losers Look Like They Will Continue to Struggle,2016-12-27 16:38:00 +0000,https://www.thestreet.com/story/13937042/1/these-3-big-2016-losers-look-like-they-will-continue-to-struggle.html?puc=yahoo&cm_ven=YAHOO,These 3 Big 2016 Losers Look Like They Will Continue to Struggle
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Stock Has Plunged 86% in 2016. When Will the Nightmare End?,2016-12-24 11:21:47 +0000,http://www.fool.com/investing/2016/12/23/valeant-pharmaceuticals-stock-has-plunged-86-in-20.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Stock Has Plunged 86% in 2016. When Will the Nightmare End?
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Stock Has Plunged 86% in 2016. When Will the Nightmare End?,2016-12-24 11:21:47 +0000,http://www.fool.com/investing/2016/12/23/valeant-pharmaceuticals-stock-has-plunged-86-in-20.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Stock Has Plunged 86% in 2016. When Will the Nightmare End?
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Stock Has Plunged 86% in 2016. When Will the Nightmare End?,2016-12-23 16:58:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ANfGcn-ZtEM/valeant-pharmaceuticals-stock-has-plunged-86-in-2016-when-will-the-nightmare-end-cm725731,Borrowing heavily to acquire drugs and then raising their prices was a fantastic business model for Valeant Pharmaceuticals NYSE VRX 160 until suddenly it wasn t It appears the company s ability to generate increasing profits through price hikes is evaporating along with
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Stock Has Plunged 86% in 2016. When Will the Nightmare End?,2016-12-23 16:58:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ANfGcn-ZtEM/valeant-pharmaceuticals-stock-has-plunged-86-in-2016-when-will-the-nightmare-end-cm725731,Borrowing heavily to acquire drugs and then raising their prices was a fantastic business model for Valeant Pharmaceuticals NYSE VRX 160 until suddenly it wasn t It appears the company s ability to generate increasing profits through price hikes is evaporating along with
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: A Trump Winner or Loser?,2016-12-23 16:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/23/valeant-pharmaceuticals-a-trump-winner-or-loser/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: A Trump Winner or Loser?
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: A Trump Winner or Loser?,2016-12-23 16:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/23/valeant-pharmaceuticals-a-trump-winner-or-loser/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: A Trump Winner or Loser?
VRX,VRX:CT,BBG000DC8S17,A Festivus for the Invest in Us -- It's Time for the Airing of Grievances,2016-12-23 13:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mRVtHnLMpoY/a-festivus-for-the-invest-in-us-its-time-for-the-airing-of-grievances-cm725514,Image source Eva Marley Flickr If you need any proof that what we watch on television helps shape our values look no further than Festivus the fictitious holiday conceived by popular comedy show Seinfeld 160 in 1997 Designed as an alternative to the commercialization
VRX,VRX:US,BBG000DLFM21,A Festivus for the Invest in Us -- It's Time for the Airing of Grievances,2016-12-23 13:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mRVtHnLMpoY/a-festivus-for-the-invest-in-us-its-time-for-the-airing-of-grievances-cm725514,Image source Eva Marley Flickr If you need any proof that what we watch on television helps shape our values look no further than Festivus the fictitious holiday conceived by popular comedy show Seinfeld 160 in 1997 Designed as an alternative to the commercialization
VRX,VRX:CT,BBG000DC8S17,A Festivus for the Invest in Us -- It's Time for the Airing of Grievances,2016-12-23 12:02:07 +0000,http://www.fool.com/investing/2016/12/23/a-festivus-for-the-invest-in-us-its-time-for-the-a.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,A Festivus for the Invest in Us -- It's Time for the Airing of Grievances
VRX,VRX:US,BBG000DLFM21,A Festivus for the Invest in Us -- It's Time for the Airing of Grievances,2016-12-23 12:02:07 +0000,http://www.fool.com/investing/2016/12/23/a-festivus-for-the-invest-in-us-its-time-for-the-a.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,A Festivus for the Invest in Us -- It's Time for the Airing of Grievances
VRX,VRX:US,BBG000DLFM21,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-23 11:36:39 +0000,http://www.fool.com/investing/2016/12/22/are-these-3-stocks-the-biggest-comeback-opportunit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?
VRX,VRX:CT,BBG000DC8S17,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-23 11:36:39 +0000,http://www.fool.com/investing/2016/12/22/are-these-3-stocks-the-biggest-comeback-opportunit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?
VRX,VRX:CT,BBG000DC8S17,The Worst Performing Stocks on U.S. Exchanges in 2016,2016-12-23 11:00:00 +0000,http://www.investopedia.com/articles/investing/122316/worst-performing-stocks-us-exchanges-2016-vrx-drys.asp?partner=YahooSA,The Worst Performing Stocks on U.S. Exchanges in 2016
VRX,VRX:US,BBG000DLFM21,The Worst Performing Stocks on U.S. Exchanges in 2016,2016-12-23 11:00:00 +0000,http://www.investopedia.com/articles/investing/122316/worst-performing-stocks-us-exchanges-2016-vrx-drys.asp?partner=YahooSA,The Worst Performing Stocks on U.S. Exchanges in 2016
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Gold Stocks Shine -- Canadian Commentary,2016-12-23 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pz-sum38770/canadian-stocks-are-rising-as-gold-stocks-shine--canadian-commentary-20161223-00281,Canadian Stocks Are Rising As Gold Stocks Shine -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Gold Stocks Shine -- Canadian Commentary,2016-12-23 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pz-sum38770/canadian-stocks-are-rising-as-gold-stocks-shine--canadian-commentary-20161223-00281,Canadian Stocks Are Rising As Gold Stocks Shine -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : December 22, 2016",2016-12-22 19:22:49 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-december-22-2016/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : December 22, 2016"
VRX,VRX:US,BBG000DLFM21,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : December 22, 2016",2016-12-22 19:22:49 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-december-22-2016/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : December 22, 2016"
VRX,VRX:CT,BBG000DC8S17,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-22 17:01:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JqWGDEjmx7c/are-these-3-stocks-the-biggest-comeback-opportunities-of-2017-cm725176,Don t try to catch a falling knife That s good advice literally and figuratively when it comes to buying stocks You never know if a plunging stock will go down a lot more Three stocks that have certainly fallen this year are Alexion Pharmaceuticals NASDAQ ALXN
VRX,VRX:US,BBG000DLFM21,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-22 17:01:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JqWGDEjmx7c/are-these-3-stocks-the-biggest-comeback-opportunities-of-2017-cm725176,Don t try to catch a falling knife That s good advice literally and figuratively when it comes to buying stocks You never know if a plunging stock will go down a lot more Three stocks that have certainly fallen this year are Alexion Pharmaceuticals NASDAQ ALXN
VRX,VRX:US,BBG000DLFM21,2016 Was a Terrible Year for Biotech but the Tweets Were on Point,2016-12-22 14:24:00 +0000,https://www.thestreet.com/story/13925755/1/2016-was-a-terrible-year-for-biotech-but-the-tweets-were-on-point.html?puc=yahoo&cm_ven=YAHOO,2016 Was a Terrible Year for Biotech but the Tweets Were on Point
VRX,VRX:CT,BBG000DC8S17,2016 Was a Terrible Year for Biotech but the Tweets Were on Point,2016-12-22 14:24:00 +0000,https://www.thestreet.com/story/13925755/1/2016-was-a-terrible-year-for-biotech-but-the-tweets-were-on-point.html?puc=yahoo&cm_ven=YAHOO,2016 Was a Terrible Year for Biotech but the Tweets Were on Point
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up Slightly In Pre-Holiday Trade -- Canadian Commentary,2016-12-22 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g68FL8gnZ1o/canadian-stocks-are-up-slightly-in-preholiday-trade--canadian-commentary-20161222-00463,Canadian Stocks Are Up Slightly In Pre-Holiday Trade -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up Slightly In Pre-Holiday Trade -- Canadian Commentary,2016-12-22 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g68FL8gnZ1o/canadian-stocks-are-up-slightly-in-preholiday-trade--canadian-commentary-20161222-00463,Canadian Stocks Are Up Slightly In Pre-Holiday Trade -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Senators urge action to block drastic drug price hikes,2016-12-21 22:01:14 +0000,http://sg.finance.yahoo.com/news/senators-urge-action-block-drastic-203402211.html,Senators urge action to block drastic drug price hikes
VRX,VRX:CT,BBG000DC8S17,Senators urge action to block drastic drug price hikes,2016-12-21 22:01:14 +0000,http://sg.finance.yahoo.com/news/senators-urge-action-block-drastic-203402211.html,Senators urge action to block drastic drug price hikes
VRX,VRX:CT,BBG000DC8S17,The Senate just released a massive report on drug pricing — here's what you need to know,2016-12-21 16:09:00 +0000,http://finance.yahoo.com/news/senate-just-released-massive-report-160900797.html,The Senate just released a massive report on drug pricing — here's what you need to know
VRX,VRX:US,BBG000DLFM21,The Senate just released a massive report on drug pricing — here's what you need to know,2016-12-21 16:09:00 +0000,http://finance.yahoo.com/news/senate-just-released-massive-report-160900797.html,The Senate just released a massive report on drug pricing — here's what you need to know
VRX,VRX:US,BBG000DLFM21,Valeant: Is This the Way Out?,2016-12-21 15:37:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/21/valeant-is-this-the-way-out/?mod=yahoobarrons&ru=yahoo,Valeant: Is This the Way Out?
VRX,VRX:CT,BBG000DC8S17,Valeant: Is This the Way Out?,2016-12-21 15:37:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/21/valeant-is-this-the-way-out/?mod=yahoobarrons&ru=yahoo,Valeant: Is This the Way Out?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Gains After EIA Report -- Canadian Commentary,2016-12-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IsN6IDiZ95s/canadian-stocks-are-paring-gains-after-eia-report--canadian-commentary-20161221-00514,Canadian Stocks Are Paring Gains After EIA Report -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Gains After EIA Report -- Canadian Commentary,2016-12-21 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IsN6IDiZ95s/canadian-stocks-are-paring-gains-after-eia-report--canadian-commentary-20161221-00514,Canadian Stocks Are Paring Gains After EIA Report -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Inside the Mind of Bill Ackman As Valeant Collapsed,2016-12-21 01:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S9HTJa1kmOg/inside-the-mind-of-bill-ackman-as-valeant-collapsed-cm724334,Welcome to Mind Over Money I m Kevin Cook your field guide and story teller for the fascinating arena of Behavioral Economics I m back after a 3 week bout with bronchitis I ve got a funny story about what I learned at the doctor that ties into a great neuroscience topic how we acquire
VRX,VRX:CT,BBG000DC8S17,Inside the Mind of Bill Ackman As Valeant Collapsed,2016-12-21 01:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S9HTJa1kmOg/inside-the-mind-of-bill-ackman-as-valeant-collapsed-cm724334,Welcome to Mind Over Money I m Kevin Cook your field guide and story teller for the fascinating arena of Behavioral Economics I m back after a 3 week bout with bronchitis I ve got a funny story about what I learned at the doctor that ties into a great neuroscience topic how we acquire
VRX,VRX:CT,BBG000DC8S17,Inside the Mind of Bill Ackman As Valeant Collapsed,2016-12-20 23:22:11 +0000,http://finance.yahoo.com/news/inside-mind-bill-ackman-valeant-232211992.html,Inside the Mind of Bill Ackman As Valeant Collapsed
VRX,VRX:US,BBG000DLFM21,Inside the Mind of Bill Ackman As Valeant Collapsed,2016-12-20 23:22:11 +0000,http://finance.yahoo.com/news/inside-mind-bill-ackman-valeant-232211992.html,Inside the Mind of Bill Ackman As Valeant Collapsed
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up Despite Weakness In Gold -- Canadian Commentary,2016-12-20 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OudTNuYXj3c/canadian-stocks-are-up-despite-weakness-in-gold--canadian-commentary-20161220-00581,Canadian Stocks Are Up Despite Weakness In Gold -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up Despite Weakness In Gold -- Canadian Commentary,2016-12-20 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OudTNuYXj3c/canadian-stocks-are-up-despite-weakness-in-gold--canadian-commentary-20161220-00581,Canadian Stocks Are Up Despite Weakness In Gold -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2016-12-19 16:00:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ndfb27xMqnw/do-options-traders-know-something-about-valeant-pharmaceuticals-vrx-stock-we-dont-cm723197,Investors in shares of Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the Call which expires on Jan 20 2017 for the 200 00 strike price had some of the highest implied volatility of all
VRX,VRX:US,BBG000DLFM21,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2016-12-19 16:00:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ndfb27xMqnw/do-options-traders-know-something-about-valeant-pharmaceuticals-vrx-stock-we-dont-cm723197,Investors in shares of Valeant Pharmaceuticals International Inc VRX need to pay close attention to the stock based on moves in the options market lately That is because the Call which expires on Jan 20 2017 for the 200 00 strike price had some of the highest implied volatility of all
VRX,VRX:CT,BBG000DC8S17,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2016-12-19 13:56:01 +0000,http://finance.yahoo.com/news/options-traders-know-something-valeant-135601851.html,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?
VRX,VRX:US,BBG000DLFM21,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?,2016-12-19 13:56:01 +0000,http://finance.yahoo.com/news/options-traders-know-something-valeant-135601851.html,Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?
VRX,VRX:CT,BBG000DC8S17,The 11 Biggest Manager Changes of 2016,2016-12-19 12:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=784966&SR=Yahoo,The 11 Biggest Manager Changes of 2016
VRX,VRX:US,BBG000DLFM21,The 11 Biggest Manager Changes of 2016,2016-12-19 12:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=784966&SR=Yahoo,The 11 Biggest Manager Changes of 2016
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Healthcare Strength -- Canadian Commentary,2016-12-19 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dyqb7NCd7RU/canadian-stocks-are-climbing-on-healthcare-strength--canadian-commentary-20161219-00571,Canadian Stocks Are Climbing On Healthcare Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Healthcare Strength -- Canadian Commentary,2016-12-19 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dyqb7NCd7RU/canadian-stocks-are-climbing-on-healthcare-strength--canadian-commentary-20161219-00571,Canadian Stocks Are Climbing On Healthcare Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Hospitals Alter Routines to Control Drug Spending,2016-12-19 05:06:44 +0000,http://www.wsj.com/articles/hospitals-alter-routines-to-control-drug-spending-1482062403?ru=yahoo?mod=yahoo_itp,Hospitals Alter Routines to Control Drug Spending
VRX,VRX:CT,BBG000DC8S17,Hospitals Alter Routines to Control Drug Spending,2016-12-19 05:06:44 +0000,http://www.wsj.com/articles/hospitals-alter-routines-to-control-drug-spending-1482062403?ru=yahoo?mod=yahoo_itp,Hospitals Alter Routines to Control Drug Spending
VRX,VRX:CT,BBG000DC8S17,A Look Back At Valeant's Tumultuous 2016,2016-12-19 02:18:42 +0000,http://finance.yahoo.com/news/look-back-valeants-tumultuous-2016-021842170.html,A Look Back At Valeant's Tumultuous 2016
VRX,VRX:US,BBG000DLFM21,A Look Back At Valeant's Tumultuous 2016,2016-12-19 02:18:42 +0000,http://finance.yahoo.com/news/look-back-valeants-tumultuous-2016-021842170.html,A Look Back At Valeant's Tumultuous 2016
VRX,VRX:US,BBG000DLFM21,The 3 Most Compelling Reasons to Buy Valeant Pharmaceuticals Stock Right Now,2016-12-18 13:57:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n9iwJNeAmYA/the-3-most-compelling-reasons-to-buy-valeant-pharmaceuticals-stock-right-now-cm722954,Valeant Pharmaceuticals NYSE VRX CEO Joe Papa might not have been a cheerleader in school but he s definitely one now With his company s stock in tatters Papa was asked at the BMO Capital Markets Healthcare Conference on Wednesday what are the most compelling reasons to
VRX,VRX:CT,BBG000DC8S17,The 3 Most Compelling Reasons to Buy Valeant Pharmaceuticals Stock Right Now,2016-12-18 13:57:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n9iwJNeAmYA/the-3-most-compelling-reasons-to-buy-valeant-pharmaceuticals-stock-right-now-cm722954,Valeant Pharmaceuticals NYSE VRX CEO Joe Papa might not have been a cheerleader in school but he s definitely one now With his company s stock in tatters Papa was asked at the BMO Capital Markets Healthcare Conference on Wednesday what are the most compelling reasons to
VRX,VRX:CT,BBG000DC8S17,The 3 Most Compelling Reasons to Buy Valeant Pharmaceuticals Stock Right Now,2016-12-18 12:52:17 +0000,http://www.fool.com/investing/2016/12/18/3-most-compelling-reasons-to-buy-valeant-pharmaceu.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 3 Most Compelling Reasons to Buy Valeant Pharmaceuticals Stock Right Now
VRX,VRX:US,BBG000DLFM21,The 3 Most Compelling Reasons to Buy Valeant Pharmaceuticals Stock Right Now,2016-12-18 12:52:17 +0000,http://www.fool.com/investing/2016/12/18/3-most-compelling-reasons-to-buy-valeant-pharmaceu.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 3 Most Compelling Reasons to Buy Valeant Pharmaceuticals Stock Right Now
VRX,VRX:US,BBG000DLFM21,"Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More",2016-12-17 14:45:08 +0000,http://247wallst.com/investing/2016/12/17/massive-bill-ackman-trade-highlights-insider-selling-valeant-pharmaceuticals-starbucks-schlumberger-validus-and-more/,"Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More"
VRX,VRX:CT,BBG000DC8S17,"Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More",2016-12-17 14:45:08 +0000,http://247wallst.com/investing/2016/12/17/massive-bill-ackman-trade-highlights-insider-selling-valeant-pharmaceuticals-starbucks-schlumberger-validus-and-more/,"Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up As Commodity Prices Recover -- Canadian Commentary,2016-12-16 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UisJQVdcF_E/canadian-stocks-are-up-as-commodity-prices-recover--canadian-commentary-20161216-00431,Canadian Stocks Are Up As Commodity Prices Recover -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up As Commodity Prices Recover -- Canadian Commentary,2016-12-16 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UisJQVdcF_E/canadian-stocks-are-up-as-commodity-prices-recover--canadian-commentary-20161216-00431,Canadian Stocks Are Up As Commodity Prices Recover -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Valeant’s 2016 Has Been All Pain, No Gain Amid Record Stock Drop",2016-12-16 10:00:00 +0000,http://www.bloomberg.com/news/articles/2016-12-16/valeant-s-2016-has-been-all-pain-no-gain-amid-record-stock-drop?cmpid=yhoo.headline,"Valeant’s 2016 Has Been All Pain, No Gain Amid Record Stock Drop"
VRX,VRX:CT,BBG000DC8S17,"Valeant’s 2016 Has Been All Pain, No Gain Amid Record Stock Drop",2016-12-16 10:00:00 +0000,http://www.bloomberg.com/news/articles/2016-12-16/valeant-s-2016-has-been-all-pain-no-gain-amid-record-stock-drop?cmpid=yhoo.headline,"Valeant’s 2016 Has Been All Pain, No Gain Amid Record Stock Drop"
VRX,VRX:US,BBG000DLFM21,[$$] Overheard,2016-12-16 05:29:00 +0000,http://www.wsj.com/articles/overheard-1481861438?ru=yahoo?mod=yahoo_itp,[$$] Overheard
VRX,VRX:CT,BBG000DC8S17,[$$] Overheard,2016-12-16 05:29:00 +0000,http://www.wsj.com/articles/overheard-1481861438?ru=yahoo?mod=yahoo_itp,[$$] Overheard
VRX,VRX:US,BBG000DLFM21,Valeant CEO will listen if there's 'inbound interest' in core businesses,2016-12-15 22:31:38 +0000,http://www.cnbc.com/id/104169795?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104169795,Valeant CEO will listen if there's 'inbound interest' in core businesses
VRX,VRX:CT,BBG000DC8S17,Valeant CEO will listen if there's 'inbound interest' in core businesses,2016-12-15 22:31:38 +0000,http://www.cnbc.com/id/104169795?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104169795,Valeant CEO will listen if there's 'inbound interest' in core businesses
VRX,VRX:US,BBG000DLFM21,"Valeant, HiMax Lead Thursday’s 52-Week Low Club",2016-12-15 21:04:12 +0000,http://247wallst.com/investing/2016/12/15/valeant-himax-lead-thursdays-52-week-low-club/,"Valeant, HiMax Lead Thursday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,"Valeant, HiMax Lead Thursday’s 52-Week Low Club",2016-12-15 21:04:12 +0000,http://247wallst.com/investing/2016/12/15/valeant-himax-lead-thursdays-52-week-low-club/,"Valeant, HiMax Lead Thursday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,The Valeant Pharmaceuticals Intl Inc (VRX) Death Spiral Continues,2016-12-15 20:58:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hjo0Z7q8DgA/the-valeant-pharmaceuticals-intl-inc-vrx-death-spiral-continues-cm722158,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The death spiral in Valeant Pharmaceuticals Intl Inc NYSE VRX 160 stock continued in earnest this week and accelerated on Thursday Today s 7 5 plunge is carrying shares of the ailing drugmaker
VRX,VRX:US,BBG000DLFM21,The Valeant Pharmaceuticals Intl Inc (VRX) Death Spiral Continues,2016-12-15 20:58:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hjo0Z7q8DgA/the-valeant-pharmaceuticals-intl-inc-vrx-death-spiral-continues-cm722158,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The death spiral in Valeant Pharmaceuticals Intl Inc NYSE VRX 160 stock continued in earnest this week and accelerated on Thursday Today s 7 5 plunge is carrying shares of the ailing drugmaker
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Is a Toxic Stock,2016-12-15 18:53:00 +0000,https://www.thestreet.com/story/13927480/1/why-valeant-pharmaceuticals-is-a-toxic-stock.html?puc=yahoo&cm_ven=YAHOO,Why Valeant Pharmaceuticals Is a Toxic Stock
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Is a Toxic Stock,2016-12-15 18:53:00 +0000,https://www.thestreet.com/story/13927480/1/why-valeant-pharmaceuticals-is-a-toxic-stock.html?puc=yahoo&cm_ven=YAHOO,Why Valeant Pharmaceuticals Is a Toxic Stock
VRX,VRX:CT,BBG000DC8S17,"Valeant's Defense Is All Noise, No Substance",2016-12-15 18:44:32 +0000,http://www.bloomberg.com/gadfly/articles/2016-12-15/valeant-s-noise-complaint-lacks-substance?cmpid=yhoo.headline,"Valeant's Defense Is All Noise, No Substance"
VRX,VRX:US,BBG000DLFM21,"Valeant's Defense Is All Noise, No Substance",2016-12-15 18:44:32 +0000,http://www.bloomberg.com/gadfly/articles/2016-12-15/valeant-s-noise-complaint-lacks-substance?cmpid=yhoo.headline,"Valeant's Defense Is All Noise, No Substance"
VRX,VRX:CT,BBG000DC8S17,"Company News for December 15, 2016",2016-12-15 16:58:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wNdCdTtlxbc/company-news-for-december-15-2016-cm721968,ABM Industries Incorporated s ABM shares decreased 8 after reporting fiscal fourth quarter adjusted earnings of 0 51 per share lower than year over year figure of 0 55 per share 160 Shares of Johnson amp Johnson JNJ fell 0 8 after the company decided to abandon talks
VRX,VRX:US,BBG000DLFM21,"Company News for December 15, 2016",2016-12-15 16:58:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wNdCdTtlxbc/company-news-for-december-15-2016-cm721968,ABM Industries Incorporated s ABM shares decreased 8 after reporting fiscal fourth quarter adjusted earnings of 0 51 per share lower than year over year figure of 0 55 per share 160 Shares of Johnson amp Johnson JNJ fell 0 8 after the company decided to abandon talks
VRX,VRX:US,BBG000DLFM21,No End in Sight for Valeant's Downtrend,2016-12-15 16:21:00 +0000,http://realmoney.thestreet.com/articles/12/15/2016/no-end-sight-valeants-downtrend?puc=yahoo&cm_ven=YAHOO,No End in Sight for Valeant's Downtrend
VRX,VRX:CT,BBG000DC8S17,No End in Sight for Valeant's Downtrend,2016-12-15 16:21:00 +0000,http://realmoney.thestreet.com/articles/12/15/2016/no-end-sight-valeants-downtrend?puc=yahoo&cm_ven=YAHOO,No End in Sight for Valeant's Downtrend
VRX,VRX:CT,BBG000DC8S17,Mondelez takeover talk; athenahealth soars; Pier 1 shares skyrocket,2016-12-15 16:18:53 +0000,http://finance.yahoo.com/news/mondelez-takeover-talk-athenahealth-soars-pier-1-shares-skyrocket-161853559.html,Mondelez takeover talk; athenahealth soars; Pier 1 shares skyrocket
VRX,VRX:US,BBG000DLFM21,Mondelez takeover talk; athenahealth soars; Pier 1 shares skyrocket,2016-12-15 16:18:53 +0000,http://finance.yahoo.com/news/mondelez-takeover-talk-athenahealth-soars-pier-1-shares-skyrocket-161853559.html,Mondelez takeover talk; athenahealth soars; Pier 1 shares skyrocket
VRX,VRX:US,BBG000DLFM21,Valeant Just Can't Get Past the Noise,2016-12-15 16:15:44 +0000,http://blogs.wsj.com/moneybeat/2016/12/15/valeant-just-cant-get-past-the-noise/?mod=yahoo_hs,Valeant Just Can't Get Past the Noise
VRX,VRX:CT,BBG000DC8S17,Valeant Just Can't Get Past the Noise,2016-12-15 16:15:44 +0000,http://blogs.wsj.com/moneybeat/2016/12/15/valeant-just-cant-get-past-the-noise/?mod=yahoo_hs,Valeant Just Can't Get Past the Noise
VRX,VRX:CT,BBG000DC8S17,"Company News for December 15, 2016",2016-12-15 15:10:03 +0000,http://finance.yahoo.com/news/company-news-december-15-2016-151003960.html,"Company News for December 15, 2016"
VRX,VRX:US,BBG000DLFM21,"Company News for December 15, 2016",2016-12-15 15:10:03 +0000,http://finance.yahoo.com/news/company-news-december-15-2016-151003960.html,"Company News for December 15, 2016"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals: We Were Wrong, Morgan Stanley Says",2016-12-15 14:57:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/15/valeant-pharmaceuticals-we-were-wrong-morgan-stanley-says/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: We Were Wrong, Morgan Stanley Says"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals: We Were Wrong, Morgan Stanley Says",2016-12-15 14:57:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/15/valeant-pharmaceuticals-we-were-wrong-morgan-stanley-says/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: We Were Wrong, Morgan Stanley Says"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma downgraded by Morgan Stanley,2016-12-15 11:30:39 +0000,http://finance.yahoo.com/q/ud?s=VRX,Valeant Pharma downgraded by Morgan Stanley
VRX,VRX:US,BBG000DLFM21,Valeant Pharma downgraded by Morgan Stanley,2016-12-15 11:30:39 +0000,http://finance.yahoo.com/q/ud?s=VRX,Valeant Pharma downgraded by Morgan Stanley
VRX,VRX:US,BBG000DLFM21,Should You Avoid Brookfield Infrastructure Partners L.P. (BIP)?,2016-12-15 10:58:03 +0000,http://www.insidermonkey.com/blog/should-you-avoid-brookfield-infrastructure-partners-l-p-bip-510311/,Should You Avoid Brookfield Infrastructure Partners L.P. (BIP)?
VRX,VRX:CT,BBG000DC8S17,Should You Avoid Brookfield Infrastructure Partners L.P. (BIP)?,2016-12-15 10:58:03 +0000,http://www.insidermonkey.com/blog/should-you-avoid-brookfield-infrastructure-partners-l-p-bip-510311/,Should You Avoid Brookfield Infrastructure Partners L.P. (BIP)?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising Despite Commodity Weakness -- Canadian Commentary,2016-12-15 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X1gxWUnVBpY/canadian-stocks-are-rising-despite-commodity-weakness--canadian-commentary-20161215-00680,Canadian Stocks Are Rising Despite Commodity Weakness -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising Despite Commodity Weakness -- Canadian Commentary,2016-12-15 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X1gxWUnVBpY/canadian-stocks-are-rising-despite-commodity-weakness--canadian-commentary-20161215-00680,Canadian Stocks Are Rising Despite Commodity Weakness -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Emcore and Valeant are this weeks Blowouts,2016-12-15 00:56:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jnv4exOzGh0/emcore-and-valeant-are-this-weeks-blowouts-cm721657,Brian Bolan is back with another edition of Bolan s Blowouts 160 This time we are taking a look at Valeant Pharma VRX and why it has been a Zacks Rank 5 Strong Sell for some time 160 Brian points to falling earnings estimates and then highlights who has been blowing out of
VRX,VRX:US,BBG000DLFM21,Emcore and Valeant are this weeks Blowouts,2016-12-15 00:56:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jnv4exOzGh0/emcore-and-valeant-are-this-weeks-blowouts-cm721657,Brian Bolan is back with another edition of Bolan s Blowouts 160 This time we are taking a look at Valeant Pharma VRX and why it has been a Zacks Rank 5 Strong Sell for some time 160 Brian points to falling earnings estimates and then highlights who has been blowing out of
VRX,VRX:US,BBG000DLFM21,Bill Ackman Reduces Valeant Stake to Benefit Clients,2016-12-14 23:21:53 +0000,http://finance.yahoo.com/news/bill-ackman-sells-3-million-171142021.html,Bill Ackman Reduces Valeant Stake to Benefit Clients
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Reduces Valeant Stake to Benefit Clients,2016-12-14 23:21:53 +0000,http://finance.yahoo.com/news/bill-ackman-sells-3-million-171142021.html,Bill Ackman Reduces Valeant Stake to Benefit Clients
VRX,VRX:CT,BBG000DC8S17,Emcore and Valeant are this weeks Blowouts,2016-12-14 23:01:11 +0000,http://finance.yahoo.com/news/emcore-valeant-weeks-blowouts-230111861.html,Emcore and Valeant are this weeks Blowouts
VRX,VRX:US,BBG000DLFM21,Emcore and Valeant are this weeks Blowouts,2016-12-14 23:01:11 +0000,http://finance.yahoo.com/news/emcore-valeant-weeks-blowouts-230111861.html,Emcore and Valeant are this weeks Blowouts
VRX,VRX:CT,BBG000DC8S17,Fed Dooms Dow Jones Industrial Average Win Streak,2016-12-14 22:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZzeP5NLvP8A/fed-dooms-dow-jones-industrial-average-win-streak-cm721578,The 160 Dow Jones Industrial Average DJIA 160 flirted with positive territory around midday even hitting another all time high but stocks fell sharply following the Fed s policy decision and forecast Specifically the Federal Open Market Committee FOMC unanimously voted to increase
VRX,VRX:US,BBG000DLFM21,Fed Dooms Dow Jones Industrial Average Win Streak,2016-12-14 22:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZzeP5NLvP8A/fed-dooms-dow-jones-industrial-average-win-streak-cm721578,The 160 Dow Jones Industrial Average DJIA 160 flirted with positive territory around midday even hitting another all time high but stocks fell sharply following the Fed s policy decision and forecast Specifically the Federal Open Market Committee FOMC unanimously voted to increase
VRX,VRX:CT,BBG000DC8S17,"TSX Movers: Valeant, Merus Labs, Teck Resources",2016-12-14 22:29:23 +0000,http://finance.yahoo.com/video/tsx-movers-valeant-merus-labs-222923118.html,"TSX Movers: Valeant, Merus Labs, Teck Resources"
VRX,VRX:US,BBG000DLFM21,"TSX Movers: Valeant, Merus Labs, Teck Resources",2016-12-14 22:29:23 +0000,http://finance.yahoo.com/video/tsx-movers-valeant-merus-labs-222923118.html,"TSX Movers: Valeant, Merus Labs, Teck Resources"
VRX,VRX:US,BBG000DLFM21,Ackman's Pershing Sq. Dumps 3.4M Valeant Shares at a Loss,2016-12-14 19:46:00 +0000,http://www.investopedia.com/news/ackmans-pershing-sq-dumps-34m-valeant-shares-loss-vrx-pshas/?partner=YahooSA,Ackman's Pershing Sq. Dumps 3.4M Valeant Shares at a Loss
VRX,VRX:CT,BBG000DC8S17,Ackman's Pershing Sq. Dumps 3.4M Valeant Shares at a Loss,2016-12-14 19:46:00 +0000,http://www.investopedia.com/news/ackmans-pershing-sq-dumps-34m-valeant-shares-loss-vrx-pshas/?partner=YahooSA,Ackman's Pershing Sq. Dumps 3.4M Valeant Shares at a Loss
VRX,VRX:CT,BBG000DC8S17,"[video]Ackman Drops Some Valeant Shares, Papa Blames Media for Plummeting Share Prices",2016-12-14 19:25:00 +0000,https://www.thestreet.com/story/13926098/1/ackman-drops-some-valeant-shares-papa-blames-media-for-plummeting-share-prices.html?puc=yahoo&cm_ven=YAHOO,"[video]Ackman Drops Some Valeant Shares, Papa Blames Media for Plummeting Share Prices"
VRX,VRX:US,BBG000DLFM21,"[video]Ackman Drops Some Valeant Shares, Papa Blames Media for Plummeting Share Prices",2016-12-14 19:25:00 +0000,https://www.thestreet.com/story/13926098/1/ackman-drops-some-valeant-shares-papa-blames-media-for-plummeting-share-prices.html?puc=yahoo&cm_ven=YAHOO,"[video]Ackman Drops Some Valeant Shares, Papa Blames Media for Plummeting Share Prices"
VRX,VRX:US,BBG000DLFM21,Ackman sells a chunk of troubled Valeant one day after 3 execs quit,2016-12-14 18:15:06 +0000,http://www.bizjournals.com/newyork/news/2016/12/14/ackman-sells-a-chunk-of-troubled-valeant-one-day.html?ana=yahoo,Ackman sells a chunk of troubled Valeant one day after 3 execs quit
VRX,VRX:CT,BBG000DC8S17,Ackman sells a chunk of troubled Valeant one day after 3 execs quit,2016-12-14 18:15:06 +0000,http://www.bizjournals.com/newyork/news/2016/12/14/ackman-sells-a-chunk-of-troubled-valeant-one-day.html?ana=yahoo,Ackman sells a chunk of troubled Valeant one day after 3 execs quit
VRX,VRX:CT,BBG000DC8S17,Stocks Reverse Before Fed Decision; Which IBD 50 Names Are Standouts?,2016-12-14 17:17:38 +0000,http://finance.yahoo.com/video/stocks-reverse-fed-decision-ibd-171738494.html,Stocks Reverse Before Fed Decision; Which IBD 50 Names Are Standouts?
VRX,VRX:US,BBG000DLFM21,Stocks Reverse Before Fed Decision; Which IBD 50 Names Are Standouts?,2016-12-14 17:17:38 +0000,http://finance.yahoo.com/video/stocks-reverse-fed-decision-ibd-171738494.html,Stocks Reverse Before Fed Decision; Which IBD 50 Names Are Standouts?
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo,2016-12-14 16:32:45 +0000,http://finance.yahoo.com/news/valeant-shares-carry-too-much-163245723.html,Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo
VRX,VRX:US,BBG000DLFM21,Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo,2016-12-14 16:32:45 +0000,http://finance.yahoo.com/news/valeant-shares-carry-too-much-163245723.html,Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo
VRX,VRX:US,BBG000DLFM21,Why Did Ackman Trim Valeant Stake?,2016-12-14 16:31:00 +0000,http://blogs.barrons.com/focusonfunds/2016/12/14/why-did-ackman-trim-valeant-stake/?mod=yahoobarrons&ru=yahoo,Why Did Ackman Trim Valeant Stake?
VRX,VRX:CT,BBG000DC8S17,Why Did Ackman Trim Valeant Stake?,2016-12-14 16:31:00 +0000,http://blogs.barrons.com/focusonfunds/2016/12/14/why-did-ackman-trim-valeant-stake/?mod=yahoobarrons&ru=yahoo,Why Did Ackman Trim Valeant Stake?
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Wednesday: Heico Corp (HEI), Hertz Global Holdings, Inc. (HTZ) and Valeant Pharmaceuticals Intl Inc (VRX)",2016-12-14 15:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HK1YXEQ7Rmk/3-stocks-to-watch-on-wednesday-heico-corp-hei-hertz-global-holdings-inc-htz-and-valeant-pharmaceuticals-intl-inc-vrx-cm721242,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Energy stocks had a good day rising 1 3 while oil prices lost 0 6 and the dollar remained largely unchanged The 160 S amp P 500 Index grew 0 7 the 160 Dow Jones Industrial
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Wednesday: Heico Corp (HEI), Hertz Global Holdings, Inc. (HTZ) and Valeant Pharmaceuticals Intl Inc (VRX)",2016-12-14 15:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HK1YXEQ7Rmk/3-stocks-to-watch-on-wednesday-heico-corp-hei-hertz-global-holdings-inc-htz-and-valeant-pharmaceuticals-intl-inc-vrx-cm721242,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Energy stocks had a good day rising 1 3 while oil prices lost 0 6 and the dollar remained largely unchanged The 160 S amp P 500 Index grew 0 7 the 160 Dow Jones Industrial
VRX,VRX:CT,BBG000DC8S17,The Worst Biopharma CEOs of 2016 Are ...,2016-12-14 15:52:00 +0000,https://www.thestreet.com/story/13924750/1/the-worst-biopharma-ceos-of-2016-are.html?puc=yahoo&cm_ven=YAHOO,The Worst Biopharma CEOs of 2016 Are ...
VRX,VRX:US,BBG000DLFM21,The Worst Biopharma CEOs of 2016 Are ...,2016-12-14 15:52:00 +0000,https://www.thestreet.com/story/13924750/1/the-worst-biopharma-ceos-of-2016-are.html?puc=yahoo&cm_ven=YAHOO,The Worst Biopharma CEOs of 2016 Are ...
VRX,VRX:US,BBG000DLFM21,"Man, has it been a hectic end-of-year for Bill Ackman and Valeant",2016-12-14 14:43:06 +0000,http://finance.yahoo.com/news/man-hectic-end-bill-ackman-144306075.html,"Man, has it been a hectic end-of-year for Bill Ackman and Valeant"
VRX,VRX:CT,BBG000DC8S17,"Man, has it been a hectic end-of-year for Bill Ackman and Valeant",2016-12-14 14:43:06 +0000,http://finance.yahoo.com/news/man-hectic-end-bill-ackman-144306075.html,"Man, has it been a hectic end-of-year for Bill Ackman and Valeant"
VRX,VRX:CT,BBG000DC8S17,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season,2016-12-14 14:17:48 +0000,http://finance.yahoo.com/tumblr/blog-dont-get-caught-with-these-5-stocks-ahead-of-141758667.html,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season
VRX,VRX:US,BBG000DLFM21,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season,2016-12-14 14:17:48 +0000,http://finance.yahoo.com/tumblr/blog-dont-get-caught-with-these-5-stocks-ahead-of-141758667.html,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Crude Rally Stalls -- Canadian Commentary,2016-12-14 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T_UJAuw-e2g/canadian-stocks-are-falling-as-crude-rally-stalls--canadian-commentary-20161214-00600,Canadian Stocks Are Falling As Crude Rally Stalls -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Crude Rally Stalls -- Canadian Commentary,2016-12-14 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T_UJAuw-e2g/canadian-stocks-are-falling-as-crude-rally-stalls--canadian-commentary-20161214-00600,Canadian Stocks Are Falling As Crude Rally Stalls -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,U.S. Hot Stocks: Hot Stocks to Watch,2016-12-14 09:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0ZHb6iaDuHU/us-hot-stocks-hot-stocks-to-watch-20161214-00487,U.S. Hot Stocks: Hot Stocks to Watch
VRX,VRX:CT,BBG000DC8S17,U.S. Hot Stocks: Hot Stocks to Watch,2016-12-14 09:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0ZHb6iaDuHU/us-hot-stocks-hot-stocks-to-watch-20161214-00487,U.S. Hot Stocks: Hot Stocks to Watch
VRX,VRX:CT,BBG000DC8S17,"After-hours buzz: HTZ, WFC, VRX & more",2016-12-13 22:57:37 +0000,http://www.cnbc.com/id/104164672?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104164672,"After-hours buzz: HTZ, WFC, VRX & more"
VRX,VRX:US,BBG000DLFM21,"After-hours buzz: HTZ, WFC, VRX & more",2016-12-13 22:57:37 +0000,http://www.cnbc.com/id/104164672?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104164672,"After-hours buzz: HTZ, WFC, VRX & more"
VRX,VRX:CT,BBG000DC8S17,"Dow Jones Industrial Average Brings 20,000 Into Focus Ahead of Fed",2016-12-13 22:56:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j6mix7gNli0/dow-jones-industrial-average-brings-20000-into-focus-ahead-of-fed-cm721006,The 160 Dow Jones Industrial Average DJIA jumped out of the gate and came within 47 points of the 20 000 mark at its intraday peak on its way to yet another all time closing high and a seventh straight win The 160 S amp P 500 Index SPX 160 and 160 Nasdaq
VRX,VRX:US,BBG000DLFM21,"Dow Jones Industrial Average Brings 20,000 Into Focus Ahead of Fed",2016-12-13 22:56:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j6mix7gNli0/dow-jones-industrial-average-brings-20000-into-focus-ahead-of-fed-cm721006,The 160 Dow Jones Industrial Average DJIA jumped out of the gate and came within 47 points of the 20 000 mark at its intraday peak on its way to yet another all time closing high and a seventh straight win The 160 S amp P 500 Index SPX 160 and 160 Nasdaq
VRX,VRX:US,BBG000DLFM21,Pershing Square Discloses Sale Of Valeant Shares To 'Generate A Tax Loss In 2016 For Their Investors',2016-12-13 21:44:45 +0000,http://finance.yahoo.com/news/pershing-square-discloses-sale-valeant-214445506.html,Pershing Square Discloses Sale Of Valeant Shares To 'Generate A Tax Loss In 2016 For Their Investors'
VRX,VRX:CT,BBG000DC8S17,Pershing Square Discloses Sale Of Valeant Shares To 'Generate A Tax Loss In 2016 For Their Investors',2016-12-13 21:44:45 +0000,http://finance.yahoo.com/news/pershing-square-discloses-sale-valeant-214445506.html,Pershing Square Discloses Sale Of Valeant Shares To 'Generate A Tax Loss In 2016 For Their Investors'
VRX,VRX:CT,BBG000DC8S17,The Valeant Pharmaceuticals Exodus Continues -- Only This Time It's Internal,2016-12-13 19:57:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pt4DpLJC1aU/the-valeant-pharmaceuticals-exodus-continues-only-this-time-its-internal-cm720906,Image source Getty Images You don t have to be a stock market maven to understand that Valeant Pharmaceuticals NYSE VRX has had a brutal year The embattled drugmaker is down more than 80 year to date and it s off more than 94 since hitting its all time highs during the
VRX,VRX:US,BBG000DLFM21,The Valeant Pharmaceuticals Exodus Continues -- Only This Time It's Internal,2016-12-13 19:57:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pt4DpLJC1aU/the-valeant-pharmaceuticals-exodus-continues-only-this-time-its-internal-cm720906,Image source Getty Images You don t have to be a stock market maven to understand that Valeant Pharmaceuticals NYSE VRX has had a brutal year The embattled drugmaker is down more than 80 year to date and it s off more than 94 since hitting its all time highs during the
VRX,VRX:US,BBG000DLFM21,The Valeant Pharmaceuticals Exodus Continues -- Only This Time It's Internal,2016-12-13 18:48:47 +0000,http://www.fool.com/investing/2016/12/13/the-valeant-pharmaceuticals-exodus-continues-only.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Valeant Pharmaceuticals Exodus Continues -- Only This Time It's Internal
VRX,VRX:CT,BBG000DC8S17,The Valeant Pharmaceuticals Exodus Continues -- Only This Time It's Internal,2016-12-13 18:48:47 +0000,http://www.fool.com/investing/2016/12/13/the-valeant-pharmaceuticals-exodus-continues-only.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Valeant Pharmaceuticals Exodus Continues -- Only This Time It's Internal
VRX,VRX:CT,BBG000DC8S17,"Bet on a Little Micron Technology, Inc. (MU) Stock Magic",2016-12-13 17:57:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/feWcJtosApo/bet-on-a-little-micron-technology-inc-mu-stock-magic-cm720806,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips While most tech stocks took a beating in the wake of Donald Trump s election win Micron Technology Inc NASDAQ MU has been an exception to the rule The shares are up nearly 20 since Nov 9
VRX,VRX:US,BBG000DLFM21,"Bet on a Little Micron Technology, Inc. (MU) Stock Magic",2016-12-13 17:57:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/feWcJtosApo/bet-on-a-little-micron-technology-inc-mu-stock-magic-cm720806,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips While most tech stocks took a beating in the wake of Donald Trump s election win Micron Technology Inc NASDAQ MU has been an exception to the rule The shares are up nearly 20 since Nov 9
VRX,VRX:CT,BBG000DC8S17,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss -- Upate",2016-12-13 17:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JdYkdEt4ZIo/pershing-square-sells-some-valeant-shares-seeking-tax-loss--upate-20161213-00985,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss -- Upate"
VRX,VRX:US,BBG000DLFM21,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss -- Upate",2016-12-13 17:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JdYkdEt4ZIo/pershing-square-sells-some-valeant-shares-seeking-tax-loss--upate-20161213-00985,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss -- Upate"
VRX,VRX:US,BBG000DLFM21,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss",2016-12-13 17:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YvQc15DyTBo/pershing-square-sells-some-valeant-shares-seeking-tax-loss-20161213-00974,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss"
VRX,VRX:CT,BBG000DC8S17,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss",2016-12-13 17:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YvQc15DyTBo/pershing-square-sells-some-valeant-shares-seeking-tax-loss-20161213-00974,"Pershing Square Sells Some Valeant Shares, Seeking Tax Loss"
VRX,VRX:CT,BBG000DC8S17,Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits,2016-12-13 16:57:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JIPzdVytWQA/trade-valeant-pharmaceuticals-intl-inc-vrx-stock-for-free-profits-cm720711,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX finished down 5 on Monday which caught my attention The last trade I wrote on VRX stock was an easy win using the December contract and I think it s
VRX,VRX:US,BBG000DLFM21,Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits,2016-12-13 16:57:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JIPzdVytWQA/trade-valeant-pharmaceuticals-intl-inc-vrx-stock-for-free-profits-cm720711,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX finished down 5 on Monday which caught my attention The last trade I wrote on VRX stock was an easy win using the December contract and I think it s
VRX,VRX:US,BBG000DLFM21,"TSX Extends Rally, Energy Sector Giddy For Trump -- Canadian Commentary",2016-12-13 16:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MKu4c5sT27U/tsx-extends-rally-energy-sector-giddy-for-trump--canadian-commentary-20161213-00900,"TSX Extends Rally, Energy Sector Giddy For Trump -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"TSX Extends Rally, Energy Sector Giddy For Trump -- Canadian Commentary",2016-12-13 16:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MKu4c5sT27U/tsx-extends-rally-energy-sector-giddy-for-trump--canadian-commentary-20161213-00900,"TSX Extends Rally, Energy Sector Giddy For Trump -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Round and Round and Round We Go,2016-12-13 14:45:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/13/valeant-pharmaceuticals-round-and-round-and-round-we-go/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Round and Round and Round We Go
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Round and Round and Round We Go,2016-12-13 14:45:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/13/valeant-pharmaceuticals-round-and-round-and-round-we-go/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Round and Round and Round We Go
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Achaogen, Inovalon, Valeant",2016-12-13 14:36:34 +0000,http://blogs.wsj.com/moneybeat/2016/12/13/stocks-to-watch-achaogen-inovalon-valeant/?mod=yahoo_hs,"Stocks to Watch: Achaogen, Inovalon, Valeant"
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Achaogen, Inovalon, Valeant",2016-12-13 14:36:34 +0000,http://blogs.wsj.com/moneybeat/2016/12/13/stocks-to-watch-achaogen-inovalon-valeant/?mod=yahoo_hs,"Stocks to Watch: Achaogen, Inovalon, Valeant"
VRX,VRX:US,BBG000DLFM21,Valeant Stock Falls as Three Top Executives Quit,2016-12-13 13:13:00 +0000,http://www.investopedia.com/news/valeant-stock-falls-three-top-executives-quit-vrx/?partner=YahooSA,Valeant Stock Falls as Three Top Executives Quit
VRX,VRX:CT,BBG000DC8S17,Valeant Stock Falls as Three Top Executives Quit,2016-12-13 13:13:00 +0000,http://www.investopedia.com/news/valeant-stock-falls-three-top-executives-quit-vrx/?partner=YahooSA,Valeant Stock Falls as Three Top Executives Quit
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Gains As Crude Prices Dip -- Canadian Commentary,2016-12-13 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-FOrWfyCl_Q/canadian-stocks-are-paring-gains-as-crude-prices-dip--canadian-commentary-20161213-00618,Canadian Stocks Are Paring Gains As Crude Prices Dip -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Gains As Crude Prices Dip -- Canadian Commentary,2016-12-13 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-FOrWfyCl_Q/canadian-stocks-are-paring-gains-as-crude-prices-dip--canadian-commentary-20161213-00618,Canadian Stocks Are Paring Gains As Crude Prices Dip -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Trump, OPEC Bring Gifts For Energy Industry -- Canadian Commentary",2016-12-13 08:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q9CKwR03_S0/trump-opec-bring-gifts-for-energy-industry--canadian-commentary-20161213-00416,"Trump, OPEC Bring Gifts For Energy Industry -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Trump, OPEC Bring Gifts For Energy Industry -- Canadian Commentary",2016-12-13 08:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q9CKwR03_S0/trump-opec-bring-gifts-for-energy-industry--canadian-commentary-20161213-00416,"Trump, OPEC Bring Gifts For Energy Industry -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Valeant Appoints William Humphries As EVP, Dermatology",2016-12-12 23:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZkWBkr19C64/valeant-appoints-william-humphries-as-evp-dermatology-20161212-01060,"Valeant Appoints William Humphries As EVP, Dermatology"
VRX,VRX:CT,BBG000DC8S17,"Valeant Appoints William Humphries As EVP, Dermatology",2016-12-12 23:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZkWBkr19C64/valeant-appoints-william-humphries-as-evp-dermatology-20161212-01060,"Valeant Appoints William Humphries As EVP, Dermatology"
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial",2016-12-12 22:30:53 +0000,http://biz.yahoo.com/e/161212/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial",2016-12-12 22:30:53 +0000,http://biz.yahoo.com/e/161212/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial"
VRX,VRX:US,BBG000DLFM21,"After Hours Most Active for Dec 12, 2016 :  KR, VRX, IFGL, CAA, V, LEN, CHK, SPLS, AKAO, VCLT, FOXA, AMAT",2016-12-12 21:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hpu6vmc7Ff4/after-hours-most-active-for-dec-12-2016-kr-vrx-ifgl-caa-v-len-chk-spls-akao-vclt-foxa-amat-cm720389,The NASDAQ 100 After Hours Indicator is down 66 to 4 873 64 The total After hours volume is currently 28 121 893 shares traded The following are the most active stocks for the after hours session Kroger Company The KR is unchanged at 34 22 with 3 977 599
VRX,VRX:CT,BBG000DC8S17,"After Hours Most Active for Dec 12, 2016 :  KR, VRX, IFGL, CAA, V, LEN, CHK, SPLS, AKAO, VCLT, FOXA, AMAT",2016-12-12 21:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hpu6vmc7Ff4/after-hours-most-active-for-dec-12-2016-kr-vrx-ifgl-caa-v-len-chk-spls-akao-vclt-foxa-amat-cm720389,The NASDAQ 100 After Hours Indicator is down 66 to 4 873 64 The total After hours volume is currently 28 121 893 shares traded The following are the most active stocks for the after hours session Kroger Company The KR is unchanged at 34 22 with 3 977 599
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals loses three top executives,2016-12-12 21:34:04 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=32777EA6-083F-4AE0-A217-0ACD8712EC0E&siteid=yhoof2,Valeant Pharmaceuticals loses three top executives
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals loses three top executives,2016-12-12 21:34:04 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=32777EA6-083F-4AE0-A217-0ACD8712EC0E&siteid=yhoof2,Valeant Pharmaceuticals loses three top executives
VRX,VRX:CT,BBG000DC8S17,"Valeant Appoints William D. Humphries As EVP, Dermatology",2016-12-12 21:05:00 +0000,http://finance.yahoo.com/news/valeant-appoints-william-d-humphries-210500768.html,"[CNW Group] - Valeant Appoints William D. Humphries As EVP, Dermatology"
VRX,VRX:US,BBG000DLFM21,"Valeant Appoints William D. Humphries As EVP, Dermatology",2016-12-12 21:05:00 +0000,http://finance.yahoo.com/news/valeant-appoints-william-d-humphries-210500768.html,"[CNW Group] - Valeant Appoints William D. Humphries As EVP, Dermatology"
VRX,VRX:CT,BBG000DC8S17,"A bad day for Valeant is coming sooner than expected, and the stock is falling",2016-12-12 20:33:00 +0000,http://finance.yahoo.com/news/bad-day-valeant-coming-sooner-203300287.html,"A bad day for Valeant is coming sooner than expected, and the stock is falling"
VRX,VRX:US,BBG000DLFM21,"A bad day for Valeant is coming sooner than expected, and the stock is falling",2016-12-12 20:33:00 +0000,http://finance.yahoo.com/news/bad-day-valeant-coming-sooner-203300287.html,"A bad day for Valeant is coming sooner than expected, and the stock is falling"
VRX,VRX:US,BBG000DLFM21,Marijuana Investing in 2017: 5 Numbers Everyone Should Know,2016-12-12 20:04:59 +0000,http://www.fool.com/investing/2016/12/11/marijuana-investing-in-2017-5-numbers-everyone-sho.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Marijuana Investing in 2017: 5 Numbers Everyone Should Know
VRX,VRX:CT,BBG000DC8S17,Marijuana Investing in 2017: 5 Numbers Everyone Should Know,2016-12-12 20:04:59 +0000,http://www.fool.com/investing/2016/12/11/marijuana-investing-in-2017-5-numbers-everyone-sho.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Marijuana Investing in 2017: 5 Numbers Everyone Should Know
VRX,VRX:CT,BBG000DC8S17,Marijuana Investing in 2017: 5 Numbers Everyone Should Know,2016-12-11 21:55:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HGIxS8JDCy0/marijuana-investing-in-2017-5-numbers-everyone-should-know-cm719863,Many marijuana stocks have soared in 2016 with one enjoying especially impressive gains of well over 2 000 However this speculative industry is fraught with risk If you re considering investing in marijuana stocks in the new year here are five numbers you should know
VRX,VRX:US,BBG000DLFM21,Marijuana Investing in 2017: 5 Numbers Everyone Should Know,2016-12-11 21:55:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HGIxS8JDCy0/marijuana-investing-in-2017-5-numbers-everyone-should-know-cm719863,Many marijuana stocks have soared in 2016 with one enjoying especially impressive gains of well over 2 000 However this speculative industry is fraught with risk If you re considering investing in marijuana stocks in the new year here are five numbers you should know
VRX,VRX:US,BBG000DLFM21,Bill Ackman Comments on Valeant Pharmaceuticals International,2016-12-10 15:55:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8hTVGTY_NM/bill-ackman-comments-on-valeant-pharmaceuticals-international-cm719749,Since our last update in August Valeant VRX has bolstered its management ranks improved dermatology average selling prices ASPs stabilized its salesforces and experienced acceleration in Salix script trends Despite these positive developments financial results continue to be
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Comments on Valeant Pharmaceuticals International,2016-12-10 15:55:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8hTVGTY_NM/bill-ackman-comments-on-valeant-pharmaceuticals-international-cm719749,Since our last update in August Valeant VRX has bolstered its management ranks improved dermatology average selling prices ASPs stabilized its salesforces and experienced acceleration in Salix script trends Despite these positive developments financial results continue to be
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Comments on Valeant Pharmaceuticals International,2016-12-09 19:40:00 +0000,http://finance.yahoo.com/news/bill-ackman-comments-valeant-pharmaceuticals-194000596.html,Bill Ackman Comments on Valeant Pharmaceuticals International
VRX,VRX:US,BBG000DLFM21,Bill Ackman Comments on Valeant Pharmaceuticals International,2016-12-09 19:40:00 +0000,http://finance.yahoo.com/news/bill-ackman-comments-valeant-pharmaceuticals-194000596.html,Bill Ackman Comments on Valeant Pharmaceuticals International
VRX,VRX:CT,BBG000DC8S17,Why These Billionaire Steve Cohen Picks Deserve Your Attention,2016-12-09 13:00:30 +0000,http://www.insidermonkey.com/blog/why-these-billionaire-steve-cohen-picks-deserve-your-attention-502090/,Why These Billionaire Steve Cohen Picks Deserve Your Attention
VRX,VRX:US,BBG000DLFM21,Why These Billionaire Steve Cohen Picks Deserve Your Attention,2016-12-09 13:00:30 +0000,http://www.insidermonkey.com/blog/why-these-billionaire-steve-cohen-picks-deserve-your-attention-502090/,Why These Billionaire Steve Cohen Picks Deserve Your Attention
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Risen To A New 19-Month High -- Canadian Commentary,2016-12-09 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XP-37NJzO98/canadian-stocks-have-risen-to-a-new-19month-high--canadian-commentary-20161209-00373,Canadian Stocks Have Risen To A New 19-Month High -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Risen To A New 19-Month High -- Canadian Commentary,2016-12-09 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XP-37NJzO98/canadian-stocks-have-risen-to-a-new-19month-high--canadian-commentary-20161209-00373,Canadian Stocks Have Risen To A New 19-Month High -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"FOLD Slowly Unfolding, EBS Continues Contract Spree, HZNP Plunges On Trial Data",2016-12-09 01:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r0x3bVdhiw8/fold-slowly-unfolding-ebs-continues-contract-spree-hznp-plunges-on-trial-data-20161209-00013,"FOLD Slowly Unfolding, EBS Continues Contract Spree, HZNP Plunges On Trial Data"
VRX,VRX:CT,BBG000DC8S17,"FOLD Slowly Unfolding, EBS Continues Contract Spree, HZNP Plunges On Trial Data",2016-12-09 01:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r0x3bVdhiw8/fold-slowly-unfolding-ebs-continues-contract-spree-hznp-plunges-on-trial-data-20161209-00013,"FOLD Slowly Unfolding, EBS Continues Contract Spree, HZNP Plunges On Trial Data"
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Announces Phase 3 Results For Psoriasis Treatment IDP-118,2016-12-08 23:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QH0R2YzbLEs/valeant-pharma-announces-phase-3-results-for-psoriasis-treatment-idp118-20161208-01161,Valeant Pharma Announces Phase 3 Results For Psoriasis Treatment IDP-118
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Announces Phase 3 Results For Psoriasis Treatment IDP-118,2016-12-08 23:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QH0R2YzbLEs/valeant-pharma-announces-phase-3-results-for-psoriasis-treatment-idp118-20161208-01161,Valeant Pharma Announces Phase 3 Results For Psoriasis Treatment IDP-118
VRX,VRX:CT,BBG000DC8S17,5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices,2016-12-08 22:57:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YofTRa5XzCU/5-drug-stocks-to-avoid-as-trump-vows-to-lower-drug-prices-cm718932,For those who thought that the pharma biotech sector is in for an extraordinary run after Donald Trump s unexpected victory his latest vow to crack down on excessive drug price hikes comes as a bolt from the blue This year has been fraught with headwinds for the pharma biotech sector
VRX,VRX:US,BBG000DLFM21,5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices,2016-12-08 22:57:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YofTRa5XzCU/5-drug-stocks-to-avoid-as-trump-vows-to-lower-drug-prices-cm718932,For those who thought that the pharma biotech sector is in for an extraordinary run after Donald Trump s unexpected victory his latest vow to crack down on excessive drug price hikes comes as a bolt from the blue This year has been fraught with headwinds for the pharma biotech sector
VRX,VRX:US,BBG000DLFM21,Express Scripts Responds To Citron: 'We're Nothing Like Philidor',2016-12-08 22:40:57 +0000,http://www.investors.com/news/express-scripts-after-citron-criticism-were-nothing-like-philidor/,Express Scripts Responds To Citron: 'We're Nothing Like Philidor'
VRX,VRX:CT,BBG000DC8S17,Express Scripts Responds To Citron: 'We're Nothing Like Philidor',2016-12-08 22:40:57 +0000,http://www.investors.com/news/express-scripts-after-citron-criticism-were-nothing-like-philidor/,Express Scripts Responds To Citron: 'We're Nothing Like Philidor'
VRX,VRX:US,BBG000DLFM21,5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices,2016-12-08 21:19:09 +0000,http://finance.yahoo.com/news/5-drug-stocks-avoid-trump-211909752.html,5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
VRX,VRX:CT,BBG000DC8S17,5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices,2016-12-08 21:19:09 +0000,http://finance.yahoo.com/news/5-drug-stocks-avoid-trump-211909752.html,5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
VRX,VRX:CT,BBG000DC8S17,Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK,2016-12-08 16:57:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MAimRKI2pk4/pfizer-pfe-fined-for-price-hike-of-anti-epilepsy-drug-in-uk-cm718656,Leading pharma company Pfizer Inc PFE was levied a fine of 107 million 84 2 million by the Competition and Markets Authority CMA of the UK upon finding that it had violated competition laws by charging excessive and unfair prices for its anti epilepsy drug phenytoin sodium capsules
VRX,VRX:US,BBG000DLFM21,Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK,2016-12-08 16:57:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MAimRKI2pk4/pfizer-pfe-fined-for-price-hike-of-anti-epilepsy-drug-in-uk-cm718656,Leading pharma company Pfizer Inc PFE was levied a fine of 107 million 84 2 million by the Competition and Markets Authority CMA of the UK upon finding that it had violated competition laws by charging excessive and unfair prices for its anti epilepsy drug phenytoin sodium capsules
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Phase 3 Results For Psoriasis Treatment IDP-118,2016-12-08 16:55:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-phase-3-165500949.html,"[PR Newswire] - LAVAL, Quebec, Dec. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced positive results from a Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety and efficacy of IDP-118 (halobetasol propionate and tazarotene) lotion in the treatment of plaque psoriasis. The Phase 3 program was preceded by a successful Phase 2 study where the combination product IDP-118, with a treatment success rate of 52.5%, was superior to each of the actives halobetasol propionate and tazarotene as well as the vehicle."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Phase 3 Results For Psoriasis Treatment IDP-118,2016-12-08 16:55:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-announces-phase-3-165500949.html,"[PR Newswire] - LAVAL, Quebec, Dec. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today announced positive results from a Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety and efficacy of IDP-118 (halobetasol propionate and tazarotene) lotion in the treatment of plaque psoriasis. The Phase 3 program was preceded by a successful Phase 2 study where the combination product IDP-118, with a treatment success rate of 52.5%, was superior to each of the actives halobetasol propionate and tazarotene as well as the vehicle."
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Releases Pershing Square 3rd-Quarter Letter,2016-12-08 16:52:59 +0000,http://finance.yahoo.com/news/bill-ackman-discusses-rebounding-stocks-165259654.html,Bill Ackman Releases Pershing Square 3rd-Quarter Letter
VRX,VRX:US,BBG000DLFM21,Bill Ackman Releases Pershing Square 3rd-Quarter Letter,2016-12-08 16:52:59 +0000,http://finance.yahoo.com/news/bill-ackman-discusses-rebounding-stocks-165259654.html,Bill Ackman Releases Pershing Square 3rd-Quarter Letter
VRX,VRX:US,BBG000DLFM21,"Bill Ackman's Pershing Square Q3 Shareholder Letter Weighs In On Valeant, Chipotle",2016-12-08 15:16:41 +0000,http://finance.yahoo.com/news/bill-ackmans-pershing-square-q3-151641658.html,"Bill Ackman's Pershing Square Q3 Shareholder Letter Weighs In On Valeant, Chipotle"
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman's Pershing Square Q3 Shareholder Letter Weighs In On Valeant, Chipotle",2016-12-08 15:16:41 +0000,http://finance.yahoo.com/news/bill-ackmans-pershing-square-q3-151641658.html,"Bill Ackman's Pershing Square Q3 Shareholder Letter Weighs In On Valeant, Chipotle"
VRX,VRX:CT,BBG000DC8S17,"Amid Horrendous Year, Crispin Odey Turns to These Stocks for Reprieve",2016-12-08 13:47:51 +0000,http://www.insidermonkey.com/blog/amid-horrendous-year-crispin-odey-turns-to-these-stocks-for-reprieve-488054/,"Amid Horrendous Year, Crispin Odey Turns to These Stocks for Reprieve"
VRX,VRX:US,BBG000DLFM21,"Amid Horrendous Year, Crispin Odey Turns to These Stocks for Reprieve",2016-12-08 13:47:51 +0000,http://www.insidermonkey.com/blog/amid-horrendous-year-crispin-odey-turns-to-these-stocks-for-reprieve-488054/,"Amid Horrendous Year, Crispin Odey Turns to These Stocks for Reprieve"
VRX,VRX:CT,BBG000DC8S17,Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST® From Valeant,2016-12-08 06:00:00 +0000,http://finance.yahoo.com/news/pharming-announces-completion-acquisition-north-060000285.html,"[PR Newswire] - Pharming Group N.V. (""Pharming"" or ""the Company"") (PHARM.AS) announces today that it has completed a definitive agreement to acquire all North American commercialisation rights for its own product, RUCONEST® (recombinant human C1 esterase inhibitor), including all rights in the US, Mexico and Canada, from certain subsidiaries of Valeant Pharmaceuticals International, Inc. (""Valeant"") (NYSE/TSX: VRX). RUCONEST® is an orphan drug designated therapy developed by Pharming, already approved for the treatment of acute Hereditary Angioedema (""HAE"") attacks in patients in the US and EU. This transaction will accelerate Pharming's development into a profitable specialty pharmaceutical company with its own independent commercial infrastructure, which will form the foundation for future growth."
VRX,VRX:US,BBG000DLFM21,Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST® From Valeant,2016-12-08 06:00:00 +0000,http://finance.yahoo.com/news/pharming-announces-completion-acquisition-north-060000285.html,"[PR Newswire] - Pharming Group N.V. (""Pharming"" or ""the Company"") (PHARM.AS) announces today that it has completed a definitive agreement to acquire all North American commercialisation rights for its own product, RUCONEST® (recombinant human C1 esterase inhibitor), including all rights in the US, Mexico and Canada, from certain subsidiaries of Valeant Pharmaceuticals International, Inc. (""Valeant"") (NYSE/TSX: VRX). RUCONEST® is an orphan drug designated therapy developed by Pharming, already approved for the treatment of acute Hereditary Angioedema (""HAE"") attacks in patients in the US and EU. This transaction will accelerate Pharming's development into a profitable specialty pharmaceutical company with its own independent commercial infrastructure, which will form the foundation for future growth."
VRX,VRX:CT,BBG000DC8S17,Cramer: Make a Deal or Face the Wheel,2016-12-08 00:01:00 +0000,http://realmoney.thestreet.com/articles/12/07/2016/cramer-make-deal-or-face-wheel?puc=yahoo&cm_ven=YAHOO,Cramer: Make a Deal or Face the Wheel
VRX,VRX:US,BBG000DLFM21,Cramer: Make a Deal or Face the Wheel,2016-12-08 00:01:00 +0000,http://realmoney.thestreet.com/articles/12/07/2016/cramer-make-deal-or-face-wheel?puc=yahoo&cm_ven=YAHOO,Cramer: Make a Deal or Face the Wheel
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump,2016-12-07 18:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VoWEsSNcHck/why-valeant-pharmaceuticals-vrx-could-be-positioned-for-a-slump-cm718140,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump,2016-12-07 18:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VoWEsSNcHck/why-valeant-pharmaceuticals-vrx-could-be-positioned-for-a-slump-cm718140,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:US,BBG000DLFM21,Is The Valspar Corp (VAL) A Good Stock To Buy?,2016-12-07 17:39:49 +0000,http://www.insidermonkey.com/blog/is-the-valspar-corp-val-a-good-stock-to-buy-500915/,Is The Valspar Corp (VAL) A Good Stock To Buy?
VRX,VRX:CT,BBG000DC8S17,Is The Valspar Corp (VAL) A Good Stock To Buy?,2016-12-07 17:39:49 +0000,http://www.insidermonkey.com/blog/is-the-valspar-corp-val-a-good-stock-to-buy-500915/,Is The Valspar Corp (VAL) A Good Stock To Buy?
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump,2016-12-07 16:49:04 +0000,http://finance.yahoo.com/news/why-valeant-pharmaceuticals-vrx-could-164904931.html,Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump,2016-12-07 16:49:04 +0000,http://finance.yahoo.com/news/why-valeant-pharmaceuticals-vrx-could-164904931.html,Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump
VRX,VRX:CT,BBG000DC8S17,3 Toxic Value Stocks to Avoid in 2017,2016-12-07 15:57:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VaVsE1cP6-Q/3-toxic-value-stocks-to-avoid-in-2017-cm717930,Image source Getty Images Don t look now but in less than four weeks 2016 will be in the rearview mirror While it began about as horribly as you can imagine with all three major U S indexes losing at least 10 of their value through mid February it looks to end on a high
VRX,VRX:US,BBG000DLFM21,3 Toxic Value Stocks to Avoid in 2017,2016-12-07 15:57:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VaVsE1cP6-Q/3-toxic-value-stocks-to-avoid-in-2017-cm717930,Image source Getty Images Don t look now but in less than four weeks 2016 will be in the rearview mirror While it began about as horribly as you can imagine with all three major U S indexes losing at least 10 of their value through mid February it looks to end on a high
VRX,VRX:US,BBG000DLFM21,"Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November",2016-12-07 14:33:24 +0000,http://www.fool.com/investing/2016/12/06/why-progenics-pharmaceuticals-inc-stock-climbed-76.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November"
VRX,VRX:CT,BBG000DC8S17,"Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November",2016-12-07 14:33:24 +0000,http://www.fool.com/investing/2016/12/06/why-progenics-pharmaceuticals-inc-stock-climbed-76.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November"
VRX,VRX:CT,BBG000DC8S17,3 Toxic Value Stocks to Avoid in 2017,2016-12-07 14:26:00 +0000,http://www.fool.com/investing/2016/12/07/3-toxic-value-stocks-to-avoid-in-2017.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Toxic Value Stocks to Avoid in 2017
VRX,VRX:US,BBG000DLFM21,3 Toxic Value Stocks to Avoid in 2017,2016-12-07 14:26:00 +0000,http://www.fool.com/investing/2016/12/07/3-toxic-value-stocks-to-avoid-in-2017.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Toxic Value Stocks to Avoid in 2017
VRX,VRX:CT,BBG000DC8S17,Trump: I'm Going To Bring Down Drug Prices,2016-12-07 14:14:05 +0000,http://finance.yahoo.com/news/trump-im-going-bring-down-141405273.html,Trump: I'm Going To Bring Down Drug Prices
VRX,VRX:US,BBG000DLFM21,Trump: I'm Going To Bring Down Drug Prices,2016-12-07 14:14:05 +0000,http://finance.yahoo.com/news/trump-im-going-bring-down-141405273.html,Trump: I'm Going To Bring Down Drug Prices
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Holding Gains After BoC Holds Rates -- Canadian Commentary,2016-12-07 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pPu4TzVxtnc/canadian-stocks-are-holding-gains-after-boc-holds-rates--canadian-commentary-20161207-00676,Canadian Stocks Are Holding Gains After BoC Holds Rates -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Holding Gains After BoC Holds Rates -- Canadian Commentary,2016-12-07 10:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pPu4TzVxtnc/canadian-stocks-are-holding-gains-after-boc-holds-rates--canadian-commentary-20161207-00676,Canadian Stocks Are Holding Gains After BoC Holds Rates -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November",2016-12-06 21:28:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/07HlzB5WTxc/why-progenics-pharmaceuticals-inc-stock-climbed-765-in-november-cm717661,Image source Getty Images What happened Shares of Progenics Pharmaceuticals Inc NASDAQ PGNX a small biotech with an oncology focus rocketed up 76 5 in November according to data from S amp P Global Market Intelligence 160 An inflow of capital on the heels
VRX,VRX:US,BBG000DLFM21,"Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November",2016-12-06 21:28:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/07HlzB5WTxc/why-progenics-pharmaceuticals-inc-stock-climbed-765-in-november-cm717661,Image source Getty Images What happened Shares of Progenics Pharmaceuticals Inc NASDAQ PGNX a small biotech with an oncology focus rocketed up 76 5 in November according to data from S amp P Global Market Intelligence 160 An inflow of capital on the heels
VRX,VRX:US,BBG000DLFM21,"OPEC Drives Dow Jones Industrial Average, S&P to Record Highs",2016-12-06 21:13:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mOGh-SU0EiY/opec-drives-dow-jones-industrial-average-sp-to-record-highs-cm717264,The 160 Dow Jones Industrial Average DJIA 160 touched another record high and finished in the black buoyed by strong economic data and a production cut agreement at the Organization of the Petroleum Exporting Countries OPEC However even as energy stocks stormed higher
VRX,VRX:CT,BBG000DC8S17,"OPEC Drives Dow Jones Industrial Average, S&P to Record Highs",2016-12-06 21:13:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mOGh-SU0EiY/opec-drives-dow-jones-industrial-average-sp-to-record-highs-cm717264,The 160 Dow Jones Industrial Average DJIA 160 touched another record high and finished in the black buoyed by strong economic data and a production cut agreement at the Organization of the Petroleum Exporting Countries OPEC However even as energy stocks stormed higher
VRX,VRX:US,BBG000DLFM21,Surprise! The SEC Isn't Happy With Valeant Pharmaceuticals Again,2016-12-06 19:49:05 +0000,http://www.fool.com/investing/2016/12/05/surprise-the-sec-isnt-happy-with-valeant-pharmaceu.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Surprise! The SEC Isn't Happy With Valeant Pharmaceuticals Again
VRX,VRX:CT,BBG000DC8S17,Surprise! The SEC Isn't Happy With Valeant Pharmaceuticals Again,2016-12-06 19:49:05 +0000,http://www.fool.com/investing/2016/12/05/surprise-the-sec-isnt-happy-with-valeant-pharmaceu.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Surprise! The SEC Isn't Happy With Valeant Pharmaceuticals Again
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Has Slipped Into The Red -- Canadian Commentary,2016-12-06 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SxBRZiMhHCs/canadian-stocks-has-slipped-into-the-red--canadian-commentary-20161206-00761,Canadian Stocks Has Slipped Into The Red -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Has Slipped Into The Red -- Canadian Commentary,2016-12-06 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SxBRZiMhHCs/canadian-stocks-has-slipped-into-the-red--canadian-commentary-20161206-00761,Canadian Stocks Has Slipped Into The Red -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,3 Prime Reasons Valeant Pharmaceuticals Intl. Inc. Shares Dove 11% in November,2016-12-05 17:48:35 +0000,http://www.fool.com/investing/2016/12/05/3-prime-reasons-valeant-pharmaceuticals-intl-inc-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Prime Reasons Valeant Pharmaceuticals Intl. Inc. Shares Dove 11% in November
VRX,VRX:US,BBG000DLFM21,3 Prime Reasons Valeant Pharmaceuticals Intl. Inc. Shares Dove 11% in November,2016-12-05 17:48:35 +0000,http://www.fool.com/investing/2016/12/05/3-prime-reasons-valeant-pharmaceuticals-intl-inc-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Prime Reasons Valeant Pharmaceuticals Intl. Inc. Shares Dove 11% in November
VRX,VRX:US,BBG000DLFM21,"Can Donald Trump Make Valeant Stock Great Again? (VRX, XLV)",2016-12-05 17:25:00 +0000,http://www.investopedia.com/news/can-donald-trump-make-valeant-stock-great-again-vrx-xlv/?partner=YahooSA,"Can Donald Trump Make Valeant Stock Great Again? (VRX, XLV)"
VRX,VRX:CT,BBG000DC8S17,"Can Donald Trump Make Valeant Stock Great Again? (VRX, XLV)",2016-12-05 17:25:00 +0000,http://www.investopedia.com/news/can-donald-trump-make-valeant-stock-great-again-vrx-xlv/?partner=YahooSA,"Can Donald Trump Make Valeant Stock Great Again? (VRX, XLV)"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Off Early Highs On Gold Weakness -- Canadian Commentary,2016-12-05 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/um6fNI0_5WM/canadian-stocks-are-off-early-highs-on-gold-weakness--canadian-commentary-20161205-00694,Canadian Stocks Are Off Early Highs On Gold Weakness -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Off Early Highs On Gold Weakness -- Canadian Commentary,2016-12-05 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/um6fNI0_5WM/canadian-stocks-are-off-early-highs-on-gold-weakness--canadian-commentary-20161205-00694,Canadian Stocks Are Off Early Highs On Gold Weakness -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals Intl Inc (VRX) A Good Stock To Buy?,2016-12-04 22:12:32 +0000,http://www.insidermonkey.com/blog/is-valeant-pharmaceuticals-intl-inc-vrx-a-good-stock-to-buy-490051/,Is Valeant Pharmaceuticals Intl Inc (VRX) A Good Stock To Buy?
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals Intl Inc (VRX) A Good Stock To Buy?,2016-12-04 22:12:32 +0000,http://www.insidermonkey.com/blog/is-valeant-pharmaceuticals-intl-inc-vrx-a-good-stock-to-buy-490051/,Is Valeant Pharmaceuticals Intl Inc (VRX) A Good Stock To Buy?
VRX,VRX:US,BBG000DLFM21,Is Mylan Being Really Smart -- Or Really Arrogant?,2016-12-04 11:49:32 +0000,http://www.fool.com/investing/2016/12/04/is-mylan-being-really-smart-or-really-arrogant.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Mylan Being Really Smart -- Or Really Arrogant?
VRX,VRX:CT,BBG000DC8S17,Is Mylan Being Really Smart -- Or Really Arrogant?,2016-12-04 11:49:32 +0000,http://www.fool.com/investing/2016/12/04/is-mylan-being-really-smart-or-really-arrogant.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Mylan Being Really Smart -- Or Really Arrogant?
VRX,VRX:CT,BBG000DC8S17,"[$$] Week in Review, December 2",2016-12-02 23:06:32 +0000,"http://www.ft.com/cms/s/6eb4cec0-b8b1-11e6-ba85-95d1533d9a62,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - A round up of some of the week's most significant corporate events and news stories. Glencore to restart dividend as debt cuts plan nears end Glencore, the miner and commodity trader, said this week it ..."
VRX,VRX:US,BBG000DLFM21,"[$$] Week in Review, December 2",2016-12-02 23:06:32 +0000,"http://www.ft.com/cms/s/6eb4cec0-b8b1-11e6-ba85-95d1533d9a62,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - A round up of some of the week's most significant corporate events and news stories. Glencore to restart dividend as debt cuts plan nears end Glencore, the miner and commodity trader, said this week it ..."
VRX,VRX:CT,BBG000DC8S17,Analysts Are Bullish on Valeant,2016-12-02 16:04:40 +0000,http://marketrealist.com/2016/11/analysts-are-bullish-on-valeant/?utm_source=yahoo&utm_medium=feed,Analysts Are Bullish on Valeant
VRX,VRX:US,BBG000DLFM21,Analysts Are Bullish on Valeant,2016-12-02 16:04:40 +0000,http://marketrealist.com/2016/11/analysts-are-bullish-on-valeant/?utm_source=yahoo&utm_medium=feed,Analysts Are Bullish on Valeant
VRX,VRX:CT,BBG000DC8S17,Bill Ackman’s Biggest Q3 Moves As He Seeks Elusive Turnaround,2016-12-02 16:00:54 +0000,http://www.insidermonkey.com/blog/bill-ackmans-biggest-q3-moves-as-he-seeks-elusive-turnaround-488425/,Bill Ackman’s Biggest Q3 Moves As He Seeks Elusive Turnaround
VRX,VRX:US,BBG000DLFM21,Bill Ackman’s Biggest Q3 Moves As He Seeks Elusive Turnaround,2016-12-02 16:00:54 +0000,http://www.insidermonkey.com/blog/bill-ackmans-biggest-q3-moves-as-he-seeks-elusive-turnaround-488425/,Bill Ackman’s Biggest Q3 Moves As He Seeks Elusive Turnaround
VRX,VRX:US,BBG000DLFM21,"Ackman Scores Big November on Fannie, Freddie Gains",2016-12-02 15:07:50 +0000,http://blogs.wsj.com/moneybeat/2016/12/02/ackman-scores-big-november-on-fannie-freddie-gains/?mod=yahoo_hs,"Ackman Scores Big November on Fannie, Freddie Gains"
VRX,VRX:CT,BBG000DC8S17,"Ackman Scores Big November on Fannie, Freddie Gains",2016-12-02 15:07:50 +0000,http://blogs.wsj.com/moneybeat/2016/12/02/ackman-scores-big-november-on-fannie-freddie-gains/?mod=yahoo_hs,"Ackman Scores Big November on Fannie, Freddie Gains"
VRX,VRX:US,BBG000DLFM21,Is Valeant Exposed to Default Risk?,2016-12-02 15:04:31 +0000,http://marketrealist.com/2016/11/is-valeant-exposed-to-default-risk/?utm_source=yahoo&utm_medium=feed,Is Valeant Exposed to Default Risk?
VRX,VRX:CT,BBG000DC8S17,Is Valeant Exposed to Default Risk?,2016-12-02 15:04:31 +0000,http://marketrealist.com/2016/11/is-valeant-exposed-to-default-risk/?utm_source=yahoo&utm_medium=feed,Is Valeant Exposed to Default Risk?
VRX,VRX:US,BBG000DLFM21,"Yes, There Will Be Margin Erosion for Valeant in 2017",2016-12-02 13:04:40 +0000,http://marketrealist.com/2016/11/yes-there-will-be-margin-erosion-for-valeant-in-2017/?utm_source=yahoo&utm_medium=feed,"Yes, There Will Be Margin Erosion for Valeant in 2017"
VRX,VRX:CT,BBG000DC8S17,"Yes, There Will Be Margin Erosion for Valeant in 2017",2016-12-02 13:04:40 +0000,http://marketrealist.com/2016/11/yes-there-will-be-margin-erosion-for-valeant-in-2017/?utm_source=yahoo&utm_medium=feed,"Yes, There Will Be Margin Erosion for Valeant in 2017"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary,2016-12-02 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NI4lqm07Tz0/canadian-stocks-are-climbing-on-gold-strength--canadian-commentary-20161202-00428,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary,2016-12-02 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NI4lqm07Tz0/canadian-stocks-are-climbing-on-gold-strength--canadian-commentary-20161202-00428,Canadian Stocks Are Climbing On Gold Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Valeant, Salix, Sales Force and Asset Sales",2016-12-01 20:32:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J46sIJoWyu8/valeant-salix-sales-force-and-asset-sales-cm716440,Valeant VRX put out a press release today about expansion of sales force for their Salix business Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan And Relistor LAVAL Quebec Nov 9 6 PRNewswire Valeant Pharmaceuticals International
VRX,VRX:CT,BBG000DC8S17,"Valeant, Salix, Sales Force and Asset Sales",2016-12-01 20:32:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J46sIJoWyu8/valeant-salix-sales-force-and-asset-sales-cm716440,Valeant VRX put out a press release today about expansion of sales force for their Salix business Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan And Relistor LAVAL Quebec Nov 9 6 PRNewswire Valeant Pharmaceuticals International
VRX,VRX:US,BBG000DLFM21,3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017,2016-12-01 17:20:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UWcLqN5GzcQ/3-drug-stocks-investors-shouldnt-touch-with-a-10-foot-pole-in-2017-cm716423,Image source Getty Images Despite beginning the year on a rough note the broad based S amp P 500 is up a solid 8 year to date On the flip side drug stock investors seemingly can t catch a break The SPDR S amp P Biotech ETF is off a little more than 7 year to date while
VRX,VRX:CT,BBG000DC8S17,3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017,2016-12-01 17:20:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UWcLqN5GzcQ/3-drug-stocks-investors-shouldnt-touch-with-a-10-foot-pole-in-2017-cm716423,Image source Getty Images Despite beginning the year on a rough note the broad based S amp P 500 is up a solid 8 year to date On the flip side drug stock investors seemingly can t catch a break The SPDR S amp P Biotech ETF is off a little more than 7 year to date while
VRX,VRX:US,BBG000DLFM21,What’s Forcing Valeant to Sell Its Core Assets?,2016-12-01 16:04:50 +0000,http://marketrealist.com/2016/11/whats-forcing-valeant-to-sell-its-core-assets/?utm_source=yahoo&utm_medium=feed,What’s Forcing Valeant to Sell Its Core Assets?
VRX,VRX:CT,BBG000DC8S17,What’s Forcing Valeant to Sell Its Core Assets?,2016-12-01 16:04:50 +0000,http://marketrealist.com/2016/11/whats-forcing-valeant-to-sell-its-core-assets/?utm_source=yahoo&utm_medium=feed,What’s Forcing Valeant to Sell Its Core Assets?
VRX,VRX:CT,BBG000DC8S17,3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017,2016-12-01 15:47:54 +0000,http://www.fool.com/investing/2016/12/01/3-drug-stocks-investors-shouldnt-touch-with-a-10-f.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
VRX,VRX:US,BBG000DLFM21,3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017,2016-12-01 15:47:54 +0000,http://www.fool.com/investing/2016/12/01/3-drug-stocks-investors-shouldnt-touch-with-a-10-f.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
VRX,VRX:CT,BBG000DC8S17,How Does Valeant Plan to Resume Growth beyond 2016?,2016-12-01 15:05:02 +0000,http://marketrealist.com/2016/11/how-does-valeant-plan-to-resume-growth-beyond-2016/?utm_source=yahoo&utm_medium=feed,How Does Valeant Plan to Resume Growth beyond 2016?
VRX,VRX:US,BBG000DLFM21,How Does Valeant Plan to Resume Growth beyond 2016?,2016-12-01 15:05:02 +0000,http://marketrealist.com/2016/11/how-does-valeant-plan-to-resume-growth-beyond-2016/?utm_source=yahoo&utm_medium=feed,How Does Valeant Plan to Resume Growth beyond 2016?
VRX,VRX:US,BBG000DLFM21,"Chou Associates REALLY Loves Its Portfolio, Because It Didn’t Touch It Last Quarter",2016-12-01 13:11:45 +0000,http://www.insidermonkey.com/blog/chou-associates-really-loves-its-portfolio-because-it-didnt-touch-it-last-quarter-484580/,"Chou Associates REALLY Loves Its Portfolio, Because It Didn’t Touch It Last Quarter"
VRX,VRX:CT,BBG000DC8S17,"Chou Associates REALLY Loves Its Portfolio, Because It Didn’t Touch It Last Quarter",2016-12-01 13:11:45 +0000,http://www.insidermonkey.com/blog/chou-associates-really-loves-its-portfolio-because-it-didnt-touch-it-last-quarter-484580/,"Chou Associates REALLY Loves Its Portfolio, Because It Didn’t Touch It Last Quarter"
VRX,VRX:US,BBG000DLFM21,Why Wasn’t Valeant’s Enormous Growth Sustainable?,2016-12-01 13:05:06 +0000,http://marketrealist.com/2016/11/why-wasnt-valeants-enormous-growth-sustainable/?utm_source=yahoo&utm_medium=feed,Why Wasn’t Valeant’s Enormous Growth Sustainable?
VRX,VRX:CT,BBG000DC8S17,Why Wasn’t Valeant’s Enormous Growth Sustainable?,2016-12-01 13:05:06 +0000,http://marketrealist.com/2016/11/why-wasnt-valeants-enormous-growth-sustainable/?utm_source=yahoo&utm_medium=feed,Why Wasn’t Valeant’s Enormous Growth Sustainable?
VRX,VRX:US,BBG000DLFM21,Ranking the Activists for Proxy Season 2016,2016-12-01 13:02:00 +0000,https://www.thestreet.com/story/13910348/1/ranking-the-activists-for-proxy-season-2016.html?puc=yahoo&cm_ven=YAHOO,Ranking the Activists for Proxy Season 2016
VRX,VRX:CT,BBG000DC8S17,Ranking the Activists for Proxy Season 2016,2016-12-01 13:02:00 +0000,https://www.thestreet.com/story/13910348/1/ranking-the-activists-for-proxy-season-2016.html?puc=yahoo&cm_ven=YAHOO,Ranking the Activists for Proxy Season 2016
VRX,VRX:CT,BBG000DC8S17,Valeant Stock Plunges 11% on Failed Salix Sale (VRX),2016-12-01 12:06:00 +0000,http://www.investopedia.com/news/valeant-stock-plunges-11-failed-salix-sale-vrx/?partner=YahooSA,Valeant Stock Plunges 11% on Failed Salix Sale (VRX)
VRX,VRX:US,BBG000DLFM21,Valeant Stock Plunges 11% on Failed Salix Sale (VRX),2016-12-01 12:06:00 +0000,http://www.investopedia.com/news/valeant-stock-plunges-11-failed-salix-sale-vrx/?partner=YahooSA,Valeant Stock Plunges 11% on Failed Salix Sale (VRX)
VRX,VRX:US,BBG000DLFM21,Is Computer Sciences Corporation (CSC) A Good Stock To Buy?,2016-12-01 11:49:35 +0000,http://www.insidermonkey.com/blog/is-computer-sciences-corporation-csc-a-good-stock-to-buy-492182/,Is Computer Sciences Corporation (CSC) A Good Stock To Buy?
VRX,VRX:CT,BBG000DC8S17,Is Computer Sciences Corporation (CSC) A Good Stock To Buy?,2016-12-01 11:49:35 +0000,http://www.insidermonkey.com/blog/is-computer-sciences-corporation-csc-a-good-stock-to-buy-492182/,Is Computer Sciences Corporation (CSC) A Good Stock To Buy?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up On Continued Energy Rally -- Canadian Commentary,2016-12-01 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PQBc2V_rZns/canadian-stocks-are-up-on-continued-energy-rally--canadian-commentary-20161201-00786,Canadian Stocks Are Up On Continued Energy Rally -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up On Continued Energy Rally -- Canadian Commentary,2016-12-01 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PQBc2V_rZns/canadian-stocks-are-up-on-continued-energy-rally--canadian-commentary-20161201-00786,Canadian Stocks Are Up On Continued Energy Rally -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,SEC Discloses Correspondence Over Valeant's Accounting Practices,2016-11-30 23:47:00 +0000,https://www.thestreet.com/story/13909972/1/sec-discloses-correspondence-over-valeant-s-accounting-practices.html?puc=yahoo&cm_ven=YAHOO,SEC Discloses Correspondence Over Valeant's Accounting Practices
VRX,VRX:US,BBG000DLFM21,SEC Discloses Correspondence Over Valeant's Accounting Practices,2016-11-30 23:47:00 +0000,https://www.thestreet.com/story/13909972/1/sec-discloses-correspondence-over-valeant-s-accounting-practices.html?puc=yahoo&cm_ven=YAHOO,SEC Discloses Correspondence Over Valeant's Accounting Practices
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today",2016-11-30 23:17:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FRhVcEj1-pQ/why-valeant-pharmaceuticals-costamare-and-first-bancorp-slumped-today-cm716046,Wednesday was a mixed day for the stock market with major market benchmarks showing considerable disparities in results The energy sector soared and oil s 4 gain to 49 per barrel helped lift the Dow to the best performance among the major averages Meanwhile performance
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today",2016-11-30 23:17:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FRhVcEj1-pQ/why-valeant-pharmaceuticals-costamare-and-first-bancorp-slumped-today-cm716046,Wednesday was a mixed day for the stock market with major market benchmarks showing considerable disparities in results The energy sector soared and oil s 4 gain to 49 per barrel helped lift the Dow to the best performance among the major averages Meanwhile performance
VRX,VRX:US,BBG000DLFM21,SEC Again Criticizes Valeant Over Non-GAAP Financial Measures,2016-11-30 22:41:41 +0000,http://blogs.wsj.com/moneybeat/2016/11/30/sec-again-criticizes-valeant-over-non-gaap-financial-measures/?mod=yahoo_hs,SEC Again Criticizes Valeant Over Non-GAAP Financial Measures
VRX,VRX:CT,BBG000DC8S17,SEC Again Criticizes Valeant Over Non-GAAP Financial Measures,2016-11-30 22:41:41 +0000,http://blogs.wsj.com/moneybeat/2016/11/30/sec-again-criticizes-valeant-over-non-gaap-financial-measures/?mod=yahoo_hs,SEC Again Criticizes Valeant Over Non-GAAP Financial Measures
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today",2016-11-30 22:04:06 +0000,http://www.fool.com/investing/2016/11/30/why-valeant-pharmaceuticals-costamare-and-first-ba.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today"
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today",2016-11-30 22:04:06 +0000,http://www.fool.com/investing/2016/11/30/why-valeant-pharmaceuticals-costamare-and-first-ba.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today"
VRX,VRX:CT,BBG000DC8S17,Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report,2016-11-30 22:03:47 +0000,http://www.investors.com/news/technology/valeant-takeda-salix-negotiations-bust-on-10-billion-price-report/,Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report
VRX,VRX:US,BBG000DLFM21,Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report,2016-11-30 22:03:47 +0000,http://www.investors.com/news/technology/valeant-takeda-salix-negotiations-bust-on-10-billion-price-report/,Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report
VRX,VRX:CT,BBG000DC8S17,Valeant slumps 8% after talks to sell stomach-drug unit fall apart,2016-11-30 21:49:55 +0000,http://www.cnbc.com/id/104137504?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104137504,Valeant slumps 8% after talks to sell stomach-drug unit fall apart
VRX,VRX:US,BBG000DLFM21,Valeant slumps 8% after talks to sell stomach-drug unit fall apart,2016-11-30 21:49:55 +0000,http://www.cnbc.com/id/104137504?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104137504,Valeant slumps 8% after talks to sell stomach-drug unit fall apart
VRX,VRX:US,BBG000DLFM21,"Valeant, Salix, Sales Force and Asset Sales",2016-11-30 21:10:46 +0000,http://finance.yahoo.com/news/valeant-salix-sales-force-asset-211046030.html,"Valeant, Salix, Sales Force and Asset Sales"
VRX,VRX:CT,BBG000DC8S17,"Valeant, Salix, Sales Force and Asset Sales",2016-11-30 21:10:46 +0000,http://finance.yahoo.com/news/valeant-salix-sales-force-asset-211046030.html,"Valeant, Salix, Sales Force and Asset Sales"
VRX,VRX:US,BBG000DLFM21,When Will Valeant Resume Its Top Line Growth?,2016-11-30 20:04:05 +0000,http://marketrealist.com/2016/11/when-will-valeant-resume-its-top-line-growth/?utm_source=yahoo&utm_medium=feed,When Will Valeant Resume Its Top Line Growth?
VRX,VRX:CT,BBG000DC8S17,When Will Valeant Resume Its Top Line Growth?,2016-11-30 20:04:05 +0000,http://marketrealist.com/2016/11/when-will-valeant-resume-its-top-line-growth/?utm_source=yahoo&utm_medium=feed,When Will Valeant Resume Its Top Line Growth?
VRX,VRX:US,BBG000DLFM21,"Valeant: First No Salix Sale, Now the SEC Sees Accounting Issues?!?!",2016-11-30 19:50:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/30/valeant-first-no-salix-sale-now-the-sec-sees-accounting-issues/?mod=yahoobarrons&ru=yahoo,"Valeant: First No Salix Sale, Now the SEC Sees Accounting Issues?!?!"
VRX,VRX:CT,BBG000DC8S17,"Valeant: First No Salix Sale, Now the SEC Sees Accounting Issues?!?!",2016-11-30 19:50:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/30/valeant-first-no-salix-sale-now-the-sec-sees-accounting-issues/?mod=yahoobarrons&ru=yahoo,"Valeant: First No Salix Sale, Now the SEC Sees Accounting Issues?!?!"
VRX,VRX:US,BBG000DLFM21,"Dow Climbs as Crude Rally Lights Fire Under Energy Sector, S&P 500 Falls",2016-11-30 19:44:00 +0000,https://www.thestreet.com/story/13909340/1/stocks-mixed-as-opec-deal-boosts-energy-shares-biotech-sinks-nasdaq.html?puc=yahoo&cm_ven=YAHOO,"Dow Climbs as Crude Rally Lights Fire Under Energy Sector, S&P 500 Falls"
VRX,VRX:CT,BBG000DC8S17,"Dow Climbs as Crude Rally Lights Fire Under Energy Sector, S&P 500 Falls",2016-11-30 19:44:00 +0000,https://www.thestreet.com/story/13909340/1/stocks-mixed-as-opec-deal-boosts-energy-shares-biotech-sinks-nasdaq.html?puc=yahoo&cm_ven=YAHOO,"Dow Climbs as Crude Rally Lights Fire Under Energy Sector, S&P 500 Falls"
VRX,VRX:US,BBG000DLFM21,"Can Bill Ackman Revive Chipotle Mexican Grill, Inc. (CMG) Stock?",2016-11-30 18:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xoAVMPLVOuc/can-bill-ackman-revive-chipotle-mexican-grill-inc-cmg-stock-cm715893,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The last 12 months haven t been great ones for either Bill Ackman or Chipotle Mexican Grill Inc NYSE CMG In 2015 Ackman s Pershing Square lost 20 of its value As of October it was down
VRX,VRX:CT,BBG000DC8S17,"Can Bill Ackman Revive Chipotle Mexican Grill, Inc. (CMG) Stock?",2016-11-30 18:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xoAVMPLVOuc/can-bill-ackman-revive-chipotle-mexican-grill-inc-cmg-stock-cm715893,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The last 12 months haven t been great ones for either Bill Ackman or Chipotle Mexican Grill Inc NYSE CMG In 2015 Ackman s Pershing Square lost 20 of its value As of October it was down
VRX,VRX:CT,BBG000DC8S17,What Does Valeant’s Institutional Ownership Look Like?,2016-11-30 18:04:18 +0000,http://marketrealist.com/2016/11/what-does-valeants-institutional-ownership-look-like/?utm_source=yahoo&utm_medium=feed,What Does Valeant’s Institutional Ownership Look Like?
VRX,VRX:US,BBG000DLFM21,What Does Valeant’s Institutional Ownership Look Like?,2016-11-30 18:04:18 +0000,http://marketrealist.com/2016/11/what-does-valeants-institutional-ownership-look-like/?utm_source=yahoo&utm_medium=feed,What Does Valeant’s Institutional Ownership Look Like?
VRX,VRX:CT,BBG000DC8S17,"How to Trade Wednesday's Most Active Stocks -- Chesapeake Energy, American Eagle, More",2016-11-30 18:04:00 +0000,https://www.thestreet.com/story/13909413/1/how-to-trade-wednesday-s-most-active-stocks-chesapeake-energy-american-eagle-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Wednesday's Most Active Stocks -- Chesapeake Energy, American Eagle, More"
VRX,VRX:US,BBG000DLFM21,"How to Trade Wednesday's Most Active Stocks -- Chesapeake Energy, American Eagle, More",2016-11-30 18:04:00 +0000,https://www.thestreet.com/story/13909413/1/how-to-trade-wednesday-s-most-active-stocks-chesapeake-energy-american-eagle-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Wednesday's Most Active Stocks -- Chesapeake Energy, American Eagle, More"
VRX,VRX:CT,BBG000DC8S17,Valeant and Tribune Media Rebounds Not in Sight,2016-11-30 17:40:00 +0000,https://www.thestreet.com/story/13908040/1/valeant-and-tribune-media-rebounds-not-in-sight.html?puc=yahoo&cm_ven=YAHOO,Valeant and Tribune Media Rebounds Not in Sight
VRX,VRX:US,BBG000DLFM21,Valeant and Tribune Media Rebounds Not in Sight,2016-11-30 17:40:00 +0000,https://www.thestreet.com/story/13908040/1/valeant-and-tribune-media-rebounds-not-in-sight.html?puc=yahoo&cm_ven=YAHOO,Valeant and Tribune Media Rebounds Not in Sight
VRX,VRX:CT,BBG000DC8S17,Takeda's talks to acquire Valeant's Salix stall - sources,2016-11-30 17:36:42 +0000,http://sg.finance.yahoo.com/news/takedas-talks-acquire-valeants-salix-173642704.html,Takeda's talks to acquire Valeant's Salix stall - sources
VRX,VRX:US,BBG000DLFM21,Takeda's talks to acquire Valeant's Salix stall - sources,2016-11-30 17:36:42 +0000,http://sg.finance.yahoo.com/news/takedas-talks-acquire-valeants-salix-173642704.html,Takeda's talks to acquire Valeant's Salix stall - sources
VRX,VRX:US,BBG000DLFM21,Takeda's talks to acquire Valeant's Salix stall-sources,2016-11-30 17:34:25 +0000,http://finance.yahoo.com/news/takedas-talks-acquire-valeants-salix-173425690.html,Takeda's talks to acquire Valeant's Salix stall-sources
VRX,VRX:CT,BBG000DC8S17,Takeda's talks to acquire Valeant's Salix stall-sources,2016-11-30 17:34:25 +0000,http://finance.yahoo.com/news/takedas-talks-acquire-valeants-salix-173425690.html,Takeda's talks to acquire Valeant's Salix stall-sources
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant's talks to sell Salix unit for $10bn break down,2016-11-30 17:21:26 +0000,"http://www.ft.com/cms/s/3edeb036-b71b-11e6-961e-a1acd97f622d,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Valeant abandoned attempts to sell its gastrointestinal division to Japan's Takeda for $10bn after negotiations between the drugmakers broke down, dashing one of the company's best hopes of reducing its ..."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant's talks to sell Salix unit for $10bn break down,2016-11-30 17:21:26 +0000,"http://www.ft.com/cms/s/3edeb036-b71b-11e6-961e-a1acd97f622d,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Valeant abandoned attempts to sell its gastrointestinal division to Japan's Takeda for $10bn after negotiations between the drugmakers broke down, dashing one of the company's best hopes of reducing its ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Said to Plan to Keep Salix After Takeda Deal Falls Apart,2016-11-30 16:54:22 +0000,http://finance.yahoo.com/news/valeant-said-plan-keep-salix-165422231.html,Valeant Said to Plan to Keep Salix After Takeda Deal Falls Apart
VRX,VRX:CT,BBG000DC8S17,Valeant Said to Keep Salix After Takeda Deal Falls Apart,2016-11-30 16:54:22 +0000,http://www.bloomberg.com/news/articles/2016-11-30/valeant-said-to-plan-to-keep-salix-after-takeda-deal-falls-apart?cmpid=yhoo.headline,Valeant Said to Keep Salix After Takeda Deal Falls Apart
VRX,VRX:US,BBG000DLFM21,Valeant Said to Keep Salix After Takeda Deal Falls Apart,2016-11-30 16:54:22 +0000,http://www.bloomberg.com/news/articles/2016-11-30/valeant-said-to-plan-to-keep-salix-after-takeda-deal-falls-apart?cmpid=yhoo.headline,Valeant Said to Keep Salix After Takeda Deal Falls Apart
VRX,VRX:US,BBG000DLFM21,Valeant Said to Plan to Keep Salix After Takeda Deal Falls Apart,2016-11-30 16:54:22 +0000,http://finance.yahoo.com/news/valeant-said-plan-keep-salix-165422231.html,Valeant Said to Plan to Keep Salix After Takeda Deal Falls Apart
VRX,VRX:US,BBG000DLFM21,Why Valeant is Crumbling,2016-11-30 16:49:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/30/why-valeant-is-crumbling/?mod=yahoobarrons&ru=yahoo,Why Valeant is Crumbling
VRX,VRX:CT,BBG000DC8S17,Why Valeant is Crumbling,2016-11-30 16:49:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/30/why-valeant-is-crumbling/?mod=yahoobarrons&ru=yahoo,Why Valeant is Crumbling
VRX,VRX:US,BBG000DLFM21,Has Valeant Really Bottomed Out?,2016-11-30 16:04:30 +0000,http://marketrealist.com/2016/11/has-valeant-really-bottomed-out/?utm_source=yahoo&utm_medium=feed,Has Valeant Really Bottomed Out?
VRX,VRX:CT,BBG000DC8S17,Has Valeant Really Bottomed Out?,2016-11-30 16:04:30 +0000,http://marketrealist.com/2016/11/has-valeant-really-bottomed-out/?utm_source=yahoo&utm_medium=feed,Has Valeant Really Bottomed Out?
VRX,VRX:US,BBG000DLFM21,Valeant Plummets on Reports of Salix Takeover Breakdown,2016-11-30 15:58:00 +0000,https://www.thestreet.com/story/13909253/1/valeant-plummets-on-reports-of-salix-takeover-breakdown.html?puc=yahoo&cm_ven=YAHOO,Valeant Plummets on Reports of Salix Takeover Breakdown
VRX,VRX:CT,BBG000DC8S17,Valeant Plummets on Reports of Salix Takeover Breakdown,2016-11-30 15:58:00 +0000,https://www.thestreet.com/story/13909253/1/valeant-plummets-on-reports-of-salix-takeover-breakdown.html?puc=yahoo&cm_ven=YAHOO,Valeant Plummets on Reports of Salix Takeover Breakdown
VRX,VRX:US,BBG000DLFM21,Valeant Drops After Report Salix Sale Discussions Broke Down,2016-11-30 15:34:58 +0000,http://finance.yahoo.com/news/valeant-drops-report-salix-sale-153458101.html,Valeant Drops After Report Salix Sale Discussions Broke Down
VRX,VRX:CT,BBG000DC8S17,Valeant Drops After Report Salix Sale Discussions Broke Down,2016-11-30 15:34:58 +0000,http://finance.yahoo.com/news/valeant-drops-report-salix-sale-153458101.html,Valeant Drops After Report Salix Sale Discussions Broke Down
VRX,VRX:US,BBG000DLFM21,"It looks like a key Valeant deal might be falling apart, and now the stock is tanking",2016-11-30 15:18:11 +0000,http://finance.yahoo.com/news/looks-key-valeant-deal-might-151811103.html,"It looks like a key Valeant deal might be falling apart, and now the stock is tanking"
VRX,VRX:CT,BBG000DC8S17,"It looks like a key Valeant deal might be falling apart, and now the stock is tanking",2016-11-30 15:18:11 +0000,http://finance.yahoo.com/news/looks-key-valeant-deal-might-151811103.html,"It looks like a key Valeant deal might be falling apart, and now the stock is tanking"
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor,2016-11-30 14:56:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mMEU4KKNzoY/valeant-vrx-ups-sales-force-to-support-xifaxanrelistor-cm715682,Valeant Pharmaceuticals International Inc VRX announced that it is expanding its sales force to reach primary care physicians The new sales force team is going to promote the company s two products Xifaxan for irritable bowel syndrome with diarrhea IBS D and Relistor for opioid
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor,2016-11-30 14:56:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mMEU4KKNzoY/valeant-vrx-ups-sales-force-to-support-xifaxanrelistor-cm715682,Valeant Pharmaceuticals International Inc VRX announced that it is expanding its sales force to reach primary care physicians The new sales force team is going to promote the company s two products Xifaxan for irritable bowel syndrome with diarrhea IBS D and Relistor for opioid
VRX,VRX:CT,BBG000DC8S17,"Uh Oh, Valeant's Hiring. Why That's Very Bad News.",2016-11-30 14:40:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/30/uh-oh-valeants-hiring-why-thats-very-bad-news/?mod=yahoobarrons&ru=yahoo,"Uh Oh, Valeant's Hiring. Why That's Very Bad News."
VRX,VRX:US,BBG000DLFM21,"Uh Oh, Valeant's Hiring. Why That's Very Bad News.",2016-11-30 14:40:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/30/uh-oh-valeants-hiring-why-thats-very-bad-news/?mod=yahoobarrons&ru=yahoo,"Uh Oh, Valeant's Hiring. Why That's Very Bad News."
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor,2016-11-30 13:32:01 +0000,http://finance.yahoo.com/news/valeant-vrx-ups-sales-force-133201087.html,Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor,2016-11-30 13:32:01 +0000,http://finance.yahoo.com/news/valeant-vrx-ups-sales-force-133201087.html,Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up As OPEC Cuts Spark Energy Rally -- Canadian Commentary,2016-11-30 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hy48MWnKn3E/canadian-stocks-are-up-as-opec-cuts-spark-energy-rally--canadian-commentary-20161130-00728,Canadian Stocks Are Up As OPEC Cuts Spark Energy Rally -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up As OPEC Cuts Spark Energy Rally -- Canadian Commentary,2016-11-30 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hy48MWnKn3E/canadian-stocks-are-up-as-opec-cuts-spark-energy-rally--canadian-commentary-20161130-00728,Canadian Stocks Are Up As OPEC Cuts Spark Energy Rally -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Is Falling On Reports That Talks With Takeda Have Broken Down,2016-11-30 10:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YpUdEfQReuI/valeant-vrx-is-falling-on-reports-that-talks-with-takeda-have-broken-down-20161130-00683,Valeant (VRX) Is Falling On Reports That Talks With Takeda Have Broken Down
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Is Falling On Reports That Talks With Takeda Have Broken Down,2016-11-30 10:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YpUdEfQReuI/valeant-vrx-is-falling-on-reports-that-talks-with-takeda-have-broken-down-20161130-00683,Valeant (VRX) Is Falling On Reports That Talks With Takeda Have Broken Down
VRX,VRX:CT,BBG000DC8S17,"Mallinckrodt Earnings Top, But Stock Dives On Guidance",2016-11-29 21:03:13 +0000,http://www.investors.com/news/technology/mallinckrodt-sales-beat-led-by-specialty-brands-acthar-up-19/,"Mallinckrodt Earnings Top, But Stock Dives On Guidance"
VRX,VRX:US,BBG000DLFM21,"Mallinckrodt Earnings Top, But Stock Dives On Guidance",2016-11-29 21:03:13 +0000,http://www.investors.com/news/technology/mallinckrodt-sales-beat-led-by-specialty-brands-acthar-up-19/,"Mallinckrodt Earnings Top, But Stock Dives On Guidance"
VRX,VRX:US,BBG000DLFM21,Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor®,2016-11-29 21:01:00 +0000,http://finance.yahoo.com/news/valeant-announces-initiation-primary-care-210100019.html,[CNW Group] - Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor®
VRX,VRX:CT,BBG000DC8S17,Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor®,2016-11-29 21:01:00 +0000,http://finance.yahoo.com/news/valeant-announces-initiation-primary-care-210100019.html,[CNW Group] - Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor®
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Initiation Of Primary Care Sales Force For Xifaxan & Relistor,2016-11-29 20:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2G83rElEuqQ/valeant-announces-initiation-of-primary-care-sales-force-for-xifaxan--relistor-20161129-01200,Valeant Announces Initiation Of Primary Care Sales Force For Xifaxan & Relistor
VRX,VRX:US,BBG000DLFM21,Valeant Announces Initiation Of Primary Care Sales Force For Xifaxan & Relistor,2016-11-29 20:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2G83rElEuqQ/valeant-announces-initiation-of-primary-care-sales-force-for-xifaxan--relistor-20161129-01200,Valeant Announces Initiation Of Primary Care Sales Force For Xifaxan & Relistor
VRX,VRX:CT,BBG000DC8S17,What Do Analysts Have to Say about Mallinckrodt?,2016-11-29 16:05:12 +0000,http://marketrealist.com/2016/11/what-do-analysts-have-to-say-about-mallinckrodt/?utm_source=yahoo&utm_medium=feed,What Do Analysts Have to Say about Mallinckrodt?
VRX,VRX:US,BBG000DLFM21,What Do Analysts Have to Say about Mallinckrodt?,2016-11-29 16:05:12 +0000,http://marketrealist.com/2016/11/what-do-analysts-have-to-say-about-mallinckrodt/?utm_source=yahoo&utm_medium=feed,What Do Analysts Have to Say about Mallinckrodt?
VRX,VRX:CT,BBG000DC8S17,Valeant: Rooting For a Salix Sale?,2016-11-29 15:01:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/29/valeant-rooting-for-a-salix-sale/?mod=yahoobarrons&ru=yahoo,Valeant: Rooting For a Salix Sale?
VRX,VRX:US,BBG000DLFM21,Valeant: Rooting For a Salix Sale?,2016-11-29 15:01:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/29/valeant-rooting-for-a-salix-sale/?mod=yahoobarrons&ru=yahoo,Valeant: Rooting For a Salix Sale?
VRX,VRX:US,BBG000DLFM21,Mallinckrodt’s Greater Dependence on Acthar and Generic Business,2016-11-28 23:25:02 +0000,http://marketrealist.com/2016/11/mallinckrodts-greater-dependence-on-acthar-and-generic-business/?utm_source=yahoo&utm_medium=feed,Mallinckrodt’s Greater Dependence on Acthar and Generic Business
VRX,VRX:CT,BBG000DC8S17,Mallinckrodt’s Greater Dependence on Acthar and Generic Business,2016-11-28 23:25:02 +0000,http://marketrealist.com/2016/11/mallinckrodts-greater-dependence-on-acthar-and-generic-business/?utm_source=yahoo&utm_medium=feed,Mallinckrodt’s Greater Dependence on Acthar and Generic Business
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling On Global Cues -- Canadian Commentary,2016-11-28 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aYQxOozCsXQ/canadian-stocks-are-falling-on-global-cues--canadian-commentary-20161128-00537,Canadian Stocks Are Falling On Global Cues -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling On Global Cues -- Canadian Commentary,2016-11-28 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aYQxOozCsXQ/canadian-stocks-are-falling-on-global-cues--canadian-commentary-20161128-00537,Canadian Stocks Are Falling On Global Cues -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/behind-mallinckrodts-performance-based-ev-ebitda/?utm_source=yahoo&utm_medium=feed,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA
VRX,VRX:CT,BBG000DC8S17,Why Mallinckrodt Is Trading at a Discount on PE Basis,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/mallinckrodt-trading-discount-pe-basis/?utm_source=yahoo&utm_medium=feed,Why Mallinckrodt Is Trading at a Discount on PE Basis
VRX,VRX:CT,BBG000DC8S17,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/behind-mallinckrodts-performance-based-ev-ebitda/?utm_source=yahoo&utm_medium=feed,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA
VRX,VRX:US,BBG000DLFM21,Why Mallinckrodt Is Trading at a Discount on PE Basis,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/mallinckrodt-trading-discount-pe-basis/?utm_source=yahoo&utm_medium=feed,Why Mallinckrodt Is Trading at a Discount on PE Basis
VRX,VRX:CT,BBG000DC8S17,Smart Money is Pouring Into NetApp Inc. (NTAP),2016-11-26 18:45:03 +0000,http://www.insidermonkey.com/blog/smart-money-is-pouring-into-netapp-inc-ntap-492561/,Smart Money is Pouring Into NetApp Inc. (NTAP)
VRX,VRX:US,BBG000DLFM21,Smart Money is Pouring Into NetApp Inc. (NTAP),2016-11-26 18:45:03 +0000,http://www.insidermonkey.com/blog/smart-money-is-pouring-into-netapp-inc-ntap-492561/,Smart Money is Pouring Into NetApp Inc. (NTAP)
VRX,VRX:US,BBG000DLFM21,Valeant Stock Could Fall 35%: Analyst (VRX),2016-11-26 01:44:00 +0000,http://www.investopedia.com/news/valeant-stock-could-fall-35-analyst-vrx/?partner=YahooSA,Valeant Stock Could Fall 35%: Analyst (VRX)
VRX,VRX:CT,BBG000DC8S17,Valeant Stock Could Fall 35%: Analyst (VRX),2016-11-26 01:44:00 +0000,http://www.investopedia.com/news/valeant-stock-could-fall-35-analyst-vrx/?partner=YahooSA,Valeant Stock Could Fall 35%: Analyst (VRX)
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary,2016-11-25 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GzhIQHCFTCg/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20161125-00170,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary,2016-11-25 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GzhIQHCFTCg/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20161125-00170,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,3 Stocks That Have Been Complete Turkeys in 2016,2016-11-24 18:05:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6cfFzVgtuAU/3-stocks-that-have-been-complete-turkeys-in-2016-cm713709,Image source Getty Images Despite starting off the year in the worst way imaginable with 8 to 10 losses over two weeks for all three major indexes all of the major U S indexes are now up nicely for the year The S amp P 500 which is arguably the best overall indicator
VRX,VRX:CT,BBG000DC8S17,3 Stocks That Have Been Complete Turkeys in 2016,2016-11-24 18:05:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6cfFzVgtuAU/3-stocks-that-have-been-complete-turkeys-in-2016-cm713709,Image source Getty Images Despite starting off the year in the worst way imaginable with 8 to 10 losses over two weeks for all three major indexes all of the major U S indexes are now up nicely for the year The S amp P 500 which is arguably the best overall indicator
VRX,VRX:US,BBG000DLFM21,3 Stocks That Have Been Complete Turkeys in 2016,2016-11-24 16:02:06 +0000,http://www.fool.com/investing/2016/11/24/3-stocks-that-have-been-complete-turkeys-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Have Been Complete Turkeys in 2016
VRX,VRX:CT,BBG000DC8S17,3 Stocks That Have Been Complete Turkeys in 2016,2016-11-24 16:02:06 +0000,http://www.fool.com/investing/2016/11/24/3-stocks-that-have-been-complete-turkeys-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Have Been Complete Turkeys in 2016
VRX,VRX:CT,BBG000DC8S17,"Bill Miller Likes Buffett’s Timing On Airlines, Talks Valeant (VRX)’s Free Cash Flow, Amazon (AMZN)’s Fate Under Trump",2016-11-24 02:39:12 +0000,http://www.insidermonkey.com/blog/bill-miller-likes-buffetts-timing-on-airlines-talks-valeant-vrxs-free-cash-flow-amazon-amzns-fate-under-trump-488619/,"Bill Miller Likes Buffett’s Timing On Airlines, Talks Valeant (VRX)’s Free Cash Flow, Amazon (AMZN)’s Fate Under Trump"
VRX,VRX:US,BBG000DLFM21,"Bill Miller Likes Buffett’s Timing On Airlines, Talks Valeant (VRX)’s Free Cash Flow, Amazon (AMZN)’s Fate Under Trump",2016-11-24 02:39:12 +0000,http://www.insidermonkey.com/blog/bill-miller-likes-buffetts-timing-on-airlines-talks-valeant-vrxs-free-cash-flow-amazon-amzns-fate-under-trump-488619/,"Bill Miller Likes Buffett’s Timing On Airlines, Talks Valeant (VRX)’s Free Cash Flow, Amazon (AMZN)’s Fate Under Trump"
VRX,VRX:CT,BBG000DC8S17,Eli Lilly: What Really Ails Big Pharma,2016-11-23 20:18:40 +0000,http://blogs.wsj.com/moneybeat/2016/11/23/eli-lilly-what-really-ails-big-pharma/?mod=yahoo_hs,Eli Lilly: What Really Ails Big Pharma
VRX,VRX:US,BBG000DLFM21,Eli Lilly: What Really Ails Big Pharma,2016-11-23 20:18:40 +0000,http://blogs.wsj.com/moneybeat/2016/11/23/eli-lilly-what-really-ails-big-pharma/?mod=yahoo_hs,Eli Lilly: What Really Ails Big Pharma
VRX,VRX:US,BBG000DLFM21,[$$] Four traders exit Paulson & Co's London office,2016-11-23 17:10:28 +0000,"http://www.ft.com/cms/s/b2c6a4bc-b190-11e6-9c37-5787335499a0,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Four traders at Paulson & Co's London office have left this month as the shrinking New York-based hedge fund continues to downsize. Assets under management at the merger arbitrage fund, run by billionaire ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Four traders exit Paulson & Co's London office,2016-11-23 17:10:28 +0000,"http://www.ft.com/cms/s/b2c6a4bc-b190-11e6-9c37-5787335499a0,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Four traders at Paulson & Co's London office have left this month as the shrinking New York-based hedge fund continues to downsize. Assets under management at the merger arbitrage fund, run by billionaire ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary,2016-11-23 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RQV4DNp4Esk/canadian-stocks-are-pulling-back-on-gold-weakness--canadian-commentary-20161123-00457,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary,2016-11-23 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RQV4DNp4Esk/canadian-stocks-are-pulling-back-on-gold-weakness--canadian-commentary-20161123-00457,Canadian Stocks Are Pulling Back On Gold Weakness -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Are These Criminal Charges the Nail in Valeant's Coffin?,2016-11-22 22:19:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0XSCHqDeWRg/are-these-criminal-charges-the-nail-in-valeants-coffin-cm712986,Image source Getty Images While most Americans are eagerly counting down to the holidays shareholders of Valeant Pharmaceuticals NYSE VRX can t wait until January hits so they can put this miserable year in the rearview mirror Unfortunately even when we officially turn
VRX,VRX:US,BBG000DLFM21,Are These Criminal Charges the Nail in Valeant's Coffin?,2016-11-22 22:19:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0XSCHqDeWRg/are-these-criminal-charges-the-nail-in-valeants-coffin-cm712986,Image source Getty Images While most Americans are eagerly counting down to the holidays shareholders of Valeant Pharmaceuticals NYSE VRX can t wait until January hits so they can put this miserable year in the rearview mirror Unfortunately even when we officially turn
VRX,VRX:CT,BBG000DC8S17,Are These Criminal Charges the Nail in Valeant's Coffin?,2016-11-22 20:27:22 +0000,http://www.fool.com/investing/2016/11/22/are-these-criminal-charges-the-nail-in-valeants-co.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Are These Criminal Charges the Nail in Valeant's Coffin?
VRX,VRX:US,BBG000DLFM21,Are These Criminal Charges the Nail in Valeant's Coffin?,2016-11-22 20:27:22 +0000,http://www.fool.com/investing/2016/11/22/are-these-criminal-charges-the-nail-in-valeants-co.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Are These Criminal Charges the Nail in Valeant's Coffin?
VRX,VRX:US,BBG000DLFM21,Index-Fund Bans and Hedge-Fund Data,2016-11-22 13:59:13 +0000,http://www.bloomberg.com/view/articles/2016-11-22/index-fund-bans-and-hedge-fund-data?cmpid=yhoo.headline,Index-Fund Bans and Hedge-Fund Data
VRX,VRX:CT,BBG000DC8S17,Index-Fund Bans and Hedge-Fund Data,2016-11-22 13:59:13 +0000,http://www.bloomberg.com/view/articles/2016-11-22/index-fund-bans-and-hedge-fund-data?cmpid=yhoo.headline,Index-Fund Bans and Hedge-Fund Data
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary,2016-11-22 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M08g_fCBowY/canadian-stocks-are-extending-recent-gains--canadian-commentary-20161122-00736,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary,2016-11-22 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M08g_fCBowY/canadian-stocks-are-extending-recent-gains--canadian-commentary-20161122-00736,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,[$$] Valuation Experts Will Be Held to a New Standard,2016-11-22 05:05:45 +0000,http://www.wsj.com/articles/valuation-experts-will-be-held-to-a-new-standard-1479740400?ru=yahoo?mod=yahoo_itp,[$$] Valuation Experts Will Be Held to a New Standard
VRX,VRX:CT,BBG000DC8S17,[$$] Valuation Experts Will Be Held to a New Standard,2016-11-22 05:05:45 +0000,http://www.wsj.com/articles/valuation-experts-will-be-held-to-a-new-standard-1479740400?ru=yahoo?mod=yahoo_itp,[$$] Valuation Experts Will Be Held to a New Standard
VRX,VRX:US,BBG000DLFM21,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them,2016-11-21 18:19:33 +0000,http://www.fool.com/investing/2016/11/20/5-most-expensive-medicare-drugs-and-which-companie.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
VRX,VRX:CT,BBG000DC8S17,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them,2016-11-21 18:19:33 +0000,http://www.fool.com/investing/2016/11/20/5-most-expensive-medicare-drugs-and-which-companie.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
VRX,VRX:US,BBG000DLFM21,Valeant Stock Attracting More Short Sellers (VRX),2016-11-21 15:43:00 +0000,http://www.investopedia.com/news/valeant-stock-attracting-more-short-sellers-vrx/?partner=YahooSA,Valeant Stock Attracting More Short Sellers (VRX)
VRX,VRX:CT,BBG000DC8S17,Valeant Stock Attracting More Short Sellers (VRX),2016-11-21 15:43:00 +0000,http://www.investopedia.com/news/valeant-stock-attracting-more-short-sellers-vrx/?partner=YahooSA,Valeant Stock Attracting More Short Sellers (VRX)
VRX,VRX:US,BBG000DLFM21,Vetr Thinks Regeneron Is Looking Healthy,2016-11-21 13:12:27 +0000,http://finance.yahoo.com/news/vetr-thinks-regeneron-looking-healthy-131227407.html,Vetr Thinks Regeneron Is Looking Healthy
VRX,VRX:CT,BBG000DC8S17,Vetr Thinks Regeneron Is Looking Healthy,2016-11-21 13:12:27 +0000,http://finance.yahoo.com/news/vetr-thinks-regeneron-looking-healthy-131227407.html,Vetr Thinks Regeneron Is Looking Healthy
VRX,VRX:US,BBG000DLFM21,Valeant's Asset Sale Clock is Ticking,2016-11-21 13:00:12 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-21/valeant-asset-sales-the-clock-is-ticking?cmpid=yhoo.headline,Valeant's Asset Sale Clock is Ticking
VRX,VRX:CT,BBG000DC8S17,Valeant's Asset Sale Clock is Ticking,2016-11-21 13:00:12 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-21/valeant-asset-sales-the-clock-is-ticking?cmpid=yhoo.headline,Valeant's Asset Sale Clock is Ticking
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Crude Prices Rally -- Canadian Commentary,2016-11-21 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0VKm9d06Fs8/canadian-stocks-are-rising-as-crude-prices-rally--canadian-commentary-20161121-00673,Canadian Stocks Are Rising As Crude Prices Rally -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Crude Prices Rally -- Canadian Commentary,2016-11-21 10:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0VKm9d06Fs8/canadian-stocks-are-rising-as-crude-prices-rally--canadian-commentary-20161121-00673,Canadian Stocks Are Rising As Crude Prices Rally -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Pharming Announces Financing Plans for Closing of RUCONEST® North American Rights Acquisition,2016-11-21 06:00:00 +0000,http://finance.yahoo.com/news/pharming-announces-financing-plans-closing-060000591.html,"[PR Newswire] - Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) announces its financing plans to enable the completion of the acquisition of the North American commercialization rights to RUCONEST® from Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) (""Valeant""), as announced on 9 August 2016."
VRX,VRX:CT,BBG000DC8S17,Pharming Announces Financing Plans for Closing of RUCONEST® North American Rights Acquisition,2016-11-21 06:00:00 +0000,http://finance.yahoo.com/news/pharming-announces-financing-plans-closing-060000591.html,"[PR Newswire] - Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) announces its financing plans to enable the completion of the acquisition of the North American commercialization rights to RUCONEST® from Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) (""Valeant""), as announced on 9 August 2016."
VRX,VRX:US,BBG000DLFM21,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them,2016-11-20 21:49:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hDywVZ9ryNo/5-most-expensive-medicare-drugs-and-which-companies-are-getting-rich-from-them-cm711719,Medicare spends billions of dollars each year on prescription drugs That s not surprising What might be surprising though is how much the federal healthcare program spends per patient on some of these drugs Here are the five most expensive drugs covered by Medicare on a per
VRX,VRX:CT,BBG000DC8S17,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them,2016-11-20 21:49:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hDywVZ9ryNo/5-most-expensive-medicare-drugs-and-which-companies-are-getting-rich-from-them-cm711719,Medicare spends billions of dollars each year on prescription drugs That s not surprising What might be surprising though is how much the federal healthcare program spends per patient on some of these drugs Here are the five most expensive drugs covered by Medicare on a per
VRX,VRX:US,BBG000DLFM21,The 10 Best Pharma Stocks Under President Donald Trump,2016-11-18 21:50:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rr-p2ujnig0/the-10-best-pharma-stocks-under-president-donald-trump-cm710889,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a little over a week yet the news has yet to fully sink in for many folks Donald Trump the mogul the mastermind the most interesting man in the world according to Donald Trump will be
VRX,VRX:CT,BBG000DC8S17,The 10 Best Pharma Stocks Under President Donald Trump,2016-11-18 21:50:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rr-p2ujnig0/the-10-best-pharma-stocks-under-president-donald-trump-cm710889,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a little over a week yet the news has yet to fully sink in for many folks Donald Trump the mogul the mastermind the most interesting man in the world according to Donald Trump will be
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals the Turnaround Opportunity of a Lifetime?,2016-11-18 20:50:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MHM8yf6vncM/is-valeant-pharmaceuticals-the-turnaround-opportunity-of-a-lifetime-cm711413,They say that one man s trash is another man s treasure and Valeant Pharmaceuticals NYSE VRX stock probably fits in the trash category for many right now Shares of the embattled drugmaker have nose dived more than 80 in 2016 However CEO Joe Papa sees his company as a
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals the Turnaround Opportunity of a Lifetime?,2016-11-18 20:50:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MHM8yf6vncM/is-valeant-pharmaceuticals-the-turnaround-opportunity-of-a-lifetime-cm711413,They say that one man s trash is another man s treasure and Valeant Pharmaceuticals NYSE VRX stock probably fits in the trash category for many right now Shares of the embattled drugmaker have nose dived more than 80 in 2016 However CEO Joe Papa sees his company as a
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals the Turnaround Opportunity of a Lifetime?,2016-11-18 19:55:00 +0000,http://www.fool.com/investing/2016/11/18/is-valeant-pharmaceuticals-the-turnaround-opportun.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals the Turnaround Opportunity of a Lifetime?
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals the Turnaround Opportunity of a Lifetime?,2016-11-18 19:55:00 +0000,http://www.fool.com/investing/2016/11/18/is-valeant-pharmaceuticals-the-turnaround-opportun.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals the Turnaround Opportunity of a Lifetime?
VRX,VRX:US,BBG000DLFM21,Criminal Charges Against Former Valeant Exec 'Not Pertinent But Underscores Cautious Outlook',2016-11-18 17:45:59 +0000,http://finance.yahoo.com/news/criminal-charges-against-former-valeant-174559993.html,Criminal Charges Against Former Valeant Exec 'Not Pertinent But Underscores Cautious Outlook'
VRX,VRX:CT,BBG000DC8S17,Criminal Charges Against Former Valeant Exec 'Not Pertinent But Underscores Cautious Outlook',2016-11-18 17:45:59 +0000,http://finance.yahoo.com/news/criminal-charges-against-former-valeant-174559993.html,Criminal Charges Against Former Valeant Exec 'Not Pertinent But Underscores Cautious Outlook'
VRX,VRX:CT,BBG000DC8S17,Valeant and Philidor After the Criminal Charges,2016-11-18 16:57:26 +0000,http://finance.yahoo.com/news/valeant-philidor-criminal-charges-165726541.html,Valeant and Philidor After the Criminal Charges
VRX,VRX:US,BBG000DLFM21,Valeant and Philidor After the Criminal Charges,2016-11-18 16:57:26 +0000,http://finance.yahoo.com/news/valeant-philidor-criminal-charges-165726541.html,Valeant and Philidor After the Criminal Charges
VRX,VRX:US,BBG000DLFM21,Financials Lead TSX Higher Once Again -- Canadian Commentary,2016-11-18 16:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-VVJfnwrREU/financials-lead-tsx-higher-once-again--canadian-commentary-20161118-00736,Financials Lead TSX Higher Once Again -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Financials Lead TSX Higher Once Again -- Canadian Commentary,2016-11-18 16:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-VVJfnwrREU/financials-lead-tsx-higher-once-again--canadian-commentary-20161118-00736,Financials Lead TSX Higher Once Again -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant: The Shorts Are Back in Town,2016-11-18 16:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/18/valeant-the-shorts-are-back-in-town/?mod=yahoobarrons&ru=yahoo,Valeant: The Shorts Are Back in Town
VRX,VRX:CT,BBG000DC8S17,Valeant: The Shorts Are Back in Town,2016-11-18 16:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/18/valeant-the-shorts-are-back-in-town/?mod=yahoobarrons&ru=yahoo,Valeant: The Shorts Are Back in Town
VRX,VRX:CT,BBG000DC8S17,Does Valeant's Bad News Even Matter Anymore?,2016-11-18 13:51:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HrsANJmq1nY/does-valeants-bad-news-even-matter-anymore-cm711057,Investors would be hard pressed to find a company that s endured more bad news in the past year than Valeant Pharmaceuticals NYSE VRX Revelations of triple digit price increases on decades old drugs led to Congressional hearings the dismantling of its distribution
VRX,VRX:US,BBG000DLFM21,Does Valeant's Bad News Even Matter Anymore?,2016-11-18 13:51:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HrsANJmq1nY/does-valeants-bad-news-even-matter-anymore-cm711057,Investors would be hard pressed to find a company that s endured more bad news in the past year than Valeant Pharmaceuticals NYSE VRX Revelations of triple digit price increases on decades old drugs led to Congressional hearings the dismantling of its distribution
VRX,VRX:CT,BBG000DC8S17,Valeant Suffers From Too Much Legal Risk: Wells Fargo (VRX),2016-11-18 12:49:00 +0000,http://www.investopedia.com/news/valeant-suffers-too-much-legal-risk-wells-fargo-vrx/?partner=YahooSA,Valeant Suffers From Too Much Legal Risk: Wells Fargo (VRX)
VRX,VRX:US,BBG000DLFM21,Valeant Suffers From Too Much Legal Risk: Wells Fargo (VRX),2016-11-18 12:49:00 +0000,http://www.investopedia.com/news/valeant-suffers-too-much-legal-risk-wells-fargo-vrx/?partner=YahooSA,Valeant Suffers From Too Much Legal Risk: Wells Fargo (VRX)
VRX,VRX:CT,BBG000DC8S17,Does Valeant's Bad News Even Matter Anymore?,2016-11-18 12:45:23 +0000,http://www.fool.com/investing/2016/11/18/does-valeants-bad-news-even-matter-anymore.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Does Valeant's Bad News Even Matter Anymore?
VRX,VRX:US,BBG000DLFM21,Does Valeant's Bad News Even Matter Anymore?,2016-11-18 12:45:23 +0000,http://www.fool.com/investing/2016/11/18/does-valeants-bad-news-even-matter-anymore.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Does Valeant's Bad News Even Matter Anymore?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Flat After Early Gains Erode -- Canadian Commentary,2016-11-18 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8muX0QExlzE/canadian-stocks-are-flat-after-early-gains-erode--canadian-commentary-20161118-00446,Canadian Stocks Are Flat After Early Gains Erode -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Flat After Early Gains Erode -- Canadian Commentary,2016-11-18 10:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8muX0QExlzE/canadian-stocks-are-flat-after-early-gains-erode--canadian-commentary-20161118-00446,Canadian Stocks Are Flat After Early Gains Erode -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bay Street May Sleepwalk Through Quiet Session -- Canadian Commentary,2016-11-18 08:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fafxU_Ydz3I/bay-street-may-sleepwalk-through-quiet-session--canadian-commentary-20161118-00305,Bay Street May Sleepwalk Through Quiet Session -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Bay Street May Sleepwalk Through Quiet Session -- Canadian Commentary,2016-11-18 08:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fafxU_Ydz3I/bay-street-may-sleepwalk-through-quiet-session--canadian-commentary-20161118-00305,Bay Street May Sleepwalk Through Quiet Session -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Chipotle, Ackman Near Settlement Over Company's Board",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n2_oJyav35s/chipotle-ackman-near-settlement-over-companys-board-20161118-00481,"Chipotle, Ackman Near Settlement Over Company's Board"
VRX,VRX:CT,BBG000DC8S17,"Chipotle, Ackman Near Settlement Over Company''s Board",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oUKoeUCyjng/chipotle-ackman-near-settlement-over-companys-board-20161118-00482,"Chipotle, Ackman Near Settlement Over Company''s Board"
VRX,VRX:US,BBG000DLFM21,"Chipotle, Ackman Near Settlement Over Company''s Board",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oUKoeUCyjng/chipotle-ackman-near-settlement-over-companys-board-20161118-00482,"Chipotle, Ackman Near Settlement Over Company''s Board"
VRX,VRX:CT,BBG000DC8S17,"Chipotle, William Ackman Near Settlement Over the Board",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HP50ygq0C1A/chipotle-william-ackman-near-settlement-over-the-board-20161118-00251,"Chipotle, William Ackman Near Settlement Over the Board"
VRX,VRX:US,BBG000DLFM21,"Chipotle, William Ackman Near Settlement Over the Board",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HP50ygq0C1A/chipotle-william-ackman-near-settlement-over-the-board-20161118-00251,"Chipotle, William Ackman Near Settlement Over the Board"
VRX,VRX:CT,BBG000DC8S17,"Chipotle, Ackman Near Settlement",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mT141NqT8sI/chipotle-ackman-near-settlement-20161118-00197,"Chipotle, Ackman Near Settlement"
VRX,VRX:US,BBG000DLFM21,"Chipotle, Ackman Near Settlement",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mT141NqT8sI/chipotle-ackman-near-settlement-20161118-00197,"Chipotle, Ackman Near Settlement"
VRX,VRX:CT,BBG000DC8S17,"Chipotle, Ackman Near Settlement Over Company's Board",2016-11-18 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n2_oJyav35s/chipotle-ackman-near-settlement-over-companys-board-20161118-00481,"Chipotle, Ackman Near Settlement Over Company's Board"
VRX,VRX:CT,BBG000DC8S17,"[$$] U.S. Attorney Charges Former Valeant, Philidor Executives, Alleging Fraud and Kickback Scheme",2016-11-18 05:23:33 +0000,http://www.wsj.com/articles/u-s-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme-1479394276?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Federal prosecutors filed charges against former Valeant executive Gary Tanner and former Philidor Chief Executive Andrew Davenport, alleging they engaged in a multimillion-dollar fraud and kickback scheme...."
VRX,VRX:US,BBG000DLFM21,"[$$] U.S. Attorney Charges Former Valeant, Philidor Executives, Alleging Fraud and Kickback Scheme",2016-11-18 05:23:33 +0000,http://www.wsj.com/articles/u-s-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme-1479394276?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Federal prosecutors filed charges against former Valeant executive Gary Tanner and former Philidor Chief Executive Andrew Davenport, alleging they engaged in a multimillion-dollar fraud and kickback scheme...."
VRX,VRX:US,BBG000DLFM21,Former Executives Accused In Fraud Against Valeant -- WSJ,2016-11-18 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CG0ApI8Gt7Y/former-executives-accused-in-fraud-against-valeant--wsj-20161118-00043,Former Executives Accused In Fraud Against Valeant -- WSJ
VRX,VRX:CT,BBG000DC8S17,Former Executives Accused In Fraud Against Valeant -- WSJ,2016-11-18 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CG0ApI8Gt7Y/former-executives-accused-in-fraud-against-valeant--wsj-20161118-00043,Former Executives Accused In Fraud Against Valeant -- WSJ
VRX,VRX:US,BBG000DLFM21,"[$$] U.S. Prosecutors Charge Former Valeant, Philidor Executives",2016-11-18 01:22:47 +0000,http://www.wsj.com/articles/u-s-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme-1479394276?mod=yahoo_hs,"[$$] U.S. Prosecutors Charge Former Valeant, Philidor Executives"
VRX,VRX:CT,BBG000DC8S17,"[$$] U.S. Prosecutors Charge Former Valeant, Philidor Executives",2016-11-18 01:22:47 +0000,http://www.wsj.com/articles/u-s-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme-1479394276?mod=yahoo_hs,"[$$] U.S. Prosecutors Charge Former Valeant, Philidor Executives"
VRX,VRX:US,BBG000DLFM21,Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most,2016-11-18 00:27:41 +0000,http://www.bizjournals.com/portland/news/2016/11/17/money-in-medicine-the-top-30-drug-and-device.html?ana=yahoo,Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most
VRX,VRX:CT,BBG000DC8S17,Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most,2016-11-18 00:27:41 +0000,http://www.bizjournals.com/portland/news/2016/11/17/money-in-medicine-the-top-30-drug-and-device.html?ana=yahoo,Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most
VRX,VRX:US,BBG000DLFM21,'Charged with a crime for doing his job': VALEANT DUO FIGHTS BACK,2016-11-17 23:10:37 +0000,http://finance.yahoo.com/news/charged-crime-doing-job-philidor-231037336.html,'Charged with a crime for doing his job': VALEANT DUO FIGHTS BACK
VRX,VRX:CT,BBG000DC8S17,'Charged with a crime for doing his job': VALEANT DUO FIGHTS BACK,2016-11-17 23:10:37 +0000,http://finance.yahoo.com/news/charged-crime-doing-job-philidor-231037336.html,'Charged with a crime for doing his job': VALEANT DUO FIGHTS BACK
VRX,VRX:CT,BBG000DC8S17,10 Pharma Stocks That Are Prescribed Under President Trump,2016-11-17 22:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w2zuywKHp48/10-pharma-stocks-that-are-prescribed-under-president-trump-cm710889,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a little over a week yet the news has yet to fully sink in for many folks Donald Trump the mogul the mastermind the most interesting man in the world according to Donald Trump will be
VRX,VRX:US,BBG000DLFM21,10 Pharma Stocks That Are Prescribed Under President Trump,2016-11-17 22:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w2zuywKHp48/10-pharma-stocks-that-are-prescribed-under-president-trump-cm710889,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a little over a week yet the news has yet to fully sink in for many folks Donald Trump the mogul the mastermind the most interesting man in the world according to Donald Trump will be
VRX,VRX:US,BBG000DLFM21,"Ex-Valeant, Philidor execs arrested for fraud, conspiracy",2016-11-17 21:56:45 +0000,http://sg.finance.yahoo.com/news/ex-valeant-philidor-execs-charged-154434094.html,"Ex-Valeant, Philidor execs arrested for fraud, conspiracy"
VRX,VRX:CT,BBG000DC8S17,"Ex-Valeant, Philidor execs arrested for fraud, conspiracy",2016-11-17 21:56:45 +0000,http://sg.finance.yahoo.com/news/ex-valeant-philidor-execs-charged-154434094.html,"Ex-Valeant, Philidor execs arrested for fraud, conspiracy"
VRX,VRX:CT,BBG000DC8S17,Finally Some Good News for Valeant Pharmaceuticals and Its Shareholders,2016-11-17 21:50:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lvtcbTvdrqI/finally-some-good-news-for-valeant-pharmaceuticals-and-its-shareholders-cm710816,Image source Getty Images It s been nothing short of a miserable year for embattled drugmaker Valeant Pharmaceuticals NYSE VRX with its shares having fallen 83 year to date Valeant s woes are almost too many to list but they essentially boil down to two primary
VRX,VRX:US,BBG000DLFM21,Finally Some Good News for Valeant Pharmaceuticals and Its Shareholders,2016-11-17 21:50:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lvtcbTvdrqI/finally-some-good-news-for-valeant-pharmaceuticals-and-its-shareholders-cm710816,Image source Getty Images It s been nothing short of a miserable year for embattled drugmaker Valeant Pharmaceuticals NYSE VRX with its shares having fallen 83 year to date Valeant s woes are almost too many to list but they essentially boil down to two primary
VRX,VRX:US,BBG000DLFM21,Valeant's Pharmacy Ties Get Even Murkier,2016-11-17 21:13:11 +0000,http://www.bloomberg.com/view/articles/2016-11-17/valeant-s-pharmacy-ties-get-even-murkier?cmpid=yhoo.headline,Valeant's Pharmacy Ties Get Even Murkier
VRX,VRX:CT,BBG000DC8S17,Valeant's Pharmacy Ties Get Even Murkier,2016-11-17 21:13:11 +0000,http://www.bloomberg.com/view/articles/2016-11-17/valeant-s-pharmacy-ties-get-even-murkier?cmpid=yhoo.headline,Valeant's Pharmacy Ties Get Even Murkier
VRX,VRX:US,BBG000DLFM21,Former Valeant Pharma And Philidor Executives Charged In Kickback Scheme,2016-11-17 21:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rhOhbAiT7Vg/former-valeant-pharma-and-philidor-executives-charged-in-kickback-scheme-20161117-01405,Former Valeant Pharma And Philidor Executives Charged In Kickback Scheme
VRX,VRX:CT,BBG000DC8S17,Former Valeant Pharma And Philidor Executives Charged In Kickback Scheme,2016-11-17 21:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rhOhbAiT7Vg/former-valeant-pharma-and-philidor-executives-charged-in-kickback-scheme-20161117-01405,Former Valeant Pharma And Philidor Executives Charged In Kickback Scheme
VRX,VRX:CT,BBG000DC8S17,What we know about the former Valeant employee who just got arrested on fraud charges,2016-11-17 21:00:56 +0000,http://finance.yahoo.com/news/know-former-valeant-employee-just-210056923.html,What we know about the former Valeant employee who just got arrested on fraud charges
VRX,VRX:US,BBG000DLFM21,What we know about the former Valeant employee who just got arrested on fraud charges,2016-11-17 21:00:56 +0000,http://finance.yahoo.com/news/know-former-valeant-employee-just-210056923.html,What we know about the former Valeant employee who just got arrested on fraud charges
VRX,VRX:US,BBG000DLFM21,STOCKS RISE: Here's what you need to know,2016-11-17 21:00:15 +0000,http://finance.yahoo.com/news/stocks-rise-heres-know-210015812.html,STOCKS RISE: Here's what you need to know
VRX,VRX:CT,BBG000DC8S17,STOCKS RISE: Here's what you need to know,2016-11-17 21:00:15 +0000,http://finance.yahoo.com/news/stocks-rise-heres-know-210015812.html,STOCKS RISE: Here's what you need to know
VRX,VRX:US,BBG000DLFM21,Finally Some Good News for Valeant Pharmaceuticals and Its Shareholders,2016-11-17 20:46:51 +0000,http://www.fool.com/investing/2016/11/17/finally-some-good-news-for-valeant-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Finally Some Good News for Valeant Pharmaceuticals and Its Shareholders
VRX,VRX:CT,BBG000DC8S17,Finally Some Good News for Valeant Pharmaceuticals and Its Shareholders,2016-11-17 20:46:51 +0000,http://www.fool.com/investing/2016/11/17/finally-some-good-news-for-valeant-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Finally Some Good News for Valeant Pharmaceuticals and Its Shareholders
VRX,VRX:CT,BBG000DC8S17,"Valeant and Philidor Execs Were Building 'Nest Eggs' from Valeant Stakeholders' Money, Bharara Says",2016-11-17 20:06:00 +0000,https://www.thestreet.com/story/13898373/1/valeant-and-philidor-execs-were-building-quot-nest-eggs-quot-from-valeant-stakeholder-s-money-bharara-says.html?puc=yahoo&cm_ven=YAHOO,"Valeant and Philidor Execs Were Building 'Nest Eggs' from Valeant Stakeholders' Money, Bharara Says"
VRX,VRX:US,BBG000DLFM21,"Valeant and Philidor Execs Were Building 'Nest Eggs' from Valeant Stakeholders' Money, Bharara Says",2016-11-17 20:06:00 +0000,https://www.thestreet.com/story/13898373/1/valeant-and-philidor-execs-were-building-quot-nest-eggs-quot-from-valeant-stakeholder-s-money-bharara-says.html?puc=yahoo&cm_ven=YAHOO,"Valeant and Philidor Execs Were Building 'Nest Eggs' from Valeant Stakeholders' Money, Bharara Says"
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) 'Ripped Off Pretty Hard' by Own People,2016-11-17 19:02:00 +0000,https://www.thestreet.com/story/13898331/1/valeant-vrx-ripped-off-pretty-hard-by-own-people.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) 'Ripped Off Pretty Hard' by Own People
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) 'Ripped Off Pretty Hard' by Own People,2016-11-17 19:02:00 +0000,https://www.thestreet.com/story/13898331/1/valeant-vrx-ripped-off-pretty-hard-by-own-people.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) 'Ripped Off Pretty Hard' by Own People
VRX,VRX:US,BBG000DLFM21,[$$] Two executives charged over illegal kickback scheme at Valeant,2016-11-17 18:53:10 +0000,"http://www.ft.com/cms/s/6eace1ae-acdd-11e6-ba7d-76378e4fef24,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Two executives charged over illegal kickback scheme at Valeant
VRX,VRX:CT,BBG000DC8S17,[$$] Two executives charged over illegal kickback scheme at Valeant,2016-11-17 18:53:10 +0000,"http://www.ft.com/cms/s/6eace1ae-acdd-11e6-ba7d-76378e4fef24,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Two executives charged over illegal kickback scheme at Valeant
VRX,VRX:CT,BBG000DC8S17,"Fraud Charges for Former Valeant, Philidor Executives",2016-11-17 18:30:55 +0000,http://finance.yahoo.com/video/fraud-charges-former-valeant-philidor-183055233.html,"Fraud Charges for Former Valeant, Philidor Executives"
VRX,VRX:US,BBG000DLFM21,"Fraud Charges for Former Valeant, Philidor Executives",2016-11-17 18:30:55 +0000,http://finance.yahoo.com/video/fraud-charges-former-valeant-philidor-183055233.html,"Fraud Charges for Former Valeant, Philidor Executives"
VRX,VRX:CT,BBG000DC8S17,The market is ignoring a massive elephant in the room at Valeant,2016-11-17 18:28:22 +0000,http://finance.yahoo.com/news/market-ignoring-massive-elephant-room-182822114.html,The market is ignoring a massive elephant in the room at Valeant
VRX,VRX:US,BBG000DLFM21,The market is ignoring a massive elephant in the room at Valeant,2016-11-17 18:28:22 +0000,http://finance.yahoo.com/news/market-ignoring-massive-elephant-room-182822114.html,The market is ignoring a massive elephant in the room at Valeant
VRX,VRX:US,BBG000DLFM21,"First criminal charges in Valeant investigation nab former exec, Philidor CEO",2016-11-17 18:04:55 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=39F7117A-ACE0-11E6-A769-02A54265C928&siteid=yhoof2,"First criminal charges in Valeant investigation nab former exec, Philidor CEO"
VRX,VRX:CT,BBG000DC8S17,"First criminal charges in Valeant investigation nab former exec, Philidor CEO",2016-11-17 18:04:55 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=39F7117A-ACE0-11E6-A769-02A54265C928&siteid=yhoof2,"First criminal charges in Valeant investigation nab former exec, Philidor CEO"
VRX,VRX:US,BBG000DLFM21,Ex-Valeant Execs Tied to Philidor Charged in Fraud,2016-11-17 18:04:00 +0000,http://www.investopedia.com/news/exvaleant-execs-tied-philidor-charged-fraud-vrx/?partner=YahooSA,Ex-Valeant Execs Tied to Philidor Charged in Fraud
VRX,VRX:CT,BBG000DC8S17,Ex-Valeant Execs Tied to Philidor Charged in Fraud,2016-11-17 18:04:00 +0000,http://www.investopedia.com/news/exvaleant-execs-tied-philidor-charged-fraud-vrx/?partner=YahooSA,Ex-Valeant Execs Tied to Philidor Charged in Fraud
VRX,VRX:CT,BBG000DC8S17,Two men charged with kickback scheme at Valeant,2016-11-17 16:54:03 +0000,http://finance.yahoo.com/news/u-unveils-criminal-charges-valeant-144647854.html,"[Reuters] - U.S. prosecutors on Thursday charged a former Valeant Pharmaceuticals International Inc(VRX.TO) executive and the head of a specialty pharmacy company with engaging in a multi-million dollar fraud and kickback scheme. Gary Tanner, the former Valeant executive, and Andrew Davenport, the former chief executive of specialty pharmacy Philidor Rx Services LLC, were charged in a criminal complaint filed in Manhattan federal court, prosecutors said. The Federal Bureau of Investigation arrested Tanner, 39, and Davenport, 48, on Thursday morning at their residences in Phoenix and Philadelphia, respectively, an agency spokeswoman said."
VRX,VRX:US,BBG000DLFM21,Two men charged with kickback scheme at Valeant,2016-11-17 16:54:03 +0000,http://finance.yahoo.com/news/u-unveils-criminal-charges-valeant-144647854.html,"[Reuters] - U.S. prosecutors on Thursday charged a former Valeant Pharmaceuticals International Inc(VRX.TO) executive and the head of a specialty pharmacy company with engaging in a multi-million dollar fraud and kickback scheme. Gary Tanner, the former Valeant executive, and Andrew Davenport, the former chief executive of specialty pharmacy Philidor Rx Services LLC, were charged in a criminal complaint filed in Manhattan federal court, prosecutors said. The Federal Bureau of Investigation arrested Tanner, 39, and Davenport, 48, on Thursday morning at their residences in Phoenix and Philadelphia, respectively, an agency spokeswoman said."
VRX,VRX:CT,BBG000DC8S17,"Federal prosecutors to charge Valeant, Philidor execs with fraud and kickback scheme: WSJ",2016-11-17 16:16:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=96AF7832-2E3E-4AD1-A9BF-812499EA1191&siteid=yhoof2,"Federal prosecutors to charge Valeant, Philidor execs with fraud and kickback scheme: WSJ"
VRX,VRX:US,BBG000DLFM21,"Federal prosecutors to charge Valeant, Philidor execs with fraud and kickback scheme: WSJ",2016-11-17 16:16:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=96AF7832-2E3E-4AD1-A9BF-812499EA1191&siteid=yhoof2,"Federal prosecutors to charge Valeant, Philidor execs with fraud and kickback scheme: WSJ"
VRX,VRX:US,BBG000DLFM21,"Valeant: Why Fraud Charges are Bad, Bad, News",2016-11-17 16:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/17/valeant-why-fraud-charges-are-bad-bad-news/?mod=yahoobarrons&ru=yahoo,"Valeant: Why Fraud Charges are Bad, Bad, News"
VRX,VRX:CT,BBG000DC8S17,"Valeant: Why Fraud Charges are Bad, Bad, News",2016-11-17 16:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/17/valeant-why-fraud-charges-are-bad-bad-news/?mod=yahoobarrons&ru=yahoo,"Valeant: Why Fraud Charges are Bad, Bad, News"
VRX,VRX:US,BBG000DLFM21,"Valeant confirms criminal charges filed against Valeant, Philidor executives",2016-11-17 16:08:36 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=DB4FE1EB-E284-42A6-9FDA-BE966BF69680&siteid=yhoof2,"Valeant confirms criminal charges filed against Valeant, Philidor executives"
VRX,VRX:CT,BBG000DC8S17,"Valeant confirms criminal charges filed against Valeant, Philidor executives",2016-11-17 16:08:36 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=DB4FE1EB-E284-42A6-9FDA-BE966BF69680&siteid=yhoof2,"Valeant confirms criminal charges filed against Valeant, Philidor executives"
VRX,VRX:US,BBG000DLFM21,Billionaire James Chanos: Valeant is Worse than Enron,2016-11-17 16:07:00 +0000,http://www.investopedia.com/news/billionaire-james-chanos-valeant-worse-enron-vrx-baba/?partner=YahooSA,Billionaire James Chanos: Valeant is Worse than Enron
VRX,VRX:CT,BBG000DC8S17,Billionaire James Chanos: Valeant is Worse than Enron,2016-11-17 16:07:00 +0000,http://www.investopedia.com/news/billionaire-james-chanos-valeant-worse-enron-vrx-baba/?partner=YahooSA,Billionaire James Chanos: Valeant is Worse than Enron
VRX,VRX:CT,BBG000DC8S17,Analysts Forecast 14% Gains Ahead For The Holdings of GURU,2016-11-17 15:50:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7yaSjGGhDuM/analysts-forecast-14-gains-ahead-for-the-holdings-of-guru-cm710537,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:US,BBG000DLFM21,Analysts Forecast 14% Gains Ahead For The Holdings of GURU,2016-11-17 15:50:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7yaSjGGhDuM/analysts-forecast-14-gains-ahead-for-the-holdings-of-guru-cm710537,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:CT,BBG000DC8S17,Valeant Comments On Issued Philidor Criminal Charges,2016-11-17 15:46:00 +0000,http://finance.yahoo.com/news/valeant-comments-issued-philidor-criminal-154600554.html,"[PR Newswire] - LAVAL, Quebec, Nov. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today learned that a criminal complaint was filed in relation to ..."
VRX,VRX:US,BBG000DLFM21,Valeant Comments On Issued Philidor Criminal Charges,2016-11-17 15:46:00 +0000,http://finance.yahoo.com/news/valeant-comments-issued-philidor-criminal-154600554.html,"[PR Newswire] - LAVAL, Quebec, Nov. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (""Valeant"") today learned that a criminal complaint was filed in relation to ..."
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 8th Update",2016-11-17 15:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IS9NcmA-6Xc/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--8th-update-20161117-01054,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 8th Update"
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 8th Update",2016-11-17 15:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IS9NcmA-6Xc/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--8th-update-20161117-01054,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 8th Update"
VRX,VRX:US,BBG000DLFM21,Valeant and Philidor Execs Face Fraud Charges,2016-11-17 15:07:00 +0000,https://www.thestreet.com/story/13897853/1/valeant-and-philidor-execs-face-fraud-charges.html?puc=yahoo&cm_ven=YAHOO,Valeant and Philidor Execs Face Fraud Charges
VRX,VRX:CT,BBG000DC8S17,Valeant and Philidor Execs Face Fraud Charges,2016-11-17 15:07:00 +0000,https://www.thestreet.com/story/13897853/1/valeant-and-philidor-execs-face-fraud-charges.html?puc=yahoo&cm_ven=YAHOO,Valeant and Philidor Execs Face Fraud Charges
VRX,VRX:US,BBG000DLFM21,Valeant tumbles after the CEO of its secret pharmacy was arrested,2016-11-17 14:41:00 +0000,http://finance.yahoo.com/news/valeant-tumbles-following-arrest-ceo-144100498.html,Valeant tumbles after the CEO of its secret pharmacy was arrested
VRX,VRX:CT,BBG000DC8S17,Valeant tumbles after the CEO of its secret pharmacy was arrested,2016-11-17 14:41:00 +0000,http://finance.yahoo.com/news/valeant-tumbles-following-arrest-ceo-144100498.html,Valeant tumbles after the CEO of its secret pharmacy was arrested
VRX,VRX:CT,BBG000DC8S17,"Valeant, Philidor Executives Charged With Fraud by U.S.",2016-11-17 14:40:05 +0000,http://www.bloomberg.com/news/articles/2016-11-17/philidor-executives-charged-with-fraud-in-valeant-pharmacy-probe?cmpid=yhoo.headline,"Valeant, Philidor Executives Charged With Fraud by U.S."
VRX,VRX:US,BBG000DLFM21,"Valeant, Philidor Executives Charged With Fraud by U.S.",2016-11-17 14:40:05 +0000,http://www.bloomberg.com/news/articles/2016-11-17/philidor-executives-charged-with-fraud-in-valeant-pharmacy-probe?cmpid=yhoo.headline,"Valeant, Philidor Executives Charged With Fraud by U.S."
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 7th Update",2016-11-17 14:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/32u8jpsFTfM/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--7th-update-20161117-00994,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 7th Update"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 7th Update",2016-11-17 14:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/32u8jpsFTfM/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--7th-update-20161117-00994,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 7th Update"
VRX,VRX:US,BBG000DLFM21,Press Release: Former Valeant Executive and Former Philidor CEO Charged in Manhattan Federal Court for Illegal Fraud and Kickback Scheme,2016-11-17 14:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FEq8NDS08Vo/press-release-former-valeant-executive-and-former-philidor-ceo-charged-in-manhattan-federal-court-20161117-00992,Press Release: Former Valeant Executive and Former Philidor CEO Charged in Manhattan Federal Court for Illegal Fraud and Kickback Scheme
VRX,VRX:CT,BBG000DC8S17,Press Release: Former Valeant Executive and -2-,2016-11-17 14:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qzUi0EyC0hE/press-release-former-valeant-executive-and-2-20161117-00993,Press Release: Former Valeant Executive and -2-
VRX,VRX:US,BBG000DLFM21,Press Release: Former Valeant Executive and -2-,2016-11-17 14:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qzUi0EyC0hE/press-release-former-valeant-executive-and-2-20161117-00993,Press Release: Former Valeant Executive and -2-
VRX,VRX:CT,BBG000DC8S17,Press Release: Former Valeant Executive and Former Philidor CEO Charged in Manhattan Federal Court for Illegal Fraud and Kickback Scheme,2016-11-17 14:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FEq8NDS08Vo/press-release-former-valeant-executive-and-former-philidor-ceo-charged-in-manhattan-federal-court-20161117-00992,Press Release: Former Valeant Executive and Former Philidor CEO Charged in Manhattan Federal Court for Illegal Fraud and Kickback Scheme
VRX,VRX:US,BBG000DLFM21,The CEO of Valeant's secret pharmacy has been charged with 'engaging in a multi-million dollar fraud and kickback scheme',2016-11-17 14:19:39 +0000,http://finance.yahoo.com/news/charges-against-valeants-secret-pharmacy-141939163.html,The CEO of Valeant's secret pharmacy has been charged with 'engaging in a multi-million dollar fraud and kickback scheme'
VRX,VRX:CT,BBG000DC8S17,The CEO of Valeant's secret pharmacy has been charged with 'engaging in a multi-million dollar fraud and kickback scheme',2016-11-17 14:19:39 +0000,http://finance.yahoo.com/news/charges-against-valeants-secret-pharmacy-141939163.html,The CEO of Valeant's secret pharmacy has been charged with 'engaging in a multi-million dollar fraud and kickback scheme'
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 6th Update",2016-11-17 14:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kO8JyTzpU98/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--6th-update-20161117-00967,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 6th Update"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 6th Update",2016-11-17 14:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kO8JyTzpU98/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--6th-update-20161117-00967,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 6th Update"
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- 5th Update",2016-11-17 13:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YIgPrMwocbA/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--5th-update-20161117-00929,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- 5th Update"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 5th Update",2016-11-17 13:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m-_Q_xgyz3s/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--5th-update-20161117-00928,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 5th Update"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- 5th Update",2016-11-17 13:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YIgPrMwocbA/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--5th-update-20161117-00929,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- 5th Update"
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 5th Update",2016-11-17 13:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m-_Q_xgyz3s/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--5th-update-20161117-00928,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 5th Update"
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 4th Update",2016-11-17 12:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/klkXP8cOBjk/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--4th-update-20161117-00864,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 4th Update"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 4th Update",2016-11-17 12:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/klkXP8cOBjk/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--4th-update-20161117-00864,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- 4th Update"
VRX,VRX:US,BBG000DLFM21,"U.S. Prosecutors to Charge Two Valeant, Philidor Executives",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9nhwBoKgKWk/us-prosecutors-to-charge-two-valeant-philidor-executives-20161117-00756,"U.S. Prosecutors to Charge Two Valeant, Philidor Executives"
VRX,VRX:US,BBG000DLFM21,"Federal Prosecutors to Charge Two Valeant, Philidor Executives",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g3mWDylHyv8/federal-prosecutors-to-charge-two-valeant-philidor-executives-20161117-00747,"Federal Prosecutors to Charge Two Valeant, Philidor Executives"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- Update",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dJ6qdi9s3pg/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--update-20161117-00748,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- Update"
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- Update",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dJ6qdi9s3pg/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--update-20161117-00748,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme'' -- Update"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- Update",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w67cAplMq58/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--update-20161117-00753,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- Update"
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- Update",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w67cAplMq58/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme--update-20161117-00753,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging 'Fraud and Kickback Scheme' -- Update"
VRX,VRX:CT,BBG000DC8S17,"U.S. Prosecutors to Charge Two Valeant, Philidor Executives",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9nhwBoKgKWk/us-prosecutors-to-charge-two-valeant-philidor-executives-20161117-00756,"U.S. Prosecutors to Charge Two Valeant, Philidor Executives"
VRX,VRX:CT,BBG000DC8S17,"Federal Prosecutors to Charge Two Valeant, Philidor Executives",2016-11-17 10:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g3mWDylHyv8/federal-prosecutors-to-charge-two-valeant-philidor-executives-20161117-00747,"Federal Prosecutors to Charge Two Valeant, Philidor Executives"
VRX,VRX:US,BBG000DLFM21,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme''",2016-11-17 10:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aVhQ2icbjxE/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme-20161117-00733,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme''"
VRX,VRX:CT,BBG000DC8S17,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme''",2016-11-17 10:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aVhQ2icbjxE/us-attorney-to-charge-two-valeant-philidor-executives-alleging-fraud-and-kickback-scheme-20161117-00733,"U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging ''Fraud and Kickback Scheme''"
VRX,VRX:CT,BBG000DC8S17,"Mizuho Defends Mallinckrodt Against Citron, Says Buy The Dip",2016-11-16 19:15:58 +0000,http://finance.yahoo.com/news/mizuho-defends-mallinckrodt-against-citron-191558466.html,"Mizuho Defends Mallinckrodt Against Citron, Says Buy The Dip"
VRX,VRX:US,BBG000DLFM21,"Mizuho Defends Mallinckrodt Against Citron, Says Buy The Dip",2016-11-16 19:15:58 +0000,http://finance.yahoo.com/news/mizuho-defends-mallinckrodt-against-citron-191558466.html,"Mizuho Defends Mallinckrodt Against Citron, Says Buy The Dip"
VRX,VRX:CT,BBG000DC8S17,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2016-11-16 17:51:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c9YYuvja-Mg/should-you-get-rid-of-valeant-pharmaceuticals-international-vrx-now-cm710146,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:US,BBG000DLFM21,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2016-11-16 17:51:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c9YYuvja-Mg/should-you-get-rid-of-valeant-pharmaceuticals-international-vrx-now-cm710146,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRX,VRX:CT,BBG000DC8S17,Andrew Left: Dump Mallinckrodt,2016-11-16 17:25:00 +0000,http://realmoney.thestreet.com/articles/11/16/2016/andrew-left-dump-mallinckrodt?puc=yahoo&cm_ven=YAHOO,Andrew Left: Dump Mallinckrodt
VRX,VRX:US,BBG000DLFM21,Andrew Left: Dump Mallinckrodt,2016-11-16 17:25:00 +0000,http://realmoney.thestreet.com/articles/11/16/2016/andrew-left-dump-mallinckrodt?puc=yahoo&cm_ven=YAHOO,Andrew Left: Dump Mallinckrodt
VRX,VRX:US,BBG000DLFM21,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2016-11-16 15:30:03 +0000,http://finance.yahoo.com/news/rid-valeant-pharmaceuticals-international-vrx-153003984.html,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?
VRX,VRX:CT,BBG000DC8S17,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?,2016-11-16 15:30:03 +0000,http://finance.yahoo.com/news/rid-valeant-pharmaceuticals-international-vrx-153003984.html,Should You Get Rid of Valeant Pharmaceuticals International (VRX) Now?
VRX,VRX:CT,BBG000DC8S17,Is Bill Ackman Changing His Stance on Valeant Pharmaceuticals?,2016-11-16 15:04:21 +0000,http://marketrealist.com/2016/11/bill-ackman-change-stance-valeant-pharmaceuticals/?utm_source=yahoo&utm_medium=feed,Is Bill Ackman Changing His Stance on Valeant Pharmaceuticals?
VRX,VRX:US,BBG000DLFM21,Is Bill Ackman Changing His Stance on Valeant Pharmaceuticals?,2016-11-16 15:04:21 +0000,http://marketrealist.com/2016/11/bill-ackman-change-stance-valeant-pharmaceuticals/?utm_source=yahoo&utm_medium=feed,Is Bill Ackman Changing His Stance on Valeant Pharmaceuticals?
VRX,VRX:CT,BBG000DC8S17,5 Stocks Bill Ackman Is Buying and Selling,2016-11-16 14:51:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KrP9rvvTojA/5-stocks-bill-ackman-is-buying-and-selling-cm709874,Image source Getty Images Bill Ackman s year hasn t exactly gone to plan After enduring billion dollar losses in Valeant his hedge fund management company Pershing Square Capital needs nothing more than a very big win Ackman s on the hunt for big winners but he s also
VRX,VRX:US,BBG000DLFM21,5 Stocks Bill Ackman Is Buying and Selling,2016-11-16 14:51:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KrP9rvvTojA/5-stocks-bill-ackman-is-buying-and-selling-cm709874,Image source Getty Images Bill Ackman s year hasn t exactly gone to plan After enduring billion dollar losses in Valeant his hedge fund management company Pershing Square Capital needs nothing more than a very big win Ackman s on the hunt for big winners but he s also
VRX,VRX:CT,BBG000DC8S17,Lou Simpson Goes — for — in ‘rd Quarter,2016-11-16 12:49:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vvhJGzqM3HI/lou-simpson-goes-for-in-rd-quarter-cm709639,Lou Simpson Trades Portfolio manager of SQ Advisors LLC eliminated his positions in Valeant Pharmaceuticals International Inc VRX and U S Bancorp USB during the third quarter With the proceeds from these two transactions Simpson invested in Axalta Coating Systems
VRX,VRX:US,BBG000DLFM21,Lou Simpson Goes — for — in ‘rd Quarter,2016-11-16 12:49:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vvhJGzqM3HI/lou-simpson-goes-for-in-rd-quarter-cm709639,Lou Simpson Trades Portfolio manager of SQ Advisors LLC eliminated his positions in Valeant Pharmaceuticals International Inc VRX and U S Bancorp USB during the third quarter With the proceeds from these two transactions Simpson invested in Axalta Coating Systems
VRX,VRX:US,BBG000DLFM21,"Should You Buy Shares of American Airlines Group Inc (AAL), Valeant Pharmaceuticals Intl Inc (VRX) & Two Other Stocks?",2016-11-15 18:00:41 +0000,http://www.insidermonkey.com/blog/should-you-buy-shares-of-american-airlines-group-inc-aal-valeant-pharmaceuticals-intl-inc-vrx-two-other-stocks-485408/,"Should You Buy Shares of American Airlines Group Inc (AAL), Valeant Pharmaceuticals Intl Inc (VRX) & Two Other Stocks?"
VRX,VRX:CT,BBG000DC8S17,"Should You Buy Shares of American Airlines Group Inc (AAL), Valeant Pharmaceuticals Intl Inc (VRX) & Two Other Stocks?",2016-11-15 18:00:41 +0000,http://www.insidermonkey.com/blog/should-you-buy-shares-of-american-airlines-group-inc-aal-valeant-pharmaceuticals-intl-inc-vrx-two-other-stocks-485408/,"Should You Buy Shares of American Airlines Group Inc (AAL), Valeant Pharmaceuticals Intl Inc (VRX) & Two Other Stocks?"
VRX,VRX:CT,BBG000DC8S17,"Valeant, BP, Euroseas, and More: Here’s Why These Stocks Are Trending Today",2016-11-15 17:54:39 +0000,http://www.insidermonkey.com/blog/valeant-bp-euroseas-and-more-heres-why-these-stocks-are-trending-today-488225/,"Valeant, BP, Euroseas, and More: Here’s Why These Stocks Are Trending Today"
VRX,VRX:US,BBG000DLFM21,"Valeant, BP, Euroseas, and More: Here’s Why These Stocks Are Trending Today",2016-11-15 17:54:39 +0000,http://www.insidermonkey.com/blog/valeant-bp-euroseas-and-more-heres-why-these-stocks-are-trending-today-488225/,"Valeant, BP, Euroseas, and More: Here’s Why These Stocks Are Trending Today"
VRX,VRX:CT,BBG000DC8S17,"Even with 10.2% Yield, Valeant Bonds Too Risky, Says Analyst",2016-11-15 16:18:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/11/15/even-with-10-2-yield-valeant-bonds-too-risky-says-analyst/?mod=yahoobarrons&ru=yahoo,"Even with 10.2% Yield, Valeant Bonds Too Risky, Says Analyst"
VRX,VRX:US,BBG000DLFM21,"Even with 10.2% Yield, Valeant Bonds Too Risky, Says Analyst",2016-11-15 16:18:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/11/15/even-with-10-2-yield-valeant-bonds-too-risky-says-analyst/?mod=yahoobarrons&ru=yahoo,"Even with 10.2% Yield, Valeant Bonds Too Risky, Says Analyst"
VRX,VRX:CT,BBG000DC8S17,An Update on Valeant’s R&D Program,2016-11-15 16:04:15 +0000,http://marketrealist.com/2016/11/an-update-on-valeants-rd-program/?utm_source=yahoo&utm_medium=feed,An Update on Valeant’s R&D Program
VRX,VRX:US,BBG000DLFM21,An Update on Valeant’s R&D Program,2016-11-15 16:04:15 +0000,http://marketrealist.com/2016/11/an-update-on-valeants-rd-program/?utm_source=yahoo&utm_medium=feed,An Update on Valeant’s R&D Program
VRX,VRX:US,BBG000DLFM21,"Battered Valeant stock worth double the current price, value investor Bill Miller says",2016-11-15 15:37:14 +0000,http://www.cnbc.com/id/104108962?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104108962,"Battered Valeant stock worth double the current price, value investor Bill Miller says"
VRX,VRX:CT,BBG000DC8S17,"Battered Valeant stock worth double the current price, value investor Bill Miller says",2016-11-15 15:37:14 +0000,http://www.cnbc.com/id/104108962?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104108962,"Battered Valeant stock worth double the current price, value investor Bill Miller says"
VRX,VRX:CT,BBG000DC8S17,Why Did Valeant Revise Its 2016 EPS Guidance?,2016-11-15 15:04:11 +0000,http://marketrealist.com/2016/11/why-did-valeant-revise-its-2016-eps-guidance/?utm_source=yahoo&utm_medium=feed,Why Did Valeant Revise Its 2016 EPS Guidance?
VRX,VRX:US,BBG000DLFM21,Why Did Valeant Revise Its 2016 EPS Guidance?,2016-11-15 15:04:11 +0000,http://marketrealist.com/2016/11/why-did-valeant-revise-its-2016-eps-guidance/?utm_source=yahoo&utm_medium=feed,Why Did Valeant Revise Its 2016 EPS Guidance?
VRX,VRX:US,BBG000DLFM21,Why Valeant's Enormous Debt Might Become an Even Bigger Problem,2016-11-15 14:58:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/15/why-valeants-enormous-debt-might-become-an-even-bigger-problem/?mod=yahoobarrons&ru=yahoo,Why Valeant's Enormous Debt Might Become an Even Bigger Problem
VRX,VRX:CT,BBG000DC8S17,Why Valeant's Enormous Debt Might Become an Even Bigger Problem,2016-11-15 14:58:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/15/why-valeants-enormous-debt-might-become-an-even-bigger-problem/?mod=yahoobarrons&ru=yahoo,Why Valeant's Enormous Debt Might Become an Even Bigger Problem
VRX,VRX:CT,BBG000DC8S17,"Ackman Conference Call Updates Several Key Positions, Claims Herbalife (HLF) Endgame is Near",2016-11-15 14:22:38 +0000,http://www.insidermonkey.com/blog/ackman-conference-call-updates-several-key-positions-claims-herbalife-hlf-endgame-is-near-488026/,"Ackman Conference Call Updates Several Key Positions, Claims Herbalife (HLF) Endgame is Near"
VRX,VRX:US,BBG000DLFM21,"Ackman Conference Call Updates Several Key Positions, Claims Herbalife (HLF) Endgame is Near",2016-11-15 14:22:38 +0000,http://www.insidermonkey.com/blog/ackman-conference-call-updates-several-key-positions-claims-herbalife-hlf-endgame-is-near-488026/,"Ackman Conference Call Updates Several Key Positions, Claims Herbalife (HLF) Endgame is Near"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals receives bids for core assets - CEO,2016-11-15 13:47:26 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-receives-bids-core-134726049.html,Valeant Pharmaceuticals receives bids for core assets - CEO
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals receives bids for core assets - CEO,2016-11-15 13:47:26 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-receives-bids-core-134726049.html,Valeant Pharmaceuticals receives bids for core assets - CEO
VRX,VRX:CT,BBG000DC8S17,"Neurology, Generics Businesses Drag Valeant’s 2017 Revenue and EBITDA",2016-11-15 13:04:15 +0000,http://marketrealist.com/2016/11/neurology-generics-businesses-drag-valeants-2017-revenue-and-ebitda/?utm_source=yahoo&utm_medium=feed,"Neurology, Generics Businesses Drag Valeant’s 2017 Revenue and EBITDA"
VRX,VRX:US,BBG000DLFM21,"Neurology, Generics Businesses Drag Valeant’s 2017 Revenue and EBITDA",2016-11-15 13:04:15 +0000,http://marketrealist.com/2016/11/neurology-generics-businesses-drag-valeants-2017-revenue-and-ebitda/?utm_source=yahoo&utm_medium=feed,"Neurology, Generics Businesses Drag Valeant’s 2017 Revenue and EBITDA"
VRX,VRX:CT,BBG000DC8S17,The State of Bill Ackman's Union,2016-11-15 12:30:06 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-15/bill-ackman-trusts-trump-to-make-returns-great-again?cmpid=yhoo.headline,The State of Bill Ackman's Union
VRX,VRX:US,BBG000DLFM21,The State of Bill Ackman's Union,2016-11-15 12:30:06 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-15/bill-ackman-trusts-trump-to-make-returns-great-again?cmpid=yhoo.headline,The State of Bill Ackman's Union
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma To Present At Stifel Healthcare Conference; Webcast At 8:00 AM ET,2016-11-15 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fXD8LennOW0/valeant-pharma-to-present-at-stifel-healthcare-conference-webcast-at-800-am-et-20161115-00298,Valeant Pharma To Present At Stifel Healthcare Conference; Webcast At 8:00 AM ET
VRX,VRX:US,BBG000DLFM21,Valeant Pharma To Present At Stifel Healthcare Conference; Webcast At 8:00 AM ET,2016-11-15 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fXD8LennOW0/valeant-pharma-to-present-at-stifel-healthcare-conference-webcast-at-800-am-et-20161115-00298,Valeant Pharma To Present At Stifel Healthcare Conference; Webcast At 8:00 AM ET
VRX,VRX:CT,BBG000DC8S17,Dim Prospects for Valeant Pharmaceuticals as Former CEOs Face Criminal Probes,2016-11-15 00:28:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8bwkwBk59vs/dim-prospects-for-valeant-pharmaceuticals-as-former-ceos-face-criminal-probes-cm709054,In this segment from Market Foolery 160 Chris Hill is joined by Bill Barker and Jim Gillies as they consider the growing challenges at Valeant Pharmaceuticals NYSE VRX which has seen scandal after scandal tank its stock price and reputation The question remains
VRX,VRX:US,BBG000DLFM21,Dim Prospects for Valeant Pharmaceuticals as Former CEOs Face Criminal Probes,2016-11-15 00:28:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8bwkwBk59vs/dim-prospects-for-valeant-pharmaceuticals-as-former-ceos-face-criminal-probes-cm709054,In this segment from Market Foolery 160 Chris Hill is joined by Bill Barker and Jim Gillies as they consider the growing challenges at Valeant Pharmaceuticals NYSE VRX which has seen scandal after scandal tank its stock price and reputation The question remains
VRX,VRX:CT,BBG000DC8S17,Lou Simpson Goes 2 for 2 in 3rd Quarter,2016-11-14 23:33:07 +0000,http://finance.yahoo.com/news/lou-simpson-goes-2-2-233307204.html,Lou Simpson Goes 2 for 2 in 3rd Quarter
VRX,VRX:US,BBG000DLFM21,Lou Simpson Goes 2 for 2 in 3rd Quarter,2016-11-14 23:33:07 +0000,http://finance.yahoo.com/news/lou-simpson-goes-2-2-233307204.html,Lou Simpson Goes 2 for 2 in 3rd Quarter
VRX,VRX:US,BBG000DLFM21,Dim Prospects for Valeant Pharmaceuticals as Former CEOs Face Criminal Probes,2016-11-14 22:30:08 +0000,http://www.fool.com/investing/2016/11/14/dim-prospects-for-valeant-pharmaceuticals-as-forme.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Dim Prospects for Valeant Pharmaceuticals as Former CEOs Face Criminal Probes
VRX,VRX:CT,BBG000DC8S17,Dim Prospects for Valeant Pharmaceuticals as Former CEOs Face Criminal Probes,2016-11-14 22:30:08 +0000,http://www.fool.com/investing/2016/11/14/dim-prospects-for-valeant-pharmaceuticals-as-forme.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Dim Prospects for Valeant Pharmaceuticals as Former CEOs Face Criminal Probes
VRX,VRX:CT,BBG000DC8S17,These drugs had the highest price increases in 2015 — according to the government agency that pays for them,2016-11-14 22:24:54 +0000,http://finance.yahoo.com/news/drugs-had-highest-price-increases-222454688.html,These drugs had the highest price increases in 2015 — according to the government agency that pays for them
VRX,VRX:US,BBG000DLFM21,These drugs had the highest price increases in 2015 — according to the government agency that pays for them,2016-11-14 22:24:54 +0000,http://finance.yahoo.com/news/drugs-had-highest-price-increases-222454688.html,These drugs had the highest price increases in 2015 — according to the government agency that pays for them
VRX,VRX:CT,BBG000DC8S17,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : November 14, 2016",2016-11-14 19:38:36 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-november-14-2016/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : November 14, 2016"
VRX,VRX:US,BBG000DLFM21,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : November 14, 2016",2016-11-14 19:38:36 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-valeant-pharmaceuticals-international-inc-november-14-2016/,"ETFs with exposure to Valeant Pharmaceuticals International, Inc. : November 14, 2016"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals: Wait, There's Something to Like?",2016-11-14 18:24:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/14/valeant-pharmaceuticals-wait-theres-something-to-like/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Wait, There's Something to Like?"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals: Wait, There's Something to Like?",2016-11-14 18:24:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/14/valeant-pharmaceuticals-wait-theres-something-to-like/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Wait, There's Something to Like?"
VRX,VRX:CT,BBG000DC8S17,Why Valeant Stock Declined 6% Last Week (VRX),2016-11-14 18:08:00 +0000,http://www.investopedia.com/news/why-valeant-stock-declined-6-last-week-vrx/?partner=YahooSA,Why Valeant Stock Declined 6% Last Week (VRX)
VRX,VRX:US,BBG000DLFM21,Why Valeant Stock Declined 6% Last Week (VRX),2016-11-14 18:08:00 +0000,http://www.investopedia.com/news/why-valeant-stock-declined-6-last-week-vrx/?partner=YahooSA,Why Valeant Stock Declined 6% Last Week (VRX)
VRX,VRX:US,BBG000DLFM21,Medicare Identifies Which Prescription Drugs Were Costliest in 2015,2016-11-14 16:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KLAbpdENvhA/medicare-identifies-which-prescription-drugs-were-costliest-in-2015-20161114-01209,Medicare Identifies Which Prescription Drugs Were Costliest in 2015
VRX,VRX:CT,BBG000DC8S17,Medicare Identifies Which Prescription Drugs Were Costliest in 2015,2016-11-14 16:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KLAbpdENvhA/medicare-identifies-which-prescription-drugs-were-costliest-in-2015-20161114-01209,Medicare Identifies Which Prescription Drugs Were Costliest in 2015
VRX,VRX:CT,BBG000DC8S17,How Did VRX’s US Diversified Business Perform in 3Q16?,2016-11-14 16:04:20 +0000,http://marketrealist.com/2016/11/how-did-vrxs-us-diversified-business-perform-in-3q16/?utm_source=yahoo&utm_medium=feed,How Did VRX’s US Diversified Business Perform in 3Q16?
VRX,VRX:US,BBG000DLFM21,How Did VRX’s US Diversified Business Perform in 3Q16?,2016-11-14 16:04:20 +0000,http://marketrealist.com/2016/11/how-did-vrxs-us-diversified-business-perform-in-3q16/?utm_source=yahoo&utm_medium=feed,How Did VRX’s US Diversified Business Perform in 3Q16?
VRX,VRX:US,BBG000DLFM21,Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals,2016-11-14 15:37:55 +0000,http://finance.yahoo.com/news/analysts-having-difficulty-getting-comfortable-153755581.html,Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals
VRX,VRX:CT,BBG000DC8S17,Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals,2016-11-14 15:37:55 +0000,http://finance.yahoo.com/news/analysts-having-difficulty-getting-comfortable-153755581.html,Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals
VRX,VRX:CT,BBG000DC8S17,Branded Rx Still a Pain for Valeant Pharmaceuticals,2016-11-14 15:04:30 +0000,http://marketrealist.com/2016/11/branded-rx-still-a-pain-for-valeant-pharmaceuticals/?utm_source=yahoo&utm_medium=feed,Branded Rx Still a Pain for Valeant Pharmaceuticals
VRX,VRX:US,BBG000DLFM21,Branded Rx Still a Pain for Valeant Pharmaceuticals,2016-11-14 15:04:30 +0000,http://marketrealist.com/2016/11/branded-rx-still-a-pain-for-valeant-pharmaceuticals/?utm_source=yahoo&utm_medium=feed,Branded Rx Still a Pain for Valeant Pharmaceuticals
VRX,VRX:CT,BBG000DC8S17,"Trump Supporters Icahn, Paulson Score Huge Returns After Election Win",2016-11-14 14:57:58 +0000,http://www.insidermonkey.com/blog/trump-supporters-icahn-paulson-score-huge-returns-after-election-win-487780/,"Trump Supporters Icahn, Paulson Score Huge Returns After Election Win"
VRX,VRX:US,BBG000DLFM21,"Trump Supporters Icahn, Paulson Score Huge Returns After Election Win",2016-11-14 14:57:58 +0000,http://www.insidermonkey.com/blog/trump-supporters-icahn-paulson-score-huge-returns-after-election-win-487780/,"Trump Supporters Icahn, Paulson Score Huge Returns After Election Win"
VRX,VRX:CT,BBG000DC8S17,Valeant: The Good News? There's More Visibility. The Bad? We Don't Like What We See,2016-11-14 14:42:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/14/valeant-the-good-news-theres-more-visibility-the-bad-we-dont-like-what-we-see/?mod=yahoobarrons&ru=yahoo,Valeant: The Good News? There's More Visibility. The Bad? We Don't Like What We See
VRX,VRX:US,BBG000DLFM21,Valeant: The Good News? There's More Visibility. The Bad? We Don't Like What We See,2016-11-14 14:42:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/14/valeant-the-good-news-theres-more-visibility-the-bad-we-dont-like-what-we-see/?mod=yahoobarrons&ru=yahoo,Valeant: The Good News? There's More Visibility. The Bad? We Don't Like What We See
VRX,VRX:US,BBG000DLFM21,Could Valeant Benefit from Trump’s Presidency?,2016-11-14 13:05:07 +0000,http://marketrealist.com/2016/11/could-valeant-benefit-from-trumps-presidency/?utm_source=yahoo&utm_medium=feed,Could Valeant Benefit from Trump’s Presidency?
VRX,VRX:CT,BBG000DC8S17,Could Valeant Benefit from Trump’s Presidency?,2016-11-14 13:05:07 +0000,http://marketrealist.com/2016/11/could-valeant-benefit-from-trumps-presidency/?utm_source=yahoo&utm_medium=feed,Could Valeant Benefit from Trump’s Presidency?
VRX,VRX:US,BBG000DLFM21,How Did the Bausch & Lomb Division Perform in 3Q16?,2016-11-14 13:04:30 +0000,http://marketrealist.com/2016/11/bausch-lomb-division-perform-3q16/?utm_source=yahoo&utm_medium=feed,How Did the Bausch & Lomb Division Perform in 3Q16?
VRX,VRX:CT,BBG000DC8S17,How Did the Bausch & Lomb Division Perform in 3Q16?,2016-11-14 13:04:30 +0000,http://marketrealist.com/2016/11/bausch-lomb-division-perform-3q16/?utm_source=yahoo&utm_medium=feed,How Did the Bausch & Lomb Division Perform in 3Q16?
VRX,VRX:US,BBG000DLFM21,Pharming Announces the Presentation of the Results of the RUCONEST® Phase II Study for Prophylaxis of Hereditary Angioedema Attacks,2016-11-14 13:00:00 +0000,http://finance.yahoo.com/news/pharming-announces-presentation-results-ruconest-130000119.html,"[PR Newswire] - LEIDEN, The Netherlands, November 14, 2016 /PRNewswire/ -- Pharming Group N.V. (the ""Company"") (EURONEXT: PHARM) today announced that the results of its ""Randomized, Double-Blind, Placebo-Controlled ..."
VRX,VRX:CT,BBG000DC8S17,Pharming Announces the Presentation of the Results of the RUCONEST® Phase II Study for Prophylaxis of Hereditary Angioedema Attacks,2016-11-14 13:00:00 +0000,http://finance.yahoo.com/news/pharming-announces-presentation-results-ruconest-130000119.html,"[PR Newswire] - LEIDEN, The Netherlands, November 14, 2016 /PRNewswire/ -- Pharming Group N.V. (the ""Company"") (EURONEXT: PHARM) today announced that the results of its ""Randomized, Double-Blind, Placebo-Controlled ..."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary,2016-11-14 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LlVLOjJnQoA/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20161114-00838,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary,2016-11-14 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LlVLOjJnQoA/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20161114-00838,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,[$$] New Valeant chief nurses $1.3m paper loss on shares,2016-11-13 11:37:49 +0000,"http://www.ft.com/cms/s/f14606a8-a84c-11e6-8898-79a99e2a4de6,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - The chief executive of Valeant is nursing a paper loss of almost $1.3m on the value of shares he bought when he joined the besieged Canadian drugmaker this year. Joseph Papa purchased about 200,000 shares ..."
VRX,VRX:CT,BBG000DC8S17,[$$] New Valeant chief nurses $1.3m paper loss on shares,2016-11-13 11:37:49 +0000,"http://www.ft.com/cms/s/f14606a8-a84c-11e6-8898-79a99e2a4de6,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - The chief executive of Valeant is nursing a paper loss of almost $1.3m on the value of shares he bought when he joined the besieged Canadian drugmaker this year. Joseph Papa purchased about 200,000 shares ..."
VRX,VRX:US,BBG000DLFM21,What Boosted Healthcare Stocks after Trump’s Victory?,2016-11-11 22:35:13 +0000,http://marketrealist.com/2016/11/what-boosted-healthcare-stocks-after-trumps-victory/?utm_source=yahoo&utm_medium=feed,What Boosted Healthcare Stocks after Trump’s Victory?
VRX,VRX:CT,BBG000DC8S17,What Boosted Healthcare Stocks after Trump’s Victory?,2016-11-11 22:35:13 +0000,http://marketrealist.com/2016/11/what-boosted-healthcare-stocks-after-trumps-victory/?utm_source=yahoo&utm_medium=feed,What Boosted Healthcare Stocks after Trump’s Victory?
VRX,VRX:US,BBG000DLFM21,Trouble Developing for Generic Pharma Stocks?,2016-11-11 19:50:39 +0000,http://finance.yahoo.com/tumblr/blog-trouble-developing-for-generic-pharma-stocks-195047922.html,Trouble Developing for Generic Pharma Stocks?
VRX,VRX:CT,BBG000DC8S17,Trouble Developing for Generic Pharma Stocks?,2016-11-11 19:50:39 +0000,http://finance.yahoo.com/tumblr/blog-trouble-developing-for-generic-pharma-stocks-195047922.html,Trouble Developing for Generic Pharma Stocks?
VRX,VRX:CT,BBG000DC8S17,Gauging Valeant Pharmaceuticals’s 3Q16 Segmental Performance,2016-11-11 16:04:43 +0000,http://marketrealist.com/2016/11/gauging-valeant-pharmaceuticalss-3q16-segmental-performance/?utm_source=yahoo&utm_medium=feed,Gauging Valeant Pharmaceuticals’s 3Q16 Segmental Performance
VRX,VRX:US,BBG000DLFM21,Gauging Valeant Pharmaceuticals’s 3Q16 Segmental Performance,2016-11-11 16:04:43 +0000,http://marketrealist.com/2016/11/gauging-valeant-pharmaceuticalss-3q16-segmental-performance/?utm_source=yahoo&utm_medium=feed,Gauging Valeant Pharmaceuticals’s 3Q16 Segmental Performance
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Fell on Lowered Growth Outlook,2016-11-11 15:05:01 +0000,http://marketrealist.com/2016/11/valeant-pharmaceuticals-fell-on-lowered-growth-outlook/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals Fell on Lowered Growth Outlook
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Fell on Lowered Growth Outlook,2016-11-11 15:05:01 +0000,http://marketrealist.com/2016/11/valeant-pharmaceuticals-fell-on-lowered-growth-outlook/?utm_source=yahoo&utm_medium=feed,Valeant Pharmaceuticals Fell on Lowered Growth Outlook
VRX,VRX:CT,BBG000DC8S17,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?",2016-11-11 13:55:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pharma-stocks-135501273.html,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?"
VRX,VRX:US,BBG000DLFM21,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?",2016-11-11 13:55:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pharma-stocks-135501273.html,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?"
VRX,VRX:US,BBG000DLFM21,Here’s What Billionaire Bill Ackman Had to Say About His Biggest Investments at the DealBook Conference,2016-11-11 13:32:37 +0000,http://www.insidermonkey.com/blog/heres-what-billionaire-bill-ackman-had-to-say-about-his-biggest-investments-at-the-dealbook-conference-487148/,Here’s What Billionaire Bill Ackman Had to Say About His Biggest Investments at the DealBook Conference
VRX,VRX:CT,BBG000DC8S17,Here’s What Billionaire Bill Ackman Had to Say About His Biggest Investments at the DealBook Conference,2016-11-11 13:32:37 +0000,http://www.insidermonkey.com/blog/heres-what-billionaire-bill-ackman-had-to-say-about-his-biggest-investments-at-the-dealbook-conference-487148/,Here’s What Billionaire Bill Ackman Had to Say About His Biggest Investments at the DealBook Conference
VRX,VRX:CT,BBG000DC8S17,Great Disappointment in Valeant Pharmaceuticals’s 3Q16 Earnings,2016-11-11 13:04:54 +0000,http://marketrealist.com/2016/11/great-disappointment-in-valeant-pharmaceuticalss-3q16-earnings/?utm_source=yahoo&utm_medium=feed,Great Disappointment in Valeant Pharmaceuticals’s 3Q16 Earnings
VRX,VRX:US,BBG000DLFM21,Great Disappointment in Valeant Pharmaceuticals’s 3Q16 Earnings,2016-11-11 13:04:54 +0000,http://marketrealist.com/2016/11/great-disappointment-in-valeant-pharmaceuticalss-3q16-earnings/?utm_source=yahoo&utm_medium=feed,Great Disappointment in Valeant Pharmaceuticals’s 3Q16 Earnings
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Climbing Further Off Multi-Year Low,2016-11-11 12:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/90DynTzqnQE/valeant-pharmaceuticals-climbing-further-off-multiyear-low-20161111-00481,Valeant Pharmaceuticals Climbing Further Off Multi-Year Low
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Climbing Further Off Multi-Year Low,2016-11-11 12:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/90DynTzqnQE/valeant-pharmaceuticals-climbing-further-off-multiyear-low-20161111-00481,Valeant Pharmaceuticals Climbing Further Off Multi-Year Low
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Sinking As Commodity Prices Drop -- Canadian Commentary,2016-11-11 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C9OSlBO7gBE/canadian-stocks-are-sinking-as-commodity-prices-drop--canadian-commentary-20161111-00402,Canadian Stocks Are Sinking As Commodity Prices Drop -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Sinking As Commodity Prices Drop -- Canadian Commentary,2016-11-11 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C9OSlBO7gBE/canadian-stocks-are-sinking-as-commodity-prices-drop--canadian-commentary-20161111-00402,Canadian Stocks Are Sinking As Commodity Prices Drop -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST®,2016-11-11 06:00:00 +0000,http://finance.yahoo.com/news/chmp-adopts-positive-opinion-self-060000996.html,"[PR Newswire] - Pharming Group N.V. (the ""Company"") (PHARM.AS) today announced that following evaluation of a dossier submitted by the Company earlier this year, the Committee for Medicinal Products for Human Use (CHMP), an advisory committee of the European Medicine Agency (EMA), has adopted a positive opinion recommending an extension to the terms of the marketing authorisation for RUCONEST® to the European Commission. This recommendation will allow self-administration of RUCONEST® for acute hereditary angioedema (HAE) attacks by adolescents and adults with a new custom-designed administration kit."
VRX,VRX:US,BBG000DLFM21,CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST®,2016-11-11 06:00:00 +0000,http://finance.yahoo.com/news/chmp-adopts-positive-opinion-self-060000996.html,"[PR Newswire] - Pharming Group N.V. (the ""Company"") (PHARM.AS) today announced that following evaluation of a dossier submitted by the Company earlier this year, the Committee for Medicinal Products for Human Use (CHMP), an advisory committee of the European Medicine Agency (EMA), has adopted a positive opinion recommending an extension to the terms of the marketing authorisation for RUCONEST® to the European Commission. This recommendation will allow self-administration of RUCONEST® for acute hereditary angioedema (HAE) attacks by adolescents and adults with a new custom-designed administration kit."
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant's morality tale is a comfort to Big Pharma,2016-11-11 04:00:20 +0000,"http://www.ft.com/cms/s/0ed3d118-a763-11e6-8898-79a99e2a4de6,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Valeant's morality tale is a comfort to Big Pharma
VRX,VRX:US,BBG000DLFM21,[$$] Valeant's morality tale is a comfort to Big Pharma,2016-11-11 04:00:20 +0000,"http://www.ft.com/cms/s/0ed3d118-a763-11e6-8898-79a99e2a4de6,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Valeant's morality tale is a comfort to Big Pharma
VRX,VRX:US,BBG000DLFM21,Valeant may seek to clean up its name by changing it: Ackman,2016-11-11 00:37:13 +0000,http://finance.yahoo.com/news/valeant-may-seek-clean-name-001420757.html,"[Reuters] - Valeant Pharmaceuticals International Plc (VRX.TO), the drugmaker that became a poster child for high drug prices during the U.S. election season, may change its name to help boost its reputation, board member and top investor William Ackman told CNBC on Wednesday. A name change would be the latest effort by the company to break from its past, after hiring a new chief executive, overhauling the board and exploring billions of dollars in asset sales to pay down a $30 billion debt load. Valeant's stock has declined more than 90 percent in the past year, erasing nearly $90 billion in market capitalization, over disclosures that it secretly worked with a specialty pharmacy to boost sales of its medicines."
VRX,VRX:CT,BBG000DC8S17,Valeant may seek to clean up its name by changing it: Ackman,2016-11-11 00:37:13 +0000,http://finance.yahoo.com/news/valeant-may-seek-clean-name-001420757.html,"[Reuters] - Valeant Pharmaceuticals International Plc (VRX.TO), the drugmaker that became a poster child for high drug prices during the U.S. election season, may change its name to help boost its reputation, board member and top investor William Ackman told CNBC on Wednesday. A name change would be the latest effort by the company to break from its past, after hiring a new chief executive, overhauling the board and exploring billions of dollars in asset sales to pay down a $30 billion debt load. Valeant's stock has declined more than 90 percent in the past year, erasing nearly $90 billion in market capitalization, over disclosures that it secretly worked with a specialty pharmacy to boost sales of its medicines."
VRX,VRX:CT,BBG000DC8S17,Valeant may seek to clean up its name by changing it -Ackman,2016-11-11 00:12:28 +0000,http://finance.yahoo.com/news/valeant-may-seek-clean-name-001228926.html,"[Reuters] - Valeant Pharmaceuticals International Plc, the drugmaker that became a poster child for high drug prices during the U.S. election season, may change its name to help boost its reputation, board member and top investor William Ackman told CNBC on Wednesday. A name change would be the latest effort by the company to break from its past, after hiring a new chief executive, overhauling the board and exploring billions of dollars in asset sales to pay down a $30 billion debt load. Valeant's stock has declined more than 90 percent in the past year, erasing nearly $90 billion in market capitalization, over disclosures that it secretly worked with a specialty pharmacy to boost sales of its medicines."
VRX,VRX:US,BBG000DLFM21,Valeant may seek to clean up its name by changing it -Ackman,2016-11-11 00:12:28 +0000,http://finance.yahoo.com/news/valeant-may-seek-clean-name-001228926.html,"[Reuters] - Valeant Pharmaceuticals International Plc, the drugmaker that became a poster child for high drug prices during the U.S. election season, may change its name to help boost its reputation, board member and top investor William Ackman told CNBC on Wednesday. A name change would be the latest effort by the company to break from its past, after hiring a new chief executive, overhauling the board and exploring billions of dollars in asset sales to pay down a $30 billion debt load. Valeant's stock has declined more than 90 percent in the past year, erasing nearly $90 billion in market capitalization, over disclosures that it secretly worked with a specialty pharmacy to boost sales of its medicines."
VRX,VRX:CT,BBG000DC8S17,Ackman: Valeant Can Sell Non-Core Assets to Reduce Debt,2016-11-10 23:33:00 +0000,https://www.thestreet.com/story/13889553/1/ackman-valeant-can-sell-non-core-assets-to-reduce-debt.html?puc=yahoo&cm_ven=YAHOO,Ackman: Valeant Can Sell Non-Core Assets to Reduce Debt
VRX,VRX:US,BBG000DLFM21,Ackman: Valeant Can Sell Non-Core Assets to Reduce Debt,2016-11-10 23:33:00 +0000,https://www.thestreet.com/story/13889553/1/ackman-valeant-can-sell-non-core-assets-to-reduce-debt.html?puc=yahoo&cm_ven=YAHOO,Ackman: Valeant Can Sell Non-Core Assets to Reduce Debt
VRX,VRX:CT,BBG000DC8S17,How to Avoid the Same Mistakes Your Heroes Made,2016-11-10 23:19:26 +0000,http://finance.yahoo.com/news/avoid-same-mistakes-heroes-made-173016398.html,How to Avoid the Same Mistakes Your Heroes Made
VRX,VRX:US,BBG000DLFM21,How to Avoid the Same Mistakes Your Heroes Made,2016-11-10 23:19:26 +0000,http://finance.yahoo.com/news/avoid-same-mistakes-heroes-made-173016398.html,How to Avoid the Same Mistakes Your Heroes Made
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Says Valeant Diversified Pharma Is a Buffett 'Cigar Butt' in Conference Call,2016-11-10 21:35:28 +0000,http://finance.yahoo.com/news/bill-ackman-valeant-diversified-pharma-213023975.html,Bill Ackman Says Valeant Diversified Pharma Is a Buffett 'Cigar Butt' in Conference Call
VRX,VRX:US,BBG000DLFM21,Bill Ackman Says Valeant Diversified Pharma Is a Buffett 'Cigar Butt' in Conference Call,2016-11-10 21:35:28 +0000,http://finance.yahoo.com/news/bill-ackman-valeant-diversified-pharma-213023975.html,Bill Ackman Says Valeant Diversified Pharma Is a Buffett 'Cigar Butt' in Conference Call
VRX,VRX:US,BBG000DLFM21,Valeant Still Working on Paying Down Credit Line,2016-11-10 20:48:25 +0000,http://blogs.wsj.com/cfo/2016/11/10/valeant-still-working-on-paying-down-credit-line/?mod=yahoo_hs,Valeant Still Working on Paying Down Credit Line
VRX,VRX:CT,BBG000DC8S17,Valeant Still Working on Paying Down Credit Line,2016-11-10 20:48:25 +0000,http://blogs.wsj.com/cfo/2016/11/10/valeant-still-working-on-paying-down-credit-line/?mod=yahoo_hs,Valeant Still Working on Paying Down Credit Line
VRX,VRX:US,BBG000DLFM21,"Valeant Can Escape Debt Quagmire, Ackman Says",2016-11-10 19:54:00 +0000,http://realmoney.thestreet.com/articles/11/10/2016/valeant-can-escape-debt-quagmire-ackman-says?puc=yahoo&cm_ven=YAHOO,"Valeant Can Escape Debt Quagmire, Ackman Says"
VRX,VRX:CT,BBG000DC8S17,"Valeant Can Escape Debt Quagmire, Ackman Says",2016-11-10 19:54:00 +0000,http://realmoney.thestreet.com/articles/11/10/2016/valeant-can-escape-debt-quagmire-ackman-says?puc=yahoo&cm_ven=YAHOO,"Valeant Can Escape Debt Quagmire, Ackman Says"
VRX,VRX:CT,BBG000DC8S17,"Mylan Posts Loss Amid Investigation, Settlement",2016-11-10 17:40:23 +0000,http://finance.yahoo.com/news/mylan-posts-loss-amid-investigation-174023694.html,"Mylan Posts Loss Amid Investigation, Settlement"
VRX,VRX:US,BBG000DLFM21,"Mylan Posts Loss Amid Investigation, Settlement",2016-11-10 17:40:23 +0000,http://finance.yahoo.com/news/mylan-posts-loss-amid-investigation-174023694.html,"Mylan Posts Loss Amid Investigation, Settlement"
VRX,VRX:US,BBG000DLFM21,Valeant: What If You Downgraded a Stock and No One Noticed?,2016-11-10 15:10:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/10/valeant-what-if-you-downgraded-a-stock-and-no-one-noticed/?mod=yahoobarrons&ru=yahoo,Valeant: What If You Downgraded a Stock and No One Noticed?
VRX,VRX:CT,BBG000DC8S17,Valeant: What If You Downgraded a Stock and No One Noticed?,2016-11-10 15:10:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/10/valeant-what-if-you-downgraded-a-stock-and-no-one-noticed/?mod=yahoobarrons&ru=yahoo,Valeant: What If You Downgraded a Stock and No One Noticed?
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016",2016-11-10 14:33:06 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q3-2016-by-the-numbers-november-10-2016/,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016",2016-11-10 14:33:06 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-vrx-us-earnings-analysis-q3-2016-by-the-numbers-november-10-2016/,"Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016"
VRX,VRX:US,BBG000DLFM21,"Top Analyst Upgrades and Downgrades After Election: IBM, Qualcomm, Valeant, Yum China, CSX, DeVry and More",2016-11-10 14:05:53 +0000,http://247wallst.com/investing/2016/11/10/top-analyst-upgrades-and-downgrades-after-election-ibm-qualcomm-valeant-yum-china-csx-devry-and-more/,"Top Analyst Upgrades and Downgrades After Election: IBM, Qualcomm, Valeant, Yum China, CSX, DeVry and More"
VRX,VRX:CT,BBG000DC8S17,"Top Analyst Upgrades and Downgrades After Election: IBM, Qualcomm, Valeant, Yum China, CSX, DeVry and More",2016-11-10 14:05:53 +0000,http://247wallst.com/investing/2016/11/10/top-analyst-upgrades-and-downgrades-after-election-ibm-qualcomm-valeant-yum-china-csx-devry-and-more/,"Top Analyst Upgrades and Downgrades After Election: IBM, Qualcomm, Valeant, Yum China, CSX, DeVry and More"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Participate In Healthcare Conferences,2016-11-10 13:30:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-healthcare-conferences-133000331.html,[CNW Group] - Valeant Pharmaceuticals To Participate In Healthcare Conferences
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Participate In Healthcare Conferences,2016-11-10 13:30:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-healthcare-conferences-133000331.html,[CNW Group] - Valeant Pharmaceuticals To Participate In Healthcare Conferences
VRX,VRX:US,BBG000DLFM21,Valeant’s 3Q16 Earnings: What Will Drive Its Revenue?,2016-11-10 11:25:20 +0000,http://marketrealist.com/2016/11/earnings-preview-expect-valeants-upcoming-3q16-earnings/?utm_source=yahoo&utm_medium=feed,Valeant’s 3Q16 Earnings: What Will Drive Its Revenue?
VRX,VRX:CT,BBG000DC8S17,Valeant’s 3Q16 Earnings: What Will Drive Its Revenue?,2016-11-10 11:25:20 +0000,http://marketrealist.com/2016/11/earnings-preview-expect-valeants-upcoming-3q16-earnings/?utm_source=yahoo&utm_medium=feed,Valeant’s 3Q16 Earnings: What Will Drive Its Revenue?
VRX,VRX:CT,BBG000DC8S17,"Jim Cramer's Top Takeaways: Chipotle, Merck, Pfizer",2016-11-10 11:00:00 +0000,https://www.thestreet.com/story/13753587/1/jim-cramer-s-top-takeaways-chipotle-merck-pfizer.html?puc=yahoo&cm_ven=YAHOO,"Jim Cramer's Top Takeaways: Chipotle, Merck, Pfizer"
VRX,VRX:US,BBG000DLFM21,"Jim Cramer's Top Takeaways: Chipotle, Merck, Pfizer",2016-11-10 11:00:00 +0000,https://www.thestreet.com/story/13753587/1/jim-cramer-s-top-takeaways-chipotle-merck-pfizer.html?puc=yahoo&cm_ven=YAHOO,"Jim Cramer's Top Takeaways: Chipotle, Merck, Pfizer"
VRX,VRX:CT,BBG000DC8S17,"Canadian Stocks Are Off Early Highs, But Remain Positive -- Canadian Commentary",2016-11-10 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FaHlqPvAJeo/canadian-stocks-are-off-early-highs-but-remain-positive--canadian-commentary-20161110-00908,"Canadian Stocks Are Off Early Highs, But Remain Positive -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Canadian Stocks Are Off Early Highs, But Remain Positive -- Canadian Commentary",2016-11-10 10:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FaHlqPvAJeo/canadian-stocks-are-off-early-highs-but-remain-positive--canadian-commentary-20161110-00908,"Canadian Stocks Are Off Early Highs, But Remain Positive -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"Blackstone, KKR Said to Ready Bid Financing for Valeant’s iNova",2016-11-10 09:01:26 +0000,http://finance.yahoo.com/news/blackstone-kkr-said-ready-bid-090126793.html,"Blackstone, KKR Said to Ready Bid Financing for Valeant’s iNova"
VRX,VRX:US,BBG000DLFM21,"Blackstone, KKR Said to Ready Bid Financing for Valeant’s iNova",2016-11-10 09:01:26 +0000,http://finance.yahoo.com/news/blackstone-kkr-said-ready-bid-090126793.html,"Blackstone, KKR Said to Ready Bid Financing for Valeant’s iNova"
VRX,VRX:CT,BBG000DC8S17,"Blackstone, KKR Said to Ready Financing for Valeant’s INova",2016-11-10 09:01:26 +0000,http://www.bloomberg.com/news/articles/2016-11-10/blackstone-kkr-said-to-ready-bid-financing-for-valeant-s-inova?cmpid=yhoo.headline,"Blackstone, KKR Said to Ready Financing for Valeant’s INova"
VRX,VRX:US,BBG000DLFM21,"Blackstone, KKR Said to Ready Financing for Valeant’s INova",2016-11-10 09:01:26 +0000,http://www.bloomberg.com/news/articles/2016-11-10/blackstone-kkr-said-to-ready-bid-financing-for-valeant-s-inova?cmpid=yhoo.headline,"Blackstone, KKR Said to Ready Financing for Valeant’s INova"
VRX,VRX:CT,BBG000DC8S17,Jim Cramer's 'Mad Money' Recap: Willing Buyers Produce Improbable Rally,2016-11-10 01:50:00 +0000,https://www.thestreet.com/story/13753560/1/jim-cramer-s-mad-money-recap-willing-buyers-produce-improbable-rally.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer's 'Mad Money' Recap: Willing Buyers Produce Improbable Rally
VRX,VRX:US,BBG000DLFM21,Jim Cramer's 'Mad Money' Recap: Willing Buyers Produce Improbable Rally,2016-11-10 01:50:00 +0000,https://www.thestreet.com/story/13753560/1/jim-cramer-s-mad-money-recap-willing-buyers-produce-improbable-rally.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer's 'Mad Money' Recap: Willing Buyers Produce Improbable Rally
VRX,VRX:CT,BBG000DC8S17,Valeant gets investigative subpoena over former ties with Philidor,2016-11-10 00:27:48 +0000,http://finance.yahoo.com/news/valeant-gets-investigative-subpoena-over-002748224.html,"[Reuters] - Canadian drugmaker Valeant Pharmaceuticals International Inc said on Wednesday it received an investigative subpoena from the California Department of Insurance in September over its ties to pharmacies and marketing. The request follows allegations against Valeant that it used speciality pharmacy Philidor Rx Services Llc to force customers to pay higher prices for its drugs. The subpoena seeks materials including documents concerning Valeant's former relationship with Philidor, now defunct, and certain California-based pharmacies, the marketing and distribution of its products in California, the company said in a filing."
VRX,VRX:US,BBG000DLFM21,Valeant gets investigative subpoena over former ties with Philidor,2016-11-10 00:27:48 +0000,http://finance.yahoo.com/news/valeant-gets-investigative-subpoena-over-002748224.html,"[Reuters] - Canadian drugmaker Valeant Pharmaceuticals International Inc said on Wednesday it received an investigative subpoena from the California Department of Insurance in September over its ties to pharmacies and marketing. The request follows allegations against Valeant that it used speciality pharmacy Philidor Rx Services Llc to force customers to pay higher prices for its drugs. The subpoena seeks materials including documents concerning Valeant's former relationship with Philidor, now defunct, and certain California-based pharmacies, the marketing and distribution of its products in California, the company said in a filing."
VRX,VRX:US,BBG000DLFM21,Selling Salix Could Be the Most &quot;Valeant&quot; Move Ever,2016-11-09 21:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E9R4Q88zVcQ/selling-salix-could-be-the-most-valeant-move-ever-cm706765,Image source Getty Images Embattled drugmaker Valeant Pharmaceuticals NYSE VRX and its management team have had so many miscues since the summer of 2015 that Wall Street and investors have probably lost count Valeant s laundry list of troubles For starters
VRX,VRX:CT,BBG000DC8S17,Selling Salix Could Be the Most &quot;Valeant&quot; Move Ever,2016-11-09 21:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E9R4Q88zVcQ/selling-salix-could-be-the-most-valeant-move-ever-cm706765,Image source Getty Images Embattled drugmaker Valeant Pharmaceuticals NYSE VRX and its management team have had so many miscues since the summer of 2015 that Wall Street and investors have probably lost count Valeant s laundry list of troubles For starters
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report",2016-11-09 21:14:07 +0000,http://biz.yahoo.com/e/161109/vrx10-q.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report"
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report",2016-11-09 21:14:07 +0000,http://biz.yahoo.com/e/161109/vrx10-q.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Intl Inc (VRX), Transocean LTD (RIG) & More: How Q Investments Managed to Outperform the Market?",2016-11-09 21:12:53 +0000,http://www.insidermonkey.com/blog/valeant-pharmaceuticals-intl-inc-vrx-transocean-ltd-rig-more-how-q-investments-managed-to-outperform-the-market-485481/,"Valeant Pharmaceuticals Intl Inc (VRX), Transocean LTD (RIG) & More: How Q Investments Managed to Outperform the Market?"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Intl Inc (VRX), Transocean LTD (RIG) & More: How Q Investments Managed to Outperform the Market?",2016-11-09 21:12:53 +0000,http://www.insidermonkey.com/blog/valeant-pharmaceuticals-intl-inc-vrx-transocean-ltd-rig-more-how-q-investments-managed-to-outperform-the-market-485481/,"Valeant Pharmaceuticals Intl Inc (VRX), Transocean LTD (RIG) & More: How Q Investments Managed to Outperform the Market?"
VRX,VRX:CT,BBG000DC8S17,"Selling Salix Could Be the Most ""Valeant"" Move Ever",2016-11-09 21:12:07 +0000,http://www.fool.com/investing/2016/11/09/selling-salix-could-be-the-most-valeant-move-ever.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Selling Salix Could Be the Most ""Valeant"" Move Ever"
VRX,VRX:US,BBG000DLFM21,"Selling Salix Could Be the Most ""Valeant"" Move Ever",2016-11-09 21:12:07 +0000,http://www.fool.com/investing/2016/11/09/selling-salix-could-be-the-most-valeant-move-ever.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Selling Salix Could Be the Most ""Valeant"" Move Ever"
VRX,VRX:US,BBG000DLFM21,"Wednesday’s Vital Data: Facebook Inc (FB), Valeant Pharmaceuticals Intl Inc (VRX) and Freeport-McMoRan Inc (FCX)",2016-11-09 18:54:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iGpM5m0YkJQ/wednesdays-vital-data-facebook-inc-fb-valeant-pharmaceuticals-intl-inc-vrx-and-freeport-mcmoran-inc-fcx-cm706637,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures took a hit this morning as Wall Street dealt with the shock and potential implications of a Trump presidency Futures on the Dow Jones Industrial Average S amp P
VRX,VRX:CT,BBG000DC8S17,"Wednesday’s Vital Data: Facebook Inc (FB), Valeant Pharmaceuticals Intl Inc (VRX) and Freeport-McMoRan Inc (FCX)",2016-11-09 18:54:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iGpM5m0YkJQ/wednesdays-vital-data-facebook-inc-fb-valeant-pharmaceuticals-intl-inc-vrx-and-freeport-mcmoran-inc-fcx-cm706637,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures took a hit this morning as Wall Street dealt with the shock and potential implications of a Trump presidency Futures on the Dow Jones Industrial Average S amp P
VRX,VRX:CT,BBG000DC8S17,"In Order To Make A Turnaround, Valeant Will Need To Go Back To Basics",2016-11-09 17:27:41 +0000,http://finance.yahoo.com/news/order-turnaround-valeant-back-basics-172741662.html,"In Order To Make A Turnaround, Valeant Will Need To Go Back To Basics"
VRX,VRX:US,BBG000DLFM21,"In Order To Make A Turnaround, Valeant Will Need To Go Back To Basics",2016-11-09 17:27:41 +0000,http://finance.yahoo.com/news/order-turnaround-valeant-back-basics-172741662.html,"In Order To Make A Turnaround, Valeant Will Need To Go Back To Basics"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Why a Trump Presidency Can't Solve All Its Woes,2016-11-09 17:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/09/valeant-pharmaceuticals-why-a-trump-presidency-cant-solve-all-its-woes/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Why a Trump Presidency Can't Solve All Its Woes
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Why a Trump Presidency Can't Solve All Its Woes,2016-11-09 17:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/09/valeant-pharmaceuticals-why-a-trump-presidency-cant-solve-all-its-woes/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Why a Trump Presidency Can't Solve All Its Woes
VRX,VRX:CT,BBG000DC8S17,"Company News for November 09, 2016",2016-11-09 16:55:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kx05YYpY3Mw/company-news-for-november-09-2016-cm706464,160 160 160 Shares of Valeant Pharmaceuticals International Inc VRX plunged 21 7 after the company said it expects its earnings per share to be 5 30 to 5 50 for the year lower than its previous guidance of 6 60 to 7 160 160 160 Shares of CVS Health Corp
VRX,VRX:US,BBG000DLFM21,"Company News for November 09, 2016",2016-11-09 16:55:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kx05YYpY3Mw/company-news-for-november-09-2016-cm706464,160 160 160 Shares of Valeant Pharmaceuticals International Inc VRX plunged 21 7 after the company said it expects its earnings per share to be 5 30 to 5 50 for the year lower than its previous guidance of 6 60 to 7 160 160 160 Shares of CVS Health Corp
VRX,VRX:CT,BBG000DC8S17,"Company News for November 09, 2016",2016-11-09 15:10:03 +0000,http://finance.yahoo.com/news/company-news-november-09-2016-151003288.html,"Company News for November 09, 2016"
VRX,VRX:US,BBG000DLFM21,"Company News for November 09, 2016",2016-11-09 15:10:03 +0000,http://finance.yahoo.com/news/company-news-november-09-2016-151003288.html,"Company News for November 09, 2016"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance",2016-11-09 14:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_rpXNVRjHm8/valeant-pharma-vrx-q3-earnings-miss-slashes-guidance-cm706290,Shares of pharmaceutical company Valeant Pharmaceuticals Inc VRX fell over 21 after the company reported disappointing third quarter 2016 results and slashed its sales and earnings outlook for the year The company s adjusted earnings per share of 1 55 missed the Zacks Consensus Estimate
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance",2016-11-09 14:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_rpXNVRjHm8/valeant-pharma-vrx-q3-earnings-miss-slashes-guidance-cm706290,Shares of pharmaceutical company Valeant Pharmaceuticals Inc VRX fell over 21 after the company reported disappointing third quarter 2016 results and slashed its sales and earnings outlook for the year The company s adjusted earnings per share of 1 55 missed the Zacks Consensus Estimate
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Just Delivered a Trifecta of Bad News in Its Q3 Report,2016-11-09 14:55:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9zYmoySB_hA/valeant-pharmaceuticals-just-delivered-a-trifecta-of-bad-news-in-its-q3-report-cm706266,Image source Getty Images Somehow it seems only fitting that embattled drugmaker Valeant Pharmaceuticals NYSE VRX reported its third quarter earnings results on Election Day which can itself be described as somewhat chaotic Not surprisingly as has become something of a
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Just Delivered a Trifecta of Bad News in Its Q3 Report,2016-11-09 14:55:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9zYmoySB_hA/valeant-pharmaceuticals-just-delivered-a-trifecta-of-bad-news-in-its-q3-report-cm706266,Image source Getty Images Somehow it seems only fitting that embattled drugmaker Valeant Pharmaceuticals NYSE VRX reported its third quarter earnings results on Election Day which can itself be described as somewhat chaotic Not surprisingly as has become something of a
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Here’s Why It Got Crushed,2016-11-09 14:53:38 +0000,http://www.insidermonkey.com/blog/valeant-pharmaceuticals-intl-inc-vrx-stock-heres-why-it-got-crushed-485871/,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Here’s Why It Got Crushed
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Here’s Why It Got Crushed,2016-11-09 14:53:38 +0000,http://www.insidermonkey.com/blog/valeant-pharmaceuticals-intl-inc-vrx-stock-heres-why-it-got-crushed-485871/,Valeant Pharmaceuticals Intl Inc (VRX) Stock: Here’s Why It Got Crushed
VRX,VRX:US,BBG000DLFM21,"Brambles, Partners and Options",2016-11-09 14:27:38 +0000,http://www.bloomberg.com/view/articles/2016-11-09/brambles-partners-and-options?cmpid=yhoo.headline,"Brambles, Partners and Options"
VRX,VRX:CT,BBG000DC8S17,"Brambles, Partners and Options",2016-11-09 14:27:38 +0000,http://www.bloomberg.com/view/articles/2016-11-09/brambles-partners-and-options?cmpid=yhoo.headline,"Brambles, Partners and Options"
VRX,VRX:US,BBG000DLFM21,5 Stocks to Watch After the Market Closes Today,2016-11-09 14:22:56 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-after-the-market-closes-today-142304922.html,5 Stocks to Watch After the Market Closes Today
VRX,VRX:CT,BBG000DC8S17,5 Stocks to Watch After the Market Closes Today,2016-11-09 14:22:56 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-after-the-market-closes-today-142304922.html,5 Stocks to Watch After the Market Closes Today
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Nov 9, 2016 :  BAC, XIV, CX, QQQ, VALE, TVIX, AAPL, VRX, PFE, AZN, ARWR, FB",2016-11-09 13:53:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XFMFFbKhuuw/pre-market-most-active-for-nov-9-2016-bac-xiv-cx-qqq-vale-tvix-aapl-vrx-pfe-azn-arwr-fb-cm706238,The NASDAQ 100 Pre Market Indicator is down 64 46 to 4 740 46 The total Pre Market volume is currently 31 588 977 shares traded The following are the most active stocks for the pre market session Bank of America Corporation BAC is 0 42 at 17 42 with 5 827 880
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Nov 9, 2016 :  BAC, XIV, CX, QQQ, VALE, TVIX, AAPL, VRX, PFE, AZN, ARWR, FB",2016-11-09 13:53:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XFMFFbKhuuw/pre-market-most-active-for-nov-9-2016-bac-xiv-cx-qqq-vale-tvix-aapl-vrx-pfe-azn-arwr-fb-cm706238,The NASDAQ 100 Pre Market Indicator is down 64 46 to 4 740 46 The total Pre Market volume is currently 31 588 977 shares traded The following are the most active stocks for the pre market session Bank of America Corporation BAC is 0 42 at 17 42 with 5 827 880
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Just Delivered a Trifecta of Bad News in Its Q3 Report,2016-11-09 13:37:37 +0000,http://www.fool.com/investing/2016/11/09/valeant-pharmaceuticals-just-delivered-a-trifecta.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Just Delivered a Trifecta of Bad News in Its Q3 Report
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Just Delivered a Trifecta of Bad News in Its Q3 Report,2016-11-09 13:37:37 +0000,http://www.fool.com/investing/2016/11/09/valeant-pharmaceuticals-just-delivered-a-trifecta.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Just Delivered a Trifecta of Bad News in Its Q3 Report
VRX,VRX:US,BBG000DLFM21,"Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance",2016-11-09 12:57:12 +0000,http://finance.yahoo.com/news/valeant-pharma-vrx-q3-earnings-125712822.html,"Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance",2016-11-09 12:57:12 +0000,http://finance.yahoo.com/news/valeant-pharma-vrx-q3-earnings-125712822.html,"Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance"
VRX,VRX:US,BBG000DLFM21,"Drug stocks rally premarket, while health insurers and hospital operators slide",2016-11-09 11:56:43 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=7393A720-5177-4DA0-84D1-3F590C5AABCB&siteid=yhoof2,"Drug stocks rally premarket, while health insurers and hospital operators slide"
VRX,VRX:CT,BBG000DC8S17,"Drug stocks rally premarket, while health insurers and hospital operators slide",2016-11-09 11:56:43 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=7393A720-5177-4DA0-84D1-3F590C5AABCB&siteid=yhoof2,"Drug stocks rally premarket, while health insurers and hospital operators slide"
VRX,VRX:CT,BBG000DC8S17,[$$] Overheard: Valeant CEO Values Election,2016-11-09 08:59:45 +0000,http://www.wsj.com/articles/overheard-valeant-ceo-values-election-1478668956?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Valeant Pharmaceuticals gets high marks for civic engagement. At the start of Tuesday’s earnings call, CEO Joseph Papa reminded the audience that the results are overshadowed by today’s election."
VRX,VRX:US,BBG000DLFM21,[$$] Overheard: Valeant CEO Values Election,2016-11-09 08:59:45 +0000,http://www.wsj.com/articles/overheard-valeant-ceo-values-election-1478668956?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Valeant Pharmaceuticals gets high marks for civic engagement. At the start of Tuesday’s earnings call, CEO Joseph Papa reminded the audience that the results are overshadowed by today’s election."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Shares Plunge as It Slashes Guidance Again,2016-11-09 08:56:57 +0000,http://www.wsj.com/articles/valeant-goes-back-to-slashing-guidance-1478604091?ru=yahoo?mod=yahoo_itp,[$$] Valeant Shares Plunge as It Slashes Guidance Again
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Shares Plunge as It Slashes Guidance Again,2016-11-09 08:56:57 +0000,http://www.wsj.com/articles/valeant-goes-back-to-slashing-guidance-1478604091?ru=yahoo?mod=yahoo_itp,[$$] Valeant Shares Plunge as It Slashes Guidance Again
VRX,VRX:US,BBG000DLFM21,"VALEANT INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Valeant Pharmaceuticals International, Inc. for Possible Securities Fraud – VRX",2016-11-09 03:07:00 +0000,http://finance.yahoo.com/news/valeant-investigation-initiated-former-louisiana-030700379.html,"[Business Wire] - Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Valeant Pharmaceuticals International, Inc."
VRX,VRX:CT,BBG000DC8S17,"VALEANT INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Valeant Pharmaceuticals International, Inc. for Possible Securities Fraud – VRX",2016-11-09 03:07:00 +0000,http://finance.yahoo.com/news/valeant-investigation-initiated-former-louisiana-030700379.html,"[Business Wire] - Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Valeant Pharmaceuticals International, Inc."
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Avis Budget Group, and ArcelorMittal Slumped Today",2016-11-09 01:56:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h5oh_AqViRM/why-valeant-pharmaceuticals-avis-budget-group-and-arcelormittal-slumped-today-cm706058,Tuesday s news centered on the presidential election and despite uncertainty about both the result and the aftermath in the days to come the stock market nevertheless gained ground The Dow was up 73 points and other major market benchmarks were up roughly 0 5 but not all
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Avis Budget Group, and ArcelorMittal Slumped Today",2016-11-09 01:56:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h5oh_AqViRM/why-valeant-pharmaceuticals-avis-budget-group-and-arcelormittal-slumped-today-cm706058,Tuesday s news centered on the presidential election and despite uncertainty about both the result and the aftermath in the days to come the stock market nevertheless gained ground The Dow was up 73 points and other major market benchmarks were up roughly 0 5 but not all
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals Intl Inc (VRX), CVS Health Corp (CVS) and ArcelorMittal SA (ADR) (MT) Are 3 of Today’s Worst Stocks",2016-11-09 00:53:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/67g39h5WGaQ/why-valeant-pharmaceuticals-intl-inc-vrx-cvs-health-corp-cvs-and-arcelormittal-sa-adr-mt-are-3-of-todays-worst-stocks-cm706026,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Following through on Monday s bullishness and perhaps emboldened by more confidence in the outcome of Tuesday s voting the bulls charged again today The S amp P 500 s close of 2139 53
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals Intl Inc (VRX), CVS Health Corp (CVS) and ArcelorMittal SA (ADR) (MT) Are 3 of Today’s Worst Stocks",2016-11-09 00:53:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/67g39h5WGaQ/why-valeant-pharmaceuticals-intl-inc-vrx-cvs-health-corp-cvs-and-arcelormittal-sa-adr-mt-are-3-of-todays-worst-stocks-cm706026,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Following through on Monday s bullishness and perhaps emboldened by more confidence in the outcome of Tuesday s voting the bulls charged again today The S amp P 500 s close of 2139 53
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals, Avis Budget Group, and ArcelorMittal Slumped Today",2016-11-09 00:24:00 +0000,http://www.fool.com/investing/2016/11/08/why-valeant-pharmaceuticals-avis-budget-group-and.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Valeant Pharmaceuticals, Avis Budget Group, and ArcelorMittal Slumped Today"
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals, Avis Budget Group, and ArcelorMittal Slumped Today",2016-11-09 00:24:00 +0000,http://www.fool.com/investing/2016/11/08/why-valeant-pharmaceuticals-avis-budget-group-and.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Valeant Pharmaceuticals, Avis Budget Group, and ArcelorMittal Slumped Today"
VRX,VRX:CT,BBG000DC8S17,Cramer: Food Companies Are Ripe for Acquisitions,2016-11-09 00:01:00 +0000,http://realmoney.thestreet.com/articles/11/08/2016/cramer-food-companies-are-ripe-acquisitions?puc=yahoo&cm_ven=YAHOO,Cramer: Food Companies Are Ripe for Acquisitions
VRX,VRX:US,BBG000DLFM21,Cramer: Food Companies Are Ripe for Acquisitions,2016-11-09 00:01:00 +0000,http://realmoney.thestreet.com/articles/11/08/2016/cramer-food-companies-are-ripe-acquisitions?puc=yahoo&cm_ven=YAHOO,Cramer: Food Companies Are Ripe for Acquisitions
VRX,VRX:CT,BBG000DC8S17,Valeant's 'Guidance Bomb' Could Be Just the Beginning,2016-11-08 21:43:00 +0000,http://realmoney.thestreet.com/articles/11/08/2016/valeants-guidance-bomb-could-be-just-beginning?puc=yahoo&cm_ven=YAHOO,Valeant's 'Guidance Bomb' Could Be Just the Beginning
VRX,VRX:US,BBG000DLFM21,Valeant's 'Guidance Bomb' Could Be Just the Beginning,2016-11-08 21:43:00 +0000,http://realmoney.thestreet.com/articles/11/08/2016/valeants-guidance-bomb-could-be-just-beginning?puc=yahoo&cm_ven=YAHOO,Valeant's 'Guidance Bomb' Could Be Just the Beginning
VRX,VRX:US,BBG000DLFM21,Is It Over Yet?,2016-11-08 21:31:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F8W8ANlLW9U/is-it-over-yet-cm705840,Tuesday November 8 2016 The South and the Farm Belt are solidly red The Northeast and West Coast are solidly blue Great Lakes are mixed Today lays plain the U S s political landscape as it always does the first Tuesday after the first Monday in November every four years We ve
VRX,VRX:CT,BBG000DC8S17,Is It Over Yet?,2016-11-08 21:31:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F8W8ANlLW9U/is-it-over-yet-cm705840,Tuesday November 8 2016 The South and the Farm Belt are solidly red The Northeast and West Coast are solidly blue Great Lakes are mixed Today lays plain the U S s political landscape as it always does the first Tuesday after the first Monday in November every four years We ve
VRX,VRX:CT,BBG000DC8S17,"Embattled Valeant Pharma reports 3Q loss, slashes guidance",2016-11-08 21:24:47 +0000,http://sg.finance.yahoo.com/news/valeant-reports-3q-loss-111045535.html,"Embattled Valeant Pharma reports 3Q loss, slashes guidance"
VRX,VRX:US,BBG000DLFM21,"Embattled Valeant Pharma reports 3Q loss, slashes guidance",2016-11-08 21:24:47 +0000,http://sg.finance.yahoo.com/news/valeant-reports-3q-loss-111045535.html,"Embattled Valeant Pharma reports 3Q loss, slashes guidance"
VRX,VRX:CT,BBG000DC8S17,Valeant Falls After CFO Warns About Possible 'Surprises',2016-11-08 21:14:01 +0000,http://www.bloomberg.com/news/videos/2016-11-08/valeant-plunges-after-cfo-warns-about-possible-surprises?cmpid=yhoo.headline,Valeant Falls After CFO Warns About Possible 'Surprises'
VRX,VRX:US,BBG000DLFM21,Valeant Falls After CFO Warns About Possible 'Surprises',2016-11-08 21:14:01 +0000,http://www.bloomberg.com/news/videos/2016-11-08/valeant-plunges-after-cfo-warns-about-possible-surprises?cmpid=yhoo.headline,Valeant Falls After CFO Warns About Possible 'Surprises'
VRX,VRX:US,BBG000DLFM21,"Valeant Crashes On Q3 Sales, EPS Miss; Slashes 2016 Guidance",2016-11-08 21:10:03 +0000,http://www.investors.com/news/technology/valeant-crashes-on-q3-sales-eps-miss-slashes-2016-guidance/,"Valeant Crashes On Q3 Sales, EPS Miss; Slashes 2016 Guidance"
VRX,VRX:CT,BBG000DC8S17,"Valeant Crashes On Q3 Sales, EPS Miss; Slashes 2016 Guidance",2016-11-08 21:10:03 +0000,http://www.investors.com/news/technology/valeant-crashes-on-q3-sales-eps-miss-slashes-2016-guidance/,"Valeant Crashes On Q3 Sales, EPS Miss; Slashes 2016 Guidance"
VRX,VRX:CT,BBG000DC8S17,"Valeant, CVS Tumble into Tuesday’s 52-Week Low Club",2016-11-08 21:04:35 +0000,http://247wallst.com/investing/2016/11/08/valeant-cvs-tumble-into-tuesdays-52-week-low-club/,"Valeant, CVS Tumble into Tuesday’s 52-Week Low Club"
VRX,VRX:US,BBG000DLFM21,"Valeant, CVS Tumble into Tuesday’s 52-Week Low Club",2016-11-08 21:04:35 +0000,http://247wallst.com/investing/2016/11/08/valeant-cvs-tumble-into-tuesdays-52-week-low-club/,"Valeant, CVS Tumble into Tuesday’s 52-Week Low Club"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Reports Big Q3 Loss on Lower Product Sales,2016-11-08 20:38:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6oDEbm4XRHg/valeant-pharmaceuticals-reports-big-q3-loss-on-lower-product-sales-cm705900,Image source Getty Images Valeant Pharmaceuticals NYSE VRX announced its third quarter earnings results before the market opened on Tuesday With Valeant s stock plunging over 20 in early trading it s obvious that the results weren t good 160 Here s what you need to
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Reports Big Q3 Loss on Lower Product Sales,2016-11-08 20:38:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6oDEbm4XRHg/valeant-pharmaceuticals-reports-big-q3-loss-on-lower-product-sales-cm705900,Image source Getty Images Valeant Pharmaceuticals NYSE VRX announced its third quarter earnings results before the market opened on Tuesday With Valeant s stock plunging over 20 in early trading it s obvious that the results weren t good 160 Here s what you need to
VRX,VRX:US,BBG000DLFM21,Valeant’s new finance head warns that things won’t get any better in 2017,2016-11-08 20:33:20 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=11A2566A-A5CB-11E6-9FB3-ED22A22D76AF&siteid=yhoof2,Valeant’s new finance head warns that things won’t get any better in 2017
VRX,VRX:CT,BBG000DC8S17,Valeant’s new finance head warns that things won’t get any better in 2017,2016-11-08 20:33:20 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=11A2566A-A5CB-11E6-9FB3-ED22A22D76AF&siteid=yhoof2,Valeant’s new finance head warns that things won’t get any better in 2017
VRX,VRX:US,BBG000DLFM21,Wells Fargo Analyst Maris Sees Valeant (VRX) Story as a 'Big Mystery',2016-11-08 20:26:00 +0000,https://www.thestreet.com/story/13885533/1/wells-fargo-analyst-maris-sees-valeant-vrx-story-as-a-big-mystery.html?puc=yahoo&cm_ven=YAHOO,Wells Fargo Analyst Maris Sees Valeant (VRX) Story as a 'Big Mystery'
VRX,VRX:CT,BBG000DC8S17,Wells Fargo Analyst Maris Sees Valeant (VRX) Story as a 'Big Mystery',2016-11-08 20:26:00 +0000,https://www.thestreet.com/story/13885533/1/wells-fargo-analyst-maris-sees-valeant-vrx-story-as-a-big-mystery.html?puc=yahoo&cm_ven=YAHOO,Wells Fargo Analyst Maris Sees Valeant (VRX) Story as a 'Big Mystery'
VRX,VRX:CT,BBG000DC8S17,"Valeant shares are 'too risky,' analyst says",2016-11-08 20:09:26 +0000,http://www.cnbc.com/id/104090284?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104090284,"Valeant shares are 'too risky,' analyst says"
VRX,VRX:US,BBG000DLFM21,"Valeant shares are 'too risky,' analyst says",2016-11-08 20:09:26 +0000,http://www.cnbc.com/id/104090284?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104090284,"Valeant shares are 'too risky,' analyst says"
VRX,VRX:CT,BBG000DC8S17,Valeant Credit Is Looking Worse than Ever,2016-11-08 20:09:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/11/08/valleant-credit-looking-worse-than-ever/?mod=yahoobarrons&ru=yahoo,Valeant Credit Is Looking Worse than Ever
VRX,VRX:US,BBG000DLFM21,Valeant Credit Is Looking Worse than Ever,2016-11-08 20:09:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/11/08/valleant-credit-looking-worse-than-ever/?mod=yahoobarrons&ru=yahoo,Valeant Credit Is Looking Worse than Ever
VRX,VRX:CT,BBG000DC8S17,Valeant shares sink as company warns of rocky year ahead,2016-11-08 20:03:36 +0000,http://in.finance.yahoo.com/news/drugmaker-valeant-cuts-guidance-warns-162957997.html,Valeant shares sink as company warns of rocky year ahead
VRX,VRX:US,BBG000DLFM21,Valeant shares sink as company warns of rocky year ahead,2016-11-08 20:03:36 +0000,http://in.finance.yahoo.com/news/drugmaker-valeant-cuts-guidance-warns-162957997.html,Valeant shares sink as company warns of rocky year ahead
VRX,VRX:US,BBG000DLFM21,Valeant's Possible Fire Sale Looks Worse Than Ever,2016-11-08 19:36:17 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-08/valeant-earnings-possible-fire-sale-looks-even-worse?cmpid=yhoo.headline,Valeant's Possible Fire Sale Looks Worse Than Ever
VRX,VRX:CT,BBG000DC8S17,Valeant's Possible Fire Sale Looks Worse Than Ever,2016-11-08 19:36:17 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-08/valeant-earnings-possible-fire-sale-looks-even-worse?cmpid=yhoo.headline,Valeant's Possible Fire Sale Looks Worse Than Ever
VRX,VRX:CT,BBG000DC8S17,Valeant credit rating downgraded by Moody's after weak earnings,2016-11-08 19:16:31 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9FEFFA0B-10AB-49E5-9EFB-C571C1D6017E&siteid=yhoof2,Valeant credit rating downgraded by Moody's after weak earnings
VRX,VRX:US,BBG000DLFM21,Valeant credit rating downgraded by Moody's after weak earnings,2016-11-08 19:16:31 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9FEFFA0B-10AB-49E5-9EFB-C571C1D6017E&siteid=yhoof2,Valeant credit rating downgraded by Moody's after weak earnings
VRX,VRX:US,BBG000DLFM21,VRX Escrow Corp. -- Moody's downgrades Valeant (CFR to B3 from B2); negative outlook,2016-11-08 19:07:06 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_357743&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20161108_PR_357743,VRX Escrow Corp. -- Moody's downgrades Valeant (CFR to B3 from B2); negative outlook
VRX,VRX:CT,BBG000DC8S17,VRX Escrow Corp. -- Moody's downgrades Valeant (CFR to B3 from B2); negative outlook,2016-11-08 19:07:06 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_357743&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20161108_PR_357743,VRX Escrow Corp. -- Moody's downgrades Valeant (CFR to B3 from B2); negative outlook
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: A Race to $0?,2016-11-08 18:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/08/valeant-pharmaceuticals-a-race-to-0/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: A Race to $0?
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: A Race to $0?,2016-11-08 18:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/08/valeant-pharmaceuticals-a-race-to-0/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: A Race to $0?
VRX,VRX:US,BBG000DLFM21,Here's Why Shares of Valeant are Tanking on Tuesday,2016-11-08 18:13:00 +0000,http://www.thestreet.com/video/13885363/here-s-why-shares-of-valeant-are-tanking-on-tuesday.html?puc=yahoov&cm_ven=YAHOOV,Here's Why Shares of Valeant are Tanking on Tuesday
VRX,VRX:CT,BBG000DC8S17,Here's Why Shares of Valeant are Tanking on Tuesday,2016-11-08 18:13:00 +0000,http://www.thestreet.com/video/13885363/here-s-why-shares-of-valeant-are-tanking-on-tuesday.html?puc=yahoov&cm_ven=YAHOOV,Here's Why Shares of Valeant are Tanking on Tuesday
VRX,VRX:US,BBG000DLFM21,Let's look beyond the ballot box,2016-11-08 18:04:43 +0000,http://finance.yahoo.com/tumblr/blog-lets-look-beyond-the-ballot-box-180447634.html,Let's look beyond the ballot box
VRX,VRX:CT,BBG000DC8S17,Let's look beyond the ballot box,2016-11-08 18:04:43 +0000,http://finance.yahoo.com/tumblr/blog-lets-look-beyond-the-ballot-box-180447634.html,Let's look beyond the ballot box
VRX,VRX:CT,BBG000DC8S17,While You Were Voting,2016-11-08 18:03:29 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-08/election-offers-no-cover-for-companies-bad-news?cmpid=yhoo.headline,While You Were Voting
VRX,VRX:US,BBG000DLFM21,While You Were Voting,2016-11-08 18:03:29 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-08/election-offers-no-cover-for-companies-bad-news?cmpid=yhoo.headline,While You Were Voting
VRX,VRX:US,BBG000DLFM21,Biopharmaceutical Investors Among The Most Fed Up With The Election,2016-11-08 17:53:42 +0000,http://finance.yahoo.com/news/biopharmaceutical-investors-among-most-fed-175342267.html,Biopharmaceutical Investors Among The Most Fed Up With The Election
VRX,VRX:CT,BBG000DC8S17,Biopharmaceutical Investors Among The Most Fed Up With The Election,2016-11-08 17:53:42 +0000,http://finance.yahoo.com/news/biopharmaceutical-investors-among-most-fed-175342267.html,Biopharmaceutical Investors Among The Most Fed Up With The Election
VRX,VRX:CT,BBG000DC8S17,TSX Flat As Markets Await Word On U.S. Election -- Canadian Commentary,2016-11-08 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kJsSiAErWpw/tsx-flat-as-markets-await-word-on-us-election--canadian-commentary-20161108-01193,TSX Flat As Markets Await Word On U.S. Election -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,TSX Flat As Markets Await Word On U.S. Election -- Canadian Commentary,2016-11-08 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kJsSiAErWpw/tsx-flat-as-markets-await-word-on-us-election--canadian-commentary-20161108-01193,TSX Flat As Markets Await Word On U.S. Election -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl Inc Stock Is Slumping Today,2016-11-08 16:13:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IFQE2xqXQCI/why-valeant-pharmaceuticals-intl-inc-stock-is-slumping-today-cm705612,Image source Getty Images What happened Valeant Pharmaceuticals Intl Inc NYSE VRX stock dropped by more than 10 today in pre marketing trading after the company posted weaker than expected third quarter results Specifically Valeant posted 160 non GAAP 160 earnings
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl Inc Stock Is Slumping Today,2016-11-08 16:13:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IFQE2xqXQCI/why-valeant-pharmaceuticals-intl-inc-stock-is-slumping-today-cm705612,Image source Getty Images What happened Valeant Pharmaceuticals Intl Inc NYSE VRX stock dropped by more than 10 today in pre marketing trading after the company posted weaker than expected third quarter results Specifically Valeant posted 160 non GAAP 160 earnings
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Stock Slides After Profit Forecast Is Chopped,2016-11-08 15:49:55 +0000,http://www.wsj.com/articles/valeant-goes-back-to-slashing-guidance-1478604091?mod=yahoo_hs,[$$] Valeant Stock Slides After Profit Forecast Is Chopped
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Stock Slides After Profit Forecast Is Chopped,2016-11-08 15:49:55 +0000,http://www.wsj.com/articles/valeant-goes-back-to-slashing-guidance-1478604091?mod=yahoo_hs,[$$] Valeant Stock Slides After Profit Forecast Is Chopped
VRX,VRX:US,BBG000DLFM21,[$$] Valeant shares fall after sales and earnings targets cut,2016-11-08 15:34:06 +0000,"http://www.ft.com/cms/s/8efd1d18-a5b0-11e6-8b69-02899e8bd9d1,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Shares in Valeant dropped more than 20 per cent on Tuesday after the besieged drugmaker shocked investors by warning its profits and sales would continue to tumble next year, dashing hopes the company ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant shares fall after sales and earnings targets cut,2016-11-08 15:34:06 +0000,"http://www.ft.com/cms/s/8efd1d18-a5b0-11e6-8b69-02899e8bd9d1,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Shares in Valeant dropped more than 20 per cent on Tuesday after the besieged drugmaker shocked investors by warning its profits and sales would continue to tumble next year, dashing hopes the company ..."
VRX,VRX:US,BBG000DLFM21,Is It Over Yet?,2016-11-08 15:22:03 +0000,http://finance.yahoo.com/news/over-yet-152203733.html,Is It Over Yet?
VRX,VRX:CT,BBG000DC8S17,Is It Over Yet?,2016-11-08 15:22:03 +0000,http://finance.yahoo.com/news/over-yet-152203733.html,Is It Over Yet?
VRX,VRX:US,BBG000DLFM21,What Are Valeant’s Potential Growth Drivers?,2016-11-08 15:04:48 +0000,http://marketrealist.com/2016/11/what-are-valeants-potential-growth-drivers/?utm_source=yahoo&utm_medium=feed,What Are Valeant’s Potential Growth Drivers?
VRX,VRX:CT,BBG000DC8S17,What Are Valeant’s Potential Growth Drivers?,2016-11-08 15:04:48 +0000,http://marketrealist.com/2016/11/what-are-valeants-potential-growth-drivers/?utm_source=yahoo&utm_medium=feed,What Are Valeant’s Potential Growth Drivers?
VRX,VRX:US,BBG000DLFM21,Valeant Tumbles on Earnings Woes,2016-11-08 14:54:00 +0000,https://www.thestreet.com/story/13885107/1/valeant-tumbles-on-earnings-woes.html?puc=yahoo&cm_ven=YAHOO,Valeant Tumbles on Earnings Woes
VRX,VRX:CT,BBG000DC8S17,Valeant Tumbles on Earnings Woes,2016-11-08 14:54:00 +0000,https://www.thestreet.com/story/13885107/1/valeant-tumbles-on-earnings-woes.html?puc=yahoo&cm_ven=YAHOO,Valeant Tumbles on Earnings Woes
VRX,VRX:US,BBG000DLFM21,Valeant is getting decimated,2016-11-08 14:47:00 +0000,http://finance.yahoo.com/news/valeant-getting-destroyed-earnings-announcement-130400058.html,Valeant is getting decimated
VRX,VRX:CT,BBG000DC8S17,"Stressed Out: Valeant Craters on Guidance Cut, Earnings Whiff",2016-11-08 14:47:00 +0000,http://realmoney.thestreet.com/articles/11/08/2016/stressed-out-valeant-craters-guidance-cut-earnings-whiff?puc=yahoo&cm_ven=YAHOO,"Stressed Out: Valeant Craters on Guidance Cut, Earnings Whiff"
VRX,VRX:US,BBG000DLFM21,"Stressed Out: Valeant Craters on Guidance Cut, Earnings Whiff",2016-11-08 14:47:00 +0000,http://realmoney.thestreet.com/articles/11/08/2016/stressed-out-valeant-craters-guidance-cut-earnings-whiff?puc=yahoo&cm_ven=YAHOO,"Stressed Out: Valeant Craters on Guidance Cut, Earnings Whiff"
VRX,VRX:CT,BBG000DC8S17,Valeant is getting decimated,2016-11-08 14:47:00 +0000,http://finance.yahoo.com/news/valeant-getting-destroyed-earnings-announcement-130400058.html,Valeant is getting decimated
VRX,VRX:US,BBG000DLFM21,Wall Street Tips Lower as Markets Stuck in Nervous Wait Ahead of Election Outcome,2016-11-08 14:36:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wea6HB3kcDY/wall-street-tips-lower-as-markets-stuck-in-nervous-wait-ahead-of-election-outcome-cm705470,U S stocks were pointing to a slightly lower open on Tuesday as traders minimized their exposure to risky assets ahead of the result of a highly contentious U S presidential election U S stocks were pointing to a slightly lower open on Tuesday as traders minimized their exposure to risky
VRX,VRX:CT,BBG000DC8S17,Wall Street Tips Lower as Markets Stuck in Nervous Wait Ahead of Election Outcome,2016-11-08 14:36:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wea6HB3kcDY/wall-street-tips-lower-as-markets-stuck-in-nervous-wait-ahead-of-election-outcome-cm705470,U S stocks were pointing to a slightly lower open on Tuesday as traders minimized their exposure to risky assets ahead of the result of a highly contentious U S presidential election U S stocks were pointing to a slightly lower open on Tuesday as traders minimized their exposure to risky
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Valeant, CVS Health, Hertz Global",2016-11-08 14:29:11 +0000,http://blogs.wsj.com/moneybeat/2016/11/08/stocks-to-watch-valeant-cvs-health-hertz-global/?mod=yahoo_hs,"Stocks to Watch: Valeant, CVS Health, Hertz Global"
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Valeant, CVS Health, Hertz Global",2016-11-08 14:29:11 +0000,http://blogs.wsj.com/moneybeat/2016/11/08/stocks-to-watch-valeant-cvs-health-hertz-global/?mod=yahoo_hs,"Stocks to Watch: Valeant, CVS Health, Hertz Global"
VRX,VRX:US,BBG000DLFM21,Why Valeant Earnings Have Brought a New Multiyear Low for Investors,2016-11-08 14:10:51 +0000,http://247wallst.com/healthcare-business/2016/11/08/why-valeant-earnings-may-have-brought-a-new-52-week-low-for-investors/,Why Valeant Earnings Have Brought a New Multiyear Low for Investors
VRX,VRX:CT,BBG000DC8S17,Why Valeant Earnings Have Brought a New Multiyear Low for Investors,2016-11-08 14:10:51 +0000,http://247wallst.com/healthcare-business/2016/11/08/why-valeant-earnings-may-have-brought-a-new-52-week-low-for-investors/,Why Valeant Earnings Have Brought a New Multiyear Low for Investors
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Nov 8, 2016 :  MT, VRX, CVS, HTZ, STO, BUD, XIV, DEPO, MOMO, TVIX, ENDP, WBA",2016-11-08 13:58:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ckC_lFkL65U/pre-market-most-active-for-nov-8-2016-mt-vrx-cvs-htz-sto-bud-xiv-depo-momo-tvix-endp-wba-cm705414,The NASDAQ 100 Pre Market Indicator is down 16 to 4 773 57 The total Pre Market volume is currently 16 853 716 shares traded The following are the most active stocks for the pre market session ArcelorMittal MT is 0 44 at 6 38 with 6 784 366 shares traded MT
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Nov 8, 2016 :  MT, VRX, CVS, HTZ, STO, BUD, XIV, DEPO, MOMO, TVIX, ENDP, WBA",2016-11-08 13:58:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ckC_lFkL65U/pre-market-most-active-for-nov-8-2016-mt-vrx-cvs-htz-sto-bud-xiv-depo-momo-tvix-endp-wba-cm705414,The NASDAQ 100 Pre Market Indicator is down 16 to 4 773 57 The total Pre Market volume is currently 16 853 716 shares traded The following are the most active stocks for the pre market session ArcelorMittal MT is 0 44 at 6 38 with 6 784 366 shares traded MT
VRX,VRX:CT,BBG000DC8S17,U.S. Futures Edge Lower as Election Day Begins,2016-11-08 13:58:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/COrOjpBGWEY/us-futures-edge-lower-as-election-day-begins-cm705412,U S stock futures pulled back slightly on Tuesday as traders minimized their exposure to risky assets ahead of the result of a highly contentious U S presidential election U S stock futures pulled back slightly on Tuesday as traders minimized their exposure to risky assets ahead of the result
VRX,VRX:US,BBG000DLFM21,U.S. Futures Edge Lower as Election Day Begins,2016-11-08 13:58:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/COrOjpBGWEY/us-futures-edge-lower-as-election-day-begins-cm705412,U S stock futures pulled back slightly on Tuesday as traders minimized their exposure to risky assets ahead of the result of a highly contentious U S presidential election U S stock futures pulled back slightly on Tuesday as traders minimized their exposure to risky assets ahead of the result
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals Intl Inc Stock Is Slumping Today,2016-11-08 13:57:22 +0000,http://www.fool.com/investing/2016/11/08/why-valeant-pharmaceuticals-intl-inc-stock-is-slum.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Valeant Pharmaceuticals Intl Inc Stock Is Slumping Today
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals Intl Inc Stock Is Slumping Today,2016-11-08 13:57:22 +0000,http://www.fool.com/investing/2016/11/08/why-valeant-pharmaceuticals-intl-inc-stock-is-slum.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Valeant Pharmaceuticals Intl Inc Stock Is Slumping Today
VRX,VRX:US,BBG000DLFM21,How Valeant’s Salix Sales News Could Be Positive for Investors,2016-11-08 13:04:59 +0000,http://marketrealist.com/2016/11/how-valeants-salix-sales-news-could-be-positive-for-investors/?utm_source=yahoo&utm_medium=feed,How Valeant’s Salix Sales News Could Be Positive for Investors
VRX,VRX:CT,BBG000DC8S17,How Valeant’s Salix Sales News Could Be Positive for Investors,2016-11-08 13:04:59 +0000,http://marketrealist.com/2016/11/how-valeants-salix-sales-news-could-be-positive-for-investors/?utm_source=yahoo&utm_medium=feed,How Valeant’s Salix Sales News Could Be Positive for Investors
VRX,VRX:CT,BBG000DC8S17,"Valeant Tumbles On Disappointing Q3 Results, Lower Guidance",2016-11-08 12:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EkhRJdLQqnY/valeant-tumbles-on-disappointing-q3-results-lower-guidance-20161108-00918,"Valeant Tumbles On Disappointing Q3 Results, Lower Guidance"
VRX,VRX:US,BBG000DLFM21,"Valeant Tumbles On Disappointing Q3 Results, Lower Guidance",2016-11-08 12:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EkhRJdLQqnY/valeant-tumbles-on-disappointing-q3-results-lower-guidance-20161108-00918,"Valeant Tumbles On Disappointing Q3 Results, Lower Guidance"
VRX,VRX:US,BBG000DLFM21,Valeant adj profit misses estimates; FY forecast cut,2016-11-08 12:16:37 +0000,http://finance.yahoo.com/news/valeant-adj-profit-misses-estimates-113436257.html,Valeant adj profit misses estimates; FY forecast cut
VRX,VRX:CT,BBG000DC8S17,Valeant adj profit misses estimates; FY forecast cut,2016-11-08 12:16:37 +0000,http://finance.yahoo.com/news/valeant-adj-profit-misses-estimates-113436257.html,Valeant adj profit misses estimates; FY forecast cut
VRX,VRX:US,BBG000DLFM21,Valeant Reports Third Quarter 2016 Financial Results,2016-11-08 11:36:14 +0000,http://www.publicnow.com/view/36E4665575CA23CC2E7AA445714F00CEFE6B906F,"[at noodls] - - Total Revenues of $2.48 billion - GAAP Cash Flow from Operations of $570 million - GAAP EPS of ($3.49) and Adjusted EPS (non-GAAP) of $1.55 - Revising 2016 Full Year Guidance LAVAL, Quebec, Nov. 8, 2016 ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Reports Third Quarter 2016 Financial Results,2016-11-08 11:36:14 +0000,http://www.publicnow.com/view/36E4665575CA23CC2E7AA445714F00CEFE6B906F,"[at noodls] - - Total Revenues of $2.48 billion - GAAP Cash Flow from Operations of $570 million - GAAP EPS of ($3.49) and Adjusted EPS (non-GAAP) of $1.55 - Revising 2016 Full Year Guidance LAVAL, Quebec, Nov. 8, 2016 ..."
VRX,VRX:CT,BBG000DC8S17,Valeant posts 11 pct fall in revenue; cuts FY forecast,2016-11-08 11:12:16 +0000,http://finance.yahoo.com/news/valeant-posts-11-pct-fall-111216114.html,Valeant posts 11 pct fall in revenue; cuts FY forecast
VRX,VRX:US,BBG000DLFM21,Valeant posts 11 pct fall in revenue; cuts FY forecast,2016-11-08 11:12:16 +0000,http://finance.yahoo.com/news/valeant-posts-11-pct-fall-111216114.html,Valeant posts 11 pct fall in revenue; cuts FY forecast
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ",2016-11-08 11:10:30 +0000,http://biz.yahoo.com/e/161108/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ"
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ",2016-11-08 11:10:30 +0000,http://biz.yahoo.com/e/161108/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financ"
VRX,VRX:US,BBG000DLFM21,Valeant Slumps as CFO Warns ‘There Could Still Be Surprises’,2016-11-08 11:06:32 +0000,http://www.bloomberg.com/news/articles/2016-11-08/valeant-cuts-2016-forecast-after-quarterly-profit-falls-short?cmpid=yhoo.headline,Valeant Slumps as CFO Warns ‘There Could Still Be Surprises’
VRX,VRX:CT,BBG000DC8S17,Valeant Slumps as CFO Warns ‘There Could Still Be Surprises’,2016-11-08 11:06:32 +0000,http://www.bloomberg.com/news/articles/2016-11-08/valeant-cuts-2016-forecast-after-quarterly-profit-falls-short?cmpid=yhoo.headline,Valeant Slumps as CFO Warns ‘There Could Still Be Surprises’
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down As Valeant Sinks -- Canadian Commentary,2016-11-08 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_njMCu14YeY/canadian-stocks-are-down-as-valeant-sinks--canadian-commentary-20161108-00801,Canadian Stocks Are Down As Valeant Sinks -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down As Valeant Sinks -- Canadian Commentary,2016-11-08 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_njMCu14YeY/canadian-stocks-are-down-as-valeant-sinks--canadian-commentary-20161108-00801,Canadian Stocks Are Down As Valeant Sinks -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Bay Street Awaits U.S. Election -- Canadian Commentary,2016-11-08 08:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ClWaG7JxEYM/bay-street-awaits-us-election--canadian-commentary-20161108-00521,Bay Street Awaits U.S. Election -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bay Street Awaits U.S. Election -- Canadian Commentary,2016-11-08 08:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ClWaG7JxEYM/bay-street-awaits-us-election--canadian-commentary-20161108-00521,Bay Street Awaits U.S. Election -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Q3 16 Earnings Conference Call At 8:00 AM ET,2016-11-08 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HCBEhpw4vhE/valeant-pharmaceuticals-q3-16-earnings-conference-call-at-800-am-et-20161108-00328,Valeant Pharmaceuticals Q3 16 Earnings Conference Call At 8:00 AM ET
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Q3 16 Earnings Conference Call At 8:00 AM ET,2016-11-08 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HCBEhpw4vhE/valeant-pharmaceuticals-q3-16-earnings-conference-call-at-800-am-et-20161108-00328,Valeant Pharmaceuticals Q3 16 Earnings Conference Call At 8:00 AM ET
VRX,VRX:CT,BBG000DC8S17,Leaked documents shed light on the defunct pharmacy that brought Valeant to its knees,2016-11-08 00:18:59 +0000,http://finance.yahoo.com/news/leaked-valeant-documents-just-gave-001859524.html,Leaked documents shed light on the defunct pharmacy that brought Valeant to its knees
VRX,VRX:US,BBG000DLFM21,Leaked documents shed light on the defunct pharmacy that brought Valeant to its knees,2016-11-08 00:18:59 +0000,http://finance.yahoo.com/news/leaked-valeant-documents-just-gave-001859524.html,Leaked documents shed light on the defunct pharmacy that brought Valeant to its knees
VRX,VRX:US,BBG000DLFM21,Valeant earnings: Expect an update on plans to sell Salix,2016-11-07 22:23:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=BFB5BD54-A513-11E6-AC92-00B121487ADF&siteid=yhoof2,Valeant earnings: Expect an update on plans to sell Salix
VRX,VRX:CT,BBG000DC8S17,Valeant earnings: Expect an update on plans to sell Salix,2016-11-07 22:23:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=BFB5BD54-A513-11E6-AC92-00B121487ADF&siteid=yhoof2,Valeant earnings: Expect an update on plans to sell Salix
VRX,VRX:US,BBG000DLFM21,Valeant To Divest Paragon To Settle FTC Charges,2016-11-07 21:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4jvKtX4nqlQ/valeant-to-divest-paragon-to-settle-ftc-charges-20161107-01549,Valeant To Divest Paragon To Settle FTC Charges
VRX,VRX:CT,BBG000DC8S17,Valeant To Divest Paragon To Settle FTC Charges,2016-11-07 21:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4jvKtX4nqlQ/valeant-to-divest-paragon-to-settle-ftc-charges-20161107-01549,Valeant To Divest Paragon To Settle FTC Charges
VRX,VRX:CT,BBG000DC8S17,Valeant agrees to sell Paragon to settle U.S. antitrust charges,2016-11-07 21:25:41 +0000,http://finance.yahoo.com/news/valeant-agrees-sell-paragon-settle-212541068.html,"[Reuters] - Valeant Pharmaceuticals, which owns Bausch & Lomb, has agreed to sell Paragon Holdings to settle allegations that its acquisition of the company was illegal under antitrust law, the Federal Trade Commission ..."
VRX,VRX:US,BBG000DLFM21,Valeant agrees to sell Paragon to settle U.S. antitrust charges,2016-11-07 21:25:41 +0000,http://finance.yahoo.com/news/valeant-agrees-sell-paragon-settle-212541068.html,"[Reuters] - Valeant Pharmaceuticals, which owns Bausch & Lomb, has agreed to sell Paragon Holdings to settle allegations that its acquisition of the company was illegal under antitrust law, the Federal Trade Commission ..."
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Earnings Report for November 8, 2016 :  CVS, JCI, DHI, AER, FANG, VRX, WLK, GLPI, CNK, OA, MOMO, ENDP",2016-11-07 21:12:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xWFsvimAUwg/pre-market-earnings-report-for-november-8-2016-cvs-jci-dhi-aer-fang-vrx-wlk-glpi-cnk-oa-momo-endp-cm705260,The following companies are expected to report earnings prior to market open on 11 08 2016 Visit our Earnings Calendar for a full list of expected earnings releases CVS Health Corporation CVS is reporting for the quarter ending September 30 2016 The
VRX,VRX:US,BBG000DLFM21,"Pre-Market Earnings Report for November 8, 2016 :  CVS, JCI, DHI, AER, FANG, VRX, WLK, GLPI, CNK, OA, MOMO, ENDP",2016-11-07 21:12:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xWFsvimAUwg/pre-market-earnings-report-for-november-8-2016-cvs-jci-dhi-aer-fang-vrx-wlk-glpi-cnk-oa-momo-endp-cm705260,The following companies are expected to report earnings prior to market open on 11 08 2016 Visit our Earnings Calendar for a full list of expected earnings releases CVS Health Corporation CVS is reporting for the quarter ending September 30 2016 The
VRX,VRX:US,BBG000DLFM21,5 Stocks to Watch Before the Market Opens on Election Day,2016-11-07 21:00:33 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-on-210040442.html,5 Stocks to Watch Before the Market Opens on Election Day
VRX,VRX:CT,BBG000DC8S17,5 Stocks to Watch Before the Market Opens on Election Day,2016-11-07 21:00:33 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-on-210040442.html,5 Stocks to Watch Before the Market Opens on Election Day
VRX,VRX:CT,BBG000DC8S17,What Caused These Generic Drug Companies’ Stocks to Fall?,2016-11-07 20:04:21 +0000,http://marketrealist.com/2016/11/what-caused-these-generic-drug-companies-stocks-to-fall/?utm_source=yahoo&utm_medium=feed,What Caused These Generic Drug Companies’ Stocks to Fall?
VRX,VRX:US,BBG000DLFM21,What Caused These Generic Drug Companies’ Stocks to Fall?,2016-11-07 20:04:21 +0000,http://marketrealist.com/2016/11/what-caused-these-generic-drug-companies-stocks-to-fall/?utm_source=yahoo&utm_medium=feed,What Caused These Generic Drug Companies’ Stocks to Fall?
VRX,VRX:CT,BBG000DC8S17,Jim Cramer -- Valeant Needs to Shed Some Debt,2016-11-07 19:52:00 +0000,https://www.thestreet.com/story/13883906/1/jim-cramer-valeant-needs-to-shed-some-debt.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer -- Valeant Needs to Shed Some Debt
VRX,VRX:US,BBG000DLFM21,Jim Cramer -- Valeant Needs to Shed Some Debt,2016-11-07 19:52:00 +0000,https://www.thestreet.com/story/13883906/1/jim-cramer-valeant-needs-to-shed-some-debt.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer -- Valeant Needs to Shed Some Debt
VRX,VRX:US,BBG000DLFM21,Analysts Remain Wary Ahead of Valeant Earnings,2016-11-07 19:49:00 +0000,https://www.thestreet.com/story/13883256/1/analysts-remain-wary-ahead-of-valeant-earnings.html?puc=yahoo&cm_ven=YAHOO,Analysts Remain Wary Ahead of Valeant Earnings
VRX,VRX:CT,BBG000DC8S17,Analysts Remain Wary Ahead of Valeant Earnings,2016-11-07 19:49:00 +0000,https://www.thestreet.com/story/13883256/1/analysts-remain-wary-ahead-of-valeant-earnings.html?puc=yahoo&cm_ven=YAHOO,Analysts Remain Wary Ahead of Valeant Earnings
VRX,VRX:US,BBG000DLFM21,"Two Villains At Bat On Election Day (SEAS, VRX)",2016-11-07 19:14:00 +0000,http://www.investopedia.com/stock-analysis/cotd/110716/two-villains-bat-election-day-seas-vrx-seas-vrx.aspx?partner=YahooSA,"Two Villains At Bat On Election Day (SEAS, VRX)"
VRX,VRX:CT,BBG000DC8S17,"Two Villains At Bat On Election Day (SEAS, VRX)",2016-11-07 19:14:00 +0000,http://www.investopedia.com/stock-analysis/cotd/110716/two-villains-bat-election-day-seas-vrx-seas-vrx.aspx?partner=YahooSA,"Two Villains At Bat On Election Day (SEAS, VRX)"
VRX,VRX:US,BBG000DLFM21,"Another Month, Another 27% Decline for Valeant Pharmaceuticals Intl. Inc. in October",2016-11-07 19:11:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tb5Z4yuBSLw/another-month-another-27-decline-for-valeant-pharmaceuticals-intl-inc-in-october-cm705126,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker known best for its use of mergers and acquisitions and price increases to grow its top and bottom lines plunged 27 in October according to data from S amp P
VRX,VRX:CT,BBG000DC8S17,"Another Month, Another 27% Decline for Valeant Pharmaceuticals Intl. Inc. in October",2016-11-07 19:11:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tb5Z4yuBSLw/another-month-another-27-decline-for-valeant-pharmaceuticals-intl-inc-in-october-cm705126,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker known best for its use of mergers and acquisitions and price increases to grow its top and bottom lines plunged 27 in October according to data from S amp P
VRX,VRX:US,BBG000DLFM21,Why Valeant Has Been in the News Recently,2016-11-07 19:04:13 +0000,http://marketrealist.com/2016/11/why-valeant-has-been-making-news-recently/?utm_source=yahoo&utm_medium=feed,Why Valeant Has Been in the News Recently
VRX,VRX:CT,BBG000DC8S17,Why Valeant Has Been in the News Recently,2016-11-07 19:04:13 +0000,http://marketrealist.com/2016/11/why-valeant-has-been-making-news-recently/?utm_source=yahoo&utm_medium=feed,Why Valeant Has Been in the News Recently
VRX,VRX:US,BBG000DLFM21,Former Sprout shareholders sue Valeant over female libido drug marketing,2016-11-07 18:52:22 +0000,http://www.bizjournals.com/triangle/news/2016/11/02/former-sprout-shareholders-sue-valeant-over-female.html?ana=yahoo,Former Sprout shareholders sue Valeant over female libido drug marketing
VRX,VRX:CT,BBG000DC8S17,Former Sprout shareholders sue Valeant over female libido drug marketing,2016-11-07 18:52:22 +0000,http://www.bizjournals.com/triangle/news/2016/11/02/former-sprout-shareholders-sue-valeant-over-female.html?ana=yahoo,Former Sprout shareholders sue Valeant over female libido drug marketing
VRX,VRX:CT,BBG000DC8S17,"Another Month, Another 27% Decline for Valeant Pharmaceuticals Intl. Inc. in October",2016-11-07 17:53:58 +0000,http://www.fool.com/investing/2016/11/07/another-month-another-27-decline-for-valeant-pharm.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Another Month, Another 27% Decline for Valeant Pharmaceuticals Intl. Inc. in October"
VRX,VRX:US,BBG000DLFM21,"Another Month, Another 27% Decline for Valeant Pharmaceuticals Intl. Inc. in October",2016-11-07 17:53:58 +0000,http://www.fool.com/investing/2016/11/07/another-month-another-27-decline-for-valeant-pharm.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Another Month, Another 27% Decline for Valeant Pharmaceuticals Intl. Inc. in October"
VRX,VRX:US,BBG000DLFM21,"Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences",2016-11-07 17:21:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0OZAYe2gkVc/zacks-industry-outlook-highlights-amgen-vertex-valeant-pharmaceuticals-international-mylan-nv-and-gilead-sciences-cm705009,For Immediate Release Chicago IL November 07 2016 Today Zacks Equity Research discusses the Pharmaceuticals Part 3 including Amgen NASDAQ AMGN Free Report Vertex NASDAQ VRTX Free Report Valeant Pharmaceuticals International Inc NYSE VRX Free
VRX,VRX:CT,BBG000DC8S17,"Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences",2016-11-07 17:21:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0OZAYe2gkVc/zacks-industry-outlook-highlights-amgen-vertex-valeant-pharmaceuticals-international-mylan-nv-and-gilead-sciences-cm705009,For Immediate Release Chicago IL November 07 2016 Today Zacks Equity Research discusses the Pharmaceuticals Part 3 including Amgen NASDAQ AMGN Free Report Vertex NASDAQ VRTX Free Report Valeant Pharmaceuticals International Inc NYSE VRX Free
VRX,VRX:CT,BBG000DC8S17,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys",2016-11-07 17:17:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEFch77D0EY/if-hillary-clinton-wins-these-2-beaten-down-stocks-are-buys-cm705012,With the major market indices dropping in sync leading up to the U S presidential election I think it s safe to say the market isn t pleased with the uncertainty Tuesday s vote is stirring up The flip side of the coin though is that this cliff dive has arguably created some
VRX,VRX:US,BBG000DLFM21,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys",2016-11-07 17:17:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEFch77D0EY/if-hillary-clinton-wins-these-2-beaten-down-stocks-are-buys-cm705012,With the major market indices dropping in sync leading up to the U S presidential election I think it s safe to say the market isn t pleased with the uncertainty Tuesday s vote is stirring up The flip side of the coin though is that this cliff dive has arguably created some
VRX,VRX:US,BBG000DLFM21,The Hillary Clinton Rally: Wall Street Becomes a Blue State,2016-11-07 17:05:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/57qcnLlunHY/the-hillary-clinton-rally-wall-street-becomes-a-blue-state-cm704993,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Throughout my life Wall Street has been a red state Source Gage Skidmore via Flickr It didn t matter that stocks rose more under Democrats or that economic growth was better under Democrats Wall
VRX,VRX:CT,BBG000DC8S17,The Hillary Clinton Rally: Wall Street Becomes a Blue State,2016-11-07 17:05:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/57qcnLlunHY/the-hillary-clinton-rally-wall-street-becomes-a-blue-state-cm704993,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Throughout my life Wall Street has been a red state Source Gage Skidmore via Flickr It didn t matter that stocks rose more under Democrats or that economic growth was better under Democrats Wall
VRX,VRX:US,BBG000DLFM21,"LendingClub Corp (LC) Stock Cleans House, Cleans Up!",2016-11-07 17:02:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sDtM7tIjmR0/lendingclub-corp-lc-stock-cleans-house-cleans-up-cm704987,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips LendingClub Corp NYSE LC shares surged nearly 10 in Monday s premarket trade despite continuing losses as LC stock holders bought the company s housecleaning and the return of its
VRX,VRX:CT,BBG000DC8S17,"LendingClub Corp (LC) Stock Cleans House, Cleans Up!",2016-11-07 17:02:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sDtM7tIjmR0/lendingclub-corp-lc-stock-cleans-house-cleans-up-cm704987,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips LendingClub Corp NYSE LC shares surged nearly 10 in Monday s premarket trade despite continuing losses as LC stock holders bought the company s housecleaning and the return of its
VRX,VRX:US,BBG000DLFM21,What Do Analysts Recommend for Valeant after Recent Happenings,2016-11-07 16:53:59 +0000,http://marketrealist.com/2016/11/what-do-analysts-recommend-for-valeant-after-recent-happenings/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for Valeant after Recent Happenings
VRX,VRX:CT,BBG000DC8S17,What Do Analysts Recommend for Valeant after Recent Happenings,2016-11-07 16:53:59 +0000,http://marketrealist.com/2016/11/what-do-analysts-recommend-for-valeant-after-recent-happenings/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for Valeant after Recent Happenings
VRX,VRX:US,BBG000DLFM21,How Do the Charts Look for Jim Cramer's Weekly Shopping List? Part 2,2016-11-07 15:56:00 +0000,http://realmoney.thestreet.com/articles/11/07/2016/how-do-charts-look-jim-cramers-weekly-shopping-list-part-2?puc=yahoo&cm_ven=YAHOO,How Do the Charts Look for Jim Cramer's Weekly Shopping List? Part 2
VRX,VRX:CT,BBG000DC8S17,How Do the Charts Look for Jim Cramer's Weekly Shopping List? Part 2,2016-11-07 15:56:00 +0000,http://realmoney.thestreet.com/articles/11/07/2016/how-do-charts-look-jim-cramers-weekly-shopping-list-part-2?puc=yahoo&cm_ven=YAHOO,How Do the Charts Look for Jim Cramer's Weekly Shopping List? Part 2
VRX,VRX:CT,BBG000DC8S17,Can Valeant Turn Itself Around With This Earnings Report?,2016-11-07 15:55:05 +0000,http://247wallst.com/healthcare-business/2016/11/07/can-valeant-turn-itself-around-with-this-earnings-report/,Can Valeant Turn Itself Around With This Earnings Report?
VRX,VRX:US,BBG000DLFM21,Can Valeant Turn Itself Around With This Earnings Report?,2016-11-07 15:55:05 +0000,http://247wallst.com/healthcare-business/2016/11/07/can-valeant-turn-itself-around-with-this-earnings-report/,Can Valeant Turn Itself Around With This Earnings Report?
VRX,VRX:US,BBG000DLFM21,Insiders Buy the Holdings of ACTX ETF,2016-11-07 15:53:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kGDf-KH5FzY/insiders-buy-the-holdings-of-actx-etf-cm704963,A look at the weighted underlying holdings of the Guru Activist Index ETF Symbol ACTX shows an impressive 11 7 of holdings on a weighted basis have experienced insider buying within the past six months Valeant Pharmaceuticals International Inc Symbol VRX which makes up 0 37 of
VRX,VRX:CT,BBG000DC8S17,Insiders Buy the Holdings of ACTX ETF,2016-11-07 15:53:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kGDf-KH5FzY/insiders-buy-the-holdings-of-actx-etf-cm704963,A look at the weighted underlying holdings of the Guru Activist Index ETF Symbol ACTX shows an impressive 11 7 of holdings on a weighted basis have experienced insider buying within the past six months Valeant Pharmaceuticals International Inc Symbol VRX which makes up 0 37 of
VRX,VRX:US,BBG000DLFM21,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys",2016-11-07 15:37:15 +0000,http://www.fool.com/investing/2016/11/07/if-hillary-clinton-wins-these-2-beaten-down-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys"
VRX,VRX:CT,BBG000DC8S17,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys",2016-11-07 15:37:15 +0000,http://www.fool.com/investing/2016/11/07/if-hillary-clinton-wins-these-2-beaten-down-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys"
VRX,VRX:US,BBG000DLFM21,"Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences",2016-11-07 14:30:02 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-amgen-143002777.html,"Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences"
VRX,VRX:CT,BBG000DC8S17,"Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences",2016-11-07 14:30:02 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-amgen-143002777.html,"Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences"
VRX,VRX:CT,BBG000DC8S17,"Drug Stock Earnings to Watch on Nov 8: JAZZ, VRX, TBPH, OPHT",2016-11-07 12:52:12 +0000,http://finance.yahoo.com/news/drug-stock-earnings-watch-nov-125212881.html,"Drug Stock Earnings to Watch on Nov 8: JAZZ, VRX, TBPH, OPHT"
VRX,VRX:US,BBG000DLFM21,"Drug Stock Earnings to Watch on Nov 8: JAZZ, VRX, TBPH, OPHT",2016-11-07 12:52:12 +0000,http://finance.yahoo.com/news/drug-stock-earnings-watch-nov-125212881.html,"Drug Stock Earnings to Watch on Nov 8: JAZZ, VRX, TBPH, OPHT"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rebounding After Clinton Cleared -- Canadian Commentary,2016-11-07 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9wytojA004/canadian-stocks-are-rebounding-after-clinton-cleared--canadian-commentary-20161107-00884,Canadian Stocks Are Rebounding After Clinton Cleared -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rebounding After Clinton Cleared -- Canadian Commentary,2016-11-07 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9wytojA004/canadian-stocks-are-rebounding-after-clinton-cleared--canadian-commentary-20161107-00884,Canadian Stocks Are Rebounding After Clinton Cleared -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Sued: Female Libido Drug Was a Dud (VRX),2016-11-06 22:26:00 +0000,http://www.investopedia.com/news/valeant-sued-over-female-viagra-pill-vrx/?partner=YahooSA,Valeant Sued: Female Libido Drug Was a Dud (VRX)
VRX,VRX:CT,BBG000DC8S17,Valeant Sued: Female Libido Drug Was a Dud (VRX),2016-11-06 22:26:00 +0000,http://www.investopedia.com/news/valeant-sued-over-female-viagra-pill-vrx/?partner=YahooSA,Valeant Sued: Female Libido Drug Was a Dud (VRX)
VRX,VRX:US,BBG000DLFM21,Top 10 Earnings Coming This Week,2016-11-06 15:25:34 +0000,http://247wallst.com/investing/2016/11/06/top-10-earnings-coming-this-week/,Top 10 Earnings Coming This Week
VRX,VRX:CT,BBG000DC8S17,Top 10 Earnings Coming This Week,2016-11-06 15:25:34 +0000,http://247wallst.com/investing/2016/11/06/top-10-earnings-coming-this-week/,Top 10 Earnings Coming This Week
VRX,VRX:US,BBG000DLFM21,"Week Ahead On Wall Street: Markets Brace For Election Results, Retail Earnings Pour In",2016-11-05 16:00:00 +0000,http://www.forbes.com/sites/laurengensler/2016/11/05/week-ahead-on-wall-street-election-results-retail-earnings/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Week Ahead On Wall Street: Markets Brace For Election Results, Retail Earnings Pour In"
VRX,VRX:CT,BBG000DC8S17,"Week Ahead On Wall Street: Markets Brace For Election Results, Retail Earnings Pour In",2016-11-05 16:00:00 +0000,http://www.forbes.com/sites/laurengensler/2016/11/05/week-ahead-on-wall-street-election-results-retail-earnings/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Week Ahead On Wall Street: Markets Brace For Election Results, Retail Earnings Pour In"
VRX,VRX:CT,BBG000DC8S17,[$$] Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson,2016-11-05 04:12:33 +0000,http://www.wsj.com/articles/big-hit-on-drug-stocks-caps-26-billion-decline-for-john-paulson-1478251807?ru=yahoo?mod=yahoo_itp,[$$] Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson
VRX,VRX:US,BBG000DLFM21,[$$] Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson,2016-11-05 04:12:33 +0000,http://www.wsj.com/articles/big-hit-on-drug-stocks-caps-26-billion-decline-for-john-paulson-1478251807?ru=yahoo?mod=yahoo_itp,[$$] Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson
VRX,VRX:US,BBG000DLFM21,Valeant Can't Afford Too Many More Legal Nightmares,2016-11-05 00:42:33 +0000,http://www.bloomberg.com/news/videos/2016-11-05/valeant-can-t-afford-too-many-more-legal-nightmares-gadfly?cmpid=yhoo.headline,Valeant Can't Afford Too Many More Legal Nightmares
VRX,VRX:CT,BBG000DC8S17,Valeant Can't Afford Too Many More Legal Nightmares,2016-11-05 00:42:33 +0000,http://www.bloomberg.com/news/videos/2016-11-05/valeant-can-t-afford-too-many-more-legal-nightmares-gadfly?cmpid=yhoo.headline,Valeant Can't Afford Too Many More Legal Nightmares
VRX,VRX:US,BBG000DLFM21,Retail Politics: How Might Clinton vs. Trump Play Out At The Cash Register?,2016-11-04 18:16:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j9CBtEinjoA/retail-politics-how-might-clinton-vs-trump-play-out-at-the-cash-register-cm704245,As the 2016 presidential campaign mercifully comes to an end let us briefly look back on all the large publicly traded companies that the candidates have trashed Democrat Hillary Clinton denounced Wells Fargo WFC over its fake account scandal accused
VRX,VRX:CT,BBG000DC8S17,Retail Politics: How Might Clinton vs. Trump Play Out At The Cash Register?,2016-11-04 18:16:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j9CBtEinjoA/retail-politics-how-might-clinton-vs-trump-play-out-at-the-cash-register-cm704245,As the 2016 presidential campaign mercifully comes to an end let us briefly look back on all the large publicly traded companies that the candidates have trashed Democrat Hillary Clinton denounced Wells Fargo WFC over its fake account scandal accused
VRX,VRX:CT,BBG000DC8S17,Retail Politics: How Might Clinton vs. Trump Play Out At The Cash Register?,2016-11-04 16:01:52 +0000,http://www.investors.com/research/industry-snapshot/for-retail-winners-are-scarce-under-clinton-or-trump/,Retail Politics: How Might Clinton vs. Trump Play Out At The Cash Register?
VRX,VRX:US,BBG000DLFM21,Retail Politics: How Might Clinton vs. Trump Play Out At The Cash Register?,2016-11-04 16:01:52 +0000,http://www.investors.com/research/industry-snapshot/for-retail-winners-are-scarce-under-clinton-or-trump/,Retail Politics: How Might Clinton vs. Trump Play Out At The Cash Register?
VRX,VRX:CT,BBG000DC8S17,How Could a Salix Sale Impact Valeant’s Financials?,2016-11-04 12:04:40 +0000,http://marketrealist.com/2016/11/how-could-a-salix-sale-impact-valeants-financials/?utm_source=yahoo&utm_medium=feed,How Could a Salix Sale Impact Valeant’s Financials?
VRX,VRX:US,BBG000DLFM21,How Could a Salix Sale Impact Valeant’s Financials?,2016-11-04 12:04:40 +0000,http://marketrealist.com/2016/11/how-could-a-salix-sale-impact-valeants-financials/?utm_source=yahoo&utm_medium=feed,How Could a Salix Sale Impact Valeant’s Financials?
VRX,VRX:US,BBG000DLFM21,Jim Chanos on Valeant Pharmaceuticals: Is More Pain Ahead?,2016-11-04 12:04:26 +0000,http://marketrealist.com/2016/11/jim-chanos-valeant-pharmaceuticals-pain-ahead/?utm_source=yahoo&utm_medium=feed,Jim Chanos on Valeant Pharmaceuticals: Is More Pain Ahead?
VRX,VRX:CT,BBG000DC8S17,Jim Chanos on Valeant Pharmaceuticals: Is More Pain Ahead?,2016-11-04 12:04:26 +0000,http://marketrealist.com/2016/11/jim-chanos-valeant-pharmaceuticals-pain-ahead/?utm_source=yahoo&utm_medium=feed,Jim Chanos on Valeant Pharmaceuticals: Is More Pain Ahead?
VRX,VRX:CT,BBG000DC8S17,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson,2016-11-04 06:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mNbvi-Fa7J0/big-hit-on-drug-stocks-caps-26-billion-decline-for-john-paulson-20161104-00162,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson
VRX,VRX:US,BBG000DLFM21,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson,2016-11-04 06:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mNbvi-Fa7J0/big-hit-on-drug-stocks-caps-26-billion-decline-for-john-paulson-20161104-00162,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson
VRX,VRX:CT,BBG000DC8S17,"Consumer Sector Update for 11/03/2016: VRX,CCRN,AAC",2016-11-03 20:27:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tvoea7S8QMY/consumer-sector-update-for-11032016-vrxccrnaac-cm703627,Top Health Care StocksTop Health Care Stocks JNJ 0 16 JNJ 0 16 PFE 2 35 PFE 2 35 MRK 0 93 MRK 0 93 ABT 0 71 ABT 0 71 AMGN 2 24 AMGN 2 24 Health care stocks turned sharply lower in afternoon trade reversing small gains around mid day as the NYSE Health Care Index plunged just
VRX,VRX:US,BBG000DLFM21,"Consumer Sector Update for 11/03/2016: VRX,CCRN,AAC",2016-11-03 20:27:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tvoea7S8QMY/consumer-sector-update-for-11032016-vrxccrnaac-cm703627,Top Health Care StocksTop Health Care Stocks JNJ 0 16 JNJ 0 16 PFE 2 35 PFE 2 35 MRK 0 93 MRK 0 93 ABT 0 71 ABT 0 71 AMGN 2 24 AMGN 2 24 Health care stocks turned sharply lower in afternoon trade reversing small gains around mid day as the NYSE Health Care Index plunged just
VRX,VRX:US,BBG000DLFM21,Aerie Pharma Dips On 'Minor' Glaucoma Setback And Q3 Miss,2016-11-03 20:16:33 +0000,http://www.investors.com/news/technology/aerie-pharma-dips-on-minor-glaucoma-setback-following-q3-miss/,Aerie Pharma Dips On 'Minor' Glaucoma Setback And Q3 Miss
VRX,VRX:CT,BBG000DC8S17,Aerie Pharma Dips On 'Minor' Glaucoma Setback And Q3 Miss,2016-11-03 20:16:33 +0000,http://www.investors.com/news/technology/aerie-pharma-dips-on-minor-glaucoma-setback-following-q3-miss/,Aerie Pharma Dips On 'Minor' Glaucoma Setback And Q3 Miss
VRX,VRX:CT,BBG000DC8S17,Valeant to Sell Salix Business to Takeda,2016-11-03 20:04:08 +0000,http://marketrealist.com/2016/11/valeant-to-sell-salix-business-to-takeda/?utm_source=yahoo&utm_medium=feed,Valeant to Sell Salix Business to Takeda
VRX,VRX:US,BBG000DLFM21,Valeant to Sell Salix Business to Takeda,2016-11-03 20:04:08 +0000,http://marketrealist.com/2016/11/valeant-to-sell-salix-business-to-takeda/?utm_source=yahoo&utm_medium=feed,Valeant to Sell Salix Business to Takeda
VRX,VRX:CT,BBG000DC8S17,What Might Have Fueled Valeant’s Interest in Salix?,2016-11-03 19:04:13 +0000,http://marketrealist.com/2016/11/what-might-have-fueled-valeants-interest-in-salix/?utm_source=yahoo&utm_medium=feed,What Might Have Fueled Valeant’s Interest in Salix?
VRX,VRX:US,BBG000DLFM21,What Might Have Fueled Valeant’s Interest in Salix?,2016-11-03 19:04:13 +0000,http://marketrealist.com/2016/11/what-might-have-fueled-valeants-interest-in-salix/?utm_source=yahoo&utm_medium=feed,What Might Have Fueled Valeant’s Interest in Salix?
VRX,VRX:US,BBG000DLFM21,Valeant’s Salix Acquisition Saga,2016-11-03 17:03:31 +0000,http://marketrealist.com/2016/11/valeants-salix-acquisition-saga/?utm_source=yahoo&utm_medium=feed,Valeant’s Salix Acquisition Saga
VRX,VRX:CT,BBG000DC8S17,Valeant’s Salix Acquisition Saga,2016-11-03 17:03:31 +0000,http://marketrealist.com/2016/11/valeants-salix-acquisition-saga/?utm_source=yahoo&utm_medium=feed,Valeant’s Salix Acquisition Saga
VRX,VRX:CT,BBG000DC8S17,DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg,2016-11-03 15:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a_8Tr5zcdTE/doj-looking-into-possible-price-collusion-in-generic-drug-sector-bloomberg-20161103-02025,DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg
VRX,VRX:US,BBG000DLFM21,DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg,2016-11-03 15:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a_8Tr5zcdTE/doj-looking-into-possible-price-collusion-in-generic-drug-sector-bloomberg-20161103-02025,DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Considers Disposing Its Eye-Surgery Business,2016-11-03 15:13:22 +0000,http://www.insidermonkey.com/blog/valeant-pharmaceuticals-intl-inc-vrx-considers-disposing-its-eye-surgery-business-484778/,Valeant Pharmaceuticals Intl Inc (VRX) Considers Disposing Its Eye-Surgery Business
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Considers Disposing Its Eye-Surgery Business,2016-11-03 15:13:22 +0000,http://www.insidermonkey.com/blog/valeant-pharmaceuticals-intl-inc-vrx-considers-disposing-its-eye-surgery-business-484778/,Valeant Pharmaceuticals Intl Inc (VRX) Considers Disposing Its Eye-Surgery Business
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up Following Yesterday''s Sell-Off -- Canadian Commentary,2016-11-03 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ijCtmg7OUgw/canadian-stocks-are-up-following-yesterdays-selloff--canadian-commentary-20161103-00526,Canadian Stocks Are Up Following Yesterday''s Sell-Off -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up Following Yesterday''s Sell-Off -- Canadian Commentary,2016-11-03 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ijCtmg7OUgw/canadian-stocks-are-up-following-yesterdays-selloff--canadian-commentary-20161103-00526,Canadian Stocks Are Up Following Yesterday''s Sell-Off -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Exploring Sale of Eye-Surgery Equipment Business,2016-11-03 05:24:26 +0000,http://www.wsj.com/articles/valeant-exploring-sale-of-eye-surgery-equipment-business-1478114287?ru=yahoo?mod=yahoo_itp,Valeant Exploring Sale of Eye-Surgery Equipment Business
VRX,VRX:CT,BBG000DC8S17,Valeant Exploring Sale of Eye-Surgery Equipment Business,2016-11-03 05:24:26 +0000,http://www.wsj.com/articles/valeant-exploring-sale-of-eye-surgery-equipment-business-1478114287?ru=yahoo?mod=yahoo_itp,Valeant Exploring Sale of Eye-Surgery Equipment Business
VRX,VRX:US,BBG000DLFM21,Bill Ackman's Pershing Square Returns Slide in October,2016-11-02 23:12:21 +0000,http://finance.yahoo.com/news/bill-ackman-slumps-further-october-231221249.html,Bill Ackman's Pershing Square Returns Slide in October
VRX,VRX:CT,BBG000DC8S17,Bill Ackman's Pershing Square Returns Slide in October,2016-11-02 23:12:21 +0000,http://finance.yahoo.com/news/bill-ackman-slumps-further-october-231221249.html,Bill Ackman's Pershing Square Returns Slide in October
VRX,VRX:US,BBG000DLFM21,"[$$] Valeant, Pushing to Pare Debt, Weighs Sale of Eye-Surgery Unit",2016-11-02 21:51:43 +0000,http://www.wsj.com/articles/valeant-exploring-sale-of-eye-surgery-equipment-business-1478114287?mod=yahoo_hs,"[$$] Valeant, Pushing to Pare Debt, Weighs Sale of Eye-Surgery Unit"
VRX,VRX:CT,BBG000DC8S17,"[$$] Valeant, Pushing to Pare Debt, Weighs Sale of Eye-Surgery Unit",2016-11-02 21:51:43 +0000,http://www.wsj.com/articles/valeant-exploring-sale-of-eye-surgery-equipment-business-1478114287?mod=yahoo_hs,"[$$] Valeant, Pushing to Pare Debt, Weighs Sale of Eye-Surgery Unit"
VRX,VRX:CT,BBG000DC8S17,Valeant sued for botching marketing of female libido pill,2016-11-02 21:12:33 +0000,http://sg.finance.yahoo.com/news/valeant-sued-ex-sprout-investors-180908308.html,Valeant sued for botching marketing of female libido pill
VRX,VRX:US,BBG000DLFM21,Valeant sued for botching marketing of female libido pill,2016-11-02 21:12:33 +0000,http://sg.finance.yahoo.com/news/valeant-sued-ex-sprout-investors-180908308.html,Valeant sued for botching marketing of female libido pill
VRX,VRX:CT,BBG000DC8S17,Negative Analyst Commentary Pushes Valeant Pharmaceuticals Intl. Inc. Lower by 11%,2016-11-02 21:08:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qRkGGhO4ido/negative-analyst-commentary-pushes-valeant-pharmaceuticals-intl-inc-lower-by-11-cm702823,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX a drugmaker that s made a name for itself in recent years by acquiring brand name drugs and entire companies were down 11 during Wednesday s trading session as of 2 35 p m EDT The
VRX,VRX:US,BBG000DLFM21,Negative Analyst Commentary Pushes Valeant Pharmaceuticals Intl. Inc. Lower by 11%,2016-11-02 21:08:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qRkGGhO4ido/negative-analyst-commentary-pushes-valeant-pharmaceuticals-intl-inc-lower-by-11-cm702823,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX a drugmaker that s made a name for itself in recent years by acquiring brand name drugs and entire companies were down 11 during Wednesday s trading session as of 2 35 p m EDT The
VRX,VRX:US,BBG000DLFM21,Valeant is being sued by the backers of ‘female Viagra’ — and its secret pharmacy is at the heart of the complaint,2016-11-02 20:43:00 +0000,http://finance.yahoo.com/news/valeant-being-sued-investors-backed-185042168.html,Valeant is being sued by the backers of ‘female Viagra’ — and its secret pharmacy is at the heart of the complaint
VRX,VRX:CT,BBG000DC8S17,Valeant is being sued by the backers of ‘female Viagra’ — and its secret pharmacy is at the heart of the complaint,2016-11-02 20:43:00 +0000,http://finance.yahoo.com/news/valeant-being-sued-investors-backed-185042168.html,Valeant is being sued by the backers of ‘female Viagra’ — and its secret pharmacy is at the heart of the complaint
VRX,VRX:CT,BBG000DC8S17,Valeant exploring sale of eye-surgery equipment business - WSJ,2016-11-02 19:40:25 +0000,http://finance.yahoo.com/news/valeant-exploring-sale-eye-surgery-194025725.html,Valeant exploring sale of eye-surgery equipment business - WSJ
VRX,VRX:US,BBG000DLFM21,Valeant exploring sale of eye-surgery equipment business - WSJ,2016-11-02 19:40:25 +0000,http://finance.yahoo.com/news/valeant-exploring-sale-eye-surgery-194025725.html,Valeant exploring sale of eye-surgery equipment business - WSJ
VRX,VRX:US,BBG000DLFM21,Valeant: A Good Strategic Move?,2016-11-02 19:28:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/02/valeant-a-good-strategic-move/?mod=yahoobarrons&ru=yahoo,Valeant: A Good Strategic Move?
VRX,VRX:CT,BBG000DC8S17,Valeant: A Good Strategic Move?,2016-11-02 19:28:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/02/valeant-a-good-strategic-move/?mod=yahoobarrons&ru=yahoo,Valeant: A Good Strategic Move?
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Falls Amid Potential Asset Sales,2016-11-02 19:25:00 +0000,https://www.thestreet.com/story/13878073/1/valeant-vrx-stock-falls-amid-potential-asset-sales.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Falls Amid Potential Asset Sales
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Falls Amid Potential Asset Sales,2016-11-02 19:25:00 +0000,https://www.thestreet.com/story/13878073/1/valeant-vrx-stock-falls-amid-potential-asset-sales.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Falls Amid Potential Asset Sales
VRX,VRX:US,BBG000DLFM21,Negative Analyst Commentary Pushes Valeant Pharmaceuticals Intl. Inc. Lower by 11%,2016-11-02 19:22:05 +0000,http://www.fool.com/investing/2016/11/02/negative-analyst-commentary-pushes-valeant-pharmac.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Negative Analyst Commentary Pushes Valeant Pharmaceuticals Intl. Inc. Lower by 11%
VRX,VRX:CT,BBG000DC8S17,Negative Analyst Commentary Pushes Valeant Pharmaceuticals Intl. Inc. Lower by 11%,2016-11-02 19:22:05 +0000,http://www.fool.com/investing/2016/11/02/negative-analyst-commentary-pushes-valeant-pharmac.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Negative Analyst Commentary Pushes Valeant Pharmaceuticals Intl. Inc. Lower by 11%
VRX,VRX:CT,BBG000DC8S17,"[$$] Valeant: I love you, you pay my rent",2016-11-02 18:28:00 +0000,"http://www.ft.com/cms/s/0d014022-a11f-11e6-891e-abe238dee8e2,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - The financial crisis and its aftermath had the salutary effect of exposing the rent-seeking that had come to define the Wall Street business model. Banking has since become systemically safer and less ...
VRX,VRX:US,BBG000DLFM21,What's Valeant Worth Without Salix?,2016-11-02 18:28:00 +0000,http://realmoney.thestreet.com/articles/11/02/2016/whats-valeant-worth-without-salix?puc=yahoo&cm_ven=YAHOO,What's Valeant Worth Without Salix?
VRX,VRX:US,BBG000DLFM21,"[$$] Valeant: I love you, you pay my rent",2016-11-02 18:28:00 +0000,"http://www.ft.com/cms/s/0d014022-a11f-11e6-891e-abe238dee8e2,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - The financial crisis and its aftermath had the salutary effect of exposing the rent-seeking that had come to define the Wall Street business model. Banking has since become systemically safer and less ...
VRX,VRX:CT,BBG000DC8S17,What's Valeant Worth Without Salix?,2016-11-02 18:28:00 +0000,http://realmoney.thestreet.com/articles/11/02/2016/whats-valeant-worth-without-salix?puc=yahoo&cm_ven=YAHOO,What's Valeant Worth Without Salix?
VRX,VRX:CT,BBG000DC8S17,A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer,2016-11-02 17:43:35 +0000,http://finance.yahoo.com/news/deeper-look-valeants-assets-searches-174335254.html,A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer
VRX,VRX:US,BBG000DLFM21,A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer,2016-11-02 17:43:35 +0000,http://finance.yahoo.com/news/deeper-look-valeants-assets-searches-174335254.html,A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Mess. What Do You Do?,2016-11-02 17:08:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8gaXrHkoB9Y/valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-mess-what-do-you-do-cm702574,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX 160 shares have hot mess written all of over them Since last year s destruction ushered the Quebec based drugmaker 160 into the abyss VRX stock has
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Mess. What Do You Do?,2016-11-02 17:08:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8gaXrHkoB9Y/valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-mess-what-do-you-do-cm702574,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX 160 shares have hot mess written all of over them Since last year s destruction ushered the Quebec based drugmaker 160 into the abyss VRX stock has
VRX,VRX:CT,BBG000DC8S17,"Valeant: Don't Get Too Excited, the Trend Is Still Down",2016-11-02 16:47:00 +0000,http://realmoney.thestreet.com/articles/11/02/2016/valeant-dont-get-too-excited-trend-still-down?puc=yahoo&cm_ven=YAHOO,"Valeant: Don't Get Too Excited, the Trend Is Still Down"
VRX,VRX:US,BBG000DLFM21,"Valeant: Don't Get Too Excited, the Trend Is Still Down",2016-11-02 16:47:00 +0000,http://realmoney.thestreet.com/articles/11/02/2016/valeant-dont-get-too-excited-trend-still-down?puc=yahoo&cm_ven=YAHOO,"Valeant: Don't Get Too Excited, the Trend Is Still Down"
VRX,VRX:US,BBG000DLFM21,"How to Trade Today's Most Active Stocks -- Ford, Palatin, More",2016-11-02 16:44:00 +0000,https://www.thestreet.com/story/13877841/1/how-to-trade-today-s-most-active-stocks-ford-palatin-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Today's Most Active Stocks -- Ford, Palatin, More"
VRX,VRX:CT,BBG000DC8S17,"How to Trade Today's Most Active Stocks -- Ford, Palatin, More",2016-11-02 16:44:00 +0000,https://www.thestreet.com/story/13877841/1/how-to-trade-today-s-most-active-stocks-ford-palatin-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Today's Most Active Stocks -- Ford, Palatin, More"
VRX,VRX:CT,BBG000DC8S17,Valeant sued by ex-Sprout investors over libido pill,2016-11-02 16:41:37 +0000,http://finance.yahoo.com/news/valeant-sued-ex-sprout-investors-164137722.html,Valeant sued by ex-Sprout investors over libido pill
VRX,VRX:US,BBG000DLFM21,Valeant sued by ex-Sprout investors over libido pill,2016-11-02 16:41:37 +0000,http://finance.yahoo.com/news/valeant-sued-ex-sprout-investors-164137722.html,Valeant sued by ex-Sprout investors over libido pill
VRX,VRX:US,BBG000DLFM21,Valeant Accused of Bungling Marketing of Female Libido Drug,2016-11-02 16:39:41 +0000,http://www.bloomberg.com/news/articles/2016-11-02/valeant-accused-of-bungling-marketing-of-female-libido-drug?cmpid=yhoo.headline,Valeant Accused of Bungling Marketing of Female Libido Drug
VRX,VRX:CT,BBG000DC8S17,Valeant Accused of Bungling Marketing of Female Libido Drug,2016-11-02 16:39:41 +0000,http://www.bloomberg.com/news/articles/2016-11-02/valeant-accused-of-bungling-marketing-of-female-libido-drug?cmpid=yhoo.headline,Valeant Accused of Bungling Marketing of Female Libido Drug
VRX,VRX:US,BBG000DLFM21,Valeant May Sell Stomach Drug Ops for $10B (VRX),2016-11-02 16:35:00 +0000,http://www.investopedia.com/news/valeant-may-sell-salix-unit-10-billion-vrx/?partner=YahooSA,Valeant May Sell Stomach Drug Ops for $10B (VRX)
VRX,VRX:CT,BBG000DC8S17,Valeant May Sell Stomach Drug Ops for $10B (VRX),2016-11-02 16:35:00 +0000,http://www.investopedia.com/news/valeant-may-sell-salix-unit-10-billion-vrx/?partner=YahooSA,Valeant May Sell Stomach Drug Ops for $10B (VRX)
VRX,VRX:CT,BBG000DC8S17,"Trump Trepidation, Plunging Oil Prices Hit Stocks -- Canadian Commentary",2016-11-02 16:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lKpvIxUBIX0/trump-trepidation-plunging-oil-prices-hit-stocks--canadian-commentary-20161102-00877,"Trump Trepidation, Plunging Oil Prices Hit Stocks -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Trump Trepidation, Plunging Oil Prices Hit Stocks -- Canadian Commentary",2016-11-02 16:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lKpvIxUBIX0/trump-trepidation-plunging-oil-prices-hit-stocks--canadian-commentary-20161102-00877,"Trump Trepidation, Plunging Oil Prices Hit Stocks -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"Wednesday’s Vital Data: Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) and Bank of America Corp (BAC)",2016-11-02 16:09:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R_Xa8L_dwss/wednesdays-vital-data-apple-inc-aapl-valeant-pharmaceuticals-intl-inc-vrx-and-bank-of-america-corp-bac-cm702489,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are largely piling on to yesterday s losses as Wall Street frets over the tightening presidential race Recent polls indicate that Donald Trump has narrowed the gap
VRX,VRX:US,BBG000DLFM21,"Wednesday’s Vital Data: Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) and Bank of America Corp (BAC)",2016-11-02 16:09:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R_Xa8L_dwss/wednesdays-vital-data-apple-inc-aapl-valeant-pharmaceuticals-intl-inc-vrx-and-bank-of-america-corp-bac-cm702489,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are largely piling on to yesterday s losses as Wall Street frets over the tightening presidential race Recent polls indicate that Donald Trump has narrowed the gap
VRX,VRX:US,BBG000DLFM21,Wall Street just raised an eyebrow at Valeant,2016-11-02 15:43:43 +0000,http://finance.yahoo.com/news/wall-street-just-raised-eyebrow-154343020.html,Wall Street just raised an eyebrow at Valeant
VRX,VRX:CT,BBG000DC8S17,Wall Street just raised an eyebrow at Valeant,2016-11-02 15:43:43 +0000,http://finance.yahoo.com/news/wall-street-just-raised-eyebrow-154343020.html,Wall Street just raised an eyebrow at Valeant
VRX,VRX:CT,BBG000DC8S17,Valeant Reportedly Looks at Selling Salix Business,2016-11-02 15:38:00 +0000,http://www.thestreet.com/video/13877530/valeant-reportedly-looks-at-selling-salix-business.html?puc=yahoov&cm_ven=YAHOOV,Valeant Reportedly Looks at Selling Salix Business
VRX,VRX:US,BBG000DLFM21,Valeant Reportedly Looks at Selling Salix Business,2016-11-02 15:38:00 +0000,http://www.thestreet.com/video/13877530/valeant-reportedly-looks-at-selling-salix-business.html?puc=yahoov&cm_ven=YAHOOV,Valeant Reportedly Looks at Selling Salix Business
VRX,VRX:CT,BBG000DC8S17,Valeant's Salix Story: To Sell Or Not To Sell?,2016-11-02 15:00:50 +0000,http://finance.yahoo.com/news/valeants-salix-story-sell-not-150050128.html,Valeant's Salix Story: To Sell Or Not To Sell?
VRX,VRX:US,BBG000DLFM21,Valeant's Salix Story: To Sell Or Not To Sell?,2016-11-02 15:00:50 +0000,http://finance.yahoo.com/news/valeants-salix-story-sell-not-150050128.html,Valeant's Salix Story: To Sell Or Not To Sell?
VRX,VRX:CT,BBG000DC8S17,"Here’s Why Tesla Motors, Wal-Mart Stores, and Herbalife Are Trending Today",2016-11-02 14:41:09 +0000,http://www.insidermonkey.com/blog/heres-why-tesla-motors-wal-mart-stores-and-herbalife-are-trending-today-484572/,"Here’s Why Tesla Motors, Wal-Mart Stores, and Herbalife Are Trending Today"
VRX,VRX:US,BBG000DLFM21,"Here’s Why Tesla Motors, Wal-Mart Stores, and Herbalife Are Trending Today",2016-11-02 14:41:09 +0000,http://www.insidermonkey.com/blog/heres-why-tesla-motors-wal-mart-stores-and-herbalife-are-trending-today-484572/,"Here’s Why Tesla Motors, Wal-Mart Stores, and Herbalife Are Trending Today"
VRX,VRX:CT,BBG000DC8S17,Hold the Valeant Applause,2016-11-02 14:01:45 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-02/valeant-salix-sale-talks-hold-your-applause?cmpid=yhoo.headline,Hold the Valeant Applause
VRX,VRX:US,BBG000DLFM21,Hold the Valeant Applause,2016-11-02 14:01:45 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-02/valeant-salix-sale-talks-hold-your-applause?cmpid=yhoo.headline,Hold the Valeant Applause
VRX,VRX:CT,BBG000DC8S17,Valeant: Selling Salix a Warning of Trouble to Come?,2016-11-02 13:54:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/02/valeant-selling-salix-a-warning-of-trouble-to-come/?mod=yahoobarrons&ru=yahoo,Valeant: Selling Salix a Warning of Trouble to Come?
VRX,VRX:US,BBG000DLFM21,Valeant: Selling Salix a Warning of Trouble to Come?,2016-11-02 13:54:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/02/valeant-selling-salix-a-warning-of-trouble-to-come/?mod=yahoobarrons&ru=yahoo,Valeant: Selling Salix a Warning of Trouble to Come?
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Nov 2, 2016 :  BRCD, BABA, MT, BP, CHL, VRX, OCLR, CCI, TVIX, FB, QQQ, XIV",2016-11-02 12:54:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/attJMboiuwM/pre-market-most-active-for-nov-2-2016-brcd-baba-mt-bp-chl-vrx-oclr-cci-tvix-fb-qqq-xiv-cm702229,The NASDAQ 100 Pre Market Indicator is down 4 32 to 4 762 62 The total Pre Market volume is currently 7 142 149 shares traded The following are the most active stocks for the pre market session Brocade Communications Systems Inc BRCD is 1 05 at 12 29
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Nov 2, 2016 :  BRCD, BABA, MT, BP, CHL, VRX, OCLR, CCI, TVIX, FB, QQQ, XIV",2016-11-02 12:54:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/attJMboiuwM/pre-market-most-active-for-nov-2-2016-brcd-baba-mt-bp-chl-vrx-oclr-cci-tvix-fb-qqq-xiv-cm702229,The NASDAQ 100 Pre Market Indicator is down 4 32 to 4 762 62 The total Pre Market volume is currently 7 142 149 shares traded The following are the most active stocks for the pre market session Brocade Communications Systems Inc BRCD is 1 05 at 12 29
VRX,VRX:CT,BBG000DC8S17,5 Things You Must Know Before the Market Opens Wednesday,2016-11-02 11:22:00 +0000,https://www.thestreet.com/story/13874489/1/5-things-you-must-know-before-the-market-opens-wednesday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Wednesday
VRX,VRX:US,BBG000DLFM21,5 Things You Must Know Before the Market Opens Wednesday,2016-11-02 11:22:00 +0000,https://www.thestreet.com/story/13874489/1/5-things-you-must-know-before-the-market-opens-wednesday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Wednesday
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down On Continued Energy Weakness -- Canadian Commentary,2016-11-02 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2uakIHhAnXA/canadian-stocks-are-down-on-continued-energy-weakness--canadian-commentary-20161102-00378,Canadian Stocks Are Down On Continued Energy Weakness -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down On Continued Energy Weakness -- Canadian Commentary,2016-11-02 10:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2uakIHhAnXA/canadian-stocks-are-down-on-continued-energy-weakness--canadian-commentary-20161102-00378,Canadian Stocks Are Down On Continued Energy Weakness -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,[$$] Valeant in talks to sell Salix to Takeda for $10bn,2016-11-02 09:35:31 +0000,"http://www.ft.com/cms/s/54f4a64e-a075-11e6-86d5-4e36b35c3550,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Takeda, Japan's largest pharmaceuticals group, is in advanced talks with Valeant to acquire Salix Pharmaceuticals for about $10bn, according to people briefed about the negotiations. The exact terms of ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant in talks to sell Salix to Takeda for $10bn,2016-11-02 09:35:31 +0000,"http://www.ft.com/cms/s/54f4a64e-a075-11e6-86d5-4e36b35c3550,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Takeda, Japan's largest pharmaceuticals group, is in advanced talks with Valeant to acquire Salix Pharmaceuticals for about $10bn, according to people briefed about the negotiations. The exact terms of ..."
VRX,VRX:CT,BBG000DC8S17,Investors Are Hooked On Flipping Pharmaceutical Companies,2016-11-02 09:00:00 +0000,http://www.bloomberg.com/news/articles/2016-11-02/buy-and-flip-booms-in-drugs-market-as-private-equity-moves-in?cmpid=yhoo.headline,Investors Are Hooked On Flipping Pharmaceutical Companies
VRX,VRX:US,BBG000DLFM21,Investors Are Hooked On Flipping Pharmaceutical Companies,2016-11-02 09:00:00 +0000,http://www.bloomberg.com/news/articles/2016-11-02/buy-and-flip-booms-in-drugs-market-as-private-equity-moves-in?cmpid=yhoo.headline,Investors Are Hooked On Flipping Pharmaceutical Companies
VRX,VRX:US,BBG000DLFM21,US Stocks Looking At More Downside On Uncertainty Over Election,2016-11-02 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IxkUg6t_BCs/us-stocks-looking-at-more-downside-on-uncertainty-over-election-20161102-01486,US Stocks Looking At More Downside On Uncertainty Over Election
VRX,VRX:CT,BBG000DC8S17,US Stocks Looking At More Downside On Uncertainty Over Election,2016-11-02 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IxkUg6t_BCs/us-stocks-looking-at-more-downside-on-uncertainty-over-election-20161102-01486,US Stocks Looking At More Downside On Uncertainty Over Election
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Gets Some Breathing Room,2016-11-02 04:14:21 +0000,http://www.wsj.com/articles/valeant-gets-some-breathing-room-1478031741?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Finally, some positive news for Valeant Pharmaceuticals investors."
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Gets Some Breathing Room,2016-11-02 04:14:21 +0000,http://www.wsj.com/articles/valeant-gets-some-breathing-room-1478031741?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Finally, some positive news for Valeant Pharmaceuticals investors."
VRX,VRX:CT,BBG000DC8S17,Asian Shares Fall On US Election Jitters,2016-11-02 03:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TKCD159M6kM/asian-shares-fall-on-us-election-jitters-20161102-01390,Asian Shares Fall On US Election Jitters
VRX,VRX:US,BBG000DLFM21,Asian Shares Fall On US Election Jitters,2016-11-02 03:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TKCD159M6kM/asian-shares-fall-on-us-election-jitters-20161102-01390,Asian Shares Fall On US Election Jitters
VRX,VRX:CT,BBG000DC8S17,Takeda Trading Halted: Will Takeda Buy Valeant's Stomach Drug Business?,2016-11-02 01:48:00 +0000,http://blogs.barrons.com/asiastocks/2016/11/01/takeda-trading-halted-in-talk-to-buy-valeants-stomach-drug-business/?mod=yahoobarrons&ru=yahoo,Takeda Trading Halted: Will Takeda Buy Valeant's Stomach Drug Business?
VRX,VRX:US,BBG000DLFM21,Takeda Trading Halted: Will Takeda Buy Valeant's Stomach Drug Business?,2016-11-02 01:48:00 +0000,http://blogs.barrons.com/asiastocks/2016/11/01/takeda-trading-halted-in-talk-to-buy-valeants-stomach-drug-business/?mod=yahoobarrons&ru=yahoo,Takeda Trading Halted: Will Takeda Buy Valeant's Stomach Drug Business?
VRX,VRX:US,BBG000DLFM21,Valeant's Debt Ratios Might Not Improve with Salix Sale,2016-11-02 00:37:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/11/01/valeants-debt-ratios-might-not-improve-with-salix-sale/?mod=yahoobarrons&ru=yahoo,Valeant's Debt Ratios Might Not Improve with Salix Sale
VRX,VRX:CT,BBG000DC8S17,Valeant's Debt Ratios Might Not Improve with Salix Sale,2016-11-02 00:37:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/11/01/valeants-debt-ratios-might-not-improve-with-salix-sale/?mod=yahoobarrons&ru=yahoo,Valeant's Debt Ratios Might Not Improve with Salix Sale
VRX,VRX:CT,BBG000DC8S17,Valeant Said in Talks for Salix Sale,2016-11-02 00:31:00 +0000,http://finance.yahoo.com/video/valeant-said-talks-salix-sale-003100160.html,Valeant Said in Talks for Salix Sale
VRX,VRX:US,BBG000DLFM21,Valeant Said in Talks for Salix Sale,2016-11-02 00:31:00 +0000,http://finance.yahoo.com/video/valeant-said-talks-salix-sale-003100160.html,Valeant Said in Talks for Salix Sale
VRX,VRX:US,BBG000DLFM21,Japan's Takeda shares halted on news of interest in Valeant assets,2016-11-02 00:21:26 +0000,http://sg.finance.yahoo.com/news/japans-takeda-shares-halted-news-001946012.html,Japan's Takeda shares halted on news of interest in Valeant assets
VRX,VRX:CT,BBG000DC8S17,Japan's Takeda shares halted on news of interest in Valeant assets,2016-11-02 00:21:26 +0000,http://sg.finance.yahoo.com/news/japans-takeda-shares-halted-news-001946012.html,Japan's Takeda shares halted on news of interest in Valeant assets
VRX,VRX:US,BBG000DLFM21,Asian Markets In Negative Territory,2016-11-01 23:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a6jQ-47OHIQ/asian-markets-in-negative-territory-20161101-01820,Asian Markets In Negative Territory
VRX,VRX:CT,BBG000DC8S17,Asian Markets In Negative Territory,2016-11-01 23:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a6jQ-47OHIQ/asian-markets-in-negative-territory-20161101-01820,Asian Markets In Negative Territory
VRX,VRX:CT,BBG000DC8S17,Japanese Market Notably Lower,2016-11-01 23:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v1t2J3QDr9k/japanese-market-notably-lower-20161101-01819,Japanese Market Notably Lower
VRX,VRX:US,BBG000DLFM21,Japanese Market Notably Lower,2016-11-01 23:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v1t2J3QDr9k/japanese-market-notably-lower-20161101-01819,Japanese Market Notably Lower
VRX,VRX:US,BBG000DLFM21,"Cramer: With the Election Coming, Valeant's Problem Is Increasing",2016-11-01 23:01:00 +0000,http://realmoney.thestreet.com/articles/11/01/2016/cramer-election-coming-valeants-problem-increasing?puc=yahoo&cm_ven=YAHOO,"Cramer: With the Election Coming, Valeant's Problem Is Increasing"
VRX,VRX:CT,BBG000DC8S17,"Cramer: With the Election Coming, Valeant's Problem Is Increasing",2016-11-01 23:01:00 +0000,http://realmoney.thestreet.com/articles/11/01/2016/cramer-election-coming-valeants-problem-increasing?puc=yahoo&cm_ven=YAHOO,"Cramer: With the Election Coming, Valeant's Problem Is Increasing"
VRX,VRX:CT,BBG000DC8S17,Valeant says in talks to sell Salix stomach-drug business,2016-11-01 22:56:38 +0000,http://sg.finance.yahoo.com/news/valeant-talks-sell-salix-stomach-202100544.html,Valeant says in talks to sell Salix stomach-drug business
VRX,VRX:US,BBG000DLFM21,Valeant says in talks to sell Salix stomach-drug business,2016-11-01 22:56:38 +0000,http://sg.finance.yahoo.com/news/valeant-talks-sell-salix-stomach-202100544.html,Valeant says in talks to sell Salix stomach-drug business
VRX,VRX:US,BBG000DLFM21,Valeant shares jump more than 30% on divestiture talks,2016-11-01 22:33:59 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=6A0F3830-A07C-11E6-9366-DA5A2C56F495&siteid=yhoof2,Valeant shares jump more than 30% on divestiture talks
VRX,VRX:CT,BBG000DC8S17,Valeant shares jump more than 30% on divestiture talks,2016-11-01 22:33:59 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=6A0F3830-A07C-11E6-9366-DA5A2C56F495&siteid=yhoof2,Valeant shares jump more than 30% on divestiture talks
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl. Inc. Surges 34% on Reports of a Possible Sale of Salix,2016-11-01 22:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vzrgrInFwco/valeant-pharmaceuticals-intl-inc-surges-34-on-reports-of-a-possible-sale-of-salix-cm702084,Could a deal be in the works Image source Getty Images What happened Shares of embattled drugmaker Valeant Pharmaceuticals NYSE VRX skyrocketed as much as 36 in late day trading on Tuesday after reports surfaced that the company is in discussion with Japan s
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl. Inc. Surges 34% on Reports of a Possible Sale of Salix,2016-11-01 22:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vzrgrInFwco/valeant-pharmaceuticals-intl-inc-surges-34-on-reports-of-a-possible-sale-of-salix-cm702084,Could a deal be in the works Image source Getty Images What happened Shares of embattled drugmaker Valeant Pharmaceuticals NYSE VRX skyrocketed as much as 36 in late day trading on Tuesday after reports surfaced that the company is in discussion with Japan s
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Comments On Press Report Regarding Its Gastroenterology Business Unit,2016-11-01 21:40:08 +0000,http://www.publicnow.com/view/B4F1490F51663A53D43A88FC86A61CC9BCA47EFD,"[at noodls] - LAVAL, Quebec, Nov. 1, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Comments On Press Report Regarding Its Gastroenterology Business Unit,2016-11-01 21:40:08 +0000,http://www.publicnow.com/view/B4F1490F51663A53D43A88FC86A61CC9BCA47EFD,"[at noodls] - LAVAL, Quebec, Nov. 1, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ..."
VRX,VRX:CT,BBG000DC8S17,Valeant shares spike more than 30% on report it is in talks to sell Salix unit,2016-11-01 21:39:49 +0000,http://www.cnbc.com/id/104002753?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104002753,Valeant shares spike more than 30% on report it is in talks to sell Salix unit
VRX,VRX:US,BBG000DLFM21,Valeant shares spike more than 30% on report it is in talks to sell Salix unit,2016-11-01 21:39:49 +0000,http://www.cnbc.com/id/104002753?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104002753,Valeant shares spike more than 30% on report it is in talks to sell Salix unit
VRX,VRX:CT,BBG000DC8S17,Valeant in talks to sell Salix stomach-drug business -sources,2016-11-01 21:23:11 +0000,http://finance.yahoo.com/news/valeant-talks-sell-salix-stomach-212311494.html,Valeant in talks to sell Salix stomach-drug business -sources
VRX,VRX:US,BBG000DLFM21,Valeant in talks to sell Salix stomach-drug business -sources,2016-11-01 21:23:11 +0000,http://finance.yahoo.com/news/valeant-talks-sell-salix-stomach-212311494.html,Valeant in talks to sell Salix stomach-drug business -sources
VRX,VRX:US,BBG000DLFM21,Valeant Confirms Talks With Third Parties For Various Divestitures,2016-11-01 21:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nqTJ2WDD1pA/valeant-confirms-talks-with-third-parties-for-various-divestitures-20161101-01809,Valeant Confirms Talks With Third Parties For Various Divestitures
VRX,VRX:CT,BBG000DC8S17,Valeant Confirms Talks With Third Parties For Various Divestitures,2016-11-01 21:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nqTJ2WDD1pA/valeant-confirms-talks-with-third-parties-for-various-divestitures-20161101-01809,Valeant Confirms Talks With Third Parties For Various Divestitures
VRX,VRX:US,BBG000DLFM21,Why Valeant Soared on Salix Sale Report,2016-11-01 21:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/01/valeant-pharmaceuticals-soars-on-salix-sale-report/?mod=yahoobarrons&ru=yahoo,Why Valeant Soared on Salix Sale Report
VRX,VRX:CT,BBG000DC8S17,Why Valeant Soared on Salix Sale Report,2016-11-01 21:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/01/valeant-pharmaceuticals-soars-on-salix-sale-report/?mod=yahoobarrons&ru=yahoo,Why Valeant Soared on Salix Sale Report
VRX,VRX:US,BBG000DLFM21,Valeant Shares Soar On Plans To Sell Stomach-Disorder Business,2016-11-01 20:56:33 +0000,http://www.investors.com/news/valeant-shares-soar-on-plans-to-sell-stomach-disorder-business/,Valeant Shares Soar On Plans To Sell Stomach-Disorder Business
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Soar On Plans To Sell Stomach-Disorder Business,2016-11-01 20:56:33 +0000,http://www.investors.com/news/valeant-shares-soar-on-plans-to-sell-stomach-disorder-business/,Valeant Shares Soar On Plans To Sell Stomach-Disorder Business
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl. Inc. Surges 34% on Reports of a Possible Sale of Salix,2016-11-01 20:43:52 +0000,http://www.fool.com/investing/2016/11/01/valeant-pharmaceuticals-intl-inc-surges-34-on-repo.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Intl. Inc. Surges 34% on Reports of a Possible Sale of Salix
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl. Inc. Surges 34% on Reports of a Possible Sale of Salix,2016-11-01 20:43:52 +0000,http://www.fool.com/investing/2016/11/01/valeant-pharmaceuticals-intl-inc-surges-34-on-repo.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Intl. Inc. Surges 34% on Reports of a Possible Sale of Salix
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Gets Some Breathing Room,2016-11-01 20:37:05 +0000,http://www.wsj.com/articles/valeant-gets-some-breathing-room-1478031741?mod=yahoo_hs,[$$] Valeant Gets Some Breathing Room
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Gets Some Breathing Room,2016-11-01 20:37:05 +0000,http://www.wsj.com/articles/valeant-gets-some-breathing-room-1478031741?mod=yahoo_hs,[$$] Valeant Gets Some Breathing Room
VRX,VRX:CT,BBG000DC8S17,Why Prosecutors Are Investigating Valeant,2016-11-01 20:25:45 +0000,http://finance.yahoo.com/video/why-prosecutors-investigating-valeant-202545722.html,Why Prosecutors Are Investigating Valeant
VRX,VRX:US,BBG000DLFM21,Why Prosecutors Are Investigating Valeant,2016-11-01 20:25:45 +0000,http://finance.yahoo.com/video/why-prosecutors-investigating-valeant-202545722.html,Why Prosecutors Are Investigating Valeant
VRX,VRX:CT,BBG000DC8S17,3 Figures in Focus When Valeant Pharmaceuticals Intl. Inc. Reports Its Q3 Results,2016-11-01 20:16:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nSFx--TU3TA/3-figures-in-focus-when-valeant-pharmaceuticals-intl-inc-reports-its-q3-results-cm702001,Image source Getty Images Valeant Pharmaceuticals NYSE VRX has had a miserable year Shares of the embattled drugmaker are down nearly 80 year to date and dating back to last summer its shares have shed more than 90 which translates to more than 80 billion in lost
VRX,VRX:US,BBG000DLFM21,3 Figures in Focus When Valeant Pharmaceuticals Intl. Inc. Reports Its Q3 Results,2016-11-01 20:16:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nSFx--TU3TA/3-figures-in-focus-when-valeant-pharmaceuticals-intl-inc-reports-its-q3-results-cm702001,Image source Getty Images Valeant Pharmaceuticals NYSE VRX has had a miserable year Shares of the embattled drugmaker are down nearly 80 year to date and dating back to last summer its shares have shed more than 90 which translates to more than 80 billion in lost
VRX,VRX:US,BBG000DLFM21,Valeant Skyrockets on Rumored $10B Salix Sale,2016-11-01 20:16:00 +0000,http://realmoney.thestreet.com/articles/11/01/2016/valeant-skyrockets-rumored-10b-salix-sale?puc=yahoo&cm_ven=YAHOO,Valeant Skyrockets on Rumored $10B Salix Sale
VRX,VRX:CT,BBG000DC8S17,Valeant Skyrockets on Rumored $10B Salix Sale,2016-11-01 20:16:00 +0000,http://realmoney.thestreet.com/articles/11/01/2016/valeant-skyrockets-rumored-10b-salix-sale?puc=yahoo&cm_ven=YAHOO,Valeant Skyrockets on Rumored $10B Salix Sale
VRX,VRX:CT,BBG000DC8S17,Valeant in talks to sell Salix stomach business -sources,2016-11-01 20:11:19 +0000,http://finance.yahoo.com/news/valeant-talks-sell-salix-stomach-201119858.html,Valeant in talks to sell Salix stomach business -sources
VRX,VRX:US,BBG000DLFM21,Valeant in talks to sell Salix stomach business -sources,2016-11-01 20:11:19 +0000,http://finance.yahoo.com/news/valeant-talks-sell-salix-stomach-201119858.html,Valeant in talks to sell Salix stomach business -sources
VRX,VRX:CT,BBG000DC8S17,"Valeant says it may sell the family jewels to survive, and stock is soaring",2016-11-01 20:10:33 +0000,http://finance.yahoo.com/news/valeant-says-may-sell-1-201033241.html,"Valeant says it may sell the family jewels to survive, and stock is soaring"
VRX,VRX:US,BBG000DLFM21,"Valeant says it may sell the family jewels to survive, and stock is soaring",2016-11-01 20:10:33 +0000,http://finance.yahoo.com/news/valeant-says-may-sell-1-201033241.html,"Valeant says it may sell the family jewels to survive, and stock is soaring"
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX ends barely lower as banks, industrials weigh",2016-11-01 20:06:04 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-ends-barely-200604283.html,"CANADA STOCKS-TSX ends barely lower as banks, industrials weigh"
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX ends barely lower as banks, industrials weigh",2016-11-01 20:06:04 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-ends-barely-200604283.html,"CANADA STOCKS-TSX ends barely lower as banks, industrials weigh"
VRX,VRX:CT,BBG000DC8S17,Valeant Said to Be in Talks for Sale of Salix to Takeda,2016-11-01 19:43:16 +0000,http://www.bloomberg.com/news/articles/2016-11-01/valeant-surges-on-report-it-s-in-talks-to-sell-salix-business?cmpid=yhoo.headline,Valeant Said to Be in Talks for Sale of Salix to Takeda
VRX,VRX:US,BBG000DLFM21,Valeant Said to Be in Talks for Sale of Salix to Takeda,2016-11-01 19:43:16 +0000,http://www.bloomberg.com/news/articles/2016-11-01/valeant-surges-on-report-it-s-in-talks-to-sell-salix-business?cmpid=yhoo.headline,Valeant Said to Be in Talks for Sale of Salix to Takeda
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Soars on Potential $10 Billion Asset Sale,2016-11-01 19:43:00 +0000,https://www.thestreet.com/story/13876096/1/valeant-vrx-stock-soars-on-potential-10-billion-asset-sale.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Soars on Potential $10 Billion Asset Sale
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Soars on Potential $10 Billion Asset Sale,2016-11-01 19:43:00 +0000,https://www.thestreet.com/story/13876096/1/valeant-vrx-stock-soars-on-potential-10-billion-asset-sale.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Soars on Potential $10 Billion Asset Sale
VRX,VRX:CT,BBG000DC8S17,Scout Daily Update: Will The Election Cause Increased Volatility?,2016-11-01 18:51:39 +0000,http://www.insidermonkey.com/blog/scout-daily-update-will-the-election-cause-increased-volatility-484503/,Scout Daily Update: Will The Election Cause Increased Volatility?
VRX,VRX:US,BBG000DLFM21,Scout Daily Update: Will The Election Cause Increased Volatility?,2016-11-01 18:51:39 +0000,http://www.insidermonkey.com/blog/scout-daily-update-will-the-election-cause-increased-volatility-484503/,Scout Daily Update: Will The Election Cause Increased Volatility?
VRX,VRX:US,BBG000DLFM21,3 Figures in Focus When Valeant Pharmaceuticals Intl. Inc. Reports Its Q3 Results,2016-11-01 18:26:11 +0000,http://www.fool.com/investing/2016/11/01/3-figures-in-focus-when-valeant-pharmaceuticals-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Figures in Focus When Valeant Pharmaceuticals Intl. Inc. Reports Its Q3 Results
VRX,VRX:CT,BBG000DC8S17,3 Figures in Focus When Valeant Pharmaceuticals Intl. Inc. Reports Its Q3 Results,2016-11-01 18:26:11 +0000,http://www.fool.com/investing/2016/11/01/3-figures-in-focus-when-valeant-pharmaceuticals-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Figures in Focus When Valeant Pharmaceuticals Intl. Inc. Reports Its Q3 Results
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) U.S. Attorney Probe Details Are 'Vague,' Wells Fargo's Maris Says",2016-11-01 18:16:00 +0000,https://www.thestreet.com/story/13875881/1/valeant-vrx-u-s-attorney-probe-details-are-vague-wells-fargo-s-maris-says.html?puc=yahoo&cm_ven=YAHOO,"Valeant (VRX) U.S. Attorney Probe Details Are 'Vague,' Wells Fargo's Maris Says"
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) U.S. Attorney Probe Details Are 'Vague,' Wells Fargo's Maris Says",2016-11-01 18:16:00 +0000,https://www.thestreet.com/story/13875881/1/valeant-vrx-u-s-attorney-probe-details-are-vague-wells-fargo-s-maris-says.html?puc=yahoo&cm_ven=YAHOO,"Valeant (VRX) U.S. Attorney Probe Details Are 'Vague,' Wells Fargo's Maris Says"
VRX,VRX:CT,BBG000DC8S17,Earnings Weigh on Health-Care Shares -- Health Care Roundup,2016-11-01 18:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/idTxJwCdn_o/earnings-weigh-on-healthcare-shares--health-care-roundup-20161101-01042,Earnings Weigh on Health-Care Shares -- Health Care Roundup
VRX,VRX:US,BBG000DLFM21,Earnings Weigh on Health-Care Shares -- Health Care Roundup,2016-11-01 18:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/idTxJwCdn_o/earnings-weigh-on-healthcare-shares--health-care-roundup-20161101-01042,Earnings Weigh on Health-Care Shares -- Health Care Roundup
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Is What’s Wrong With America,2016-11-01 17:16:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SwtNmlLfxRQ/valeant-pharmaceuticals-intl-inc-vrx-is-whats-wrong-with-america-cm701887,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Just when you think Valeant Pharmaceuticals Intl Inc NYSE VRX is finally going to work its way out of the scrutinizing spotlight it finds a way to fall back into it Source Wikimedia
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Is What’s Wrong With America,2016-11-01 17:16:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SwtNmlLfxRQ/valeant-pharmaceuticals-intl-inc-vrx-is-whats-wrong-with-america-cm701887,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Just when you think Valeant Pharmaceuticals Intl Inc NYSE VRX is finally going to work its way out of the scrutinizing spotlight it finds a way to fall back into it Source Wikimedia
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: It's Not Just the Investigation,2016-11-01 16:55:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/01/valeant-pharmaceuticals-its-not-just-the-investigation/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: It's Not Just the Investigation
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: It's Not Just the Investigation,2016-11-01 16:55:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/01/valeant-pharmaceuticals-its-not-just-the-investigation/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: It's Not Just the Investigation
VRX,VRX:US,BBG000DLFM21,Bay Street Anxious Over U.S. Election -- Canadian Commentary,2016-11-01 16:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Vyt2MnmQ4w/bay-street-anxious-over-us-election--canadian-commentary-20161101-00914,Bay Street Anxious Over U.S. Election -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bay Street Anxious Over U.S. Election -- Canadian Commentary,2016-11-01 16:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Vyt2MnmQ4w/bay-street-anxious-over-us-election--canadian-commentary-20161101-00914,Bay Street Anxious Over U.S. Election -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canada Stocks Slip as Valeant Surge Offsets Broad Declines,2016-11-01 14:37:51 +0000,http://www.bloomberg.com/news/articles/2016-11-01/canada-stocks-rise-for-second-day-amid-lift-in-commodity-prices?cmpid=yhoo.headline,Canada Stocks Slip as Valeant Surge Offsets Broad Declines
VRX,VRX:CT,BBG000DC8S17,Canada Stocks Slip as Valeant Surge Offsets Broad Declines,2016-11-01 14:37:51 +0000,http://www.bloomberg.com/news/articles/2016-11-01/canada-stocks-rise-for-second-day-amid-lift-in-commodity-prices?cmpid=yhoo.headline,Canada Stocks Slip as Valeant Surge Offsets Broad Declines
VRX,VRX:US,BBG000DLFM21,"Five Stocks Traders Are Watching Today: Brocade Communications, Valeant, BlackBerry, and More",2016-11-01 14:16:56 +0000,http://www.insidermonkey.com/blog/five-stocks-traders-are-watching-today-brocade-communications-valeant-blackberry-and-more-484357/,"Five Stocks Traders Are Watching Today: Brocade Communications, Valeant, BlackBerry, and More"
VRX,VRX:CT,BBG000DC8S17,"Five Stocks Traders Are Watching Today: Brocade Communications, Valeant, BlackBerry, and More",2016-11-01 14:16:56 +0000,http://www.insidermonkey.com/blog/five-stocks-traders-are-watching-today-brocade-communications-valeant-blackberry-and-more-484357/,"Five Stocks Traders Are Watching Today: Brocade Communications, Valeant, BlackBerry, and More"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl. Inc. Tumbled 12% on Monday Following Reports of a Criminal Probe,2016-11-01 14:16:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OCDd7EfPIDE/valeant-pharmaceuticals-intl-inc-tumbled-12-on-monday-following-reports-of-a-criminal-probe-cm701579,Image source Getty Images What happened Shares of embattled drugmaker Valeant Pharmaceuticals NYSE VRX tumbled 12 3 on Monday screaming to a fresh 52 week low after reports hit the newswires of a possible criminal probe facing the now former CEO and CFO of the
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl. Inc. Tumbled 12% on Monday Following Reports of a Criminal Probe,2016-11-01 14:16:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OCDd7EfPIDE/valeant-pharmaceuticals-intl-inc-tumbled-12-on-monday-following-reports-of-a-criminal-probe-cm701579,Image source Getty Images What happened Shares of embattled drugmaker Valeant Pharmaceuticals NYSE VRX tumbled 12 3 on Monday screaming to a fresh 52 week low after reports hit the newswires of a possible criminal probe facing the now former CEO and CFO of the
VRX,VRX:US,BBG000DLFM21,Don't Sell Valeant Based on U.S. Attorney Probe: More Squawk From Jim Cramer,2016-11-01 14:12:00 +0000,https://www.thestreet.com/story/13875194/1/don-t-sell-valeant-based-on-u-s-attorney-probe-more-squawk-from-jim-cramer.html?puc=yahoo&cm_ven=YAHOO,Don't Sell Valeant Based on U.S. Attorney Probe: More Squawk From Jim Cramer
VRX,VRX:CT,BBG000DC8S17,Don't Sell Valeant Based on U.S. Attorney Probe: More Squawk From Jim Cramer,2016-11-01 14:12:00 +0000,https://www.thestreet.com/story/13875194/1/don-t-sell-valeant-based-on-u-s-attorney-probe-more-squawk-from-jim-cramer.html?puc=yahoo&cm_ven=YAHOO,Don't Sell Valeant Based on U.S. Attorney Probe: More Squawk From Jim Cramer
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: 3 Reasons Fraud Investigation is Bad News,2016-11-01 13:52:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/01/valeant-pharmaceuticals-3-reasons-fraud-investigation-is-bad-news/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: 3 Reasons Fraud Investigation is Bad News
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: 3 Reasons Fraud Investigation is Bad News,2016-11-01 13:52:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/01/valeant-pharmaceuticals-3-reasons-fraud-investigation-is-bad-news/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: 3 Reasons Fraud Investigation is Bad News
VRX,VRX:CT,BBG000DC8S17,Valeant Walks a Thin Green Line,2016-11-01 13:37:40 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-01/michael-pearson-howard-schillar-probe-valeant-walks-thin-line?cmpid=yhoo.headline,Valeant Walks a Thin Green Line
VRX,VRX:US,BBG000DLFM21,Valeant Walks a Thin Green Line,2016-11-01 13:37:40 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-01/michael-pearson-howard-schillar-probe-valeant-walks-thin-line?cmpid=yhoo.headline,Valeant Walks a Thin Green Line
VRX,VRX:CT,BBG000DC8S17,Big Data and Expected Returns,2016-11-01 13:22:28 +0000,http://www.bloomberg.com/view/articles/2016-11-01/big-data-and-expected-returns?cmpid=yhoo.headline,Big Data and Expected Returns
VRX,VRX:US,BBG000DLFM21,Big Data and Expected Returns,2016-11-01 13:22:28 +0000,http://www.bloomberg.com/view/articles/2016-11-01/big-data-and-expected-returns?cmpid=yhoo.headline,Big Data and Expected Returns
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl. Inc. Tumbled 12% on Monday Following Reports of a Criminal Probe,2016-11-01 12:30:08 +0000,http://www.fool.com/investing/2016/11/01/valeant-pharmaceuticals-intl-inc-tumbled-12-on-mon.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Intl. Inc. Tumbled 12% on Monday Following Reports of a Criminal Probe
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl. Inc. Tumbled 12% on Monday Following Reports of a Criminal Probe,2016-11-01 12:30:08 +0000,http://www.fool.com/investing/2016/11/01/valeant-pharmaceuticals-intl-inc-tumbled-12-on-mon.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Valeant Pharmaceuticals Intl. Inc. Tumbled 12% on Monday Following Reports of a Criminal Probe
VRX,VRX:US,BBG000DLFM21,Valeant Investors Are Voting With Their Feet; Don't Fight the Trend,2016-11-01 12:13:00 +0000,http://realmoney.thestreet.com/articles/11/01/2016/valeant-investors-are-voting-their-feet-dont-fight-trend?puc=yahoo&cm_ven=YAHOO,Valeant Investors Are Voting With Their Feet; Don't Fight the Trend
VRX,VRX:CT,BBG000DC8S17,Valeant Investors Are Voting With Their Feet; Don't Fight the Trend,2016-11-01 12:13:00 +0000,http://realmoney.thestreet.com/articles/11/01/2016/valeant-investors-are-voting-their-feet-dont-fight-trend?puc=yahoo&cm_ven=YAHOO,Valeant Investors Are Voting With Their Feet; Don't Fight the Trend
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains -- Canadian Commentary,2016-11-01 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MomYOVPyas/canadian-stocks-are-paring-early-gains--canadian-commentary-20161101-01136,Canadian Stocks Are Paring Early Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains -- Canadian Commentary,2016-11-01 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MomYOVPyas/canadian-stocks-are-paring-early-gains--canadian-commentary-20161101-01136,Canadian Stocks Are Paring Early Gains -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Bay Street Eyes U.S. Election With Trepidation -- Canadian Commentary,2016-11-01 08:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gD26q2mhwGY/bay-street-eyes-us-election-with-trepidation--canadian-commentary-20161101-00072,Bay Street Eyes U.S. Election With Trepidation -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Bay Street Eyes U.S. Election With Trepidation -- Canadian Commentary,2016-11-01 08:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gD26q2mhwGY/bay-street-eyes-us-election-with-trepidation--canadian-commentary-20161101-00072,Bay Street Eyes U.S. Election With Trepidation -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Federal Probe Is No Halloween Treat for Valeant,2016-10-31 22:48:00 +0000,https://www.thestreet.com/story/13874249/1/federal-probe-is-no-halloween-treat-for-valeant.html?puc=yahoo&cm_ven=YAHOO,Federal Probe Is No Halloween Treat for Valeant
VRX,VRX:US,BBG000DLFM21,Federal Probe Is No Halloween Treat for Valeant,2016-10-31 22:48:00 +0000,https://www.thestreet.com/story/13874249/1/federal-probe-is-no-halloween-treat-for-valeant.html?puc=yahoo&cm_ven=YAHOO,Federal Probe Is No Halloween Treat for Valeant
VRX,VRX:CT,BBG000DC8S17,The criminal probe into Valeant's former CEO raises 2 big questions,2016-10-31 22:00:49 +0000,http://finance.yahoo.com/news/criminal-probe-valeants-former-ceo-220049463.html,The criminal probe into Valeant's former CEO raises 2 big questions
VRX,VRX:US,BBG000DLFM21,The criminal probe into Valeant's former CEO raises 2 big questions,2016-10-31 22:00:49 +0000,http://finance.yahoo.com/news/criminal-probe-valeants-former-ceo-220049463.html,The criminal probe into Valeant's former CEO raises 2 big questions
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX near flat as energy shares fall, gold miners gain",2016-10-31 21:24:13 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-near-flat-212413991.html,"CANADA STOCKS-TSX near flat as energy shares fall, gold miners gain"
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX near flat as energy shares fall, gold miners gain",2016-10-31 21:24:13 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-near-flat-212413991.html,"CANADA STOCKS-TSX near flat as energy shares fall, gold miners gain"
VRX,VRX:US,BBG000DLFM21,Valeant issues statement on report about potential criminal charges,2016-10-31 21:14:13 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=BC14AFA3-A2BA-49D2-A069-0912D6E201DC&siteid=yhoof2,Valeant issues statement on report about potential criminal charges
VRX,VRX:CT,BBG000DC8S17,Valeant issues statement on report about potential criminal charges,2016-10-31 21:14:13 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=BC14AFA3-A2BA-49D2-A069-0912D6E201DC&siteid=yhoof2,Valeant issues statement on report about potential criminal charges
VRX,VRX:US,BBG000DLFM21,"Berkshire Talks Apple, Bill Miller Thinks Valeant Could Double, Plus Hedge Fund Commentary on 3 Other Stocks",2016-10-31 21:10:57 +0000,http://www.insidermonkey.com/blog/berkshire-portfolio-managegetalks-apple-bill-miller-thinks-valeant-could-double-plus-hedge-fund-commentary-on-3-other-stocks-484088/,"Berkshire Talks Apple, Bill Miller Thinks Valeant Could Double, Plus Hedge Fund Commentary on 3 Other Stocks"
VRX,VRX:CT,BBG000DC8S17,"Berkshire Talks Apple, Bill Miller Thinks Valeant Could Double, Plus Hedge Fund Commentary on 3 Other Stocks",2016-10-31 21:10:57 +0000,http://www.insidermonkey.com/blog/berkshire-portfolio-managegetalks-apple-bill-miller-thinks-valeant-could-double-plus-hedge-fund-commentary-on-3-other-stocks-484088/,"Berkshire Talks Apple, Bill Miller Thinks Valeant Could Double, Plus Hedge Fund Commentary on 3 Other Stocks"
VRX,VRX:US,BBG000DLFM21,Valeant Falls On Report Of Possible Criminal Charges,2016-10-31 21:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H1CXNiGYxnc/valeant-falls-on-report-of-possible-criminal-charges-20161031-01420,Valeant Falls On Report Of Possible Criminal Charges
VRX,VRX:CT,BBG000DC8S17,Valeant Falls On Report Of Possible Criminal Charges,2016-10-31 21:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H1CXNiGYxnc/valeant-falls-on-report-of-possible-criminal-charges-20161031-01420,Valeant Falls On Report Of Possible Criminal Charges
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Comments On Press Report,2016-10-31 20:53:11 +0000,http://www.publicnow.com/view/7624F2727F53773DA4D05F817B47123086BE4440,"[at noodls] - LAVAL, Quebec, Oct. 31, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Comments On Press Report,2016-10-31 20:53:11 +0000,http://www.publicnow.com/view/7624F2727F53773DA4D05F817B47123086BE4440,"[at noodls] - LAVAL, Quebec, Oct. 31, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ..."
VRX,VRX:US,BBG000DLFM21,Valeant's Frightful Halloween,2016-10-31 20:48:00 +0000,http://realmoney.thestreet.com/articles/10/31/2016/valeants-frightful-halloween?puc=yahoo&cm_ven=YAHOO,Valeant's Frightful Halloween
VRX,VRX:CT,BBG000DC8S17,Valeant's Frightful Halloween,2016-10-31 20:48:00 +0000,http://realmoney.thestreet.com/articles/10/31/2016/valeants-frightful-halloween?puc=yahoo&cm_ven=YAHOO,Valeant's Frightful Halloween
VRX,VRX:US,BBG000DLFM21,Valeant shares drop on report of criminal probe of ex-CEO and CFO,2016-10-31 20:28:12 +0000,http://www.cnbc.com/id/103964557?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103964557,Valeant shares drop on report of criminal probe of ex-CEO and CFO
VRX,VRX:CT,BBG000DC8S17,Valeant shares drop on report of criminal probe of ex-CEO and CFO,2016-10-31 20:28:12 +0000,http://www.cnbc.com/id/103964557?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103964557,Valeant shares drop on report of criminal probe of ex-CEO and CFO
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals (VRX) Stock Lower on DOJ Probe,2016-10-31 20:14:00 +0000,https://www.thestreet.com/story/13874050/1/valeant-pharmaceuticals-vrx-stock-lower-on-doj-probe.html?puc=yahoo&cm_ven=YAHOO,Valeant Pharmaceuticals (VRX) Stock Lower on DOJ Probe
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals (VRX) Stock Lower on DOJ Probe,2016-10-31 20:14:00 +0000,https://www.thestreet.com/story/13874050/1/valeant-pharmaceuticals-vrx-stock-lower-on-doj-probe.html?puc=yahoo&cm_ven=YAHOO,Valeant Pharmaceuticals (VRX) Stock Lower on DOJ Probe
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX ends barely higher as energy stocks, Valeant weigh",2016-10-31 20:12:01 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-ends-barely-201201633.html,"CANADA STOCKS-TSX ends barely higher as energy stocks, Valeant weigh"
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX ends barely higher as energy stocks, Valeant weigh",2016-10-31 20:12:01 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-ends-barely-201201633.html,"CANADA STOCKS-TSX ends barely higher as energy stocks, Valeant weigh"
VRX,VRX:US,BBG000DLFM21,DOJ Probes Valeant for Accounting Fraud,2016-10-31 20:04:59 +0000,http://finance.yahoo.com/video/doj-probes-valeant-accounting-fraud-200459135.html,DOJ Probes Valeant for Accounting Fraud
VRX,VRX:CT,BBG000DC8S17,DOJ Probes Valeant for Accounting Fraud,2016-10-31 20:04:59 +0000,http://finance.yahoo.com/video/doj-probes-valeant-accounting-fraud-200459135.html,DOJ Probes Valeant for Accounting Fraud
VRX,VRX:US,BBG000DLFM21,"Valeant ex-CEO, ex-CFO focus of U.S. criminal probe: Bloomberg",2016-10-31 20:02:34 +0000,http://finance.yahoo.com/news/valeant-ex-ceo-ex-cfo-194257115.html,"Valeant ex-CEO, ex-CFO focus of U.S. criminal probe: Bloomberg"
VRX,VRX:CT,BBG000DC8S17,"Valeant ex-CEO, ex-CFO focus of U.S. criminal probe: Bloomberg",2016-10-31 20:02:34 +0000,http://finance.yahoo.com/news/valeant-ex-ceo-ex-cfo-194257115.html,"Valeant ex-CEO, ex-CFO focus of U.S. criminal probe: Bloomberg"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Hits 52-Week Low on Reports of Investigation of Former CEO,2016-10-31 19:58:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/31/valeant-pharmaceuticals-hits-52-week-low-on-reports-of-investigation-of-former-ceo/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals Hits 52-Week Low on Reports of Investigation of Former CEO
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Hits 52-Week Low on Reports of Investigation of Former CEO,2016-10-31 19:58:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/31/valeant-pharmaceuticals-hits-52-week-low-on-reports-of-investigation-of-former-ceo/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals Hits 52-Week Low on Reports of Investigation of Former CEO
VRX,VRX:US,BBG000DLFM21,"Valeant shares drop after ex-CEO, CFO said to be part of criminal probe",2016-10-31 19:39:34 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1BF45A0F-D03A-4AFB-8B84-7A7AF1EEFF61&siteid=yhoof2,"Valeant shares drop after ex-CEO, CFO said to be part of criminal probe"
VRX,VRX:CT,BBG000DC8S17,"Valeant shares drop after ex-CEO, CFO said to be part of criminal probe",2016-10-31 19:39:34 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1BF45A0F-D03A-4AFB-8B84-7A7AF1EEFF61&siteid=yhoof2,"Valeant shares drop after ex-CEO, CFO said to be part of criminal probe"
VRX,VRX:CT,BBG000DC8S17,Valeant crashes on report the Feds are launching an investigation into its former CEO,2016-10-31 19:28:01 +0000,http://finance.yahoo.com/news/feds-launched-criminal-probe-former-192801048.html,Valeant crashes on report the Feds are launching an investigation into its former CEO
VRX,VRX:US,BBG000DLFM21,Valeant crashes on report the Feds are launching an investigation into its former CEO,2016-10-31 19:28:01 +0000,http://finance.yahoo.com/news/feds-launched-criminal-probe-former-192801048.html,Valeant crashes on report the Feds are launching an investigation into its former CEO
VRX,VRX:US,BBG000DLFM21,"Valeant Ex-CEO, Ex-CFO Are Focus of U.S. Criminal Probe",2016-10-31 19:24:34 +0000,http://finance.yahoo.com/news/valeant-ex-ceo-ex-cfo-192434497.html,"Valeant Ex-CEO, Ex-CFO Are Focus of U.S. Criminal Probe"
VRX,VRX:CT,BBG000DC8S17,"Valeant Ex-CEO, Ex-CFO Are Focus of U.S. Criminal Probe",2016-10-31 19:24:34 +0000,http://finance.yahoo.com/news/valeant-ex-ceo-ex-cfo-192434497.html,"Valeant Ex-CEO, Ex-CFO Are Focus of U.S. Criminal Probe"
VRX,VRX:US,BBG000DLFM21,"Valeant Ex-CEO, Ex-CFO Are a Focus of U.S. Criminal Probe",2016-10-31 19:24:34 +0000,http://www.bloomberg.com/news/articles/2016-10-31/valeant-ex-ceo-ex-cfo-said-to-be-a-focus-of-u-s-criminal-probe?cmpid=yhoo.headline,"Valeant Ex-CEO, Ex-CFO Are a Focus of U.S. Criminal Probe"
VRX,VRX:CT,BBG000DC8S17,"Valeant Ex-CEO, Ex-CFO Are a Focus of U.S. Criminal Probe",2016-10-31 19:24:34 +0000,http://www.bloomberg.com/news/articles/2016-10-31/valeant-ex-ceo-ex-cfo-said-to-be-a-focus-of-u-s-criminal-probe?cmpid=yhoo.headline,"Valeant Ex-CEO, Ex-CFO Are a Focus of U.S. Criminal Probe"
VRX,VRX:CT,BBG000DC8S17,Andrew Left Case Is Bad Sign for Hong Kong,2016-10-31 12:00:00 +0000,http://realmoney.thestreet.com/articles/10/31/2016/andrew-left-case-bad-sign-hong-kong?puc=yahoo&cm_ven=YAHOO,Andrew Left Case Is Bad Sign for Hong Kong
VRX,VRX:US,BBG000DLFM21,Andrew Left Case Is Bad Sign for Hong Kong,2016-10-31 12:00:00 +0000,http://realmoney.thestreet.com/articles/10/31/2016/andrew-left-case-bad-sign-hong-kong?puc=yahoo&cm_ven=YAHOO,Andrew Left Case Is Bad Sign for Hong Kong
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling On Energy Weakness -- Canadian Commentary,2016-10-31 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bj5liEidRDE/canadian-stocks-are-falling-on-energy-weakness--canadian-commentary-20161031-00867,Canadian Stocks Are Falling On Energy Weakness -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling On Energy Weakness -- Canadian Commentary,2016-10-31 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bj5liEidRDE/canadian-stocks-are-falling-on-energy-weakness--canadian-commentary-20161031-00867,Canadian Stocks Are Falling On Energy Weakness -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Make Valeant Pharmaceuticals Intl Inc (VRX) Stock Pay YOU,2016-10-28 20:34:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3W2XeqIiy1k/make-valeant-pharmaceuticals-intl-inc-vrx-stock-pay-you-cm700527,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has been nothing short of a casino trade for most traders Luckily we ve used the options markets to sell risk and that
VRX,VRX:US,BBG000DLFM21,Make Valeant Pharmaceuticals Intl Inc (VRX) Stock Pay YOU,2016-10-28 20:34:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3W2XeqIiy1k/make-valeant-pharmaceuticals-intl-inc-vrx-stock-pay-you-cm700527,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has been nothing short of a casino trade for most traders Luckily we ve used the options markets to sell risk and that
VRX,VRX:US,BBG000DLFM21,Stressed Out: Valeant Shareholders Flee on McKesson Warning,2016-10-28 19:04:00 +0000,http://realmoney.thestreet.com/articles/10/28/2016/stressed-out-valeant-shareholders-flee-mckesson-warning?puc=yahoo&cm_ven=YAHOO,Stressed Out: Valeant Shareholders Flee on McKesson Warning
VRX,VRX:CT,BBG000DC8S17,Stressed Out: Valeant Shareholders Flee on McKesson Warning,2016-10-28 19:04:00 +0000,http://realmoney.thestreet.com/articles/10/28/2016/stressed-out-valeant-shareholders-flee-mckesson-warning?puc=yahoo&cm_ven=YAHOO,Stressed Out: Valeant Shareholders Flee on McKesson Warning
VRX,VRX:CT,BBG000DC8S17,Cramer: Here's the Secret to Driving Stocks Higher in This Market,2016-10-27 23:01:00 +0000,http://realmoney.thestreet.com/articles/10/27/2016/cramer-heres-secret-driving-stocks-higher-market?puc=yahoo&cm_ven=YAHOO,Cramer: Here's the Secret to Driving Stocks Higher in This Market
VRX,VRX:US,BBG000DLFM21,Cramer: Here's the Secret to Driving Stocks Higher in This Market,2016-10-27 23:01:00 +0000,http://realmoney.thestreet.com/articles/10/27/2016/cramer-heres-secret-driving-stocks-higher-market?puc=yahoo&cm_ven=YAHOO,Cramer: Here's the Secret to Driving Stocks Higher in This Market
VRX,VRX:US,BBG000DLFM21,The woman behind 'female Viagra' sold her company for $1 billion — that's when everything fell apart,2016-10-27 15:45:00 +0000,http://finance.yahoo.com/news/woman-behind-female-viagra-sold-154500022.html,The woman behind 'female Viagra' sold her company for $1 billion — that's when everything fell apart
VRX,VRX:CT,BBG000DC8S17,The woman behind 'female Viagra' sold her company for $1 billion — that's when everything fell apart,2016-10-27 15:45:00 +0000,http://finance.yahoo.com/news/woman-behind-female-viagra-sold-154500022.html,The woman behind 'female Viagra' sold her company for $1 billion — that's when everything fell apart
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals Now a Drug-Pricing Role Model?,2016-10-27 14:44:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1eIFRgAHDRc/is-valeant-pharmaceuticals-now-a-drug-pricing-role-model-cm699257,Predatory pricing That s what Valeant Pharmaceuticals NYSE VRX has been accused of and not just by anybody Those words were leveled at the drugmaker by Hillary Clinton who could very well become the next leader of the free world But is it possible that Valeant could now
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals Now a Drug-Pricing Role Model?,2016-10-27 14:44:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1eIFRgAHDRc/is-valeant-pharmaceuticals-now-a-drug-pricing-role-model-cm699257,Predatory pricing That s what Valeant Pharmaceuticals NYSE VRX has been accused of and not just by anybody Those words were leveled at the drugmaker by Hillary Clinton who could very well become the next leader of the free world But is it possible that Valeant could now
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals Now a Drug-Pricing Role Model?,2016-10-27 13:30:34 +0000,http://www.fool.com/investing/2016/10/27/is-valeant-pharmaceuticals-now-a-drug-pricing-role.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals Now a Drug-Pricing Role Model?
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals Now a Drug-Pricing Role Model?,2016-10-27 13:30:34 +0000,http://www.fool.com/investing/2016/10/27/is-valeant-pharmaceuticals-now-a-drug-pricing-role.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals Now a Drug-Pricing Role Model?
VRX,VRX:CT,BBG000DC8S17,Biotech Stocks Facing FDA Decision In November,2016-10-27 11:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yP8sYx6pvkQ/biotech-stocks-facing-fda-decision-in-november-20161027-01106,Biotech Stocks Facing FDA Decision In November
VRX,VRX:US,BBG000DLFM21,Biotech Stocks Facing FDA Decision In November,2016-10-27 11:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yP8sYx6pvkQ/biotech-stocks-facing-fda-decision-in-november-20161027-01106,Biotech Stocks Facing FDA Decision In November
VRX,VRX:CT,BBG000DC8S17,Pharming Reports on Financial Results for the First Nine Months of 2016,2016-10-27 06:04:00 +0000,http://finance.yahoo.com/news/pharming-reports-financial-results-first-060400538.html,"[PR Newswire] - LEIDEN, The Netherlands, October 27, 2016 /PRNewswire/ -- Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) presents its (unaudited) financial report for ..."
VRX,VRX:US,BBG000DLFM21,Pharming Reports on Financial Results for the First Nine Months of 2016,2016-10-27 06:04:00 +0000,http://finance.yahoo.com/news/pharming-reports-financial-results-first-060400538.html,"[PR Newswire] - LEIDEN, The Netherlands, October 27, 2016 /PRNewswire/ -- Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) presents its (unaudited) financial report for ..."
VRX,VRX:CT,BBG000DC8S17,Bill Miller Says Valeant Pharmaceuticals Could Double in 3 Years,2016-10-26 22:04:05 +0000,http://marketrealist.com/2016/10/bill-miller-long-valeant-pharma-stock-double-next-3-years/?utm_source=yahoo&utm_medium=feed,Bill Miller Says Valeant Pharmaceuticals Could Double in 3 Years
VRX,VRX:US,BBG000DLFM21,Bill Miller Says Valeant Pharmaceuticals Could Double in 3 Years,2016-10-26 22:04:05 +0000,http://marketrealist.com/2016/10/bill-miller-long-valeant-pharma-stock-double-next-3-years/?utm_source=yahoo&utm_medium=feed,Bill Miller Says Valeant Pharmaceuticals Could Double in 3 Years
VRX,VRX:CT,BBG000DC8S17,Bill Miller: Valeant Can Double in 3 Years,2016-10-26 20:58:11 +0000,http://finance.yahoo.com/news/bill-miller-valeant-double-3-205811849.html,Bill Miller: Valeant Can Double in 3 Years
VRX,VRX:US,BBG000DLFM21,Bill Miller: Valeant Can Double in 3 Years,2016-10-26 20:58:11 +0000,http://finance.yahoo.com/news/bill-miller-valeant-double-3-205811849.html,Bill Miller: Valeant Can Double in 3 Years
VRX,VRX:CT,BBG000DC8S17,Is This MannKind's Last Remaining Option?,2016-10-26 15:15:18 +0000,http://www.fool.com/investing/2016/10/25/is-this-mannkinds-last-remaining-option.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is This MannKind's Last Remaining Option?
VRX,VRX:US,BBG000DLFM21,Is This MannKind's Last Remaining Option?,2016-10-26 15:15:18 +0000,http://www.fool.com/investing/2016/10/25/is-this-mannkinds-last-remaining-option.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is This MannKind's Last Remaining Option?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down As Crude Oil Prices Fall -- Canadian Commentary,2016-10-26 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5j0y5h1F_cU/canadian-stocks-are-down-as-crude-oil-prices-fall--canadian-commentary-20161026-01196,Canadian Stocks Are Down As Crude Oil Prices Fall -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down As Crude Oil Prices Fall -- Canadian Commentary,2016-10-26 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5j0y5h1F_cU/canadian-stocks-are-down-as-crude-oil-prices-fall--canadian-commentary-20161026-01196,Canadian Stocks Are Down As Crude Oil Prices Fall -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Is This MannKind's Last Remaining Option?,2016-10-25 22:24:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6ii1_xvIW4/is-this-mannkinds-last-remaining-option-cm698249,Image source Getty Images MannKind Corp NASDAQ MNKD 160 is in deep trouble Earlier this year the French biopharma Sanofi NYSE SNY returned the commercial rights for MannKind s only product inhaled insulin Afrezza due to an extremely disappointing launch that
VRX,VRX:US,BBG000DLFM21,Is This MannKind's Last Remaining Option?,2016-10-25 22:24:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6ii1_xvIW4/is-this-mannkinds-last-remaining-option-cm698249,Image source Getty Images MannKind Corp NASDAQ MNKD 160 is in deep trouble Earlier this year the French biopharma Sanofi NYSE SNY returned the commercial rights for MannKind s only product inhaled insulin Afrezza due to an extremely disappointing launch that
VRX,VRX:US,BBG000DLFM21,"A Month Later, the For Sale Sign Still Sits in iNova's Front Yard, Much to Valeant's Dismay",2016-10-25 20:25:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7oDisNgIpDc/a-month-later-the-for-sale-sign-still-sits-in-inovas-front-yard-much-to-valeants-dismay-cm698148,Image source Getty Images Don t look now but embattled drug company Valeant Pharmaceuticals NYSE VRX has been melting lower once again after experiencing quite the summer rally following its second quarter report Despite sticking by its full year earnings forecast
VRX,VRX:CT,BBG000DC8S17,"A Month Later, the For Sale Sign Still Sits in iNova's Front Yard, Much to Valeant's Dismay",2016-10-25 20:25:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7oDisNgIpDc/a-month-later-the-for-sale-sign-still-sits-in-inovas-front-yard-much-to-valeants-dismay-cm698148,Image source Getty Images Don t look now but embattled drug company Valeant Pharmaceuticals NYSE VRX has been melting lower once again after experiencing quite the summer rally following its second quarter report Despite sticking by its full year earnings forecast
VRX,VRX:CT,BBG000DC8S17,"Citron's Andrew Left Likes Amazon, Says He's Long",2016-10-25 19:40:00 +0000,http://finance.yahoo.com/news/citrons-andrew-left-likes-amazon-194000557.html,"Citron's Andrew Left Likes Amazon, Says He's Long"
VRX,VRX:US,BBG000DLFM21,"Citron's Andrew Left Likes Amazon, Says He's Long",2016-10-25 19:40:00 +0000,http://finance.yahoo.com/news/citrons-andrew-left-likes-amazon-194000557.html,"Citron's Andrew Left Likes Amazon, Says He's Long"
VRX,VRX:CT,BBG000DC8S17,"A Month Later, the For Sale Sign Still Sits in iNova's Front Yard, Much to Valeant's Dismay",2016-10-25 19:11:07 +0000,http://www.fool.com/investing/2016/10/25/a-month-later-the-for-sale-sign-still-sits-in-inov.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"A Month Later, the For Sale Sign Still Sits in iNova's Front Yard, Much to Valeant's Dismay"
VRX,VRX:US,BBG000DLFM21,"A Month Later, the For Sale Sign Still Sits in iNova's Front Yard, Much to Valeant's Dismay",2016-10-25 19:11:07 +0000,http://www.fool.com/investing/2016/10/25/a-month-later-the-for-sale-sign-still-sits-in-inov.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"A Month Later, the For Sale Sign Still Sits in iNova's Front Yard, Much to Valeant's Dismay"
VRX,VRX:US,BBG000DLFM21,"Here’s Why Tesla Motors Inc (TSLA), Netflix, Inc. (NFLX), and Three Other Stocks Are in Spotlight",2016-10-25 13:18:13 +0000,http://www.insidermonkey.com/blog/heres-why-tesla-motors-inc-tsla-netflix-inc-nflx-and-three-other-stocks-are-in-spotlight-483005/,"Here’s Why Tesla Motors Inc (TSLA), Netflix, Inc. (NFLX), and Three Other Stocks Are in Spotlight"
VRX,VRX:CT,BBG000DC8S17,"Here’s Why Tesla Motors Inc (TSLA), Netflix, Inc. (NFLX), and Three Other Stocks Are in Spotlight",2016-10-25 13:18:13 +0000,http://www.insidermonkey.com/blog/heres-why-tesla-motors-inc-tsla-netflix-inc-nflx-and-three-other-stocks-are-in-spotlight-483005/,"Here’s Why Tesla Motors Inc (TSLA), Netflix, Inc. (NFLX), and Three Other Stocks Are in Spotlight"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Bill Miller Isn't Following JPMorgan's Advice,2016-10-24 19:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/24/valeant-pharmaceuticals-bill-miller-isnt-following-jpmorgans-advice/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Bill Miller Isn't Following JPMorgan's Advice
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Bill Miller Isn't Following JPMorgan's Advice,2016-10-24 19:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/24/valeant-pharmaceuticals-bill-miller-isnt-following-jpmorgans-advice/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Bill Miller Isn't Following JPMorgan's Advice
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Stock Down, JPMorgan: Avoid Before Q3 Results",2016-10-24 18:16:00 +0000,https://www.thestreet.com/story/13864380/1/valeant-vrx-stock-down-jpmorgan-avoid-before-q3-results.html?puc=yahoo&cm_ven=YAHOO,"Valeant (VRX) Stock Down, JPMorgan: Avoid Before Q3 Results"
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Stock Down, JPMorgan: Avoid Before Q3 Results",2016-10-24 18:16:00 +0000,https://www.thestreet.com/story/13864380/1/valeant-vrx-stock-down-jpmorgan-avoid-before-q3-results.html?puc=yahoo&cm_ven=YAHOO,"Valeant (VRX) Stock Down, JPMorgan: Avoid Before Q3 Results"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals (VRX) Stock Could Double in Three Years, LMM CIO Bill Miller Says",2016-10-24 17:52:00 +0000,https://www.thestreet.com/story/13864346/1/valeant-pharmaceuticals-vrx-stock-could-double-in-three-years-lmm-cio-bill-miller-says.html?puc=yahoo&cm_ven=YAHOO,"Valeant Pharmaceuticals (VRX) Stock Could Double in Three Years, LMM CIO Bill Miller Says"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals (VRX) Stock Could Double in Three Years, LMM CIO Bill Miller Says",2016-10-24 17:52:00 +0000,https://www.thestreet.com/story/13864346/1/valeant-pharmaceuticals-vrx-stock-could-double-in-three-years-lmm-cio-bill-miller-says.html?puc=yahoo&cm_ven=YAHOO,"Valeant Pharmaceuticals (VRX) Stock Could Double in Three Years, LMM CIO Bill Miller Says"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says",2016-10-24 17:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/24/valeant-pharmaceuticals-stay-far-away-jpmorgan-says/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says",2016-10-24 17:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/24/valeant-pharmaceuticals-stay-far-away-jpmorgan-says/?mod=yahoobarrons&ru=yahoo,"Valeant Pharmaceuticals: Stay Far Away, JPMorgan Says"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down As Commodities Struggle -- Canadian Commentary,2016-10-24 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6nQM_FUxnos/canadian-stocks-are-down-as-commodities-struggle--canadian-commentary-20161024-01099,Canadian Stocks Are Down As Commodities Struggle -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down As Commodities Struggle -- Canadian Commentary,2016-10-24 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6nQM_FUxnos/canadian-stocks-are-down-as-commodities-struggle--canadian-commentary-20161024-01099,Canadian Stocks Are Down As Commodities Struggle -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry,2016-10-21 12:00:22 +0000,http://www.investors.com/etfs-and-funds/etfs/the-best-and-worst-biotech-etfs-of-2016-tell-a-tale-about-this-industry/,Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry
VRX,VRX:US,BBG000DLFM21,Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry,2016-10-21 12:00:22 +0000,http://www.investors.com/etfs-and-funds/etfs/the-best-and-worst-biotech-etfs-of-2016-tell-a-tale-about-this-industry/,Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry
VRX,VRX:US,BBG000DLFM21,Headline Risk Is Still Poison for These Stocks,2016-10-20 20:51:58 +0000,http://finance.yahoo.com/news/headline-risk-still-poison-stocks-205158556.html,Headline Risk Is Still Poison for These Stocks
VRX,VRX:CT,BBG000DC8S17,Headline Risk Is Still Poison for These Stocks,2016-10-20 20:51:58 +0000,http://finance.yahoo.com/news/headline-risk-still-poison-stocks-205158556.html,Headline Risk Is Still Poison for These Stocks
VRX,VRX:US,BBG000DLFM21,Headline Risk Is Still Poison For These Stocks,2016-10-20 13:00:56 +0000,http://finance.yahoo.com/tumblr/blog-headline-risk-is-still-poison-for-these-stocks-130059919.html,Headline Risk Is Still Poison For These Stocks
VRX,VRX:CT,BBG000DC8S17,Headline Risk Is Still Poison For These Stocks,2016-10-20 13:00:56 +0000,http://finance.yahoo.com/tumblr/blog-headline-risk-is-still-poison-for-these-stocks-130059919.html,Headline Risk Is Still Poison For These Stocks
VRX,VRX:US,BBG000DLFM21,"BMRA: Base Business Bounces Back, InFoods Continues To Attract Who’s-Who of IBS",2016-10-20 13:00:00 +0000,http://finance.yahoo.com/news/bmra-business-bounces-back-infoods-130000176.html,"BMRA: Base Business Bounces Back, InFoods Continues To Attract Who’s-Who of IBS"
VRX,VRX:CT,BBG000DC8S17,"BMRA: Base Business Bounces Back, InFoods Continues To Attract Who’s-Who of IBS",2016-10-20 13:00:00 +0000,http://finance.yahoo.com/news/bmra-business-bounces-back-infoods-130000176.html,"BMRA: Base Business Bounces Back, InFoods Continues To Attract Who’s-Who of IBS"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Under Pressure As Crude Oil Weakens -- Canadian Commentary,2016-10-20 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qravLyG7NiM/canadian-stocks-are-under-pressure-as-crude-oil-weakens--canadian-commentary-20161020-00843,Canadian Stocks Are Under Pressure As Crude Oil Weakens -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Under Pressure As Crude Oil Weakens -- Canadian Commentary,2016-10-20 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qravLyG7NiM/canadian-stocks-are-under-pressure-as-crude-oil-weakens--canadian-commentary-20161020-00843,Canadian Stocks Are Under Pressure As Crude Oil Weakens -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Jim Chanos uses this 7-point checklist for companies he's going to short,2016-10-19 19:58:53 +0000,http://finance.yahoo.com/news/jim-chanos-7-point-checklist-for-companies-hes-short-195853257.html,Jim Chanos uses this 7-point checklist for companies he's going to short
VRX,VRX:US,BBG000DLFM21,Jim Chanos uses this 7-point checklist for companies he's going to short,2016-10-19 19:58:53 +0000,http://finance.yahoo.com/news/jim-chanos-7-point-checklist-for-companies-hes-short-195853257.html,Jim Chanos uses this 7-point checklist for companies he's going to short
VRX,VRX:CT,BBG000DC8S17,Another shady business relationship has Wall Street worried about Valeant,2016-10-18 14:37:46 +0000,http://finance.yahoo.com/news/another-shady-business-relationship-wall-143746882.html,Another shady business relationship has Wall Street worried about Valeant
VRX,VRX:US,BBG000DLFM21,Another shady business relationship has Wall Street worried about Valeant,2016-10-18 14:37:46 +0000,http://finance.yahoo.com/news/another-shady-business-relationship-wall-143746882.html,Another shady business relationship has Wall Street worried about Valeant
VRX,VRX:CT,BBG000DC8S17,How Valeant Is Expected to Pay down Its Debt,2016-10-18 14:05:32 +0000,http://marketrealist.com/2016/10/cash-generating-segment-expected-help-valeant-pay-back-debt-future-years/?utm_source=yahoo&utm_medium=feed,How Valeant Is Expected to Pay down Its Debt
VRX,VRX:US,BBG000DLFM21,How Valeant Is Expected to Pay down Its Debt,2016-10-18 14:05:32 +0000,http://marketrealist.com/2016/10/cash-generating-segment-expected-help-valeant-pay-back-debt-future-years/?utm_source=yahoo&utm_medium=feed,How Valeant Is Expected to Pay down Its Debt
VRX,VRX:US,BBG000DLFM21,Valeant’s Investment Here Could Improve Future Profit Margins,2016-10-18 12:05:36 +0000,http://marketrealist.com/2016/10/growth-segment-expected-drive-valeant-pharmaceuticals-profit-margins-future-years/?utm_source=yahoo&utm_medium=feed,Valeant’s Investment Here Could Improve Future Profit Margins
VRX,VRX:CT,BBG000DC8S17,Valeant’s Investment Here Could Improve Future Profit Margins,2016-10-18 12:05:36 +0000,http://marketrealist.com/2016/10/growth-segment-expected-drive-valeant-pharmaceuticals-profit-margins-future-years/?utm_source=yahoo&utm_medium=feed,Valeant’s Investment Here Could Improve Future Profit Margins
VRX,VRX:US,BBG000DLFM21,"Pharma Stocks Prone to Decline From Democratic Win (MYL, ARIA)",2016-10-17 22:15:00 +0000,http://www.investopedia.com/news/pharma-stocks-prone-decline-democratic-win-myl-aria/?partner=YahooSA,"Pharma Stocks Prone to Decline From Democratic Win (MYL, ARIA)"
VRX,VRX:CT,BBG000DC8S17,"Pharma Stocks Prone to Decline From Democratic Win (MYL, ARIA)",2016-10-17 22:15:00 +0000,http://www.investopedia.com/news/pharma-stocks-prone-decline-democratic-win-myl-aria/?partner=YahooSA,"Pharma Stocks Prone to Decline From Democratic Win (MYL, ARIA)"
VRX,VRX:CT,BBG000DC8S17,Valeant Ends Marketing Relationship Pharmacy That Distributed Antidepressant,2016-10-17 21:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4K7-dTpSumk/valeant-ends-marketing-relationship-pharmacy-that-distributed-antidepressant-20161017-00969,Valeant Ends Marketing Relationship Pharmacy That Distributed Antidepressant
VRX,VRX:US,BBG000DLFM21,Valeant Ends Marketing Relationship Pharmacy That Distributed Antidepressant,2016-10-17 21:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4K7-dTpSumk/valeant-ends-marketing-relationship-pharmacy-that-distributed-antidepressant-20161017-00969,Valeant Ends Marketing Relationship Pharmacy That Distributed Antidepressant
VRX,VRX:CT,BBG000DC8S17,Valeant Cuts Ties With Pharmacy That Distributed Antidepressant,2016-10-17 21:57:13 +0000,http://www.bloomberg.com/news/articles/2016-10-17/valeant-cuts-ties-with-pharmacy-that-distributed-antidepressant?cmpid=yhoo.headline,Valeant Cuts Ties With Pharmacy That Distributed Antidepressant
VRX,VRX:US,BBG000DLFM21,Valeant Cuts Ties With Pharmacy That Distributed Antidepressant,2016-10-17 21:57:13 +0000,http://www.bloomberg.com/news/articles/2016-10-17/valeant-cuts-ties-with-pharmacy-that-distributed-antidepressant?cmpid=yhoo.headline,Valeant Cuts Ties With Pharmacy That Distributed Antidepressant
VRX,VRX:US,BBG000DLFM21,Valeant Counts on Baush + Lomb for Revenue Growth,2016-10-17 21:04:26 +0000,http://marketrealist.com/2016/10/durable-growth-segment-expected-report-robust-financial-metrics-future-years/?utm_source=yahoo&utm_medium=feed,Valeant Counts on Baush + Lomb for Revenue Growth
VRX,VRX:CT,BBG000DC8S17,Valeant Counts on Baush + Lomb for Revenue Growth,2016-10-17 21:04:26 +0000,http://marketrealist.com/2016/10/durable-growth-segment-expected-report-robust-financial-metrics-future-years/?utm_source=yahoo&utm_medium=feed,Valeant Counts on Baush + Lomb for Revenue Growth
VRX,VRX:US,BBG000DLFM21,3 Things Valeant Pharmaceuticals Needs to Do to Win Over Wall Street,2016-10-17 20:47:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I2uYUI-Jkbc/3-things-valeant-pharmaceuticals-needs-to-do-to-win-over-wall-street-cm694429,Can Valeant get back in Wall Street s good graces Image source Getty Images For Valeant Pharmaceuticals NYSE VRX shareholders this year can t end quickly enough Through Oct 13 2016 shares of the embattled pharmaceutical company have fallen 78 and they re down more
VRX,VRX:CT,BBG000DC8S17,3 Things Valeant Pharmaceuticals Needs to Do to Win Over Wall Street,2016-10-17 20:47:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I2uYUI-Jkbc/3-things-valeant-pharmaceuticals-needs-to-do-to-win-over-wall-street-cm694429,Can Valeant get back in Wall Street s good graces Image source Getty Images For Valeant Pharmaceuticals NYSE VRX shareholders this year can t end quickly enough Through Oct 13 2016 shares of the embattled pharmaceutical company have fallen 78 and they re down more
VRX,VRX:US,BBG000DLFM21,3 Things Valeant Pharmaceuticals Needs to Do to Win Over Wall Street,2016-10-17 19:50:31 +0000,http://www.fool.com/investing/2016/10/17/3-things-valeant-pharmaceuticals-needs-to-do-to-wi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Things Valeant Pharmaceuticals Needs to Do to Win Over Wall Street
VRX,VRX:CT,BBG000DC8S17,3 Things Valeant Pharmaceuticals Needs to Do to Win Over Wall Street,2016-10-17 19:50:31 +0000,http://www.fool.com/investing/2016/10/17/3-things-valeant-pharmaceuticals-needs-to-do-to-wi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Things Valeant Pharmaceuticals Needs to Do to Win Over Wall Street
VRX,VRX:US,BBG000DLFM21,Valeant’s Reorganization Efforts Could Boost Investor Confidence,2016-10-17 19:04:20 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-aims-reorganize-business-segments-3q16/?utm_source=yahoo&utm_medium=feed,Valeant’s Reorganization Efforts Could Boost Investor Confidence
VRX,VRX:CT,BBG000DC8S17,Valeant’s Reorganization Efforts Could Boost Investor Confidence,2016-10-17 19:04:20 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-aims-reorganize-business-segments-3q16/?utm_source=yahoo&utm_medium=feed,Valeant’s Reorganization Efforts Could Boost Investor Confidence
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Has a Chance to Outperform After Earnings,2016-10-17 17:49:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TL6UtbZQ5hQ/valeant-pharmaceuticals-intl-inc-vrx-has-a-chance-to-outperform-after-earnings-cm694347,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX will report third quarter fiscal 2016 earning results on Tuesday before the opening bell And by the recent reaction in Valeant stock
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Has a Chance to Outperform After Earnings,2016-10-17 17:49:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TL6UtbZQ5hQ/valeant-pharmaceuticals-intl-inc-vrx-has-a-chance-to-outperform-after-earnings-cm694347,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc 160 NYSE VRX will report third quarter fiscal 2016 earning results on Tuesday before the opening bell And by the recent reaction in Valeant stock
VRX,VRX:US,BBG000DLFM21,"Netflix, Inc. (NFLX) Stock Has Lost Its Biggest Selling Point",2016-10-17 17:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v7J_FbmYA-U/netflix-inc-nflx-stock-has-lost-its-biggest-selling-point-cm694344,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Netflix Inc NASDAQ NFLX was the top performing stock in the entire S amp P 500 in 2015 So far in 2016 NFLX stock has severely lagged the market falling 11 4
VRX,VRX:CT,BBG000DC8S17,"Netflix, Inc. (NFLX) Stock Has Lost Its Biggest Selling Point",2016-10-17 17:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v7J_FbmYA-U/netflix-inc-nflx-stock-has-lost-its-biggest-selling-point-cm694344,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Netflix Inc NASDAQ NFLX was the top performing stock in the entire S amp P 500 in 2015 So far in 2016 NFLX stock has severely lagged the market falling 11 4
VRX,VRX:CT,BBG000DC8S17,Valeant Looks to Line Its Coffers Using These Five Strategies,2016-10-17 17:17:24 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-plans-focus-five-strategic-imperatives-2016/?utm_source=yahoo&utm_medium=feed,Valeant Looks to Line Its Coffers Using These Five Strategies
VRX,VRX:US,BBG000DLFM21,Valeant Looks to Line Its Coffers Using These Five Strategies,2016-10-17 17:17:24 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-plans-focus-five-strategic-imperatives-2016/?utm_source=yahoo&utm_medium=feed,Valeant Looks to Line Its Coffers Using These Five Strategies
VRX,VRX:CT,BBG000DC8S17,Valeant Announces Third Quarter Financial Results Date And Conference Call Details,2016-10-17 16:23:06 +0000,http://www.publicnow.com/view/741280190E9B938D3DE220A4E6DFCD060763273B,"[at noodls] - LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release third quarter 2016 financial results on Tuesday, ..."
VRX,VRX:US,BBG000DLFM21,Valeant Announces Third Quarter Financial Results Date And Conference Call Details,2016-10-17 16:23:06 +0000,http://www.publicnow.com/view/741280190E9B938D3DE220A4E6DFCD060763273B,"[at noodls] - LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release third quarter 2016 financial results on Tuesday, ..."
VRX,VRX:US,BBG000DLFM21,Add Up The Parts: GURU Could Be Worth $27,2016-10-17 13:42:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/saoewZOdJtY/add-up-the-parts-guru-could-be-worth-27-cm693979,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:CT,BBG000DC8S17,Add Up The Parts: GURU Could Be Worth $27,2016-10-17 13:42:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/saoewZOdJtY/add-up-the-parts-guru-could-be-worth-27-cm693979,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRX,VRX:US,BBG000DLFM21,"Blog Coverage Valeant Pharma Announces Moderate Increase in Prices of its Neurology, Gastrointestinal and Urology Drugs",2016-10-17 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeant-pharma-announces-131500757.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / October 17, 2016 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) as the company announced on October 14, 2016 ..."
VRX,VRX:CT,BBG000DC8S17,"Blog Coverage Valeant Pharma Announces Moderate Increase in Prices of its Neurology, Gastrointestinal and Urology Drugs",2016-10-17 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-valeant-pharma-announces-131500757.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / October 17, 2016 / Active Wall St. blog coverage looks at the headline from Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) as the company announced on October 14, 2016 ..."
VRX,VRX:US,BBG000DLFM21,This Space Presents a Market Opportunity for Valeant,2016-10-17 12:04:25 +0000,http://marketrealist.com/2016/10/xifaxan-may-witness-strong-growth-trends-hepatic-encephalopathy-segment-2016/?utm_source=yahoo&utm_medium=feed,This Space Presents a Market Opportunity for Valeant
VRX,VRX:CT,BBG000DC8S17,This Space Presents a Market Opportunity for Valeant,2016-10-17 12:04:25 +0000,http://marketrealist.com/2016/10/xifaxan-may-witness-strong-growth-trends-hepatic-encephalopathy-segment-2016/?utm_source=yahoo&utm_medium=feed,This Space Presents a Market Opportunity for Valeant
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Gold Provides Support -- Canadian Commentary,2016-10-17 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CnAsxDcfAFs/canadian-stocks-are-rising-as-gold-provides-support--canadian-commentary-20161017-00671,Canadian Stocks Are Rising As Gold Provides Support -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Gold Provides Support -- Canadian Commentary,2016-10-17 10:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CnAsxDcfAFs/canadian-stocks-are-rising-as-gold-provides-support--canadian-commentary-20161017-00671,Canadian Stocks Are Rising As Gold Provides Support -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,5 Things You Must Know Before the Market Opens Monday,2016-10-17 09:56:00 +0000,https://www.thestreet.com/story/13853447/1/5-things-you-must-know-before-the-market-opens-monday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Monday
VRX,VRX:CT,BBG000DC8S17,5 Things You Must Know Before the Market Opens Monday,2016-10-17 09:56:00 +0000,https://www.thestreet.com/story/13853447/1/5-things-you-must-know-before-the-market-opens-monday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Monday
VRX,VRX:US,BBG000DLFM21,Why Biotech Investors Are Terrified of the Upcoming Elections,2016-10-16 16:41:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V4ojt-wBdDE/why-biotech-investors-are-terrified-of-the-upcoming-elections-cm693866,Image source Getty Images Biotech stocks nice run seems to have ended While the first half of 2016 was pretty dismal for biotech stocks in general the sector began bouncing back in July The iShares Nasdaq Biotechnology exchange traded fund ETF NASDAQ IBB fell nearly 30
VRX,VRX:CT,BBG000DC8S17,Why Biotech Investors Are Terrified of the Upcoming Elections,2016-10-16 16:41:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V4ojt-wBdDE/why-biotech-investors-are-terrified-of-the-upcoming-elections-cm693866,Image source Getty Images Biotech stocks nice run seems to have ended While the first half of 2016 was pretty dismal for biotech stocks in general the sector began bouncing back in July The iShares Nasdaq Biotechnology exchange traded fund ETF NASDAQ IBB fell nearly 30
VRX,VRX:CT,BBG000DC8S17,Why Biotech Investors Are Terrified of the Upcoming Elections,2016-10-16 15:16:04 +0000,http://www.fool.com/investing/2016/10/16/why-biotech-investors-are-terrified-of-the-upcomin.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Biotech Investors Are Terrified of the Upcoming Elections
VRX,VRX:US,BBG000DLFM21,Why Biotech Investors Are Terrified of the Upcoming Elections,2016-10-16 15:16:04 +0000,http://www.fool.com/investing/2016/10/16/why-biotech-investors-are-terrified-of-the-upcomin.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Biotech Investors Are Terrified of the Upcoming Elections
VRX,VRX:US,BBG000DLFM21,Here’s Why These Five Stocks Are in the Spotlight,2016-10-15 16:34:41 +0000,http://www.insidermonkey.com/blog/heres-why-these-five-stocks-are-in-the-spotlight-3-481461/,Here’s Why These Five Stocks Are in the Spotlight
VRX,VRX:CT,BBG000DC8S17,Here’s Why These Five Stocks Are in the Spotlight,2016-10-15 16:34:41 +0000,http://www.insidermonkey.com/blog/heres-why-these-five-stocks-are-in-the-spotlight-3-481461/,Here’s Why These Five Stocks Are in the Spotlight
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Sets Price Increases for Some Drugs,2016-10-15 03:06:32 +0000,http://www.wsj.com/articles/valeant-sets-price-increases-for-some-drugs-1476466911?ru=yahoo?mod=yahoo_itp,[$$] Valeant Sets Price Increases for Some Drugs
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Sets Price Increases for Some Drugs,2016-10-15 03:06:32 +0000,http://www.wsj.com/articles/valeant-sets-price-increases-for-some-drugs-1476466911?ru=yahoo?mod=yahoo_itp,[$$] Valeant Sets Price Increases for Some Drugs
VRX,VRX:CT,BBG000DC8S17,Gimme Credit: Valeant May Fall Short of Guidance Again,2016-10-14 22:49:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/10/14/gimme-credit-valeant-may-fall-short-of-guidance-again/?mod=yahoobarrons&ru=yahoo,Gimme Credit: Valeant May Fall Short of Guidance Again
VRX,VRX:US,BBG000DLFM21,Gimme Credit: Valeant May Fall Short of Guidance Again,2016-10-14 22:49:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/10/14/gimme-credit-valeant-may-fall-short-of-guidance-again/?mod=yahoobarrons&ru=yahoo,Gimme Credit: Valeant May Fall Short of Guidance Again
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Sets Price Increases for Some Drugs,2016-10-14 20:28:22 +0000,http://www.wsj.com/articles/valeant-sets-price-increases-for-some-drugs-1476466911?mod=yahoo_hs,[$$] Valeant Sets Price Increases for Some Drugs
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Sets Price Increases for Some Drugs,2016-10-14 20:28:22 +0000,http://www.wsj.com/articles/valeant-sets-price-increases-for-some-drugs-1476466911?mod=yahoo_hs,[$$] Valeant Sets Price Increases for Some Drugs
VRX,VRX:US,BBG000DLFM21,Here's Why Valeant Pharmaceuticals (VRX) Stock Closed Lower Today,2016-10-14 20:08:00 +0000,https://www.thestreet.com/story/13854344/1/here-s-why-valeant-pharmaceuticals-vrx-stock-closed-lower-today.html?puc=yahoo&cm_ven=YAHOO,Here's Why Valeant Pharmaceuticals (VRX) Stock Closed Lower Today
VRX,VRX:CT,BBG000DC8S17,Here's Why Valeant Pharmaceuticals (VRX) Stock Closed Lower Today,2016-10-14 20:08:00 +0000,https://www.thestreet.com/story/13854344/1/here-s-why-valeant-pharmaceuticals-vrx-stock-closed-lower-today.html?puc=yahoo&cm_ven=YAHOO,Here's Why Valeant Pharmaceuticals (VRX) Stock Closed Lower Today
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: And You Thought They Changed…,2016-10-14 19:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/14/valeant-pharmaceuticals-and-you-thought-they-changed/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: And You Thought They Changed…
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: And You Thought They Changed…,2016-10-14 19:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/14/valeant-pharmaceuticals-and-you-thought-they-changed/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: And You Thought They Changed…
VRX,VRX:US,BBG000DLFM21,"Valeant announces price increases of 2% to 9% for neurology, gastrointestinal disorder and urology portfolios",2016-10-14 18:30:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=5DDD9CC3-20DA-4B19-B6FF-BA243A60CC27&siteid=yhoof2,"Valeant announces price increases of 2% to 9% for neurology, gastrointestinal disorder and urology portfolios"
VRX,VRX:CT,BBG000DC8S17,"Valeant announces price increases of 2% to 9% for neurology, gastrointestinal disorder and urology portfolios",2016-10-14 18:30:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=5DDD9CC3-20DA-4B19-B6FF-BA243A60CC27&siteid=yhoof2,"Valeant announces price increases of 2% to 9% for neurology, gastrointestinal disorder and urology portfolios"
VRX,VRX:US,BBG000DLFM21,Stressed Out: Free Cash Flow Is All That Counts Now for Valeant,2016-10-14 18:15:00 +0000,http://realmoney.thestreet.com/articles/10/14/2016/stressed-out-free-cash-flow-all-counts-now-valeant?puc=yahoo&cm_ven=YAHOO,Stressed Out: Free Cash Flow Is All That Counts Now for Valeant
VRX,VRX:CT,BBG000DC8S17,Stressed Out: Free Cash Flow Is All That Counts Now for Valeant,2016-10-14 18:15:00 +0000,http://realmoney.thestreet.com/articles/10/14/2016/stressed-out-free-cash-flow-all-counts-now-valeant?puc=yahoo&cm_ven=YAHOO,Stressed Out: Free Cash Flow Is All That Counts Now for Valeant
VRX,VRX:US,BBG000DLFM21,Valeant Releases Drug Price Information Ahead of Earnings,2016-10-14 17:49:00 +0000,https://www.thestreet.com/story/13854187/1/valeant-releases-drug-price-information-ahead-of-earnings.html?puc=yahoo&cm_ven=YAHOO,Valeant Releases Drug Price Information Ahead of Earnings
VRX,VRX:CT,BBG000DC8S17,Valeant Releases Drug Price Information Ahead of Earnings,2016-10-14 17:49:00 +0000,https://www.thestreet.com/story/13854187/1/valeant-releases-drug-price-information-ahead-of-earnings.html?puc=yahoo&cm_ven=YAHOO,Valeant Releases Drug Price Information Ahead of Earnings
VRX,VRX:CT,BBG000DC8S17,3 Candidates for Worst CEO of 2016,2016-10-14 17:42:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/re7mI5AhIhk/3-candidates-for-worst-ceo-of-2016-cm693550,Image source Getty Images It s been a volatile year for the stock market but at the end of the day the scoreboard still reads green on a year to date basis Long term investors who stuck with their game plans are probably doing just fine But the same can t be said of
VRX,VRX:US,BBG000DLFM21,3 Candidates for Worst CEO of 2016,2016-10-14 17:42:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/re7mI5AhIhk/3-candidates-for-worst-ceo-of-2016-cm693550,Image source Getty Images It s been a volatile year for the stock market but at the end of the day the scoreboard still reads green on a year to date basis Long term investors who stuck with their game plans are probably doing just fine But the same can t be said of
VRX,VRX:US,BBG000DLFM21,Valeant raises list prices of some products by up to 9 pct,2016-10-14 17:33:29 +0000,http://finance.yahoo.com/news/valeant-raises-list-prices-products-173329734.html,"[Reuters] - Canadian drugmaker Valeant Pharmaceuticals Inc said it will increase the list prices of products in its neurology, gastro-intestinal and urology portfolios by 2 percent-9 percent. Shares of the Laval, Quebec-based company were down 2.4 pct on the Toronto Stock Exchange. The changes are in line with the company's plans to ensure average annual price increases for its prescription pharmaceutical products are no greater than single digits and below the five-year weighted average of increases within the industry."
VRX,VRX:CT,BBG000DC8S17,Valeant raises list prices of some products by up to 9 pct,2016-10-14 17:33:29 +0000,http://finance.yahoo.com/news/valeant-raises-list-prices-products-173329734.html,"[Reuters] - Canadian drugmaker Valeant Pharmaceuticals Inc said it will increase the list prices of products in its neurology, gastro-intestinal and urology portfolios by 2 percent-9 percent. Shares of the Laval, Quebec-based company were down 2.4 pct on the Toronto Stock Exchange. The changes are in line with the company's plans to ensure average annual price increases for its prescription pharmaceutical products are no greater than single digits and below the five-year weighted average of increases within the industry."
VRX,VRX:US,BBG000DLFM21,Ruane Cunniff Makes One Significant Buy,2016-10-14 17:20:55 +0000,http://finance.yahoo.com/news/ruane-cunniff-makes-one-significant-221440485.html,Ruane Cunniff Makes One Significant Buy
VRX,VRX:CT,BBG000DC8S17,Ruane Cunniff Makes One Significant Buy,2016-10-14 17:20:55 +0000,http://finance.yahoo.com/news/ruane-cunniff-makes-one-significant-221440485.html,Ruane Cunniff Makes One Significant Buy
VRX,VRX:US,BBG000DLFM21,Valeant Patient Access And Pricing Committee Comments On Recent Pricing Action Decisions,2016-10-14 17:11:02 +0000,http://www.publicnow.com/view/6370ED49C0B3354F063CCD3A60A584C278012D62,"[at noodls] - LAVAL, Quebec, Oct. 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the company's Patient Access and Pricing Committee (the 'Committee') ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Patient Access And Pricing Committee Comments On Recent Pricing Action Decisions,2016-10-14 17:11:02 +0000,http://www.publicnow.com/view/6370ED49C0B3354F063CCD3A60A584C278012D62,"[at noodls] - LAVAL, Quebec, Oct. 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the company's Patient Access and Pricing Committee (the 'Committee') ..."
VRX,VRX:CT,BBG000DC8S17,3 Candidates for Worst CEO of 2016,2016-10-14 16:22:06 +0000,http://www.fool.com/investing/2016/10/14/3-candidates-for-the-worst-ceo-of-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Candidates for Worst CEO of 2016
VRX,VRX:US,BBG000DLFM21,3 Candidates for Worst CEO of 2016,2016-10-14 16:22:06 +0000,http://www.fool.com/investing/2016/10/14/3-candidates-for-the-worst-ceo-of-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Candidates for Worst CEO of 2016
VRX,VRX:CT,BBG000DC8S17,Valeant Raises Prices On Certain Products,2016-10-14 15:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HexJElHXMoM/valeant-raises-prices-on-certain-products-20161014-00367,Valeant Raises Prices On Certain Products
VRX,VRX:US,BBG000DLFM21,Valeant Raises Prices On Certain Products,2016-10-14 15:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HexJElHXMoM/valeant-raises-prices-on-certain-products-20161014-00367,Valeant Raises Prices On Certain Products
VRX,VRX:CT,BBG000DC8S17,How Valeant Is Trying to Improve Its Profit Margins,2016-10-14 15:04:41 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-focuses-improving-profit-margins-2016/?utm_source=yahoo&utm_medium=feed,How Valeant Is Trying to Improve Its Profit Margins
VRX,VRX:US,BBG000DLFM21,How Valeant Is Trying to Improve Its Profit Margins,2016-10-14 15:04:41 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-focuses-improving-profit-margins-2016/?utm_source=yahoo&utm_medium=feed,How Valeant Is Trying to Improve Its Profit Margins
VRX,VRX:CT,BBG000DC8S17,Valeant Sets Price Increases for Some Drugs,2016-10-14 14:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NYp0Dyy-bv0/valeant-sets-price-increases-for-some-drugs-20161014-00377,Valeant Sets Price Increases for Some Drugs
VRX,VRX:US,BBG000DLFM21,Valeant Sets Price Increases for Some Drugs,2016-10-14 14:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NYp0Dyy-bv0/valeant-sets-price-increases-for-some-drugs-20161014-00377,Valeant Sets Price Increases for Some Drugs
VRX,VRX:CT,BBG000DC8S17,Valeant Looks to Boost Profit Margins through the Walgreens Deal,2016-10-14 14:04:39 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-implements-strategy-boost-profit-margins-walgreens-deal/?utm_source=yahoo&utm_medium=feed,Valeant Looks to Boost Profit Margins through the Walgreens Deal
VRX,VRX:US,BBG000DLFM21,Valeant Looks to Boost Profit Margins through the Walgreens Deal,2016-10-14 14:04:39 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-implements-strategy-boost-profit-margins-walgreens-deal/?utm_source=yahoo&utm_medium=feed,Valeant Looks to Boost Profit Margins through the Walgreens Deal
VRX,VRX:CT,BBG000DC8S17,Valeant Is Poised to Disappoint,2016-10-14 12:30:08 +0000,http://www.bloomberg.com/gadfly/articles/2016-10-14/valeant-third-quarter-earnings-poised-to-disappoint?cmpid=yhoo.headline,Valeant Is Poised to Disappoint
VRX,VRX:US,BBG000DLFM21,Valeant Is Poised to Disappoint,2016-10-14 12:30:08 +0000,http://www.bloomberg.com/gadfly/articles/2016-10-14/valeant-third-quarter-earnings-poised-to-disappoint?cmpid=yhoo.headline,Valeant Is Poised to Disappoint
VRX,VRX:US,BBG000DLFM21,Strong Tailwinds Expected to Boost Valeant’s Earnings This Year,2016-10-14 12:04:57 +0000,http://marketrealist.com/2016/10/strong-tailwinds-expected-boost-valeant-pharmaceuticals-eps-2016/?utm_source=yahoo&utm_medium=feed,Strong Tailwinds Expected to Boost Valeant’s Earnings This Year
VRX,VRX:CT,BBG000DC8S17,Strong Tailwinds Expected to Boost Valeant’s Earnings This Year,2016-10-14 12:04:57 +0000,http://marketrealist.com/2016/10/strong-tailwinds-expected-boost-valeant-pharmaceuticals-eps-2016/?utm_source=yahoo&utm_medium=feed,Strong Tailwinds Expected to Boost Valeant’s Earnings This Year
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Crude Prices Stabilize -- Canadian Commentary,2016-10-14 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N7rnAfSDQxM/canadian-stocks-are-rising-as-crude-prices-stabilize--canadian-commentary-20161014-00283,Canadian Stocks Are Rising As Crude Prices Stabilize -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Crude Prices Stabilize -- Canadian Commentary,2016-10-14 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N7rnAfSDQxM/canadian-stocks-are-rising-as-crude-prices-stabilize--canadian-commentary-20161014-00283,Canadian Stocks Are Rising As Crude Prices Stabilize -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Thinks It Will Hit Its Financial Targets in 2016,2016-10-13 21:04:05 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-expected-witness-year-year-revenue-decline-2016/?utm_source=yahoo&utm_medium=feed,Valeant Thinks It Will Hit Its Financial Targets in 2016
VRX,VRX:CT,BBG000DC8S17,Valeant Thinks It Will Hit Its Financial Targets in 2016,2016-10-13 21:04:05 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-expected-witness-year-year-revenue-decline-2016/?utm_source=yahoo&utm_medium=feed,Valeant Thinks It Will Hit Its Financial Targets in 2016
VRX,VRX:CT,BBG000DC8S17,Valeant Could Move Higher If This Strategy Is Successful,2016-10-13 20:04:16 +0000,http://marketrealist.com/2016/10/analyst-recommendations-valeant-pharmaceutical-peers-2016/?utm_source=yahoo&utm_medium=feed,Valeant Could Move Higher If This Strategy Is Successful
VRX,VRX:US,BBG000DLFM21,Valeant Could Move Higher If This Strategy Is Successful,2016-10-13 20:04:16 +0000,http://marketrealist.com/2016/10/analyst-recommendations-valeant-pharmaceutical-peers-2016/?utm_source=yahoo&utm_medium=feed,Valeant Could Move Higher If This Strategy Is Successful
VRX,VRX:CT,BBG000DC8S17,Valuation Multiples: How Valeant Compares to Its Peers,2016-10-13 17:53:04 +0000,http://marketrealist.com/2016/10/valuation-multiples-valeant-pharmaceutical-compare-peers/?utm_source=yahoo&utm_medium=feed,Valuation Multiples: How Valeant Compares to Its Peers
VRX,VRX:US,BBG000DLFM21,Valuation Multiples: How Valeant Compares to Its Peers,2016-10-13 17:53:04 +0000,http://marketrealist.com/2016/10/valuation-multiples-valeant-pharmaceutical-compare-peers/?utm_source=yahoo&utm_medium=feed,Valuation Multiples: How Valeant Compares to Its Peers
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling On Global Growth Concerns -- Canadian Commentary,2016-10-13 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xiRQnts_svQ/canadian-stocks-are-falling-on-global-growth-concerns--canadian-commentary-20161013-00734,Canadian Stocks Are Falling On Global Growth Concerns -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling On Global Growth Concerns -- Canadian Commentary,2016-10-13 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xiRQnts_svQ/canadian-stocks-are-falling-on-global-growth-concerns--canadian-commentary-20161013-00734,Canadian Stocks Are Falling On Global Growth Concerns -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,The Pharmaceutical Sector Looks Attractive,2016-10-12 22:09:02 +0000,http://finance.yahoo.com/news/pharmaceutical-sector-looks-attractive-220902262.html,The Pharmaceutical Sector Looks Attractive
VRX,VRX:CT,BBG000DC8S17,The Pharmaceutical Sector Looks Attractive,2016-10-12 22:09:02 +0000,http://finance.yahoo.com/news/pharmaceutical-sector-looks-attractive-220902262.html,The Pharmaceutical Sector Looks Attractive
VRX,VRX:US,BBG000DLFM21,This Bernie Sanders tweet about Flint's water crisis could be a big problem for Valeant,2016-10-12 19:46:23 +0000,http://finance.yahoo.com/news/bernie-sanders-tweet-flints-water-194623072.html,This Bernie Sanders tweet about Flint's water crisis could be a big problem for Valeant
VRX,VRX:CT,BBG000DC8S17,This Bernie Sanders tweet about Flint's water crisis could be a big problem for Valeant,2016-10-12 19:46:23 +0000,http://finance.yahoo.com/news/bernie-sanders-tweet-flints-water-194623072.html,This Bernie Sanders tweet about Flint's water crisis could be a big problem for Valeant
VRX,VRX:CT,BBG000DC8S17,This is the earnings metric stock-market investors should focus on,2016-10-12 15:53:07 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=460C7F28-8FF2-11E6-94B4-A9EAC68D0F98&siteid=yhoof2,This is the earnings metric stock-market investors should focus on
VRX,VRX:US,BBG000DLFM21,This is the earnings metric stock-market investors should focus on,2016-10-12 15:53:07 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=460C7F28-8FF2-11E6-94B4-A9EAC68D0F98&siteid=yhoof2,This is the earnings metric stock-market investors should focus on
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Up Slightly In Cautious Trade -- Canadian Commentary,2016-10-12 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N9a7rxygFNw/canadian-stocks-are-up-slightly-in-cautious-trade--canadian-commentary-20161012-00661,Canadian Stocks Are Up Slightly In Cautious Trade -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Up Slightly In Cautious Trade -- Canadian Commentary,2016-10-12 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N9a7rxygFNw/canadian-stocks-are-up-slightly-in-cautious-trade--canadian-commentary-20161012-00661,Canadian Stocks Are Up Slightly In Cautious Trade -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,7 Stocks the 2016 Presidential Candidates Have Called Out By Name,2016-10-11 23:19:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YltziDzPfP4/7-stocks-the-2016-presidential-candidates-have-called-out-by-name-cm692092,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The 2016 160 election is now less than one month away Lists are popping up all over the internet of which stocks to buy and sell depending on whether Hillary Clinton or Donald Trump wins Most of these
VRX,VRX:US,BBG000DLFM21,7 Stocks the 2016 Presidential Candidates Have Called Out By Name,2016-10-11 23:19:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YltziDzPfP4/7-stocks-the-2016-presidential-candidates-have-called-out-by-name-cm692092,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The 2016 160 election is now less than one month away Lists are popping up all over the internet of which stocks to buy and sell depending on whether Hillary Clinton or Donald Trump wins Most of these
VRX,VRX:US,BBG000DLFM21,Marketplace Roundtable: The State Of Biotech,2016-10-11 18:20:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-dXRuyLW5JM/marketplace-roundtable-the-state-of-biotech-cm687454,By SA Marketplace BySA Marketplace It would be fair to say biotech has had an interesting time of it over the course of the past 15 months Except of course that biotech always has an interesting time of it The go big or go home sector of the market attracts speculators scientists
VRX,VRX:CT,BBG000DC8S17,Marketplace Roundtable: The State Of Biotech,2016-10-11 18:20:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-dXRuyLW5JM/marketplace-roundtable-the-state-of-biotech-cm687454,By SA Marketplace BySA Marketplace It would be fair to say biotech has had an interesting time of it over the course of the past 15 months Except of course that biotech always has an interesting time of it The go big or go home sector of the market attracts speculators scientists
VRX,VRX:CT,BBG000DC8S17,Stay Away From These 5 Stocks This Earnings Season,2016-10-11 14:00:44 +0000,http://finance.yahoo.com/tumblr/blog-stay-away-from-these-5-stocks-this-earnings-season-140048416.html,Stay Away From These 5 Stocks This Earnings Season
VRX,VRX:US,BBG000DLFM21,Stay Away From These 5 Stocks This Earnings Season,2016-10-11 14:00:44 +0000,http://finance.yahoo.com/tumblr/blog-stay-away-from-these-5-stocks-this-earnings-season-140048416.html,Stay Away From These 5 Stocks This Earnings Season
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Little Changed After Long Weekend -- Canadian Commentary,2016-10-11 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y70K3GYBP8A/canadian-stocks-are-little-changed-after-long-weekend--canadian-commentary-20161011-00571,Canadian Stocks Are Little Changed After Long Weekend -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Little Changed After Long Weekend -- Canadian Commentary,2016-10-11 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y70K3GYBP8A/canadian-stocks-are-little-changed-after-long-weekend--canadian-commentary-20161011-00571,Canadian Stocks Are Little Changed After Long Weekend -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Play the Russian Freeze With VelocityShares 3x Long Crude Oil ETN (UWTI),2016-10-10 19:19:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L12DAm3n0SA/play-the-russian-freeze-with-velocityshares-3x-long-crude-oil-etn-uwti-cm691243,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The rout in oil prices hasn t just affected those firms that produce energy It has also hit those nations that rely on oil for their life blood Many of the nations in OPEC have been driven to the brink
VRX,VRX:CT,BBG000DC8S17,Play the Russian Freeze With VelocityShares 3x Long Crude Oil ETN (UWTI),2016-10-10 19:19:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L12DAm3n0SA/play-the-russian-freeze-with-velocityshares-3x-long-crude-oil-etn-uwti-cm691243,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The rout in oil prices hasn t just affected those firms that produce energy It has also hit those nations that rely on oil for their life blood Many of the nations in OPEC have been driven to the brink
VRX,VRX:CT,BBG000DC8S17,2 Ways to Make Bank on Valeant Pharmaceuticals Intl Inc (VRX),2016-10-10 17:18:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6dzlrchRw_A/2-ways-to-make-bank-on-valeant-pharmaceuticals-intl-inc-vrx-cm691159,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has been on a wild ride in 2016 I usually avoid selling premium in headline tickers like VRX When selling premium I
VRX,VRX:US,BBG000DLFM21,2 Ways to Make Bank on Valeant Pharmaceuticals Intl Inc (VRX),2016-10-10 17:18:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6dzlrchRw_A/2-ways-to-make-bank-on-valeant-pharmaceuticals-intl-inc-vrx-cm691159,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has been on a wild ride in 2016 I usually avoid selling premium in headline tickers like VRX When selling premium I
VRX,VRX:CT,BBG000DC8S17,Mindset Shifts Take Time,2016-10-09 19:30:55 +0000,http://finance.yahoo.com/tumblr/blog-mindset-shifts-take-time-193102164.html,Mindset Shifts Take Time
VRX,VRX:US,BBG000DLFM21,Mindset Shifts Take Time,2016-10-09 19:30:55 +0000,http://finance.yahoo.com/tumblr/blog-mindset-shifts-take-time-193102164.html,Mindset Shifts Take Time
VRX,VRX:CT,BBG000DC8S17,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System",2016-10-09 18:28:54 +0000,http://www.fool.com/investing/2016/10/08/dont-blame-mylans-ceo-for-epipens-soaring-price-bl.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System"
VRX,VRX:US,BBG000DLFM21,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System",2016-10-09 18:28:54 +0000,http://www.fool.com/investing/2016/10/08/dont-blame-mylans-ceo-for-epipens-soaring-price-bl.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System"
VRX,VRX:US,BBG000DLFM21,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System",2016-10-08 19:43:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A3j-ISPYg1M/dont-blame-mylans-ceo-for-epipens-soaring-price-blame-the-us-healthcare-system-cm690719,Image source Getty Images No your eyes or wallet aren t deceiving you the perception of pharmaceutical price gouging has certainly become more commonplace over the past year Last September Martin Shkreli the Bad Boy of Pharma increased the price of a 62 year
VRX,VRX:CT,BBG000DC8S17,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System",2016-10-08 19:43:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A3j-ISPYg1M/dont-blame-mylans-ceo-for-epipens-soaring-price-blame-the-us-healthcare-system-cm690719,Image source Getty Images No your eyes or wallet aren t deceiving you the perception of pharmaceutical price gouging has certainly become more commonplace over the past year Last September Martin Shkreli the Bad Boy of Pharma increased the price of a 62 year
VRX,VRX:US,BBG000DLFM21,These 2 Factors Pushed Valeant Pharmaceuticals Intl. Inc. Down 15% in September,2016-10-07 18:44:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Esf6R0c4hb8/these-2-factors-pushed-valeant-pharmaceuticals-intl-inc-down-15-in-september-cm690480,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX a pharmaceutical company that s primarily grown through M amp A in recent years plunged 15 during the month of September according to S amp P Global Market Intelligence Weakness
VRX,VRX:CT,BBG000DC8S17,These 2 Factors Pushed Valeant Pharmaceuticals Intl. Inc. Down 15% in September,2016-10-07 18:44:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Esf6R0c4hb8/these-2-factors-pushed-valeant-pharmaceuticals-intl-inc-down-15-in-september-cm690480,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX a pharmaceutical company that s primarily grown through M amp A in recent years plunged 15 during the month of September according to S amp P Global Market Intelligence Weakness
VRX,VRX:US,BBG000DLFM21,These 2 Factors Pushed Valeant Pharmaceuticals Intl. Inc. Down 15% in September,2016-10-07 16:56:42 +0000,http://www.fool.com/investing/2016/10/07/these-2-factors-pushed-valeant-pharmaceuticals-int.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 2 Factors Pushed Valeant Pharmaceuticals Intl. Inc. Down 15% in September
VRX,VRX:CT,BBG000DC8S17,These 2 Factors Pushed Valeant Pharmaceuticals Intl. Inc. Down 15% in September,2016-10-07 16:56:42 +0000,http://www.fool.com/investing/2016/10/07/these-2-factors-pushed-valeant-pharmaceuticals-int.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 2 Factors Pushed Valeant Pharmaceuticals Intl. Inc. Down 15% in September
VRX,VRX:US,BBG000DLFM21,BioDelivery Sciences (BDSI) Board Appoints New Members,2016-10-07 16:45:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hY9ZfCD8DrE/biodelivery-sciences-bdsi-board-appoints-new-members-cm690413,BioDelivery Sciences International Inc BDSI announced a couple of changes in its management While Timothy C Tyson has been appointed to the company s board of directors as an independent member Dr Mark A Sirgo the present President and Chief Executive Officer CEO and board member
VRX,VRX:CT,BBG000DC8S17,BioDelivery Sciences (BDSI) Board Appoints New Members,2016-10-07 16:45:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hY9ZfCD8DrE/biodelivery-sciences-bdsi-board-appoints-new-members-cm690413,BioDelivery Sciences International Inc BDSI announced a couple of changes in its management While Timothy C Tyson has been appointed to the company s board of directors as an independent member Dr Mark A Sirgo the present President and Chief Executive Officer CEO and board member
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling After U.S. Jobs Report -- Canadian Commentary,2016-10-07 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ar8ms4sgpGY/canadian-stocks-are-falling-after-us-jobs-report--canadian-commentary-20161007-00240,Canadian Stocks Are Falling After U.S. Jobs Report -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling After U.S. Jobs Report -- Canadian Commentary,2016-10-07 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ar8ms4sgpGY/canadian-stocks-are-falling-after-us-jobs-report--canadian-commentary-20161007-00240,Canadian Stocks Are Falling After U.S. Jobs Report -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer",2016-10-06 20:20:00 +0000,http://finance.yahoo.com/news/valeant-appoints-louis-w-yu-202000347.html,"[PR Newswire] - Dr. Yu will report to Joseph C. Papa, Chairman and CEO of Valeant. As a new member of Valeant's Executive Committee, Dr. Yu will oversee all aspects of quality and regulatory compliance for all of Valeant's global businesses and operating sites. Dr. Yu joins Valeant with more than 30 years of leadership experience in the Quality and R&D functions of generic and branded pharmaceutical companies."
VRX,VRX:US,BBG000DLFM21,"Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer",2016-10-06 20:20:00 +0000,http://finance.yahoo.com/news/valeant-appoints-louis-w-yu-202000347.html,"[PR Newswire] - Dr. Yu will report to Joseph C. Papa, Chairman and CEO of Valeant. As a new member of Valeant's Executive Committee, Dr. Yu will oversee all aspects of quality and regulatory compliance for all of Valeant's global businesses and operating sites. Dr. Yu joins Valeant with more than 30 years of leadership experience in the Quality and R&D functions of generic and branded pharmaceutical companies."
VRX,VRX:CT,BBG000DC8S17,Specialty Pharma: Drug Pricing Controversies Just Won't Die!,2016-10-06 19:02:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/06/specialty-pharma-drug-pricing-controversies-just-wont-die/?mod=yahoobarrons&ru=yahoo,Specialty Pharma: Drug Pricing Controversies Just Won't Die!
VRX,VRX:US,BBG000DLFM21,Specialty Pharma: Drug Pricing Controversies Just Won't Die!,2016-10-06 19:02:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/06/specialty-pharma-drug-pricing-controversies-just-wont-die/?mod=yahoobarrons&ru=yahoo,Specialty Pharma: Drug Pricing Controversies Just Won't Die!
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary,2016-10-06 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UeQ0bZgvKjM/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20161006-00637,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary,2016-10-06 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UeQ0bZgvKjM/canadian-stocks-are-struggling-to-find-direction--canadian-commentary-20161006-00637,Canadian Stocks Are Struggling To Find Direction -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,This Is Why Tesla Motors Inc Struggles to Turn a Profit (TSLA),2016-10-05 18:43:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_bON4Wj50jY/this-is-why-tesla-motors-inc-struggles-to-turn-a-profit-tsla-cm689345,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Famous Wall Street short seller Jim Chanos has never hidden his disdain for the way Tesla Motors Inc NASDAQ TSLA conducts its affairs Chanos warned Tesla 160 stock investors in July to read
VRX,VRX:US,BBG000DLFM21,This Is Why Tesla Motors Inc Struggles to Turn a Profit (TSLA),2016-10-05 18:43:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_bON4Wj50jY/this-is-why-tesla-motors-inc-struggles-to-turn-a-profit-tsla-cm689345,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Famous Wall Street short seller Jim Chanos has never hidden his disdain for the way Tesla Motors Inc NASDAQ TSLA conducts its affairs Chanos warned Tesla 160 stock investors in July to read
VRX,VRX:US,BBG000DLFM21,Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year,2016-10-05 18:41:09 +0000,http://finance.yahoo.com/news/ariad-pharmaceuticals-raises-cancer-drug-184109762.html,Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year
VRX,VRX:CT,BBG000DC8S17,Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year,2016-10-05 18:41:09 +0000,http://finance.yahoo.com/news/ariad-pharmaceuticals-raises-cancer-drug-184109762.html,Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year
VRX,VRX:US,BBG000DLFM21,Pharming Reports on Extraordinary General Meeting of Shareholders,2016-10-05 16:30:00 +0000,http://finance.yahoo.com/news/pharming-reports-extraordinary-general-meeting-163000150.html,"[PR Newswire] - Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) announces that at its Extraordinary General Meeting of shareholders (EGM), held today, all proposals were unanimously approved. This means that Pharming will now be able to execute on the financing necessary to acquire the North-American rights for its own therapy RUCONEST® from its US partner Valeant Pharmaceuticals International Inc. (NYSE:VRX/TSX:VRX) for an upfront payment of US$60 million and self funding future sales milestones of up to US$65 million (""The Transaction""). As announced previously, the Company is aiming to raise a total of US$80-100 million (€72-89 million) by means of a combination of an increase of the current Straight Debt and the issue of new Equity, either through a supported rights issue or possibly by means of a convertible bond at a premium to the current market price. The use of a convertible bond would enable even less new Equity to be issued now when the price is low, reducing the effects on shareholders from the financing for the Transaction."
VRX,VRX:CT,BBG000DC8S17,Pharming Reports on Extraordinary General Meeting of Shareholders,2016-10-05 16:30:00 +0000,http://finance.yahoo.com/news/pharming-reports-extraordinary-general-meeting-163000150.html,"[PR Newswire] - Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) announces that at its Extraordinary General Meeting of shareholders (EGM), held today, all proposals were unanimously approved. This means that Pharming will now be able to execute on the financing necessary to acquire the North-American rights for its own therapy RUCONEST® from its US partner Valeant Pharmaceuticals International Inc. (NYSE:VRX/TSX:VRX) for an upfront payment of US$60 million and self funding future sales milestones of up to US$65 million (""The Transaction""). As announced previously, the Company is aiming to raise a total of US$80-100 million (€72-89 million) by means of a combination of an increase of the current Straight Debt and the issue of new Equity, either through a supported rights issue or possibly by means of a convertible bond at a premium to the current market price. The use of a convertible bond would enable even less new Equity to be issued now when the price is low, reducing the effects on shareholders from the financing for the Transaction."
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising On Energy Strength -- Canadian Commentary,2016-10-05 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/azvi2VQt_-4/canadian-stocks-are-rising-on-energy-strength--canadian-commentary-20161005-00690,Canadian Stocks Are Rising On Energy Strength -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising On Energy Strength -- Canadian Commentary,2016-10-05 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/azvi2VQt_-4/canadian-stocks-are-rising-on-energy-strength--canadian-commentary-20161005-00690,Canadian Stocks Are Rising On Energy Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Why Progenics Pharmaceuticals, Inc. Is Rising Today",2016-10-04 16:18:20 +0000,http://www.fool.com/investing/2016/10/04/why-progenics-pharmaceuticals-inc-is-rising-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Progenics Pharmaceuticals, Inc. Is Rising Today"
VRX,VRX:CT,BBG000DC8S17,"Why Progenics Pharmaceuticals, Inc. Is Rising Today",2016-10-04 16:18:20 +0000,http://www.fool.com/investing/2016/10/04/why-progenics-pharmaceuticals-inc-is-rising-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Progenics Pharmaceuticals, Inc. Is Rising Today"
VRX,VRX:CT,BBG000DC8S17,3 Beaten-Up Healthcare Stocks: Are They Bargains?,2016-10-04 13:44:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N_njHLornWk/3-beaten-up-healthcare-stocks-are-they-bargains-cm688283,Image source Getty Images If you re looking beaten up stocks to scoop up at a discount the healthcare sector has more than its fair share While clinical stage biotechs without products to sell have had it toughest over the past year the pain hasn t been limited to any
VRX,VRX:US,BBG000DLFM21,3 Beaten-Up Healthcare Stocks: Are They Bargains?,2016-10-04 13:44:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N_njHLornWk/3-beaten-up-healthcare-stocks-are-they-bargains-cm688283,Image source Getty Images If you re looking beaten up stocks to scoop up at a discount the healthcare sector has more than its fair share While clinical stage biotechs without products to sell have had it toughest over the past year the pain hasn t been limited to any
VRX,VRX:US,BBG000DLFM21,3 Beaten-Up Healthcare Stocks: Are They Bargains?,2016-10-04 12:27:09 +0000,http://www.fool.com/investing/2016/10/04/3-beaten-up-healthcare-stocks-are-they-bargains.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Beaten-Up Healthcare Stocks: Are They Bargains?
VRX,VRX:CT,BBG000DC8S17,3 Beaten-Up Healthcare Stocks: Are They Bargains?,2016-10-04 12:27:09 +0000,http://www.fool.com/investing/2016/10/04/3-beaten-up-healthcare-stocks-are-they-bargains.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Beaten-Up Healthcare Stocks: Are They Bargains?
VRX,VRX:CT,BBG000DC8S17,AP Top Extended Financial Headlines at 11:09 p.m. EDT,2016-10-04 03:09:55 +0000,http://sg.finance.yahoo.com/news/ap-top-extended-financial-headlines-065929670.html,AP Top Extended Financial Headlines at 11:09 p.m. EDT
VRX,VRX:US,BBG000DLFM21,AP Top Extended Financial Headlines at 11:09 p.m. EDT,2016-10-04 03:09:55 +0000,http://sg.finance.yahoo.com/news/ap-top-extended-financial-headlines-065929670.html,AP Top Extended Financial Headlines at 11:09 p.m. EDT
VRX,VRX:CT,BBG000DC8S17,AP Top Extended Financial Headlines at 5:24 p.m. EDT,2016-10-03 21:25:26 +0000,http://finance.yahoo.com/news/ap-top-extended-financial-headlines-065929240.html,AP Top Extended Financial Headlines at 5:24 p.m. EDT
VRX,VRX:US,BBG000DLFM21,AP Top Extended Financial Headlines at 5:24 p.m. EDT,2016-10-03 21:25:26 +0000,http://finance.yahoo.com/news/ap-top-extended-financial-headlines-065929240.html,AP Top Extended Financial Headlines at 5:24 p.m. EDT
VRX,VRX:CT,BBG000DC8S17,Hedge Funds Must Regret Having Sold Off These 5 Stocks: from Apple Inc. (AAPL) to Valeant Pharmaceuticals Inc. (VRX),2016-10-03 20:51:31 +0000,http://www.insidermonkey.com/blog/hedge-funds-must-regret-having-sold-off-these-5-stocks-from-apple-inc-aapl-to-valeant-pharmaceuticals-inc-vrx-477454/,Hedge Funds Must Regret Having Sold Off These 5 Stocks: from Apple Inc. (AAPL) to Valeant Pharmaceuticals Inc. (VRX)
VRX,VRX:US,BBG000DLFM21,Hedge Funds Must Regret Having Sold Off These 5 Stocks: from Apple Inc. (AAPL) to Valeant Pharmaceuticals Inc. (VRX),2016-10-03 20:51:31 +0000,http://www.insidermonkey.com/blog/hedge-funds-must-regret-having-sold-off-these-5-stocks-from-apple-inc-aapl-to-valeant-pharmaceuticals-inc-vrx-477454/,Hedge Funds Must Regret Having Sold Off These 5 Stocks: from Apple Inc. (AAPL) to Valeant Pharmaceuticals Inc. (VRX)
VRX,VRX:CT,BBG000DC8S17,Valeant’s Stock Becomes (Relatively) Quiet After Wild Year,2016-10-03 18:17:05 +0000,http://www.bloomberg.com/news/articles/2016-10-03/valeant-s-stock-becomes-relatively-quiet-after-wild-year?cmpid=yhoo.headline,Valeant’s Stock Becomes (Relatively) Quiet After Wild Year
VRX,VRX:US,BBG000DLFM21,Valeant’s Stock Becomes (Relatively) Quiet After Wild Year,2016-10-03 18:17:05 +0000,http://www.bloomberg.com/news/articles/2016-10-03/valeant-s-stock-becomes-relatively-quiet-after-wild-year?cmpid=yhoo.headline,Valeant’s Stock Becomes (Relatively) Quiet After Wild Year
VRX,VRX:US,BBG000DLFM21,The Street Is Underestimating Valeant's Potential Downside From Legal Woes,2016-10-03 15:31:44 +0000,http://finance.yahoo.com/news/street-underestimating-valeants-potential-downside-153144132.html,The Street Is Underestimating Valeant's Potential Downside From Legal Woes
VRX,VRX:CT,BBG000DC8S17,The Street Is Underestimating Valeant's Potential Downside From Legal Woes,2016-10-03 15:31:44 +0000,http://finance.yahoo.com/news/street-underestimating-valeants-potential-downside-153144132.html,The Street Is Underestimating Valeant's Potential Downside From Legal Woes
VRX,VRX:US,BBG000DLFM21,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season,2016-10-03 13:05:36 +0000,http://finance.yahoo.com/tumblr/blog-dont-get-caught-with-these-5-stocks-ahead-of-131519606.html,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season
VRX,VRX:CT,BBG000DC8S17,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season,2016-10-03 13:05:36 +0000,http://finance.yahoo.com/tumblr/blog-dont-get-caught-with-these-5-stocks-ahead-of-131519606.html,Don’t Get Caught With These 5 Stocks Ahead of Earnings Season
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down As Commodity Prices Struggle -- Canadian Commentary,2016-10-03 11:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPm3ARIwTcw/canadian-stocks-are-down-as-commodity-prices-struggle--canadian-commentary-20161003-00835,Canadian Stocks Are Down As Commodity Prices Struggle -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down As Commodity Prices Struggle -- Canadian Commentary,2016-10-03 11:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPm3ARIwTcw/canadian-stocks-are-down-as-commodity-prices-struggle--canadian-commentary-20161003-00835,Canadian Stocks Are Down As Commodity Prices Struggle -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Pharming Reports on Financial Results for the First Eight Months of 2016,2016-10-03 05:00:00 +0000,http://finance.yahoo.com/news/pharming-reports-financial-results-first-050000404.html,"[PR Newswire] - LEIDEN, the Netherlands, October 3, 2016 /PRNewswire/ -- Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) announces its (unaudited) financial report for ..."
VRX,VRX:CT,BBG000DC8S17,Pharming Reports on Financial Results for the First Eight Months of 2016,2016-10-03 05:00:00 +0000,http://finance.yahoo.com/news/pharming-reports-financial-results-first-050000404.html,"[PR Newswire] - LEIDEN, the Netherlands, October 3, 2016 /PRNewswire/ -- Pharming Group N.V. (""Pharming"" or ""the Company"") (Euronext Amsterdam: PHARM) announces its (unaudited) financial report for ..."
VRX,VRX:US,BBG000DLFM21,Passing Inflection Point on Pricing and Profits,2016-10-02 16:44:49 +0000,http://finance.yahoo.com/tumblr/blog-passing-inflection-point-on-pricing-and-profits-164452728.html,Passing Inflection Point on Pricing and Profits
VRX,VRX:CT,BBG000DC8S17,Passing Inflection Point on Pricing and Profits,2016-10-02 16:44:49 +0000,http://finance.yahoo.com/tumblr/blog-passing-inflection-point-on-pricing-and-profits-164452728.html,Passing Inflection Point on Pricing and Profits
VRX,VRX:CT,BBG000DC8S17,What Are Analysts Saying about Mallinckrodt?,2016-09-30 18:04:22 +0000,http://marketrealist.com/2016/09/what-are-analysts-saying-about-mallinckrodt/?utm_source=yahoo&utm_medium=feed,What Are Analysts Saying about Mallinckrodt?
VRX,VRX:US,BBG000DLFM21,What Are Analysts Saying about Mallinckrodt?,2016-09-30 18:04:22 +0000,http://marketrealist.com/2016/09/what-are-analysts-saying-about-mallinckrodt/?utm_source=yahoo&utm_medium=feed,What Are Analysts Saying about Mallinckrodt?
VRX,VRX:US,BBG000DLFM21,How Valeant’s Scandal Has Impacted Its Stock Price (VRX),2016-09-30 17:58:00 +0000,http://www.investopedia.com/stock-analysis/093016/how-valeants-scandal-has-impacted-its-stock-price-vrx-vrx.aspx?partner=YahooSA,How Valeant’s Scandal Has Impacted Its Stock Price (VRX)
VRX,VRX:CT,BBG000DC8S17,How Valeant’s Scandal Has Impacted Its Stock Price (VRX),2016-09-30 17:58:00 +0000,http://www.investopedia.com/stock-analysis/093016/how-valeants-scandal-has-impacted-its-stock-price-vrx-vrx.aspx?partner=YahooSA,How Valeant’s Scandal Has Impacted Its Stock Price (VRX)
VRX,VRX:CT,BBG000DC8S17,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc",2016-09-30 13:22:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kBNG13HLk1A/better-buy-valeant-pharmaceuticals-international-inc-vs-endo-international-plc-cm686972,Image source Getty Images Let s play a quick game of guess the pharmaceutical A growing pharma company goes on a major acquisition spree taking on a lot of debt in the process It then runs into problems that force it to drastically reduce its financial projections Shares
VRX,VRX:US,BBG000DLFM21,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc",2016-09-30 13:22:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kBNG13HLk1A/better-buy-valeant-pharmaceuticals-international-inc-vs-endo-international-plc-cm686972,Image source Getty Images Let s play a quick game of guess the pharmaceutical A growing pharma company goes on a major acquisition spree taking on a lot of debt in the process It then runs into problems that force it to drastically reduce its financial projections Shares
VRX,VRX:CT,BBG000DC8S17,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc",2016-09-30 12:05:00 +0000,http://www.fool.com/investing/2016/09/30/better-buy-valeant-pharmaceuticals-international-i.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc"
VRX,VRX:US,BBG000DLFM21,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc",2016-09-30 12:05:00 +0000,http://www.fool.com/investing/2016/09/30/better-buy-valeant-pharmaceuticals-international-i.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc"
VRX,VRX:US,BBG000DLFM21,"No Matter Who Becomes President, Valeant Pharmaceuticals Could Lose Pricing Power",2016-09-29 21:22:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fd4dXqXJ5DM/no-matter-who-becomes-president-valeant-pharmaceuticals-could-lose-pricing-power-cm686804,Image source Getty Images It s been nothing short of nightmarish past year and change for shareholders of drugmaker Valeant Pharmaceuticals NYSE VRX which have seen their shares fall 90 from their all time high The issues Valeant is dealing with reads like a laundry
VRX,VRX:CT,BBG000DC8S17,"No Matter Who Becomes President, Valeant Pharmaceuticals Could Lose Pricing Power",2016-09-29 21:22:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fd4dXqXJ5DM/no-matter-who-becomes-president-valeant-pharmaceuticals-could-lose-pricing-power-cm686804,Image source Getty Images It s been nothing short of nightmarish past year and change for shareholders of drugmaker Valeant Pharmaceuticals NYSE VRX which have seen their shares fall 90 from their all time high The issues Valeant is dealing with reads like a laundry
VRX,VRX:US,BBG000DLFM21,CANADA STOCKS-TSX rises to 1-week high as energy adds to OPEC-related gains,2016-09-29 20:50:26 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-1-205026788.html,CANADA STOCKS-TSX rises to 1-week high as energy adds to OPEC-related gains
VRX,VRX:CT,BBG000DC8S17,CANADA STOCKS-TSX rises to 1-week high as energy adds to OPEC-related gains,2016-09-29 20:50:26 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-rises-1-205026788.html,CANADA STOCKS-TSX rises to 1-week high as energy adds to OPEC-related gains
VRX,VRX:US,BBG000DLFM21,"No Matter Who Becomes President, Valeant Pharmaceuticals Could Lose Pricing Power",2016-09-29 19:22:15 +0000,http://www.fool.com/investing/2016/09/29/no-matter-who-becomes-president-valeant-pharmaceut.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"No Matter Who Becomes President, Valeant Pharmaceuticals Could Lose Pricing Power"
VRX,VRX:CT,BBG000DC8S17,"No Matter Who Becomes President, Valeant Pharmaceuticals Could Lose Pricing Power",2016-09-29 19:22:15 +0000,http://www.fool.com/investing/2016/09/29/no-matter-who-becomes-president-valeant-pharmaceut.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"No Matter Who Becomes President, Valeant Pharmaceuticals Could Lose Pricing Power"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: At Least They Have a Sense of Humor,2016-09-29 15:20:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/29/valeant-pharmaceuticals-at-least-they-have-a-sense-of-humor/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: At Least They Have a Sense of Humor
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: At Least They Have a Sense of Humor,2016-09-29 15:20:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/29/valeant-pharmaceuticals-at-least-they-have-a-sense-of-humor/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: At Least They Have a Sense of Humor
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Climbing On Energy Strength -- Canadian Commentary,2016-09-29 11:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LO3ICQ70_k/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20160929-00662,Canadian Stocks Are Climbing On Energy Strength -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Climbing On Energy Strength -- Canadian Commentary,2016-09-29 11:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LO3ICQ70_k/canadian-stocks-are-climbing-on-energy-strength--canadian-commentary-20160929-00662,Canadian Stocks Are Climbing On Energy Strength -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : September 28, 2016",2016-09-28 14:40:01 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-september-28-2016/,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : September 28, 2016"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : September 28, 2016",2016-09-28 14:40:01 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-value-analysis-nysevrx-september-28-2016/,"Valeant Pharmaceuticals International, Inc. – Value Analysis (NYSE:VRX) : September 28, 2016"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising As Crude Prices Head Higher -- Canadian Commentary,2016-09-28 11:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pPi7LdCBwVs/canadian-stocks-are-rising-as-crude-prices-head-higher--canadian-commentary-20160928-00636,Canadian Stocks Are Rising As Crude Prices Head Higher -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising As Crude Prices Head Higher -- Canadian Commentary,2016-09-28 11:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pPi7LdCBwVs/canadian-stocks-are-rising-as-crude-prices-head-higher--canadian-commentary-20160928-00636,Canadian Stocks Are Rising As Crude Prices Head Higher -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Drug Price Bubble A Result Of Decade-Long Economic Policy Issues,2016-09-27 18:01:43 +0000,http://finance.yahoo.com/news/drug-price-bubble-result-decade-180143128.html,Drug Price Bubble A Result Of Decade-Long Economic Policy Issues
VRX,VRX:US,BBG000DLFM21,Drug Price Bubble A Result Of Decade-Long Economic Policy Issues,2016-09-27 18:01:43 +0000,http://finance.yahoo.com/news/drug-price-bubble-result-decade-180143128.html,Drug Price Bubble A Result Of Decade-Long Economic Policy Issues
VRX,VRX:US,BBG000DLFM21,Mylan NV (MYL) Scandal Taking Down the Generic Drug Sector,2016-09-27 17:22:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YIE75GtHHi4/mylan-nv-myl-scandal-taking-down-the-generic-drug-sector-cm685436,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Mylan NV NYSE MYL is down roughly 16 since its most recent peak in mid August when Congress and the media first began taking notice of what is now called the EpiPen Scandal huge hikes in
VRX,VRX:CT,BBG000DC8S17,Mylan NV (MYL) Scandal Taking Down the Generic Drug Sector,2016-09-27 17:22:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YIE75GtHHi4/mylan-nv-myl-scandal-taking-down-the-generic-drug-sector-cm685436,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Mylan NV NYSE MYL is down roughly 16 since its most recent peak in mid August when Congress and the media first began taking notice of what is now called the EpiPen Scandal huge hikes in
VRX,VRX:US,BBG000DLFM21,Here's Why You Shouldn't Pay Much Attention to Wall Street Analysts' Stock Ratings,2016-09-27 17:21:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-ZkH7oFrEFI/heres-why-you-shouldnt-pay-much-attention-to-wall-street-analysts-stock-ratings-cm685426,Image source Getty Images Chances are as an investor a stock you ve owned has gained at some point as a result of a Wall Street analyst s buy or strong buy rating accompanied by a price target considerably higher than where it was currently trading I know I have However
VRX,VRX:CT,BBG000DC8S17,Here's Why You Shouldn't Pay Much Attention to Wall Street Analysts' Stock Ratings,2016-09-27 17:21:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-ZkH7oFrEFI/heres-why-you-shouldnt-pay-much-attention-to-wall-street-analysts-stock-ratings-cm685426,Image source Getty Images Chances are as an investor a stock you ve owned has gained at some point as a result of a Wall Street analyst s buy or strong buy rating accompanied by a price target considerably higher than where it was currently trading I know I have However
VRX,VRX:CT,BBG000DC8S17,"Revisiting Three Market Villains (CMG, VRX)",2016-09-27 17:07:00 +0000,http://www.investopedia.com/stock-analysis/cotd/092716/revisiting-three-market-villains-cmg-vrx-cmg-vrx-myl-wfc.aspx?partner=YahooSA,"Revisiting Three Market Villains (CMG, VRX)"
VRX,VRX:US,BBG000DLFM21,"Revisiting Three Market Villains (CMG, VRX)",2016-09-27 17:07:00 +0000,http://www.investopedia.com/stock-analysis/cotd/092716/revisiting-three-market-villains-cmg-vrx-cmg-vrx-myl-wfc.aspx?partner=YahooSA,"Revisiting Three Market Villains (CMG, VRX)"
VRX,VRX:US,BBG000DLFM21,Here's Why You Shouldn't Pay Much Attention to Wall Street Analysts' Stock Ratings,2016-09-27 15:55:00 +0000,http://www.fool.com/retirement/2016/09/27/heres-why-you-shouldnt-pay-much-attention-to-wall.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why You Shouldn't Pay Much Attention to Wall Street Analysts' Stock Ratings
VRX,VRX:CT,BBG000DC8S17,Here's Why You Shouldn't Pay Much Attention to Wall Street Analysts' Stock Ratings,2016-09-27 15:55:00 +0000,http://www.fool.com/retirement/2016/09/27/heres-why-you-shouldnt-pay-much-attention-to-wall.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why You Shouldn't Pay Much Attention to Wall Street Analysts' Stock Ratings
VRX,VRX:US,BBG000DLFM21,Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO,2016-09-27 15:23:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o0mCh0260pI/pharma-etf-looks-healthy-in-a-sick-market-after-endo-names-new-ceo-cm684033,A pharmaceuticals sector exchange traded fund perked up Friday after Endo International NasdaqGS ENDP Chief Executive Rajiv De Silva stepped aside to be replaced by generics division head Paul Campanelli The SPDR Pharmaceuticals ETF NYSEArca XPH rose 0 8
VRX,VRX:CT,BBG000DC8S17,Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO,2016-09-27 15:23:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o0mCh0260pI/pharma-etf-looks-healthy-in-a-sick-market-after-endo-names-new-ceo-cm684033,A pharmaceuticals sector exchange traded fund perked up Friday after Endo International NasdaqGS ENDP Chief Executive Rajiv De Silva stepped aside to be replaced by generics division head Paul Campanelli The SPDR Pharmaceuticals ETF NYSEArca XPH rose 0 8
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : September 27, 2016",2016-09-27 12:33:21 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-us-september-27-2016/,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : September 27, 2016"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : September 27, 2016",2016-09-27 12:33:21 +0000,http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-us-september-27-2016/,"Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-US : September 27, 2016"
VRX,VRX:US,BBG000DLFM21,2 Trades to Go Long Valeant Pharmaceuticals Intl Inc (VRX) With Gusto!,2016-09-26 20:22:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tx18BJyhOwk/2-trades-to-go-long-valeant-pharmaceuticals-intl-inc-vrx-with-gusto-cm684807,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has had its fair share of headlines The price swings have been huge and daunting enough to keep even seasoned traders out
VRX,VRX:CT,BBG000DC8S17,2 Trades to Go Long Valeant Pharmaceuticals Intl Inc (VRX) With Gusto!,2016-09-26 20:22:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tx18BJyhOwk/2-trades-to-go-long-valeant-pharmaceuticals-intl-inc-vrx-with-gusto-cm684807,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX has had its fair share of headlines The price swings have been huge and daunting enough to keep even seasoned traders out
VRX,VRX:US,BBG000DLFM21,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says",2016-09-26 19:42:00 +0000,https://www.thestreet.com/story/13752208/1/clinton-trump-share-big-pharma-attack-goals-andrew-left-says.html?puc=yahoo&cm_ven=YAHOO,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says"
VRX,VRX:CT,BBG000DC8S17,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says",2016-09-26 19:42:00 +0000,https://www.thestreet.com/story/13752208/1/clinton-trump-share-big-pharma-attack-goals-andrew-left-says.html?puc=yahoo&cm_ven=YAHOO,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says"
VRX,VRX:US,BBG000DLFM21,Andrew Left Says Trump and Clinton Agree on Just One Thing,2016-09-26 17:30:00 +0000,http://realmoney.thestreet.com/articles/09/26/2016/andrew-left-says-trump-and-clinton-agree-just-one-thing?puc=yahoo&cm_ven=YAHOO,Andrew Left Says Trump and Clinton Agree on Just One Thing
VRX,VRX:CT,BBG000DC8S17,Andrew Left Says Trump and Clinton Agree on Just One Thing,2016-09-26 17:30:00 +0000,http://realmoney.thestreet.com/articles/09/26/2016/andrew-left-says-trump-and-clinton-agree-just-one-thing?puc=yahoo&cm_ven=YAHOO,Andrew Left Says Trump and Clinton Agree on Just One Thing
VRX,VRX:US,BBG000DLFM21,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?,2016-09-26 14:24:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RSiQpnt4TAk/can-you-guess-which-big-pharma-has-raised-its-drug-prices-5-times-since-june-2014-cm684421,Image source Getty Images This is probably far from breaking news or in any way shocking but prescription drug prices are soaring If you ve filled a prescription recently you probably don t need that affirmation According to an analysis conducted by healthcare data
VRX,VRX:CT,BBG000DC8S17,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?,2016-09-26 14:24:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RSiQpnt4TAk/can-you-guess-which-big-pharma-has-raised-its-drug-prices-5-times-since-june-2014-cm684421,Image source Getty Images This is probably far from breaking news or in any way shocking but prescription drug prices are soaring If you ve filled a prescription recently you probably don t need that affirmation According to an analysis conducted by healthcare data
VRX,VRX:US,BBG000DLFM21,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?,2016-09-26 12:25:40 +0000,http://www.fool.com/investing/2016/09/26/can-you-guess-which-big-pharma-has-raised-its-drug.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?
VRX,VRX:CT,BBG000DC8S17,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?,2016-09-26 12:25:40 +0000,http://www.fool.com/investing/2016/09/26/can-you-guess-which-big-pharma-has-raised-its-drug.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?
VRX,VRX:US,BBG000DLFM21,“Don’t fire until you see the whites of their eyes”,2016-09-25 17:04:26 +0000,http://finance.yahoo.com/tumblr/blog-dont-fire-until-you-see-the-whites-of-their-170432457.html,“Don’t fire until you see the whites of their eyes”
VRX,VRX:CT,BBG000DC8S17,“Don’t fire until you see the whites of their eyes”,2016-09-25 17:04:26 +0000,http://finance.yahoo.com/tumblr/blog-dont-fire-until-you-see-the-whites-of-their-170432457.html,“Don’t fire until you see the whites of their eyes”
VRX,VRX:US,BBG000DLFM21,"Wealth Preservation: ""All I Know Is That I Know Nothing""",2016-09-25 14:00:00 +0000,http://www.investopedia.com/articles/investing-strategy/092516/wealth-preservation-all-i-know-i-know-nothing.asp?partner=YahooSA,"Wealth Preservation: ""All I Know Is That I Know Nothing"""
VRX,VRX:CT,BBG000DC8S17,"Wealth Preservation: ""All I Know Is That I Know Nothing""",2016-09-25 14:00:00 +0000,http://www.investopedia.com/articles/investing-strategy/092516/wealth-preservation-all-i-know-i-know-nothing.asp?partner=YahooSA,"Wealth Preservation: ""All I Know Is That I Know Nothing"""
VRX,VRX:CT,BBG000DC8S17,Investing for the Next 100 Years,2016-09-23 21:25:00 +0000,http://blogs.barrons.com/penta/2016/09/23/investing-for-the-next-100-years/?mod=yahoobarrons&ru=yahoo,Investing for the Next 100 Years
VRX,VRX:US,BBG000DLFM21,Investing for the Next 100 Years,2016-09-23 21:25:00 +0000,http://blogs.barrons.com/penta/2016/09/23/investing-for-the-next-100-years/?mod=yahoobarrons&ru=yahoo,Investing for the Next 100 Years
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals Playing With Fire?,2016-09-23 21:20:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R4YCW1LbBBw/is-valeant-pharmaceuticals-playing-with-fire-cm684050,Image source Getty Images As shareholders of Valeant Pharmaceuticals NYSE VRX would likely testify little has gone right for the former megacap pharmaceutical company since last summer Shares of Valeant have essentially dropped 90 from their all time high on account
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals Playing With Fire?,2016-09-23 21:20:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R4YCW1LbBBw/is-valeant-pharmaceuticals-playing-with-fire-cm684050,Image source Getty Images As shareholders of Valeant Pharmaceuticals NYSE VRX would likely testify little has gone right for the former megacap pharmaceutical company since last summer Shares of Valeant have essentially dropped 90 from their all time high on account
VRX,VRX:US,BBG000DLFM21,"Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest",2016-09-23 20:46:44 +0000,http://www.investors.com/research/ibd-industry-themes/amgen-biogen-pitted-in-ma-scenario-adamas-acadia-draw-interest/,"Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest"
VRX,VRX:CT,BBG000DC8S17,"Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest",2016-09-23 20:46:44 +0000,http://www.investors.com/research/ibd-industry-themes/amgen-biogen-pitted-in-ma-scenario-adamas-acadia-draw-interest/,"Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest"
VRX,VRX:US,BBG000DLFM21,Is Valeant Pharmaceuticals Playing With Fire?,2016-09-23 20:11:24 +0000,http://www.fool.com/investing/2016/09/23/is-valeant-pharmaceuticals-playing-with-fire.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals Playing With Fire?
VRX,VRX:CT,BBG000DC8S17,Is Valeant Pharmaceuticals Playing With Fire?,2016-09-23 20:11:24 +0000,http://www.fool.com/investing/2016/09/23/is-valeant-pharmaceuticals-playing-with-fire.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Valeant Pharmaceuticals Playing With Fire?
VRX,VRX:US,BBG000DLFM21,"New Research Reports for General Mills, Cisco & Charter Comm",2016-09-23 19:23:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUt9-xaDRNY/new-research-reports-for-general-mills-cisco-charter-comm-cm683969,Friday September 23 2016 Today s Research Daily features new research reports on 16 major stocks including General Mills GIS Charter Communications CHTR and Cisco CSCO General Mills is in a tough spot having to respond to ever changing consumer tastes The issue
VRX,VRX:CT,BBG000DC8S17,"New Research Reports for General Mills, Cisco & Charter Comm",2016-09-23 19:23:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUt9-xaDRNY/new-research-reports-for-general-mills-cisco-charter-comm-cm683969,Friday September 23 2016 Today s Research Daily features new research reports on 16 major stocks including General Mills GIS Charter Communications CHTR and Cisco CSCO General Mills is in a tough spot having to respond to ever changing consumer tastes The issue
VRX,VRX:US,BBG000DLFM21,Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO,2016-09-23 18:23:22 +0000,http://finance.yahoo.com/news/pharma-etf-looks-healthy-sick-182322652.html,Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO
VRX,VRX:CT,BBG000DC8S17,Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO,2016-09-23 18:23:22 +0000,http://finance.yahoo.com/news/pharma-etf-looks-healthy-sick-182322652.html,Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO
VRX,VRX:US,BBG000DLFM21,"Endo Int'l: New CEO ""Has His Work Cut Out For Him""",2016-09-23 17:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/23/endo-intl-new-ceo-has-his-work-cut-out-for-him/?mod=yahoobarrons&ru=yahoo,"Endo Int'l: New CEO ""Has His Work Cut Out For Him"""
VRX,VRX:CT,BBG000DC8S17,"Endo Int'l: New CEO ""Has His Work Cut Out For Him""",2016-09-23 17:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/23/endo-intl-new-ceo-has-his-work-cut-out-for-him/?mod=yahoobarrons&ru=yahoo,"Endo Int'l: New CEO ""Has His Work Cut Out For Him"""
VRX,VRX:US,BBG000DLFM21,Valeant Needs Time If It Is to Recover and Rise,2016-09-23 16:18:00 +0000,http://realmoney.thestreet.com/articles/09/23/2016/valeant-needs-time-if-it-recover-and-rise?puc=yahoo&cm_ven=YAHOO,Valeant Needs Time If It Is to Recover and Rise
VRX,VRX:CT,BBG000DC8S17,Valeant Needs Time If It Is to Recover and Rise,2016-09-23 16:18:00 +0000,http://realmoney.thestreet.com/articles/09/23/2016/valeant-needs-time-if-it-recover-and-rise?puc=yahoo&cm_ven=YAHOO,Valeant Needs Time If It Is to Recover and Rise
VRX,VRX:CT,BBG000DC8S17,"Jim Chanos Is Still Short on Valeant, Bill Miller Is Positive",2016-09-22 15:04:53 +0000,http://marketrealist.com/2016/09/jim-chanos-still-short-valeant-bill-miller-positive-stance/?utm_source=yahoo&utm_medium=feed,"Jim Chanos Is Still Short on Valeant, Bill Miller Is Positive"
VRX,VRX:US,BBG000DLFM21,"Jim Chanos Is Still Short on Valeant, Bill Miller Is Positive",2016-09-22 15:04:53 +0000,http://marketrealist.com/2016/09/jim-chanos-still-short-valeant-bill-miller-positive-stance/?utm_source=yahoo&utm_medium=feed,"Jim Chanos Is Still Short on Valeant, Bill Miller Is Positive"
VRX,VRX:CT,BBG000DC8S17,[$$] Mylan chief comes under fire over cost of EpiPen,2016-09-21 22:49:56 +0000,"http://www.ft.com/cms/s/64f0cb22-8040-11e6-bc52-0c7211ef3198,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Mylan was accused of raising the price of its EpiPen allergy injection by almost 5,000 per cent since 2007 so its executives could get ""filthy rich"" at the expense of American taxpayers during ..."
VRX,VRX:US,BBG000DLFM21,[$$] Mylan chief comes under fire over cost of EpiPen,2016-09-21 22:49:56 +0000,"http://www.ft.com/cms/s/64f0cb22-8040-11e6-bc52-0c7211ef3198,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Mylan was accused of raising the price of its EpiPen allergy injection by almost 5,000 per cent since 2007 so its executives could get ""filthy rich"" at the expense of American taxpayers during ..."
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Higher on Potential $1 Billion iNova Sale,2016-09-21 16:16:00 +0000,https://www.thestreet.com/story/13747684/1/valeant-vrx-stock-higher-on-potential-1-billion-inova-sale.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Higher on Potential $1 Billion iNova Sale
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Higher on Potential $1 Billion iNova Sale,2016-09-21 16:16:00 +0000,https://www.thestreet.com/story/13747684/1/valeant-vrx-stock-higher-on-potential-1-billion-inova-sale.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Higher on Potential $1 Billion iNova Sale
VRX,VRX:CT,BBG000DC8S17,What Is the Upside Potential for Valeant?,2016-09-21 12:04:25 +0000,http://marketrealist.com/2016/09/what-is-the-upside-potential-for-valeant/?utm_source=yahoo&utm_medium=feed,What Is the Upside Potential for Valeant?
VRX,VRX:US,BBG000DLFM21,What Is the Upside Potential for Valeant?,2016-09-21 12:04:25 +0000,http://marketrealist.com/2016/09/what-is-the-upside-potential-for-valeant/?utm_source=yahoo&utm_medium=feed,What Is the Upside Potential for Valeant?
VRX,VRX:CT,BBG000DC8S17,Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt,2016-09-20 17:30:00 +0000,https://www.thestreet.com/story/13746109/1/valeant-s-1-5-billion-capital-hole-and-31-billion-in-debt.html?puc=yahoo&cm_ven=YAHOO,Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt
VRX,VRX:US,BBG000DLFM21,Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt,2016-09-20 17:30:00 +0000,https://www.thestreet.com/story/13746109/1/valeant-s-1-5-billion-capital-hole-and-31-billion-in-debt.html?puc=yahoo&cm_ven=YAHOO,Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt
VRX,VRX:CT,BBG000DC8S17,Five Canadian Stocks Hedge Funds Like,2016-09-20 16:07:11 +0000,http://www.insidermonkey.com/blog/five-canadian-stocks-hedge-funds-like-474295/,Five Canadian Stocks Hedge Funds Like
VRX,VRX:US,BBG000DLFM21,Five Canadian Stocks Hedge Funds Like,2016-09-20 16:07:11 +0000,http://www.insidermonkey.com/blog/five-canadian-stocks-hedge-funds-like-474295/,Five Canadian Stocks Hedge Funds Like
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Remember Them?,2016-09-20 15:42:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/20/valeant-pharmaceuticals-remember-them/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Remember Them?
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Remember Them?,2016-09-20 15:42:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/20/valeant-pharmaceuticals-remember-them/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Remember Them?
VRX,VRX:US,BBG000DLFM21,Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole',2016-09-20 15:30:00 +0000,http://realmoney.thestreet.com/articles/09/20/2016/stressed-out-valeant-may-need-1.5b-new-debt-fill-capital-hole?puc=yahoo&cm_ven=YAHOO,Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'
VRX,VRX:CT,BBG000DC8S17,Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole',2016-09-20 15:30:00 +0000,http://realmoney.thestreet.com/articles/09/20/2016/stressed-out-valeant-may-need-1.5b-new-debt-fill-capital-hole?puc=yahoo&cm_ven=YAHOO,Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Receives 'Hold' Rating at Deutsche Bank,2016-09-20 15:27:00 +0000,https://www.thestreet.com/story/13746002/1/valeant-vrx-stock-receives-hold-rating-at-deutsche-bank.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Receives 'Hold' Rating at Deutsche Bank
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Receives 'Hold' Rating at Deutsche Bank,2016-09-20 15:27:00 +0000,https://www.thestreet.com/story/13746002/1/valeant-vrx-stock-receives-hold-rating-at-deutsche-bank.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Receives 'Hold' Rating at Deutsche Bank
VRX,VRX:CT,BBG000DC8S17,How Will Valeant’s Profitability Pan Out over the Long Term?,2016-09-20 15:04:34 +0000,http://marketrealist.com/2016/09/how-will-valeants-profitability-pan-out-over-the-long-term/?utm_source=yahoo&utm_medium=feed,How Will Valeant’s Profitability Pan Out over the Long Term?
VRX,VRX:US,BBG000DLFM21,How Will Valeant’s Profitability Pan Out over the Long Term?,2016-09-20 15:04:34 +0000,http://marketrealist.com/2016/09/how-will-valeants-profitability-pan-out-over-the-long-term/?utm_source=yahoo&utm_medium=feed,How Will Valeant’s Profitability Pan Out over the Long Term?
VRX,VRX:CT,BBG000DC8S17,Why Valeant Offers Volume-Based Discounts for These Drugs,2016-09-20 14:04:44 +0000,http://marketrealist.com/2016/09/why-valeant-offers-volume-based-discounts-for-these-drugs/?utm_source=yahoo&utm_medium=feed,Why Valeant Offers Volume-Based Discounts for These Drugs
VRX,VRX:US,BBG000DLFM21,Why Valeant Offers Volume-Based Discounts for These Drugs,2016-09-20 14:04:44 +0000,http://marketrealist.com/2016/09/why-valeant-offers-volume-based-discounts-for-these-drugs/?utm_source=yahoo&utm_medium=feed,Why Valeant Offers Volume-Based Discounts for These Drugs
VRX,VRX:CT,BBG000DC8S17,"Valeant’s Strategies for Its Dermatology, Gastroenterology Drugs",2016-09-20 12:04:48 +0000,http://marketrealist.com/2016/09/valeants-strategies-for-its-dermatology-gastroenterology-drugs/?utm_source=yahoo&utm_medium=feed,"Valeant’s Strategies for Its Dermatology, Gastroenterology Drugs"
VRX,VRX:US,BBG000DLFM21,"Valeant’s Strategies for Its Dermatology, Gastroenterology Drugs",2016-09-20 12:04:48 +0000,http://marketrealist.com/2016/09/valeants-strategies-for-its-dermatology-gastroenterology-drugs/?utm_source=yahoo&utm_medium=feed,"Valeant’s Strategies for Its Dermatology, Gastroenterology Drugs"
VRX,VRX:CT,BBG000DC8S17,"After Hours Most Active for Sep 19, 2016 :  MDLZ, VRX, F, INTC, V, SGYP, HPQ, MSFT, VZ, CHK, AMAT, VIP",2016-09-19 21:00:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rA5wf8wiKYg/after-hours-most-active-for-sep-19-2016-mdlz-vrx-f-intc-v-sgyp-hpq-msft-vz-chk-amat-vip-cm681600,The NASDAQ 100 After Hours Indicator is up 34 to 4 796 41 The total After hours volume is currently 30 695 120 shares traded The following are the most active stocks for the after hours session Mondelez International Inc MDLZ is 0 3314 at 43 20 with 4 391
VRX,VRX:US,BBG000DLFM21,"After Hours Most Active for Sep 19, 2016 :  MDLZ, VRX, F, INTC, V, SGYP, HPQ, MSFT, VZ, CHK, AMAT, VIP",2016-09-19 21:00:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rA5wf8wiKYg/after-hours-most-active-for-sep-19-2016-mdlz-vrx-f-intc-v-sgyp-hpq-msft-vz-chk-amat-vip-cm681600,The NASDAQ 100 After Hours Indicator is up 34 to 4 796 41 The total After hours volume is currently 30 695 120 shares traded The following are the most active stocks for the after hours session Mondelez International Inc MDLZ is 0 3314 at 43 20 with 4 391
VRX,VRX:US,BBG000DLFM21,How Valeant Plans to Its Fix Dermatology Portfolio,2016-09-19 20:04:12 +0000,http://marketrealist.com/2016/09/how-valeant-plans-to-its-fix-dermatology-portfolio/?utm_source=yahoo&utm_medium=feed,How Valeant Plans to Its Fix Dermatology Portfolio
VRX,VRX:CT,BBG000DC8S17,How Valeant Plans to Its Fix Dermatology Portfolio,2016-09-19 20:04:12 +0000,http://marketrealist.com/2016/09/how-valeant-plans-to-its-fix-dermatology-portfolio/?utm_source=yahoo&utm_medium=feed,How Valeant Plans to Its Fix Dermatology Portfolio
VRX,VRX:CT,BBG000DC8S17,"Hateful Paper: Washed Out, Worth A Shot",2016-09-19 19:56:00 +0000,http://www.forbes.com/sites/martinsosnoff/2016/09/19/hateful-paper-washed-out-worth-a-shot/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Hateful Paper: Washed Out, Worth A Shot"
VRX,VRX:US,BBG000DLFM21,"Hateful Paper: Washed Out, Worth A Shot",2016-09-19 19:56:00 +0000,http://www.forbes.com/sites/martinsosnoff/2016/09/19/hateful-paper-washed-out-worth-a-shot/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Hateful Paper: Washed Out, Worth A Shot"
VRX,VRX:CT,BBG000DC8S17,Projected Revenue for Valeant in 2017,2016-09-19 19:04:09 +0000,http://marketrealist.com/2016/09/projected-revenue-for-valeant-in-2017/?utm_source=yahoo&utm_medium=feed,Projected Revenue for Valeant in 2017
VRX,VRX:US,BBG000DLFM21,Projected Revenue for Valeant in 2017,2016-09-19 19:04:09 +0000,http://marketrealist.com/2016/09/projected-revenue-for-valeant-in-2017/?utm_source=yahoo&utm_medium=feed,Projected Revenue for Valeant in 2017
VRX,VRX:US,BBG000DLFM21,Understanding Valeant’s Improved Valuation Multiple,2016-09-19 16:59:52 +0000,http://marketrealist.com/2016/09/understanding-valeants-improved-valuation-multiple/?utm_source=yahoo&utm_medium=feed,Understanding Valeant’s Improved Valuation Multiple
VRX,VRX:CT,BBG000DC8S17,Understanding Valeant’s Improved Valuation Multiple,2016-09-19 16:59:52 +0000,http://marketrealist.com/2016/09/understanding-valeants-improved-valuation-multiple/?utm_source=yahoo&utm_medium=feed,Understanding Valeant’s Improved Valuation Multiple
VRX,VRX:CT,BBG000DC8S17,Valeant has started taking a huge risk,2016-09-19 15:22:00 +0000,http://finance.yahoo.com/news/valeant-started-taking-huge-risk-152200943.html,Valeant has started taking a huge risk
VRX,VRX:US,BBG000DLFM21,Valeant has started taking a huge risk,2016-09-19 15:22:00 +0000,http://finance.yahoo.com/news/valeant-started-taking-huge-risk-152200943.html,Valeant has started taking a huge risk
VRX,VRX:US,BBG000DLFM21,"Valeant Keeps Raising Drug Prices, Stock Still Carries Too Much Risk: Wells Fargo",2016-09-19 13:07:17 +0000,http://finance.yahoo.com/news/valeant-keeps-raising-drug-prices-130717111.html,"Valeant Keeps Raising Drug Prices, Stock Still Carries Too Much Risk: Wells Fargo"
VRX,VRX:CT,BBG000DC8S17,"Valeant Keeps Raising Drug Prices, Stock Still Carries Too Much Risk: Wells Fargo",2016-09-19 13:07:17 +0000,http://finance.yahoo.com/news/valeant-keeps-raising-drug-prices-130717111.html,"Valeant Keeps Raising Drug Prices, Stock Still Carries Too Much Risk: Wells Fargo"
VRX,VRX:CT,BBG000DC8S17,From a wrist slap to jail time: how the SEC deals with dodgy accounting,2016-09-19 11:00:09 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=30DFD2F2-7C2F-11E6-AA97-CF05589A95D8&siteid=yhoof2,[at MarketWatch] - What exactly does it take for a company to move from getting a slap on the wrist from the Securities and Exchange Committee for accounting issues to being slapped with criminal charges that could lead ...
VRX,VRX:US,BBG000DLFM21,From a wrist slap to jail time: how the SEC deals with dodgy accounting,2016-09-19 11:00:09 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=30DFD2F2-7C2F-11E6-AA97-CF05589A95D8&siteid=yhoof2,[at MarketWatch] - What exactly does it take for a company to move from getting a slap on the wrist from the Securities and Exchange Committee for accounting issues to being slapped with criminal charges that could lead ...
VRX,VRX:US,BBG000DLFM21,Trump Means Change Equals Major Inflection Point,2016-09-19 10:00:52 +0000,http://finance.yahoo.com/tumblr/blog-trump-means-change-equals-major-inflection-point-100058139.html,Trump Means Change Equals Major Inflection Point
VRX,VRX:CT,BBG000DC8S17,Trump Means Change Equals Major Inflection Point,2016-09-19 10:00:52 +0000,http://finance.yahoo.com/tumblr/blog-trump-means-change-equals-major-inflection-point-100058139.html,Trump Means Change Equals Major Inflection Point
VRX,VRX:US,BBG000DLFM21,Is It Time to Get Small?,2016-09-18 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=769337&SR=Yahoo,Is It Time to Get Small?
VRX,VRX:CT,BBG000DC8S17,Is It Time to Get Small?,2016-09-18 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=769337&SR=Yahoo,Is It Time to Get Small?
VRX,VRX:US,BBG000DLFM21,Valeant says discount program for heart drugs on track,2016-09-16 21:25:37 +0000,http://finance.yahoo.com/news/valeant-says-discount-program-heart-212537439.html,[Reuters] - Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cover over 90 percent U.S. hospitals once it had finalized the last of the 14 group purchasing organizations. Valeant's statement comes after Bloomberg reported that some medical centers had yet to see a cent of savings on Nitropress or Isuprel. Valeant said on Friday that group purchasing organizations may provide hospitals with upfront discounts and/or volume-based rebates after the end of the quarter in which the purchases were made.
VRX,VRX:CT,BBG000DC8S17,Valeant says discount program for heart drugs on track,2016-09-16 21:25:37 +0000,http://finance.yahoo.com/news/valeant-says-discount-program-heart-212537439.html,[Reuters] - Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cover over 90 percent U.S. hospitals once it had finalized the last of the 14 group purchasing organizations. Valeant's statement comes after Bloomberg reported that some medical centers had yet to see a cent of savings on Nitropress or Isuprel. Valeant said on Friday that group purchasing organizations may provide hospitals with upfront discounts and/or volume-based rebates after the end of the quarter in which the purchases were made.
VRX,VRX:CT,BBG000DC8S17,Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel,2016-09-16 20:38:08 +0000,http://www.publicnow.com/view/F533724D904956CC71224CD857F06C9A3A79DF50,"[at noodls] - LAVAL, Quebec, Sept. 16, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') seeks to clarify statements made in a media report today. Pursuant ..."
VRX,VRX:US,BBG000DLFM21,Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel,2016-09-16 20:38:08 +0000,http://www.publicnow.com/view/F533724D904956CC71224CD857F06C9A3A79DF50,"[at noodls] - LAVAL, Quebec, Sept. 16, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') seeks to clarify statements made in a media report today. Pursuant ..."
VRX,VRX:CT,BBG000DC8S17,Hospitals say Valeant may be blowing off the government more than we thought,2016-09-16 19:13:00 +0000,http://finance.yahoo.com/news/hospitals-valeant-may-blowing-off-191300483.html,Hospitals say Valeant may be blowing off the government more than we thought
VRX,VRX:US,BBG000DLFM21,Hospitals say Valeant may be blowing off the government more than we thought,2016-09-16 19:13:00 +0000,http://finance.yahoo.com/news/hospitals-valeant-may-blowing-off-191300483.html,Hospitals say Valeant may be blowing off the government more than we thought
VRX,VRX:CT,BBG000DC8S17,Two Key Checklist Items,2016-09-16 18:17:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dSGJLBgTIJQ/two-key-checklist-items-cm680559,I am not a big fan of going through specific checklist items one by one when evaluating an investment idea I know this idea has gained enormous popularity in recent years partly due to the good book The Checklist Manifesto and partly popularized in value investing circles by Mohnish
VRX,VRX:US,BBG000DLFM21,Two Key Checklist Items,2016-09-16 18:17:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dSGJLBgTIJQ/two-key-checklist-items-cm680559,I am not a big fan of going through specific checklist items one by one when evaluating an investment idea I know this idea has gained enormous popularity in recent years partly due to the good book The Checklist Manifesto and partly popularized in value investing circles by Mohnish
VRX,VRX:US,BBG000DLFM21,SolarCity Corp (SCTY) Is Not Valeant and Tesla Motors Inc (TSLA) Is Not Enron,2016-09-16 17:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vvgJWt6mUz0/solarcity-corp-scty-is-not-valeant-and-tesla-motors-inc-tsla-is-not-enron-cm680055,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Short seller Jim Chanos made headlines this week by loudly calling Tesla Motors Inc 160 NASDAQ TSLA a walking insolvency because of its pending acquisition of SolarCity Corp 160 NASDAQ
VRX,VRX:CT,BBG000DC8S17,SolarCity Corp (SCTY) Is Not Valeant and Tesla Motors Inc (TSLA) Is Not Enron,2016-09-16 17:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vvgJWt6mUz0/solarcity-corp-scty-is-not-valeant-and-tesla-motors-inc-tsla-is-not-enron-cm680055,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Short seller Jim Chanos made headlines this week by loudly calling Tesla Motors Inc 160 NASDAQ TSLA a walking insolvency because of its pending acquisition of SolarCity Corp 160 NASDAQ
VRX,VRX:CT,BBG000DC8S17,Why Does Bill Miller Like Valeant Pharmaceuticals?,2016-09-16 15:04:49 +0000,http://marketrealist.com/2016/09/bill-miller-likes-valeant-pharmaceuticals-heres/?utm_source=yahoo&utm_medium=feed,Why Does Bill Miller Like Valeant Pharmaceuticals?
VRX,VRX:US,BBG000DLFM21,Why Does Bill Miller Like Valeant Pharmaceuticals?,2016-09-16 15:04:49 +0000,http://marketrealist.com/2016/09/bill-miller-likes-valeant-pharmaceuticals-heres/?utm_source=yahoo&utm_medium=feed,Why Does Bill Miller Like Valeant Pharmaceuticals?
VRX,VRX:CT,BBG000DC8S17,"Valeant Drug Discounts Haven’t Materialized, Hospitals Say",2016-09-16 09:00:00 +0000,http://www.bloomberg.com/news/articles/2016-09-16/valeant-heart-drug-discounts-haven-t-materialized-hospitals-say?cmpid=yhoo.headline,"Valeant Drug Discounts Haven’t Materialized, Hospitals Say"
VRX,VRX:US,BBG000DLFM21,"Valeant Drug Discounts Haven’t Materialized, Hospitals Say",2016-09-16 09:00:00 +0000,http://www.bloomberg.com/news/articles/2016-09-16/valeant-heart-drug-discounts-haven-t-materialized-hospitals-say?cmpid=yhoo.headline,"Valeant Drug Discounts Haven’t Materialized, Hospitals Say"
VRX,VRX:US,BBG000DLFM21,The Single Most Important Metric to Determine if Valeant Pharmaceuticals Is a Buy,2016-09-15 21:18:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IZSlKuvKgM0/the-single-most-important-metric-to-determine-if-valeant-pharmaceuticals-is-a-buy-cm680240,Image source Getty Images Valeant Pharmaceuticals NYSE VRX has been in the spotlight for more than a year now for all the wrong reasons After peaking at 264 a share in the summer of 2015 Valeant s stock dipped below 20 at one point with John and Jane Investor along
VRX,VRX:CT,BBG000DC8S17,The Single Most Important Metric to Determine if Valeant Pharmaceuticals Is a Buy,2016-09-15 21:18:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IZSlKuvKgM0/the-single-most-important-metric-to-determine-if-valeant-pharmaceuticals-is-a-buy-cm680240,Image source Getty Images Valeant Pharmaceuticals NYSE VRX has been in the spotlight for more than a year now for all the wrong reasons After peaking at 264 a share in the summer of 2015 Valeant s stock dipped below 20 at one point with John and Jane Investor along
VRX,VRX:CT,BBG000DC8S17,The Single Most Important Metric to Determine if Valeant Pharmaceuticals Is a Buy,2016-09-15 19:29:41 +0000,http://www.fool.com/investing/2016/09/15/the-single-most-important-metric-to-determine-if-v.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Single Most Important Metric to Determine if Valeant Pharmaceuticals Is a Buy
VRX,VRX:US,BBG000DLFM21,The Single Most Important Metric to Determine if Valeant Pharmaceuticals Is a Buy,2016-09-15 19:29:41 +0000,http://www.fool.com/investing/2016/09/15/the-single-most-important-metric-to-determine-if-v.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Single Most Important Metric to Determine if Valeant Pharmaceuticals Is a Buy
VRX,VRX:CT,BBG000DC8S17,Guggenheim Analyst Chen Takes Bullish Outlook On Valeant's (VRX) Growth Potential,2016-09-14 18:11:00 +0000,https://www.thestreet.com/story/13733537/1/guggenheim-analyst-chen-takes-bullish-outlook-on-valeant-s-vrx-growth-potential.html?puc=yahoo&cm_ven=YAHOO,Guggenheim Analyst Chen Takes Bullish Outlook On Valeant's (VRX) Growth Potential
VRX,VRX:US,BBG000DLFM21,Guggenheim Analyst Chen Takes Bullish Outlook On Valeant's (VRX) Growth Potential,2016-09-14 18:11:00 +0000,https://www.thestreet.com/story/13733537/1/guggenheim-analyst-chen-takes-bullish-outlook-on-valeant-s-vrx-growth-potential.html?puc=yahoo&cm_ven=YAHOO,Guggenheim Analyst Chen Takes Bullish Outlook On Valeant's (VRX) Growth Potential
VRX,VRX:US,BBG000DLFM21,Delivering Alpha -- and Animosity: Conference Speakers Agree on Little,2016-09-14 15:29:00 +0000,http://realmoney.thestreet.com/articles/09/14/2016/delivering-alpha-and-animosity-conference-speakers-agree-little?puc=yahoo&cm_ven=YAHOO,Delivering Alpha -- and Animosity: Conference Speakers Agree on Little
VRX,VRX:CT,BBG000DC8S17,Delivering Alpha -- and Animosity: Conference Speakers Agree on Little,2016-09-14 15:29:00 +0000,http://realmoney.thestreet.com/articles/09/14/2016/delivering-alpha-and-animosity-conference-speakers-agree-little?puc=yahoo&cm_ven=YAHOO,Delivering Alpha -- and Animosity: Conference Speakers Agree on Little
VRX,VRX:US,BBG000DLFM21,Look Out For In-Kind Tender Offer Problems At This Closed-End Fund,2016-09-14 14:49:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q186Z06Eabk/look-out-for-in-kind-tender-offer-problems-at-this-closed-end-fund-cm678259,By Gwailo ByGwailo 1 Introduction 1 Introduction1 Introduction Following up on a recent piece about the pay in kind plan that the New Ireland Fund IRL wants to use in a tender offer for 25 of its shares let s look at how another fund Advent Claymore Enhanced Growth
VRX,VRX:CT,BBG000DC8S17,Look Out For In-Kind Tender Offer Problems At This Closed-End Fund,2016-09-14 14:49:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q186Z06Eabk/look-out-for-in-kind-tender-offer-problems-at-this-closed-end-fund-cm678259,By Gwailo ByGwailo 1 Introduction 1 Introduction1 Introduction Following up on a recent piece about the pay in kind plan that the New Ireland Fund IRL wants to use in a tender offer for 25 of its shares let s look at how another fund Advent Claymore Enhanced Growth
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rebounding After Reversal In Crude -- Canadian Commentary,2016-09-14 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GUzpypmmfeU/canadian-stocks-are-rebounding-after-reversal-in-crude--canadian-commentary-20160914-00701,Canadian Stocks Are Rebounding After Reversal In Crude -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rebounding After Reversal In Crude -- Canadian Commentary,2016-09-14 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GUzpypmmfeU/canadian-stocks-are-rebounding-after-reversal-in-crude--canadian-commentary-20160914-00701,Canadian Stocks Are Rebounding After Reversal In Crude -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Cramer: We Need to Be Able to Predict a Clear Election Winner,2016-09-13 23:01:00 +0000,http://realmoney.thestreet.com/articles/09/13/2016/cramer-we-need-be-able-predict-clear-election-winner?puc=yahoo&cm_ven=YAHOO,Cramer: We Need to Be Able to Predict a Clear Election Winner
VRX,VRX:CT,BBG000DC8S17,Cramer: We Need to Be Able to Predict a Clear Election Winner,2016-09-13 23:01:00 +0000,http://realmoney.thestreet.com/articles/09/13/2016/cramer-we-need-be-able-predict-clear-election-winner?puc=yahoo&cm_ven=YAHOO,Cramer: We Need to Be Able to Predict a Clear Election Winner
VRX,VRX:CT,BBG000DC8S17,Bill Miller: Valeant shares could post 25-30 pct returns over 5 years,2016-09-13 20:35:14 +0000,http://finance.yahoo.com/news/bill-miller-valeant-shares-could-203514081.html,"[Reuters] - Noted value investor Bill Miller said on Tuesday that Valeant Pharmaceuticals International Inc, the troubled Canadian drugmaker, is one of his top holdings, with the company's expected cash flows making the stock attractive. Valeant's market value has fallen by some 90 percent in the last year as the company's drug pricing and other business practices prompted investigations by multiple U.S. government agencies and by Congress. ""We think with Valeant right now, it's a completely different company,"" Miller said at the CNBC Institutional Investor Delivering Alpha Conference in New York."
VRX,VRX:US,BBG000DLFM21,Bill Miller: Valeant shares could post 25-30 pct returns over 5 years,2016-09-13 20:35:14 +0000,http://finance.yahoo.com/news/bill-miller-valeant-shares-could-203514081.html,"[Reuters] - Noted value investor Bill Miller said on Tuesday that Valeant Pharmaceuticals International Inc, the troubled Canadian drugmaker, is one of his top holdings, with the company's expected cash flows making the stock attractive. Valeant's market value has fallen by some 90 percent in the last year as the company's drug pricing and other business practices prompted investigations by multiple U.S. government agencies and by Congress. ""We think with Valeant right now, it's a completely different company,"" Miller said at the CNBC Institutional Investor Delivering Alpha Conference in New York."
VRX,VRX:CT,BBG000DC8S17,Top Stock Picks From CNBC's Delivering Alpha Conference,2016-09-13 18:02:00 +0000,https://www.thestreet.com/story/13727315/1/top-stock-picks-from-cnbc-s-delivering-alpha-conference.html?puc=yahoo&cm_ven=YAHOO,Top Stock Picks From CNBC's Delivering Alpha Conference
VRX,VRX:US,BBG000DLFM21,Top Stock Picks From CNBC's Delivering Alpha Conference,2016-09-13 18:02:00 +0000,https://www.thestreet.com/story/13727315/1/top-stock-picks-from-cnbc-s-delivering-alpha-conference.html?puc=yahoo&cm_ven=YAHOO,Top Stock Picks From CNBC's Delivering Alpha Conference
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals (VRX) Stock Down, CEO Papa Mulls Asset Sales",2016-09-13 14:12:00 +0000,https://www.thestreet.com/story/13726743/1/valeant-pharmaceuticals-vrx-stock-down-ceo-papa-mulls-asset-sales.html?puc=yahoo&cm_ven=YAHOO,"Valeant Pharmaceuticals (VRX) Stock Down, CEO Papa Mulls Asset Sales"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals (VRX) Stock Down, CEO Papa Mulls Asset Sales",2016-09-13 14:12:00 +0000,https://www.thestreet.com/story/13726743/1/valeant-pharmaceuticals-vrx-stock-down-ceo-papa-mulls-asset-sales.html?puc=yahoo&cm_ven=YAHOO,"Valeant Pharmaceuticals (VRX) Stock Down, CEO Papa Mulls Asset Sales"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Sinking As Crude Oil Prices Drop -- Canadian Commentary,2016-09-13 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wFAVp7NV0iQ/canadian-stocks-are-sinking-as-crude-oil-prices-drop--canadian-commentary-20160913-00751,Canadian Stocks Are Sinking As Crude Oil Prices Drop -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Sinking As Crude Oil Prices Drop -- Canadian Commentary,2016-09-13 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wFAVp7NV0iQ/canadian-stocks-are-sinking-as-crude-oil-prices-drop--canadian-commentary-20160913-00751,Canadian Stocks Are Sinking As Crude Oil Prices Drop -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,2 Things Ackman Wants to Change at Chipotle,2016-09-12 20:35:03 +0000,http://finance.yahoo.com/news/2-things-ackman-wants-change-203503875.html,2 Things Ackman Wants to Change at Chipotle
VRX,VRX:US,BBG000DLFM21,2 Things Ackman Wants to Change at Chipotle,2016-09-12 20:35:03 +0000,http://finance.yahoo.com/news/2-things-ackman-wants-change-203503875.html,2 Things Ackman Wants to Change at Chipotle
VRX,VRX:CT,BBG000DC8S17,"Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes",2016-09-12 20:25:12 +0000,http://www.investors.com/news/technology/perrigo-jumps-as-starboard-reveals-big-stake-demands-changes/,"Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes"
VRX,VRX:US,BBG000DLFM21,"Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes",2016-09-12 20:25:12 +0000,http://www.investors.com/news/technology/perrigo-jumps-as-starboard-reveals-big-stake-demands-changes/,"Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes"
VRX,VRX:US,BBG000DLFM21,Valeant's CEO was clueless when analysts asked about a specialty pharmacy his company deals with,2016-09-12 16:58:00 +0000,http://finance.yahoo.com/news/valeants-ceo-clueless-analysts-asked-165800993.html,Valeant's CEO was clueless when analysts asked about a specialty pharmacy his company deals with
VRX,VRX:CT,BBG000DC8S17,Valeant's CEO was clueless when analysts asked about a specialty pharmacy his company deals with,2016-09-12 16:58:00 +0000,http://finance.yahoo.com/news/valeants-ceo-clueless-analysts-asked-165800993.html,Valeant's CEO was clueless when analysts asked about a specialty pharmacy his company deals with
VRX,VRX:US,BBG000DLFM21,Starboard Value Takes 4.6% Stake in Perrigo,2016-09-11 23:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wO_YiKtizJg/starboard-value-takes-46-stake-in-perrigo-20160911-00049,Starboard Value Takes 4.6% Stake in Perrigo
VRX,VRX:CT,BBG000DC8S17,Starboard Value Takes 4.6% Stake in Perrigo,2016-09-11 23:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wO_YiKtizJg/starboard-value-takes-46-stake-in-perrigo-20160911-00049,Starboard Value Takes 4.6% Stake in Perrigo
VRX,VRX:CT,BBG000DC8S17,"One year after it was approved, a look back on the 'female Viagra'",2016-09-11 18:00:00 +0000,http://finance.yahoo.com/news/one-approved-look-back-female-180000993.html,"One year after it was approved, a look back on the 'female Viagra'"
VRX,VRX:US,BBG000DLFM21,"One year after it was approved, a look back on the 'female Viagra'",2016-09-11 18:00:00 +0000,http://finance.yahoo.com/news/one-approved-look-back-female-180000993.html,"One year after it was approved, a look back on the 'female Viagra'"
VRX,VRX:US,BBG000DLFM21,Teva Discusses EpiPen Comps as Host of Generics Unveiled,2016-09-09 20:34:00 +0000,https://www.thestreet.com/slideshow/13700288/1/teva-discusses-epipen-comps-as-host-of-generics-unveiled.html?puc=yahoo&cm_ven=YAHOO,Teva Discusses EpiPen Comps as Host of Generics Unveiled
VRX,VRX:CT,BBG000DC8S17,Teva Discusses EpiPen Comps as Host of Generics Unveiled,2016-09-09 20:34:00 +0000,https://www.thestreet.com/slideshow/13700288/1/teva-discusses-epipen-comps-as-host-of-generics-unveiled.html?puc=yahoo&cm_ven=YAHOO,Teva Discusses EpiPen Comps as Host of Generics Unveiled
VRX,VRX:CT,BBG000DC8S17,Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan,2016-09-09 20:32:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FHkEetHceQY/hillary-clintons-new-prescription-drug-proposal-takes-aim-at-valeant-pharmaceuticals-and-mylan-cm677149,Image source Getty Images With the election of the 45th president of the United States just two months away the focus on issues important to the American public is intensifying Chief among those issues is the rising cost of prescription drugs According to the Rx Price
VRX,VRX:US,BBG000DLFM21,Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan,2016-09-09 20:32:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FHkEetHceQY/hillary-clintons-new-prescription-drug-proposal-takes-aim-at-valeant-pharmaceuticals-and-mylan-cm677149,Image source Getty Images With the election of the 45th president of the United States just two months away the focus on issues important to the American public is intensifying Chief among those issues is the rising cost of prescription drugs According to the Rx Price
VRX,VRX:CT,BBG000DC8S17,Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan,2016-09-09 18:54:32 +0000,http://www.fool.com/investing/2016/09/09/hillary-clintons-new-prescription-drug-proposal-ta.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan
VRX,VRX:US,BBG000DLFM21,Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan,2016-09-09 18:54:32 +0000,http://www.fool.com/investing/2016/09/09/hillary-clintons-new-prescription-drug-proposal-ta.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan
VRX,VRX:CT,BBG000DC8S17,Bill Ackman’s Stances on Valeant Pharmaceuticals and Herbalife,2016-09-09 14:02:22 +0000,http://marketrealist.com/2016/09/bill-ackmans-stance-valeant-pharmaceuticals-herbalife/?utm_source=yahoo&utm_medium=feed,Bill Ackman’s Stances on Valeant Pharmaceuticals and Herbalife
VRX,VRX:US,BBG000DLFM21,Bill Ackman’s Stances on Valeant Pharmaceuticals and Herbalife,2016-09-09 14:02:22 +0000,http://marketrealist.com/2016/09/bill-ackmans-stance-valeant-pharmaceuticals-herbalife/?utm_source=yahoo&utm_medium=feed,Bill Ackman’s Stances on Valeant Pharmaceuticals and Herbalife
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Sinking Despite Jump In Jobs Growth -- Canadian Commentary,2016-09-09 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7nqbYKUpHZA/canadian-stocks-are-sinking-despite-jump-in-jobs-growth--canadian-commentary-20160909-00426,Canadian Stocks Are Sinking Despite Jump In Jobs Growth -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Sinking Despite Jump In Jobs Growth -- Canadian Commentary,2016-09-09 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7nqbYKUpHZA/canadian-stocks-are-sinking-despite-jump-in-jobs-growth--canadian-commentary-20160909-00426,Canadian Stocks Are Sinking Despite Jump In Jobs Growth -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Get Into Valeant Pharmaceuticals Intl Inc (VRX) With Limited Risk,2016-09-08 17:19:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bEY8jewwPiw/get-into-valeant-pharmaceuticals-intl-inc-vrx-with-limited-risk-cm676389,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is looking more promising on and off the price chart these days Nevertheless this strategist maintains the right
VRX,VRX:US,BBG000DLFM21,Get Into Valeant Pharmaceuticals Intl Inc (VRX) With Limited Risk,2016-09-08 17:19:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bEY8jewwPiw/get-into-valeant-pharmaceuticals-intl-inc-vrx-with-limited-risk-cm676389,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Valeant Pharmaceuticals Intl Inc NYSE VRX is looking more promising on and off the price chart these days Nevertheless this strategist maintains the right
VRX,VRX:US,BBG000DLFM21,3 Reasons Behind Valeant Pharmaceuticals Intl. Inc.'s 30% Ascent in August,2016-09-08 15:20:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lS-AIDp7Rc8/3-reasons-behind-valeant-pharmaceuticals-intl-incs-30-ascent-in-august-cm676200,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled pharmaceutical company that s primary grown over the years through acquisitions and strong pricing power surged 30 in August based on data from S amp P Global
VRX,VRX:CT,BBG000DC8S17,3 Reasons Behind Valeant Pharmaceuticals Intl. Inc.'s 30% Ascent in August,2016-09-08 15:20:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lS-AIDp7Rc8/3-reasons-behind-valeant-pharmaceuticals-intl-incs-30-ascent-in-august-cm676200,Image source Getty Images What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled pharmaceutical company that s primary grown over the years through acquisitions and strong pricing power surged 30 in August based on data from S amp P Global
VRX,VRX:CT,BBG000DC8S17,The EpiPen isn't the only drug that's more than doubled in price,2016-09-08 14:10:00 +0000,http://finance.yahoo.com/news/epipen-isnt-only-drug-thats-134952846.html,The EpiPen isn't the only drug that's more than doubled in price
VRX,VRX:US,BBG000DLFM21,The EpiPen isn't the only drug that's more than doubled in price,2016-09-08 14:10:00 +0000,http://finance.yahoo.com/news/epipen-isnt-only-drug-thats-134952846.html,The EpiPen isn't the only drug that's more than doubled in price
VRX,VRX:US,BBG000DLFM21,3 Reasons Behind Valeant Pharmaceuticals Intl. Inc.'s 30% Ascent in August,2016-09-08 13:41:06 +0000,http://www.fool.com/investing/2016/09/08/3-reasons-behind-valeant-pharmaceuticals-intl-incs.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Behind Valeant Pharmaceuticals Intl. Inc.'s 30% Ascent in August
VRX,VRX:CT,BBG000DC8S17,3 Reasons Behind Valeant Pharmaceuticals Intl. Inc.'s 30% Ascent in August,2016-09-08 13:41:06 +0000,http://www.fool.com/investing/2016/09/08/3-reasons-behind-valeant-pharmaceuticals-intl-incs.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Behind Valeant Pharmaceuticals Intl. Inc.'s 30% Ascent in August
VRX,VRX:US,BBG000DLFM21,What’s Been Helping PRITX Year-to-Date?,2016-09-07 23:04:24 +0000,http://marketrealist.com/2016/09/whats-been-helping-pritx-year-to-date/?utm_source=yahoo&utm_medium=feed,What’s Been Helping PRITX Year-to-Date?
VRX,VRX:CT,BBG000DC8S17,What’s Been Helping PRITX Year-to-Date?,2016-09-07 23:04:24 +0000,http://marketrealist.com/2016/09/whats-been-helping-pritx-year-to-date/?utm_source=yahoo&utm_medium=feed,What’s Been Helping PRITX Year-to-Date?
VRX,VRX:US,BBG000DLFM21,"Bill Ackman Buys 9.9% of Chipotle Mexican Grill, Inc. (CMG)",2016-09-07 17:20:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mt7xRba8ELA/bill-ackman-buys-99-of-chipotle-mexican-grill-inc-cmg-cm675378,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Chipotle Mexican Grill Inc NYSE CMG has lost its spice and Chipotle stock is off more than 40 over the past 12 months However things might be taking a turn for the better Bill Ackman who
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman Buys 9.9% of Chipotle Mexican Grill, Inc. (CMG)",2016-09-07 17:20:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mt7xRba8ELA/bill-ackman-buys-99-of-chipotle-mexican-grill-inc-cmg-cm675378,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Chipotle Mexican Grill Inc NYSE CMG has lost its spice and Chipotle stock is off more than 40 over the past 12 months However things might be taking a turn for the better Bill Ackman who
VRX,VRX:US,BBG000DLFM21,[$$] Chipotle shares jump as Ackman builds 9.9% stake,2016-09-07 17:14:07 +0000,"http://www.ft.com/cms/s/1e0c64cc-7506-11e6-bf48-b372cdb1043a,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Dissident investors in Chipotle welcomed Pershing Square's investment in the burrito chain on Wednesday, as the company's shares jumped following disclosure from the activist group that it had built a ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Chipotle shares jump as Ackman builds 9.9% stake,2016-09-07 17:14:07 +0000,"http://www.ft.com/cms/s/1e0c64cc-7506-11e6-bf48-b372cdb1043a,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Dissident investors in Chipotle welcomed Pershing Square's investment in the burrito chain on Wednesday, as the company's shares jumped following disclosure from the activist group that it had built a ..."
VRX,VRX:US,BBG000DLFM21,Invest Where You Eat: Ackman's Love of Chipotle Burritos,2016-09-07 16:40:59 +0000,http://blogs.wsj.com/moneybeat/2016/09/07/invest-where-you-eat-ackmans-love-of-chipotle-burritos/?mod=yahoo_hs,Invest Where You Eat: Ackman's Love of Chipotle Burritos
VRX,VRX:CT,BBG000DC8S17,Invest Where You Eat: Ackman's Love of Chipotle Burritos,2016-09-07 16:40:59 +0000,http://blogs.wsj.com/moneybeat/2016/09/07/invest-where-you-eat-ackmans-love-of-chipotle-burritos/?mod=yahoo_hs,Invest Where You Eat: Ackman's Love of Chipotle Burritos
VRX,VRX:CT,BBG000DC8S17,"Burlington Stores, Movado Group, Mylan, Allergan and Valeant highlighted as Zacks Bull and Bear of the Day",2016-09-07 15:21:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RjMKHAOv8Zs/burlington-stores-movado-group-mylan-allergan-and-valeant-highlighted-as-zacks-bull-and-bear-of-the-day-cm675562,For Immediate Release Chicago IL September 07 2016 Zacks Equity Research highlights 160 Burlington Stores Inc BURL as the Bull of the Day and Movado Group Inc MOV as the Bear of the Day In addition Zacks Equity Research provides analysis on Mylan NV
VRX,VRX:US,BBG000DLFM21,"Burlington Stores, Movado Group, Mylan, Allergan and Valeant highlighted as Zacks Bull and Bear of the Day",2016-09-07 15:21:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RjMKHAOv8Zs/burlington-stores-movado-group-mylan-allergan-and-valeant-highlighted-as-zacks-bull-and-bear-of-the-day-cm675562,For Immediate Release Chicago IL September 07 2016 Zacks Equity Research highlights 160 Burlington Stores Inc BURL as the Bull of the Day and Movado Group Inc MOV as the Bear of the Day In addition Zacks Equity Research provides analysis on Mylan NV
VRX,VRX:US,BBG000DLFM21,INDUSTRY FOCUS // Healthcare // 08-31-2016,2016-09-07 15:18:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ibcpfILV58A/industry-focus-healthcare-08-31-2016-cm675569,Americans are spending more money on their pets than ever before and that s been good news for people investing in pet stocks Companies like Zoetis Inc NYSE ZTS VCA Inc NASDAQ WOOF and IDEXX Laboratories Inc NASDAQ IDXX have enjoyed sales and profit
VRX,VRX:CT,BBG000DC8S17,INDUSTRY FOCUS // Healthcare // 08-31-2016,2016-09-07 15:18:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ibcpfILV58A/industry-focus-healthcare-08-31-2016-cm675569,Americans are spending more money on their pets than ever before and that s been good news for people investing in pet stocks Companies like Zoetis Inc NYSE ZTS VCA Inc NASDAQ WOOF and IDEXX Laboratories Inc NASDAQ IDXX have enjoyed sales and profit
VRX,VRX:US,BBG000DLFM21,"Ackman's Pershing Square Bets on Chipotle (CMG, VRX)",2016-09-07 14:20:00 +0000,http://www.investopedia.com/news/ackmans-pershing-square-bets-chipotle-cmg-vrx/?partner=YahooSA,"Ackman's Pershing Square Bets on Chipotle (CMG, VRX)"
VRX,VRX:CT,BBG000DC8S17,"Ackman's Pershing Square Bets on Chipotle (CMG, VRX)",2016-09-07 14:20:00 +0000,http://www.investopedia.com/news/ackmans-pershing-square-bets-chipotle-cmg-vrx/?partner=YahooSA,"Ackman's Pershing Square Bets on Chipotle (CMG, VRX)"
VRX,VRX:US,BBG000DLFM21,Post Earnings Coverage as Cooper Cos Earnings Grows 97 Percent,2016-09-07 13:17:51 +0000,http://news.investornetwork.com/2016/09/07/post-earnings-coverage-as-cooper-cos-earnings-grows-97-percent/?1=1&1473254271,Post Earnings Coverage as Cooper Cos Earnings Grows 97 Percent
VRX,VRX:CT,BBG000DC8S17,Post Earnings Coverage as Cooper Cos Earnings Grows 97 Percent,2016-09-07 13:17:51 +0000,http://news.investornetwork.com/2016/09/07/post-earnings-coverage-as-cooper-cos-earnings-grows-97-percent/?1=1&1473254271,Post Earnings Coverage as Cooper Cos Earnings Grows 97 Percent
VRX,VRX:CT,BBG000DC8S17,"Chipotle May Further Franchise, Prep for Sale as Ackman Launches Campaign",2016-09-07 11:52:00 +0000,https://www.thestreet.com/story/13695834/1/chipotle-options-include-more-franchising-prepping-for-sale-as-ackman-launches-campaign.html?puc=yahoo&cm_ven=YAHOO,"Chipotle May Further Franchise, Prep for Sale as Ackman Launches Campaign"
VRX,VRX:US,BBG000DLFM21,"Chipotle May Further Franchise, Prep for Sale as Ackman Launches Campaign",2016-09-07 11:52:00 +0000,https://www.thestreet.com/story/13695834/1/chipotle-options-include-more-franchising-prepping-for-sale-as-ackman-launches-campaign.html?puc=yahoo&cm_ven=YAHOO,"Chipotle May Further Franchise, Prep for Sale as Ackman Launches Campaign"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Dipping In Cautious Trade -- Canadian Commentary,2016-09-07 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y-DqtvoGj7s/canadian-stocks-are-dipping-in-cautious-trade--canadian-commentary-20160907-00865,Canadian Stocks Are Dipping In Cautious Trade -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Dipping In Cautious Trade -- Canadian Commentary,2016-09-07 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y-DqtvoGj7s/canadian-stocks-are-dipping-in-cautious-trade--canadian-commentary-20160907-00865,Canadian Stocks Are Dipping In Cautious Trade -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet,2016-09-06 23:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4nz68wzruXA/valeant-and-progenics-announce-us-commercial-launch-of-relistor-tablet-20160906-01408,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet
VRX,VRX:US,BBG000DLFM21,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet,2016-09-06 23:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4nz68wzruXA/valeant-and-progenics-announce-us-commercial-launch-of-relistor-tablet-20160906-01408,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet
VRX,VRX:CT,BBG000DC8S17,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet,2016-09-06 23:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yuzWacIRbEI/valeant-and-progenics-announce-us-commercial-launch-of-relistor-tablet-20160906-01407,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet
VRX,VRX:US,BBG000DLFM21,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet,2016-09-06 23:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yuzWacIRbEI/valeant-and-progenics-announce-us-commercial-launch-of-relistor-tablet-20160906-01407,Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet
VRX,VRX:CT,BBG000DC8S17,"Pharma Round-Up: Mylan's Antitrust Probe, Allergan Limits Drug Price Hikes",2016-09-06 23:16:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PmkRzZfp2wY/pharma-round-up-mylans-antitrust-probe-allergan-limits-drug-price-hikes-cm675253,On Tuesday New York Attorney General Eric Schneiderman opened an investigation into Mylan NV MYL that focuses on the drugmaker s contracts with local school districts to purchase its EpiPens In a statement Schneiderman said No child s life should be put at risk because a parent school
VRX,VRX:US,BBG000DLFM21,"Pharma Round-Up: Mylan's Antitrust Probe, Allergan Limits Drug Price Hikes",2016-09-06 23:16:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PmkRzZfp2wY/pharma-round-up-mylans-antitrust-probe-allergan-limits-drug-price-hikes-cm675253,On Tuesday New York Attorney General Eric Schneiderman opened an investigation into Mylan NV MYL that focuses on the drugmaker s contracts with local school districts to purchase its EpiPens In a statement Schneiderman said No child s life should be put at risk because a parent school
VRX,VRX:CT,BBG000DC8S17,Chipotle Jumps Late On 9.9% Pershing Square Stake,2016-09-06 22:13:09 +0000,http://www.investors.com/news/chipotle-jumps-after-hours-on-pershing-square-stake/,Chipotle Jumps Late On 9.9% Pershing Square Stake
VRX,VRX:US,BBG000DLFM21,Chipotle Jumps Late On 9.9% Pershing Square Stake,2016-09-06 22:13:09 +0000,http://www.investors.com/news/chipotle-jumps-after-hours-on-pershing-square-stake/,Chipotle Jumps Late On 9.9% Pershing Square Stake
VRX,VRX:US,BBG000DLFM21,Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets,2016-09-06 21:09:05 +0000,http://www.publicnow.com/view/91B608427A9370F9E9D4A8BE1B515FBBF86761E2,"[at noodls] - LAVAL, Quebec, Sept. 6, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) ('Progenics') today announced ..."
VRX,VRX:CT,BBG000DC8S17,Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets,2016-09-06 21:09:05 +0000,http://www.publicnow.com/view/91B608427A9370F9E9D4A8BE1B515FBBF86761E2,"[at noodls] - LAVAL, Quebec, Sept. 6, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) ('Progenics') today announced ..."
VRX,VRX:US,BBG000DLFM21,Allergan CEO: No More Predatory Drug Pricing,2016-09-06 13:20:00 +0000,https://www.thestreet.com/story/13694738/1/allergan-ceo-no-more-predatory-drug-pricing.html?puc=yahoo&cm_ven=YAHOO,Allergan CEO: No More Predatory Drug Pricing
VRX,VRX:CT,BBG000DC8S17,Allergan CEO: No More Predatory Drug Pricing,2016-09-06 13:20:00 +0000,https://www.thestreet.com/story/13694738/1/allergan-ceo-no-more-predatory-drug-pricing.html?puc=yahoo&cm_ven=YAHOO,Allergan CEO: No More Predatory Drug Pricing
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Struggling After Reversal In Crude -- Canadian Commentary,2016-09-06 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53JO6AxoEQw/canadian-stocks-are-struggling-after-reversal-in-crude--canadian-commentary-20160906-00890,Canadian Stocks Are Struggling After Reversal In Crude -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Struggling After Reversal In Crude -- Canadian Commentary,2016-09-06 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53JO6AxoEQw/canadian-stocks-are-struggling-after-reversal-in-crude--canadian-commentary-20160906-00890,Canadian Stocks Are Struggling After Reversal In Crude -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Drug Stocks Remain in Focus as Pricing Debate Continues,2016-09-05 15:17:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zaf-TReFEgo/drug-stocks-remain-in-focus-as-pricing-debate-continues-cm674655,The drug pricing controversy continues to make news with lawmakers now questioning Medicaid rebates for Mylan N V s MYL EpiPen and Democratic Presidential candidate Hillary Clinton announcing a health care plan that will address the excessive price hikes of treatments that have been available
VRX,VRX:US,BBG000DLFM21,Drug Stocks Remain in Focus as Pricing Debate Continues,2016-09-05 15:17:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zaf-TReFEgo/drug-stocks-remain-in-focus-as-pricing-debate-continues-cm674655,The drug pricing controversy continues to make news with lawmakers now questioning Medicaid rebates for Mylan N V s MYL EpiPen and Democratic Presidential candidate Hillary Clinton announcing a health care plan that will address the excessive price hikes of treatments that have been available
VRX,VRX:US,BBG000DLFM21,Stop Fighting the Tape,2016-09-05 10:08:33 +0000,http://finance.yahoo.com/tumblr/blog-stop-fighting-the-tape-100837669.html,Stop Fighting the Tape
VRX,VRX:CT,BBG000DC8S17,Stop Fighting the Tape,2016-09-05 10:08:33 +0000,http://finance.yahoo.com/tumblr/blog-stop-fighting-the-tape-100837669.html,Stop Fighting the Tape
VRX,VRX:CT,BBG000DC8S17,Is EpiPen's Price The FDA's Fault? What's Holding Up New Generics?,2016-09-03 12:00:35 +0000,http://www.investors.com/news/technology/is-epipens-price-the-fdas-fault-whats-holding-up-new-generics/,Is EpiPen's Price The FDA's Fault? What's Holding Up New Generics?
VRX,VRX:US,BBG000DLFM21,Is EpiPen's Price The FDA's Fault? What's Holding Up New Generics?,2016-09-03 12:00:35 +0000,http://www.investors.com/news/technology/is-epipens-price-the-fdas-fault-whats-holding-up-new-generics/,Is EpiPen's Price The FDA's Fault? What's Holding Up New Generics?
VRX,VRX:CT,BBG000DC8S17,Clinton's New Drug-Price Plan Only a Good Start,2016-09-02 18:33:33 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-02/clinton-drug-price-plan-a-good-start?cmpid=yhoo.headline,Clinton's New Drug-Price Plan Only a Good Start
VRX,VRX:US,BBG000DLFM21,Clinton's New Drug-Price Plan Only a Good Start,2016-09-02 18:33:33 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-02/clinton-drug-price-plan-a-good-start?cmpid=yhoo.headline,Clinton's New Drug-Price Plan Only a Good Start
VRX,VRX:CT,BBG000DC8S17,[$$] Clinton promises panel to vet drug price rises,2016-09-02 17:59:56 +0000,"http://www.ft.com/cms/s/56424e1c-712b-11e6-9ac1-1055824ca907,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - Hillary Clinton has pledged to create a government panel with far-reaching powers to punish drug companies for price rises in the wake of a politically charged backlash over the soaring price of the EpiPen. ...
VRX,VRX:US,BBG000DLFM21,[$$] Clinton promises panel to vet drug price rises,2016-09-02 17:59:56 +0000,"http://www.ft.com/cms/s/56424e1c-712b-11e6-9ac1-1055824ca907,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - Hillary Clinton has pledged to create a government panel with far-reaching powers to punish drug companies for price rises in the wake of a politically charged backlash over the soaring price of the EpiPen. ...
VRX,VRX:US,BBG000DLFM21,"Is Mylan The Next Valeant Trade? (MYL, VRX)",2016-09-02 15:24:00 +0000,http://www.investopedia.com/stock-analysis/cotd/090216/mylan-next-valeant-trade-myl-vrx-myl-vrx-teva.aspx?partner=YahooSA,"Is Mylan The Next Valeant Trade? (MYL, VRX)"
VRX,VRX:CT,BBG000DC8S17,"Is Mylan The Next Valeant Trade? (MYL, VRX)",2016-09-02 15:24:00 +0000,http://www.investopedia.com/stock-analysis/cotd/090216/mylan-next-valeant-trade-myl-vrx-myl-vrx-teva.aspx?partner=YahooSA,"Is Mylan The Next Valeant Trade? (MYL, VRX)"
VRX,VRX:US,BBG000DLFM21,Ackman's Pershing Square Holdings gains 5.8 percent in August,2016-09-01 23:36:33 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-holdings-gains-233633310.html,Ackman's Pershing Square Holdings gains 5.8 percent in August
VRX,VRX:CT,BBG000DC8S17,Ackman's Pershing Square Holdings gains 5.8 percent in August,2016-09-01 23:36:33 +0000,http://finance.yahoo.com/news/ackmans-pershing-square-holdings-gains-233633310.html,Ackman's Pershing Square Holdings gains 5.8 percent in August
VRX,VRX:CT,BBG000DC8S17,Chou RRSP Fund Buys Valeant,2016-09-01 15:19:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZepgrBgKeGE/chou-rrsp-fund-buys-valeant-cm673305,The Chou RRSP Fund Trades Portfolio acquired a new holding in Valeant Pharmaceuticals International Inc VRX VRX in the second quarter The fund purchased 6 shares in Valeant for an average price of 6 5 Canadian dollars 7 8 per share The transaction had
VRX,VRX:US,BBG000DLFM21,Chou RRSP Fund Buys Valeant,2016-09-01 15:19:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZepgrBgKeGE/chou-rrsp-fund-buys-valeant-cm673305,The Chou RRSP Fund Trades Portfolio acquired a new holding in Valeant Pharmaceuticals International Inc VRX VRX in the second quarter The fund purchased 6 shares in Valeant for an average price of 6 5 Canadian dollars 7 8 per share The transaction had
VRX,VRX:CT,BBG000DC8S17,"If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me",2016-08-31 20:51:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mm0y9Qzw_w0/if-i-were-a-valeant-pharmaceuticals-shareholder-this-would-infuriate-me-cm673101,Image source Getty Images Drugmaker Valeant Pharmaceuticals NYSE VRX has had a really rough go of things over the past year Since peaking at approximately 264 a share last summer shares of the once nearly megacap company have fallen back into mid cap status At the heart
VRX,VRX:US,BBG000DLFM21,"If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me",2016-08-31 20:51:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mm0y9Qzw_w0/if-i-were-a-valeant-pharmaceuticals-shareholder-this-would-infuriate-me-cm673101,Image source Getty Images Drugmaker Valeant Pharmaceuticals NYSE VRX has had a really rough go of things over the past year Since peaking at approximately 264 a share last summer shares of the once nearly megacap company have fallen back into mid cap status At the heart
VRX,VRX:US,BBG000DLFM21,Motley Fool Answers: What Do Hedge Fund Managers Do?,2016-08-31 20:13:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_I7IRhXXU8w/motley-fool-answers-what-do-hedge-fund-managers-do-cm673084,"Hedge funds are a bit mysterious to regular investors, since they're not something most people ever have anything to do with.  One this episode of Motley Fool Answers , Ron Gross joins Alison Southwick and Robert"
VRX,VRX:CT,BBG000DC8S17,Motley Fool Answers: What Do Hedge Fund Managers Do?,2016-08-31 20:13:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_I7IRhXXU8w/motley-fool-answers-what-do-hedge-fund-managers-do-cm673084,"Hedge funds are a bit mysterious to regular investors, since they're not something most people ever have anything to do with.  One this episode of Motley Fool Answers , Ron Gross joins Alison Southwick and Robert"
VRX,VRX:CT,BBG000DC8S17,"If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me",2016-08-31 19:49:54 +0000,http://www.fool.com/investing/2016/08/31/if-i-were-a-valeant-pharmaceuticals-shareholder-th.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me"
VRX,VRX:US,BBG000DLFM21,"If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me",2016-08-31 19:49:54 +0000,http://www.fool.com/investing/2016/08/31/if-i-were-a-valeant-pharmaceuticals-shareholder-th.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me"
VRX,VRX:CT,BBG000DC8S17,Elizabeth Warren just demanded Mylan come clean about one of the biggest secrets in pharma,2016-08-31 17:38:00 +0000,http://finance.yahoo.com/news/elizabeth-warren-just-demanded-mylan-173800046.html,Elizabeth Warren just demanded Mylan come clean about one of the biggest secrets in pharma
VRX,VRX:US,BBG000DLFM21,Elizabeth Warren just demanded Mylan come clean about one of the biggest secrets in pharma,2016-08-31 17:38:00 +0000,http://finance.yahoo.com/news/elizabeth-warren-just-demanded-mylan-173800046.html,Elizabeth Warren just demanded Mylan come clean about one of the biggest secrets in pharma
VRX,VRX:CT,BBG000DC8S17,Chou RRSP Fund Buys Valeant,2016-08-31 17:25:37 +0000,http://finance.yahoo.com/news/chou-rrsp-fund-buys-valeant-172537904.html,Chou RRSP Fund Buys Valeant
VRX,VRX:US,BBG000DLFM21,Chou RRSP Fund Buys Valeant,2016-08-31 17:25:37 +0000,http://finance.yahoo.com/news/chou-rrsp-fund-buys-valeant-172537904.html,Chou RRSP Fund Buys Valeant
VRX,VRX:US,BBG000DLFM21,"Bill Ackman's Cry: ""Worst Period Of Performance"" (HLN, VRX)",2016-08-31 16:27:00 +0000,http://www.investopedia.com/news/bill-ackmans-cry-worst-period-performance-hln-vrx/?partner=YahooSA,"Bill Ackman's Cry: ""Worst Period Of Performance"" (HLN, VRX)"
VRX,VRX:CT,BBG000DC8S17,"Bill Ackman's Cry: ""Worst Period Of Performance"" (HLN, VRX)",2016-08-31 16:27:00 +0000,http://www.investopedia.com/news/bill-ackmans-cry-worst-period-performance-hln-vrx/?partner=YahooSA,"Bill Ackman's Cry: ""Worst Period Of Performance"" (HLN, VRX)"
VRX,VRX:US,BBG000DLFM21,Orexigen Stock Up on Commercialization Deal for Contrave,2016-08-31 15:16:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xRj-7fnSTVE/orexigen-stock-up-on-commercialization-deal-for-contrave-cm672782,"Orexigen Therapeutics, Inc. 's OREX shares were up 4.2% after the company announced that it has entered into a commercialization and distributorship agreement with Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc. VRX , for its"
VRX,VRX:CT,BBG000DC8S17,Orexigen Stock Up on Commercialization Deal for Contrave,2016-08-31 15:16:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xRj-7fnSTVE/orexigen-stock-up-on-commercialization-deal-for-contrave-cm672782,"Orexigen Therapeutics, Inc. 's OREX shares were up 4.2% after the company announced that it has entered into a commercialization and distributorship agreement with Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc. VRX , for its"
VRX,VRX:US,BBG000DLFM21,Will Xtandi Fuel Pfizer’s Top-Line Growth?,2016-08-31 15:05:02 +0000,http://marketrealist.com/2016/08/will-xtandi-fuel-pfizers-top-line-growth/?utm_source=yahoo&utm_medium=feed,Will Xtandi Fuel Pfizer’s Top-Line Growth?
VRX,VRX:CT,BBG000DC8S17,Will Xtandi Fuel Pfizer’s Top-Line Growth?,2016-08-31 15:05:02 +0000,http://marketrealist.com/2016/08/will-xtandi-fuel-pfizers-top-line-growth/?utm_source=yahoo&utm_medium=feed,Will Xtandi Fuel Pfizer’s Top-Line Growth?
VRX,VRX:CT,BBG000DC8S17,How The Parts Add Up: GURU Targets $26,2016-08-31 14:12:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byZKB1cz4Nw/how-the-parts-add-up-guru-targets-26-cm672676,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
VRX,VRX:US,BBG000DLFM21,How The Parts Add Up: GURU Targets $26,2016-08-31 14:12:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byZKB1cz4Nw/how-the-parts-add-up-guru-targets-26-cm672676,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
VRX,VRX:US,BBG000DLFM21,Orexigen Stock Up on Commercialization Deal for Contrave,2016-08-31 13:11:01 +0000,http://finance.yahoo.com/news/orexigen-stock-commercialization-deal-contrave-131101448.html,Orexigen Stock Up on Commercialization Deal for Contrave
VRX,VRX:CT,BBG000DC8S17,Orexigen Stock Up on Commercialization Deal for Contrave,2016-08-31 13:11:01 +0000,http://finance.yahoo.com/news/orexigen-stock-commercialization-deal-contrave-131101448.html,Orexigen Stock Up on Commercialization Deal for Contrave
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down After GDP Disappoints -- Canadian Commentary,2016-08-31 11:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/354ayV-0AG0/canadian-stocks-are-down-after-gdp-disappoints--canadian-commentary-20160831-00640,Canadian Stocks Are Down After GDP Disappoints -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down After GDP Disappoints -- Canadian Commentary,2016-08-31 11:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/354ayV-0AG0/canadian-stocks-are-down-after-gdp-disappoints--canadian-commentary-20160831-00640,Canadian Stocks Are Down After GDP Disappoints -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Participate In September Healthcare Conferences,2016-08-30 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-september-healthcare-210000478.html,[CNW Group] - Valeant Pharmaceuticals To Participate In September Healthcare Conferences
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Participate In September Healthcare Conferences,2016-08-30 21:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-participate-september-healthcare-210000478.html,[CNW Group] - Valeant Pharmaceuticals To Participate In September Healthcare Conferences
VRX,VRX:US,BBG000DLFM21,"Tuesday’s Vital Data: Bank of America Corp (BAC), Valeant Pharmaceuticals Intl Inc (VRX) and Netflix, Inc. (NFLX)",2016-08-30 19:13:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jq9JrdoLr0Q/tuesdays-vital-data-bank-of-america-corp-bac-valeant-pharmaceuticals-intl-inc-vrx-and-netflix-inc-nflx-cm672407,U.S. stock futures are trading flat to lower this morning ahead of a speech from Federal Reserve Vice Chairman Stanley Fischer. Wall Street will be
VRX,VRX:CT,BBG000DC8S17,"Tuesday’s Vital Data: Bank of America Corp (BAC), Valeant Pharmaceuticals Intl Inc (VRX) and Netflix, Inc. (NFLX)",2016-08-30 19:13:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jq9JrdoLr0Q/tuesdays-vital-data-bank-of-america-corp-bac-valeant-pharmaceuticals-intl-inc-vrx-and-netflix-inc-nflx-cm672407,U.S. stock futures are trading flat to lower this morning ahead of a speech from Federal Reserve Vice Chairman Stanley Fischer. Wall Street will be
VRX,VRX:US,BBG000DLFM21,Billionaire Showdown: Is Valeant Pharmaceuticals International Worth the Risk?,2016-08-30 19:12:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6hxvMQBlFy8/billionaire-showdown-is-valeant-pharmaceuticals-international-worth-the-risk-cm672396,"Image source  Getty Images.  Last quarter, the billionaire super investors Bill Ackman of Pershing Square and David Tepper ofAppaloosa Management took very different stances on the beaten down Canadian drugmaker Valeant Pharmaceuticals International (NYSE"
VRX,VRX:CT,BBG000DC8S17,Billionaire Showdown: Is Valeant Pharmaceuticals International Worth the Risk?,2016-08-30 19:12:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6hxvMQBlFy8/billionaire-showdown-is-valeant-pharmaceuticals-international-worth-the-risk-cm672396,"Image source  Getty Images.  Last quarter, the billionaire super investors Bill Ackman of Pershing Square and David Tepper ofAppaloosa Management took very different stances on the beaten down Canadian drugmaker Valeant Pharmaceuticals International (NYSE"
VRX,VRX:US,BBG000DLFM21,Bill Ackman Comments on Valeant,2016-08-30 18:10:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hMGvIPCxm6U/bill-ackman-comments-on-valeant-cm672064,"At the time of our last financial report in March, Steve Fraidin and I had just joined the board of Valeant ( VRX ) in an attempt to stabilize and enhance our investment in the company. Since we joined"
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Comments on Valeant,2016-08-30 18:10:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hMGvIPCxm6U/bill-ackman-comments-on-valeant-cm672064,"At the time of our last financial report in March, Steve Fraidin and I had just joined the board of Valeant ( VRX ) in an attempt to stabilize and enhance our investment in the company. Since we joined"
VRX,VRX:US,BBG000DLFM21,Billionaire Showdown: Is Valeant Pharmaceuticals International Worth the Risk?,2016-08-30 17:49:50 +0000,http://www.fool.com/investing/2016/08/30/billionaire-showdown-is-valeant-pharmaceuticals-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Billionaire Showdown: Is Valeant Pharmaceuticals International Worth the Risk?
VRX,VRX:CT,BBG000DC8S17,Billionaire Showdown: Is Valeant Pharmaceuticals International Worth the Risk?,2016-08-30 17:49:50 +0000,http://www.fool.com/investing/2016/08/30/billionaire-showdown-is-valeant-pharmaceuticals-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Billionaire Showdown: Is Valeant Pharmaceuticals International Worth the Risk?
VRX,VRX:CT,BBG000DC8S17,Midday Updates: Stocks Turn Bearish as Fed Heats up Rate Debate; Apple Gets $14.6 Bln Tax Bill,2016-08-30 17:12:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g9muNADT_E4/midday-updates-stocks-turn-bearish-as-fed-heats-up-rate-debate-apple-gets-146-bln-tax-bill-cm672349,"Stocks were trading modestly lower in Tuesday's midday trade as Wall Street weighed recent remarks from Federal Reserve Vice Chairman Stanley Fischer, and as oil prices drifted lower and due to pressure on Dow Jones component stock Apple ("
VRX,VRX:US,BBG000DLFM21,Midday Updates: Stocks Turn Bearish as Fed Heats up Rate Debate; Apple Gets $14.6 Bln Tax Bill,2016-08-30 17:12:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g9muNADT_E4/midday-updates-stocks-turn-bearish-as-fed-heats-up-rate-debate-apple-gets-146-bln-tax-bill-cm672349,"Stocks were trading modestly lower in Tuesday's midday trade as Wall Street weighed recent remarks from Federal Reserve Vice Chairman Stanley Fischer, and as oil prices drifted lower and due to pressure on Dow Jones component stock Apple ("
VRX,VRX:US,BBG000DLFM21,Big Pharma's Punishment in Court of Public Opinion,2016-08-30 15:30:00 +0000,https://www.thestreet.com/story/13689183/1/big-pharma-s-punishment-in-court-of-public-opinion.html?puc=yahoo&cm_ven=YAHOO,Big Pharma's Punishment in Court of Public Opinion
VRX,VRX:CT,BBG000DC8S17,Big Pharma's Punishment in Court of Public Opinion,2016-08-30 15:30:00 +0000,https://www.thestreet.com/story/13689183/1/big-pharma-s-punishment-in-court-of-public-opinion.html?puc=yahoo&cm_ven=YAHOO,Big Pharma's Punishment in Court of Public Opinion
VRX,VRX:US,BBG000DLFM21,Why Do Hedge Funds Like AMAG Pharmaceuticals?,2016-08-30 13:31:41 +0000,http://www.insidermonkey.com/blog/why-do-hedge-funds-like-amag-pharmaceuticals-471319/,Why Do Hedge Funds Like AMAG Pharmaceuticals?
VRX,VRX:CT,BBG000DC8S17,Why Do Hedge Funds Like AMAG Pharmaceuticals?,2016-08-30 13:31:41 +0000,http://www.insidermonkey.com/blog/why-do-hedge-funds-like-amag-pharmaceuticals-471319/,Why Do Hedge Funds Like AMAG Pharmaceuticals?
VRX,VRX:US,BBG000DLFM21,Big Pharma Has No Rx for Viral Social Media Reactions,2016-08-30 13:30:00 +0000,http://realmoney.thestreet.com/articles/08/30/2016/big-pharma-has-no-rx-viral-social-media-reactions?puc=yahoo&cm_ven=YAHOO,Big Pharma Has No Rx for Viral Social Media Reactions
VRX,VRX:CT,BBG000DC8S17,Big Pharma Has No Rx for Viral Social Media Reactions,2016-08-30 13:30:00 +0000,http://realmoney.thestreet.com/articles/08/30/2016/big-pharma-has-no-rx-viral-social-media-reactions?puc=yahoo&cm_ven=YAHOO,Big Pharma Has No Rx for Viral Social Media Reactions
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Gains As Gold Weakens -- Canadian Commentary,2016-08-30 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C-CfEKbeqtA/canadian-stocks-are-paring-gains-as-gold-weakens--canadian-commentary-20160830-00597,Canadian Stocks Are Paring Gains As Gold Weakens -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Gains As Gold Weakens -- Canadian Commentary,2016-08-30 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C-CfEKbeqtA/canadian-stocks-are-paring-gains-as-gold-weakens--canadian-commentary-20160830-00597,Canadian Stocks Are Paring Gains As Gold Weakens -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Valeant is being sued under racketeering law over drug price hikes,2016-08-30 10:56:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B51098DE-6E1C-11E6-8E4D-E6CB5401D4DD&siteid=yhoof2,Valeant is being sued under racketeering law over drug price hikes
VRX,VRX:US,BBG000DLFM21,Valeant is being sued under racketeering law over drug price hikes,2016-08-30 10:56:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B51098DE-6E1C-11E6-8E4D-E6CB5401D4DD&siteid=yhoof2,Valeant is being sued under racketeering law over drug price hikes
VRX,VRX:CT,BBG000DC8S17,Orexigen in Canadian Marketing Pact With Valeant for Diet Drug,2016-08-30 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ce4G5ErBp64/orexigen-in-canadian-marketing-pact-with-valeant-for-diet-drug-20160830-00523,Orexigen in Canadian Marketing Pact With Valeant for Diet Drug
VRX,VRX:US,BBG000DLFM21,Orexigen in Canadian Marketing Pact With Valeant for Diet Drug,2016-08-30 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ce4G5ErBp64/orexigen-in-canadian-marketing-pact-with-valeant-for-diet-drug-20160830-00523,Orexigen in Canadian Marketing Pact With Valeant for Diet Drug
VRX,VRX:CT,BBG000DC8S17,"Why Gilead Sciences, Inc. (GILD), Valeant Pharmaceuticals Intl Inc (VRX) and Core-Mark Holding Company, Inc. (CORE) Are 3 of Today’s Worst Stocks",2016-08-30 07:11:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A9i7FeTusT4/why-gilead-sciences-inc-gild-valeant-pharmaceuticals-intl-inc-vrx-and-core-mark-holding-company-inc-core-are-3-of-todays-worst-stocks-cm671969,"After having a weekend to think about it, investors decided the prospect and potential impact of rising interest rates may not be as great as"
VRX,VRX:US,BBG000DLFM21,"Why Gilead Sciences, Inc. (GILD), Valeant Pharmaceuticals Intl Inc (VRX) and Core-Mark Holding Company, Inc. (CORE) Are 3 of Today’s Worst Stocks",2016-08-30 07:11:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A9i7FeTusT4/why-gilead-sciences-inc-gild-valeant-pharmaceuticals-intl-inc-vrx-and-core-mark-holding-company-inc-core-are-3-of-todays-worst-stocks-cm671969,"After having a weekend to think about it, investors decided the prospect and potential impact of rising interest rates may not be as great as"
VRX,VRX:US,BBG000DLFM21,Valeant International Sued For Alleged Racketeering (VRX),2016-08-30 03:40:00 +0000,http://www.investopedia.com/news/valeant-international-sued-alleged-racketeering-vrx/?partner=YahooSA,Valeant International Sued For Alleged Racketeering (VRX)
VRX,VRX:CT,BBG000DC8S17,Valeant International Sued For Alleged Racketeering (VRX),2016-08-30 03:40:00 +0000,http://www.investopedia.com/news/valeant-international-sued-alleged-racketeering-vrx/?partner=YahooSA,Valeant International Sued For Alleged Racketeering (VRX)
VRX,VRX:US,BBG000DLFM21,"Valeant is sued over Philidor ties, alleged racketeering",2016-08-29 21:41:07 +0000,http://finance.yahoo.com/news/valeant-sued-over-philidor-ties-181938722.html,"Valeant is sued over Philidor ties, alleged racketeering"
VRX,VRX:CT,BBG000DC8S17,"Valeant is sued over Philidor ties, alleged racketeering",2016-08-29 21:41:07 +0000,http://finance.yahoo.com/news/valeant-sued-over-philidor-ties-181938722.html,"Valeant is sued over Philidor ties, alleged racketeering"
VRX,VRX:US,BBG000DLFM21,"Healthcare Winners: Stryker Corp., UnitedHealth Group Inc.",2016-08-29 21:03:03 +0000,http://finance.yahoo.com/news/healthcare-winners-stryker-corp-unitedhealth-183420996.html,"Healthcare Winners: Stryker Corp., UnitedHealth Group Inc."
VRX,VRX:CT,BBG000DC8S17,"Healthcare Winners: Stryker Corp., UnitedHealth Group Inc.",2016-08-29 21:03:03 +0000,http://finance.yahoo.com/news/healthcare-winners-stryker-corp-unitedhealth-183420996.html,"Healthcare Winners: Stryker Corp., UnitedHealth Group Inc."
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Falls on Lawsuit,2016-08-29 19:58:00 +0000,https://www.thestreet.com/story/13688185/1/valeant-vrx-stock-falls-on-lawsuit.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Falls on Lawsuit
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Falls on Lawsuit,2016-08-29 19:58:00 +0000,https://www.thestreet.com/story/13688185/1/valeant-vrx-stock-falls-on-lawsuit.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Falls on Lawsuit
VRX,VRX:US,BBG000DLFM21,Valeant Being Sued In NY Federal Court Over Alleged Overcharges,2016-08-29 19:53:09 +0000,http://finance.yahoo.com/news/valeant-being-sued-ny-federal-195309193.html,Valeant Being Sued In NY Federal Court Over Alleged Overcharges
VRX,VRX:CT,BBG000DC8S17,Valeant Being Sued In NY Federal Court Over Alleged Overcharges,2016-08-29 19:53:09 +0000,http://finance.yahoo.com/news/valeant-being-sued-ny-federal-195309193.html,Valeant Being Sued In NY Federal Court Over Alleged Overcharges
VRX,VRX:US,BBG000DLFM21,"Valeant is sued over Philidor ties, alleged racketeering",2016-08-29 19:39:35 +0000,http://in.finance.yahoo.com/news/valeant-sued-over-philidor-ties-192532942.html,"Valeant is sued over Philidor ties, alleged racketeering"
VRX,VRX:CT,BBG000DC8S17,"Valeant is sued over Philidor ties, alleged racketeering",2016-08-29 19:39:35 +0000,http://in.finance.yahoo.com/news/valeant-sued-over-philidor-ties-192532942.html,"Valeant is sued over Philidor ties, alleged racketeering"
VRX,VRX:CT,BBG000DC8S17,"Valeant is sued over Philidor ties, alleged racketeering",2016-08-29 18:29:04 +0000,http://sg.finance.yahoo.com/news/valeant-sued-over-philidor-ties-182904100.html,"Valeant is sued over Philidor ties, alleged racketeering"
VRX,VRX:US,BBG000DLFM21,"Valeant is sued over Philidor ties, alleged racketeering",2016-08-29 18:29:04 +0000,http://sg.finance.yahoo.com/news/valeant-sued-over-philidor-ties-182904100.html,"Valeant is sued over Philidor ties, alleged racketeering"
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Comments on Valeant,2016-08-29 17:07:54 +0000,http://finance.yahoo.com/news/bill-ackman-comments-valeant-170754370.html,Bill Ackman Comments on Valeant
VRX,VRX:US,BBG000DLFM21,Bill Ackman Comments on Valeant,2016-08-29 17:07:54 +0000,http://finance.yahoo.com/news/bill-ackman-comments-valeant-170754370.html,Bill Ackman Comments on Valeant
VRX,VRX:US,BBG000DLFM21,"EYEG: Posisitve Cataract Surgery Data, Initial CMHA-S Clinical Program",2016-08-29 15:30:00 +0000,http://finance.yahoo.com/news/eyeg-posisitve-cataract-surgery-data-153000912.html,"EYEG: Posisitve Cataract Surgery Data, Initial CMHA-S Clinical Program"
VRX,VRX:CT,BBG000DC8S17,"EYEG: Posisitve Cataract Surgery Data, Initial CMHA-S Clinical Program",2016-08-29 15:30:00 +0000,http://finance.yahoo.com/news/eyeg-posisitve-cataract-surgery-data-153000912.html,"EYEG: Posisitve Cataract Surgery Data, Initial CMHA-S Clinical Program"
VRX,VRX:US,BBG000DLFM21,[$$] Mylan to launch cut-price generic version of EpiPen,2016-08-29 14:00:59 +0000,"http://www.ft.com/cms/s/b3a63228-6de6-11e6-a0c9-1365ce54b926,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - The maker of a $300 injection for severe allergic shock bowed to a week of public pressure over the high price of the medicine and said it would introduce a copycat generic version that costs half as much. ...
VRX,VRX:CT,BBG000DC8S17,[$$] Mylan to launch cut-price generic version of EpiPen,2016-08-29 14:00:59 +0000,"http://www.ft.com/cms/s/b3a63228-6de6-11e6-a0c9-1365ce54b926,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - The maker of a $300 injection for severe allergic shock bowed to a week of public pressure over the high price of the medicine and said it would introduce a copycat generic version that costs half as much. ...
VRX,VRX:CT,BBG000DC8S17,What''s Smoking In The Legal Pot?,2016-08-29 13:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TJ-s1s8rF1I/whats-smoking-in-the-legal-pot-20160829-00574,What''s Smoking In The Legal Pot?
VRX,VRX:US,BBG000DLFM21,What''s Smoking In The Legal Pot?,2016-08-29 13:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TJ-s1s8rF1I/whats-smoking-in-the-legal-pot-20160829-00574,What''s Smoking In The Legal Pot?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising In Cautious Trade -- Canadian Commentary,2016-08-29 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VJPeIQRrIsE/canadian-stocks-are-rising-in-cautious-trade--canadian-commentary-20160829-00491,Canadian Stocks Are Rising In Cautious Trade -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising In Cautious Trade -- Canadian Commentary,2016-08-29 11:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VJPeIQRrIsE/canadian-stocks-are-rising-in-cautious-trade--canadian-commentary-20160829-00491,Canadian Stocks Are Rising In Cautious Trade -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Time to Shift Your Focus,2016-08-28 11:07:40 +0000,http://finance.yahoo.com/tumblr/blog-time-to-shift-your-focus-110745912.html,Time to Shift Your Focus
VRX,VRX:US,BBG000DLFM21,Time to Shift Your Focus,2016-08-28 11:07:40 +0000,http://finance.yahoo.com/tumblr/blog-time-to-shift-your-focus-110745912.html,Time to Shift Your Focus
VRX,VRX:CT,BBG000DC8S17,[$$] Hong Kong Tribunal Rules Against U.S. Short-Seller Andrew Left,2016-08-27 04:30:03 +0000,http://www.wsj.com/articles/hong-kong-tribunal-rules-against-u-s-short-seller-andrew-left-1472185068?ru=yahoo?mod=yahoo_itp,[$$] Hong Kong Tribunal Rules Against U.S. Short-Seller Andrew Left
VRX,VRX:US,BBG000DLFM21,[$$] Hong Kong Tribunal Rules Against U.S. Short-Seller Andrew Left,2016-08-27 04:30:03 +0000,http://www.wsj.com/articles/hong-kong-tribunal-rules-against-u-s-short-seller-andrew-left-1472185068?ru=yahoo?mod=yahoo_itp,[$$] Hong Kong Tribunal Rules Against U.S. Short-Seller Andrew Left
VRX,VRX:US,BBG000DLFM21,"MOVES-Pershing Square's Valeant analyst to exit, Ackman sees stock rising",2016-08-26 23:22:18 +0000,http://finance.yahoo.com/news/moves-pershing-squares-valeant-analyst-232218010.html,"MOVES-Pershing Square's Valeant analyst to exit, Ackman sees stock rising"
VRX,VRX:CT,BBG000DC8S17,"MOVES-Pershing Square's Valeant analyst to exit, Ackman sees stock rising",2016-08-26 23:22:18 +0000,http://finance.yahoo.com/news/moves-pershing-squares-valeant-analyst-232218010.html,"MOVES-Pershing Square's Valeant analyst to exit, Ackman sees stock rising"
VRX,VRX:US,BBG000DLFM21,Bill Ackman Discusses Worst Year Ever in Mid-Year Letter,2016-08-26 23:02:20 +0000,http://finance.yahoo.com/news/bill-ackmans-addresses-challenging-quarter-230220480.html,Bill Ackman Discusses Worst Year Ever in Mid-Year Letter
VRX,VRX:CT,BBG000DC8S17,Bill Ackman Discusses Worst Year Ever in Mid-Year Letter,2016-08-26 23:02:20 +0000,http://finance.yahoo.com/news/bill-ackmans-addresses-challenging-quarter-230220480.html,Bill Ackman Discusses Worst Year Ever in Mid-Year Letter
VRX,VRX:CT,BBG000DC8S17,"MOVES-Pershing Square's Valeant analyst to exit, Ackman optimistic price",2016-08-26 21:48:03 +0000,http://finance.yahoo.com/news/moves-pershing-squares-valeant-analyst-214803086.html,"MOVES-Pershing Square's Valeant analyst to exit, Ackman optimistic price"
VRX,VRX:US,BBG000DLFM21,"MOVES-Pershing Square's Valeant analyst to exit, Ackman optimistic price",2016-08-26 21:48:03 +0000,http://finance.yahoo.com/news/moves-pershing-squares-valeant-analyst-214803086.html,"MOVES-Pershing Square's Valeant analyst to exit, Ackman optimistic price"
VRX,VRX:US,BBG000DLFM21,Bill Ackman: Valeant 'One Very Big Mistake',2016-08-26 20:24:04 +0000,http://finance.yahoo.com/news/bill-ackman-valeant-one-very-202404913.html,Bill Ackman: Valeant 'One Very Big Mistake'
VRX,VRX:CT,BBG000DC8S17,Bill Ackman: Valeant 'One Very Big Mistake',2016-08-26 20:24:04 +0000,http://finance.yahoo.com/news/bill-ackman-valeant-one-very-202404913.html,Bill Ackman: Valeant 'One Very Big Mistake'
VRX,VRX:CT,BBG000DC8S17,One of the key men behind Bill Ackman's bet on Valeant is leaving to launch a healthcare startup,2016-08-26 20:13:11 +0000,http://finance.yahoo.com/news/one-key-men-behind-bill-201311618.html,One of the key men behind Bill Ackman's bet on Valeant is leaving to launch a healthcare startup
VRX,VRX:US,BBG000DLFM21,One of the key men behind Bill Ackman's bet on Valeant is leaving to launch a healthcare startup,2016-08-26 20:13:11 +0000,http://finance.yahoo.com/news/one-key-men-behind-bill-201311618.html,One of the key men behind Bill Ackman's bet on Valeant is leaving to launch a healthcare startup
VRX,VRX:CT,BBG000DC8S17,Bill Ackman: 'We made one very big mistake' with Valeant and lost big time,2016-08-26 15:46:45 +0000,http://www.cnbc.com/id/103895913?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103895913,Bill Ackman: 'We made one very big mistake' with Valeant and lost big time
VRX,VRX:US,BBG000DLFM21,Bill Ackman: 'We made one very big mistake' with Valeant and lost big time,2016-08-26 15:46:45 +0000,http://www.cnbc.com/id/103895913?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103895913,Bill Ackman: 'We made one very big mistake' with Valeant and lost big time
VRX,VRX:CT,BBG000DC8S17,[$$] Hong Kong watchdog finds short seller culpable of market misconduct,2016-08-26 14:04:14 +0000,"http://www.ft.com/cms/s/7b9e181a-6b6a-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - Short seller Andrew Left has been found culpable of market misconduct by a Hong Kong tribunal in the first example of the city's watchdog pursuing unregulated published commentary. The case against Mr ...
VRX,VRX:US,BBG000DLFM21,[$$] Hong Kong watchdog finds short seller culpable of market misconduct,2016-08-26 14:04:14 +0000,"http://www.ft.com/cms/s/7b9e181a-6b6a-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - Short seller Andrew Left has been found culpable of market misconduct by a Hong Kong tribunal in the first example of the city's watchdog pursuing unregulated published commentary. The case against Mr ...
VRX,VRX:US,BBG000DLFM21,Mylan offers price plan to help patients but its programs are still short on details,2016-08-26 12:00:29 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0F216CFA-6AF7-11E6-933B-8BAFB8E4E1DA&siteid=yhoof2,Mylan offers price plan to help patients but its programs are still short on details
VRX,VRX:CT,BBG000DC8S17,Mylan offers price plan to help patients but its programs are still short on details,2016-08-26 12:00:29 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0F216CFA-6AF7-11E6-933B-8BAFB8E4E1DA&siteid=yhoof2,Mylan offers price plan to help patients but its programs are still short on details
VRX,VRX:CT,BBG000DC8S17,Short seller Andrew Left deemed ‘reckless’ by Hong Kong regulator,2016-08-26 11:53:36 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1AEC7950-6B81-11E6-8915-31A2D5A5E29E&siteid=yhoof2,Short seller Andrew Left deemed ‘reckless’ by Hong Kong regulator
VRX,VRX:US,BBG000DLFM21,Short seller Andrew Left deemed ‘reckless’ by Hong Kong regulator,2016-08-26 11:53:36 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1AEC7950-6B81-11E6-8915-31A2D5A5E29E&siteid=yhoof2,Short seller Andrew Left deemed ‘reckless’ by Hong Kong regulator
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising After Yellen Comments -- Canadian Commentary,2016-08-26 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yE1eveuLRy8/canadian-stocks-are-rising-after-yellen-comments--canadian-commentary-20160826-00331,Canadian Stocks Are Rising After Yellen Comments -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising After Yellen Comments -- Canadian Commentary,2016-08-26 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yE1eveuLRy8/canadian-stocks-are-rising-after-yellen-comments--canadian-commentary-20160826-00331,Canadian Stocks Are Rising After Yellen Comments -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,"Mylan boosts EpiPen patient programs, doesn't budge on price",2016-08-25 21:45:23 +0000,http://sg.finance.yahoo.com/news/mylan-says-expand-programs-lower-112811449.html,"Mylan boosts EpiPen patient programs, doesn't budge on price"
VRX,VRX:US,BBG000DLFM21,"Mylan boosts EpiPen patient programs, doesn't budge on price",2016-08-25 21:45:23 +0000,http://sg.finance.yahoo.com/news/mylan-says-expand-programs-lower-112811449.html,"Mylan boosts EpiPen patient programs, doesn't budge on price"
VRX,VRX:US,BBG000DLFM21,Mylan NV (MYL): Stop Rewarding Big Pharma Greed!,2016-08-25 20:47:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4J8u-QE_i1g/mylan-nv-myl-stop-rewarding-big-pharma-greed-cm670291,A 5.5% fall in shares of  Mylan NV  (NASDAQ  MYL ) on Aug. 24 trade was quickly followed by a 2% gain for MYL
VRX,VRX:CT,BBG000DC8S17,Mylan NV (MYL): Stop Rewarding Big Pharma Greed!,2016-08-25 20:47:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4J8u-QE_i1g/mylan-nv-myl-stop-rewarding-big-pharma-greed-cm670291,A 5.5% fall in shares of  Mylan NV  (NASDAQ  MYL ) on Aug. 24 trade was quickly followed by a 2% gain for MYL
VRX,VRX:US,BBG000DLFM21,Healthcare Drug Pricing a Factor for the Market on Wednesday,2016-08-25 19:45:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B4KoPRnA9IE/healthcare-drug-pricing-a-factor-for-the-market-on-wednesday-cm669883,"U.S. market indexes were lower on Wednesday. For the day, the Dow Jones Industrial Average closed at 18481.48 for a loss of  65.82 points, or  0.35%. The S&P 500 was also lower, closing at 2175.44"
VRX,VRX:CT,BBG000DC8S17,Healthcare Drug Pricing a Factor for the Market on Wednesday,2016-08-25 19:45:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B4KoPRnA9IE/healthcare-drug-pricing-a-factor-for-the-market-on-wednesday-cm669883,"U.S. market indexes were lower on Wednesday. For the day, the Dow Jones Industrial Average closed at 18481.48 for a loss of  65.82 points, or  0.35%. The S&P 500 was also lower, closing at 2175.44"
VRX,VRX:US,BBG000DLFM21,[$$] Mylan: pen is not mightier,2016-08-25 17:29:34 +0000,"http://www.ft.com/cms/s/7f9f9c84-6ae0-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - American consumers forking out more for their healthcare is a feature not a bug of system that is growing more efficient. But the backlash against transparent costs will not be shared equally between the ...
VRX,VRX:CT,BBG000DC8S17,[$$] Mylan: pen is not mightier,2016-08-25 17:29:34 +0000,"http://www.ft.com/cms/s/7f9f9c84-6ae0-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - American consumers forking out more for their healthcare is a feature not a bug of system that is growing more efficient. But the backlash against transparent costs will not be shared equally between the ...
VRX,VRX:US,BBG000DLFM21,Here's A Reason Why Valeant (VRX) Stock Is Climbing Today,2016-08-25 15:13:00 +0000,https://www.thestreet.com/story/13685506/1/here-s-a-reason-why-valeant-vrx-stock-is-climbing-today.html?puc=yahoo&cm_ven=YAHOO,Here's A Reason Why Valeant (VRX) Stock Is Climbing Today
VRX,VRX:CT,BBG000DC8S17,Here's A Reason Why Valeant (VRX) Stock Is Climbing Today,2016-08-25 15:13:00 +0000,https://www.thestreet.com/story/13685506/1/here-s-a-reason-why-valeant-vrx-stock-is-climbing-today.html?puc=yahoo&cm_ven=YAHOO,Here's A Reason Why Valeant (VRX) Stock Is Climbing Today
VRX,VRX:CT,BBG000DC8S17,The maker of the EpiPen is playing another dirty trick right from Martin Shkreli's book,2016-08-25 15:10:52 +0000,http://finance.yahoo.com/news/maker-epipen-playing-dirty-trick-151052051.html,The maker of the EpiPen is playing another dirty trick right from Martin Shkreli's book
VRX,VRX:US,BBG000DLFM21,The maker of the EpiPen is playing another dirty trick right from Martin Shkreli's book,2016-08-25 15:10:52 +0000,http://finance.yahoo.com/news/maker-epipen-playing-dirty-trick-151052051.html,The maker of the EpiPen is playing another dirty trick right from Martin Shkreli's book
VRX,VRX:US,BBG000DLFM21,Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny,2016-08-25 14:39:00 +0000,https://www.thestreet.com/story/13685271/1/mallinckrodt-could-be-next-in-spotlight-thanks-to-epipen-scrutiny.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
VRX,VRX:CT,BBG000DC8S17,Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny,2016-08-25 14:39:00 +0000,https://www.thestreet.com/story/13685271/1/mallinckrodt-could-be-next-in-spotlight-thanks-to-epipen-scrutiny.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
VRX,VRX:CT,BBG000DC8S17,Valeant's Management Continues To Take The Right Steps,2016-08-25 13:21:54 +0000,http://finance.yahoo.com/news/valeants-management-continues-steps-132154282.html,Valeant's Management Continues To Take The Right Steps
VRX,VRX:US,BBG000DLFM21,Valeant's Management Continues To Take The Right Steps,2016-08-25 13:21:54 +0000,http://finance.yahoo.com/news/valeants-management-continues-steps-132154282.html,Valeant's Management Continues To Take The Right Steps
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Aug 25, 2016 :  MT, ERIC, QQQ, MYL, HPQ, FCX, AZN, SBGL, VRX, NFLX, DLTR, MU",2016-08-25 12:59:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qOPsnFkka0E/pre-market-most-active-for-aug-25-2016-mt-eric-qqq-myl-hpq-fcx-azn-sbgl-vrx-nflx-dltr-mu-cm669993,"The NASDAQ 100 Pre Market Indicator is down 5.04 to 4,778.45. The total Pre Market volume is currently 4,128,603 shares traded. The following are the most active stocks for the pre market session ArcelorMittal ( MT ) is +0.01"
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Aug 25, 2016 :  MT, ERIC, QQQ, MYL, HPQ, FCX, AZN, SBGL, VRX, NFLX, DLTR, MU",2016-08-25 12:59:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qOPsnFkka0E/pre-market-most-active-for-aug-25-2016-mt-eric-qqq-myl-hpq-fcx-azn-sbgl-vrx-nflx-dltr-mu-cm669993,"The NASDAQ 100 Pre Market Indicator is down 5.04 to 4,778.45. The total Pre Market volume is currently 4,128,603 shares traded. The following are the most active stocks for the pre market session ArcelorMittal ( MT ) is +0.01"
VRX,VRX:CT,BBG000DC8S17,Mylan says it will expand programs that lower EpiPen costs,2016-08-25 11:28:11 +0000,http://finance.yahoo.com/news/mylan-says-expand-programs-lower-112811817.html,Mylan says it will expand programs that lower EpiPen costs
VRX,VRX:US,BBG000DLFM21,Mylan says it will expand programs that lower EpiPen costs,2016-08-25 11:28:11 +0000,http://finance.yahoo.com/news/mylan-says-expand-programs-lower-112811817.html,Mylan says it will expand programs that lower EpiPen costs
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Turned Positive After Weak Start -- Canadian Commentary,2016-08-25 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rvZkLQbdVgg/canadian-stocks-have-turned-positive-after-weak-start--canadian-commentary-20160825-00581,Canadian Stocks Have Turned Positive After Weak Start -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Turned Positive After Weak Start -- Canadian Commentary,2016-08-25 11:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rvZkLQbdVgg/canadian-stocks-have-turned-positive-after-weak-start--canadian-commentary-20160825-00581,Canadian Stocks Have Turned Positive After Weak Start -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Mylan Faces Scrutiny Over EpiPen Price Increases,2016-08-24 18:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hou_TLhs5y0/mylan-faces-scrutiny-over-epipen-price-increases-20160824-00817,Mylan Faces Scrutiny Over EpiPen Price Increases
VRX,VRX:CT,BBG000DC8S17,Mylan Faces Scrutiny Over EpiPen Price Increases,2016-08-24 18:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hou_TLhs5y0/mylan-faces-scrutiny-over-epipen-price-increases-20160824-00817,Mylan Faces Scrutiny Over EpiPen Price Increases
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary,2016-08-24 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wRPDNYZtbJs/canadian-stocks-are-falling-along-with-commodity-prices--canadian-commentary-20160824-00458,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary,2016-08-24 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wRPDNYZtbJs/canadian-stocks-are-falling-along-with-commodity-prices--canadian-commentary-20160824-00458,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary,2016-08-24 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AFwHxdedFCk/canadian-stocks-are-falling-along-with-commodity-prices--canadian-commentary-20160824-00457,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary,2016-08-24 11:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AFwHxdedFCk/canadian-stocks-are-falling-along-with-commodity-prices--canadian-commentary-20160824-00457,Canadian Stocks Are Falling Along With Commodity Prices -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pays up for New CFO Herendeen,2016-08-23 22:13:37 +0000,http://blogs.wsj.com/cfo/2016/08/23/valeant-pays-up-for-new-cfo-herendeen/?mod=yahoo_hs,Valeant Pays up for New CFO Herendeen
VRX,VRX:CT,BBG000DC8S17,Valeant Pays up for New CFO Herendeen,2016-08-23 22:13:37 +0000,http://blogs.wsj.com/cfo/2016/08/23/valeant-pays-up-for-new-cfo-herendeen/?mod=yahoo_hs,Valeant Pays up for New CFO Herendeen
VRX,VRX:CT,BBG000DC8S17,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation",2016-08-23 21:03:35 +0000,http://biz.yahoo.com/e/160823/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation"
VRX,VRX:US,BBG000DLFM21,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation",2016-08-23 21:03:35 +0000,http://biz.yahoo.com/e/160823/vrx8-k.html,"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation"
VRX,VRX:CT,BBG000DC8S17,"Tuesday’s Vital Data: Bank of America Corp (BAC), Starbucks Corporation (SBUX) and Freeport-McMoRan Inc (FCX)",2016-08-23 20:47:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bew50dKn4FU/tuesdays-vital-data-bank-of-america-corp-bac-starbucks-corporation-sbux-and-freeport-mcmoran-inc-fcx-cm669137,"U.S. stock futures are set to bounce back this morning, as Wall Street prepares for a round of economic data that could set the tone"
VRX,VRX:US,BBG000DLFM21,"Tuesday’s Vital Data: Bank of America Corp (BAC), Starbucks Corporation (SBUX) and Freeport-McMoRan Inc (FCX)",2016-08-23 20:47:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bew50dKn4FU/tuesdays-vital-data-bank-of-america-corp-bac-starbucks-corporation-sbux-and-freeport-mcmoran-inc-fcx-cm669137,"U.S. stock futures are set to bounce back this morning, as Wall Street prepares for a round of economic data that could set the tone"
VRX,VRX:US,BBG000DLFM21,"3 Big Stock Charts: United States Oil Fund LP (ETF) (USO), Sirius XM Holdings Inc. (SIRI) and Valeant Pharmaceuticals Intl Inc (VRX)",2016-08-23 20:46:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oEwXLxAEHwU/3-big-stock-charts-united-states-oil-fund-lp-etf-uso-sirius-xm-holdings-inc-siri-and-valeant-pharmaceuticals-intl-inc-vrx-cm669194,"Trades and investors appear unwilling to take big steps in front of Friday's speech from Janet Yellen in Jackson Hole, as interest rates have once"
VRX,VRX:CT,BBG000DC8S17,"3 Big Stock Charts: United States Oil Fund LP (ETF) (USO), Sirius XM Holdings Inc. (SIRI) and Valeant Pharmaceuticals Intl Inc (VRX)",2016-08-23 20:46:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oEwXLxAEHwU/3-big-stock-charts-united-states-oil-fund-lp-etf-uso-sirius-xm-holdings-inc-siri-and-valeant-pharmaceuticals-intl-inc-vrx-cm669194,"Trades and investors appear unwilling to take big steps in front of Friday's speech from Janet Yellen in Jackson Hole, as interest rates have once"
VRX,VRX:US,BBG000DLFM21,4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnaround,2016-08-23 20:46:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yRtydod82hs/4-big-name-investment-funds-that-strongly-believe-in-a-valeant-pharmaceuticals-turnaround-cm669187,"Image source  Getty Images.  What a difference a year makes. In August 2015, shares of Valeant Pharmaceuticals (NYSE  VRX) were trading north of $250. Today, they're struggling to find support around the"
VRX,VRX:CT,BBG000DC8S17,4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnaround,2016-08-23 20:46:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yRtydod82hs/4-big-name-investment-funds-that-strongly-believe-in-a-valeant-pharmaceuticals-turnaround-cm669187,"Image source  Getty Images.  What a difference a year makes. In August 2015, shares of Valeant Pharmaceuticals (NYSE  VRX) were trading north of $250. Today, they're struggling to find support around the"
VRX,VRX:US,BBG000DLFM21,4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnaround,2016-08-23 19:01:00 +0000,http://www.fool.com/investing/2016/08/23/4-big-name-investment-funds-that-strongly-believe.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnaround
VRX,VRX:CT,BBG000DC8S17,4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnaround,2016-08-23 19:01:00 +0000,http://www.fool.com/investing/2016/08/23/4-big-name-investment-funds-that-strongly-believe.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnaround
VRX,VRX:US,BBG000DLFM21,Concordia's Uncanny Comparisons to Valeant Continue (Unfortunately),2016-08-23 16:39:25 +0000,http://blogs.wsj.com/moneybeat/2016/08/23/concordias-uncanny-comparisons-to-valeant-continue-unfortunately/?mod=yahoo_hs,Concordia's Uncanny Comparisons to Valeant Continue (Unfortunately)
VRX,VRX:CT,BBG000DC8S17,Concordia's Uncanny Comparisons to Valeant Continue (Unfortunately),2016-08-23 16:39:25 +0000,http://blogs.wsj.com/moneybeat/2016/08/23/concordias-uncanny-comparisons-to-valeant-continue-unfortunately/?mod=yahoo_hs,Concordia's Uncanny Comparisons to Valeant Continue (Unfortunately)
VRX,VRX:US,BBG000DLFM21,"Mylan: In EpiPen Controversy, Shades of Valeant",2016-08-23 14:30:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/23/mylan-in-epipen-controversy-shades-of-valeant/?mod=yahoobarrons&ru=yahoo,"Mylan: In EpiPen Controversy, Shades of Valeant"
VRX,VRX:CT,BBG000DC8S17,"Mylan: In EpiPen Controversy, Shades of Valeant",2016-08-23 14:30:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/23/mylan-in-epipen-controversy-shades-of-valeant/?mod=yahoobarrons&ru=yahoo,"Mylan: In EpiPen Controversy, Shades of Valeant"
VRX,VRX:US,BBG000DLFM21,"Stock Market News for August 23, 2016",2016-08-23 14:10:02 +0000,http://finance.yahoo.com/news/stock-market-news-august-23-141002044.html,"Stock Market News for August 23, 2016"
VRX,VRX:CT,BBG000DC8S17,"Stock Market News for August 23, 2016",2016-08-23 14:10:02 +0000,http://finance.yahoo.com/news/stock-market-news-august-23-141002044.html,"Stock Market News for August 23, 2016"
VRX,VRX:CT,BBG000DC8S17,Blog Coverage Valeant Pharma Appoints New CEO,2016-08-23 13:20:47 +0000,http://news.investornetwork.com/2016/08/23/blog-coverage-valeant-pharma-appoints-new-ceo/?1=1&1471958447,Blog Coverage Valeant Pharma Appoints New CEO
VRX,VRX:US,BBG000DLFM21,Blog Coverage Valeant Pharma Appoints New CEO,2016-08-23 13:20:47 +0000,http://news.investornetwork.com/2016/08/23/blog-coverage-valeant-pharma-appoints-new-ceo/?1=1&1471958447,Blog Coverage Valeant Pharma Appoints New CEO
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Aug 23, 2016 :  BBY, NVO, AZN, SQ, VRX, MON, QQQ, MDVN, PAAS, GPRO, XIV, AAPL",2016-08-23 12:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zKGUs9xffEI/pre-market-most-active-for-aug-23-2016-bby-nvo-azn-sq-vrx-mon-qqq-mdvn-paas-gpro-xiv-aapl-cm668893,"The NASDAQ 100 Pre Market Indicator is up 5.83 to 4,814.39. The total Pre Market volume is currently 6,870,315 shares traded. The following are the most active stocks for the pre market session Best Buy Co., Inc. ( BBY"
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Aug 23, 2016 :  BBY, NVO, AZN, SQ, VRX, MON, QQQ, MDVN, PAAS, GPRO, XIV, AAPL",2016-08-23 12:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zKGUs9xffEI/pre-market-most-active-for-aug-23-2016-bby-nvo-azn-sq-vrx-mon-qqq-mdvn-paas-gpro-xiv-aapl-cm668893,"The NASDAQ 100 Pre Market Indicator is up 5.83 to 4,814.39. The total Pre Market volume is currently 6,870,315 shares traded. The following are the most active stocks for the pre market session Best Buy Co., Inc. ( BBY"
VRX,VRX:CT,BBG000DC8S17,Valeant’s stock soars as investors cheer poaching of Zoetis CFO,2016-08-23 12:22:07 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1A14CCC0-68A3-11E6-AF2A-021016061ED1&siteid=yhoof2,Valeant’s stock soars as investors cheer poaching of Zoetis CFO
VRX,VRX:US,BBG000DLFM21,Valeant’s stock soars as investors cheer poaching of Zoetis CFO,2016-08-23 12:22:07 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1A14CCC0-68A3-11E6-AF2A-021016061ED1&siteid=yhoof2,Valeant’s stock soars as investors cheer poaching of Zoetis CFO
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Rising After Strong Report From BMO -- Canadian Commentary,2016-08-23 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0m7g57JRWTI/canadian-stocks-are-rising-after-strong-report-from-bmo--canadian-commentary-20160823-00556,Canadian Stocks Are Rising After Strong Report From BMO -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Rising After Strong Report From BMO -- Canadian Commentary,2016-08-23 10:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0m7g57JRWTI/canadian-stocks-are-rising-after-strong-report-from-bmo--canadian-commentary-20160823-00556,Canadian Stocks Are Rising After Strong Report From BMO -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Pharming Convene an Extraordinary General Meeting of Shareholders,2016-08-23 05:00:00 +0000,http://finance.yahoo.com/news/pharming-convene-extraordinary-general-meeting-050000816.html,"[PR Newswire] - Pharming Group N.V. (the ""Company"") (PHARM.AS) announces today that it will hold an Extraordinary General Meeting (EGM) of shareholders to discuss the Company's definitive agreement to acquire all North American commercialisation rights to its product RUCONEST® (recombinant human C1 esterase inhibitor), including all rights in the US, Mexico and Canada, from Valeant Pharmaceuticals International, Inc. (""Valeant"") (NYSE/TSX: VRX) (the ""Transaction, announced on 09 August 2016""), and to seek approval to increase the Company's authorized share capital. The EGM will be held at Holiday Inn Leiden, Haagse Schouwweg 10, 2332 KG Leiden, the Netherlands on Wednesday 05 October 2016 at 14:00 CET."
VRX,VRX:CT,BBG000DC8S17,Pharming Convene an Extraordinary General Meeting of Shareholders,2016-08-23 05:00:00 +0000,http://finance.yahoo.com/news/pharming-convene-extraordinary-general-meeting-050000816.html,"[PR Newswire] - Pharming Group N.V. (the ""Company"") (PHARM.AS) announces today that it will hold an Extraordinary General Meeting (EGM) of shareholders to discuss the Company's definitive agreement to acquire all North American commercialisation rights to its product RUCONEST® (recombinant human C1 esterase inhibitor), including all rights in the US, Mexico and Canada, from Valeant Pharmaceuticals International, Inc. (""Valeant"") (NYSE/TSX: VRX) (the ""Transaction, announced on 09 August 2016""), and to seek approval to increase the Company's authorized share capital. The EGM will be held at Holiday Inn Leiden, Haagse Schouwweg 10, 2332 KG Leiden, the Netherlands on Wednesday 05 October 2016 at 14:00 CET."
VRX,VRX:US,BBG000DLFM21,[$$] A Window of Opportunity Cracks Open at Valeant,2016-08-23 04:07:10 +0000,http://www.wsj.com/articles/a-window-of-opportunity-cracks-open-at-valeant-1471877243?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - Easing financial conditions could give Valeant’s new finance chief an assist.
VRX,VRX:CT,BBG000DC8S17,[$$] A Window of Opportunity Cracks Open at Valeant,2016-08-23 04:07:10 +0000,http://www.wsj.com/articles/a-window-of-opportunity-cracks-open-at-valeant-1471877243?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - Easing financial conditions could give Valeant’s new finance chief an assist.
VRX,VRX:US,BBG000DLFM21,New CFO Tops Off Shake-Up At Valeant -- WSJ,2016-08-23 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JhpqvejUjhY/new-cfo-tops-off-shakeup-at-valeant--wsj-20160823-00035,New CFO Tops Off Shake-Up At Valeant -- WSJ
VRX,VRX:CT,BBG000DC8S17,New CFO Tops Off Shake-Up At Valeant -- WSJ,2016-08-23 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JhpqvejUjhY/new-cfo-tops-off-shakeup-at-valeant--wsj-20160823-00035,New CFO Tops Off Shake-Up At Valeant -- WSJ
VRX,VRX:US,BBG000DLFM21,"Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today",2016-08-22 23:44:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pRGymE6JKDE/why-syngenta-valeant-pharmaceuticals-and-biomarin-pharmaceutical-jumped-today-cm668741,"Image source  Syngenta.  Monday was a generally quiet day for the stock market, and the Dow and S&P 500 both posted very slight declines of around a tenth of a percent each. In"
VRX,VRX:CT,BBG000DC8S17,"Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today",2016-08-22 23:44:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pRGymE6JKDE/why-syngenta-valeant-pharmaceuticals-and-biomarin-pharmaceutical-jumped-today-cm668741,"Image source  Syngenta.  Monday was a generally quiet day for the stock market, and the Dow and S&P 500 both posted very slight declines of around a tenth of a percent each. In"
VRX,VRX:CT,BBG000DC8S17,Stocks Calm As Crude Plunges; Busy Day For Medical Sector,2016-08-22 22:54:24 +0000,http://finance.yahoo.com/video/stocks-calm-crude-plunges-busy-225424193.html,Stocks Calm As Crude Plunges; Busy Day For Medical Sector
VRX,VRX:US,BBG000DLFM21,Stocks Calm As Crude Plunges; Busy Day For Medical Sector,2016-08-22 22:54:24 +0000,http://finance.yahoo.com/video/stocks-calm-crude-plunges-busy-225424193.html,Stocks Calm As Crude Plunges; Busy Day For Medical Sector
VRX,VRX:CT,BBG000DC8S17,Concordia Healthcare Says Chunk Of CEO's Shares Sold In Margin Call,2016-08-22 22:22:00 +0000,http://www.forbes.com/sites/nathanvardi/2016/08/22/concordia-healthcare-says-chunk-of-ceos-shares-sold-in-margin-call/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Concordia Healthcare Says Chunk Of CEO's Shares Sold In Margin Call
VRX,VRX:US,BBG000DLFM21,Concordia Healthcare Says Chunk Of CEO's Shares Sold In Margin Call,2016-08-22 22:22:00 +0000,http://www.forbes.com/sites/nathanvardi/2016/08/22/concordia-healthcare-says-chunk-of-ceos-shares-sold-in-margin-call/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Concordia Healthcare Says Chunk Of CEO's Shares Sold In Margin Call
VRX,VRX:CT,BBG000DC8S17,"Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today",2016-08-22 21:57:00 +0000,http://www.fool.com/investing/2016/08/22/why-syngenta-valeant-pharmaceuticals-and-biomari-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today"
VRX,VRX:US,BBG000DLFM21,"Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today",2016-08-22 21:57:00 +0000,http://www.fool.com/investing/2016/08/22/why-syngenta-valeant-pharmaceuticals-and-biomari-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today"
VRX,VRX:CT,BBG000DC8S17,"Raging Capital Double-Shorting Valeant, Goes Long AFI, CAVM, Others",2016-08-22 20:35:40 +0000,http://www.insidermonkey.com/blog/raging-capital-double-shorting-valeant-goes-long-afi-cavm-others-470032/,"Raging Capital Double-Shorting Valeant, Goes Long AFI, CAVM, Others"
VRX,VRX:US,BBG000DLFM21,"Raging Capital Double-Shorting Valeant, Goes Long AFI, CAVM, Others",2016-08-22 20:35:40 +0000,http://www.insidermonkey.com/blog/raging-capital-double-shorting-valeant-goes-long-afi-cavm-others-470032/,"Raging Capital Double-Shorting Valeant, Goes Long AFI, CAVM, Others"
VRX,VRX:US,BBG000DLFM21,Valeant Bonds Rise on New CFO Choice,2016-08-22 20:31:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/08/22/valeant-bonds-rise-on-new-cfo-choice/?mod=yahoobarrons&ru=yahoo,Valeant Bonds Rise on New CFO Choice
VRX,VRX:CT,BBG000DC8S17,Valeant Bonds Rise on New CFO Choice,2016-08-22 20:31:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/08/22/valeant-bonds-rise-on-new-cfo-choice/?mod=yahoobarrons&ru=yahoo,Valeant Bonds Rise on New CFO Choice
VRX,VRX:US,BBG000DLFM21,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise",2016-08-22 20:05:36 +0000,http://www.investors.com/news/technology/valeant-stock-up-on-cfo-appointment-as-ma-hopes-rise/,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise"
VRX,VRX:CT,BBG000DC8S17,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise",2016-08-22 20:05:36 +0000,http://www.investors.com/news/technology/valeant-stock-up-on-cfo-appointment-as-ma-hopes-rise/,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%",2016-08-22 19:46:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vr7cGhiHVBI/valeant-pharmaceuticals-vrx-appoints-new-cfo-stock-gains-72-cm668632,Shares of Valeant Pharmaceuticals VRX were up over 7% in midday trading on Monday after the company announced the appointment of a new Chief Financial Officer (CFO). Monday's stock movement reflects is yet another continuation in the
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%",2016-08-22 19:46:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vr7cGhiHVBI/valeant-pharmaceuticals-vrx-appoints-new-cfo-stock-gains-72-cm668632,Shares of Valeant Pharmaceuticals VRX were up over 7% in midday trading on Monday after the company announced the appointment of a new Chief Financial Officer (CFO). Monday's stock movement reflects is yet another continuation in the
VRX,VRX:US,BBG000DLFM21,Valeant's C-Suite Sees Another Shake-Up,2016-08-22 19:41:00 +0000,https://www.thestreet.com/story/13681669/1/valeant-s-c-suite-sees-another-shake-up.html?puc=yahoo&cm_ven=YAHOO,Valeant's C-Suite Sees Another Shake-Up
VRX,VRX:CT,BBG000DC8S17,Valeant's C-Suite Sees Another Shake-Up,2016-08-22 19:41:00 +0000,https://www.thestreet.com/story/13681669/1/valeant-s-c-suite-sees-another-shake-up.html?puc=yahoo&cm_ven=YAHOO,Valeant's C-Suite Sees Another Shake-Up
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: Three Reasons Its New CFO is the Right Choice,2016-08-22 19:18:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/22/valeant-pharmaceuticals-three-reasons-its-new-cfo-is-the-right-choice/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Three Reasons Its New CFO is the Right Choice
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: Three Reasons Its New CFO is the Right Choice,2016-08-22 19:18:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/22/valeant-pharmaceuticals-three-reasons-its-new-cfo-is-the-right-choice/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Three Reasons Its New CFO is the Right Choice
VRX,VRX:CT,BBG000DC8S17,"3 Stocks to Watch on Monday: Alphabet Inc (GOOG), Syngenta AG (ADR) (SYT) and Valeant Pharmaceuticals Intl Inc (VRX)",2016-08-22 18:46:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b7QRx63sfJQ/3-stocks-to-watch-on-monday-alphabet-inc-goog-syngenta-ag-adr-syt-and-valeant-pharmaceuticals-intl-inc-vrx-cm668603,"The stock markets appear to be in waiting mode as investors wait for the Federal Reserve's speech in Jackson Hole, Wyoming, this week. What everyone"
VRX,VRX:US,BBG000DLFM21,"3 Stocks to Watch on Monday: Alphabet Inc (GOOG), Syngenta AG (ADR) (SYT) and Valeant Pharmaceuticals Intl Inc (VRX)",2016-08-22 18:46:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b7QRx63sfJQ/3-stocks-to-watch-on-monday-alphabet-inc-goog-syngenta-ag-adr-syt-and-valeant-pharmaceuticals-intl-inc-vrx-cm668603,"The stock markets appear to be in waiting mode as investors wait for the Federal Reserve's speech in Jackson Hole, Wyoming, this week. What everyone"
VRX,VRX:CT,BBG000DC8S17,7 Red Flags of an Imminent Company Meltdown,2016-08-22 18:45:00 +0000,https://www.thestreet.com/story/13681167/1/7-red-flags-of-an-imminent-company-meltdown.html?puc=yahoo&cm_ven=YAHOO,7 Red Flags of an Imminent Company Meltdown
VRX,VRX:US,BBG000DLFM21,7 Red Flags of an Imminent Company Meltdown,2016-08-22 18:45:00 +0000,https://www.thestreet.com/story/13681167/1/7-red-flags-of-an-imminent-company-meltdown.html?puc=yahoo&cm_ven=YAHOO,7 Red Flags of an Imminent Company Meltdown
VRX,VRX:US,BBG000DLFM21,Mid-Day Market Update: Crude Oil Down 2.8%; Intersil Shares Spike Higher,2016-08-22 17:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BkO2-kEfPrc/mid-day-market-update-crude-oil-down-28-intersil-shares-spike-higher-cm668615,"Midway through trading Monday, the Dow traded up 0.02 percent to 18,556.55 while the NASDAQ rose 0.06 percent to 5,241.33. The S&P also rose, gaining 0.01 percent to 2,183.90.  Leading and Lagging Sectors"
VRX,VRX:CT,BBG000DC8S17,Mid-Day Market Update: Crude Oil Down 2.8%; Intersil Shares Spike Higher,2016-08-22 17:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BkO2-kEfPrc/mid-day-market-update-crude-oil-down-28-intersil-shares-spike-higher-cm668615,"Midway through trading Monday, the Dow traded up 0.02 percent to 18,556.55 while the NASDAQ rose 0.06 percent to 5,241.33. The S&P also rose, gaining 0.01 percent to 2,183.90.  Leading and Lagging Sectors"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%",2016-08-22 17:16:05 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-vrx-appoints-cfo-171605390.html,"Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%",2016-08-22 17:16:05 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-vrx-appoints-cfo-171605390.html,"Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%"
VRX,VRX:US,BBG000DLFM21,Valeant Shares Rise on New CFO Appointment,2016-08-22 17:16:00 +0000,http://www.thestreet.com/video/13681515/valeant-shares-rise-on-new-cfo-appointment.html?puc=yahoov&cm_ven=YAHOOV,Valeant Shares Rise on New CFO Appointment
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Rise on New CFO Appointment,2016-08-22 17:16:00 +0000,http://www.thestreet.com/video/13681515/valeant-shares-rise-on-new-cfo-appointment.html?puc=yahoov&cm_ven=YAHOOV,Valeant Shares Rise on New CFO Appointment
VRX,VRX:US,BBG000DLFM21,What you need to know on Wall Street right now,2016-08-22 16:53:50 +0000,http://finance.yahoo.com/news/know-wall-street-now-165350784.html,What you need to know on Wall Street right now
VRX,VRX:CT,BBG000DC8S17,What you need to know on Wall Street right now,2016-08-22 16:53:50 +0000,http://finance.yahoo.com/news/know-wall-street-now-165350784.html,What you need to know on Wall Street right now
VRX,VRX:US,BBG000DLFM21,"Valeant, attempting to normalize operations, names new CFO",2016-08-22 16:21:19 +0000,http://sg.finance.yahoo.com/news/valeant-attempting-normalize-operations-names-112728943.html,"Valeant, attempting to normalize operations, names new CFO"
VRX,VRX:CT,BBG000DC8S17,"Valeant, attempting to normalize operations, names new CFO",2016-08-22 16:21:19 +0000,http://sg.finance.yahoo.com/news/valeant-attempting-normalize-operations-names-112728943.html,"Valeant, attempting to normalize operations, names new CFO"
VRX,VRX:US,BBG000DLFM21,Why the Market is Cheering Valeant's New CFO,2016-08-22 15:50:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/22/why-the-market-is-cheering-valeants-new-cfo/?mod=yahoobarrons&ru=yahoo,Why the Market is Cheering Valeant's New CFO
VRX,VRX:CT,BBG000DC8S17,Why the Market is Cheering Valeant's New CFO,2016-08-22 15:50:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/22/why-the-market-is-cheering-valeants-new-cfo/?mod=yahoobarrons&ru=yahoo,Why the Market is Cheering Valeant's New CFO
VRX,VRX:CT,BBG000DC8S17,Allergan Makes an Eye-Opening Acquisition,2016-08-22 15:48:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AQD8b83dmDU/allergan-makes-an-eye-opening-acquisition-cm668466,"Image source  Getty Images.  Global pharmaceutical company Allergan (NYSE  AGN) may have just revealed its plans for the future. On Aug. 11, the company announced its plan to acquire ForSight Vision5, a"
VRX,VRX:US,BBG000DLFM21,Allergan Makes an Eye-Opening Acquisition,2016-08-22 15:48:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AQD8b83dmDU/allergan-makes-an-eye-opening-acquisition-cm668466,"Image source  Getty Images.  Global pharmaceutical company Allergan (NYSE  AGN) may have just revealed its plans for the future. On Aug. 11, the company announced its plan to acquire ForSight Vision5, a"
VRX,VRX:CT,BBG000DC8S17,Valeant Names Zoetis Executive as Financial Chief--Update,2016-08-22 15:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Msjcq9V41us/valeant-names-zoetis-executive-as-financial-chiefupdate-20160822-00444,Valeant Names Zoetis Executive as Financial Chief--Update
VRX,VRX:US,BBG000DLFM21,Valeant Names Zoetis Executive as Financial Chief--Update,2016-08-22 15:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Msjcq9V41us/valeant-names-zoetis-executive-as-financial-chiefupdate-20160822-00444,Valeant Names Zoetis Executive as Financial Chief--Update
VRX,VRX:US,BBG000DLFM21,"Valeant, attempting to normalize operations, names new CFO",2016-08-22 15:11:34 +0000,http://finance.yahoo.com/news/valeant-attempting-normalize-operations-names-112728299.html,"Valeant, attempting to normalize operations, names new CFO"
VRX,VRX:CT,BBG000DC8S17,"Valeant, attempting to normalize operations, names new CFO",2016-08-22 15:11:34 +0000,http://finance.yahoo.com/news/valeant-attempting-normalize-operations-names-112728299.html,"Valeant, attempting to normalize operations, names new CFO"
VRX,VRX:US,BBG000DLFM21,"Executive Shuffling, Bullish Write-ups, and Analyst Rating Changes: Here’s Why These 5 Stocks Are Trending",2016-08-22 14:52:02 +0000,http://www.insidermonkey.com/blog/executive-shuffling-bullish-write-ups-and-analyst-rating-changes-heres-why-these-5-stocks-are-trending-469984/,"Executive Shuffling, Bullish Write-ups, and Analyst Rating Changes: Here’s Why These 5 Stocks Are Trending"
VRX,VRX:CT,BBG000DC8S17,"Executive Shuffling, Bullish Write-ups, and Analyst Rating Changes: Here’s Why These 5 Stocks Are Trending",2016-08-22 14:52:02 +0000,http://www.insidermonkey.com/blog/executive-shuffling-bullish-write-ups-and-analyst-rating-changes-heres-why-these-5-stocks-are-trending-469984/,"Executive Shuffling, Bullish Write-ups, and Analyst Rating Changes: Here’s Why These 5 Stocks Are Trending"
VRX,VRX:CT,BBG000DC8S17,[$$] A Window of Opportunity Cracks Open at Valeant,2016-08-22 14:47:25 +0000,http://www.wsj.com/articles/a-window-of-opportunity-cracks-open-at-valeant-1471877243?mod=yahoo_hs,[$$] A Window of Opportunity Cracks Open at Valeant
VRX,VRX:US,BBG000DLFM21,[$$] A Window of Opportunity Cracks Open at Valeant,2016-08-22 14:47:25 +0000,http://www.wsj.com/articles/a-window-of-opportunity-cracks-open-at-valeant-1471877243?mod=yahoo_hs,[$$] A Window of Opportunity Cracks Open at Valeant
VRX,VRX:US,BBG000DLFM21,Valeant Gains Momentum With New CFO Appointment,2016-08-22 14:25:03 +0000,http://247wallst.com/healthcare-business/2016/08/22/valeant-gains-momentum-with-new-cfo-appointment/,Valeant Gains Momentum With New CFO Appointment
VRX,VRX:CT,BBG000DC8S17,Valeant Gains Momentum With New CFO Appointment,2016-08-22 14:25:03 +0000,http://247wallst.com/healthcare-business/2016/08/22/valeant-gains-momentum-with-new-cfo-appointment/,Valeant Gains Momentum With New CFO Appointment
VRX,VRX:CT,BBG000DC8S17,Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO,2016-08-22 14:21:00 +0000,https://www.thestreet.com/story/13681368/1/jim-cramer-valeant-investors-should-welcome-a-high-quality-cfo.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO
VRX,VRX:US,BBG000DLFM21,Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO,2016-08-22 14:21:00 +0000,https://www.thestreet.com/story/13681368/1/jim-cramer-valeant-investors-should-welcome-a-high-quality-cfo.html?puc=yahoo&cm_ven=YAHOO,Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO
VRX,VRX:CT,BBG000DC8S17,Allergan Makes an Eye-Opening Acquisition,2016-08-22 14:05:00 +0000,http://www.fool.com/investing/2016/08/22/allergan-makes-an-eye-opening-acquisition.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Allergan Makes an Eye-Opening Acquisition
VRX,VRX:US,BBG000DLFM21,Allergan Makes an Eye-Opening Acquisition,2016-08-22 14:05:00 +0000,http://www.fool.com/investing/2016/08/22/allergan-makes-an-eye-opening-acquisition.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Allergan Makes an Eye-Opening Acquisition
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Aug 22, 2016 :  MDVN, CST, VRX, SYT, QQQ, CHK, BCS, BHP, TVIX, GOLD, AMAT, USLV",2016-08-22 12:59:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1vRChbOFvrk/pre-market-most-active-for-aug-22-2016-mdvn-cst-vrx-syt-qqq-chk-bcs-bhp-tvix-gold-amat-uslv-cm668317,"The NASDAQ 100 Pre Market Indicator is down 1.54 to 4,804.6. The total Pre Market volume is currently 3,907,514 shares traded. The following are the most active stocks for the pre market session Medivation, Inc. ( MDVN ) is"
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Aug 22, 2016 :  MDVN, CST, VRX, SYT, QQQ, CHK, BCS, BHP, TVIX, GOLD, AMAT, USLV",2016-08-22 12:59:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1vRChbOFvrk/pre-market-most-active-for-aug-22-2016-mdvn-cst-vrx-syt-qqq-chk-bcs-bhp-tvix-gold-amat-uslv-cm668317,"The NASDAQ 100 Pre Market Indicator is down 1.54 to 4,804.6. The total Pre Market volume is currently 3,907,514 shares traded. The following are the most active stocks for the pre market session Medivation, Inc. ( MDVN ) is"
VRX,VRX:CT,BBG000DC8S17,Valeant names Paul Herendeen as its new CFO,2016-08-22 11:39:41 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=EFFB6A82-67FF-11E6-9466-B35C1E3D9BB5&siteid=yhoof2,Valeant names Paul Herendeen as its new CFO
VRX,VRX:US,BBG000DLFM21,Valeant names Paul Herendeen as its new CFO,2016-08-22 11:39:41 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=EFFB6A82-67FF-11E6-9466-B35C1E3D9BB5&siteid=yhoof2,Valeant names Paul Herendeen as its new CFO
VRX,VRX:US,BBG000DLFM21,"Valeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFO",2016-08-22 11:39:00 +0000,https://www.thestreet.com/story/13680963/1/valeant-vrx-stock-climbs-hires-zoetis-herendeen-as-cfo.html?puc=yahoo&cm_ven=YAHOO,"Valeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFO"
VRX,VRX:CT,BBG000DC8S17,"Valeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFO",2016-08-22 11:39:00 +0000,https://www.thestreet.com/story/13680963/1/valeant-vrx-stock-climbs-hires-zoetis-herendeen-as-cfo.html?puc=yahoo&cm_ven=YAHOO,"Valeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFO"
VRX,VRX:CT,BBG000DC8S17,Valeant hires Zoetis's Paul Herendeen as CFO,2016-08-22 11:12:17 +0000,http://sg.finance.yahoo.com/news/valeant-hires-zoetiss-paul-herendeen-111217790.html,Valeant hires Zoetis's Paul Herendeen as CFO
VRX,VRX:US,BBG000DLFM21,Valeant hires Zoetis's Paul Herendeen as CFO,2016-08-22 11:12:17 +0000,http://sg.finance.yahoo.com/news/valeant-hires-zoetiss-paul-herendeen-111217790.html,Valeant hires Zoetis's Paul Herendeen as CFO
VRX,VRX:CT,BBG000DC8S17,"Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan",2016-08-22 10:47:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Poq_E1GFhSE/valeant-stock-down-on-lawsuit-by-t-rowe-alters-credit-loan-cm667833,"Valeant Pharmaceuticals International, Inc . VRX announced that it has received the requisite lender approval for an amendment to its credit facility which is scheduled to close next week. The amendment will result in a reduction in"
VRX,VRX:US,BBG000DLFM21,"Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan",2016-08-22 10:47:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Poq_E1GFhSE/valeant-stock-down-on-lawsuit-by-t-rowe-alters-credit-loan-cm667833,"Valeant Pharmaceuticals International, Inc . VRX announced that it has received the requisite lender approval for an amendment to its credit facility which is scheduled to close next week. The amendment will result in a reduction in"
VRX,VRX:CT,BBG000DC8S17,Valeant names Paul Herendeen as new CFO,2016-08-22 10:33:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=DB195E41-1357-4E5B-81B3-13046C285CFC&siteid=yhoof2,Valeant names Paul Herendeen as new CFO
VRX,VRX:US,BBG000DLFM21,Valeant names Paul Herendeen as new CFO,2016-08-22 10:33:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=DB195E41-1357-4E5B-81B3-13046C285CFC&siteid=yhoof2,Valeant names Paul Herendeen as new CFO
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer",2016-08-22 10:18:07 +0000,http://www.publicnow.com/view/CA8FDDADEC0D083FE5244ED05B7D3A65F4186F72,"[at noodls] - Robert L. Rosiello to Remain at Valeant as Executive Vice President, Corporate Development and Strategy LAVAL, Quebec, Aug. 22, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer",2016-08-22 10:18:07 +0000,http://www.publicnow.com/view/CA8FDDADEC0D083FE5244ED05B7D3A65F4186F72,"[at noodls] - Robert L. Rosiello to Remain at Valeant as Executive Vice President, Corporate Development and Strategy LAVAL, Quebec, Aug. 22, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ..."
VRX,VRX:CT,BBG000DC8S17,Valeant names former Zoetis executive Paul Herendeen as CFO,2016-08-22 10:11:36 +0000,http://finance.yahoo.com/news/valeant-names-former-zoetis-executive-101136358.html,Valeant names former Zoetis executive Paul Herendeen as CFO
VRX,VRX:US,BBG000DLFM21,Valeant names former Zoetis executive Paul Herendeen as CFO,2016-08-22 10:11:36 +0000,http://finance.yahoo.com/news/valeant-names-former-zoetis-executive-101136358.html,Valeant names former Zoetis executive Paul Herendeen as CFO
VRX,VRX:US,BBG000DLFM21,Valeant Picks New CFO From Zoetis in Ongoing Company Shakeup,2016-08-22 10:09:15 +0000,http://www.bloomberg.com/news/articles/2016-08-22/valeant-names-herendeen-from-zoetis-as-cfo-to-replace-rosiello?cmpid=yhoo.headline,Valeant Picks New CFO From Zoetis in Ongoing Company Shakeup
VRX,VRX:CT,BBG000DC8S17,Valeant Picks New CFO From Zoetis in Ongoing Company Shakeup,2016-08-22 10:09:15 +0000,http://www.bloomberg.com/news/articles/2016-08-22/valeant-names-herendeen-from-zoetis-as-cfo-to-replace-rosiello?cmpid=yhoo.headline,Valeant Picks New CFO From Zoetis in Ongoing Company Shakeup
VRX,VRX:CT,BBG000DC8S17,Valeant poached a new CFO from the animal-health company Zoetis,2016-08-22 10:06:00 +0000,http://finance.yahoo.com/news/valeant-reportedly-poached-cfo-animal-100600854.html,Valeant poached a new CFO from the animal-health company Zoetis
VRX,VRX:US,BBG000DLFM21,Valeant poached a new CFO from the animal-health company Zoetis,2016-08-22 10:06:00 +0000,http://finance.yahoo.com/news/valeant-reportedly-poached-cfo-animal-100600854.html,Valeant poached a new CFO from the animal-health company Zoetis
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer",2016-08-22 10:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-appoints-paul-herendeen-100000638.html,"[CNW Group] - Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer",2016-08-22 10:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-appoints-paul-herendeen-100000638.html,"[CNW Group] - Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer"
VRX,VRX:CT,BBG000DC8S17,"Couche-Tarde, Valeant In Focus -- Canadian Commentary",2016-08-22 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DjHht-Np_Ko/couchetarde-valeant-in-focus--canadian-commentary-20160822-00309,"Couche-Tarde, Valeant In Focus -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Couche-Tarde, Valeant In Focus -- Canadian Commentary",2016-08-22 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DjHht-Np_Ko/couchetarde-valeant-in-focus--canadian-commentary-20160822-00309,"Couche-Tarde, Valeant In Focus -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,Valeant Names Zoetis Executive as CFO,2016-08-22 07:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lpz4ut4DILM/valeant-names-zoetis-executive-as-cfo-20160822-00098,Valeant Names Zoetis Executive as CFO
VRX,VRX:CT,BBG000DC8S17,Valeant Names Zoetis Executive as CFO,2016-08-22 07:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lpz4ut4DILM/valeant-names-zoetis-executive-as-cfo-20160822-00098,Valeant Names Zoetis Executive as CFO
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Appoints Paul Herendeen To Succeed Robert Rosiello As CFO,2016-08-22 06:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5xkzJMtzwA8/valeant-pharma-appoints-paul-herendeen-to-succeed-robert-rosiello-as-cfo-20160822-00083,Valeant Pharma Appoints Paul Herendeen To Succeed Robert Rosiello As CFO
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Appoints Paul Herendeen To Succeed Robert Rosiello As CFO,2016-08-22 06:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5xkzJMtzwA8/valeant-pharma-appoints-paul-herendeen-to-succeed-robert-rosiello-as-cfo-20160822-00083,Valeant Pharma Appoints Paul Herendeen To Succeed Robert Rosiello As CFO
VRX,VRX:CT,BBG000DC8S17,"Valeant to Tap New CFO, As Shake-Up Continues -- WSJ",2016-08-22 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A1XYvsNcPL8/valeant-to-tap-new-cfo-as-shakeup-continues--wsj-20160822-00027,"Valeant to Tap New CFO, As Shake-Up Continues -- WSJ"
VRX,VRX:US,BBG000DLFM21,"Valeant to Tap New CFO, As Shake-Up Continues -- WSJ",2016-08-22 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A1XYvsNcPL8/valeant-to-tap-new-cfo-as-shakeup-continues--wsj-20160822-00027,"Valeant to Tap New CFO, As Shake-Up Continues -- WSJ"
VRX,VRX:CT,BBG000DC8S17,Valeant Is Said to Hire Zoetis’ Paul Herendeen as CFO,2016-08-22 01:33:23 +0000,http://www.bloomberg.com/news/articles/2016-08-22/valeant-is-said-to-hire-zoetis-paul-herendeen-as-cfo?cmpid=yhoo.headline,Valeant Is Said to Hire Zoetis’ Paul Herendeen as CFO
VRX,VRX:US,BBG000DLFM21,Valeant Is Said to Hire Zoetis’ Paul Herendeen as CFO,2016-08-22 01:33:23 +0000,http://www.bloomberg.com/news/articles/2016-08-22/valeant-is-said-to-hire-zoetis-paul-herendeen-as-cfo?cmpid=yhoo.headline,Valeant Is Said to Hire Zoetis’ Paul Herendeen as CFO
VRX,VRX:US,BBG000DLFM21,Valeant has reportedly poached a new CFO from the animal-health company Zoetis,2016-08-22 01:10:05 +0000,http://finance.yahoo.com/news/valeant-reportedly-poached-cfo-animal-011005070.html,Valeant has reportedly poached a new CFO from the animal-health company Zoetis
VRX,VRX:CT,BBG000DC8S17,Valeant has reportedly poached a new CFO from the animal-health company Zoetis,2016-08-22 01:10:05 +0000,http://finance.yahoo.com/news/valeant-reportedly-poached-cfo-animal-011005070.html,Valeant has reportedly poached a new CFO from the animal-health company Zoetis
VRX,VRX:US,BBG000DLFM21,Valeant expected to announce Herendeen as new CFO - WSJ,2016-08-22 00:44:26 +0000,http://sg.finance.yahoo.com/news/valeant-expected-announce-herendeen-cfo-004426829.html,Valeant expected to announce Herendeen as new CFO - WSJ
VRX,VRX:CT,BBG000DC8S17,Valeant expected to announce Herendeen as new CFO - WSJ,2016-08-22 00:44:26 +0000,http://sg.finance.yahoo.com/news/valeant-expected-announce-herendeen-cfo-004426829.html,Valeant expected to announce Herendeen as new CFO - WSJ
VRX,VRX:CT,BBG000DC8S17,"Pershing Square Cuts Positions to Fight Losses (VRX, ZTS)",2016-08-21 23:15:00 +0000,http://www.investopedia.com/news/pershing-square-cuts-positions-fight-losses-vrx-zts/?partner=YahooSA,"Pershing Square Cuts Positions to Fight Losses (VRX, ZTS)"
VRX,VRX:US,BBG000DLFM21,"Pershing Square Cuts Positions to Fight Losses (VRX, ZTS)",2016-08-21 23:15:00 +0000,http://www.investopedia.com/news/pershing-square-cuts-positions-fight-losses-vrx-zts/?partner=YahooSA,"Pershing Square Cuts Positions to Fight Losses (VRX, ZTS)"
VRX,VRX:CT,BBG000DC8S17,Valeant Reportedly Appoints Zoetis' Executive Paul Herendeen As CFO,2016-08-21 22:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4ElVfWeTho8/valeant-reportedly-appoints-zoetis-executive-paul-herendeen-as-cfo-20160821-00054,Valeant Reportedly Appoints Zoetis' Executive Paul Herendeen As CFO
VRX,VRX:US,BBG000DLFM21,Valeant Reportedly Appoints Zoetis' Executive Paul Herendeen As CFO,2016-08-21 22:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4ElVfWeTho8/valeant-reportedly-appoints-zoetis-executive-paul-herendeen-as-cfo-20160821-00054,Valeant Reportedly Appoints Zoetis' Executive Paul Herendeen As CFO
VRX,VRX:US,BBG000DLFM21,Valeant Hiring Paul Herendeen as New CFO,2016-08-21 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yeFyLSu3Lus/valeant-hiring-paul-herendeen-as-new-cfo-20160821-00049,Valeant Hiring Paul Herendeen as New CFO
VRX,VRX:CT,BBG000DC8S17,Valeant Hiring Paul Herendeen as New CFO,2016-08-21 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yeFyLSu3Lus/valeant-hiring-paul-herendeen-as-new-cfo-20160821-00049,Valeant Hiring Paul Herendeen as New CFO
VRX,VRX:CT,BBG000DC8S17,"Valeant Hiring Paul Herendeen From Zoetis as New CFO, Sources Say -- Update",2016-08-21 20:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yAWmCKEpYL0/valeant-hiring-paul-herendeen-from-zoetis-as-new-cfo-sources-say--update-20160821-00034,"Valeant Hiring Paul Herendeen From Zoetis as New CFO, Sources Say -- Update"
VRX,VRX:US,BBG000DLFM21,"Valeant Hiring Paul Herendeen From Zoetis as New CFO, Sources Say -- Update",2016-08-21 20:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yAWmCKEpYL0/valeant-hiring-paul-herendeen-from-zoetis-as-new-cfo-sources-say--update-20160821-00034,"Valeant Hiring Paul Herendeen From Zoetis as New CFO, Sources Say -- Update"
VRX,VRX:US,BBG000DLFM21,[$$] Pharmaceuticals: Staying power,2016-08-21 18:20:58 +0000,"http://www.ft.com/cms/s/d7b1c59e-65fb-11e6-a08a-c7ac04ef00aa,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - It was October of last year and the pharmaceuticals industry was firefighting an explosion set off by Martin Shkreli, the enfant terrible of drug making, who sparked an international outcry by raising ..."
VRX,VRX:CT,BBG000DC8S17,[$$] Pharmaceuticals: Staying power,2016-08-21 18:20:58 +0000,"http://www.ft.com/cms/s/d7b1c59e-65fb-11e6-a08a-c7ac04ef00aa,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - It was October of last year and the pharmaceuticals industry was firefighting an explosion set off by Martin Shkreli, the enfant terrible of drug making, who sparked an international outcry by raising ..."
VRX,VRX:US,BBG000DLFM21,[$$] US doctors waste millions on branded medicines,2016-08-21 16:04:14 +0000,"http://www.ft.com/cms/s/e2a44bf6-6647-11e6-a08a-c7ac04ef00aa,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an analysis by the Financial ..."
VRX,VRX:CT,BBG000DC8S17,[$$] US doctors waste millions on branded medicines,2016-08-21 16:04:14 +0000,"http://www.ft.com/cms/s/e2a44bf6-6647-11e6-a08a-c7ac04ef00aa,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an analysis by the Financial ..."
VRX,VRX:US,BBG000DLFM21,"[$$] Hedge Funds Snap Up Banks, Unload Apple",2016-08-20 04:01:00 +0000,http://www.barrons.com/articles/hedge-funds-snap-up-bank-shares-unload-apple-1471670317?mod=yahoobarrons&ru=yahoo,"[$$] Hedge Funds Snap Up Banks, Unload Apple"
VRX,VRX:CT,BBG000DC8S17,"[$$] Hedge Funds Snap Up Banks, Unload Apple",2016-08-20 04:01:00 +0000,http://www.barrons.com/articles/hedge-funds-snap-up-bank-shares-unload-apple-1471670317?mod=yahoobarrons&ru=yahoo,"[$$] Hedge Funds Snap Up Banks, Unload Apple"
VRX,VRX:US,BBG000DLFM21,"Friday’s Vital Data: Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) and Twitter Inc (TWTR)",2016-08-19 20:47:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6igiYoPvPX8/fridays-vital-data-apple-inc-aapl-valeant-pharmaceuticals-intl-inc-vrx-and-twitter-inc-twtr-cm667931,"U.S. stock futures are pointed lower heading into the open this morning, as Wall Street begins to digest the possibility of a Federal Reserve interest"
VRX,VRX:CT,BBG000DC8S17,"Friday’s Vital Data: Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) and Twitter Inc (TWTR)",2016-08-19 20:47:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6igiYoPvPX8/fridays-vital-data-apple-inc-aapl-valeant-pharmaceuticals-intl-inc-vrx-and-twitter-inc-twtr-cm667931,"U.S. stock futures are pointed lower heading into the open this morning, as Wall Street begins to digest the possibility of a Federal Reserve interest"
VRX,VRX:CT,BBG000DC8S17,Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof,2016-08-19 20:46:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OjMFhgbObdU/big-money-really-wants-nothing-to-do-with-valeant-pharmaceuticals-heres-proof-cm667946,"Image source  Getty Images.  Shareholders of drugmaker Valeant Pharmaceuticals (NYSE  VRX) have had a rough go of things over the trailing 12 month period. After peaking at $264 per share in 2015,"
VRX,VRX:US,BBG000DLFM21,Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof,2016-08-19 20:46:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OjMFhgbObdU/big-money-really-wants-nothing-to-do-with-valeant-pharmaceuticals-heres-proof-cm667946,"Image source  Getty Images.  Shareholders of drugmaker Valeant Pharmaceuticals (NYSE  VRX) have had a rough go of things over the trailing 12 month period. After peaking at $264 per share in 2015,"
VRX,VRX:CT,BBG000DC8S17,Hunting For Biotech Stocks? Understand The Earnings Formula First,2016-08-19 20:19:11 +0000,http://www.investors.com/news/technology/biotech-sales-growth-how-much-is-demand-how-much-is-price/,Hunting For Biotech Stocks? Understand The Earnings Formula First
VRX,VRX:US,BBG000DLFM21,Hunting For Biotech Stocks? Understand The Earnings Formula First,2016-08-19 20:19:11 +0000,http://www.investors.com/news/technology/biotech-sales-growth-how-much-is-demand-how-much-is-price/,Hunting For Biotech Stocks? Understand The Earnings Formula First
VRX,VRX:US,BBG000DLFM21,"T. Rowe Price Sues Valeant Pharmaceuticals For Fraud (TROW, VRX)",2016-08-19 19:41:00 +0000,http://www.investopedia.com/news/t-rowe-price-sues-valeant-pharmaceuticals-fraud-trow-vrx/?partner=YahooSA,"T. Rowe Price Sues Valeant Pharmaceuticals For Fraud (TROW, VRX)"
VRX,VRX:CT,BBG000DC8S17,"T. Rowe Price Sues Valeant Pharmaceuticals For Fraud (TROW, VRX)",2016-08-19 19:41:00 +0000,http://www.investopedia.com/news/t-rowe-price-sues-valeant-pharmaceuticals-fraud-trow-vrx/?partner=YahooSA,"T. Rowe Price Sues Valeant Pharmaceuticals For Fraud (TROW, VRX)"
VRX,VRX:CT,BBG000DC8S17,Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof,2016-08-19 18:42:00 +0000,http://www.fool.com/investing/2016/08/19/big-money-really-wants-nothing-to-do-with-valeant.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof
VRX,VRX:US,BBG000DLFM21,Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof,2016-08-19 18:42:00 +0000,http://www.fool.com/investing/2016/08/19/big-money-really-wants-nothing-to-do-with-valeant.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof
VRX,VRX:US,BBG000DLFM21,"Health Care Sector Update for 08/19/2016: VRX,VRX.TO",2016-08-19 18:19:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8m3ybyY8aeo/health-care-sector-update-for-08192016-vrxvrxto-cm667909,"Top Health Care Stocks JNJ 0.20% PFE 0.71% MRK 0.47% ABT 0.80% AMGN 0.86% Health care stocks were broadly lower Friday afternoon, with the NYSE Health Care Index dropping almost 0.6% while shares of health care companies in the"
VRX,VRX:CT,BBG000DC8S17,"Health Care Sector Update for 08/19/2016: VRX,VRX.TO",2016-08-19 18:19:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8m3ybyY8aeo/health-care-sector-update-for-08192016-vrxvrxto-cm667909,"Top Health Care Stocks JNJ 0.20% PFE 0.71% MRK 0.47% ABT 0.80% AMGN 0.86% Health care stocks were broadly lower Friday afternoon, with the NYSE Health Care Index dropping almost 0.6% while shares of health care companies in the"
VRX,VRX:US,BBG000DLFM21,"T. Rowe Price sues Valeant Pharmaceuticals, alleging 'fraudulent scheme'",2016-08-19 17:31:31 +0000,http://www.bizjournals.com/baltimore/news/2016/08/18/t-rowe-price-sues-valeant-pharmaceuticals-alleging.html?ana=yahoo,"T. Rowe Price sues Valeant Pharmaceuticals, alleging 'fraudulent scheme'"
VRX,VRX:CT,BBG000DC8S17,"T. Rowe Price sues Valeant Pharmaceuticals, alleging 'fraudulent scheme'",2016-08-19 17:31:31 +0000,http://www.bizjournals.com/baltimore/news/2016/08/18/t-rowe-price-sues-valeant-pharmaceuticals-alleging.html?ana=yahoo,"T. Rowe Price sues Valeant Pharmaceuticals, alleging 'fraudulent scheme'"
VRX,VRX:US,BBG000DLFM21,'If you ever saw Wolves of Wall Street well that was sorta what some of us saw at Philidor',2016-08-19 17:28:49 +0000,http://finance.yahoo.com/news/ever-saw-wolves-wall-street-172849795.html,'If you ever saw Wolves of Wall Street well that was sorta what some of us saw at Philidor'
VRX,VRX:CT,BBG000DC8S17,'If you ever saw Wolves of Wall Street well that was sorta what some of us saw at Philidor',2016-08-19 17:28:49 +0000,http://finance.yahoo.com/news/ever-saw-wolves-wall-street-172849795.html,'If you ever saw Wolves of Wall Street well that was sorta what some of us saw at Philidor'
VRX,VRX:CT,BBG000DC8S17,"Company News for August 19, 2016",2016-08-19 16:49:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0EislhWpaHg/company-news-for-august-19-2016-cm667847,"•    Shares of Cisco Systems, Inc. ( CSCO ) dropped 0.8% after the network equipment provider declared that it will trim 5,500 jobs  •    Shares of NetApp, Inc. ( NTAP ) soared 17.4% after the company"
VRX,VRX:US,BBG000DLFM21,"Company News for August 19, 2016",2016-08-19 16:49:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0EislhWpaHg/company-news-for-august-19-2016-cm667847,"•    Shares of Cisco Systems, Inc. ( CSCO ) dropped 0.8% after the network equipment provider declared that it will trim 5,500 jobs  •    Shares of NetApp, Inc. ( NTAP ) soared 17.4% after the company"
VRX,VRX:US,BBG000DLFM21,Here's the meltdown Bill Ackman had when he found out what was going on at Valeant,2016-08-19 16:27:00 +0000,http://finance.yahoo.com/news/heres-meltdown-bill-ackman-had-162700980.html,Here's the meltdown Bill Ackman had when he found out what was going on at Valeant
VRX,VRX:CT,BBG000DC8S17,Here's the meltdown Bill Ackman had when he found out what was going on at Valeant,2016-08-19 16:27:00 +0000,http://finance.yahoo.com/news/heres-meltdown-bill-ackman-had-162700980.html,Here's the meltdown Bill Ackman had when he found out what was going on at Valeant
VRX,VRX:CT,BBG000DC8S17,"Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC",2016-08-19 14:33:00 +0000,https://www.thestreet.com/story/13680200/1/allergan-agn-stock-should-outperform-analyst-tells-cnbc.html?puc=yahoo&cm_ven=YAHOO,"Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC"
VRX,VRX:US,BBG000DLFM21,"Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC",2016-08-19 14:33:00 +0000,https://www.thestreet.com/story/13680200/1/allergan-agn-stock-should-outperform-analyst-tells-cnbc.html?puc=yahoo&cm_ven=YAHOO,"Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC"
VRX,VRX:US,BBG000DLFM21,"Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan",2016-08-19 14:21:02 +0000,http://finance.yahoo.com/news/valeant-stock-down-lawsuit-t-142102410.html,"Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan"
VRX,VRX:CT,BBG000DC8S17,"Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan",2016-08-19 14:21:02 +0000,http://finance.yahoo.com/news/valeant-stock-down-lawsuit-t-142102410.html,"Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan"
VRX,VRX:CT,BBG000DC8S17,"Company News for August 19, 2016",2016-08-19 14:10:02 +0000,http://finance.yahoo.com/news/company-news-august-19-2016-141002548.html,"Company News for August 19, 2016"
VRX,VRX:US,BBG000DLFM21,"Company News for August 19, 2016",2016-08-19 14:10:02 +0000,http://finance.yahoo.com/news/company-news-august-19-2016-141002548.html,"Company News for August 19, 2016"
VRX,VRX:CT,BBG000DC8S17,"A.M. Roundup: Hedge Fund Icon Sees ""Biggest Bond Bubble Ever""; Changes At Edward Jones",2016-08-19 12:56:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/19/a-m-roundup-hedge-fund-icon-sees-biggest-bond-bubble-ever-changes-at-edward-jones/?mod=yahoobarrons&ru=yahoo,"A.M. Roundup: Hedge Fund Icon Sees ""Biggest Bond Bubble Ever""; Changes At Edward Jones"
VRX,VRX:US,BBG000DLFM21,"A.M. Roundup: Hedge Fund Icon Sees ""Biggest Bond Bubble Ever""; Changes At Edward Jones",2016-08-19 12:56:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/19/a-m-roundup-hedge-fund-icon-sees-biggest-bond-bubble-ever-changes-at-edward-jones/?mod=yahoobarrons&ru=yahoo,"A.M. Roundup: Hedge Fund Icon Sees ""Biggest Bond Bubble Ever""; Changes At Edward Jones"
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Down On Weak Data -- Canadian Commentary,2016-08-19 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DCApooUdo9Y/canadian-stocks-are-down-on-weak-data--canadian-commentary-20160819-00276,Canadian Stocks Are Down On Weak Data -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Down On Weak Data -- Canadian Commentary,2016-08-19 10:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DCApooUdo9Y/canadian-stocks-are-down-on-weak-data--canadian-commentary-20160819-00276,Canadian Stocks Are Down On Weak Data -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Again Able to Loosen Debt Terms,2016-08-19 04:20:13 +0000,http://www.wsj.com/articles/valeant-secures-another-debt-amendment-1471524157?ru=yahoo?mod=yahoo_itp,[$$] Valeant Again Able to Loosen Debt Terms
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Again Able to Loosen Debt Terms,2016-08-19 04:20:13 +0000,http://www.wsj.com/articles/valeant-secures-another-debt-amendment-1471524157?ru=yahoo?mod=yahoo_itp,[$$] Valeant Again Able to Loosen Debt Terms
VRX,VRX:CT,BBG000DC8S17,Valeant Makes Deal To Loosen Debt Terms -- WSJ,2016-08-19 02:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0e10dUqOOTc/valeant-makes-deal-to-loosen-debt-terms--wsj-20160819-00022,Valeant Makes Deal To Loosen Debt Terms -- WSJ
VRX,VRX:US,BBG000DLFM21,Valeant Makes Deal To Loosen Debt Terms -- WSJ,2016-08-19 02:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0e10dUqOOTc/valeant-makes-deal-to-loosen-debt-terms--wsj-20160819-00022,Valeant Makes Deal To Loosen Debt Terms -- WSJ
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX slips as energy boost offset by banks, Valeant",2016-08-18 21:25:46 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-slips-energy-212546585.html,"CANADA STOCKS-TSX slips as energy boost offset by banks, Valeant"
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX slips as energy boost offset by banks, Valeant",2016-08-18 21:25:46 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-slips-energy-212546585.html,"CANADA STOCKS-TSX slips as energy boost offset by banks, Valeant"
VRX,VRX:CT,BBG000DC8S17,"T. Rowe Price sues Valeant over ""fraudulent scheme""",2016-08-18 20:34:45 +0000,http://finance.yahoo.com/news/t-rowe-price-sues-valeant-163917344.html,"[Reuters] - T. Rowe Price Group Inc has sued Valeant Pharmaceuticals International Inc , alleging that investors in the Canadian drugmaker lost billions of dollars as a result of the company's ""fraudulent scheme"". Valeant's U.S.-listed shares reversed course to close down 3.4 percent at $37.19 on Thursday. T. Rowe Price, one of the biggest investment managers in the world, said Valeant had used a secret pharmacy network, deceptive pricing and reimbursement practices, and fictitious accounting to shield the company's branded drugs from generic competition and artificially inflate revenues and profits."
VRX,VRX:US,BBG000DLFM21,"T. Rowe Price sues Valeant over ""fraudulent scheme""",2016-08-18 20:34:45 +0000,http://finance.yahoo.com/news/t-rowe-price-sues-valeant-163917344.html,"[Reuters] - T. Rowe Price Group Inc has sued Valeant Pharmaceuticals International Inc , alleging that investors in the Canadian drugmaker lost billions of dollars as a result of the company's ""fraudulent scheme"". Valeant's U.S.-listed shares reversed course to close down 3.4 percent at $37.19 on Thursday. T. Rowe Price, one of the biggest investment managers in the world, said Valeant had used a secret pharmacy network, deceptive pricing and reimbursement practices, and fictitious accounting to shield the company's branded drugs from generic competition and artificially inflate revenues and profits."
VRX,VRX:US,BBG000DLFM21,JAIL STOCKS CRASH: Here's what you need to know,2016-08-18 20:00:31 +0000,http://finance.yahoo.com/news/jail-stocks-crash-heres-know-200031515.html,JAIL STOCKS CRASH: Here's what you need to know
VRX,VRX:CT,BBG000DC8S17,JAIL STOCKS CRASH: Here's what you need to know,2016-08-18 20:00:31 +0000,http://finance.yahoo.com/news/jail-stocks-crash-heres-know-200031515.html,JAIL STOCKS CRASH: Here's what you need to know
VRX,VRX:CT,BBG000DC8S17,[$$] Valeant Able to Loosen Debt Terms,2016-08-18 19:59:59 +0000,http://www.wsj.com/articles/valeant-secures-another-debt-amendment-1471524157?mod=yahoo_hs,[$$] Valeant Able to Loosen Debt Terms
VRX,VRX:US,BBG000DLFM21,[$$] Valeant Able to Loosen Debt Terms,2016-08-18 19:59:59 +0000,http://www.wsj.com/articles/valeant-secures-another-debt-amendment-1471524157?mod=yahoo_hs,[$$] Valeant Able to Loosen Debt Terms
VRX,VRX:US,BBG000DLFM21,"Thursday’s Vital Data: Bank of America Corp (BAC), Cisco Systems, Inc. (CSCO) and Target Corporation (TGT)",2016-08-18 19:48:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9pwNgR4ZoTk/thursdays-vital-data-bank-of-america-corp-bac-cisco-systems-inc-csco-and-target-corporation-tgt-cm667308,"U.S. stock futures are trading flat to lower heading into the open this morning, as Wall Street braces for weekly jobless claims data and a"
VRX,VRX:CT,BBG000DC8S17,"Thursday’s Vital Data: Bank of America Corp (BAC), Cisco Systems, Inc. (CSCO) and Target Corporation (TGT)",2016-08-18 19:48:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9pwNgR4ZoTk/thursdays-vital-data-bank-of-america-corp-bac-cisco-systems-inc-csco-and-target-corporation-tgt-cm667308,"U.S. stock futures are trading flat to lower heading into the open this morning, as Wall Street braces for weekly jobless claims data and a"
VRX,VRX:CT,BBG000DC8S17,Valeant’s Debt Agreement Comes With Freedom to Miss Forecast,2016-08-18 19:37:32 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-s-new-debt-agreement-comes-with-freedom-to-miss-forecast?cmpid=yhoo.headline,Valeant’s Debt Agreement Comes With Freedom to Miss Forecast
VRX,VRX:US,BBG000DLFM21,Valeant’s Debt Agreement Comes With Freedom to Miss Forecast,2016-08-18 19:37:32 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-s-new-debt-agreement-comes-with-freedom-to-miss-forecast?cmpid=yhoo.headline,Valeant’s Debt Agreement Comes With Freedom to Miss Forecast
VRX,VRX:CT,BBG000DC8S17,Valeant's Feel-Good Moments Don't Last,2016-08-18 19:06:17 +0000,http://www.bloomberg.com/gadfly/articles/2016-08-18/valeant-feel-good-moments-don-t-last?cmpid=yhoo.headline,Valeant's Feel-Good Moments Don't Last
VRX,VRX:US,BBG000DLFM21,Valeant's Feel-Good Moments Don't Last,2016-08-18 19:06:17 +0000,http://www.bloomberg.com/gadfly/articles/2016-08-18/valeant-feel-good-moments-don-t-last?cmpid=yhoo.headline,Valeant's Feel-Good Moments Don't Last
VRX,VRX:US,BBG000DLFM21,Why T. Rowe Price Is Suing Valeant Now,2016-08-18 18:37:16 +0000,http://finance.yahoo.com/video/why-t-rowe-price-suing-183716833.html,Why T. Rowe Price Is Suing Valeant Now
VRX,VRX:CT,BBG000DC8S17,Why T. Rowe Price Is Suing Valeant Now,2016-08-18 18:37:16 +0000,http://finance.yahoo.com/video/why-t-rowe-price-suing-183716833.html,Why T. Rowe Price Is Suing Valeant Now
VRX,VRX:CT,BBG000DC8S17,[$$] T Rowe Price sues Valeant for vast fraud,2016-08-18 17:23:01 +0000,"http://www.ft.com/cms/s/3cc9dfe8-6561-11e6-8310-ecf0bddad227,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Valeant, the Canadian drugmaker, perpetrated a vast fraud by operating a secret network of pharmacies, employing deceptive pricing practices and using fictitious accounting techniques, according to a lawsuit ..."
VRX,VRX:US,BBG000DLFM21,[$$] T Rowe Price sues Valeant for vast fraud,2016-08-18 17:23:01 +0000,"http://www.ft.com/cms/s/3cc9dfe8-6561-11e6-8310-ecf0bddad227,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Valeant, the Canadian drugmaker, perpetrated a vast fraud by operating a secret network of pharmacies, employing deceptive pricing practices and using fictitious accounting techniques, according to a lawsuit ..."
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Falls on T. Rowe Price Lawsuit,2016-08-18 17:21:00 +0000,https://www.thestreet.com/story/13679472/1/valeant-vrx-stock-falls-on-t-rowe-price-lawsuit.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Falls on T. Rowe Price Lawsuit
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Falls on T. Rowe Price Lawsuit,2016-08-18 17:21:00 +0000,https://www.thestreet.com/story/13679472/1/valeant-vrx-stock-falls-on-t-rowe-price-lawsuit.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Falls on T. Rowe Price Lawsuit
VRX,VRX:CT,BBG000DC8S17,Wells Fargo Analyst Maris Weighs In on Valeant (VRX) Lawsuit on CNBC,2016-08-18 16:36:00 +0000,https://www.thestreet.com/story/13679437/1/wells-fargo-analyst-maris-weighs-in-on-valeant-vrx-lawsuit-on-cnbc.html?puc=yahoo&cm_ven=YAHOO,Wells Fargo Analyst Maris Weighs In on Valeant (VRX) Lawsuit on CNBC
VRX,VRX:US,BBG000DLFM21,Wells Fargo Analyst Maris Weighs In on Valeant (VRX) Lawsuit on CNBC,2016-08-18 16:36:00 +0000,https://www.thestreet.com/story/13679437/1/wells-fargo-analyst-maris-weighs-in-on-valeant-vrx-lawsuit-on-cnbc.html?puc=yahoo&cm_ven=YAHOO,Wells Fargo Analyst Maris Weighs In on Valeant (VRX) Lawsuit on CNBC
VRX,VRX:US,BBG000DLFM21,"Oh look, another nasty problem for Valeant",2016-08-18 16:21:32 +0000,http://finance.yahoo.com/news/oh-look-another-nasty-problem-162132637.html,"Oh look, another nasty problem for Valeant"
VRX,VRX:CT,BBG000DC8S17,"Oh look, another nasty problem for Valeant",2016-08-18 16:21:32 +0000,http://finance.yahoo.com/news/oh-look-another-nasty-problem-162132637.html,"Oh look, another nasty problem for Valeant"
VRX,VRX:CT,BBG000DC8S17,"Valeant sued by T. Rowe Price, claiming fraud",2016-08-18 16:14:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=28D3086A-655D-11E6-A628-30DF258FF106&siteid=yhoof2,"Valeant sued by T. Rowe Price, claiming fraud"
VRX,VRX:US,BBG000DLFM21,"Valeant sued by T. Rowe Price, claiming fraud",2016-08-18 16:14:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=28D3086A-655D-11E6-A628-30DF258FF106&siteid=yhoof2,"Valeant sued by T. Rowe Price, claiming fraud"
VRX,VRX:CT,BBG000DC8S17,Valeant Again Able to Loosen Debt Terms -- 6th Update,2016-08-18 16:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gth90aN2rio/valeant-again-able-to-loosen-debt-terms--6th-update-20160818-00814,Valeant Again Able to Loosen Debt Terms -- 6th Update
VRX,VRX:US,BBG000DLFM21,Valeant Again Able to Loosen Debt Terms -- 6th Update,2016-08-18 16:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gth90aN2rio/valeant-again-able-to-loosen-debt-terms--6th-update-20160818-00814,Valeant Again Able to Loosen Debt Terms -- 6th Update
VRX,VRX:US,BBG000DLFM21,"[$$] T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'",2016-08-18 15:50:25 +0000,http://www.wsj.com/articles/t-rowe-price-sues-valeant-alleging-fraudulent-scheme-1471532680?mod=yahoo_hs,"[$$] T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'"
VRX,VRX:CT,BBG000DC8S17,"[$$] T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'",2016-08-18 15:50:25 +0000,http://www.wsj.com/articles/t-rowe-price-sues-valeant-alleging-fraudulent-scheme-1471532680?mod=yahoo_hs,"[$$] T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'"
VRX,VRX:US,BBG000DLFM21,T. Rowe Price sues Valeant,2016-08-18 15:43:45 +0000,http://finance.yahoo.com/news/t-rowe-price-sues-valeant-154345356.html,T. Rowe Price sues Valeant
VRX,VRX:CT,BBG000DC8S17,T. Rowe Price sues Valeant,2016-08-18 15:43:45 +0000,http://finance.yahoo.com/news/t-rowe-price-sues-valeant-154345356.html,T. Rowe Price sues Valeant
VRX,VRX:US,BBG000DLFM21,Why Valeant Pharmaceuticals is Tanking,2016-08-18 15:31:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/18/why-valeant-pharmaceuticals-is-tanking/?mod=yahoobarrons&ru=yahoo,Why Valeant Pharmaceuticals is Tanking
VRX,VRX:CT,BBG000DC8S17,Why Valeant Pharmaceuticals is Tanking,2016-08-18 15:31:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/18/why-valeant-pharmaceuticals-is-tanking/?mod=yahoobarrons&ru=yahoo,Why Valeant Pharmaceuticals is Tanking
VRX,VRX:US,BBG000DLFM21,Valeant Accused in Suit of Secretly Refilling Prescriptions,2016-08-18 15:24:40 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-pharmaceuticals-accused-of-fraud-in-t-rowe-price-suit?cmpid=yhoo.headline,Valeant Accused in Suit of Secretly Refilling Prescriptions
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Accused of Fraud in T. Rowe Price Suit,2016-08-18 15:24:40 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-accused-fraud-t-152440844.html,Valeant Pharmaceuticals Accused of Fraud in T. Rowe Price Suit
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Accused of Fraud in T. Rowe Price Suit,2016-08-18 15:24:40 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-accused-fraud-t-152440844.html,Valeant Pharmaceuticals Accused of Fraud in T. Rowe Price Suit
VRX,VRX:CT,BBG000DC8S17,Valeant Accused in Suit of Secretly Refilling Prescriptions,2016-08-18 15:24:40 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-pharmaceuticals-accused-of-fraud-in-t-rowe-price-suit?cmpid=yhoo.headline,Valeant Accused in Suit of Secretly Refilling Prescriptions
VRX,VRX:US,BBG000DLFM21,"CANADA STOCKS-TSX nearly flat as energy stocks gain offset by telecoms, banks",2016-08-18 14:46:44 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-nearly-flat-144644028.html,"CANADA STOCKS-TSX nearly flat as energy stocks gain offset by telecoms, banks"
VRX,VRX:CT,BBG000DC8S17,"CANADA STOCKS-TSX nearly flat as energy stocks gain offset by telecoms, banks",2016-08-18 14:46:44 +0000,http://finance.yahoo.com/news/canada-stocks-tsx-nearly-flat-144644028.html,"CANADA STOCKS-TSX nearly flat as energy stocks gain offset by telecoms, banks"
VRX,VRX:US,BBG000DLFM21,Managing Your Swing Positions/Trades Better,2016-08-18 14:38:28 +0000,http://finance.yahoo.com/tumblr/blog-managing-your-swing-positionstrades-better-143832161.html,Managing Your Swing Positions/Trades Better
VRX,VRX:CT,BBG000DC8S17,Managing Your Swing Positions/Trades Better,2016-08-18 14:38:28 +0000,http://finance.yahoo.com/tumblr/blog-managing-your-swing-positionstrades-better-143832161.html,Managing Your Swing Positions/Trades Better
VRX,VRX:CT,BBG000DC8S17,Valeant Again Able to Loosen Debt Terms -- 5th Update,2016-08-18 14:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zuMecEYI-RA/valeant-again-able-to-loosen-debt-terms--5th-update-20160818-00703,Valeant Again Able to Loosen Debt Terms -- 5th Update
VRX,VRX:US,BBG000DLFM21,Valeant Again Able to Loosen Debt Terms -- 5th Update,2016-08-18 14:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zuMecEYI-RA/valeant-again-able-to-loosen-debt-terms--5th-update-20160818-00703,Valeant Again Able to Loosen Debt Terms -- 5th Update
VRX,VRX:US,BBG000DLFM21,Valeant’s Climb Offsets Financials as Canada Stocks Fluctuate,2016-08-18 14:21:34 +0000,http://finance.yahoo.com/news/valeant-climb-offsets-financials-canada-142134617.html,Valeant’s Climb Offsets Financials as Canada Stocks Fluctuate
VRX,VRX:US,BBG000DLFM21,Canada Stocks Little Changed as Valeant Loss Offsets Oil Gain,2016-08-18 14:21:34 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-s-climb-offsets-financials-as-canada-stocks-fluctuate?cmpid=yhoo.headline,Canada Stocks Little Changed as Valeant Loss Offsets Oil Gain
VRX,VRX:CT,BBG000DC8S17,Canada Stocks Little Changed as Valeant Loss Offsets Oil Gain,2016-08-18 14:21:34 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-s-climb-offsets-financials-as-canada-stocks-fluctuate?cmpid=yhoo.headline,Canada Stocks Little Changed as Valeant Loss Offsets Oil Gain
VRX,VRX:CT,BBG000DC8S17,Valeant’s Climb Offsets Financials as Canada Stocks Fluctuate,2016-08-18 14:21:34 +0000,http://finance.yahoo.com/news/valeant-climb-offsets-financials-canada-142134617.html,Valeant’s Climb Offsets Financials as Canada Stocks Fluctuate
VRX,VRX:US,BBG000DLFM21,Valeant Climbs After Lenders Agree to Amend Credit Line: Chart,2016-08-18 14:03:11 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-climbs-after-lenders-agree-to-amend-credit-line-chart?cmpid=yhoo.headline,Valeant Climbs After Lenders Agree to Amend Credit Line: Chart
VRX,VRX:CT,BBG000DC8S17,Valeant Climbs After Lenders Agree to Amend Credit Line: Chart,2016-08-18 14:03:11 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-climbs-after-lenders-agree-to-amend-credit-line-chart?cmpid=yhoo.headline,Valeant Climbs After Lenders Agree to Amend Credit Line: Chart
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Wal-Mart, Valeant, SunEdison, Cisco, Auris Medical",2016-08-18 13:31:34 +0000,http://blogs.wsj.com/moneybeat/2016/08/18/stocks-to-watch-wal-mart-valeant-sunedison-cisco-auris-medical/?mod=yahoo_hs,"Stocks to Watch: Wal-Mart, Valeant, SunEdison, Cisco, Auris Medical"
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Wal-Mart, Valeant, SunEdison, Cisco, Auris Medical",2016-08-18 13:31:34 +0000,http://blogs.wsj.com/moneybeat/2016/08/18/stocks-to-watch-wal-mart-valeant-sunedison-cisco-auris-medical/?mod=yahoo_hs,"Stocks to Watch: Wal-Mart, Valeant, SunEdison, Cisco, Auris Medical"
VRX,VRX:US,BBG000DLFM21,LPC: Valeant lenders agree to loan amendment to loosen covenants,2016-08-18 13:17:13 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-lenders-agree-loan-131713796.html,LPC: Valeant lenders agree to loan amendment to loosen covenants
VRX,VRX:CT,BBG000DC8S17,LPC: Valeant lenders agree to loan amendment to loosen covenants,2016-08-18 13:17:13 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-lenders-agree-loan-131713796.html,LPC: Valeant lenders agree to loan amendment to loosen covenants
VRX,VRX:CT,BBG000DC8S17,Valeant’s Plan to Reduce Debt,2016-08-18 13:04:37 +0000,http://marketrealist.com/2016/08/valeants-plan-to-reduce-debt/?utm_source=yahoo&utm_medium=feed,Valeant’s Plan to Reduce Debt
VRX,VRX:US,BBG000DLFM21,Valeant’s Plan to Reduce Debt,2016-08-18 13:04:37 +0000,http://marketrealist.com/2016/08/valeants-plan-to-reduce-debt/?utm_source=yahoo&utm_medium=feed,Valeant’s Plan to Reduce Debt
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Aug 18, 2016 :  SEMI, VRX, WMT, TLK, PTLA, AZN, TWTR, RPTP, CSIQ, CHK, BLDP, MOMO",2016-08-18 12:59:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qu4lAWyazas/pre-market-most-active-for-aug-18-2016-semi-vrx-wmt-tlk-ptla-azn-twtr-rptp-csiq-chk-bldp-momo-cm666982,"The NASDAQ 100 Pre Market Indicator is down 2.91 to 4,802.54. The total Pre Market volume is currently 6,747,583 shares traded. The following are the most active stocks for the pre market session SunEdison Semiconductor Limited ( SEMI )"
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Aug 18, 2016 :  SEMI, VRX, WMT, TLK, PTLA, AZN, TWTR, RPTP, CSIQ, CHK, BLDP, MOMO",2016-08-18 12:59:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qu4lAWyazas/pre-market-most-active-for-aug-18-2016-semi-vrx-wmt-tlk-ptla-azn-twtr-rptp-csiq-chk-bldp-momo-cm666982,"The NASDAQ 100 Pre Market Indicator is down 2.91 to 4,802.54. The total Pre Market volume is currently 6,747,583 shares traded. The following are the most active stocks for the pre market session SunEdison Semiconductor Limited ( SEMI )"
VRX,VRX:US,BBG000DLFM21,Valeant amends credit facility for second time in six months,2016-08-18 12:37:27 +0000,http://finance.yahoo.com/news/valeant-amends-credit-facility-second-123727123.html,"[Reuters] - The embattled drugmaker, which is amending its credit agreement for the second time in six months, agreed to increase the interest on the facility by 0.50 percent, it said in a statement on Thursday. Valeant, whose long-term debt stood at about $31 billion as of June 30, had asked lenders in March to amend its credit agreement to give it more time to file its financials. Reuters reported last week that Valeant offered to pay lenders higher rates to win approval for an amendment."
VRX,VRX:CT,BBG000DC8S17,Valeant amends credit facility for second time in six months,2016-08-18 12:37:27 +0000,http://finance.yahoo.com/news/valeant-amends-credit-facility-second-123727123.html,"[Reuters] - The embattled drugmaker, which is amending its credit agreement for the second time in six months, agreed to increase the interest on the facility by 0.50 percent, it said in a statement on Thursday. Valeant, whose long-term debt stood at about $31 billion as of June 30, had asked lenders in March to amend its credit agreement to give it more time to file its financials. Reuters reported last week that Valeant offered to pay lenders higher rates to win approval for an amendment."
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Higher on Credit Facility Amendment,2016-08-18 12:26:00 +0000,https://www.thestreet.com/story/13678871/1/valeant-vrx-stock-higher-on-credit-facility-amendment.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Higher on Credit Facility Amendment
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Higher on Credit Facility Amendment,2016-08-18 12:26:00 +0000,https://www.thestreet.com/story/13678871/1/valeant-vrx-stock-higher-on-credit-facility-amendment.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Higher on Credit Facility Amendment
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment,2016-08-18 12:21:09 +0000,http://www.publicnow.com/view/F9A95680881CD97A07DF364826AE4804FA8B4A07,"[at noodls] - LAVAL, Quebec, Aug. 18, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') today announced that it has obtained the requisite lender approval ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment,2016-08-18 12:21:09 +0000,http://www.publicnow.com/view/F9A95680881CD97A07DF364826AE4804FA8B4A07,"[at noodls] - LAVAL, Quebec, Aug. 18, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') today announced that it has obtained the requisite lender approval ..."
VRX,VRX:US,BBG000DLFM21,Valeant Gets Lenders’ Blessing to Loosen Debt Requirements,2016-08-18 12:15:27 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-gets-blessing-from-lenders-to-loosen-debt-requirements?cmpid=yhoo.headline,Valeant Gets Lenders’ Blessing to Loosen Debt Requirements
VRX,VRX:CT,BBG000DC8S17,Valeant Gets Lenders’ Blessing to Loosen Debt Requirements,2016-08-18 12:15:27 +0000,http://www.bloomberg.com/news/articles/2016-08-18/valeant-gets-blessing-from-lenders-to-loosen-debt-requirements?cmpid=yhoo.headline,Valeant Gets Lenders’ Blessing to Loosen Debt Requirements
VRX,VRX:US,BBG000DLFM21,Valeant's stock jumps after credit facility amendment approved,2016-08-18 12:11:42 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B08D4E8F-F56B-4ACE-AE54-AD8ACA7E73A9&siteid=yhoof2,Valeant's stock jumps after credit facility amendment approved
VRX,VRX:CT,BBG000DC8S17,Valeant's stock jumps after credit facility amendment approved,2016-08-18 12:11:42 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B08D4E8F-F56B-4ACE-AE54-AD8ACA7E73A9&siteid=yhoof2,Valeant's stock jumps after credit facility amendment approved
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment,2016-08-18 12:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-receives-lender-consent-120000108.html,[CNW Group] - Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment,2016-08-18 12:00:00 +0000,http://finance.yahoo.com/news/valeant-pharmaceuticals-receives-lender-consent-120000108.html,[CNW Group] - Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment
VRX,VRX:US,BBG000DLFM21,"T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'",2016-08-18 11:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hLoxRlMwEC8/t-rowe-price-sues-valeant-alleging-fraudulent-scheme-20160818-00574,"T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'"
VRX,VRX:CT,BBG000DC8S17,"T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'",2016-08-18 11:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hLoxRlMwEC8/t-rowe-price-sues-valeant-alleging-fraudulent-scheme-20160818-00574,"T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme'"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary,2016-08-18 11:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cyd_HJOtf84/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20160818-00565,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary,2016-08-18 11:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cyd_HJOtf84/canadian-stocks-have-slipped-into-negative-territory--canadian-commentary-20160818-00565,Canadian Stocks Have Slipped Into Negative Territory -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Able to Loosen Debt Terms,2016-08-18 09:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ig9wvWPA27I/valeant-able-to-loosen-debt-terms-20160818-00742,Valeant Able to Loosen Debt Terms
VRX,VRX:CT,BBG000DC8S17,Valeant Able to Loosen Debt Terms,2016-08-18 09:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ig9wvWPA27I/valeant-able-to-loosen-debt-terms-20160818-00742,Valeant Able to Loosen Debt Terms
VRX,VRX:US,BBG000DLFM21,Canadian Stocks In Doldrums Despite Oil Rally -- Canadian Commentary,2016-08-18 08:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oH7Igk9gAB8/canadian-stocks-in-doldrums-despite-oil-rally--canadian-commentary-20160818-00333,Canadian Stocks In Doldrums Despite Oil Rally -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks In Doldrums Despite Oil Rally -- Canadian Commentary,2016-08-18 08:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oH7Igk9gAB8/canadian-stocks-in-doldrums-despite-oil-rally--canadian-commentary-20160818-00333,Canadian Stocks In Doldrums Despite Oil Rally -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Gets Lender Approval For Amendment To Its Credit Facility,2016-08-18 08:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iCQ39XifcUs/valeant-pharma-gets-lender-approval-for-amendment-to-its-credit-facility-20160818-00295,Valeant Pharma Gets Lender Approval For Amendment To Its Credit Facility
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Gets Lender Approval For Amendment To Its Credit Facility,2016-08-18 08:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iCQ39XifcUs/valeant-pharma-gets-lender-approval-for-amendment-to-its-credit-facility-20160818-00295,Valeant Pharma Gets Lender Approval For Amendment To Its Credit Facility
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma Gets Lender Consent To Amend Credit Facility - Quick Facts,2016-08-18 08:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OTMsac_QZqo/valeant-pharma-gets-lender-consent-to-amend-credit-facility--quick-facts-20160818-00287,Valeant Pharma Gets Lender Consent To Amend Credit Facility - Quick Facts
VRX,VRX:US,BBG000DLFM21,Valeant Pharma Gets Lender Consent To Amend Credit Facility - Quick Facts,2016-08-18 08:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OTMsac_QZqo/valeant-pharma-gets-lender-consent-to-amend-credit-facility--quick-facts-20160818-00287,Valeant Pharma Gets Lender Consent To Amend Credit Facility - Quick Facts
VRX,VRX:US,BBG000DLFM21,"Why Lumber Liquidators Holdings Inc (LL), Urban Outfitters, Inc. (URBN) and Valeant Pharmaceuticals Intl Inc (VRX) Are 3 of Today’s Best Stocks",2016-08-18 07:44:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YTx2HkbosX8/why-lumber-liquidators-holdings-inc-ll-urban-outfitters-inc-urbn-and-valeant-pharmaceuticals-intl-inc-vrx-are-3-of-todays-best-stocks-cm666912,Stocks rose modestly Wednesday even after meeting minutes from the Federal Reserve's July meeting revealed the central bank's members believe an interest rate hike could
VRX,VRX:CT,BBG000DC8S17,"Why Lumber Liquidators Holdings Inc (LL), Urban Outfitters, Inc. (URBN) and Valeant Pharmaceuticals Intl Inc (VRX) Are 3 of Today’s Best Stocks",2016-08-18 07:44:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YTx2HkbosX8/why-lumber-liquidators-holdings-inc-ll-urban-outfitters-inc-urbn-and-valeant-pharmaceuticals-intl-inc-vrx-are-3-of-todays-best-stocks-cm666912,Stocks rose modestly Wednesday even after meeting minutes from the Federal Reserve's July meeting revealed the central bank's members believe an interest rate hike could
VRX,VRX:US,BBG000DLFM21,"Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals Jumped Today",2016-08-17 23:44:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0kUXHtdxs8k/why-caesars-entertainment-och-ziff-capital-management-and-valeant-pharmaceuticals-jumped-today-cm666847,"Image source  Caesars.  The stock market continued its up and down path on Wednesday, bouncing back from losses on Tuesday with minor gains of 0.1% to 0.2% for major market benchmarks. Most of"
VRX,VRX:CT,BBG000DC8S17,"Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals Jumped Today",2016-08-17 23:44:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0kUXHtdxs8k/why-caesars-entertainment-och-ziff-capital-management-and-valeant-pharmaceuticals-jumped-today-cm666847,"Image source  Caesars.  The stock market continued its up and down path on Wednesday, bouncing back from losses on Tuesday with minor gains of 0.1% to 0.2% for major market benchmarks. Most of"
VRX,VRX:US,BBG000DLFM21,"Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals Jumped Today",2016-08-17 22:15:00 +0000,http://www.fool.com/investing/2016/08/17/why-caesars-entertainment-och-ziff-capital-managem.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals Jumped Today"
VRX,VRX:CT,BBG000DC8S17,"Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals Jumped Today",2016-08-17 22:15:00 +0000,http://www.fool.com/investing/2016/08/17/why-caesars-entertainment-och-ziff-capital-managem.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals Jumped Today"
VRX,VRX:US,BBG000DLFM21,2 Stocks Bill Ackman Is Dumping,2016-08-17 22:03:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CDawIDD3lkg/2-stocks-bill-ackman-is-dumping-cm666563,"Photo by  Getty Images.  Bill Ackman's Pershing Square Capital Management has seen better days. The publicly traded version of the company's hedge fund, Pershing Square Holdings , was down by 21.1% net of"
VRX,VRX:CT,BBG000DC8S17,2 Stocks Bill Ackman Is Dumping,2016-08-17 22:03:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CDawIDD3lkg/2-stocks-bill-ackman-is-dumping-cm666563,"Photo by  Getty Images.  Bill Ackman's Pershing Square Capital Management has seen better days. The publicly traded version of the company's hedge fund, Pershing Square Holdings , was down by 21.1% net of"
VRX,VRX:CT,BBG000DC8S17,Buy Valeant Stock for a 45% Profit? 3 Things You Need to Know,2016-08-17 22:02:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/71IFW6zKCxc/buy-valeant-stock-for-a-45-profit-3-things-you-need-to-know-cm666671,"Valeant Pharmaceuticals '(NYSE  VRX) stock is on a tear    up nearly 17% so far this week, in the wake of a call with analysts in which the company detailed new plans"
VRX,VRX:US,BBG000DLFM21,Buy Valeant Stock for a 45% Profit? 3 Things You Need to Know,2016-08-17 22:02:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/71IFW6zKCxc/buy-valeant-stock-for-a-45-profit-3-things-you-need-to-know-cm666671,"Valeant Pharmaceuticals '(NYSE  VRX) stock is on a tear    up nearly 17% so far this week, in the wake of a call with analysts in which the company detailed new plans"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc (VRX) Shorts Thwacked by Morgan Stanley,2016-08-17 21:56:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jZstTbHZWVU/valeant-pharmaceuticals-intl-inc-vrx-shorts-thwacked-by-morgan-stanley-cm666723,Betting against Valeant Pharmaceuticals Intl Inc (NYSE VRX ) is no longer a wise move. VRX stock short sellers are learning that the hard way these days. Source Wikimedia (Modified)Shares
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc (VRX) Shorts Thwacked by Morgan Stanley,2016-08-17 21:56:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jZstTbHZWVU/valeant-pharmaceuticals-intl-inc-vrx-shorts-thwacked-by-morgan-stanley-cm666723,Betting against Valeant Pharmaceuticals Intl Inc (NYSE VRX ) is no longer a wise move. VRX stock short sellers are learning that the hard way these days. Source Wikimedia (Modified)Shares
VRX,VRX:CT,BBG000DC8S17,"Director at Valeant buys 4,000 shares",2016-08-17 21:50:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0sjTPmaR3n8/director-at-valeant-buys-4000-shares-cm665436,"Argeris Karabelis, Director at Valeant Pharmaceuticals International  ( VRX ), bought 4,000 shares of the company's common stock on August 12. Karabelis  bought the shares at $24.65  for a total of  $98,600.00.     InvestorsKeyhole Trade AlertIK > The"
VRX,VRX:US,BBG000DLFM21,"Director at Valeant buys 4,000 shares",2016-08-17 21:50:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0sjTPmaR3n8/director-at-valeant-buys-4000-shares-cm665436,"Argeris Karabelis, Director at Valeant Pharmaceuticals International  ( VRX ), bought 4,000 shares of the company's common stock on August 12. Karabelis  bought the shares at $24.65  for a total of  $98,600.00.     InvestorsKeyhole Trade AlertIK > The"
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Aug 17, 2016 :  SO, VRX, AEO, SCYX, LOW, TGT, SMFG, AUPH, ERIC, QQQ, URBN, CREE",2016-08-17 21:39:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i2HCWe979lo/pre-market-most-active-for-aug-17-2016-so-vrx-aeo-scyx-low-tgt-smfg-auph-eric-qqq-urbn-cree-cm666405,"The NASDAQ 100 Pre Market Indicator is up .2 to 4,797.39. The total Pre Market volume is currently 7,922,700 shares traded. The following are the most active stocks for the pre market session Southern Company (The) ( SO )"
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Aug 17, 2016 :  SO, VRX, AEO, SCYX, LOW, TGT, SMFG, AUPH, ERIC, QQQ, URBN, CREE",2016-08-17 21:39:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i2HCWe979lo/pre-market-most-active-for-aug-17-2016-so-vrx-aeo-scyx-low-tgt-smfg-auph-eric-qqq-urbn-cree-cm666405,"The NASDAQ 100 Pre Market Indicator is up .2 to 4,797.39. The total Pre Market volume is currently 7,922,700 shares traded. The following are the most active stocks for the pre market session Southern Company (The) ( SO )"
VRX,VRX:US,BBG000DLFM21,"Valeant Upgraded; Urban Outfitters In Buy Range On Q2 Beat, PT Hike",2016-08-17 20:26:59 +0000,http://www.investors.com/news/valeant-upgraded-urban-outfitters-home-depot-pt-raised/,"Valeant Upgraded; Urban Outfitters In Buy Range On Q2 Beat, PT Hike"
VRX,VRX:CT,BBG000DC8S17,"Valeant Upgraded; Urban Outfitters In Buy Range On Q2 Beat, PT Hike",2016-08-17 20:26:59 +0000,http://www.investors.com/news/valeant-upgraded-urban-outfitters-home-depot-pt-raised/,"Valeant Upgraded; Urban Outfitters In Buy Range On Q2 Beat, PT Hike"
VRX,VRX:US,BBG000DLFM21,This private investor document perfectly shows why people are sick and tired of hedge funds,2016-08-17 20:24:34 +0000,http://finance.yahoo.com/news/private-investor-document-perfectly-shows-202434267.html,This private investor document perfectly shows why people are sick and tired of hedge funds
VRX,VRX:CT,BBG000DC8S17,This private investor document perfectly shows why people are sick and tired of hedge funds,2016-08-17 20:24:34 +0000,http://finance.yahoo.com/news/private-investor-document-perfectly-shows-202434267.html,This private investor document perfectly shows why people are sick and tired of hedge funds
VRX,VRX:US,BBG000DLFM21,Valeant Upgraded Again As Restructuring Plans Impress,2016-08-17 20:22:02 +0000,http://www.investors.com/news/technology/valeant-upgraded-again-as-restructuring-plans-impress/,Valeant Upgraded Again As Restructuring Plans Impress
VRX,VRX:CT,BBG000DC8S17,Valeant Upgraded Again As Restructuring Plans Impress,2016-08-17 20:22:02 +0000,http://www.investors.com/news/technology/valeant-upgraded-again-as-restructuring-plans-impress/,Valeant Upgraded Again As Restructuring Plans Impress
VRX,VRX:US,BBG000DLFM21,[$$] Four Picks for a Specialty Pharma Comeback,2016-08-17 20:21:00 +0000,http://www.barrons.com/articles/four-picks-for-a-specialty-pharma-comeback-1471465279?mod=yahoobarrons&ru=yahoo,[$$] Four Picks for a Specialty Pharma Comeback
VRX,VRX:CT,BBG000DC8S17,[$$] Four Picks for a Specialty Pharma Comeback,2016-08-17 20:21:00 +0000,http://www.barrons.com/articles/four-picks-for-a-specialty-pharma-comeback-1471465279?mod=yahoobarrons&ru=yahoo,[$$] Four Picks for a Specialty Pharma Comeback
VRX,VRX:US,BBG000DLFM21,Troubled drug company Valeant handed second upgrade of the week,2016-08-17 19:06:40 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=68D8BD76-6489-11E6-A91B-CC094CD5E4A5&siteid=yhoof2,Troubled drug company Valeant handed second upgrade of the week
VRX,VRX:CT,BBG000DC8S17,Troubled drug company Valeant handed second upgrade of the week,2016-08-17 19:06:40 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=68D8BD76-6489-11E6-A91B-CC094CD5E4A5&siteid=yhoof2,Troubled drug company Valeant handed second upgrade of the week
VRX,VRX:CT,BBG000DC8S17,A Look at Five Stocks Gaining Ground on Wednesday,2016-08-17 17:18:47 +0000,http://www.insidermonkey.com/blog/a-look-at-five-stocks-gaining-ground-on-wednesday-469477/,A Look at Five Stocks Gaining Ground on Wednesday
VRX,VRX:US,BBG000DLFM21,A Look at Five Stocks Gaining Ground on Wednesday,2016-08-17 17:18:47 +0000,http://www.insidermonkey.com/blog/a-look-at-five-stocks-gaining-ground-on-wednesday-469477/,A Look at Five Stocks Gaining Ground on Wednesday
VRX,VRX:US,BBG000DLFM21,"Trending Tickers: CIT, VRX, BWLD, BKS",2016-08-17 17:16:00 +0000,http://realmoney.thestreet.com/articles/08/17/2016/trending-tickers-cit-vrx-bwld-bks?puc=yahoo&cm_ven=YAHOO,"Trending Tickers: CIT, VRX, BWLD, BKS"
VRX,VRX:CT,BBG000DC8S17,"Trending Tickers: CIT, VRX, BWLD, BKS",2016-08-17 17:16:00 +0000,http://realmoney.thestreet.com/articles/08/17/2016/trending-tickers-cit-vrx-bwld-bks?puc=yahoo&cm_ven=YAHOO,"Trending Tickers: CIT, VRX, BWLD, BKS"
VRX,VRX:CT,BBG000DC8S17,"Dow Jones, S&P 500 Keep Melting Up to New Highs",2016-08-17 16:38:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X_TuYe4fHoU/dow-jones-sp-500-keep-melting-up-to-new-highs-cm665720,The Dow Jones Industrial Average and other major indices pushed higher on Monday amid quiet trading as crude oil continues to benefit from chatter of a
VRX,VRX:US,BBG000DLFM21,"Dow Jones, S&P 500 Keep Melting Up to New Highs",2016-08-17 16:38:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X_TuYe4fHoU/dow-jones-sp-500-keep-melting-up-to-new-highs-cm665720,The Dow Jones Industrial Average and other major indices pushed higher on Monday amid quiet trading as crude oil continues to benefit from chatter of a
VRX,VRX:US,BBG000DLFM21,Buy Valeant Stock for a 45% Profit? 3 Things You Need to Know,2016-08-17 15:54:34 +0000,http://www.fool.com/investing/2016/08/17/buy-valeant-stock-for-a-45-profit-3-things-you-nee.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Buy Valeant Stock for a 45% Profit? 3 Things You Need to Know
VRX,VRX:CT,BBG000DC8S17,Buy Valeant Stock for a 45% Profit? 3 Things You Need to Know,2016-08-17 15:54:34 +0000,http://www.fool.com/investing/2016/08/17/buy-valeant-stock-for-a-45-profit-3-things-you-nee.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Buy Valeant Stock for a 45% Profit? 3 Things You Need to Know
VRX,VRX:US,BBG000DLFM21,Valeant's been ripping higher on some of the most trifling Wall Street analysis we've seen in a while,2016-08-17 15:54:33 +0000,http://finance.yahoo.com/news/valeants-ripping-higher-most-trifling-155433838.html,Valeant's been ripping higher on some of the most trifling Wall Street analysis we've seen in a while
VRX,VRX:CT,BBG000DC8S17,Valeant's been ripping higher on some of the most trifling Wall Street analysis we've seen in a while,2016-08-17 15:54:33 +0000,http://finance.yahoo.com/news/valeants-ripping-higher-most-trifling-155433838.html,Valeant's been ripping higher on some of the most trifling Wall Street analysis we've seen in a while
VRX,VRX:CT,BBG000DC8S17,TSX Wavers But Valeant Rallies -- Canadian Commentary,2016-08-17 15:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bzm16OFPXrk/tsx-wavers-but-valeant-rallies--canadian-commentary-20160817-00685,TSX Wavers But Valeant Rallies -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,TSX Wavers But Valeant Rallies -- Canadian Commentary,2016-08-17 15:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bzm16OFPXrk/tsx-wavers-but-valeant-rallies--canadian-commentary-20160817-00685,TSX Wavers But Valeant Rallies -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,How Did Valeant Manage Its Operating Expenses in 2Q16?,2016-08-17 15:04:30 +0000,http://marketrealist.com/2016/08/how-did-valeant-manage-its-operating-expenses-in-2q16/?utm_source=yahoo&utm_medium=feed,How Did Valeant Manage Its Operating Expenses in 2Q16?
VRX,VRX:US,BBG000DLFM21,How Did Valeant Manage Its Operating Expenses in 2Q16?,2016-08-17 15:04:30 +0000,http://marketrealist.com/2016/08/how-did-valeant-manage-its-operating-expenses-in-2q16/?utm_source=yahoo&utm_medium=feed,How Did Valeant Manage Its Operating Expenses in 2Q16?
VRX,VRX:US,BBG000DLFM21,Morgan Stanley Says It's Time to Buy Valeant Again,2016-08-17 14:55:00 +0000,https://www.thestreet.com/story/13677871/1/morgan-stanley-says-it-s-time-to-buy-valeant-again.html?puc=yahoo&cm_ven=YAHOO,Morgan Stanley Says It's Time to Buy Valeant Again
VRX,VRX:CT,BBG000DC8S17,Morgan Stanley Says It's Time to Buy Valeant Again,2016-08-17 14:55:00 +0000,https://www.thestreet.com/story/13677871/1/morgan-stanley-says-it-s-time-to-buy-valeant-again.html?puc=yahoo&cm_ven=YAHOO,Morgan Stanley Says It's Time to Buy Valeant Again
VRX,VRX:US,BBG000DLFM21,Why Valeant Got Its First Big Analyst Upgrade of 2016,2016-08-17 14:35:35 +0000,http://247wallst.com/healthcare-business/2016/08/17/why-valeant-got-its-first-big-analyst-upgrade-of-2016/,Why Valeant Got Its First Big Analyst Upgrade of 2016
VRX,VRX:CT,BBG000DC8S17,Why Valeant Got Its First Big Analyst Upgrade of 2016,2016-08-17 14:35:35 +0000,http://247wallst.com/healthcare-business/2016/08/17/why-valeant-got-its-first-big-analyst-upgrade-of-2016/,Why Valeant Got Its First Big Analyst Upgrade of 2016
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals: The Power of a Morgan Stanley Upgrade,2016-08-17 13:56:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/17/valeant-pharmaceuticals-the-power-of-a-morgan-stanley-upgrade/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: The Power of a Morgan Stanley Upgrade
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals: The Power of a Morgan Stanley Upgrade,2016-08-17 13:56:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/17/valeant-pharmaceuticals-the-power-of-a-morgan-stanley-upgrade/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: The Power of a Morgan Stanley Upgrade
VRX,VRX:US,BBG000DLFM21,Valeant Wins Upgrade From Morgan Stanley,2016-08-17 13:53:25 +0000,http://blogs.wsj.com/moneybeat/2016/08/17/valeant-wins-upgrade-from-morgan-stanley/?mod=yahoo_hs,Valeant Wins Upgrade From Morgan Stanley
VRX,VRX:CT,BBG000DC8S17,Valeant Wins Upgrade From Morgan Stanley,2016-08-17 13:53:25 +0000,http://blogs.wsj.com/moneybeat/2016/08/17/valeant-wins-upgrade-from-morgan-stanley/?mod=yahoo_hs,Valeant Wins Upgrade From Morgan Stanley
VRX,VRX:CT,BBG000DC8S17,"Stocks to Watch: Target, Valeant, Lowe's Cos.",2016-08-17 13:36:23 +0000,http://blogs.wsj.com/moneybeat/2016/08/17/stocks-to-watch-target-valeant-lowes-cos/?mod=yahoo_hs,"Stocks to Watch: Target, Valeant, Lowe's Cos."
VRX,VRX:US,BBG000DLFM21,"Stocks to Watch: Target, Valeant, Lowe's Cos.",2016-08-17 13:36:23 +0000,http://blogs.wsj.com/moneybeat/2016/08/17/stocks-to-watch-target-valeant-lowes-cos/?mod=yahoo_hs,"Stocks to Watch: Target, Valeant, Lowe's Cos."
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Rise as Once-Burned Analysts Regain Optimism,2016-08-17 13:36:18 +0000,http://www.bloomberg.com/news/articles/2016-08-17/valeant-shares-gain-as-once-burned-analysts-regain-optimism?cmpid=yhoo.headline,Valeant Shares Rise as Once-Burned Analysts Regain Optimism
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Gain as Once-Burned Analysts Regain Optimism,2016-08-17 13:36:18 +0000,http://finance.yahoo.com/news/valeant-shares-gain-once-burned-133618177.html,Valeant Shares Gain as Once-Burned Analysts Regain Optimism
VRX,VRX:US,BBG000DLFM21,Valeant Shares Rise as Once-Burned Analysts Regain Optimism,2016-08-17 13:36:18 +0000,http://www.bloomberg.com/news/articles/2016-08-17/valeant-shares-gain-as-once-burned-analysts-regain-optimism?cmpid=yhoo.headline,Valeant Shares Rise as Once-Burned Analysts Regain Optimism
VRX,VRX:US,BBG000DLFM21,Valeant Shares Gain as Once-Burned Analysts Regain Optimism,2016-08-17 13:36:18 +0000,http://finance.yahoo.com/news/valeant-shares-gain-once-burned-133618177.html,Valeant Shares Gain as Once-Burned Analysts Regain Optimism
VRX,VRX:CT,BBG000DC8S17,Wall Street Wavers Ahead of Fed Minutes,2016-08-17 13:32:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DbccLlnHXw4/wall-street-wavers-ahead-of-fed-minutes-cm666418,U.S. stock futures were struggling for a direction close to Wednesday's open with investors opting for caution ahead of the release of the Federal Reserve minutes which could reveal if a 2016 rate hike is still on the table.
VRX,VRX:US,BBG000DLFM21,Wall Street Wavers Ahead of Fed Minutes,2016-08-17 13:32:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DbccLlnHXw4/wall-street-wavers-ahead-of-fed-minutes-cm666418,U.S. stock futures were struggling for a direction close to Wednesday's open with investors opting for caution ahead of the release of the Federal Reserve minutes which could reveal if a 2016 rate hike is still on the table.
VRX,VRX:CT,BBG000DC8S17,"A.M. Roundup: Problems At Brevan Howard, Tudor; Fidelity Adds To Valeant Stake; A Utilities Bubble?",2016-08-17 13:21:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/17/a-m-roundup-problems-at-brevan-howard-tudor-fidelity-adds-to-valeant-stake-a-utilities-bubble/?mod=yahoobarrons&ru=yahoo,"A.M. Roundup: Problems At Brevan Howard, Tudor; Fidelity Adds To Valeant Stake; A Utilities Bubble?"
VRX,VRX:US,BBG000DLFM21,"A.M. Roundup: Problems At Brevan Howard, Tudor; Fidelity Adds To Valeant Stake; A Utilities Bubble?",2016-08-17 13:21:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/17/a-m-roundup-problems-at-brevan-howard-tudor-fidelity-adds-to-valeant-stake-a-utilities-bubble/?mod=yahoobarrons&ru=yahoo,"A.M. Roundup: Problems At Brevan Howard, Tudor; Fidelity Adds To Valeant Stake; A Utilities Bubble?"
VRX,VRX:CT,BBG000DC8S17,Is Valeant’s Xifaxan Resuming Growth?,2016-08-17 13:04:39 +0000,http://marketrealist.com/2016/08/is-valeants-xifaxan-resuming-growth/?utm_source=yahoo&utm_medium=feed,Is Valeant’s Xifaxan Resuming Growth?
VRX,VRX:US,BBG000DLFM21,Is Valeant’s Xifaxan Resuming Growth?,2016-08-17 13:04:39 +0000,http://marketrealist.com/2016/08/is-valeants-xifaxan-resuming-growth/?utm_source=yahoo&utm_medium=feed,Is Valeant’s Xifaxan Resuming Growth?
VRX,VRX:US,BBG000DLFM21,Valeant's stock soars after Morgan Stanley analyst turns bullish,2016-08-17 12:58:52 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9B1BC723-3021-4FAD-A38E-404E133902EB&siteid=yhoof2,Valeant's stock soars after Morgan Stanley analyst turns bullish
VRX,VRX:CT,BBG000DC8S17,Valeant's stock soars after Morgan Stanley analyst turns bullish,2016-08-17 12:58:52 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9B1BC723-3021-4FAD-A38E-404E133902EB&siteid=yhoof2,Valeant's stock soars after Morgan Stanley analyst turns bullish
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Spike as Morgan Stanley Analysts Go Bullish Again,2016-08-17 12:55:00 +0000,http://realmoney.thestreet.com/articles/08/17/2016/valeant-shares-spike-morgan-stanley-analysts-go-bullish-again?puc=yahoo&cm_ven=YAHOO,Valeant Shares Spike as Morgan Stanley Analysts Go Bullish Again
VRX,VRX:US,BBG000DLFM21,Valeant Shares Spike as Morgan Stanley Analysts Go Bullish Again,2016-08-17 12:55:00 +0000,http://realmoney.thestreet.com/articles/08/17/2016/valeant-shares-spike-morgan-stanley-analysts-go-bullish-again?puc=yahoo&cm_ven=YAHOO,Valeant Shares Spike as Morgan Stanley Analysts Go Bullish Again
VRX,VRX:CT,BBG000DC8S17,U.S. Stock Futures Near Flat of Fed Minutes,2016-08-17 12:49:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cenvj9A3CU4/us-stock-futures-near-flat-of-fed-minutes-cm666392,U.S. stock futures were near unchanged on Wednesday with investors opting for caution ahead of the release of the Federal Reserve minutes which could reveal if a 2016 rate hike is still on the table. Oil prices fell for
VRX,VRX:US,BBG000DLFM21,U.S. Stock Futures Near Flat of Fed Minutes,2016-08-17 12:49:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cenvj9A3CU4/us-stock-futures-near-flat-of-fed-minutes-cm666392,U.S. stock futures were near unchanged on Wednesday with investors opting for caution ahead of the release of the Federal Reserve minutes which could reveal if a 2016 rate hike is still on the table. Oil prices fell for
VRX,VRX:CT,BBG000DC8S17,Stock Futures Little Changed as Wall Street Awaits Word From the Fed,2016-08-17 12:49:00 +0000,https://www.thestreet.com/story/13676848/1/stock-futures-little-changed-as-wall-street-awaits-word-from-the-fed.html?puc=yahoo&cm_ven=YAHOO,Stock Futures Little Changed as Wall Street Awaits Word From the Fed
VRX,VRX:US,BBG000DLFM21,Stock Futures Little Changed as Wall Street Awaits Word From the Fed,2016-08-17 12:49:00 +0000,https://www.thestreet.com/story/13676848/1/stock-futures-little-changed-as-wall-street-awaits-word-from-the-fed.html?puc=yahoo&cm_ven=YAHOO,Stock Futures Little Changed as Wall Street Awaits Word From the Fed
VRX,VRX:US,BBG000DLFM21,Valeant (VRX) Stock Soars After Ratings Upgrade,2016-08-17 11:52:00 +0000,https://www.thestreet.com/story/13677463/1/valeant-vrx-stock-soars-after-ratings-upgrade.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Soars After Ratings Upgrade
VRX,VRX:CT,BBG000DC8S17,Valeant (VRX) Stock Soars After Ratings Upgrade,2016-08-17 11:52:00 +0000,https://www.thestreet.com/story/13677463/1/valeant-vrx-stock-soars-after-ratings-upgrade.html?puc=yahoo&cm_ven=YAHOO,Valeant (VRX) Stock Soars After Ratings Upgrade
VRX,VRX:US,BBG000DLFM21,"Valeant Wins Huge Upgrades, Shares Rebound",2016-08-17 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-dyOVYdJ6c/valeant-wins-huge-upgrades-shares-rebound-20160817-00485,"Valeant Wins Huge Upgrades, Shares Rebound"
VRX,VRX:CT,BBG000DC8S17,"Valeant Wins Huge Upgrades, Shares Rebound",2016-08-17 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-dyOVYdJ6c/valeant-wins-huge-upgrades-shares-rebound-20160817-00485,"Valeant Wins Huge Upgrades, Shares Rebound"
VRX,VRX:US,BBG000DLFM21,"Hey, Valeant Pharmaceuticals, Less Bad Still Isn't Good",2016-08-16 20:33:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gajjemcLImk/hey-valeant-pharmaceuticals-less-bad-still-isnt-good-cm666150,"Image source  Getty Images.  It's been a wild week for Valeant Pharmaceuticals (NYSE  VRX)    but when hasn't it been since August 2015. Over the trailing year, shares of Valeant"
VRX,VRX:CT,BBG000DC8S17,"Hey, Valeant Pharmaceuticals, Less Bad Still Isn't Good",2016-08-16 20:33:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gajjemcLImk/hey-valeant-pharmaceuticals-less-bad-still-isnt-good-cm666150,"Image source  Getty Images.  It's been a wild week for Valeant Pharmaceuticals (NYSE  VRX)    but when hasn't it been since August 2015. Over the trailing year, shares of Valeant"
VRX,VRX:CT,BBG000DC8S17,Fidelity Was a Big Second-Quarter Buyer of Valeant Shares,2016-08-16 20:17:56 +0000,http://blogs.wsj.com/moneybeat/2016/08/16/fidelity-was-a-big-second-quarter-buyer-of-valeant-shares/?mod=yahoo_hs,Fidelity Was a Big Second-Quarter Buyer of Valeant Shares
VRX,VRX:US,BBG000DLFM21,Fidelity Was a Big Second-Quarter Buyer of Valeant Shares,2016-08-16 20:17:56 +0000,http://blogs.wsj.com/moneybeat/2016/08/16/fidelity-was-a-big-second-quarter-buyer-of-valeant-shares/?mod=yahoo_hs,Fidelity Was a Big Second-Quarter Buyer of Valeant Shares
VRX,VRX:CT,BBG000DC8S17,"Hey, Valeant Pharmaceuticals, Less Bad Still Isn't Good",2016-08-16 19:09:00 +0000,http://www.fool.com/investing/2016/08/16/hey-valeant-pharmaceuticals-less-bad-still-isnt-go.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Hey, Valeant Pharmaceuticals, Less Bad Still Isn't Good"
VRX,VRX:US,BBG000DLFM21,"Hey, Valeant Pharmaceuticals, Less Bad Still Isn't Good",2016-08-16 19:09:00 +0000,http://www.fool.com/investing/2016/08/16/hey-valeant-pharmaceuticals-less-bad-still-isnt-go.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Hey, Valeant Pharmaceuticals, Less Bad Still Isn't Good"
VRX,VRX:CT,BBG000DC8S17,10 Best-Performing Stocks This Earnings Season,2016-08-16 15:15:00 +0000,https://www.thestreet.com/slideshow/13676573/1/10-best-performing-stocks-this-earnings-season.html?puc=yahoo&cm_ven=YAHOO,10 Best-Performing Stocks This Earnings Season
VRX,VRX:US,BBG000DLFM21,10 Best-Performing Stocks This Earnings Season,2016-08-16 15:15:00 +0000,https://www.thestreet.com/slideshow/13676573/1/10-best-performing-stocks-this-earnings-season.html?puc=yahoo&cm_ven=YAHOO,10 Best-Performing Stocks This Earnings Season
VRX,VRX:US,BBG000DLFM21,Read The Letters Before Checking Out 13F Data,2016-08-16 13:23:49 +0000,http://finance.yahoo.com/tumblr/blog-13f-data-vs-hedge-fund-letter-132353090.html,Read The Letters Before Checking Out 13F Data
VRX,VRX:CT,BBG000DC8S17,Read The Letters Before Checking Out 13F Data,2016-08-16 13:23:49 +0000,http://finance.yahoo.com/tumblr/blog-13f-data-vs-hedge-fund-letter-132353090.html,Read The Letters Before Checking Out 13F Data
VRX,VRX:US,BBG000DLFM21,Valeant: Are the Salix and Dermatology Portfolios Recovering?,2016-08-16 13:05:44 +0000,http://marketrealist.com/2016/08/valeant-are-the-salix-and-dermatology-portfolios-recovering/?utm_source=yahoo&utm_medium=feed,Valeant: Are the Salix and Dermatology Portfolios Recovering?
VRX,VRX:CT,BBG000DC8S17,Valeant: Are the Salix and Dermatology Portfolios Recovering?,2016-08-16 13:05:44 +0000,http://marketrealist.com/2016/08/valeant-are-the-salix-and-dermatology-portfolios-recovering/?utm_source=yahoo&utm_medium=feed,Valeant: Are the Salix and Dermatology Portfolios Recovering?
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Falling As Commodity Prices Fizzle -- Canadian Commentary,2016-08-16 11:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eDy01Lr71yY/canadian-stocks-are-falling-as-commodity-prices-fizzle--canadian-commentary-20160816-00636,Canadian Stocks Are Falling As Commodity Prices Fizzle -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Falling As Commodity Prices Fizzle -- Canadian Commentary,2016-08-16 11:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eDy01Lr71yY/canadian-stocks-are-falling-as-commodity-prices-fizzle--canadian-commentary-20160816-00636,Canadian Stocks Are Falling As Commodity Prices Fizzle -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,[$$] ValueAct takes $1bn stake in Morgan Stanley,2016-08-16 00:57:43 +0000,"http://www.ft.com/cms/s/5a22fa08-6335-11e6-a08a-c7ac04ef00aa,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - The activist hedge fund ValueAct has disclosed a $1.1bn investment in Morgan Stanley, giving it a powerful voice at a bank still trying to come to terms with the radically changed regulatory landscape. ..."
VRX,VRX:US,BBG000DLFM21,[$$] ValueAct takes $1bn stake in Morgan Stanley,2016-08-16 00:57:43 +0000,"http://www.ft.com/cms/s/5a22fa08-6335-11e6-a08a-c7ac04ef00aa,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - The activist hedge fund ValueAct has disclosed a $1.1bn investment in Morgan Stanley, giving it a powerful voice at a bank still trying to come to terms with the radically changed regulatory landscape. ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Intl Inc: VRX Can Be an “Income” Stock!,2016-08-15 23:36:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7xKa9YHYrWk/valeant-pharmaceuticals-intl-inc-vrx-can-be-an-income-stock-cm665630,"After a nearly 10 for 1 price cut in Valeant Pharmaceuticals Intl Inc (NYSE  VRX ) stock, shares have recently settled in a trough in"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Intl Inc: VRX Can Be an “Income” Stock!,2016-08-15 23:36:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7xKa9YHYrWk/valeant-pharmaceuticals-intl-inc-vrx-can-be-an-income-stock-cm665630,"After a nearly 10 for 1 price cut in Valeant Pharmaceuticals Intl Inc (NYSE  VRX ) stock, shares have recently settled in a trough in"
VRX,VRX:CT,BBG000DC8S17,Valeant shares jump 6% after analyst says 'short thesis has been debunked',2016-08-15 21:37:27 +0000,http://www.cnbc.com/id/103868873?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103868873,Valeant shares jump 6% after analyst says 'short thesis has been debunked'
VRX,VRX:US,BBG000DLFM21,Valeant shares jump 6% after analyst says 'short thesis has been debunked',2016-08-15 21:37:27 +0000,http://www.cnbc.com/id/103868873?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103868873,Valeant shares jump 6% after analyst says 'short thesis has been debunked'
VRX,VRX:US,BBG000DLFM21,Valeant Shares Jump as Short Thesis 'Debunked',2016-08-15 20:59:00 +0000,http://www.thestreet.com/video/13675516/valeant-shares-jump-as-short-thesis-debunked.html?puc=yahoov&cm_ven=YAHOOV,Valeant Shares Jump as Short Thesis 'Debunked'
VRX,VRX:CT,BBG000DC8S17,Valeant Shares Jump as Short Thesis 'Debunked',2016-08-15 20:59:00 +0000,http://www.thestreet.com/video/13675516/valeant-shares-jump-as-short-thesis-debunked.html?puc=yahoov&cm_ven=YAHOOV,Valeant Shares Jump as Short Thesis 'Debunked'
VRX,VRX:US,BBG000DLFM21,"McDonald's Rating Cut On Sales, Labor Costs; Lululemon, JCPenney Targets Raised",2016-08-15 20:26:03 +0000,http://www.investors.com/news/valeant-upgraded-mcdonalds-downgraded-lulu-and-penneys-pt-raised/,"McDonald's Rating Cut On Sales, Labor Costs; Lululemon, JCPenney Targets Raised"
VRX,VRX:CT,BBG000DC8S17,"McDonald's Rating Cut On Sales, Labor Costs; Lululemon, JCPenney Targets Raised",2016-08-15 20:26:03 +0000,http://www.investors.com/news/valeant-upgraded-mcdonalds-downgraded-lulu-and-penneys-pt-raised/,"McDonald's Rating Cut On Sales, Labor Costs; Lululemon, JCPenney Targets Raised"
VRX,VRX:CT,BBG000DC8S17,Hedge funds made big changes at drug companies in 2nd qtr -filings,2016-08-15 20:25:30 +0000,http://finance.yahoo.com/news/hedge-funds-made-big-changes-202530271.html,Hedge funds made big changes at drug companies in 2nd qtr -filings
VRX,VRX:US,BBG000DLFM21,Hedge funds made big changes at drug companies in 2nd qtr -filings,2016-08-15 20:25:30 +0000,http://finance.yahoo.com/news/hedge-funds-made-big-changes-202530271.html,Hedge funds made big changes at drug companies in 2nd qtr -filings
VRX,VRX:CT,BBG000DC8S17,Valeant Rises As Analyst Admits 'Short Thesis Debunked',2016-08-15 20:12:09 +0000,http://www.investors.com/news/technology/valeant-rises-on-upgrade-as-analyst-ditches-her-short-thesis/,Valeant Rises As Analyst Admits 'Short Thesis Debunked'
VRX,VRX:US,BBG000DLFM21,Valeant Rises As Analyst Admits 'Short Thesis Debunked',2016-08-15 20:12:09 +0000,http://www.investors.com/news/technology/valeant-rises-on-upgrade-as-analyst-ditches-her-short-thesis/,Valeant Rises As Analyst Admits 'Short Thesis Debunked'
VRX,VRX:US,BBG000DLFM21,ValueAct Bets on Morgan Stanley,2016-08-15 18:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pp0K3CD9otk/valueact-bets-on-morgan-stanley-20160815-00976,ValueAct Bets on Morgan Stanley
VRX,VRX:CT,BBG000DC8S17,ValueAct Bets on Morgan Stanley,2016-08-15 18:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6kxtHXu8Yl0/valueact-bets-on-morgan-stanley-20160815-00975,ValueAct Bets on Morgan Stanley
VRX,VRX:US,BBG000DLFM21,ValueAct Bets on Morgan Stanley,2016-08-15 18:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6kxtHXu8Yl0/valueact-bets-on-morgan-stanley-20160815-00975,ValueAct Bets on Morgan Stanley
VRX,VRX:CT,BBG000DC8S17,ValueAct Bets on Morgan Stanley,2016-08-15 18:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pp0K3CD9otk/valueact-bets-on-morgan-stanley-20160815-00976,ValueAct Bets on Morgan Stanley
VRX,VRX:US,BBG000DLFM21,Hain Celestial Shares Drop as Accounting Review Will Delay Results,2016-08-15 18:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HJlv_qzOhyQ/hain-celestial-shares-drop-as-accounting-review-will-delay-results-20160815-00965,Hain Celestial Shares Drop as Accounting Review Will Delay Results
VRX,VRX:CT,BBG000DC8S17,Hain Celestial Shares Drop as Accounting Review Will Delay Results,2016-08-15 18:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HJlv_qzOhyQ/hain-celestial-shares-drop-as-accounting-review-will-delay-results-20160815-00965,Hain Celestial Shares Drop as Accounting Review Will Delay Results
VRX,VRX:CT,BBG000DC8S17,A Look at Five Stocks on the Move on Monday,2016-08-15 17:24:23 +0000,http://www.insidermonkey.com/blog/a-look-at-five-stocks-on-the-move-on-monday-469081/,A Look at Five Stocks on the Move on Monday
VRX,VRX:US,BBG000DLFM21,A Look at Five Stocks on the Move on Monday,2016-08-15 17:24:23 +0000,http://www.insidermonkey.com/blog/a-look-at-five-stocks-on-the-move-on-monday-469081/,A Look at Five Stocks on the Move on Monday
VRX,VRX:CT,BBG000DC8S17,CNBC's 'Halftime Report' Panel Debates Valeant (VRX) Stock After Mizuho Ratings Upgrade,2016-08-15 17:14:00 +0000,https://www.thestreet.com/story/13675303/1/cnbc-s-halftime-report-panel-debates-valeant-vrx-stock-after-mizuho-ratings-upgrade.html?puc=yahoo&cm_ven=YAHOO,CNBC's 'Halftime Report' Panel Debates Valeant (VRX) Stock After Mizuho Ratings Upgrade
VRX,VRX:US,BBG000DLFM21,CNBC's 'Halftime Report' Panel Debates Valeant (VRX) Stock After Mizuho Ratings Upgrade,2016-08-15 17:14:00 +0000,https://www.thestreet.com/story/13675303/1/cnbc-s-halftime-report-panel-debates-valeant-vrx-stock-after-mizuho-ratings-upgrade.html?puc=yahoo&cm_ven=YAHOO,CNBC's 'Halftime Report' Panel Debates Valeant (VRX) Stock After Mizuho Ratings Upgrade
VRX,VRX:US,BBG000DLFM21,Valeant upgraded by Mizuho: ‘We know when to fold ‘em’,2016-08-15 17:05:39 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=A2837F12-62F3-11E6-8D5F-A15BD7E07EB1&siteid=yhoof2,Valeant upgraded by Mizuho: ‘We know when to fold ‘em’
VRX,VRX:CT,BBG000DC8S17,Valeant upgraded by Mizuho: ‘We know when to fold ‘em’,2016-08-15 17:05:39 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=A2837F12-62F3-11E6-8D5F-A15BD7E07EB1&siteid=yhoof2,Valeant upgraded by Mizuho: ‘We know when to fold ‘em’
VRX,VRX:CT,BBG000DC8S17,"Canada Stocks Rise, Trade Near Year-High as Crude Prices Advance",2016-08-15 14:32:03 +0000,http://finance.yahoo.com/news/canada-stocks-rise-trade-near-143203447.html,"Canada Stocks Rise, Trade Near Year-High as Crude Prices Advance"
VRX,VRX:US,BBG000DLFM21,"Canada Stocks Rise, Trade Near Year-High as Crude Prices Advance",2016-08-15 14:32:03 +0000,http://finance.yahoo.com/news/canada-stocks-rise-trade-near-143203447.html,"Canada Stocks Rise, Trade Near Year-High as Crude Prices Advance"
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals (VRX) Stock Gains, Mizuho Upgrades",2016-08-15 14:25:00 +0000,https://www.thestreet.com/story/13675039/1/valeant-pharmaceuticals-vrx-stock-gains-mizuho-upgrades.html?puc=yahoo&cm_ven=YAHOO,"Valeant Pharmaceuticals (VRX) Stock Gains, Mizuho Upgrades"
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals (VRX) Stock Gains, Mizuho Upgrades",2016-08-15 14:25:00 +0000,https://www.thestreet.com/story/13675039/1/valeant-pharmaceuticals-vrx-stock-gains-mizuho-upgrades.html?puc=yahoo&cm_ven=YAHOO,"Valeant Pharmaceuticals (VRX) Stock Gains, Mizuho Upgrades"
VRX,VRX:US,BBG000DLFM21,Is Valeant a Good Bet on a Price-to-Earnings Basis?,2016-08-15 14:09:41 +0000,http://marketrealist.com/2016/08/is-valeant-a-good-bet-on-a-price-to-earnings-basis/?utm_source=yahoo&utm_medium=feed,Is Valeant a Good Bet on a Price-to-Earnings Basis?
VRX,VRX:CT,BBG000DC8S17,Is Valeant a Good Bet on a Price-to-Earnings Basis?,2016-08-15 14:09:41 +0000,http://marketrealist.com/2016/08/is-valeant-a-good-bet-on-a-price-to-earnings-basis/?utm_source=yahoo&utm_medium=feed,Is Valeant a Good Bet on a Price-to-Earnings Basis?
VRX,VRX:CT,BBG000DC8S17,Valeant: 'Our Short Thesis Has Been Debunked',2016-08-15 13:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/15/valeant-our-short-thesis-has-been-debunked/?mod=yahoobarrons&ru=yahoo,Valeant: 'Our Short Thesis Has Been Debunked'
VRX,VRX:US,BBG000DLFM21,Valeant: 'Our Short Thesis Has Been Debunked',2016-08-15 13:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/15/valeant-our-short-thesis-has-been-debunked/?mod=yahoobarrons&ru=yahoo,Valeant: 'Our Short Thesis Has Been Debunked'
VRX,VRX:CT,BBG000DC8S17,Valeant's Latest Problems Are a Red Flag for Investors,2016-08-15 13:53:00 +0000,https://www.thestreet.com/story/13672904/1/valeant-s-latest-problems-are-a-red-flag-for-investors.html?puc=yahoo&cm_ven=YAHOO,Valeant's Latest Problems Are a Red Flag for Investors
VRX,VRX:US,BBG000DLFM21,Valeant's Latest Problems Are a Red Flag for Investors,2016-08-15 13:53:00 +0000,https://www.thestreet.com/story/13672904/1/valeant-s-latest-problems-are-a-red-flag-for-investors.html?puc=yahoo&cm_ven=YAHOO,Valeant's Latest Problems Are a Red Flag for Investors
VRX,VRX:CT,BBG000DC8S17,"Mizuho Upgrades Valeant, Says Financial Engineering Helped Company 'Outfox The Shorts'",2016-08-15 13:50:26 +0000,http://finance.yahoo.com/news/mizuho-upgrades-valeant-says-financial-135026820.html,"Mizuho Upgrades Valeant, Says Financial Engineering Helped Company 'Outfox The Shorts'"
VRX,VRX:US,BBG000DLFM21,"Mizuho Upgrades Valeant, Says Financial Engineering Helped Company 'Outfox The Shorts'",2016-08-15 13:50:26 +0000,http://finance.yahoo.com/news/mizuho-upgrades-valeant-says-financial-135026820.html,"Mizuho Upgrades Valeant, Says Financial Engineering Helped Company 'Outfox The Shorts'"
VRX,VRX:CT,BBG000DC8S17,Post Earnings Coverage as Perrigo Doubles Profit,2016-08-15 13:15:11 +0000,http://news.investornetwork.com/2016/08/15/post-earnings-coverage-as-perrigo-doubles-profit/?1=1&1471266911,Post Earnings Coverage as Perrigo Doubles Profit
VRX,VRX:US,BBG000DLFM21,Post Earnings Coverage as Perrigo Doubles Profit,2016-08-15 13:15:11 +0000,http://news.investornetwork.com/2016/08/15/post-earnings-coverage-as-perrigo-doubles-profit/?1=1&1471266911,Post Earnings Coverage as Perrigo Doubles Profit
VRX,VRX:US,BBG000DLFM21,Analyzing Valeant’s New Segments,2016-08-15 13:05:06 +0000,http://marketrealist.com/2016/08/analyzing-valeants-new-segments/?utm_source=yahoo&utm_medium=feed,Analyzing Valeant’s New Segments
VRX,VRX:CT,BBG000DC8S17,Analyzing Valeant’s New Segments,2016-08-15 13:05:06 +0000,http://marketrealist.com/2016/08/analyzing-valeants-new-segments/?utm_source=yahoo&utm_medium=feed,Analyzing Valeant’s New Segments
VRX,VRX:US,BBG000DLFM21,"Pre-Market Most Active for Aug 15, 2016 :  BABA, AUPH, YHOO, TWTR, CHK, VRX, X, TWLO, ACRX, XIV, ACIA, AAPL",2016-08-15 13:00:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tvjcBCIkHMA/pre-market-most-active-for-aug-15-2016-baba-auph-yhoo-twtr-chk-vrx-x-twlo-acrx-xiv-acia-aapl-cm665203,"The NASDAQ 100 Pre Market Indicator is up 7.89 to 4,814.97. The total Pre Market volume is currently 3,068,948 shares traded. The following are the most active stocks for the pre market session Alibaba Group Holding Limited ( BABA"
VRX,VRX:CT,BBG000DC8S17,"Pre-Market Most Active for Aug 15, 2016 :  BABA, AUPH, YHOO, TWTR, CHK, VRX, X, TWLO, ACRX, XIV, ACIA, AAPL",2016-08-15 13:00:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tvjcBCIkHMA/pre-market-most-active-for-aug-15-2016-baba-auph-yhoo-twtr-chk-vrx-x-twlo-acrx-xiv-acia-aapl-cm665203,"The NASDAQ 100 Pre Market Indicator is up 7.89 to 4,814.97. The total Pre Market volume is currently 3,068,948 shares traded. The following are the most active stocks for the pre market session Alibaba Group Holding Limited ( BABA"
VRX,VRX:CT,BBG000DC8S17,Morning Movers: Valeant Gains on Upgrade; Chesapeake Energy Rises on Loan,2016-08-15 12:43:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/15/morning-movers-valeant-gains-on-upgrade-chesapeake-energy-rises-on-loan/?mod=yahoobarrons&ru=yahoo,Morning Movers: Valeant Gains on Upgrade; Chesapeake Energy Rises on Loan
VRX,VRX:US,BBG000DLFM21,Morning Movers: Valeant Gains on Upgrade; Chesapeake Energy Rises on Loan,2016-08-15 12:43:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/15/morning-movers-valeant-gains-on-upgrade-chesapeake-energy-rises-on-loan/?mod=yahoobarrons&ru=yahoo,Morning Movers: Valeant Gains on Upgrade; Chesapeake Energy Rises on Loan
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Holding Onto Modest Gains -- Canadian Commentary,2016-08-15 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ipOi6DVK4W4/canadian-stocks-are-holding-onto-modest-gains--canadian-commentary-20160815-00526,Canadian Stocks Are Holding Onto Modest Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Holding Onto Modest Gains -- Canadian Commentary,2016-08-15 11:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ipOi6DVK4W4/canadian-stocks-are-holding-onto-modest-gains--canadian-commentary-20160815-00526,Canadian Stocks Are Holding Onto Modest Gains -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Stay the Course,2016-08-14 13:56:45 +0000,http://finance.yahoo.com/tumblr/blog-stay-the-course-163144526.html,Stay the Course
VRX,VRX:US,BBG000DLFM21,Stay the Course,2016-08-14 13:56:45 +0000,http://finance.yahoo.com/tumblr/blog-stay-the-course-163144526.html,Stay the Course
VRX,VRX:CT,BBG000DC8S17,"Global Stocks Rally Ahead of US Retail Sales, Eurozone GDP Numbers",2016-08-13 01:34:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NAgJUDdmITs/global-stocks-rally-ahead-of-us-retail-sales-eurozone-gdp-numbers-cm664957,"The global stock market appears to have fully recovered from the early scare experienced in January. Since February, stocks have rallied significantly, with notable rebounds whenever a pullback occurred. This rally continued on Thursday with most indices recording significant"
VRX,VRX:US,BBG000DLFM21,"Global Stocks Rally Ahead of US Retail Sales, Eurozone GDP Numbers",2016-08-13 01:34:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NAgJUDdmITs/global-stocks-rally-ahead-of-us-retail-sales-eurozone-gdp-numbers-cm664957,"The global stock market appears to have fully recovered from the early scare experienced in January. Since February, stocks have rallied significantly, with notable rebounds whenever a pullback occurred. This rally continued on Thursday with most indices recording significant"
VRX,VRX:CT,BBG000DC8S17,Realities of Retail; Remembrance of Probes Past: Jim Cramer's Best Blogs,2016-08-13 01:00:00 +0000,https://www.thestreet.com/story/13674285/1/realities-of-retail-remembrance-of-probes-past-jim-cramer-rsquo-s-best-blogs.html?puc=yahoo&cm_ven=YAHOO,Realities of Retail; Remembrance of Probes Past: Jim Cramer's Best Blogs
VRX,VRX:US,BBG000DLFM21,Realities of Retail; Remembrance of Probes Past: Jim Cramer's Best Blogs,2016-08-13 01:00:00 +0000,https://www.thestreet.com/story/13674285/1/realities-of-retail-remembrance-of-probes-past-jim-cramer-rsquo-s-best-blogs.html?puc=yahoo&cm_ven=YAHOO,Realities of Retail; Remembrance of Probes Past: Jim Cramer's Best Blogs
VRX,VRX:US,BBG000DLFM21,Francis Chou Adds to 2 Positions in 2nd Quarter,2016-08-12 23:33:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AtAILJ60BMQ/francis-chou-adds-to-2-positions-in-2nd-quarter-cm664929,"During the second quarter, Francis Chou ( Trades , Portfolio ) of Chou Associates Management added 48.11% and 38.77% to its positions in Valeant Pharmaceuticals International Inc. ( VRX ) and Sears Holdings Corp. ( SHLD ). As the"
VRX,VRX:CT,BBG000DC8S17,Francis Chou Adds to 2 Positions in 2nd Quarter,2016-08-12 23:33:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AtAILJ60BMQ/francis-chou-adds-to-2-positions-in-2nd-quarter-cm664929,"During the second quarter, Francis Chou ( Trades , Portfolio ) of Chou Associates Management added 48.11% and 38.77% to its positions in Valeant Pharmaceuticals International Inc. ( VRX ) and Sears Holdings Corp. ( SHLD ). As the"
VRX,VRX:CT,BBG000DC8S17,"Third Point Buys Facebook, Cuts Alphabet; Appaloosa Dumps Facebook",2016-08-12 22:55:53 +0000,http://www.investors.com/news/googles-parent-alphabet-valeant-delta-among-big-fund-trades-in-q2/,"Third Point Buys Facebook, Cuts Alphabet; Appaloosa Dumps Facebook"
VRX,VRX:US,BBG000DLFM21,"Third Point Buys Facebook, Cuts Alphabet; Appaloosa Dumps Facebook",2016-08-12 22:55:53 +0000,http://www.investors.com/news/googles-parent-alphabet-valeant-delta-among-big-fund-trades-in-q2/,"Third Point Buys Facebook, Cuts Alphabet; Appaloosa Dumps Facebook"
VRX,VRX:US,BBG000DLFM21,"Why Valeant Pharmaceuticals Intl Inc (VRX), Flowers Foods, Inc. (FLO) and General Growth Properties Inc (GGP) Are 3 of Today’s Worst Stocks",2016-08-12 21:23:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yeeh45WOtFQ/why-valeant-pharmaceuticals-intl-inc-vrx-flowers-foods-inc-flo-and-general-growth-properties-inc-ggp-are-3-of-todays-worst-stocks-cm664471,"Recovering from yesterday's sizable setback, the bulls charged early today and never let go, mostly inspired by the absence of any bad news. By the"
VRX,VRX:CT,BBG000DC8S17,"Why Valeant Pharmaceuticals Intl Inc (VRX), Flowers Foods, Inc. (FLO) and General Growth Properties Inc (GGP) Are 3 of Today’s Worst Stocks",2016-08-12 21:23:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yeeh45WOtFQ/why-valeant-pharmaceuticals-intl-inc-vrx-flowers-foods-inc-flo-and-general-growth-properties-inc-ggp-are-3-of-todays-worst-stocks-cm664471,"Recovering from yesterday's sizable setback, the bulls charged early today and never let go, mostly inspired by the absence of any bad news. By the"
VRX,VRX:US,BBG000DLFM21,Alibaba: Earnings Propel BABA Stock to New Highs,2016-08-12 20:25:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/THjfEVWAE_0/alibaba-earnings-propel-baba-stock-to-new-highs-cm664284,"Alibaba Group Holding Ltd (NYSE BABA ) shares are soaring Thursday morning, with BA BA stock touching new 2016 highs thanks to a big earnings beat. Source Charles Chan Via"
VRX,VRX:CT,BBG000DC8S17,Alibaba: Earnings Propel BABA Stock to New Highs,2016-08-12 20:25:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/THjfEVWAE_0/alibaba-earnings-propel-baba-stock-to-new-highs-cm664284,"Alibaba Group Holding Ltd (NYSE BABA ) shares are soaring Thursday morning, with BA BA stock touching new 2016 highs thanks to a big earnings beat. Source Charles Chan Via"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals (VRX) Stock: The Philidor Nightmare Isn’t Over,2016-08-12 20:24:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/shAS8OsO3yA/valeant-pharmaceuticals-vrx-stock-the-philidor-nightmare-isnt-over-cm664277,"The U.S. Attorney for the Southern District of New York, which often prosecutes Wall Street cases, has opened an investigation into Valeant Pharmaceuticals Intl Inc (NYSE VRX ). The topic Valeant's"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals (VRX) Stock: The Philidor Nightmare Isn’t Over,2016-08-12 20:24:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/shAS8OsO3yA/valeant-pharmaceuticals-vrx-stock-the-philidor-nightmare-isnt-over-cm664277,"The U.S. Attorney for the Southern District of New York, which often prosecutes Wall Street cases, has opened an investigation into Valeant Pharmaceuticals Intl Inc (NYSE VRX ). The topic Valeant's"
VRX,VRX:CT,BBG000DC8S17,J C Penney Company Inc (JCP): It’s Make-or-Break Time,2016-08-12 20:24:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5zQu706JkOg/j-c-penney-company-inc-jcp-its-make-or-break-time-cm664317,It hasn't been easy to be bullish on J C Penney Company Inc (NYSE JCP ) of late. Aside from the fact that the once iconic department store chain is
VRX,VRX:US,BBG000DLFM21,J C Penney Company Inc (JCP): It’s Make-or-Break Time,2016-08-12 20:24:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5zQu706JkOg/j-c-penney-company-inc-jcp-its-make-or-break-time-cm664317,It hasn't been easy to be bullish on J C Penney Company Inc (NYSE JCP ) of late. Aside from the fact that the once iconic department store chain is
VRX,VRX:US,BBG000DLFM21,FB Stock: Facebook Inc Poised to Resume Its Rally,2016-08-12 20:24:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gGD0lmtHtK0/fb-stock-facebook-inc-poised-to-resume-its-rally-cm664315,"After hitting a fresh all time high and threatening to challenge $130 in the wake of a better than expected earnings report, Facebook Inc (NASDAQ FB ) stock has settled"
VRX,VRX:CT,BBG000DC8S17,FB Stock: Facebook Inc Poised to Resume Its Rally,2016-08-12 20:24:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gGD0lmtHtK0/fb-stock-facebook-inc-poised-to-resume-its-rally-cm664315,"After hitting a fresh all time high and threatening to challenge $130 in the wake of a better than expected earnings report, Facebook Inc (NASDAQ FB ) stock has settled"
VRX,VRX:CT,BBG000DC8S17,Williams Companies Inc (WMB) – The Dividend Cut Is a GOOD Thing,2016-08-12 20:24:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/107TexYEgyg/williams-companies-inc-wmb-the-dividend-cut-is-a-good-thing-cm664351,"For investors in natural gas midstream giant Williams Companies Inc  (NYSE  WMB ), this hasn't been a great couple of quarters. Its proposed mega"
VRX,VRX:US,BBG000DLFM21,Williams Companies Inc (WMB) – The Dividend Cut Is a GOOD Thing,2016-08-12 20:24:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/107TexYEgyg/williams-companies-inc-wmb-the-dividend-cut-is-a-good-thing-cm664351,"For investors in natural gas midstream giant Williams Companies Inc  (NYSE  WMB ), this hasn't been a great couple of quarters. Its proposed mega"
VRX,VRX:US,BBG000DLFM21,"Valeant's Legal Woes Aren't New, but They Are Mounting",2016-08-11 22:51:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E7pZ4ypSFlU/valeants-legal-woes-arent-new-but-they-are-mounting-cm664372,"Image source  Getty Images.  On the heels of a dramatic post second quarter earnings run up in shares, reports of a federal criminal investigation into its past business dealings has Valeant Pharmaceuticals (NYSE"
VRX,VRX:CT,BBG000DC8S17,"Valeant's Legal Woes Aren't New, but They Are Mounting",2016-08-11 22:51:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E7pZ4ypSFlU/valeants-legal-woes-arent-new-but-they-are-mounting-cm664372,"Image source  Getty Images.  On the heels of a dramatic post second quarter earnings run up in shares, reports of a federal criminal investigation into its past business dealings has Valeant Pharmaceuticals (NYSE"
VRX,VRX:US,BBG000DLFM21,"Why Shake Shack, Amarin, and Valeant Pharmaceuticals Slumped Today",2016-08-11 22:51:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8I88fh5qojU/why-shake-shack-amarin-and-valeant-pharmaceuticals-slumped-today-cm664369,"Image source  Shake Shack.  The stock market climbed higher into record territory on Thursday, overcoming a minor decline on Wednesday on renewed strength in several key sectors of the economy. In particular, favorable"
VRX,VRX:CT,BBG000DC8S17,"Why Shake Shack, Amarin, and Valeant Pharmaceuticals Slumped Today",2016-08-11 22:51:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8I88fh5qojU/why-shake-shack-amarin-and-valeant-pharmaceuticals-slumped-today-cm664369,"Image source  Shake Shack.  The stock market climbed higher into record territory on Thursday, overcoming a minor decline on Wednesday on renewed strength in several key sectors of the economy. In particular, favorable"
VRX,VRX:US,BBG000DLFM21,Criminal Probe Pushes Valeant Pharmaceuticals Stock Down Nearly 11%,2016-08-11 21:51:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_6MTp5lXN6E/criminal-probe-pushes-valeant-pharmaceuticals-stock-down-nearly-11-cm664345,"Image source  Getty Images.  What  Shares of Valeant Pharmaceuticals (NYSE  VRX) , a global pharmaceutical company that has primarily grown by mergers and acquisitions throughout the years, tumbled as much as"
VRX,VRX:CT,BBG000DC8S17,Criminal Probe Pushes Valeant Pharmaceuticals Stock Down Nearly 11%,2016-08-11 21:51:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_6MTp5lXN6E/criminal-probe-pushes-valeant-pharmaceuticals-stock-down-nearly-11-cm664345,"Image source  Getty Images.  What  Shares of Valeant Pharmaceuticals (NYSE  VRX) , a global pharmaceutical company that has primarily grown by mergers and acquisitions throughout the years, tumbled as much as"
VRX,VRX:US,BBG000DLFM21,"After Hours Most Active for Aug 11, 2016 :  GE, VRX, FTR, F, KEY, HPE, RIG, NVDA, ON, MSFT, FOXA, FITB",2016-08-11 21:04:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Qklq85xRwQ/after-hours-most-active-for-aug-11-2016-ge-vrx-ftr-f-key-hpe-rig-nvda-on-msft-foxa-fitb-cm664353,"The NASDAQ 100 After Hours Indicator is up .5 to 4,803.81. The total After hours volume is currently 37,950,666 shares traded. The following are the most active stocks for the after hours session General Electric Company ( GE )"
VRX,VRX:CT,BBG000DC8S17,"After Hours Most Active for Aug 11, 2016 :  GE, VRX, FTR, F, KEY, HPE, RIG, NVDA, ON, MSFT, FOXA, FITB",2016-08-11 21:04:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Qklq85xRwQ/after-hours-most-active-for-aug-11-2016-ge-vrx-ftr-f-key-hpe-rig-nvda-on-msft-foxa-fitb-cm664353,"The NASDAQ 100 After Hours Indicator is up .5 to 4,803.81. The total After hours volume is currently 37,950,666 shares traded. The following are the most active stocks for the after hours session General Electric Company ( GE )"
VRX,VRX:CT,BBG000DC8S17,US stocks surge to new records as oil shares rally,2016-08-11 20:53:15 +0000,http://uk.finance.yahoo.com/news/us-stocks-surge-records-oil-205315713.html,US stocks surge to new records as oil shares rally
VRX,VRX:US,BBG000DLFM21,US stocks surge to new records as oil shares rally,2016-08-11 20:53:15 +0000,http://uk.finance.yahoo.com/news/us-stocks-surge-records-oil-205315713.html,US stocks surge to new records as oil shares rally
VRX,VRX:CT,BBG000DC8S17,Valeant stock falls as report of criminal probe adds to woes,2016-08-11 19:37:34 +0000,http://sg.finance.yahoo.com/news/valeant-stock-falls-report-criminal-130059625.html,Valeant stock falls as report of criminal probe adds to woes
VRX,VRX:US,BBG000DLFM21,Valeant stock falls as report of criminal probe adds to woes,2016-08-11 19:37:34 +0000,http://sg.finance.yahoo.com/news/valeant-stock-falls-report-criminal-130059625.html,Valeant stock falls as report of criminal probe adds to woes
VRX,VRX:CT,BBG000DC8S17,"If You Own Valeant (VRX) Stock, You May Want to Sell Now",2016-08-11 18:48:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gwp4Wcr6OG0/if-you-own-valeant-vrx-stock-you-may-want-to-sell-now-cm664239,"On Thursday, shares of pharmaceutical company Valeant Pharmaceuticals Inc. VRX are crashing, down almost 10% in late morning trading following reports that the company is under a criminal investigation. According to The Wall Street Journal , U.S. prosecutors opened"
VRX,VRX:US,BBG000DLFM21,"If You Own Valeant (VRX) Stock, You May Want to Sell Now",2016-08-11 18:48:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gwp4Wcr6OG0/if-you-own-valeant-vrx-stock-you-may-want-to-sell-now-cm664239,"On Thursday, shares of pharmaceutical company Valeant Pharmaceuticals Inc. VRX are crashing, down almost 10% in late morning trading following reports that the company is under a criminal investigation. According to The Wall Street Journal , U.S. prosecutors opened"
VRX,VRX:US,BBG000DLFM21,Can Anything More Go Wrong for Valeant?,2016-08-11 15:52:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_uefmNoC5dM/can-anything-more-go-wrong-for-valeant-cm664044,"Image source  Getty Images.  Embattled pharma company Valeant Pharmaceuticals (NYSE  VRX) has been one of the worst performers in the stock market, losing almost 90% of its value in just the past"
VRX,VRX:CT,BBG000DC8S17,Can Anything More Go Wrong for Valeant?,2016-08-11 15:52:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_uefmNoC5dM/can-anything-more-go-wrong-for-valeant-cm664044,"Image source  Getty Images.  Embattled pharma company Valeant Pharmaceuticals (NYSE  VRX) has been one of the worst performers in the stock market, losing almost 90% of its value in just the past"
VRX,VRX:CT,BBG000DC8S17,"Valeant, down 70 pct this year, plunges on WSJ report",2016-08-11 11:15:09 +0000,http://sg.finance.yahoo.com/news/valeant-down-70-pct-plunges-111509634.html,"Valeant, down 70 pct this year, plunges on WSJ report"
VRX,VRX:US,BBG000DLFM21,"Valeant, down 70 pct this year, plunges on WSJ report",2016-08-11 11:15:09 +0000,http://sg.finance.yahoo.com/news/valeant-down-70-pct-plunges-111509634.html,"Valeant, down 70 pct this year, plunges on WSJ report"
VRX,VRX:US,BBG000DLFM21,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary",2016-08-11 11:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mm_I5g-6tI8/canadian-stocks-are-rising-but-valeant-weighs--canadian-commentary-20160811-00693,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary",2016-08-11 11:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AVLr9IRLywY/canadian-stocks-are-rising-but-valeant-weighs--canadian-commentary-20160811-00694,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary",2016-08-11 11:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AVLr9IRLywY/canadian-stocks-are-rising-but-valeant-weighs--canadian-commentary-20160811-00694,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary",2016-08-11 11:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mm_I5g-6tI8/canadian-stocks-are-rising-but-valeant-weighs--canadian-commentary-20160811-00693,"Canadian Stocks Are Rising, But Valeant Weighs -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,"MARKET SNAPSHOT: Stocks Flirt With Records As Macy's Soars, Oil Rebounds",2016-08-11 09:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/19mbQXUTomU/market-snapshot-stocks-flirt-with-records-as-macys-soars-oil-rebounds-20160811-00592,"MARKET SNAPSHOT: Stocks Flirt With Records As Macy's Soars, Oil Rebounds"
VRX,VRX:CT,BBG000DC8S17,"MARKET SNAPSHOT: Stocks Flirt With Records As Macy's Soars, Oil Rebounds",2016-08-11 09:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/19mbQXUTomU/market-snapshot-stocks-flirt-with-records-as-macys-soars-oil-rebounds-20160811-00592,"MARKET SNAPSHOT: Stocks Flirt With Records As Macy's Soars, Oil Rebounds"
VRX,VRX:US,BBG000DLFM21,"Canadian Stocks On Pause, Valeant In Crosshairs -- Canadian Commentary",2016-08-11 08:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/738wm8qFeJc/canadian-stocks-on-pause-valeant-in-crosshairs--canadian-commentary-20160811-00457,"Canadian Stocks On Pause, Valeant In Crosshairs -- Canadian Commentary"
VRX,VRX:CT,BBG000DC8S17,"Canadian Stocks On Pause, Valeant In Crosshairs -- Canadian Commentary",2016-08-11 08:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/738wm8qFeJc/canadian-stocks-on-pause-valeant-in-crosshairs--canadian-commentary-20160811-00457,"Canadian Stocks On Pause, Valeant In Crosshairs -- Canadian Commentary"
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Comments On SDNY Investigation,2016-08-11 03:01:20 +0000,http://www.publicnow.com/view/A5A9D62E6E14FE486936F96E198FB6528DED47B4,"[at noodls] - LAVAL, Quebec, Aug. 10, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding the ongoing investigation being ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Comments On SDNY Investigation,2016-08-11 03:01:20 +0000,http://www.publicnow.com/view/A5A9D62E6E14FE486936F96E198FB6528DED47B4,"[at noodls] - LAVAL, Quebec, Aug. 10, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding the ongoing investigation being ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Faces Criminal Probe -- WSJ,2016-08-11 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZDH5VEQAEX0/valeant-faces-criminal-probe--wsj-20160811-00051,Valeant Faces Criminal Probe -- WSJ
VRX,VRX:US,BBG000DLFM21,Valeant Faces Criminal Probe -- WSJ,2016-08-11 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZDH5VEQAEX0/valeant-faces-criminal-probe--wsj-20160811-00051,Valeant Faces Criminal Probe -- WSJ
VRX,VRX:US,BBG000DLFM21,Valeant under criminal investigation over Philidor ties - WSJ,2016-08-11 01:20:18 +0000,http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-over-012018663.html,Valeant under criminal investigation over Philidor ties - WSJ
VRX,VRX:CT,BBG000DC8S17,Valeant under criminal investigation over Philidor ties - WSJ,2016-08-11 01:20:18 +0000,http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-over-012018663.html,Valeant under criminal investigation over Philidor ties - WSJ
VRX,VRX:CT,BBG000DC8S17,Valeant under criminal investigation - WSJ,2016-08-10 23:32:37 +0000,http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-wsj-230653215.html,Valeant under criminal investigation - WSJ
VRX,VRX:US,BBG000DLFM21,Valeant under criminal investigation - WSJ,2016-08-10 23:32:37 +0000,http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-wsj-230653215.html,Valeant under criminal investigation - WSJ
VRX,VRX:US,BBG000DLFM21,Valeant Comments On SDNY Investigation,2016-08-10 23:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Enl-hZI--ZI/valeant-comments-on-sdny-investigation-20160810-01174,Valeant Comments On SDNY Investigation
VRX,VRX:CT,BBG000DC8S17,Valeant Comments On SDNY Investigation,2016-08-10 23:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Enl-hZI--ZI/valeant-comments-on-sdny-investigation-20160810-01174,Valeant Comments On SDNY Investigation
VRX,VRX:CT,BBG000DC8S17,Valeant Comments On SDNY Investigation,2016-08-10 23:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oBDGJ-JG7yU/valeant-comments-on-sdny-investigation-20160810-01175,Valeant Comments On SDNY Investigation
VRX,VRX:US,BBG000DLFM21,Valeant Comments On SDNY Investigation,2016-08-10 23:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oBDGJ-JG7yU/valeant-comments-on-sdny-investigation-20160810-01175,Valeant Comments On SDNY Investigation
VRX,VRX:US,BBG000DLFM21,WSJ : Valeant Under Criminal Investigation Over Philidor,2016-08-10 22:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ZFIPr_vMFM/wsj--valeant-under-criminal-investigation-over-philidor-20160810-01159,WSJ : Valeant Under Criminal Investigation Over Philidor
VRX,VRX:CT,BBG000DC8S17,WSJ : Valeant Under Criminal Investigation Over Philidor,2016-08-10 22:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ZFIPr_vMFM/wsj--valeant-under-criminal-investigation-over-philidor-20160810-01159,WSJ : Valeant Under Criminal Investigation Over Philidor
VRX,VRX:CT,BBG000DC8S17,Valeant Under Criminal Investigation,2016-08-10 19:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sKLjwHIUsV0/valeant-under-criminal-investigation-20160810-01114,Valeant Under Criminal Investigation
VRX,VRX:US,BBG000DLFM21,Valeant Under Criminal Investigation,2016-08-10 19:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sKLjwHIUsV0/valeant-under-criminal-investigation-20160810-01114,Valeant Under Criminal Investigation
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Paring Early Gains -- Canadian Commentary,2016-08-10 11:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LIt5C1oiugo/canadian-stocks-are-paring-early-gains--canadian-commentary-20160810-00666,Canadian Stocks Are Paring Early Gains -- Canadian Commentary
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Paring Early Gains -- Canadian Commentary,2016-08-10 11:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LIt5C1oiugo/canadian-stocks-are-paring-early-gains--canadian-commentary-20160810-00666,Canadian Stocks Are Paring Early Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,LPC: Valeant loans rise after CEO says company to seek debt amendment,2016-08-09 20:11:30 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-loans-rise-ceo-201130398.html,LPC: Valeant loans rise after CEO says company to seek debt amendment
VRX,VRX:CT,BBG000DC8S17,LPC: Valeant loans rise after CEO says company to seek debt amendment,2016-08-09 20:11:30 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-loans-rise-ceo-201130398.html,LPC: Valeant loans rise after CEO says company to seek debt amendment
VRX,VRX:CT,BBG000DC8S17,"Valeant's rosy forecast and promised changes, fire up shares",2016-08-09 18:11:02 +0000,http://sg.finance.yahoo.com/news/solid-outlook-valeant-promised-changes-120753176.html,"Valeant's rosy forecast and promised changes, fire up shares"
VRX,VRX:US,BBG000DLFM21,"Valeant's rosy forecast and promised changes, fire up shares",2016-08-09 18:11:02 +0000,http://sg.finance.yahoo.com/news/solid-outlook-valeant-promised-changes-120753176.html,"Valeant's rosy forecast and promised changes, fire up shares"
VRX,VRX:CT,BBG000DC8S17,U.S. Stocks Little Changed as Oil Slips,2016-08-09 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bNB7MVG4TL8/us-stocks-little-changed-as-oil-slips-20160809-01210,U.S. Stocks Little Changed as Oil Slips
VRX,VRX:US,BBG000DLFM21,U.S. Stocks Little Changed as Oil Slips,2016-08-09 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bNB7MVG4TL8/us-stocks-little-changed-as-oil-slips-20160809-01210,U.S. Stocks Little Changed as Oil Slips
VRX,VRX:US,BBG000DLFM21,"Solid outlook from Valeant, promised changes, fire up shares",2016-08-09 11:18:52 +0000,http://sg.finance.yahoo.com/news/valeant-reports-2q-loss-102145793.html,"Solid outlook from Valeant, promised changes, fire up shares"
VRX,VRX:CT,BBG000DC8S17,"Solid outlook from Valeant, promised changes, fire up shares",2016-08-09 11:18:52 +0000,http://sg.finance.yahoo.com/news/valeant-reports-2q-loss-102145793.html,"Solid outlook from Valeant, promised changes, fire up shares"
VRX,VRX:CT,BBG000DC8S17,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary,2016-08-09 11:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WxA6IglLTpE/canadian-stocks-are-extending-recent-gains--canadian-commentary-20160809-00768,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary,2016-08-09 11:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WxA6IglLTpE/canadian-stocks-are-extending-recent-gains--canadian-commentary-20160809-00768,Canadian Stocks Are Extending Recent Gains -- Canadian Commentary
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results,2016-08-09 10:10:08 +0000,http://www.publicnow.com/view/220D7A4E104294546F66D6981108546BFE140148,"[at noodls] - 2016 Full Year Guidance Reconfirmed LAVAL, Quebec, Aug. 9, 2016 /PRNewswire/ -- Total Revenues of $2.4 billion, a decrease of 11% versus the second quarter of 2015 GAAP EPS ($0.88) and Adjusted EPS (non-GAAP) ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results,2016-08-09 10:10:08 +0000,http://www.publicnow.com/view/220D7A4E104294546F66D6981108546BFE140148,"[at noodls] - 2016 Full Year Guidance Reconfirmed LAVAL, Quebec, Aug. 9, 2016 /PRNewswire/ -- Total Revenues of $2.4 billion, a decrease of 11% versus the second quarter of 2015 GAAP EPS ($0.88) and Adjusted EPS (non-GAAP) ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Relaunch Of Generic Ofloxacin Otic Solution,2016-08-08 21:10:16 +0000,http://www.publicnow.com/view/3E2B92B2573830CCB56B85E274AFEF6F1EA4A7F7,"[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced the relaunch of its generic ofloxacin otic solution to treat bacterial ear ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Relaunch Of Generic Ofloxacin Otic Solution,2016-08-08 21:10:16 +0000,http://www.publicnow.com/view/3E2B92B2573830CCB56B85E274AFEF6F1EA4A7F7,"[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced the relaunch of its generic ofloxacin otic solution to treat bacterial ear ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Significant Support For Education And Research Regarding Wilson Disease,2016-08-08 21:10:16 +0000,http://www.publicnow.com/view/F8F1EDC41C15A84BC4A4E7E085E78BDEBB97C894,"[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced its commitment to improving the lives of Wilson disease patients around ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Significant Support For Education And Research Regarding Wilson Disease,2016-08-08 21:10:16 +0000,http://www.publicnow.com/view/F8F1EDC41C15A84BC4A4E7E085E78BDEBB97C894,"[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced its commitment to improving the lives of Wilson disease patients around ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Licensing Agreement With Norgine B.V. For NER1006 In U.S. And Canada,2016-08-08 12:18:05 +0000,http://www.publicnow.com/view/0FB0D110D34FF0B5041B22D25EC8775160289A8A,"[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today announced that it has entered into a licensing agreement ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Licensing Agreement With Norgine B.V. For NER1006 In U.S. And Canada,2016-08-08 12:18:05 +0000,http://www.publicnow.com/view/0FB0D110D34FF0B5041B22D25EC8775160289A8A,"[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today announced that it has entered into a licensing agreement ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Changes To Executive Management Team,2016-08-08 12:18:05 +0000,http://www.publicnow.com/view/8CAEED134A161936DAA5F9DEB6CF51A686E3C611,"[at noodls] - Christina Ackermann Named Executive Vice President and General Counsel Scott Hirsch Joins Valeant as Senior Vice President, Business Strategy and Communications Senior Leaders Take on Expanded Roles; Executive ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Changes To Executive Management Team,2016-08-08 12:18:05 +0000,http://www.publicnow.com/view/8CAEED134A161936DAA5F9DEB6CF51A686E3C611,"[at noodls] - Christina Ackermann Named Executive Vice President and General Counsel Scott Hirsch Joins Valeant as Senior Vice President, Business Strategy and Communications Senior Leaders Take on Expanded Roles; Executive ..."
VRX,VRX:US,BBG000DLFM21,Business events scheduled for the coming week,2016-08-05 17:17:37 +0000,http://sg.finance.yahoo.com/news/business-events-scheduled-coming-week-171737384.html,Business events scheduled for the coming week
VRX,VRX:CT,BBG000DC8S17,Business events scheduled for the coming week,2016-08-05 17:17:37 +0000,http://sg.finance.yahoo.com/news/business-events-scheduled-coming-week-171737384.html,Business events scheduled for the coming week
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors,2016-07-28 21:28:04 +0000,http://www.publicnow.com/view/2A3F975B6C9B30C3306DF81DD1CC80A186F1F511,"[at noodls] - LAVAL, Quebec, July 28, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors,2016-07-28 21:28:04 +0000,http://www.publicnow.com/view/2A3F975B6C9B30C3306DF81DD1CC80A186F1F511,"[at noodls] - LAVAL, Quebec, July 28, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve ..."
VRX,VRX:US,BBG000DLFM21,Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain,2016-07-26 12:58:04 +0000,http://www.publicnow.com/view/E91E5284CE6AEE98805C67071021C00623C3D912,"[at noodls] - July 26, 2016 TARRYTOWN, N.Y., July 26, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced today that it has received a $50 million milestone payment from its worldwide collaboration ..."
VRX,VRX:CT,BBG000DC8S17,Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain,2016-07-26 12:58:04 +0000,http://www.publicnow.com/view/E91E5284CE6AEE98805C67071021C00623C3D912,"[at noodls] - July 26, 2016 TARRYTOWN, N.Y., July 26, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced today that it has received a $50 million milestone payment from its worldwide collaboration ..."
VRX,VRX:US,BBG000DLFM21,U.S. FDA panel backs Valeant psoriasis drug with risk program,2016-07-19 20:22:17 +0000,http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-194117169.html,U.S. FDA panel backs Valeant psoriasis drug with risk program
VRX,VRX:CT,BBG000DC8S17,U.S. FDA panel backs Valeant psoriasis drug with risk program,2016-07-19 20:22:17 +0000,http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-194117169.html,U.S. FDA panel backs Valeant psoriasis drug with risk program
VRX,VRX:US,BBG000DLFM21,U.S. FDA panel backs Valeant psoriasis drug with risk management,2016-07-19 19:25:41 +0000,http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-192541935.html,U.S. FDA panel backs Valeant psoriasis drug with risk management
VRX,VRX:CT,BBG000DC8S17,U.S. FDA panel backs Valeant psoriasis drug with risk management,2016-07-19 19:25:41 +0000,http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-192541935.html,U.S. FDA panel backs Valeant psoriasis drug with risk management
VRX,VRX:CT,BBG000DC8S17,Bad year for Wall Street's Golden Boy Ackman,2016-07-17 03:15:23 +0000,http://uk.finance.yahoo.com/news/bad-wall-streets-golden-boy-031523835.html,Bad year for Wall Street's Golden Boy Ackman
VRX,VRX:US,BBG000DLFM21,Bad year for Wall Street's Golden Boy Ackman,2016-07-17 03:15:23 +0000,http://uk.finance.yahoo.com/news/bad-wall-streets-golden-boy-031523835.html,Bad year for Wall Street's Golden Boy Ackman
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details,2016-07-15 12:28:05 +0000,http://www.publicnow.com/view/B07EB068DD46FE3EBDA1BCE61764CFA9143C9D80,"[at noodls] - LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details,2016-07-15 12:28:05 +0000,http://www.publicnow.com/view/B07EB068DD46FE3EBDA1BCE61764CFA9143C9D80,"[at noodls] - LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 ..."
VRX,VRX:US,BBG000DLFM21,Valeant psoriasis drug safety challenging to assess -FDA Staff,2016-07-15 12:26:01 +0000,http://uk.finance.yahoo.com/news/valeant-psoriasis-drug-safety-challenging-122601422.html,Valeant psoriasis drug safety challenging to assess -FDA Staff
VRX,VRX:CT,BBG000DC8S17,Valeant psoriasis drug safety challenging to assess -FDA Staff,2016-07-15 12:26:01 +0000,http://uk.finance.yahoo.com/news/valeant-psoriasis-drug-safety-challenging-122601422.html,Valeant psoriasis drug safety challenging to assess -FDA Staff
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Comments On Recent Stock Transactions,2016-07-14 13:28:07 +0000,http://www.publicnow.com/view/A1E981997F5F5F90CD074FA524F820C5C5D08096,"[at noodls] - LAVAL, Quebec, July 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today commented on recent stock transactions made by Valeant's ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Comments On Recent Stock Transactions,2016-07-14 13:28:07 +0000,http://www.publicnow.com/view/A1E981997F5F5F90CD074FA524F820C5C5D08096,"[at noodls] - LAVAL, Quebec, July 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today commented on recent stock transactions made by Valeant's ..."
VRX,VRX:US,BBG000DLFM21,Bausch + Lomb and Nicox Announce the Publication of Latanoprostene Bunod Ophthalmic Solution 0.024% Phase 3 Study Results in American Journal of Ophthalmology,2016-07-06 06:01:01 +0000,http://www.publicnow.com/view/8076CF8D8CD78D28C9AD29BD98EA54B3FE163430,"[at noodls] - Second Published Phase 3 Trial to Demonstrate Significantly Greater Efficacy vs. Timolol Maleate 0.5% LAVAL, Quebec and SOPHIA ANTIPOLIS, France, July 6, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, ..."
VRX,VRX:CT,BBG000DC8S17,Bausch + Lomb and Nicox Announce the Publication of Latanoprostene Bunod Ophthalmic Solution 0.024% Phase 3 Study Results in American Journal of Ophthalmology,2016-07-06 06:01:01 +0000,http://www.publicnow.com/view/8076CF8D8CD78D28C9AD29BD98EA54B3FE163430,"[at noodls] - Second Published Phase 3 Trial to Demonstrate Significantly Greater Efficacy vs. Timolol Maleate 0.5% LAVAL, Quebec and SOPHIA ANTIPOLIS, France, July 6, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe,2016-07-01 06:11:05 +0000,http://www.publicnow.com/view/471F9812C98D4B946AA00A9CE144B623AB669279,"[at noodls] - Valeant Receives Upfront Payment & Milestone Payments from AstraZeneca In Exchange for Termination of European Rights to Brodalumab LAVAL, Quebec, July 1, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe,2016-07-01 06:11:05 +0000,http://www.publicnow.com/view/471F9812C98D4B946AA00A9CE144B623AB669279,"[at noodls] - Valeant Receives Upfront Payment & Milestone Payments from AstraZeneca In Exchange for Termination of European Rights to Brodalumab LAVAL, Quebec, July 1, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, ..."
VRX,VRX:CT,BBG000DC8S17,Canadian Shopper Study Names Bausch + Lomb Most Trusted Brand For Contact Lens Care,2016-06-27 12:11:07 +0000,http://www.publicnow.com/view/0E2F1A20E3FF2C614FE9EE9DED93C81383CA61BE,"[at noodls] - 40,000 Canadian Shoppers Voted Across 140 Categories for Most Trusted Retail Brands LAVAL, Quebec, June 27, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today ..."
VRX,VRX:US,BBG000DLFM21,Canadian Shopper Study Names Bausch + Lomb Most Trusted Brand For Contact Lens Care,2016-06-27 12:11:07 +0000,http://www.publicnow.com/view/0E2F1A20E3FF2C614FE9EE9DED93C81383CA61BE,"[at noodls] - 40,000 Canadian Shoppers Voted Across 140 Categories for Most Trusted Retail Brands LAVAL, Quebec, June 27, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations,2016-06-17 12:19:39 +0000,http://www.publicnow.com/view/D56E5C2D779D5E8247B10E6289946D3EBA69546D,"[at noodls] - $15 Million Investment in Steinbach, Manitoba Facility and Transfer of Xifaxan® and Apriso® Production $12.5 Million Investment in Laval, Quebec Facility and Transfer of Arestin® Production Increases Local ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations,2016-06-17 12:19:39 +0000,http://www.publicnow.com/view/D56E5C2D779D5E8247B10E6289946D3EBA69546D,"[at noodls] - $15 Million Investment in Steinbach, Manitoba Facility and Transfer of Xifaxan® and Apriso® Production $12.5 Million Investment in Laval, Quebec Facility and Transfer of Arestin® Production Increases Local ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Announces Launch Of New PreserVision® AREDS 2 Formula + Multivitamin,2016-06-16 12:39:02 +0000,http://www.publicnow.com/view/4673C35743942BAEE0558C0CE40FA16A2B20F11D,"[at noodls] - Inventive Eye Supplement from Bausch + Lomb Offers Consumers Greater Ease and Convenience LAVAL, Quebec, June 16, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Announces Launch Of New PreserVision® AREDS 2 Formula + Multivitamin,2016-06-16 12:39:02 +0000,http://www.publicnow.com/view/4673C35743942BAEE0558C0CE40FA16A2B20F11D,"[at noodls] - Inventive Eye Supplement from Bausch + Lomb Offers Consumers Greater Ease and Convenience LAVAL, Quebec, June 16, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ..."
VRX,VRX:US,BBG000DLFM21,"Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director",2016-06-15 12:09:02 +0000,http://www.publicnow.com/view/0C8F21E819DCBD1FA3882A94621BBEAF9DFF2BE8,"[at noodls] - All Eleven Director Nominees Elected to the Board at Annual Meeting of Shareholders LAVAL, Quebec, June 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director",2016-06-15 12:09:02 +0000,http://www.publicnow.com/view/0C8F21E819DCBD1FA3882A94621BBEAF9DFF2BE8,"[at noodls] - All Eleven Director Nominees Elected to the Board at Annual Meeting of Shareholders LAVAL, Quebec, June 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today ..."
VRX,VRX:US,BBG000DLFM21,LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment,2016-06-10 17:41:42 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-chips-away-us-174142508.html,LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment
VRX,VRX:CT,BBG000DC8S17,LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment,2016-06-10 17:41:42 +0000,http://uk.finance.yahoo.com/news/lpc-valeant-chips-away-us-174142508.html,LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment
VRX,VRX:CT,BBG000DC8S17,Valeant To Participate In FDA Advisory Committee Meeting On July 19,2016-06-09 21:59:10 +0000,http://www.publicnow.com/view/83834F5A080E969D153F6D6A62356465ADD894FB,"[at noodls] - Committee to Review Valeant's BLA 761032 Brodalumab Subcutaneous Injection For Treatment of Adult Patients with Moderate to Severe Plaque Psoriasis LAVAL, Quebec, June 9, 2016 /PRNewswire/ -- Valeant Pharmaceuticals ..."
VRX,VRX:US,BBG000DLFM21,Valeant To Participate In FDA Advisory Committee Meeting On July 19,2016-06-09 21:59:10 +0000,http://www.publicnow.com/view/83834F5A080E969D153F6D6A62356465ADD894FB,"[at noodls] - Committee to Review Valeant's BLA 761032 Brodalumab Subcutaneous Injection For Treatment of Adult Patients with Moderate to Severe Plaque Psoriasis LAVAL, Quebec, June 9, 2016 /PRNewswire/ -- Valeant Pharmaceuticals ..."
VRX,VRX:CT,BBG000DC8S17,"Valeant loses money in 1Q, cuts outlook, shares plunge",2016-06-07 21:30:52 +0000,http://sg.finance.yahoo.com/news/valeant-reports-1q-loss-101601505.html,"Valeant loses money in 1Q, cuts outlook, shares plunge"
VRX,VRX:US,BBG000DLFM21,"Valeant loses money in 1Q, cuts outlook, shares plunge",2016-06-07 21:30:52 +0000,http://sg.finance.yahoo.com/news/valeant-reports-1q-loss-101601505.html,"Valeant loses money in 1Q, cuts outlook, shares plunge"
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals To Webcast 2016 Annual Meeting Of Shareholders,2016-06-07 21:18:06 +0000,http://www.publicnow.com/view/183B9C3E8F2027D5F81AE7461930539B10226145,"[at noodls] - LAVAL, Quebec, June 7, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual meeting of shareholders ..."
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals To Webcast 2016 Annual Meeting Of Shareholders,2016-06-07 21:18:06 +0000,http://www.publicnow.com/view/183B9C3E8F2027D5F81AE7461930539B10226145,"[at noodls] - LAVAL, Quebec, June 7, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual meeting of shareholders ..."
VRX,VRX:US,BBG000DLFM21,Valeant shares plunge after it slashes profit forecast,2016-06-07 14:45:15 +0000,http://sg.finance.yahoo.com/news/valeant-shares-plunge-slashes-profit-144515239.html,Valeant shares plunge after it slashes profit forecast
VRX,VRX:CT,BBG000DC8S17,Valeant shares plunge after it slashes profit forecast,2016-06-07 14:45:15 +0000,http://sg.finance.yahoo.com/news/valeant-shares-plunge-slashes-profit-144515239.html,Valeant shares plunge after it slashes profit forecast
VRX,VRX:US,BBG000DLFM21,Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results,2016-06-07 10:18:04 +0000,http://www.publicnow.com/view/60AE738DEE7A82EBCCC9C967458E319466CF4FF4,"[at noodls] - LAVAL, Quebec, June 7, 2016 /PRNewswire/ -- Total Revenues of $2.4 billion, an increase of 9% versus the first quarter of 2015 (restated) GAAP EPS ($1.08); Adjusted EPS (non-GAAP) $1.27 GAAP Cash Flow ..."
VRX,VRX:CT,BBG000DC8S17,Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results,2016-06-07 10:18:04 +0000,http://www.publicnow.com/view/60AE738DEE7A82EBCCC9C967458E319466CF4FF4,"[at noodls] - LAVAL, Quebec, June 7, 2016 /PRNewswire/ -- Total Revenues of $2.4 billion, an increase of 9% versus the first quarter of 2015 (restated) GAAP EPS ($1.08); Adjusted EPS (non-GAAP) $1.27 GAAP Cash Flow ..."
VRX,VRX:CT,BBG000DC8S17,Business Highlights,2016-06-03 22:00:30 +0000,http://sg.finance.yahoo.com/news/business-highlights-220030661.html,Business Highlights
VRX,VRX:US,BBG000DLFM21,Business Highlights,2016-06-03 22:00:30 +0000,http://sg.finance.yahoo.com/news/business-highlights-220030661.html,Business Highlights
VRX,VRX:CT,BBG000DC8S17,Valeant defaults on some of its debt,2016-06-03 13:33:45 +0000,http://sg.finance.yahoo.com/news/valeant-defaults-debt-133345418.html,Valeant defaults on some of its debt
VRX,VRX:US,BBG000DLFM21,Valeant defaults on some of its debt,2016-06-03 13:33:45 +0000,http://sg.finance.yahoo.com/news/valeant-defaults-debt-133345418.html,Valeant defaults on some of its debt
VRX,VRX:CT,BBG000DC8S17,"Valeant rejected joint takeover bid from Takeda, TPG in spring - source",2016-05-27 03:31:48 +0000,http://sg.finance.yahoo.com/news/valeant-rejected-joint-takeover-bid-033148516.html,"Valeant rejected joint takeover bid from Takeda, TPG in spring - source"
VRX,VRX:US,BBG000DLFM21,"Valeant rejected joint takeover bid from Takeda, TPG in spring - source",2016-05-27 03:31:48 +0000,http://sg.finance.yahoo.com/news/valeant-rejected-joint-takeover-bid-033148516.html,"Valeant rejected joint takeover bid from Takeda, TPG in spring - source"
VRX,VRX:US,BBG000DLFM21,Valeant appoints Tyco's Sam Eldessouky corporate controller,2016-05-26 15:52:33 +0000,http://sg.finance.yahoo.com/news/valeant-appoints-tycos-sam-eldessouky-112139669.html,Valeant appoints Tyco's Sam Eldessouky corporate controller
VRX,VRX:CT,BBG000DC8S17,Valeant appoints Tyco's Sam Eldessouky corporate controller,2016-05-26 15:52:33 +0000,http://sg.finance.yahoo.com/news/valeant-appoints-tycos-sam-eldessouky-112139669.html,Valeant appoints Tyco's Sam Eldessouky corporate controller
VRX,VRX:CT,BBG000DC8S17,Valeant CEO Papa plans to lower debt by more than $1.5 billion in 2016,2016-05-23 14:33:36 +0000,http://sg.finance.yahoo.com/news/valeants-ceo-papa-says-lot-125951258.html,Valeant CEO Papa plans to lower debt by more than $1.5 billion in 2016
VRX,VRX:US,BBG000DLFM21,Valeant CEO Papa plans to lower debt by more than $1.5 billion in 2016,2016-05-23 14:33:36 +0000,http://sg.finance.yahoo.com/news/valeants-ceo-papa-says-lot-125951258.html,Valeant CEO Papa plans to lower debt by more than $1.5 billion in 2016
VRX,VRX:US,BBG000DLFM21,Valeant Pharma promises to do better with deadlines,2016-05-09 14:18:21 +0000,http://sg.finance.yahoo.com/news/valeant-pharma-promises-better-deadlines-135938012.html,Valeant Pharma promises to do better with deadlines
VRX,VRX:CT,BBG000DC8S17,Valeant Pharma promises to do better with deadlines,2016-05-09 14:18:21 +0000,http://sg.finance.yahoo.com/news/valeant-pharma-promises-better-deadlines-135938012.html,Valeant Pharma promises to do better with deadlines
VRX,VRX:CT,BBG000DC8S17,Warren Buffett says more likely to buy IBM shares than sell - CNBC,2016-05-02 19:27:59 +0000,http://in.finance.yahoo.com/news/warren-buffett-says-more-likely-145701817.html,Warren Buffett says more likely to buy IBM shares than sell - CNBC
VRX,VRX:US,BBG000DLFM21,Warren Buffett says more likely to buy IBM shares than sell - CNBC,2016-05-02 19:27:59 +0000,http://in.finance.yahoo.com/news/warren-buffett-says-more-likely-145701817.html,Warren Buffett says more likely to buy IBM shares than sell - CNBC
VRX,VRX:CT,BBG000DC8S17,Buffett says drugmaker Valeant had flawed business model,2016-05-02 12:12:10 +0000,http://sg.finance.yahoo.com/news/buffett-says-drugmaker-valeant-had-121210569.html,Buffett says drugmaker Valeant had flawed business model
VRX,VRX:US,BBG000DLFM21,Buffett says drugmaker Valeant had flawed business model,2016-05-02 12:12:10 +0000,http://sg.finance.yahoo.com/news/buffett-says-drugmaker-valeant-had-121210569.html,Buffett says drugmaker Valeant had flawed business model
VRX,VRX:CT,BBG000DC8S17,"Valeant files overdue financial report, ending debt default",2016-04-29 20:36:19 +0000,http://sg.finance.yahoo.com/news/valeant-files-overdue-financial-report-131820625.html,"Valeant files overdue financial report, ending debt default"
VRX,VRX:US,BBG000DLFM21,"Valeant files overdue financial report, ending debt default",2016-04-29 20:36:19 +0000,http://sg.finance.yahoo.com/news/valeant-files-overdue-financial-report-131820625.html,"Valeant files overdue financial report, ending debt default"
VRX,VRX:CT,BBG000DC8S17,"Valeant files overdue financials, averts debt default",2016-04-29 18:33:35 +0000,http://uk.finance.yahoo.com/news/valeant-files-overdue-financials-averts-183335090.html,"Valeant files overdue financials, averts debt default"
VRX,VRX:US,BBG000DLFM21,"Valeant files overdue financials, averts debt default",2016-04-29 18:33:35 +0000,http://uk.finance.yahoo.com/news/valeant-files-overdue-financials-averts-183335090.html,"Valeant files overdue financials, averts debt default"
VRX,VRX:CT,BBG000DC8S17,Lawmakers blast Valeant for price-gouging tactics,2016-04-27 23:42:32 +0000,http://sg.finance.yahoo.com/news/valeant-ceo-cite-mistakes-price-040540682.html,Lawmakers blast Valeant for price-gouging tactics
VRX,VRX:US,BBG000DLFM21,Lawmakers blast Valeant for price-gouging tactics,2016-04-27 23:42:32 +0000,http://sg.finance.yahoo.com/news/valeant-ceo-cite-mistakes-price-040540682.html,Lawmakers blast Valeant for price-gouging tactics
VRX,VRX:US,BBG000DLFM21,US open: Stocks decline as investors digest data,2016-04-15 16:13:00 +0000,http://uk.finance.yahoo.com/news/us-open-stocks-decline-investors-161300297.html,US open: Stocks decline as investors digest data
VRX,VRX:CT,BBG000DC8S17,US open: Stocks decline as investors digest data,2016-04-15 16:13:00 +0000,http://uk.finance.yahoo.com/news/us-open-stocks-decline-investors-161300297.html,US open: Stocks decline as investors digest data
VRX,VRX:CT,BBG000DC8S17,Exclusive: Valeant calls in investment banks to weigh options - sources,2016-04-14 22:13:09 +0000,http://sg.finance.yahoo.com/news/exclusive-valeant-calls-investment-banks-221309491.html,Exclusive: Valeant calls in investment banks to weigh options - sources
VRX,VRX:US,BBG000DLFM21,Exclusive: Valeant calls in investment banks to weigh options - sources,2016-04-14 22:13:09 +0000,http://sg.finance.yahoo.com/news/exclusive-valeant-calls-investment-banks-221309491.html,Exclusive: Valeant calls in investment banks to weigh options - sources
VRX,VRX:US,BBG000DLFM21,"Valeant directors, CEO ordered to cease trading shares",2016-03-31 16:32:28 +0000,http://sg.finance.yahoo.com/news/valeant-directors-ceo-ordered-cease-163204122.html,"Valeant directors, CEO ordered to cease trading shares"
VRX,VRX:CT,BBG000DC8S17,"Valeant directors, CEO ordered to cease trading shares",2016-03-31 16:32:28 +0000,http://sg.finance.yahoo.com/news/valeant-directors-ceo-ordered-cease-163204122.html,"Valeant directors, CEO ordered to cease trading shares"
VRX,VRX:CT,BBG000DC8S17,"US stocks near flat ahead of Yellen speech, jobs data",2016-03-28 20:28:45 +0000,http://uk.finance.yahoo.com/news/us-stocks-near-flat-ahead-200932805.html,"US stocks near flat ahead of Yellen speech, jobs data"
VRX,VRX:US,BBG000DLFM21,"US stocks near flat ahead of Yellen speech, jobs data",2016-03-28 20:28:45 +0000,http://uk.finance.yahoo.com/news/us-stocks-near-flat-ahead-200932805.html,"US stocks near flat ahead of Yellen speech, jobs data"
VRX,VRX:US,BBG000DLFM21,US STOCKS-Wall St ends flat as recent rally spurs caution,2016-03-21 20:54:06 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-ends-205406240.html,US STOCKS-Wall St ends flat as recent rally spurs caution
VRX,VRX:CT,BBG000DC8S17,US STOCKS-Wall St ends flat as recent rally spurs caution,2016-03-21 20:54:06 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-ends-205406240.html,US STOCKS-Wall St ends flat as recent rally spurs caution
VRX,VRX:US,BBG000DLFM21,"Valeant CEO Pearson to exit, Ackman to join board",2016-03-21 20:42:53 +0000,http://uk.finance.yahoo.com/news/valeant-ceo-pearson-exit-ackman-204253671.html,"Valeant CEO Pearson to exit, Ackman to join board"
VRX,VRX:CT,BBG000DC8S17,"Valeant CEO Pearson to exit, Ackman to join board",2016-03-21 20:42:53 +0000,http://uk.finance.yahoo.com/news/valeant-ceo-pearson-exit-ackman-204253671.html,"Valeant CEO Pearson to exit, Ackman to join board"
VRX,VRX:US,BBG000DLFM21,US STOCKS-Wall St flat as Fed still dominates investor sentiment,2016-03-21 19:06:07 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-flat-190607844.html,US STOCKS-Wall St flat as Fed still dominates investor sentiment
VRX,VRX:CT,BBG000DC8S17,US STOCKS-Wall St flat as Fed still dominates investor sentiment,2016-03-21 19:06:07 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-flat-190607844.html,US STOCKS-Wall St flat as Fed still dominates investor sentiment
VRX,VRX:CT,BBG000DC8S17,S&P says it may cut Ackman hedge fund's rating,2016-03-17 21:12:14 +0000,http://in.finance.yahoo.com/news/p-says-may-cut-ackman-211214242.html,S&P says it may cut Ackman hedge fund's rating
VRX,VRX:US,BBG000DLFM21,S&P says it may cut Ackman hedge fund's rating,2016-03-17 21:12:14 +0000,http://in.finance.yahoo.com/news/p-says-may-cut-ackman-211214242.html,S&P says it may cut Ackman hedge fund's rating
VRX,VRX:CT,BBG000DC8S17,US STOCKS-Wall St dips as healthcare lags before Fed statement,2016-03-15 20:30:38 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-dips-203038623.html,US STOCKS-Wall St dips as healthcare lags before Fed statement
VRX,VRX:US,BBG000DLFM21,US STOCKS-Wall St dips as healthcare lags before Fed statement,2016-03-15 20:30:38 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-dips-203038623.html,US STOCKS-Wall St dips as healthcare lags before Fed statement
VRX,VRX:US,BBG000DLFM21,"Valeant shares plunge 49% on default warning, outlook",2016-03-15 19:18:35 +0000,http://uk.finance.yahoo.com/news/valeant-shares-plunge-49-default-191835944.html,"Valeant shares plunge 49% on default warning, outlook"
VRX,VRX:CT,BBG000DC8S17,"Valeant shares plunge 49% on default warning, outlook",2016-03-15 19:18:35 +0000,http://uk.finance.yahoo.com/news/valeant-shares-plunge-49-default-191835944.html,"Valeant shares plunge 49% on default warning, outlook"
VRX,VRX:US,BBG000DLFM21,"US STOCKS-Health, materials shares drag on Wall St in lull before Fed news",2016-03-15 19:14:10 +0000,http://uk.finance.yahoo.com/news/us-stocks-health-materials-shares-191410321.html,"US STOCKS-Health, materials shares drag on Wall St in lull before Fed news"
VRX,VRX:CT,BBG000DC8S17,"US STOCKS-Health, materials shares drag on Wall St in lull before Fed news",2016-03-15 19:14:10 +0000,http://uk.finance.yahoo.com/news/us-stocks-health-materials-shares-191410321.html,"US STOCKS-Health, materials shares drag on Wall St in lull before Fed news"
VRX,VRX:US,BBG000DLFM21,Valeant shares plunge 45% on revised forecasts,2016-03-15 16:55:32 +0000,http://uk.finance.yahoo.com/news/valeant-shares-plunge-45-revised-165532986.html,Valeant shares plunge 45% on revised forecasts
VRX,VRX:CT,BBG000DC8S17,Valeant shares plunge 45% on revised forecasts,2016-03-15 16:55:32 +0000,http://uk.finance.yahoo.com/news/valeant-shares-plunge-45-revised-165532986.html,Valeant shares plunge 45% on revised forecasts
VRX,VRX:CT,BBG000DC8S17,"US STOCKS-S&P 500 ticks above 2,000 as energy offsets tech slide",2016-03-07 21:52:47 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-ticks-215247260.html,"US STOCKS-S&P 500 ticks above 2,000 as energy offsets tech slide"
VRX,VRX:US,BBG000DLFM21,"US STOCKS-S&P 500 ticks above 2,000 as energy offsets tech slide",2016-03-07 21:52:47 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-ticks-215247260.html,"US STOCKS-S&P 500 ticks above 2,000 as energy offsets tech slide"
VRX,VRX:CT,BBG000DC8S17,US STOCKS-S&P 500 flat as energy spike offsets tech slide,2016-03-07 20:38:47 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-flat-203847217.html,US STOCKS-S&P 500 flat as energy spike offsets tech slide
VRX,VRX:US,BBG000DLFM21,US STOCKS-S&P 500 flat as energy spike offsets tech slide,2016-03-07 20:38:47 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-flat-203847217.html,US STOCKS-S&P 500 flat as energy spike offsets tech slide
VRX,VRX:CT,BBG000DC8S17,Valeant shares slide on news of probe by U.S. SEC,2016-03-01 00:54:38 +0000,http://in.finance.yahoo.com/news/valeant-shares-slide-news-probe-005438647.html,Valeant shares slide on news of probe by U.S. SEC
VRX,VRX:US,BBG000DLFM21,Valeant shares slide on news of probe by U.S. SEC,2016-03-01 00:54:38 +0000,http://in.finance.yahoo.com/news/valeant-shares-slide-news-probe-005438647.html,Valeant shares slide on news of probe by U.S. SEC
VRX,VRX:CT,BBG000DC8S17,US STOCKS-S&P 500 falls below closely watched threshold,2016-02-29 20:31:44 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-falls-203144340.html,US STOCKS-S&P 500 falls below closely watched threshold
VRX,VRX:US,BBG000DLFM21,US STOCKS-S&P 500 falls below closely watched threshold,2016-02-29 20:31:44 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-falls-203144340.html,US STOCKS-S&P 500 falls below closely watched threshold
VRX,VRX:US,BBG000DLFM21,Exclusive: Valeant considers selling contact lens maker Paragon - sources,2015-12-08 01:01:27 +0000,http://in.finance.yahoo.com/news/exclusive-valeant-considers-selling-contact-010127434.html,Exclusive: Valeant considers selling contact lens maker Paragon - sources
VRX,VRX:CT,BBG000DC8S17,Exclusive: Valeant considers selling contact lens maker Paragon - sources,2015-12-08 01:01:27 +0000,http://in.finance.yahoo.com/news/exclusive-valeant-considers-selling-contact-010127434.html,Exclusive: Valeant considers selling contact lens maker Paragon - sources
VRX,VRX:US,BBG000DLFM21,Ackman boosts stake in drugmaker Valeant,2015-11-23 23:45:00 +0000,http://in.finance.yahoo.com/news/ackman-raises-stake-valeant-pharma-224507717.html,Ackman boosts stake in drugmaker Valeant
VRX,VRX:CT,BBG000DC8S17,Ackman boosts stake in drugmaker Valeant,2015-11-23 23:45:00 +0000,http://in.finance.yahoo.com/news/ackman-raises-stake-valeant-pharma-224507717.html,Ackman boosts stake in drugmaker Valeant
VRX,VRX:US,BBG000DLFM21,Exclusive - ValueAct gains for the year wiped out by Valeant loss,2015-11-23 23:39:19 +0000,http://in.finance.yahoo.com/news/exclusive-valueact-gains-wiped-valeant-224833764.html,Exclusive - ValueAct gains for the year wiped out by Valeant loss
VRX,VRX:CT,BBG000DC8S17,Exclusive - ValueAct gains for the year wiped out by Valeant loss,2015-11-23 23:39:19 +0000,http://in.finance.yahoo.com/news/exclusive-valueact-gains-wiped-valeant-224833764.html,Exclusive - ValueAct gains for the year wiped out by Valeant loss
